Citrus Sinensis ID: 014762

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------42
Protein Sequence
MKDAPRKHKHKHKHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV
Secondary Structure (PSIPRED)
cccccccccccccccHHHHHHHccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccccccccccccccccccccccccccEEEccccccccEEEEEEccccccEEEEEEcccccEEEEEEccccccHHHHHHHHHHHHccccccEEEEccEEEcccccccEEEEEccccccHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEccccccEEEEEcccccccccccccEEEEEccccccHHHHccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccHHHHHHHccccccHHHHHHHcccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccHHHHHHHcccccccccccccccccccccHHHHccHHHHcHHHcccccccHHHEEEEEEEEEcccEEEEEEEEcccccEEEEEEEccccHHHHHHHHHHHHHccccccEccEEEEEEccccccEEEEEEccccccHHHHcccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEEccccEEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHccHHHHHHHHHccccccHHHHHcccccccccHHHHcccccHHHccHHHHHHHHHHccccHHHcccHHHHHccccHHHHHccc
Coil and Loop (DISEMBL)
mkdaprkhkhkhkhpAVLAAQVQVLPLRFLLACAVLALRapiahhpilrtpcrsstynlNIITDTIAATTVVYEGAIIDKIeernlaeiplpamskarvytdvnvlrpkeywdyesltvqwgdqddyEVVRKVGRGKYSEVFEGinvntnerCIIKILKPVKKKKIKREIKILQNlcggpnvvKLLDIVRdqhsktpsLIFEYVNstdfkvlyptltdyDIRYYIYELLKALDYchsqgimhrdvkphnvmiDHELRKLRLIDwglaefyhpgkeyNVRVASryfkgpellvDLQDYDYSLDMWSLGCMFAgmifrkepffyghdnHDQLVKIAKVLGTDELNAYLNKYHLeldpqldalvgrhsrkpwskfinadnqhlvspeAIDFLDKLLRYDHQDRLTAREAMVISSispifslv
Flexible Loop (DISEMBL)
mkdaprkhkhkhkhpavlAAQVQVLPLRFLLACAVLALRAPIahhpilrtpcrssTYNLNIITDTIAATTVVYEGAIIDKIEernlaeiplpamskarvyTDVNVLRPKEYWdyesltvqwgdqddYEVVRKVGRGKYSevfeginvntnerciikilkpvkkkkiKREIKIlqnlcggpnvVKLLDIVRDQHSKTPSLifeyvnstdfkvLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKfinadnqhlvsPEAIDFLDKLLRYDHQDRLTAReamvissispifslv
Low Complexity Region (SEG)
MKDAPRkhkhkhkhPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNiitdtiaattVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCiikilkpvkkkkikreikiLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV
Disordered region (IsUnstruct)
***************AVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS******
Disordered Region (DISOPRED)
*****************LAAQVQVLPLRFLLACAVLA*************************************************************VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV
Disordered Region (DISEMBL)
***************AVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV
Disordered Region (DISPRO)
************KHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIID******************RVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS**
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKDAPRKHKHKHKHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	419	2.2.26 [Sep-21-2011]
Q08467	409	Casein kinase II subunit	yes	no	0.847	0.867	0.844	1e-173
Q08466	403	Casein kinase II subunit	no	no	0.856	0.890	0.836	1e-170
P28523	332	Casein kinase II subunit	N/A	no	0.751	0.948	0.946	1e-167
O64817	333	Probable casein kinase II	no	no	0.749	0.942	0.929	1e-164
O64816	432	Casein kinase II subunit	no	no	0.770	0.747	0.857	1e-157
Q60737	391	Casein kinase II subunit	yes	no	0.754	0.808	0.768	1e-138
P21868	391	Casein kinase II subunit	yes	no	0.773	0.828	0.756	1e-138
P19139	391	Casein kinase II subunit	yes	no	0.754	0.808	0.768	1e-138
P68400	391	Casein kinase II subunit	yes	no	0.754	0.808	0.768	1e-138
P68399	391	Casein kinase II subunit	yes	no	0.754	0.808	0.768	1e-138

>sp|Q08467|CSK21_ARATH Casein kinase II subunit alpha-1 OS=Arabidopsis thaliana GN=CKA1 PE=1 SV=3

 Score =  608 bits (1567), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 315/373 (84%), Positives = 333/373 (89%), Gaps = 18/373 (4%)

Query: 41  PIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIID-----KIEERNLAEIPLPAMS 95
           P AH PILR+         +I+T T  A + V     ID     +I + N       AMS
Sbjct: 32  PTAHSPILRS---------SIVTPTARAVSEVSGCTTIDPDFLVEISDSNQTR----AMS 78

Query: 96  KARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCII 155
           KARVYT+VNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGINVN+ E+CII
Sbjct: 79  KARVYTEVNVIRPKDYWDYESLIVQWGEQDDYEVVRKVGRGKYSEVFEGINVNSKEKCII 138

Query: 156 KILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT 215
           KILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLYPT
Sbjct: 139 KILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPT 198

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           LTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE
Sbjct: 199 LTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 258

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIAK
Sbjct: 259 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAK 318

Query: 336 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 395
           VLGTDELNAYLNKY LELDPQL+ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY
Sbjct: 319 VLGTDELNAYLNKYQLELDPQLEALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 378

Query: 396 DHQDRLTAREAMV 408
           DHQDRLTA+EAM 
Sbjct: 379 DHQDRLTAKEAMA 391

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q08466|CSK22_ARATH Casein kinase II subunit alpha-2 OS=Arabidopsis thaliana GN=CKA2 PE=2 SV=3

 Score =  597 bits (1538), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 311/372 (83%), Positives = 333/372 (89%), Gaps = 13/372 (3%)

Query: 39  RAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDK-IEERNLAEIPLPA-MSK 96
           RAP+AH  I    C        + T T+ +      G   D+ ++  +LA+I L   MSK
Sbjct: 25  RAPLAHSLIPPLTC--------VNTGTVESDVT---GIRFDRCLDTDSLAKISLSTVMSK 73

Query: 97  ARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK 156
           ARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGIN+N NE+CIIK
Sbjct: 74  ARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKCIIK 133

Query: 157 ILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL 216
           ILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLYPTL
Sbjct: 134 ILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPTL 193

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           TDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY
Sbjct: 194 TDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 253

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
           NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKIAKV
Sbjct: 254 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAKV 313

Query: 337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 396
           LGTDELNAYLNKY LELD QL+ALVGRHSRKPWSKFINADN+HLVSPEAID+LDKLLRYD
Sbjct: 314 LGTDELNAYLNKYQLELDTQLEALVGRHSRKPWSKFINADNRHLVSPEAIDYLDKLLRYD 373

Query: 397 HQDRLTAREAMV 408
           HQDRLTA+EAM 
Sbjct: 374 HQDRLTAKEAMA 385

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28523|CSK2A_MAIZE Casein kinase II subunit alpha OS=Zea mays GN=ACK2 PE=1 SV=1

 Score =  586 bits (1511), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 298/315 (94%), Positives = 307/315 (97%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 1   MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           IIKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300

Query: 394 RYDHQDRLTAREAMV 408
           RYDHQ+RLTA EAM 
Sbjct: 301 RYDHQERLTALEAMT 315

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site.

Zea mays (taxid: 4577)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64817|CSK23_ARATH Probable casein kinase II subunit alpha OS=Arabidopsis thaliana GN=At2g23080 PE=1 SV=1

 Score =  577 bits (1488), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 292/314 (92%), Positives = 305/314 (97%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNV+RPKEYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG NVNTNERC
Sbjct: 1   MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           +IKILKPVKKKKIKREIKILQNLCGGPN+VKL DIVRD+HSKTPSL+FE+VNS DFKVLY
Sbjct: 61  VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+LRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGT+EL+ YLNKY L+LDPQL+ALVGRH  KPWSKFINADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFLDKLL 300

Query: 394 RYDHQDRLTAREAM 407
           +YDHQDRLTAREAM
Sbjct: 301 QYDHQDRLTAREAM 314

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64816|CSK2P_ARATH Casein kinase II subunit alpha, chloroplastic OS=Arabidopsis thaliana GN=At2g23070 PE=2 SV=1

 Score =  555 bits (1431), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 277/323 (85%), Positives = 301/323 (93%)

Query: 93  AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER 152
           A SKARVY DVNV+RPK+YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEGI+   NE+
Sbjct: 98  APSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEK 157

Query: 153 CIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
           C+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQ SKTPSLIFE+VN+ DFKVL
Sbjct: 158 CVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVL 217

Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
           YPTL+DYD+RYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct: 218 YPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 277

Query: 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
           GKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVK
Sbjct: 278 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 337

Query: 333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 392
           IAKVLGTDELNAYLNKY +ELDP L +LVGRHSRKPW+KFIN++NQHL  PEA+DF+DKL
Sbjct: 338 IAKVLGTDELNAYLNKYRIELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKL 397

Query: 393 LRYDHQDRLTAREAMVISSISPI 415
           LRYDHQ+R TA+EAM      PI
Sbjct: 398 LRYDHQERPTAKEAMAHPYFYPI 420

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q60737|CSK21_MOUSE Casein kinase II subunit alpha OS=Mus musculus GN=Csnk2a1 PE=1 SV=2

 Score =  491 bits (1263), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 243/316 (76%), Positives = 286/316 (90%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P21868|CSK21_CHICK Casein kinase II subunit alpha OS=Gallus gallus GN=CSNK2A1 PE=2 SV=1

 Score =  491 bits (1263), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 245/324 (75%), Positives = 288/324 (88%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 392 LLRYDHQDRLTAREAMVISSISPI 415
           LLRYDHQ RLTAREAM      PI
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYPI 327

Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P19139|CSK21_RAT Casein kinase II subunit alpha OS=Rattus norvegicus GN=Csnk2a1 PE=1 SV=2

 Score =  491 bits (1263), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 243/316 (76%), Positives = 286/316 (90%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P68400|CSK21_HUMAN Casein kinase II subunit alpha OS=Homo sapiens GN=CSNK2A1 PE=1 SV=1

 Score =  490 bits (1262), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 243/316 (76%), Positives = 286/316 (90%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P68399|CSK21_BOVIN Casein kinase II subunit alpha OS=Bos taurus GN=CSNK2A1 PE=1 SV=1

 Score =  490 bits (1262), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 243/316 (76%), Positives = 286/316 (90%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	419
356511951	411	PREDICTED: casein kinase II subunit alph	0.906	0.924	0.858	0.0
147815306	333	hypothetical protein VITISV_028706 [Viti	0.751	0.945	0.980	0.0
363814459	398	uncharacterized protein LOC100820471 pre	0.914	0.962	0.830	0.0
357476359	388	Casein kinase 2 alpha subunit [Medicago	0.885	0.956	0.836	1e-180
391605	333	casein kinase II catalytic subunit [Arab	0.768	0.966	0.911	1e-177
297816254	405	hypothetical protein ARALYDRAFT_485358 [	0.883	0.913	0.831	1e-175
449448246	397	PREDICTED: casein kinase II subunit alph	0.909	0.959	0.839	1e-175
388510076	333	unknown [Medicago truncatula]	0.768	0.966	0.950	1e-174
224074233	333	predicted protein [Populus trichocarpa]	0.768	0.966	0.963	1e-173
356541665	333	PREDICTED: casein kinase II subunit alph	0.768	0.966	0.963	1e-173

>gi|356511951|ref|XP_003524685.1| PREDICTED: casein kinase II subunit alpha-2-like [Glycine max]

 Score =  647 bits (1668), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/396 (85%), Positives = 354/396 (89%), Gaps = 16/396 (4%)

Query: 24  VLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEE 83
            L LRFLL C ++ALRAP+A  PI+R P        N +T+T    TV+    I+ +   
Sbjct: 21  ALLLRFLLVCTLVALRAPVAQPPIVRIPP-------NHLTET--TNTVI---TIVHQRHR 68

Query: 84  RNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFE 143
             ++    PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFE
Sbjct: 69  TQISGSTRPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFE 128

Query: 144 GINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203
           GINVN+NERCIIKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEY
Sbjct: 129 GINVNSNERCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEY 188

Query: 204 VNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 263
           VNSTDFKVLYPTLTDYDIRYYIYELLKA+DYCHSQGIMHRDVKPHNVMIDHELRKLRLID
Sbjct: 189 VNSTDFKVLYPTLTDYDIRYYIYELLKAIDYCHSQGIMHRDVKPHNVMIDHELRKLRLID 248

Query: 264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
           WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG
Sbjct: 249 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 308

Query: 324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSP 383
           HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSP
Sbjct: 309 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSP 368

Query: 384 EAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV 419
           EAIDFLDKLLRYDHQDRLTAREAM      P FS V
Sbjct: 369 EAIDFLDKLLRYDHQDRLTAREAMA----HPYFSQV 400

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147815306|emb|CAN72246.1| hypothetical protein VITISV_028706 [Vitis vinifera] gi|296087344|emb|CBI33718.3| unnamed protein product [Vitis vinifera]

 Score =  645 bits (1665), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 309/315 (98%), Positives = 312/315 (99%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPK+YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERC
Sbjct: 1   MSKARVYADVNVLRPKDYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTDELNAYLNKY LELDPQLDALVGRHSRKPWSKFI+ADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDELNAYLNKYRLELDPQLDALVGRHSRKPWSKFIHADNQHLVSPEAIDFLDKLL 300

Query: 394 RYDHQDRLTAREAMV 408
           RYDHQDRLTAREAM 
Sbjct: 301 RYDHQDRLTAREAMA 315

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363814459|ref|NP_001242864.1| uncharacterized protein LOC100820471 precursor [Glycine max] gi|255638871|gb|ACU19738.1| unknown [Glycine max]

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/408 (83%), Positives = 353/408 (86%), Gaps = 25/408 (6%)

Query: 12  HKHPAVLAAQVQVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTV 71
           H+ PA L        LRFLL C ++ALRAP+A  PILR P        N + +T    T+
Sbjct: 5   HEAPAALL-------LRFLLVCTIVALRAPVAQPPILRIP--------NHLIETTNTFTI 49

Query: 72  VYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR 131
           V++           ++     AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR
Sbjct: 50  VHQRY------RTQISGSNRRAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR 103

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD 191
           KVGRGKYSEVFEGINVN+NERC+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRD
Sbjct: 104 KVGRGKYSEVFEGINVNSNERCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD 163

Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ IMHRDVKPHNVM
Sbjct: 164 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQSIMHRDVKPHNVM 223

Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY KGPELLVDLQDYDYSLDMWSLGCMFA
Sbjct: 224 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYIKGPELLVDLQDYDYSLDMWSLGCMFA 283

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 371
           GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK
Sbjct: 284 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 343

Query: 372 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV 419
           FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM      P FS V
Sbjct: 344 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMA----HPYFSQV 387

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357476359|ref|XP_003608465.1| Casein kinase 2 alpha subunit [Medicago truncatula] gi|355509520|gb|AES90662.1| Casein kinase 2 alpha subunit [Medicago truncatula]

 Score =  638 bits (1646), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 332/397 (83%), Positives = 348/397 (87%), Gaps = 26/397 (6%)

Query: 23  QVLPLRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIE 82
           Q   LR LL C +++LRAP+A  P +R P +S+  N          TT+     I+ +I 
Sbjct: 7   QAPQLRLLLVCTLISLRAPVAQPPNVRIPTQSNESN--------TTTTI-----IVSQIS 53

Query: 83  ERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF 142
                      MSKARVYTDVNV+RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF
Sbjct: 54  S---------TMSKARVYTDVNVIRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF 104

Query: 143 EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202
           EGINVN++ERC+IKILKPVKKKKIKREIKILQNLCGGPN+VKLLDIVRDQHSKTPSLIFE
Sbjct: 105 EGINVNSSERCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFE 164

Query: 203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262
           YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI
Sbjct: 165 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 224

Query: 263 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
           DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY
Sbjct: 225 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 284

Query: 323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 382
           GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS
Sbjct: 285 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 344

Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV 419
           PEAID+LDKLLRYDHQDRLTAREAM      P FS V
Sbjct: 345 PEAIDYLDKLLRYDHQDRLTAREAMA----HPYFSQV 377

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|391605|dbj|BAA01091.1| casein kinase II catalytic subunit [Arabidopsis thaliana]

 Score =  625 bits (1613), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 297/326 (91%), Positives = 312/326 (95%), Gaps = 4/326 (1%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVFEGIN+N NE+C
Sbjct: 1   MSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVFEGINMNNNEKC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           IIKILKPVKKK+I+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  IIKILKPVKKKEIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH LRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHGLRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN DQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNQDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTDELNAYLNKY LELD QL+ALVGRHSRKPWSKFINADN+HLVSPEAID+LDKLL
Sbjct: 241 AKVLGTDELNAYLNKYQLELDTQLEALVGRHSRKPWSKFINADNRHLVSPEAIDYLDKLL 300

Query: 394 RYDHQDRLTAREAMVISSISPIFSLV 419
           RYDHQDRLTA+EAM      P F+ V
Sbjct: 301 RYDHQDRLTAKEAMA----HPYFAQV 322

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297816254|ref|XP_002876010.1| hypothetical protein ARALYDRAFT_485358 [Arabidopsis lyrata subsp. lyrata] gi|297321848|gb|EFH52269.1| hypothetical protein ARALYDRAFT_485358 [Arabidopsis lyrata subsp. lyrata]

 Score =  620 bits (1599), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 321/386 (83%), Positives = 344/386 (89%), Gaps = 16/386 (4%)

Query: 28  RFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDK-IEERNL 86
           RFLL CA+L LRAP AH PI    C        + T T+ +      G   ++ ++  +L
Sbjct: 13  RFLLLCAILILRAPTAHSPIPPLTC--------VATGTVESDV---SGISFNRCLDSDSL 61

Query: 87  AEIPLP----AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVF 142
           AEI L     AMSKARVYTDVNV+RPK+YWDYESL VQWG+QDDYEVVRKVGRGKYSEVF
Sbjct: 62  AEISLSSVTGAMSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGKYSEVF 121

Query: 143 EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE 202
           EGIN+N+NE+CIIKILKPVKKKKI+REIKILQNLCGGPN+VKLLD+VRDQHSKTPSLIFE
Sbjct: 122 EGINMNSNEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTPSLIFE 181

Query: 203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262
           YVNSTDFKVLYPTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHELRKLRLI
Sbjct: 182 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELRKLRLI 241

Query: 263 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
           DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY
Sbjct: 242 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 301

Query: 323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 382
           GHDN DQLVKIAKVLGTDELNAYLNKY LELD QL+ALVGRHSRKPWSKFINADN+HLVS
Sbjct: 302 GHDNQDQLVKIAKVLGTDELNAYLNKYQLELDAQLEALVGRHSRKPWSKFINADNRHLVS 361

Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMV 408
           PEAID+LDKLLRYDHQDRLTA+EAM 
Sbjct: 362 PEAIDYLDKLLRYDHQDRLTAKEAMA 387

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449448246|ref|XP_004141877.1| PREDICTED: casein kinase II subunit alpha-1-like [Cucumis sativus] gi|449510998|ref|XP_004163833.1| PREDICTED: casein kinase II subunit alpha-1-like [Cucumis sativus]

 Score =  620 bits (1598), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 330/393 (83%), Positives = 340/393 (86%), Gaps = 12/393 (3%)

Query: 27  LRFLLACAVLALRAPIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNL 86
           LR LL   V  L  P++H P LR+P    + + +  +  + A          DKI    L
Sbjct: 6   LRLLLVFTVFFL-LPVSHPPTLRSPPLPPSSDASFFSSAVGAVHG-------DKITPIGL 57

Query: 87  AEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGIN 146
                P MSKARVY DVNVLRPK+YWDYESL VQWGDQDDYEVVRKVGRGKYSEVFEGIN
Sbjct: 58  LGSSYPLMSKARVYADVNVLRPKDYWDYESLAVQWGDQDDYEVVRKVGRGKYSEVFEGIN 117

Query: 147 VNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206
           VN NERCIIKILKPVKKKKIKREIKILQNLCGGPN+VKL DIVRDQHSKTPSLIFEYVNS
Sbjct: 118 VNNNERCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLFDIVRDQHSKTPSLIFEYVNS 177

Query: 207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
           TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL
Sbjct: 178 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 237

Query: 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
           AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN
Sbjct: 238 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 297

Query: 327 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 386
           HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI
Sbjct: 298 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 357

Query: 387 DFLDKLLRYDHQDRLTAREAMVISSISPIFSLV 419
           DFLDKLLRYDHQDRLTAREAM      P FS V
Sbjct: 358 DFLDKLLRYDHQDRLTAREAMA----HPYFSQV 386

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388510076|gb|AFK43104.1| unknown [Medicago truncatula]

 Score =  618 bits (1594), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 310/326 (95%), Positives = 317/326 (97%), Gaps = 4/326 (1%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNV+RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVN++ERC
Sbjct: 1   MSKARVYTDVNVIRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSSERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           +IKILKPVKKKKIKRE+KILQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  VIKILKPVKKKKIKREMKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRY IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYCIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID+LDKLL
Sbjct: 241 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDYLDKLL 300

Query: 394 RYDHQDRLTAREAMVISSISPIFSLV 419
           RYDHQDRLTAREAM      P FS V
Sbjct: 301 RYDHQDRLTAREAMA----HPYFSQV 322

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224074233|ref|XP_002304312.1| predicted protein [Populus trichocarpa] gi|222841744|gb|EEE79291.1| predicted protein [Populus trichocarpa]

 Score =  614 bits (1584), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 314/326 (96%), Positives = 318/326 (97%), Gaps = 4/326 (1%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERC
Sbjct: 1   MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           +IKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  VIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN+DNQHLVSPEA+DFLDKLL
Sbjct: 241 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINSDNQHLVSPEALDFLDKLL 300

Query: 394 RYDHQDRLTAREAMVISSISPIFSLV 419
           RYDHQDRLTAREAM      P FS V
Sbjct: 301 RYDHQDRLTAREAMA----HPYFSQV 322

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356541665|ref|XP_003539294.1| PREDICTED: casein kinase II subunit alpha-2-like [Glycine max]

 Score =  612 bits (1579), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 314/326 (96%), Positives = 318/326 (97%), Gaps = 4/326 (1%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVYTDVNVLRPKEYWDYESLT+QWGDQDDYEVVRKVGRGKYSEVFEGINVN+NERC
Sbjct: 1   MSKARVYTDVNVLRPKEYWDYESLTLQWGDQDDYEVVRKVGRGKYSEVFEGINVNSNERC 60

Query: 154 IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
           IIKILKPVKKKKIKREIKILQN+CGGPN+VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNICGGPNIVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 120

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 300

Query: 394 RYDHQDRLTAREAMVISSISPIFSLV 419
           RYDHQDRLTAREAM      P FS V
Sbjct: 301 RYDHQDRLTAREAMA----HPYFSQV 322

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	419
UNIPROTKB|Q9AR27	333	OSCKA2 "Casein kinase II alpha	0.749	0.942	0.901	2.1e-157
TAIR|locus:2045349	333	CKA3 "casein kinase II, alpha	0.749	0.942	0.872	1.4e-151
TAIR|locus:2045339	432	AT2G23070 [Arabidopsis thalian	0.770	0.747	0.801	4.6e-144
UNIPROTKB|P21868	391	CSNK2A1 "Casein kinase II subu	0.773	0.828	0.703	2.8e-128
UNIPROTKB|P68399	391	CSNK2A1 "Casein kinase II subu	0.754	0.808	0.715	3.6e-128
UNIPROTKB|E2RHZ1	391	CSNK2A1 "Uncharacterized prote	0.754	0.808	0.715	3.6e-128
UNIPROTKB|E7EU96	385	CSNK2A1 "Casein kinase II subu	0.754	0.820	0.715	3.6e-128
UNIPROTKB|P68400	391	CSNK2A1 "Casein kinase II subu	0.754	0.808	0.715	3.6e-128
UNIPROTKB|F2Z5I5	391	CSNK2A1 "Uncharacterized prote	0.754	0.808	0.715	3.6e-128
MGI|MGI:88543	391	Csnk2a1 "casein kinase 2, alph	0.754	0.808	0.715	3.6e-128

UNIPROTKB|Q9AR27 OSCKA2 "Casein kinase II alpha subunit" [Oryza sativa Indica Group (taxid:39946)]

 Score = 1534 (545.1 bits), Expect = 2.1e-157, P = 2.1e-157
 Identities = 283/314 (90%), Positives = 292/314 (92%)

Query:    94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
             MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct:     1 MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60

Query:   154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                                LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct:    61 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120

Query:   214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
             PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct:   121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180

Query:   274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct:   181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query:   334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
             AKVLGT+ LNAYLNKYH+ELDPQL+ALVGRHSRKPWSKFINADNQHLVSPEA+DFLDKLL
Sbjct:   241 AKVLGTEALNAYLNKYHIELDPQLEALVGRHSRKPWSKFINADNQHLVSPEAVDFLDKLL 300

Query:   394 RYDHQDRLTAREAM 407
             RYDHQDRLTAREAM
Sbjct:   301 RYDHQDRLTAREAM 314

GO:0009648 "photoperiodism" evidence=IGI

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2045349 CKA3 "casein kinase II, alpha chain 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1479 (525.7 bits), Expect = 1.4e-151, P = 1.4e-151
 Identities = 274/314 (87%), Positives = 286/314 (91%)

Query:    94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
             MSKARVYTDVNV+RPKEYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG NVNTNERC
Sbjct:     1 MSKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERC 60

Query:   154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                                LQNLCGGPN+VKL DIVRD+HSKTPSL+FE+VNS DFKVLY
Sbjct:    61 VIKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLY 120

Query:   214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
             PTLTDYDIRYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+LRKLRLIDWGLAEFYHPG
Sbjct:   121 PTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPG 180

Query:   274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct:   181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240

Query:   334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
             AKVLGT+EL+ YLNKY L+LDPQL+ALVGRH  KPWSKFINADNQHLVSPEAIDFLDKLL
Sbjct:   241 AKVLGTNELDHYLNKYQLDLDPQLEALVGRHVPKPWSKFINADNQHLVSPEAIDFLDKLL 300

Query:   394 RYDHQDRLTAREAM 407
             +YDHQDRLTAREAM
Sbjct:   301 QYDHQDRLTAREAM 314

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007623 "circadian rhythm" evidence=IGI

GO:0006281 "DNA repair" evidence=IDA

GO:0006325 "chromatin organization" evidence=IEP;IDA

GO:0010225 "response to UV-C" evidence=IMP

GO:0010332 "response to gamma radiation" evidence=IMP

GO:0051726 "regulation of cell cycle" evidence=IEP

GO:2001020 "regulation of response to DNA damage stimulus" evidence=IEP

GO:0009612 "response to mechanical stimulus" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2045339 AT2G23070 [Arabidopsis thaliana (taxid:3702)]

 Score = 1408 (500.7 bits), Expect = 4.6e-144, P = 4.6e-144
 Identities = 259/323 (80%), Positives = 282/323 (87%)

Query:    93 AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER 152
             A SKARVY DVNV+RPK+YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEGI+   NE+
Sbjct:    98 APSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEK 157

Query:   153 CXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
             C                   LQNLCGGPN+VKLLDIVRDQ SKTPSLIFE+VN+ DFKVL
Sbjct:   158 CVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVL 217

Query:   213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
             YPTL+DYD+RYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHP
Sbjct:   218 YPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 277

Query:   273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
             GKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVK
Sbjct:   278 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 337

Query:   333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 392
             IAKVLGTDELNAYLNKY +ELDP L +LVGRHSRKPW+KFIN++NQHL  PEA+DF+DKL
Sbjct:   338 IAKVLGTDELNAYLNKYRIELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKL 397

Query:   393 LRYDHQDRLTAREAMVISSISPI 415
             LRYDHQ+R TA+EAM      PI
Sbjct:   398 LRYDHQERPTAKEAMAHPYFYPI 420

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

UNIPROTKB|P21868 CSNK2A1 "Casein kinase II subunit alpha" [Gallus gallus (taxid:9031)]

 Score = 1259 (448.2 bits), Expect = 2.8e-128, P = 2.8e-128
 Identities = 228/324 (70%), Positives = 269/324 (83%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAMVISSISPI 415
             LLRYDHQ RLTAREAM      PI
Sbjct:   304 LLRYDHQSRLTAREAMEHPYFYPI 327

GO:0005524 "ATP binding" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0031519 "PcG protein complex" evidence=ISS

UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)]

 Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
 Identities = 226/316 (71%), Positives = 267/316 (84%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAM 407
             LLRYDHQ RLTAREAM
Sbjct:   304 LLRYDHQSRLTAREAM 319

GO:0047485 "protein N-terminus binding" evidence=ISS

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0071174 "mitotic spindle checkpoint" evidence=ISS

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISS

GO:0031519 "PcG protein complex" evidence=ISS

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
 Identities = 226/316 (71%), Positives = 267/316 (84%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAM 407
             LLRYDHQ RLTAREAM
Sbjct:   304 LLRYDHQSRLTAREAM 319

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0031519 "PcG protein complex" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)]

 Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
 Identities = 226/316 (71%), Positives = 267/316 (84%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAM 407
             LLRYDHQ RLTAREAM
Sbjct:   304 LLRYDHQSRLTAREAM 319

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)]

 Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
 Identities = 226/316 (71%), Positives = 267/316 (84%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAM 407
             LLRYDHQ RLTAREAM
Sbjct:   304 LLRYDHQSRLTAREAM 319

GO:0005524 "ATP binding" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA;TAS

GO:0047485 "protein N-terminus binding" evidence=IPI

GO:0005515 "protein binding" evidence=IPI

GO:0045732 "positive regulation of protein catabolic process" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0030307 "positive regulation of cell growth" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=IDA

GO:0031519 "PcG protein complex" evidence=IDA

GO:0071174 "mitotic spindle checkpoint" evidence=IMP

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IMP

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IMP

GO:0051879 "Hsp90 protein binding" evidence=TAS

GO:0061077 "chaperone-mediated protein folding" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005886 "plasma membrane" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0016581 "NuRD complex" evidence=IDA

GO:0016580 "Sin3 complex" evidence=IDA

UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
 Identities = 226/316 (71%), Positives = 267/316 (84%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAM 407
             LLRYDHQ RLTAREAM
Sbjct:   304 LLRYDHQSRLTAREAM 319

GO:0071174 "mitotic spindle checkpoint" evidence=IEA

GO:0047485 "protein N-terminus binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=IEA

GO:0031519 "PcG protein complex" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IEA

GO:0016581 "NuRD complex" evidence=IEA

GO:0016580 "Sin3 complex" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:88543 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Mus musculus (taxid:10090)]

 Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
 Identities = 226/316 (71%), Positives = 267/316 (84%)

Query:    92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
             P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct:     4 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63

Query:   152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
             +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct:    64 KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123

Query:   212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
             LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct:   124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183

Query:   272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
             PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct:   184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243

Query:   332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
             +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct:   244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303

Query:   392 LLRYDHQDRLTAREAM 407
             LLRYDHQ RLTAREAM
Sbjct:   304 LLRYDHQSRLTAREAM 319

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005956 "protein kinase CK2 complex" evidence=TAS

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IDA

GO:0006915 "apoptotic process" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=ISO

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016301 "kinase activity" evidence=IDA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016580 "Sin3 complex" evidence=ISO

GO:0016581 "NuRD complex" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019888 "protein phosphatase regulator activity" evidence=IDA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=ISO

GO:0030307 "positive regulation of cell growth" evidence=ISO

GO:0043154 "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process" evidence=ISO

GO:0045732 "positive regulation of protein catabolic process" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0047485 "protein N-terminus binding" evidence=ISO

GO:0050790 "regulation of catalytic activity" evidence=IDA

GO:0071174 "mitotic spindle checkpoint" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P19454	CSK22_YEAST	2, ., 7, ., 1, 1, ., 1	0.6242	0.7446	0.9203	yes	no
O64817	CSK23_ARATH	2, ., 7, ., 1, 1, ., 1	0.9299	0.7494	0.9429	no	no
P21868	CSK21_CHICK	2, ., 7, ., 1, 1, ., 1	0.7561	0.7732	0.8286	yes	no
Q8TG13	CSK2A_NEUCR	2, ., 7, ., 1, 1, ., 1	0.7523	0.7613	0.9494	N/A	no
P68399	CSK21_BOVIN	2, ., 7, ., 1, 1, ., 1	0.7689	0.7541	0.8081	yes	no
P28523	CSK2A_MAIZE	2, ., 7, ., 1, 1, ., 1	0.9460	0.7517	0.9487	N/A	no
P18334	CSK2A_CAEEL	2, ., 7, ., 1, 1, ., 1	0.7208	0.7732	0.9	yes	no
P08181	CSK2A_DROME	2, ., 7, ., 1, 1, ., 1	0.7601	0.7661	0.9553	yes	no
P19139	CSK21_RAT	2, ., 7, ., 1, 1, ., 1	0.7689	0.7541	0.8081	yes	no
O76484	CSK2A_SPOFR	2, ., 7, ., 1, 1, ., 1	0.7476	0.7661	0.9093	N/A	no
P28547	CSK2A_THEPA	2, ., 7, ., 1, 1, ., 1	0.6967	0.7398	0.8908	yes	no
P68400	CSK21_HUMAN	2, ., 7, ., 1, 1, ., 1	0.7689	0.7541	0.8081	yes	no
Q8SRU0	CSK2A_ENCCU	2, ., 7, ., 1, 1, ., 1	0.5032	0.7255	0.9529	yes	no
P40231	CSK2A_SCHPO	2, ., 7, ., 1, 1, ., 1	0.7034	0.7565	0.9548	yes	no
Q02720	CSK2A_DICDI	2, ., 7, ., 1, 1, ., 1	0.7102	0.7661	0.9525	yes	no
P33674	CSK21_RABIT	2, ., 7, ., 1, 1, ., 1	0.7658	0.7541	0.8081	yes	no
P28020	CSK21_XENLA	2, ., 7, ., 1, 1, ., 1	0.7530	0.7732	0.8265	N/A	no
Q60737	CSK21_MOUSE	2, ., 7, ., 1, 1, ., 1	0.7689	0.7541	0.8081	yes	no
Q08467	CSK21_ARATH	2, ., 7, ., 1, 1, ., 1	0.8445	0.8472	0.8679	yes	no
Q08466	CSK22_ARATH	2, ., 7, ., 1, 1, ., 1	0.8360	0.8568	0.8908	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	419
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-68
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-67
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-61
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-58
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-55
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-53
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-52
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-52
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-44
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-44
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-44
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-44
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-43
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-43
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-43
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-42
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-42
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-41
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-40
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-40
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-40
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-40
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-40
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-39
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-39
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-38
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-38
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-38
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-38
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-37
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-37
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-36
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-36
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-35
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-34
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-33
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-32
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-32
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-32
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-32
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-31
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-30
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-30
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-30
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-30
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-30
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-29
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-29
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-28
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-28
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-28
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-27
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-26
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-25
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-24
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-24
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-24
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-22
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-22
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-21
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-20
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-20
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-20
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-19
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-19
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-16
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-16
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-15
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-14
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-13
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-12
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-10
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-10
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-09
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	5e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-07
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-05
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-05
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-05
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-04
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-04
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-04
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-04
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-04
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	3e-04
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-04
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-04
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-04
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	7e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-04
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.001
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	0.002
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	0.002
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.003
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	0.003
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.003
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	0.004
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  217 bits (555), Expect = 2e-68
 Identities = 83/290 (28%), Positives = 132/290 (45%), Gaps = 44/290 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----REIKILQNLCGGPN 181
           YE++RK+G G +  V++  +  T +   +KILK   +K  K     REI+IL+ L   PN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +V+L+D   D       L+ EY    D          L++ + +    ++L+ L+Y HS 
Sbjct: 60  IVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           GI+HRD+KP N+++D     +++ D+GLA+            V + ++  PE+L+    Y
Sbjct: 118 GIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
              +D+WSLG +   ++  K PF  G +  DQL  I ++LG            LE D   
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPF-SGENILDQLQLIRRILGPP----------LEFDEPK 225

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                   S EA D + K L  D   R TA E +
Sbjct: 226 W--------------------SSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  213 bits (546), Expect = 3e-67
 Identities = 91/288 (31%), Positives = 147/288 (51%), Gaps = 46/288 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNV 182
           YE++ K+G G + +V+   +  T +   IK++K  K KK    I REIKIL+ L   PN+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYCHSQG 239
           V+L D+  D+      L+ EY    D F +L     L++ + R+Y+ ++L AL+Y HS+G
Sbjct: 60  VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           I+HRD+KP N+++D +   ++L D+GLA    PG++    V +  +  PE+L+  + Y  
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGK 175

Query: 300 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 359
           ++D+WSLG +   ++  K P F G D   +L K                           
Sbjct: 176 AVDIWSLGVILYELLTGK-PPFPGDDQLLELFKK-------------------------- 208

Query: 360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            +G+          +      +SPEA D + KLL  D + RLTA EA+
Sbjct: 209 -IGKPKPPFPPPEWD------ISPEAKDLIRKLLVKDPEKRLTAEEAL 249

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  198 bits (506), Expect = 7e-61
 Identities = 97/291 (33%), Positives = 157/291 (53%), Gaps = 24/291 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-IK----REIKILQNLCGGPN 181
           YE + K+G G Y  V++  +  T E   +K ++   +++ I     REI +L+ L   PN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           +VKLLD++     +   L+FEY +  D K         L+   I+  +Y+LL+ L YCHS
Sbjct: 60  IVKLLDVIH--TERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 296
             I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ PE+L+  + 
Sbjct: 117 HRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+FA MI   +P F G    DQL KI ++LGT    ++     L   P 
Sbjct: 176 YSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL---PD 231

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                 +   K   K +       + PE ID L K+L+Y+   R++A+EA+
Sbjct: 232 YKPTFPKFPPKDLEKVLPR-----LDPEGIDLLSKMLQYNPAKRISAKEAL 277

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  190 bits (486), Expect = 8e-58
 Identities = 93/296 (31%), Positives = 155/296 (52%), Gaps = 29/296 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPN 181
           YE + ++G G Y +V++  N  T E   +K ++   +K+       REIK+LQ L   PN
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           +V+L +IV  +   +  ++FEY+   D   L        T+  I+ Y+ +LL+ L Y HS
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELLVDLQ 295
            GI+HRD+K  N++I+++   L+L D+GLA  Y      +Y  RV + +++ PELL+   
Sbjct: 119 NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y   +DMWS+GC+ A + F  +P F G    +QL KI ++ G+     +         P
Sbjct: 178 RYGPEVDMWSVGCILAEL-FLGKPIFQGSTELEQLEKIFELCGSPTDENW---------P 227

Query: 356 QLDALVG----RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            +  L      +  +    +      +HL+ P A+D LDKLL  D + R++A +A+
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFF-KHLIDPSALDLLDKLLTLDPKKRISADQAL 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  186 bits (475), Expect = 1e-55
 Identities = 106/306 (34%), Positives = 170/306 (55%), Gaps = 45/306 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGGPN 181
           YE+++ +G G Y  V   ++  T  +  IK I          K+I REIK+L++L    N
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60

Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLY--PTLTDYDIRYYIYELLKALDYC 235
           ++ LLDI+R    +  +   ++ E +  TD  KV+     LTD  I+Y++Y++L+ L Y 
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGP 288
           HS  ++HRD+KP N++++     L++ D+GLA     +    G   EY   V +R+++ P
Sbjct: 120 HSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEY---VVTRWYRAP 175

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAY 345
           ELL+    Y  ++D+WS+GC+FA ++ RK P F G D  DQL  I +VLGT   ++L   
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234

Query: 346 LN---KYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
            +   + +L+  P+         +KP SK F  A      SPEAID L+K+L +D + R+
Sbjct: 235 TSEKARNYLKSLPK-------KPKKPLSKLFPGA------SPEAIDLLEKMLVFDPKKRI 281

Query: 402 TAREAM 407
           TA EA+
Sbjct: 282 TADEAL 287

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  179 bits (455), Expect = 2e-53
 Identities = 96/294 (32%), Positives = 151/294 (51%), Gaps = 26/294 (8%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLCGGP 180
            Y+++ ++G G +  VF+  +  T E   +K +     +  I     REIK LQ  C  P
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCH 236
            VVKLLD+    H     L+ EY+ S   +VL     P L +  ++ Y+  LLK + Y H
Sbjct: 60  YVVKLLDVFP--HGSGFVLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH 116

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 294
           + GIMHRD+KP N++I      L++ D+GLA  +   +   Y+ +VA+R+++ PELL   
Sbjct: 117 ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + YD  +D+W++GC+FA ++    P F G ++ +QL  + + LGT     +     L   
Sbjct: 176 RKYDPGVDLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRTLGTPNEETWPG---LTSL 231

Query: 355 PQLDALVGRHS-RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           P  + +    S   P  +          SPEA+D L  LL YD   RL+A EA+
Sbjct: 232 PDYNKITFPESKPIPLEEIFPD-----ASPEALDLLKGLLVYDPSKRLSAAEAL 280

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  177 bits (451), Expect = 1e-52
 Identities = 100/299 (33%), Positives = 140/299 (46%), Gaps = 36/299 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           YEV+  VG G Y  V +  N  T E   IK  K        KK   RE+K+L+ L    N
Sbjct: 3   YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN 61

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCHSQ 238
           +V L +  R        L+FEYV  T  ++L   P     D +R YI++LL+A+ YCHS 
Sbjct: 62  IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--PGKEYNVRVASRYFKGPELLVDLQD 296
            I+HRD+KP N+++      L+L D+G A      P       VA+R+++ PELLV   +
Sbjct: 120 NIIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y   +D+W++GC+ A ++   EP F G  + DQL  I K LG              L P 
Sbjct: 179 YGKPVDVWAIGCIMAELL-DGEPLFPGDSDIDQLYLIQKCLGP-------------LPPS 224

Query: 357 LDALVGRHSRKPWSKFINADNQH--------LVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              L   + R     F                VS  A+DFL   LR D ++RLT  E +
Sbjct: 225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  175 bits (446), Expect = 4e-52
 Identities = 99/295 (33%), Positives = 158/295 (53%), Gaps = 31/295 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           Y+ + K+G G Y  V++  +  T E   IK +K         K   REIK+L+ L   PN
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           ++KLLD+ R +      L+FE++++  +K++       L +  I+ Y+Y+LL+ L +CHS
Sbjct: 60  IIKLLDVFRHK--GDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            GI+HRD+KP N++I+ E   L+L D+GLA  F  P + Y   V +R+++ PELL+  + 
Sbjct: 117 HGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL-ELDP 355
           Y   +D+WS+GC+FA ++ R+ P F G    DQL KI + LGT       +     +   
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTLGT------PDPEVWPKFTS 228

Query: 356 QLDALVGRHSRK---PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                     +K   P  K          SP+A+D L ++L YD   R+TA +A+
Sbjct: 229 LARNYKFSFPKKAGMPLPKLFPN-----ASPQALDLLSQMLHYDPHKRITAEQAL 278

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  173 bits (441), Expect = 5e-51
 Identities = 98/299 (32%), Positives = 157/299 (52%), Gaps = 38/299 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           YE  +K+G G Y+ V++  +  T     IK +K  ++K+ K        REIK+LQ L  
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDY 234
            PN++ LLD+    H    +L+FE++  TD + +       LT  DI+ Y+   L+ L+Y
Sbjct: 61  HPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 293
            HS  I+HRD+KP+N++I  +   L+L D+GLA  +  P ++   +V +R+++ PELL  
Sbjct: 118 LHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN----AYLNKY 349
            + Y   +DMWS+GC+FA ++ R  PF  G  + DQL KI + LGT              
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235

Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           ++E  P            P  + F  A +      +A+D L +LL  +   R+TAR+A+
Sbjct: 236 YVEFKPF--------PPTPLKQIFPAASD------DALDLLQRLLTLNPNKRITARQAL 280

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  154 bits (391), Expect = 1e-44
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 12/190 (6%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLDI 188
           +G G +  V+   +  T ++  IKI+K          + REI+IL+ L   PN+VKL  +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59

Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRD 244
             D+      L+ EY      K L       L++ +I   + ++L+ L+Y HS GI+HRD
Sbjct: 60  FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117

Query: 245 VKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 303
           +KP N+++D +  K++L D+GL++            V +  +  PE+L+    Y    D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177

Query: 304 WSLGCMFAGM 313
           WSLG +   +
Sbjct: 178 WSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  156 bits (396), Expect = 1e-44
 Identities = 99/312 (31%), Positives = 158/312 (50%), Gaps = 52/312 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----------REIKIL 173
           D YE + K+G G Y +V++  + NT +      L  +KK +++           REI +L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54

Query: 174 QNLCGGPNVVKLLDIVR-DQHSKTPSL--IFEYVNSTDFKVLYPT--------LTDYDIR 222
           Q L     +V+LLD+   ++ +  PSL  +FEY+  +D K    +        L    I+
Sbjct: 55  QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVA 281
            ++Y+LLK + +CH  G+MHRD+KP N+++D +   L++ D GL   F  P K Y   + 
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           + +++ PE+L+    Y   +D+WS+GC+FA M  RK+P F G     QL+ I K+LGT  
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFKLLGT-- 230

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRY 395
                        P      G    + W +F     Q L      +SPE +D L K+LRY
Sbjct: 231 -------------PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRY 277

Query: 396 DHQDRLTAREAM 407
           D   R++A+ A+
Sbjct: 278 DPAKRISAKAAL 289

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  156 bits (397), Expect = 3e-44
 Identities = 100/304 (32%), Positives = 159/304 (52%), Gaps = 42/304 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI-------------KREIKIL 173
           YE+++K+G+G Y  V++ I+  T E         V  KKI              REI  L
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKAL 232
           Q L   PN+VKLL++++ ++ K   L+FEY+ +    V+    L D   RY +Y+LLKAL
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMYQLLKAL 120

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR------VASRYFK 286
            Y HS  ++HRD+KP N++++ + R ++L D+GLA      +E          VA+R+++
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWYR 179

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG---TDELN 343
            PE+L+    Y   +DMWS+GC+   M+  K P F G    +QL KI +V+G    +++ 
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLFPGTSTLNQLEKIIEVIGPPSAEDIE 238

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
           +  + +       LD+L  R  +        A      S +A+D L KLL ++   RLTA
Sbjct: 239 SIKSPF---AATMLDSLPSRPRKPLDELLPKA------SDDALDLLKKLLVFNPNKRLTA 289

Query: 404 REAM 407
            EA+
Sbjct: 290 EEAL 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  154 bits (391), Expect = 5e-44
 Identities = 96/300 (32%), Positives = 156/300 (52%), Gaps = 41/300 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKIL 173
           Y+ V K+G G Y  V++  +  T E         V  KKI+             REI +L
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-----VLYPTLTDYDIRYYIYEL 228
           + L   PN+V+LLD+V  ++     L+FE+++  D K          L    I+ Y+Y+L
Sbjct: 53  KEL-NHPNIVRLLDVVHSENKLY--LVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKG 287
           L+ + YCHS  ++HRD+KP N++ID E   L+L D+GLA  F  P + Y   V + +++ 
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
           PE+L+  + Y   +D+WS+GC+FA M+ R+ P F G    DQL +I + LGT + + +  
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              L   P       + +R+  SK +       +  + +D L K+L YD   R++A+ A+
Sbjct: 227 VTSL---PDYKPTFPKWARQDLSKVVPN-----LDEDGLDLLSKMLVYDPAKRISAKAAL 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  153 bits (389), Expect = 1e-43
 Identities = 92/300 (30%), Positives = 145/300 (48%), Gaps = 41/300 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           Y+V++++G G +  V+   N  T E   IK +K    KK          RE+K L+ L  
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD--------IRYYIYELLK 230
            PN+VKL ++ R+  +     +FEY+       LY  + D          IR  IY++L+
Sbjct: 57  HPNIVKLKEVFRE--NDELYFVFEYMEGN----LYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            L + H  G  HRD+KP N+++      +++ D+GLA        Y   V++R+++ PE+
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEI 169

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L+    Y   +D+W+LGC+ A + +   P F G    DQL KI  VLGT     +   Y 
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228

Query: 351 L--ELDPQLDALVGRHSRKPWSKFI-NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           L  +L  +              + I NA      SPEAID +  +LR+D + R TA +A+
Sbjct: 229 LASKLGFRFPQFAP----TSLHQLIPNA------SPEAIDLIKDMLRWDPKKRPTASQAL 278

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  152 bits (387), Expect = 6e-43
 Identities = 94/301 (31%), Positives = 160/301 (53%), Gaps = 32/301 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTN--ERCIIKILKPVKKKKIK-----REIKILQNLCGG 179
           YE+++++G+G Y  V    N  T+  E   IK +  V  KKI      RE+K+L++  G 
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 180 PNVVKL--LDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYC 235
            N+  L  +DIV   +     L  E + +   +++     LTD   + +IY++L  L Y 
Sbjct: 62  KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-----VASRYFKGPEL 290
           HS  ++HRD+KP N++++ +  +L++ D+GLA  +      N       VA+R+++ PE+
Sbjct: 122 HSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLN 347
           ++  Q Y  ++D+WS+GC+ A ++ RK P F G D  DQL +I +VLGT   + L+   +
Sbjct: 181 MLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 348 KYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                    L  +     +KP+   F NA      +P A+D L+KLL +D   R++  EA
Sbjct: 240 PKAQNYIRSLPNIP----KKPFESIFPNA------NPLALDLLEKLLAFDPTKRISVEEA 289

Query: 407 M 407
           +
Sbjct: 290 L 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  151 bits (383), Expect = 8e-43
 Identities = 89/298 (29%), Positives = 159/298 (53%), Gaps = 38/298 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           Y+++ K+G G +SEV +  +  T +   IK +K    K  K        REI+ L+ L  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK----KHFKSLEQVNNLREIQALRRLSP 56

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDY 234
            PN+++L++++ D+ +   +L+FE ++   ++++     P L +  ++ Y+Y+LLK+LD+
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDH 115

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
            H  GI HRD+KP N++I  ++  L+L D+G     +    Y   +++R+++ PE L+  
Sbjct: 116 MHRNGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DELNAYLNKY-HL 351
             Y   +D+W++GC+F  ++    P F G +  DQ+ KI  VLGT   E+     K  H+
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF-PLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232

Query: 352 ELDPQLDALVGRHSRKP--WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             +          S+K     K +        S E +D L KLL YD  +R+TA++A+
Sbjct: 233 NYNFP--------SKKGTGLRKLL-----PNASAEGLDLLKKLLAYDPDERITAKQAL 277

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  152 bits (386), Expect = 1e-42
 Identities = 92/300 (30%), Positives = 161/300 (53%), Gaps = 29/300 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQNLCGG 179
             Y+ +  +G G Y  V   I+  + ++  IK +      P   K+  RE+KIL++    
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KH 63

Query: 180 PNVVKLLDIVR--DQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYC 235
            N++ + DI+R      K   ++ + + S    +++    LT+  IRY++Y+LL+ L Y 
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY------HPG--KEYNVRVASRYFKG 287
           HS  ++HRD+KP N++++ +  +LR+ D+G+A         H     EY   VA+R+++ 
Sbjct: 124 HSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEY---VATRWYRA 179

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
           PELL+ L +Y  ++DMWS+GC+FA M+ R++  F G +   QL  I  VLG+      LN
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-LFPGKNYVHQLKLILSVLGSPS-EEVLN 237

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           +   +   +    + R    PWSK          SPEA+D L ++L++D ++R+T  +A+
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPK-----ASPEALDLLSQMLQFDPEERITVEQAL 292

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  149 bits (379), Expect = 3e-42
 Identities = 100/298 (33%), Positives = 159/298 (53%), Gaps = 32/298 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
           D YE V K+G G Y  V++  +  TNE   +K ++       V    I REI +L+ +  
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD-----IRYYIYELLKALD 233
           G N+V+L D+V  +  K   L+FEY++  D K    +  D+      I+ Y+Y++L+ + 
Sbjct: 61  G-NIVRLQDVVHSE--KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           YCHS  ++HRD+KP N++ID     L+L D+GLA  F  P + +   V + +++ PE+L+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y   +D+WS+GC+FA M+ +K P F G    D+L KI ++LGT     +       
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK-PLFPGDSEIDELFKIFRILGTPNEETW------- 228

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLV---SPEAIDFLDKLLRYDHQDRLTAREAM 407
             P + +L    S  P  K+   D   +V    P  +D L K+LR D   R+TAR A+
Sbjct: 229 --PGVTSLPDYKSAFP--KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282

Length = 294

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  146 bits (370), Expect = 6e-41
 Identities = 87/294 (29%), Positives = 145/294 (49%), Gaps = 29/294 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCG 178
           YE + K+G G Y  VF+  N  T+E   I  LK V+             REI +L+ L  
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL-K 57

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDY 234
             N+V+L D++      T  L+FEY +  D K  + +         ++ ++++LLK L +
Sbjct: 58  HKNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 293
           CHS  ++HRD+KP N++I+    +L+L D+GLA  +  P + Y+  V + +++ P++L  
Sbjct: 115 CHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  S+DMWS GC+FA +     P F G+D  DQL +I ++LGT    ++     L  
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL-- 231

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            P         +       +       ++    D L  LL  +   R++A EA+
Sbjct: 232 -PDYKPYPMYPATTSLVNVVPK-----LNSTGRDLLQNLLVCNPVQRISAEEAL 279

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 2e-40
 Identities = 92/302 (30%), Positives = 166/302 (54%), Gaps = 35/302 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK----KIKREIKILQNLCGGP 180
             Y+ +  +G G Y  V    +  T  +  IK + P + +    +  REIKIL+      
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHE 63

Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCH 236
           N++ +LDI+R    ++ +   ++ E + +  +K++    L++  I+Y++Y++L+ L Y H
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGPE 289
           S  ++HRD+KP N++++     L++ D+GLA     E  H G   EY   VA+R+++ PE
Sbjct: 124 SANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEHDHTGFLTEY---VATRWYRAPE 179

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYL 346
           ++++ + Y  ++D+WS+GC+ A M+  + P F G D   QL  I  VLGT   ++LN  +
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238

Query: 347 NKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
           +         + +L  +  + PW+K F NAD      P+A+D LDK+L ++   R+T  E
Sbjct: 239 SLRARNY---IKSLPFK-PKVPWNKLFPNAD------PKALDLLDKMLTFNPHKRITVEE 288

Query: 406 AM 407
           A+
Sbjct: 289 AL 290

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  144 bits (365), Expect = 4e-40
 Identities = 88/313 (28%), Positives = 153/313 (48%), Gaps = 63/313 (20%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKIL 173
           YE + ++G G Y  V++  ++NT         + V  KK++             REI +L
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52

Query: 174 QNL--CGGPNVVKLLDI---VRDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYY 224
           + L     PN+V+LLD+    R       +L+FE+V+     +  K   P L    I+  
Sbjct: 53  KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----V 280
           + +LL+ +D+ HS  I+HRD+KP N+++  + + +++ D+GLA  Y     + +     V
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SFEMALTSVV 167

Query: 281 ASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
            + +++ PE+L  LQ  Y   +DMWS+GC+FA + FR+ P F G    DQL KI  V+G 
Sbjct: 168 VTLWYRAPEVL--LQSSYATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVIGL 224

Query: 340 ---DE--LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
              +E   N  L +               ++ + +  F+       +  E +D L K+L 
Sbjct: 225 PSEEEWPRNVSLPRSSFP----------SYTPRSFKSFVPE-----ICEEGLDLLKKMLT 269

Query: 395 YDHQDRLTAREAM 407
           ++   R++A EA+
Sbjct: 270 FNPHKRISAFEAL 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  144 bits (364), Expect = 6e-40
 Identities = 84/310 (27%), Positives = 161/310 (51%), Gaps = 36/310 (11%)

Query: 121 WGDQ--DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKIL 173
           WG +  D ++++ ++G G Y +V++  + +T E   +K ++   +K+       REIKIL
Sbjct: 1   WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKIL 60

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTP--------SLIFEYVNSTDFKVLYPTLTDYD---IR 222
           + L    N+V L +IV D+              L+FEY++     +L   L  +    I+
Sbjct: 61  RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYNVRV 280
            ++ +LL+ L+YCH +  +HRD+K  N++++++  +++L D+GLA  Y+    + Y  +V
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYTNKV 178

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            + +++ PELL+  + Y  ++D+WS GC+  G +F K+P F  +    QL  I+++ G+ 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCIL-GELFTKKPIFQANQELAQLELISRLCGSP 237

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKP---WSKFINADNQHLVSPEAIDFLDKLLRYDH 397
               +         P +  L   ++ KP   + + +  +   +    A+D LD +L  D 
Sbjct: 238 CPAVW---------PDVIKLPYFNTMKPKKQYRRRLREEFSFI-PTPALDLLDHMLTLDP 287

Query: 398 QDRLTAREAM 407
             R TA EA+
Sbjct: 288 SKRCTAEEAL 297

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  142 bits (361), Expect = 7e-40
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 47/290 (16%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IKREIKILQNLCGGPNV 182
            +E++ K+G+G + EV++  +  T +   IK++K   K+K   I  EI+IL+  C  PN+
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNI 59

Query: 183 VKLLDIVRDQHSKTPSLIFEYVN----STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           VK              ++ E+ +        K    TLT+  I Y   ELLK L+Y HS 
Sbjct: 60  VKYYGSY--LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
           GI+HRD+K  N+++  +  +++LID+GL+      K  N  V + Y+  PE++   + YD
Sbjct: 118 GIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175

Query: 299 YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD 358
           Y  D+WSLG     +   K P+                               EL P   
Sbjct: 176 YKADIWSLGITAIELAEGKPPYS------------------------------ELPPMK- 204

Query: 359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
           AL  + +           N    S E  DFL K L+ + + R TA + + 
Sbjct: 205 ALF-KIATNGPPGL---RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  146 bits (367), Expect = 8e-40
 Identities = 83/305 (27%), Positives = 136/305 (44%), Gaps = 55/305 (18%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGG 179
            Y ++RK+G G + EV+   +    +   +K+L    + K        REI+IL +L   
Sbjct: 1   SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PN+VKL D    Q   +  L+ EYV+    + L         L++ +  + + ++L AL+
Sbjct: 58  PNIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-------HPGKEYNVRVASRYFK 286
           Y HS+GI+HRD+KP N+++D + R ++LID+GLA+               +  V +  + 
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 287 GPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQLVKIAKVLGTDEL 342
            PE+L+   L     S D+WSLG     ++    PF          Q +KI   L T  L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
            + L+                             N  L+S  A D L KLL  D ++RL+
Sbjct: 236 ASPLSP---------------------------SNPELISKAASDLLKKLLAKDPKNRLS 268

Query: 403 AREAM 407
           +   +
Sbjct: 269 SSSDL 273

Length = 384

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  143 bits (362), Expect = 4e-39
 Identities = 93/308 (30%), Positives = 160/308 (51%), Gaps = 43/308 (13%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQN 175
           W   D Y+ +  VG G Y +V    +  T  +  IK L       +  K+  RE+++L++
Sbjct: 11  WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH 70

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIR 222
           +    NV+ LLD+       TP+   E  +  D  ++                L+D  I+
Sbjct: 71  MDH-ENVIGLLDVF------TPASSLE--DFQDVYLVTHLMGADLNNIVKCQKLSDDHIQ 121

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           + +Y++L+ L Y HS GI+HRD+KP N+ ++ E  +L+++D+GLA   H   E    VA+
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGYVAT 178

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--D 340
           R+++ PE++++   Y+ ++D+WS+GC+ A ++  K   F G D+ DQL +I  ++GT  +
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSDHIDQLKRIMNLVGTPDE 237

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQD 399
           EL   L K   E        + +  +K + + F  A      +P AID L+K+L  D   
Sbjct: 238 EL---LQKISSESARNYIQSLPQMPKKDFKEVFSGA------NPLAIDLLEKMLVLDPDK 288

Query: 400 RLTAREAM 407
           R+TA EA+
Sbjct: 289 RITAAEAL 296

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  140 bits (355), Expect = 8e-39
 Identities = 88/293 (30%), Positives = 155/293 (52%), Gaps = 25/293 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           ++ V K+G G Y  V++  N  T E   +K ++       V    I REI +L+ L   P
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCH 236
           N+VKLLD++  +      L+FE+++    K +  +    +    I+ Y+++LL+ L +CH
Sbjct: 60  NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+     ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 118 SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     L   P
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL---P 232

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
                  + +R+ +SK +       +  +  D L ++L YD   R++A+ A+ 
Sbjct: 233 DYKPSFPKWARQDFSKVVP-----PLDEDGRDLLSQMLHYDPNKRISAKAALA 280

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  139 bits (353), Expect = 2e-38
 Identities = 99/306 (32%), Positives = 160/306 (52%), Gaps = 48/306 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PVKKKKIKREIKILQNLC 177
           + YE + K+G G Y  VF+  N  T +  I+ I K       PV KK   REI++L+ L 
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQ--IVAIKKFVESEDDPVIKKIALREIRMLKQL- 57

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKALDY 234
             PN+V L+++ R    +   L+FEY + T    L   P  + ++ I+  I++ L+A+++
Sbjct: 58  KHPNLVNLIEVFR--RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV- 292
           CH    +HRDVKP N++I  +  +++L D+G A     PG +Y   VA+R+++ PELLV 
Sbjct: 116 CHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG 174

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL---------- 342
           D Q Y   +D+W++GC+FA ++   +P + G  + DQL  I K LG  +L          
Sbjct: 175 DTQ-YGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQLYLIRKTLG--DLIPRHQQIFST 230

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPW-SKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
           N +     +  +P+        +R+P  SKF N       S  A+ FL   L+ D  +RL
Sbjct: 231 NQFFKGLSIP-EPE--------TREPLESKFPNI------SSPALSFLKGCLQMDPTERL 275

Query: 402 TAREAM 407
           +  E +
Sbjct: 276 SCEELL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  140 bits (355), Expect = 2e-38
 Identities = 94/312 (30%), Positives = 155/312 (49%), Gaps = 40/312 (12%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLCG 178
             DYE++ K+G G + EV++   + T     +K IL   +K        REIKIL+ L  
Sbjct: 7   LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65

Query: 179 GPNVVKLLDIV---RDQHSKTPS---LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELL 229
            PNVV L+D+     D+  +      ++  Y++     +L      LT+  I+ Y+ +LL
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLL 125

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY--------HPG----KEYN 277
           + ++Y H   I+HRD+K  N++ID++   L++ D+GLA  Y          G    ++Y 
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLARPYDGPPPNPKGGGGGGTRKYT 184

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             V +R+++ PELL+  + Y  ++D+W +GC+FA M  R+ P   G  + DQL  I K+ 
Sbjct: 185 NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHLIFKLC 243

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL--VSPEAIDFLDKLLRY 395
           GT        +   E  P   +L G      ++ +     +    + PE +D L KLL  
Sbjct: 244 GT------PTE---ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL 294

Query: 396 DHQDRLTAREAM 407
           D   RLTA +A+
Sbjct: 295 DPYKRLTASDAL 306

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  139 bits (352), Expect = 2e-38
 Identities = 93/304 (30%), Positives = 158/304 (51%), Gaps = 44/304 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIKI 172
           DY  + K+G G Y  V++G N  T         + V  KKI+             REI +
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIY 226
           L+ L   PN+V L D++  Q S+   LIFE++ S D K    +L          ++ Y+Y
Sbjct: 53  LKEL-QHPNIVCLQDVLM-QESRL-YLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLY 108

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYF 285
           ++L+ + +CHS+ ++HRD+KP N++ID++   ++L D+GLA  F  P + Y   V + ++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVYTHEVVTLWY 167

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 345
           + PE+L+    Y   +D+WS+G +FA M  +K P F+G    DQL +I ++LGT   + +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK-PLFHGDSEIDQLFRIFRILGTPTEDVW 226

Query: 346 LNKYHLELDPQLDALVGRHSRKP-WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                    P + +L    +  P W K         +  + +D L+K+L YD   R++A+
Sbjct: 227 ---------PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277

Query: 405 EAMV 408
           +A+ 
Sbjct: 278 KALN 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 5e-38
 Identities = 94/313 (30%), Positives = 154/313 (49%), Gaps = 53/313 (16%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------R 168
           +G  + Y+ + K+G G Y+ V++G +  T +         V  K+I+            R
Sbjct: 1   FGKLETYKKLDKLGEGSYATVYKGRSKLTGQL--------VALKEIRLEHEEGAPFTAIR 52

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTD-YDIRYY 224
           E  +L++L    N+V L DI+  +  KT +L+FEY++ TD K            +++R +
Sbjct: 53  EASLLKDL-KHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF 108

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
           +++LL+ L YCH + ++HRD+KP N++I  E  +L+L D+GLA     P K Y+  V + 
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTL 167

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-DNHDQLVKIAKVLGTD-- 340
           +++ P++L+   +Y  SLDMW +GC+F  M     P F G  D  DQL KI +VLGT   
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVEDQLHKIFRVLGTPTE 226

Query: 341 ------ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
                   N     Y              +  +P    IN   +    P   +   K L+
Sbjct: 227 ETWPGVSSNPEFKPYSF----------PFYPPRP---LINHAPRLDRIPHGEELALKFLQ 273

Query: 395 YDHQDRLTAREAM 407
           Y+ + R++A EAM
Sbjct: 274 YEPKKRISAAEAM 286

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  137 bits (348), Expect = 8e-38
 Identities = 83/295 (28%), Positives = 152/295 (51%), Gaps = 31/295 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------KKKIKREIKILQNLCGG 179
           ++ + K+G G Y+ V++G N  T E   I  LK +             REI +++ L   
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKEL-KH 57

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY------DIRYYIYELLKALD 233
            N+V+L D++  ++     L+FEY++  D K    T           ++ + Y+LLK + 
Sbjct: 58  ENIVRLHDVIHTENKLM--LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CH   ++HRD+KP N++I+     L+L D+GLA  F  P   ++  V + +++ P++L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  S+D+WS+GC+ A MI  + P F G +N DQL+KI +++GT   + +     + 
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFRIMGTPTESTWPG---IS 229

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P+      R+  +   +           P  ID L +LL+ + + R++A +A+
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPH-----ADPLGIDLLHRLLQLNPELRISAHDAL 279

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  136 bits (344), Expect = 2e-37
 Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 51/292 (17%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKK---IKREIKILQNLCGGP 180
           ++     +GRG +  V+  ++ +T E   +K   L    +++   ++REI+IL +L   P
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+     RD+   T ++  EYV+    +     +  L +  IR Y  ++L+ L Y HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDL 294
            GI+HRD+K  N+++D +   ++L D+G A        G+       + Y+  PE++   
Sbjct: 120 NGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG- 177

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNAYLNKYHLEL 353
           ++Y  + D+WSLGC    M   K P +    N    + KI       E+  +L       
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP-WSELGNPMAALYKIGSSGEPPEIPEHL------- 229

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                                       S EA DFL K LR D + R TA E
Sbjct: 230 ----------------------------SEEAKDFLRKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  136 bits (344), Expect = 4e-37
 Identities = 93/291 (31%), Positives = 147/291 (50%), Gaps = 26/291 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCGGP 180
           YE +  VG G Y  V +  +  T +   IK        K VKK  + REI++L+ L    
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQL-RHE 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCHS 237
           N+V L+++ R +  K   L+FE+V+ T    L  YP   D   +R Y++++L+ +++CHS
Sbjct: 61  NLVNLIEVFRRK--KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 296
             I+HRD+KP N+++      ++L D+G A     PG+ Y   VA+R+++ PELLV    
Sbjct: 119 HNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+W++GC+   M    EP F G  + DQL  I K LG       L   H E+  +
Sbjct: 178 YGRAVDIWAVGCLVTEM-LTGEPLFPGDSDIDQLYHIIKCLGN------LIPRHQEIFQK 230

Query: 357 LDALVGRHSRKPWSKFINADNQHL--VSPEAIDFLDKLLRYDHQDRLTARE 405
                G   R P  K I    +    +S   +D   + LR D  DR ++ +
Sbjct: 231 NPLFAG--MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  135 bits (340), Expect = 5e-36
 Identities = 95/303 (31%), Positives = 162/303 (53%), Gaps = 34/303 (11%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQN 175
           W   + Y  +++VG G Y  V   I+  T E+  IK L +P +     K+  RE+ +L++
Sbjct: 11  WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70

Query: 176 LCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
           +    NV+ LLD+     S    +   L+  Y+ +   K++   L++  ++Y +Y++L  
Sbjct: 71  M-QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L Y HS GI+HRD+KP N+ ++ +  +L+++D+GLA   H   E    V +R+++ PE++
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 186

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG------TDELNAY 345
           ++   Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I KV G        +L   
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
             K +++  P+         RK +S  F  A      SP+A+D L+K+L  D   RLTA 
Sbjct: 246 AAKSYIKSLPKY-------PRKDFSTLFPKA------SPQAVDLLEKMLELDVDKRLTAT 292

Query: 405 EAM 407
           EA+
Sbjct: 293 EAL 295

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  134 bits (338), Expect = 8e-36
 Identities = 95/318 (29%), Positives = 167/318 (52%), Gaps = 43/318 (13%)

Query: 111 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KK 165
           Y+  E     W   D Y  +++VG G Y  V   ++  T  +  IK L +P +     K+
Sbjct: 1   YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60

Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----------- 214
             RE+++L+++    NV+ LLD+       TP L  +  +  DF ++ P           
Sbjct: 61  AYRELRLLKHM-KHENVIGLLDVF------TPDLSLDRFH--DFYLVMPFMGTDLGKLMK 111

Query: 215 --TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
              L++  I++ +Y++LK L Y H+ GI+HRD+KP N+ ++ +  +L+++D+GLA     
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--QT 168

Query: 273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
             E    V +R+++ PE++++   Y  ++D+WS+GC+ A M+  K P F GHD+ DQL++
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLME 227

Query: 333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL---VSPEAIDFL 389
           I KV GT            E   +L +   ++  K   +F   D + L    +P A++ L
Sbjct: 228 IMKVTGTPS---------KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVL 278

Query: 390 DKLLRYDHQDRLTAREAM 407
           +K+L  D + R+TA EA+
Sbjct: 279 EKMLVLDAESRITAAEAL 296

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  132 bits (333), Expect = 3e-35
 Identities = 101/302 (33%), Positives = 160/302 (52%), Gaps = 34/302 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKP----VKKKKIKREIKILQNLCGGPN 181
           Y  ++ VG G +  V    +  T +   IK I+KP    V  K+  RE+K+L++L    N
Sbjct: 12  YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHEN 70

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVN---STDFKVLYPT--LTDYDIRYYIYELLKALDYCH 236
           ++ L DI       +P     +V     TD   L  +  L    I+Y++Y++L+ L Y H
Sbjct: 71  IISLSDIF-----ISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S G++HRD+KP N++I+ E   L++ D+GLA    P  +    V++RY++ PE+++  Q 
Sbjct: 126 SAGVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQK 182

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYHLEL 353
           YD  +D+WS GC+FA M    +P F G D+ +Q   I  +LGT   D +N   ++  L  
Sbjct: 183 YDVEVDIWSAGCIFAEM-LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241

Query: 354 DPQLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI 412
              L     +    P+S KF NAD      P AID L+K+L +D Q R++A EA+    +
Sbjct: 242 VQSLP----KREPVPFSEKFKNAD------PSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Query: 413 SP 414
           +P
Sbjct: 292 AP 293

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  128 bits (324), Expect = 4e-34
 Identities = 90/297 (30%), Positives = 153/297 (51%), Gaps = 27/297 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IK--REIKILQNLCGG 179
           D+YE + ++  G Y  V+   +  T E   +K LK  K+K+   I   REI IL  L   
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QH 63

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDYC 235
           PN+V + ++V   +     ++ EYV   D K L  T+       +++  + +LL  + + 
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           H   I+HRD+K  N+++++    L++ D+GLA E+  P K Y   V + +++ PELL+  
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           ++Y  ++DMWS+GC+FA ++  K+P F G    DQL KI K+LGT     +         
Sbjct: 182 KEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFKLLGTPTEKIW--------- 231

Query: 355 PQLDALVG----RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           P    L G      ++ P+++         +S    D L++LL YD   R++A +A+
Sbjct: 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  128 bits (324), Expect = 1e-33
 Identities = 95/303 (31%), Positives = 163/303 (53%), Gaps = 42/303 (13%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 181
           Y  ++ +GRG Y  V    N  TNE+  IK +       +  K+  REIK+L++L    N
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN 65

Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
           V+ + DI+   H +  +   +++E ++ TD   +     TL+D   +Y++Y+LL+ L Y 
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-------EFYHPGKEYNVRVASRYFKGP 288
           HS  ++HRD+KP N++++     L++ D+GLA       +F     EY   V +R+++ P
Sbjct: 125 HSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFM---TEY---VVTRWYRAP 177

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAY 345
           ELL++  +Y  ++D+WS+GC+FA ++ RK P F G D   QL  I ++LG+   ++L   
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFPGKDYVHQLKLITELLGSPSEEDLGFI 236

Query: 346 LNKYHLELDPQLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
            N+        L        R+ ++  F +A      +P AID L+K+L +D   R+T  
Sbjct: 237 RNEKARRYIRSL----PYTPRQSFARLFPHA------NPLAIDLLEKMLVFDPSKRITVE 286

Query: 405 EAM 407
           EA+
Sbjct: 287 EAL 289

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  125 bits (314), Expect = 2e-32
 Identities = 90/309 (29%), Positives = 156/309 (50%), Gaps = 45/309 (14%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KP----VKKKKIKREIKILQN 175
           W   + Y+ +  VG G Y  V    +    ++  +K L +P    +  ++  RE+++L++
Sbjct: 11  WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---------TDFK--VLYPTLTDYDIRYY 224
           +    NV+ LLD+       TP+   E  N           D    V    L+D  +++ 
Sbjct: 71  M-KHENVIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           IY+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA       E    VA+R+
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADDEMTGYVATRW 180

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           ++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G+D  DQL +I +V+GT     
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDYIDQLKRIMEVVGTPSPEV 239

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL------VSPEAIDFLDKLLRYDHQ 398
                       L  +   H+RK      +   Q L       +P AID L+K+L  D  
Sbjct: 240 ------------LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSD 287

Query: 399 DRLTAREAM 407
            R++A EA+
Sbjct: 288 KRISASEAL 296

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  122 bits (308), Expect = 5e-32
 Identities = 87/317 (27%), Positives = 135/317 (42%), Gaps = 80/317 (25%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
           DD++  + +G G +S V       TN+   IKIL     +K+KK   +K E ++L  L G
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIF--EYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
            P ++KL    +D+ +    L F  EY  + +       Y +L +   R+Y  E+L AL+
Sbjct: 61  HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------------EYNV 278
           Y HS+GI+HRD+KP N+++D ++  +++ D+G A+   P                     
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 279 RVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV- 331
           R     F G      PELL + +    S D+W+LGC+   M+  K PF     +++ L  
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPF---RGSNEYLTF 231

Query: 332 -KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
            KI K               LE                +      D        A D ++
Sbjct: 232 QKILK---------------LEYS--------------FPPNFPPD--------AKDLIE 254

Query: 391 KLLRYDHQDRLTAREAM 407
           KLL  D QDRL   E  
Sbjct: 255 KLLVLDPQDRLGVNEGY 271

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  123 bits (309), Expect = 9e-32
 Identities = 87/303 (28%), Positives = 152/303 (50%), Gaps = 33/303 (10%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KP----VKKKKIKREIKILQN 175
           W   + Y+ +  VG G Y  V    +  T  R  +K L +P    +  K+  RE+++L++
Sbjct: 13  WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 72

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---------TDFK--VLYPTLTDYDIRYY 224
           +    NV+ LLD+       TP+   E  N           D    V    LTD  +++ 
Sbjct: 73  M-KHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E    VA+R+
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMTGYVATRW 182

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           ++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++GT     
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAEL 241

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                       + +L         + FI A+      P A+D L+K+L  D   R+TA 
Sbjct: 242 LKKISSESARNYIQSLTQMPKMNFANVFIGAN------PLAVDLLEKMLVLDSDKRITAA 295

Query: 405 EAM 407
           +A+
Sbjct: 296 QAL 298

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  121 bits (306), Expect = 9e-32
 Identities = 85/302 (28%), Positives = 157/302 (51%), Gaps = 29/302 (9%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G    Y  + K+G G Y+ V++GI+    +   +K++    ++ +     RE  +L+ L
Sbjct: 1   FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNS--TDFKVLYPT-LTDYDIRYYIYELLKALD 233
               N+V L DI+  + + T   +FEY+++    + + +P  L  Y++R ++++LL+ L 
Sbjct: 61  -KHANIVLLHDIIHTKETLT--FVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA 117

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 292
           Y H Q I+HRD+KP N++I + L +L+L D+GLA     P + Y+  V + +++ P++L+
Sbjct: 118 YIHGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLL 176

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKVLGTDELNAY-----L 346
              DY  +LD+W  GC+F  M  + +P F G  +  +QL KI  VLG    + +     L
Sbjct: 177 GATDYSSALDIWGAGCIFIEM-LQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             Y  E          +  R  W +           P+A D   ++L    +DR++A++A
Sbjct: 236 PNYKPEWFLPCKP---QQLRVVWKRLSRP-------PKAEDLASQMLMMFPKDRISAQDA 285

Query: 407 MV 408
           ++
Sbjct: 286 LL 287

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  121 bits (306), Expect = 3e-31
 Identities = 88/305 (28%), Positives = 154/305 (50%), Gaps = 37/305 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---REIKILQNLCGGPNVV 183
           Y  +R +G G    VF  ++ + ++R  +K +     + +K   REIKI++ L    N+V
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 65

Query: 184 KLLDIVRDQHSKTPS------------LIFEYVNSTDFKVL--YPTLTDYDIRYYIYELL 229
           K+ +++    S                ++ EY+  TD   +     L++   R ++Y+LL
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLL 124

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYF 285
           + L Y HS  ++HRD+KP NV I+ E   L++ D+GLA    P   +    +  + ++++
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK---VLGTDEL 342
           + P LL+   +Y  ++DMW+ GC+FA M+  K P F G    +Q+  I +   V+  ++ 
Sbjct: 185 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLILESVPVVREEDR 243

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
           N  LN       P      G   R+P    +       V+PEA+DFL+++L ++  DRLT
Sbjct: 244 NELLNV-----IPSFVRNDGGEPRRPLRDLLPG-----VNPEALDFLEQILTFNPMDRLT 293

Query: 403 AREAM 407
           A EA+
Sbjct: 294 AEEAL 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  122 bits (306), Expect = 1e-30
 Identities = 89/297 (29%), Positives = 155/297 (52%), Gaps = 31/297 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIKREIKILQNLCGGPNVVKL 185
           Y++   +G G +  V+E I ++T+E+  IK +L+  + K   RE+ I++NL    N++ L
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL-NHINIIFL 124

Query: 186 LD------IVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
            D        +++ +   +++ E++  T  K +         L  + ++ Y Y+L +AL 
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           Y HS+ I HRD+KP N++ID     L+L D+G A+    G+     + SR+++ PEL++ 
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYH 350
             +Y   +D+WSLGC+ A MI    P F G  + DQLV+I +VLGT   D+L      Y 
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY- 302

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              D +   +  +  +K + K            +AI+F+ + L+Y+   RL   EA+
Sbjct: 303 --ADIKFPDVKPKDLKKVFPKG--------TPDDAINFISQFLKYEPLKRLNPIEAL 349

Length = 440

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  117 bits (296), Expect = 5e-30
 Identities = 84/307 (27%), Positives = 143/307 (46%), Gaps = 45/307 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLC 177
           ++E + ++G G Y  V+   +  + E   I  LK V+    +        REI +L N  
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLN-L 63

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDY 234
             PN+V+L ++V  +H  +  L+ EY       +L       ++  ++  + +LL+ L Y
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 235 CHSQGIMHRDVKPHNV-MIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLV 292
            H   I+HRD+K  N+ + D     L++ D+GLA  Y  P K    +V + +++ PELL+
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---------DELN 343
               Y  ++DMW++GC+ A +    +P   G    +QL  I ++LGT          +L 
Sbjct: 182 GCTTYTTAIDMWAVGCILAEL-LAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
               K+ L   P  +    +H + PW           +S   +  L+ LL YD + R TA
Sbjct: 241 LV-GKFTLPKQPYNNL---KH-KFPW-----------LSEAGLRLLNFLLMYDPKKRATA 284

Query: 404 REAMVIS 410
            EA+  S
Sbjct: 285 EEALESS 291

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  117 bits (294), Expect = 6e-30
 Identities = 89/298 (29%), Positives = 161/298 (54%), Gaps = 23/298 (7%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  D YE + K+G G Y+ V++G +    +   +K+++  +++       RE  +L+ L
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60

Query: 177 CGGPNVVKLLDIVRDQHSK-TPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKAL 232
               N+V L DI+   H+K T +L+FEYV++   + +  +P  L   +++ ++++LL+ L
Sbjct: 61  -KHANIVLLHDII---HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGL 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
            Y H + I+HRD+KP N++I  +  +L+L D+GLA     P   Y+  V + +++ P++L
Sbjct: 117 SYIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +   +Y   LDMW +GC+F  MI     F    D  DQL +I  VLGT   + +   + L
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235

Query: 352 -ELDPQLDALV-GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
               P+   L   ++ R+ W+K    ++       A D   KLL+   ++RL+A+ A+
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVNH-------AEDLASKLLQCFPKNRLSAQAAL 286

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  117 bits (293), Expect = 8e-30
 Identities = 88/307 (28%), Positives = 162/307 (52%), Gaps = 44/307 (14%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  + Y  + K+G G Y+ V++G +  T+    +K ++   ++       RE+ +L++L
Sbjct: 2   FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-------YDIRYYIYELL 229
               N+V L DI+  +  K+ +L+FEY++    K L   L D       ++++ ++++LL
Sbjct: 62  -KHANIVTLHDIIHTE--KSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLL 114

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGP 288
           + L+YCH + ++HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           ++L+   DY   +DMW +GC+F  M   + P F G    +QL  I ++LGT         
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRILGT--------- 223

Query: 349 YHLELDPQLDALVGRHSRKPWSKF----INADNQHLVSP----EAIDFLDKLLRYDHQDR 400
                 P  +   G  S + +  +      AD  H  +P    +  + L KLL+++ + R
Sbjct: 224 ------PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKR 277

Query: 401 LTAREAM 407
           ++A EAM
Sbjct: 278 ISAEEAM 284

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  116 bits (292), Expect = 8e-30
 Identities = 80/224 (35%), Positives = 120/224 (53%), Gaps = 16/224 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG 179
           + +EV+  VG G Y  V +  +  T E   IK  K  +     K+   RE+K+L+ L   
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQ 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYD-IRYYIYELLKALDYCH 236
            N+V+L +  R +      L+FEYV     ++L   P     + +R YIY+L+KA+ +CH
Sbjct: 60  ENIVELKEAFRRRGKLY--LVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 294
              I+HRD+KP N++I H    L+L D+G A     G    Y   VA+R+++ PELL+  
Sbjct: 118 KNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
             Y  ++DMWS+GC+  G +   +P F G    DQL  I KVLG
Sbjct: 176 APYGKAVDMWSVGCIL-GELSDGQPLFPGESEIDQLFTIQKVLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  116 bits (292), Expect = 1e-29
 Identities = 92/309 (29%), Positives = 157/309 (50%), Gaps = 48/309 (15%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  + Y  + K+G G Y+ VF+G +  T     +K ++   ++       RE+ +L++L
Sbjct: 2   FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKAL 232
               N+V L DIV    S T  L+FEY++  D K         ++ ++++ ++Y++L+ L
Sbjct: 62  -KHANIVTLHDIVHTDKSLT--LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGL 117

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
            YCH + ++HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P++L
Sbjct: 118 AYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------------ 339
           +   +Y   +DMW +GC+F  M   + P F G    D+L  I ++LGT            
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235

Query: 340 DELNAY-LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 398
           DE   Y   KY     PQ                IN   +  +  E I+ L K L+Y+ +
Sbjct: 236 DEFKNYNFPKY----KPQ--------------PLINHAPR--LDTEGIELLTKFLQYESK 275

Query: 399 DRLTAREAM 407
            R++A EAM
Sbjct: 276 KRISAEEAM 284

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  115 bits (289), Expect = 2e-29
 Identities = 75/232 (32%), Positives = 127/232 (54%), Gaps = 22/232 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           YE V ++G G Y +VF+  ++    R +   LK V+ +  +        RE+ +L++L  
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 179 --GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELL 229
              PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           +L+    Y   +D+WS+GC+FA M FR++P F G  + DQL KI  V+G   
Sbjct: 180 VLLQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPG 229

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  113 bits (285), Expect = 2e-28
 Identities = 91/306 (29%), Positives = 145/306 (47%), Gaps = 31/306 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIK----REIKILQNLC 177
           +   YE + K+G+G + EVF+  +  T +   +K +L   +K+       REIKILQ L 
Sbjct: 10  EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL- 68

Query: 178 GGPNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
              NVV L++I R + +       +  L+FE+    D   L        T  +I+  +  
Sbjct: 69  KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----YNVRVAS 282
           LL  L Y H   I+HRD+K  N++I  +   L+L D+GLA  +   K      Y  RV +
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
            +++ PELL+  +DY   +DMW  GC+ A M  R  P   G+    QL  I+++ G+   
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCGSITP 245

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS-PEAIDFLDKLLRYDHQDRL 401
             +     LEL  +++   G+  +           +  V  P A+D +DKLL  D   R+
Sbjct: 246 EVWPGVDKLELFKKMELPQGQKRKVK------ERLKPYVKDPHALDLIDKLLVLDPAKRI 299

Query: 402 TAREAM 407
            A  A+
Sbjct: 300 DADTAL 305

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  112 bits (283), Expect = 4e-28
 Identities = 89/302 (29%), Positives = 150/302 (49%), Gaps = 36/302 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPN 181
           Y++   +G+G Y  V   I+ +T E+  IK +  V        +I REIK+L+       
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR------- 54

Query: 182 VVKLLDIVRDQHSKTPS---------LIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLK 230
           +++  DIV  +H   P          ++FE + S   +V+     LT    ++++Y+LL+
Sbjct: 55  LLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR 114

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFK 286
           AL Y H+  + HRD+KP N++ + +  KL++ D+GLA          +     VA+R+++
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 287 GPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 345
            PEL       Y  ++D+WS+GC+FA ++  K P F G +   QL  I  +LGT      
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGTPSPETI 232

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
               + +    L ++  +       KF NAD      P A+  L++LL +D +DR TA E
Sbjct: 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNAD------PLALRLLERLLAFDPKDRPTAEE 286

Query: 406 AM 407
           A+
Sbjct: 287 AL 288

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 9e-28
 Identities = 88/320 (27%), Positives = 151/320 (47%), Gaps = 49/320 (15%)

Query: 127 YEVVRKVGRGKYSEVFE--GINVNTNERCIIKILKPVKKKKIK------REIKILQNLCG 178
           YE+   +GRG Y  V++    N    +   IK  K  K++         REI +L+ L  
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-K 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYV----------NSTDFKVLYPTLTDYDIRYYIYEL 228
             NVV L+++  +   K+  L+F+Y           +    +V  P      ++  ++++
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM---VKSLLWQI 117

Query: 229 LKALDYCHSQGIMHRDVKPHN--VMIDHELR-KLRLIDWGLAEFYH----PGKEYNVRVA 281
           L  + Y HS  ++HRD+KP N  VM +   R  +++ D GLA  ++    P  + +  V 
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVK 332
           + +++ PELL+  + Y  ++D+W++GC+FA ++   EP F G +           DQL +
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 333 IAKVLG--TDELNAYLNKYHLELDPQLDALVGRHSRK--PWSKFINADNQHL-VSPEAID 387
           I +VLG  T++    + K      P+ D L+     K  P +       +H     +  D
Sbjct: 237 IFEVLGTPTEKDWPDIKKM-----PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291

Query: 388 FLDKLLRYDHQDRLTAREAM 407
            L KLL YD   R+TA EA+
Sbjct: 292 LLRKLLEYDPTKRITAEEAL 311

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  110 bits (277), Expect = 9e-28
 Identities = 86/304 (28%), Positives = 155/304 (50%), Gaps = 38/304 (12%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNL 176
           +G  + Y  + K+G G Y+ VF+G +  T     +K ++   ++       RE+ +L+NL
Sbjct: 1   FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKAL 232
               N+V L DI+  +   T  L+FEY++S D K         ++ ++++ ++++LL+ L
Sbjct: 61  -KHANIVTLHDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGL 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
            YCH + I+HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P++L
Sbjct: 117 SYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +   +Y   +DMW +GC+   M   + P F G    ++L  I ++LGT            
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLIFRLLGT------------ 222

Query: 352 ELDPQLDALVGRHSRKPWSK--FINADNQHLVS------PEAIDFLDKLLRYDHQDRLTA 403
              P  +   G  S + +    F     Q L++       + ID L  LL Y+ + R++A
Sbjct: 223 ---PTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA 279

Query: 404 REAM 407
             A+
Sbjct: 280 EAAL 283

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 2e-27
 Identities = 77/302 (25%), Positives = 128/302 (42%), Gaps = 70/302 (23%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
           +G+G + +V      +T +   +K+LK   KKKI +         E  IL  +   P +V
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56

Query: 184 KLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKALDYC 235
           KL       H   +T     L+ EY    + F  L      ++   R+Y  E++ AL+Y 
Sbjct: 57  KL-------HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYL 109

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS GI++RD+KP N+++D +   ++L D+GLA E    G   N    +  +  PE+L   
Sbjct: 110 HSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL-LG 167

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D WSLG +   M+  K PF+   ++  ++                 +  L+  
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPFY--AEDRKEIY----------------EKILKDP 209

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP 414
            +                        +SPEA D +  LL+ D   RL +  A  I +  P
Sbjct: 210 LRFPE--------------------FLSPEARDLISGLLQKDPTKRLGSGGAEEIKA-HP 248

Query: 415 IF 416
            F
Sbjct: 249 FF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  108 bits (270), Expect = 1e-26
 Identities = 81/297 (27%), Positives = 145/297 (48%), Gaps = 31/297 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIK----REIKILQNL--CGG 179
           YE V ++G G Y  V++  + ++     +K ++    +  +     RE+ +L+ L     
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 180 PNVVKLLDIV----RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLK 230
           PN+V+L+D+      D+ +K  +L+FE+V+  D      KV  P L    I+  + + L+
Sbjct: 62  PNIVRLMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            LD+ H+  I+HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L+    Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++G            
Sbjct: 179 LLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGLPP--------- 227

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            E D   D  + R +  P            +       L ++L ++   R++A  A+
Sbjct: 228 -EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  108 bits (272), Expect = 3e-26
 Identities = 84/298 (28%), Positives = 148/298 (49%), Gaps = 28/298 (9%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGP 180
           D E  R +G G +  V+   +    +R  +K +  V       K++ RE+K+L       
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKML-CFFKHD 59

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYC 235
           NV+  LDI++  H      I+   E + S   K++     L+   ++ ++Y++L+ L Y 
Sbjct: 60  NVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYL 119

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELLVD 293
           HS GI+HRD+KP N++++     L++ D+GLA    P   K     V ++Y++ PE+L+ 
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D+WS+GC+FA ++ R+   F       QL  I  +LGT  L A   +   E 
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR-ILFQAQSPIQQLDLITDLLGTPSLEAM--RSACE- 234

Query: 354 DPQLDALVGRHSRKPWSK----FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                A + R   KP S      +++   H    EA+  L ++L +D   R++A +A+
Sbjct: 235 --GARAHILRGPHKPPSLPVLYTLSSQATH----EAVHLLCRMLVFDPDKRISAADAL 286

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  105 bits (265), Expect = 3e-26
 Identities = 73/284 (25%), Positives = 117/284 (41%), Gaps = 51/284 (17%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK--------KKIKREIKILQNLCGGPNVVK 184
           +G G +  V+EG+N++  +   +K +             K++++EI +L  L   PN+V+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQ 66

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
            L   R+       +  E V       L   Y +  +  IR Y  ++L  L+Y H +  +
Sbjct: 67  YLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           HRD+K  N+++D     ++L D+G+A+             S Y+  PE++     Y  + 
Sbjct: 125 HRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 302 DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV 361
           D+WSLGC    M   K P+        QL  +A V                        +
Sbjct: 184 DIWSLGCTVLEMATGKPPW-------SQLEGVAAVFK----------------------I 214

Query: 362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
           GR    P          HL S EA DF+ K L+ D   R TA E
Sbjct: 215 GRSKELP------PIPDHL-SDEAKDFILKCLQRDPSLRPTAAE 251

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (259), Expect = 4e-25
 Identities = 81/298 (27%), Positives = 130/298 (43%), Gaps = 52/298 (17%)

Query: 119 VQWGDQDD-YEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQN 175
           V  GD  + Y+ + K+G G   EV++  +  T +   IK   L+   K+ I  EI I+++
Sbjct: 12  VSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD 71

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPT---LTDYDIRYYIYELL 229
            C  PN+V   D           ++ EY++    TD  ++      + +  I Y   E+L
Sbjct: 72  -CKHPNIVDYYDSYLVG--DELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVL 126

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
           + L+Y HSQ ++HRD+K  N+++  +   ++L D+G  A+      + N  V + Y+  P
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E++   +DY   +D+WSLG M   M    EP                         YL  
Sbjct: 186 EVIKR-KDYGPKVDIWSLGIMCIEMA-EGEP------------------------PYLR- 218

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                +P L AL    + K         N    SPE  DFL+K L  D + R +A E 
Sbjct: 219 -----EPPLRALF-LITTKGIPPL---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 1e-24
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 18/205 (8%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGG 179
           D++++ +VG+G Y +VF     +T E   +K +K        + + +  E  IL      
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCH 236
             +VKLL   +D   +   L  EYV   DF+ L      L++   R+Y+ E+ +A+D  H
Sbjct: 61  EWLVKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 295
             G +HRD+KP N +ID     ++L D+GL++       Y N  V S  +  PE+L   +
Sbjct: 119 ELGYIHRDLKPENFLID-ASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRG-K 173

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            YD+++D WSLGCM    +    PF
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  102 bits (257), Expect = 2e-24
 Identities = 78/314 (24%), Positives = 143/314 (45%), Gaps = 58/314 (18%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-----------------REIKILQN 175
           +G G Y +V +  +  T +   IK +K ++                      RE+KI+  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALD 233
           +    N++ L+D+  +      +L+ + + S   KV+     LT+  ++  + ++L  L+
Sbjct: 77  I-KHENIMGLVDVYVEG--DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLN 133

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---------------EFYHPGKEYNV 278
             H    MHRD+ P N+ I+ +    ++ D+GLA               E     +E   
Sbjct: 134 VLHKWYFMHRDLSPANIFINSK-GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +V + +++ PELL+  + Y +++DMWS+GC+FA ++  K P F G +  DQL +I ++LG
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLGRIFELLG 251

Query: 339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWS-----KFINADNQHLVSPEAIDFLDKLL 393
           T   + +     L L  +         RKP          + D        AID L  LL
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTP------RKPKDLKTIFPNASDD--------AIDLLQSLL 297

Query: 394 RYDHQDRLTAREAM 407
           + +  +R++A+EA+
Sbjct: 298 KLNPLERISAKEAL 311

Length = 335

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 99.2 bits (248), Expect = 9e-24
 Identities = 79/292 (27%), Positives = 123/292 (42%), Gaps = 63/292 (21%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCGGPNVVK 184
           + +G Y  VF     +T +   IK++K  K   I++        E  IL      P VVK
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQ-AQSPYVVK 57

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
           L      Q  K   L+ EY+   D   L     +L +   R YI E++ AL+Y HS GI+
Sbjct: 58  LYYSF--QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---------YFKGPELLV 292
           HRD+KP N++ID     L+L D+GL++     ++ N+    +          +  PE+++
Sbjct: 116 HRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             Q +  ++D WSLGC+    +    PF   H    + +    +L          K    
Sbjct: 175 -GQGHSKTVDWWSLGCILYEFLVGIPPF---HGETPEEI-FQNILN--------GKI--- 218

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                           W + +       VS EAID + KLL  D + RL A+
Sbjct: 219 ---------------EWPEDVE------VSDEAIDLISKLLVPDPEKRLGAK 249

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 98.0 bits (245), Expect = 2e-23
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 20/209 (9%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGGP 180
            YE+++++G+G + +V+     +  +  ++K      +   +++    E+KIL+ L   P
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59

Query: 181 NVVKLLD-IVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           N++K  +            ++ EY +  D        K       +  I  +  +L  AL
Sbjct: 60  NIIKYYESFEEKGKL---CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 291
            Y HS+ I+HRD+KP N+ +      ++L D+G+++      +     V + Y+  PEL 
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            + + Y+Y  D+WSLGC+   +   K PF
Sbjct: 176 QN-KPYNYKSDIWSLGCVLYELCTLKHPF 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNV 182
             +E+V  +G G Y +V++  +  T +   IKI+  ++  +++IK E  IL+     PN+
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65

Query: 183 VKLLDIVRDQHSKTPS----LIFEYVNS---TD----FKVLYPTLTDYDIRYYIYELLKA 231
                    ++         L+ E       TD     +     L +  I Y + E L+ 
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPEL 290
           L Y H   ++HRD+K  N+++      ++L+D+G+ A+        N  + + Y+  PE+
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184

Query: 291 LV-DLQD---YDYSLDMWSLG 307
           +  D Q    YD   D+WSLG
Sbjct: 185 IACDEQPDASYDARSDVWSLG 205

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 97.4 bits (242), Expect = 2e-22
 Identities = 80/320 (25%), Positives = 155/320 (48%), Gaps = 35/320 (10%)

Query: 113 DYESLTVQWGDQ-----DDYEVVRKVGRGKYSEVFE------GINVNTNERCIIKILKPV 161
           D +  +VQ  D        Y+ ++ +G G    V        GINV      + K+ +P 
Sbjct: 4   DSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINV-----AVKKLSRPF 58

Query: 162 KK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLY 213
           +     K+  RE+ +L+ +    N++ LL++   Q S    +   L+ E +++   +V++
Sbjct: 59  QNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH 117

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
             L    + Y +Y++L  + + HS GI+HRD+KP N+++  +   L+++D+GLA      
Sbjct: 118 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTN 176

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                 V +RY++ PE+++ +  Y  ++D+WS+GC+   ++ +    F G D+ DQ  K+
Sbjct: 177 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKV 234

Query: 334 AKVLGTDELNAYLN------KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID 387
            + LGT     ++N      + ++E  PQ   +        W     ++   L + +A D
Sbjct: 235 IEQLGTPSAE-FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293

Query: 388 FLDKLLRYDHQDRLTAREAM 407
            L K+L  D   R++  EA+
Sbjct: 294 LLSKMLVIDPDKRISVDEAL 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 83/297 (27%), Positives = 133/297 (44%), Gaps = 67/297 (22%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKL 185
            K+G G + +V+  +N++T E   +K ++     P   K+I  E+K+L+ L   PN+VK 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKY 64

Query: 186 --LDIVRDQHSKTPSLIF-EYVN-STDFKVL-YPTLTDYD-IRYYIYELLKALDYCHSQG 239
             +++ R++       IF EY +  T  ++L +  + D   IR Y  +LL+ L Y HS G
Sbjct: 65  YGVEVHREK-----VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG 119

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PEL 290
           I+HRD+KP N+ +DH    ++L D+G A                  +          PE+
Sbjct: 120 IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNT----TTMGEEVQSLAGTPAYMAPEV 174

Query: 291 LV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           +     + +  + D+WSLGC+   M   K P +   DN  Q++                 
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNEFQIM----------------- 216

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
           +H          VG   + P    I    Q  +SPE  DFLD+ L  D + R TA E
Sbjct: 217 FH----------VGAGHKPP----IPDSLQ--LSPEGKDFLDRCLESDPKKRPTASE 257

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 95.6 bits (238), Expect = 9e-22
 Identities = 75/301 (24%), Positives = 148/301 (49%), Gaps = 29/301 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           Y+ ++ +G G    V    +  T +   IK L          K+  RE+ +++ L    N
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKN 76

Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           ++ LL++   Q S    +   L+ E +++   +V+   L    + Y +Y++L  + + HS
Sbjct: 77  IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS 136

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  Y
Sbjct: 137 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 194

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             ++D+WS+GC+   MI R    F G D+ DQ  KI + LGT   + ++++    L P +
Sbjct: 195 KENVDIWSVGCIMGEMI-RGTVLFPGTDHIDQWNKIIEQLGTPS-DEFMSR----LQPTV 248

Query: 358 DALV---GRHSRKPWSKFI--------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
              V    +++   + +          +  +  L + +A D L K+L  D + R++  +A
Sbjct: 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308

Query: 407 M 407
           +
Sbjct: 309 L 309

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 56/209 (26%), Positives = 108/209 (51%), Gaps = 20/209 (9%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGP 180
           +Y++   +GRG +  V++G+N+ T +   IK +   K K+     I +EI +L+NL   P
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIYELLKALDY 234
           N+VK +  +    S +  +I EY    +   L   +  +       +  Y+Y++L+ L Y
Sbjct: 60  NIVKYIGSIET--SDSLYIILEYA---ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 293
            H QG++HRD+K  N++   +   ++L D+G+A +     K+    V + Y+  PE +++
Sbjct: 115 LHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE-VIE 172

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
           +     + D+WSLGC    ++    P++ 
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYD 201

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 56/211 (26%), Positives = 104/211 (49%), Gaps = 19/211 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
            ++++ +K+G+G++S V++ I +       +K ++         ++   +EI +L+ L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-D 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
            PNV+K L    + +     ++ E  ++ D       FK     + +  I  Y  +L  A
Sbjct: 61  HPNVIKYLASFIENNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS+ IMHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           + +   Y++  D+WSLGC+   M   + PF+
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 91.8 bits (228), Expect = 4e-21
 Identities = 78/299 (26%), Positives = 124/299 (41%), Gaps = 51/299 (17%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI---KREIKILQNLCGGPNVV 183
           ++ + +G +  V+     +T +   IK+LK    + K ++   K E  I+      P V 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGI 240
           KL      Q      L+ EY+N  D   L  TL        + YI E++  ++  H +GI
Sbjct: 61  KLYYSF--QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 300
           +HRD+KP N++ID +   L+L D+GL+      K++   V +  +  PE ++ + D D  
Sbjct: 119 IHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGD-DKM 173

Query: 301 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL 360
            D WSLGC+    +F   PF   H      V    +L                       
Sbjct: 174 SDWWSLGCVIFEFLFGYPPF---HAETPDAV-FDNIL----------------------- 206

Query: 361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV 419
                R  W + +        SPEA+D +++LL  D   RL A     I S  P F  +
Sbjct: 207 ---SRRINWPEEVK----EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS-HPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 90.8 bits (226), Expect = 7e-21
 Identities = 52/192 (27%), Positives = 105/192 (54%), Gaps = 15/192 (7%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPN 181
           ++ ++++ K+G G Y  V++ I+  T +   IK++ PV++  ++I +EI IL+  C  P 
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPY 59

Query: 182 VVKLL-DIVRDQHSKTPSLIFEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYCH 236
           +VK      ++       ++ EY  +       K+   TLT+ +I   +Y+ LK L+Y H
Sbjct: 60  IVKYYGSYFKNTDL---WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S   +HRD+K  N++++ E  + +L D+G++ +      + N  + + ++  PE++ +  
Sbjct: 117 SNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174

Query: 296 DYDYSLDMWSLG 307
            Y+   D+WSLG
Sbjct: 175 GYNNKADIWSLG 186

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 53/286 (18%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIK---REIKILQNLCGGP 180
           +E++R +G+G + +V      +T +   +K +   K V+K  ++    E +ILQ L   P
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
            +V L    +D   +   L+ + +   D +  Y        ++  ++++I E++ AL+Y 
Sbjct: 61  FLVNLWYSFQD--EENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEYL 116

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+GI+HRD+KP N+++D E   + + D+ +A    P         +  +  PE+L   Q
Sbjct: 117 HSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-Q 174

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D WSLG      +  K P + GH    +    AK    D L             
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP-YRGHSRTIRDQIRAKQETADVL------------- 220

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                        WS             EAID ++KLL  D Q RL
Sbjct: 221 ---------YPATWST------------EAIDAINKLLERDPQKRL 245

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 90.9 bits (225), Expect = 4e-20
 Identities = 77/300 (25%), Positives = 143/300 (47%), Gaps = 28/300 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 181
           Y+ ++ +G G    V    +        IK L +P +     K+  RE+ +L       N
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 84

Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           ++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + HS
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 202

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             ++D+WS+GC+   MI      F G D+ DQ  K+ + LGT        ++  +L P +
Sbjct: 203 KENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPTV 256

Query: 358 DALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              V    +     F          AD++H  L + +A D L K+L  D   R++  EA+
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 90.1 bits (223), Expect = 7e-20
 Identities = 78/300 (26%), Positives = 145/300 (48%), Gaps = 28/300 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 181
           Y+ ++ +G G    V    +   +    IK L +P +     K+  RE+ +L       N
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKCVNHKN 77

Query: 182 VVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           ++ LL++   Q S    +   L+ E +++   +V+   L    + Y +Y++L  + + HS
Sbjct: 78  IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GY 195

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P +
Sbjct: 196 KENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPTV 249

Query: 358 DALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              V    +     F          AD++H  L + +A D L K+L  D   R++  EA+
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 87.4 bits (216), Expect = 4e-19
 Identities = 77/309 (24%), Positives = 143/309 (46%), Gaps = 37/309 (11%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNLCGGPNVVKLLD 187
           KVGRG Y  V++    +  +      LK ++   I     REI +L+ L   PNV+ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYA-LKQIEGTGISMSACREIALLREL-KHPNVIALQK 65

Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCH 236
           +      +   L+F+Y     + ++              L    ++  +Y++L  + Y H
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 237 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 289
           +  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKVLGTD 340
           LL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V+G  
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF--LDKLLRYDHQ 398
               + +   +   P L     R +    S  I    +H V P++  F  L KLL  D  
Sbjct: 245 ADKDWEDIRKMPEYPTLQKDF-RRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303

Query: 399 DRLTAREAM 407
            R+T+ +A+
Sbjct: 304 KRITSEQAL 312

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 78/311 (25%), Positives = 145/311 (46%), Gaps = 41/311 (13%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----REIKILQNLCGGPNVVKLLD 187
           KVGRG Y  V++    +  +      LK ++   I     REI +L+ L   PNV+ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYA-LKQIEGTGISMSACREIALLREL-KHPNVISLQK 65

Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCH 236
           +      +   L+F+Y     + ++              L    ++  +Y++L  + Y H
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 237 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 289
           +  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVKIAKVLGTD 340
           LL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +I  V+G  
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG-- 242

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSK--FINADNQHLVSPE--AIDFLDKLLRYD 396
              A  +   ++  P+   L+    R  ++    I    +H V P+  A   L KLL  D
Sbjct: 243 -FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 301

Query: 397 HQDRLTAREAM 407
              R+T+ +AM
Sbjct: 302 PIKRITSEQAM 312

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 86/326 (26%), Positives = 132/326 (40%), Gaps = 91/326 (27%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI-----KREIKILQNL 176
           DD+EV++ +GRG + EV+   + +T +   +K+L+    +K+ +I     +R+I    + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD- 59

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
              P +VKL    +D+      L+ EY+   D   L        +   R+YI EL+ ALD
Sbjct: 60  --SPWIVKLYYSFQDEEHLY--LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115

Query: 234 YCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLA----------------------- 267
             H  G +HRD+KP N++ID   H    ++L D+GL                        
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGH----IKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 268 ---EFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                    K+  VR    V +  +  PE+L     Y    D WSLG +   M++   P 
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPP- 229

Query: 321 FYGHDNHDQLVKIAKVLGTDELNAYLN-KYHLELDPQLDALVGRHSRKPWSKFINADNQH 379
           FY     +   KI            +N K  L   P                        
Sbjct: 230 FYSDTLQETYNKI------------INWKESLRFPP----------------------DP 255

Query: 380 LVSPEAIDFLDKLLRYDHQDRLTARE 405
            VSPEAID + +LL  D +DRL + E
Sbjct: 256 PVSPEAIDLICRLLC-DPEDRLGSFE 280

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 18/200 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNV 182
           D +E++  +G+G Y +V++  N        +KIL P+    ++I+ E  ILQ+L   PNV
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81

Query: 183 VKLLDIV--RDQHSKTPS-LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKAL 232
           VK   +    D+       L+ E  N      L          L +  I Y +Y  L  L
Sbjct: 82  VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 291
            + H+  I+HRDVK +N+++  E   ++L+D+G+ A+        N  V + ++  PE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200

Query: 292 VDLQDYDYSL----DMWSLG 307
              Q YDYS     D+WSLG
Sbjct: 201 ACEQQYDYSYDARCDVWSLG 220

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 55/210 (26%), Positives = 106/210 (50%), Gaps = 19/210 (9%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERC------IIKILKPVKKKKIKREIKILQNLCGG 179
           ++++ +K+GRG++SEV+    +   +        I +++    ++   +EI +L+ L   
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           PNV+K LD   + +    +++ E  ++ D       FK     + +  +  Y  +L  A+
Sbjct: 62  PNVIKYLDSFIEDNEL--NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 291
           ++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +   Y++  D+WSLGC+   M   + PF+
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 73/299 (24%), Positives = 130/299 (43%), Gaps = 68/299 (22%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK-------------KKIKREIKILQNLCGG 179
           +G+G Y  V+  +NV T E   +K ++                 K ++ EI+ L++L   
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCH 236
            N+V+ L     +  +  S+  EYV          T   ++   +R++  ++L+ L Y H
Sbjct: 68  LNIVQYLGFETTE--EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL----AEFYHPGKEYNVRVASRYFKGPELLV 292
           S+GI+HRD+K  N+++D +    ++ D+G+     + Y   +  +++  S ++  PE ++
Sbjct: 126 SKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE-VI 182

Query: 293 DLQDYDYS--LDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
                 YS  +D+WSLGC    MFAG    + P+                   +E  A +
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAG----RRPW-----------------SDEEAIAAM 221

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
            K            +G     P    I  D    +SP A+DFL+     +  +R TARE
Sbjct: 222 FK------------LGNKRSAP---PIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 20/209 (9%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG--PNVVKLL 186
           +GRG Y  V+ G +V T     +KI+           I+RE+ +L  L     PN+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 187 DIVRDQHSKTPSL--IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMH 242
                 + K P L  I EY      + L     + +  I   I E+L AL Y H  G++H
Sbjct: 69  G----SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIH 124

Query: 243 RDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           RD+K  N+++ +    ++L D+G+ A       + +  V + Y+  PE++ + + YD   
Sbjct: 125 RDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183

Query: 302 DMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           D+WSLG     M     P    + + D  
Sbjct: 184 DIWSLGITIYEMATGNPP----YSDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 79.7 bits (197), Expect = 8e-17
 Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 51/214 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
           DDYE++  +G G  + V+  I +  NE+  IK +          ++++E++ + + C  P
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59

Query: 181 NVVK----------------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD 218
           NVVK                      LLDI++   S  P    +                
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAI------------- 103

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPG---- 273
             I   + E+LK L+Y HS G +HRD+K  N+++  E   +++ D+G+ A     G    
Sbjct: 104 --IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTR 160

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           K     V +  +  PE++  +  YD+  D+WS G
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG 194

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 23/225 (10%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIK-----ILKPVKKKKIKREIKILQNLCGGP 180
           DYEV+  +G+G +  V +    +  +  + K      +   +K+++  E+ IL+ L   P
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIY----ELLKALD 233
           N+V+  D + D+ ++T  ++ EY    D   L         Y    +I+    +LL AL 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 234 YCH-----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKG 287
            CH        ++HRD+KP N+ +D     ++L D+GLA+       +    V + Y+  
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK 332
           PE L     YD   D+WSLGC+   +     P F    N  QL  
Sbjct: 179 PEQLNH-MSYDEKSDIWSLGCLIYELCALSPP-FTAR-NQLQLAS 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 49/191 (25%), Positives = 95/191 (49%), Gaps = 12/191 (6%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGP 180
           + + ++  +G+G + EV++ I+  TN+   IK++   + +     I++EI+ L   C  P
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQ 238
            + K              +I EY    +   +L P  L +  I + + E+L  L+Y H +
Sbjct: 60  YITKYYGSFLKGSKLW--IIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           G +HRD+K  N+++  E   ++L D+G++ +      + N  V + ++  PE++     Y
Sbjct: 118 GKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-SGY 175

Query: 298 DYSLDMWSLGC 308
           D   D+WSLG 
Sbjct: 176 DEKADIWSLGI 186

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 64/297 (21%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL-------KPVKKKK-----IKREIKILQNLCGGP 180
           +G G +  V+ G+N ++ E   +K +           +K+     + REI +L+ L    
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+ L    D       +  EYV       L   Y    +  +R ++ ++LK L+Y H+
Sbjct: 67  NIVQYLGSSLDADHLN--IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-------YFKGPEL 290
           +GI+HRD+K  N+++D++   +++ D+G+++             +R       ++  PE 
Sbjct: 125 RGIIHRDIKGANILVDNK-GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE- 182

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +V    Y    D+WSLGC+   M+  K PF     +  QL  I K+              
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFKI-------------- 224

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                               +  + +    +S EAIDFL+K    DH  R TA E +
Sbjct: 225 -------------------GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKR----EIKILQNLCGGPNVVKLL 186
           +G+G + EV       T +    K L  K +KK+K ++    E KIL+       +V L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSL- 58

Query: 187 DIVRDQHSKTP-SLIFEYVNSTDFK-----VLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
                  +K    L+   +N  D K     V  P   +    +Y  +++  L++ H + I
Sbjct: 59  --AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI 116

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 300
           ++RD+KP NV++D +   +R+ D GLA     GK+   R  +  +  PE+L   + YD+S
Sbjct: 117 VYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFS 174

Query: 301 LDMWSLGCMFAGMIFRKEPF 320
           +D ++LGC    MI  + PF
Sbjct: 175 VDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 34/223 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKK---IKREIKILQNLCG 178
           DD+E ++ +G G +  V    +  + +   +KIL   K VK K+   +  E +ILQ++  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYC 235
            P +V L      Q      L+ EYV   + F  L       +   R+Y  +++ AL+Y 
Sbjct: 61  -PFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--------G 287
           HS  I++RD+KP N+++D +   +++ D+G A           RV  R +          
Sbjct: 118 HSLDIVYRDLKPENLLLDSD-GYIKITDFGFA----------KRVKGRTYTLCGTPEYLA 166

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           PE+++  + Y  ++D W+LG +   M+    PFF   DN  Q+
Sbjct: 167 PEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFF--DDNPIQI 206

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNV 182
           D +E++  +G+G Y +VF+ +N     +  +KIL P+    ++I+ E  IL+ L   PNV
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 183 VKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKAL 232
           VK   +   +  K      L+ E  N      L          + +  I Y ++E L  L
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 291
            + H    +HRDVK +N+++  E   ++L+D+G+ A+        N  V + ++  PE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196

Query: 292 VDLQD----YDYSLDMWSLG 307
              Q     YD   D+WSLG
Sbjct: 197 ACEQQLDSTYDARCDVWSLG 216

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.1 bits (190), Expect = 6e-16
 Identities = 48/207 (23%), Positives = 92/207 (44%), Gaps = 19/207 (9%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
           ++++G G + +V    ++ +  NT E+  +K L        +   +REI+IL+ L    N
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN 67

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR----YYIYELLKALDYCHS 237
           +VK   +      ++  LI EY+ S   +       D         +  ++ K +DY  S
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVD 293
           Q  +HRD+   N++++ E   +++ D+GLA+     K+Y        +  ++  PE L  
Sbjct: 128 QRYIHRDLAARNILVESE-DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            +    S D+WS G     +    +P 
Sbjct: 187 SKFSSAS-DVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.5 bits (189), Expect = 8e-16
 Identities = 69/292 (23%), Positives = 133/292 (45%), Gaps = 52/292 (17%)

Query: 133 VGRGKYSEVFEGINVNTNE----RCIIK--ILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           +G G +  V      + N     +C+ K  I++  +++ I  E +IL+  C  P +VKL 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLY 59

Query: 187 DIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHR 243
              +D+  K   ++ EY    + + +L       +Y  R+YI  ++ A +Y H++GI++R
Sbjct: 60  RTFKDK--KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117

Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 303
           D+KP N+++D     ++L+D+G A+    G++      +  +  PE++++ + YD+S+D 
Sbjct: 118 DLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDY 175

Query: 304 WSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGR 363
           WSLG +   ++  + PF  G D+ D +     +L             LE           
Sbjct: 176 WSLGILLYELLTGRPPF--GEDDEDPMEIYNDILK--------GNGKLE----------- 214

Query: 364 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI 415
                +  +I           A D + +LLR + ++RL      +   I  I
Sbjct: 215 -----FPNYI--------DKAAKDLIKQLLRRNPEERL----GNLKGGIKDI 249

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 14/194 (7%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGP 180
           Q+DYE+++++G G Y +V++  ++ T E   IK++K       + I++EI +L+  C  P
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRHP 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV--NSTD--FKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N+V        +      ++ EY    S    ++V    L++  I Y   E LK L Y H
Sbjct: 61  NIVAYFGSYLRRD--KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
             G +HRD+K  N+++  E   ++L D+G+ A+      +    + + Y+  PE+    +
Sbjct: 119 ETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177

Query: 296 --DYDYSLDMWSLG 307
              YD   D+W+LG
Sbjct: 178 KGGYDGKCDIWALG 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 79.0 bits (194), Expect = 1e-15
 Identities = 65/260 (25%), Positives = 125/260 (48%), Gaps = 44/260 (16%)

Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVK 162
           P +Y D ES        ++YEV++K+G G++ EVF   +  T E    K      LK  +
Sbjct: 2   PGKYDDGESRL------NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE 55

Query: 163 KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-------VLYPT 215
           K ++  E+ +++ L    N+V+ +D   ++ ++   ++ E+ ++ D          ++  
Sbjct: 56  KSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114

Query: 216 LTDYDIRYYIYELLKALDYCHS-------QGIMHRDVKPHNVMIDHELRKL--------- 259
           + ++ I     +LL AL YCH+       + ++HRD+KP N+ +   +R +         
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174

Query: 260 -------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV-DLQDYDYSLDMWSLGCMFA 311
                  ++ D+GL++        +  V + Y+  PELL+ + + YD   DMW+LGC+  
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234

Query: 312 GMIFRKEPFFYGHDNHDQLV 331
            +   K P F+  +N  QL+
Sbjct: 235 ELCSGKTP-FHKANNFSQLI 253

Length = 1021

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 25/215 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNL 176
            D++V   VGRG + EV       T +   +K++K         V   + +R+I  + N 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYD-IRYYIYELLKAL 232
              P + +L    +D+ +    L+ EY    D   L   Y    D D  ++Y+ EL+ A+
Sbjct: 60  --SPWIPQLQYAFQDKDNLY--LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI 115

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPEL 290
              H  G +HRD+KP NV+ID     ++L D+G A      K  N +  V +  +  PE+
Sbjct: 116 HSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174

Query: 291 LVDLQD-----YDYSLDMWSLGCMFAGMIFRKEPF 320
           L  +       Y    D WSLG +   MI+ + PF
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 47/290 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
            D E V+ +G+G    V++  +  T +   +K +        +K++ RE+K L++ C  P
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
            VVK             S++ EY++     D       + +  + Y   ++LK LDY H+
Sbjct: 60  YVVKCYGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 238 Q-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 295
           +  I+HRD+KP N++I+ +  ++++ D+G+++      +  N  V +  +  PE +   +
Sbjct: 118 KRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y Y+ D+WSLG         K PF                    EL   +        P
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPF-----------LPPGQPSFFELMQAICD---GPPP 221

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
            L A                      SPE  DF+   L+ D + R +A E
Sbjct: 222 SLPA-------------------EEFSPEFRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 60/234 (25%), Positives = 106/234 (45%), Gaps = 23/234 (9%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---------IKREIKILQNLCGGPNVV 183
           +G G +S  ++  +V T     +K +  V+            +++EI+++  L   P+++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHII 66

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGI 240
           ++L           +L  E++       L   Y    +  I  Y  +LL+ L Y H   I
Sbjct: 67  RMLGAT--CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           +HRDVK  N++ID   ++LR+ D+G A     +    G+     + +  F  PE+L   +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-E 183

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF-FYGHDNHDQLV-KIAKVLGTDELNAYLN 347
            Y  S D+WS+GC+   M   K P+    H NH  L+ KIA       +  +L+
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 56/210 (26%), Positives = 104/210 (49%), Gaps = 19/210 (9%)

Query: 126 DYEVVRKVGRGKYSEVF------EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG 179
           ++ + +K+GRG++SEV+      +G+ V   +  I  ++    +    +EI +L+ L   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           PNV+K      + +    +++ E  ++ D       FK     + +  +  Y  +L  AL
Sbjct: 62  PNVIKYYASFIEDNEL--NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELL 291
           ++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE +
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +   Y++  D+WSLGC+   M   + PF+
Sbjct: 179 HE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 37/205 (18%)

Query: 131 RKVGRGKYSEVFEGI---NVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNVV 183
           +K+G G + EV++G             +K LK      ++K   +E ++++ L G PNVV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFK------------VLYPTLTDYDIRYYIYELLKA 231
           +LL +  ++      L+ EY+   D                  TL+  D+  +  ++ K 
Sbjct: 60  RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           ++Y  S+  +HRD+   N ++  +L  +++ D+GL+   +    Y  +       G    
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLV-VKISDFGLSRDVYDDDYYRKKT-----GGKLPI 171

Query: 288 ----PELLVDLQDYDYSLDMWSLGC 308
               PE L D   +    D+WS G 
Sbjct: 172 RWMAPESLKD-GIFTSKSDVWSFGV 195

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGPNVV 183
           +R++G G +  V+   +V TNE   IK +    K+       I +E+K LQ +   PN +
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSI 88

Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           +       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS  +
Sbjct: 89  EYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
           +HRD+K  N+++  E  +++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 147 IHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYD 202

Query: 299 YSLDMWSLGCMFAGMIFRKEPFF 321
             +D+WSLG     +  RK P F
Sbjct: 203 GKVDVWSLGITCIELAERKPPLF 225

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 20/211 (9%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQNLCGGPN 181
           R +GRG Y++V   + +  N++  I  +K VKK+ +         + E  + +     P 
Sbjct: 1   RVIGRGSYAKVLL-VRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ 238
           +V L      Q +    L+ EYVN  D          L +   R+Y  E+  AL++ H +
Sbjct: 58  LVGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           GI++RD+K  NV++D +   ++L D+G+  E   PG   +    +  +  PE+L   ++Y
Sbjct: 116 GIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEY 173

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
            +S+D W+LG +   M+  + PF    DN D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKL 185
           + K+G+G + EVF+GI+  T +   IKI+   + +     I++EI +L   C  P V K 
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKY 67

Query: 186 L-DIVRDQHSKTPSLIFEYVNS-TDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMH 242
               ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  +H
Sbjct: 68  YGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124

Query: 243 RDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           RD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD   
Sbjct: 125 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKA 182

Query: 302 DMWSLGCMFAGMIFRKEP 319
           D+WSLG + A  + + EP
Sbjct: 183 DIWSLG-ITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 18/203 (8%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGPNVV 183
           +R++G G +  V+   +V  +E   IK +    K+       I +E++ LQ L   PN +
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78

Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           +       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS  +
Sbjct: 79  QYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
           +HRDVK  N+++  E   ++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192

Query: 299 YSLDMWSLGCMFAGMIFRKEPFF 321
             +D+WSLG     +  RK P F
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 32/219 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQNLCGGPN 181
           R +GRG Y++V   + +   ER  I  +K VKK+ +         + E  + +     P 
Sbjct: 1   RVIGRGSYAKVLL-VRLKKTER--IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57

Query: 182 VVKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYP---TLTDYDIRYYIYELLKALD 233
           +V L       HS  +T S +F   EYVN  D          L +   R+Y  E+  AL+
Sbjct: 58  LVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
           Y H +GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  PE+L 
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 169

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF--FYGHDNHDQ 329
             +DY +S+D W+LG +   M+  + PF      DN DQ
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 81/315 (25%), Positives = 139/315 (44%), Gaps = 60/315 (19%)

Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD +  Y    K+G+G    VF  I+V T +   IK   + K  KK+ I  EI +++
Sbjct: 12  VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLK 230
            L   PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+
Sbjct: 72  EL-KNPNIVNFLDSFLVGDELF----VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
           AL++ H+  ++HRD+K  NV++  +   ++L D+G      P + + +  V + Y+  PE
Sbjct: 127 ALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            +V  + Y   +D+WSLG M   M+  + P+   ++N  + + +    GT EL       
Sbjct: 186 -VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQ------ 236

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE---- 405
                                      N   +SP   DFL++ L  D + R +A+E    
Sbjct: 237 ---------------------------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269

Query: 406 -----AMVISSISPI 415
                A  +SS++P+
Sbjct: 270 PFLKLAKPLSSLTPL 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK------KIKREIKILQNLCGGPNVV 183
           + ++G G +  V+   N +TNE   +K +    K+       I +E+K LQ L   PN +
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTI 84

Query: 184 KLLDIVRDQHSKTPSLIFEYV--NSTD-FKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           +       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS  +
Sbjct: 85  EYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 298
           +HRD+K  N+++  E  +++L D+G A    P   +   V + Y+  PE+++ + +  YD
Sbjct: 143 IHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYD 198

Query: 299 YSLDMWSLGCMFAGMIFRKEPFF 321
             +D+WSLG     +  RK P F
Sbjct: 199 GKVDVWSLGITCIELAERKPPLF 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 30/208 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---------IKREIKILQNLCGGPN 181
           R +GRG Y++V   + +    R  I  +K +KK+          ++ E  + +     P 
Sbjct: 1   RVIGRGSYAKVLL-VELKKTRR--IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPF 57

Query: 182 VVKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYP---TLTDYDIRYYIYELLKALD 233
           +V L       HS  +T S +F   E+V+  D          L +   R+Y  E+  AL+
Sbjct: 58  LVGL-------HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
           + H +GI++RD+K  NV++D E   ++L D+G+  E   PG   +    +  +  PE+L 
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             +DY +S+D W+LG +   M+  + PF
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 18/162 (11%)

Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 182
           +K+G G + EV++G              +K LK        ++  RE +I++ L   PNV
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHS 237
           VKLL +  ++      ++ EY+   D    Y     P L+  D+  +  ++ + ++Y  S
Sbjct: 64  VKLLGVCTEEEP--LYIVMEYMEGGDLL-SYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279
           +  +HRD+   N ++   L  +++ D+GL+   +    Y  R
Sbjct: 121 KNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYRKR 161

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 65/296 (21%), Positives = 120/296 (40%), Gaps = 54/296 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
           DD E + ++G G    V + ++  T +   +K     +    +K+I RE+ IL   C  P
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 236
            +V       +      S+  EY++      +       + +  +      +LK L Y H
Sbjct: 60  YIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 237 SQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 291
            +  I+HRDVKP N++++    +++L D+G++     G+  N      V +  +  PE +
Sbjct: 118 EKHKIIHRDVKPSNILVNS-RGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
               DY    D+WSLG     +   + P+       +       +   + L   +N    
Sbjct: 172 QGN-DYSVKSDIWSLGLSLIELATGRFPY----PPENDPPD--GIF--ELLQYIVN---- 218

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           E  P+L          P  KF         SP+  DF++  L  D ++R + +E +
Sbjct: 219 EPPPRL----------PSGKF---------SPDFQDFVNLCLIKDPRERPSYKELL 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 56/185 (30%), Positives = 96/185 (51%), Gaps = 16/185 (8%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLD 187
           ++G+G + EV++GI+  T E   IKI+   + +     I++EI +L   C  P + +   
Sbjct: 11  RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYITRYYG 69

Query: 188 IVRDQHSKTPSL--IFEYVNS-TDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHR 243
                + K   L  I EY+   +   +L P  L +  I   + E+LK LDY HS+  +HR
Sbjct: 70  ----SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHR 125

Query: 244 DVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
           D+K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    YD+  D
Sbjct: 126 DIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKAD 183

Query: 303 MWSLG 307
           +WSLG
Sbjct: 184 IWSLG 188

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 54/211 (25%), Positives = 103/211 (48%), Gaps = 15/211 (7%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPN 181
           Q+D+E+++++G G Y +V++  NVNT E   IK++K  P +   + ++  I+   C   N
Sbjct: 8   QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 182 VVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCH 236
           +V      + RD+      +  E+      + +Y     L++  I Y   E L+ L Y H
Sbjct: 68  IVAYFGSYLRRDKL----WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S+G MHRD+K  N+++      ++L D+G+ A+      +    + + Y+  PE+    +
Sbjct: 124 SKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182

Query: 296 D--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
              Y+   D+W++G     +   + P F  H
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 29/216 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
           +DYEVV+ +GRG + EV    + +T +   +K+L   K + IKR       E + +    
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
             P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ AL
Sbjct: 101 NSPWVVQLFYAFQD--DRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 155

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 288
           D  HS G +HRDVKP N+++D +   L+L D+G        KE  VR    V +  +  P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 212

Query: 289 ELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           E+L        Y    D WS+G     M+    PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.0 bits (168), Expect = 3e-13
 Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 17/197 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVK 184
           +E+V  VG G Y +V++G +V T +   IK++     ++++IK+EI +L+      N+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 185 LLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYC 235
                  ++         L+ E+  +     L       TL +  I Y   E+L+ L + 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H   ++HRD+K  NV++  E  +++L+D+G+ A+        N  + + Y+  PE++   
Sbjct: 128 HQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 295 QD----YDYSLDMWSLG 307
           ++    YD+  D+WSLG
Sbjct: 187 ENPDATYDFKSDLWSLG 203

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 20/222 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPNV 182
           YE+++K+G G + +++     + +E C+IK +     PVK+K+  ++  IL      PN+
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFK--------VLYPTLTDYDIRYYIYELLKALDY 234
           V        Q +    ++ EY +  D          VL+   ++  I  +  ++   L +
Sbjct: 62  VTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQISLGLKH 116

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 293
            H + I+HRD+K  N+ +       +L D+G+A   +   E     V + Y+  PE+  +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            + Y+   D+WSLGC+   +   K P F G++ H  ++KI +
Sbjct: 177 -RPYNNKTDIWSLGCVLYELCTLKHP-FEGNNLHQLVLKICQ 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 76/293 (25%), Positives = 121/293 (41%), Gaps = 60/293 (20%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLCGGP 180
           +  +R++G G +  V+   +V TNE   IK +    K+       I +E++ LQ     P
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ-LRHP 75

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV--NSTD-FKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N ++       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y HS
Sbjct: 76  NTIEYKGCYLREH--TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 238 QGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVDL 294
              +HRD+K  N+++ +    KL   D+G A    P    N  V + Y+  PE  L +D 
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLA--DFGSASLVSPA---NSFVGTPYWMAPEVILAMDE 188

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             YD  +D+WSLG     +  RK P F                    +NA    YH+  +
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQN 229

Query: 355 --PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
             P L       S   WS                +F+D  L+   QDR ++ E
Sbjct: 230 DSPTL-------SSNDWSD------------YFRNFVDSCLQKIPQDRPSSEE 263

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 68.3 bits (168), Expect = 4e-13
 Identities = 37/162 (22%), Positives = 75/162 (46%), Gaps = 17/162 (10%)

Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNV 182
           +K+G G + EV++G              +K LK        ++  RE +I++ L   PN+
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFK-VL----YPTLTDYDIRYYIYELLKALDYCHS 237
           VKLL +  ++      ++ EY+   D    L       L+  D+  +  ++ + ++Y  S
Sbjct: 64  VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279
           +  +HRD+   N ++   L  +++ D+GL+   +    Y V+
Sbjct: 122 KNFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYKVK 162

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 57/186 (30%), Positives = 95/186 (51%), Gaps = 18/186 (9%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLD 187
           ++G+G + EVF+GI+  T +   IKI+   + +     I++EI +L   C  P V K   
Sbjct: 11  RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKYYG 69

Query: 188 IVRDQHSKTPSL--IFEYV---NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMH 242
                + K   L  I EY+   ++ D     P   ++ I   + E+LK LDY HS+  +H
Sbjct: 70  ----SYLKGTKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIH 124

Query: 243 RDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           RD+K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    YD   
Sbjct: 125 RDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKA 182

Query: 302 DMWSLG 307
           D+WSLG
Sbjct: 183 DIWSLG 188

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 53/197 (26%), Positives = 98/197 (49%), Gaps = 17/197 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVK 184
           +E+V  VG G Y +V++G +V T +   IK++   +  +++IK EI +L+      N+  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 185 LLDIVRDQ----HSKTPSLIFEYVNS---TDF--KVLYPTLTDYDIRYYIYELLKALDYC 235
                  +    H     L+ E+  +   TD         L +  I Y   E+L+ L + 
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  ++HRD+K  NV++  E  +++L+D+G+ A+        N  + + Y+  PE++   
Sbjct: 138 HAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 196

Query: 295 QD----YDYSLDMWSLG 307
           ++    YDY  D+WSLG
Sbjct: 197 ENPDATYDYRSDIWSLG 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 68.2 bits (166), Expect = 7e-13
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
           +G+G +  V+   +V+T      K ++     P   K++     EI++L+NL     +V+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD+  KT ++  EY+     K     Y  LT+   R Y  ++L+ + Y HS  I+
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128

Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D     ++L D+G    L      G        + Y+  PE ++  + Y
Sbjct: 129 HRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE-VISGEGY 186

Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
               D+WSLGC    M+  K P+
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 67.8 bits (165), Expect = 8e-13
 Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
           +G+G +  V+   + +T     +K ++     P   K++     EI++L+NL     +V+
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH-ERIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD   +T S+  E++     K     Y  LT+   R Y  ++L+ + Y HS  I+
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128

Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D  +  ++L D+G    L      G        + Y+  PE ++  + Y
Sbjct: 129 HRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VISGEGY 186

Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
               D+WS+GC    M+  K P+
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 22/215 (10%)

Query: 119 VQWGDQD-DYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD    Y    K+G+G    V+  I+V T +   IK   + +  KK+ I  EI +++
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYV---NSTDFKVLYPTLTDYDIRYYIYELL 229
                PN+V  LD  +V D+      ++ EY+   + TD  V    + +  I     E L
Sbjct: 72  EN-KHPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECL 125

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFK 286
           +AL++ HS  ++HRD+K  N+++  +   ++L D+G      P  E + R   V + Y+ 
Sbjct: 126 QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITP--EQSKRSTMVGTPYWM 182

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            PE +V  + Y   +D+WSLG M   M+  + P+ 
Sbjct: 183 APE-VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 62/235 (26%), Positives = 119/235 (50%), Gaps = 19/235 (8%)

Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---EI 170
           YE +       + +E++ ++G G + +V++  N  T      K+++   +++++    EI
Sbjct: 1   YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEI 60

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY-----VNSTDFKVLYPTLTDYDIRYYI 225
           +IL   C  P +VKLL            ++ E+     V++   + L   LT+  I+   
Sbjct: 61  EILAT-CNHPYIVKLLGAF--YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQVIC 116

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRY 284
            ++L+AL Y HS  I+HRD+K  NV++  +   ++L D+G+ A+     +  +  + + Y
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPY 175

Query: 285 FKGPELLV--DLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +  PE+++   ++D  YDY  D+WSLG     M  + EP  +  +    L+KIAK
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 229

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 67.1 bits (163), Expect = 2e-12
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 18/233 (7%)

Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD +  Y    K+G+G    V+  I++ T +   IK   + +  KK+ I  EI +++
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLK 230
                PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+
Sbjct: 72  E-NKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
           ALD+ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
            +V  + Y   +D+WSLG M   M+  + P+   ++N  + + +    GT EL
Sbjct: 186 -VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPEL 235

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 26/214 (12%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192
           +GRG + EV+     +T +   +K L        K+ IK+ Q      N   +L +V   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTG 54

Query: 193 HS----------KTP---SLIFEYVNSTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 236
                        TP   S I + +N  D       +   ++ ++R+Y  E++  L++ H
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           ++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L     
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVA 172

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           YD S D +SLGCM   ++    P F  H   D+ 
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 75/293 (25%), Positives = 135/293 (46%), Gaps = 52/293 (17%)

Query: 126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKP---VKKKKI----KREIKILQN 175
           ++E+++ +G G Y +VF    V   +T +   +K+L+    V+K K     + E  +L++
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKAL 232
           +   P +V L      Q      LI +YV+  + F  LY     ++ ++R+Y  E++ AL
Sbjct: 61  VRQSPFLVTLHYAF--QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR-VASRYFKGPEL 290
           ++ H  GI++RD+K  N+++D E   + L D+GL+ EF    KE       +  +  PE+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +     +  ++D WSLG +   ++    PF    + + Q              + +++  
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--------------SEVSRRI 223

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
           L+ DP   + +G                    PEA D L KLLR D + RL A
Sbjct: 224 LKCDPPFPSFIG--------------------PEAQDLLHKLLRKDPKKRLGA 256

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 19/213 (8%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK---IKREIKILQNLCGGP 180
           Q DYE++++VG G Y +V++  N++T E   +KI+K         I++EI +++  C   
Sbjct: 8   QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-CKHC 66

Query: 181 NVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYC 235
           N+V      + R++      +  EY      + +Y     L++  I Y   E L+ L Y 
Sbjct: 67  NIVAYFGSYLSREKL----WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYL 122

Query: 236 HSQGIMHRDVKPHNVMI-DHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS+G MHRD+K  N+++ D+    ++L D+G+ A+      +    + + Y+  PE+   
Sbjct: 123 HSKGKMHRDIKGANILLTDNG--DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 294 LQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            ++  Y+   D+W++G     +   + P F  H
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 64/240 (26%), Positives = 117/240 (48%), Gaps = 28/240 (11%)

Query: 106 LRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK 165
           L P+E+W               E++ ++G G + +V++  N  T      K++    +++
Sbjct: 1   LNPEEFW---------------EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE 45

Query: 166 IKR---EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD 220
           ++    EI IL + C  PN+VKLLD    +++    + F    + D  +L     LT+  
Sbjct: 46  LEDYMVEIDILAS-CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQ 104

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVR 279
           IR    + L+AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  
Sbjct: 105 IRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSF 163

Query: 280 VASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           + + Y+  PE+++      + YDY  D+WSLG     M  + EP  +  +    L+KIAK
Sbjct: 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 222

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 42/121 (34%), Positives = 68/121 (56%), Gaps = 6/121 (4%)

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPGK 274
           T+ D+++Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  K
Sbjct: 96  TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKK 154

Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I 
Sbjct: 155 AYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMIL 211

Query: 335 K 335
           K
Sbjct: 212 K 212

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
           +DY+VV+ +GRG + EV    + ++ +   +K+L   K + IKR       E + +    
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
             P VV+L    +D   K   ++ EY+   D   L   +++YD+     ++Y  E++ AL
Sbjct: 101 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLAL 155

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPEL 290
           D  HS G++HRDVKP N+++D +   L+L D+G   +    G    +  V +  +  PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214

Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 80/311 (25%), Positives = 136/311 (43%), Gaps = 60/311 (19%)

Query: 126 DYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKKI----KREIKILQN 175
           ++E++R +G G Y +VF   +    +  +   +K+LK    V+K K     + E ++L+ 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKAL 232
           +   P +V L      Q      LI +YVN  + F  LY     T+ ++R YI E++ AL
Sbjct: 61  VRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPEL 290
           D+ H  GI++RD+K  N+++D E   + L D+GL++ +   +E        +  +  PE+
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177

Query: 291 LVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
           +      +D ++D WSLG +   ++    PF               V G           
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPF--------------TVDG----------- 212

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADN---QHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                        ++S+   S+ I          +S EA DF+ KLL  D + RL A  A
Sbjct: 213 ------------EQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGA 260

Query: 407 MVISSISPIFS 417
             I +  P F 
Sbjct: 261 DEIKN-HPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 65.4 bits (159), Expect = 6e-12
 Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 7/127 (5%)

Query: 199 LIFEYVNSTDFKV-LY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           L+   +N  D K  +Y    P   +    +Y  E+L  L+  H +  ++RD+KP N+++D
Sbjct: 77  LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD 136

Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM 313
            +   +R+ D GLA     G+    RV +  +  PE+L + Q Y  S D W LGC+   M
Sbjct: 137 -DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEM 194

Query: 314 IFRKEPF 320
           I  + PF
Sbjct: 195 IEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 64.8 bits (159), Expect = 7e-12
 Identities = 47/199 (23%), Positives = 87/199 (43%), Gaps = 34/199 (17%)

Query: 131 RKVGRGKYSEVFEGI----NVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNV 182
           +K+G G + EV++G        T  +  +K LK      ++++   E  I++ L   PN+
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHS 237
           V+LL +      +   ++ EY+   D    +       LT  D+     ++ K ++Y  S
Sbjct: 64  VRLLGVCT--QGEPLYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---------VASRYFKGP 288
           +  +HRD+   N ++   L  +++ D+GL+   +    Y  R         +A      P
Sbjct: 121 KNFVHRDLAARNCLVTENL-VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA------P 173

Query: 289 ELLVDLQDYDYSLDMWSLG 307
           E L D +    S D+WS G
Sbjct: 174 ESLKDGKFTSKS-DVWSFG 191

Length = 258

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 8e-12
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 34/210 (16%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKI------LKPVKKKKIKR---------EIKILQN 175
           R +G+G + EV           C ++        K ++KK+IK+         E +IL+ 
Sbjct: 6   RVLGKGGFGEVCA---------CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 56

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LY----PTLTDYDIRYYIYELLK 230
           +     VV L      + +    L+   +N  D K  +Y    P   +    +Y  E+  
Sbjct: 57  V-NSRFVVSLAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            L+  H + I++RD+KP N+++D +   +R+ D GLA     G+    RV +  +  PE 
Sbjct: 114 GLEDLHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE- 171

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +V  + Y +S D W LGC+   MI  K PF
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 64.8 bits (158), Expect = 9e-12
 Identities = 53/181 (29%), Positives = 80/181 (44%), Gaps = 44/181 (24%)

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYF 285
           LKAL + H+QG++HRD+K  ++++  + R ++L D+G        KE   R   V + Y+
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPYW 181

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 345
             PE++  L  Y   +D+WSLG M   M+  + P+F                        
Sbjct: 182 MAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFN----------------------- 217

Query: 346 LNKYHLELDPQLDALVG-RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                   +P L A+   R +  P  K     N H VSP    FLD++L  D   R TA 
Sbjct: 218 --------EPPLQAMKRIRDNLPPKLK-----NLHKVSPRLRSFLDRMLVRDPAQRATAA 264

Query: 405 E 405
           E
Sbjct: 265 E 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 22/143 (15%)

Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   D+RY+IY                   +++  L++ H +
Sbjct: 57  SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA-SRYFKGPELLVDLQDY 297
            I++RD+KP NV++D++   +R+ D GLA     G+      A +  F  PELL   ++Y
Sbjct: 117 RIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEY 174

Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
           D+S+D ++LG     MI  + PF
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 64.4 bits (156), Expect = 1e-11
 Identities = 64/233 (27%), Positives = 114/233 (48%), Gaps = 18/233 (7%)

Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK---ILKPVKKKKIKREIKILQ 174
           V  GD +  Y    K+G+G    V+  ++V T +   I+   + +  KK+ I  EI +++
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDY-DIRYYIYELLK 230
                PN+V  LD  +V D+      ++ EY+       V+  T  D   I     E L+
Sbjct: 73  E-NKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 289
           AL++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
            +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL
Sbjct: 187 -VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPEL 236

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 36/215 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           YE +R VGRG +  V         +  IIK + PV++   K E    QN C    V+KLL
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMT-KDERLAAQNEC---QVLKLL 56

Query: 187 DIVRDQHSKTPSLIFEYVNSTDFKVL-----YP---TLTDY------------DIRYYIY 226
                 H   P++I  Y N  + K L     Y    TL +Y             I ++  
Sbjct: 57  -----SH---PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           ++L AL + H++ I+HRD+K  N+++D     +++ D+G++       K Y V V +  +
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCY 167

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE L + + Y+   D+W+LGC+   +   K  F
Sbjct: 168 ISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 25/204 (12%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192
           +GRG + EV+     +T +   +K L        K+ IK+ Q      N   +L +V   
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLD-------KKRIKMKQGETLALNERIMLSLVSTG 54

Query: 193 HS----------KTPS---LIFEYVNSTDFKV---LYPTLTDYDIRYYIYELLKALDYCH 236
                        TP     I + +N  D       +   ++ ++R+Y  E++  L++ H
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           ++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L     
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGTA 172

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
           YD S D +SLGCM   ++    PF
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 37/212 (17%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ 192
           +G+G + +V++   V   +   I  +K + KK+I  + ++   + G  N+     +VR  
Sbjct: 1   IGKGTFGQVYQ---VRKKDTRRIYAMKVLSKKEIVAKKEVAHTI-GERNI-----LVRTL 51

Query: 193 HSKTPSLI---FEYVNSTDFKVLYPTLTDY-------------------DIRYYIYELLK 230
             ++P ++   F +   +D   LY  +TDY                     ++YI EL+ 
Sbjct: 52  LDESPFIVGLKFSFQTDSD---LY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPE 289
           AL++ H   I++RD+KP N+++D     + L D+GL++      K  N    +  +  PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           +L+D + Y   +D WSLG +   M     PF+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 19/194 (9%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPN 181
           +R +G G + +V    ++    NT E+  +K LKP         +K+EI+IL+NL    N
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-EN 67

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKALDYCHS 237
           +VK   I  +       LI E++ S   K   P   +         Y  ++ K +DY  S
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLVD 293
           +  +HRD+   NV+++ E  ++++ D+GL +     KEY        +  ++  PE L+ 
Sbjct: 128 RQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 294 LQDYDYSLDMWSLG 307
            + Y  S D+WS G
Sbjct: 187 SKFYIAS-DVWSFG 199

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKR------EIKILQNLCGGPNVVK 184
           +GRG + EV+   + +T     +K +   P  ++  K       EI++L+NL     +V+
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD   K  S+  EY+     K     Y  LT+   R Y  ++L+ + Y HS  I+
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIV 128

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAE----FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D     ++L D+G ++        G        + Y+  PE ++  + Y
Sbjct: 129 HRDIKGANILRDSA-GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE-VISGEGY 186

Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
               D+WS+ C    M+  K P+
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 46/214 (21%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
           +G+G + EV   + V    +  +   K + KK++K+         E +IL+ +   P +V
Sbjct: 1   LGKGGFGEVC-AVQVKNTGK--MYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIV 56

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------ELLKALDYC- 235
                         +L + + + T   ++   +   D++Y+IY       E+ + + Y  
Sbjct: 57  --------------NLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 236 ---------HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
                    HS  I++RD+KP NV++D +    RL D GLA     GK    R  +  + 
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYM 161

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE+L + + Y Y +D +++GC    M+  + PF
Sbjct: 162 APEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 38/193 (19%)

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
           L +  I      +L+AL Y HSQG++HRD+K  ++++  + R ++L D+G  A+      
Sbjct: 114 LNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP 172

Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           +    V + Y+  PE ++    Y   +D+WSLG M   M+  + P+F      D  V+  
Sbjct: 173 KRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF-----SDSPVQAM 226

Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           K L                         R S  P        N H +SP   DFL+++L 
Sbjct: 227 KRL-------------------------RDSPPP-----KLKNAHKISPVLRDFLERMLT 256

Query: 395 YDHQDRLTAREAM 407
            + Q+R TA+E +
Sbjct: 257 REPQERATAQELL 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 71/296 (23%), Positives = 134/296 (45%), Gaps = 53/296 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---EIKILQNLCGGPN 181
           D +E++ ++G G + +V++  +  T      KI++   +++++    EI IL   C  PN
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE-CKHPN 63

Query: 182 VVKLLDIVRDQHSKTPSLIFEY-----VNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           +V L +     +     ++ E+     ++S   ++    LT+  IRY   ++L+AL++ H
Sbjct: 64  IVGLYEAY--FYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLH 120

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV--- 292
           S  ++HRD+K  N+++  +   ++L D+G+ A+     ++ +  + + Y+  PE++    
Sbjct: 121 SHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 293 -DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
                YDY  D+WSLG     +   + P    H+ +   V + K+L ++           
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPP---HHELNPMRV-LLKILKSEP---------- 225

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              P LD        K WS   N            DFL   L  D  DR TA E +
Sbjct: 226 ---PTLDQ-----PSK-WSSSFN------------DFLKSCLVKDPDDRPTAAELL 260

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 39/236 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILK----PVKKKKIKREIKILQN 175
            ++D  + R +G G++ +V++G+ ++     I   +K  K    P  ++K  +E  I++ 
Sbjct: 4   QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ 63

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI------------FEYVNSTDFKVLYPTLTDYDIRY 223
               P++VKL+ ++ +     P  I            +  VN     +    L       
Sbjct: 64  F-DHPHIVKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLIL------- 111

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           Y Y+L  AL Y  S+  +HRD+   NV++   +  KL   D+GL+ +      Y      
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLG--DFGLSRYLEDESYYKASKGK 169

Query: 283 RYFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
              K   PE  ++ + +  + D+W  G CM+  ++   +PF  G  N+D + +I  
Sbjct: 170 LPIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIEN 223

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 55/183 (30%), Positives = 85/183 (46%), Gaps = 42/183 (22%)

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRY 284
           +LKAL   H+QG++HRD+K  ++++ H+ R ++L D+G        KE   R   V + Y
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPY 181

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           +  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++  +K  K++  +    
Sbjct: 182 WMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF-----NEPPLKAMKMIRDN---- 231

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                   L P+L                   N H VSP    FLD+LL  D   R TA 
Sbjct: 232 --------LPPKL------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAA 265

Query: 405 EAM 407
           E +
Sbjct: 266 ELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 47/160 (29%), Positives = 79/160 (49%), Gaps = 21/160 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKRE----IKILQNLCG-- 178
           DD+E ++ +GRG + EV      +T     +K L+  K + +++E    ++  +++    
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58

Query: 179 -GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
             P VVKL    +D       LI EY+   D   L     T T+ + R+YI E + A+D 
Sbjct: 59  DNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116

Query: 235 CHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYH 271
            H  G +HRD+KP N+++D   H    ++L D+GL     
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGH----IKLSDFGLCTGLK 152

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
           DD+E+++ +GRG + EV      +T     +KIL      K  +    + E  +L N  G
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN--G 58

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+YI E++ A+  
Sbjct: 59  DCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS 117

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 292
            H    +HRD+KP NV++D     +RL D+G  L        + +V V +  +  PE+L 
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 293 DLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF 321
            ++D    Y    D WSLG CM+  M++ + PF+
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYE-MLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 36/134 (26%), Positives = 71/134 (52%), Gaps = 7/134 (5%)

Query: 199 LIFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EY+N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  N+++D +
Sbjct: 73  FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132

Query: 256 LRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+G+ +    G  +      +  +  PE+L+  Q Y+ S+D WS G +   M+
Sbjct: 133 -GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEML 190

Query: 315 FRKEPFFYGHDNHD 328
             + P F+GHD  +
Sbjct: 191 IGQSP-FHGHDEEE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 71/236 (30%), Positives = 108/236 (45%), Gaps = 37/236 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           DD+E+++ +GRG + EV      NT +   +KIL   K + +KR        E  +L N 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN--KWEMLKRAETACFREERDVLVN- 57

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKAL 232
            G    +  L     Q      L+ +Y    D   L     D    D+ R+Y+ E++ A+
Sbjct: 58  -GDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPEL 290
           D  H  G +HRD+KP NV++D     +RL D+G  L        + NV V +  +  PE+
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174

Query: 291 LVDLQD----YDYSLDMWSLG-CMFAGMIFRKEPFF-------YG----HDNHDQL 330
           L  ++D    Y    D WSLG CM+  M++ + PF+       YG    H  H Q 
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYE-MLYGETPFYAESLVETYGKIMNHKEHFQF 229

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 28/212 (13%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLC 177
           D++V++K+G+G Y  V++   V          LK V         ++    EI+IL ++ 
Sbjct: 1   DFKVLKKLGKGSYGSVYK---VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV- 56

Query: 178 GGPNVVK----LLDIVR----DQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
             PN++      LD  +     +++    L          + L P    +  R +I +LL
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW--RIFI-QLL 113

Query: 230 KALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           + L   H Q I+HRD+K  N+++  ++L K+   D G+++           + + ++  P
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLVKIG--DLGISKVLKKNMAKTQ-IGTPHYMAP 170

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           E+    + Y Y  D+WSLGC+   M     PF
Sbjct: 171 EVWKG-RPYSYKSDIWSLGCLLYEMATFAPPF 201

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
           +R +G G + +V    ++  N  T E   +K LK           K+EI IL+ L    N
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHEN 67

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQG 239
           +VK      +Q  K   LI EYV     +   P   L    +  +  ++ + + Y HSQ 
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-----YFKGPELLVDL 294
            +HRD+   NV++D++ R +++ D+GLA+    G EY  RV        ++   E L + 
Sbjct: 128 YIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAVECLKEN 185

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   Y+ D+WS G     ++   +  
Sbjct: 186 KFS-YASDVWSFGVTLYELLTHCDSK 210

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 29/216 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR-------EIKILQNLC 177
           +D++V++ +GRG + EV    + ++ +   +K+L   K + IKR       E + +    
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHA 100

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKAL 232
               +V+L    +D   K   ++ EY+   D   L   +++YDI     R+Y  E++ AL
Sbjct: 101 NSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLAL 155

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 288
           D  HS G +HRDVKP N+++D     L+L D+G            VR    V +  +  P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISP 212

Query: 289 ELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPFF 321
           E+L        Y    D WS+G     M+    PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
           +D+E+++ +GRG + EV      N ++   +KIL      K  +    + E  +L N  G
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN--G 58

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+Y+ E++ A+D 
Sbjct: 59  DNQWITTLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELLV 292
            H    +HRD+KP N+++D     +RL D+G  L        + +V V +  +  PE+L 
Sbjct: 118 VHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 293 DLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++D    Y    D WSLG     M++ + PF+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 30/217 (13%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCGGPNV 182
           + +G+G + +V       T+E   +K+LK  K   ++         E ++L      P +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLK--KDVILQDDDVECTMTEKRVLALAGKHPFL 58

Query: 183 VKLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDY 234
            +L       HS  +T   +F   EYVN  D          +D    R+Y  E++  L +
Sbjct: 59  TQL-------HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQF 111

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 293
            H +GI++RD+K  NV++D E   +++ D+G+  E    G   +    +  +  PE+L  
Sbjct: 112 LHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
            Q Y  ++D W+LG +   M+  + PF    D+ D+L
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPF--EGDDEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 34/101 (33%), Positives = 55/101 (54%), Gaps = 3/101 (2%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  AL Y HS  I++RD+KP N+++D +   + L D+GL  E     K  +   
Sbjct: 99  RFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +  +  PE+L   Q YD ++D W LG +   M++   PF+
Sbjct: 158 GTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKR---EIKILQNLCGGPNVVK 184
           +G+G +  V+   +V+T     +K +      P  KK++     EI++L+NL     +V+
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQ 68

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
               +RD   +T S+  EY+     K     Y  LT+   R Y  ++L+ ++Y HS  I+
Sbjct: 69  YYGCLRDD--ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 242 HRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+K  N++ D     ++L D+G    L      G        + Y+  PE ++  + Y
Sbjct: 127 HRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISGEGY 184

Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
               D+WS+GC    M+  K P+
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPW 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 2/98 (2%)

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  E+   L+  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGT 164

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             +  PE +V  + Y +S D W+LGC+   MI  + PF
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 32/216 (14%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNVV 183
           +G+G + +V       T+E   IK+LK   K  I +         E +IL      P + 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLK---KDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 184 KLLDIVRDQHS--KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYC 235
            L       H   +T   +F   EYVN  D          +D    R+Y  E+  AL + 
Sbjct: 60  AL-------HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           H  G+++RD+K  N+++D E    +L D+G+  E    G        +  +  PE+L + 
Sbjct: 113 HRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE- 170

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
            +Y  S+D W+LG +   M+  + PF    DN D L
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPF--EADNEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 50/241 (20%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
           DD+E ++ +GRG + EV      +T     +KIL+    ++K++   I+ E  IL     
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-AD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
           G  VVK+    +D+  +   LI E++   D   L     TL++   ++YI E + A+D  
Sbjct: 60  GAWVVKMFYSFQDK--RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFY-----HPGKEYNVR-- 279
           H  G +HRD+KP N+++D +   ++L D+GL          EFY     +P  +++ +  
Sbjct: 118 HQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 280 --------------------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
                               V +  +  PE+ +    Y+   D WSLG +   M+    P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 320 F 320
           F
Sbjct: 236 F 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 64/261 (24%), Positives = 114/261 (43%), Gaps = 51/261 (19%)

Query: 127 YEVVRKVGRGKYSE-------------VFEGINVNTNERCIIKILKPVKKKKIKREIKIL 173
           Y  +R +G+G + E             V++ +N        +  L   +++    EI IL
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--------LTRLSEKERRDALNEIVIL 53

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTLTDYDIRY---YIYEL 228
             L   PN++   +   D    T  +  EY N      K++      ++      Y++++
Sbjct: 54  SLL-QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI---DWGLAEFYHPGKEYNVR---VAS 282
           + A+ Y H  GI+HRD+K  N+     L K  LI   D+G+++    G EY++    V +
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIF----LTKAGLIKLGDFGISKIL--GSEYSMAETVVGT 164

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDE 341
            Y+  PE L     Y++  D+W+LGC+   ++  K  F     N   LV KI +   T  
Sbjct: 165 PYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTPV 221

Query: 342 LNAYLNKYH------LELDPQ 356
           ++ Y ++        L+ DP+
Sbjct: 222 VSVYSSELISLVHSLLQQDPE 242

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 50/206 (24%), Positives = 102/206 (49%), Gaps = 16/206 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKK---IKREIKILQNLCG 178
           DD E ++ VG G +  V    +  +     +K++     ++ K+   +  E ++L+ +  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYC 235
            P +++L     DQ      ++ EYV   + F  L      ++    +Y  E++ AL+Y 
Sbjct: 60  HPFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+ I++RD+KP N+++D E   ++L D+G A+     + + +     Y   PE++   +
Sbjct: 118 HSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLR-DRTWTLCGTPEYL-APEVIQS-K 173

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++ ++D W+LG +   M+    PFF
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFF 199

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 63/291 (21%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIK----------ILQNLCGG 179
           ++ +G+G Y +VF+   V   +   I  +K +KK  I R  K          IL+ +   
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KH 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI------RYYIYELLKALD 233
           P +V L  I   Q      LI EY++  +   L+  L    I       +Y+ E+  AL+
Sbjct: 60  PFIVDL--IYAFQTGGKLYLILEYLSGGE---LFMHLEREGIFMEDTACFYLSEISLALE 114

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 292
           + H QGI++RD+KP N+++D +   ++L D+GL  E  H G   +    +  +  PE+L+
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
               +  ++D WSLG +   M+    PF    +N  +   I K+L          K  L 
Sbjct: 174 R-SGHGKAVDWWSLGALMYDMLTGAPPF--TAENRKK--TIDKIL----------KGKLN 218

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
           L P L                        +PEA D L KLL+ +   RL A
Sbjct: 219 LPPYL------------------------TPEARDLLKKLLKRNPSSRLGA 245

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 57/227 (25%), Positives = 107/227 (47%), Gaps = 28/227 (12%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLC 177
           D+E++ K+G+G +  VF+ +    ++R  +  +K +   K+ R        E ++L  L 
Sbjct: 1   DFEILNKIGKGSFGVVFKVVR-KADKR--VYAMKQIDLSKMNRREREEAIDEARVLAKL- 56

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKA 231
               +++  +   D+     +++ EY  + D   L       P   D   R++I  LL  
Sbjct: 57  DSSYIIRYYESFLDK--GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-G 113

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
           L + HS+ I+HRD+K  N+ +D     +++ D G+A+       + N  V + Y+  PEL
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             D + Y+   D+W+LG +       K PF    D ++Q   I K++
Sbjct: 173 CED-KPYNEKSDVWALGVVLYECCTGKHPF----DANNQGALILKII 214

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 53/197 (26%), Positives = 78/197 (39%), Gaps = 41/197 (20%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  AL Y HS  I++RD+KP N+++D     + L D+GL  E            
Sbjct: 99  RFYAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            +  +  PE++   Q YD ++D W LG +   M++   P FY  D  +            
Sbjct: 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPP-FYCRDVAEM----------- 204

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
               Y N  H  L  +  A     S   WS                  L++LL  D Q R
Sbjct: 205 ----YDNILHKPLVLRPGA-----SLTAWS-----------------ILEELLEKDRQRR 238

Query: 401 LTAREAMVISSISPIFS 417
           L A+E  +     P F 
Sbjct: 239 LGAKEDFLEIQEHPFFE 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 32/101 (31%), Positives = 56/101 (55%), Gaps = 3/101 (2%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  A+ Y HS  I++RD+KP N+++D +   + L D+GL  E   P +  +   
Sbjct: 99  RFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +  +  PE+L   + YD ++D W LG +   M++   PF+
Sbjct: 158 GTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 11/143 (7%)

Query: 195 KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPH 248
           +TP  +F   E+VN  D          +D    R+Y  E+  AL + H +GI++RD+K  
Sbjct: 66  QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125

Query: 249 NVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           NV++DHE    +L D+G+  E    GK  +    +  +  PE+L ++  Y  S+D W++G
Sbjct: 126 NVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMG 183

Query: 308 CMFAGMIFRKEPFFYGHDNHDQL 330
            +   M+    PF    +N D L
Sbjct: 184 VLLYEMLCGHAPF--EAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 32/98 (32%), Positives = 54/98 (55%), Gaps = 2/98 (2%)

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  EL   L+    + I++RD+KP N+++D +   +R+ D GLA     G+    RV +
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGT 164

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             +  PE++ + + Y +S D W LGC+   MI  + PF
Sbjct: 165 VGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 33/101 (32%), Positives = 54/101 (53%), Gaps = 3/101 (2%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E+  AL Y HS  I++RD+KP N+++D +   + L D+GL  E        +   
Sbjct: 99  RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFC 157

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +  +  PE+L   Q YD ++D W LG +   M++   PF+
Sbjct: 158 GTPEYLAPEVL-HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 34/113 (30%), Positives = 65/113 (57%), Gaps = 5/113 (4%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G       
Sbjct: 98  RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
            +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL 206

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 28/198 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPN 181
           + E V ++G G    V++ I+  T     +K++    +   +++I REI+IL+++   PN
Sbjct: 75  ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPN 133

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS 237
           VVK  D+    H+    ++ E+++    +  +      L D        ++L  + Y H 
Sbjct: 134 VVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-----RQILSGIAYLHR 186

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELL-V 292
           + I+HRD+KP N++I+   + +++ D+G    LA+   P    N  V +  +  PE +  
Sbjct: 187 RHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINT 242

Query: 293 DLQD--YD-YSLDMWSLG 307
           DL    YD Y+ D+WSLG
Sbjct: 243 DLNHGAYDGYAGDIWSLG 260

Length = 353

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 38/216 (17%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR------EIKILQNLCGG 179
           D+E+   +G G +  V    +  T E   IK LK  +  K+K+      E  IL  L   
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH- 77

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDI-RYYIYELLKAL 232
           P +V ++   +D+       + E+V   + F  L     +P     D+ ++Y  EL+ A 
Sbjct: 78  PFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPN----DVAKFYHAELVLAF 131

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK---GPE 289
           +Y HS+ I++RD+KP N+++D++   +++ D+G A+          +V  R F     PE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAK----------KVPDRTFTLCGTPE 180

Query: 290 LL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            L    +  + +  ++D W++G +    I    PFF
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216

Length = 329

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIK--REIKILQNLCGGPNV 182
            Y V+R VG G +       +VN++++  +K ++ P     ++  R+  +L      PN+
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 183 VKLLDIVR-DQHSKTPSLIFEYVNSTDF--KV------LYPTLTDYDIRYYIYELLKALD 233
           V   +    D H     ++ EY +  D   K+      L+P  T   I  +  ++   + 
Sbjct: 61  VAFKESFEADGHL---YIVMEYCDGGDLMQKIKLQRGKLFPEDT---ILQWFVQMCLGVQ 114

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLV 292
           + H + ++HRD+K  N+ +     K++L D+G A     PG      V + Y+  PE+  
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWE 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++  Y+   D+WSLGC+   +   K PF
Sbjct: 174 NMP-YNNKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 34/112 (30%), Positives = 61/112 (54%), Gaps = 3/112 (2%)

Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+ 
Sbjct: 110 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQV 168

Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
                +    V + Y+  PE++  L  Y   +D+WSLG M   MI  + P+F
Sbjct: 169 SKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYF 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 41/139 (29%), Positives = 73/139 (52%), Gaps = 8/139 (5%)

Query: 199 LIFEYVNSTD--FKVLYPTLTDYD-IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  +  F +    +   D  R+Y  E++ ALDY HS  I++RD+K  N+M+D +
Sbjct: 72  FVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD 131

Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+GL  E             +  +  PE+L D  DY  ++D W LG +   M+
Sbjct: 132 -GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 189

Query: 315 FRKEPFFYGHDNHDQLVKI 333
             + PF+  + +H++L ++
Sbjct: 190 CGRLPFY--NQDHEKLFEL 206

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 80/333 (24%), Positives = 142/333 (42%), Gaps = 79/333 (23%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           ++++  +G G + +V E  +    E C +KI++ V K    R+ KI          ++ +
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKI---------EIQFM 179

Query: 187 DIVR--DQHSKTPSLIFE--YVNSTDFKVLY-----PTLTDYDIRY----------YIYE 227
           + VR  D   + P +  +  + N T    +      P L D+ +++           I++
Sbjct: 180 EKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQ 239

Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVM-------IDHELRK--------LRLIDWGLAEFYH 271
              ALDY H++  +MH D+KP N++       +D    +        +R+ D G      
Sbjct: 240 TGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC---- 295

Query: 272 PGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
              E + R   V++R+++ PE+++ L  + YS DMWS+GC+   + +  +  +  HDN +
Sbjct: 296 -CDERHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYEL-YTGKLLYDTHDNLE 352

Query: 329 QLVKIAKVL-----------GTDELNAYLNKY-HLE--LDPQLDALVGRHSRKPWSKFIN 374
            L  + K L           GT+E     N    L    DP+  A + R   +P  + I 
Sbjct: 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR--ARPVREVIR 410

Query: 375 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                       D +  LL YD Q RL AR+  
Sbjct: 411 -------DDLLCDLIYGLLHYDRQKRLNARQMT 436

Length = 467

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 36/110 (32%), Positives = 60/110 (54%), Gaps = 5/110 (4%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
           R+Y  E++ AL Y HS  +++RD+K  N+M+D +   +++ D+GL  E    G       
Sbjct: 98  RFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC 156

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
            +  +  PE+L D  DY  ++D W LG +   M+  + P FY  D H++L
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD-HEKL 203

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 13/156 (8%)

Query: 160 PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
           P  +K+I RE++I ++ C  P +VK      D+ S +  +  EY        +Y  +   
Sbjct: 40  PDLQKQILRELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98

Query: 220 DIRYYIYEL-------LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYH 271
             R     L       LK L Y HS+ I+HRD+KP N+++  +  +++L D+G++ E  +
Sbjct: 99  GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVN 157

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
                     + ++  PE +   + Y  + D+WSLG
Sbjct: 158 SLA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLG 190

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 36/119 (30%), Positives = 66/119 (55%), Gaps = 5/119 (4%)

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYN 277
           Y   +Y  E++  L + HS+GI++RD+K  NVM+D +   +++ D+G+  E        +
Sbjct: 96  YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRAS 154

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
               +  +  PE+L  L+ Y +S+D WS G +   M+  + P F+G D+ D+L +  +V
Sbjct: 155 TFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSP-FHG-DDEDELFESIRV 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 6e-09
 Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 15/154 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKR---EIKILQNLCG 178
             ++ ++ +G+G    VF      T +   +K+L     +K+ K+KR   E +IL  L  
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-D 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALD 233
            P +  L      Q      L+ +Y    +   L        L++   R+Y  E+L AL+
Sbjct: 60  HPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE 117

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           Y H  GI++RD+KP N+++ HE   + L D+ L+
Sbjct: 118 YLHLLGIVYRDLKPENILL-HESGHIMLSDFDLS 150

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 26/205 (12%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGPNVVKLLDI 188
           +G+G Y  V+   +++T  R  IK + P +  +    +  EI +   L    N+V+ L  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKHR-NIVQYLG- 72

Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYPT----LTDYD--IRYYIYELLKALDYCHSQGIMH 242
             D  +    +  E V       L  +    L D +  I +Y  ++L+ L Y H   I+H
Sbjct: 73  -SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL-VDLQ 295
           RD+K  NV+++     +++ D+G ++     +   +   +  F G      PE++    +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            Y    D+WSLGC    M   K PF
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 20/47 (42%), Positives = 29/47 (61%)

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           I+  + ++L ALD  HS GI+HRDVKP N++        ++ID G A
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 43/151 (28%), Positives = 79/151 (52%), Gaps = 11/151 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQN---LCGG 179
           +++ +V+ + RG + +V+ G   N ++   +K++K      K +  +++  ++   L   
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCH 236
           P +V L   +  Q +    L+ EY+   D K L      +D      YI E+  ALDY H
Sbjct: 64  PFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             GI+HRD+KP N++I +E   ++L D+GL+
Sbjct: 122 RHGIIHRDLKPDNMLISNE-GHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 35/114 (30%), Positives = 65/114 (57%), Gaps = 6/114 (5%)

Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 98  RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 156

Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 39/136 (28%), Positives = 70/136 (51%), Gaps = 10/136 (7%)

Query: 200 IFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 256
           + EY+N  D      +   +D    R+Y  E++  L + H +GI++RD+K  NV++D + 
Sbjct: 74  VMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG 133

Query: 257 RKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
             +++ D+G+        GK  +    +  +  PE+L   Q Y+ S+D WS G +   M+
Sbjct: 134 H-IKIADFGMCKENMNGEGKA-STFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEML 190

Query: 315 FRKEPFFYGHDNHDQL 330
             + P F+G D  D+L
Sbjct: 191 IGQSP-FHGED-EDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 49/221 (22%), Positives = 105/221 (47%), Gaps = 21/221 (9%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI----------KREIKILQN 175
           ++E+++ +G G Y +VF    V+ ++   +  +K +KK  I          + E ++L++
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKAL 232
           +   P +V L      Q      LI +Y+N  +            + +++ Y  E++ AL
Sbjct: 61  IRQSPFLVTLHYAF--QTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPE 289
           ++ H  GI++RD+K  N+++D     + L D+GL++ +H     + Y+      Y   P+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM-APD 176

Query: 290 LLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
           ++      +D ++D WS+G +   ++    PF    + + Q
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 3/104 (2%)

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN 277
              R+Y  ELL AL+  H   +++RD+KP N+++D++   + L D+GL +      +  N
Sbjct: 93  SRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTN 151

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
               +  +  PELL+    Y  ++D W+LG +   M+    PF+
Sbjct: 152 TFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFY 194

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 69/330 (20%), Positives = 118/330 (35%), Gaps = 97/330 (29%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNLCG 178
           +  ++ +G G + EV     V+TN    +K L+  K   + R        E  IL     
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLR--KADVLMRNQAAHVKAERDILAE-AD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYC 235
              VVKL    +D+ +     + +Y+   D   L   L  ++    R+YI EL  A++  
Sbjct: 60  NEWVVKLYYSFQDKDNLY--FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL---------AEFYHPG------------- 273
           H  G +HRD+KP N++ID +   ++L D+GL         +++Y  G             
Sbjct: 118 HKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 274 ------------KEYNVR----------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
                       +    R          V +  +  PE+L+    Y    D WS+G +  
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 235

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 371
            M+  + PF     +            T                       +     W  
Sbjct: 236 EMLVGQPPF---LAD--------TPAET-----------------------QLKVINWET 261

Query: 372 FINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
            ++  +Q  +S EA D + +L     +DRL
Sbjct: 262 TLHIPSQAKLSREASDLILRLCC-GAEDRL 290

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 53.3 bits (128), Expect = 5e-08
 Identities = 48/212 (22%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 181
           Y  V+K+G G + +     +    ++ +IK      + P ++++ ++E+ +L N+   PN
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FK-------VLYPTLTDYDIRYYIYELLKALD 233
           +V+  +    + +    ++ +Y    D +K       VL+P   +  I  +  ++  AL 
Sbjct: 61  IVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFP---EDQILDWFVQICLALK 115

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 292
           + H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + + Y+  PE + 
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-IC 173

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
           + + Y+   D+W+LGC+   M   K  F  G+
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 13/156 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKK-----IKREIKILQNLCG 178
           +D+  V+ +G+G + EV      +T +   +K +LK    KK     +K E  +L     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            P VV L    +D  ++   LI E++   D   +   Y T ++   R+Y+ E + A++  
Sbjct: 60  SPWVVSLYYSFQD--AQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           H  G +HRD+KP N++ID     ++L D+GL+  +H
Sbjct: 118 HKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFH 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 46/151 (30%), Positives = 81/151 (53%), Gaps = 13/151 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKK---IKREIKILQNLCG 178
           +D+E ++ +GRG + EV      +T     +KIL+    ++K++   I+ E  IL     
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-AD 59

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
              VVK+    +D+ +    LI E++   D   L     TLT+ + ++YI E + A+D  
Sbjct: 60  SLWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
           H  G +HRD+KP N+++D +   ++L D+GL
Sbjct: 118 HQLGFIHRDIKPDNLLLDSK-GHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 48/203 (23%), Positives = 91/203 (44%), Gaps = 22/203 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNLCG 178
           Y + +++G+G +  V+   +        +K+LK +   ++         +E ++L  L  
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-D 60

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
            P +VK      ++ +    +I EY    D        K    TL++  +  +  +LL  
Sbjct: 61  HPAIVKFHASFLERDAFC--IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
           + Y H + I+HRD+K  N+ + + L  L++ D+G++       +       + Y+  PE 
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176

Query: 291 LVDLQDYDYSLDMWSLGCMFAGM 313
           L   Q YD   D+WSLGC+   M
Sbjct: 177 LKH-QGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 3/99 (3%)

Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 281
           +Y  E+   L + HS+GI++RD+K  NVM+D E   +++ D+G+  E    GK       
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTTRTFCG 163

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +  +  PE ++  Q Y  S+D W+ G +   M+  + PF
Sbjct: 164 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 16/167 (9%)

Query: 165 KIKREIKILQNLCGGPNVVKL---------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPT 215
            I  E+ I++     PN+V+          L IV D     P  + E+ NS   K     
Sbjct: 54  DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP--LGEHFNS--LKEKKQR 109

Query: 216 LTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
            T+  I     +++ AL Y H +  I+HRD+ P+N+M+  E  K+ + D+GLA+   P  
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPES 168

Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           +    V +  +  PE++ +   Y    D+W+ GC+   M   + PF+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.0 bits (123), Expect = 3e-07
 Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 38/178 (21%)

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           I +L++AL+  H   I+H D+K  NV+ D    ++ L D+GL +       Y+  +   Y
Sbjct: 115 IRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD--Y 172

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           F  PE +    +YD S D W++G +   ++  K PF    D                   
Sbjct: 173 FS-PEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE------------------ 212

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
                  ELD   ++L+ R  +K    FI       VS  A DF+  +L+Y+   RLT
Sbjct: 213 -------ELDL--ESLLKRQQKKL--PFIKN-----VSKNANDFVQSMLKYNINYRLT 254

Length = 267

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 52/233 (22%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQN--------- 175
           +D+E ++ +  G Y  V+   +  T +R  +K        KI ++  IL+N         
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMK--------KINKQNLILRNQIQQVFVER 52

Query: 176 ----LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI---RYYIYEL 228
                   P VV +      +  +   ++ EYV   D   L   +    +   R Y  E 
Sbjct: 53  DILTFAENPFVVSMF--CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAET 110

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---------FYHPGKEYNVR 279
           + AL+Y H+ GI+HRD+KP N++I   +  ++L D+GL++          Y    E ++ 
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLY----EGHIE 165

Query: 280 VASRYFK-----------GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             +R F             PE+++  Q Y   +D W++G +    +    PFF
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFF 217

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 53/208 (25%), Positives = 82/208 (39%), Gaps = 26/208 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINV--NTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
           Y ++  +  G   EVF          ++ I+K +     K   REI IL+ +     ++ 
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTI-SHRAIIN 150

Query: 185 LLDIVRDQHSKTPSL------IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           L+   R + +    +      +F YV+ +        L           LL+AL Y H +
Sbjct: 151 LIHAYRWKSTVCMVMPKYKCDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR 204

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVD 293
           GI+HRDVK  N+ +D E     L D+G A         P + Y     +     PELL  
Sbjct: 205 GIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTP-QCYG-WSGTLETNSPELLA- 260

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           L  Y    D+WS G +   M  +    F
Sbjct: 261 LDPYCAKTDIWSAGLVLFEMSVKNVTLF 288

Length = 392

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 46/191 (24%), Positives = 83/191 (43%), Gaps = 40/191 (20%)

Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL+Y HS+  ++HRDVKP NV+I+    +++L D+G++ +        +    + + 
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170

Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            PE +   ++ + YD   D+WSLG     +   + P+        QL ++ +        
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-------- 222

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                   E  PQL          P  KF         SPE  DF++K L+ ++++R   
Sbjct: 223 --------EPSPQL----------PAEKF---------SPEFQDFVNKCLKKNYKERPNY 255

Query: 404 REAMVISSISP 414
            E +       
Sbjct: 256 PELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 71/306 (23%), Positives = 120/306 (39%), Gaps = 53/306 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           Y V++ +  G    VF        +  ++KI    +K     E  +LQN+   P+V+++ 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNV-NHPSVIRMK 123

Query: 187 DIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDYCHSQGIMHR 243
           D +         ++  + +S  +  L        I        ++L+ L Y H+Q I+HR
Sbjct: 124 DTL--VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181

Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PELLVDL 294
           DVK  N+ I+    ++ + D G A+F          V +  F G         PE+L   
Sbjct: 182 DVKTENIFINDV-DQVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEVLAR- 230

Query: 295 QDYDYSLDMWSLGCMFAGM------IFRKEPFF---YGHDNHDQLVKIAKVLGTDELNAY 345
             Y+   D+WS G +   M      IF   P     Y    H  L+KI   L        
Sbjct: 231 DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK------- 283

Query: 346 LNKYHLELDPQLDALVG-----RHSRKPWSKFINADNQHLVSPEAIDFL-DKLLRYDHQD 399
           ++      DP    + G        R+P++++     Q +  P   +FL  K+L +D   
Sbjct: 284 VHPEEFPRDPGSRLVRGFIEYASLERQPYTRY--PCFQRVNLPIDGEFLVHKMLTFDAAM 341

Query: 400 RLTARE 405
           R +A E
Sbjct: 342 RPSAEE 347

Length = 357

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 38/214 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI--NVNTNE---RCIIKILKPV----KKKKIKREIKIL 173
            ++   ++R++G+G +  V+EG+   V   E   R  IK +       ++ +   E  ++
Sbjct: 4   PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVM 63

Query: 174 QNL-CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-------------LYPTLTDY 219
           +   C   +VV+LL +V     +   ++ E +   D K                   T  
Sbjct: 64  KEFNC--HHVVRLLGVVSTG--QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPG 273
                  E+   + Y  ++  +HRD+   N M+  +L  +++ D+G+       ++Y  G
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKG 178

Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
            +  + V  R+   PE L D   +    D+WS G
Sbjct: 179 GKGLLPV--RWM-APESLKD-GVFTTKSDVWSFG 208

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 46/185 (24%), Positives = 77/185 (41%), Gaps = 41/185 (22%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRV 280
            +Y   ++  L Y H   I++RD+K  N+++D E   +++ D+GL  E    G   +   
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFC 162

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            +  F  PE+L +   Y  ++D W LG +   M+  + PF                 G D
Sbjct: 163 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF----------------PGDD 205

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
           E            +   D++V    R P         + L S EAI  + +LLR + + R
Sbjct: 206 E------------EEVFDSIVNDEVRYP---------RFL-SREAISIMRRLLRRNPERR 243

Query: 401 LTARE 405
           L + E
Sbjct: 244 LGSGE 248

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 49.6 bits (118), Expect = 9e-07
 Identities = 53/228 (23%), Positives = 107/228 (46%), Gaps = 29/228 (12%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
           ++  ++V+K+G G++ EV+ G   N + +  +K LKP  +  +    E  +++ L     
Sbjct: 5   RESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDK 62

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNS---TDF-------KVLYPTLTDYDIRYYIYELLKA 231
           +V+L  +V  +  +   +I EY+      DF       KVL P L D+       ++ + 
Sbjct: 63  LVRLYAVVTKE--EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEG 115

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 288
           + Y   +  +HRD++  NV++  E    ++ D+GLA       EY  R  +++   +  P
Sbjct: 116 MAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 173

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKIAK 335
           E  ++   +    D+WS G +   ++ + K P + G  N D +  + +
Sbjct: 174 E-AINFGSFTIKSDVWSFGILLYEIVTYGKIP-YPGMSNSDVMSALQR 219

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 19/204 (9%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVR 190
           +G+G Y  V+ G+  N  +   +K   L        ++E + LQ        +K ++IV+
Sbjct: 8   LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 191 D----QHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHR 243
                    T S+  E+V       +   +  L +     Y  ++L  + Y H+  ++HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 244 DVKPHNVMIDHELRKLRLIDWG----LAEFYHPGKEYNVRVASR---YFKGPELLVDLQD 296
           D+K +NVM+      ++LID+G    LA     G   N+  +     Y+  PE++ +   
Sbjct: 127 DIKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SG 184

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
           Y    D+WS+GC    M   K P 
Sbjct: 185 YGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 39/132 (29%), Positives = 64/132 (48%), Gaps = 18/132 (13%)

Query: 199 LIFEYVNSTDFKVLYPTLTDY---DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L + H +GI++RD+K  NVM+D E
Sbjct: 78  FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE 137

Query: 256 LRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKG------PELLVDLQDYDYSLDMWSLGC 308
              +++ D+G+       KE+ V  V +R F G      PE++   Q Y  S+D W+ G 
Sbjct: 138 -GHIKIADFGMC------KEHMVDGVTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGV 189

Query: 309 MFAGMIFRKEPF 320
           +   M+  + PF
Sbjct: 190 LLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 22/193 (11%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIK----ILKPVKKKKIKREIKILQNLCGGPNVVKLLD 187
           ++GRG + EVF G     N    +K     L P  K K  +E +IL+     PN+V+L+ 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60

Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-------ALDYCHSQGI 240
           +   +      ++ E V   DF      L     R  + EL++        ++Y  S+  
Sbjct: 61  VCTQKQPIY--IVMELVQGGDFLTF---LRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDY 297
           +HRD+   N ++  E   L++ D+G++     G       ++     +  PE L +   Y
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRY 173

Query: 298 DYSLDMWSLGCMF 310
               D+WS G + 
Sbjct: 174 SSESDVWSFGILL 186

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPN 181
           Y  VR VG+G Y EV    +    ++ +IK L        ++K  ++E ++L  L   PN
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPN 60

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALD 233
           +V      R+       L++  +   +   LY          L +  +  +  ++  AL 
Sbjct: 61  IV----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 292
           Y H + I+HRD+K  NV +      +++ D G+A       +  +  + + Y+  PEL  
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           + + Y+Y  D+W+LGC    M   K  F
Sbjct: 176 N-KPYNYKSDVWALGCCVYEMATLKHAF 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 24/210 (11%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIK---REIKILQNLCGG 179
           D+  +  +G+G + +V       T+E   IKILK    ++   ++    E ++L  L G 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGK 59

Query: 180 PNVVKLLDIVRDQHSKTPSL-----IFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           P  +  L      HS   ++     + EYVN  D       +  +      +Y  E+   
Sbjct: 60  PPFLTQL------HSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG 113

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 290
           L + HS+GI++RD+K  NVM+D E   +++ D+G+  E    G        +  +  PE+
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   Q Y  S+D W+ G +   M+  + PF
Sbjct: 173 IA-YQPYGKSVDWWAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 39/163 (23%), Positives = 72/163 (44%), Gaps = 24/163 (14%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           Y+++R +G+G   EV+   +   + R  +K ++      P+ KK+  RE KI  +L   P
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-P 62

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL-------TDYDIRYYIYELLKALD 233
            +V +  I  D           Y+     K L  ++        +   +  +   L    
Sbjct: 63  GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 234 -------YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
                  Y HS+G++HRD+KP N+++     ++ ++DWG A F
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLG-LFGEVVILDWGAAIF 162

Length = 932

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 19/117 (16%)

Query: 149 TNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---- 198
           T     IK+L+        ++ + +RE  +   L   PN+V LLD       + P     
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARL-YHPNIVALLD-----SGEAPPGLLF 55

Query: 199 LIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252
            +FEYV     + +      L   +    + ++L AL   H+QGI+HRD+KP N+M+
Sbjct: 56  AVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 5/106 (4%)

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           +Y++    Y+++ ALD  HS+ +MHRD+K  N+ +      ++L D+G ++ Y      +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 278 VRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           V  +   + Y+  PEL  + + Y    DMWSLG +   ++    PF
Sbjct: 227 VASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPF 271

Length = 478

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 44/187 (23%), Positives = 69/187 (36%), Gaps = 41/187 (21%)

Query: 226 YELLKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
             ++KAL Y     G++HRDVKP N+++D     ++L D+G++      K          
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179

Query: 285 FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
           +  PE + D  D    YD   D+WSLG     +   + P+       + L KI       
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI------- 231

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
                     L+ +P                          SP+   F+D  L  DH+ R
Sbjct: 232 ----------LQEEPPS-----------------LPPNEGFSPDFCSFVDLCLTKDHRKR 264

Query: 401 LTAREAM 407
              RE +
Sbjct: 265 PKYRELL 271

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.5 bits (113), Expect = 5e-06
 Identities = 49/200 (24%), Positives = 96/200 (48%), Gaps = 32/200 (16%)

Query: 130 VRKVGRGKYSEV----FEGINVNTNERCIIKILKPVKKKKI---KREIKILQNLCGGPNV 182
           ++++G+G +  V    ++ +  NT E   +K L+    + +   +REI+IL++L    N+
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNI 67

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-----------YIYELLKA 231
           VK   +      +   L+ EY+        Y +L DY  ++           Y  ++ K 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLP-------YGSLRDYLQKHRERLDHRKLLLYASQICKG 120

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASR---YFKG 287
           ++Y  S+  +HRD+   N++++ E R +++ D+GL +     KE Y VR       ++  
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 288 PELLVDLQDYDYSLDMWSLG 307
           PE L +   +  + D+WS G
Sbjct: 180 PESLTE-SKFSVASDVWSFG 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 54/223 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKI-LKPVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    VF+  +  +     R +I + +KP  + +I RE+++L   C  P
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 63

Query: 181 NVVKL---------------------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
            +V                       LD V  +  + P  I   V+              
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVS-------------- 109

Query: 220 DIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
                   ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N 
Sbjct: 110 ------IAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NS 161

Query: 279 RVASRYFKGPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
            V +R +  PE    LQ   YS+  D+WS+G     M   + P
Sbjct: 162 FVGTRSYMSPE---RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.7 bits (113), Expect = 6e-06
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 28/193 (14%)

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV-ASRYF- 285
           +L+A+ Y H   I+HRD+K  N+ I+H    + L D+G A        + V + A++Y+ 
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAA-------CFPVDINANKYYG 242

Query: 286 -------KGPELLVDLQDYDYSLDMWSLGCMFAGM------IFRKEPFFYGHDNHDQLVK 332
                    PELL     Y  ++D+WS G +   M      +F K+      D+  Q+  
Sbjct: 243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301

Query: 333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD-K 391
           I +  GT   N +       LD     L  + SRKP S+ +  +   L  P  +++L  K
Sbjct: 302 IIRRSGTHP-NEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL--PIDLEYLICK 358

Query: 392 LLRYDHQDRLTAR 404
           +L +D   R +A 
Sbjct: 359 MLAFDAHHRPSAE 371

Length = 391

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 12/102 (11%)

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------LRK-LRLIDWGL- 266
           +++  I Y +  +LKALDY H  G +HR VK  +++I  +       LR  L +I+ G  
Sbjct: 98  MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157

Query: 267 AEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLG 307
               H   +Y+V+V    +  PE+L  +LQ YD   D++S+G
Sbjct: 158 LRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVG 197

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 15/147 (10%)

Query: 130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR----EIKILQNLCGGPN---V 182
           ++ +G G + EV     V+T+    +K L+  KK  + R     +K  +++    +   V
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLR--KKDVLNRNQVAHVKAERDILAEADNEWV 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQG 239
           VKL    +D+ +     + +Y+   D   L        +   R+YI EL  A++  H  G
Sbjct: 64  VKLYYSFQDKDNLY--FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGL 266
            +HRD+KP N++ID +   ++L D+GL
Sbjct: 122 FIHRDIKPDNILIDLD-GHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 29/226 (12%)

Query: 99  VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEG-----INVNTNERC 153
           VY D   L     W++    + +G        + +G G + +V E         +   + 
Sbjct: 17  VYIDPTQLPYDLKWEFPRNNLSFG--------KTLGAGAFGKVVEATAYGLSKSDAVMKV 68

Query: 154 IIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF 209
            +K+LKP     +++ +  E+KI+ +L    N+V LL            +I EY    D 
Sbjct: 69  AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC--TIGGPILVITEYCCYGDL 126

Query: 210 -----KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
                +     LT  D+  + Y++ K + +  S+  +HRD+   NV++ H  + +++ D+
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDF 185

Query: 265 GLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG 307
           GLA        Y V+  +R    +  PE + +   Y +  D+WS G
Sbjct: 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYG 230

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 50/209 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKI-LKPVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    V + ++  +     R +I + +KP  + +I RE+K+L   C  P
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSP 59

Query: 181 NVVKL---------------------LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
            +V                       LD V  +  + P  I   ++              
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS-------------- 105

Query: 220 DIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
                   +L+ L Y   +  IMHRDVKP N++++    +++L D+G++         N 
Sbjct: 106 ------IAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NS 157

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLG 307
            V +R +  PE L     Y    D+WSLG
Sbjct: 158 FVGTRSYMSPERLQG-THYTVQSDIWSLG 185

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 21/209 (10%)

Query: 125 DDYEVVRKVGRGKYSEV---------FEGINVNTNERCIIKILKPVKKKKIKREIKILQN 175
           +D+  +R +G G +  V         F  + +   E+   KI+K  +   +  E KIL N
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKIL-N 86

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY--DIR-YYIYELLKAL 232
               P  V L    +D+      L+ E+V   +F         +  D+  +Y  +++   
Sbjct: 87  YINHPFCVNLYGSFKDE--SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
           +Y  S  I++RD+KP N+++D +   +++ D+G A+     + Y +     Y   PE+L+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT-RTYTLCGTPEYI-APEILL 201

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           ++  +  + D W+LG     ++    PF+
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPPFY 229

Length = 340

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 47/207 (22%), Positives = 93/207 (44%), Gaps = 15/207 (7%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPNVVKLLDI 188
           +G G    V++  ++ T     +K++        +K+I  E++IL   C  P ++     
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYK-CDSPYIIGFYGA 67

Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH 248
              ++    S+  E+++     V Y  + ++ +      ++K L Y  S  I+HRDVKP 
Sbjct: 68  FFVENRI--SICTEFMDGGSLDV-YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPS 124

Query: 249 NVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSL 306
           N++++    +++L D+G++        K Y   V +  +  PE +   Q Y    D+WSL
Sbjct: 125 NMLVNTR-GQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISGEQ-YGIHSDVWSL 179

Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           G  F  +   + P+     N   L+ +
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMPL 206

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 19/50 (38%), Positives = 31/50 (62%), Gaps = 1/50 (2%)

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 270
           I+  + ++L  L+Y H  GI H D+KP N+M+D   R   +ID+G+A  +
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176

Length = 294

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 48/226 (21%), Positives = 103/226 (45%), Gaps = 26/226 (11%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
           ++  ++++K+G G++ EV+ G   N N +  +K LKP  +  +    E +I++ L     
Sbjct: 5   RESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDK 62

Query: 182 VVKLLDIVRDQHSKTP-SLIFEYVNSTDFKVLYPTLTDYDIRY--------YIYELLKAL 232
           +V+L  +V    S+ P  ++ EY++      L   L D + R            ++   +
Sbjct: 63  LVQLYAVV----SEEPIYIVTEYMSKGS---LLDFLKDGEGRALKLPNLVDMAAQVAAGM 115

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPE 289
            Y      +HRD++  N+++   L   ++ D+GLA       EY  R  +++   +  PE
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
             +    +    D+WS G +   ++ +    + G +N + L ++ +
Sbjct: 174 AAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 4/58 (6%)

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEY 276
           R+YI EL  A++  H  G +HRD+KP N++ID +   ++L D+GL     + H  K Y
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYY 160

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 47/210 (22%), Positives = 96/210 (45%), Gaps = 30/210 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNER---CIIKILKPVKK----KKIKREIKILQNLCGGPNVV 183
           R +G+G +  V+ G  ++++ +   C +K L  +      ++  +E  I+++    PNV+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVL 59

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHS 237
            LL I       +P ++  Y+   D +         PT+ D  +  +  ++ K ++Y  S
Sbjct: 60  SLLGICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYLAS 116

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELL 291
           +  +HRD+   N M+D E   +++ D+GLA      E+Y        ++  ++      L
Sbjct: 117 KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA----L 171

Query: 292 VDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
             LQ   ++   D+WS G +   ++ R  P
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 5/109 (4%)

Query: 202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
           EY +  D +    TLT  D+  + Y++ + +++  S+  +HRD+   NV++  +   +++
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKI 173

Query: 262 IDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDMWSLG 307
            D+GLA   H    Y      R    +  PE L D + Y +  D+WS G
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 221

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 43.6 bits (103), Expect = 9e-05
 Identities = 66/296 (22%), Positives = 123/296 (41%), Gaps = 49/296 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCG 178
             +D E +  +G G    V +  ++ T      K++    K   +K+I RE++I+   C 
Sbjct: 3   RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CR 61

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCH 236
            P +V       ++++    + F    S D  +K   P   +  +      +++ L Y +
Sbjct: 62  SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLTYLY 120

Query: 237 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 291
           +   IMHRD+KP N++++    +++L D+G++     G+  N      V +  +  PE  
Sbjct: 121 NVHRIMHRDIKPSNILVNSR-GQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE-- 172

Query: 292 VDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
             +Q   Y++  D+WSLG     +   K PF + + + D       +L  D L   +   
Sbjct: 173 -RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL--DLLQQIVQ-- 227

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
             E  P+L          P S F           +  DF+D  L  D  +R T ++
Sbjct: 228 --EPPPRL----------PSSDF---------PEDLRDFVDACLLKDPTERPTPQQ 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 30/126 (23%), Positives = 52/126 (41%), Gaps = 4/126 (3%)

Query: 148 NTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS 206
             +E  ++KI     K    +RE+ ILQ L      V  + +   +      L+ E++  
Sbjct: 19  TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV-LASGESDGWSYLLMEWIEG 77

Query: 207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
                +       DI   + ELL  L       + H D+ P N+++D + + L +IDW  
Sbjct: 78  ETLDEV-SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEY 135

Query: 267 AEFYHP 272
           A +  P
Sbjct: 136 AGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 7/100 (7%)

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-- 272
            LT  D+    Y++ + ++Y  SQ  +HRD+   NV++  +   +++ D+GLA   H   
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED-NVMKIADFGLARDVHNID 188

Query: 273 --GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
              K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 189 YYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLL 226

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 51/227 (22%), Positives = 101/227 (44%), Gaps = 33/227 (14%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNV 182
           ++ + RK+G G + EV+EG+  N   R  IKILK    +K++  ++E++ L+ L    ++
Sbjct: 7   EFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHL 64

Query: 183 VKLLDIVRDQHSKTPSLIF----------EYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           + L  +        P  I            ++ S + +VL P  +  D+   + E    +
Sbjct: 65  ISLFAVCS---VGEPVYIITELMEKGSLLAFLRSPEGQVL-PVASLIDMACQVAE---GM 117

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKG 287
            Y   Q  +HRD+   N+++  +L   ++ D+GLA     + Y      + ++  ++   
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLS---SDKKIPYKW-TA 172

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           PE       +    D+WS G +   M    +  + G +NH+   +I 
Sbjct: 173 PEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 15/89 (16%)

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF--------YHPGKEYNV 278
           +LL A+DY H +GI+HRD+K  NV+++     + L D+G A F        +H G    V
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLG 307
                    PE+L     Y  S+D+WS G
Sbjct: 327 DT-----NAPEVLAG-DPYTPSVDIWSAG 349

Length = 461

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 39/204 (19%), Positives = 94/204 (46%), Gaps = 30/204 (14%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 4   ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP 62

Query: 181 NVVKLLDIVRDQHSKTPSL-----------IFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
           N+V+LL +     ++ P             + +Y+   + + +   +    + Y   ++ 
Sbjct: 63  NLVQLLGVC----TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQIS 114

Query: 230 KALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---F 285
            A++Y   +  +HRD+   N ++ ++ L  +++ D+GL+     G  Y     +++   +
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMT-GDTYTAHAGAKFPIKW 171

Query: 286 KGPELLVDLQDYDYSLDMWSLGCM 309
             PE L     +    D+W+ G +
Sbjct: 172 TAPESLA-YNKFSIKSDVWAFGVL 194

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 7/98 (7%)

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 272
           +T  D+    Y++ + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA   +    
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDY 192

Query: 273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 309
             K  N R+  ++   PE L D + Y +  D+WS G +
Sbjct: 193 YKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVL 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 46/207 (22%), Positives = 96/207 (46%), Gaps = 30/207 (14%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPN 181
           ++  ++V+K+G G++ EV+ G   N + +  IK LK   +  +    E  +++ L   P 
Sbjct: 5   RETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPR 62

Query: 182 VVKLLDIVRDQHSKTPSLIF-EYVNS---TDFKVLYPTLTDYDIRYYIYELL-------K 230
           +V+L  +V    ++ P  I  EY+ +    DF       T   I+  I +L+       +
Sbjct: 63  LVRLYAVV----TQEPIYIITEYMENGSLVDF-----LKTPEGIKLTINKLIDMAAQIAE 113

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 287
            + +   +  +HRD++  N+++   L   ++ D+GLA       EY  R  +++   +  
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED-NEYTAREGAKFPIKWTA 171

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMI 314
           PE  ++   +    D+WS G +   ++
Sbjct: 172 PE-AINYGTFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 40/209 (19%), Positives = 82/209 (39%), Gaps = 29/209 (13%)

Query: 132 KVGRGKYSEVFEGINVNTNERCI---IKILKPVKKKKIK----REIKILQNLCGGPNVVK 184
           K+G G +  V  G    +  + I   +K LK  K   I     +E  I+ +L    N+++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIR 60

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL--------KALDYCH 236
           L  +V         ++ E         L   L    + +++   L          + Y  
Sbjct: 61  LYGVVLTHPLM---MVTEL---APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK----GPELLV 292
           S+  +HRD+   N+++  +  K+++ D+GL       +++ V             PE L 
Sbjct: 115 SKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 293 DLQDYDYSLDMWSLG-CMFAGMIFRKEPF 320
               + ++ D+W  G  ++    + +EP+
Sbjct: 174 TRT-FSHASDVWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 42.6 bits (101), Expect = 3e-04
 Identities = 19/83 (22%), Positives = 40/83 (48%), Gaps = 9/83 (10%)

Query: 188 IVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK 246
           ++ D   +  +++ EY+   D K VL            + ++ + +   H  GI+H D+ 
Sbjct: 402 VIYDVDPEEKTIVMEYIGGKDLKDVLEGNPE------LVRKVGEIVAKLHKAGIVHGDLT 455

Query: 247 PHNVMIDHELRKLRLIDWGLAEF 269
             N ++  +  +L LID+GL ++
Sbjct: 456 TSNFIVRDD--RLYLIDFGLGKY 476

Length = 535

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 46/190 (24%), Positives = 80/190 (42%), Gaps = 21/190 (11%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGPNVVKLL 186
            K+G+G + +V++G+ +  N    +K     L P  K+K  +E +IL+     PN+VKL+
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLI 58

Query: 187 DIVRDQHSKTPSLI-FEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIM 241
            +      K P  I  E V               LT   +     +    ++Y  S+  +
Sbjct: 59  GVCVQ---KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115

Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLVDLQDY 297
           HRD+   N ++      L++ D+G++     G  Y V    +     +  PE L +   Y
Sbjct: 116 HRDLAARNCLVGEN-NVLKISDFGMSREEEGG-IYTVSDGLKQIPIKWTAPEAL-NYGRY 172

Query: 298 DYSLDMWSLG 307
               D+WS G
Sbjct: 173 TSESDVWSYG 182

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 27/200 (13%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D+   +++RK+G G++ EV+EG+  NT     +K LKP  +  K    E +I++ L   P
Sbjct: 4   DRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKL-RHP 61

Query: 181 NVVKLLDIVRDQHS--------KTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKA 231
            +++L  +   +          K  SL+ EY+     + L  P L D        ++   
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLL-EYLQGGAGRALKLPQLIDMAA-----QVASG 115

Query: 232 LDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 287
           + Y  +Q  +HRD+   NV++ ++ + K  + D+GLA        Y  R  +++   +  
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVGENNICK--VADFGLARVIKE-DIYEAREGAKFPIKWTA 172

Query: 288 PELLVDLQDYDYSLDMWSLG 307
           PE       +    D+WS G
Sbjct: 173 PE-AALYNRFSIKSDVWSFG 191

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 30/129 (23%), Positives = 60/129 (46%), Gaps = 12/129 (9%)

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRD 244
           L + +R +    P   F+     + ++ +  L         Y++ + ++Y  S+  +HRD
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC-----AYQVARGMEYLESRRCIHRD 159

Query: 245 VKPHNVMIDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYS 300
           +   NV++  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y + 
Sbjct: 160 LAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-APEALFD-RVYTHQ 216

Query: 301 LDMWSLGCM 309
            D+WS G +
Sbjct: 217 SDVWSFGIL 225

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 36/213 (16%)

Query: 147 VNTNERCIIKILKPVKKKKI--KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204
               ER I K +K   +  I  + EI  L  L    N++K+ +I+R     + +  +   
Sbjct: 189 KPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILR-----SEANTYMIT 242

Query: 205 NSTDFKVLYPTLTDYDI-----------RYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
              DF  LY  + D              R  + +LL A++Y H + ++HRD+K  N+ ++
Sbjct: 243 QKYDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301

Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVASRY-------FKGPELLVDLQDYDYSLDMWSL 306
            +  K+ L D+G A  +        R A  Y          PE+L     Y    D+WS 
Sbjct: 302 CD-GKIVLGDFGTAMPFE-----KEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSC 354

Query: 307 GCMFAGMIFRKE-PFFYGHDN-HDQLVKIAKVL 337
           G +   M+     P   G      QL+KI   L
Sbjct: 355 GLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 49/216 (22%), Positives = 99/216 (45%), Gaps = 36/216 (16%)

Query: 128 EVVRKVGRGKYSEVFEGINVNTNER-CI---IKILK----PVKKKKIKREIKILQNLCGG 179
           E ++ +G G +  V++G+ +   E+  I   IK+L+    P   K+I  E  ++ +    
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS-VDH 68

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYV----------NSTDFKVLYPTLTDYDIRYYIYELL 229
           P+VV+LL I     S    LI + +          N  D       +    +  +  ++ 
Sbjct: 69  PHVVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKD------NIGSQYLLNWCVQIA 119

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNV---RVASRYF 285
           K + Y   + ++HRD+   NV++    + +++ D+GLA+      KEY+    +V  ++ 
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 286 KGPELLVDLQDYDYSLDMWSLGC-MFAGMIFRKEPF 320
              E ++  + Y +  D+WS G  ++  M F  +P+
Sbjct: 179 -ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 40.6 bits (95), Expect = 7e-04
 Identities = 13/53 (24%), Positives = 24/53 (45%)

Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
           ++   +   L AL       ++H D+ P N+++D   R   +ID+  A    P
Sbjct: 147 ELWERLLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDP 199

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 26/89 (29%), Positives = 47/89 (52%), Gaps = 7/89 (7%)

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP----GKEYNVRVA 281
           Y++ + ++Y  S+  +HRD+   NV++  E   +++ D+GLA   H      K  N R+ 
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
            ++   PE L D + Y +  D+WS G + 
Sbjct: 206 VKWM-APEALFD-RIYTHQSDVWSFGVLL 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 40.6 bits (95), Expect = 9e-04
 Identities = 51/227 (22%), Positives = 95/227 (41%), Gaps = 35/227 (15%)

Query: 133 VGRGKYSEVFEG-----INVNTNE-RCIIKILK----PVKKKKIKREIKILQNLCGGPNV 182
           +G G + EV+EG     +   +   R  +K L+      +KK+  +E  ++ N    PN+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTDF----------KVLYPTLTDYDIRYYIYELLKAL 232
           VKLL +      +   +I E +   D           +   P LT  ++     ++ K  
Sbjct: 62  VKLLGVCLLNEPQ--YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 233 DYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAEFYHPGKEYNVR----VASRY 284
            Y      +HRD+   N ++  +     R +++ D+GLA   +    Y       +  R+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 285 FKGPELLVDLQDYDYSLDMWSLGC-MFAGMIFRKEPFFYGHDNHDQL 330
              PE L+D +    S D+WS G  M+  +   ++P +   +N + L
Sbjct: 180 M-APESLLDGKFTTQS-DVWSFGVLMWEILTLGQQP-YPALNNQEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.5 bits (93), Expect = 0.001
 Identities = 36/151 (23%), Positives = 69/151 (45%), Gaps = 25/151 (16%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKP-----------VKKKKIKREIKIL-QNLCGGP 180
           + RG  +E++ G  +    + +IK   P           +++++ +RE +I+ +    G 
Sbjct: 4   IKRGAEAEIYLGDFLG--IKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61

Query: 181 NV--VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           NV  V  +D           ++ EY+     K L  +    ++     E+ + +   HS 
Sbjct: 62  NVPAVYFVDPENF------IIVMEYIEGEPLKDLINSNGMEELELS-REIGRLVGKLHSA 114

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
           GI+H D+   N+++     K+ LID+GLAEF
Sbjct: 115 GIIHGDLTTSNMILSG--GKIYLIDFGLAEF 143

Length = 211

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 49/208 (23%), Positives = 79/208 (37%), Gaps = 38/208 (18%)

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------LRKLRLID----WGLAEF 269
           I + + ++L ALDY HS+G +HR VK  ++++  +       LR    +           
Sbjct: 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 270 YHP-GKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLG---CMFAGMIFRKEPFFYGH 324
             P     N+   S     PE+L  +LQ Y+   D++S+G   C  A       PF    
Sbjct: 163 DFPKSSVKNLPWLS-----PEVLQQNLQGYNEKSDIYSVGITACELANGH---VPFK--- 211

Query: 325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV--- 381
           D     + + KV GT       + Y L  D          SR       N D+       
Sbjct: 212 DMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ------SRSSNEHPNNRDSVDHPYTR 265

Query: 382 --SPEAIDFLDKLLRYDHQDRLTAREAM 407
             S     F++  L+ D + R +A + +
Sbjct: 266 TFSEHFHQFVELCLQRDPESRPSASQLL 293

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 26/104 (25%), Positives = 49/104 (47%), Gaps = 11/104 (10%)

Query: 167 KREIKILQNLC-GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI 225
           + E ++L      G N   + D+  D  +KT  ++ EY+     K +     D      +
Sbjct: 45  RNEARLLSRARKAGVNTPVVYDV--DPDNKT--IVMEYIEGKPLKDVIEEGNDE----LL 96

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
            E+ + +   H  GI+H D+   N+++  +  KL LID+GL ++
Sbjct: 97  REIGRLVGKLHKAGIVHGDLTTSNIIVRDD--KLYLIDFGLGKY 138

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 44/216 (20%)

Query: 133 VGRGKYSEVFEGINVNTNER-----CIIKILK----PVKKKKIKREIKILQNLCGGPNVV 183
           +G G++ +V +        R       +K+LK      + + +  E  +L+ +   P+V+
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVI 66

Query: 184 KLLDIVRDQHSKTPSLIFEYV---------------------------NSTDFKVLYPTL 216
           KL             LI EY                            +S         L
Sbjct: 67  KLYGAC--SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           T  D+  + +++ + + Y     ++HRD+   NV++  E RK+++ D+GL+   +    Y
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDSY 183

Query: 277 NVRVASRY---FKGPELLVDLQDYDYSLDMWSLGCM 309
             R   R    +   E L D   Y    D+WS G +
Sbjct: 184 VKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVL 218

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 51/224 (22%), Positives = 100/224 (44%), Gaps = 32/224 (14%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI----KREIK--ILQNLC----GGP 180
           + +G G++  V EG      +  I+K+   VK  KI    + E++  + + +C      P
Sbjct: 5   KTLGEGEFGSVMEGQL--NQDDSILKV--AVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 181 NVVKLLDI----VRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRY-------YIYE 227
           NV++L+ +    V  +   +P +I  ++   D    +LY  L D            ++ +
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-RVASRYFK 286
           +   ++Y  S+  +HRD+   N M++  +  + + D+GL++  + G  Y   R+A    K
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 287 --GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
               E L D + Y    D+WS G     +  R +  + G +N +
Sbjct: 180 WIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 38.5 bits (90), Expect = 0.003
 Identities = 38/193 (19%), Positives = 83/193 (43%), Gaps = 24/193 (12%)

Query: 131 RKVGRGKYSEVFEGINVNTNER---CIIKILKPVK----KKKIKREIKILQNLCGGPNVV 183
           +++G G +  V +G+ +  + +     +K LK       KK+  RE  ++  L   P +V
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV 59

Query: 184 KLLDIVRDQHSKTPS--LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +L+ +      K     L+ E         +      +   D++   +++   + Y  S+
Sbjct: 60  RLIGV-----CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRY---FKGPELLVDL 294
             +HRD+   NV++ +   + ++ D+G++     G + Y    A R+   +  PE  ++ 
Sbjct: 115 HFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE-CINY 172

Query: 295 QDYDYSLDMWSLG 307
             +    D+WS G
Sbjct: 173 GKFSSKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 29/95 (30%), Positives = 49/95 (51%), Gaps = 8/95 (8%)

Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           +L+ L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 169

Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
            PE    LQ   YS+  D+WS+G     +   + P
Sbjct: 170 SPE---RLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 38.5 bits (90), Expect = 0.004
 Identities = 44/212 (20%), Positives = 82/212 (38%), Gaps = 50/212 (23%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCG---------GPNVV 183
           +G+G++ +V  G              + V  K +K +    Q              PN+V
Sbjct: 14  IGKGEFGDVMLGDYRG----------QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLV 63

Query: 184 KLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           +LL +V          ++    SL+ +Y+ S    V+    T      +  ++ + ++Y 
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLV-DYLRSRGRAVI----TLAQQLGFALDVCEGMEYL 118

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF----KGPELL 291
             +  +HRD+   NV++  +L   ++ D+GLA      KE +    S         PE L
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVA-KVSDFGLA------KEASQGQDSGKLPVKWTAPEAL 171

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
              + +    D+WS G      I   E + +G
Sbjct: 172 -REKKFSTKSDVWSFG------ILLWEIYSFG 196

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 38.5 bits (90), Expect = 0.004
 Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 8/87 (9%)

Query: 226 YELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVAS 282
              +KAL+Y   +  I+HRDVKP N+++D   R   ++L D+G++               
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRDAGC 170

Query: 283 RYFKGPELLV--DLQDYDYSLDMWSLG 307
           R +  PE +       YD   D+WSLG
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLG 197

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	419
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
PRK10345	210	hypothetical protein; Provisional	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
smart00090	237	RIO RIO-like kinase.	99.8
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
KOG1243	690	consensus Protein kinase [General function predict	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.39
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.36
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.19
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.19
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.17
COG4248	637	Uncharacterized protein with protein kinase and he	99.15
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.93
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.85
PRK09902	216	hypothetical protein; Provisional	98.75
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.68
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.52
PF01636	239	APH: Phosphotransferase enzyme family This family	98.5
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.5
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.5
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.44
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.44
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.39
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.33
PLN02876	822	acyl-CoA dehydrogenase	98.3
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.2
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.18
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.13
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.13
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.09
PRK10593	297	hypothetical protein; Provisional	98.02
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.93
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.83
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.75
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.69
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.66
PRK05231	319	homoserine kinase; Provisional	97.5
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.47
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.32
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.31
KOG2270	520	consensus Serine/threonine protein kinase involved	97.19
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.14
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.1
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.09
PLN02236	344	choline kinase	96.95
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.93
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.82
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.75
COG2334	331	Putative homoserine kinase type II (protein kinase	96.6
PTZ00384	383	choline kinase; Provisional	96.29
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.27
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.17
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.02
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.93
PLN02756	418	S-methyl-5-thioribose kinase	95.5
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.47
PRK06148	1013	hypothetical protein; Provisional	95.21
PRK11768	325	serine/threonine protein kinase; Provisional	95.21
PTZ00296	442	choline kinase; Provisional	95.13
PRK12396	409	5-methylribose kinase; Reviewed	95.03
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.51
PRK06149	972	hypothetical protein; Provisional	94.05

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.2e-68  Score=452.34  Aligned_cols=326  Identities=83%  Similarity=1.357  Sum_probs=318.2

Q ss_pred             cCcccccccccccCCCcccCCCCCceeccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHH
Q 014762           93 AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKI  172 (419)
Q Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~  172 (419)
                      ..+.++++++++..++.+||+|+...+.++.+++|++.+++|+|.++.||.|.+..+++.++||++++...+++.+|+.|
T Consensus         6 v~s~ARvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikI   85 (338)
T KOG0668|consen    6 VPSVARVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKI   85 (338)
T ss_pred             cchhhhhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHH
Confidence            45788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE
Q 014762          173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (419)
Q Consensus       173 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl  252 (419)
                      |..|++||||++++++..++.++.+.||+||+++.++..+.+.++..+++.++.|++.||+|||++||+|||+||.|+++
T Consensus        86 L~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI  165 (338)
T KOG0668|consen   86 LQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI  165 (338)
T ss_pred             HHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 014762          253 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVK  332 (419)
Q Consensus       253 ~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~  332 (419)
                      |.....++|+|||+|.+..++..++.++.+.+|-.||.+.+.+.|+.+-|+|||||++.+|+..+.|||.|.++.+|+..
T Consensus       166 dh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk  245 (338)
T KOG0668|consen  166 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK  245 (338)
T ss_pred             chhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence            99888999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       333 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      |.+++|+..+..++.++.+.+++.+.++.+...+++|..|+..++++..++++.||+.++|.+|.++|+||.|++.||||
T Consensus       246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccc
Q 014762          413 SPIFSL  418 (419)
Q Consensus       413 ~~~~~~  418 (419)
                      .+++++
T Consensus       326 ~~~~~~  331 (338)
T KOG0668|consen  326 APVREA  331 (338)
T ss_pred             HHHHHH
Confidence            988753

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.9e-55  Score=382.71  Aligned_cols=275  Identities=36%  Similarity=0.689  Sum_probs=231.8

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|...++||+|.||.||+|+|..+|+.||||.++..+     .-...|||+.|+.+ +|+||+.++++|  .+...+.|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F--~~~~~l~l   78 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVF--PHKSNLSL   78 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhc--cCCCceEE
Confidence            46888899999999999999999999999999997543     24578999999999 899999999999  55577889


Q ss_pred             EEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          200 IFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      |+|||+ .+|+..++    -++..+++.++.++++||+|||++.|+||||||.|+|++++ +.+||+|||+|+...+.. 
T Consensus        79 VfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   79 VFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             EEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccCCCCc
Confidence            999998 45666653    38999999999999999999999999999999999999999 899999999999876543 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ..+..+.|.+|+|||.+.|...|+..+||||.||++.||+-|. ||++|.++.+|+..|.+.+|+|..+.|.+-..+   
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l---  232 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL---  232 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcccCcccccc---
Confidence            3455689999999999999999999999999999999999765 899999999999999999999998887643222   


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      +++..+. .....+....+     ..+++++.||+.+||.+||.+|+||.|+|+|+||++
T Consensus       233 pdY~~~~-~~P~~~~~~lf-----~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  233 PDYVKIQ-QFPKPPLNNLF-----PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             ccHHHHh-cCCCCcccccc-----ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence            2222221 11111111111     126888999999999999999999999999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.8e-56  Score=392.82  Aligned_cols=278  Identities=31%  Similarity=0.563  Sum_probs=231.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      +.|+.+.++|+|+||.||+|+++.||+.||||.+..+.     ++-..||+.+|+++ .|+|+|.++++|...  +.++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrk--rklhL   78 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRK--RKLHL   78 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhc--ceeEE
Confidence            56888999999999999999999999999999985332     45678999999999 999999999999654  77889


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc-CCCc
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKE  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~-~~~~  275 (419)
                      |+|||+..-|..+-   ..++...++.+++|++.|+.|+|++++|||||||+|||++.+ +.+||||||.|+... ++..
T Consensus        79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCcch
Confidence            99999998776654   568999999999999999999999999999999999999998 899999999999887 7788


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHH--HHHhhcCCCC
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN--AYLNKYHLEL  353 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~--~~~~~~~~~~  353 (419)
                      ++..+.|.||+|||.+.+...|+..+||||+||++.||++|. |+++|.++.+|+..|.+.+|.-...  ........  
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~-pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~--  234 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE-PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF--  234 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC-cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc--
Confidence            888999999999999999889999999999999999999998 6679999999999999999974332  22111110  


Q ss_pred             ChhhHHhhccCCCCCccccc--cccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFI--NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                         +..+.     -+-....  .+..-..++..+.||+.+||..||.+|+|.+++|.||||.++.+
T Consensus       235 ---F~Gv~-----lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e  292 (396)
T KOG0593|consen  235 ---FHGVR-----LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE  292 (396)
T ss_pred             ---eeeee-----cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence               00000     0000000  00111236778899999999999999999999999999987654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-55  Score=404.93  Aligned_cols=258  Identities=27%  Similarity=0.429  Sum_probs=212.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----------hHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++++..          .....+|+++|++| +|||||+++++|..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVP  248 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecC
Confidence            4678999999999999999999999999999999996421          12356999999999 999999999999665


Q ss_pred             CCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccc
Q 014762          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA  267 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla  267 (419)
                        ...|+||||++||+|.+..   ..+.+...+.+++|++.|+.|||++||+||||||+|||+..+  .-.+||+|||+|
T Consensus       249 --ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  249 --DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             --CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence              5678999999999998876   458888889999999999999999999999999999999765  246899999999


Q ss_pred             eeccCCCcceeecccccccccccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          268 EFYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      +..+......+.|||+.|.|||++.+.  ..+..++|+||+||+||-+++|..||.....+....++|.+          
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~----------  396 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK----------  396 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc----------
Confidence            998877778889999999999999762  22445889999999999999999999433333222333222          


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                         +...+.+           ..         +..++++.++||.+||..||++|||+.|+|+||||+.+.
T Consensus       397 ---G~y~f~p-----------~~---------w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  397 ---GRYAFGP-----------LQ---------WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             ---CcccccC-----------hh---------hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence               1111110           11         123899999999999999999999999999999999653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-55  Score=398.38  Aligned_cols=255  Identities=21%  Similarity=0.364  Sum_probs=217.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEe----cCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~----~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .++.+.++.||+|..|+||++.++.|++.+|+|++    ++..++++.+|+++++.+ +|||||.+||.|..+.. .+++
T Consensus        78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI  155 (364)
T KOG0581|consen   78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISI  155 (364)
T ss_pred             HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEe
Confidence            34677788999999999999999999999999999    345568899999999998 99999999999987643 5889


Q ss_pred             EEEecCCCChhhhcCC---CCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          200 IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~~~---l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||||++|+|+..+..   +++..+..++.++++||.|||+ ++||||||||+|||++.. |.|||||||.++..... .
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS-~  233 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNS-I  233 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEeccccccHHhhhh-h
Confidence            9999999999998854   9999999999999999999995 999999999999999998 89999999999877655 5


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG-HDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~-~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      .+..+||..|||||-+.+ ..|+.++||||||++++|+.+|+.||... .+....+..+..+...++..           
T Consensus       234 a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~-----------  301 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR-----------  301 (364)
T ss_pred             cccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC-----------
Confidence            567899999999999988 89999999999999999999999999553 11222333333322211100           


Q ss_pred             hhhHHhhccCCCCCccccccccccC-CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQH-LVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                            .+. .+|+++++|+..||+.||.+|+|+.|+++|||++...
T Consensus       302 ----------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  302 ----------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             ----------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence                                  011 3799999999999999999999999999999998653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-55  Score=411.81  Aligned_cols=280  Identities=30%  Similarity=0.555  Sum_probs=235.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--h--HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--K--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++|.++++||.|.||.||+|+...+|+.||||.++..-  .  -.-.||+..|+++..||||+++.+++.+.. ..++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~-~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND-RILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC-ceEe
Confidence            3578999999999999999999999999999999987432  1  234689999999944999999999998764 3899


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +|||||+....+-..   +.|++..++.|+.||++||+|+|++|+.|||+||+|||+..+ ..+||+|||+|+.......
T Consensus        87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEecccccccccccCCC
Confidence            999999976544332   459999999999999999999999999999999999999976 6899999999999998899


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ++..+.|+||+|||+++....|+.+.|||++||+++|+.+-+ |.|.|.++.+++.+|.+++|.+....|.....+.   
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr-PLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La---  241 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR-PLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA---  241 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc-ccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH---
Confidence            999999999999999998889999999999999999999887 6679999999999999999999887765532111   


Q ss_pred             hhHHhhccCCC---CCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          356 QLDALVGRHSR---KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                        ..+.-....   .+...++     ..++.++.++|.+||.|||.+||||.|+|+||||+.-
T Consensus       242 --~~mnf~~P~~~~~~l~~L~-----p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  242 --SAMNFRFPQVKPSPLKDLL-----PNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             --HHhccCCCcCCCCChHHhC-----cccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence              000001111   1111111     2378999999999999999999999999999999853

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-54  Score=406.82  Aligned_cols=279  Identities=32%  Similarity=0.611  Sum_probs=237.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .+.|+.+++||+|.||.||+|++..+|+.||+|.+.-..     ..-..|||.||++| +||||++|.+...+.....+|
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEE
Confidence            567999999999999999999999999999999986332     34567999999999 999999999999887678899


Q ss_pred             EEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      ||+|||+.........   .|++.+++.++.|++.||+|||++||+|||||.+|||||.+ +.+||+|||+|+++.... 
T Consensus       195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-GVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC-CCEEeccccceeeccCCCC
Confidence            9999999766554443   59999999999999999999999999999999999999988 899999999999876554 


Q ss_pred             -cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       275 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       .++..+.|.||+|||++++...|+.++|+||.||+|.||+.|+ |+++|.++.+|+..|.+.+|.+....|. ...+..
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gk-PI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~  351 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGK-PILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPH  351 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCC-CCcCCccHHHHHHHHHHHhCCCChhccc-cccCCc
Confidence             4677899999999999999999999999999999999999998 5569999999999999999999988776 333332


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                      ...+..      ..+....+.+. -..++....+|+..||..||.+|.||.++|+|+||+
T Consensus       352 ~~~~kp------~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  352 ATIFKP------QQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             ccccCC------CCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            221111      11111112111 234889999999999999999999999999999995

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-54  Score=394.27  Aligned_cols=282  Identities=32%  Similarity=0.575  Sum_probs=235.7

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC---ccEEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK---TPSLIF  201 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---~~~lv~  201 (419)
                      -.|+..+.+|.|+||.||+|....+++.||||..-+.. +--.+|+.+|+.+ .|||||++.-+|....+.   +..+||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-RYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-CcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            35788999999999999999999999999999875433 2334799999998 999999999988755444   567899


Q ss_pred             EecCCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          202 EYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       202 e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+....+...      ..++...++.+.+||++||.|||+.||+||||||.|+|+|.+.+.+||||||.|+....+..
T Consensus       102 eymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  102 EYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             HhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            999976554433      46888899999999999999999999999999999999999999999999999999998888


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ......|++|+|||.+.+...|+.+.||||.||++.||+.|+ |+|.|.+..+|+.+|++++|.+..+....-.......
T Consensus       182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~-plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~  260 (364)
T KOG0658|consen  182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQ-PLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF  260 (364)
T ss_pred             ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCC-cccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence            888899999999999999999999999999999999999998 5569999999999999999998877653211111010


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                          .........|..+    .....+++..||+.++|+++|.+|.||.|+|+||||..+++
T Consensus       261 ----~~p~ik~~~~~~~----~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  261 ----KFPQIKAHPWHKV----FFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             ----cCcccccccceee----cccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence                0111222333331    22347899999999999999999999999999999998865

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-53  Score=406.77  Aligned_cols=247  Identities=25%  Similarity=0.475  Sum_probs=215.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..+|...+.||+|||++||++++..+|+.||+|++.+      ..++++.+||+|.+.| +|||||+++++|++  ..++
T Consensus        17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FED--s~nV   93 (592)
T KOG0575|consen   17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFED--SNNV   93 (592)
T ss_pred             cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeec--CCce
Confidence            3779999999999999999999999999999999864      3467899999999999 99999999999966  4889


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-  273 (419)
                      |+|+|+|..++|..++   +.++|.+++.+++||+.||.|||+++|+|||||..|+|++++ ..|||+|||+|..+... 
T Consensus        94 YivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc-CcEEecccceeeeecCcc
Confidence            9999999999998887   469999999999999999999999999999999999999998 78999999999888754 


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      ....+.+||+.|.|||++.. ...++.+||||+||+||.|+.|+.||. ..+-.+.+..|...                 
T Consensus       173 Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFe-tk~vkety~~Ik~~-----------------  233 (592)
T KOG0575|consen  173 ERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFE-TKTVKETYNKIKLN-----------------  233 (592)
T ss_pred             cccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcc-cchHHHHHHHHHhc-----------------
Confidence            55567899999999999986 789999999999999999999999993 22222333332210                 


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                                          +...+..++.++++||++||+.||.+|||++++|.|+||+
T Consensus       234 --------------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~  273 (592)
T KOG0575|consen  234 --------------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK  273 (592)
T ss_pred             --------------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence                                1112235899999999999999999999999999999994

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-53  Score=385.04  Aligned_cols=288  Identities=31%  Similarity=0.578  Sum_probs=238.3

Q ss_pred             eccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEc--
Q 014762          119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRD--  191 (419)
Q Consensus       119 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--  191 (419)
                      ..+.....|..++.||+|+||.|+.+.+..+|+.||||.+..     ...++..||+.+|+.+ +|+||+.+.+++..  
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPS   94 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeeccccc
Confidence            334456777778999999999999999999999999998862     2346788999999999 79999999999975  


Q ss_pred             -cCCCccEEEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccc
Q 014762          192 -QHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (419)
Q Consensus       192 -~~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla  267 (419)
                       +..+.+|+|+|+| +.+|...++   .+++..++.++.|+++||.|+|+.+++||||||+|+|++.+ ..+||||||+|
T Consensus        95 ~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFGLA  172 (359)
T KOG0660|consen   95 RDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFGLA  172 (359)
T ss_pred             ccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEeccccce
Confidence             3446789999999 467776662   38999999999999999999999999999999999999999 77899999999


Q ss_pred             eeccC---CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          268 EFYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       268 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      +....   ....+..+.|.+|+|||++++...|+.+.||||.||++.||++|+ |.|.|.+..+|+..|.+.+|.++.+.
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk-plFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK-PLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC-CCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            98864   344467799999999999999899999999999999999999998 55699999999999999999987665


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ...-..... ..+-.........+|...+.     .+++++.||+.+||.+||.+|+|++|+|+||||.+..
T Consensus       252 l~~i~s~~a-r~yi~slp~~p~~~f~~~fp-----~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  252 LQKIRSEKA-RPYIKSLPQIPKQPFSSIFP-----NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             HHHhccHHH-HHHHHhCCCCCCCCHHHHcC-----CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence            432211111 11111122333445554443     4899999999999999999999999999999998764

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-53  Score=380.19  Aligned_cols=282  Identities=30%  Similarity=0.528  Sum_probs=233.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-----HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      -+.|+.+++|++|+||.||+|+|+.|++.||+|.++....     -...|||.+|.++ +|||||.+-+++.+.+...+|
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceee
Confidence            4679999999999999999999999999999999975432     2357999999999 899999999999988888899


Q ss_pred             EEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-
Q 014762          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-  273 (419)
                      +|||||+.. |..++    +.|...+++.++.|+++|++|||.+.|+|||||++|+|++.. |.+||+|||+|+.++.. 
T Consensus       154 ~VMe~~EhD-Lksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  154 IVMEYVEHD-LKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeHHHHHhh-HHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhcCCc
Confidence            999999864 33333    579999999999999999999999999999999999999988 89999999999987654 


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      ..++..+.|.+|+|||.+++...|+.++|+||+||++.||++++ |.++|.+..+|+..|.+.+|.+....|..-.... 
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k-Plf~G~sE~dQl~~If~llGtPte~iwpg~~~lp-  309 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK-PLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP-  309 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC-CCCCCCchHHHHHHHHHHhCCCccccCCCccccc-
Confidence            45677789999999999999999999999999999999999987 6669999999999999999998877664322221 


Q ss_pred             ChhhHHh-hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          354 DPQLDAL-VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                        .+... .........+..+..   ..+++...+|++++|.+||.+|.||+|+|+|+||...
T Consensus       310 --~~k~~~f~~~pyn~lr~kF~~---~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  310 --AVKKMTFSEHPYNNLRKKFGA---LSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             --hhhccccCCCCchhhhhhccc---cccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence              11100 000001111111111   1167899999999999999999999999999999863

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-52  Score=381.56  Aligned_cols=251  Identities=30%  Similarity=0.511  Sum_probs=216.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++++.||+|+||+||.++.+.+++.+|+|++++.      ..+...+|..||..+ +||.||.++..|+  +...
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQ--t~~k   99 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQ--TEEK   99 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecc--cCCe
Confidence            467899999999999999999999999999999999753      346678999999998 9999999999994  4588


Q ss_pred             cEEEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc-C
Q 014762          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~-~  272 (419)
                      +|+|+||+.||.|..+++   .+++..++.++.+|+.||.|||++|||||||||+|||+|.+ |+++|+|||+++... .
T Consensus       100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhcccC
Confidence            999999999999999885   69999999999999999999999999999999999999999 999999999998544 3


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      +..+...+||+.|||||++.+ ..|+.++|.||||+++|||++|..||. +.+..+..+.|.+.-.              
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~-~~~~~~~~~~I~~~k~--------------  242 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFY-AEDVKKMYDKILKGKL--------------  242 (357)
T ss_pred             CCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCc-CccHHHHHHHHhcCcC--------------
Confidence            445566799999999999998 799999999999999999999999983 4444444444433110              


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC----CHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----TAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----ta~elL~hp~f~~~  415 (419)
                                            ...+..++.++++|++++|+.||++|.    +++++-+||||+.+
T Consensus       243 ----------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  243 ----------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             ----------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence                                  001123789999999999999999996    79999999999976

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-51  Score=384.73  Aligned_cols=252  Identities=30%  Similarity=0.498  Sum_probs=219.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .-++|.+++.||.|+|++|++|++..+++.+|||++.+      ...+-+.+|-.+|.+|.+||.|++|+-.|.++  ..
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--~s  148 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--ES  148 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--cc
Confidence            35689999999999999999999999999999999864      22345678899999999999999999999665  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      +|+|+||+++|+|..++   +.|++...+.++.||+.||+|||++|||||||||+|||+|.+ +++||+|||.|+.+.+.
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeeccccccCChh
Confidence            89999999999998887   569999999999999999999999999999999999999999 89999999999887542


Q ss_pred             Ccc--------------eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCC
Q 014762          274 KEY--------------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (419)
Q Consensus       274 ~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~  339 (419)
                      ...              ...+||-.|.+||++.+ ...++.+|+|+|||++|.|+.|..|| .+.++.-.+++|+++-  
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPF-ra~NeyliFqkI~~l~--  303 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPF-RAANEYLIFQKIQALD--  303 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCC-ccccHHHHHHHHHHhc--
Confidence            211              34689999999999987 88999999999999999999999998 5666667777777631  


Q ss_pred             chHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                                         .+....+++.++||++++|..||.+|+|++++-+||||+.|.
T Consensus       304 -----------------------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  304 -----------------------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             -----------------------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence                                               112234789999999999999999999999999999999873

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-50  Score=383.09  Aligned_cols=254  Identities=31%  Similarity=0.502  Sum_probs=217.4

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ...++|+++..||+|+||.||+|+.+.||+.+|+|+++++.      .+.++.|-.+|... ++|+||+++..|.+  ..
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD--~~  214 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQD--KE  214 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecC--CC
Confidence            35789999999999999999999999999999999997643      45678899999996 99999999999954  58


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ++||||||++||++..++   ..|++..++.++.+++.|++-||+.|+|||||||+|+|||.. |++||+||||+.....
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLDK  293 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CCEeeccccccchhhh
Confidence            899999999999999887   569999999999999999999999999999999999999998 9999999999842210


Q ss_pred             ----------------------CC-c-------------------------ceeecccccccccccccCCCCCCccccHH
Q 014762          273 ----------------------GK-E-------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMW  304 (419)
Q Consensus       273 ----------------------~~-~-------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  304 (419)
                                            .. .                         ....+||+.|+|||++++ ..|+..+|+|
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwW  372 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWW  372 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHH
Confidence                                  00 0                         012379999999999998 7899999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHH
Q 014762          305 SLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE  384 (419)
Q Consensus       305 SlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (419)
                      |||||+|||+.|..|| .+.+..+....|..                                 |+..+.......++++
T Consensus       373 SLG~ImyEmLvGyPPF-~s~tp~~T~rkI~n---------------------------------wr~~l~fP~~~~~s~e  418 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPF-CSETPQETYRKIVN---------------------------------WRETLKFPEEVDLSDE  418 (550)
T ss_pred             HHHHHHHHHHhCCCCC-CCCCHHHHHHHHHH---------------------------------HhhhccCCCcCcccHH
Confidence            9999999999999998 45666666666553                                 3333333344558899


Q ss_pred             HHHHHHHhcCCCCCCCC---CHHHHhcCCCcccc
Q 014762          385 AIDFLDKLLRYDHQDRL---TAREAMVISSISPI  415 (419)
Q Consensus       385 ~~~li~~~L~~dP~~Rp---ta~elL~hp~f~~~  415 (419)
                      +.|||.+||+ ||++|.   .++|+-+||||+.|
T Consensus       419 A~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  419 AKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            9999999999 999999   49999999999987

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-50  Score=368.83  Aligned_cols=253  Identities=28%  Similarity=0.506  Sum_probs=211.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|.+.++||+|+||+||+|+++.++..||||.+...     ..+.+..|+.+|+.+ +|||||++++++..+  +.+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~--~~i   84 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDD--DFI   84 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecC--CeE
Confidence            357899999999999999999999999999999998654     345678899999999 899999999999665  689


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--C---CcEEEEeccccee
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--L---RKLRLIDWGLAEF  269 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~---~~~kl~Dfgla~~  269 (419)
                      |||||||+||+|..++   +.+++..++.++.|++.||++||+++||||||||.|||++..  .   ..+||+|||+|+.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999998   468999999999999999999999999999999999999864  1   3589999999999


Q ss_pred             ccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      +.++......+|++.|||||++.. +.|+.|+|+||+|+++|+|++|+.||. ..+..+.+..+.+  |...        
T Consensus       165 L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~-a~t~~eL~~~~~k--~~~~--------  232 (429)
T KOG0595|consen  165 LQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFD-AETPKELLLYIKK--GNEI--------  232 (429)
T ss_pred             CCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCcc-ccCHHHHHHHHhc--cccc--------
Confidence            998887788899999999999976 899999999999999999999999983 2333333322111  0000        


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                          .+                    ..+..+++...+++...|+.+|..|.+..+-+.|+++..
T Consensus       233 ----~~--------------------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  233 ----VP--------------------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             ----cC--------------------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                00                    001125667779999999999999999999999988763

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.7e-50  Score=388.38  Aligned_cols=285  Identities=27%  Similarity=0.461  Sum_probs=222.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCC-----CCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGG-----PNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h-----~niv~l~~~~~~~~~~~  196 (419)
                      ..+|++++.||+|+||.|.+|.|..|++.||||++++..  ..+...|+.+|..+..|     -|+|+++++|.  ..++
T Consensus       185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~--fr~H  262 (586)
T KOG0667|consen  185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY--FRNH  262 (586)
T ss_pred             EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc--cccc
Confidence            347899999999999999999999999999999998544  35667899999999523     49999999994  4589


Q ss_pred             cEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC-CCcEEEEecccceec
Q 014762          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFY  270 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~-~~~~kl~Dfgla~~~  270 (419)
                      .|||+|.++... .+++     ..++...++.++.||+.||.+||+.||||+||||+||||... ...+||+|||+|+..
T Consensus       263 lciVfELL~~NL-YellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLSTNL-YELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhhhhH-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999999988554 4444     458999999999999999999999999999999999999643 457999999999876


Q ss_pred             cCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ...-  ...+.+..|+|||++++ .+|+.+.|||||||+++||++| .|+|+|.++.+|+..|++.+|.++...+.....
T Consensus       342 ~q~v--ytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  342 SQRV--YTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             CCcc--eeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            5332  26789999999999999 8999999999999999999999 688899999999999999999887665432221


Q ss_pred             CC--CCh---hhH-----H----------------hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 014762          351 LE--LDP---QLD-----A----------------LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR  404 (419)
Q Consensus       351 ~~--~~~---~~~-----~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~  404 (419)
                      ..  ++.   .++     +                ........+-..-........-...+.|||.+||.|||.+|+|+.
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence            11  000   000     0                000000000000000000011234578999999999999999999


Q ss_pred             HHhcCCCcccc
Q 014762          405 EAMVISSISPI  415 (419)
Q Consensus       405 elL~hp~f~~~  415 (419)
                      ++|+||||+..
T Consensus       498 qal~Hpfl~~~  508 (586)
T KOG0667|consen  498 QALNHPFLTGT  508 (586)
T ss_pred             HHhcCcccccc
Confidence            99999999843

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.1e-50  Score=366.41  Aligned_cols=283  Identities=32%  Similarity=0.561  Sum_probs=229.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCC-eeEEEeEEEccC----
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPN-VVKLLDIVRDQH----  193 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~----  193 (419)
                      ...|+.+++||+|.||+||+|+++.+|+.||+|.+.-..     .....+|+.+|+.+ +|+| |+.+++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence            455777889999999999999999999999999986432     34568999999999 8999 999999997643    


Q ss_pred             CCccEEEEEecCCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ...+++|+||++. +|..++.       .++...++.+++|++.||+|||+++|+||||||.|||++++ +.+||+|||+
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~-G~lKlaDFGl  166 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS-GVLKLADFGL  166 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC-CcEeeeccch
Confidence            2367899999984 4444432       46667899999999999999999999999999999999997 9999999999


Q ss_pred             ceecc-CCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          267 AEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       267 a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      |+... +...++..++|.+|+|||++++...|+...||||+||+++||++++ |.|.|.++.+++..|.+.+|++....|
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~-~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR-PLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC-CCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            98766 4555778899999999999999889999999999999999999966 667999999999999999999988776


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      ...........  ....+.....+..     .....+++..|++.+||+++|.+|.||+.+|+||||..+.+
T Consensus       246 p~v~~~~~~k~--~f~~~~~~~~l~~-----~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  246 PGVSSLPDYKA--PFPKWPGPKDLSS-----ILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             CCccccccccc--cCcCCCCccchHH-----hccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            54322221110  0111111111111     11224578999999999999999999999999999998743

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-50  Score=382.32  Aligned_cols=252  Identities=26%  Similarity=0.467  Sum_probs=218.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ...|....+||+|..|.||.|....+++.||||.+..   ..++-+.+|+.+|+.. .|+|||.+++.|...  ..++.|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~--deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVG--DELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhccc--ceeEEE
Confidence            5678999999999999999999999999999999853   3456688999999999 999999999988654  668899


Q ss_pred             EEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cce
Q 014762          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (419)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~  277 (419)
                      ||||+||+|.+...  .+++.++..++++++.||+|||.+||+|||||.+|||++.+ +.+||+|||++..+.... ...
T Consensus       349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeeccccccCccc
Confidence            99999999988874  48999999999999999999999999999999999999998 889999999987776544 445


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ..+||++|||||++.. ..|++++||||||++++||+.|..||+.  ++.-+...++...|.+.+..             
T Consensus       428 TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYln--E~PlrAlyLIa~ng~P~lk~-------------  491 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLN--ENPLRALYLIATNGTPKLKN-------------  491 (550)
T ss_pred             cccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccC--CChHHHHHHHhhcCCCCcCC-------------
Confidence            6799999999999977 8899999999999999999999999965  33333334445555554432             


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                          ++.+|++++||+.+||+.|+++|+||.|||+||||+..
T Consensus       492 --------------------~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  492 --------------------PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             --------------------ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence                                34589999999999999999999999999999999754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-49  Score=345.99  Aligned_cols=247  Identities=23%  Similarity=0.426  Sum_probs=215.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|+.++.||.|+||.|.+++.+.+|..+|+|++++..      .+...+|..+|+.+ .||+++++++.|.+  ...+
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d--~~~l  119 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKD--NSNL  119 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeecc--CCeE
Confidence            567899999999999999999999999999999997543      35567899999999 89999999999955  4789


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||.+||.+..++   +++++..++.++.||+.||+|||+++|++|||||+|||+|.+ |.+||+|||.|+..... 
T Consensus       120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC-CcEEEEeccceEEecCc-
Confidence            9999999999998887   469999999999999999999999999999999999999999 99999999999987643 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                       +-..|||+.|+|||++.. ++|+.++|.|||||++|||+.|..||+.. +......+|.+.             ..   
T Consensus       198 -T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~-~~~~iY~KI~~~-------------~v---  258 (355)
T KOG0616|consen  198 -TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDD-NPIQIYEKILEG-------------KV---  258 (355)
T ss_pred             -EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCC-ChHHHHHHHHhC-------------cc---
Confidence             556799999999999988 89999999999999999999999999543 335555555441             01   


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                           ..+..+++++++|++++|+.|-.+|.     ...++..||||+.+
T Consensus       259 ---------------------~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  259 ---------------------KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             ---------------------cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence                                 11234799999999999999999994     67899999999976

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.8e-48  Score=366.34  Aligned_cols=287  Identities=30%  Similarity=0.482  Sum_probs=220.7

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ++..++|++.++||+|+||+||+|.+..+++.||+|+++...    ...+.+|+.+++.+ +||||+++++++.++  ..
T Consensus         1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~   77 (303)
T cd07869           1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTK--ET   77 (303)
T ss_pred             CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecC--Ce
Confidence            356789999999999999999999999999999999986432    24577899999999 999999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++||||+.++.+....   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        78 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          78 LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKSVP  156 (303)
T ss_pred             EEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceeccCC
Confidence            89999999765443333   348899999999999999999999999999999999999987 78999999998754322


Q ss_pred             -CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       274 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                       .......++..|+|||++.+...++.++|||||||++|+|++|..||....+..+.+..+...++.+....+.......
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             2223456788999999987656789999999999999999999999965555566777777777766544332211110


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ...  ...........+..   .......++++.+|+++||++||++|||+.|+|+||||+++.
T Consensus       237 ~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         237 HFK--PERFTLYSPKNLRQ---AWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccc--cccccccCCccHHH---HhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            000  00000000000000   001112567899999999999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-49  Score=365.06  Aligned_cols=256  Identities=25%  Similarity=0.408  Sum_probs=205.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++...+.||+|+||+||++.+..+|...|||.+....   .+.+.+|+.+|.++ +|||||+++|.........+++.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEee
Confidence            445677889999999999999999999999999987544   45689999999999 69999999997543322468899


Q ss_pred             EEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC----
Q 014762          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP----  272 (419)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~----  272 (419)
                      |||+++|++..++.    .+++..++.+.+|+++||+|||++|||||||||+|||++...+.+||+|||+++....    
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999999873    5899999999999999999999999999999999999998337899999999987653    


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      ........||+.|||||++.+......++|||||||++.||+||..||...   .+....+.......            
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~------------  239 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGRED------------  239 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccC------------
Confidence            122334689999999999985223345999999999999999999998322   11111111110000            


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                   ..       ...+..+++++++|+++||..||++||||.++|+|||.++-
T Consensus       240 -------------~~-------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  240 -------------SL-------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             -------------CC-------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence                         00       01123489999999999999999999999999999999763

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-48  Score=377.28  Aligned_cols=252  Identities=27%  Similarity=0.443  Sum_probs=222.1

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ...++|.+++.||+|+||+|+++..+.+++.+|||++++.      ..+....|-.|+....+||.+++++..|  +...
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~~  442 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTKE  442 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccCC
Confidence            3467899999999999999999999999999999999853      3466788999999887899999999999  5568


Q ss_pred             ccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc-C
Q 014762          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-P  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~-~  272 (419)
                      ++|.||||+.||++..+.  ..|++..++.|+.+++.||.|||++||||||||.+|||+|.+ |.+||+|||+++..- .
T Consensus       443 ~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEecccccccccCCC
Confidence            999999999999955444  469999999999999999999999999999999999999999 999999999998654 4


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      +..+.+.+||+.|+|||++.+ +.|+.++|.|||||+||||+.|..|| .|++.++.+..|...-               
T Consensus       522 g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF-~gddEee~FdsI~~d~---------------  584 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPF-PGDDEEEVFDSIVNDE---------------  584 (694)
T ss_pred             CCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhcCC---------------
Confidence            556677899999999999988 89999999999999999999999998 7788888887765410               


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                            ..-+..+|.++.++|+++|+.||++|..     ++++.+||||+.|
T Consensus       585 ----------------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  585 ----------------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             ----------------------CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence                                  0012237999999999999999999994     6889999999987

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-48  Score=370.47  Aligned_cols=252  Identities=29%  Similarity=0.472  Sum_probs=212.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|.+.+.||+|+||+|+.|.+..+++.||+|+++..        ..+.+.+|+.+++.+..||||+++++++...  
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~--   92 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP--   92 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence            467899999999999999999999999999999987653        2346778999999994499999999999665  


Q ss_pred             CccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec-
Q 014762          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~-  270 (419)
                      ..+++||||+.||+|.+++   ..+.+.+++.+++|++.|++|||++||+||||||+|||++.+.+.+||+|||++... 
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            5589999999999998877   468999999999999999999999999999999999999987678999999999988 


Q ss_pred             cCCCcceeecccccccccccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQDY-DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ..+......+||+.|+|||++.+...| +.++||||+||+||.|++|+.||.. .+.......+.+             .
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~-------------~  238 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRK-------------G  238 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhc-------------C
Confidence            466677888999999999999884426 4899999999999999999999942 111112221111             0


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCC-CHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLV-SPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      .                        ...+..+ |+++++|+++||..||.+|+|+.+++.||||+.
T Consensus       239 ~------------------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  239 E------------------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             C------------------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            0                        0111235 899999999999999999999999999999996

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-48  Score=357.41  Aligned_cols=263  Identities=22%  Similarity=0.349  Sum_probs=214.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      +.+.|++...||.|..++||+|+...+++.||||+++-.    ..+.+.+|+..|+.+ +||||++++..|..+  ..++
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~--~~LW  100 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVD--SELW  100 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEec--ceeE
Confidence            467899999999999999999999999999999999632    347788999999998 999999999999765  6789


Q ss_pred             EEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          199 LIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      +||.||.+|++.+++     ..+++..+..+++++++||.|||++|.||||||+.||||+.+ |.|||+|||.+-.+...
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLADFGVSASLFDS  179 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEcCceeeeeeccc
Confidence            999999999988776     469999999999999999999999999999999999999999 99999999987554433


Q ss_pred             C-cc----eeeccccccccccc-ccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          274 K-EY----NVRVASRYFKGPEL-LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       274 ~-~~----~~~~~~~~y~aPE~-~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      . ..    +..+||++|||||+ ..+...|+.|+||||||++..||.+|..||. .....+.  .+.+..+.++...   
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~-k~pPmkv--Ll~tLqn~pp~~~---  253 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS-KYPPMKV--LLLTLQNDPPTLL---  253 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc-cCChHHH--HHHHhcCCCCCcc---
Confidence            2 22    33489999999999 4555789999999999999999999999982 2222222  2223333322110   


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                            ....+.+....++..+++++..||+.||++||||+++|+|+||++.+.
T Consensus       254 ----------------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  254 ----------------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             ----------------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence                                  001111112236778999999999999999999999999999998753

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.9e-47  Score=360.12  Aligned_cols=277  Identities=28%  Similarity=0.560  Sum_probs=219.7

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      +..++|++.++||.|+||+||+|.+..++..||+|.++..    ....+.+|+.+++.+ +||||+++++++..  ....
T Consensus         2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~   78 (288)
T cd07871           2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHT--ERCL   78 (288)
T ss_pred             CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeE
Confidence            4567899999999999999999999999999999998632    234677999999999 99999999999955  3678


Q ss_pred             EEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++||||+++ ++..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        79 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          79 TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVP  156 (288)
T ss_pred             EEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeeccCC
Confidence            899999986 666554    237888999999999999999999999999999999999988 78999999998764322


Q ss_pred             C-cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      . ......++..|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+.+..+.+.++.+....+..-.   
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  232 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-PGSTVKEELHLIFRLLGTPTEETWPGIT---  232 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHHhhccc---
Confidence            2 2234567889999999876567899999999999999999999887 5566677788888888877665543211   


Q ss_pred             CChhhHHhh-ccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          353 LDPQLDALV-GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       353 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ....+.... ......++.     .....+++++++||++||++||++|||++|+|+||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLI-----NHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cchhhhccccCccCCCchH-----HhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            111111100 000001110     1123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-47  Score=381.76  Aligned_cols=283  Identities=29%  Similarity=0.503  Sum_probs=222.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEcc------CCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ------HSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------~~~~  196 (419)
                      ...+|++.+.||+|+||+||+|.+..+++.||||.+... .....+|+.+++.+ +||||+++++++...      ....
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceE
Confidence            467899999999999999999999999999999988543 23456899999999 999999999987432      1234


Q ss_pred             cEEEEEecCCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          197 PSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      +++||||++++......      ..+++..++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+++..
T Consensus       142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~  221 (440)
T PTZ00036        142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL  221 (440)
T ss_pred             EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence            67899999975433221      358899999999999999999999999999999999999977567999999999876


Q ss_pred             cCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ..........+|+.|+|||++.+...++.++|||||||++|||++|..|| .+.+..+++..+.+.+|.+....+.... 
T Consensus       222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~p~~~~~~~~~-  299 (440)
T PTZ00036        222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF-SGQSSVDQLVRIIQVLGTPTEDQLKEMN-  299 (440)
T ss_pred             cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhc-
Confidence            55444445678999999999877567999999999999999999999887 5677788889999999887665443211 


Q ss_pred             CCCChhhHHhh-ccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          351 LELDPQLDALV-GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       351 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                          +.+.... .......+...    .+...++++++||.+||++||++|||+.|+|+||||..+++
T Consensus       300 ----~~~~~~~~~~~~~~~l~~~----~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        300 ----PNYADIKFPDVKPKDLKKV----FPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             ----hhhhcccCCccCchhHHHH----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                0010000 00000111111    12236889999999999999999999999999999987754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-50  Score=350.78  Aligned_cols=241  Identities=24%  Similarity=0.500  Sum_probs=199.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-----CcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..+|+++++||+|+||+||++++..+|..+|.|.+.     ...++....|+.+|++| +|||||++++.--.+...-++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhH
Confidence            567999999999999999999999999999999875     23456788999999999 999999999933233335578


Q ss_pred             EEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH--CC--cEeecCCCCceEEcCCCCcEEEEecccc
Q 014762          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHS--QG--IMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (419)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~--~~--ivH~Dlk~~NILl~~~~~~~kl~Dfgla  267 (419)
                      +|||||..|+|...+       +.+++..+++++.|++.||..+|+  .+  |+||||||.||+++.+ |.|||+|||++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~  175 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLG  175 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhH
Confidence            999999999998876       348999999999999999999998  55  9999999999999988 89999999999


Q ss_pred             eeccCCCcc-eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          268 EFYHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       268 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      +........ ...+||++||+||.+.+ .+|+++|||||+||++|||..-..||+ |. +...+.+-++....++..   
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~-g~-n~~~L~~KI~qgd~~~~p---  249 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFY-GD-NLLSLCKKIEQGDYPPLP---  249 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcc-cc-cHHHHHHHHHcCCCCCCc---
Confidence            988755443 45799999999999988 899999999999999999999999984 33 333333222211111110   


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA  403 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta  403 (419)
                                                     .+..|.++.+++..|+..||+.||+.
T Consensus       250 -------------------------------~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  250 -------------------------------DEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             -------------------------------HHHhhhHHHHHHHHHccCCcccCCCc
Confidence                                           02368899999999999999999986

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=342.57  Aligned_cols=254  Identities=27%  Similarity=0.480  Sum_probs=215.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-----CcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..+.|++.+.||+|.|+.||++.+..+|+.+|+|+++     ....+++.+|+.|-+.| +||||+++.+.+.+.  ...
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~--~~~   85 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE--SFH   85 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhccc--cee
Confidence            4678999999999999999999999999999998875     34568899999999999 999999999999554  677


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~  272 (419)
                      |+|+|+|.|+++-.-+   .-+++..+-.+++||+++|.|+|.+||||||+||+|+|+-+.  ...+||+|||+|.....
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            8999999999885543   236888889999999999999999999999999999999543  34689999999998886


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      +......+||+.|+|||++.. .+|+..+|||+.||+||-|+.|+.||+ +.+..+.+++|.+-             ...
T Consensus       166 g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~-~~~~~rlye~I~~g-------------~yd  230 (355)
T KOG0033|consen  166 GEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYEQIKAG-------------AYD  230 (355)
T ss_pred             ccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCC-CccHHHHHHHHhcc-------------ccC
Confidence            666677899999999999977 899999999999999999999999984 44555555555541             011


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                          ++...+..+++++++|+++||..||.+|+||.|+|+|||+.+
T Consensus       231 --------------------~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  231 --------------------YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             --------------------CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                                111123348999999999999999999999999999999875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-48  Score=359.12  Aligned_cols=253  Identities=28%  Similarity=0.517  Sum_probs=210.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------------hHHHHHHHHHHHHhcCCCCeeEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------KKKIKREIKILQNLCGGPNVVKLL  186 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~~E~~~l~~l~~h~niv~l~  186 (419)
                      .++|++...||+|.||.|-+|++..+++.||||++.+..                 .++..+||.||+++ .|||||+|+
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li  174 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI  174 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence            578999999999999999999999999999999996321                 25788999999999 999999999


Q ss_pred             eEEEccCCCccEEEEEecCCCChhhhc--C-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEe
Q 014762          187 DIVRDQHSKTPSLIFEYVNSTDFKVLY--P-TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (419)
Q Consensus       187 ~~~~~~~~~~~~lv~e~~~~~~l~~~~--~-~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~D  263 (419)
                      ++..++....+|||+|||..|.+...-  . .+++.+++.+++++..||+|||.+|||||||||+|+|++.+ ++|||+|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-g~VKIsD  253 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-GTVKISD  253 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC-CcEEeec
Confidence            999999999999999999998876543  2 28999999999999999999999999999999999999999 9999999


Q ss_pred             cccceeccCC------CcceeecccccccccccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014762          264 WGLAEFYHPG------KEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (419)
Q Consensus       264 fgla~~~~~~------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~  334 (419)
                      ||.+.....+      ......+||+.|+|||.+.+.   ...+.+.||||+||+||.|+.|+.||+ +....+...+|+
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~-~~~~~~l~~KIv  332 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF-DDFELELFDKIV  332 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-cchHHHHHHHHh
Confidence            9998765222      223447999999999998762   235689999999999999999999995 223333333333


Q ss_pred             HHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      +.    ++                               .......+.++++|||.+||+.||++|.|..++-.|||...
T Consensus       333 n~----pL-------------------------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  333 ND----PL-------------------------------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             cC----cc-------------------------------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            21    00                               01111236889999999999999999999999999999764

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-48  Score=371.54  Aligned_cols=251  Identities=26%  Similarity=0.441  Sum_probs=217.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      -+-|++.+.||.|+.|.|-+|++..||+.+|||++.+.      ....+.+||-||+.+ .|||++++++++++  ..++
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~--~~~l   87 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWEN--KQHL   87 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeecc--CceE
Confidence            34588899999999999999999999999999999643      246789999999999 99999999999954  5889


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      |+|.||+++|.|.+++   +.+++.++..+++||+.|+.|||..+|+|||+||+|+|+|.+ +.+||+|||+|..-.++.
T Consensus        88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcc-cCEeeeccceeecccCCc
Confidence            9999999999988876   679999999999999999999999999999999999999998 569999999999888788


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      .....||++.|.+||++.+...-+.++||||.||+||.|++|+.||.  +++...+-.-++. |.               
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--DdNir~LLlKV~~-G~---------------  228 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--DDNIRVLLLKVQR-GV---------------  228 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--CccHHHHHHHHHc-Cc---------------
Confidence            88889999999999999995555799999999999999999999993  4444333322210 00               


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                          .+.++.++.++++||++||..||++|+|.+|+++|||+....
T Consensus       229 --------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  229 --------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             --------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence                                112345899999999999999999999999999999998654

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=9.2e-47  Score=355.06  Aligned_cols=277  Identities=31%  Similarity=0.557  Sum_probs=215.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|++.+.||+|+||+||+|++..+++.+|+|+++..     ..+.+.+|+.+++.+ +||||+++++++...  ...++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   77 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRR--GKLYL   77 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecC--CEEEE
Confidence            4799999999999999999999999999999998642     235678999999999 999999999999654  67899


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC--
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~--  274 (419)
                      ||||++++++..+.   ..+++..++.++.|++.||.|||+.|++||||||+||+++.+ +.+||+|||++.......  
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~  156 (287)
T cd07848          78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNA  156 (287)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCcccccccccc
Confidence            99999998877654   358999999999999999999999999999999999999988 789999999998654322  


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..++.+...+.....   .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  231 (287)
T cd07848         157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLF-PGESEIDQLFTIQKVLGPLPAEQMKLFYS---N  231 (287)
T ss_pred             cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhhCCCCHHHHHhhhc---c
Confidence            2233468889999999977 67899999999999999999999887 45556666667777766654433221110   0


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      +.+....  ........-........+++++.+||++||++||++|||++|+|+||||
T Consensus       232 ~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         232 PRFHGLR--FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             chhcccc--cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            0000000  0000000000001112378899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-46  Score=360.13  Aligned_cols=282  Identities=30%  Similarity=0.548  Sum_probs=216.8

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC---Ccc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTP  197 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~  197 (419)
                      +|++.++||+|+||.||+|.+..++..||+|.++..     ....+.+|+.+++.+ +||||+++++++.....   ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence            589999999999999999999999999999998632     234678999999999 99999999998864322   357


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||+++ ++..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus        80 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          80 YVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCcccccccccc
Confidence            999999974 666554   358999999999999999999999999999999999999988 889999999997543221


Q ss_pred             c----ceeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          275 E----YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       275 ~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      .    .....++..|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+...++..+.+.+|.+.......-.
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1    1235788999999997542 56899999999999999999999887 5556667777777888876654432211


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      .......+....... ..+..     .....+++++.+++.+||+.||++|||++|+|+||||+.+..
T Consensus       237 ~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         237 NEKARRYLSSMRKKQ-PVPFS-----QKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hhhHHHHHHhhcccC-CCchH-----HhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence            111111111111100 00000     011236788999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.8e-48  Score=337.48  Aligned_cols=254  Identities=24%  Similarity=0.463  Sum_probs=212.9

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-------c----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------K----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      +.|.-.+.||+|..++|.++.+..+|..+|+|++...       .    .+.-.+|+.||+++.+||||+++.++++.  
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--   94 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--   94 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence            4566778899999999999999999999999998521       1    24456899999999999999999999954  


Q ss_pred             CCccEEEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ....++|+|.|+.|.|.+++.   .+++.+.+.+++|+++|++|||.++||||||||+|||++++ ..+||+|||.|+.+
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn-~~i~isDFGFa~~l  173 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN-MNIKISDFGFACQL  173 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc-cceEEeccceeecc
Confidence            478889999999999999885   48999999999999999999999999999999999999998 78999999999999


Q ss_pred             cCCCcceeeccccccccccccc-----CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          271 HPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      .++......+||++|.|||.+.     +...|+..+|+|++||+||.|+.|..||+.    ..|+. |..++....    
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH----RkQml-MLR~ImeGk----  244 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH----RKQML-MLRMIMEGK----  244 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH----HHHHH-HHHHHHhcc----
Confidence            9999888899999999999984     345789999999999999999999999952    22221 111111100    


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                           ..                    +..+.+.+++.+.+|||++||+.||++|.|++|+|+||||.++
T Consensus       245 -----yq--------------------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  245 -----YQ--------------------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             -----cc--------------------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence                 00                    1112233478999999999999999999999999999999764

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.7e-46  Score=363.38  Aligned_cols=283  Identities=25%  Similarity=0.450  Sum_probs=220.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC---
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (419)
                      ..++|++.+.||+|+||+||+|.+..+|..||+|.+...     ....+.+|+.+++.+ +||||+++++++.....   
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccc
Confidence            367899999999999999999999999999999998632     245677899999999 99999999999864422   


Q ss_pred             -CccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          195 -KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       195 -~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                       ...++||||++++........+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~  176 (359)
T cd07876          98 FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTACTN  176 (359)
T ss_pred             cceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCCCccccccC
Confidence             3578999999987666655678999999999999999999999999999999999999988 88999999999765444


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+.++.+.........    
T Consensus       177 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~----  250 (359)
T cd07876         177 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQ-GTDHIDQWNKVIEQLGTPSAEFMNRLQ----  250 (359)
T ss_pred             ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCcHHHHHHHH----
Confidence            44445678899999999987 789999999999999999999999984 556667777788877776543221100    


Q ss_pred             ChhhHHhhccCC----------CCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          354 DPQLDALVGRHS----------RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       354 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                       ...........          ...|............++++++||.+||++||++|||+.|+|+||||+.
T Consensus       251 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         251 -PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             -HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence             00000000000          0011100011112235788999999999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.2e-48  Score=366.41  Aligned_cols=246  Identities=28%  Similarity=0.505  Sum_probs=210.5

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchH-----HHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+.     .+.+|++|++.+ +||||+.++++|  +...++++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esf--Et~~~~~v   78 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESF--ETSAHLWV   78 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhh--cccceEEE
Confidence            5788899999999999999999999999999999765543     488999999999 999999999999  44588999


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      |.||+.| +|..++   ..++++.++.++.|+..||.|||+.+|+|||+||.|||++.. +.+|+||||+|+.+..+...
T Consensus        79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCcee
Confidence            9999998 777776   569999999999999999999999999999999999999988 89999999999988765443


Q ss_pred             -eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       277 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                       +...||+.|||||++.+ ++|+..+|+||+||++||+..|+.||+.  ....++.+++.  .. +.             
T Consensus       157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a--~si~~Lv~~I~--~d-~v-------------  217 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYA--RSITQLVKSIL--KD-PV-------------  217 (808)
T ss_pred             eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchH--HHHHHHHHHHh--cC-CC-------------
Confidence             44579999999999987 8999999999999999999999999952  12222222221  11 10             


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                  .|        +..++..+..|++.+|+.||.+|.|-.+++.|||.+.
T Consensus       218 ------------~~--------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  218 ------------KP--------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             ------------CC--------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence                        00        1137899999999999999999999999999999875

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-46  Score=352.56  Aligned_cols=252  Identities=24%  Similarity=0.371  Sum_probs=206.3

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .|+..+.||+|+||+||+|.+..+|+.||+|.+....      ...+.+|+.+++.+ +|+|++++++.+.+.  ...++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~--~~~~l   77 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETK--DALCL   77 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccC--CeEEE
Confidence            3788999999999999999999999999999986422      23567899999999 999999999999654  67899


Q ss_pred             EEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ||||+++++|...+     ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++.......
T Consensus        78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCC
Confidence            99999999997654     248899999999999999999999999999999999999987 789999999998765444


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+...+....             
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~-------------  221 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-VKREEVDRRVKEDQ-------------  221 (285)
T ss_pred             eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-hhHHHHHHHhhccc-------------
Confidence            4455678999999999987 78999999999999999999999999543221 11111111110000             


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCccccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPIF  416 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~  416 (419)
                                          ......+++++.+|+++||+.||++|||     ++++++||||+++.
T Consensus       222 --------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         222 --------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             --------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence                                0011236889999999999999999997     99999999999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-45  Score=347.45  Aligned_cols=274  Identities=30%  Similarity=0.543  Sum_probs=211.9

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEecCc-----chHHHHHHHHHHHHhc--CCCCeeEEEeEEEc---cC
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRD---QH  193 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---~~  193 (419)
                      .+|++.+.||+|+||+||+|.+.. ++..||+|.++..     ....+.+|+.+++.+.  .||||+++++++..   ..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            478999999999999999999854 5788999988632     2245677888887763  69999999999853   23


Q ss_pred             CCccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          194 SKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                      ...+++||||+++ ++..++     ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus        81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg~~~  158 (290)
T cd07862          81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR  158 (290)
T ss_pred             CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC-CCEEEccccceE
Confidence            4568899999985 565554     247889999999999999999999999999999999999988 789999999998


Q ss_pred             eccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ............++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.++.+.+..+.+..+.+....+...
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f-~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            7655444455678999999999876 67899999999999999999999887 556667778888877776554433221


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ....  ..   ........+....     ...+++.+.+|+.+||+.||++|||+.|+|+||||
T Consensus       237 ~~~~--~~---~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALP--RQ---AFHSKSAQPIEKF-----VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hccc--ch---hccCCCCCCHHHH-----ccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            1100  00   0000000111111     12378899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-46  Score=365.37  Aligned_cols=282  Identities=24%  Similarity=0.327  Sum_probs=214.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      .++|++.++||+|+||.||+|.+..+++.||+|...   .+.+.+|+.+++++ +||||++++++|...  ...++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAI-NHPSIIQLKGTFTYN--KFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhC-CCCCCCCEeEEEEEC--CeeEEEEec
Confidence            568999999999999999999999999999999753   45678999999999 999999999999654  678899999


Q ss_pred             cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC--Cccee
Q 014762          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYNV  278 (419)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~--~~~~~  278 (419)
                      +.+ ++..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....  .....
T Consensus       165 ~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        165 YKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             CCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-CCEEEEeCCccccccccccccccc
Confidence            975 554443   458899999999999999999999999999999999999988 78999999999753321  12234


Q ss_pred             ecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------CCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH------DNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~------~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      ..||..|+|||++.+ ..++.++|||||||++|||++|..||+...      +...++..+.+.+|..+..... .....
T Consensus       243 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~-~~~~~  320 (391)
T PHA03212        243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI-DAQAN  320 (391)
T ss_pred             ccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc-chhHH
Confidence            578999999999877 789999999999999999999999987543      2345677777777765422100 00000


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ....+..........+... ........++.++.+||.+||++||++||||+|+|+||||+.+.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSR-PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             HHHHHHHHHhccCCCCCCC-CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence            0000101111111110000 00001112577899999999999999999999999999998763

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-46  Score=357.29  Aligned_cols=257  Identities=30%  Similarity=0.536  Sum_probs=217.9

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ...+.|++.+.||+|.||.||+|+++.+|+.+|+|.+.+..      ...+.+|+.+|+++.+||||+.+++.|++.  .
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~  109 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--D  109 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--C
Confidence            34678999999999999999999999999999999996432      357899999999995599999999999765  5


Q ss_pred             ccEEEEEecCCCChhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC---CcEEEEecccceec
Q 014762          196 TPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAEFY  270 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~~--l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~---~~~kl~Dfgla~~~  270 (419)
                      ..++|||++.||.|.+.+..  +++..+..++.|++.++.|||+.|++||||||+|+|+....   +.+|++|||++...
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            78899999999998887643  99999999999999999999999999999999999997552   37999999999998


Q ss_pred             cCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ..+......+||+.|+|||++.. ..|+..+||||+||++|.|++|..||... +..+....+..  |..          
T Consensus       190 ~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~-~~~~~~~~i~~--~~~----------  255 (382)
T KOG0032|consen  190 KPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGE-TEFEIFLAILR--GDF----------  255 (382)
T ss_pred             cCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCC-ChhHHHHHHHc--CCC----------
Confidence            87666778899999999999876 78999999999999999999999999533 32233322221  100          


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                  .         +..+.+..+++.+++|+++||..||.+|+||.++|+|||++..
T Consensus       256 ------------~---------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  256 ------------D---------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             ------------C---------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence                        1         1122233489999999999999999999999999999999875

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.4e-45  Score=350.53  Aligned_cols=280  Identities=24%  Similarity=0.467  Sum_probs=209.7

Q ss_pred             EeeeeeeCceEEEEEEEc--CCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          130 VRKVGRGKYSEVFEGINV--NTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ..+||+|+||+||+|.+.  .+++.+|+|.+.... ...+.+|+.+++++ +||||+++++.+........+++|||+++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            457999999999999865  467899999987533 45678999999999 99999999999977666778999999986


Q ss_pred             CChhhhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEc---CCCCcEEEEecccceecc
Q 014762          207 TDFKVLY------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       207 ~~l~~~~------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~---~~~~~~kl~Dfgla~~~~  271 (419)
                      . +..++            ..+++..++.++.|++.||+|||++||+||||||+|||++   ...+.+||+|||+++...
T Consensus        85 ~-l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          85 D-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             C-HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence            4 43332            1488899999999999999999999999999999999994   233689999999998654


Q ss_pred             CCC----cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHHHHHcCC
Q 014762          272 PGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVKIAKVLGT  339 (419)
Q Consensus       272 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--------~~~~~~~i~~~lg~  339 (419)
                      ...    ......+|..|+|||++.+...++.++||||+||++|+|++|+.||.....        ..+++..+.+.+|.
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF  243 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence            322    123457788999999998756789999999999999999999999854332        24667788888887


Q ss_pred             chHHHHHhhcCCCCChhhH-HhhccC-CCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          340 DELNAYLNKYHLELDPQLD-ALVGRH-SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      +....+............. ...... ......... .......+.++.+||++||++||++|||++|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM-EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CChHHhHHHhhccchhhhhhhhhccccCcccccchH-HhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            7666554332222111111 110000 000000000 01112246678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-46  Score=353.93  Aligned_cols=245  Identities=20%  Similarity=0.323  Sum_probs=199.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcE-EEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-CIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~-vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .+...+.+.||+|+||+||+|.+.  |.. ||+|++....     .+.|.+|+.+|.++ +|||||+++|+|.++.. ..
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~-~~  115 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG-SL  115 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC-ce
Confidence            344555666999999999999764  455 9999997544     45899999999999 99999999999976532 68


Q ss_pred             EEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-cEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          198 SLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~-ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ++||||+++|+|..++     ..++...+..++.||++||+|||+++ ||||||||+|||++.+..++||+|||+++...
T Consensus       116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            8999999999999987     35899999999999999999999999 99999999999999983399999999998766


Q ss_pred             CC-CcceeecccccccccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          272 PG-KEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       272 ~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      .. ...+...||..|||||++.+ ...|+.++||||||+++|||+||+.||. +....+....+......+         
T Consensus       196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~-~~~~~~~~~~v~~~~~Rp---------  265 (362)
T KOG0192|consen  196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE-DLAPVQVASAVVVGGLRP---------  265 (362)
T ss_pred             cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcCCCC---------
Confidence            54 33344789999999999985 2689999999999999999999999983 333322222222111111         


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                ..+..+++.+.++|.+||..||++||+..+++.
T Consensus       266 --------------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  266 --------------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             --------------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence                                      111227889999999999999999999998865

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-46  Score=351.30  Aligned_cols=246  Identities=23%  Similarity=0.403  Sum_probs=205.1

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++...      ..+.+.+|+.+++.+ +||||+++++++.+  ....+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~   77 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHD--QRFLY   77 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhcc--CCeEE
Confidence            4789999999999999999999999999999998632      234578899999999 99999999999855  46789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....  
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhccCC--
Confidence            999999999998876   458899999999999999999999999999999999999987 88999999999765432  


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+...  .           .    
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~--~-----------~----  215 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAG--K-----------L----  215 (291)
T ss_pred             cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC--C-----------c----
Confidence            223578999999999877 6789999999999999999999999843 2222222222210  0           0    


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                          ..+..+++.+++||++||+.||.+|++     ++++++||||+.+
T Consensus       216 --------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         216 --------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             --------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence                                001225788999999999999999995     9999999999865

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.6e-45  Score=349.08  Aligned_cols=283  Identities=28%  Similarity=0.558  Sum_probs=220.8

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ++..++|++.++||+|+||+||+|.+..+++.||+|.++...    ...+.+|+.+++++ +||||+++++++..+  ..
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~   78 (309)
T cd07872           2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTD--KS   78 (309)
T ss_pred             CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeC--Ce
Confidence            456788999999999999999999999999999999986322    34577899999999 999999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++ ++..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          79 LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSV  156 (309)
T ss_pred             EEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecCC
Confidence            8999999987 444443    237889999999999999999999999999999999999988 7899999999876433


Q ss_pred             CC-cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          273 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       273 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      .. ......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.+|.+....+..-...
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF-PGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            22 2233567889999999876567899999999999999999999887 455666777888888887766554321110


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      .   .+... ...... .....  .....+++++++||.+||+.||++|||+.|+|+||||+.+.
T Consensus       236 ~---~~~~~-~~~~~~-~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         236 D---EFKNY-NFPKYK-PQPLI--NHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             h---hhhhh-hcCccC-CCchh--hhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            0   00000 000000 00000  11124788999999999999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.5e-45  Score=356.20  Aligned_cols=284  Identities=25%  Similarity=0.455  Sum_probs=220.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (419)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...     ..+.+.+|+.+++.+ +||||+++++++....    
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence            367899999999999999999999999999999998642     235677899999999 9999999999885432    


Q ss_pred             CCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ....++||||++++........+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~  179 (364)
T cd07875         101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  179 (364)
T ss_pred             cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCCCccccCCC
Confidence            24578999999986665555678999999999999999999999999999999999999988 88999999999876544


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+....+.+.++.+....... .    
T Consensus       180 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~-~----  252 (364)
T cd07875         180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMKK-L----  252 (364)
T ss_pred             CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHh-h----
Confidence            44445678999999999987 78999999999999999999999998 55666777777877777654332111 0    


Q ss_pred             ChhhHHhhccC---CCCCccccc-------cccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRH---SRKPWSKFI-------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~---~~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      .+.........   ....+....       ........++++++||.+||+.||++|||+.|+|+||||...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            00000000000   000000000       011112246789999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.7e-45  Score=357.25  Aligned_cols=284  Identities=25%  Similarity=0.454  Sum_probs=219.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (419)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+...     ....+.+|+.+++.+ +||||+++++++....    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccc
Confidence            367899999999999999999999999999999998642     235677899999999 9999999999986432    


Q ss_pred             CCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ....++||||++++........+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~~kl~Dfg~~~~~~~~  172 (355)
T cd07874          94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  172 (355)
T ss_pred             cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CCEEEeeCcccccCCCc
Confidence            23578999999987666565678999999999999999999999999999999999999988 88999999999876544


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+....+.+.++.+..+.....     
T Consensus       173 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  245 (355)
T cd07874         173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKL-----  245 (355)
T ss_pred             cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhh-----
Confidence            44445678999999999977 67999999999999999999999998 455666677777777776543322110     


Q ss_pred             ChhhHHhhccCC---CCCcc-----ccc--cccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHS---RKPWS-----KFI--NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~---~~~~~-----~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      .+..........   .....     ...  ........+.++++||.+||+.||++|||+.|+|+||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence            000111000000   00000     000  011122356789999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.8e-46  Score=355.05  Aligned_cols=247  Identities=23%  Similarity=0.395  Sum_probs=206.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++..      ..+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~   93 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDE--NRV   93 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcC--CEE
Confidence            57899999999999999999999999999999998642      235678999999999 999999999999654  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||+.+++|...+   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceEcCCCc
Confidence            9999999999998776   358899999999999999999999999999999999999988 889999999998764322


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                        ....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+.+  +.           .   
T Consensus       173 --~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~--~~-----------~---  232 (329)
T PTZ00263        173 --FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILA--GR-----------L---  232 (329)
T ss_pred             --ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhc--CC-----------c---
Confidence              33578999999999987 6789999999999999999999999842 222222221111  00           0   


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                           ..+..+++.+++|+++||+.||++|++     ++++++||||+.+
T Consensus       233 ---------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        233 ---------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence                                 001126788999999999999999997     7999999999874

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.2e-45  Score=358.63  Aligned_cols=281  Identities=28%  Similarity=0.499  Sum_probs=219.0

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC---Ccc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTP  197 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~  197 (419)
                      +|++.+.||+|+||+||+|.+..+++.||+|.+...     ..+.+.+|+.+++.+ +|+||+++++++.....   ...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence            477889999999999999999999999999998642     235678999999999 99999999999965421   267


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++|+||+.++ +...+   ..+++..++.++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+++......
T Consensus        80 ~lv~e~~~~~-l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          80 YVVTELMQSD-LHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEEeeccccC-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeecccCc
Confidence            8999999854 44443   458999999999999999999999999999999999999988 889999999998654322


Q ss_pred             c--ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          275 E--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       275 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .  .....++..|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.+....+.....  
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~~~~--  234 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-QAQSPIQQLDLITDLLGTPSLEAMRSACE--  234 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhhH--
Confidence            2  233467889999999987566899999999999999999999987 56667788888999999887655432110  


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                         ............+.............++++.+||.+||++||++|||+.|+|+||||+..
T Consensus       235 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         235 ---GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             ---HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence               111111111111100000001112358899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-45  Score=354.04  Aligned_cols=242  Identities=26%  Similarity=0.433  Sum_probs=199.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||+||+|.+..+|+.||+|+++..      ....+.+|+.+++.+ +||||+++++++...  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcC--CEEEEEEeCC
Confidence            3699999999999999999999999998642      224567899999999 999999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCcceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~~~~~~  280 (419)
                      ++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~  156 (323)
T cd05571          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCccccee
Confidence            999997776   458999999999999999999999999999999999999988 7899999999875322 22334457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      ||..|+|||++.+ ..++.++|||||||++|||++|+.||... +.......+..  +.           .         
T Consensus       157 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~~~~--~~-----------~---------  212 (323)
T cd05571         157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM--EE-----------I---------  212 (323)
T ss_pred             cCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCC-CHHHHHHHHHc--CC-----------C---------
Confidence            8999999999877 78999999999999999999999999532 21111111110  00           0         


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                     ..+..+++++.+||.+||+.||++||     ++.++++||||+.+
T Consensus       213 ---------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         213 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                           00123788999999999999999999     89999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.4e-45  Score=355.30  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=202.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.++..+ +|+||+++++.+.+.  ...+
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~--~~~~   77 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDK--LNLY   77 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecC--CeEE
Confidence            4799999999999999999999999999999999642      224577899999999 999999999999654  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCccccccccc
Confidence            999999999998876   458999999999999999999999999999999999999988 889999999987543211 


Q ss_pred             -----------------------------------cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 014762          275 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (419)
Q Consensus       275 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~p  319 (419)
                                                         .....+||..|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                               0123478999999999987 7899999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCC-
Q 014762          320 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ-  398 (419)
Q Consensus       320 f~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~-  398 (419)
                      |. +.+..+....+......                                 ........+++++++|+.+|+. +|+ 
T Consensus       236 f~-~~~~~~~~~~i~~~~~~---------------------------------~~~p~~~~~s~~~~~li~~l~~-~~~~  280 (363)
T cd05628         236 FC-SETPQETYKKVMNWKET---------------------------------LIFPPEVPISEKAKDLILRFCC-EWEH  280 (363)
T ss_pred             CC-CCCHHHHHHHHHcCcCc---------------------------------ccCCCcCCCCHHHHHHHHHHcC-Chhh
Confidence            84 33333333333221000                                 0000112368899999999875 454 


Q ss_pred             --CCCCHHHHhcCCCcccc
Q 014762          399 --DRLTAREAMVISSISPI  415 (419)
Q Consensus       399 --~Rpta~elL~hp~f~~~  415 (419)
                        .||+++|+++||||+.+
T Consensus       281 r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         281 RIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             cCCCCCHHHHhCCCCCCCC
Confidence              45899999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.7e-45  Score=364.86  Aligned_cols=287  Identities=22%  Similarity=0.375  Sum_probs=210.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhc-----CCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC-----GGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~-----~h~niv~l~~~~~~~~~~~  196 (419)
                      .++|++.++||+|+||+||+|.+..+++.||||+++..  .......|+.++..+.     .|.++++++++|... ..+
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~~  206 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TGH  206 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-Cce
Confidence            57899999999999999999999999999999999642  2345677888888772     234689999998654 357


Q ss_pred             cEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCC---------------c
Q 014762          197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELR---------------K  258 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~---------------~  258 (419)
                      .|+|||++.+..+..+.  ..+++..+..++.|++.||+|||+ .|||||||||+|||++.+..               .
T Consensus       207 ~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~  286 (467)
T PTZ00284        207 MCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR  286 (467)
T ss_pred             EEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence            89999998654444333  358999999999999999999998 59999999999999986521               4


Q ss_pred             EEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcC
Q 014762          259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG  338 (419)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg  338 (419)
                      +||+|||.+....  .......||..|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.++.+++..+.+.+|
T Consensus       287 vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~g  362 (467)
T PTZ00284        287 VRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLY-DTHDNLEHLHLMEKTLG  362 (467)
T ss_pred             EEECCCCccccCc--cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHcC
Confidence            8999999875432  22344688999999999987 78999999999999999999999887 56667788888888888


Q ss_pred             CchHHHHHhhcCCCCChhh-HHhhccCCC---CCcccccccc--ccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          339 TDELNAYLNKYHLELDPQL-DALVGRHSR---KPWSKFINAD--NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ..+... ...........+ .........   ..+.......  .....++.+.|||++||++||++||||+|+|+||||
T Consensus       363 ~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~  441 (467)
T PTZ00284        363 RLPSEW-AGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV  441 (467)
T ss_pred             CCCHHH-HhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence            765332 111111000000 000000000   0000000000  000124678899999999999999999999999999


Q ss_pred             cccc
Q 014762          413 SPIF  416 (419)
Q Consensus       413 ~~~~  416 (419)
                      +...
T Consensus       442 ~~~~  445 (467)
T PTZ00284        442 LKYY  445 (467)
T ss_pred             cccC
Confidence            9864

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-45  Score=352.44  Aligned_cols=254  Identities=29%  Similarity=0.482  Sum_probs=207.8

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++..      ....+.+|+.++..+ +||||+++++++.+  ....+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~   77 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQD--DEYLY   77 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEc--CCEEE
Confidence            4799999999999999999999999999999998643      234577899999999 89999999999965  46789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||||+++++|..++   ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.....  .
T Consensus        78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~  154 (333)
T cd05600          78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--Y  154 (333)
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCccccc--c
Confidence            999999999999887   358999999999999999999999999999999999999987 8899999999976543  2


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+......           .    
T Consensus       155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~-----------~----  217 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFS-GSTPNETWENLKYWKET-----------L----  217 (333)
T ss_pred             cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCC-CCCHHHHHHHHHhcccc-----------c----
Confidence            334578999999999987 689999999999999999999999984 33333333322210000           0    


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                               ....+     ......+++++.+||.+||+.+|++|||+.++++||||+.+
T Consensus       218 ---------~~~~~-----~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         218 ---------QRPVY-----DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             ---------cCCCC-----CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence                     00000     00012368999999999999999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.8e-45  Score=343.46  Aligned_cols=273  Identities=27%  Similarity=0.517  Sum_probs=211.8

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhc--CCCCeeEEEeEEEcc---CCC
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLC--GGPNVVKLLDIVRDQ---HSK  195 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~---~~~  195 (419)
                      +|++.+.||+|+||+||+|.+..+++.||+|.++...     .....+|+.+++.+.  +||||+++++++...   ...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5889999999999999999999999999999986421     235667888877663  699999999998643   234


Q ss_pred             ccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ..+++|||+.+ ++..++     ..+++..++.++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+++..
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIY  158 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCccccc
Confidence            57899999986 555544     238999999999999999999999999999999999999988 88999999999876


Q ss_pred             cCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ..........++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.+..+....+.+....+.....
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCc-CCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            54444444577889999999977 67999999999999999999998776 55666677777877777655443322111


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      .....     ........+.     .....+++++.+++.+||+.||++|||+.|++.||||
T Consensus       237 ~~~~~-----~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGA-----FSPRGPRPVQ-----SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccc-----cCCCCCCchH-----HhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00000     0000000011     1112378889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-45  Score=339.74  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=213.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..+.|++++.||.|.-|+||++....++..+|+|++.+..      ..+...|-+||+.+ +||.++++|..|+.  .+.
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet--~~~  151 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFET--DKY  151 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeec--cce
Confidence            3567999999999999999999999999999999997532      24566799999999 99999999999954  588


Q ss_pred             cEEEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      .||+||||+||+|..+.+     .+++..++.++.+++.||+|||-.|||+|||||+||||.++ |++.|+||.++..+.
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLSLRCP  230 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeeccccccCC
Confidence            999999999999988873     49999999999999999999999999999999999999998 999999999974321


Q ss_pred             C---------------------------------C-C-----------------------cceeecccccccccccccCC
Q 014762          272 P---------------------------------G-K-----------------------EYNVRVASRYFKGPELLVDL  294 (419)
Q Consensus       272 ~---------------------------------~-~-----------------------~~~~~~~~~~y~aPE~~~~~  294 (419)
                      .                                 . .                       ..+..+||..|.|||++.+ 
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-  309 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-  309 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence            0                                 0 0                       0122368888999999998 


Q ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCcccccc
Q 014762          295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN  374 (419)
Q Consensus       295 ~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (419)
                      ..-+.++|+|+|||++|||+.|..|| .|.++.+.+..++.   .+..                                
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPF-KG~~~~~Tl~NIv~---~~l~--------------------------------  353 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPF-KGSNNKETLRNIVG---QPLK--------------------------------  353 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCc-CCCCchhhHHHHhc---CCCc--------------------------------
Confidence            77899999999999999999999998 67777777766543   1110                                


Q ss_pred             ccccCCCCHHHHHHHHHhcCCCCCCCCC----HHHHhcCCCccccc
Q 014762          375 ADNQHLVSPEAIDFLDKLLRYDHQDRLT----AREAMVISSISPIF  416 (419)
Q Consensus       375 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~elL~hp~f~~~~  416 (419)
                      ......++..++|||+++|..||++|..    |.|+-+||||+.|.
T Consensus       354 Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  354 FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN  399 (459)
T ss_pred             CCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence            0011136789999999999999999998    99999999999885

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-45  Score=356.04  Aligned_cols=251  Identities=28%  Similarity=0.467  Sum_probs=203.8

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||+||+|.+..+++.||||+++..      ....+.+|+.++..+ +||||+++++++.+.  ...+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~--~~~~   77 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDE--NYLY   77 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcC--CeEE
Confidence            4799999999999999999999999999999999642      224577899999999 899999999999654  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++.......
T Consensus        78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceecccccc
Confidence            999999999998876   358999999999999999999999999999999999999988 8899999999875432110


Q ss_pred             ---------------------------------------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhC
Q 014762          276 ---------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR  316 (419)
Q Consensus       276 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g  316 (419)
                                                             ....+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence                                                   012358999999999876 7899999999999999999999


Q ss_pred             CCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCC
Q 014762          317 KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD  396 (419)
Q Consensus       317 ~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  396 (419)
                      ..||.. .+..+....+.+.                                 ...........+++++++||.+||. +
T Consensus       236 ~~Pf~~-~~~~~~~~~i~~~---------------------------------~~~~~~~~~~~~s~~~~~li~~ll~-~  280 (364)
T cd05599         236 YPPFCS-DNPQETYRKIINW---------------------------------KETLQFPDEVPLSPEAKDLIKRLCC-E  280 (364)
T ss_pred             CCCCCC-CCHHHHHHHHHcC---------------------------------CCccCCCCCCCCCHHHHHHHHHHcc-C
Confidence            999842 2222222222110                                 0000000111368899999999997 9


Q ss_pred             CCCCCC---HHHHhcCCCcccc
Q 014762          397 HQDRLT---AREAMVISSISPI  415 (419)
Q Consensus       397 P~~Rpt---a~elL~hp~f~~~  415 (419)
                      |.+|++   +.++++||||+.+
T Consensus       281 p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         281 AERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             HhhcCCCCCHHHHhcCCCcCCC
Confidence            999998   9999999999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.8e-45  Score=351.44  Aligned_cols=248  Identities=21%  Similarity=0.361  Sum_probs=205.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCC-cEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.+.||+|+||.||+|.+..++ ..||+|.+...      ..+.+.+|+.+++.+ +||||+++++++.+.  .
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~  104 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDE--S  104 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeC--C
Confidence            4678999999999999999999876654 68999998532      235677899999999 999999999999654  6


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ..++||||+.+++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEecCCCCeecCC
Confidence            789999999999998876   358999999999999999999999999999999999999987 8899999999987543


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .  .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+.......+...  .           . 
T Consensus       184 ~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~--~-----------~-  245 (340)
T PTZ00426        184 R--TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEG--I-----------I-  245 (340)
T ss_pred             C--cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcC--C-----------C-
Confidence            2  234578999999999977 6789999999999999999999999953 2222222222110  0           0 


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                             ..+..+++.+.++|++||+.||++|+     |++++++||||+++
T Consensus       246 -----------------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        246 -----------------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                                   01123688999999999999999995     89999999999876

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-45  Score=357.10  Aligned_cols=251  Identities=25%  Similarity=0.434  Sum_probs=201.7

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.++||+|+||+||+|.+..+++.||||++...      ..+.+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~--~~~~   77 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDA--QYLY   77 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC--CeeE
Confidence            4789999999999999999999999999999998532      234577899999999 999999999999654  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeecccccccccccc
Confidence            999999999998876   458899999999999999999999999999999999999987 8899999999863211000


Q ss_pred             ------------------------------------------------ceeecccccccccccccCCCCCCccccHHHHH
Q 014762          276 ------------------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLG  307 (419)
Q Consensus       276 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG  307 (419)
                                                                      ....+||..|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG  235 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG  235 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence                                                            012368899999999877 7799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHH
Q 014762          308 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID  387 (419)
Q Consensus       308 ~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (419)
                      |++|||++|..||.. .+..+.+..+.....                                 .........++.++++
T Consensus       236 vil~elltG~~Pf~~-~~~~~~~~~i~~~~~---------------------------------~~~~p~~~~~s~~~~d  281 (377)
T cd05629         236 AIMFECLIGWPPFCS-ENSHETYRKIINWRE---------------------------------TLYFPDDIHLSVEAED  281 (377)
T ss_pred             hhhhhhhcCCCCCCC-CCHHHHHHHHHccCC---------------------------------ccCCCCCCCCCHHHHH
Confidence            999999999999842 233333333221000                                 0000011236889999


Q ss_pred             HHHHhcCCCCCCC---CCHHHHhcCCCcccc
Q 014762          388 FLDKLLRYDHQDR---LTAREAMVISSISPI  415 (419)
Q Consensus       388 li~~~L~~dP~~R---pta~elL~hp~f~~~  415 (419)
                      ||.+||+ +|.+|   +|+.|+++||||+.+
T Consensus       282 li~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         282 LIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             HHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9999998 77765   599999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1e-44  Score=354.96  Aligned_cols=252  Identities=25%  Similarity=0.423  Sum_probs=201.1

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..|++++.||+|+||+||+|.+..+++.||+|++...      ....+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~--~~~~   77 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDK--DNLY   77 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecC--CEEE
Confidence            3688999999999999999999999999999998642      234578899999999 999999999999654  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||+.||+||||||+|||++.+ +.+||+|||+++...... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCcccccccc
Confidence            999999999998876   458899999999999999999999999999999999999987 899999999975321000 


Q ss_pred             -----------------------------------------------cceeecccccccccccccCCCCCCccccHHHHH
Q 014762          275 -----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG  307 (419)
Q Consensus       275 -----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG  307 (419)
                                                                     ......||..|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG  235 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVG  235 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehh
Confidence                                                           0012468899999999877 7799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHH
Q 014762          308 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID  387 (419)
Q Consensus       308 ~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (419)
                      |++|||++|..||.... ..+....+.....                                 .........+++++.+
T Consensus       236 ~il~elltG~~Pf~~~~-~~~~~~~i~~~~~---------------------------------~~~~~~~~~~s~~~~d  281 (381)
T cd05626         236 VILFEMLVGQPPFLAPT-PTETQLKVINWEN---------------------------------TLHIPPQVKLSPEAVD  281 (381)
T ss_pred             hHHHHHHhCCCCCcCCC-HHHHHHHHHcccc---------------------------------ccCCCCCCCCCHHHHH
Confidence            99999999999995432 2222222211000                                 0001111237899999


Q ss_pred             HHHHhcCC--CCCCCCCHHHHhcCCCcccc
Q 014762          388 FLDKLLRY--DHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       388 li~~~L~~--dP~~Rpta~elL~hp~f~~~  415 (419)
                      ||.+|+..  ++..|+|++++++||||+.+
T Consensus       282 li~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         282 LITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            99996655  44459999999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-46  Score=306.33  Aligned_cols=279  Identities=30%  Similarity=0.566  Sum_probs=232.8

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|.-.++||+|.||+||+|++..+++.||+|.+.-.     ......+|+.+++.+ .|+|||+++++...+  +.+.+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsd--kkltlv   79 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSD--KKLTLV   79 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccC--ceeEEe
Confidence            355578899999999999999999999999998632     246788999999999 999999999998554  667899


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-c
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~  275 (419)
                      +|||... +..+.    ..++.+.++.++.|+++||.++|++++.|||+||.|.|++.+ +.+|++|||+++..+-.- .
T Consensus        80 fe~cdqd-lkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-gelkladfglarafgipvrc  157 (292)
T KOG0662|consen   80 FEFCDQD-LKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHHhhHH-HHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-CcEEecccchhhhcCCceEe
Confidence            9999753 33333    558889999999999999999999999999999999999999 899999999998765433 4


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      +...+.|.+|++|.++.+.+-|+.+.|+||-||++.|+.....|.|+|.+-.+|+..|...+|.+....|..-..   -+
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~---lp  234 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK---LP  234 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc---CC
Confidence            566789999999999999889999999999999999999988899999999999999999999988776653222   22


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      ++....-......|.++..     .++...+|+++++|..+|.+|.+|+++|+||||....+
T Consensus       235 dyk~yp~ypattswsqivp-----~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s~  291 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVP-----KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFSP  291 (292)
T ss_pred             CCcccCCccccchHHHHhh-----hhcchhHHHHHHHhccCcccccCHHHHhcCccccccCC
Confidence            2222223333445554443     36667899999999999999999999999999987653

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-45  Score=353.76  Aligned_cols=251  Identities=31%  Similarity=0.523  Sum_probs=207.0

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.++..+ +||||+++++.+.+  ....+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~   77 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQD--EEHLY   77 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheec--CCeEE
Confidence            4799999999999999999999999999999998642      235678899999999 89999999999965  46789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      +||||+.+++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... 
T Consensus        78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEeecCCCCccCcccCc
Confidence            999999999998876   358999999999999999999999999999999999999988 889999999997654333 


Q ss_pred             -----------------------------cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 014762          275 -----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (419)
Q Consensus       275 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~  325 (419)
                                                   ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-  234 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT-  234 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCC-
Confidence                                         2234578899999999987 689999999999999999999999985332 


Q ss_pred             CHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-HH
Q 014762          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-AR  404 (419)
Q Consensus       326 ~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-a~  404 (419)
                      ..+....+.....                                 .........+++++.+||.+||+ ||++|++ ++
T Consensus       235 ~~~~~~~i~~~~~---------------------------------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~  280 (350)
T cd05573         235 LQETYNKIINWKE---------------------------------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFE  280 (350)
T ss_pred             HHHHHHHHhccCC---------------------------------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence            2222222221000                                 00001111268999999999998 9999999 99


Q ss_pred             HHhcCCCcccc
Q 014762          405 EAMVISSISPI  415 (419)
Q Consensus       405 elL~hp~f~~~  415 (419)
                      ++++||||+++
T Consensus       281 ~ll~hp~~~~~  291 (350)
T cd05573         281 EIKSHPFFKGI  291 (350)
T ss_pred             HHhcCCCcCCC
Confidence            99999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-44  Score=349.90  Aligned_cols=283  Identities=29%  Similarity=0.527  Sum_probs=217.0

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC---
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---  193 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  193 (419)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|.+...     ..+.+.+|+.+++.+ +||||+++++++....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhccccccc
Confidence            3467899999999999999999999999999999998642     234577899999999 9999999999885331   


Q ss_pred             -CCccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          194 -SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       194 -~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                       ....+++++++ ++++..++  ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~  168 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRILDFGLARQA  168 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEcCCccceec
Confidence             24568999988 56676665  459999999999999999999999999999999999999988 88999999999865


Q ss_pred             cCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ...  .....++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+.+....... ..
T Consensus       169 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  244 (343)
T cd07878         169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF-PGNDYIDQLKRIMEVVGTPSPEVLKK-IS  244 (343)
T ss_pred             CCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHh-cc
Confidence            432  234578899999999877567899999999999999999999987 45555667777777777655433211 00


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ......+...........+....     ...++.+.+|+.+||+.||++|||+.|+|+||||.+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIF-----RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhc-----cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence            00000000000000001111111     12577899999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.6e-44  Score=339.27  Aligned_cols=275  Identities=29%  Similarity=0.521  Sum_probs=218.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.+.||+|+||+||+|.+..+|+.+|+|.++...     ...+.+|+.+++.+ +|||++++++++.+.  ...+++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   77 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSD--KKLTLV   77 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccC--CceEEE
Confidence            5889999999999999999999999999999986321     24577899999999 999999999999654  678999


Q ss_pred             EEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cc
Q 014762          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (419)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~  276 (419)
                      +||++++.+..+.   ..+++..++.++.|+++||.|||++|++|+||||+||+++.+ +.++|+|||+++...... ..
T Consensus        78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccCCCCCCc
Confidence            9999865443332   348999999999999999999999999999999999999988 889999999987654322 22


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....++..|+|||++.+...++.++|||||||++|+|++|+.||+.+.+..+.+..+.+.++.+....+.........  
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  234 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY--  234 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc--
Confidence            334677889999998775568999999999999999999999998888888888888888887765554321111110  


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                       ...........|..     ....+++++++|+.+||+.||++|||++++++||||
T Consensus       235 -~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         235 -KPYPMYPATTSLVN-----VVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             -cccCCCCCcchhhh-----hcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence             00000001111111     122478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-44  Score=354.85  Aligned_cols=251  Identities=26%  Similarity=0.419  Sum_probs=202.1

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|+++++||+|+||+||+|.+..+++.+|+|++....      ...+.+|+.+++.+ +||||+++++.|.+.  ...+
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~--~~~~   77 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDK--DNLY   77 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeC--CEEE
Confidence            36899999999999999999999999999999986432      34678899999999 999999999999654  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC--
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~--  273 (419)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++......  
T Consensus        78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          78 FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCcccccccc
Confidence            999999999998876   347899999999999999999999999999999999999988 88999999997532100  


Q ss_pred             ----------------------------------------------CcceeecccccccccccccCCCCCCccccHHHHH
Q 014762          274 ----------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG  307 (419)
Q Consensus       274 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG  307 (419)
                                                                    ......+||..|+|||++.+ ..++.++||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG  235 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVG  235 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEech
Confidence                                                          00112368899999999877 7899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHH
Q 014762          308 CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID  387 (419)
Q Consensus       308 ~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  387 (419)
                      |++|||++|+.||.. .+..+....+.....                                 .........+++++.+
T Consensus       236 vil~elltG~~Pf~~-~~~~~~~~~i~~~~~---------------------------------~~~~p~~~~~s~~~~~  281 (382)
T cd05625         236 VILYEMLVGQPPFLA-QTPLETQMKVINWQT---------------------------------SLHIPPQAKLSPEASD  281 (382)
T ss_pred             HHHHHHHhCCCCCCC-CCHHHHHHHHHccCC---------------------------------CcCCCCcccCCHHHHH
Confidence            999999999999843 232222222221000                                 0001111237899999


Q ss_pred             HHHHhcCCCCCCCCC---HHHHhcCCCcccc
Q 014762          388 FLDKLLRYDHQDRLT---AREAMVISSISPI  415 (419)
Q Consensus       388 li~~~L~~dP~~Rpt---a~elL~hp~f~~~  415 (419)
                      +|.+|+ .+|++|++   ++++++||||+.+
T Consensus       282 li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         282 LIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            999986 59999997   9999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-46  Score=318.71  Aligned_cols=248  Identities=26%  Similarity=0.434  Sum_probs=215.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|-||.||.|+...++-.||+|++.++.      ..++.+|++|-+.| +||||.+++++|.+.  ..
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~--~r   96 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDS--KR   96 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheecc--ce
Confidence            4678999999999999999999999999999999986432      46788999999999 999999999999664  78


Q ss_pred             cEEEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      +||++||...|.+...+.     .+++.....++.|++.||.|+|.++++||||||+|+|++.+ +.+||+|||-+...+
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP  175 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC
Confidence            899999999998877663     58999999999999999999999999999999999999999 889999999987654


Q ss_pred             CCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                       .......+||..|.+||+..+ ...+..+|+|++|++.||++.|..||.+.. ..+..++|.++-              
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~--------------  238 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD--------------  238 (281)
T ss_pred             -CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc--------------
Confidence             445566799999999999987 789999999999999999999999995443 555555555421              


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                             ...+..++.+++|+|.+||..+|.+|.+..|++.|||...
T Consensus       239 -----------------------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  239 -----------------------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             -----------------------ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence                                   1112348999999999999999999999999999999764

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.1e-44  Score=338.93  Aligned_cols=283  Identities=27%  Similarity=0.536  Sum_probs=218.6

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      +..++|++.++||.|+||.||+|.+..+++.||+|.++..    ....+.+|+.+++.+ +||||+++++++..+  ...
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~--~~~   79 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTE--KSL   79 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecC--CeE
Confidence            4567899999999999999999999999999999998632    234677899999999 999999999999654  678


Q ss_pred             EEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++||||+++ ++..++    ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          80 TLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIP  157 (301)
T ss_pred             EEEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccCCC
Confidence            999999985 555544    347899999999999999999999999999999999999988 78999999998754322


Q ss_pred             C-cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      . ......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..++...+...++.+....+.......
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            2 2233466888999999876566889999999999999999999887 4555566777777777765544332110000


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                         .+.    ......+...........+++++++||.+||+.||++|||++|+|+||||+.+.+
T Consensus       237 ---~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         237 ---EFK----SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             ---ccc----ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence               000    0000000000000112347889999999999999999999999999999997754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-44  Score=351.23  Aligned_cols=280  Identities=20%  Similarity=0.315  Sum_probs=208.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|+...   .....|+.+++++ +||||+++++++...  ...++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV-NHPSVIRMKDTLVSG--AITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhC-CCCCCcChhheEEeC--CeeEEEEE
Confidence            35689999999999999999999999999999998543   3345799999999 999999999999654  66789999


Q ss_pred             ecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceee
Q 014762          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  279 (419)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (419)
                      ++.+..+..+.   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++...........
T Consensus       138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~~  216 (357)
T PHA03209        138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAPAFLGL  216 (357)
T ss_pred             ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEecCccccccccCcccccc
Confidence            99764443332   358999999999999999999999999999999999999988 78999999999754433333445


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC---------HHHHHHHHHHcCCchHHHHHhhcC
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN---------HDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~---------~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      .||..|+|||++.+ ..++.++|||||||++|||+++..+++.....         ..++..+...++..+... .....
T Consensus       217 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~  294 (357)
T PHA03209        217 AGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF-PRDPG  294 (357)
T ss_pred             cccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc-CCCCc
Confidence            78999999999987 67999999999999999999987777554322         223344444444322110 00000


Q ss_pred             CCCChhhHHhhcc--CCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          351 LELDPQLDALVGR--HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       351 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                         ..........  ..+.++... .......++.++.+||.+||++||++||||.|+|+||||+++
T Consensus       295 ---~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        295 ---SRLVRGFIEYASLERQPYTRY-PCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             ---cHHHHHHHhhcccCCCccccc-HHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence               0000111100  111111111 001122467788999999999999999999999999999874

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=338.97  Aligned_cols=309  Identities=24%  Similarity=0.388  Sum_probs=244.5

Q ss_pred             ccCCCcccCCCCCceeccCCC-CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcC--
Q 014762          104 NVLRPKEYWDYESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCG--  178 (419)
Q Consensus       104 ~~~~~~~~~~~~~~~~~~~~~-~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~--  178 (419)
                      +....+....|....++.... .+|.+.++||.|-|+|||+|.|.++.+.||+|+.+...  .+....||.+|++++.  
T Consensus        56 E~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~D  135 (590)
T KOG1290|consen   56 EDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGD  135 (590)
T ss_pred             cChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcC
Confidence            344455667788888888776 99999999999999999999999999999999997543  4667899999999852  


Q ss_pred             -----CCCeeEEEeEEE--ccCCCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCC
Q 014762          179 -----GPNVVKLLDIVR--DQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVK  246 (419)
Q Consensus       179 -----h~niv~l~~~~~--~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk  246 (419)
                           ..+||++++.|.  +.++.++|+|+|++....|....    +.++...++.|++||+.||.|||. .||||.|||
T Consensus       136 p~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlK  215 (590)
T KOG1290|consen  136 PNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLK  215 (590)
T ss_pred             CCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCC
Confidence                 347999999996  45788999999999988776554    679999999999999999999996 699999999


Q ss_pred             CCceEEc-------------------------------------------------------------------------
Q 014762          247 PHNVMID-------------------------------------------------------------------------  253 (419)
Q Consensus       247 ~~NILl~-------------------------------------------------------------------------  253 (419)
                      |+|||+.                                                                         
T Consensus       216 PENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~  295 (590)
T KOG1290|consen  216 PENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIE  295 (590)
T ss_pred             cceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccc
Confidence            9999982                                                                         


Q ss_pred             -----------------------------------------CC-------------------------------------
Q 014762          254 -----------------------------------------HE-------------------------------------  255 (419)
Q Consensus       254 -----------------------------------------~~-------------------------------------  255 (419)
                                                               ..                                     
T Consensus       296 ~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~  375 (590)
T KOG1290|consen  296 EEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIA  375 (590)
T ss_pred             ccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccc
Confidence                                                     00                                     


Q ss_pred             --------------CCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCC
Q 014762          256 --------------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF  321 (419)
Q Consensus       256 --------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~  321 (419)
                                    .-+|||+|||.|+...  ...+...+|..|+|||++++ ..|++.+||||++|++|||.||...|.
T Consensus       376 ~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFe  452 (590)
T KOG1290|consen  376 SNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFE  452 (590)
T ss_pred             cccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeec
Confidence                          0137999999998754  45566789999999999999 889999999999999999999999986


Q ss_pred             CC-----CCCHHHHHHHHHHcCCchHHHHHh-hcCCCCChhhHHhhccCCCCCcccccccccc----CCCCHHHHHHHHH
Q 014762          322 YG-----HDNHDQLVKIAKVLGTDELNAYLN-KYHLELDPQLDALVGRHSRKPWSKFINADNQ----HLVSPEAIDFLDK  391 (419)
Q Consensus       322 ~~-----~~~~~~~~~i~~~lg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~  391 (419)
                      +-     ..++++++.|++.+|.-+..-.+. ++.-.+...-.++......+.|...--....    +.-..++.+|+.-
T Consensus       453 PhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~P  532 (590)
T KOG1290|consen  453 PHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSP  532 (590)
T ss_pred             CCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHH
Confidence            42     346889999999999876654442 2222222222333334445666633211111    1223457799999


Q ss_pred             hcCCCCCCCCCHHHHhcCCCcccc
Q 014762          392 LLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       392 ~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      ||+++|++|+||.++|+||||+++
T Consensus       533 mLef~PeKR~tA~~cl~hPwLn~~  556 (590)
T KOG1290|consen  533 MLEFDPEKRPTAAQCLKHPWLNPV  556 (590)
T ss_pred             HHhcCccccccHHHHhcCccccCC
Confidence            999999999999999999999975

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.2e-45  Score=353.59  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=207.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.++||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.+++.+ +||||+++++++.+  ...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~--~~~  117 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQD--DKY  117 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCE
Confidence            467899999999999999999999999999999998632      224467899999999 99999999999965  467


Q ss_pred             cEEEEEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      .++||||+++++|..++.  .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEeccceeeccCCC
Confidence            899999999999988874  47888899999999999999999999999999999999988 899999999997664332


Q ss_pred             c--ceeecccccccccccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          275 E--YNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       275 ~--~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      .  .....||+.|+|||++.+.   ..++.++|||||||++|||++|+.||.. .+.......+......          
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~----------  265 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNS----------  265 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCc----------
Confidence            2  2345789999999998652   2478999999999999999999999843 2222222222210000          


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~  415 (419)
                                             ........++.++.+||.+||+.+|++  |+|++++++||||++.
T Consensus       266 -----------------------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         266 -----------------------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             -----------------------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence                                   000011237899999999999999988  9999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-44  Score=346.83  Aligned_cols=242  Identities=26%  Similarity=0.430  Sum_probs=199.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||+||++.+..+|..||+|+++..      ....+.+|+.+++.+ +||||+++++.|...  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecC--CEEEEEEeCC
Confidence            3699999999999999999999999998642      224567899999999 999999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Ccceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~~~~~~  280 (419)
                      ++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .......
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~  156 (323)
T cd05595          78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFC  156 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcccccc
Confidence            999997765   358999999999999999999999999999999999999988 88999999998753222 2223457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      |+..|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+...  .           .         
T Consensus       157 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~~~~~--~-----------~---------  212 (323)
T cd05595         157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILME--E-----------I---------  212 (323)
T ss_pred             CCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHhcC--C-----------C---------
Confidence            8999999999877 78899999999999999999999998532 222222221110  0           0         


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                     ..+..+++++.+||.+||+.||++|+     ++.++++||||..+
T Consensus       213 ---------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         213 ---------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence                           00123789999999999999999998     99999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-45  Score=349.24  Aligned_cols=242  Identities=19%  Similarity=0.349  Sum_probs=201.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .+.+.++++||+|.||.||.|.+. ....||+|.++..  ..+.|.+|+++|++| +|+|||+++++|..+  ..++|||
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~--~piyIVt  280 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQ--EPIYIVT  280 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecC--CceEEEE
Confidence            445677889999999999999763 4458999999863  347899999999999 999999999999765  4689999


Q ss_pred             EecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      |||+.|+|.++++     .+...+...++.|||+||+||+++++|||||.++||||+++ ..+||+|||+|+... ++.+
T Consensus       281 E~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~-d~~Y  358 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVKISDFGLARLIG-DDEY  358 (468)
T ss_pred             EecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEEEcccccccccC-CCce
Confidence            9999999999985     37888999999999999999999999999999999999999 799999999999443 4444


Q ss_pred             eeeccc---ccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          277 NVRVAS---RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       277 ~~~~~~---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      ....+.   ..|.|||.+.. ..++.+||||||||+||||+|-....+.+.++.+.+..+.+-.                
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy----------------  421 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY----------------  421 (468)
T ss_pred             eecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC----------------
Confidence            444444   34999999876 7899999999999999999994444447777777776654411                


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                          +...++.|++++.++|..||..+|++|||.+.+..
T Consensus       422 --------------------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  422 --------------------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             --------------------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence                                11223459999999999999999999999997654

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.6e-44  Score=344.55  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=202.7

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      +|++++.||+|+||.||+|.+..+++.||+|+++..      ..+.+..|+.++..+..|++|+++++++.+.  ...++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF   78 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence            588999999999999999999999999999998642      2345778999999984456788999998654  67899


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc-CCCc
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKE  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~-~~~~  275 (419)
                      ||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++... ....
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecCCCCCc
Confidence            99999999998776   358999999999999999999999999999999999999988 889999999987532 2223


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.+..                  
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~~~------------------  217 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELFQSIMEHN------------------  217 (324)
T ss_pred             eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCC------------------
Confidence            344578999999999987 778999999999999999999999984 333222222221100                  


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~elL~hp~f~~~  415 (419)
                                         ...+..+++++.+++.+||+.||++|+++     .++++||||+.+
T Consensus       218 -------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         218 -------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                               00012368899999999999999999976     899999999875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-45  Score=345.66  Aligned_cols=240  Identities=23%  Similarity=0.380  Sum_probs=197.6

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.++.++ +||||+++++++.+.  ...++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSP--EKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecC--CeEEEEEcCCCC
Confidence            79999999999999999999999998632      234577899999999 999999999999654  678999999999


Q ss_pred             CChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Ccceeeccc
Q 014762          207 TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVAS  282 (419)
Q Consensus       207 ~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~  282 (419)
                      ++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++..... .......||
T Consensus        78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt  156 (312)
T cd05585          78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCGT  156 (312)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCccccccCC
Confidence            9998776   358999999999999999999999999999999999999988 78999999998754322 223345789


Q ss_pred             ccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhc
Q 014762          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG  362 (419)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  362 (419)
                      ..|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+..  +.                       
T Consensus       157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~--~~-----------------------  209 (312)
T cd05585         157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQ--EP-----------------------  209 (312)
T ss_pred             cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHc--CC-----------------------
Confidence            99999999987 7799999999999999999999999843 222222211111  00                       


Q ss_pred             cCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCCCcccc
Q 014762          363 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMVISSISPI  415 (419)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---ta~elL~hp~f~~~  415 (419)
                                  ...+..+++++.+|+.+||+.||++||   ++.|+++||||+.+
T Consensus       210 ------------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         210 ------------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             ------------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence                        001123788999999999999999997   68999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.2e-44  Score=339.46  Aligned_cols=281  Identities=24%  Similarity=0.471  Sum_probs=207.0

Q ss_pred             EeeeeeeCceEEEEEEEcC--CCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          130 VRKVGRGKYSEVFEGINVN--TNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ..+||+|+||+||+|.+..  ++..+|+|.++... ...+.+|+.+++.+ +||||+++++++........++||||+++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            3579999999999998654  56789999987543 35678999999999 99999999999976666778999999987


Q ss_pred             CChhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEc---CCCCcEEEEecccceeccC
Q 014762          207 TDFKVLY-----------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       207 ~~l~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~---~~~~~~kl~Dfgla~~~~~  272 (419)
                      +.+....           ..+++..++.++.|++.||.|||++||+||||||+|||+.   .+.+.+||+|||+++....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence            5433221           1378888999999999999999999999999999999994   2236899999999986543


Q ss_pred             CCc----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHHHHHcCCc
Q 014762          273 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVKIAKVLGTD  340 (419)
Q Consensus       273 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--------~~~~~~~i~~~lg~~  340 (419)
                      ...    .....+|..|+|||++.+...++.++|||||||++|||++|+.||.....        ...++..+...+|.+
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07867         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP  244 (317)
T ss_pred             CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence            321    23346788999999987756689999999999999999999999854322        234566777777766


Q ss_pred             hHHHHHhhcCCCCChhhHHhhccCCC--CCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          341 ELNAYLNKYHLELDPQLDALVGRHSR--KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ....+.........+...........  ...... ........+..+.+|+.+||+.||++|||+.|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKY-MEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ChhhhhhhhhcccchhhhhhhcccccCCchhhhh-hhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            65544332222111111111110000  000000 011112246779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.4e-44  Score=345.62  Aligned_cols=243  Identities=23%  Similarity=0.373  Sum_probs=199.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||+||+|.+..+++.||+|+++..      ..+.+.+|..++..+.+||||+++++++...  ...++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--~~~~iv~Ey~   78 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP--DRLFFVMEFV   78 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC--CEEEEEEcCC
Confidence            3699999999999999999999999998642      2345678888888776899999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCcceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~~~~~~  280 (419)
                      ++++|..++   ..+++..+..++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~~~  157 (320)
T cd05590          79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFC  157 (320)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcccccc
Confidence            999998765   468999999999999999999999999999999999999988 8899999999875432 22233457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+...  .           .         
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~-~~~~~~~~~~i~~~--~-----------~---------  213 (320)
T cd05590         158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILND--E-----------V---------  213 (320)
T ss_pred             cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhcC--C-----------C---------
Confidence            8999999999876 678999999999999999999999984 22222222222110  0           0         


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCCCcccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMVISSISPI  415 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta------~elL~hp~f~~~  415 (419)
                                     ..+..+++++.+|+++||+.||++|+|+      +++++||||+.+
T Consensus       214 ---------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         214 ---------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence                           0012368899999999999999999998      999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-44  Score=353.35  Aligned_cols=251  Identities=26%  Similarity=0.422  Sum_probs=202.1

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|+++++||+|+||+||+|.+..+++.||+|++...      ....+.+|+.+++.+ +|+||+++++.+.+.  ..++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~--~~~~   77 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDK--DNLY   77 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcC--CEEE
Confidence            4799999999999999999999999999999998642      235678899999999 999999999999654  6889


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC--
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~--  273 (419)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++......  
T Consensus        78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccc
Confidence            999999999998876   347889999999999999999999999999999999999988 88999999997422100  


Q ss_pred             ------------------------------------------CcceeecccccccccccccCCCCCCccccHHHHHHHHH
Q 014762          274 ------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA  311 (419)
Q Consensus       274 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~  311 (419)
                                                                .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvily  235 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY  235 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceee
Confidence                                                      00012368899999999877 77999999999999999


Q ss_pred             HHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHH
Q 014762          312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK  391 (419)
Q Consensus       312 ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  391 (419)
                      +|++|+.||... +..+....+...                                 ...........+++++.+||.+
T Consensus       236 ell~G~~Pf~~~-~~~~~~~~i~~~---------------------------------~~~~~~~~~~~~s~~~~~li~~  281 (376)
T cd05598         236 EMLVGQPPFLAD-TPAETQLKVINW---------------------------------ETTLHIPSQAKLSREASDLILR  281 (376)
T ss_pred             ehhhCCCCCCCC-CHHHHHHHHhcc---------------------------------CccccCCCCCCCCHHHHHHHHH
Confidence            999999998432 222222211110                                 0000011112378899999999


Q ss_pred             hcCCCCCCCC---CHHHHhcCCCcccc
Q 014762          392 LLRYDHQDRL---TAREAMVISSISPI  415 (419)
Q Consensus       392 ~L~~dP~~Rp---ta~elL~hp~f~~~  415 (419)
                      |+ .+|++|+   |+.++++||||+.+
T Consensus       282 l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         282 LC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             Hh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            77 5999999   99999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-44  Score=346.53  Aligned_cols=242  Identities=26%  Similarity=0.416  Sum_probs=198.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||.||++.+..+++.||+|++...      ....+.+|+.+++.+ +||||+++++.+...  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv~Ey~   77 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTK--DRLCFVMEYV   77 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcC--CEEEEEEeCC
Confidence            3599999999999999999999999998642      234677899999999 999999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Ccceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~~~~~~  280 (419)
                      +++++...+   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .......
T Consensus        78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~  156 (328)
T cd05593          78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFC  156 (328)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCCCccccccccc
Confidence            999997765   458999999999999999999999999999999999999988 88999999998754322 2223457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+..  +.           .         
T Consensus       157 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~~~~--~~-----------~---------  212 (328)
T cd05593         157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM--ED-----------I---------  212 (328)
T ss_pred             CCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCC-CHHHHHHHhcc--CC-----------c---------
Confidence            8999999999877 67899999999999999999999998432 22221111110  00           0         


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                     ..+..+++++.+||++||+.||++|+     |+.++++||||+.+
T Consensus       213 ---------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  257 (328)
T cd05593         213 ---------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             ---------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                           00123688999999999999999997     89999999999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-44  Score=337.12  Aligned_cols=251  Identities=25%  Similarity=0.368  Sum_probs=205.6

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      +|++.+.||+|+||+||++.+..+++.||+|.+....      ...+.+|+.+++.+ +||||+++++.+..+  ...++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   77 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETK--DALCL   77 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCC--CeEEE
Confidence            4888999999999999999999999999999986422      23467899999999 999999999999654  67899


Q ss_pred             EEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ||||+.+++|..++     ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCC
Confidence            99999999997665     248899999999999999999999999999999999999987 789999999998765444


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||.. .+.......+...+....             
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~-------------  221 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQ-RKEKVKREEVERRVKEDQ-------------  221 (285)
T ss_pred             ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCC-CchhhHHHHHHHHhhhcc-------------
Confidence            4445578899999999876 6789999999999999999999999843 222222222211110000             


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                          ......+++.+.+|+.+||..||++||     |++++++||||...
T Consensus       222 --------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         222 --------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             --------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence                                000122688999999999999999999     99999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.6e-44  Score=344.49  Aligned_cols=246  Identities=24%  Similarity=0.416  Sum_probs=200.8

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHH---HhcCCCCeeEEEeEEEccCCCcc
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQ---NLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~---~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      |++.+.||+|+||+||+|.+..+++.||||+++..      ..+.+.+|+.++.   .+ +||||+++++++..  ....
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~--~~~~   77 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQT--EDHV   77 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEc--CCEE
Confidence            67899999999999999999999999999999643      2245667776654   44 79999999999965  4678


Q ss_pred             EEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CC
Q 014762          198 SLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~  274 (419)
                      ++||||+++++|...+  ..+++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+++.... ..
T Consensus        78 ~lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05589          78 CFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGD  156 (324)
T ss_pred             EEEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CcEEeCcccCCccCCCCCC
Confidence            9999999999998776  358999999999999999999999999999999999999988 8999999999875332 22


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||. +.+..+....+...  .           .   
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~-~~~~~~~~~~i~~~--~-----------~---  218 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFP-GDDEEEVFDSIVND--E-----------V---  218 (324)
T ss_pred             cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC--C-----------C---
Confidence            2334578999999999877 778999999999999999999999984 22222222222110  0           0   


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                           ..+..+++++.+||.+||+.||++||     ++.++++||||+++
T Consensus       219 ---------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         219 ---------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence                                 00123688999999999999999999     79999999999875

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.6e-44  Score=342.27  Aligned_cols=278  Identities=19%  Similarity=0.307  Sum_probs=209.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++|++.+.||+|+||.||++++..++..+|+|.+...    ..+.+.+|+.+++.+ +||||+++++++...  ...+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~   79 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEIS   79 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--CEEE
Confidence            367899999999999999999999999999999998643    235688999999999 999999999999654  6788


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +||||+++++|..++   ..+++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.+||+|||++...... 
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-  157 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-  157 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCccccccccc-
Confidence            999999999998887   3588999999999999999999986 69999999999999988 78999999998765432 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC----
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH----  350 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~----  350 (419)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....  ...+   ...++.+..........    
T Consensus       158 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~--~~~~---~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPD--AKEL---EAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCC--HHHH---HHHhcccccccccCCccccCc
Confidence            2234568899999999887 679999999999999999999999984322  2222   22222211100000000    


Q ss_pred             -------------CCCC--hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          351 -------------LELD--PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       351 -------------~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                   ....  .............    .........+++++++||.+||++||++|||+.|+|+||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNE----PPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhC----CCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                         0000  0000000000000    00000112368899999999999999999999999999999854

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.6e-44  Score=346.82  Aligned_cols=252  Identities=27%  Similarity=0.437  Sum_probs=205.9

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||+||+|.+..+|+.||+|+++..      ..+.+.+|+.+++.+ +|+||+++++++.+.  ...+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~--~~~~   77 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDK--DNLY   77 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecC--CeEE
Confidence            4799999999999999999999999999999998743      234577899999998 999999999999654  6789


Q ss_pred             EEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +||||+++++|..++    ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANK  156 (330)
T ss_pred             EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECCCCC
Confidence            999999999998876    458999999999999999999999999999999999999988 889999999998765433


Q ss_pred             cc--eeecccccccccccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          275 EY--NVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       275 ~~--~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ..  ....+|..|+|||++..     ...++.++|||||||++|+|++|+.||... +..+.+..+....          
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~----------  225 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQ----------  225 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCC----------
Confidence            22  23468899999999863     256789999999999999999999998432 2222222222110          


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                             ..........+++++.+|+++||+ ||++|||++++++||||+.+
T Consensus       226 -----------------------~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         226 -----------------------RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             -----------------------CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence                                   000001112378899999999998 99999999999999999865

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.2e-44  Score=344.27  Aligned_cols=251  Identities=24%  Similarity=0.423  Sum_probs=202.0

Q ss_pred             CeEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      +|++.+.||+|+||+||++.+.   .+++.||+|++...       ..+.+.+|+.++..+.+||||+++++++...  .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--~   78 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE--A   78 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC--C
Confidence            5889999999999999998764   47899999998632       1245778999999997799999999999554  6


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ..++||||++++++..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~  157 (332)
T cd05614          79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-CCEEEeeCcCCccccc
Confidence            788999999999998776   458999999999999999999999999999999999999988 7899999999976433


Q ss_pred             CCc--ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHcCCchHHHHHhh
Q 014762          273 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       273 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ...  .....||..|+|||++.+...++.++|||||||++|+|++|..||.....  ....+.....  ..         
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~---------  226 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KC---------  226 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cC---------
Confidence            222  23357899999999987745688999999999999999999999843211  1111111000  00         


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                               .......+++.+.+|+.+||+.||++||     +++++++||||+.+
T Consensus       227 -------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         227 -------------------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence                                     0001123688999999999999999999     88999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.2e-44  Score=350.65  Aligned_cols=255  Identities=25%  Similarity=0.376  Sum_probs=205.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|+++..      ....+.+|+.+++.+ +||||+++++.+.+  ...
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~~  117 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQD--DKY  117 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCE
Confidence            467899999999999999999999999999999998632      234577899999998 99999999999965  477


Q ss_pred             cEEEEEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      .++||||+++++|..++.  .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccceecccCC
Confidence            899999999999988874  47888999999999999999999999999999999999988 889999999998764332


Q ss_pred             c--ceeecccccccccccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          275 E--YNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       275 ~--~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      .  .....||..|+|||++.+.   ..++.++|+||+||++|+|++|+.||.. .+.......+......          
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~----------  265 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNS----------  265 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcc----------
Confidence            2  2345789999999998652   2378999999999999999999999943 2323333332221000          


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~  415 (419)
                       .                .+      .....++..+++++.+||+.++.+  |+|+.|+++||||+..
T Consensus       266 -~----------------~~------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         266 -L----------------NF------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             -c----------------CC------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence             0                00      011136889999999999865544  8899999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=346.54  Aligned_cols=251  Identities=25%  Similarity=0.391  Sum_probs=208.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ...|+.++.||+|+||.||+|.+..+++.||+|++.-    ...+.+.+|+.+|.++ +++||.++|+.+...  ..+++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g--~~Lwi   88 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKG--TKLWI   88 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeec--ccHHH
Confidence            4457778899999999999999999999999999963    2346788999999998 899999999988654  66789


Q ss_pred             EEEecCCCChhhhcC--C-CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-
Q 014762          200 IFEYVNSTDFKVLYP--T-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~~--~-l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      +||||.||++...++  . +.+..+..++++++.||.|||.++.+|||||+.|||+..+ +.+||+|||.+........ 
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeeechhhc
Confidence            999999999988874  2 4888888999999999999999999999999999999999 8999999999876654332 


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ....+||++|||||++.. ..|+.++||||||++.+||.+|..|+. ...+...+..|-+                    
T Consensus       168 r~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s-~~hPmrvlflIpk--------------------  225 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHS-KLHPMRVLFLIPK--------------------  225 (467)
T ss_pred             cccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCc-ccCcceEEEeccC--------------------
Confidence            256799999999999985 789999999999999999999999982 2222111111100                    


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                .      ........+++.+++|+..||+.||+.||||.++|+|+|+++.+
T Consensus       226 ----------~------~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  226 ----------S------APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             ----------C------CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence                      0      00111124789999999999999999999999999999998754

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.3e-44  Score=343.69  Aligned_cols=248  Identities=24%  Similarity=0.401  Sum_probs=198.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||+||+|.+..+++.||+|+++..      ..+.+.+|..++..+.+||||++++++|.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~--~~~~lv~e~~   78 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE--SRLFFVIEFV   78 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC--CEEEEEEeCC
Confidence            3699999999999999999999999999742      2245778999999887899999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec-cCCCcceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~-~~~~~~~~~~  280 (419)
                      ++++|..++   ..+++..++.++.|++.||+|||++|++||||||+|||++.+ +.+||+|||+++.. ..........
T Consensus        79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (329)
T cd05588          79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccccCCCcccccc
Confidence            999997765   468999999999999999999999999999999999999988 88999999998753 2223334457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC---HH-HHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN---HD-QLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~---~~-~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ||..|+|||++.+ ..++.++|+|||||++|+|++|+.||......   .. ....+.+                     
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~---------------------  215 (329)
T cd05588         158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ---------------------  215 (329)
T ss_pred             CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHH---------------------
Confidence            8999999999987 78999999999999999999999999421100   00 0000000                     


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCCCcccc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMVISSISPI  415 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------a~elL~hp~f~~~  415 (419)
                        .......          ..+..++.++.++|++||+.||++|+|      ++++++||||+.+
T Consensus       216 --~~~~~~~----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         216 --VILEKQI----------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             --HHHcCCC----------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence              0000000          011236889999999999999999997      7899999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=334.10  Aligned_cols=292  Identities=24%  Similarity=0.419  Sum_probs=224.4

Q ss_pred             eeccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCC-C----CeeEEEeEEE
Q 014762          118 TVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGG-P----NVVKLLDIVR  190 (419)
Q Consensus       118 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h-~----niv~l~~~~~  190 (419)
                      .+.....++|.+..++|+|.||.|-++.|..++..||+|+++...  ++...-|+++|+++..+ |    -++++.++| 
T Consensus        82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-  160 (415)
T KOG0671|consen   82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-  160 (415)
T ss_pred             EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-
Confidence            334444899999999999999999999999999999999998654  35667799999999322 2    478888889 


Q ss_pred             ccCCCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC-----------
Q 014762          191 DQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-----------  255 (419)
Q Consensus       191 ~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~-----------  255 (419)
                       +..++.|+|+|.++....+.+-    .+++...++.+++|++++++|||+.+++|.||||+|||+.+.           
T Consensus       161 -dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  161 -DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             -hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence             5558899999998765554433    248999999999999999999999999999999999998421           


Q ss_pred             --------CCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 014762          256 --------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH  327 (419)
Q Consensus       256 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~  327 (419)
                              ...++|+|||.|+......  ...+.|..|+|||++++ -+|+.++||||+||+|+|+.+|...| +++++.
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LF-qtHen~  315 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLF-QTHENL  315 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceec-ccCCcH
Confidence                    1358999999998765333  55789999999999999 78999999999999999999999876 788899


Q ss_pred             HHHHHHHHHcCCchHHHHHhh--------cCCCCChhhHHh-hccCC--CCCccccccccccCCCCHHHHHHHHHhcCCC
Q 014762          328 DQLVKIAKVLGTDELNAYLNK--------YHLELDPQLDAL-VGRHS--RKPWSKFINADNQHLVSPEAIDFLDKLLRYD  396 (419)
Q Consensus       328 ~~~~~i~~~lg~~~~~~~~~~--------~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  396 (419)
                      |+++-|..++|+.+.......        ..++|++....- .+...  -++....+..  ....-.++.|||++||.+|
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~--~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ--DDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc--CcHHHhHHHHHHHHHHccC
Confidence            999999999997665433322        223333221110 00000  0111111111  1112345889999999999


Q ss_pred             CCCCCCHHHHhcCCCcccccc
Q 014762          397 HQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       397 P~~Rpta~elL~hp~f~~~~~  417 (419)
                      |.+|+|+.|+|+||||+..++
T Consensus       394 P~~RiTl~EAL~HpFF~~~~~  414 (415)
T KOG0671|consen  394 PARRITLREALSHPFFARLTP  414 (415)
T ss_pred             ccccccHHHHhcCHHhhcCCC
Confidence            999999999999999997654

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.4e-44  Score=341.64  Aligned_cols=248  Identities=24%  Similarity=0.365  Sum_probs=203.2

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      +|++.+.||+|+||+||+|.+..+++.||+|+++...      ...+..|..++..+..|++|+++++++.+.  ...++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM--DRLYF   78 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC--CEEEE
Confidence            5888999999999999999999999999999986421      234567888888876789999999999654  67899


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCc
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKE  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~  275 (419)
                      ||||+++++|...+   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ...
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~~  157 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVT  157 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-CcEEEccCCCceecCCCCCc
Confidence            99999999998776   458999999999999999999999999999999999999988 8899999999875432 222


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+....             .    
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~-~~~~~~~~~~i~~~~-------------~----  218 (323)
T cd05616         158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEHN-------------V----  218 (323)
T ss_pred             cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCC-CCCHHHHHHHHHhCC-------------C----
Confidence            334578999999999987 789999999999999999999999984 333333333222100             0    


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                          ..+..+++++.+++.+||+.||++|++     ..++++||||+.+
T Consensus       219 --------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         219 --------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             --------------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence                                001236889999999999999999998     4899999999865

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.5e-44  Score=347.81  Aligned_cols=251  Identities=26%  Similarity=0.428  Sum_probs=202.8

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++..      ....+.+|+.++..+ +||||+++++.+.+  ....+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--~~~~~   77 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQD--KRNLY   77 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence            4789999999999999999999999999999998632      235677899999999 99999999999965  46789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      +||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++...... 
T Consensus        78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCcccccccc
Confidence            999999999998876   358999999999999999999999999999999999999988 899999999986442110 


Q ss_pred             -----------------------------------cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 014762          275 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (419)
Q Consensus       275 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~p  319 (419)
                                                         .....+||..|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence                                               0113468999999999987 7899999999999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCC
Q 014762          320 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD  399 (419)
Q Consensus       320 f~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  399 (419)
                      |.. .+..+....+.....                                 .........+++++++||.+|+ .||++
T Consensus       236 f~~-~~~~~~~~~i~~~~~---------------------------------~~~~p~~~~~s~~~~~li~~l~-~~p~~  280 (360)
T cd05627         236 FCS-ETPQETYRKVMNWKE---------------------------------TLVFPPEVPISEKAKDLILRFC-TDSEN  280 (360)
T ss_pred             CCC-CCHHHHHHHHHcCCC---------------------------------ceecCCCCCCCHHHHHHHHHhc-cChhh
Confidence            842 232222222221000                                 0000011136889999999987 49999


Q ss_pred             CC---CHHHHhcCCCcccc
Q 014762          400 RL---TAREAMVISSISPI  415 (419)
Q Consensus       400 Rp---ta~elL~hp~f~~~  415 (419)
                      |+   +++++++||||+++
T Consensus       281 R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         281 RIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             cCCCCCHHHHhcCCCCCCC
Confidence            99   48999999999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.7e-44  Score=343.05  Aligned_cols=243  Identities=23%  Similarity=0.345  Sum_probs=199.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||+||+|.+..+++.||+|+++..      ..+.+..|..++..+.+||||+++++++...  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~   78 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV   78 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence            3699999999999999999999999998642      2245677888988776899999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Ccceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~~~~~~  280 (419)
                      ++++|...+   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++...... .......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~  157 (321)
T cd05591          79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFC  157 (321)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeecccceecccCCccccccc
Confidence            999997765   458899999999999999999999999999999999999988 88999999998754322 2233456


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      |+..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+...  .                     
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~-~~~~~~~~~~i~~~--~---------------------  212 (321)
T cd05591         158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFE-ADNEDDLFESILHD--D---------------------  212 (321)
T ss_pred             cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCC-CCCHHHHHHHHHcC--C---------------------
Confidence            8999999999876 789999999999999999999999984 33333333222210  0                     


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-------CHHHHhcCCCcccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-------TAREAMVISSISPI  415 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-------ta~elL~hp~f~~~  415 (419)
                                    ...+..++.++.+++.+||+.||++|+       ++.++++||||+.+
T Consensus       213 --------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         213 --------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence                          000112688999999999999999999       99999999999865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.4e-44  Score=347.79  Aligned_cols=253  Identities=22%  Similarity=0.360  Sum_probs=200.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .++|+.+++||+|+||+||+|.+..+++.||+|++....    .+.+.+|+.+++.+ +|+||+++++++..  ....++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l  149 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDH--NGEIQV  149 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEecc--CCeEEE
Confidence            466888999999999999999999999999999986432    35688999999999 89999999999954  467889


Q ss_pred             EEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-ccee
Q 014762          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV  278 (419)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~~  278 (419)
                      ||||+.+++|... ....+..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ....
T Consensus       150 v~e~~~~~~L~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        150 LLEFMDGGSLEGT-HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             EEecCCCCccccc-ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEcccccceecccccccccc
Confidence            9999999998654 245677888999999999999999999999999999999988 889999999998764332 2234


Q ss_pred             ecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          279 RVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ..|+..|+|||++..    ....+.++|||||||++|||++|+.||...... +....+......               
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~---------------  291 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICMS---------------  291 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhcc---------------
Confidence            578999999998743    123457899999999999999999999522111 111111000000               


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                        ........++.++++||.+||+.||++|||+.|+|+||||..-
T Consensus       292 ------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~  334 (353)
T PLN00034        292 ------------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA  334 (353)
T ss_pred             ------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence                              0000112368899999999999999999999999999999854

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.5e-44  Score=340.09  Aligned_cols=243  Identities=23%  Similarity=0.386  Sum_probs=197.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||.||+|.+..+|+.||+|+++..      .......|..++....+||||+++++++.+.  .+.++||||+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~lv~E~~   78 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK--EHLFFVMEFL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC--CEEEEEECCC
Confidence            3699999999999999999999999998642      2345667888887666899999999999654  6889999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCcceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~~~~~~  280 (419)
                      .+++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++.... ........
T Consensus        79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05620          79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCceeccC
Confidence            999998776   358899999999999999999999999999999999999988 7899999999875322 22234457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      |+..|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+..  +.+                    
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~--~~~--------------------  213 (316)
T cd05620         158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRV--DTP--------------------  213 (316)
T ss_pred             CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHh--CCC--------------------
Confidence            8999999999987 7899999999999999999999999842 222222221110  000                    


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH-HHHhcCCCcccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-REAMVISSISPI  415 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-~elL~hp~f~~~  415 (419)
                                     ..+..++.++++|+++||+.||++|+|+ +++++||||+.+
T Consensus       214 ---------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         214 ---------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             ---------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence                           0011268899999999999999999997 588899999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-45  Score=340.04  Aligned_cols=263  Identities=26%  Similarity=0.395  Sum_probs=220.3

Q ss_pred             CCCCCceeccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch------HHHHHHHHHHHHhcCCCCeeEE
Q 014762          112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCGGPNVVKL  185 (419)
Q Consensus       112 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~h~niv~l  185 (419)
                      ..|+.+..+....+.|+.-+.||+||||.||-++-..||+.+|+|.+.+...      ....+|-.||.++ +.+.||.+
T Consensus       172 lQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVsl  250 (591)
T KOG0986|consen  172 LQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSL  250 (591)
T ss_pred             HHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEE
Confidence            3455555566678889999999999999999999999999999998864332      3456899999999 89999999


Q ss_pred             EeEEEccCCCccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEE
Q 014762          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (419)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~k  260 (419)
                      --.|+.  ...+|+|+..|+||+|..++     +.|++..++.++.+|+.||++||+.+||+||+||+|||+|+. |+++
T Consensus       251 aYAfeT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~-GhvR  327 (591)
T KOG0986|consen  251 AYAFET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH-GHVR  327 (591)
T ss_pred             eeeecC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC-CCeE
Confidence            888844  47899999999999998877     369999999999999999999999999999999999999988 9999


Q ss_pred             EEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHcC
Q 014762          261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVLG  338 (419)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--~~~~~~~i~~~lg  338 (419)
                      |+|+|+|..+..+.....++||.+|||||++.+ +.|+.+.|.|||||++|||+.|+.||-.-.+  ..+.+.+++.   
T Consensus       328 ISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~---  403 (591)
T KOG0986|consen  328 ISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL---  403 (591)
T ss_pred             eeccceEEecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh---
Confidence            999999999988888888899999999999988 6699999999999999999999999932111  1111111110   


Q ss_pred             CchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcc
Q 014762          339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSIS  413 (419)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~  413 (419)
                      .                                 ...+-++.+|++++++.+.+|+.||++|.     ++.++-+||||+
T Consensus       404 ~---------------------------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk  450 (591)
T KOG0986|consen  404 E---------------------------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK  450 (591)
T ss_pred             c---------------------------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence            0                                 01111234899999999999999999998     678999999999


Q ss_pred             cc
Q 014762          414 PI  415 (419)
Q Consensus       414 ~~  415 (419)
                      .+
T Consensus       451 ~l  452 (591)
T KOG0986|consen  451 DL  452 (591)
T ss_pred             cC
Confidence            76

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-43  Score=333.07  Aligned_cols=244  Identities=23%  Similarity=0.369  Sum_probs=196.9

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ||+|+||+||++.+..+++.+|+|.+....      .+.+..|+.+++.+ +|+||+++.+++...  ...++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTK--TDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCC--CeEEEEEeCCCC
Confidence            799999999999999999999999986422      24567899999999 999999999998554  678999999999


Q ss_pred             CChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-cee
Q 014762          207 TDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNV  278 (419)
Q Consensus       207 ~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~~  278 (419)
                      ++|...+       ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.++|+|||++........ ...
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccccc
Confidence            9997654       348899999999999999999999999999999999999987 7899999999976543322 233


Q ss_pred             ecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhH
Q 014762          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~  358 (419)
                      ..++..|+|||++.+ ..++.++|+|||||++|+|++|+.||........ ...+....-..                  
T Consensus       157 ~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~------------------  216 (280)
T cd05608         157 YAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILND------------------  216 (280)
T ss_pred             cCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhccc------------------
Confidence            468889999999987 7889999999999999999999999843222111 11111100000                  


Q ss_pred             HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                               .      ......+++++.+++.+||+.||++||     |++++++||||+.+
T Consensus       217 ---------~------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         217 ---------S------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             ---------C------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence                     0      001123788999999999999999999     89999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.5e-44  Score=339.71  Aligned_cols=243  Identities=25%  Similarity=0.411  Sum_probs=197.0

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||+||+|.+..+++.||+|+++..      ..+....|..++..+.+||||+++++++..  ....++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~   78 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence            3699999999999999999999999998642      223456677777766589999999999965  46789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Ccceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~~~~~~  280 (419)
                      ++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .......
T Consensus        79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~  157 (316)
T cd05592          79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCcccccc
Confidence            999998776   468999999999999999999999999999999999999988 88999999999764322 2234457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+...  .                     
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~--~---------------------  212 (316)
T cd05592         158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFH-GEDEDELFDSILND--R---------------------  212 (316)
T ss_pred             CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcC--C---------------------
Confidence            8999999999877 678999999999999999999999984 33322222222110  0                     


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH-HHHhcCCCcccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-REAMVISSISPI  415 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-~elL~hp~f~~~  415 (419)
                                    ...+..++.++.+|+.+||+.||++||++ .++++||||+.+
T Consensus       213 --------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         213 --------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence                          00012368899999999999999999986 588899999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.7e-44  Score=344.50  Aligned_cols=242  Identities=27%  Similarity=0.439  Sum_probs=198.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||+||++.+..+|+.||+|+++..      ....+.+|+.++..+ +||||+++++.+...  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~--~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTH--DRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcC--CEEEEEEeCC
Confidence            3599999999999999999999999998642      224567899999998 999999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCcceee
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~~~~~  279 (419)
                      ++++|..++   ..+++..+..++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~  156 (325)
T cd05594          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF  156 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccccc
Confidence            999997765   358999999999999999999997 799999999999999988 8899999999875432 2223345


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      .||..|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+..  +.           .        
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~-~~~~~~~~i~~--~~-----------~--------  213 (325)
T cd05594         157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM--EE-----------I--------  213 (325)
T ss_pred             cCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCC-CHHHHHHHHhc--CC-----------C--------
Confidence            78999999999877 68899999999999999999999998432 22222111110  00           0        


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                      ..+..+++++.+|+.+||+.||++|+     ++.++++||||+++
T Consensus       214 ----------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         214 ----------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence                            00123688999999999999999997     99999999999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.4e-44  Score=341.62  Aligned_cols=248  Identities=24%  Similarity=0.404  Sum_probs=197.9

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||+||+|.+..+++.+|+|+++..      ..+.+.+|+.++.++.+||||+++++++...  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~E~~   78 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRLFFVIEYV   78 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC--CEEEEEEeCC
Confidence            3699999999999999999999999998642      2245678898888876899999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCcceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~~~~~~  280 (419)
                      ++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~~~~  157 (329)
T cd05618          79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFC  157 (329)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCcccccc
Confidence            999997765   468999999999999999999999999999999999999988 8899999999875322 22334457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC----HHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN----HDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~----~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||......    ......+.+.                    
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------------  216 (329)
T cd05618         158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------------------  216 (329)
T ss_pred             CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------------------
Confidence            8999999999987 78899999999999999999999998421100    0000000000                    


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCCCcccc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMVISSISPI  415 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------a~elL~hp~f~~~  415 (419)
                         .....          ...+..++.++.+||.+||+.||++|+|      +.++++||||+++
T Consensus       217 ---i~~~~----------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         217 ---ILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             ---HhcCC----------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence               00000          0011236889999999999999999998      4799999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-43  Score=351.47  Aligned_cols=275  Identities=21%  Similarity=0.312  Sum_probs=206.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|...   ...+.+|+.+++++ +|+||+++++++...  ...++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L-~HpnIv~l~~~~~~~--~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRL-SHPAVLALLDVRVVG--GLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHC-CCCCCCcEEEEEEEC--CEEEEEEEc
Confidence            457999999999999999999999999999999643   34567899999999 999999999998654  667899999


Q ss_pred             cCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc---c
Q 014762          204 VNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---Y  276 (419)
Q Consensus       204 ~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~---~  276 (419)
                      +.+ ++..++    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.......   .
T Consensus       242 ~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        242 YRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             cCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-CCEEEcccCCceecccccccccc
Confidence            975 444443    358999999999999999999999999999999999999987 7899999999986543222   1


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC------CHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD------NHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~------~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ....||..|+|||++.+ ..++.++|||||||++|||++|..|++....      ...++..+++..+..... +.....
T Consensus       320 ~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~-~~~~~~  397 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE-FPQHAG  397 (461)
T ss_pred             cccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc-CCCCcc
Confidence            23468999999999987 6799999999999999999999988765432      234455555543321100 000000


Q ss_pred             CCCChhhHHhh-----ccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          351 LELDPQLDALV-----GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       351 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      ..+...+....     .......|..+      ..++.++.+||.+||++||++|||+.|+|+||||++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRY------YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhh------ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            00000000000     00111122221      135778999999999999999999999999999975

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=9.5e-44  Score=339.71  Aligned_cols=243  Identities=23%  Similarity=0.390  Sum_probs=199.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||+||+|.+..+++.||+|+++..      ....+.+|..++..+.+||||+++++++...  ...++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~--~~~~lv~e~~   78 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK--DRLFFVMEYV   78 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CEEEEEEcCC
Confidence            3699999999999999999999999998742      2345678889998886899999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCcceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~~~~~~  280 (419)
                      ++++|...+   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (318)
T cd05570          79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFC  157 (318)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCccccee
Confidence            999997765   368999999999999999999999999999999999999988 7899999999875322 22233456


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      ++..|+|||++.+ ..++.++|+|||||++|+|++|+.||. +.+..+....+...             ..         
T Consensus       158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~-~~~~~~~~~~i~~~-------------~~---------  213 (318)
T cd05570         158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFE-GDDEDELFQSILED-------------EV---------  213 (318)
T ss_pred             cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCC-CCCHHHHHHHHHcC-------------CC---------
Confidence            8899999999987 789999999999999999999999984 22222222211110             00         


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCCCcccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMVISSISPI  415 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~elL~hp~f~~~  415 (419)
                                     ..+..+++++.+||++||+.||++|||+     .++++||||+.+
T Consensus       214 ---------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         214 ---------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             ---------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence                           0012368899999999999999999999     999999999875

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.2e-43  Score=332.03  Aligned_cols=249  Identities=25%  Similarity=0.409  Sum_probs=204.0

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .|+..+.||+|+||+||++.+..+++.+|+|.+....      ...+.+|+.+++.+ +|+|++.+++.+.+.  ...++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~l   77 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETK--DALCL   77 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecC--CEEEE
Confidence            3778899999999999999999999999999986422      23467899999999 999999999999654  67899


Q ss_pred             EEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ||||+++++|..++     ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++.......
T Consensus        78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCc
Confidence            99999999998765     248889999999999999999999999999999999999987 789999999997655444


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH--HHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~--~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.......  +....+.....              
T Consensus       157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------------  221 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ--------------  221 (285)
T ss_pred             cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------
Confidence            4344578899999999877 679999999999999999999999995332211  11111110000              


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                            ......+++++.+|+++||+.||++|||     ++|+++||||+.+
T Consensus       222 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         222 ----------------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             ----------------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence                                  0001236888999999999999999999     9999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.4e-43  Score=336.51  Aligned_cols=243  Identities=23%  Similarity=0.379  Sum_probs=197.8

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||+||+|.+..+++.||+|+++..      .......|..++..+.+||||+++++++.+.  ...++||||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~   78 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL   78 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence            3699999999999999999999999998643      2344667888887655899999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCcceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~~~~~~  280 (419)
                      ++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... ........
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (316)
T cd05619          79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFC  157 (316)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCceeeec
Confidence            999998876   358899999999999999999999999999999999999988 7899999999875322 22334457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+.. . .+                    
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~-~-~~--------------------  213 (316)
T cd05619         158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRM-D-NP--------------------  213 (316)
T ss_pred             CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh-C-CC--------------------
Confidence            8999999999877 6799999999999999999999999843 222222221110 0 00                    


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCCCcccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMVISSISPI  415 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~-elL~hp~f~~~  415 (419)
                                     ..+..++.++.+|+.+||+.||++|+++. ++++||||+.+
T Consensus       214 ---------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         214 ---------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             ---------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence                           00112678899999999999999999996 89999999876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.3e-43  Score=327.61  Aligned_cols=273  Identities=30%  Similarity=0.567  Sum_probs=209.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.+.||+|++|+||+|.+..++..||+|.++..     ..+.+.+|+.+++.+ +|||++++++++.++  ...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v   77 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQE--SRLYLI   77 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeC--CeEEEE
Confidence            588999999999999999999999999999998632     235678999999999 899999999999654  678999


Q ss_pred             EEecCCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          201 FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       201 ~e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      |||+++ ++..++      ..+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++.......
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPV  155 (285)
T ss_pred             EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeecCCCc
Confidence            999985 555544      347899999999999999999999999999999999999988 889999999987654322


Q ss_pred             -cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       275 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       ......++..|+|||++.+...++.++|+|||||++|+|++|+.||. +.+..+....+.+.++......+....   .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  231 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH-GDSEIDQLFRIFRILGTPTEDVWPGVT---S  231 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhcch---h
Confidence             22334667889999998765668899999999999999999998874 444455555555555544333221100   0


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      .+.+.....     .+...........+++++.+||++||+.||++|||+.++++||||
T Consensus       232 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         232 LPDYKNTFP-----KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hHHHHhhcc-----ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            011111000     111111111122378999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.1e-43  Score=329.62  Aligned_cols=245  Identities=24%  Similarity=0.334  Sum_probs=196.7

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ||+|+||+||++.+..+|+.+|+|.+....      ...+..|+.+++++ +||||+++++.+..  ....++||||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFES--KTHLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence            799999999999999999999999986321      23456799999999 99999999999965  4678999999999


Q ss_pred             CChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeecc
Q 014762          207 TDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (419)
Q Consensus       207 ~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (419)
                      ++|..++     ..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.............+
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAG  156 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCC
Confidence            9997765     247888889999999999999999999999999999999987 7899999999987655444445678


Q ss_pred             cccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhh
Q 014762          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV  361 (419)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~  361 (419)
                      +..|+|||++.+ ..++.++|+||+||++|+|++|+.||........ ...+....-.         .            
T Consensus       157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~---------~------------  213 (277)
T cd05607         157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLE---------D------------  213 (277)
T ss_pred             CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhc---------c------------
Confidence            899999999887 6699999999999999999999999843222111 1111110000         0            


Q ss_pred             ccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCCcccc
Q 014762          362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMVISSISPI  415 (419)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp~f~~~  415 (419)
                            .    .. .....+++++++|+++||+.||++|||+    ++++.||||+.+
T Consensus       214 ------~----~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         214 ------E----VK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             ------c----cc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence                  0    00 0011368899999999999999999999    678899999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-43  Score=339.07  Aligned_cols=242  Identities=28%  Similarity=0.456  Sum_probs=196.8

Q ss_pred             eeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          131 RKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +.||+|+||.||++.+.   .+++.||+|+++..       ....+.+|+.+++.+ +||||+++++.|..+  ...++|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~--~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTG--GKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecC--CeEEEE
Confidence            57999999999999864   47889999998642       124567899999999 999999999999654  678999


Q ss_pred             EEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cc
Q 014762          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (419)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~  276 (419)
                      |||+++++|...+   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... ..
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  157 (323)
T cd05584          79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT  157 (323)
T ss_pred             EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcc
Confidence            9999999998776   347888999999999999999999999999999999999988 889999999987543222 23


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.. .+..+....+..  +.           .     
T Consensus       158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~--~~-----------~-----  217 (323)
T cd05584         158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILK--GK-----------L-----  217 (323)
T ss_pred             cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHc--CC-----------C-----
Confidence            34578999999999877 6789999999999999999999999842 222222222211  00           0     


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                         ..+..+++++.+||.+||+.||++||     +++++++||||+..
T Consensus       218 -------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         218 -------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence                               00123688999999999999999999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.7e-43  Score=338.70  Aligned_cols=281  Identities=21%  Similarity=0.313  Sum_probs=207.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++|++.++||+|+||+||++.+..++..+|+|.+...    ..+.+.+|+.+++.+ +||||++++++|.+.  ...+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~   79 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEIS   79 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEEC--CEEE
Confidence            357899999999999999999999999999999988643    235688999999999 899999999999764  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +||||+.+++|..++   ..+++..+..++.|++.||.|||+. +++|+||||+|||++.+ +.+||+|||++...... 
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh-
Confidence            999999999998876   3578889999999999999999985 79999999999999987 78999999998755322 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH--cCCchHHHHHhhc---
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV--LGTDELNAYLNKY---  349 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~--lg~~~~~~~~~~~---  349 (419)
                      ......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.....  ..+..+...  .+...........   
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcCcccCCccccccCcccCCc
Confidence            2233468889999999877 6789999999999999999999999843222  222221110  0000000000000   


Q ss_pred             -------CCCCChh--hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          350 -------HLELDPQ--LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       350 -------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                             .....+.  ............    ........++.++++|+.+||++||++|||+.|+++||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEP----PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCC----CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                   0000000  000000000000    0000111367889999999999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=336.51  Aligned_cols=253  Identities=25%  Similarity=0.438  Sum_probs=222.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..=|.+.+.||+|.|+.|-+|++..+|+.||||++.+..     ...+.+|+..|+.+ +|||||++|++...+  ..+|
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQ--TKly   93 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQ--TKLY   93 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhccc--ceEE
Confidence            345788889999999999999999999999999997644     35678999999999 999999999999554  6688


Q ss_pred             EEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ||+|.-.+|++.+++    ..+.+...++++.||+.|+.|+|+..+|||||||+|+.+-+..|-|||.|||++..+.++.
T Consensus        94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            999999999999987    5699999999999999999999999999999999999998888999999999999999999


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ..+..+|+..|.|||++++...-.+++|||||||+||.|++|+.|| ...++.+.+-.|+.+.-.               
T Consensus       174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF-qeANDSETLTmImDCKYt---------------  237 (864)
T KOG4717|consen  174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF-QEANDSETLTMIMDCKYT---------------  237 (864)
T ss_pred             hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc-ccccchhhhhhhhccccc---------------
Confidence            9999999999999999999544457899999999999999999998 455666666666554211               


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                            -+..++.++++||.+||..||++|.|.+++..|+|++++.+
T Consensus       238 ----------------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  238 ----------------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             ----------------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence                                  12347899999999999999999999999999999998754

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-43  Score=338.34  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=202.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||+||++.+..+++.||+|++...      ..+.+.+|+.++..+ +|+||+++++++.+.  .+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~   77 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDE--NNLY   77 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecC--CeEE
Confidence            5799999999999999999999999999999998632      234577899999998 999999999999654  6789


Q ss_pred             EEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +||||+.+++|..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecCCCC
Confidence            999999999998876    358899999999999999999999999999999999999987 889999999987654333


Q ss_pred             cc--eeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          275 EY--NVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       275 ~~--~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ..  ....||..|+|||++.+    ...++.++|||||||++|+|++|+.||.. .+..+....+......         
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~---------  226 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEH---------  226 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCc---------
Confidence            22  23468999999999863    24578899999999999999999999842 2222222222110000         


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCcccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMVISSISPI  415 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~  415 (419)
                                        ...     ......+++++++|+++||+.++++  |+++.++++||||+.+
T Consensus       227 ------------------~~~-----~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         227 ------------------FQF-----PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             ------------------ccC-----CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence                              000     0001227889999999999765544  7899999999999875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-44  Score=331.91  Aligned_cols=247  Identities=21%  Similarity=0.465  Sum_probs=213.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..+|++.+.||+|.||+|-+|.+...|+.||||.+++..      .-.+.+||+||..| +||||++++++|+  +...+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFE--NkdKI  128 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFE--NKDKI  128 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhc--CCceE
Confidence            568999999999999999999999999999999986432      23578999999999 9999999999994  45778


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      .+||||..+|.|.+++   +.+++.+++.+++||..|+.|+|+++++|||||.+|||+|.+ +.+||+|||++..+....
T Consensus       129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-NNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-CCeeeeccchhhhhcccc
Confidence            9999999999999998   579999999999999999999999999999999999999999 789999999999998888


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ..+..+|++.|.+||++.+...-++.+|-|||||+||.|+.|..|| .|.+......+|..-    .         .   
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF-DG~Dhk~lvrQIs~G----a---------Y---  270 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF-DGRDHKRLVRQISRG----A---------Y---  270 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc-CCchHHHHHHHhhcc----c---------c---
Confidence            8889999999999999988444468999999999999999999998 444444333333220    0         0   


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                                            ....-+.++.-||+.||..||++|.|++++-.|=|.+
T Consensus       271 ----------------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  271 ----------------------REPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             ----------------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                                  0011366789999999999999999999999998876

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-45  Score=322.56  Aligned_cols=259  Identities=25%  Similarity=0.403  Sum_probs=210.1

Q ss_pred             CCCeEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEcc--CCCccEEE
Q 014762          124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~lv  200 (419)
                      +++|++. ++||-|-.|.|-.|.++.||+.+|+|++.  +..+..+|++.--...+|||||+++++|++.  +.+.+.+|
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~--Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV  137 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL--DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV  137 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh--cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence            5666654 45899999999999999999999999986  4456678888766667999999999999753  34567889


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCC
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~  273 (419)
                      ||.|+||.|...++     .+++.++..|+.||+.|+.|||+.+|.||||||+|+|....  +..+||+|||.|+.-...
T Consensus       138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~  217 (400)
T KOG0604|consen  138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP  217 (400)
T ss_pred             eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence            99999999988773     49999999999999999999999999999999999999654  246899999999987666


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      ......+.|++|.|||++-. ++|+..+|+||+||++|-|++|..||++..... .-         +.+.........  
T Consensus       218 ~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-is---------pgMk~rI~~gqy--  284 (400)
T KOG0604|consen  218 GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-IS---------PGMKRRIRTGQY--  284 (400)
T ss_pred             ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCcc-CC---------hhHHhHhhccCc--
Confidence            66677899999999999754 889999999999999999999999997643310 00         111111111111  


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                        -+..+++..+|++.+|+|+++|+.+|++|.|+.++++|||+++.
T Consensus       285 ------------------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  285 ------------------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             ------------------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence                              12233344589999999999999999999999999999999865

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-42  Score=337.30  Aligned_cols=286  Identities=24%  Similarity=0.437  Sum_probs=217.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|.+...     ..+.+.+|+.+++.+ +||||++++++|....    
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccc
Confidence            368899999999999999999999999999999998532     234677899999999 9999999999986432    


Q ss_pred             CCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ....++||||+.+.........+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||+++.....
T Consensus        93 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~  171 (353)
T cd07850          93 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTS  171 (353)
T ss_pred             cCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCccceeCCCC
Confidence            23578999999875444444568999999999999999999999999999999999999988 78999999999876544


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|| .+.+..+....+.+.+|.+....... .....
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  248 (353)
T cd07850         172 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLF-PGTDHIDQWNKIIEQLGTPSDEFMSR-LQPTV  248 (353)
T ss_pred             CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHH-hhhhh
Confidence            33344567888999999987 78999999999999999999999998 45566677778888888765432111 00000


Q ss_pred             ChhhHHhhccCCCCCcccccc--------ccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          354 DPQLDALVGRHSRKPWSKFIN--------ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      ...... ........+.....        .......++++++||.+||++||++|||+.|+|+||||+.
T Consensus       249 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         249 RNYVEN-RPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             hHHhhc-CCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence            000000 00000011111100        0112235677899999999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-44  Score=321.22  Aligned_cols=287  Identities=28%  Similarity=0.519  Sum_probs=221.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ...|+.+++||+|.||.||+|....++.    .+|+|.++.+.     ....-||+.+++.+ .|||++.+..+|... .
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~-d  100 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH-D  100 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc-C
Confidence            4568889999999999999997655443    68999987542     24577999999999 999999999998764 5


Q ss_pred             CccEEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC---CCcEEEEec
Q 014762          195 KTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDW  264 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~---~~~~kl~Df  264 (419)
                      ..+++++||.+...+.-..       +.++...++.++.||+.|+.|||++=|+||||||.|||+..+   .|.|||+||
T Consensus       101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            7889999999976654332       358999999999999999999999999999999999999644   578999999


Q ss_pred             ccceeccCCCc----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------CCHHHHHH
Q 014762          265 GLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--------DNHDQLVK  332 (419)
Q Consensus       265 gla~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~--------~~~~~~~~  332 (419)
                      |+++.+...-.    ....+.|.+|+|||.+++...|+.+.|||+.||++.||++-...|.-..        -..+++..
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            99998754322    2345789999999999999999999999999999999999876553211        13678899


Q ss_pred             HHHHcCCchHHHHHhhcCCCCChh-hHHhhccCCCC-CccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014762          333 IAKVLGTDELNAYLNKYHLELDPQ-LDALVGRHSRK-PWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVIS  410 (419)
Q Consensus       333 i~~~lg~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp  410 (419)
                      |.+.+|.+....|..-...+.... +.++....... ....+..  ....-++...+|+.+||++||.+|.||+++|+|+
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~--~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYH--KHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHH--HhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            999999999888765444433321 12211111000 0001110  0111355589999999999999999999999999


Q ss_pred             Cccc
Q 014762          411 SISP  414 (419)
Q Consensus       411 ~f~~  414 (419)
                      ||+.
T Consensus       339 yF~~  342 (438)
T KOG0666|consen  339 YFTE  342 (438)
T ss_pred             cccc
Confidence            9985

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4e-43  Score=336.67  Aligned_cols=245  Identities=26%  Similarity=0.449  Sum_probs=199.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||+|+||+||+|.+..+++.||+|+++..      ..+.+.+|+.++.++.+||||+++++++.+.  ..+++||||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~   78 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV   78 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence            3699999999999999999999999999743      2245778999999887899999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc-CCCcceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~-~~~~~~~~~  280 (419)
                      ++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++... .........
T Consensus        79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  157 (327)
T cd05617          79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFC  157 (327)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCceeccc
Confidence            999997765   469999999999999999999999999999999999999988 789999999987532 223334467


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-----HHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-----HDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-----~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ||..|+|||++.+ ..++.++|||||||++|+|++|+.||....++     .+........                   
T Consensus       158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------  217 (327)
T cd05617         158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE-------------------  217 (327)
T ss_pred             CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh-------------------
Confidence            8999999999977 78999999999999999999999999532211     1111111100                   


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC------HHHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT------AREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt------a~elL~hp~f~~~  415 (419)
                             .    +      ...+..++..+.+++.+||+.||++|++      .+++++||||+.+
T Consensus       218 -------~----~------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         218 -------K----P------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             -------C----C------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence                   0    0      0011236889999999999999999998      4699999999876

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.3e-43  Score=335.27  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=202.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      +|+..+.||+|+||+||+|.+..+|+.||+|+++..      ..+.+..|..++..+.+|++|+++++++.+.  ...++
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l   78 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF   78 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence            477889999999999999999999999999998642      2245677888998885678888999998654  67899


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-c
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~  275 (419)
                      ||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .
T Consensus        79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeccccccccCCCCcc
Confidence            99999999998876   458999999999999999999999999999999999999988 789999999987543222 2


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.+.             ..    
T Consensus       158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~~-------------~~----  218 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDELFQSIMEH-------------NV----  218 (323)
T ss_pred             ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------CC----
Confidence            234568999999999876 779999999999999999999999984 22222222222210             00    


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                          ..+..++.++.+++.+||+.||++|++     ..++++||||+.+
T Consensus       219 --------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         219 --------------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             --------------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence                                001236889999999999999999997     5789999999976

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3e-43  Score=342.97  Aligned_cols=255  Identities=25%  Similarity=0.367  Sum_probs=204.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.+|+|+++..      ....+.+|+.+++.+ +||||+++++.+.+  ...
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~~  117 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DRY  117 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CCE
Confidence            468999999999999999999999999999999998632      224467899999998 99999999999965  477


Q ss_pred             cEEEEEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          197 PSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      .++||||+++++|..++.  .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEEEeCCceeEcCcCC
Confidence            899999999999988773  57888899999999999999999999999999999999988 889999999998764332


Q ss_pred             c--ceeecccccccccccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          275 E--YNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       275 ~--~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      .  .....||+.|+|||++.+.   ..++.++|||||||++|+|++|..||.. .+.......+.......         
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~---------  266 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSL---------  266 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcc---------
Confidence            2  2345789999999998652   2378999999999999999999999842 22222222222110000         


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~  415 (419)
                                              .......++.+++++|.+||+.++.+  |++++++++||||++.
T Consensus       267 ------------------------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         267 ------------------------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             ------------------------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence                                    00011237899999999999844433  7799999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.9e-42  Score=325.19  Aligned_cols=282  Identities=27%  Similarity=0.479  Sum_probs=213.1

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      +..++|++.+.||+|+||.||+|.+..+|..+|+|.+....    ...+.+|+.+++.+ +|+||+++++++...  ...
T Consensus         2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~--~~~   78 (291)
T cd07870           2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTK--ETL   78 (291)
T ss_pred             CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecC--CeE
Confidence            45688999999999999999999999999999999986432    23577899999999 999999999999654  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-  273 (419)
                      ++||||+.++.+....   ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||+++..... 
T Consensus        79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-GELKLADFGLARAKSIPS  157 (291)
T ss_pred             EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-CcEEEeccccccccCCCC
Confidence            8999999755444433   246788899999999999999999999999999999999987 78999999998754322 


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......++..|+|||.+.+...++.++|+|||||++|+|++|..||....+..+++.++...+|.+....+..-.... 
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  236 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP-  236 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc-
Confidence            1223345688899999987645688999999999999999999999976666667777777777765443322111000 


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                       ..................   ......+.++.+++.+||+.||++|||+.|++.||||
T Consensus       237 -~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         237 -NYKPEWFLPCKPQQLRVV---WKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             -cccchhccccCCcchhhh---ccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             000000000000000000   0011136789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-43  Score=345.55  Aligned_cols=281  Identities=21%  Similarity=0.287  Sum_probs=211.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc--CCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV--NTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ..+|+++++||+|+||.||+|...  .++..||+|.+...  ....+|+.+++.+ +||||+++++.+...  ...+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l-~h~~iv~~~~~~~~~--~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTI-SHRAIINLIHAYRWK--STVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhc-CCCCccceeeeEeeC--CEEEEEe
Confidence            567999999999999999999754  35678999988643  3457899999999 999999999999654  6788999


Q ss_pred             EecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc---
Q 014762          202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---  275 (419)
Q Consensus       202 e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~---  275 (419)
                      |++.+. +..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++|+|||+++.......   
T Consensus       166 e~~~~~-l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        166 PKYKCD-LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             hhcCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEccCccccccCccccccc
Confidence            999864 44443   458999999999999999999999999999999999999988 7899999999976543322   


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--CCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~--~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .....||..|+|||++.+ ..++.++|||||||++|||++|+.||+...  ....++..+.+.++..+.... .......
T Consensus       244 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~-~~~~~~~  321 (392)
T PHA03207        244 CYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP-QNGSTNL  321 (392)
T ss_pred             ccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC-CccchhH
Confidence            123468999999999876 779999999999999999999999996543  345677778877776443211 0000000


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      ...+.... ...+.++. .........++.++.+||.+||++||++|||+.|+|+||||+..
T Consensus       322 ~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        322 CKHFKQYA-IVLRPPYT-IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HHHHHhhc-ccccCCcc-ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            00111110 00011110 00001112357789999999999999999999999999999864

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1e-42  Score=327.52  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=205.0

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .|+..+.||.|+||+||+|.+..+++.+|+|.+....      ...+.+|+.+++.+ +|+|++.+++.+...  ...++
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~--~~~~l   77 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETK--DALCL   77 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecC--CEEEE
Confidence            3778899999999999999999999999999986432      23467899999999 999999999998654  67899


Q ss_pred             EEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +|||+.++++..++     ..+++..+..++.|++.||.|||++||+||||||+||+++.+ +.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecCCCC
Confidence            99999999987665     248999999999999999999999999999999999999988 789999999997654444


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||... .+......+.+.......            
T Consensus       157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~-~~~~~~~~~~~~~~~~~~------------  222 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGR-KEKVKREEVDRRVLETEE------------  222 (285)
T ss_pred             cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhhcccc------------
Confidence            4444578899999999977 67999999999999999999999998432 222222222211110000            


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                           .....+++++.+|+.+||+.||++|||     +.++++||||+.+
T Consensus       223 ---------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         223 ---------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             ---------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence                                 001236788999999999999999999     8999999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1e-42  Score=331.16  Aligned_cols=281  Identities=27%  Similarity=0.501  Sum_probs=216.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.++...     ...+.+|+.+++++ +|+|++++++++.+......
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence            3578999999999999999999999999999999986322     23466899999999 99999999999976655678


Q ss_pred             EEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++||||+++ ++..++    ..+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||++......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeecCCc
Confidence            999999986 454443    358999999999999999999999999999999999999987 78999999999876533


Q ss_pred             C-cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      . ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....+..-....
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL-PGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            2 2233345778999999876567899999999999999999999887 4566677788888877766544322111100


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      ......     .....+..+.  ......++++.+||.+||++||++|||+.++++||||+.
T Consensus       241 ~~~~~~-----~~~~~~~~~~--~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         241 LVGKFT-----LPKQPYNNLK--HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             cccccc-----ccCCCCCchH--HhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence            000000     0000000000  001225888999999999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=330.42  Aligned_cols=282  Identities=27%  Similarity=0.506  Sum_probs=212.0

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcC--CCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVN--TNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      +|++.++||+|+||.||+|.+..  +++.||+|.+....      .+.+.+|+.+++.+ +||||+++++++.+......
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence            58899999999999999999988  89999999987522      35678899999999 99999999999987655789


Q ss_pred             EEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC----CCCcEEEEeccc
Q 014762          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----ELRKLRLIDWGL  266 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~----~~~~~kl~Dfgl  266 (419)
                      ++||||++++.+....       ..+++..++.++.|++.||.|||+.+|+||||||+||+++.    + +.+||+|||+
T Consensus        80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~-~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCcc-ceEEECCCcc
Confidence            9999999875443221       25788999999999999999999999999999999999998    6 7899999999


Q ss_pred             ceeccCCCc----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--------HHHHHHHH
Q 014762          267 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--------HDQLVKIA  334 (419)
Q Consensus       267 a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~--------~~~~~~i~  334 (419)
                      +........    .....++..|+|||++.+...++.++|||||||++++|++|+.||......        ...+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            876543222    123466788999999877566899999999999999999999998543222        23556666


Q ss_pred             HHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCcc--cc-ccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014762          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWS--KF-INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISS  411 (419)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~  411 (419)
                      +.++.+....+........   +.............  .. ...+.....+.++.+++.+||++||++|||+.|+++|||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPE---YDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHhCCCchhHHHHHhhccc---chhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            7777655443322111111   11100000011111  00 000011246788999999999999999999999999999


Q ss_pred             c
Q 014762          412 I  412 (419)
Q Consensus       412 f  412 (419)
                      |
T Consensus       316 f  316 (316)
T cd07842         316 F  316 (316)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=325.29  Aligned_cols=279  Identities=31%  Similarity=0.545  Sum_probs=213.5

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      +..++|++.+.||+|++|+||+|.+..+++.||+|.+....    ...+.+|+.+++.+ +|+||+++++++.+  ....
T Consensus         2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~   78 (291)
T cd07844           2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHT--KKTL   78 (291)
T ss_pred             CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEec--CCeE
Confidence            45688999999999999999999999899999999986422    24567899999999 99999999999965  4688


Q ss_pred             EEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++||||+.+ ++..++    ..+++..++.++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||+++.....
T Consensus        79 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          79 TLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-GELKLADFGLARAKSVP  156 (291)
T ss_pred             EEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-CCEEECccccccccCCC
Confidence            999999986 676654    347889999999999999999999999999999999999988 78999999998654321


Q ss_pred             -CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          274 -KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       274 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                       .......++..|+|||++.+...++.++||||+||++|+|++|+.||.......+++..+.+.++.+....+.......
T Consensus       157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence             1122234677899999987656689999999999999999999999855554667777777777765544432211110


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCC--HHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVS--PEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ......     ...........  ....++  .++.+++.+||++||++|||+.++++||||
T Consensus       237 ~~~~~~-----~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         237 EFKPYS-----FPFYPPRPLIN--HAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccc-----ccccCChhHHH--hCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000000     00000000000  001133  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.1e-43  Score=364.52  Aligned_cols=258  Identities=25%  Similarity=0.421  Sum_probs=209.3

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ...++|+++++||+|+||+||+|.+..++..+|+|++...     ....+.+|+.++..+ +||||++++++|.+.....
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCE
Confidence            3467899999999999999999999999999999998632     245688999999999 9999999999997666677


Q ss_pred             cEEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-------CcEeecCCCCceEEcCC-------
Q 014762          197 PSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-------GIMHRDVKPHNVMIDHE-------  255 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~-------~ivH~Dlk~~NILl~~~-------  255 (419)
                      +++||||+++++|..++       ..+++..++.++.||+.||+|||+.       +||||||||+|||++.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999998776       3589999999999999999999984       49999999999999642       


Q ss_pred             ---------CCcEEEEecccceeccCCCcceeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 014762          256 ---------LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (419)
Q Consensus       256 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~  325 (419)
                               ...+||+|||++.............+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.... 
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-
Confidence                     235899999999876544444456789999999998642 458899999999999999999999985332 


Q ss_pred             CHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 014762          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (419)
Q Consensus       326 ~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e  405 (419)
                      ....+......  .+.                                  ......+.++.+||..||+.+|.+|||+.|
T Consensus       248 ~~~qli~~lk~--~p~----------------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Q  291 (1021)
T PTZ00266        248 NFSQLISELKR--GPD----------------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQ  291 (1021)
T ss_pred             cHHHHHHHHhc--CCC----------------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHH
Confidence            22222221110  000                                  000125788999999999999999999999


Q ss_pred             HhcCCCcccccc
Q 014762          406 AMVISSISPIFS  417 (419)
Q Consensus       406 lL~hp~f~~~~~  417 (419)
                      +|.|||++.+..
T Consensus       292 lL~h~~ik~i~~  303 (1021)
T PTZ00266        292 CLGYQIIKNVGP  303 (1021)
T ss_pred             HhccHHHhhcCC
Confidence            999999987643

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.9e-42  Score=325.27  Aligned_cols=274  Identities=32%  Similarity=0.589  Sum_probs=218.2

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.+.||.|+||.||+|.+..+|+.+|+|++....     .+.+.+|+.+++.+ +|||++++++++..  ....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v   77 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPH--GSGFVLV   77 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeeEEE
Confidence            5889999999999999999999999999999986432     35788999999999 89999999999965  4678999


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC--
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~--  274 (419)
                      +||+ +++|..++    ..+++..++.++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++.......  
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCCC
Confidence            9999 88888765    348999999999999999999999999999999999999987 889999999987665433  


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|+|||.+.+...++.++||||+||++++|++|. |++.+.++.+.+..+.+.++.+....+..-...   
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL---  231 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC-cCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc---
Confidence            2344578889999999876566799999999999999999995 555777777788888887777655444321111   


Q ss_pred             hhhHHhhcc-CCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          355 PQLDALVGR-HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       355 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                      ..+...... ....++..     .....+.++.+|+++||+.||++|||++++|+||||.
T Consensus       232 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         232 PDYNKITFPESKPIPLEE-----IFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             chhhcccCCCCCcchHHH-----hCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            111110000 00011111     1123578999999999999999999999999999994

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.9e-43  Score=337.14  Aligned_cols=242  Identities=26%  Similarity=0.422  Sum_probs=194.5

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHH-HHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKI-LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      +.||+|+||+||+|.+..+|+.||+|++....      ...+.+|..+ ++.+ +||||+++++.+.+.  ...++||||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~--~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTA--DKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeC--CEEEEEEcC
Confidence            36999999999999999999999999986421      2334455554 5667 999999999999654  678999999


Q ss_pred             cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCcceee
Q 014762          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (419)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~~~~~  279 (419)
                      +++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~  156 (323)
T cd05575          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTF  156 (323)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccccc
Confidence            9999997766   358899999999999999999999999999999999999988 8899999999875322 2223345


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      .|+..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+...  .                    
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~--~--------------------  212 (323)
T cd05575         157 CGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNK--P--------------------  212 (323)
T ss_pred             cCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcC--C--------------------
Confidence            78999999999877 7799999999999999999999999843 2222222222110  0                    


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCCcccc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMVISSISPI  415 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp~f~~~  415 (419)
                                     ......+++++.++|++||+.||++||++    .++++||||+.+
T Consensus       213 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         213 ---------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence                           00012368899999999999999999998    699999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.4e-42  Score=326.12  Aligned_cols=279  Identities=30%  Similarity=0.538  Sum_probs=216.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.+.||.|+||.||+|.+..+++.+++|.++...     ...+.+|+.++.++ +||||+++++++.+......+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence            457899999999999999999999999999999986432     23467899999999 899999999999776557899


Q ss_pred             EEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-
Q 014762          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-  273 (419)
                      +||||+++ ++..++    ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++...... 
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeeccCCc
Confidence            99999986 665554    248999999999999999999999999999999999999988 88999999998866543 


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+.+..+....+...++.+....+........
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF-PGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence            23344567888999999876456789999999999999999999887 45555666777777777665554433221111


Q ss_pred             ChhhHHhhccCCCCCccccccccccCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHL-VSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ...     ........... ....+.. +++.+.++|++||+.||++|||+.|+|+||||
T Consensus       240 ~~~-----~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         240 AKK-----KTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hcc-----cccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            110     00000000000 0111111 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.6e-42  Score=328.07  Aligned_cols=276  Identities=34%  Similarity=0.566  Sum_probs=215.4

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      +|++.+.||+|+||.||+|.+..+++.||+|.++...        ...+.+|+.+++.+ +|+||+++++++.+  ....
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~   77 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH--KSNI   77 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec--CCEE
Confidence            4888999999999999999999999999999986432        23467899999999 89999999999966  4678


Q ss_pred             EEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++||||+ +++|..++.    .+++..+..++.|+++||.|||++|++|+||+|+||+++.+ +.++|+|||+++.....
T Consensus        78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCC
Confidence            9999999 888888762    48899999999999999999999999999999999999987 88999999999876543


Q ss_pred             C-cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      . ......++..|+|||.+.+...++.++|+|||||++|+|++|. |++.+.++.+.+..+...++.+....+.......
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC-ccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            2 2233456778999999866567899999999999999999995 5556666767777777666665544432211110


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                               ....................+.++.+|+.+||++||++|||+.|+|+||||++..
T Consensus       235 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         235 ---------DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             ---------ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence                     0000000000000011123678899999999999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.1e-43  Score=337.02  Aligned_cols=247  Identities=21%  Similarity=0.352  Sum_probs=193.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.++||+|+||+||+|.+.     .+++.||+|+++...    .+.+.+|+.++..+.+||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-   83 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-   83 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence            3578999999999999999999752     345789999986432    356889999999997899999999998654 


Q ss_pred             CCccEEEEEecCCCChhhhcC-----------------------------------------------------------
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (419)
                      ....+++|||+++|+|..++.                                                           
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            346789999999999976652                                                           


Q ss_pred             ------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc---eeecccccc
Q 014762          215 ------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYF  285 (419)
Q Consensus       215 ------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y  285 (419)
                            .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++........   ....++..|
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCCCccc
Confidence                  26677888899999999999999999999999999999987 78999999999765432221   123445679


Q ss_pred             cccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccC
Q 014762          286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRH  364 (419)
Q Consensus       286 ~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (419)
                      +|||++.+ ..++.++|||||||++|||++ |..||...... +.+...... +.                         
T Consensus       243 ~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~-~~-------------------------  294 (338)
T cd05102         243 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKD-GT-------------------------  294 (338)
T ss_pred             cCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhc-CC-------------------------
Confidence            99999877 679999999999999999997 88887432222 221111110 00                         


Q ss_pred             CCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          365 SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                         .      ......+++++.+++.+||+.||++|||+.|+++
T Consensus       295 ---~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         295 ---R------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ---C------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence               0      0001236889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8e-43  Score=351.12  Aligned_cols=253  Identities=21%  Similarity=0.353  Sum_probs=205.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC---
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (419)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||+++..     ....+.+|+.++..+ +|+|++++++.+.....   
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCc
Confidence            357999999999999999999999999999999998642     234577899999998 99999999987753321   


Q ss_pred             ---CccEEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEec
Q 014762          195 ---KTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (419)
Q Consensus       195 ---~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Df  264 (419)
                         ..+++||||+++++|..++       ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vkL~DF  187 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDF  187 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEEEEec
Confidence               1367999999999998766       248899999999999999999999999999999999999988 88999999


Q ss_pred             ccceeccCC---CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCch
Q 014762          265 GLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (419)
Q Consensus       265 gla~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~  341 (419)
                      |+++.....   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+..  +.  
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~-~~~~~~~~~~~~~--~~--  261 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFD-GENMEEVMHKTLA--GR--  261 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHhc--CC--
Confidence            999765432   12234578999999999977 779999999999999999999999983 2222222221111  00  


Q ss_pred             HHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                              ..        ..+..+++++.+++.+||+.||++|||+.++++|||++..
T Consensus       262 ------------------------~~--------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        262 ------------------------YD--------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             ------------------------CC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                                    00        0112378899999999999999999999999999998754

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5e-42  Score=322.36  Aligned_cols=277  Identities=30%  Similarity=0.528  Sum_probs=211.2

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|++...||+|+||.||+|.+..+++.||+|++...     ..+.+.+|+.+++.+ +|+|++++++++...  ...++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~~   77 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRK--RKLHL   77 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeC--CEEEE
Confidence            5799999999999999999999999999999988532     235578999999999 899999999999654  67889


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-c
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~  275 (419)
                      ||||++++++..+.   ..+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....... .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07847          78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDD  156 (286)
T ss_pred             EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecCCCccc
Confidence            99999999888775   358999999999999999999999999999999999999988 789999999998765433 2


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....++..|+|||++.+...++.++|+|||||++|+|++|+.|| .+.++.+.+..+...++..............+..
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW-PGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK  235 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence            233457788999999876566889999999999999999999887 4455556666555554432211100000000000


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ... ........+..     .....++..+.+|+.+||+.||++|||+.|++.||||
T Consensus       236 ~~~-~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         236 GLS-IPEPETREPLE-----SKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccc-CCCcccccCHH-----HHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            000 00000000000     0012368889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=332.81  Aligned_cols=284  Identities=29%  Similarity=0.558  Sum_probs=216.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC---CC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~  195 (419)
                      ..++|++.++||+|+||+||+|.+..+|+.||+|.+++.    ....+.+|+.+++.+ +|+||+++++++....   ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccc
Confidence            357899999999999999999999999999999998642    234577899999999 8999999999876432   24


Q ss_pred             ccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ..++++||+.+ ++...+  ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++......
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECcccceeecccc
Confidence            57899999986 454444  358999999999999999999999999999999999999988 78999999998765432


Q ss_pred             Ccc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          274 KEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       274 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ...    ....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+.......+...++.+..+.+..-.
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF-PGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            211    22467888999998766567899999999999999999999888 4555566677777777766544332111


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      .......... .......++...     ....++++.+||.+||+.||++|||+.|+++||||+++.
T Consensus       239 ~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         239 SLRARNYIKS-LPFKPKVPWNKL-----FPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             chhhhhHHhh-cCcCCcccHHHH-----hcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            0000000000 000001111111     123578899999999999999999999999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9.5e-43  Score=334.82  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=202.3

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.++||+|+||+||++.+..+++.+|+|++...      ....+.+|+.++..+ +|+||+++++.+.+.  ...+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~   77 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDE--NNLY   77 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecC--CEEE
Confidence            4799999999999999999999999999999998632      123477899999998 999999999999654  6789


Q ss_pred             EEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +||||+.+++|..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus        78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecccCC
Confidence            999999999998887    347889999999999999999999999999999999999987 789999999987654332


Q ss_pred             c--ceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          275 E--YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       275 ~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      .  .....||..|+|||++.+    ...++.++|||||||++|||++|+.||.. .+..+....+.....          
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~----------  225 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKE----------  225 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCc----------
Confidence            2  223578999999999862    24688999999999999999999999842 232233322221000          


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCcccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMVISSISPI  415 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~  415 (419)
                                       ...+.     .....+++++++|+++||+.++.+  |+|++|+++||||+++
T Consensus       226 -----------------~~~~p-----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         226 -----------------RFQFP-----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             -----------------cccCC-----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence                             00000     001237899999999999765554  6899999999999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-43  Score=337.56  Aligned_cols=242  Identities=28%  Similarity=0.463  Sum_probs=197.7

Q ss_pred             eeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          131 RKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      +.||+|+||+||++.+.   .+|+.+|+|+++..     ....+.+|+.+++++ +||||+++++++.+.  ...++|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTE--GKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcC--CEEEEEEc
Confidence            57999999999998763   57899999998642     234567899999999 999999999999654  67899999


Q ss_pred             ecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Cccee
Q 014762          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNV  278 (419)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~~~~  278 (419)
                      |+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .....
T Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~  157 (318)
T cd05582          79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYS  157 (318)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCceec
Confidence            99999998776   348999999999999999999999999999999999999988 78999999998765433 22334


Q ss_pred             ecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhH
Q 014762          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~  358 (419)
                      ..|+..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.+.             ..       
T Consensus       158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~-~~~~~~~~~~i~~~-------------~~-------  215 (318)
T cd05582         158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQ-GKDRKETMTMILKA-------------KL-------  215 (318)
T ss_pred             ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCC-CCCHHHHHHHHHcC-------------CC-------
Confidence            578899999999876 678999999999999999999999984 22222222222110             00       


Q ss_pred             HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                       ..+..+++++.+||++||+.||++|||     +.++++||||+.+
T Consensus       216 -----------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         216 -----------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence                             001236889999999999999999999     6779999999865

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-42  Score=319.59  Aligned_cols=251  Identities=30%  Similarity=0.521  Sum_probs=204.9

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchH-----HHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      |++.+.||+|+||+||++.+..+++.+|+|++......     ...+|+.+++++ +||||+++++++..  ....++||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~   77 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM   77 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence            78999999999999999999999999999999765432     234599999999 99999999999976  47788999


Q ss_pred             EecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec-cCCCcce
Q 014762          202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYN  277 (419)
Q Consensus       202 e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~-~~~~~~~  277 (419)
                      ||+.++++..++   ..+++..+..++.|++.||++||++|++|+||||+||+++.+ +.++|+|||.+... .......
T Consensus        78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSEBS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccc
Confidence            999999988766   568999999999999999999999999999999999999977 88999999999763 2233445


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...++..|+|||++.....++.++|+||+|+++|+|++|..||... ...+....+.+............          
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~----------  225 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-NSDDQLEIIEKILKRPLPSSSQQ----------  225 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-SHHHHHHHHHHHHHTHHHHHTTS----------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc-cchhhhhhhhhcccccccccccc----------
Confidence            5678889999999873378999999999999999999999998533 22333333333333222111000          


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                          ....+.++.+++.+||+.||++|||+.++++||||
T Consensus       226 --------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  226 --------------------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             --------------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             --------------------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                                00123789999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-44  Score=337.43  Aligned_cols=251  Identities=25%  Similarity=0.466  Sum_probs=215.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|..++.+|+|+||.++.++++.+++.+++|.+.-     ..+....+|+.+++++ .|||||.+.+.|..+ +...+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~-~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEED-GQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcC-CceEE
Confidence            4679999999999999999999999999999999852     2245678999999998 999999999999764 24489


Q ss_pred             EEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          199 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      +||+|++||++.+.+.     .++++.+..++.|++.|+.|||+++|+|||||+.||++..+ +.|||+|||+|+.+.+.
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-CceeecchhhhhhcCCc
Confidence            9999999999988872     48999999999999999999999999999999999999999 67899999999999877


Q ss_pred             C-cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      . .....+||++|+.||.+.+ .+|+.++|||||||++|||++-+.+| .+.+......++.+....+-           
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF-~a~~m~~Li~ki~~~~~~Pl-----------  226 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAF-KASNMSELILKINRGLYSPL-----------  226 (426)
T ss_pred             hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhccccc-CccchHHHHHHHhhccCCCC-----------
Confidence            6 5566799999999999998 89999999999999999999999888 34444444445544332111           


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                               +...+.+++.+|+.||..+|+.||+|.++|.+|.+...
T Consensus       227 -------------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  227 -------------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             -------------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence                                     12368899999999999999999999999999987643

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.5e-42  Score=324.37  Aligned_cols=278  Identities=32%  Similarity=0.583  Sum_probs=210.6

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC---Cc
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KT  196 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~  196 (419)
                      ++|++.+.||+|+||+||+|.+..+++.||+|.++...     ...+.+|+.+++.+.+||||+++++++.....   ..
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47999999999999999999999999999999876322     35678899999999667999999999865422   23


Q ss_pred             cEEEEEecCCCChhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          197 PSLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                      .++||||+++ ++..++        ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+.+.+||+|||+++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            7899999997 555543        2378999999999999999999999999999999999999844899999999987


Q ss_pred             eccCC-CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          269 FYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       269 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ..... .......++..|+|||++.+...++.++|+||||+++|+|++|..||. +.++.+.+..+.+.++.+....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP-GDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHHHhCCCChhhCcc
Confidence            65322 222334567889999998765668999999999999999999998874 5555666666666665544332211


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                      .....         .......+...........+++++.+||.+||..||++|||+.|++.||||+
T Consensus       239 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLR---------DWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhcc---------chhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            00000         0000000000000011123788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2e-42  Score=324.42  Aligned_cols=254  Identities=19%  Similarity=0.329  Sum_probs=203.8

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++|++.+.||+|+||+||+|.+..+++.+|+|.+...    ..+.+.+|+.+++++ +||||+++++.+...  ...++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVE--NRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEEC--CEEEEE
Confidence            3678899999999999999999999999999998543    235688999999999 999999999999764  667899


Q ss_pred             EEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeec
Q 014762          201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (419)
Q Consensus       201 ~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (419)
                      |||++++++..+ ..+++..+..++.|++.||+|||+.||+|+||||+|||++.+ +.++|+|||++...... ......
T Consensus        78 ~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~~~~~~  154 (279)
T cd06619          78 TEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAKTYV  154 (279)
T ss_pred             EecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-cccCCC
Confidence            999999998654 467888999999999999999999999999999999999988 88999999999765432 223457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHH--HHHHHHcCCchHHHHHhhcCCCCChhhH
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL--VKIAKVLGTDELNAYLNKYHLELDPQLD  358 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~--~~i~~~lg~~~~~~~~~~~~~~~~~~~~  358 (419)
                      ++..|+|||++.+ ..++.++|+|||||++|+|++|+.||..........  ....+....                   
T Consensus       155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------  214 (279)
T cd06619         155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-------------------  214 (279)
T ss_pred             CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-------------------
Confidence            8889999999987 678999999999999999999999985422111110  000000000                   


Q ss_pred             HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                          .. ..       .......++++.+|+.+||+.||++|||++|+++||||....
T Consensus       215 ----~~-~~-------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         215 ----ED-PP-------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             ----cC-CC-------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence                00 00       000122578899999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-42  Score=348.05  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=203.1

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCC-CcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNT-NERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~-~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..|.+.+.||+|+||.||+|.+..+ +..||+|.+....   ...+.+|+.+++.+ +||||++++++|...  ...++|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~--~~~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSD--DKLLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEEC--CEEEEE
Confidence            3499999999999999999998877 7889999764332   24567899999999 999999999999654  678999


Q ss_pred             EEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      |||+++++|..++       ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC-CcEEEEeCcCceecCCc
Confidence            9999999997654       247889999999999999999999999999999999999988 88999999999876433


Q ss_pred             Cc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          274 KE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       274 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ..   ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+..  +..          
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~-~~~~~~~~~~~~~--~~~----------  288 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFK-GPSQREIMQQVLY--GKY----------  288 (478)
T ss_pred             cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh--CCC----------
Confidence            22   233568999999999877 789999999999999999999999984 2222222222111  000          


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                      .        ..+..+++++.+||.+||..||++|||+++++.|||++.+
T Consensus       289 ----------------~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        289 ----------------D--------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             ----------------C--------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                            0        0012368899999999999999999999999999998754

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-42  Score=318.97  Aligned_cols=247  Identities=25%  Similarity=0.412  Sum_probs=201.2

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ++|++.+.||+|++|.||+|.+..+++.+|+|.+....        .+.+.+|+.+++++ +||||+++++++.++  ..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~   78 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDD--ET   78 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccC--Ce
Confidence            46888999999999999999999999999999875321        24678899999999 999999999999654  58


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++++||++++++...+   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||+++.....
T Consensus        79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecccc
Confidence            89999999999998776   357889999999999999999999999999999999999987 78999999998765432


Q ss_pred             Ccc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          274 KEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       274 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ...    ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||... +..+....+.....           
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~-----------  224 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIATQPT-----------  224 (263)
T ss_pred             ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCcccc-chHHHHHHHhccCC-----------
Confidence            211    22456778999999987 66899999999999999999999998432 21111111110000           


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                              ....+..++..+.+++++||..+|++|||+.++++||||
T Consensus       225 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         225 ------------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ------------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                    000112368899999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.1e-42  Score=324.38  Aligned_cols=258  Identities=25%  Similarity=0.389  Sum_probs=206.8

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ....+.|+++++||.|+||.||+|.+..++..+++|.+....   .+.+.+|+.+++.+ +|||++++++.+..+  ...
T Consensus         8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   84 (292)
T cd06644           8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYWD--GKL   84 (292)
T ss_pred             cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeC--CeE
Confidence            345678999999999999999999999999999999987543   35677899999999 899999999998654  678


Q ss_pred             EEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++||||++++++..++    ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus        85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKT  163 (292)
T ss_pred             EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccceecccc
Confidence            9999999999987664    358999999999999999999999999999999999999877 78999999998654322


Q ss_pred             -CcceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          274 -KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       274 -~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                       .......++..|+|||++.+    ...++.++|+|||||++|+|++|..||... +..+....+..   ...       
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~---~~~-------  232 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAK---SEP-------  232 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhc---CCC-------
Confidence             22234567889999999852    245788999999999999999999998422 22222211111   000       


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                           .   .......++.++.+++.+||..||++|||++++++||||+.+..
T Consensus       233 ---------------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  277 (292)
T cd06644         233 ---------------------P---TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS  277 (292)
T ss_pred             ---------------------c---cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                                 0   00001236788999999999999999999999999999998753

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=338.13  Aligned_cols=243  Identities=26%  Similarity=0.412  Sum_probs=194.1

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhc--CCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      ||+|+||+||+|.+..+++.||+|++....      ......|..++....  +||||+++++.+...  ...++||||+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--~~~~lv~e~~   78 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD--SDLYLVTDYM   78 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC--CeEEEEEcCC
Confidence            799999999999999999999999986421      123445667776654  799999999999654  6789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Ccceeec
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRV  280 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~~~~~~  280 (419)
                      .+++|...+   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .......
T Consensus        79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCccCcc
Confidence            999987765   458999999999999999999999999999999999999988 78999999998754322 2234457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      ||..|+|||++.+...++.++|||||||++|+|++|+.||... +..+....+..  +.           ..        
T Consensus       158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-~~~~~~~~i~~--~~-----------~~--------  215 (330)
T cd05586         158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-DTQQMYRNIAF--GK-----------VR--------  215 (330)
T ss_pred             CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-CHHHHHHHHHc--CC-----------CC--------
Confidence            8999999999876556899999999999999999999998432 22222211110  00           00        


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC----CHHHHhcCCCcccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL----TAREAMVISSISPI  415 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----ta~elL~hp~f~~~  415 (419)
                              +       ....+++++.+|+++||+.||++||    ++.++++||||+.+
T Consensus       216 --------~-------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         216 --------F-------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             --------C-------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence                    0       0112688999999999999999998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.9e-42  Score=324.10  Aligned_cols=281  Identities=32%  Similarity=0.576  Sum_probs=213.5

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|++.+.||+|++|+||+|.+..+|+.||+|.+...     ..+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   78 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSE--KRLYL   78 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecC--CeEEE
Confidence            5799999999999999999999999999999988532     235678999999999 999999999999654  68899


Q ss_pred             EEEecCCCChhhhc-C----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          200 IFEYVNSTDFKVLY-P----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~-~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ||||+++ ++...+ .    .+++..+..++.|++.||+|||++|++|+||+|+||+++.+.+.+||+|||++.......
T Consensus        79 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         79 VFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             EEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9999976 444443 1    257788889999999999999999999999999999998765789999999997653321


Q ss_pred             -cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       275 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       ......++..|+|||++.+...++.++|||||||++|+|++|+.||. +.+..+...++.+..+.+....+.....   
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  233 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP-GDSEIDELFKIFRILGTPNEETWPGVTS---  233 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCChhhcccccc---
Confidence             22334667889999998765568999999999999999999998884 3444555556666666554333211000   


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSL  418 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~  418 (419)
                      -+.+...     ...|...........+++++.+++.+||+.||++|||+.++++||||++++++
T Consensus       234 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~  293 (294)
T PLN00009        234 LPDYKSA-----FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA  293 (294)
T ss_pred             chhhhhh-----cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence            0011000     00111111111123468899999999999999999999999999999998764

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1e-42  Score=333.60  Aligned_cols=242  Identities=25%  Similarity=0.408  Sum_probs=194.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHH-HHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKI-LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~-l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      +.||+|+||+||+|.+..+|+.+|+|++...      ....+.+|..+ ++.+ +||||+++++.+...  ...++||||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~--~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTT--EKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecC--CEEEEEEcC
Confidence            3699999999999999999999999998642      22345556554 5556 999999999999654  678999999


Q ss_pred             cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCcceee
Q 014762          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (419)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~~~~~  279 (419)
                      +.++++...+   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~  156 (325)
T cd05604          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTTTF  156 (325)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcccc
Confidence            9999987765   458999999999999999999999999999999999999988 7899999999875322 2223445


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      .|+..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+...             ..        
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~-------------~~--------  213 (325)
T cd05604         157 CGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHK-------------PL--------  213 (325)
T ss_pred             cCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcC-------------Cc--------
Confidence            78999999999877 7789999999999999999999999853 2222222222110             00        


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCCcccc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMVISSISPI  415 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp~f~~~  415 (419)
                                      ......+..+.+++++||+.||++||++    .++++||||+.+
T Consensus       214 ----------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         214 ----------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             ----------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence                            0011267889999999999999999977    589999999865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.8e-42  Score=332.62  Aligned_cols=254  Identities=25%  Similarity=0.382  Sum_probs=202.0

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||+||++.+..+++.||+|++...      ....+.+|+.++..+ +|+||+++++++.+.  ...+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~--~~~~   77 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDE--NYLY   77 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--CEEE
Confidence            5799999999999999999999999999999998642      123467889999988 999999999999654  7789


Q ss_pred             EEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +||||+.+++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus        78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-CCEEEEeccceeeccCCC
Confidence            999999999998876    357899999999999999999999999999999999999987 789999999997765433


Q ss_pred             cc--eeecccccccccccccCC----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          275 EY--NVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       275 ~~--~~~~~~~~y~aPE~~~~~----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ..  ....|+..|+|||++.+.    ..++.++|||||||++|+|++|+.||.. .+..+....+.....          
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~----------  225 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEE----------  225 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCC----------
Confidence            22  234689999999998642    3578899999999999999999999842 222222222211000          


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCcccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMVISSISPI  415 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~  415 (419)
                                       ...+..     ....+++++++++.+||+.++++  |++++++++||||+.+
T Consensus       226 -----------------~~~~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         226 -----------------RFQFPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             -----------------cccCCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence                             000000     01236889999999999976654  5699999999999875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.9e-42  Score=332.09  Aligned_cols=282  Identities=19%  Similarity=0.205  Sum_probs=198.9

Q ss_pred             EEeeeeee--CceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          129 VVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       129 ~~~~lG~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ++++||+|  +||+||++.+..+|+.||+|.++...     .+.+.+|+.+++.+ +||||++++++|..+  ...++||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~--~~~~lv~   78 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD--NELWVVT   78 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC--CEEEEEE
Confidence            46789999  78999999999999999999986431     24577899999999 999999999999664  6788999


Q ss_pred             EecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC--
Q 014762          202 EYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (419)
Q Consensus       202 e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~--  274 (419)
                      ||++++++..++     ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++++||+.+.......  
T Consensus        79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-CcEEEcccchhhcccccccc
Confidence            999999998776     348899999999999999999999999999999999999988 789999998654322111  


Q ss_pred             ------cceeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCch------
Q 014762          275 ------EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE------  341 (419)
Q Consensus       275 ------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~------  341 (419)
                            ......++..|+|||++.+. ..++.++|||||||++|+|++|+.||..... ........  .+..+      
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~--~~~~~~~~~~~  234 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA-TQMLLEKL--NGTVPCLLDTT  234 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch-hHHHHHHh--cCCcccccccc
Confidence                  01123456679999998653 4689999999999999999999999853222 22111111  11100      


Q ss_pred             ---HHHHH-hhcCCCCChhhHHhhccC-CCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          342 ---LNAYL-NKYHLELDPQLDALVGRH-SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       342 ---~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                         .+... .......+.......... ................+++++.+|+++||++||++|||++|+++||||+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence               00000 000000000000000000 0000000000011223678999999999999999999999999999999875


Q ss_pred             c
Q 014762          417 S  417 (419)
Q Consensus       417 ~  417 (419)
                      .
T Consensus       315 ~  315 (327)
T cd08227         315 R  315 (327)
T ss_pred             h
Confidence            3

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.5e-42  Score=321.05  Aligned_cols=273  Identities=31%  Similarity=0.598  Sum_probs=210.0

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|+..+.||.|+||.||+|.+..+++.||+|.++..     ..+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v   77 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYLV   77 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhccc--CCcEEEE
Confidence            488899999999999999999999999999988632     235688999999999 99999999999954  4678999


Q ss_pred             EEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      |||+.+ ++..++     ..+++..+..++.|++.||+|||+++++|+||+|+||+++.+ +.+||+|||++....... 
T Consensus        78 ~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          78 FEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             eecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEeeccchhhcccCcc
Confidence            999974 565554     347899999999999999999999999999999999999988 789999999987654322 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|+|||++.+...++.++|||||||++|+|++|+.||. +.+..+...++.+.++.+....+......   
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP-GDSEIDQLFRIFRTLGTPDEVVWPGVTSL---  231 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhhhhHH---
Confidence            22334567889999998764557899999999999999999999984 44555666667777776543322210000   


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      +....   .........+.  .....++++++++|.+||+.||++|||++++++||||
T Consensus       232 ~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYKP---SFPKWARQDFS--KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHh---hcccccccCHH--HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            00000   00000000000  0012368899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.8e-42  Score=320.39  Aligned_cols=275  Identities=29%  Similarity=0.536  Sum_probs=209.9

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      |++.++||+|+||.||+|.+..+++.+|+|.++...    .....+|+.++.++.+|+|++++++++.+......++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            678899999999999999999999999999986432    2234578999999866999999999997765577899999


Q ss_pred             ecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceee
Q 014762          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  279 (419)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (419)
                      |++++.+....   ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.  +.+||+|||+++...........
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~  158 (282)
T cd07831          81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYTEY  158 (282)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCCcCCC
Confidence            99865444433   24899999999999999999999999999999999999998  78999999999876544443445


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      .++..|+|||.+.....++.++|||||||++|+|++|..|| .+.+..+....+.+.+|.+...... .........+  
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--  234 (282)
T cd07831         159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF-PGTNELDQIAKIHDVLGTPDAEVLK-KFRKSRHMNY--  234 (282)
T ss_pred             CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC-CCCCHHHHHHHHHHHcCCCCHHHHH-hhcccccccc--
Confidence            67889999998765466789999999999999999998887 5556666677777777765443211 1000000000  


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                         .........+  ......++.++.++|.+||+.||++|||++++++||||
T Consensus       235 ---~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         235 ---NFPSKKGTGL--RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ---cCcccccccH--HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence               0000000000  00012368999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.7e-42  Score=332.15  Aligned_cols=242  Identities=25%  Similarity=0.425  Sum_probs=194.3

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHH-HHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      +.||+|+||+||+|.+..+++.||+|++....      ...+.+|.. +++.+ +||||+++++++...  ...++||||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~--~~~~lv~e~   77 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTA--DKLYFVLDY   77 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcC--CeEEEEEeC
Confidence            36999999999999999999999999986422      123444444 45666 999999999999654  678999999


Q ss_pred             cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCcceee
Q 014762          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (419)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~~~~~  279 (419)
                      ++++++..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~~  156 (325)
T cd05602          78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTF  156 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCcccc
Confidence            9999998876   357889999999999999999999999999999999999987 7899999999875322 2233445


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      .||..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+...  .                    
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~--------------------  212 (325)
T cd05602         157 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK--P--------------------  212 (325)
T ss_pred             cCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhC--C--------------------
Confidence            78999999999887 7899999999999999999999999852 2322222222110  0                    


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHH----HHhcCCCcccc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR----EAMVISSISPI  415 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~----elL~hp~f~~~  415 (419)
                                     ......+++.+.+++.+||+.||.+|+++.    ++++|+||+++
T Consensus       213 ---------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         213 ---------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             ---------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence                           000123788999999999999999999876    89999999865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.3e-42  Score=329.36  Aligned_cols=284  Identities=30%  Similarity=0.554  Sum_probs=218.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC---CC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~  195 (419)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|.+...     ....+.+|+.+++.+ +|+||+++++++....   ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccC
Confidence            56899999999999999999999999999999988642     234677899999999 9999999999886432   24


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ..++++||+.+ ++..++   ..+++..+..++.|++.||.|||+++++|+||||+||+++.+ +.+||+|||+++....
T Consensus        83 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          83 DVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTTSE  160 (337)
T ss_pred             cEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCccccccCC
Confidence            57999999974 555554   458999999999999999999999999999999999999988 7899999999976543


Q ss_pred             CC-cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          273 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       273 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      .. ......++..|+|||.+.+...++.++|+|||||++|+|++|+.|| .+.+..+....+.+..|.+....+..    
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~----  235 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF-PGKDYVHQLKLITELLGSPSEEDLGF----  235 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCChHHhhh----
Confidence            32 2233467888999999876456899999999999999999999887 45555666777777777655443211    


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      ......................  .....+++++.+|+++||+.||++|||++++++||||+.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHH--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence            0111111111111111111100  011247899999999999999999999999999999987653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.8e-42  Score=321.78  Aligned_cols=252  Identities=25%  Similarity=0.422  Sum_probs=201.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----CCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~~  197 (419)
                      .+.|++.+.||+|+||+||+|.+..+++.+|+|.+...  ....+.+|+.++.++.+|+|++++++++....    ....
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            56788899999999999999999999999999998643  34578899999999867999999999986532    2457


Q ss_pred             EEEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      +++|||+.++++..++.     .+++..+..++.|++.||+|||+++|+|+||||+||+++.+ +.++|+|||++.....
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~~~~~~~  163 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-CCEEEccCCCceeccc
Confidence            89999999999988753     47889999999999999999999999999999999999988 7899999999876543


Q ss_pred             CC-cceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          273 GK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       273 ~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      .. ......++..|+|||++.+    ...++.++|+|||||++|+|++|+.||.... ..........            
T Consensus       164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~------------  230 (272)
T cd06637         164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPR------------  230 (272)
T ss_pred             ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhc------------
Confidence            22 2234567888999999863    2458889999999999999999999984221 1110000000            


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                      .   .    ........++.++.+|+.+||+.||++|||+.++++||||
T Consensus       231 ----------------~---~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         231 ----------------N---P----APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             ----------------C---C----CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                            0   0    0000112367899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-42  Score=331.14  Aligned_cols=260  Identities=20%  Similarity=0.337  Sum_probs=197.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .+++|...+.||+|+||+||+|.. .+|..||||.++...   ..+|.+|+.++.++ +|||+|+++|||.+... ..+|
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~~~-~~~L  149 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLEGGE-HRLL  149 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEecCCc-eEEE
Confidence            478888899999999999999974 556899999987543   46799999999999 79999999999976532 5889


Q ss_pred             EEEecCCCChhhhc----C-CCCHHHHHHHHHHHHHHHHHHHHC---CcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          200 IFEYVNSTDFKVLY----P-TLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       200 v~e~~~~~~l~~~~----~-~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      |||||.+|+|.+++    . .++|..+.+|+.++|+||+|||+.   .|||||||++|||+|.+ ..+||+|||+|+...
T Consensus       150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~  228 (361)
T KOG1187|consen  150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGP  228 (361)
T ss_pred             EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCC
Confidence            99999999999887    2 679999999999999999999985   49999999999999988 789999999997665


Q ss_pred             C-CCcceee-cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHH-HHHcCCchHHHHHh
Q 014762          272 P-GKEYNVR-VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKI-AKVLGTDELNAYLN  347 (419)
Q Consensus       272 ~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~~i-~~~lg~~~~~~~~~  347 (419)
                      . ....... .||.+|+|||++.. +..+.++|||||||+|.|+++|+.+....... ...+... ...+.......+. 
T Consensus       229 ~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii-  306 (361)
T KOG1187|consen  229 EGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV-  306 (361)
T ss_pred             ccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee-
Confidence            4 3333333 89999999999976 78999999999999999999999887543211 1112221 1111111111110 


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                            ++.+..       ....       ....-..+..+..+|++.+|++||++.|+++
T Consensus       307 ------D~~l~~-------~~~~-------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  307 ------DPRLKE-------GEYP-------DEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ------CCCccC-------CCCC-------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence                  000000       0000       0001223668999999999999999999754

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.9e-42  Score=331.16  Aligned_cols=242  Identities=26%  Similarity=0.409  Sum_probs=193.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHH-HHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      +.||+|+||+||+|++..+++.||+|++....      ...+.+|.. +++.+ +||||+++++.+.+.  ...++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~--~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTA--EKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcC--CEEEEEEcC
Confidence            36999999999999999999999999986422      233455554 46667 999999999999654  678999999


Q ss_pred             cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-CCcceee
Q 014762          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVR  279 (419)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~~~~~~~  279 (419)
                      +++++|...+   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .......
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~  156 (321)
T cd05603          78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTF  156 (321)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccccc
Confidence            9999997765   458899999999999999999999999999999999999988 8899999999875322 2223445


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      .|+..|+|||++.+ ..++.++|||||||++|+|++|..||... +..+....+..   .          ..        
T Consensus       157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~---~----------~~--------  213 (321)
T cd05603         157 CGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILH---K----------PL--------  213 (321)
T ss_pred             cCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCC-CHHHHHHHHhc---C----------CC--------
Confidence            78999999999876 67999999999999999999999998432 22222221111   0          00        


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCCcccc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMVISSISPI  415 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp~f~~~  415 (419)
                                      ..+...+.++.+++.+||+.||++|+++    .++++||||+++
T Consensus       214 ----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         214 ----------------QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI  257 (321)
T ss_pred             ----------------CCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence                            0012257889999999999999999976    599999999865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-44  Score=343.09  Aligned_cols=256  Identities=26%  Similarity=0.418  Sum_probs=209.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ..+-|+++..||.|+||.||+|.++.++-..|-|++....   .+.+.-||+||..+ +||+||++++.|.-+  +.+++
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~e--nkLwi  106 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFE--NKLWI  106 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhcc--CceEE
Confidence            3566888999999999999999999999889999986443   45677899999998 899999999977444  66889


Q ss_pred             EEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc-CCC
Q 014762          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGK  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~-~~~  274 (419)
                      +.|||.||..+..+    +.+++.+++.+++|++.||.|||+++|||||||..|||+.-+ |.++|+|||.+-... ...
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-CcEeeecccccccchhHHh
Confidence            99999999987765    679999999999999999999999999999999999999998 899999999874322 122


Q ss_pred             cceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          275 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ......||++|||||+.+.    ..+|++++||||||++|.||..+..|- ...+....+..+.+.-.+ .+.       
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH-helnpMRVllKiaKSePP-TLl-------  256 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSEPP-TLL-------  256 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc-cccchHHHHHHHhhcCCC-ccc-------
Confidence            2345799999999999753    268999999999999999999998774 444555555554442111 110       


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                                .+...+..+.||+.+||..||..||+++++|+||||+++.+
T Consensus       257 --------------------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  257 --------------------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             --------------------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence                                      11224778999999999999999999999999999997643

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-41  Score=315.94  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=198.8

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .+|+..+.||+|+||.||+|.+..++..+++|.+...        ....+.+|+.+++.+ +||||+++++++.+.....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence            4688899999999999999999999999999988532        124578899999999 8999999999987655567


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++++||+++++|..++   ..+++.....++.|++.||+|||+++++|+||+|+||+++.+ +.++|+|||+++.....
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCCCccccccc
Confidence            88999999999998776   357889999999999999999999999999999999999987 78999999998754321


Q ss_pred             C----cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          274 K----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       274 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      .    ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... +..+....+..   ...        
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~-~~~~~~~~~~~---~~~--------  226 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEY-EAMAAIFKIAT---QPT--------  226 (266)
T ss_pred             cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcccc-chHHHHHHHhc---CCC--------
Confidence            1    1122457778999999877 67899999999999999999999998422 11111111110   000        


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                                              ....+..+++.+.+++ +||..+|++|||++|+++||||+
T Consensus       227 ------------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ------------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ------------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                    0000112578889999 67778999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-42  Score=344.72  Aligned_cols=244  Identities=20%  Similarity=0.390  Sum_probs=205.5

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEc
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (419)
                      .....+.+..++||+|.||+||+|+-..     ....||||.++..    .+++|+||++++..+ +|||||+++|+|..
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVCRE  560 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEcc
Confidence            3346778889999999999999997432     3457999999753    357899999999999 99999999999965


Q ss_pred             cCCCccEEEEEecCCCChhhhcC-------------C----CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC
Q 014762          192 QHSKTPSLIFEYVNSTDFKVLYP-------------T----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (419)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------~----l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~  254 (419)
                      .  +..++|+|||..|||.+++.             .    ++..+...|+.|||.||+||-++.+|||||..+|+||.+
T Consensus       561 ~--~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  561 G--DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE  638 (774)
T ss_pred             C--CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence            4  67889999999999999871             2    788899999999999999999999999999999999999


Q ss_pred             CCCcEEEEecccceeccCCCcceee---cccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014762          255 ELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (419)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~  330 (419)
                      + ..|||+|||+++.....+.+...   .-...||+||.++- .+|+.+||||||||+|||+++ |+.|+ .+.++.|.+
T Consensus       639 ~-l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy-~glSn~EVI  715 (774)
T KOG1026|consen  639 N-LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPY-YGLSNQEVI  715 (774)
T ss_pred             c-eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcc-cccchHHHH
Confidence            8 79999999999877655555433   33456999999987 899999999999999999998 77776 577777777


Q ss_pred             HHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014762          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  406 (419)
Q Consensus       331 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el  406 (419)
                      +.+.+-  .                                 . ...++.++.++.+||..||+.+|++|||+.|+
T Consensus       716 e~i~~g--~---------------------------------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  716 ECIRAG--Q---------------------------------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHHHcC--C---------------------------------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            665431  0                                 0 12234589999999999999999999999986

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=9.9e-42  Score=328.06  Aligned_cols=283  Identities=31%  Similarity=0.590  Sum_probs=218.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc--CCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  196 (419)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+...     ..+.+.+|+.+++.+ +||||+++++++...  ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence            47899999999999999999999999999999998642     235677899999999 899999999988643  3356


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++||||+.+ ++..++   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++......
T Consensus        83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceeeccc
Confidence            8999999975 666665   358999999999999999999999999999999999999988 88999999998765332


Q ss_pred             Cc-----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          274 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       274 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ..     .....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+...++..+...+|.++.......
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf-~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF-PGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc-CCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            21     123467888999999866556899999999999999999999988 555666777777788887655432211


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ........+. ........+|....     ...++++.++|.+||+.||++|||++++++||||+...
T Consensus       240 ~~~~~~~~~~-~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         240 GSDRVRKYIQ-NLPRKQPVPWSKIF-----PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             chhhHHHHHh-hcccCCCCCHHHHc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence            1000000000 00111111121111     23688999999999999999999999999999998653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.9e-41  Score=319.53  Aligned_cols=247  Identities=25%  Similarity=0.440  Sum_probs=205.7

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||.||++.+..+++.+|+|.+...      ..+.+.+|+.+++++ +||||+++++++.+  +...+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~   77 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQD--DSNLY   77 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCeEE
Confidence            4799999999999999999999999999999998642      235678899999999 89999999999965  46789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||||+++++|..++   ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.+||+|||++......  
T Consensus        78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--
Confidence            999999999998876   458999999999999999999999999999999999999988 78999999999876543  


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.... ..+....+..  +...              
T Consensus       155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~--~~~~--------------  216 (290)
T cd05580         155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKILE--GKVR--------------  216 (290)
T ss_pred             CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc--CCcc--------------
Confidence            233467889999999876 678899999999999999999999984322 2222222110  0000              


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCccccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPIF  416 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~  416 (419)
                                           ....+++.+.+++.+||+.||++|+     +++|+++||||+.+.
T Consensus       217 ---------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         217 ---------------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             ---------------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence                                 0112578899999999999999999     999999999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.7e-41  Score=318.44  Aligned_cols=252  Identities=23%  Similarity=0.378  Sum_probs=198.6

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++...    ...+..|+.++.+..+|||++++++++...  ...+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence            47899999999999999999999999999999986432    234556777644444899999999999654  568899


Q ss_pred             EEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      |||+++ ++..++       ..+++..+..++.|++.||+|||++ +++||||||+||+++.+ +.+||+|||++.....
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~  156 (283)
T cd06617          79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeeccccccccc
Confidence            999985 443332       2488999999999999999999997 99999999999999988 7899999999976543


Q ss_pred             CCcceeecccccccccccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          273 GKEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ....+...++..|+|||.+.+.   ..++.++|+|||||++|+|++|+.||.......+.+.........          
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------  226 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP----------  226 (283)
T ss_pred             ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC----------
Confidence            3333345678889999987542   357889999999999999999999985433333333222110000          


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                           .    .....+++++.+|+.+||..+|++|||+.++++||||+..
T Consensus       227 ---------------------~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         227 ---------------------Q----LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             ---------------------C----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence                                 0    0011268899999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-41  Score=326.10  Aligned_cols=283  Identities=30%  Similarity=0.542  Sum_probs=214.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (419)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|.+...     ....+.+|+.+++.+ +||||+++++++....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCC
Confidence            357899999999999999999999999999999998632     134578899999999 9999999999986432    


Q ss_pred             CCccEEEEEecCCCChhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ....++|+||+.. ++..... .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+++....
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL~dfg~~~~~~~  169 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKILDFGLARHADA  169 (342)
T ss_pred             CceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCCCCcCCCC
Confidence            1346899999975 5655544 68999999999999999999999999999999999999988 8899999999875432


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                        ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||. +.+....+..+....|.+.......... .
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  245 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILKVTGVPGPEFVQKLED-K  245 (342)
T ss_pred             --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCHHHHHHhcc-c
Confidence              22234567889999998764568899999999999999999999984 4444556666666666544332211100 0


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      ....+...........+...     ....++++.+||.+||+.||++|||+++++.||||+.++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTL-----FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             chHHHHhhcCCcccchHHHH-----hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            00000000000111111110     1136788999999999999999999999999999998864

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.4e-41  Score=320.40  Aligned_cols=280  Identities=31%  Similarity=0.491  Sum_probs=206.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC-----
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH-----  193 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  193 (419)
                      -++|++.++||+|+||.||+|.+..+++.||+|.+....     ...+.+|+.+++++ +||||+++++++....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence            567999999999999999999999999999999885321     23567899999999 9999999999986542     


Q ss_pred             -CCccEEEEEecCCCChhhhc-C---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          194 -SKTPSLIFEYVNSTDFKVLY-P---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       194 -~~~~~lv~e~~~~~~l~~~~-~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                       ....++||||+.+ ++...+ .   .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~  167 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLAR  167 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEECcCCCcc
Confidence             2356899999986 444443 2   58999999999999999999999999999999999999988 789999999997


Q ss_pred             eccCCCc-----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHH
Q 014762          269 FYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (419)
Q Consensus       269 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~  343 (419)
                      .......     .....++..|+|||.+.+...++.++|+||||+++|+|++|+.|| .+.+.......+.+..|..+..
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~-~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM-QGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChh
Confidence            6543221     123456778999999876456789999999999999999999887 4555555666666665543332


Q ss_pred             HHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      .+........   +....  ..................++.+.+||.+||+.||++|||++++|+||||
T Consensus       247 ~~~~~~~~~~---~~~~~--~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLEL---FKKME--LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhh---hhhcc--CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            2111100000   00000  0000000000000011246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.5e-41  Score=319.76  Aligned_cols=254  Identities=28%  Similarity=0.464  Sum_probs=207.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..+|++.+.||.|+||+||+|.+..+++.|++|.+...   ..+.+.+|+.+++.+ +|||++++++++..  ....++|
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv   94 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLV--GDELFVV   94 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEec--CceEEEE
Confidence            56799999999999999999999999999999988532   345678899999999 99999999999965  4678999


Q ss_pred             EEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-ce
Q 014762          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (419)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~  277 (419)
                      +||+.++++..++.  .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhcccccccCC
Confidence            99999999988764  48999999999999999999999999999999999999987 7899999999876543322 22


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.... ..+....+.. .+.+.                
T Consensus       174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~-~~~~~~~~~~-~~~~~----------------  234 (296)
T cd06655         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-PLRALYLIAT-NGTPE----------------  234 (296)
T ss_pred             CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh-cCCcc----------------
Confidence            3467788999999876 678999999999999999999999984322 2222111111 00000                


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                       ......+++.+.+||++||..||++|||+.++++||||+..+.
T Consensus       235 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         235 -----------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             -----------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence                             0011236889999999999999999999999999999997553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.5e-41  Score=321.23  Aligned_cols=254  Identities=26%  Similarity=0.434  Sum_probs=207.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..+|++.+.||+|+||.||+|.+..+++.+++|.+...   ..+.+.+|+.+++.+ +|+|++++++.+...  ...++|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~--~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEeC--CEEEEe
Confidence            56899999999999999999999999999999988643   235678899999998 999999999999654  678999


Q ss_pred             EEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-ce
Q 014762          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (419)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~  277 (419)
                      |||+.+++|..++.  .+++.++..++.|++.||+|||+.||+|+||||+||+++.+ +.++|+|||++........ ..
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEECccccchhccccccccC
Confidence            99999999988874  47899999999999999999999999999999999999987 7899999999876543322 23


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.... .......+.. .+.+.                
T Consensus       175 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~-~~~~~~~~~~-~~~~~----------------  235 (296)
T cd06654         175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-PLRALYLIAT-NGTPE----------------  235 (296)
T ss_pred             cccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC-HHHhHHHHhc-CCCCC----------------
Confidence            3467889999999876 678999999999999999999999984322 1111111110 00000                


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                       ......++..+.+++.+||..||++|||+.++++||||...++
T Consensus       236 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         236 -----------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             -----------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence                             0011236788999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.3e-41  Score=323.61  Aligned_cols=279  Identities=21%  Similarity=0.290  Sum_probs=206.3

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+...    ...++.+|+++++++ +||||+++++.|.++  ...++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSD--GEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC--CEEEEE
Confidence            4699999999999999999999999999999998643    235578899999999 999999999999654  678999


Q ss_pred             EEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      |||+++++|..++   ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.+ +.++|+|||++...... ..
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~~  155 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA  155 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCccccccc-cc
Confidence            9999999998887   357899999999999999999997 699999999999999987 78999999998755322 22


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHH-HH---HhhcCCC
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN-AY---LNKYHLE  352 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~-~~---~~~~~~~  352 (419)
                      ....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||....  ................. ..   .......
T Consensus       156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCCC
Confidence            34567889999999876 678999999999999999999999985332  22222221111000000 00   0000000


Q ss_pred             CCh--hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          353 LDP--QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      ...  ..............    .......++.++++|+.+||..||++|||+.++++||||.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPP----PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             ccchhhHHHHHHHHhcCCC----ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            000  00000000000000    000112367889999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-41  Score=322.64  Aligned_cols=254  Identities=26%  Similarity=0.440  Sum_probs=207.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+...   ..+.+.+|+.+++.+ +|+|++++++++..  ....++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCEEEEe
Confidence            57899999999999999999999999999999998642   235678899999998 99999999999965  4678999


Q ss_pred             EEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-ce
Q 014762          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (419)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~  277 (419)
                      |||++++++..++  ..+++..+..++.|++.||.|||+.|++|+||||+|||++.+ +.++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             ecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEccCCccCcC
Confidence            9999999998886  357889999999999999999999999999999999999987 8899999999876544332 23


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ......+. ..+.+.                
T Consensus       174 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~-~~~~~~~~-~~~~~~----------------  234 (297)
T cd06656         174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-LRALYLIA-TNGTPE----------------  234 (297)
T ss_pred             cccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc-chheeeec-cCCCCC----------------
Confidence            3467888999999877 7789999999999999999999999843221 11111000 000000                


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                       ......++..+.+|+.+||+.||++|||++++++||||+..+.
T Consensus       235 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         235 -----------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             -----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence                             0011236788999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=317.43  Aligned_cols=252  Identities=24%  Similarity=0.386  Sum_probs=207.0

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+....    ...+.+|+.+++.+ +|+|++++++++.+.  ...++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKG--SKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEEC--CeEEEE
Confidence            46888999999999999999999999999999986432    35678999999999 899999999999654  678999


Q ss_pred             EEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Ccce
Q 014762          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (419)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~~~  277 (419)
                      +||+.++++..++.  .+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||+++..... ....
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeecccccccc
Confidence            99999999988874  57999999999999999999999999999999999999988 88999999999876543 2223


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...++..|+|||.+.+ ..++.++|||||||++|+|++|..||... +..+....+.....                   
T Consensus       157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~-------------------  215 (274)
T cd06609         157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNP-------------------  215 (274)
T ss_pred             cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCC-------------------
Confidence            4567788999999987 66999999999999999999999998432 21111111111000                   


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                      .......+++++.+++.+||..||++|||++++++||||+..+.
T Consensus       216 ----------------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         216 ----------------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             ----------------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence                            00000115788999999999999999999999999999997654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.4e-41  Score=311.39  Aligned_cols=245  Identities=22%  Similarity=0.436  Sum_probs=201.5

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.+.||+|+||.||+|.+..+++.|++|.+..     ...+.+.+|+.+++.+ +|||++++++++.+.  ...++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   77 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDK--GKLNIV   77 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccC--CEEEEE
Confidence            47889999999999999999999999999998853     2346788899999999 999999999999654  678999


Q ss_pred             EEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+++++|..++     ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||+++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-CCEEEcccccceeccCccc
Confidence            9999999998876     347888999999999999999999999999999999999988 7899999999886654332


Q ss_pred             -ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                       .....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||... +..+....+.+  +.               
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~--~~---------------  217 (256)
T cd08529         157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIR--GV---------------  217 (256)
T ss_pred             hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHc--CC---------------
Confidence             233467888999999877 67899999999999999999999998432 22221211111  00               


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                               .          ......++.++.+++++||+.+|++||++.++++|||+
T Consensus       218 ---------~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 ---------F----------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ---------C----------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                     0          00011267899999999999999999999999999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.7e-41  Score=310.80  Aligned_cols=246  Identities=23%  Similarity=0.395  Sum_probs=200.2

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.+.||.|++|.||++.+..+++.+|+|.+...     ..+.+.+|+.+++.+ +|+|++++++.+... ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGE-DGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCC-CCEEEEE
Confidence            589999999999999999999999999999998532     235678899999999 899999999987533 3457899


Q ss_pred             EEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||++++++..++     ..+++.++..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++........
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEecccCC
Confidence            9999999998765     248999999999999999999999999999999999999987 7899999999976643222


Q ss_pred             -ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                       .....++..|+|||++.+ ..++.++|+|||||++++|++|+.||.. .+..+....+...  ..              
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~-~~~~~~~~~~~~~--~~--------------  219 (257)
T cd08223         158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEG--KL--------------  219 (257)
T ss_pred             ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhc--CC--------------
Confidence             233467888999999877 6789999999999999999999999842 2222222111110  00              


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                          ...+...++++.+|+.+||+.||++|||+.++++||||
T Consensus       220 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 --------------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             --------------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                00012368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-41  Score=316.58  Aligned_cols=262  Identities=21%  Similarity=0.315  Sum_probs=205.1

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++|+..++||.|++|.||+|.+..+++.+|+|.+...    ....+.+|+++++++ +||||++++++|.+......++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence            4789999999999999999999999999999998643    235688999999999 89999999999976666678999


Q ss_pred             EEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      |||+++++|.+++       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeecccccccccc
Confidence            9999999997764       247888999999999999999999999999999999999987 78999999998654322


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .. ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+....+.......         
T Consensus       159 ~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------  227 (287)
T cd06621         159 LA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE---------  227 (287)
T ss_pred             cc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh---------
Confidence            21 23456778999999876 67899999999999999999999998543221000011111000000000         


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                     ...  ........++++.+|+.+||..||++|||+.|+++||||++..
T Consensus       228 ---------------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         228 ---------------LKD--EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             ---------------hcc--CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                           000  0000012467899999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-41  Score=316.13  Aligned_cols=278  Identities=33%  Similarity=0.532  Sum_probs=213.7

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++..     ..+.+.+|+.+++.+ +|+||+++++++..  ....++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~i   77 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRR--KGRLYL   77 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEE--CCEEEE
Confidence            4799999999999999999999999999999988642     246788999999999 89999999999965  467899


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC--
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~--  274 (419)
                      +|||++++++..+.   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.+||+|||++.......  
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~~  156 (288)
T cd07833          78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARPAS  156 (288)
T ss_pred             EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCccc
Confidence            99999998887655   348899999999999999999999999999999999999987 889999999987765433  


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|+|||++.+...++.++|+||||+++|+|++|+.|| .+.+..+.+..+...++...........   ..
T Consensus       157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  232 (288)
T cd07833         157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF-PGDSDIDQLYLIQKCLGPLPPSHQELFS---SN  232 (288)
T ss_pred             cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHhhhcc---cC
Confidence            2234567788999999987447899999999999999999999877 4455556666666655543332111100   00


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      +.+...  ..................++.++++|+++||..+|++|||++++++||||
T Consensus       233 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         233 PRFAGV--AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccccc--ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000000  00000000000111122358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.3e-41  Score=319.66  Aligned_cols=277  Identities=29%  Similarity=0.490  Sum_probs=210.6

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|++.++||+|+||.||+|.+..+++.+|+|.+...     ..+.+.+|+.+++.+ +||||+++++++.+  ....++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l   77 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRR--KKRLYL   77 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhccc--CCeEEE
Confidence            4799999999999999999999889999999987532     235678999999999 99999999999954  467899


Q ss_pred             EEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-c
Q 014762          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~  275 (419)
                      |+||++++++..+..   .+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus        78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~  156 (286)
T cd07846          78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEV  156 (286)
T ss_pred             EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCccc
Confidence            999999999887653   58999999999999999999999999999999999999988 789999999987654332 2


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+....+....+.........   ....+
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  232 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF-PGDSDIDQLYHIIKCLGNLIPRHQEI---FQKNP  232 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHHHhCCCchhhHHH---hccch
Confidence            233467888999999876556789999999999999999998776 44455556666665555422111000   00000


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ....  .......... ........++..+.+|+.+||+.+|++|||+.++++||||
T Consensus       233 ~~~~--~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         233 LFAG--MRLPEVKEIE-PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             Hhhc--cccccccCcc-hHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0000  0000000000 0000112478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.1e-41  Score=311.70  Aligned_cols=246  Identities=22%  Similarity=0.360  Sum_probs=203.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+...     ..+.+.+|+.+++.+ +|||++++++.+..  ....++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLE--DKALMIV   77 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEec--CCEEEEE
Confidence            588999999999999999999999999999998542     245788999999999 89999999999854  4678999


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+++++|..++.     .+++..+..++.|++.||+|||++|++|+||+|+||+++.+.+.++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999988763     3788999999999999999999999999999999999987756789999999987654444


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.. .+.......+.....                 
T Consensus       158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~-~~~~~~~~~~~~~~~-----------------  218 (256)
T cd08220         158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSGTF-----------------  218 (256)
T ss_pred             ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCccc-CchHHHHHHHHhcCC-----------------
Confidence            344567889999999876 6788999999999999999999999832 222222222111000                 


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                         ......++.++.+++.+||..||++|||+.|+++||||
T Consensus       219 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         219 -------------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             -------------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                               00011268899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.7e-41  Score=315.12  Aligned_cols=255  Identities=26%  Similarity=0.412  Sum_probs=203.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC---CCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~  197 (419)
                      ..++|++.+.||+|+||.||++.+..+++.+|+|++...  ....+.+|+.++.++.+|||++++++++....   ....
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            478899999999999999999999999999999998753  34567889999999878999999999986432   2468


Q ss_pred             EEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ++||||+++++|..++       ..+++..++.++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++...
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~-~~~kl~dfg~~~~~  178 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEeecccchhc
Confidence            9999999999998764       357899999999999999999999999999999999999987 78999999998765


Q ss_pred             cCCC-cceeecccccccccccccCCC----CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          271 HPGK-EYNVRVASRYFKGPELLVDLQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       271 ~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      .... ......++..|+|||++....    .++.++|+|||||++|+|++|+.||... +..+.+..+.+.  ..     
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~-~~~~~~~~~~~~--~~-----  250 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM-HPVKTLFKIPRN--PP-----  250 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHhcC--CC-----
Confidence            4322 123346788899999875422    3688999999999999999999998432 222222211110  00     


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                                             . .   .......+..+.+|+.+||+.||++|||+.|+++||||+
T Consensus       251 -----------------------~-~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 -----------------------P-T---LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             -----------------------C-C---CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                                   0 0   000112567899999999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-41  Score=315.73  Aligned_cols=276  Identities=33%  Similarity=0.612  Sum_probs=212.4

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      |++.++||.|+||.||+|.+..+++.+|+|.+...     ....+.+|+.+++.+ +|+|++++++++.+......++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence            67889999999999999999999999999999754     235678899999999 899999999999765346789999


Q ss_pred             EecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC--c
Q 014762          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--E  275 (419)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~--~  275 (419)
                      ||+++ ++..++    ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++.......  .
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCCccc
Confidence            99986 555554    258999999999999999999999999999999999999988 889999999998765433  2


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....++..|+|||.+.+...++.++||||||+++|+|++|+.||. ..+..+.+..+.+..+.+....+........  
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  234 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ-GSTELEQLEKIFELCGSPTDENWPGVSKLPW--  234 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCchhhccccccchh--
Confidence            2334667889999988765568999999999999999999998874 4445666666666666554433321111100  


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                       ..   ...................+++++.+++++||++||++|||++++++||||
T Consensus       235 -~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         235 -FE---NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             -hh---hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence             00   000001111111111111248899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=323.58  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=204.3

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||+||+|.+..+++.+|+|.+...      ..+.+.+|+.+++.+ +|+||+++++.+.+  ....+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~   77 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQT--ETYLC   77 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeec--CCEEE
Confidence            4799999999999999999999999999999998643      234578899999999 89999999999955  46789


Q ss_pred             EEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          199 LIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      +||||+.+++|..++.     .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhccccc
Confidence            9999999999988762     47899999999999999999999999999999999999987 78999999998654321


Q ss_pred             Cc------------------------------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 014762          274 KE------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG  323 (419)
Q Consensus       274 ~~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~  323 (419)
                      ..                              .....|+..|+|||++.+ ..++.++||||||+++|+|++|..||. +
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~-~  234 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK-G  234 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCC-C
Confidence            11                              112356788999999977 678999999999999999999999984 3


Q ss_pred             CCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-
Q 014762          324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-  402 (419)
Q Consensus       324 ~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-  402 (419)
                      .+..+.+..+..   ..                          ..+.      ....+++++.+++.+||..||++||| 
T Consensus       235 ~~~~~~~~~~~~---~~--------------------------~~~~------~~~~~~~~~~~li~~~l~~~p~~R~s~  279 (316)
T cd05574         235 SNRDETFSNILK---KE--------------------------VTFP------GSPPVSSSARDLIRKLLVKDPSKRLGS  279 (316)
T ss_pred             CchHHHHHHHhc---CC--------------------------ccCC------CccccCHHHHHHHHHHccCCHhHCCCc
Confidence            333333322211   00                          0000      01115889999999999999999999 


Q ss_pred             ---HHHHhcCCCccccc
Q 014762          403 ---AREAMVISSISPIF  416 (419)
Q Consensus       403 ---a~elL~hp~f~~~~  416 (419)
                         ++++|+||||++++
T Consensus       280 ~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         280 KRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             hhhHHHHHcCchhhcCC
Confidence               99999999999763

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.7e-41  Score=318.43  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=201.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc----CCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~  196 (419)
                      ..+.|++.+.||.|+||+||+|.+..+++.+|+|++...  ....+..|+.+++++.+|+|++++++++...    ....
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            357889999999999999999999999999999998643  3456788999999987799999999998532    2457


Q ss_pred             cEEEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      .+++|||++++++..++.     .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~-~~~~l~dfg~~~~~~  172 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD  172 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCcchhhhh
Confidence            899999999999987762     37888889999999999999999999999999999999988 789999999987543


Q ss_pred             CC-CcceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          272 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       272 ~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .. .......++..|+|||.+..    ...++.++|+|||||++|+|++|..||.... ..+....+..   ..      
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-~~~~~~~~~~---~~------  242 (282)
T cd06636         173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-PMRALFLIPR---NP------  242 (282)
T ss_pred             ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-HHhhhhhHhh---CC------
Confidence            22 12234567888999999752    2468889999999999999999999984321 1111111000   00      


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                                ........++.++.+||++||..||++|||+.|+|+||||
T Consensus       243 --------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         243 --------------------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --------------------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                      0000012368899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8.3e-42  Score=317.84  Aligned_cols=251  Identities=23%  Similarity=0.404  Sum_probs=201.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .++|++.++||+|+||.||+|.+..+++.+|+|.++...   ...+.+|+.+++.+ +||||+++++.+...  ...+++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~--~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRR--DKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeC--CEEEEE
Confidence            568899999999999999999999999999999987543   34577899999999 999999999999654  678899


Q ss_pred             EEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-c
Q 014762          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  276 (419)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~  276 (419)
                      |||+++++|..++   ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++........ .
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECcceeeeEccCccccc
Confidence            9999999998876   458999999999999999999999999999999999999987 7899999999876543221 2


Q ss_pred             eeeccccccccccccc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          277 NVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~--~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ....++..|+|||++.  ....++.++|+|||||++|+|++|..||+...... ....+..  ..           .   
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~~~~~~~--~~-----------~---  226 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMTK--SN-----------F---  226 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-hHHhhhc--cC-----------C---
Confidence            3346888999999874  22468899999999999999999999985432211 1111100  00           0   


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISS  411 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~  411 (419)
                                ....+      .....++..+.+|+.+||+.||++|||++++++|||
T Consensus       227 ----------~~~~~------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         227 ----------QPPKL------KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             ----------CCCcc------cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                      00000      001126788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=332.75  Aligned_cols=243  Identities=16%  Similarity=0.337  Sum_probs=195.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      -+...+...||+|+||+||+|.+-   -.||||+++.     ...+.|++|+.++++- +|-||+-+.|+|..+  .. .
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p--~~-A  463 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNP--PL-A  463 (678)
T ss_pred             HHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCC--ce-e
Confidence            455678899999999999999763   3699999963     3457899999999998 999999999999664  33 8


Q ss_pred             EEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee---cc
Q 014762          199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YH  271 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~---~~  271 (419)
                      +|..+|+|.+|..++.    +|.....+.|++|+++|+.|||.++|||||||..||++.++ ++|||+|||++..   ..
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~  542 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWS  542 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeeeeeec
Confidence            9999999999998873    58888899999999999999999999999999999999998 8999999999853   22


Q ss_pred             CCCcceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-cCCchHHHHHhh
Q 014762          272 PGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV-LGTDELNAYLNK  348 (419)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~-lg~~~~~~~~~~  348 (419)
                      .........+...|||||++..  ..+|++.+|||||||++|||++|..||.  ..+.+++.-++.. .+.++..     
T Consensus       543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmVGrG~l~pd~s-----  615 (678)
T KOG0193|consen  543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMVGRGYLMPDLS-----  615 (678)
T ss_pred             cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEecccccCccch-----
Confidence            2333445677888999999964  2478999999999999999999999984  4444433222110 0001110     


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                 .....++.++++|+..||.+++++||+..++|.
T Consensus       616 ---------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  616 ---------------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ---------------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                                       011237789999999999999999999998876

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-41  Score=316.69  Aligned_cols=252  Identities=24%  Similarity=0.394  Sum_probs=200.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ..++|++.++||+|+||.||+|.+..+++.||+|++...   ....+.+|+.+++.+ +||||+++++++...  ...++
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~--~~~~i   83 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSR--EKLWI   83 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC--CEEEE
Confidence            467899999999999999999999999999999998643   234677899999999 999999999999654  67889


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      ||||+++++|..++   ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++........ 
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-GDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEECcCccceeecccccc
Confidence            99999999998875   358899999999999999999999999999999999999987 7899999999976543221 


Q ss_pred             ceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .....++..|+|||.+..  ...++.++|+|||||++|+|++|+.||+..... +....+...                 
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-~~~~~~~~~-----------------  224 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMSKS-----------------  224 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-hhheeeecC-----------------
Confidence            233467788999998742  245788999999999999999999998432211 110000000                 


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISS  411 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~  411 (419)
                               ......+      .....++..+.+|+++||+.||++|||++++++|+|
T Consensus       225 ---------~~~~~~~------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 ---------NFQPPKL------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ---------CCCCCCC------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                     0000000      001236789999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-41  Score=338.48  Aligned_cols=281  Identities=20%  Similarity=0.251  Sum_probs=198.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCC-cEEEEE------------------EecC--cchHHHHHHHHHHHHhcCCCCe
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIK------------------ILKP--VKKKKIKREIKILQNLCGGPNV  182 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vavK------------------~~~~--~~~~~~~~E~~~l~~l~~h~ni  182 (419)
                      .++|+++++||+|+||+||+|...... ...+.|                  .+..  .....+.+|+.+++++ +||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCc
Confidence            578999999999999999998754322 222222                  1111  1134578999999999 99999


Q ss_pred             eEEEeEEEccCCCccEEEEEecCCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC
Q 014762          183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (419)
Q Consensus       183 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~  255 (419)
                      +++++++...  ...+++++++.+..+.....       ......++.++.|++.||+|||++||+||||||+|||++.+
T Consensus       226 v~l~~~~~~~--~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        226 LKIEEILRSE--ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             CcEeEEEEEC--CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            9999999665  56789999987655544321       23456678899999999999999999999999999999988


Q ss_pred             CCcEEEEecccceeccCCCcc--eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--CCHHHHH
Q 014762          256 LRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLV  331 (419)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~--~~~~~~~  331 (419)
                       +.+||+|||+++........  ....||..|+|||++.+ ..++.++|||||||++|||++|..+++...  ....++.
T Consensus       304 -~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        304 -GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             -CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence             88999999999876543221  23578999999999987 779999999999999999999987654332  3445666


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccC-CCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRH-SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVIS  410 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp  410 (419)
                      +++..++....+ +..     ....+....... .......+........++.++.+++.+||++||++||||.|+|+||
T Consensus       382 ~~~~~~~~~~~~-~p~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp  455 (501)
T PHA03210        382 KIIDSLSVCDEE-FPD-----PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP  455 (501)
T ss_pred             HHHHhcccChhh-cCC-----cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence            666655532211 000     000000000000 0000000000011123677899999999999999999999999999


Q ss_pred             Ccccc
Q 014762          411 SISPI  415 (419)
Q Consensus       411 ~f~~~  415 (419)
                      ||...
T Consensus       456 ~f~~~  460 (501)
T PHA03210        456 LFSAE  460 (501)
T ss_pred             hhhcC
Confidence            99864

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=317.97  Aligned_cols=254  Identities=25%  Similarity=0.410  Sum_probs=205.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .++|++.++||.|+||+||+|.+..++..+|+|.++...   .+.+.+|+.+++++ +|||++++++.+..+  ...++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYE--NKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecC--CeEEEE
Confidence            467999999999999999999998899999999986443   34678899999999 899999999999654  678899


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-c
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~  275 (419)
                      |||++++++..++    ..+++..++.++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++....... .
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhcccccc
Confidence            9999999998876    348999999999999999999999999999999999999988 889999999886543222 2


Q ss_pred             ceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          276 YNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      .....++..|++||++..    ...++.++|+|||||++|+|++|+.||. +.+..+....+..  +..           
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~--~~~-----------  225 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH-ELNPMRVLLKILK--SEP-----------  225 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc-cCCHHHHHHHHhc--CCC-----------
Confidence            234567888999999752    2457889999999999999999999984 2222222211111  000           


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                        .   .......++.++.+|+.+||+.||++|||+.++++||||+...
T Consensus       226 ------------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         226 ------------------P---TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             ------------------C---CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence                              0   0001123678999999999999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-43  Score=335.54  Aligned_cols=249  Identities=27%  Similarity=0.411  Sum_probs=205.1

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..|+.++.||.|+||.||.|++..+.+.||||.++-+      .-.++..|+..|.++ .|||++.+.|+|..+  ...+
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre--~TaW  102 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLRE--HTAW  102 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeecc--chHH
Confidence            3577789999999999999999999999999998632      235688999999999 999999999999765  4566


Q ss_pred             EEEEecCCC--C-hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNST--D-FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~--~-l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      ||||||-|.  + +..+.+++.+.++..|..+.+.||+|||+.+.||||||..|||+++. +.|||+|||.|....+.  
T Consensus       103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~~PA--  179 (948)
T KOG0577|consen  103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-GLVKLADFGSASIMAPA--  179 (948)
T ss_pred             HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-CeeeeccccchhhcCch--
Confidence            999999775  3 33444779999999999999999999999999999999999999988 89999999999876543  


Q ss_pred             ceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       +..+||++|||||+++.  .+.|+-++||||||++..||...+.|+|+ .+-...+..|... ..|.+.          
T Consensus       180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn-MNAMSALYHIAQN-esPtLq----------  246 (948)
T KOG0577|consen  180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQN-ESPTLQ----------  246 (948)
T ss_pred             -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC-chHHHHHHHHHhc-CCCCCC----------
Confidence             45799999999999964  46799999999999999999999999863 2222233333321 111111          


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                              ....|+.++.|+..||+.-|++|||++++|.|+|...-|
T Consensus       247 ------------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  247 ------------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             ------------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence                                    112478899999999999999999999999999976544

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.7e-41  Score=324.34  Aligned_cols=282  Identities=29%  Similarity=0.522  Sum_probs=208.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC------
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS------  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------  194 (419)
                      ..+|++.+.||.|+||+||+|.+..+|+.||+|.+...   ..+.+.+|+.+++.+ +||||+++++.+.....      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccc
Confidence            57899999999999999999999999999999998643   245678899999999 99999999987754321      


Q ss_pred             ------CccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          195 ------KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       195 ------~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                            ...++||||+++ ++...+  ..+++..++.++.|++.||.|||+.|++||||||+||+++.+.+.++|+|||.
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~  161 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL  161 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence                  246899999985 666655  35899999999999999999999999999999999999987657889999999


Q ss_pred             ceeccCCC----cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchH
Q 014762          267 AEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL  342 (419)
Q Consensus       267 a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~  342 (419)
                      ++......    ......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+....+.+.......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA-GAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCh
Confidence            97653221    11223567889999987665678899999999999999999999984 33444444444443332222


Q ss_pred             HHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      ........ ....... ........+...+     ...++.++.+|+.+||+.||++|||+.++++||||+.+
T Consensus       241 ~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         241 EDRNELLN-VIPSFVR-NDGGEPRRPLRDL-----LPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HHhhhhhh-hhhhhhh-hcccccCCCHHHH-----ccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            11110000 0000000 0000111111111     12378899999999999999999999999999999743

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.4e-41  Score=316.40  Aligned_cols=251  Identities=25%  Similarity=0.395  Sum_probs=201.8

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      -|++.+.||+|+||.||+|.+..++..+++|.+....   .+.+.+|+.+++.+ +|||++++++++...  ...++|+|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~--~~~~~v~e   82 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYE--NNLWILIE   82 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeC--CEEEEEEE
Confidence            3678889999999999999999999999999986433   35678899999999 999999999999654  67889999


Q ss_pred             ecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cce
Q 014762          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (419)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~  277 (419)
                      |++++++..++    ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++....... ...
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-CCEEEccccccccccccccccc
Confidence            99999998764    358999999999999999999999999999999999999987 789999999986543221 223


Q ss_pred             eecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          278 VRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      ...++..|+|||++..    ...++.++|+|||||++|+|++|+.||.. .+..+....+......              
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~--------------  226 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPP--------------  226 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc-cCHHHHHHHHhhcCCC--------------
Confidence            3467888999999742    24578899999999999999999999842 2222222222111000              


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                          ....+..++.++.+||.+||+.||++|||++++++||||+..
T Consensus       227 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         227 --------------------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             --------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                                000012367899999999999999999999999999999854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.4e-41  Score=312.38  Aligned_cols=249  Identities=26%  Similarity=0.442  Sum_probs=204.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .++|++.+.||+|+||.||+|.+..++..+++|.++... .+.+.+|+.+++.+ +|+|++++++++.+.  ...++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFKN--TDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecC--CcEEEEEe
Confidence            467999999999999999999998889999999987543 57889999999999 999999999999654  77899999


Q ss_pred             ecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cce
Q 014762          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (419)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~  277 (419)
                      |++++++..++    ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....... ...
T Consensus        79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-CcEEEcccccchhcccCccccc
Confidence            99999998876    357999999999999999999999999999999999999988 789999999987654333 223


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...++..|+|||++.+ ..++.++||||||+++|+|++|+.||..... .+....+.. ..                   
T Consensus       158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-~~~~~~~~~-~~-------------------  215 (256)
T cd06612         158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHP-MRAIFMIPN-KP-------------------  215 (256)
T ss_pred             cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcch-hhhhhhhcc-CC-------------------
Confidence            3457888999999876 6789999999999999999999999843211 111100000 00                   


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                              ..      .......++.++.+++.+||+.||++|||+.|+|+||||
T Consensus       216 --------~~------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         216 --------PP------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             --------CC------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                    00      000112367889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.9e-41  Score=314.42  Aligned_cols=273  Identities=29%  Similarity=0.581  Sum_probs=208.9

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      +|++.++||.|++|+||+|.+..+|+.||+|.++..    ..+.+.+|+.+++.+ +|+||+++++++.+.  ...++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTE--NKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeC--CcEEEEE
Confidence            588999999999999999999999999999998643    235677899999999 899999999999664  6778999


Q ss_pred             EecCCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          202 EYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       202 e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      ||+++ ++..++      ..+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++....... 
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVN  155 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCcc
Confidence            99996 555443      247999999999999999999999999999999999999987 789999999987543321 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|++||.+.+...++.++|+|||||++|+|++|..||. +.+..+....+.+..+.+....+..-...   
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP-GTNNEDQLLKIFRIMGTPTESTWPGISQL---  231 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCChhhHHHHhcC---
Confidence            22334567889999998765567899999999999999999998874 45556666666666555443322111100   


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      +.+............     ......++.++.+++.+||+.||++|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDL-----QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHH-----HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            000000000000000     00011357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.3e-41  Score=311.66  Aligned_cols=249  Identities=23%  Similarity=0.383  Sum_probs=199.9

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+...        ..+.+.+|+.+++.+ .||||+++++++.+.....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence            5789999999999999999999999999999987421        124678899999999 9999999999987655567


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++++|||+++++|..++   ..+++..+..++.|++.||+|||+++++|+||||+||+++.+ +.++|+|||+++.....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCccccccccc
Confidence            88999999999998876   457888899999999999999999999999999999999987 78999999998754321


Q ss_pred             ----CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       274 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                          .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... +.....   .+....+.        
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~---~~~~~~~~--------  226 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEF-EAMAAI---FKIATQPT--------  226 (265)
T ss_pred             cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCcc-chHHHH---HHHhcCCC--------
Confidence                11223457788999999877 67899999999999999999999998421 111111   11111000        


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                                              ....+..++..+.+++++|+. +|++|||++|+++|||++
T Consensus       227 ------------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ------------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ------------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                    000012257789999999994 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=7.2e-41  Score=314.71  Aligned_cols=254  Identities=28%  Similarity=0.449  Sum_probs=202.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEc---cCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRD---QHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~~  197 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.+|+|+++...  ...+.+|+.+++.+.+|||++++++++..   ..+...
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            4788999999999999999999999999999999986532  35688899999998679999999998753   234578


Q ss_pred             EEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ++||||+++++|..++       ..+++..+..++.|++.||.|||+++++|+||||+||+++.+ +.++|+|||+++..
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~  174 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQL  174 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC-CCEEEccCCceeec
Confidence            9999999999997754       347888899999999999999999999999999999999988 77999999998765


Q ss_pred             cCCC-cceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          271 HPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       271 ~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      .... ......++..|+|||++..    ...++.++|||||||++|+|++|+.||.... ..+.+..+..   .      
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~-~~~~~~~~~~---~------  244 (286)
T cd06638         175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH-PMRALFKIPR---N------  244 (286)
T ss_pred             ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc-hhHHHhhccc---c------
Confidence            4322 2233468889999998753    1457889999999999999999999984321 1111111000   0      


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                            ...   .......++.++.+++.+||+.||++|||+.|+++|+||
T Consensus       245 ----------------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         245 ----------------------PPP---TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ----------------------CCC---cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                                  000   000112257789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.3e-41  Score=313.01  Aligned_cols=251  Identities=24%  Similarity=0.421  Sum_probs=201.6

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      +|+..+.||+|+||.||+|.+..+++.+|+|.++...         .+.+.+|+.+++++ +|+|++++++++.+  ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~   77 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCE--DSH   77 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceecc--CCe
Confidence            4777889999999999999999999999999986422         35688999999999 99999999999954  467


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++|+||+.+++|..++   ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+...++|+|||.+......
T Consensus        78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            88999999999998876   458889999999999999999999999999999999999877457999999998765432


Q ss_pred             Cc-----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          274 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       274 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ..     .....++..|+|||.+.+ ..++.++|+||+||++++|++|..||..... ......+.+....         
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~---------  226 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-SNHLALIFKIASA---------  226 (268)
T ss_pred             cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC-cchHHHHHHHhcc---------
Confidence            11     122457788999999876 6789999999999999999999999843221 1111111110000         


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                                             ......+..+++++.+++.+||..+|++|||+.++++||||+
T Consensus       227 -----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         227 -----------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             -----------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                   000011123678999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.1e-41  Score=325.00  Aligned_cols=284  Identities=32%  Similarity=0.574  Sum_probs=217.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|.+..     .....+.+|+.++.++.+||||++++++|........+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            5789999999999999999999998999999998743     22345778999999987899999999999766556789


Q ss_pred             EEEEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC--
Q 014762          199 LIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~--  274 (419)
                      +||||+++ ++..++.  .+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++.......  
T Consensus        86 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~~~~~~  163 (337)
T cd07852          86 LVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEEN  163 (337)
T ss_pred             EEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhcccccccc
Confidence            99999985 6666653  47888888999999999999999999999999999999988 889999999987654322  


Q ss_pred             ----cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          275 ----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       275 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                          ......++..|+|||.+.+...++.++|+|||||++|+|++|+.|| .+....+....+....+......+..-. 
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  241 (337)
T cd07852         164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF-PGTSTLNQLEKIIEVIGPPSAEDIESIK-  241 (337)
T ss_pred             ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHHH-
Confidence                1123457888999999876567889999999999999999999987 4556666777777766654433221100 


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      .....   ............... . ....++.++.+|+.+||+.||++|||+.++++||||+.+.
T Consensus       242 ~~~~~---~~~~~~~~~~~~~~~-~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         242 SPFAA---TMLDSLPSRPRKPLD-E-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             hhhHH---Hhhhhcccccccchh-h-hccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence            00000   001110111111000 1 1122688999999999999999999999999999998763

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=319.71  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=207.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .+-|.++++||+|+||.||+|.++.+|+.+|||.+.. .+.+++..|+.||+++ ..|++|++||.+-.  ...+++|||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK--~sDLWIVME  108 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFK--HSDLWIVME  108 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhcc--CCceEeehh
Confidence            3457889999999999999999999999999999864 4568899999999998 99999999997643  256789999


Q ss_pred             ecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cce
Q 014762          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (419)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~  277 (419)
                      ||..|+..+.+    +.+++.++..++++.++||+|||...-+|||||..|||++.+ +.+||+|||.|..+.+.. ..+
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-chhhhhhccccchhhhhHHhhC
Confidence            99999988875    569999999999999999999999999999999999999999 899999999996654322 235


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...||+.|||||++.. -.|+.++||||||++..||..|+.||..-+.    +..|.                       
T Consensus       188 TVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHP----MRAIF-----------------------  239 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHP----MRAIF-----------------------  239 (502)
T ss_pred             ccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccc----cceeE-----------------------
Confidence            5789999999999987 6799999999999999999999999821111    11000                       


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                           -...++...|-..   +..|+++.||+++||..+|++|.||.++++|||.++.
T Consensus       240 -----MIPT~PPPTF~KP---E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  240 -----MIPTKPPPTFKKP---EEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             -----eccCCCCCCCCCh---HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence                 0111111222111   2258899999999999999999999999999999865

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.9e-41  Score=312.03  Aligned_cols=245  Identities=27%  Similarity=0.493  Sum_probs=198.0

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      +|.+...||.|+||.||+|.+..+++.+|+|.+....            .+.+.+|+.+++++ +||||+++++++.+. 
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-   78 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDA-   78 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC-
Confidence            4677889999999999999998899999999885321            14577899999999 999999999999654 


Q ss_pred             CCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                       ...+++|||+++++|..++   ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||.++..
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~  156 (267)
T cd06628          79 -DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKL  156 (267)
T ss_pred             -CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCccc
Confidence             6788999999999998877   357888999999999999999999999999999999999987 78999999998766


Q ss_pred             cCCCc-------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHH
Q 014762          271 HPGKE-------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (419)
Q Consensus       271 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~  343 (419)
                      .....       .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... +.......+...       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~-------  227 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDC-TQLQAIFKIGEN-------  227 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCc-cHHHHHHHHhcc-------
Confidence            42211       112346778999999876 67889999999999999999999998432 111111111100       


Q ss_pred             HHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                                   ........++.++.++|++||+.||++|||+.++++||||
T Consensus       228 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         228 -----------------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             -----------------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                         0000112368899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=310.63  Aligned_cols=250  Identities=26%  Similarity=0.440  Sum_probs=211.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|..++.||+|.||+|-+++.+.+++.+|+|++++.      ....-..|-.+|+.. .||.+..+.-.|  +....
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsF--Qt~dr  242 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSF--QTQDR  242 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhh--ccCce
Confidence            357899999999999999999999999999999999753      234456788999998 999999998888  44578


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-  272 (419)
                      +|.||||.+||.|..++   +.+++...+.+-.+|..||.|||+++||+||||.+|.|+|.+ |++||.|||+++.... 
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC-CceEeeecccchhcccc
Confidence            99999999999987776   459999999999999999999999999999999999999999 8999999999976433 


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      +......+||+.|.|||++.+ ..|+.++|.|.+||++|||++|+.||++. ++...+..|...                
T Consensus       322 g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~-dh~kLFeLIl~e----------------  383 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNK-DHEKLFELILME----------------  383 (516)
T ss_pred             cceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCccccc-chhHHHHHHHhh----------------
Confidence            445567899999999999987 89999999999999999999999999643 222223222210                


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                           ....+..++++++.|+..+|..||.+|.     .|.|+++|+||..|
T Consensus       384 ---------------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  384 ---------------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             ---------------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence                                 0011223899999999999999999998     68999999999876

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-41  Score=310.22  Aligned_cols=250  Identities=26%  Similarity=0.461  Sum_probs=202.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .++|++.+.||.|+||.||+|.+..+++.+++|++...   ..+.+.+|+.+++.+ +||||+++++++.+.  ...+++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRR--DKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEeC--CEEEEE
Confidence            46899999999999999999999999999999998643   346788999999999 999999999998654  678999


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-c
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~  275 (419)
                      |||++++++..++    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+....... .
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-CCEEECccccchhhhhhhhc
Confidence            9999999998875    468999999999999999999999999999999999999987 789999999987654322 2


Q ss_pred             ceeecccccccccccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-cCCchHHHHHhhcCCC
Q 014762          276 YNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV-LGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~-lg~~~~~~~~~~~~~~  352 (419)
                      .....++..|+|||.+.+.  ..++.++|+|||||++|+|++|+.||.... ..+....+... +..+.           
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~-~~~~~~~~~~~~~~~~~-----------  225 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH-PMRALFLISKSNFPPPK-----------  225 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCcc-----------
Confidence            2334677889999998652  278899999999999999999999985322 22222111110 00000           


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISS  411 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~  411 (419)
                                            .......+.++.+|+++||..||++|||+.+++.|||
T Consensus       226 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         226 ----------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ----------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                                  0001125678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-40  Score=321.33  Aligned_cols=282  Identities=31%  Similarity=0.553  Sum_probs=213.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC---
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (419)
                      ..++|++.+.||+|+||+||+|.+..++..||+|.+...     ..+.+.+|+.+++.+ +||||+++++++.....   
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccc
Confidence            467899999999999999999999999999999998532     124577899999999 99999999999865422   


Q ss_pred             -CccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          195 -KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       195 -~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                       ...++||||+ ++++..+.  ..+++..++.++.|++.||+|||+.||+||||||+||+++.+ +.++|+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~  169 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQTD  169 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccccccc
Confidence             2458999999 56777665  468999999999999999999999999999999999999987 789999999987653


Q ss_pred             CCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      ..  .....++..|++||.+.+...++.++|+|||||++|++++|..||. +.+.......+.+..+..+.. +......
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  245 (343)
T cd07880         170 SE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK-GHDHLDQLMEIMKVTGTPSKE-FVQKLQS  245 (343)
T ss_pred             cC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCHH-HHHhhcc
Confidence            22  2234567889999998764568899999999999999999999984 444455566666555543322 1111111


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      .....   ............+.  .....+++++.++|.+||+.||++|||+.+++.||||+..+
T Consensus       246 ~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         246 EDAKN---YVKKLPRFRKKDFR--SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             hhHHH---HHHhccccCcchHH--HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            10001   11111111011000  11134788999999999999999999999999999998764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-41  Score=322.89  Aligned_cols=281  Identities=34%  Similarity=0.610  Sum_probs=220.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC---CCcc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SKTP  197 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~~~  197 (419)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+...     ..+.+.+|+.+++.+ +|+||+++++++....   ....
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence            588999999999999999999889999999998643     235788999999999 8999999999986542   2467


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +++|||+++ ++...+   ..+++..+..++.|++.||+|||++|++|+||||+|||++.+ +.++|+|||++.......
T Consensus        80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeecccc
Confidence            999999985 565554   358999999999999999999999999999999999999988 899999999998765443


Q ss_pred             ----cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          275 ----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       275 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                          ......++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+.+..+....+....|.+....+... .
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~-~  235 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-PGRDYIDQLNLIVEVLGTPSEEDLKFI-T  235 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHhcCCCChhHhhhc-c
Confidence                2334567888999999987447899999999999999999999887 555667777788887777665443210 0


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ......+-..........+....     ..++.++.+||++||++||++|||++++++||||++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLF-----PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhc-----ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            00001110001111111122111     22688999999999999999999999999999998765

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-40  Score=320.35  Aligned_cols=283  Identities=28%  Similarity=0.525  Sum_probs=213.4

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC--
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH--  193 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--  193 (419)
                      +...++|++.+.||+|+||.||+|.+..+++.||+|+++...     .+.+.+|+.++.++ +||||+++++++....  
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL   91 (345)
T ss_pred             hhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccc
Confidence            345789999999999999999999999999999999986432     34677899999999 9999999999886432  


Q ss_pred             --CCccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          194 --SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       194 --~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                        ....+++++++ ++++..++  ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++..
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~~~~  169 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARH  169 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC-CCEEEeccccccc
Confidence              23467888877 56776655  358999999999999999999999999999999999999988 7899999999876


Q ss_pred             ccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ...  ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+....+..+....+.+....... .
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~-~  245 (345)
T cd07877         170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKK-I  245 (345)
T ss_pred             ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHhh-c
Confidence            432  2233467888999999876567889999999999999999999987 44445556666666666544332211 0


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      .......+...........+...     ....++++.+||.+||+.||++|||+.++++||||++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANV-----FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhh-----cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence            00000000000001111111100     11257889999999999999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9e-41  Score=317.65  Aligned_cols=280  Identities=31%  Similarity=0.528  Sum_probs=211.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (419)
                      ..++|++.++||.|+||.||+|.+..+++.+|+|.+....     ...+.+|+.+++.+ +||||+++++++.+..    
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence            3689999999999999999999999999999999885321     24577899999999 9999999999876433    


Q ss_pred             --CCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          194 --SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       194 --~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                        ....++|+||+.+.....+.   ..+++..+..++.|+++||+|||++|++|+||||+||+++.+ +.++|+|||++.
T Consensus        85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~  163 (311)
T cd07866          85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLAR  163 (311)
T ss_pred             ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCccch
Confidence              23578999999875444333   358999999999999999999999999999999999999988 889999999987


Q ss_pred             eccCCCc------------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH
Q 014762          269 FYHPGKE------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV  336 (419)
Q Consensus       269 ~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~  336 (419)
                      .......            .....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+.......+.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~-~~~~~~~~~~~~~~~  242 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL-QGKSDIDQLHLIFKL  242 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHH
Confidence            5532221            112345778999999876556899999999999999999999887 566666677777776


Q ss_pred             cCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      .+.+....+...........      ............. ....+++.+.+|+.+||+.||++|||+.|++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEG------VHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hCCCChhhchhhhhcccccc------cccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            66554433322111111000      0000000000000 011256789999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-40  Score=309.94  Aligned_cols=252  Identities=23%  Similarity=0.389  Sum_probs=203.2

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++|++.+.||.|+||+||+|.+..++..+++|+++..    ..+.+.+|+.+++.+ +|+|++++++.+...  ...+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVG--DELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeC--CEEEEE
Confidence            4799999999999999999998889999999998642    246788999999999 999999999998654  678899


Q ss_pred             EEecCCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          201 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       201 ~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +|+++++++..++.      .+++..+..++.|++.||+|||+.|++|+||+|+||+++++ +.++|+|||++.......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGG  156 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccCc
Confidence            99999999988762      47889999999999999999999999999999999999987 789999999987654432


Q ss_pred             cc-----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          275 EY-----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       275 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ..     ....++..|++||++.....++.++|+|||||++|+|++|+.||... +..+.......   ...        
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~~---~~~--------  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY-PPMKVLMLTLQ---NDP--------  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc-ChhhhHHHHhc---CCC--------
Confidence            22     23357888999999877447899999999999999999999998432 22222221111   000        


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                          ...........+++++.+++.+||+.||++|||++++++||||
T Consensus       225 --------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         225 --------------------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             --------------------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                                0000000112368899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-40  Score=309.55  Aligned_cols=250  Identities=22%  Similarity=0.366  Sum_probs=196.9

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      +.+.....||+|+||.||+|.+..++..|++|.+....   .+.+.+|+.+++.+ +|+||+++++++...  ...++++
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~   84 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSEN--GFFKIFM   84 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccC--CEEEEEE
Confidence            33444567999999999999999999999999886543   35688999999999 999999999999654  6789999


Q ss_pred             EecCCCChhhhcC----CC--CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          202 EYVNSTDFKVLYP----TL--TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       202 e~~~~~~l~~~~~----~l--~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      ||+.+++|..++.    .+  ++..+..++.|++.||+|||++||+|+||||+||+++.+.+.++|+|||++........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            9999999988763    24  77888889999999999999999999999999999987557899999999876543222


Q ss_pred             -ceeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 -YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       .....++..|+|||++.+. ..++.++|+||||+++|+|++|+.||.............. ..+               
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~-~~~---------------  228 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG-MFK---------------  228 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-hhc---------------
Confidence             2234578889999998552 3478999999999999999999999843221111110000 000               


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                  .       ....+..+++++.+|+++||+.+|++|||+.|+++||||
T Consensus       229 ------------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 ------------I-------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ------------c-------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                        0       000112368899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.3e-41  Score=323.09  Aligned_cols=278  Identities=27%  Similarity=0.469  Sum_probs=211.1

Q ss_pred             CCCCeEE-EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-----------------HHHHHHHHHHHHhcCCCCeeE
Q 014762          123 DQDDYEV-VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------------KKIKREIKILQNLCGGPNVVK  184 (419)
Q Consensus       123 ~~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~E~~~l~~l~~h~niv~  184 (419)
                      ..++|.. .+.||.|+||+||+|.+..+++.||+|.++....                 ..+.+|+.+++.+ +|+||++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~   84 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMG   84 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceee
Confidence            3566764 4669999999999999999999999999864321                 1467899999999 9999999


Q ss_pred             EEeEEEccCCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEE
Q 014762          185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL  261 (419)
Q Consensus       185 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl  261 (419)
                      +++++...  ...++||||+.+ ++..++   ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|
T Consensus        85 ~~~~~~~~--~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl  160 (335)
T PTZ00024         85 LVDVYVEG--DFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKI  160 (335)
T ss_pred             eeEEEecC--CcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEE
Confidence            99999654  678999999985 666555   358999999999999999999999999999999999999988 78999


Q ss_pred             EecccceeccCC---------------CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC
Q 014762          262 IDWGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN  326 (419)
Q Consensus       262 ~Dfgla~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~  326 (419)
                      +|||++......               .......++..|+|||.+.+...++.++|+|||||++|+|++|..|| .+.++
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~-~~~~~  239 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF-PGENE  239 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCH
Confidence            999998765411               11122345778999999877556799999999999999999999887 45556


Q ss_pred             HHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014762          327 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  406 (419)
Q Consensus       327 ~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el  406 (419)
                      .+.+..+.+.++.+....+...........+.   . .......     ......++++.+++.+||+.||++|||++|+
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~  310 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFT---P-RKPKDLK-----TIFPNASDDAIDLLQSLLKLNPLERISAKEA  310 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccC---c-CCcccHH-----HhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence            66777777777765543322111110000000   0 0000000     0112357889999999999999999999999


Q ss_pred             hcCCCcccc
Q 014762          407 MVISSISPI  415 (419)
Q Consensus       407 L~hp~f~~~  415 (419)
                      |.||||+.-
T Consensus       311 l~~~~~~~~  319 (335)
T PTZ00024        311 LKHEYFKSD  319 (335)
T ss_pred             hcCcccCCC
Confidence            999999854

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1e-40  Score=309.36  Aligned_cols=247  Identities=27%  Similarity=0.442  Sum_probs=203.3

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.+.||.|+||+||++.+..++..+|+|.+...     ..+.+.+|+.+++.+ +|+|++++++++........+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence            588899999999999999999999999999998632     235678899999999 99999999998876656678999


Q ss_pred             EEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHH-----HCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCH-----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH-----~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                      |||+++++|..++       ..+++..+..++.|++.||.|||     +.+++|+||+|+||+++.+ +.+||+|||++.
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~~~  158 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAK  158 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEecccccc
Confidence            9999999998775       35788999999999999999999     8999999999999999987 899999999998


Q ss_pred             eccCCCc-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          269 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       269 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||... + .+.+.+.......        
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~-~~~~~~~~~~~~~--------  227 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTAR-N-QLQLASKIKEGKF--------  227 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCc-C-HHHHHHHHhcCCC--------
Confidence            7654433 234568889999999877 67899999999999999999999998432 2 2222111110000        


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                                 .......+.++.+++.+||+.+|++|||+.++++|||+
T Consensus       228 ---------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         228 ---------------------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ---------------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                                       00112367899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=311.26  Aligned_cols=254  Identities=24%  Similarity=0.394  Sum_probs=203.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----CCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  196 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.+++|+++...  .+.+.+|+.+++++.+|+||+++++++....    ...
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            4689999999999999999999998899999999987543  4678899999999867999999999997543    456


Q ss_pred             cEEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          197 PSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      .++||||++++++..++       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++..
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~~~~~~  162 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCCcccee
Confidence            88999999999887764       357899999999999999999999999999999999999988 8899999999876


Q ss_pred             ccCCC-cceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          270 YHPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       270 ~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      ..... ......++..|+|||++..    ...++.++|||||||++|+|++|..||... .......++...  ..    
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~--~~----  235 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPMRALFKIPRN--PP----  235 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc-chHHHHHHhhcc--CC----
Confidence            54322 2234567888999998753    135788999999999999999999998422 222222221110  00    


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                +               .   .......++++.+|+.+||..||++|||+.++++|||+
T Consensus       236 ----------~---------------~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 ----------P---------------T---LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ----------C---------------C---CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                      0               0   00011257889999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-41  Score=317.23  Aligned_cols=253  Identities=22%  Similarity=0.364  Sum_probs=202.7

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++|++++.||+|+||+||++.+..++..+|+|.++..    ....+.+|+.+++++ +||||+++++.+..  ....++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFI--EGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheec--CCeEEEE
Confidence            4688999999999999999999989999999988632    235688999999999 99999999999865  4678999


Q ss_pred             EEecCCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          201 FEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       201 ~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      |||++++++..++.      .+++..+..++.|++.||.|||+ .+++|+||||+||+++.+ +.++|+|||++......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccCC
Confidence            99999999987762      58899999999999999999997 599999999999999987 88999999998765322


Q ss_pred             CcceeecccccccccccccCC-----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          274 KEYNVRVASRYFKGPELLVDL-----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                       ......++..|+|||.+.+.     ..++.++|+|||||++|+|++|+.||.... .......+........       
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~-------  227 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGDP-------  227 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcCC-------
Confidence             22334677889999998542     235889999999999999999999984322 1222222111111000       


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                                ......+++++.+||.+||+.+|++|||+.++++||||...+
T Consensus       228 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         228 --------------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             --------------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence                                      000122688999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-42  Score=331.47  Aligned_cols=252  Identities=23%  Similarity=0.406  Sum_probs=209.1

Q ss_pred             CCCCe-EEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-------CcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDY-EVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-------~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++| +....||+|+|-+||+|.|..+|-.||--.++       +...++|..|+.+|+.| +||||+++++++.+...
T Consensus        37 p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n  115 (632)
T KOG0584|consen   37 PTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDN  115 (632)
T ss_pred             CCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCC
Confidence            34454 45667999999999999999999998843221       23347899999999999 99999999999998888


Q ss_pred             CccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC--CcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      +.+.+|+|.|..|+|..+.   +..+...++.+++||++||.|||++  .|+|||||-+||+|+.+.|.|||+|+|+|..
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            8899999999999999987   4678889999999999999999987  5999999999999999999999999999988


Q ss_pred             ccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ....... ..+||+.|||||++.  ..|+..+||||||++|+||+|+..||.-..+..+.+.+...  |..+....    
T Consensus       196 ~r~s~ak-svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~sl~----  266 (632)
T KOG0584|consen  196 LRKSHAK-SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAALS----  266 (632)
T ss_pred             hhccccc-eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHHhh----
Confidence            7654443 379999999999986  58999999999999999999999998444444444444433  22111110    


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                                   .--.+++++||.+||.. .++|+||.|+|.||||..
T Consensus       267 -----------------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  267 -----------------------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             -----------------------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                                         01267899999999999 999999999999999985

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.7e-40  Score=315.44  Aligned_cols=252  Identities=24%  Similarity=0.419  Sum_probs=201.8

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||.||++.+..+++.|++|.+....      .+.+.+|+.+++.+ +||||+++++.+..  ....+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~   77 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFET--KRHLC   77 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEec--CCEEE
Confidence            47899999999999999999999999999999986432      34577899999998 99999999999965  46789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||||+++++|..++   ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||+++.......
T Consensus        78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccCcCcc
Confidence            999999999998887   448889999999999999999999999999999999999987 8899999999864211100


Q ss_pred             ----------------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCC
Q 014762          276 ----------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (419)
Q Consensus       276 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~  339 (419)
                                      .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||. +.+..+....+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~-~~~~~~~~~~~~~~~~~  234 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISDDIE  234 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcccC
Confidence                            011346778999999877 678999999999999999999999984 22322222221110000


Q ss_pred             chHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCCCccccc
Q 014762          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMVISSISPIF  416 (419)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~elL~hp~f~~~~  416 (419)
                                                   +.     .....++.++.++|.+||+.||++|||   +.++|+||||...+
T Consensus       235 -----------------------------~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         235 -----------------------------WP-----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             -----------------------------CC-----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence                                         00     000126889999999999999999997   89999999997653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-41  Score=315.66  Aligned_cols=253  Identities=23%  Similarity=0.384  Sum_probs=205.1

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++|+..+.||.|+||.||++.+..+++.+|+|.+...    ..+.+.+|+.+++.+ +||||+++++.+...  ...+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNN--GDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecC--CEEEEE
Confidence            4678889999999999999999999999999998643    235688999999999 799999999999654  778999


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||+++++|..++    ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.+ +.++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhhHHHHh
Confidence            9999999998877    457889999999999999999999 999999999999999987 7899999999865543222


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH-HcCCchHHHHHhhcCCCCC
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-VLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~-~lg~~~~~~~~~~~~~~~~  354 (419)
                      .. ..++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.......+......+ ......             
T Consensus       157 ~~-~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------  221 (265)
T cd06605         157 KT-FVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------------  221 (265)
T ss_pred             hc-ccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-------------
Confidence            22 667888999999877 68999999999999999999999999644322222111111 111000             


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                     ..    .....+++++.++|.+||..||++|||+.+++.||||+..
T Consensus       222 ---------------~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         222 ---------------PR----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             ---------------CC----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                           00    0001168889999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.3e-40  Score=310.10  Aligned_cols=248  Identities=27%  Similarity=0.382  Sum_probs=193.7

Q ss_pred             CCeEEEeee--eeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          125 DDYEVVRKV--GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       125 ~~y~~~~~l--G~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      ++|++.+.+  |.|+||+||++.+..++..+|+|.+........  |+.....+.+|||++++++.+...  ...++|||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEE
Confidence            355555555  999999999999999999999999875433222  333333344799999999999664  57899999


Q ss_pred             ecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceee
Q 014762          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  279 (419)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~  279 (419)
                      |+++++|..++   ..+++..+..++.|++.||.|||+.|++|+||||+||+++.+.+.++|+|||+++......   ..
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~---~~  166 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CY  166 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc---cC
Confidence            99999998876   2589999999999999999999999999999999999999884489999999987654322   24


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      .++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.......-....+......                    
T Consensus       167 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------  225 (267)
T PHA03390        167 DGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK--------------------  225 (267)
T ss_pred             CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--------------------
Confidence            67888999999876 678999999999999999999999985322211111111111000                    


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCCCccc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-AREAMVISSISP  414 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-a~elL~hp~f~~  414 (419)
                                    .......+++.+.+||.+||+.||++|++ .+++|+||||++
T Consensus       226 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        226 --------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             --------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                          00001137899999999999999999996 599999999975

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-40  Score=307.95  Aligned_cols=245  Identities=21%  Similarity=0.437  Sum_probs=200.8

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.++||+|+||+||++.+..+|+.+|+|.+...     ..+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv   77 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEE--NGNLYIV   77 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecC--CCeEEEE
Confidence            588999999999999999999999999999988532     235788999999999 99999999999955  4678999


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||+.++++...+.     .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEEeeccceeecCcchh
Confidence            99999999887652     36888999999999999999999999999999999999987 7899999999976543322


Q ss_pred             c-eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          276 Y-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       276 ~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      . ....++..|+|||++.+ ..++.++|+|||||++++|++|+.||... +..+....+..  +..              
T Consensus       157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~--~~~--------------  218 (256)
T cd08218         157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIR--GSY--------------  218 (256)
T ss_pred             hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhc--CCC--------------
Confidence            1 23457788999999876 67889999999999999999999998532 22222221111  000              


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                          ......++.++.+++.+||+.+|++|||+.++++||||
T Consensus       219 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 --------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             --------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                                00112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.3e-41  Score=326.99  Aligned_cols=245  Identities=23%  Similarity=0.350  Sum_probs=192.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCC-----cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++.+.||+|+||.||+|.+...|     ..||+|.++...    .+.+.+|+.+++.+.+|+||+++++.|...  
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~--  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG--  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence            568999999999999999999865433     579999996432    346789999999987799999999999554  


Q ss_pred             CccEEEEEecCCCChhhhcC------------------------------------------------------------
Q 014762          195 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------  214 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  214 (419)
                      ...++||||+.+|+|..++.                                                            
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            67889999999999877641                                                            


Q ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcce---e
Q 014762          215 -------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---V  278 (419)
Q Consensus       215 -------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~---~  278 (419)
                                   .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.........   .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeeccC
Confidence                         25777889999999999999999999999999999999977 789999999997654332211   1


Q ss_pred             ecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ..++..|+|||++.+ ..++.++|||||||++|+|++ |+.||....... ....+... +.                  
T Consensus       274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~-~~------------------  332 (374)
T cd05106         274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKR-GY------------------  332 (374)
T ss_pred             CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHc-cc------------------
Confidence            234457999999876 779999999999999999997 999984322211 11111110 00                  


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                      .......+++++.+++.+||+.||++|||+.++++
T Consensus       333 ----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         333 ----------------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ----------------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            00001225789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-40  Score=314.77  Aligned_cols=278  Identities=27%  Similarity=0.548  Sum_probs=210.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC-----
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH-----  193 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  193 (419)
                      .++|++.+.||.|+||+||+|.+..+|+.||+|.++..     ....+.+|+.+++.+ +|||++++++++.+..     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhc
Confidence            57899999999999999999999999999999998632     224677899999999 8999999999986543     


Q ss_pred             ---CCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccc
Q 014762          194 ---SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (419)
Q Consensus       194 ---~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla  267 (419)
                         ....++|+||++++.+....   ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.+||+|||++
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~  163 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGLA  163 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeCccccc
Confidence               23789999999985444333   358999999999999999999999999999999999999988 88999999998


Q ss_pred             eeccCCC--cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          268 EFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       268 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      .......  ......++..|+|||.+.+...++.++|||||||++|+|++|+.||. ..+..+.+..+.+..+.+....+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ-ANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChhhc
Confidence            7654332  12223557789999988764567899999999999999999998874 44556666666666665443322


Q ss_pred             HhhcCCCCChhhHHhhccC-CCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          346 LNKYHLELDPQLDALVGRH-SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ..-.....   +....... ....+.     .....++..+.+++.+||+.||++|||+.+++.||||
T Consensus       243 ~~~~~~~~---~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPY---FNTMKPKKQYRRRLR-----EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccc---ccccccccccccchh-----hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            11000000   00000000 000000     0112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=9e-41  Score=313.86  Aligned_cols=236  Identities=18%  Similarity=0.209  Sum_probs=190.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEc--cCCCccEEEEE
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLIFE  202 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv~e  202 (419)
                      ..||+|++|.||+|..  +|+.||||.++...      .+.+.+|+.+|.++ +||||+++++++.+  +.....++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence            5699999999999976  78999999986432      25677999999999 99999999999976  44457889999


Q ss_pred             ecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCccee
Q 014762          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  278 (419)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~  278 (419)
                      |+++|+|..++   ..+++.....++.|++.||.|||+ .+++||||||+|||++.+ +.+||+|||+++......  ..
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~~--~~  179 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSPP--FK  179 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-CcEEEcccchHhhhcccc--cc
Confidence            99999999887   358888899999999999999998 499999999999999988 889999999987654322  23


Q ss_pred             ecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          279 RVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ..++..|+|||++.+. ..++.++|||||||++|||++|+.||.. .+..+....+.+.....                 
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~-----------------  241 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN-LTTKEIYDLIINKNNSL-----------------  241 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhcCCCC-----------------
Confidence            5678899999998652 5789999999999999999999999842 22222222221100000                 


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                        ..+..+++++.+|+.+||+.||++|||+.|+++
T Consensus       242 ------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 ------------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             ------------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                              001136889999999999999999999999986

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.4e-41  Score=311.35  Aligned_cols=247  Identities=26%  Similarity=0.426  Sum_probs=204.3

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      +|++.+.||.|+||.||+|.+..+++.+|+|.+...      ..+.+.+|+.+++++ +||||+++++.+.+  ....++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l   77 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQD--EENMYL   77 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcC--CCeEEE
Confidence            589999999999999999999999999999998632      246788999999999 99999999999954  467899


Q ss_pred             EEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      |+||+.+++|..++.   .+++..+..++.|+++||.|||++|++|+||+|+||+++.+ +.++|+|||++.........
T Consensus        78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccCCCccc
Confidence            999999999988762   68999999999999999999999999999999999999988 78999999998776554444


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......  ....+.+.....                
T Consensus       157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~----------------  217 (258)
T cd05578         157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETA----------------  217 (258)
T ss_pred             cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhccc----------------
Confidence            45667888999999876 66899999999999999999999998543321  111111110000                


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH--HHHhcCCCc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA--REAMVISSI  412 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta--~elL~hp~f  412 (419)
                                       ....+..++.++.++|++||+.||.+|||+  .|+++||||
T Consensus       218 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         218 -----------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             -----------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                             000112267899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=326.42  Aligned_cols=249  Identities=25%  Similarity=0.461  Sum_probs=213.3

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      .+.||+|.||+||-|.++.+|+.||||++++     .....+.+|+.||+++ .||.||.+-..|+.  ...++.|||-+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET--~ervFVVMEKl  645 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFET--PERVFVVMEKL  645 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecC--CceEEEEehhh
Confidence            3679999999999999999999999999964     3346789999999999 99999999999955  46788999999


Q ss_pred             CCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCCCccee
Q 014762          205 NSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKEYNV  278 (419)
Q Consensus       205 ~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~~~~~~  278 (419)
                      .|.-|+..+    ..+++...+.++.||+.||.|||-++|+|+||||+|||+.+.  ..++||||||.|++++.......
T Consensus       646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs  725 (888)
T KOG4236|consen  646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS  725 (888)
T ss_pred             cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence            998887776    469999999999999999999999999999999999999754  45899999999999987777777


Q ss_pred             ecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhH
Q 014762          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~  358 (419)
                      .+||+.|.|||++.+ +.|+..-|+||.||++|--++|..||..+.+-.+|++...                        
T Consensus       726 VVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa------------------------  780 (888)
T KOG4236|consen  726 VVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA------------------------  780 (888)
T ss_pred             hcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhccc------------------------
Confidence            899999999999998 8999999999999999999999999954433333333211                        


Q ss_pred             HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccccc
Q 014762          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSL  418 (419)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~  418 (419)
                         .-....+|+         .+++++.|||..+|+..=++|.|....|.|||+++..-+
T Consensus       781 ---FMyPp~PW~---------eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w  828 (888)
T KOG4236|consen  781 ---FMYPPNPWS---------EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTW  828 (888)
T ss_pred             ---cccCCCchh---------hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHH
Confidence               111223444         389999999999999999999999999999999987543

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=310.80  Aligned_cols=272  Identities=32%  Similarity=0.628  Sum_probs=207.6

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      |++.++||.|++|+||+|.+..+|..||+|++....     .+.+.+|+.+++.+ +|||++++++++.+.  ...+++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~--~~~~iv~   77 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSE--NKLYLVF   77 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccC--CeEEEEE
Confidence            567889999999999999999999999999986322     35678899999999 899999999999654  7789999


Q ss_pred             EecCCCChhhhc---C--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-c
Q 014762          202 EYVNSTDFKVLY---P--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (419)
Q Consensus       202 e~~~~~~l~~~~---~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~  275 (419)
                      ||++ +++..++   .  .+++..+..++.|++.||+|||+++++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccc
Confidence            9996 4666654   2  47899999999999999999999999999999999999987 889999999987553222 2


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....++..|+|||++.+...++.++|+||||+++|+|++|..||. +.+..+.+..+.+..+.+....+....   ..+
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  231 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP-GDSEIDQLFRIFRTLGTPDEDVWPGVT---SLP  231 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCChHHhhhhh---hch
Confidence            2334567889999988764567899999999999999999999884 344445555566655555433321110   000


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      .+......     +...........++.++.+++.+||+.||++|||++|+++||||
T Consensus       232 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYKPTFPK-----WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhhhhccc-----ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            11100000     00000011123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-41  Score=319.82  Aligned_cols=253  Identities=24%  Similarity=0.439  Sum_probs=197.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-----CcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ....|+++++||+||.+.||++.. .+...+|+|.+.     .+....+.+|+..|.+|.+|.+|+++++|-..  ...+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~l  435 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYL  435 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceE
Confidence            456799999999999999999964 445566666553     33456799999999999999999999999855  4789


Q ss_pred             EEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      |+||||-+ .+|..+++    ..+...++.+..|++.|+.++|++||||.||||.|+|+..  |.+||+|||.|..+..+
T Consensus       436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--eeEEeeeechhcccCcc
Confidence            99999754 56666663    2455688999999999999999999999999999999875  68999999999988765


Q ss_pred             Ccc---eeecccccccccccccCCC----------CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCc
Q 014762          274 KEY---NVRVASRYFKGPELLVDLQ----------DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (419)
Q Consensus       274 ~~~---~~~~~~~~y~aPE~~~~~~----------~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~  340 (419)
                      ...   ...+||..||+||.+....          +.+.++|||||||+||+|+.|+.||..   -..+.+++.++..+.
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~---~~n~~aKl~aI~~P~  589 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ---IINQIAKLHAITDPN  589 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH---HHHHHHHHHhhcCCC
Confidence            543   3468999999999986521          256899999999999999999999931   122333443333221


Q ss_pred             hHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      -.-++                        .       ...-..++.++|..||.+||.+|||+.++|+|||+..+
T Consensus       590 ~~Ief------------------------p-------~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  590 HEIEF------------------------P-------DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             ccccc------------------------c-------CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            10000                        0       00112349999999999999999999999999999863

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.2e-41  Score=326.79  Aligned_cols=246  Identities=22%  Similarity=0.378  Sum_probs=192.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++.++||+|+||+||+|.+     ..++..||+|+++..    ..+.+.+|+.++..+.+||||++++++|.+.  
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG--  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--
Confidence            56899999999999999999964     346678999998643    2356789999999987799999999999654  


Q ss_pred             CccEEEEEecCCCChhhhcC------------------------------------------------------------
Q 014762          195 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------  214 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  214 (419)
                      ...++||||+++|+|..++.                                                            
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            66889999999999876652                                                            


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          215 ------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       215 ------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                                        .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecCccceeccCcccc
Confidence                              25677888999999999999999999999999999999987 78999999999865433221


Q ss_pred             e---eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          277 N---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       277 ~---~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .   ...++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.............           ..   
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~-~~~~~~~~~~~~~~-----------~~---  334 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYP-GMPVDSKFYKMIKE-----------GY---  334 (375)
T ss_pred             cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCC-CCCchHHHHHHHHh-----------Cc---
Confidence            1   1233456999999977 789999999999999999998 777773 22222222211110           00   


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                           ....+...+.++.+|+.+||+.||++|||+.|+++.
T Consensus       335 ---------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         335 ---------------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             ---------------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                 000011257889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-40  Score=321.45  Aligned_cols=281  Identities=30%  Similarity=0.558  Sum_probs=214.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC---
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---  194 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...     ..+.+.+|+.+++.+ +|||++++++++.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccc
Confidence            367899999999999999999999999999999998632     234567899999999 99999999988754321   


Q ss_pred             -CccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          195 -KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       195 -~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                       ...++|+||++ ++|..++  ..+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||++....
T Consensus        92 ~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEcccccccccc
Confidence             34789999995 5776665  458999999999999999999999999999999999999987 789999999987654


Q ss_pred             CCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      ..  .....++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.+..+.+..+.+..+.+....+ .+...
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~-~~~~~  245 (343)
T cd07851         170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP-GSDHIDQLKRIMNLVGTPDEELL-QKISS  245 (343)
T ss_pred             cc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCHHHH-hhccc
Confidence            32  2334677889999998664568899999999999999999999984 44556667777776665543322 11111


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                         .................+..  ....+++++.+||++||+.||++|||+.++++||||++.
T Consensus       246 ---~~~~~~~~~~~~~~~~~~~~--~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~  304 (343)
T cd07851         246 ---ESARNYIQSLPQMPKKDFKE--VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY  304 (343)
T ss_pred             ---hhHHHHHHhccccCCCCHHH--HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence               11111111111110000000  011258899999999999999999999999999999865

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-40  Score=306.56  Aligned_cols=247  Identities=26%  Similarity=0.427  Sum_probs=200.6

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      +|+..+.||+|+||+||+|.+..+++.|++|.+...        ..+.+.+|+.+++.+ +|+|++++++++.+.  ...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~   77 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREE--DNL   77 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecC--CeE
Confidence            467778899999999999999889999999988532        235688999999999 999999999999654  678


Q ss_pred             EEEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++++||++++++..++.   .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccceeccccc
Confidence            89999999999988863   47889999999999999999999999999999999999987 789999999987765443


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|++||.+.....++.++|+|||||++|+|++|+.||.... ..+....+......               
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~---------------  220 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSKEL---------------  220 (258)
T ss_pred             cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhcccC---------------
Confidence            33445678889999998763338999999999999999999999984322 11111111100000               


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                          ......+++++.+|+.+||+.+|++|||+.++++|||+
T Consensus       221 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         221 --------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             --------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                                00012368899999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.3e-40  Score=314.59  Aligned_cols=283  Identities=31%  Similarity=0.546  Sum_probs=215.2

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ...++|++.+.||.|+||.||+|.+..+++.||+|.+..     ...+.+.+|+.++..+ +|||+++++++|... ...
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~~   84 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISP-LED   84 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecC-CCc
Confidence            357889999999999999999999999999999998753     2246678999999999 999999999998643 356


Q ss_pred             cEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      .++++||++ +++..++  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+...... 
T Consensus        85 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          85 IYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             EEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccCCC-
Confidence            789999995 4676665  357888889999999999999999999999999999999987 78999999998754322 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                       .....++..|+|||.+.+...++.++|+|||||++|+|++|+.|| .+.+.......+.+.+|.++.+...........
T Consensus       162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF-PGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence             223456788999998866467899999999999999999999887 444555566667777776553322110000000


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      +.+.. .......+..     .....+++++.++|++||+.+|++|||+++++.||||...+.
T Consensus       240 ~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~  296 (328)
T cd07856         240 RFVQS-LPKREPVPFS-----EKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD  296 (328)
T ss_pred             HHHhh-ccccCCCcHH-----HHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence            00000 0000000111     011236789999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.6e-40  Score=304.82  Aligned_cols=245  Identities=24%  Similarity=0.445  Sum_probs=202.4

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++++.||.|+||.||.+.+..+++.+++|.+...     ..+.+.+|+.+++++ +|+||+++++++.+.  ...+++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~~~   77 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDD--NTLLIE   77 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecC--CeEEEE
Confidence            589999999999999999999999999999987532     235688999999999 999999999999664  678999


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      |||+++++|..++.     .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++....... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence            99999999988763     37889999999999999999999999999999999999988 789999999998664433 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|.|||.+.+ ..++.++|+||||+++|+|++|..||.. .+..+....+..  +.               
T Consensus       157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~--~~---------------  217 (256)
T cd08221         157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQ--GN---------------  217 (256)
T ss_pred             cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHc--CC---------------
Confidence            2234567889999999877 5688999999999999999999999842 222222222211  00               


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                    +..     ....++.++.+++.+||+.+|++|||+.++|+|||+
T Consensus       218 --------------~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         218 --------------YTP-----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             --------------CCC-----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                          000     012368899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.5e-40  Score=314.05  Aligned_cols=250  Identities=17%  Similarity=0.341  Sum_probs=191.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcC----------------CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCee
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVN----------------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVV  183 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv  183 (419)
                      .++|++.++||+|+||.||+|.+..                ++..||+|.+....    ...+.+|+.++.++ +||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCee
Confidence            5689999999999999999997532                34479999987532    35688999999999 999999


Q ss_pred             EEEeEEEccCCCccEEEEEecCCCChhhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcE
Q 014762          184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----------------------TLTDYDIRYYIYELLKALDYCHSQGIM  241 (419)
Q Consensus       184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------------~l~~~~~~~~~~qi~~~L~~LH~~~iv  241 (419)
                      ++++++.+.  ...++||||+.+++|..++.                      .+++..+..++.|++.||.|||++||+
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          83 RLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             EEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            999999654  56889999999999987652                      256678889999999999999999999


Q ss_pred             eecCCCCceEEcCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh--C
Q 014762          242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--R  316 (419)
Q Consensus       242 H~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~--g  316 (419)
                      ||||||+|||++.+ +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++  +
T Consensus       161 H~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         161 HRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence            99999999999987 88999999999765433321   12234677999999876 679999999999999999987  4


Q ss_pred             CCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCC
Q 014762          317 KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD  396 (419)
Q Consensus       317 ~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  396 (419)
                      ..||. +.+..+....+.........                        .     ........++..+.+|+.+||..|
T Consensus       239 ~~p~~-~~~~~~~~~~~~~~~~~~~~------------------------~-----~~~~~~~~~~~~~~~li~~cl~~~  288 (304)
T cd05096         239 EQPYG-ELTDEQVIENAGEFFRDQGR------------------------Q-----VYLFRPPPCPQGLYELMLQCWSRD  288 (304)
T ss_pred             CCCCC-cCCHHHHHHHHHHHhhhccc------------------------c-----ccccCCCCCCHHHHHHHHHHccCC
Confidence            55663 23333332222211100000                        0     000011236889999999999999


Q ss_pred             CCCCCCHHHHhc
Q 014762          397 HQDRLTAREAMV  408 (419)
Q Consensus       397 P~~Rpta~elL~  408 (419)
                      |++|||+.++.+
T Consensus       289 p~~RPs~~~i~~  300 (304)
T cd05096         289 CRERPSFSDIHA  300 (304)
T ss_pred             chhCcCHHHHHH
Confidence            999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2e-40  Score=308.24  Aligned_cols=246  Identities=24%  Similarity=0.402  Sum_probs=197.2

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      +|++.+.||.|+||+||+|.+ .+++.+|+|.++...         ...+.+|+.+++.+ +|+||+++++++.+.  ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~   76 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDD--NT   76 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecC--Ce
Confidence            477889999999999999976 578899999885321         24578899999999 899999999999654  77


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++++||+++++|..++   ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++......
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhhhc
Confidence            89999999999998886   357899999999999999999999999999999999999987 88999999998754211


Q ss_pred             -------CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          274 -------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       274 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                             .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||... +.......+....+.       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-------  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASM-DRLAAMFYIGAHRGL-------  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccC-ChHHHHHHhhhccCC-------
Confidence                   11123457888999999876 67899999999999999999999998432 111111111110000       


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                                 .......+++++.+|+++||..+|++|||+.++++||||
T Consensus       227 ---------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 ---------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             ---------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                       000112368899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.5e-40  Score=310.29  Aligned_cols=245  Identities=24%  Similarity=0.391  Sum_probs=191.9

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHh--cCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      .||+|+||.||++.+..+++.+|+|.+....      ...+.+|..+++.+  .+|||++.+++.+..+  +..++||||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~   78 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL   78 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence            3899999999999999999999999885421      12334454444433  2789999999999654  578899999


Q ss_pred             cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeec
Q 014762          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (419)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (419)
                      +++++|..++   ..+++..+..++.|++.||+|||+++++|+||||+|||++.+ +.++|+|||++....... .....
T Consensus        79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~-~~~~~  156 (279)
T cd05633          79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASV  156 (279)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceeccccC-ccCcC
Confidence            9999998776   458999999999999999999999999999999999999988 789999999987554322 23356


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      ++..|+|||.+.+...++.++|+||+||++|+|++|..||...... ..........                       
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------------------  213 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------------------  213 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-----------------------
Confidence            8899999999865456899999999999999999999998533221 1111111000                       


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCccccc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPIF  416 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~  416 (419)
                                   .....+..+++++.++|.+||+.||++|+     |++++++||||+.+.
T Consensus       214 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         214 -------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             -------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence                         00001123688999999999999999999     699999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.5e-41  Score=314.61  Aligned_cols=257  Identities=19%  Similarity=0.327  Sum_probs=199.7

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++|+..+.||+|+||.||++.+..+++.+|+|.+...    ....+.+|+.++.++.+|+||+++++++..+  ...+++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~   81 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC   81 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence            4566778899999999999999999999999998643    2356788999999995599999999998654  567899


Q ss_pred             EEecCCCC--hhhh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          201 FEYVNSTD--FKVL-----YPTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       201 ~e~~~~~~--l~~~-----~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      |||+....  +...     ...+++..+..++.|++.||+|||+ .+++||||||+||+++.+ +.++|+|||+++....
T Consensus        82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhHHhcc
Confidence            99987532  2221     1458999999999999999999997 499999999999999987 7899999999876544


Q ss_pred             CCcceeecccccccccccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          273 GKEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ........++..|+|||++.+.  ..++.++|||||||++|+|++|+.||....   .....+.+.......        
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~--------  229 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKGDPP--------  229 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcCCCCC--------
Confidence            4333445678889999998763  368999999999999999999999984322   111111111110000        


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                           .........++.++.+|+.+||+.||++|||++++++||||+...
T Consensus       230 ---------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         230 ---------------------ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             ---------------------cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence                                 000011123788999999999999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-40  Score=311.45  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=203.1

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..|+..++||.|+||.||+|.+..++..||+|.++...    .+.+.+|+.+++.+ +||||+++++.+.+.  ...++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKG--TKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CEEEEE
Confidence            45778899999999999999999999999999986432    35688899999999 999999999999664  678999


Q ss_pred             EEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-ce
Q 014762          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (419)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~  277 (419)
                      |||++++++.+++.  .+++..+..++.|++.||+|||+.+++|+||+|+||+++.+ +.++|+|||++........ ..
T Consensus        81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-CCEEEcccccceeccCCccccc
Confidence            99999999988763  58889999999999999999999999999999999999987 7899999999976543332 22


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...++..|+|||++.+ ..++.++|+|||||++|+|++|..||... +.......+ .....                  
T Consensus       160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~-~~~~~------------------  218 (277)
T cd06640         160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLI-PKNNP------------------  218 (277)
T ss_pred             cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhh-hcCCC------------------
Confidence            3457788999999876 67899999999999999999999998422 211111110 00000                  


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                       ......++..+.+++.+||+.+|++|||+.++++||||....
T Consensus       219 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         219 -----------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             -----------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                             000112577899999999999999999999999999998654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.6e-40  Score=306.90  Aligned_cols=243  Identities=25%  Similarity=0.463  Sum_probs=199.3

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ||.|+||.||+|.+..+++.+|+|++...      ..+.+.+|+.+++.+ +||||+++++.+.+.  ...++++||+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDK--KYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcC--CccEEEEecCCC
Confidence            69999999999999999999999998642      235688999999999 999999999998654  678999999999


Q ss_pred             CChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeecccc
Q 014762          207 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR  283 (419)
Q Consensus       207 ~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  283 (419)
                      ++|..++.   .+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++.............++.
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~  156 (262)
T cd05572          78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTP  156 (262)
T ss_pred             CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccCCc
Confidence            99988763   47899999999999999999999999999999999999988 789999999998765443333456788


Q ss_pred             cccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHH-HHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhc
Q 014762          284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD-QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG  362 (419)
Q Consensus       284 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~-~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  362 (419)
                      .|++||.+.+ ..++.++|+||||+++|+|++|..||.....+.. ....+..  +...                     
T Consensus       157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---------------------  212 (262)
T cd05572         157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--GNGK---------------------  212 (262)
T ss_pred             CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc--cCCC---------------------
Confidence            9999999876 6789999999999999999999999854432221 1111110  0000                     


Q ss_pred             cCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          363 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                  ...+...++++.++|.+||+.||++|+|     ++|+++||||+++
T Consensus       213 ------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         213 ------------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             ------------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence                        0001124788999999999999999999     9999999999975

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.1e-40  Score=315.37  Aligned_cols=282  Identities=30%  Similarity=0.525  Sum_probs=213.8

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCC--CcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc--CCCc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNT--NERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT  196 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~--~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  196 (419)
                      +|++.+.||+|+||.||++.+..+  +..+|+|.+...     ..+.+.+|+.+++++.+||||+++++.+...  ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            588899999999999999999888  899999998632     2356778999999996799999999875432  2345


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++++||+++ +|...+   ..+++..++.++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+++.....
T Consensus        81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCceecccc
Confidence            7888998875 565554   458999999999999999999999999999999999999988 78999999999765432


Q ss_pred             Cc-----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          274 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       274 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ..     .....++..|+|||.+.+...++.++|+||+||++|+|++|..|| .+.+..+.+..+...+|.++...+...
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF-KGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC-CCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            21     122467888999998866467899999999999999999999876 555667788888888887655432211


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ..    +............+...+.  ......+..+.+|+.+||+.||++|||+.+++.||||+..+
T Consensus       238 ~~----~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         238 GS----PKAQNYIRSLPNIPKKPFE--SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             hh----hhHHHHHHhccccCCcchH--hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence            11    0000000000000000000  01123578899999999999999999999999999997554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.3e-40  Score=308.25  Aligned_cols=244  Identities=14%  Similarity=0.264  Sum_probs=193.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      +.++|++.+.||+|+||.||+|.+.   ..+..||+|.++...    ...+.+|+.++.++ +||||+++++++..  ..
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~   79 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITR--GN   79 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEec--CC
Confidence            4678999999999999999999765   456789999987532    24678999999999 99999999999965  46


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+++++|..++.    .+++..+..++.|++.||+|||++|++||||||+|||++.+ +.++++|||.+....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~~~~  158 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQEDK  158 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCccccccc
Confidence            7899999999999988762    47899999999999999999999999999999999999987 789999999876543


Q ss_pred             CCCcce--eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          272 PGKEYN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       272 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ......  ...++..|+|||++.+ ..++.++|||||||++||+++ |..||. +.+..+....+.+..           
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~-~~~~~~~~~~~~~~~-----------  225 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYW-DMSGQDVIKAVEDGF-----------  225 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHHCCC-----------
Confidence            222111  1234567999999877 789999999999999999775 888884 222222222211100           


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                               .......++..+.+++.+||+.+|++|||+.++++
T Consensus       226 -------------------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         226 -------------------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                     00011236889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.6e-40  Score=313.78  Aligned_cols=255  Identities=26%  Similarity=0.426  Sum_probs=206.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ..++|++.+.||+|+||+||++.+..++..+|+|.+...   ..+.+.+|+.+++.+ +|||++++++++...  ...++
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~l   93 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVG--DELWV   93 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeC--CcEEE
Confidence            357899999999999999999998889999999998532   235678899999999 899999999999654  67889


Q ss_pred             EEEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-c
Q 014762          200 IFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  276 (419)
Q Consensus       200 v~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~  276 (419)
                      |+||++++++..++.  .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........ .
T Consensus        94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             EEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceeccccccccc
Confidence            999999999988874  47889999999999999999999999999999999999987 7899999998875543322 2


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....++..|++||.+.+ ..++.++|+|||||++|++++|+.||.... ..+....+.. .+.                 
T Consensus       173 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~-~~~~~~~~~~-~~~-----------------  232 (293)
T cd06647         173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-PLRALYLIAT-NGT-----------------  232 (293)
T ss_pred             ccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhhheeehhc-CCC-----------------
Confidence            23467788999999876 678999999999999999999999984321 1111111000 000                 


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                ..      ......++..+.+++++||..+|++|||+.+++.||||+..+.
T Consensus       233 ----------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~  277 (293)
T cd06647         233 ----------PE------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP  277 (293)
T ss_pred             ----------CC------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence                      00      0011236788999999999999999999999999999998774

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.8e-41  Score=316.61  Aligned_cols=251  Identities=22%  Similarity=0.391  Sum_probs=202.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      +.|.....||+|+||.||++.+..++..||||.+...   ..+.+.+|+.+++.+ +|+|++++++.+...  ...++||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~--~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVG--DELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecC--CeEEEEE
Confidence            4455567799999999999999899999999998643   235678999999999 999999999998654  6789999


Q ss_pred             EecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-ccee
Q 014762          202 EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNV  278 (419)
Q Consensus       202 e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~~  278 (419)
                      ||++++++..++  ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++....... ....
T Consensus        99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhcccccccCce
Confidence            999999998876  458899999999999999999999999999999999999988 789999999986543222 2233


Q ss_pred             ecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhH
Q 014762          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~  358 (419)
                      ..++..|+|||.+.+ ..++.++|+||||+++|||++|+.||... +..+.+..+...+...                  
T Consensus       178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~------------------  237 (292)
T cd06658         178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPR------------------  237 (292)
T ss_pred             eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCc------------------
Confidence            567889999999876 67899999999999999999999998532 2222222211110000                  


Q ss_pred             HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                    .  .....+++.+.+|+.+||..||++|||++++++||||+..
T Consensus       238 --------------~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         238 --------------V--KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             --------------c--ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence                          0  0011267889999999999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=327.41  Aligned_cols=245  Identities=27%  Similarity=0.380  Sum_probs=206.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      ..+.|++...+|.|+||.|-.+.+..+++..++|++... .....+|+.++....+||||+++.+.+.+  +.+.++|||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v~e  396 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLVME  396 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecC--Cceeeeeeh
Confidence            367899999999999999999999999999999999754 34556788888888899999999999955  588899999


Q ss_pred             ecCCCChhhhcCCC--CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeec
Q 014762          203 YVNSTDFKVLYPTL--TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (419)
Q Consensus       203 ~~~~~~l~~~~~~l--~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (419)
                      .+.++.+...+...  ...++..++++|+.|+.|||++|+|||||||+|||++.+.++++|+|||.++...+.  ....+
T Consensus       397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~  474 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPA  474 (612)
T ss_pred             hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccc
Confidence            99999877666432  225677799999999999999999999999999999533388999999999876654  44567


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      -|..|.|||++.. ..|++++|+||||++||+|++|+.||....+.    .++...++.+.+.                 
T Consensus       475 ~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~~~i~~~~~s-----------------  532 (612)
T KOG0603|consen  475 LTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIHTRIQMPKFS-----------------  532 (612)
T ss_pred             hhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHHHhhcCCccc-----------------
Confidence            8889999999985 89999999999999999999999998544443    3444444444332                 


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                        ..+|++++||+++||+.||.+|+|+.+++.||||
T Consensus       533 ------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  533 ------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                              1279999999999999999999999999999999

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-43  Score=304.49  Aligned_cols=286  Identities=29%  Similarity=0.461  Sum_probs=224.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-----CcchHHHHHHHHHHHHhcCCCCeeEEEeEEEcc------
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ------  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~------  192 (419)
                      .+.|+-..+||+|.||.||+|+...+|+.||+|+.-     ..-.....+|+.+|..+ .|+|++.+++.|...      
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCccc
Confidence            566888899999999999999999999999987642     12235678999999999 999999999988632      


Q ss_pred             CCCccEEEEEecCCCCh---hhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          193 HSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l---~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      ....+|+||++|+....   ......++..+++.++.+++.||.|+|...|+|||+|+.|+|++.+ +.+||+|||+++.
T Consensus        95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilklADFGlar~  173 (376)
T KOG0669|consen   95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKLADFGLARA  173 (376)
T ss_pred             ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEeeccccccc
Confidence            12347899999986543   3333568999999999999999999999999999999999999998 8999999999976


Q ss_pred             ccCC-----CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          270 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       270 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      ....     ..++.++.|.+|++||.+++...|+++.|||.-||++.||++|. |.+++.++..++..|...+|....+.
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrs-pimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRS-PIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccC-ccccCChHHHHHHHHHHHhccCCccc
Confidence            5432     23556788999999999999999999999999999999999986 66689999999999999999876666


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      |.+-..+++....+.-  .......+...+...+---+++..||+.++|..||.+|+++.++|+|.||..
T Consensus       253 WP~~d~lpL~~sie~e--Pl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELE--PLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CCCcccchHHHhccCC--CCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            6544333332222110  0011111111111111113678999999999999999999999999999964

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=302.60  Aligned_cols=255  Identities=22%  Similarity=0.363  Sum_probs=202.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCC
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (419)
                      +.||+|+++.|--|....+|..+|||++.+.   .+.+..+|++++.+..+|+||++++++|+++  ..+|||||-|.||
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd--~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD--TRFYLVFEKMRGG  161 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc--ceEEEEEecccCc
Confidence            4699999999999999999999999999754   3678899999999999999999999999765  6789999999999


Q ss_pred             Chhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCC--------C
Q 014762          208 DFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG--------K  274 (419)
Q Consensus       208 ~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~--------~  274 (419)
                      .+...+   ..|++.++.+++.+|+.||+|||.+||.||||||+|||....  ..-+|||||.+..-..-.        .
T Consensus       162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP  241 (463)
T KOG0607|consen  162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP  241 (463)
T ss_pred             hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence            988877   359999999999999999999999999999999999998654  235899999987533211        1


Q ss_pred             cceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCC----------CCCHHHHHHHHHHcCCc
Q 014762          275 EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYG----------HDNHDQLVKIAKVLGTD  340 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~----------~~~~~~~~~i~~~lg~~  340 (419)
                      .....+|+-.|||||+..-    ...|+.++|.|||||++|-|++|..||..-          .......+.+.+.++..
T Consensus       242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG  321 (463)
T KOG0607|consen  242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG  321 (463)
T ss_pred             cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence            2234577778999999631    246899999999999999999999998421          11111122222211110


Q ss_pred             hHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                               .           ..         ++...+..+|.+.+|+++.+|..|+.+|.+|.++++|||++.+.
T Consensus       322 ---------k-----------Ye---------FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  322 ---------K-----------YE---------FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             ---------C-----------Cc---------CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence                     0           01         12223345899999999999999999999999999999998764

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.9e-41  Score=315.20  Aligned_cols=250  Identities=26%  Similarity=0.390  Sum_probs=202.2

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +.|+..+.||+|+||.||+|.+..++..||+|.++...    .+.+.+|+.+++.+ +||||+++++.+..  ....++|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLK--GTKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhccccc--CCceEEE
Confidence            34677888999999999999999999999999986322    35688999999999 89999999999965  4678999


Q ss_pred             EEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-ce
Q 014762          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (419)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~  277 (419)
                      |||++++++..++  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........ ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEccccccccccCcchhhh
Confidence            9999999998876  347899999999999999999999999999999999999987 7899999999876543322 12


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||... ........+..             .        
T Consensus       160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~~~-------------~--------  216 (277)
T cd06642         160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPK-------------N--------  216 (277)
T ss_pred             cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCccc-chhhHHhhhhc-------------C--------
Confidence            3457788999999877 67899999999999999999999998422 11111110000             0        


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                ..     ......++.++.+++.+||+.+|++|||+.++++||||+...
T Consensus       217 ----------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         217 ----------SP-----PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             ----------CC-----CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                      00     000112678899999999999999999999999999998654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=8.4e-40  Score=303.38  Aligned_cols=251  Identities=25%  Similarity=0.423  Sum_probs=207.3

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+....    .+.+.+|+.++..+ +|+|++++++++...  ...++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKE--GEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccC--CeEEEE
Confidence            46889999999999999999999999999999987543    46788999999999 899999999999654  778999


Q ss_pred             EEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      |||+++++|..++   ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceecccCCCc
Confidence            9999999998887   458999999999999999999999 999999999999999988 88999999999876543333


Q ss_pred             -eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CH-HHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NH-DQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       277 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~-~~-~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .. +....+.   ...             
T Consensus       157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~-------------  219 (264)
T cd06623         157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DGP-------------  219 (264)
T ss_pred             ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cCC-------------
Confidence             24567788999999876 6789999999999999999999999843321 11 1111111   000             


Q ss_pred             ChhhHHhhccCCCCCccccccccccCC-CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHL-VSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                  .        ...... ++..+.+++.+||..+|++|||+.++++||||+.+.
T Consensus       220 ------------~--------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         220 ------------P--------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             ------------C--------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                        0        000112 678999999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=329.24  Aligned_cols=246  Identities=22%  Similarity=0.386  Sum_probs=200.8

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCC
Q 014762          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD  208 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~  208 (419)
                      .||+|.||+||-|+|..+...+|||-+....   .+-+..||..-++| .|.|||+++|.|..  ++++-+.||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~se--nGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSE--NGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCC--CCeEEEEeecCCCCc
Confidence            5999999999999999999999999986332   34577899999999 89999999999954  467788999999999


Q ss_pred             hhhhcC----CC--CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-ceeecc
Q 014762          209 FKVLYP----TL--TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVA  281 (419)
Q Consensus       209 l~~~~~----~l--~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~~~~~  281 (419)
                      |..+++    ++  ++..+-.+..||++||.|||++.|||||||-+|+|++.-.|.+||+|||-++....-.. +....|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            999884    35  77888899999999999999999999999999999998889999999999987654333 345689


Q ss_pred             ccccccccccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          282 SRYFKGPELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       282 ~~~y~aPE~~~-~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      |..|||||++- |...|+.++|||||||++.||.||+.||..              +|.+.-..+.-. ..         
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E--------------lgspqAAMFkVG-my---------  794 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE--------------LGSPQAAMFKVG-MY---------  794 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee--------------cCChhHhhhhhc-ce---------
Confidence            99999999984 445799999999999999999999999942              222221111000 00         


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                       +.          -...++.++.+++.||.+|+..||.+||+|.++|++||++.-
T Consensus       795 -Kv----------HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  795 -KV----------HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             -ec----------CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence             00          001123378889999999999999999999999999999753

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.4e-40  Score=309.86  Aligned_cols=244  Identities=25%  Similarity=0.392  Sum_probs=196.3

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ||+|+||+||+|.+..+|+.+|+|.+....      ...+.+|+.+++.+ +|||++++++++...  ...++||||+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETK--DDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecC--CeEEEEEecCCC
Confidence            699999999999999999999999985321      23467899999999 899999999999654  678999999999


Q ss_pred             CChhhhc---C--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeecc
Q 014762          207 TDFKVLY---P--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (419)
Q Consensus       207 ~~l~~~~---~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (419)
                      ++|..++   .  .+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+.............+
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~  156 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAG  156 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccccC
Confidence            9998765   2  58899999999999999999999999999999999999988 7899999999876544333344567


Q ss_pred             cccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhh
Q 014762          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV  361 (419)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~  361 (419)
                      +..|++||++.+ ..++.++|+|||||++|+|++|+.||........ ...+....-                       
T Consensus       157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-----------------------  211 (277)
T cd05577         157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTL-----------------------  211 (277)
T ss_pred             CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhccc-----------------------
Confidence            788999999877 5689999999999999999999999843322111 111110000                       


Q ss_pred             ccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                          ..      .......+++.+.++|.+||+.||++||     |+.++++||||+.+
T Consensus       212 ----~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         212 ----EM------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             ----cc------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence                00      0001123688999999999999999999     99999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.5e-40  Score=306.06  Aligned_cols=245  Identities=24%  Similarity=0.454  Sum_probs=199.0

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.++..      ....+.+|+.+++.+ +|||++++++++.+.  ...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   78 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIED--NELN   78 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEEC--CeEE
Confidence            5799999999999999999999999999999987531      234678899999999 999999999999654  6778


Q ss_pred             EEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      +++||++++++..++       ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~  157 (267)
T cd08228          79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC-CCEEECccccceecc
Confidence            999999999998765       237888999999999999999999999999999999999987 789999999987654


Q ss_pred             CCCc-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          272 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       272 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      .... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||+....+...........+.++.        
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  228 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL--------  228 (267)
T ss_pred             chhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC--------
Confidence            3322 123467788999999876 678999999999999999999999996544333222222221111110        


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                .....+..+.+++.+||+.+|++|||+.++++
T Consensus       229 --------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         229 --------------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             --------------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                                      01125788999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.6e-40  Score=305.72  Aligned_cols=246  Identities=22%  Similarity=0.447  Sum_probs=200.4

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.+.||.|+||.||+|.+..+|..+|+|.+...     ..+.+.+|+.+++.+ +|+|++++++.+..  ....++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv   77 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQE--NGRLFIV   77 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheecc--CCeEEEE
Confidence            588999999999999999999999999999998642     345778999999999 89999999999855  4678999


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||+.++++..++.     .+++..+..++.|++.||.|||+.+++|+||||+||+++.+...++|+|||.+........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999988762     3688999999999999999999999999999999999998755679999999876644322


Q ss_pred             c-eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          276 Y-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       276 ~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      . ....++..|+|||++.+ ..++.++|+||||+++|+|++|..||... +..+....+..   .            .  
T Consensus       158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~---~------------~--  218 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQ---G------------Y--  218 (257)
T ss_pred             cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhc---c------------c--
Confidence            2 23457888999999876 67899999999999999999999998422 21111111110   0            0  


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                    +.     .....++.++.+++.+||..+|++|||+.++++||||
T Consensus       219 --------------~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         219 --------------FA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             --------------CC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                          00     0011267889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.2e-40  Score=304.37  Aligned_cols=249  Identities=29%  Similarity=0.495  Sum_probs=200.7

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.+.||+|+||.||+|.+..+++.+++|.++..     ..+.+.+|+.+++.+ +|+||+++++.+.+  ....++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~lv   77 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVH--REKVYIF   77 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEec--CCEEEEE
Confidence            588999999999999999999889999999998643     235788999999999 99999999999854  4678899


Q ss_pred             EEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc-
Q 014762          201 FEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-  276 (419)
Q Consensus       201 ~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~-  276 (419)
                      +||+.++++.+++.   .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcc
Confidence            99999999998873   37888999999999999999999999999999999999987 88999999998765433221 


Q ss_pred             ----eeecccccccccccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          277 ----NVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       277 ----~~~~~~~~y~aPE~~~~~~--~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                          ....++..|++||++.+..  .++.++||||||+++|++++|+.||............+..  +..+         
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~---------  225 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHKP---------  225 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CCCC---------
Confidence                1235677899999987622  3789999999999999999999998543322222111111  1000         


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                       .      ......+++.+.+|+.+||+.+|++|||+.++++|||+
T Consensus       226 -----------------~------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 -----------------P------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -----------------C------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                             0      00011257889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=333.36  Aligned_cols=247  Identities=20%  Similarity=0.317  Sum_probs=195.2

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEE-Ec---cC-
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIV-RD---QH-  193 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~-~~---~~-  193 (419)
                      ....++++.+.|.+|||+.||+|++...|..||+|++-..+   .+.+.+||++|+.|.+|+|||.+++.. ..   .+ 
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            45778999999999999999999999888999999874333   356789999999999999999999933 21   12 


Q ss_pred             CCccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          194 SKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ...+.|+||||.||.|-+++     ..|++.++.+|+.|+++|+.+||..+  |||||||-+||||+.+ +..||||||.
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLCDFGS  192 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLCDFGS  192 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeCcccc
Confidence            24567899999988877766     35999999999999999999999886  9999999999999998 8999999999


Q ss_pred             ceeccCCCc----------ceeeccccccccccccc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014762          267 AEFYHPGKE----------YNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (419)
Q Consensus       267 a~~~~~~~~----------~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~  334 (419)
                      |.-......          .-....|+.|+|||++-  ...++++|+|||+|||+||-|+....||..+..    ++ |+
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----la-Il  267 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LA-IL  267 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----ee-EE
Confidence            864322221          11235788999999972  226789999999999999999999999942200    00 00


Q ss_pred             HHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                   +....                      .......+..+.+||+.||+.||.+||++.+++.+
T Consensus       268 -------------ng~Y~----------------------~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  268 -------------NGNYS----------------------FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             -------------ecccc----------------------CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                         00000                      11112368899999999999999999999998763

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=309.79  Aligned_cols=273  Identities=35%  Similarity=0.621  Sum_probs=210.0

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      |++.+.||+|++|.||+|.+..+++.+++|.++...     ...+.+|+.+++.+ +|+||+++++++...  ...++|+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~   77 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHK--GDLYLVF   77 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccC--CCEEEEE
Confidence            567789999999999999998899999999986432     35678899999999 899999999999654  7788999


Q ss_pred             EecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cc
Q 014762          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (419)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~  276 (419)
                      ||+++ ++...+    ..+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.++|+|||.+....... ..
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~  155 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPY  155 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcccc
Confidence            99987 444443    268899999999999999999999999999999999999987 789999999997765443 22


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....++..|+|||.+.+...++.++|+||||+++|+|++|+.|| .+.+..+....+.+.++.+....+..-....  ..
T Consensus       156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  232 (283)
T cd05118         156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF-PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA--RN  232 (283)
T ss_pred             cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCchHhcccchhhh--hh
Confidence            33457778999999877447899999999999999999999887 4555666677776666665433221110000  00


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ..  ..........   .......+++++++||.+||+.||++||++.+++.||||
T Consensus       233 ~~--~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         233 YK--FSFPKKAGMP---LPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hh--hhhccccccC---HHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            00  0000000000   011112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-40  Score=307.51  Aligned_cols=274  Identities=31%  Similarity=0.539  Sum_probs=212.1

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      |++.+.||+|+||+||+|.+..+++.|++|.+....    .....+|+..+.++.+|+|++++++++.+  ....++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence            677899999999999999998899999999986432    23456799999999449999999999965  477899999


Q ss_pred             ecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcce
Q 014762          203 YVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (419)
Q Consensus       203 ~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~  277 (419)
                      |+ ++++...+     ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++..........
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  156 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYT  156 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCCcC
Confidence            99 56665544     257899999999999999999999999999999999999987 889999999998765544444


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...++..|+|||++.+...++.++|+||||+++++|++|+.|| .+.+..+....+.+.++.+....+.......  ...
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  233 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF-PGSSEIDQLYKICSVLGTPTKQDWPEGYKLA--SKL  233 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc-CCCChHHHHHHHHHhcCCCChhhhhhHhhhh--ccc
Confidence            5567888999999866566899999999999999999999886 5566677788888888876654443221111  000


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      .....   ...... . .......+.++.+|+++||+.||++|||+.|++.||||
T Consensus       234 ~~~~~---~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         234 GFRFP---QFAPTS-L-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccc---cccccc-H-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            00000   000000 0 00011236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.1e-39  Score=300.88  Aligned_cols=249  Identities=29%  Similarity=0.479  Sum_probs=205.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|+..+.||+|++|.||+|.+..+++.+++|++....     .+.+.+|+.+++++ +|+||+++++.+.+......+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence            4788899999999999999999899999999987544     56788999999999 89999999999976533678899


Q ss_pred             EEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc--
Q 014762          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~--  275 (419)
                      +||++++++.+++   ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||.+........  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEecccccccc
Confidence            9999999998876   357999999999999999999999999999999999999987 8899999999987665443  


Q ss_pred             -ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                       .....++..|++||.+.+ ..++.++|+||||+++++|++|..||....+.....   .......              
T Consensus       159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~--------------  220 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL---YKIGSSG--------------  220 (260)
T ss_pred             cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HhccccC--------------
Confidence             344577888999999876 568999999999999999999999985433111111   1110000              


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                   .     .......++..+.+|+.+||+.||++|||+.++++||||
T Consensus       221 -------------~-----~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         221 -------------E-----PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             -------------C-----CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                         0     000112357899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-42  Score=325.35  Aligned_cols=236  Identities=18%  Similarity=0.283  Sum_probs=195.5

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ...++-||.|+.|.||+|+.  .++.||||.++    +.-+.+|+-|++| .||||+.+.|+|..  ...+|+|||||..
T Consensus       126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~----elkETdIKHLRkL-kH~NII~FkGVCtq--sPcyCIiMEfCa~  196 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVR----ELKETDIKHLRKL-KHPNIITFKGVCTQ--SPCYCIIMEFCAQ  196 (904)
T ss_pred             hhhhhhhccCcccceeeeec--cCceehhHHHh----hhhhhhHHHHHhc-cCcceeeEeeeecC--CceeEEeeecccc
Confidence            33467799999999999954  67889999775    3345688899999 99999999999954  5789999999999


Q ss_pred             CChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeecccc
Q 014762          207 TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR  283 (419)
Q Consensus       207 ~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~  283 (419)
                      |.|...+   +.++......+..+|+.||.|||.++|||||||.-||||..+ ..|||+|||-++...........+||.
T Consensus       197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSFaGTV  275 (904)
T KOG4721|consen  197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSFAGTV  275 (904)
T ss_pred             ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhhhhhH
Confidence            9999888   458888899999999999999999999999999999999998 899999999998776555556689999


Q ss_pred             cccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhcc
Q 014762          284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGR  363 (419)
Q Consensus       284 ~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~  363 (419)
                      .|||||++.+ ++.+.|+|||||||+||||+||..||..-    +..+.|                            ..
T Consensus       276 aWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdV----dssAII----------------------------wG  322 (904)
T KOG4721|consen  276 AWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDV----DSSAII----------------------------WG  322 (904)
T ss_pred             hhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCcccc----chheeE----------------------------Ee
Confidence            9999999998 89999999999999999999999998311    111111                            00


Q ss_pred             CCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          364 HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      ...+.    +....+..+++.++=||+.||+..|..||++.++|.|
T Consensus       323 VGsNs----L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  323 VGSNS----LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             ccCCc----ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            01111    1112233488999999999999999999999999998

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-40  Score=307.97  Aligned_cols=252  Identities=26%  Similarity=0.430  Sum_probs=202.3

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhc--CCCCeeEEEeEEEccCCCccEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .|++.+.||.|+||.||+|.+..+++.+|+|.++..    ..+.+.+|+.+++.+.  .|||++++++++.+  ....++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence            477889999999999999999999999999998632    2356888999999983  49999999999865  367889


Q ss_pred             EEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-c
Q 014762          200 IFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  276 (419)
Q Consensus       200 v~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~  276 (419)
                      ||||+++++|..++  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++........ .
T Consensus        80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecCCCcccc
Confidence            99999999998876  357889999999999999999999999999999999999987 8899999999977654332 2


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....++..|+|||.+.+...++.++|+|||||++|+|++|..||... +.......+    ...                
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~-~~~~~~~~~----~~~----------------  217 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMMLI----PKS----------------  217 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC-Chhhhhhcc----ccC----------------
Confidence            33467888999999876456789999999999999999999998321 111100000    000                


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                .+. .    ......+.++.+++.+||+.||++|||+.++++||||++..
T Consensus       218 ----------~~~-~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         218 ----------KPP-R----LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             ----------CCC-C----CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                      000 0    00112578899999999999999999999999999998653

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-40  Score=309.96  Aligned_cols=257  Identities=20%  Similarity=0.352  Sum_probs=203.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .++|++.++||+|+||+||++.+..+++.+|+|++...    ..+.+.+|+++++.+ +||||+++++++...  ...++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   80 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNE--NNICM   80 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecC--CEEEE
Confidence            56789999999999999999999999999999987533    245788999999999 899999999999664  67899


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      ||||++++++..++   ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-~  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-I  158 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccchhhh-c
Confidence            99999999998776   357899999999999999999997 699999999999999987 78999999998654322 2


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH---HHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ---LVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~---~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .....++..|+|||++.+ ..++.++|+|||||++|++++|+.||.......+.   ...+.+         ..      
T Consensus       159 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~---------~~------  222 (284)
T cd06620         159 ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD---------LL------  222 (284)
T ss_pred             cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH---------HH------
Confidence            233568889999999876 68899999999999999999999998543222110   000000         00      


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                           .......    ...    .....++.++.+|+.+||+.||++|||+.|+++||||..
T Consensus       223 -----~~~~~~~----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         223 -----QQIVQEP----PPR----LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             -----HHHhhcc----CCC----CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                 0000000    000    000125778999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.3e-40  Score=306.64  Aligned_cols=249  Identities=27%  Similarity=0.393  Sum_probs=201.9

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      -|++.++||.|+||.||+|.+..++..+|+|.+....    .+.+.+|+.++.++ +||||+++++.+.+.  ...++||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~   81 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKD--TKLWIIM   81 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeC--CeEEEEE
Confidence            3677889999999999999998899999999986432    35688899999999 999999999999654  6788999


Q ss_pred             EecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-cee
Q 014762          202 EYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNV  278 (419)
Q Consensus       202 e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~~  278 (419)
                      ||++++++..++.  .+++..+..++.|++.|+.|||+.|++|+||+|+||+++.+ +.++|+|||++........ ...
T Consensus        82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecccchhhhcc
Confidence            9999999988774  48899999999999999999999999999999999999987 7899999999876543221 223


Q ss_pred             ecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhH
Q 014762          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~  358 (419)
                      ..++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.. .........+.. .+.                   
T Consensus       161 ~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~-~~~-------------------  218 (277)
T cd06641         161 FVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPK-NNP-------------------  218 (277)
T ss_pred             ccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhc-CCC-------------------
Confidence            467788999999876 6788999999999999999999999832 111111111100 000                   


Q ss_pred             HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                 .     .....++.++.+++.+||..+|++||++.++++||||.+..
T Consensus       219 -----------~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         219 -----------P-----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             -----------C-----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence                       0     00112678899999999999999999999999999998653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.4e-40  Score=308.87  Aligned_cols=244  Identities=17%  Similarity=0.324  Sum_probs=195.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCC-----cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++.+.||+|+||.||+|.+...+     ..+|+|.++...    ...+.+|+.++..+ +||||+++++++.+.  
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~--   80 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKE--   80 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCC--
Confidence            357888999999999999999876655     679999986432    35688999999999 999999999999653  


Q ss_pred             CccEEEEEecCCCChhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC
Q 014762          195 KTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~  255 (419)
                      ...+++|||+++++|..++                   ..+++..+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            6688999999999998776                   236778889999999999999999999999999999999987


Q ss_pred             CCcEEEEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 014762          256 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (419)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~  331 (419)
                       +.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||+. .+..+...
T Consensus       161 -~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~  237 (283)
T cd05048         161 -LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIE  237 (283)
T ss_pred             -CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence             7899999999976543322   123455778999999877 678999999999999999998 9989843 22222222


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      .+.+.  .                                  .......+++++.+|+.+||+.||.+|||+.|++++
T Consensus       238 ~i~~~--~----------------------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSR--Q----------------------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcC--C----------------------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            21110  0                                  000112378999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=9e-40  Score=307.42  Aligned_cols=253  Identities=22%  Similarity=0.389  Sum_probs=202.9

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ..|...+.||+|++|.||++.+..+++.+++|.++..   ..+.+.+|+.+++.+ +|||++++++++..  ....++++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~--~~~~~~v~   95 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLV--GDELWVVM   95 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEc--CCeEEEEE
Confidence            3455567899999999999999899999999988532   245678999999999 99999999999865  36789999


Q ss_pred             EecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-cee
Q 014762          202 EYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNV  278 (419)
Q Consensus       202 e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~~  278 (419)
                      ||+.+++|..++  ..+++..+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||.+........ ...
T Consensus        96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhccCCccccc
Confidence            999999998876  358889999999999999999999999999999999999988 8899999998765433221 223


Q ss_pred             ecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhH
Q 014762          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~  358 (419)
                      ..++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||+.. +..+....+... ..+.                 
T Consensus       175 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~-~~~~~~~~~~~~-~~~~-----------------  234 (285)
T cd06648         175 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNE-PPLQAMKRIRDN-LPPK-----------------  234 (285)
T ss_pred             ccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCC-CHHHHHHHHHhc-CCCC-----------------
Confidence            467889999999876 67899999999999999999999998532 222222111110 0000                 


Q ss_pred             HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                      ......++..+.+|+++||+.+|++|||+.++++||||+..+.
T Consensus       235 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         235 ----------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             ----------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence                            0001126789999999999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.5e-40  Score=319.07  Aligned_cols=282  Identities=15%  Similarity=0.207  Sum_probs=195.5

Q ss_pred             eeeeee--CceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          131 RKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       131 ~~lG~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      ..||+|  +||+||++.+..+|+.||+|++....     .+.+.+|+.+++.+ +||||++++++|...  ...++|+||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~--~~~~~v~e~   80 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTG--SWLWVISPF   80 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecC--CceEEEEec
Confidence            356666  99999999999999999999986422     35678899999988 899999999999654  678899999


Q ss_pred             cCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc---
Q 014762          204 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---  275 (419)
Q Consensus       204 ~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~---  275 (419)
                      +.++++..++.     .+++..+..++.|++.||+|||++|++||||||+|||++.+ +.++++||+.+........   
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCcccc
Confidence            99999888763     37889999999999999999999999999999999999988 7899999986532211110   


Q ss_pred             -----ceeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH-H-h
Q 014762          276 -----YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY-L-N  347 (419)
Q Consensus       276 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~-~-~  347 (419)
                           .....++..|+|||++.+. ..++.++|||||||++|+|++|..||.... ..+............+.... . .
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML-RTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC-hHHHHHHHhcCCCCCCccccccch
Confidence                 0112344569999998652 347899999999999999999999984332 22222222111110000000 0 0


Q ss_pred             hcCCC--CChhhHH-hhccCCCCCcc-----ccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          348 KYHLE--LDPQLDA-LVGRHSRKPWS-----KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       348 ~~~~~--~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      .....  ....... .........+.     ..........+++++.+|+++||++||++|||+.|+|+||||+++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence            00000  0000000 00000000000     00011112236788999999999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.2e-40  Score=304.91  Aligned_cols=251  Identities=26%  Similarity=0.467  Sum_probs=197.5

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-------------hHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.++...             .+.+.+|+.+++.+ +|||++++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence            5778899999999999999998899999999875211             13577899999999 899999999999654


Q ss_pred             CCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                        ...++||||+.+++|..++   ..+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||+++.
T Consensus        81 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~  157 (272)
T cd06629          81 --EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKK  157 (272)
T ss_pred             --CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeecccccc
Confidence              6788999999999998876   348888999999999999999999999999999999999987 8899999999875


Q ss_pred             ccCCC---cceeecccccccccccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          270 YHPGK---EYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       270 ~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      .....   ......++..|+|||.+.+.. .++.++|+||||+++|++++|..||... +.   ...+.+....      
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~---~~~~~~~~~~------  227 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-EA---IAAMFKLGNK------  227 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc-ch---HHHHHHhhcc------
Confidence            43211   112345778899999987632 4789999999999999999999998321 11   1111110000      


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                        .....    ........++.++.+|+.+||+.||++|||+.++|+||||
T Consensus       228 ------------------~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         228 ------------------RSAPP----IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ------------------ccCCc----CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                              00000    0001112368899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=294.47  Aligned_cols=257  Identities=20%  Similarity=0.319  Sum_probs=210.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      +.++.+.+..||.|+.|+||+++.+.+|...|||.+...    +.+++...+.++....++|+||+.+|+|..+.  ..+
T Consensus        90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV~  167 (391)
T KOG0983|consen   90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DVF  167 (391)
T ss_pred             ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hHH
Confidence            456677788999999999999999999999999998643    34566777777777656899999999997653  345


Q ss_pred             EEEEecCC---CChhhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          199 LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       199 lv~e~~~~---~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +.||.|..   ..|....+.+++..+-.+...+.+||.||-+ +||+|||+||+|||+|+. |.+|+||||.+..+-++.
T Consensus       168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-CCEEeecccccceeeccc
Confidence            67887753   2344445779999999999999999999985 699999999999999988 899999999998888888


Q ss_pred             cceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          275 EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      ..+...|.+.|||||-+--  ...|+.++||||||++++||.||..||.....+.+.+-.+.+... +.+.         
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L~---------  316 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLLP---------  316 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCCC---------
Confidence            8888899999999998843  246899999999999999999999999766667777766654211 1100         


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                              ....+|+++.+|+..||+.|+.+||.-.++|+|||.....
T Consensus       317 ------------------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  317 ------------------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             ------------------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence                                    0112799999999999999999999999999999987653

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-39  Score=304.91  Aligned_cols=272  Identities=29%  Similarity=0.546  Sum_probs=206.1

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhc--CCCCeeEEEeEEEccCC---Cc
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHS---KT  196 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~---~~  196 (419)
                      |++.+.||+|+||.||+|.+..+++.+|+|.++..     ....+.+|+.+++++.  .|+|++++++++.....   ..
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            67889999999999999999888999999998632     1245667888887773  59999999999975422   23


Q ss_pred             cEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      .+++|||+.+ ++..++     ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcceecc
Confidence            8899999986 555543     248999999999999999999999999999999999999998 899999999998765


Q ss_pred             CCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      .........++..|+|||++.+ ..++.++|+|||||++|+|++|..|| .+.+..+.+..+.+..+.+....+......
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLF-RGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             CCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcc-cCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            4444344457788999999877 67899999999999999999997776 556666667666665554332221110000


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      .     .............     .....+++.+.+++.+||+.||++|||+.++++||||
T Consensus       237 ~-----~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 P-----RSSFPSYTPRSFK-----SFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             c-----hhhcccccccchh-----hhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            0     0000000000000     0111357888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=288.67  Aligned_cols=252  Identities=22%  Similarity=0.312  Sum_probs=197.2

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEcc---CCC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---HSK  195 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~  195 (419)
                      .++++|++.++||+|||+-||+++...+++.+|+|.+.-   ...+...+|++..+++ +|||+++++++...+   ...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCce
Confidence            358899999999999999999999999999999998853   3456788999999999 999999999876432   345


Q ss_pred             ccEEEEEecCCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          196 TPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ..|++++|...|++.+.+.       .+++.++..++.++++||++||+..  +.||||||.|||++.. +.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEEeccC
Confidence            6899999999998877762       4899999999999999999999988  9999999999999987 8899999999


Q ss_pred             ceeccCCCc----------ceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014762          267 AEFYHPGKE----------YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (419)
Q Consensus       267 a~~~~~~~~----------~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~  334 (419)
                      ++...-.-.          -.....|..|+|||.+.-  ....+.++|||||||+||+|+.|..||...          .
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~----------~  245 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI----------Y  245 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH----------h
Confidence            875431111          112346778999998732  245789999999999999999999999311          1


Q ss_pred             HHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      + -|..          +.+.       ..      ..-+...+....|+.+.+|++.||+.||.+|||+.+++.+
T Consensus       246 ~-~GgS----------laLA-------v~------n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  246 Q-QGGS----------LALA-------VQ------NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             h-cCCe----------EEEe-------ee------ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1 0100          0000       00      0001111223479999999999999999999999999864

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.2e-40  Score=317.69  Aligned_cols=247  Identities=22%  Similarity=0.367  Sum_probs=193.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++.+.||+|+||.||+|.+..     +++.||+|+++...    .+.+.+|+.++.++.+|+||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence            5689999999999999999997443     45789999986422    245778999999987799999999988654 3


Q ss_pred             CccEEEEEecCCCChhhhcC------------------------------------------------------------
Q 014762          195 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------  214 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  214 (419)
                      ..++++|||+++++|..++.                                                            
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            56789999999999977652                                                            


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc---eeecccccccc
Q 014762          215 ----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKG  287 (419)
Q Consensus       215 ----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~a  287 (419)
                          .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++........   ....++..|+|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence                46788899999999999999999999999999999999987 78999999999865433221   22344567999


Q ss_pred             cccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCC
Q 014762          288 PELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR  366 (419)
Q Consensus       288 PE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (419)
                      ||++.+ ..++.++|||||||++|+|++ |..||.. ....+.+...... +.                           
T Consensus       244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~-~~~~~~~~~~~~~-~~---------------------------  293 (337)
T cd05054         244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPG-VQIDEEFCRRLKE-GT---------------------------  293 (337)
T ss_pred             cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCC-CCccHHHHHHHhc-cC---------------------------
Confidence            999887 789999999999999999998 8888732 2222222111110 00                           


Q ss_pred             CCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                             ........++++.+++.+||+.+|++|||+.|+++|
T Consensus       294 -------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         294 -------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             -------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                   000012357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.4e-40  Score=321.14  Aligned_cols=246  Identities=23%  Similarity=0.346  Sum_probs=192.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.++||+|+||+||+|.+...     +..||+|+++...    .+.+.+|+.+++++..||||++++++|.+  
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence            367899999999999999999986433     3479999996432    35688999999999459999999999954  


Q ss_pred             CCccEEEEEecCCCChhhhcC-----------------------------------------------------------
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (419)
                      ....++||||+++|+|..++.                                                           
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            467899999999999876531                                                           


Q ss_pred             ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC
Q 014762          215 ----------------------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (419)
Q Consensus       215 ----------------------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~  254 (419)
                                                              .+++..+..++.|++.||+|||+++|+|+||||+|||++.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~  272 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence                                                    2567778889999999999999999999999999999998


Q ss_pred             CCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014762          255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (419)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~  330 (419)
                      + +.+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.....+....
T Consensus       273 ~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         273 G-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             C-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            7 78999999999765432221   22345677999999877 678999999999999999997 888884322221111


Q ss_pred             HHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       331 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ..+..  +                          .        .......++.++.+++.+||+.||++|||+.++.+
T Consensus       351 ~~~~~--~--------------------------~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKS--G--------------------------Y--------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhc--C--------------------------C--------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            11100  0                          0        00011236889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.4e-40  Score=311.68  Aligned_cols=245  Identities=18%  Similarity=0.303  Sum_probs=191.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcE--EEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.+.||+|+||.||+|.+..++..  +++|.++..    ....+.+|+.++.++.+|+||+++++++..  ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~   83 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL   83 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCc
Confidence            56799999999999999999998777764  577776532    234678899999999789999999999954  4678


Q ss_pred             EEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCc
Q 014762          198 SLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK  258 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~  258 (419)
                      ++||||+++++|..++.                   .+++..+..++.|++.||+|||++|++||||||+|||++.+ +.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~-~~  162 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YV  162 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC-Cc
Confidence            99999999999988762                   36788999999999999999999999999999999999987 78


Q ss_pred             EEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHc
Q 014762          259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVL  337 (419)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~l  337 (419)
                      +||+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +.+..+....+..  
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~--  238 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQ--  238 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcc-cCChHHHHHHHhc--
Confidence            99999999864321111122233556999998866 678999999999999999998 888884 2222221111100  


Q ss_pred             CCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                       .                                 ........+++++.+|+.+||+.+|++|||+.+++++
T Consensus       239 -~---------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 -G---------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             -C---------------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             0                                 0000011267889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.5e-39  Score=306.40  Aligned_cols=252  Identities=20%  Similarity=0.353  Sum_probs=196.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.++||+|+||.||+|....     .+..||+|.++...    ...+.+|+.+++.+ +||||+++++++.+. 
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKG-   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC-
Confidence            46789999999999999999997542     34579999886432    24577899999999 899999999998654 


Q ss_pred             CCccEEEEEecCCCChhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEE
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPT-------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-------------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~k  260 (419)
                       ...++||||+.+++|..++..             .+...+..++.|++.||.|||+++++||||||+||+++.+ +.++
T Consensus        82 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~-~~~~  159 (288)
T cd05061          82 -QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVK  159 (288)
T ss_pred             -CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-CcEE
Confidence             568999999999999888732             3556788899999999999999999999999999999987 7899


Q ss_pred             EEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014762          261 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (419)
Q Consensus       261 l~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~  336 (419)
                      |+|||+++........   ....++..|+|||.+.+ ..++.++|+|||||++|||++ |..||. +.+..+....+.. 
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~-~~~~~~~~~~~~~-  236 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQ-GLSNEQVLKFVMD-  236 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc-
Confidence            9999998755332211   11234567999999876 678999999999999999998 676763 3332222221110 


Q ss_pred             cCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc------CC
Q 014762          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV------IS  410 (419)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~------hp  410 (419)
                      .+.                                   ......+++.+.+++.+||+.||++|||+.++++      ||
T Consensus       237 ~~~-----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         237 GGY-----------------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             CCC-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence            000                                   0001225788999999999999999999999987      99


Q ss_pred             Cccccc
Q 014762          411 SISPIF  416 (419)
Q Consensus       411 ~f~~~~  416 (419)
                      ||+++.
T Consensus       282 ~~~~~~  287 (288)
T cd05061         282 SFPEVS  287 (288)
T ss_pred             CCCCCC
Confidence            998874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.9e-40  Score=306.35  Aligned_cols=245  Identities=19%  Similarity=0.348  Sum_probs=192.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.+.     .++..||+|.++..    ...++.+|+.+++.+ +||||+++++++..  
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence            4678999999999999999999764     24567999988642    234678999999999 99999999999954  


Q ss_pred             CCccEEEEEecCCCChhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEE
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPT-------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-------------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~k  260 (419)
                      ....++||||+++++|..++..             +++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~-~~~~  159 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK  159 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-CCEE
Confidence            4678899999999999887632             4567788899999999999999999999999999999987 7899


Q ss_pred             EEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014762          261 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (419)
Q Consensus       261 l~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~  336 (419)
                      |+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~  237 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGMSNEQVLRFVMEG  237 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHcC
Confidence            9999998755432221   11244667999999876 678999999999999999999 56676 333333222211110


Q ss_pred             cCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                       +..                                   .....+++.+.+++.+||+.||++|||+.|++++
T Consensus       238 -~~~-----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 -GLL-----------------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             -CcC-----------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             000                                   0012367889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.3e-39  Score=309.61  Aligned_cols=250  Identities=27%  Similarity=0.400  Sum_probs=198.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..+|++.+.||+|+||+||+|.+..+++.||+|.+...      ..+.+.+|+.+++.+ +|||+++++++|.+.  ...
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~--~~~   90 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLRE--HTA   90 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeC--CeE
Confidence            56689999999999999999999889999999988532      124678999999999 999999999999754  567


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++|+||+.++.+....   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++...... 
T Consensus        91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSPA-  168 (307)
T ss_pred             EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecCCC-
Confidence            8999999865433332   458999999999999999999999999999999999999988 78999999998765432 


Q ss_pred             cceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          275 EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                        ....++..|+|||++.+  ...++.++||||||+++|+|++|..||... +.......+.. ...+.           
T Consensus       169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~-~~~~~-----------  233 (307)
T cd06607         169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQ-NDSPT-----------  233 (307)
T ss_pred             --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhc-CCCCC-----------
Confidence              23467788999998752  256889999999999999999999998432 11111111100 00000           


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                             .....++.++.+++.+||+.||++|||+.+++.||||..-+
T Consensus       234 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         234 -----------------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             -----------------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence                                   00112577899999999999999999999999999997543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=304.97  Aligned_cols=272  Identities=34%  Similarity=0.621  Sum_probs=213.0

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      |+..+.||+|+||.||+|.+..+++.+|+|.+....     .+.+.+|+.+++.+ +|+|++++++++.+.  ...++|+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~~v~   77 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTE--RKLYLVF   77 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcC--CceEEEe
Confidence            567888999999999999999999999999987532     35677899999999 899999999999654  6788999


Q ss_pred             EecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cc
Q 014762          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (419)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~  276 (419)
                      ||+++ ++..++    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.++...... ..
T Consensus        78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCcccc
Confidence            99985 677665    358999999999999999999999999999999999999987 889999999987654332 22


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      .....+..|+|||.+.+...++.++|+|||||++|++++|+.|| .+.+..+.+..+.+.++.+....+..-....   .
T Consensus       156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  231 (282)
T cd07829         156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF-PGDSEIDQLFKIFQILGTPTEESWPGVTKLP---D  231 (282)
T ss_pred             CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHHHhCCCcHHHHHhhcccc---c
Confidence            33456678999999877458899999999999999999998776 5566666777777777776655443222211   0


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      +............     ......++..+.+++++||..||++|||+++++.||||
T Consensus       232 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         232 YKPTFPKFPPKDL-----EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccccccccCccch-----HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0000000000011     01112257889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.9e-39  Score=301.48  Aligned_cols=243  Identities=18%  Similarity=0.348  Sum_probs=196.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ..+|++.++||+|+||.||+|.+..+++.+|+|.++...  .+.+.+|+.+++.+ +|+||+++++++..+  ...+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   81 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE--PPFYIIT   81 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcCC--CCcEEEE
Confidence            456899999999999999999999999999999987543  35788999999999 999999999999654  6778999


Q ss_pred             EecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      ||+++++|..++.     .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++.........
T Consensus        82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCccccccccceee
Confidence            9999999988762     47888899999999999999999999999999999999987 88999999998765433221


Q ss_pred             e--eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          277 N--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       277 ~--~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .  ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +.+..+....+....                
T Consensus       161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~-~~~~~~~~~~~~~~~----------------  222 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKGY----------------  222 (263)
T ss_pred             ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHCCC----------------
Confidence            1  1223456999999876 778999999999999999998 787773 333222222211100                


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                          .......++.++.+++.+||+.||++|||+.++++
T Consensus       223 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 --------------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                00111236889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-39  Score=310.88  Aligned_cols=244  Identities=18%  Similarity=0.338  Sum_probs=193.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcE----EEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~----vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ...+|++.+.||+|+||+||+|.+..+++.    ||+|.++...    .+.+.+|+.+++.+ +||||+++++++..   
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~---   80 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT---   80 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcC---
Confidence            356799999999999999999987766664    8999986432    35688899999999 99999999999965   


Q ss_pred             CccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ...++++||+.+|++.+++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~  159 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL  159 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEccccccccc
Confidence            34679999999999988763    47888899999999999999999999999999999999988 78999999999876


Q ss_pred             cCCCcce---eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          271 HPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       271 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .......   ...++..|+|||++.+ ..++.++|||||||++|||++ |..||. +. ....+..+.....        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~-~~-~~~~~~~~~~~~~--------  228 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GI-PASEISSILEKGE--------  228 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CC-CHHHHHHHHhCCC--------
Confidence            5433221   1233557999999877 789999999999999999998 888873 22 2222222211000        


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                         .        ......++.++.+++.+||..||++|||+.+++.+
T Consensus       229 -------------------~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         229 -------------------R--------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             -------------------C--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                               0        00012267789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.8e-40  Score=308.99  Aligned_cols=244  Identities=17%  Similarity=0.288  Sum_probs=191.0

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCc--EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.++..    ..+.+.+|+.++.++.+||||+++++++...  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR--GYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC--Ccce
Confidence            578999999999999999998877765  4688887632    2356888999999986799999999999654  5688


Q ss_pred             EEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcE
Q 014762          199 LIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~  259 (419)
                      +++||+++++|..++.                   .+++..+..++.|++.||+|||++|++||||||+|||++.+ +.+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~  158 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-LAS  158 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-CeE
Confidence            9999999999987762                   37788899999999999999999999999999999999987 789


Q ss_pred             EEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcC
Q 014762          260 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLG  338 (419)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg  338 (419)
                      ||+|||++..............+..|+|||++.+ ..++.++|||||||++|+|++ |..||.. .+..+....+.... 
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~-  235 (297)
T cd05089         159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGY-  235 (297)
T ss_pred             EECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCC-
Confidence            9999999864321111111223456999999876 678999999999999999997 9888842 22222222111100 


Q ss_pred             CchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                         .......++.++.+|+.+||+.||.+|||++++++.
T Consensus       236 -----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         236 -----------------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             -----------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                               000112378899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.1e-40  Score=310.92  Aligned_cols=250  Identities=22%  Similarity=0.401  Sum_probs=201.7

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .|+...+||+|+||.||+|.+..+++.||+|.+..   ...+.+.+|+.++..+ +|||++++++.+...  ...++++|
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~~~~iv~e   98 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVG--EELWVLME   98 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheeeC--CeEEEEEe
Confidence            34445679999999999999988999999999853   2345688999999999 899999999998654  67889999


Q ss_pred             ecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cceee
Q 014762          203 YVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR  279 (419)
Q Consensus       203 ~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~~~  279 (419)
                      |++++++..+..  .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....... .....
T Consensus        99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659          99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-CcEEEeechhHhhcccccccccce
Confidence            999999988763  58899999999999999999999999999999999999988 889999999986543322 22335


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      .++..|+|||++.+ ..++.++|+|||||++|+|++|+.||+.. +..+.+..+..   ...                  
T Consensus       178 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~---~~~------------------  234 (297)
T cd06659         178 VGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRD---SPP------------------  234 (297)
T ss_pred             ecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc---cCC------------------
Confidence            67889999999876 67899999999999999999999998532 22222222111   000                  


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                             ..+      .....+++.+.+++++||+.+|++|||++++++||||..-
T Consensus       235 -------~~~------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         235 -------PKL------KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             -------CCc------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence                   000      0011267889999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=300.51  Aligned_cols=248  Identities=24%  Similarity=0.395  Sum_probs=199.9

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC--------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .+|++.+.||+|+||.||+|.+..+++.+|+|.+..        .....+.+|+.+++++ +|+||+++++++.+.....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence            579999999999999999999999999999998742        1224678899999999 9999999999997665567


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++++||+++++|..++   ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||+++.....
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECccccccccccc
Confidence            88999999999998776   347889999999999999999999999999999999999987 78999999998754321


Q ss_pred             ----CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       274 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                          .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||... ..   ...+.+....+.        
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~---~~~~~~~~~~~~--------  226 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEY-EA---MAAIFKIATQPT--------  226 (264)
T ss_pred             cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCcc-CH---HHHHHHHHcCCC--------
Confidence                11123457788999999877 67899999999999999999999998421 11   122222111100        


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                              ....+..+++++.+++++||+ +|.+|||+.+++.|||.
T Consensus       227 ------------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 ------------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ------------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                    000122378899999999999 57999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-39  Score=307.44  Aligned_cols=257  Identities=22%  Similarity=0.351  Sum_probs=201.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.+|+|.++..    ....+.+|+.++.+..+||||+++++++.+.  ...+
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~   90 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD--SDVF   90 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC--CeEE
Confidence            467899999999999999999999888999999998643    2345667887777775799999999999654  6789


Q ss_pred             EEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++|||+++ ++..+.    ..+++..+..++.|++.||.|||+ .||+|+||+|+||+++.+ +.+||+|||++......
T Consensus        91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECccccchhccCC
Confidence            99999875 444433    358889999999999999999997 699999999999999977 88999999998765443


Q ss_pred             CcceeecccccccccccccCC---CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          274 KEYNVRVASRYFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      .......++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||.......+.+..+..   ...         
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~---------  236 (296)
T cd06618         169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEP---------  236 (296)
T ss_pred             CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---CCC---------
Confidence            333445677889999998652   24789999999999999999999998533222222222111   000         


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                      ..+      .....+++++.+|+.+||..||++|||++++++||||+..++
T Consensus       237 ----------------~~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         237 ----------------PSL------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             ----------------CCC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence                            000      000126788999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-39  Score=301.09  Aligned_cols=242  Identities=21%  Similarity=0.407  Sum_probs=196.4

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      +|++.++||+|+||.||++.+..+++.+|+|.++..    ..+.+.+|+.+++.+ +|+|++++++.+.+.  ...+++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEAD--GHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC--CEEEEEE
Confidence            588999999999999999999999999999988532    235678899999999 999999999999654  6789999


Q ss_pred             EecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-
Q 014762          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      ||++++++..++.     .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++++|||++........ 
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeecccccc
Confidence            9999999877652     37889999999999999999999999999999999999987 7899999999976643322 


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||... +.......+..  +.                
T Consensus       157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~~--~~----------------  216 (255)
T cd08219         157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQAN-SWKNLILKVCQ--GS----------------  216 (255)
T ss_pred             cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCC-CHHHHHHHHhc--CC----------------
Confidence            233467888999999876 67899999999999999999999998422 11111111110  00                


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                ..        .....++..+.+|+.+||+.||++|||+.++++-
T Consensus       217 ----------~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 ----------YK--------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----------CC--------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                      00        0012367889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-39  Score=304.01  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=196.5

Q ss_pred             CCe-EEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          125 DDY-EVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       125 ~~y-~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.++..    ....+.+|+.+++++ +||||+++++++......
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence            455 889999999999998764    3457889999998743    245678999999999 999999999998766556


Q ss_pred             ccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ..+++|||++++++..++  ..+++..+..++.|++.||+|||++|++|+||||+|||++.+ +.++|+|||+++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeecccccccCCc
Confidence            788999999999998876  368999999999999999999999999999999999999988 78999999999866433


Q ss_pred             Ccc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-cCCchHHHHHhh
Q 014762          274 KEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV-LGTDELNAYLNK  348 (419)
Q Consensus       274 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~-lg~~~~~~~~~~  348 (419)
                      ...    ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......   +..+... .+....      
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~------  230 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQGQMTV------  230 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcccccccch------
Confidence            221    12234566999999876 67899999999999999999999998433221   1111110 000000      


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                            ..+.........        ......++.++.+++.+||+.||++|||+.++++
T Consensus       231 ------~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         231 ------VRLIELLERGMR--------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             ------hhhhhhhhcCCC--------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                  000000000000        0112246889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.8e-39  Score=300.30  Aligned_cols=242  Identities=18%  Similarity=0.307  Sum_probs=192.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.++||+|+||+||+|.+..+ ..||+|.++..  ..+.+.+|+.+++.+ +||||+++++.+.+   ...++|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv   78 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV   78 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC---CCcEEE
Confidence            356799999999999999999987655 46999999743  346789999999999 89999999998743   457899


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||++++++..++.     .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||.++.......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeecccccc
Confidence            99999999988873     37888999999999999999999999999999999999987 7899999999976643332


Q ss_pred             c--eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .  ....++..|+|||+..+ ..++.++|+|||||++|+|++ |..|| .+....+....+......             
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~-~~~~~~~~~~~~~~~~~~-------------  222 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRM-------------  222 (262)
T ss_pred             ccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCChHHHHHHHhcCCCC-------------
Confidence            2  12345567999998876 678999999999999999999 66666 333332222221110000             


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                             .....++..+.+++.+||+.||++|||+.++++
T Consensus       223 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         223 -----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             -----------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                                   001126788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=342.75  Aligned_cols=254  Identities=27%  Similarity=0.430  Sum_probs=210.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++++.||+|+||.|..++.+.+++.||+|++++      ....-|..|-.+|..- +.+.|++++-.|.+  .++
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD--~~~  149 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQD--ERY  149 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcC--ccc
Confidence            47889999999999999999999999999999999975      2235588899999886 89999999999955  589


Q ss_pred             cEEEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      +|+|||||+||+|-.++.   .+++..++.|+.+|..||+-||+.|+|||||||+|||+|.. |++||+|||.+-.+..+
T Consensus       150 LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccchhHHhcCCC
Confidence            999999999999988874   47899999999999999999999999999999999999998 99999999998777654


Q ss_pred             Cc--ceeecccccccccccccCC----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          274 KE--YNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       274 ~~--~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      +.  ....+|||.|.+||++...    +.|+..+|.||+||++|||+.|..||+. ++-.+.+-.|+..           
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~h-----------  296 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNH-----------  296 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhch-----------
Confidence            43  3456999999999998542    4689999999999999999999999953 2222222223221           


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCCCcccc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMVISSISPI  415 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~elL~hp~f~~~  415 (419)
                                         +   ..+..+....+|+++++||+++++ +|+.|..   ++++-+||||.++
T Consensus       297 -------------------k---~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  297 -------------------K---ESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             -------------------h---hhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence                               0   000111112389999999999884 8999998   9999999999876

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.2e-39  Score=300.51  Aligned_cols=242  Identities=19%  Similarity=0.337  Sum_probs=193.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.++||+|+||+||+|.+ .++..||+|.+...  ..+.+.+|+.+++.+ +|+||+++++.+.+  ....+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTK--EEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--CCCcEEEE
Confidence            57899999999999999999985 45677999988643  346788999999999 99999999999855  46688999


Q ss_pred             EecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      ||+.++++..++     ..+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++.........
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceecCCCcee
Confidence            999999998876     247888889999999999999999999999999999999988 78999999999876433221


Q ss_pred             --eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       277 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                        ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+....+....                
T Consensus       160 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~~----------------  221 (261)
T cd05072         160 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYP-GMSNSDVMSALQRGY----------------  221 (261)
T ss_pred             ccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCC-CCCHHHHHHHHHcCC----------------
Confidence              12234567999999876 678999999999999999998 888873 322222222221100                


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                          .......++.++.+++.+||+.+|++|||++++++
T Consensus       222 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         222 --------------------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                00011236889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.2e-40  Score=311.85  Aligned_cols=273  Identities=18%  Similarity=0.185  Sum_probs=191.1

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhh
Q 014762          137 KYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV  211 (419)
Q Consensus       137 ~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~  211 (419)
                      ++|.||.+++..+++.||+|+++..     ..+.+.+|+.+++.+ +|+||+++++++.+.  ...+++|||++++++..
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~   88 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVD--SELYVVSPLMAYGSCED   88 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecC--CeEEEEEeccCCCCHHH
Confidence            4455666666779999999998643     235788999999999 899999999999654  66889999999999988


Q ss_pred             hcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc--------cee
Q 014762          212 LYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--------YNV  278 (419)
Q Consensus       212 ~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~--------~~~  278 (419)
                      ++.     .+++..+..++.|++.||+|||+++|+|+||||+||+++.+ +.+||+|||.+........        ...
T Consensus        89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~  167 (314)
T cd08216          89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKS  167 (314)
T ss_pred             HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeecccccccccccccccc
Confidence            763     47889999999999999999999999999999999999987 7899999998865432211        122


Q ss_pred             ecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          279 RVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ..++..|+|||++... ..++.++|+|||||++|+|++|..||............+.......-............... 
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  246 (314)
T cd08216         168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS-  246 (314)
T ss_pred             ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcc-
Confidence            3466779999998652 35889999999999999999999999543332222222111100000000000000000000 


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                         ....................+++++.+|+++||++||++|||+.++|+||||+.+++
T Consensus       247 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~  303 (314)
T cd08216         247 ---RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR  303 (314)
T ss_pred             ---cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence               000000000000001111225678999999999999999999999999999998864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=300.69  Aligned_cols=245  Identities=28%  Similarity=0.453  Sum_probs=192.8

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcch------HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +.||.|+||.||+|.+..+++.||+|.+.....      ..+..|..++....+|+|++++++++..  ...+++|+||+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~   79 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL   79 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence            469999999999999999999999999864321      2344555555544489999999999965  46789999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeecc
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (419)
                      ++++|..++   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++.....   .....+
T Consensus        80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceeccc---cccCCC
Confidence            999998887   458999999999999999999999999999999999999987 7899999999875432   223457


Q ss_pred             cccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhh
Q 014762          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALV  361 (419)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~  361 (419)
                      +..|++||.+.+ ..++.++|+||||+++|+|++|..||.. .+..+....+...             ..          
T Consensus       156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~-------------~~----------  210 (260)
T cd05611         156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHA-ETPDAVFDNILSR-------------RI----------  210 (260)
T ss_pred             CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhc-------------cc----------
Confidence            788999999887 5589999999999999999999999842 2222222211110             00          


Q ss_pred             ccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH---HHHhcCCCccccc
Q 014762          362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMVISSISPIF  416 (419)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta---~elL~hp~f~~~~  416 (419)
                            .+.    ......+++++.+++.+||+.||++|||+   +|++.||||+++.
T Consensus       211 ------~~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         211 ------NWP----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             ------CCC----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence                  000    00011368899999999999999999955   7999999998763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.3e-39  Score=298.73  Aligned_cols=243  Identities=17%  Similarity=0.308  Sum_probs=193.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.+.||+|+||+||.|.+. ++..+|+|.+....  .+.+.+|+.+++++ +||||+++++++...  ...+++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~   78 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQ--RPIYIVT   78 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccC--CCcEEEE
Confidence            467999999999999999999754 45569999887433  46789999999999 899999999999554  5678999


Q ss_pred             EecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcce
Q 014762          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (419)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~  277 (419)
                      ||+.++++..++.    .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||.++.........
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecCCCceee
Confidence            9999999888762    47999999999999999999999999999999999999987 789999999987654332211


Q ss_pred             --eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          278 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       278 --~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                        ...++..|++||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+....+.+...                
T Consensus       158 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~-~~~~~~~~~~~~~~~~----------------  219 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYE-RFNNSETVEKVSQGLR----------------  219 (256)
T ss_pred             cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHhcCCC----------------
Confidence              1234457999999876 678999999999999999998 888873 2222222222211000                


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                          .......++.+.+++.+||+.||++|||+.+++++
T Consensus       220 --------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         220 --------------------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                                00011257889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.2e-39  Score=298.67  Aligned_cols=242  Identities=17%  Similarity=0.289  Sum_probs=192.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.+.||+|+||.||++... ++..+|+|.+...  ..+.+.+|+.+++.+ +||||+++++++...  ...++||
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~iv~   78 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQ--KPLYIVT   78 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEccC--CCEEEEE
Confidence            467899999999999999999764 5568999988643  346788999999999 899999999999654  6788999


Q ss_pred             EecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcce
Q 014762          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (419)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~  277 (419)
                      ||+++++|..++.    .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||.++.........
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCCCceec
Confidence            9999999988763    37889999999999999999999999999999999999987 789999999987654322221


Q ss_pred             --eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          278 --VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       278 --~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                        ...++..|+|||++.+ ..++.++|+||||+++|+|++ |+.||. ..+..+....+.+.  .               
T Consensus       158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~-~~~~~~~~~~i~~~--~---------------  218 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFE-KKSNYEVVEMISRG--F---------------  218 (256)
T ss_pred             cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHCC--C---------------
Confidence              1234457999999876 678999999999999999999 888873 33332222222110  0               


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                 .        ...+...+.++.+++.+||+.||++|||++++++
T Consensus       219 -----------~--------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         219 -----------R--------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             -----------C--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                       0        0001125778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.3e-39  Score=302.48  Aligned_cols=244  Identities=24%  Similarity=0.389  Sum_probs=191.1

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHh--cCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l--~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      .||+|+||.||+|.+..+++.||+|.+....      ...+..|..+++.+  .+||||+++++.+.+.  ...++||||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~   78 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL   78 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence            3899999999999999999999999986432      11233444333332  2799999999999654  678899999


Q ss_pred             cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeec
Q 014762          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV  280 (419)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~  280 (419)
                      +.+++|..++   ..+++..++.++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++...... ......
T Consensus        79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~~~~  156 (278)
T cd05606          79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASV  156 (278)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCcCcC
Confidence            9999998776   348999999999999999999999999999999999999988 78999999998755322 223457


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH-HHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH-DQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~-~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      ++..|+|||++.+...++.++|+||+||++|+|++|+.||....... ........  .                     
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------------------  213 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--T---------------------  213 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--c---------------------
Confidence            88999999998764568999999999999999999999985332111 11111000  0                     


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                   .....+..++.++.+++.+||..+|++|+     |+.++++||||+.+
T Consensus       214 -------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         214 -------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             -------------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence                         00001123688999999999999999999     99999999999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-39  Score=304.85  Aligned_cols=243  Identities=21%  Similarity=0.398  Sum_probs=194.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.++...    .+.+.+|+.+++.+ +|+||+++++++...  
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--   80 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEG--   80 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecC--
Confidence            4568889999999999999998643     46789999987432    35788999999999 899999999999654  


Q ss_pred             CccEEEEEecCCCChhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC
Q 014762          195 KTPSLIFEYVNSTDFKVLYP-----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-----------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~  257 (419)
                      ...++||||+++++|..++.                 .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~  159 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD-L  159 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC-C
Confidence            67899999999999988762                 36788889999999999999999999999999999999988 8


Q ss_pred             cEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 014762          258 KLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI  333 (419)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i  333 (419)
                      .++|+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||+.. +..+....+
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~~~  237 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECI  237 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHH
Confidence            9999999999765332221   22344677999999877 779999999999999999998 99998532 222222221


Q ss_pred             HHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       334 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ..  +.                                 . ......++..+.+++++||+.||++|||+.|+++
T Consensus       238 ~~--~~---------------------------------~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQ--GR---------------------------------L-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             Hc--CC---------------------------------c-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            10  00                                 0 0001236889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.2e-39  Score=296.51  Aligned_cols=245  Identities=24%  Similarity=0.475  Sum_probs=201.7

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.+.||.|+||.||++.+..++..+++|.+...     ..+.+.+|+++++.+ +|+|++++++.+...  ...++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~--~~~~lv   77 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEK--GKLCIV   77 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecC--CEEEEE
Confidence            588999999999999999999989999999998643     345688999999999 899999999999654  778899


Q ss_pred             EEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      +||++++++...+       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST  156 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence            9999999988775       347899999999999999999999999999999999999987 78999999999765443


Q ss_pred             C-cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      . ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.... ..+........    .           
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~----~-----------  219 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKILKG----Q-----------  219 (258)
T ss_pred             cceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHHhcC----C-----------
Confidence            3 2233467888999999876 678999999999999999999999984221 11111111100    0           


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                      ..     .....++.++.+++.+||..+|++|||+.++|+||||
T Consensus       220 ----------------~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         220 ----------------YP-----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----------------CC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                            00     0011368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.5e-40  Score=307.25  Aligned_cols=291  Identities=27%  Similarity=0.484  Sum_probs=234.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .+.|.++++||.|.|++||++.+..   .++.||+|.+.. +....+.+|+++|..+.++.||+.+.+.+..  +...++
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~i  112 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAI  112 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CCeeEE
Confidence            5678899999999999999999887   788999998864 4568899999999999999999999999954  467789


Q ss_pred             EEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc--------
Q 014762          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH--------  271 (419)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~--------  271 (419)
                      |+||++.....+++..++..+++.+++.++.||.++|.+|||||||||+|+|.+...++-.|+|||+|....        
T Consensus       113 vlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s  192 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS  192 (418)
T ss_pred             EecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence            999999999999999999999999999999999999999999999999999999998889999999986110        


Q ss_pred             ---------C-----------------CCc-----------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHH
Q 014762          272 ---------P-----------------GKE-----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI  314 (419)
Q Consensus       272 ---------~-----------------~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell  314 (419)
                               +                 ...           ...+.||++|+|||++...+.-+.++||||.||++..++
T Consensus       193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll  272 (418)
T KOG1167|consen  193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL  272 (418)
T ss_pred             hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence                     0                 000           011368999999999999888999999999999999999


Q ss_pred             hCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC--CCC----hhhHHhhccCCCC------Cccc--cccccccCC
Q 014762          315 FRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL--ELD----PQLDALVGRHSRK------PWSK--FINADNQHL  380 (419)
Q Consensus       315 ~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~--~~~----~~~~~~~~~~~~~------~~~~--~~~~~~~~~  380 (419)
                      +++.|||...++.+.+.+++...|...+....--.+.  -+.    +...+........      .-++  .....-.+.
T Consensus       273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~  352 (418)
T KOG1167|consen  273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV  352 (418)
T ss_pred             ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence            9999999999999999999999998877655422222  111    0111111110000      0000  111122233


Q ss_pred             CCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          381 VSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       381 ~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      .+..+.||+++||..||.+|.||+++|+||||+...
T Consensus       353 ~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  353 FPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             ccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            566889999999999999999999999999999764

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.4e-39  Score=294.65  Aligned_cols=246  Identities=33%  Similarity=0.518  Sum_probs=202.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      +|+..+.||+|++|.||++.+..+++.+++|++....   .+.+.+|+.+++.+ +|+|++++++.+...  ...++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKK--DELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEEEEe
Confidence            4788999999999999999998899999999997543   46788999999999 899999999999654  66789999


Q ss_pred             ecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCccee
Q 014762          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  278 (419)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~  278 (419)
                      |+++++|..++    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+...........
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~  156 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNT  156 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeeccccccccccccccc
Confidence            99999998876    357999999999999999999999999999999999999987 8899999999877655432344


Q ss_pred             ecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhH
Q 014762          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~  358 (419)
                      ..++..|++||.+.+ ..++.++|+||||+++++|++|+.||..... .+....+.. ...+.                 
T Consensus       157 ~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~-~~~~~-----------------  216 (253)
T cd05122         157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPP-MKALFKIAT-NGPPG-----------------  216 (253)
T ss_pred             eecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCch-HHHHHHHHh-cCCCC-----------------
Confidence            577888999999876 5689999999999999999999999843221 111111111 00000                 


Q ss_pred             HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014762          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISS  411 (419)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~  411 (419)
                                      ......++..+.+++.+||+.||++|||+.++++|||
T Consensus       217 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 ----------------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ----------------cCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence                            0001114788999999999999999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4e-39  Score=302.97  Aligned_cols=254  Identities=28%  Similarity=0.463  Sum_probs=207.0

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ...+.|++.+.||+|+||.||+|.+..++..+++|+++...  .+.+.+|+.+++.+ +|+|++++++.+...  ...++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~l   92 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVG--DELWV   92 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEEC--CEEEE
Confidence            34677999999999999999999998899999999997554  56788999999999 999999999999665  67889


Q ss_pred             EEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          200 IFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      ++||+++++|.+++.    .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....... 
T Consensus        93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-CCEEECccchhhhhccchh
Confidence            999999999988862    68999999999999999999999999999999999999987 789999999886543322 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|++||.+.+ ..++.++|+|||||++|+|++|..||.. .+.......+.. .+.+.             
T Consensus       172 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~-~~~~~~~~~~~~-~~~~~-------------  235 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITT-KGIPP-------------  235 (286)
T ss_pred             hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh-cCCCC-------------
Confidence            1123356778999999876 6789999999999999999999999842 222221111111 00000             


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                          ......++.++.+||.+||+.+|.+|||+.++++||||++.
T Consensus       236 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         236 --------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             --------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence                                00011267889999999999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.1e-39  Score=303.28  Aligned_cols=244  Identities=17%  Similarity=0.341  Sum_probs=192.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      .++|++.++||+|+||+||+|.+.    .++..+++|.+....    ...+.+|+.+++.+ +||||+++++++...  .
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~   80 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQE--Q   80 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecC--C
Confidence            467899999999999999999853    456789999986422    25688999999999 999999999998654  6


Q ss_pred             ccEEEEEecCCCChhhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC
Q 014762          196 TPSLIFEYVNSTDFKVLYP--------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~--------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~  255 (419)
                      ..+++|||+.+++|..++.                    .+++..+..++.|++.||+|||++|++|+||||+|||++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence            6889999999999987751                    36778889999999999999999999999999999999987


Q ss_pred             CCcEEEEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 014762          256 LRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (419)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~  331 (419)
                       +.+||+|||+++.......   .....++..|+|||++.+ ..++.++|+|||||++|||++ |..||. +....+.. 
T Consensus       161 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~-~~~~~~~~-  236 (283)
T cd05090         161 -LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYY-GFSNQEVI-  236 (283)
T ss_pred             -CcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCCHHHHH-
Confidence             7899999999976543322   122334567999999876 678999999999999999998 887873 33322222 


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      ++.......                                   ..+..+++.+.+++.+||+.||++||++.+++++
T Consensus       237 ~~~~~~~~~-----------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         237 EMVRKRQLL-----------------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHcCCcC-----------------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            221110000                                   0112368899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.5e-39  Score=334.63  Aligned_cols=244  Identities=22%  Similarity=0.358  Sum_probs=192.2

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.++||+|+||+||+|.+..+|+.||+|++...      ..+.+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~--~~ly   78 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDG--DPVY   78 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeC--CEEE
Confidence            5799999999999999999999999999999998642      135688999999999 999999999999654  6789


Q ss_pred             EEEEecCCCChhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEec
Q 014762          199 LIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~--------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Df  264 (419)
                      ++|||++|++|..++.              ..+...+..++.|++.||+|||++||+||||||+|||++.+ +.++|+||
T Consensus        79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d-g~vKLiDF  157 (932)
T PRK13184         79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-GEVVILDW  157 (932)
T ss_pred             EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-CCEEEEec
Confidence            9999999999987652              23456678899999999999999999999999999999988 78999999


Q ss_pred             ccceeccCCC-------------------cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 014762          265 GLAEFYHPGK-------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD  325 (419)
Q Consensus       265 gla~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~  325 (419)
                      |+++......                   ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... 
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~-  235 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKK-  235 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcc-
Confidence            9997652110                   0012368999999999877 778999999999999999999999984311 


Q ss_pred             CHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 014762          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (419)
Q Consensus       326 ~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e  405 (419)
                      ..+....  ..+..+.                             .   ......+++.+.+++.+||+.||++|++..+
T Consensus       236 ~~ki~~~--~~i~~P~-----------------------------~---~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e  281 (932)
T PRK13184        236 GRKISYR--DVILSPI-----------------------------E---VAPYREIPPFLSQIAMKALAVDPAERYSSVQ  281 (932)
T ss_pred             hhhhhhh--hhccChh-----------------------------h---ccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence            1111000  0000000                             0   0001136889999999999999999987766


Q ss_pred             Hhc
Q 014762          406 AMV  408 (419)
Q Consensus       406 lL~  408 (419)
                      .+.
T Consensus       282 eLl  284 (932)
T PRK13184        282 ELK  284 (932)
T ss_pred             HHH
Confidence            554

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-39  Score=300.24  Aligned_cols=242  Identities=19%  Similarity=0.351  Sum_probs=190.2

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC----
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----  194 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  194 (419)
                      |.+.+.||+|+||.||+|....+   +..||+|.++...     ...+.+|+.+++.+ +||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence            56788999999999999987653   4789999986432     24678999999999 99999999998864322    


Q ss_pred             CccEEEEEecCCCChhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecc
Q 014762          195 KTPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfg  265 (419)
                      ...++++||+.++++..++         ..+++..+..++.|++.||+|||+++++|+||||+||+++.+ +.+||+|||
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg  158 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVADFG  158 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECCcc
Confidence            3478999999999997765         247889999999999999999999999999999999999987 789999999


Q ss_pred             cceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCch
Q 014762          266 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDE  341 (419)
Q Consensus       266 la~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~  341 (419)
                      +++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.++.+....+...  . .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~-~~~~~~~~~~~~~~~--~-~  233 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPY-PGVENHEIYDYLRHG--N-R  233 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC--C-C
Confidence            99876543322   12234567999999866 778999999999999999999 77666 343333322221110  0 0


Q ss_pred             HHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                       ......+++++.+++.+||+.||++|||+.|+++
T Consensus       234 ---------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~  267 (273)
T cd05035         234 ---------------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE  267 (273)
T ss_pred             ---------------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                             0001236889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-40  Score=316.83  Aligned_cols=252  Identities=24%  Similarity=0.439  Sum_probs=213.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ....|.+...||+|.|++|.+|.+..++..||||.+++.     ....+.+|+++|+.+ +|||||+++.+...  ...+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t--~~~l  130 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIET--EATL  130 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeee--ccee
Confidence            356799999999999999999999999999999999753     335688999999999 99999999999955  4789


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      |+||||+.+|.+.+++   ....+..++.+..|+..|++|||+++|||||||++||||+.+ ..+||+|||++..+..+.
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~~  209 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN-MNIKIADFGFSTFFDYGL  209 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc-cceeeeccccceeecccc
Confidence            9999999999999887   456778899999999999999999999999999999999998 568999999999998888


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      .....+|++.|.|||+..+.+..++.+|+||+|+++|.|+.|..||... +-.+                          
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~-~lk~--------------------------  262 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ-NLKE--------------------------  262 (596)
T ss_pred             cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc-cccc--------------------------
Confidence            8888999999999999998666689999999999999999999999311 1000                          


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                           +..+..    ..  ....+..++.++.++|+++|..+|.+|++.++++.|.|.....
T Consensus       263 -----Lr~rvl----~g--k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  263 -----LRPRVL----RG--KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             -----ccchhe----ee--eecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence                 000000    00  0011123788999999999999999999999999999987543

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.6e-38  Score=295.40  Aligned_cols=245  Identities=25%  Similarity=0.463  Sum_probs=197.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++.      ...+.+.+|+.+++++ +|+|++++++.+...  ...+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~--~~~~   78 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIEN--NELN   78 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecC--CeEE
Confidence            579999999999999999999998999999998753      1245788999999999 999999999999654  6788


Q ss_pred             EEEEecCCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ++|||+++++|..++.       .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++....
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~  157 (267)
T cd08224          79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC-CcEEEeccceeeecc
Confidence            9999999999987652       37889999999999999999999999999999999999987 789999999987654


Q ss_pred             CCCc-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          272 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       272 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      .... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.....+...+   .+.+...          
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~----------  223 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKIEKC----------  223 (267)
T ss_pred             CCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH---HhhhhcC----------
Confidence            3322 233467888999999876 678999999999999999999999985433221111   1100000          


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                       .    ........++..+.++|.+||..+|++|||+.++++
T Consensus       224 -----------------~----~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         224 -----------------D----YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             -----------------C----CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                             0    000001136788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.3e-39  Score=302.59  Aligned_cols=243  Identities=20%  Similarity=0.363  Sum_probs=193.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      .++|.+.+.||+|+||+||++.+.     .++..+|+|.+....   .+.+.+|+.+++++ +||||+++++++..  ..
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--GD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CC
Confidence            567999999999999999999752     345678999986433   35688999999999 89999999999965  46


Q ss_pred             ccEEEEEecCCCChhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcE
Q 014762          196 TPSLIFEYVNSTDFKVLYP----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~  259 (419)
                      ..++||||+++++|..++.                .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.+
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~-~~~  159 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LLV  159 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-CcE
Confidence            7899999999999987762                37899999999999999999999999999999999999988 889


Q ss_pred             EEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 014762          260 RLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAK  335 (419)
Q Consensus       260 kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~  335 (419)
                      +|+|||+++........   ....++..|+|||++.+ ..++.++|+|||||++|+|++ |..||. +....+....+..
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~-~~~~~~~~~~i~~  237 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVIECITQ  237 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc
Confidence            99999999765432221   12234567999999876 778999999999999999998 787773 3233222222211


Q ss_pred             HcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          336 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       336 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                        +..                                  ......++.++.+|+.+||+.||.+|||+.++++
T Consensus       238 --~~~----------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 --GRV----------------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             --CCc----------------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              000                                  0001126789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.3e-39  Score=303.79  Aligned_cols=246  Identities=18%  Similarity=0.349  Sum_probs=194.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||.||++.+...     ...+|+|.+....    ...+.+|+.++.++.+|+||+++++++... 
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-   88 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE-   88 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-
Confidence            467899999999999999999987643     3689999986432    245778999999986799999999999553 


Q ss_pred             CCccEEEEEecCCCChhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC
Q 014762          194 SKTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~  254 (419)
                       ...+++|||+.++++..++                   ..+++..+..++.|++.||+|||+++|+|+||||+|||++.
T Consensus        89 -~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          89 -GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             -CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence             6789999999999998776                   24788889999999999999999999999999999999998


Q ss_pred             CCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014762          255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (419)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~  330 (419)
                      + +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+..
T Consensus       168 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~  244 (293)
T cd05053         168 D-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYP-GIPVEELF  244 (293)
T ss_pred             C-CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCC-CCCHHHHH
Confidence            7 89999999999865433221   11233457999999876 778999999999999999997 888873 22222222


Q ss_pred             HHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       331 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      ..+....                                    .......++.++.+|+.+||..||++|||+.|++++
T Consensus       245 ~~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         245 KLLKEGY------------------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHcCC------------------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            2111100                                    000112367889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-40  Score=316.14  Aligned_cols=244  Identities=23%  Similarity=0.370  Sum_probs=195.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCc---E-EEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---R-CIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~-vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      .++..+.++||+|.||.||+|.....+.   . ||+|..+.      ....++.+|+++|+++ +|||||+++|++..+ 
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~-  233 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLE-  233 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCC-
Confidence            5566677999999999999998765432   3 89998873      2346788999999999 999999999999665 


Q ss_pred             CCccEEEEEecCCCChhhhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPT----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~----l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                       ..+++|||+|+||+|.++++.    ++..+...++.+.+.||+|||+++++||||..+|+|++.+ +.+||+|||+++.
T Consensus       234 -~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISDFGLs~~  311 (474)
T KOG0194|consen  234 -EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISDFGLSRA  311 (474)
T ss_pred             -CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCccccccC
Confidence             668899999999999999843    8899999999999999999999999999999999999987 6789999999876


Q ss_pred             ccCCCcce-eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          270 YHPGKEYN-VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       270 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ...-.... ...-+..|+|||.+.. ..|++++|||||||++||+++ |..|| .+....+..+.+...-          
T Consensus       312 ~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py-~g~~~~~v~~kI~~~~----------  379 (474)
T KOG0194|consen  312 GSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPY-PGMKNYEVKAKIVKNG----------  379 (474)
T ss_pred             CcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCC-CCCCHHHHHHHHHhcC----------
Confidence            54111111 1234567999999987 689999999999999999999 77776 5555554444442210          


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                       +.                        ...+...+.++..++.+|+..||++|||+.++.+
T Consensus       380 -~r------------------------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  380 -YR------------------------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             -cc------------------------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence             00                        0011125778999999999999999999998865

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.1e-38  Score=300.59  Aligned_cols=254  Identities=22%  Similarity=0.399  Sum_probs=200.6

Q ss_pred             CeEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      +|++.+.||.|+||.||++.+.   .+|+.||+|+++..       ..+.+.+|+.++..+.+|+||+++++.+..  ..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~   78 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT   78 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence            4888999999999999999874   47899999998642       235678899999999779999999999955  36


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ..++||||++++++..++   ..+++..+..++.|++.||.|||+.|++|+||+|+|||++.+ +.+||+|||++.....
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~  157 (290)
T cd05613          79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHE  157 (290)
T ss_pred             eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceeccc
Confidence            788999999999998876   348889999999999999999999999999999999999988 8899999999876543


Q ss_pred             CCc--ceeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          273 GKE--YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       273 ~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ...  .....++..|+|||.+.+. ..++.++||||||+++|+|++|..||... ........+.+....         .
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~~---------~  227 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD-GEKNSQAEISRRILK---------S  227 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC-CccccHHHHHHHhhc---------c
Confidence            221  1234578889999998652 34678999999999999999999998422 111111111111000         0


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCccccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPIF  416 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~  416 (419)
                                      ..+        .+..+++.+.+++++||+.||++|+     ++++++.||||+.+.
T Consensus       228 ----------------~~~--------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         228 ----------------EPP--------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             ----------------CCC--------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence                            000        0122678899999999999999997     899999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.3e-39  Score=304.13  Aligned_cols=243  Identities=19%  Similarity=0.320  Sum_probs=192.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..+|++.++||+|+||+||+|.+..+     +..||+|+++...    .+.+.+|+.++..+ +||||+++++++...  
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~--   80 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKE--   80 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCC--
Confidence            45688889999999999999987543     5789999997433    34578899999999 999999999999654  


Q ss_pred             CccEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC
Q 014762          195 KTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~  255 (419)
                      ...++++||+.++++..++.                   .+++..+..++.|++.||+|||++|++||||||+||+++.+
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            56789999999999887751                   36778889999999999999999999999999999999987


Q ss_pred             CCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 014762          256 LRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (419)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~  331 (419)
                       +.+||+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.+..+...
T Consensus       161 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~-~~~~~~~~~~  237 (283)
T cd05091         161 -LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVIE  237 (283)
T ss_pred             -CceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHH
Confidence             78999999998765432221   22345678999999876 678999999999999999998 66666 3443333333


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      .+.+....                                    .....++..+.+|+.+||+.+|++|||+.++++
T Consensus       238 ~i~~~~~~------------------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~  278 (283)
T cd05091         238 MIRNRQVL------------------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS  278 (283)
T ss_pred             HHHcCCcC------------------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            22211000                                    001237888999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=335.05  Aligned_cols=245  Identities=21%  Similarity=0.393  Sum_probs=201.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCC-----cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++.++.+.||+|.||.||.|....-.     ..||+|.++..    ...+|.+|..+|+++ +|||||+++|++-+  
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~--  766 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD--  766 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC--
Confidence            3667888999999999999999865432     24899998753    457899999999999 99999999999976  


Q ss_pred             CCccEEEEEecCCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEe
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~D  263 (419)
                      ....++++|||.+|+|..+++          .++..++..++.|||+|+.||+++++|||||..+|+||+.. ..|||+|
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKIaD  845 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKIAD  845 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEEcc
Confidence            466789999999999999883          37889999999999999999999999999999999999998 8999999


Q ss_pred             cccceeccCCCcceeec---ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCc
Q 014762          264 WGLAEFYHPGKEYNVRV---ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (419)
Q Consensus       264 fgla~~~~~~~~~~~~~---~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~  340 (419)
                      ||+|+.+.....+....   -...|||||.+.+ ..++.++|||||||++||++|...+.+.+.++.+.+....+     
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~-----  919 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE-----  919 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh-----
Confidence            99999655444443221   2245999999998 88999999999999999999944444466666665543322     


Q ss_pred             hHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                             ..                        +.+.+..|++.+.++|..||+.+|++||++..+++
T Consensus       920 -------gg------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  920 -------GG------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             -------CC------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                   00                        11223458999999999999999999999999886

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.4e-39  Score=300.18  Aligned_cols=245  Identities=24%  Similarity=0.437  Sum_probs=196.2

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||.||+|.+..+++.+|||.+...      ..+.+.+|+.+++.+ +|+||+++++++...  ...+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~   78 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIED--NELN   78 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeC--CeEE
Confidence            4688899999999999999999999999999987532      235678899999999 999999999999654  6788


Q ss_pred             EEEEecCCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ++|||++++++..++.       .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++....
T Consensus        79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~  157 (267)
T cd08229          79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhccc
Confidence            9999999999987652       37889999999999999999999999999999999999987 789999999987654


Q ss_pred             CCCc-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          272 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       272 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      .... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.....+.............           
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------  225 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-----------  225 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCC-----------
Confidence            3322 223467888999999876 678999999999999999999999985332221111111100000           


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                             .......+++++.+++.+||..||++|||+.++++
T Consensus       226 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         226 -----------------------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             -----------------------CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence                                   00011236789999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=295.54  Aligned_cols=243  Identities=20%  Similarity=0.326  Sum_probs=194.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.+.||+|++|.||+|.+. +++.||+|.++..  ..+.+.+|+.+++++ +|||++++++++...  ...+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   79 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLE--EPIYIV   79 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEecC--CCeeee
Confidence            3577999999999999999999864 5578999998753  346788999999999 899999999998654  668899


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+.+++|..++.     .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||+++.......
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-CCEEECCcceEEEccCCcc
Confidence            99999999988862     47899999999999999999999999999999999999988 7899999999987653221


Q ss_pred             ce--eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 YN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 ~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      ..  ....+..|+|||++.+ ..++.++|+||||+++|+|++ |+.|| .+.+..+....+......             
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~~~~-------------  223 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPY-PGMTNAEVLQQVDQGYRM-------------  223 (261)
T ss_pred             cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCC-------------
Confidence            11  1122346999999876 778999999999999999999 88777 333333222222110000             


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                             .....+++.+.+++.+||+.||++|||+.++++
T Consensus       224 -----------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         224 -----------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             -----------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence                                   001236789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-39  Score=300.50  Aligned_cols=242  Identities=32%  Similarity=0.517  Sum_probs=195.9

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ||.|+||.||++.+..+|+.+++|.+....      .+.+.+|+.+++++ +||||+++++.+..  ....++++||+.+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQG--KKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheec--CcEEEEEEecCCC
Confidence            689999999999999899999999986432      35688899999999 89999999999854  4678999999999


Q ss_pred             CChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC---------
Q 014762          207 TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------  274 (419)
Q Consensus       207 ~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~---------  274 (419)
                      ++|..++   ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++.......         
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccccc
Confidence            9998776   458999999999999999999999999999999999999988 889999999987543321         


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|++||...+ ..++.++|+||||+++|++++|..||... ...+....+..  +.               
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~--~~---------------  217 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGE-TPEEIFQNILN--GK---------------  217 (265)
T ss_pred             cccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc--CC---------------
Confidence            1223456778999999876 56889999999999999999999998432 22222211111  00               


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH---HHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta---~elL~hp~f~~~  415 (419)
                                  ..+..      ...+++.+.+|+.+||+.+|++|||+   .++|+||||+.+
T Consensus       218 ------------~~~~~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         218 ------------IEWPE------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             ------------cCCCc------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence                        00110      01147899999999999999999999   999999999876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.6e-39  Score=299.51  Aligned_cols=242  Identities=18%  Similarity=0.349  Sum_probs=188.4

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCc--EEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc----CCCc
Q 014762          128 EVVRKVGRGKYSEVFEGINVNTNE--RCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKT  196 (419)
Q Consensus       128 ~~~~~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~  196 (419)
                      .+.+.||+|+||.||+|++..++.  .+|+|.++..     ..+.+.+|+.+++.+ +|+||+++++++...    ....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence            457889999999999999877765  5899987642     235678899999999 999999999987432    1235


Q ss_pred             cEEEEEecCCCChhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccc
Q 014762          197 PSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla  267 (419)
                      .+++|||+.++++..++         ..+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||++
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~  159 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGLS  159 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCCCcc
Confidence            78999999999987764         237888999999999999999999999999999999999987 78999999999


Q ss_pred             eeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHH
Q 014762          268 EFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (419)
Q Consensus       268 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~  343 (419)
                      +........   ....++..|++||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+.+  +.    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~--~~----  231 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPY-PGVENSEIYDYLRQ--GN----  231 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHc--CC----
Confidence            876433221   12245567999999876 678999999999999999999 67776 33333222221111  00    


Q ss_pred             HHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                            .        ......+++.+.+++.+||+.||++|||+.+++++
T Consensus       232 ----------------------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         232 ----------------------R--------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             ----------------------C--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                  0        00012367889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.4e-39  Score=301.89  Aligned_cols=246  Identities=32%  Similarity=0.534  Sum_probs=200.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||.||+|.+..+++.+|+|++...      ..+.+.+|+.++.++.+||||+++++++.+  ....+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~   78 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY   78 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence            4799999999999999999999999999999998642      235678899999999339999999999854  46788


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      ++|||+.+++|..++   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++........
T Consensus        79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEecCCccccccCCccc
Confidence            999999999998877   358999999999999999999999999999999999999987 7899999999876543221


Q ss_pred             ---------------------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014762          276 ---------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (419)
Q Consensus       276 ---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~  334 (419)
                                           .....++..|++||...+ ..++.++|+||||++++++++|+.||.... ....+..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~  235 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKIL  235 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHH
Confidence                                 122356778999999876 678999999999999999999999984322 111111111


Q ss_pred             HHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCC
Q 014762          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMVIS  410 (419)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp  410 (419)
                      ..                                     .......+++.+.+|+.+||+.||++|||+    +++++||
T Consensus       236 ~~-------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~  278 (280)
T cd05581         236 KL-------------------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP  278 (280)
T ss_pred             hc-------------------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence            00                                     000011257889999999999999999999    9999999


Q ss_pred             Cc
Q 014762          411 SI  412 (419)
Q Consensus       411 ~f  412 (419)
                      ||
T Consensus       279 ~~  280 (280)
T cd05581         279 FF  280 (280)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.8e-39  Score=297.13  Aligned_cols=242  Identities=17%  Similarity=0.330  Sum_probs=193.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.++||+|+||+||+|.+. ++..+|+|.++..  ..+.+.+|+.+++++ +|+|++++++++..   ...+++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv   78 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVSE---EPIYIV   78 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEECC---CCcEEE
Confidence            3568999999999999999999754 6667999998753  346789999999999 99999999998843   457899


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+++++|..++.     .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeeccCccc
Confidence            99999999988762     37889999999999999999999999999999999999987 7899999999976543322


Q ss_pred             ce--eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 YN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 ~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      ..  ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..|| .+.+..+....+.....              
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~-~~~~~~~~~~~~~~~~~--------------  221 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPY-PGMNNREVLEQVERGYR--------------  221 (260)
T ss_pred             ccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCC--------------
Confidence            11  1234557999999876 678999999999999999999 77776 33333333332211000              


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                            .......+..+.+|+.+||..||++|||+.++.+
T Consensus       222 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         222 ----------------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             ----------------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                  0001236788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-39  Score=298.17  Aligned_cols=244  Identities=16%  Similarity=0.297  Sum_probs=193.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .++|++.+.||+|+||+||+|.+..+   ...||+|.++...    ...+.+|+.+++.+ +||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKS--RP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecC--Cc
Confidence            46799999999999999999987644   4579999986432    35678899999999 999999999999553  66


Q ss_pred             cEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .+++|||+++++|..++    ..+++..+..++.|++.||+|||+++|+|+||||+||+++.+ +.++|+|||+++....
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~  158 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLED  158 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhhcccc
Confidence            88999999999998886    248899999999999999999999999999999999999988 7899999999987642


Q ss_pred             CCc-ce--eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          273 GKE-YN--VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       273 ~~~-~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ... ..  ...++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.. ....+....+.+....         
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~---------  227 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKAVEDGYRL---------  227 (266)
T ss_pred             cccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCC---------
Confidence            211 11  1233467999999876 678999999999999999998 8888842 2222222111110000         


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                 .....+++.+.+++.+||+.+|++|||+.+++++
T Consensus       228 ---------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         228 ---------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                       0012368899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.9e-39  Score=303.92  Aligned_cols=246  Identities=22%  Similarity=0.370  Sum_probs=194.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||.||+|.+.     .++..+|+|.++...    .+.+.+|+.+++++.+||||+++++++... 
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  111 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-  111 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence            3578999999999999999999752     345689999886432    346889999999996799999999999654 


Q ss_pred             CCccEEEEEecCCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-----l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                       ...+++|||+.+++|..++..     +++.++..++.|++.||+|||+++++|+||||+|||++.+ +.++|+|||+++
T Consensus       112 -~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~dfg~~~  189 (302)
T cd05055         112 -GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLAR  189 (302)
T ss_pred             -CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-CeEEECCCcccc
Confidence             668899999999999887632     7899999999999999999999999999999999999977 789999999997


Q ss_pred             eccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          269 FYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       269 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      ........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||... ...+.+...... +      
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~-~~~~~~~~~~~~-~------  260 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGM-PVDSKFYKLIKE-G------  260 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCC-CchHHHHHHHHc-C------
Confidence            65433221   11234567999999877 678999999999999999998 88887432 222222111110 0      


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                              +    ........++++.+|+.+||..+|++|||+.|+++
T Consensus       261 ------------------------~----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         261 ------------------------Y----RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             ------------------------C----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                    0    00011225789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.4e-39  Score=310.75  Aligned_cols=247  Identities=22%  Similarity=0.352  Sum_probs=191.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++.+.||+|+||+||+|.+     ..+++.||||.++...    ...+.+|+.++.++.+||||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence            57899999999999999999974     3567899999996422    345778999999997789999999988654 3


Q ss_pred             CccEEEEEecCCCChhhhcC------------------------------------------------------------
Q 014762          195 KTPSLIFEYVNSTDFKVLYP------------------------------------------------------------  214 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------  214 (419)
                      ...+++|||+++++|..++.                                                            
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            56789999999999877642                                                            


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc---eeecc
Q 014762          215 ----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVA  281 (419)
Q Consensus       215 ----------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~  281 (419)
                                .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.........   ....+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcCCCCC
Confidence                      25667778899999999999999999999999999999987 78999999998765322221   11234


Q ss_pred             cccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      +..|+|||.+.+ ..++.++|||||||++|+|++ |..||....... ........ +.                     
T Consensus       244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~-~~---------------------  299 (343)
T cd05103         244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKE-GT---------------------  299 (343)
T ss_pred             CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhc-cC---------------------
Confidence            556999999876 778999999999999999997 888873322221 11111100 00                     


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                           .        ...+...++++.+++.+||+.||++|||+.|+++|
T Consensus       300 -----~--------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         300 -----R--------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             -----C--------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 0        00011257789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.1e-40  Score=313.80  Aligned_cols=295  Identities=26%  Similarity=0.399  Sum_probs=228.1

Q ss_pred             CCCCceeccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhc-----CCCCeeEE
Q 014762          113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC-----GGPNVVKL  185 (419)
Q Consensus       113 ~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----~h~niv~l  185 (419)
                      .|..+.++..-.++|.+....|+|-||+|..|.|...|..||||++.+..  .+.-..|++||++|.     +.-+++++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            45566666666889999999999999999999999999999999997654  366789999999993     23478999


Q ss_pred             EeEEEccCCCccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEE
Q 014762          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (419)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~k  260 (419)
                      +..|  .+.+++|||+|-+..+..+.+.     -.|....++.++.|++.||..|-.+||+|.||||+|||+++....+|
T Consensus       500 ~r~F--~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  500 FRHF--KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             HHHh--hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence            9888  5568999999988765433332     13777889999999999999999999999999999999999888999


Q ss_pred             EEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCc
Q 014762          261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (419)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~  340 (419)
                      |||||.|.....+. .+....+..|+|||+++| .+|++..|+||.||+||||.||+..| +|.++.+.+..++++-|.-
T Consensus       578 LCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlF-pG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  578 LCDFGSASFASENE-ITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILF-PGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             eccCcccccccccc-ccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceec-CCCCcHHHHHHHHHhcCCC
Confidence            99999998765443 344567788999999999 78999999999999999999999886 8999999999999998875


Q ss_pred             hHHHHHhhcCCCCChhhHHh-----------hcc------CCCCCcccccc--------ccccCCCCHHHHHHHHHhcCC
Q 014762          341 ELNAYLNKYHLELDPQLDAL-----------VGR------HSRKPWSKFIN--------ADNQHLVSPEAIDFLDKLLRY  395 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~-----------~~~------~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~  395 (419)
                      +-...- +. ...+..++.-           .+.      ..-++...+..        .+.+...-.++++|+.+||..
T Consensus       655 p~KmlR-Kg-qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  655 PNKMLR-KG-QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             cHHHhh-hc-chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence            544322 11 1111111100           000      01111111110        011122345688999999999


Q ss_pred             CCCCCCCHHHHhcCCCccc
Q 014762          396 DHQDRLTAREAMVISSISP  414 (419)
Q Consensus       396 dP~~Rpta~elL~hp~f~~  414 (419)
                      ||++|.|..++|+||||+.
T Consensus       733 dP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  733 DPEKRITVNQALKHPFITE  751 (752)
T ss_pred             ChhhcCCHHHHhcCCcccC
Confidence            9999999999999999973

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.8e-39  Score=299.01  Aligned_cols=245  Identities=19%  Similarity=0.334  Sum_probs=193.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++.+.||+|+||.||+|.+..     ++..|++|.+....    ...+.+|+.+++.+ +|+||+++++++.+.  
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER--   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC--
Confidence            5679999999999999999999877     77889999886332    34588899999999 999999999998654  


Q ss_pred             CccEEEEEecCCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC--CcEEEE
Q 014762          195 KTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLI  262 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~--~~~kl~  262 (419)
                      ...++||||+.+++|..++.          .+++..+..++.|++.||+|||+++++|+||||+||+++.+.  ..+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            56789999999999988762          378889999999999999999999999999999999998652  368999


Q ss_pred             ecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcC
Q 014762          263 DWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLG  338 (419)
Q Consensus       263 Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg  338 (419)
                      |||+++........   .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+.. .+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~-~~~~~~~~~~~~~-~~  238 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEVMEFVTG-GG  238 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHc-CC
Confidence            99999765322211   11223456999999977 679999999999999999997 888873 3332222211110 00


Q ss_pred             CchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      .                                   ......++..+.+++.+||+.||++|||+.++++|
T Consensus       239 ~-----------------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 R-----------------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             c-----------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            0                                   00012368899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5e-39  Score=303.43  Aligned_cols=250  Identities=24%  Similarity=0.385  Sum_probs=200.8

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      |....+||+|+||.||++.+..+++.||+|.+...   ....+.+|+.+++.+ +|+|++++++.+...  ...+++|||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEeC--CEEEEEEec
Confidence            33346799999999999999999999999988532   335688899999999 899999999999654  678999999


Q ss_pred             cCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cceeec
Q 014762          204 VNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRV  280 (419)
Q Consensus       204 ~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~~~~  280 (419)
                      ++++++..+.  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++....... ......
T Consensus        99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657          99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEcccccceecccccccccccc
Confidence            9999998876  457899999999999999999999999999999999999988 789999999987654322 123346


Q ss_pred             ccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       281 ~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      ++..|++||.+.+ ..++.++|+||+|+++|+|++|..||.. .+..+....+...+.. .                   
T Consensus       178 ~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~~-~-------------------  235 (292)
T cd06657         178 GTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPP-K-------------------  235 (292)
T ss_pred             cCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCCc-c-------------------
Confidence            7888999998866 6789999999999999999999999842 2222222211110000 0                   


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                              +      .....++..+.+++.+||+.||.+|||+.++++||||....
T Consensus       236 --------~------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         236 --------L------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             --------c------CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence                    0      00112678899999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-38  Score=299.46  Aligned_cols=261  Identities=20%  Similarity=0.357  Sum_probs=196.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..+|++.+.||+|+||+||+|.    +..++..||+|.+....   .+.+.+|+.+++.+ +||||+++++++.......
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCc
Confidence            4578999999999999999997    44678899999987543   34678999999999 9999999999886655567


Q ss_pred             cEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++++|..++.    .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||+++....
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~  160 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCcccccccC
Confidence            899999999999998762    37889999999999999999999999999999999999988 7899999999987644


Q ss_pred             CCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          273 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       273 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ....    ....++..|+|||++.+ ..++.++|+|||||++|||++|..++....  ...    .+.++.....     
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~----~~~~~~~~~~-----  228 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPP--AEF----MRMMGNDKQG-----  228 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcc--hhh----hhhccccccc-----
Confidence            3321    11123345999999876 678999999999999999999887753211  111    1111111000     


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                        ......+........        .......++.++.+|+.+||..+|++|||+.|+++
T Consensus       229 --~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         229 --QMIVYHLIELLKNNG--------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             --ccchHHHHHHHhcCC--------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              000000001110000        00112347889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=292.55  Aligned_cols=245  Identities=27%  Similarity=0.504  Sum_probs=202.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.+.||+|++|.||++.+..+++.+++|.+....     .+.+.+|++++.++ +|+|++++++++.+.  ...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v   77 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETS--DSLYII   77 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeC--CEEEEE
Confidence            5888999999999999999999999999999986433     35688999999999 899999999999654  678899


Q ss_pred             EEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-c
Q 014762          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  276 (419)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~  276 (419)
                      |||+++++|.+++   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+........ .
T Consensus        78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCcccc
Confidence            9999999998876   358999999999999999999999999999999999999987 8899999999987654333 2


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....++..|+|||...+ ..++.++|+||+|+++|+|++|..||.... .......+..   .                 
T Consensus       157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-~~~~~~~~~~---~-----------------  214 (254)
T cd06627         157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIVQ---D-----------------  214 (254)
T ss_pred             cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhc---c-----------------
Confidence            33467888999999876 558899999999999999999999985322 1111111100   0                 


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                              ..        ......+++.+.+++.+||..+|++|||+.+++.||||
T Consensus       215 --------~~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         215 --------DH--------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             --------CC--------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                    00        00112368899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6.7e-39  Score=295.95  Aligned_cols=244  Identities=21%  Similarity=0.424  Sum_probs=200.4

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +|++.++||.|+||.||++.+..+++.+++|.+...     ....+.+|+.+++.+ +|+||+++++++.+.  ...++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v   77 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDG--NKLCIV   77 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccC--CEEEEE
Confidence            588999999999999999999999999999998642     234677899999999 899999999998654  678999


Q ss_pred             EEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          201 FEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       201 ~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      +||++++++..++       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+|||++......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN  156 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence            9999999998775       348889999999999999999999999999999999999987 78999999999776544


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       ......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||.. .+..+....+.. ..               
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~-~~---------------  217 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKVQR-GK---------------  217 (256)
T ss_pred             -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhc-CC---------------
Confidence             3333567888999999877 7789999999999999999999999832 222111111100 00               


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                     ..     .....++.++++++.+||+.+|++|||+.++++||++
T Consensus       218 ---------------~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         218 ---------------YP-----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             ---------------CC-----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                           00     0011267889999999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.9e-39  Score=295.20  Aligned_cols=236  Identities=20%  Similarity=0.357  Sum_probs=185.9

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      +.||+|+||+||+|.+..+++.+|+|.+...    ....+.+|+.+++.+ +||||+++++++...  ...++||||+.+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQK--QPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCC--CCeEEEEeeccC
Confidence            3699999999999999999999999987632    235688999999999 999999999999654  678899999999


Q ss_pred             CChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcce---ee
Q 014762          207 TDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN---VR  279 (419)
Q Consensus       207 ~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~---~~  279 (419)
                      +++..++.    .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++..........   ..
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCcccccccccccCCCC
Confidence            99988762    37889999999999999999999999999999999999987 789999999987543221111   11


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~  358 (419)
                      ..+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.. .+..+ .........                    
T Consensus       157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~-~~~~~-~~~~~~~~~--------------------  213 (252)
T cd05084         157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYAN-LSNQQ-TREAIEQGV--------------------  213 (252)
T ss_pred             CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccc-cCHHH-HHHHHHcCC--------------------
Confidence            22345999999876 678999999999999999998 7777732 11111 111111000                    


Q ss_pred             HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                             .        ......++..+.+|+.+||+.||++|||+.++++
T Consensus       214 -------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         214 -------R--------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -------C--------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   0        0011236789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=293.23  Aligned_cols=278  Identities=28%  Similarity=0.491  Sum_probs=220.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC---ccEEEE
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK---TPSLIF  201 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~---~~~lv~  201 (419)
                      .+.||.|.||.||.+.|..+|+.||+|.+.+.     ..+.+.+|+.+|..+ .|.|++..+++....+..   .+|.+.
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            45699999999999999999999999988642     357788999999999 999999999988544322   356777


Q ss_pred             EecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc--c
Q 014762          202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--Y  276 (419)
Q Consensus       202 e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~--~  276 (419)
                      |.|.. +|...+   +.++...++.+++||++||.|||+.+|.||||||.|.|++++ ..+||||||+++..+.+..  .
T Consensus       137 ELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d~~~hM  214 (449)
T KOG0664|consen  137 ELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWDQRDRLNM  214 (449)
T ss_pred             HHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccchhhhhhh
Confidence            77764 444444   458889999999999999999999999999999999999999 7899999999998765543  3


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      +..+.|.+|+|||++++...|+.+.||||.||++.|++..+.. |...++.++++.|.+.+|++..+.......-     
T Consensus       215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrIL-FQAq~PiqQL~lItdLLGTPs~EaMr~ACEG-----  288 (449)
T KOG0664|consen  215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKIL-FQAAGPIEQLQMIIDLLGTPSQEAMKYACEG-----  288 (449)
T ss_pred             HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhh-hhccChHHHHHHHHHHhCCCcHHHHHHHhhh-----
Confidence            5567889999999999988999999999999999999966655 5788999999999999999988866432211     


Q ss_pred             hHHhh-cc-CCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          357 LDALV-GR-HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       357 ~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      .+... .. .......-......+..-..+..+++.++|.+||.+|.+.++++.|+++...|
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            11111 11 11112222222333334556788999999999999999999999999987653

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.7e-38  Score=302.78  Aligned_cols=248  Identities=25%  Similarity=0.376  Sum_probs=196.1

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      +.|...++||+|+||+||+|.+..+++.+++|.+....      ...+.+|+.+++.+ +|||++++++++.+.  ...+
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~   97 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKE--HTAW   97 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC--CEEE
Confidence            34667788999999999999999999999999986321      24577899999999 899999999999664  6688


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||||+.+..+..+.   ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.+||+|||++....   .
T Consensus        98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~---~  173 (313)
T cd06633          98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASKSS---P  173 (313)
T ss_pred             EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-CCEEEeecCCCcccC---C
Confidence            999999765443332   358899999999999999999999999999999999999987 789999999986432   2


Q ss_pred             ceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .....++..|+|||++.+  ...++.++|||||||++|+|++|..||+... .......+... ..+             
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~-~~~-------------  238 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQN-DSP-------------  238 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhc-CCC-------------
Confidence            233567888999999842  2568899999999999999999999985432 22222211110 000             


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                           ......++..+.+|+.+||+.+|++|||+.++++||||+..
T Consensus       239 ---------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         239 ---------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             ---------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                                 00011256789999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-40  Score=293.66  Aligned_cols=283  Identities=26%  Similarity=0.467  Sum_probs=225.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (419)
                      ...+|.-+..+|.|.- .|..+.|.-.++.||+|.+..     ...++..+|..++..+ .|+||++++.+|.-..    
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence            4667888899999988 788888999999999998742     2346677999999999 9999999999996431    


Q ss_pred             CCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ....|+|||+|....-....-.++-..+..+..|++.|+.|||+.||+||||||+||++..+ ..+||.|||+|+.....
T Consensus        93 ~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen   93 FQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDFGLARTEDTD  171 (369)
T ss_pred             HHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccchhhcccCcc
Confidence            23578999999987766666678889999999999999999999999999999999999998 89999999999877665


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh------
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN------  347 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~------  347 (419)
                      -..+..+.+.+|+|||++.+. .+...+||||+||++.||++|+..| .|.+..++..++.+.+|.+....+..      
T Consensus       172 ~~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf-~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  172 FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLF-PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             cccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEe-cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            455667899999999999994 5999999999999999999999876 69999999999999999987654421      


Q ss_pred             hcCCCCChhhH--HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          348 KYHLELDPQLD--ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       348 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                      .+-. ..+...  ..........|......  .+.-+..+++++.+||..||++|.++.++|+||||+
T Consensus       250 ~yv~-~~~~y~~~~f~~~fpD~~f~~~~e~--~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  250 NYVE-NRPQYQAISFSELFPDSLFPVVLEG--SKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhh-cChHhhccchhhhCCcccccccccC--CccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            1111 011111  11111222222222211  122356689999999999999999999999999997

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.7e-38  Score=294.57  Aligned_cols=241  Identities=17%  Similarity=0.301  Sum_probs=191.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.++||+|+||+||+|.+..+ ..+|+|.+...  ..+.+.+|+.+++.+ +|+|++++++++..   ...+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~   79 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE---EPIYIVT   79 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC---CCcEEEE
Confidence            46799999999999999999987554 46899988643  246788999999999 99999999998843   4578999


Q ss_pred             EecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      ||+.+++|..++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEccCCccc
Confidence            9999999988763     26888899999999999999999999999999999999988 78999999999765433221


Q ss_pred             --eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       277 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                        ....++..|+|||...+ ..++.++|+|||||++|+|++ |..||. +..+.+....+......              
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~~~~--------------  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYP-GMVNREVLEQVERGYRM--------------  222 (260)
T ss_pred             ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCCC--------------
Confidence              12234567999998876 678999999999999999999 787773 33333322222110000              


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                            ......+..+.+++++||+.||++|||++++++
T Consensus       223 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         223 ----------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             ----------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                  001126788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-38  Score=294.90  Aligned_cols=241  Identities=18%  Similarity=0.337  Sum_probs=193.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.++||+|+||+||+|.+ .+++.+|+|.+....  ...+.+|+.+++.+ +|+|++++++++..   ...+++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVTQ---EPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEcc---CCcEEEE
Confidence            57899999999999999999975 467889999987433  46789999999999 89999999998743   4578999


Q ss_pred             EecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      ||+.++++..++.     .+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++.........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecCCCCcc
Confidence            9999999988752     47888999999999999999999999999999999999988 78999999999766532221


Q ss_pred             --eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       277 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                        ....++..|+|||++.+ ..++.++||||||+++|++++ |+.||. +.+..+....+......              
T Consensus       159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~--------------  222 (260)
T cd05067         159 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYP-GMTNPEVIQNLERGYRM--------------  222 (260)
T ss_pred             cccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCC-CCChHHHHHHHHcCCCC--------------
Confidence              12344567999999876 678999999999999999998 888873 33333322222110000              


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                            .....++.++.+++.+||+.+|++|||++++++
T Consensus       223 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 ----------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                  011236789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1e-38  Score=301.06  Aligned_cols=243  Identities=21%  Similarity=0.346  Sum_probs=193.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..+|.+.+.||+|+||.||+|.+.     .++..+++|.++...   .+.+.+|+.+++++ +|+||+++++++..  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~   80 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGD--GD   80 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEcc--CC
Confidence            356899999999999999999753     345678999987543   35688999999999 89999999999965  46


Q ss_pred             ccEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC
Q 014762          196 TPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL  256 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~  256 (419)
                      ..++||||+++++|..++.                   .+++..+..++.|++.||+|||++|++|+||||+|||++.+ 
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~-  159 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-  159 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-
Confidence            7899999999999988762                   26888999999999999999999999999999999999988 


Q ss_pred             CcEEEEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 014762          257 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK  332 (419)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~  332 (419)
                      +.++|+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||+.. +..+....
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~  237 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIEC  237 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHH
Confidence            7899999999976543221   122345677999999877 778999999999999999998 88887432 22222211


Q ss_pred             HHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       333 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      +..  +                             .+.     .....++..+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~--~-----------------------------~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQ--G-----------------------------RVL-----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhC--C-----------------------------CCC-----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            110  0                             000     001125788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-38  Score=297.74  Aligned_cols=243  Identities=19%  Similarity=0.314  Sum_probs=192.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|++.++||+|+||+||+|.+..+++    .||+|+++...    ...+.+|+.+++.+ +||||+++++++..   
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---   80 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT---   80 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC---
Confidence            45789999999999999999998877776    48999986432    35678899999998 99999999999854   


Q ss_pred             CccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ...++++||+++|++..++.    .+++..+..++.|++.||+|||+++++||||||+|||++.+ +.+||+|||+++..
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~  159 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NHVKITDFGLARLL  159 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCCCceeec
Confidence            34679999999999888762    47899999999999999999999999999999999999877 78999999999876


Q ss_pred             cCCCcce---eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          271 HPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       271 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .......   ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||. ... .+.+..........      
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~-~~~~~~~~~~~~~~------  230 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYD-GIP-AREIPDLLEKGERL------  230 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCC-HHHHHHHHHCCCcC------
Confidence            5332221   1234567999999876 679999999999999999998 777773 222 12222211110000      


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                   .....++.++.+++.+||+.||++|||+.++++
T Consensus       231 -----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         231 -----------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             -----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                         001236788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.2e-38  Score=300.50  Aligned_cols=241  Identities=20%  Similarity=0.356  Sum_probs=189.2

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      +|++.+.||+|+||+||+|.+..     +...+++|.+....    ...+.+|+.+++.+ +||||+++++.+...  ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQD--GP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecC--CC
Confidence            47888999999999999998653     33578899886432    34688899999999 999999999999654  56


Q ss_pred             cEEEEEecCCCChhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCc
Q 014762          197 PSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN  249 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~---------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~N  249 (419)
                      .++++||+.+++|..++.                           .+++..+..++.|++.||+|||+++++||||||+|
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n  157 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN  157 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence            789999999999987652                           36778889999999999999999999999999999


Q ss_pred             eEEcCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCC
Q 014762          250 VMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD  325 (419)
Q Consensus       250 ILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~  325 (419)
                      ||++.+ +.+||+|||+++........   ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+..
T Consensus       158 ill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~  234 (290)
T cd05045         158 VLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIA  234 (290)
T ss_pred             EEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCC-CCCC
Confidence            999987 78999999999765332221   22244567999999876 678999999999999999998 88887 3322


Q ss_pred             CHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 014762          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (419)
Q Consensus       326 ~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e  405 (419)
                      .. .+.+....            .                       ........++.++.+|+.+||+.||++|||+.+
T Consensus       235 ~~-~~~~~~~~------------~-----------------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~  278 (290)
T cd05045         235 PE-RLFNLLKT------------G-----------------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFAD  278 (290)
T ss_pred             HH-HHHHHHhC------------C-----------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            22 11111110            0                       000111236889999999999999999999999


Q ss_pred             Hhc
Q 014762          406 AMV  408 (419)
Q Consensus       406 lL~  408 (419)
                      +++
T Consensus       279 i~~  281 (290)
T cd05045         279 ISK  281 (290)
T ss_pred             HHH
Confidence            976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=295.01  Aligned_cols=242  Identities=17%  Similarity=0.305  Sum_probs=192.3

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .+|++.+.||+|+||.||+|.+. ++..+|+|.+...  ....+.+|+.+++.+ +||||+++++++...  ...++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQ--RPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCC--CceEEEEe
Confidence            46888999999999999999875 5678999998643  345788999999999 999999999998544  67889999


Q ss_pred             ecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcce-
Q 014762          203 YVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN-  277 (419)
Q Consensus       203 ~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~-  277 (419)
                      |+++++|.+++.    .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||+++......... 
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceeccccccccc
Confidence            999999988762    47889999999999999999999999999999999999987 889999999987654322111 


Q ss_pred             -eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          278 -VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       278 -~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                       ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||. ..++.+....+....                  
T Consensus       159 ~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~~------------------  218 (256)
T cd05059         159 QGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYE-RFSNSEVVESVSAGY------------------  218 (256)
T ss_pred             CCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCC-CCCHHHHHHHHHcCC------------------
Confidence             1123346999999876 679999999999999999999 777773 322222222211100                  


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                        .......++.++.+++.+||+.+|++|||+.++++.
T Consensus       219 ------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         219 ------------------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                              000112368899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=297.51  Aligned_cols=244  Identities=19%  Similarity=0.335  Sum_probs=194.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||.||+|.+...     +..||+|.+....    ...+.+|+.+++.+ +||||+++++++... 
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-   81 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTG-   81 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCC-
Confidence            467899999999999999999987644     3789999986432    34678899999999 999999999999654 


Q ss_pred             CCccEEEEEecCCCChhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEE
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~k  260 (419)
                       ...++||||+++++|..++.             .+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +.+|
T Consensus        82 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~-~~~k  159 (277)
T cd05032          82 -QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED-LTVK  159 (277)
T ss_pred             -CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-CCEE
Confidence             67889999999999988762             25677889999999999999999999999999999999988 8899


Q ss_pred             EEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014762          261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (419)
Q Consensus       261 l~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~  336 (419)
                      |+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|++++ |..||. +.+..+....+. .
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-~~~~~~~~~~~~-~  236 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQ-GLSNEEVLKFVI-D  236 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCc-cCCHHHHHHHHh-c
Confidence            999999876543322   122345678999999876 678999999999999999998 787773 333222222111 0


Q ss_pred             cCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      .+.                                   ...+..++.++.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~-----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 GGH-----------------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCC-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            000                                   0011235789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.8e-38  Score=297.65  Aligned_cols=242  Identities=17%  Similarity=0.317  Sum_probs=189.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      .++|++.+.||+|+||+||+|.+..+++    .+++|.+....    ..++..|+.++.++ +||||+++++++.+   .
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~---~   81 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG---A   81 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC---C
Confidence            4678889999999999999999877776    47777775322    24567788888888 99999999998843   4


Q ss_pred             ccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++++||+.+++|..++    ..+++..+..++.|++.||+|||++|++|+||||+|||++.+ +.+||+|||+++...
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~  160 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADLLY  160 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccceecc
Confidence            467999999999998876    347899999999999999999999999999999999999987 889999999998654


Q ss_pred             CCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          272 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       272 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ....   .....++..|++||.+.+ ..++.++|||||||++||+++ |..||. +... .....+.+. +.        
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~-~~~~-~~~~~~~~~-~~--------  228 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYA-GMRP-HEVPDLLEK-GE--------  228 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCC-CCCH-HHHHHHHHC-CC--------
Confidence            3322   122345667999999876 679999999999999999998 888873 2222 222221110 00        


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                        ..        .....++.++.+++.+||..||++|||+.|+++
T Consensus       229 ------------------~~--------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         229 ------------------RL--------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             ------------------cC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                              00        001125678899999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.7e-38  Score=294.07  Aligned_cols=234  Identities=19%  Similarity=0.360  Sum_probs=185.4

Q ss_pred             eeeeeCceEEEEEEE--cCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          132 KVGRGKYSEVFEGIN--VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +||+|+||+||+|.+  ..++..+|+|+++...     .+.+.+|+.+++.+ +||||+++++++.+   ...++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~lv~e~~   77 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA---ESWMLVMELA   77 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CCcEEEEecC
Confidence            589999999999964  4578899999986432     35688999999999 99999999999843   4568999999


Q ss_pred             CCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc----e
Q 014762          205 NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----N  277 (419)
Q Consensus       205 ~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~----~  277 (419)
                      ++++|..++   ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||+++........    .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeecC
Confidence            999998876   358999999999999999999999999999999999999987 78999999999766443321    1


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ...++..|+|||.+.+ ..++.++|+|||||++|||++ |..||. +.+..+....+.+. ..                 
T Consensus       157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~i~~~-~~-----------------  216 (257)
T cd05116         157 HGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYK-GMKGNEVTQMIESG-ER-----------------  216 (257)
T ss_pred             CCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHCC-CC-----------------
Confidence            1223467999998865 678899999999999999998 888873 22222222221110 00                 


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                        .+.+..+++++.++|.+||+.||++|||+.++..
T Consensus       217 ------------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         217 ------------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence                              0011237889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.3e-39  Score=297.35  Aligned_cols=242  Identities=19%  Similarity=0.349  Sum_probs=196.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..+|++.++||.|+||+||+|.+.. +..+++|.+....   ...+.+|+.+++.+ +|+||+++++++.+.  ...++|
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv   80 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSVG--EPVYII   80 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEecC--CCeEEE
Confidence            4568899999999999999999877 8899999987543   46788999999999 899999999999654  678899


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+++++|..++.     .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||.+........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhcCCccc
Confidence            99999999988873     47889999999999999999999999999999999999988 7899999999976543222


Q ss_pred             c-eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 Y-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 ~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      . ....++..|++||.+.+ ..++.++|+||||+++|+|++ |+.||. +.+..+.+..+......              
T Consensus       160 ~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~-~~~~~~~~~~~~~~~~~--------------  223 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYP-GMNNHEVYDQITAGYRM--------------  223 (261)
T ss_pred             cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC-cCCHHHHHHHHHhCCcC--------------
Confidence            1 12234567999999876 678999999999999999998 788873 33333333332211000              


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                            .....+++.+.+++.+||+.||++|||+.++++
T Consensus       224 ----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 ----------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                  001236889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.7e-38  Score=302.00  Aligned_cols=250  Identities=27%  Similarity=0.396  Sum_probs=197.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ...|+..+.||+|+||.||+|.+..++..+|+|.+....      ...+.+|+.+++.+ +|||++++++++.+.  ...
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~  100 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLRE--HTA  100 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC--CeE
Confidence            345778899999999999999999999999999986321      24678899999999 899999999999654  567


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||+.+..+....   ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++...... 
T Consensus       101 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         101 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIASPA-  178 (317)
T ss_pred             EEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCccccCCc-
Confidence            8999999864433322   458899999999999999999999999999999999999987 78999999998654322 


Q ss_pred             cceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          275 EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                        ....++..|+|||.+..  ...++.++|+|||||++|+|++|+.||+.. +.......+......             
T Consensus       179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~-------------  242 (317)
T cd06635         179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESP-------------  242 (317)
T ss_pred             --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccCC-------------
Confidence              23467888999999742  256889999999999999999999998532 222222222110000             


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                            .......++.+++++.+||+.+|++|||+.++++|+|+...+
T Consensus       243 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         243 ----------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             ----------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                                  000112577899999999999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=297.30  Aligned_cols=236  Identities=18%  Similarity=0.320  Sum_probs=184.1

Q ss_pred             eeeeeCceEEEEEEEcCCCc--EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecC
Q 014762          132 KVGRGKYSEVFEGINVNTNE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (419)
                      .||+|+||.||+|.+..++.  .+++|.++..    ..+.+.+|+.++.++.+||||+++++++...  ...+++|||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEEEeCC
Confidence            58999999999999888776  4688888642    2356788999999997899999999999654  56889999999


Q ss_pred             CCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          206 STDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       206 ~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      +++|..++.                   .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||+
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~dfgl  158 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGL  158 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECCCCC
Confidence            999987752                   36788999999999999999999999999999999999988 8899999999


Q ss_pred             ceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       267 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      +..............+..|+|||++.+ ..++.++|+|||||++|+|++ |..||. +.+..+....+..          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~~----------  226 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQ----------  226 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc-ccCHHHHHHHHhC----------
Confidence            853221111111233456999999866 778999999999999999997 888883 2222221111100          


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                        ..                        ..+....++.++.+++.+||+.||.+|||+.++++
T Consensus       227 --~~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         227 --GY------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             --CC------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence              00                        00011236788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.9e-38  Score=298.74  Aligned_cols=244  Identities=18%  Similarity=0.321  Sum_probs=192.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||.||+|.+..     ++..+|+|.+....    .+.+.+|+.+++.+ +||||+++++++.+. 
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~-   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVG-   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC-
Confidence            46789999999999999999998643     67889999986432    35688899999999 999999999999653 


Q ss_pred             CCccEEEEEecCCCChhhhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP-------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPH  248 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~  248 (419)
                       ...+++|||+++++|..++.                         .+++..+..++.|++.||+|||+++++|+||||+
T Consensus        81 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          81 -KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             -CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence             66889999999999987763                         3677888999999999999999999999999999


Q ss_pred             ceEEcCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q 014762          249 NVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGH  324 (419)
Q Consensus       249 NILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~  324 (419)
                      ||+++.+ +.++|+|||++.........   .....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||+. .
T Consensus       160 nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~-~  236 (288)
T cd05050         160 NCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYG-M  236 (288)
T ss_pred             heEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCC-C
Confidence            9999987 78999999998765332211   12234556999999876 679999999999999999997 7778742 2


Q ss_pred             CCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 014762          325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR  404 (419)
Q Consensus       325 ~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~  404 (419)
                      +..+....+..             ..                 .+      .....++.++.+|+.+||+.||++|||+.
T Consensus       237 ~~~~~~~~~~~-------------~~-----------------~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  280 (288)
T cd05050         237 AHEEVIYYVRD-------------GN-----------------VL------SCPDNCPLELYNLMRLCWSKLPSDRPSFA  280 (288)
T ss_pred             CHHHHHHHHhc-------------CC-----------------CC------CCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence            22222211110             00                 00      00123678999999999999999999999


Q ss_pred             HHhc
Q 014762          405 EAMV  408 (419)
Q Consensus       405 elL~  408 (419)
                      |+++
T Consensus       281 el~~  284 (288)
T cd05050         281 SINR  284 (288)
T ss_pred             HHHH
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-38  Score=297.18  Aligned_cols=259  Identities=22%  Similarity=0.350  Sum_probs=196.2

Q ss_pred             CCeEEEeeeeeeCceEEEEEEE----cCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          125 DDYEVVRKVGRGKYSEVFEGIN----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..|++++.||+|+||.||+|..    ..++..||+|.++...    .+.+.+|+.+++.+ +|||++++++++.......
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCc
Confidence            4578899999999999999974    4578899999986432    35688999999999 9999999999997765567


Q ss_pred             cEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++++|..++.    .+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||+++....
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~  161 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIET  161 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCcccccccc
Confidence            899999999999988762    47889999999999999999999999999999999999987 7899999999976543


Q ss_pred             CCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          273 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       273 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ....    ....++..|+|||++.+ ..++.++|||||||++|+|++++.|+.....      ...+..++.......  
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~------~~~~~~~~~~~~~~~--  232 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT------LFLKMIGPTHGQMTV--  232 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc------hhhhhcccccccccH--
Confidence            3221    12345567999999877 6789999999999999999998876532211      111111111100000  


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                           ...... .....   +     ......+++.+.+|+.+||+.||++|||+.++++
T Consensus       233 -----~~~~~~-~~~~~---~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  278 (284)
T cd05079         233 -----TRLVRV-LEEGK---R-----LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE  278 (284)
T ss_pred             -----HHHHHH-HHcCc---c-----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                 000000 00000   0     0111237889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.4e-38  Score=302.50  Aligned_cols=245  Identities=20%  Similarity=0.330  Sum_probs=191.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcC-------CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      .++|.+.+.||+|+||.||++.+..       +...+|+|.++...    ...+.+|+.+++.+.+||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4689999999999999999997643       23569999997532    245778999999997899999999999654


Q ss_pred             CCCccEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEc
Q 014762          193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~  253 (419)
                        ...++||||+++++|..++.                   .+++..+..++.|++.||+|||++|++|+||||+||+++
T Consensus        97 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  174 (307)
T cd05098          97 --GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  174 (307)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence              56889999999999987763                   267788999999999999999999999999999999999


Q ss_pred             CCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014762          254 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ  329 (419)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~  329 (419)
                      .+ +.+||+|||+++........   ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..|| .+.+ .+.
T Consensus       175 ~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~-~~~~-~~~  250 (307)
T cd05098         175 ED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP-VEE  250 (307)
T ss_pred             CC-CcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCC-CcCC-HHH
Confidence            88 78999999998765422211   11223457999999877 678999999999999999998 77776 3322 222


Q ss_pred             HHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       330 ~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      +........                                   ..+....++.++.+++.+||..+|++|||+.+++++
T Consensus       251 ~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         251 LFKLLKEGH-----------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHcCC-----------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            222111000                                   000112368899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-38  Score=291.90  Aligned_cols=243  Identities=18%  Similarity=0.325  Sum_probs=196.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.++||+|+||+||+|.+. ++..+|+|.+...  ..+.+.+|+.+++.+ +|+|++++++++...  ...+++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEE--EPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeecC--CceEEE
Confidence            4678999999999999999999864 5678999998743  346789999999999 899999999998653  567899


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+++++|..++.     .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++........
T Consensus        80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceeccchhh
Confidence            99999999988762     47899999999999999999999999999999999999988 8899999999876643221


Q ss_pred             c--eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .  .....+..|+|||.+.+ ..++.++|+|||||++|++++ |+.|| .+.+....+..+......             
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~-~~~~~~~~~~~~~~~~~~-------------  223 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPY-PGMTNREVLEQVERGYRM-------------  223 (261)
T ss_pred             hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCC-------------
Confidence            1  11234457999999876 678999999999999999998 88887 344433333333211000             


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                             ......+.++.+++.+||+.+|++|||++++++
T Consensus       224 -----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         224 -----------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                                   001125788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.1e-38  Score=293.94  Aligned_cols=243  Identities=17%  Similarity=0.314  Sum_probs=192.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .++|++.+.||+|+||.||+|.+..++.   .+|+|.++..    ..+.+.+|+.+++.+ +||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKS--KP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecC--Cc
Confidence            4678999999999999999998765443   7999988643    235688999999999 999999999999643  67


Q ss_pred             cEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++++|..++.    .+++..+..++.|++.||.|||+++++|+||||+|||++.+ +.++|+|||++.....
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~  158 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSRVLED  158 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCccccccc
Confidence            899999999999988863    47888999999999999999999999999999999999987 7899999999986643


Q ss_pred             CCcce----eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          273 GKEYN----VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       273 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      .....    ...++..|++||.+.+ ..++.++|+|||||++|++++ |..||.. .+..+....+.+...         
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~---------  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWE-MSNQDVIKAIEEGYR---------  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCccc-CCHHHHHHHHhCCCc---------
Confidence            32211    1122456999999876 678999999999999999886 9999842 222222222211000         


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                 ......+++.+.+++.+||+.+|++|||+.++++
T Consensus       228 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         228 ---------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             ---------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                       0001126788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.1e-38  Score=292.51  Aligned_cols=243  Identities=18%  Similarity=0.337  Sum_probs=193.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .++|+..+.||+|+||.||+|.+..++.   .+++|.++..    ..+.+.+|+.+++.+ +|||++++.+++.+.  ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKF--KP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccC--CC
Confidence            4578889999999999999999876654   7999998643    235688999999999 999999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++++|..++    ..+++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.+||+|||++.....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~  159 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSRVLED  159 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccceeccc
Confidence            88999999999998876    247889999999999999999999999999999999999987 7899999999876543


Q ss_pred             CCccee----ecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          273 GKEYNV----RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       273 ~~~~~~----~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ......    ...+..|+|||++.+ ..++.++|||||||++|+|++ |..||... +..+....+......        
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~--------  229 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRL--------  229 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCC--------
Confidence            222111    122346999999876 678999999999999999997 99998432 222222222110000        


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                  .....++.++.+++.+||+.+|++||++.++++
T Consensus       230 ----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         230 ----------------------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                        001136788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.8e-38  Score=296.96  Aligned_cols=250  Identities=19%  Similarity=0.355  Sum_probs=194.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCC----------------cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCee
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------------ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVV  183 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~----------------~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv  183 (419)
                      ..+|++.+.||+|+||.||+|.+..++                ..||+|.+....    .+.+.+|+.+++.+ +|||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEe
Confidence            568999999999999999999876543                568999987532    45688899999999 899999


Q ss_pred             EEEeEEEccCCCccEEEEEecCCCChhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCc
Q 014762          184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN  249 (419)
Q Consensus       184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~N  249 (419)
                      ++++++...  ...+++|||+.+++|..++.              .+++..+..++.|++.||+|||++|++|+||||+|
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            999999654  67889999999999988762              47888999999999999999999999999999999


Q ss_pred             eEEcCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCC
Q 014762          250 VMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGH  324 (419)
Q Consensus       250 ILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~--g~~pf~~~~  324 (419)
                      |+++.+ +.++|+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++  |..||. ..
T Consensus       161 ili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~-~~  237 (296)
T cd05051         161 CLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYE-HL  237 (296)
T ss_pred             eeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCC-Cc
Confidence            999988 88999999998765433221   22345667999999876 679999999999999999998  666763 22


Q ss_pred             CCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 014762          325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR  404 (419)
Q Consensus       325 ~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~  404 (419)
                      +..+.+...........                           ...  .......+++++.+++.+||+.||++|||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~---------------------------~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~  288 (296)
T cd05051         238 TDQQVIENAGHFFRDDG---------------------------RQI--YLPRPPNCPKDIYELMLECWRRDEEDRPTFR  288 (296)
T ss_pred             ChHHHHHHHHhcccccc---------------------------ccc--cCCCccCCCHHHHHHHHHHhccChhcCCCHH
Confidence            33333322221110000                           000  0001123678999999999999999999999


Q ss_pred             HHhc
Q 014762          405 EAMV  408 (419)
Q Consensus       405 elL~  408 (419)
                      |+++
T Consensus       289 el~~  292 (296)
T cd05051         289 EIHL  292 (296)
T ss_pred             HHHH
Confidence            9965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-38  Score=299.04  Aligned_cols=250  Identities=18%  Similarity=0.347  Sum_probs=191.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCC--------------cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTN--------------ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKL  185 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~--------------~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l  185 (419)
                      .++|++.++||+|+||.||+|.+..++              ..||+|.++...    ...+.+|+++++++ +|+|++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence            568999999999999999999765432              358999987532    34688999999999 99999999


Q ss_pred             EeEEEccCCCccEEEEEecCCCChhhhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCce
Q 014762          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLYP---------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV  250 (419)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NI  250 (419)
                      ++++..  ....++||||+.++++..++.               .+++..+..++.|++.||+|||++|++|+||||+||
T Consensus        83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            999955  467889999999999987752               257788899999999999999999999999999999


Q ss_pred             EEcCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCCC
Q 014762          251 MIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGHD  325 (419)
Q Consensus       251 Ll~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~--g~~pf~~~~~  325 (419)
                      +++.+ +.+||+|||++.........   ....++..|+|||++.+ ..++.++|+|||||++|+|++  |..||. ..+
T Consensus       161 ll~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~-~~~  237 (295)
T cd05097         161 LVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYS-LLS  237 (295)
T ss_pred             EEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCc-ccC
Confidence            99987 78999999998765433221   12234567999999876 679999999999999999998  555663 223


Q ss_pred             CHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHH
Q 014762          326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE  405 (419)
Q Consensus       326 ~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e  405 (419)
                      ..+....+.+.......                            . ........+++.+.+|+.+||+.||++|||+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~----------------------------~-~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~  288 (295)
T cd05097         238 DEQVIENTGEFFRNQGR----------------------------Q-IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK  288 (295)
T ss_pred             hHHHHHHHHHhhhhccc----------------------------c-ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            33323222221100000                            0 000011236789999999999999999999999


Q ss_pred             Hhc
Q 014762          406 AMV  408 (419)
Q Consensus       406 lL~  408 (419)
                      +++
T Consensus       289 i~~  291 (295)
T cd05097         289 IHH  291 (295)
T ss_pred             HHH
Confidence            975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.7e-38  Score=297.64  Aligned_cols=253  Identities=27%  Similarity=0.431  Sum_probs=197.3

Q ss_pred             CeEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          126 DYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      +|++.+.||+|+||.||++.+.   .+++.+|+|.++..       ..+.+.+|+.++.++.+||||+++++.+..  ..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~   78 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT   78 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence            4888999999999999999854   46788999998632       124577899999999779999999999854  46


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ..++||||+.++++...+   ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||+++....
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~  157 (288)
T cd05583          79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECcccccccc
Confidence            788999999999998775   347889999999999999999999999999999999999987 7899999999876543


Q ss_pred             CCcc--eeecccccccccccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          273 GKEY--NVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       273 ~~~~--~~~~~~~~y~aPE~~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ....  ....++..|++||.+.+.. ..+.++|+||||+++|+|++|..||...... .....+.+..            
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~------------  224 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRI------------  224 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHH------------
Confidence            3221  2235788899999986522 3688999999999999999999998432111 1111111100            


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC---HHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT---AREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---a~elL~hp~f~~~  415 (419)
                                 ....          ...+..++.++.+++.+||+.||++|||   +.++|+||||+++
T Consensus       225 -----------~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         225 -----------LKSK----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             -----------HccC----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence                       0000          0011226788999999999999999998   5677999999876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.4e-38  Score=294.11  Aligned_cols=242  Identities=21%  Similarity=0.406  Sum_probs=192.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .++|.+.++||+|+||.||+|.+...   ...+++|......    .+.+.+|+.+++.+ +||||+++++++.+   ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~---~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE---NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC---CC
Confidence            56789999999999999999987544   3468999886432    35688999999999 89999999999864   34


Q ss_pred             cEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++++|..++.    .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~  159 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLED  159 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceeeeccc
Confidence            679999999999988863    47899999999999999999999999999999999999987 7899999999987654


Q ss_pred             CCccee--ecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          273 GKEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       273 ~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ......  ..++..|+|||.+.. ..++.++|||||||++|++++ |..||. +.+..+....+....            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~~~~------------  225 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIENGE------------  225 (270)
T ss_pred             ccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHcCC------------
Confidence            332221  223457999999866 678999999999999999986 998883 333333322221100            


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                        .      ......++.++.+++.+||..+|++|||+.++++
T Consensus       226 ------------------~------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         226 ------------------R------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             ------------------c------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                              0      0011236889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.8e-38  Score=295.36  Aligned_cols=245  Identities=18%  Similarity=0.356  Sum_probs=194.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcC----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVN----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|++.+.||+|+||.||+|.+..    ++..|++|.+....    .+.+.+|+.+++.+ +|+||+++++++... .
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIED-G   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-C
Confidence            46789999999999999999998765    36789999886432    35678899999999 999999999987654 3


Q ss_pred             CccEEEEEecCCCChhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEe
Q 014762          195 KTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~D  263 (419)
                      ...++++||+.++++..++           ..+++..+..++.|++.||+|||+++++|+||||+||+++.+ +.+||+|
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kl~d  160 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQVKITD  160 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcEEECC
Confidence            5678999999999998876           237888999999999999999999999999999999999987 8899999


Q ss_pred             cccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCC
Q 014762          264 WGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGT  339 (419)
Q Consensus       264 fgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~  339 (419)
                      ||+++.+.+....   ....++..|+|||++.+ ..++.++|||||||++|++++ |+.||.. .+..+ +...... +.
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~-~~~~~~~-~~  236 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFE-MAAYLKD-GY  236 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHH-HHHHHHc-CC
Confidence            9999865433221   12234567999999876 678999999999999999998 8988832 22211 1111110 00


Q ss_pred             chHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                  .      ......+++++.+++.+||+.||++|||+.++++
T Consensus       237 ----------------------------~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 ----------------------------R------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ----------------------------C------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                        0      0001236789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.6e-38  Score=294.64  Aligned_cols=244  Identities=23%  Similarity=0.411  Sum_probs=194.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC--------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      +|.+.++||+|+||+||++.+..++..+++|+++.        .....+.+|+.+++.+ +|||++++++++.+.  ...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   77 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLER--DAF   77 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcC--Cce
Confidence            58899999999999999999888877777777653        1223566799999999 999999999998654  568


Q ss_pred             EEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ++|+||++++++..++       ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.  +.++|+|||.+...
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~--~~~~l~d~g~~~~~  155 (260)
T cd08222          78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN--NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec--CCEeecccCceeec
Confidence            8999999999987654       35889999999999999999999999999999999999985  45899999998765


Q ss_pred             cCCCc-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          271 HPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       271 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.. ....+....+..  +..+        
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~--~~~~--------  223 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVE--GPTP--------  223 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHc--CCCC--------
Confidence            43322 223457788999999866 6788999999999999999999999832 222111111110  0000        


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                                .....++.++.++|.+||+.||++|||+.++++||||
T Consensus       224 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         224 --------------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             --------------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                                      0011267899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.8e-38  Score=301.90  Aligned_cols=249  Identities=27%  Similarity=0.389  Sum_probs=197.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .+.|+..+.||+|+||+||+|.+..+++.+|+|.+...      ..+.+.+|+.+++.+ +|+|++++++++...  ...
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   90 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTA   90 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcC--Cee
Confidence            45578889999999999999999999999999988532      124577899999999 999999999999664  667


Q ss_pred             EEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++||||+.+ ++...+    ..+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++......
T Consensus        91 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          91 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EEEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeecCc
Confidence            899999985 444332    348899999999999999999999999999999999999987 88999999998765432


Q ss_pred             CcceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                         ....++..|+|||.+.+  ...++.++|||||||++|+|++|..||.... ..+....+... .             
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~-~-------------  230 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQN-E-------------  230 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-HHHHHHHHhhc-C-------------
Confidence               23467788999999752  2457889999999999999999999984321 11111111110 0             


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                     .++      .....++..+.+||++||+.+|++|||++++++|||+...+
T Consensus       231 ---------------~~~------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         231 ---------------SPA------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             ---------------CCC------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence                           000      00112678899999999999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.3e-38  Score=291.46  Aligned_cols=234  Identities=18%  Similarity=0.349  Sum_probs=183.8

Q ss_pred             eeeeeCceEEEEEEEc--CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecC
Q 014762          132 KVGRGKYSEVFEGINV--NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (419)
                      .||+|+||.||+|.+.  .++..||+|+++...    .+.+.+|+.+++++ +||||+++++++..   ...++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~---~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA---EALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence            3899999999999765  445679999986543    35688999999999 99999999999843   46789999999


Q ss_pred             CCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc----e
Q 014762          206 STDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----N  277 (419)
Q Consensus       206 ~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~----~  277 (419)
                      +++|..++.    .+++..+..++.|++.||+|||++|++|+||||+|||++.+ +.+||+|||++.........    .
T Consensus        78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCccccccCCccceeccC
Confidence            999988762    48999999999999999999999999999999999999987 78999999998755433221    1


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ...++..|+|||.+.+ ..++.++|||||||++|++++ |..||.. ....+....+..  +.                 
T Consensus       157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~--~~-----------------  215 (257)
T cd05115         157 AGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKK-MKGPEVMSFIEQ--GK-----------------  215 (257)
T ss_pred             CCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHHC--CC-----------------
Confidence            1122457999999876 678999999999999999996 8888842 222221111110  00                 


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                       .......+++++.+++.+||..||++|||+.++.+
T Consensus       216 -----------------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         216 -----------------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             00011236889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.1e-38  Score=319.94  Aligned_cols=274  Identities=19%  Similarity=0.265  Sum_probs=182.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCC----CcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEE----EccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNT----NERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIV----RDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~----~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~----~~~~~  194 (419)
                      ..++|++.++||+|+||+||+|.+..+    +..||+|.++.....+...+.. +... .+.++..+...+    .....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~-l~~~-~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER-VRRA-CPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH-HHhh-chhhHHHHHHhhhcccccccC
Confidence            467899999999999999999999888    8999999986433222111111 1221 222222222211    11334


Q ss_pred             CccEEEEEecCCCChhhhcCCC-----------------------CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceE
Q 014762          195 KTPSLIFEYVNSTDFKVLYPTL-----------------------TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM  251 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~~l-----------------------~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NIL  251 (419)
                      ...++||||+++++|..++...                       ....+..++.|++.||+|||+++|+||||||+|||
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            6788999999999987765321                       12345678999999999999999999999999999


Q ss_pred             EcCCCCcEEEEecccceeccCCCc--ceeecccccccccccccCCC---------------------CCCccccHHHHHH
Q 014762          252 IDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQ---------------------DYDYSLDMWSLGC  308 (419)
Q Consensus       252 l~~~~~~~kl~Dfgla~~~~~~~~--~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DiwSlG~  308 (419)
                      ++.+.+.+||+|||+|+.......  .....+++.|+|||.+....                     .++.++|||||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            997657899999999976543322  23457889999999764311                     2345679999999


Q ss_pred             HHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHH
Q 014762          309 MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDF  388 (419)
Q Consensus       309 ~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  388 (419)
                      ++|||+++..++   .++...+.......+.+. ..|........            .......+.  .....+....+|
T Consensus       368 iL~el~~~~~~~---~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~------------~~~~~~~~~--~~d~~~~~~~dL  429 (566)
T PLN03225        368 IFLQMAFPNLRS---DSNLIQFNRQLKRNDYDL-VAWRKLVEPRA------------SPDLRRGFE--VLDLDGGAGWEL  429 (566)
T ss_pred             HHHHHHhCcCCC---chHHHHHHHHHHhcCCcH-HHHHHhhcccc------------chhhhhhhh--hccccchHHHHH
Confidence            999999866553   333444444444433321 11111100000            000000000  001134567799


Q ss_pred             HHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          389 LDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       389 i~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      |.+||+.||++|||+.++|+||||+...
T Consensus       430 i~~mL~~dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        430 LKSMMRFKGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             HHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence            9999999999999999999999998653

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-38  Score=299.39  Aligned_cols=246  Identities=18%  Similarity=0.301  Sum_probs=192.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-------CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (419)
                      ..++|++.+.||+|+||.||+|++.       .++..+|+|.++..    ..+.+.+|+.+++.+.+||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            4678999999999999999999753       23457999998642    235688999999998789999999999965


Q ss_pred             cCCCccEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE
Q 014762          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (419)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl  252 (419)
                      .  ...+++|||+.+++|..++.                   .+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        93 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili  170 (304)
T cd05101          93 D--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV  170 (304)
T ss_pred             C--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence            4  67789999999999987752                   25677888999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014762          253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (419)
Q Consensus       253 ~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~  328 (419)
                      +.+ +.+||+|||+++........   ....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+.+..+
T Consensus       171 ~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~  247 (304)
T cd05101         171 TEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEE  247 (304)
T ss_pred             cCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-ccCCHHH
Confidence            987 78999999999876432221   22334567999999877 678999999999999999998 66676 3332222


Q ss_pred             HHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       329 ~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ....+...            .                  .      ......++.++.+|+.+||..+|++|||+.|+++
T Consensus       248 ~~~~~~~~------------~------------------~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~  291 (304)
T cd05101         248 LFKLLKEG------------H------------------R------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE  291 (304)
T ss_pred             HHHHHHcC------------C------------------c------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            22211100            0                  0      0001236889999999999999999999999987


Q ss_pred             C
Q 014762          409 I  409 (419)
Q Consensus       409 h  409 (419)
                      .
T Consensus       292 ~  292 (304)
T cd05101         292 D  292 (304)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-38  Score=296.40  Aligned_cols=243  Identities=17%  Similarity=0.339  Sum_probs=192.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..+|+..++||+|+||+||++...     .++..+|+|.+....   .+.+.+|+.+++.+ +|+||+++++++.+.  .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEG--R   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecC--C
Confidence            467888999999999999999642     356789999886433   35788999999999 999999999999654  5


Q ss_pred             ccEEEEEecCCCChhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC
Q 014762          196 TPSLIFEYVNSTDFKVLYP------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~  257 (419)
                      ..+++|||+.+++|..++.                  .+++..+..++.|++.||+|||++|++|+||||+|||++.+ +
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~-~  159 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG-L  159 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC-C
Confidence            6789999999999987762                  36888899999999999999999999999999999999987 7


Q ss_pred             cEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 014762          258 KLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKI  333 (419)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i  333 (419)
                      .+||+|||++.........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. ....+....+
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~  237 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQ-LSNTEAIECI  237 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCcc-CCHHHHHHHH
Confidence            8999999998765433221   12234567999999877 678999999999999999998 8888742 2222222111


Q ss_pred             HHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       334 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ...  .                                  .......+++.+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~--~----------------------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQG--R----------------------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HcC--c----------------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            110  0                                  00011236889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-38  Score=290.28  Aligned_cols=239  Identities=18%  Similarity=0.338  Sum_probs=193.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.+.||.|+||.||+|..  .|+.||+|.++...  .+++.+|+.+++.+ +|+|++++++++.+  ....++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQ--GNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcC--CCCeEEEE
Confidence            56788999999999999999965  47899999997543  46788999999999 89999999999965  46788999


Q ss_pred             EecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      ||++++++..++.     .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||.++....... 
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEcccccccccccccc-
Confidence            9999999988762     48999999999999999999999999999999999999987 7899999999976532222 


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                       ....+..|+|||.+.+ ..++.++|+||||+++|++++ |..||...  +.+.+......           .       
T Consensus       158 -~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~~-----------~-------  215 (256)
T cd05039         158 -SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPHVEK-----------G-------  215 (256)
T ss_pred             -cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHhc-----------C-------
Confidence             2334557999999876 678999999999999999997 88887322  22221111110           0       


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                   +.    ......+++++.+++.+||+.+|++|||+.++++
T Consensus       216 -------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         216 -------------YR----MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             -------------CC----CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                         00    0001236889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-38  Score=294.68  Aligned_cols=239  Identities=23%  Similarity=0.434  Sum_probs=184.5

Q ss_pred             EEEeeeeeeCceEEEEEEEc----CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          128 EVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       128 ~~~~~lG~G~fg~V~~~~~~----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .+.+.||.|.||.||+|...    ..+..|+||.++..    ..+.+.+|+..+.++ +||||++++|++...  ...++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~--~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIEN--EPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESS--SSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-ccccccccccccccc--ccccc
Confidence            46788999999999999887    45678999999643    246789999999999 999999999999743  55889


Q ss_pred             EEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          200 IFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      |+||+.+++|.+++     ..+++..+..++.|++.||.|||+++++|+||+++||+++.+ +.+||+|||++.......
T Consensus        79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccc
Confidence            99999999998875     358899999999999999999999999999999999999998 799999999998763222


Q ss_pred             cc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          275 EY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       275 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ..   ........|+|||.+.+ ..++.++||||||+++||+++ |+.|| ...+..+....+.+. .            
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~-~~~~~~~~~~~~~~~-~------------  222 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPF-SDYDNEEIIEKLKQG-Q------------  222 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTT-TTSCHHHHHHHHHTT-E------------
T ss_pred             cccccccccccccccccccccc-ccccccccccccccccccccccccccc-ccccccccccccccc-c------------
Confidence            22   22345567999999877 568999999999999999999 66776 333333333332110 0            


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                             .......++..+.+++.+||..||++|||+.++++
T Consensus       223 -----------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  223 -----------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             -----------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             -----------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                   00112237889999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4e-38  Score=300.36  Aligned_cols=244  Identities=18%  Similarity=0.323  Sum_probs=191.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcC-------CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      .++|.+.++||+|+||.||+|.+..       .+..+|+|.++...    ...+.+|+.+++.+.+||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            5689999999999999999997532       34578999987432    245778999999986699999999999653


Q ss_pred             CCCccEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEc
Q 014762          193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~  253 (419)
                        ...+++|||+.+++|..++.                   .+++..+..++.|++.||.|||++|++|+||||+|||++
T Consensus        91 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~  168 (314)
T cd05099          91 --GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT  168 (314)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence              66889999999999988762                   267888899999999999999999999999999999999


Q ss_pred             CCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014762          254 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ  329 (419)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~  329 (419)
                      .+ +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+.
T Consensus       169 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~-~~~~~~~~  245 (314)
T cd05099         169 ED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPY-PGIPVEEL  245 (314)
T ss_pred             CC-CcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCC-CCCCHHHH
Confidence            87 78999999999765432211   11223457999999877 778999999999999999999 78787 33332222


Q ss_pred             HHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       330 ~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ...+...  .                            .      ......++.++.+++.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~--~----------------------------~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         246 FKLLREG--H----------------------------R------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHHcC--C----------------------------C------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2221110  0                            0      0001236789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-39  Score=304.39  Aligned_cols=252  Identities=19%  Similarity=0.340  Sum_probs=202.3

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .-..+...+.++||+|.||.|.+|. ...+..||+|.+++..    +..|.+|+++|.+| .||||++++|+|..+  +.
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~D--eP  609 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQD--DP  609 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecC--Cc
Confidence            3346778899999999999999996 4567999999998643    47799999999999 999999999999765  66


Q ss_pred             cEEEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          197 PSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      +++|+|||++|+|.+++.     .........|+.||+.||+||.+.++|||||.++|+|++.+ .++||+|||+++-+.
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIKIADFGMSRNLY  688 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEEecCcccccccc
Confidence            889999999999999872     23445567799999999999999999999999999999999 899999999998766


Q ss_pred             CCCccee---ecccccccccccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          272 PGKEYNV---RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       272 ~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~--g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .++.+..   .+-...|||||.++. ++++.++|+|+||+++||+++  ...|| ....+++......+.+..+....++
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py-~~lt~e~vven~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPY-SQLTDEQVVENAGEFFRDQGRQVVL  766 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCch-hhhhHHHHHHhhhhhcCCCCcceec
Confidence            5555533   245677999999987 899999999999999999865  66676 3334444444443333332222111


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                   ..+.-++..+.++|.+||+.|-++|||.+++-.
T Consensus       767 -----------------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  767 -----------------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             -----------------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence                                         112348899999999999999999999999854

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.6e-38  Score=290.91  Aligned_cols=240  Identities=17%  Similarity=0.337  Sum_probs=190.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .++|++.+.||+|+||.||++..  .|..+|+|.++... .+.+.+|+.+++.+ +|+|++++++++... ....+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv~e   80 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE   80 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcC-CCceEEEEE
Confidence            45789999999999999999965  47889999987543 45788999999999 999999999976543 356789999


Q ss_pred             ecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcce
Q 014762          203 YVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN  277 (419)
Q Consensus       203 ~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~  277 (419)
                      |++++++..++.     .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||+++......  .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~--~  157 (256)
T cd05082          81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--D  157 (256)
T ss_pred             CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceeccccC--C
Confidence            999999988763     27888999999999999999999999999999999999988 889999999987543222  2


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....+..|+|||++.+ ..++.++|||||||++|+|++ |+.||.. .+..+....+.+.                    
T Consensus       158 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~--------------------  215 (256)
T cd05082         158 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKG--------------------  215 (256)
T ss_pred             CCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcC--------------------
Confidence            2334567999999876 678999999999999999997 8888732 1111111111100                    


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                  +    .......+++.+.+++.+||+.||++|||+.++++
T Consensus       216 ------------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         216 ------------Y----KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             ------------C----CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                        0    00011236889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.5e-38  Score=292.51  Aligned_cols=243  Identities=16%  Similarity=0.302  Sum_probs=192.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .++|++.+.||+|+||.||+|.+..+++   .||+|.++..    ....+.+|+.+++.+ +||||+++++++.+  +..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~   79 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SRP   79 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECC--CCc
Confidence            3568899999999999999999877665   5999998643    235788999999999 99999999999954  467


Q ss_pred             cEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++++|..++.    .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~  158 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLED  158 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCcccccccc
Confidence            889999999999988763    47889999999999999999999999999999999999987 7899999999876543


Q ss_pred             CCcc---eeecc---cccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          273 GKEY---NVRVA---SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       273 ~~~~---~~~~~---~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      ....   ....+   +..|+|||.+.+ ..++.++|||||||++||+++ |..||... +..+....+....        
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~--------  228 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQDY--------  228 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCC--------
Confidence            2211   11111   346999999876 778999999999999999886 99888432 2222222111100        


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                  .......++..+.+++.+||+.+|++|||+.++++
T Consensus       229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         229 ----------------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             ----------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                        00001236788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-38  Score=290.30  Aligned_cols=235  Identities=18%  Similarity=0.324  Sum_probs=186.4

Q ss_pred             eeeeeeCceEEEEEEEcCCC---cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          131 RKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      ++||+|+||.||+|.+..++   ..+|+|.+....    .+.+.+|+.+++.+ +|+|++++++++..   ...++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG---EPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC---CceEEEEEe
Confidence            46999999999999876655   789999987433    35688999999999 99999999998853   457899999


Q ss_pred             cCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcce-e-
Q 014762          204 VNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN-V-  278 (419)
Q Consensus       204 ~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~-~-  278 (419)
                      +++++|..++.   .+++..+..++.|++.||+|||+++++|+||||+|||++.+ +.+||+|||+++......... . 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceeecCCcccccc
Confidence            99999988773   48899999999999999999999999999999999999988 789999999998664433211 1 


Q ss_pred             --ecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          279 --RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       279 --~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                        ..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. .+..+....+.. ..                 
T Consensus       156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~-~~~~~~~~~~~~-~~-----------------  215 (257)
T cd05060         156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGE-MKGAEVIAMLES-GE-----------------  215 (257)
T ss_pred             cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHc-CC-----------------
Confidence              122356999999876 679999999999999999998 8888732 222222211111 00                 


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                        .......++..+.+++.+||+.||++|||+.++++
T Consensus       216 ------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         216 ------------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             ------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                              00111236789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-38  Score=295.32  Aligned_cols=235  Identities=16%  Similarity=0.250  Sum_probs=183.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCc-------EEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          131 RKVGRGKYSEVFEGINVNTNE-------RCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~-------~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +.||+|+||+||+|.+..++.       .+++|.+....   .+.+.+|+.+++.+ +|||++++++++...  ...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~--~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCG--DESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeC--CCcEEE
Confidence            369999999999998765544       38888876433   35678899999998 899999999999654  567899


Q ss_pred             EEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC-------cEEEEeccccee
Q 014762          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR-------KLRLIDWGLAEF  269 (419)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~-------~~kl~Dfgla~~  269 (419)
                      |||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+||+++.+..       .++++|||.+..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999988873    3788899999999999999999999999999999999987632       279999999865


Q ss_pred             ccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ....   ....++..|+|||++.+...++.++|||||||++|+|++|..+++...+..........              
T Consensus       158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~--------------  220 (258)
T cd05078         158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--------------  220 (258)
T ss_pred             cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--------------
Confidence            4322   23457788999999977556899999999999999999996555433332221111000              


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                    ..          ..+...+.++.+++.+||+.||++|||++++++.
T Consensus       221 --------------~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 --------------RH----------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             --------------cc----------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                          00          0011245789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-40  Score=302.44  Aligned_cols=258  Identities=23%  Similarity=0.438  Sum_probs=210.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec--Ccc--------hHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~--~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      -+++|-++++||+|||+.||+|.|....+.||||+-.  +..        .+..-+|..|-+.| +||.||++|++|.-+
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLD  539 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeec
Confidence            4788999999999999999999999999999999863  221        13466899999999 999999999999865


Q ss_pred             CCCccEEEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC--CcEeecCCCCceEEcCC--CCcEEEEecc
Q 014762          193 HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHE--LRKLRLIDWG  265 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlk~~NILl~~~--~~~~kl~Dfg  265 (419)
                      + ..+|-|+|||+|.+|+.+++   .+++.+++.|+.||..||.||.+.  .|||.||||.|||+...  .|.+||.|||
T Consensus       540 t-dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  540 T-DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             c-ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            4 56799999999999999884   489999999999999999999975  69999999999999654  4679999999


Q ss_pred             cceeccCCCc--------ceeecccccccccccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014762          266 LAEFYHPGKE--------YNVRVASRYFKGPELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (419)
Q Consensus       266 la~~~~~~~~--------~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~  334 (419)
                      +++++..+..        +....||.||.+||.+.-   ..+.+.++||||+||++|.++.|+.||....+..+.++.-.
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            9998865432        233578999999999853   34688999999999999999999999965555444443210


Q ss_pred             HHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                .+.....                      .....+.++.++++||++||++.-++|....++-.||||.+
T Consensus       699 ----------IlkAtEV----------------------qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  699 ----------ILKATEV----------------------QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             ----------hhcceec----------------------cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence                      0000001                      11112348999999999999999999999999999999975

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.5e-38  Score=327.08  Aligned_cols=141  Identities=29%  Similarity=0.529  Sum_probs=127.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.++||+|+||+||+|.+..+++.||||+++...      ...+.+|+.++..+ +||||+++++.+...  ...
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~~~   79 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSA--NNV   79 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEEC--CEE
Confidence            468999999999999999999999999999999986432      25678899999998 999999999998554  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                      ++||||+.+++|..++   ..+++..++.++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||+++
T Consensus        80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~  152 (669)
T cd05610          80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence            9999999999998876   357889999999999999999999999999999999999987 889999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-38  Score=290.06  Aligned_cols=237  Identities=24%  Similarity=0.413  Sum_probs=192.6

Q ss_pred             eeeeeeCceEEEEEEEcCC---CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          131 RKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      +.||+|+||.||+|.+...   +..+++|.++...    .+.+.+|+.++..+ +|+|++++++++..  ....+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTE--EEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecC--CCceEEEEEe
Confidence            3699999999999998866   8899999997533    46788999999999 79999999999965  5778999999


Q ss_pred             cCCCChhhhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          204 VNSTDFKVLYP------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       204 ~~~~~l~~~~~------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      +++++|..++.            .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||.+....
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~  156 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVY  156 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEcccccccccc
Confidence            99999988763            36899999999999999999999999999999999999998 889999999998765


Q ss_pred             CCC---cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          272 PGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       272 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ...   ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+....+..  +.        
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~--~~--------  224 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYP-GLSNEEVLEYLRK--GY--------  224 (262)
T ss_pred             cccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHc--CC--------
Confidence            432   1233456778999999876 578999999999999999999 577773 3222222222111  00        


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                .......++.++.+++.+||+.||++|||+.+++++
T Consensus       225 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         225 --------------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             --------------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                                      001112368899999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-39  Score=308.68  Aligned_cols=264  Identities=26%  Similarity=0.433  Sum_probs=217.5

Q ss_pred             CCCCceeccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEE
Q 014762          113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLL  186 (419)
Q Consensus       113 ~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~  186 (419)
                      +|..+.....+..-|..++.||-|+||.|.++....|...+|+|.+.+.+      ....+.|-+||... +.+.||+||
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLy  695 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLY  695 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEE
Confidence            44555555556778999999999999999999999999999999886533      35678899999998 999999999


Q ss_pred             eEEEccCCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEe
Q 014762          187 DIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (419)
Q Consensus       187 ~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~D  263 (419)
                      -.|.+  ..++|+||||++||++..++   .-|.+..++.++.++..|+++.|..|+|||||||+|||||.+ |.+||.|
T Consensus       696 ySFQD--kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GHIKLTD  772 (1034)
T KOG0608|consen  696 YSFQD--KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTD  772 (1034)
T ss_pred             EEecc--CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cceeeee
Confidence            99955  47899999999999988776   558999999999999999999999999999999999999999 9999999


Q ss_pred             cccceec---------cCCC----------------------------------cceeecccccccccccccCCCCCCcc
Q 014762          264 WGLAEFY---------HPGK----------------------------------EYNVRVASRYFKGPELLVDLQDYDYS  300 (419)
Q Consensus       264 fgla~~~---------~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~  300 (419)
                      |||+.-+         ..+.                                  .....+||+.|+|||++.. ..|+..
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~  851 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQL  851 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCcccc
Confidence            9998422         1000                                  0012368999999999988 789999


Q ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCC
Q 014762          301 LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL  380 (419)
Q Consensus       301 ~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (419)
                      +|.||.||+||||+.|+.||........+                                  ..-..|+.++....+..
T Consensus       852 cdwws~gvil~em~~g~~pf~~~tp~~tq----------------------------------~kv~nw~~~l~~~~~~~  897 (1034)
T KOG0608|consen  852 CDWWSVGVILYEMLVGQPPFLADTPGETQ----------------------------------YKVINWRNFLHIPYQGN  897 (1034)
T ss_pred             chhhHhhHHHHHHhhCCCCccCCCCCcce----------------------------------eeeeehhhccccccccc
Confidence            99999999999999999999432222111                                  12245777777777788


Q ss_pred             CCHHHHHHHHHhcCCCCCCCC---CHHHHhcCCCccccc
Q 014762          381 VSPEAIDFLDKLLRYDHQDRL---TAREAMVISSISPIF  416 (419)
Q Consensus       381 ~~~~~~~li~~~L~~dP~~Rp---ta~elL~hp~f~~~~  416 (419)
                      ++.++.++|.++ +.+++.|+   .++++-.||||+.|.
T Consensus       898 ls~e~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgID  935 (1034)
T KOG0608|consen  898 LSKEALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGID  935 (1034)
T ss_pred             cCHHHHHHHHHH-hcChhhhhcccchhhhhcCccccccc
Confidence            999999999985 56899998   578899999999873

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=315.14  Aligned_cols=202  Identities=26%  Similarity=0.465  Sum_probs=178.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----CC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~  195 (419)
                      ...+...+.||+|+||.||+|+++.+|+.||||.+++    ...+..-+|+++|+++ +|+|||+++++-++..    ..
T Consensus        12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccc
Confidence            4456667889999999999999999999999999875    2356778999999999 7999999999876655    56


Q ss_pred             ccEEEEEecCCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC---CcEEEEeccc
Q 014762          196 TPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGL  266 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~---~~~kl~Dfgl  266 (419)
                      ...++||||.+|+|...++      .+++.++..++.++..||.|||++|||||||||.||++-...   ...||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            7889999999999999884      499999999999999999999999999999999999984331   2569999999


Q ss_pred             ceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC
Q 014762          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN  326 (419)
Q Consensus       267 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~  326 (419)
                      |+..+++...+..+||..|.+||++...+.|+..+|.|||||++|++.||..||.+...+
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            999998888888999999999999985578999999999999999999999999665443

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.2e-38  Score=295.64  Aligned_cols=250  Identities=16%  Similarity=0.332  Sum_probs=189.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcC----------------CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCee
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVN----------------TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVV  183 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv  183 (419)
                      .++|++.++||+|+||+||++.+..                ++..+|+|.+....    .+.+.+|+.+++.+ +|+||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence            4679999999999999999985432                34468999987432    35688999999999 999999


Q ss_pred             EEEeEEEccCCCccEEEEEecCCCChhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCc
Q 014762          184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN  249 (419)
Q Consensus       184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~N  249 (419)
                      ++++++...  ...+++|||+.+++|..++.              .+++..+..++.|++.||+|||++|++|+||||+|
T Consensus        83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          83 RLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             eEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            999999654  56789999999999988762              25667899999999999999999999999999999


Q ss_pred             eEEcCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCC
Q 014762          250 VMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF--RKEPFFYGH  324 (419)
Q Consensus       250 ILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~--g~~pf~~~~  324 (419)
                      ||++.+ +.++|+|||+++........   ....++..|++||+..+ ..++.++|+|||||++|||++  |..||.. .
T Consensus       161 ili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~-~  237 (296)
T cd05095         161 CLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQ-L  237 (296)
T ss_pred             EEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccc-c
Confidence            999987 78999999998765433221   11233567999998876 679999999999999999998  6677732 2


Q ss_pred             CCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 014762          325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR  404 (419)
Q Consensus       325 ~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~  404 (419)
                      +..+......+..        ....               ..    .  .......+++.+.+|+.+||+.||++|||+.
T Consensus       238 ~~~~~~~~~~~~~--------~~~~---------------~~----~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~  288 (296)
T cd05095         238 SDEQVIENTGEFF--------RDQG---------------RQ----V--YLPKPALCPDSLYKLMLSCWRRNAKERPSFQ  288 (296)
T ss_pred             ChHHHHHHHHHHH--------hhcc---------------cc----c--cCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence            2222221111100        0000               00    0  0001123678999999999999999999999


Q ss_pred             HHhc
Q 014762          405 EAMV  408 (419)
Q Consensus       405 elL~  408 (419)
                      ++++
T Consensus       289 ~i~~  292 (296)
T cd05095         289 EIHA  292 (296)
T ss_pred             HHHH
Confidence            9865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.5e-38  Score=307.82  Aligned_cols=247  Identities=21%  Similarity=0.329  Sum_probs=192.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|.+.++||+|+||.||+|.+.     .+++.||+|+++...    .+.+.+|+.++..+..||||+++++.|... 
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-  113 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-  113 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence            3567889999999999999999853     355689999997432    246788999999994499999999999654 


Q ss_pred             CCccEEEEEecCCCChhhhcC-----------------------------------------------------------
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP-----------------------------------------------------------  214 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-----------------------------------------------------------  214 (419)
                       ...++||||+.+|+|..++.                                                           
T Consensus       114 -~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         114 -GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             -CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence             67899999999999877652                                                           


Q ss_pred             ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE
Q 014762          215 ------------------------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (419)
Q Consensus       215 ------------------------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl  252 (419)
                                                                .+++..+..++.|++.||+|||+++++||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl  272 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI  272 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence                                                      24556778899999999999999999999999999999


Q ss_pred             cCCCCcEEEEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014762          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (419)
Q Consensus       253 ~~~~~~~kl~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~  328 (419)
                      +.+ +.+||+|||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||. .....+
T Consensus       273 ~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~-~~~~~~  349 (401)
T cd05107         273 CEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYP-ELPMNE  349 (401)
T ss_pred             eCC-CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCC-CCCchH
Confidence            987 7899999999976532221   122356678999999876 678999999999999999998 888873 222222


Q ss_pred             HHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       329 ~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ........ +.                                  ....+..++.++.+++.+||..+|++|||+.++++
T Consensus       350 ~~~~~~~~-~~----------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~  394 (401)
T cd05107         350 QFYNAIKR-GY----------------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH  394 (401)
T ss_pred             HHHHHHHc-CC----------------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            22221110 00                                  00011236889999999999999999999999987


Q ss_pred             C
Q 014762          409 I  409 (419)
Q Consensus       409 h  409 (419)
                      .
T Consensus       395 ~  395 (401)
T cd05107         395 L  395 (401)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.2e-37  Score=288.00  Aligned_cols=242  Identities=16%  Similarity=0.351  Sum_probs=192.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.+.||+|+||.||+|.+. .+..+|+|.++..  ....+.+|+.+++.+ +|||++++++++...  ...+++|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~   78 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTER--SPICLVF   78 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEccC--CceEEEE
Confidence            457899999999999999999875 4678999998743  346789999999999 999999999998554  5678999


Q ss_pred             EecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc-
Q 014762          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-  276 (419)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~-  276 (419)
                      ||+++++|..++.    .+++..+..++.|++.||+|||+.+++|+||||+||+++.+ +.++|+|||++......... 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeecccCcccc
Confidence            9999999987762    47889999999999999999999999999999999999977 78999999998765432211 


Q ss_pred             -eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       277 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                       ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||. .....+....+.+.                  
T Consensus       158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~------------------  217 (256)
T cd05112         158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEVVETINAG------------------  217 (256)
T ss_pred             cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCC-cCCHHHHHHHHhCC------------------
Confidence             12234567999999876 678999999999999999998 888873 22222222211100                  


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                    +    ........++.+.+|+.+||+.+|++|||+.++++
T Consensus       218 --------------~----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~  253 (256)
T cd05112         218 --------------F----RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH  253 (256)
T ss_pred             --------------C----CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                          0    00001225788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=339.25  Aligned_cols=250  Identities=24%  Similarity=0.409  Sum_probs=204.6

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      -+++-..+||.|.||.||-|.+..+|+..|+|-++-.     ..+.+.+|..++..+ +|||+|+++|+-...  ...++
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHR--ekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHR--EKVYI 1311 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecH--HHHHH
Confidence            3566688899999999999999999999999987532     235678999999999 999999999987554  45668


Q ss_pred             EEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC--
Q 014762          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~--  274 (419)
                      .||||++|+|.+.+.   ..++.-.+.+..|++.|+.|||+.|||||||||.||+++.+ +.+|++|||.|..+.+..  
T Consensus      1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-CcEEeecccceeEecCchhc
Confidence            899999999998873   36666778899999999999999999999999999999999 799999999998876542  


Q ss_pred             ---cceeecccccccccccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          275 ---EYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       275 ---~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                         ..+...||+.|||||++.+..  .-.-+.||||+||++.||+||+.||..-+++...+... ...-.|++       
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V-~~gh~Pq~------- 1462 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV-AAGHKPQI------- 1462 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH-hccCCCCC-------
Confidence               224568999999999998742  34568999999999999999999995444444443332 22122221       


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                                  +..++.+.+|||.+||+.||++|.|+.|+++|.|=+.
T Consensus      1463 ----------------------------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1463 ----------------------------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             ----------------------------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence                                        1237999999999999999999999999999998654

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8e-38  Score=290.53  Aligned_cols=234  Identities=18%  Similarity=0.254  Sum_probs=179.3

Q ss_pred             eeeeeeCceEEEEEEEcC------------CCcEEEEEEecCcch---HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          131 RKVGRGKYSEVFEGINVN------------TNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~------------~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      +.||+|+||.||+|....            ....+++|.+.....   ..+.+|+.++..+ +||||+++++++.+.  .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~--~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRD--V   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--C
Confidence            368999999999997432            223588998865433   3677889999999 999999999999654  5


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC------cEEEEecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR------KLRLIDWG  265 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~------~~kl~Dfg  265 (419)
                      ..+++|||++++++..++.    .+++..+..++.|++.||+|||+++|+||||||+|||++.+..      .++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            6789999999999887763    4889999999999999999999999999999999999986521      38999999


Q ss_pred             cceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHH-hCCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       266 la~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell-~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      ++......   ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||. .....+. .....   .     
T Consensus       158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~-~~~~~~~-~~~~~---~-----  224 (262)
T cd05077         158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK-DKTLAEK-ERFYE---G-----  224 (262)
T ss_pred             CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CcchhHH-HHHHh---c-----
Confidence            98654322   23456788999999875567899999999999999998 4776662 2221111 11000   0     


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                           ..                        ......++++.+||.+||+.||++|||+.+++++
T Consensus       225 -----~~------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 -----QC------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             -----Cc------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                 00                        0001135789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-38  Score=288.98  Aligned_cols=237  Identities=29%  Similarity=0.484  Sum_probs=194.8

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ||.|+||.||++.+..+++.+++|.+....      ...+.+|+.+++.+ +|+|++++++.+..  ....+++|||+++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQT--EEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence            699999999999998889999999986432      34688999999999 89999999999854  4778999999999


Q ss_pred             CChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Ccceeeccc
Q 014762          207 TDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVAS  282 (419)
Q Consensus       207 ~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~  282 (419)
                      ++|..++.   .+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++...... .......++
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (250)
T cd05123          78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGT  156 (250)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcCC
Confidence            99988763   47999999999999999999999999999999999999988 78999999998765443 223345678


Q ss_pred             ccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhc
Q 014762          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG  362 (419)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  362 (419)
                      ..|++||...+ ..++.++|+||||+++|++++|..||... +..+....+..  +.                       
T Consensus       157 ~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~--~~-----------------------  209 (250)
T cd05123         157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAE-DRKEIYEKILK--DP-----------------------  209 (250)
T ss_pred             ccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhc--CC-----------------------
Confidence            88999999876 66889999999999999999999998432 22111111111  00                       


Q ss_pred             cCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH---HHHhcCCCc
Q 014762          363 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA---REAMVISSI  412 (419)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta---~elL~hp~f  412 (419)
                                  ...+..++..+.+++++||..||++|||+   +++++||||
T Consensus       210 ------------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         210 ------------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                        00112257889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-37  Score=291.70  Aligned_cols=243  Identities=18%  Similarity=0.309  Sum_probs=192.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|++.+.||+|+||+||+|.+..+|+    .+|+|.+....    ...+.+|+.+++.+ +|||++++++++..   
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---   80 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS---   80 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec---
Confidence            35789999999999999999999876665    58999886432    35678999999999 99999999999965   


Q ss_pred             CccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ...++||||+.++++..++.    .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||.++..
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~~~~  159 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL  159 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCcccccc
Confidence            56789999999999988763    48899999999999999999999999999999999999987 78999999999876


Q ss_pred             cCCCccee---ecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          271 HPGKEYNV---RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       271 ~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ........   ..++..|+|||.+.+ ..++.++|+|||||++||+++ |+.||.. .... .+.........       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~-~~~~~~~~~~~-------  229 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEG-IPAV-EIPDLLEKGER-------  229 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCC-CCHH-HHHHHHhCCCC-------
Confidence            53332211   122456999999866 678999999999999999998 9988732 2222 22211110000       


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                  ...+..++..+.+++.+||..||.+|||+.++++
T Consensus       230 ----------------------------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         230 ----------------------------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             ----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                        0001125778999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.5e-37  Score=288.26  Aligned_cols=242  Identities=15%  Similarity=0.300  Sum_probs=191.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.++||+|+||.||++.+ ..+..+|+|.+....  .+.+.+|+.+++.+ +|+||+++++.+..   ...+++
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---~~~~~v   78 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYII   78 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC---CCeEEE
Confidence            367899999999999999999975 456679999887543  35788999999999 89999999999855   567899


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||++++++.+++.     .+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+||+|||.+........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeeccCCCc
Confidence            99999999988763     36778889999999999999999999999999999999987 7899999999876543222


Q ss_pred             c--eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .  ....++..|+|||++.. ..++.++|+|||||++|++++ |..||. +.+..+....+....               
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~~---------------  220 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGY---------------  220 (260)
T ss_pred             ccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHhCCC---------------
Confidence            1  12234566999999876 678999999999999999998 787873 333222222211100               


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                           ........+.++.+++.+||+.+|++|||+.++++
T Consensus       221 ---------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         221 ---------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             ---------------------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence                                 00001236789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-40  Score=321.04  Aligned_cols=244  Identities=18%  Similarity=0.330  Sum_probs=205.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      +.+...+.+.||.|.||.|++|+.+..|+   .||||.++.    ..+.+|..|+.||.++ +||||++|.|++..  .+
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTk--s~  703 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTK--SK  703 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEec--Cc
Confidence            34567889999999999999999876664   699999984    3456799999999999 99999999999954  57


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++|.|||++|+|+.+++    +|+..++..+++.|+.||.||-+.|+|||||..+|||++.+ -.+|++|||+++.+.
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLE  782 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccceeecc
Confidence            7889999999999999984    58889999999999999999999999999999999999999 789999999999886


Q ss_pred             CCCc-ceeeccc---ccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          272 PGKE-YNVRVAS---RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       272 ~~~~-~~~~~~~---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ++.. .....|.   ..|.|||.+.- .+++.++||||||++|||.++ |..||+ ..++.+.+..+.+-...|      
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYW-dmSNQdVIkaIe~gyRLP------  854 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMSNQDVIKAIEQGYRLP------  854 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCccc-ccchHHHHHHHHhccCCC------
Confidence            5542 2222222   45999999976 889999999999999999776 888985 566677777665533322      


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                    .+.+++..+.+||..||+.|-.+||+..+++.
T Consensus       855 ------------------------------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  855 ------------------------------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             ------------------------------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence                                          22348999999999999999999999999876

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=294.88  Aligned_cols=251  Identities=25%  Similarity=0.360  Sum_probs=211.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..+|.++..||+|+||+|-+|..+.+.+.+|||++++..      .+--..|-.+|.....-|.+++++..|  +....+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRL  425 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRL  425 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhhe
Confidence            457889999999999999999999999999999997532      122335666676655568899999999  445778


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc-CC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~-~~  273 (419)
                      |.||||++||+|...+   .++.+..+..++.+|+-||-+||++||++||||.+|||+|.+ +.+||+|||+++.-- .+
T Consensus       426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeecccccccccCC
Confidence            9999999999998776   568999999999999999999999999999999999999999 899999999997543 33


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      ..+...+||+.|+|||++.- ++|+.++|.||+||+||||+.|..|| .|.+..+.++.|.+..-             .+
T Consensus       505 ~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPF-dGeDE~elF~aI~ehnv-------------sy  569 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQAIMEHNV-------------SY  569 (683)
T ss_pred             cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHccC-------------cC
Confidence            44567899999999999876 89999999999999999999999997 67777777777665211             11


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCCCccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMVISSISPIF  416 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~elL~hp~f~~~~  416 (419)
                                              +..+|.++.++....|...|.+|..+     .++-.||||+.|.
T Consensus       570 ------------------------PKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  570 ------------------------PKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             ------------------------cccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence                                    12378999999999999999999954     6788999999873

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-37  Score=287.67  Aligned_cols=240  Identities=23%  Similarity=0.406  Sum_probs=193.2

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCC----cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      +++.+.||.|+||.||+|.+..++    ..+|+|.++...    .+.+.+|+.++..+ +|+||+++++++.+.  ...+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeE
Confidence            356788999999999999988766    899999997543    45788999999999 999999999999654  6788


Q ss_pred             EEEEecCCCChhhhcC---C--CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          199 LIFEYVNSTDFKVLYP---T--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~---~--l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++|||++++++..++.   .  +++..+..++.|++.||+|||+.|++|+||||+||+++.+ +.++|+|||++......
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-CeEEEcccCCceecccc
Confidence            9999999999988763   2  8999999999999999999999999999999999999988 78999999999876544


Q ss_pred             Cccee--ecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          274 KEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       274 ~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      .....  ..++..|+|||.+.+ ..++.++|+||+||++++|++ |..|| ...+..+....+....             
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~-~~~~~~~~~~~~~~~~-------------  221 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPY-PGMSNEEVLEYLKKGY-------------  221 (258)
T ss_pred             cccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhcCC-------------
Confidence            22221  235678999999865 778999999999999999998 66665 3333222222221100             


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                             .......++.++.+++.+||+.||++|||+.++++
T Consensus       222 -----------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      222 -----------------------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -----------------------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                                   00011126889999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-37  Score=289.19  Aligned_cols=238  Identities=21%  Similarity=0.349  Sum_probs=183.2

Q ss_pred             eeeeeeCceEEEEEEEcC---CCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          131 RKVGRGKYSEVFEGINVN---TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      +.||+|+||+||+|.+..   .+..+|+|.+...    ..+.+.+|+.+++.+ +|||++++++++... ....+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPS-EGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecC-CCCcEEEEec
Confidence            368999999999998653   3457999988532    235678899999998 999999999987543 2457899999


Q ss_pred             cCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc----
Q 014762          204 VNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----  275 (419)
Q Consensus       204 ~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~----  275 (419)
                      +.++++..++.    .+++..+..++.|++.||.|||+.+++|+||||+|||++.+ +.+||+|||+++.......    
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCccccccccCCcceeec
Confidence            99999988863    35677788899999999999999999999999999999987 7899999999875533211    


Q ss_pred             -ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                       .....++..|+|||.+.+ ..++.++|||||||++|||++|+.|++...+..+....+..  +.               
T Consensus       158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~--~~---------------  219 (262)
T cd05058         158 NHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GR---------------  219 (262)
T ss_pred             ccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc--CC---------------
Confidence             112234567999999876 67899999999999999999976665444333222111110  00               


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                         .......+++.+.+++.+||..+|++|||+.++++
T Consensus       220 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         220 -------------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             -------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                               00001235788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.7e-38  Score=294.95  Aligned_cols=260  Identities=21%  Similarity=0.371  Sum_probs=197.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..+|++.+.||+|+||+||+|...    .++..+|+|.++...    .+.+.+|+.+++.+ +|+||+++++++......
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCC
Confidence            356788899999999999999854    347899999997543    45789999999999 999999999999776567


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..+++|||++++++..++.    .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||.+....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~  160 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLAKVLP  160 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccccccccc
Confidence            8899999999999988873    38899999999999999999999999999999999999988 889999999998765


Q ss_pred             CCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      .....    ....++..|++||.+.+ ..++.++|+|||||++|+|++|..|+.......      ....+....     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~------~~~~~~~~~-----  228 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF------LRMIGIAQG-----  228 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchh------ccccccccc-----
Confidence            33221    11234456999999876 678999999999999999999999984322211      011111000     


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                         ......+.........        ......++.++.+++.+||+.+|++|||+.|+++
T Consensus       229 ---~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         229 ---QMIVTRLLELLKEGER--------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             ---cccHHHHHHHHHcCCc--------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence               0000000111110000        0011236788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.8e-38  Score=287.09  Aligned_cols=226  Identities=20%  Similarity=0.283  Sum_probs=181.9

Q ss_pred             eCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhc--
Q 014762          136 GKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--  213 (419)
Q Consensus       136 G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--  213 (419)
                      |.+|+||++++..+++.+|+|.+....  ...+|...+... .|||++++++++.+.  ...+++|||+++++|.+++  
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVSE--DSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheecC--CeEEEEEecCCCCCHHHHHHH
Confidence            889999999999999999999997532  344555555555 799999999999654  6789999999999998765  


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeeccccccccccccc
Q 014762          214 -PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV  292 (419)
Q Consensus       214 -~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~  292 (419)
                       ..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++++|||.+......  .....++..|+|||.+.
T Consensus        79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG  155 (237)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCccccCCcccC
Confidence             358999999999999999999999999999999999999988 78999999987655432  22344567799999886


Q ss_pred             CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCcccc
Q 014762          293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF  372 (419)
Q Consensus       293 ~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (419)
                      + ..++.++|+||+||++|+|++|+.|+......               ..                           ..
T Consensus       156 ~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~---------------------------~~  192 (237)
T cd05576         156 I-SEETEACDWWSLGAILFELLTGKTLVECHPSG---------------IN---------------------------TH  192 (237)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------cc---------------------------cc
Confidence            5 67899999999999999999999876211000               00                           00


Q ss_pred             ccccccCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCCCc
Q 014762          373 INADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMVISSI  412 (419)
Q Consensus       373 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~elL~hp~f  412 (419)
                      .....+..+++.++++|.+||+.||++|+|+     +++++||||
T Consensus       193 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         193 TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            0001112368899999999999999999996     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-37  Score=300.02  Aligned_cols=245  Identities=18%  Similarity=0.307  Sum_probs=191.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCC-------CcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNT-------NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~-------~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      ..+|++.+.||+|+||.||+|.+...       +..+|+|.++..    ..+.+.+|+.+++++.+||||++++++|...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            45799999999999999999986532       236899988642    2356889999999987799999999999654


Q ss_pred             CCCccEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEc
Q 014762          193 HSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~  253 (419)
                        ...++++||+++++|..++.                   .+++..+..++.|++.||+|||++|++||||||+|||++
T Consensus        91 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~  168 (334)
T cd05100          91 --GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             --CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence              67889999999999988752                   266778888999999999999999999999999999999


Q ss_pred             CCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014762          254 HELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ  329 (419)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~  329 (419)
                      .+ +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+.
T Consensus       169 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~  245 (334)
T cd05100         169 ED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPVEEL  245 (334)
T ss_pred             CC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHH
Confidence            88 78999999999765432221   11233456999999877 778999999999999999998 77776 33322222


Q ss_pred             HHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       330 ~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      ...+....                                    ..+....++.++.+++.+||+.+|++|||+.|++++
T Consensus       246 ~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         246 FKLLKEGH------------------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHcCC------------------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            22111000                                    000112367889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=306.49  Aligned_cols=241  Identities=20%  Similarity=0.400  Sum_probs=197.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCC--Cc--EEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNT--NE--RCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~--~~--~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ++.....++||.|.||.||+|....-  |+  -||||..+.    .+.+.|..|..+|+++ +||||++++|+|.+   .
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e---~  463 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE---Q  463 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeec---c
Confidence            45566778899999999999986432  33  488898864    4568899999999999 99999999999976   4


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++|||.+..|.|..+++    .++...+..++.||+.||.|||+.++|||||..+|||+.+. ..|||+|||+++.+.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADFGLSRYLE  542 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeecccchhhhcc
Confidence            5789999999999999983    58888899999999999999999999999999999999988 789999999999998


Q ss_pred             CCCcceeecc--cccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          272 PGKEYNVRVA--SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       272 ~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      .+..+....|  +..|||||.+.- ..++.++|||.|||.+||+++ |..||+ |-.+.+.+..+.+             
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfq-gvkNsDVI~~iEn-------------  607 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQ-GVKNSDVIGHIEN-------------  607 (974)
T ss_pred             ccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccc-cccccceEEEecC-------------
Confidence            7776655443  345999999754 789999999999999999987 888883 4333322211111             


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL  407 (419)
                                             -.+...++.|++.+..|+.+||.+||.+||+..++.
T Consensus       608 -----------------------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  608 -----------------------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             -----------------------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence                                   111223456999999999999999999999988764

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.5e-37  Score=288.98  Aligned_cols=245  Identities=18%  Similarity=0.370  Sum_probs=193.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++...||+|+||+||+|+...     +.+.+++|.+....    .+.+.+|+.+++++ +|+||+++++++.+  .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~   80 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCRE--A   80 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECC--C
Confidence            4678999999999999999998653     45679999886433    35688999999999 99999999999955  3


Q ss_pred             CccEEEEEecCCCChhhhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEE
Q 014762          195 KTPSLIFEYVNSTDFKVLYP------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~  262 (419)
                      ...++||||+++++|..++.            .+++..+..++.|++.||+|||+++|+|+||||+||+++.+ +.++++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~  159 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-REVKVS  159 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-CcEEEc
Confidence            66789999999999988762            47899999999999999999999999999999999999987 789999


Q ss_pred             ecccceeccCCC--cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCC
Q 014762          263 DWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGT  339 (419)
Q Consensus       263 Dfgla~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~  339 (419)
                      |||++.......  ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..........+..    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~-~~~~~~~~~~~~~----  233 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFY-GLSDEEVLNRLQA----  233 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccchHHHHHHHHc----
Confidence            999986543221  1122355667999999876 668899999999999999998 777873 2222221111110    


Q ss_pred             chHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                               ....|.      ....++..+.+++.+||+.||++|||+.++++.
T Consensus       234 -------------------------~~~~~~------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         234 -------------------------GKLELP------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             -------------------------CCcCCC------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence                                     000010      112368899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-37  Score=285.12  Aligned_cols=235  Identities=21%  Similarity=0.379  Sum_probs=185.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ++||+|+||.||+|.+.. ++.|++|.++..    ....+.+|+.+++++ +|+||+++++++.+.  ...++||||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~e~~~~   76 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQK--QPIYIVMELVPG   76 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecC--CCeEEEEEcCCC
Confidence            369999999999999877 999999988643    235788999999999 999999999999654  678899999999


Q ss_pred             CChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc---eee
Q 014762          207 TDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVR  279 (419)
Q Consensus       207 ~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~  279 (419)
                      +++..++    ..+++..+..++.|++.||+|||+++++|+||||+||+++.+ +.++|+|||+++........   ...
T Consensus        77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-CcEEEeeccccccccCCcceeccccC
Confidence            9998876    237888899999999999999999999999999999999988 78999999998765422111   112


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~  358 (419)
                      ..+..|+|||.+.+ ..++.++|+|||||++|+|++ |..|| .+.........+....                     
T Consensus       156 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~-~~~~~~~~~~~~~~~~---------------------  212 (251)
T cd05041         156 QIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPY-PGMSNQQTRERIESGY---------------------  212 (251)
T ss_pred             cceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCC-ccCCHHHHHHHHhcCC---------------------
Confidence            23456999999876 678999999999999999999 67776 3322221111111000                     


Q ss_pred             HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                     .......++.++.+++.+||+.+|++|||+.|+++
T Consensus       213 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         213 ---------------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             ---------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                           00011236789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.9e-37  Score=286.40  Aligned_cols=237  Identities=15%  Similarity=0.305  Sum_probs=189.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      ++|++.+.||+|+||.||++.  .+++.+|+|.++.. ..+.+.+|+.+++.+ +|||++++++++..   ...+++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILH---NGLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcC---CCcEEEEEC
Confidence            568999999999999999985  57888999998753 446788999999999 99999999999854   346899999


Q ss_pred             cCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCccee
Q 014762          204 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  278 (419)
Q Consensus       204 ~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~  278 (419)
                      +.++++..++.     .+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++......  ...
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~--~~~  156 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGSMG--VDN  156 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CcEEECCCccceecccc--CCC
Confidence            99999988763     37888899999999999999999999999999999999987 78999999998764322  122


Q ss_pred             ecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||. ..+..+....+.+.                     
T Consensus       157 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~---------------------  213 (254)
T cd05083         157 SKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYP-KMSLKEVKECVEKG---------------------  213 (254)
T ss_pred             CCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCc-cCCHHHHHHHHhCC---------------------
Confidence            334567999999876 678999999999999999997 888873 22222211111100                     


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                 +    .......+++.+.+++++||+.+|++|||+.+++.
T Consensus       214 -----------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         214 -----------Y----RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             -----------C----CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                       0    00011236889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.7e-37  Score=294.45  Aligned_cols=243  Identities=17%  Similarity=0.296  Sum_probs=191.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|+..+.||+|+||.||+|.+..+|.    .+|+|.+....    ...+.+|+.+++.+ +||||+++++++...  
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~--   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP--   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC--
Confidence            45678899999999999999999887776    46888886433    23678899999999 999999999998542  


Q ss_pred             CccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          195 KTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                       ..++++||+++|++..++.    .+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||+++..
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~  159 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLARLL  159 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEccccccccc
Confidence             3569999999999887763    47888999999999999999999999999999999999887 78999999999865


Q ss_pred             cCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          271 HPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       271 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ......   ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +. .......+......       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~-~~-~~~~~~~~~~~~~~-------  229 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYD-GI-PTREIPDLLEKGER-------  229 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCC-CC-CHHHHHHHHHCCCC-------
Confidence            432221   22334567999999876 778999999999999999997 888873 22 12222222110000       


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                  ......++..+.+++.+||..+|++|||+.++++
T Consensus       230 ----------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~  263 (303)
T cd05110         230 ----------------------------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAA  263 (303)
T ss_pred             ----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                        0001225778999999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.2e-37  Score=284.06  Aligned_cols=234  Identities=21%  Similarity=0.371  Sum_probs=185.0

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCC
Q 014762          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (419)
                      .||+|+||.||+|.. .++..+|+|.++...    ...+.+|+.+++.+ +||||+++++++...  ...++||||++++
T Consensus         2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~   77 (250)
T cd05085           2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQR--QPIYIVMELVPGG   77 (250)
T ss_pred             ccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecC--CccEEEEECCCCC
Confidence            689999999999975 578899999986432    24678999999999 999999999999654  5688999999999


Q ss_pred             ChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc--eeecc
Q 014762          208 DFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVA  281 (419)
Q Consensus       208 ~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~--~~~~~  281 (419)
                      ++..++.    .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.........  ....+
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceeccccccccCCCCCC
Confidence            9988763    47889999999999999999999999999999999999987 78999999998754332221  11233


Q ss_pred             cccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      +..|+|||++.+ ..++.++||||||+++|++++ |..||. +....+....+..  +.                     
T Consensus       157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~-~~~~~~~~~~~~~--~~---------------------  211 (250)
T cd05085         157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYP-GMTNQQAREQVEK--GY---------------------  211 (250)
T ss_pred             cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHHc--CC---------------------
Confidence            456999999876 678999999999999999998 888873 2222211111110  00                     


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                   .......++..+.+++.+||+.+|++|||+.|+++
T Consensus       212 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 -------------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                         00011236789999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-37  Score=289.32  Aligned_cols=233  Identities=15%  Similarity=0.217  Sum_probs=179.2

Q ss_pred             eeeeeCceEEEEEEEcCC------------------------CcEEEEEEecCcch---HHHHHHHHHHHHhcCCCCeeE
Q 014762          132 KVGRGKYSEVFEGINVNT------------------------NERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVK  184 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~~------------------------~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~  184 (419)
                      .||+|+||.||+|....+                        ...|++|++.....   ..+.+|+.+++.+ +||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence            599999999999974321                        23588998865432   4577889999998 9999999


Q ss_pred             EEeEEEccCCCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC-----
Q 014762          185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-----  255 (419)
Q Consensus       185 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~-----  255 (419)
                      +++++.+.  ...++||||+++++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++..     
T Consensus        81 ~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          81 VHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            99999654  5678999999999998776    247889999999999999999999999999999999999754     


Q ss_pred             -CCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHH-hCCCCCCCCCCCHHHHHHH
Q 014762          256 -LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-FRKEPFFYGHDNHDQLVKI  333 (419)
Q Consensus       256 -~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell-~g~~pf~~~~~~~~~~~~i  333 (419)
                       ...+|++|||++......   ....++..|+|||.+.+...++.++|||||||++|||+ +|..||... ...+. ...
T Consensus       159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~-~~~  233 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER-TPSEK-ERF  233 (274)
T ss_pred             ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc-ChHHH-HHH
Confidence             124899999987643221   22356778999998876567899999999999999985 688887422 22111 111


Q ss_pred             HHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       334 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      ...           ..                .          .....++++.++|.+||+.+|++|||+.+++++
T Consensus       234 ~~~-----------~~----------------~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEK-----------KH----------------R----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHh-----------cc----------------C----------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            000           00                0          001145679999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.6e-37  Score=287.05  Aligned_cols=240  Identities=19%  Similarity=0.291  Sum_probs=179.6

Q ss_pred             eeeeeCceEEEEEEEcC--CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecC
Q 014762          132 KVGRGKYSEVFEGINVN--TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (419)
                      +||+|+||+||+|....  ....+++|.+....    ...+.+|+.+++.+ +|+||+++++.+..  ....++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~--~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIE--SIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECC--CCceEEEEEeCC
Confidence            59999999999996433  44578888875432    24577899999998 99999999999954  467899999999


Q ss_pred             CCChhhhcCC--------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc-
Q 014762          206 STDFKVLYPT--------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-  276 (419)
Q Consensus       206 ~~~l~~~~~~--------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~-  276 (419)
                      +++|..++..        .++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++......... 
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEeccccccccccchhee
Confidence            9999887632        3567788999999999999999999999999999999988 78999999998654332211 


Q ss_pred             --eeecccccccccccccC------CCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          277 --NVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       277 --~~~~~~~~y~aPE~~~~------~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                        ....++..|+|||++..      ...++.++|||||||++|+|++ |..|| ....+.+.+..........       
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~~~~~-------  229 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSDEQVLKQVVREQDIK-------  229 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC-CcCCHHHHHHHHhhccCcc-------
Confidence              22344567999998742      2457889999999999999999 56665 3333333333322211000       


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                              +........+++.+.+++..|+ .||++|||++++++
T Consensus       230 ------------------------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         230 ------------------------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ------------------------CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                                    0000011236788999999999 59999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.2e-37  Score=286.62  Aligned_cols=240  Identities=18%  Similarity=0.237  Sum_probs=179.8

Q ss_pred             eeeeeCceEEEEEEEc--CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecC
Q 014762          132 KVGRGKYSEVFEGINV--NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (419)
                      .||+|+||.||+|...  .++..+|+|.++...    ...+.+|+.+++.+ +||||+++++++.+.  ...++||||++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~   78 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEV--TPYLLVMEFCP   78 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCC--CCcEEEEECCC
Confidence            5999999999999754  345679999886432    24678899999999 999999999999654  56789999999


Q ss_pred             CCChhhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc-
Q 014762          206 STDFKVLYP--------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-  276 (419)
Q Consensus       206 ~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~-  276 (419)
                      +++|..++.        ..++..+..++.|++.||+|||+++++|+||||+||+++.+ +.+||+|||.++........ 
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCcceee
Confidence            999988763        24566778899999999999999999999999999999987 88999999998754332221 


Q ss_pred             --eeecccccccccccccCC------CCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          277 --NVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       277 --~~~~~~~~y~aPE~~~~~------~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                        ....++..|+|||++.+.      ..++.++|+|||||++|||++ |..||... +..+...........        
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~--------  228 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL-SDEQVLTYTVREQQL--------  228 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHhhcccC--------
Confidence              223456779999998541      135789999999999999996 99898432 222221111100000        


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                             ...........++.+.+++++|+ .+|++|||++|+++
T Consensus       229 -----------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         229 -----------------------KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             -----------------------CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence                                   00000011125778999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.2e-37  Score=284.47  Aligned_cols=236  Identities=19%  Similarity=0.298  Sum_probs=187.5

Q ss_pred             eeeeeeCceEEEEEEEcC-CCc--EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          131 RKVGRGKYSEVFEGINVN-TNE--RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~-~~~--~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      +.||+|++|.||+|.+.. +++  .+|+|.++...    .+.+.+|+.+++++ +||||+++++.+.+   ...+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT---HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC---CeEEEEEEe
Confidence            368999999999998765 333  68999987543    35688999999999 99999999999865   678899999


Q ss_pred             cCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc--
Q 014762          204 VNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--  276 (419)
Q Consensus       204 ~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~--  276 (419)
                      +++++|...+.     .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||+++........  
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEecccccccccccccccee
Confidence            99999988762     47889999999999999999999999999999999999988 88999999999876442211  


Q ss_pred             --eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       277 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                        ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+....+... +.              
T Consensus       156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~-~~--------------  218 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKIDKE-GE--------------  218 (257)
T ss_pred             cccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHhc-CC--------------
Confidence              12345677999999876 678999999999999999998 998883 22222222222110 00              


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                    .+      .....++..+.+++.+||+.+|++|||+.++++
T Consensus       219 --------------~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         219 --------------RL------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             --------------cC------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                          00      001125788999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.4e-37  Score=285.14  Aligned_cols=232  Identities=17%  Similarity=0.249  Sum_probs=181.8

Q ss_pred             eeeeeeCceEEEEEEEcCCC----------cEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          131 RKVGRGKYSEVFEGINVNTN----------ERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~----------~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      +.||+|+||.||+|.+..++          ..+++|.+....  ...+.+|+.+++.+ +||||+++++++..   ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR---DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec---CCcE
Confidence            36999999999999988776          357888876433  46788999999999 89999999999865   4468


Q ss_pred             EEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC------cEEEEecccce
Q 014762          199 LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR------KLRLIDWGLAE  268 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~------~~kl~Dfgla~  268 (419)
                      +||||+.+++|..++.    .+++..+..++.|++.||+|||++||+|+||||+|||++.+..      .+||+|||++.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999999988763    5788899999999999999999999999999999999997731      69999999987


Q ss_pred             eccCCCcceeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g-~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ....   .....++..|+|||++.+. ..++.++|||||||++|+|++| ..||.. .+..+..... .  ..       
T Consensus       157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~-~~~~~~~~~~-~--~~-------  222 (259)
T cd05037         157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST-LSSSEKERFY-Q--DQ-------  222 (259)
T ss_pred             cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc-CCchhHHHHH-h--cC-------
Confidence            6543   2234566779999998763 3789999999999999999995 556532 2211111100 0  00       


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                        ...          .......+.+++.+||..+|++|||+.++++
T Consensus       223 ------------------~~~----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 ------------------HRL----------PMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             ------------------CCC----------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                              000          0012368999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.7e-37  Score=289.18  Aligned_cols=255  Identities=17%  Similarity=0.203  Sum_probs=180.5

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcch----H----------HHHHHHHHHHHhcCCCCee
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVKK----K----------KIKREIKILQNLCGGPNVV  183 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~----~----------~~~~E~~~l~~l~~h~niv  183 (419)
                      ....++|++.++||+|+||+||+|.+..+   +..+|+|+......    +          ....+...+..+ +|+|++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~   86 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIP   86 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCC
Confidence            34467899999999999999999998777   66777776432111    0          111222334455 899999


Q ss_pred             EEEeEEEccCC--CccEEEEEecCCCC--hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcE
Q 014762          184 KLLDIVRDQHS--KTPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (419)
Q Consensus       184 ~l~~~~~~~~~--~~~~lv~e~~~~~~--l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~  259 (419)
                      ++++.+.....  ...+++++++....  +.......++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~~~  165 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-NRG  165 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CcE
Confidence            99987654322  23356777665432  22223346788899999999999999999999999999999999987 789


Q ss_pred             EEEecccceeccCCC--------cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014762          260 RLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (419)
Q Consensus       260 kl~Dfgla~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~  331 (419)
                      +|+|||+|+......        ......||..|+|||+..+ ..++.++|||||||++|||++|..||.......+...
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            999999997653221        1123468999999999877 7799999999999999999999999853322222221


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      . .+.   ...... ....                         .....+++++.++++.|++.+|++||+..++++
T Consensus       245 ~-~~~---~~~~~~-~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        245 A-AKC---DFIKRL-HEGK-------------------------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             H-hHH---HHHHHh-hhhh-------------------------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1 110   000000 0000                         001125788999999999999999999999875

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.7e-37  Score=286.85  Aligned_cols=244  Identities=20%  Similarity=0.406  Sum_probs=192.6

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEecCc-------------chHHHHHHHHHHHHhcCCCCeeEEEeEEEc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV-------------KKKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (419)
                      +|++.+.||+|+||.||+|.+.. +++.+|+|.+...             ...++.+|+.++.+..+||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999877 6889999987521             123466788888764499999999999965


Q ss_pred             cCCCccEEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEe
Q 014762          192 QHSKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLID  263 (419)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~D  263 (419)
                        ....+++|||++++++..++       ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.+ +.++|+|
T Consensus        81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~-~~~~l~d  157 (269)
T cd08528          81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITD  157 (269)
T ss_pred             --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC-CcEEEec
Confidence              46789999999999987664       347889999999999999999996 789999999999999988 7899999


Q ss_pred             cccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHH
Q 014762          264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (419)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~  343 (419)
                      ||.+.............++..|++||.+.+ ..++.++|+||||+++|+|++|+.||... +.......+.+....    
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~----  231 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEAVYE----  231 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCccccc-CHHHHHHHHhhccCC----
Confidence            999987655444445578888999999976 67899999999999999999999998422 111111111110000    


Q ss_pred             HHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                     ......+++++.+++.+||+.||++|||+.|+.++
T Consensus       232 -------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         232 -------------------------------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             -------------------------------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                           00011267899999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.7e-38  Score=324.78  Aligned_cols=253  Identities=27%  Similarity=0.436  Sum_probs=189.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC-----
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-----  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-----  194 (419)
                      .++|+.+..||+||||.||+++++-+|..||||++.-.    ...++.+|+..|.+| +|||||+++..+.+...     
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCccccc
Confidence            45688899999999999999999999999999998532    335688999999999 99999999864311000     


Q ss_pred             --------------------------------------------------------------------------------
Q 014762          195 --------------------------------------------------------------------------------  194 (419)
Q Consensus       195 --------------------------------------------------------------------------------  194 (419)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------CccEEEEEecCCCChhhhcC--CC--CHHHHHHHHHHHHHHHHHHHHC
Q 014762          195 --------------------------------KTPSLIFEYVNSTDFKVLYP--TL--TDYDIRYYIYELLKALDYCHSQ  238 (419)
Q Consensus       195 --------------------------------~~~~lv~e~~~~~~l~~~~~--~l--~~~~~~~~~~qi~~~L~~LH~~  238 (419)
                                                      ..+|+-||||+..++..++.  .+  .....++++++|++||.|+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                            12456677777777666653  23  3567889999999999999999


Q ss_pred             CcEeecCCCCceEEcCCCCcEEEEecccceecc-------------------CCCcceeecccccccccccccCCC--CC
Q 014762          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------------PGKEYNVRVASRYFKGPELLVDLQ--DY  297 (419)
Q Consensus       239 ~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~--~~  297 (419)
                      |||||||||.||+++++ +.|||+|||+|+...                   +....+..+||..|+|||++.+..  .|
T Consensus       717 giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             ceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            99999999999999988 889999999997611                   111345568999999999998755  69


Q ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccc
Q 014762          298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN  377 (419)
Q Consensus       298 ~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  377 (419)
                      +.|+|+||||++++||+   .||..+.+....+..    +....         ++.+.               .+..   
T Consensus       796 n~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~----LR~g~---------iP~~~---------------~f~~---  841 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEML---YPFGTSMERASILTN----LRKGS---------IPEPA---------------DFFD---  841 (1351)
T ss_pred             cchhhhHHHHHHHHHHh---ccCCchHHHHHHHHh----cccCC---------CCCCc---------------cccc---
Confidence            99999999999999999   467322222222221    11111         11110               0000   


Q ss_pred             cCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          378 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       378 ~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                        .--+.-..+|++||+.||.+||||.|+|++.||-+
T Consensus       842 --~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  842 --PEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             --ccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence              01245679999999999999999999999999973

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=300.54  Aligned_cols=242  Identities=19%  Similarity=0.380  Sum_probs=199.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++.+....++||-|.||.||.|.++...-.||||.++..  ..++|..|+.+|+.+ .|||+|+++|+|..  ...+|+|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~--EpPFYIi  341 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTH--EPPFYII  341 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhcc--CCCeEEE
Confidence            356788899999999999999999999999999999854  457899999999999 99999999999954  4678899


Q ss_pred             EEecCCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~~-----l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      .|||..|+|.++++.     ++.-.+..++.||..||+||..+++|||||..+|+|+.++ ..||++|||+++++.. +.
T Consensus       342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-hiVKvADFGLsRlMtg-DT  419 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HIVKVADFGLSRLMTG-DT  419 (1157)
T ss_pred             EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-ceEEeeccchhhhhcC-Cc
Confidence            999999999998854     4444567889999999999999999999999999999998 8999999999998864 44


Q ss_pred             ceeeccc---ccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          276 YNVRVAS---RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       276 ~~~~~~~---~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      ++...|.   ..|.|||.+.- ..++.++|||+|||+|||+.| |-.|| .|.+-.+.+..+.+-               
T Consensus       420 YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPY-PGidlSqVY~LLEkg---------------  482 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYGLLEKG---------------  482 (1157)
T ss_pred             eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCC-CCccHHHHHHHHhcc---------------
Confidence            4444444   45999999865 789999999999999999998 55554 555544333332221               


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL  407 (419)
                                           ...+.+.-|++...+||+.||+|+|.+||+..|+-
T Consensus       483 ---------------------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  483 ---------------------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             ---------------------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence                                 11122234899999999999999999999998863

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.7e-37  Score=287.70  Aligned_cols=235  Identities=21%  Similarity=0.362  Sum_probs=184.5

Q ss_pred             eeeeeCceEEEEEEEcCCC------cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          132 KVGRGKYSEVFEGINVNTN------ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~~~------~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .||+|+||.||+|.+....      ..+|+|.+...    ....+.+|+.+++.+ +||||+++++++...  ...++||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v~   78 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLN--EPQYIIM   78 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCC--CCeEEEE
Confidence            5999999999999876433      67999987543    346788999999999 999999999999654  5688999


Q ss_pred             EecCCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC-----cEEEEeccc
Q 014762          202 EYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR-----KLRLIDWGL  266 (419)
Q Consensus       202 e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~-----~~kl~Dfgl  266 (419)
                      ||+++++|..++.          .+++..+..++.|++.||.|||+.+++|+||||+||+++.+ +     .++|+|||+
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~~~~~~l~dfg~  157 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEK-GYDADRVVKIGDFGL  157 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecC-CCCCCcceEECCccc
Confidence            9999999988762          26778899999999999999999999999999999999986 4     799999999


Q ss_pred             ceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchH
Q 014762          267 AEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDEL  342 (419)
Q Consensus       267 a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~  342 (419)
                      ++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. ..++.+....+.. .+.   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~-~~~---  231 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYP-ALNNQEVLQHVTA-GGR---  231 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCc-ccCHHHHHHHHhc-CCc---
Confidence            8755332211   12244567999999877 678999999999999999998 888873 2222222211110 000   


Q ss_pred             HHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                      ......+++.+.+++.+||+.+|++|||+.++++
T Consensus       232 --------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 --------------------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             --------------------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                            0001236788999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.1e-36  Score=280.72  Aligned_cols=241  Identities=16%  Similarity=0.232  Sum_probs=177.9

Q ss_pred             eeeeeCceEEEEEEEcCC--CcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecC
Q 014762          132 KVGRGKYSEVFEGINVNT--NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~~--~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (419)
                      +||+|+||+||+|....+  ...+++|.++..    ..+.+.+|+.+++.+ +||||+++++.|.+.  ...++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEA--IPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCC--CccEEEEecCC
Confidence            599999999999975433  335667776532    235788999999999 999999999999654  67889999999


Q ss_pred             CCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC---c
Q 014762          206 STDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---E  275 (419)
Q Consensus       206 ~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~---~  275 (419)
                      +++|..++.       ..++..+..++.|++.||+|||+.+++|+||||+|||++.+ +.++|+|||++.......   .
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccccCcchhhhc
Confidence            999988763       24566778899999999999999999999999999999987 789999999985432111   1


Q ss_pred             ceeecccccccccccccC------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          276 YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      .....++..|+|||++..      ...++.++|||||||++|||+++..+.+...++.+.+..+...-..          
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~----------  227 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV----------  227 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc----------
Confidence            123456788999998743      1245789999999999999998644333444443333332211000          


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                           ..........+++.+.+++..|| .+|++|||++++++
T Consensus       228 ---------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         228 ---------------------KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ---------------------ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                                 00000011126788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=302.39  Aligned_cols=255  Identities=24%  Similarity=0.422  Sum_probs=209.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEc---cCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRD---QHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~~~  197 (419)
                      ..+.|++.+.||.|.+|.||++..+.+++.+|+|++...  ..++++.|.++++.++.|||++.++|+|.-   ..+..+
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            467899999999999999999999999999999998754  457788899999999999999999998863   244678


Q ss_pred             EEEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      +||||||++|+..++.+     .+.|+.+..|++.++.||.+||.+.++|||||-.|||+..+ +.|||+|||.+.....
T Consensus        97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e-~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc-CcEEEeeeeeeeeeec
Confidence            99999999999988874     47888899999999999999999999999999999999999 8899999999866543


Q ss_pred             C-CcceeecccccccccccccCC----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          273 G-KEYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       273 ~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      . ...++..||++|||||++...    ..|+..+|+||||++..||--|..|+..-    .-+..+..+...        
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm----HPmraLF~IpRN--------  243 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM----HPMRALFLIPRN--------  243 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc----chhhhhccCCCC--------
Confidence            2 334567999999999998542    35788999999999999999999998311    111111111111        


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                                          +.......   +.-+.++.+||..||..|.++||+..++|+|||.+
T Consensus       244 --------------------PPPkLkrp---~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  244 --------------------PPPKLKRP---KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             --------------------CCccccch---hhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence                                11111111   12478899999999999999999999999999987

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-36  Score=283.58  Aligned_cols=242  Identities=18%  Similarity=0.338  Sum_probs=186.4

Q ss_pred             eEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC----
Q 014762          127 YEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----  194 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  194 (419)
                      |.+.+.||+|+||+||+|.+.   .++..+|+|++...     ..+.+.+|+.+++.+ +||||+++++++.....    
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence            566788999999999999854   35789999998642     235678999999999 89999999998864322    


Q ss_pred             CccEEEEEecCCCChhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecc
Q 014762          195 KTPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfg  265 (419)
                      ...++++||+.++++..++         ..+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg  158 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFG  158 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECccc
Confidence            2347889999999987654         136888899999999999999999999999999999999977 789999999


Q ss_pred             cceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCch
Q 014762          266 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDE  341 (419)
Q Consensus       266 la~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~  341 (419)
                      +++........   ....++..|++||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+... ..  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~-~~--  233 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPY-AGVENSEIYNYLIKG-NR--  233 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCC-CCCCHHHHHHHHHcC-Cc--
Confidence            98865432211   12234567999999876 678999999999999999999 67776 333322222111110 00  


Q ss_pred             HHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                       .......++.+.+++.+||+.+|++|||+.++++
T Consensus       234 ---------------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         234 ---------------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             ---------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                             0001125788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-37  Score=286.01  Aligned_cols=265  Identities=20%  Similarity=0.263  Sum_probs=196.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHh-cCCCCeeEEEeEEEccC--CCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQH--SKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~--~~~~~lv  200 (419)
                      ....++.+.||+|.||.||+|+.  +++.||||++....++.+.+|-+|++.. ..|+||+++++.-....  ...++||
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            55667788999999999999954  5699999999999999999998888754 28999999999865332  3468899


Q ss_pred             EEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHH---------CCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS---------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~---------~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      ++|.+.|+|.+++.  .++|.+..+++..+++||+|||+         ..|+|||||++|||+..| .++.|+|||+|..
T Consensus       287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFGLAl~  365 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFGLALR  365 (534)
T ss_pred             eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccceeEE
Confidence            99999999999984  59999999999999999999995         269999999999999999 8999999999988


Q ss_pred             ccCCCcc---eeecccccccccccccCCCCCC-----ccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCC-c
Q 014762          270 YHPGKEY---NVRVASRYFKGPELLVDLQDYD-----YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-D  340 (419)
Q Consensus       270 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~-----~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~-~  340 (419)
                      +.++...   ...+||..|||||++.+...+.     .+.||||+|.+||||++...-++.+..++-++.- .+.+|. |
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf-e~evG~hP  444 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF-EAEVGNHP  444 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch-hHHhcCCC
Confidence            7765432   3478999999999997744444     4699999999999999977665443322222211 112222 2


Q ss_pred             hHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014762          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  406 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el  406 (419)
                      .+....           ........+..|+....   .+.--..+++.+..||..||+.|.||.-+
T Consensus       445 t~e~mq-----------~~VV~kK~RP~~p~~W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  445 TLEEMQ-----------ELVVRKKQRPKIPDAWR---KHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             CHHHHH-----------HHHHhhccCCCChhhhh---cCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            221111           00001111111111111   01134568899999999999999999754

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-39  Score=281.02  Aligned_cols=257  Identities=20%  Similarity=0.325  Sum_probs=205.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .++.+.+..||.|+||+|++..++.+|+..|||.++.    .+.+++..|.+...+-.+.||||+++|.+-.+  +.-++
T Consensus        63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcWi  140 (361)
T KOG1006|consen   63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCWI  140 (361)
T ss_pred             cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--Cceee
Confidence            4556668889999999999999999999999999863    23467888888877777899999999987554  34568


Q ss_pred             EEEecCCCChhhhc--------CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          200 IFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       200 v~e~~~~~~l~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      .||.|.-. ++.+.        ..+++..+-.+......||+||-+ .+|||||+||+|||++.. |.+||||||.+..+
T Consensus       141 CMELMd~S-lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  141 CMELMDIS-LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKLCDFGICGQL  218 (361)
T ss_pred             eHHHHhhh-HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEeeecccchHhH
Confidence            89999754 33332        458888888888889999999975 689999999999999988 89999999999777


Q ss_pred             cCCCcceeecccccccccccccCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ..+-..+...|...|+|||-+..... |+.+||+||||++|+|+.||..|+....+-.+|+.+++.  |.++.       
T Consensus       219 v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~-------  289 (361)
T KOG1006|consen  219 VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPI-------  289 (361)
T ss_pred             HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCe-------
Confidence            66666677789999999999865444 999999999999999999999998544444444443322  32221       


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                            +......-+.+..+..|+.-||..|-+.||.-.+++++||++..
T Consensus       290 ----------------------l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  290 ----------------------LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             ----------------------ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence                                  11111122478899999999999999999999999999998754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.6e-36  Score=330.52  Aligned_cols=253  Identities=20%  Similarity=0.311  Sum_probs=187.8

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecC
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (419)
                      .|...+.||+|+||.||+|.+..++..||+|.++.... ....|+.+++++ +||||++++++|.+.  ...++||||++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l-~HpnIv~~~~~~~~~--~~~~lv~Ey~~  766 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKL-QHPNIVKLIGLCRSE--KGAYLIHEYIE  766 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhC-CCCCcceEEEEEEcC--CCCEEEEeCCC
Confidence            45667789999999999999989999999999864332 234678999999 999999999999664  56789999999


Q ss_pred             CCChhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeeccc
Q 014762          206 STDFKVLYPTLTDYDIRYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS  282 (419)
Q Consensus       206 ~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  282 (419)
                      +++|.+++..+++..+..++.|++.||+|||   +.+|+||||||+||+++.+ +..++. ||........   ....++
T Consensus       767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~~---~~~~~t  841 (968)
T PLN00113        767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCTD---TKCFIS  841 (968)
T ss_pred             CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-eccccccccC---CCcccc
Confidence            9999999999999999999999999999999   6699999999999999987 555654 6655432211   223678


Q ss_pred             ccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-cCCchHHHHHhhcCCCCChhhHHhh
Q 014762          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV-LGTDELNAYLNKYHLELDPQLDALV  361 (419)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~-lg~~~~~~~~~~~~~~~~~~~~~~~  361 (419)
                      ..|+|||++.+ ..++.++|||||||++|||++|+.||...........+..+. ........+       .++..    
T Consensus       842 ~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~----  909 (968)
T PLN00113        842 SAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW-------IDPSI----  909 (968)
T ss_pred             ccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe-------eCccc----
Confidence            89999999876 789999999999999999999999984332222222221111 000000000       00000    


Q ss_pred             ccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          362 GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                          ....      ........++.+++.+||+.||++|||+.|+++.
T Consensus       910 ----~~~~------~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        910 ----RGDV------SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ----cCCC------CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence                0000      0000122357799999999999999999999873

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.6e-36  Score=297.36  Aligned_cols=266  Identities=19%  Similarity=0.297  Sum_probs=182.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc----------------CCCcEEEEEEecCcc---hHH--------------HHHH
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV----------------NTNERCIIKILKPVK---KKK--------------IKRE  169 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~----------------~~~~~vavK~~~~~~---~~~--------------~~~E  169 (419)
                      ..++|++.++||+|+||+||+|.+.                ..++.||||.++...   .++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3778999999999999999999753                245679999986322   122              3346


Q ss_pred             HHHHHHhcCCCC-----eeEEEeEEEcc------CCCccEEEEEecCCCChhhhcC------------------------
Q 014762          170 IKILQNLCGGPN-----VVKLLDIVRDQ------HSKTPSLIFEYVNSTDFKVLYP------------------------  214 (419)
Q Consensus       170 ~~~l~~l~~h~n-----iv~l~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~------------------------  214 (419)
                      +.++.++ .|.+     +++++++|...      .....+|||||+++++|.+++.                        
T Consensus       223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            7777777 4544     46777877532      1245789999999999877652                        


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCccee--ecccccccccc
Q 014762          215 ---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPE  289 (419)
Q Consensus       215 ---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~--~~~~~~y~aPE  289 (419)
                         .+++..++.++.|++.||.|||+.+|+||||||+|||++.+ +.+||+|||++...........  ..+++.|+|||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence               12456678899999999999999999999999999999988 7899999999976543332222  23478899999


Q ss_pred             cccCCCC-------------------C--CccccHHHHHHHHHHHHhCCC-CCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          290 LLVDLQD-------------------Y--DYSLDMWSLGCMFAGMIFRKE-PFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       290 ~~~~~~~-------------------~--~~~~DiwSlG~~l~ell~g~~-pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      .+.....                   +  ..+.|+||+||++++|++|.. ||...    .......+.... ....|  
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~----~~f~~~~~~~~~-~~~~~--  453 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI----RLFNTELRQYDN-DLNRW--  453 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch----hhhhhHHhhccc-hHHHH--
Confidence            9754211                   1  124799999999999999876 55211    111110010000 00000  


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCC---CCCCCHHHHhcCCCcccc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH---QDRLTAREAMVISSISPI  415 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~Rpta~elL~hp~f~~~  415 (419)
                                +...    ...    .........++...||+++||..+|   .+|+|++|+|+||||.+.
T Consensus       454 ----------r~~~----~~~----~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        454 ----------RMYK----GQK----YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             ----------Hhhc----ccC----CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence                      0000    000    0111123478999999999999866   689999999999999763

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=297.21  Aligned_cols=251  Identities=24%  Similarity=0.411  Sum_probs=214.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..+++.+..||-||||.|=++........+|+|++++.      ..+.+..|-.||..+ ..|.||++|..|.+  +++.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd--~kyv  495 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD--SKYV  495 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc--chhh
Confidence            45667788899999999998876555556889988642      235677899999998 79999999999965  4889


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      |++||.|-||.+...+   ..|++...+.++..+++|++|||++|||+|||||+|.+++.+ |-+||.|||.|+.+..+.
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhccCC
Confidence            9999999999998887   469999999999999999999999999999999999999998 899999999999999999


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      .+...+||+.|.|||++++ +..+.++|.||||+++|||++|..|| ++.++......|.+-+..  +            
T Consensus       575 KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPF-s~~dpmktYn~ILkGid~--i------------  638 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPF-SGVDPMKTYNLILKGIDK--I------------  638 (732)
T ss_pred             ceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHhhhhh--h------------
Confidence            9999999999999999999 78899999999999999999999998 566665555555542211  1            


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                           ..+..++....+||+++-+.+|.+|..     +.++-+|.||.++
T Consensus       639 ---------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  639 ---------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             ---------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence                                 111236788999999999999999995     8999999999875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=275.02  Aligned_cols=252  Identities=26%  Similarity=0.453  Sum_probs=206.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|.+++.||+|+|++|.+++.+.|.+.+|+|++++.-      .+=...|-.+.....+||.+|-++.+|.  ....+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq--tesrl  326 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ--TESRL  326 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc--ccceE
Confidence            578999999999999999999999999999999987421      1224567777777779999999999994  44778


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec-cCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~-~~~  273 (419)
                      +.|.||++||+|....   ++++++.++.+..+|+.||.|||++||++||||.+|+|+|.+ +.+||.|+|+++.. .++
T Consensus       327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-CceeecccchhhcCCCCC
Confidence            8999999999986655   579999999999999999999999999999999999999999 89999999999764 455


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCCCH-----HHHHHHHHHcCCchHHHHHh
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY-GHDNH-----DQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~-~~~~~-----~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ..+...+||+.|.|||++.+ ..|++++|.|+|||+++||+.|+.||.- |.++.     +.+-+++-            
T Consensus       406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil------------  472 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL------------  472 (593)
T ss_pred             cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh------------
Confidence            66677899999999999988 8999999999999999999999999942 22221     11111110            


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC------CHHHHhcCCCcccc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL------TAREAMVISSISPI  415 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------ta~elL~hp~f~~~  415 (419)
                                    .+-          ...+..+|-.+..+++..|+.||.+|.      ...++-.|+||+.+
T Consensus       473 --------------ekq----------iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i  522 (593)
T KOG0695|consen  473 --------------EKQ----------IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI  522 (593)
T ss_pred             --------------hhc----------ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence                          000          001112566788899999999999998      46789999999976

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-37  Score=297.26  Aligned_cols=246  Identities=19%  Similarity=0.302  Sum_probs=199.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCC-Cc--EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNT-NE--RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~--~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .++..+.++||+|+||.|++|.+... |+  .||||.++..    ....|.+|+.+|.+| +|+|++++||++.+   ..
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~---qp  184 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD---QP  184 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc---ch
Confidence            45677788999999999999987653 33  5899999753    357899999999999 99999999999976   45


Q ss_pred             cEEEEEecCCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          197 PSLIFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~-----l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..+|+|.+..|+|.+.+..     |....+..++.||+.||.||.++++|||||..+|+|+-.. ..|||||||+.+.+.
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKICDFGLMRALG  263 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeeecccceeccC
Confidence            6799999999999887743     7778889999999999999999999999999999999887 789999999999887


Q ss_pred             CCCcceeec----ccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          272 PGKEYNVRV----ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       272 ~~~~~~~~~----~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .+..+....    -...|.|||.+.. ..++.++|||+|||++|||++ |..|| .|....+.+..+-+.          
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW-~G~~g~qIL~~iD~~----------  331 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPW-VGCRGIQILKNIDAG----------  331 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCC-CCCCHHHHHHhcccc----------
Confidence            665543222    2334999999876 789999999999999999999 55565 666666555544210          


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                                .....++.|++++.+++..||..+|++|||+..+.+.-++
T Consensus       332 --------------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  332 --------------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             --------------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence                                      0111234589999999999999999999999988654433

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=7.2e-35  Score=265.80  Aligned_cols=237  Identities=34%  Similarity=0.593  Sum_probs=193.8

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhh
Q 014762          137 KYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL  212 (419)
Q Consensus       137 ~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~  212 (419)
                      +||.||+|.+..+++.+++|++....    .+.+.+|+..++++ +|+|++++++.+...  ...++++||++++++..+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence            58999999998889999999997543    57889999999999 999999999999654  677899999999999887


Q ss_pred             cCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeecccccccccc
Q 014762          213 YPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE  289 (419)
Q Consensus       213 ~~~---l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE  289 (419)
                      +..   +++..+..++.+++.++.|||+.+++|+||+|+||+++.+ +.++|+|||.+.............++..|++||
T Consensus        78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE  156 (244)
T smart00220       78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPE  156 (244)
T ss_pred             HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCCCHH
Confidence            633   7889999999999999999999999999999999999988 889999999998776544445567788899999


Q ss_pred             cccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCc
Q 014762          290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPW  369 (419)
Q Consensus       290 ~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (419)
                      ...+ ..++.++|+||||++++++++|..||....+.......+.+    ....                         .
T Consensus       157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~----~~~~-------------------------~  206 (244)
T smart00220      157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK----PKPP-------------------------F  206 (244)
T ss_pred             HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc----cCCC-------------------------C
Confidence            9876 67889999999999999999999998543222222111111    0000                         0


Q ss_pred             cccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          370 SKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       370 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                           ......++.++.+++.+||..+|++|||+.++++||||
T Consensus       207 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      207 -----PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             -----ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence                 00000157889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-36  Score=297.29  Aligned_cols=244  Identities=24%  Similarity=0.342  Sum_probs=186.6

Q ss_pred             eEEEeeeeeeCceE-EEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecC
Q 014762          127 YEVVRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (419)
Q Consensus       127 y~~~~~lG~G~fg~-V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (419)
                      |.-.+.+|.|+.|+ ||+|..  .|+.||||.+-....+-..+||..|+.-..||||+++++.-.  +..+.|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~--d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQ--DRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeecc--CCceEEEEehHhh
Confidence            34455689999997 599964  688999999987777888999999999889999999998774  4578899999987


Q ss_pred             CCChhhhcCC-------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC---C-CCcEEEEecccceeccCCC
Q 014762          206 STDFKVLYPT-------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---E-LRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       206 ~~~l~~~~~~-------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~---~-~~~~kl~Dfgla~~~~~~~  274 (419)
                      . +|++++..       ......+..+.|++.||++||+.+||||||||.||||+.   + ..+++|+|||+++.+..+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            4 44555432       122345778899999999999999999999999999986   2 3578999999999887654


Q ss_pred             cc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          275 EY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       275 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g-~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ..    ....||.+|+|||++.. ..-+.++||||+||++|+.++| .+||..   ..++-..|..  |...+.      
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd---~~~R~~NIl~--~~~~L~------  733 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGD---SLERQANILT--GNYTLV------  733 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCc---hHHhhhhhhc--Ccccee------
Confidence            43    33578899999999987 5567799999999999999986 889831   1222111211  110000      


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                                           .   ...  ....++.|||.+|+..||..||||.++|.||||=
T Consensus       734 ---------------------~---L~~--~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  734 ---------------------H---LEP--LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             ---------------------e---ecc--CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence                                 0   000  0112789999999999999999999999999984

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-35  Score=246.93  Aligned_cols=210  Identities=20%  Similarity=0.393  Sum_probs=178.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++...+..||+|++|.|=+.++..+|...|+|.+..    +..++..+|+.+..+...+|.+|.++|...++  ...+
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvw  121 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVW  121 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEE
Confidence            35666778889999999999999999999999999853    34567788999888777899999999977554  5567


Q ss_pred             EEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      +.||.|... +..+.       ...++..+-+|+..+..||.|||++ .++|||+||+|||++.+ |+||+||||.+-.+
T Consensus       122 IcME~M~tS-ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  122 ICMELMDTS-LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKICDFGISGYL  199 (282)
T ss_pred             EeHHHhhhh-HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEcccccceee
Confidence            889998743 44433       3488999999999999999999975 89999999999999999 99999999999888


Q ss_pred             cCCCcceeecccccccccccccC---CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH
Q 014762          271 HPGKEYNVRVASRYFKGPELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV  336 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~  336 (419)
                      .++-..+...|...|+|||.+..   ...|+.++||||||+++.||.+++.||.+..++.+++.++++.
T Consensus       200 ~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  200 VDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             hhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence            76666666788899999998843   2479999999999999999999999999999999999888763

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=285.41  Aligned_cols=241  Identities=20%  Similarity=0.340  Sum_probs=191.5

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEec----CcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILK----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ......++||+|+||+||+|.+...|+    +||+|++.    ++...++.+|+.+|.++ +|||+++++++|...   .
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s---~  771 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS---T  771 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc---h
Confidence            345557789999999999999876665    57888874    23457899999999999 999999999999653   3


Q ss_pred             cEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      +.||++||++|.|.++.    .++.......+..||++||.|||++++|||||..+|||+..- ..+||.|||+++...+
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccCc
Confidence            77999999999998886    458888899999999999999999999999999999999987 7899999999998876


Q ss_pred             CCcc-eee--cccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          273 GKEY-NVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       273 ~~~~-~~~--~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      .... ...  ...+.|+|-|.+.. ..|+.++|||||||++||++| |..|++ +....+.-.             .++.
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~-gi~~~eI~d-------------lle~  915 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYD-GIPAEEIPD-------------LLEK  915 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccC-CCCHHHhhH-------------HHhc
Confidence            5443 222  23445999999877 789999999999999999998 888873 222221111             1110


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      .            .+           ...+..++-++.-+|-+||-.|+..||+++++-.
T Consensus       916 g------------eR-----------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  916 G------------ER-----------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             c------------cc-----------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            0            00           1112337889999999999999999999998754

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=285.57  Aligned_cols=244  Identities=23%  Similarity=0.416  Sum_probs=193.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc----C---CCcEEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV----N---TNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~----~---~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      .++..+.+.||+|.||.|++|.-.    .   ....||||.++.    ...+.+..|+.+|+.+..|+||+.++|.|.. 
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-  373 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-  373 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence            344466779999999999999632    1   245799999864    2356789999999999889999999999976 


Q ss_pred             CCCccEEEEEecCCCChhhhc--CC-----------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEc
Q 014762          193 HSKTPSLIFEYVNSTDFKVLY--PT-----------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~--~~-----------------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~  253 (419)
                       ....++|+||+..|+|..++  ..                 ++..++..++.||+.|++||++.++|||||..+|||+.
T Consensus       374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT  452 (609)
T ss_pred             -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence             57788999999999998876  23                 78889999999999999999999999999999999999


Q ss_pred             CCCCcEEEEecccceeccCCCcceee--c--ccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCC-CH
Q 014762          254 HELRKLRLIDWGLAEFYHPGKEYNVR--V--ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHD-NH  327 (419)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~--~--~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~-~~  327 (419)
                      .+ ..+||+|||+|+.......+...  .  -...|||||.+.. ..|+.++||||||++|||+++ |..|| .+.. ..
T Consensus       453 ~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PY-p~~~~~~  529 (609)
T KOG0200|consen  453 KN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPY-PGIPPTE  529 (609)
T ss_pred             CC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCC-CCCCcHH
Confidence            98 78999999999976655554322  2  2334999999988 789999999999999999999 55565 4322 22


Q ss_pred             HHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 014762          328 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (419)
Q Consensus       328 ~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL  407 (419)
                      +. .+..+. |                                  ...+.+..+++++.++|+.||+.+|++||+..++.
T Consensus       530 ~l-~~~l~~-G----------------------------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  530 EL-LEFLKE-G----------------------------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             HH-HHHHhc-C----------------------------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            22 111110 0                                  01112345899999999999999999999999886


Q ss_pred             c
Q 014762          408 V  408 (419)
Q Consensus       408 ~  408 (419)
                      +
T Consensus       574 ~  574 (609)
T KOG0200|consen  574 E  574 (609)
T ss_pred             H
Confidence            5

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-34  Score=264.52  Aligned_cols=195  Identities=20%  Similarity=0.308  Sum_probs=160.4

Q ss_pred             eeccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHh-cCCCCeeEEEeEEEccC--C
Q 014762          118 TVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQH--S  194 (419)
Q Consensus       118 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~--~  194 (419)
                      -++-....+.++.+.||+|.||.||+|.+  .|+.||||++...+...+.+|.+|++.. -+|+||+.+++.=..++  .
T Consensus       204 LVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  204 LVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             HhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            34444467899999999999999999966  5889999999987888899999988853 39999999987643222  2


Q ss_pred             CccEEEEEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHH--------CCcEeecCCCCceEEcCCCCcEEEEec
Q 014762          195 KTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS--------QGIMHRDVKPHNVMIDHELRKLRLIDW  264 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~--------~~ivH~Dlk~~NILl~~~~~~~kl~Df  264 (419)
                      -.++||.+|.+.|+|.+++.  .++.....+++..++.||++||.        ..|.|||||+.|||+..+ +.+-|+|+
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IADL  360 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADL  360 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEeec
Confidence            34789999999999999984  58889999999999999999994        259999999999999999 89999999


Q ss_pred             ccceeccCCC-----cceeecccccccccccccCCCC---CC--ccccHHHHHHHHHHHHh
Q 014762          265 GLAEFYHPGK-----EYNVRVASRYFKGPELLVDLQD---YD--YSLDMWSLGCMFAGMIF  315 (419)
Q Consensus       265 gla~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~---~~--~~~DiwSlG~~l~ell~  315 (419)
                      |+|.......     ..+.++||..|||||++-..-.   ++  ..+||||||.++||+..
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            9997655432     2466899999999999854211   11  36899999999999864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=8.7e-34  Score=274.46  Aligned_cols=255  Identities=26%  Similarity=0.436  Sum_probs=203.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      -+++|+.+..+|.|.+|.||+++|+.+++..|+|+++-   ...+.+.+|+-+++.. +||||+.++|.+...  ...++
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr~--dklwi   89 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRR--DKLWI   89 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhhh--cCcEE
Confidence            37889999999999999999999999999999999873   3346677899999997 999999999988544  55679


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Cc
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~  275 (419)
                      .||||++|++++..   ..+++.++....++.++||+|||+.|-+|||||-.|||+++. +.+|++|||.+-.+... ..
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhhhhhhh
Confidence            99999999999876   568999999999999999999999999999999999999988 89999999987544322 12


Q ss_pred             ceeeccccccccccccc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 YNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .....||++|||||+-.  ....|...+|||++|+...|+-....|.|.-+ ....+..|.+ -|.             .
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-pmr~l~LmTk-S~~-------------q  233 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-PMRALFLMTK-SGF-------------Q  233 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-hHHHHHHhhc-cCC-------------C
Confidence            23468999999999963  22578999999999999999988887764211 1111111211 111             1


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      ++.++                  ..+.-++.+-+|++.+|..+|++|||++.+|+|||...
T Consensus       234 pp~lk------------------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  234 PPTLK------------------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             CCccc------------------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            11111                  12234778999999999999999999999999999764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-31  Score=242.25  Aligned_cols=244  Identities=18%  Similarity=0.320  Sum_probs=191.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      +++++....+-+|.||.||.|.+...     .+.|.+|.++..    ....+..|...+..+ .|||+.++.+++..+. 
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~-  360 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDY-  360 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeecc-
Confidence            67889999999999999999965532     334556666532    234577888888888 7999999999987653 


Q ss_pred             CccEEEEEecCCCChhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEe
Q 014762          195 KTPSLIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLID  263 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~-----------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~D  263 (419)
                      ..++.+|.+++-|+|..++.           .++..++..++.|++.|++|||++|+||.||..+|+++|+. -++||+|
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVkltD  439 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKLTD  439 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEecc
Confidence            66788999999999998873           36777888899999999999999999999999999999988 7999999


Q ss_pred             cccceeccCCCcce---eecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCC
Q 014762          264 WGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGT  339 (419)
Q Consensus       264 fgla~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~  339 (419)
                      =.+++..-+.+...   ..-.+..||+||.+.+ ..|+.++|+|||||+||||+| |+.|+ ..-++.|. ..+.+    
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~Py-aeIDPfEm-~~ylk----  512 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPY-AEIDPFEM-EHYLK----  512 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCc-cccCHHHH-HHHHh----
Confidence            99998776655431   1233456999999988 889999999999999999998 77786 22232222 21111    


Q ss_pred             chHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                             ..+.+                        ..+.++++++...|..||..+|++||+.+|+..
T Consensus       513 -------dGyRl------------------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  513 -------DGYRL------------------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -------cccee------------------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence                   01111                        112348999999999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.3e-29  Score=225.48  Aligned_cols=205  Identities=32%  Similarity=0.602  Sum_probs=179.3

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcch----HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCC
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD  208 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~  208 (419)
                      ||+|++|.||++.+..+++.+++|++.....    +.+.+|+..++.+ .|++++++++++...  ...++++|++.+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDE--NHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence            6899999999999888899999999986654    6899999999999 899999999999654  67789999999999


Q ss_pred             hhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC-CCCcEEEEecccceeccCCC-cceeeccc
Q 014762          209 FKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGK-EYNVRVAS  282 (419)
Q Consensus       209 l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~-~~~~~kl~Dfgla~~~~~~~-~~~~~~~~  282 (419)
                      +..++.    .++...+..++.+++.++.+||+.|++|+||+|.||+++. + +.++|+|||.+....... ......+.
T Consensus        78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~  156 (215)
T cd00180          78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDN-GKVKLADFGLSKLLTSDKSLLKTIVGT  156 (215)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCC-CcEEEecCCceEEccCCcchhhcccCC
Confidence            988873    4789999999999999999999999999999999999998 5 789999999997665432 12335677


Q ss_pred             ccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhc
Q 014762          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG  362 (419)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  362 (419)
                      ..|.+||.......++.++|+|++|++++++                                                 
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------------  187 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------------  187 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence            7899999987633788999999999999998                                                 


Q ss_pred             cCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014762          363 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVIS  410 (419)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp  410 (419)
                                          ..+.+++.+|++.||++|||+.++++|+
T Consensus       188 --------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                1477999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=254.14  Aligned_cols=195  Identities=26%  Similarity=0.493  Sum_probs=168.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-----------HHHHHHHHHHHHhc--CCCCeeEEEeEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------KKIKREIKILQNLC--GGPNVVKLLDIVR  190 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~E~~~l~~l~--~h~niv~l~~~~~  190 (419)
                      ..+|..+..+|.|+||.|+.|.++.....|+||.+.+++.           -..-.||.||..+.  .|+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            4579999999999999999999999999999999875431           23457999999992  3999999999996


Q ss_pred             ccCCCccEEEEEecCC-CChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          191 DQHSKTPSLIFEYVNS-TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       191 ~~~~~~~~lv~e~~~~-~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ++  .++||+||--.. -+|.+++   +++++.++..|.+|+..|+++||+.||||||||-+|+.++.+ |-+||+|||.
T Consensus       640 dd--d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~-g~~klidfgs  716 (772)
T KOG1152|consen  640 DD--DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN-GFVKLIDFGS  716 (772)
T ss_pred             cC--CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecC-CeEEEeeccc
Confidence            64  788999997644 4666665   679999999999999999999999999999999999999999 8999999999


Q ss_pred             ceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 014762          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY  322 (419)
Q Consensus       267 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~  322 (419)
                      |.... +.......||..|.|||++-+.+..+..-|||++|++||.++....||++
T Consensus       717 aa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            86543 44556689999999999998866668889999999999999999999863

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-31  Score=231.15  Aligned_cols=257  Identities=19%  Similarity=0.330  Sum_probs=191.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC--cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .+.|.+.+.||+|.||.+-+|.++.++..+++|.+..  ...++|.+|...--.|..|.||+.-|+..- +....++.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEee
Confidence            5779999999999999999999999999999999864  345788899877666778999998776432 3346788999


Q ss_pred             EecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE-cCCCCcEEEEecccceeccCCCccee
Q 014762          202 EYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNV  278 (419)
Q Consensus       202 e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl-~~~~~~~kl~Dfgla~~~~~~~~~~~  278 (419)
                      ||++.|+|..-..  .+.+...+.++.|++.|++|||++++||||||.+|||+ +.+..++||||||+++..+.  ....
T Consensus       102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--tV~~  179 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--TVKY  179 (378)
T ss_pred             ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--eehh
Confidence            9999999988774  58888899999999999999999999999999999997 55556899999999875431  1122


Q ss_pred             ecccccccccccccCCC----CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          279 RVASRYFKGPELLVDLQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~----~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      .-.+..|-+||+.....    ..++.+|+|.||+++|.+++|..||...........+..+         |..+.....+
T Consensus       180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~---------w~~rk~~~~P  250 (378)
T KOG1345|consen  180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ---------WLKRKNPALP  250 (378)
T ss_pred             hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH---------HhcccCccCc
Confidence            23445588998874321    2467899999999999999999999533222222222221         1111111111


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCCCcc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR---LTAREAMVISSIS  413 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pta~elL~hp~f~  413 (419)
                      ..+                     ..+++.+..++++-|..++++|   -++.......|-.
T Consensus       251 ~~F---------------------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  251 KKF---------------------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             hhh---------------------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            111                     1278899999999999999999   5666655555543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=7e-29  Score=224.04  Aligned_cols=192  Identities=33%  Similarity=0.646  Sum_probs=166.9

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      |.+.+.||.|++|+||++.+..+++.+++|.+...    ..+.+.+|+..++.+ +|+|++++++++...  ...++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~--~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDP--EPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecC--CceEEEEe
Confidence            56788999999999999999888999999999754    456788999999999 899999999998654  66789999


Q ss_pred             ecCCCChhhhcC---C-CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC--cc
Q 014762          203 YVNSTDFKVLYP---T-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EY  276 (419)
Q Consensus       203 ~~~~~~l~~~~~---~-l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~--~~  276 (419)
                      ++.++++..++.   . +++..+..++.+++.++.+||+.+++|+||++.||+++.+ +.++|+|||.+.......  ..
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccccc
Confidence            999999988863   2 7889999999999999999999999999999999999988 889999999998765443  33


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY  322 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~  322 (419)
                      ....++..|++||...+...++.++|+||||+++++|++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            4456778899999873336788899999999999999999999943

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1e-29  Score=270.56  Aligned_cols=197  Identities=14%  Similarity=0.173  Sum_probs=140.8

Q ss_pred             CC-CCeeEEEeEEEcc-----CCCccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCC
Q 014762          178 GG-PNVVKLLDIVRDQ-----HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP  247 (419)
Q Consensus       178 ~h-~niv~l~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~  247 (419)
                      .| +||++++++|...     ....+++++||+. ++|..++.    .+++..+..++.||+.||+|||++||+||||||
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP  108 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP  108 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence            44 5888888887321     1245677888875 47777773    389999999999999999999999999999999


Q ss_pred             CceEEcCC------------------CCcEEEEecccceeccCCC-----------------cceeeccccccccccccc
Q 014762          248 HNVMIDHE------------------LRKLRLIDWGLAEFYHPGK-----------------EYNVRVASRYFKGPELLV  292 (419)
Q Consensus       248 ~NILl~~~------------------~~~~kl~Dfgla~~~~~~~-----------------~~~~~~~~~~y~aPE~~~  292 (419)
                      +|||++..                  ...+|++|||+++......                 ......+|++|+|||++.
T Consensus       109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  188 (793)
T PLN00181        109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN  188 (793)
T ss_pred             hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence            99999532                  2456777777775421100                 001235788899999988


Q ss_pred             CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCcccc
Q 014762          293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF  372 (419)
Q Consensus       293 ~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (419)
                      + ..++.++|||||||+||||++|..|+..   ....+..+....               .++..               
T Consensus       189 ~-~~~~~~sDVwSlGviL~ELl~~~~~~~~---~~~~~~~~~~~~---------------~~~~~---------------  234 (793)
T PLN00181        189 G-SSSNCASDVYRLGVLLFELFCPVSSREE---KSRTMSSLRHRV---------------LPPQI---------------  234 (793)
T ss_pred             c-CCCCchhhhhhHHHHHHHHhhCCCchhh---HHHHHHHHHHhh---------------cChhh---------------
Confidence            7 6799999999999999999998877521   111111111000               00000               


Q ss_pred             ccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          373 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       373 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                            ....+...+++.+||+.||.+|||+.|+|+||||...
T Consensus       235 ------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        235 ------LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             ------hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence                  0013456789999999999999999999999999764

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.6e-27  Score=206.26  Aligned_cols=164  Identities=21%  Similarity=0.256  Sum_probs=122.2

Q ss_pred             CChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeeccc
Q 014762          207 TDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS  282 (419)
Q Consensus       207 ~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  282 (419)
                      |+|.+++    ..+++..++.++.|++.||.|||+++      ||+|||++.+ +.+|+  ||+++......    ..++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~~----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPEQ----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeecccc----CCCc
Confidence            3455554    24899999999999999999999998      9999999988 78888  99998754322    3678


Q ss_pred             ccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhc
Q 014762          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVG  362 (419)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~  362 (419)
                      ..|+|||++.+ ..++.++|||||||++|||++|+.||.........+..+...........         .+       
T Consensus        68 ~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~-------  130 (176)
T smart00750       68 PYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD---------RS-------  130 (176)
T ss_pred             ccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc---------cc-------
Confidence            99999999987 78999999999999999999999998533322222322222111100000         00       


Q ss_pred             cCCCCCccccccccccCCCCH--HHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          363 RHSRKPWSKFINADNQHLVSP--EAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                    ....+++  ++.+|+.+||+.||++|||+.++++|+|+..
T Consensus       131 --------------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      131 --------------NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             --------------cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                          0001233  6999999999999999999999999999764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=2.7e-25  Score=212.34  Aligned_cols=157  Identities=19%  Similarity=0.270  Sum_probs=124.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeE-EEeEEEccC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVK-LLDIVRDQH  193 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~-l~~~~~~~~  193 (419)
                      .++|++.+.||+|+||+||+|++.. +++.+|||++...        ....+.+|+.+|+++ +|+|++. +++ +    
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~-~----   90 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA-T----   90 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE-c----
Confidence            5779999999999999999998876 6788899986422        235688999999999 8999885 443 2    


Q ss_pred             CCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecC-CCCceEEcCCCCcEEEEecccceeccC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dl-k~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                       ...++||||++|++|.... ...   ...++.|+++||.|||++||+|||| ||+|||++.+ +.+||+|||+|+....
T Consensus        91 -~~~~LVmE~~~G~~L~~~~-~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLAR-PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLASVFRR  164 (365)
T ss_pred             -CCcEEEEEccCCCCHHHhC-ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccceeccc
Confidence             3468999999999997432 111   2467899999999999999999999 9999999877 7899999999987654


Q ss_pred             CCcc---------eeeccccccccccccc
Q 014762          273 GKEY---------NVRVASRYFKGPELLV  292 (419)
Q Consensus       273 ~~~~---------~~~~~~~~y~aPE~~~  292 (419)
                      ....         ....++..|+|||.+.
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            3311         2235667799999874

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=3.8e-23  Score=196.16  Aligned_cols=255  Identities=32%  Similarity=0.538  Sum_probs=195.5

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCC-CeeEEEeEEEccCCCccEE
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~l  199 (419)
                      |.+...||.|+||.||++.+.   ..+++|.+...      ....+.+|+.++..+ .|+ +++++.+.+...  ...++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~--~~~~~   75 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDE--GSLYL   75 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecC--CEEEE
Confidence            778899999999999999876   78899988642      245688999999999 666 899999999443  44789


Q ss_pred             EEEecCCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          200 IFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       200 v~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      +++++.++++.....      .+.......++.|++.++.|+|+.+++|||+||+||+++.....++++|||.++.....
T Consensus        76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999999986653      68889999999999999999999999999999999999988337999999999755433


Q ss_pred             C-------cceeecccccccccccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHcCCchH
Q 014762          274 K-------EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDEL  342 (419)
Q Consensus       274 ~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~--~~~~~~i~~~lg~~~~  342 (419)
                      .       ......++..|++||.+.+.  ..++...|+||+|++++++++|..||......  ...........+.+..
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL  235 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence            2       23556899999999998763  47889999999999999999999996433321  2233332222221100


Q ss_pred             HHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      .                       ........    ......+.+++.+++..+|..|.+..+...++|...
T Consensus       236 ~-----------------------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         236 A-----------------------SPLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             c-----------------------cccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            0                       00000000    112357889999999999999999999888866554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=1.3e-25  Score=228.03  Aligned_cols=254  Identities=25%  Similarity=0.382  Sum_probs=185.3

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEec----Ccch-----HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKK-----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       128 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~----~~~~-----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ...+.+|.|.+|.|+.+......+..+.|.+.    +...     ..+..|+.+-..+ .|+|++..+..+.+..  ...
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~--~~~  397 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEID--GIL  397 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcc--cch
Confidence            45677999999988888877766666665443    1111     1144456566666 8999988777664432  222


Q ss_pred             EEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      -.||||++ +|..++.   .++..++..++.|++.|+.|||+.||.|||+|++|+++..+ +.+||+|||.+........
T Consensus       398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceeeccCcc
Confidence            34999999 8777662   58999999999999999999999999999999999999998 8999999999875533222


Q ss_pred             -----ceeecccccccccccccCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          276 -----YNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       276 -----~~~~~~~~~y~aPE~~~~~~~~~-~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                           ....+|+..|.|||++.+ ..|+ ...||||.|+++..|++|+.||.......+++..+.   +....       
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~-~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---~~~~~-------  544 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTG-KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---YSDQR-------  544 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccc-cccCcchhhhhhccceEEEEecCCCccccccccccchhhhc---ccccc-------
Confidence                 234578889999999987 5555 579999999999999999999965443333321100   00000       


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ...             ..++      .....++...+.+|.+||++||.+|.|++++++.+||+.+.
T Consensus       545 ~~~-------------~~~~------~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  545 NIF-------------EGPN------RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             ccc-------------cChH------HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            000             0000      01123678889999999999999999999999999999874

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=7.7e-23  Score=195.37  Aligned_cols=194  Identities=23%  Similarity=0.324  Sum_probs=156.5

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCC-cEEEEEEecCcc---hHHHHHHHHHHHHhc---CCCCeeEEEeEEEccCCCccE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPVK---KKKIKREIKILQNLC---GGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~E~~~l~~l~---~h~niv~l~~~~~~~~~~~~~  198 (419)
                      +|.+.++||+|+||.||.|.+..++ ..+|+|+.....   ...+..|+.++..+.   +.+++..+++... ....+-+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence            8999999999999999999987775 678888876432   226889999999984   2368888888884 2345678


Q ss_pred             EEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC----CcEEEEecccce-
Q 014762          199 LIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAE-  268 (419)
Q Consensus       199 lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~----~~~kl~Dfgla~-  268 (419)
                      +||+.++.+ |.++.     +.++...+..++.|++.+|++||+.|++||||||+|+++....    ..+.|.|||+++ 
T Consensus        98 iVM~l~G~s-L~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   98 IVMSLLGPS-LEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEeccCcc-HHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            999877654 44333     5689999999999999999999999999999999999998653    469999999998 


Q ss_pred             -eccCCC--------c-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 014762          269 -FYHPGK--------E-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY  322 (419)
Q Consensus       269 -~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~  322 (419)
                       ......        . .....||..|.++.+..+ ...+.+.|+||++.++.+++.|..||..
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~  239 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEA  239 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCcc
Confidence             321111        1 122348999999998877 7889999999999999999999999843

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.7e-23  Score=179.54  Aligned_cols=195  Identities=22%  Similarity=0.388  Sum_probs=159.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ..+.|.++++||.|+||.+|.|....+|+.||||+-+. ....++..|..+...|.+...|..+..+..+.  .+-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~--~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEK--DYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhcccc--ccceeee
Confidence            46789999999999999999999999999999999764 34567889999999997777888888887543  5667999


Q ss_pred             EecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCCCc
Q 014762          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |.+.. +|+++.    +.++...+..++-|++.-++|+|.++++||||||+|.|+.-+  ..++.++|||+|+.+.+...
T Consensus        91 dLLGP-sLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t  169 (341)
T KOG1163|consen   91 DLLGP-SLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT  169 (341)
T ss_pred             eccCc-cHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence            98864 444443    679999999999999999999999999999999999998543  45789999999987653321


Q ss_pred             --------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCC
Q 014762          276 --------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF  321 (419)
Q Consensus       276 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~  321 (419)
                              .....||..|.+=....+ ..-+.+.|+-|+|.+|.+..-|..||.
T Consensus       170 ~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQ  222 (341)
T KOG1163|consen  170 RQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQ  222 (341)
T ss_pred             cccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCccc
Confidence                    122367777877666655 556789999999999999999999984

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1e-22  Score=183.61  Aligned_cols=219  Identities=19%  Similarity=0.339  Sum_probs=176.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-CcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .-.|.+.++||+|+||..+.|.+.-++++||||.-. +++..++..|....+.|.+.+.|...+-+-  +.+.+-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhhh
Confidence            457999999999999999999999999999999864 345578899999999998889999887766  44567779999


Q ss_pred             ecCCC--Chhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC----CCcEEEEecccceeccCCCc
Q 014762          203 YVNST--DFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       203 ~~~~~--~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~----~~~~kl~Dfgla~~~~~~~~  275 (419)
                      .+...  +|.++. +.|+...+..++.|++.-++|+|++.+|.|||||+|+||...    ...+.++|||+|+.+.+...
T Consensus       105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence            88643  344444 679999999999999999999999999999999999999642    34689999999998765432


Q ss_pred             c--------eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC--CCCCHHHHHHHHHHcCCchHHHH
Q 014762          276 Y--------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY--GHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       276 ~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~--~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      .        ....||-.||+=...++ ..-+.+.|+-|||-++++.+-|..||..  ..++.+..++|-+.....++..+
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L  263 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL  263 (449)
T ss_pred             cccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH
Confidence            1        23468889999888887 6788999999999999999999999842  23455556666555444444444

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.90  E-value=9.1e-25  Score=212.44  Aligned_cols=232  Identities=26%  Similarity=0.374  Sum_probs=187.7

Q ss_pred             eeeeCceEEEEEEE---cCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          133 VGRGKYSEVFEGIN---VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       133 lG~G~fg~V~~~~~---~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +|+|.||.|+++..   ...|..+|+|++++..     +.....|..++..+++||.++++...+..+  ...++++++.
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--~kl~l~ld~~   79 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--GKLYLILDFL   79 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc--cchhHhhhhc
Confidence            79999999987642   3456778898876422     224556888888887799999999999554  5567999999


Q ss_pred             CCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeecc
Q 014762          205 NSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA  281 (419)
Q Consensus       205 ~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~  281 (419)
                      .++++...+.   .+++.....+...++.+++++|+.+|+|||+|++||+++.+ |.+++.|||+++..-.....   +|
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-CccccCCchhhhHhHhhhhc---cc
Confidence            9999877763   47888889999999999999999999999999999999999 89999999999876544332   89


Q ss_pred             cccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH-HcCCchHHHHHhhcCCCCChhhHHh
Q 014762          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK-VLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~-~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      |..|||||++.   ....++|.||||+++++|++|..||..     +....|.+ .++.+                    
T Consensus       156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~~p--------------------  207 (612)
T KOG0603|consen  156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELEMP--------------------  207 (612)
T ss_pred             chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccCCc--------------------
Confidence            99999999986   467899999999999999999999953     44444433 22111                    


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCCCccccc
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMVISSISPIF  416 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~elL~hp~f~~~~  416 (419)
                                        ..++..++++++.++..+|.+|.-+     .|+.+|+||..+.
T Consensus       208 ------------------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  208 ------------------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             ------------------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence                              1257789999999999999999954     7899999998763

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=5.6e-23  Score=183.03  Aligned_cols=168  Identities=13%  Similarity=0.199  Sum_probs=130.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hH----H------HHHHHHHHHHhcCCCCeeEEEeEEEc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KK----K------IKREIKILQNLCGGPNVVKLLDIVRD  191 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~----~------~~~E~~~l~~l~~h~niv~l~~~~~~  191 (419)
                      +++|++++.||.|+||.||+..+  ++..+|+|++.+..  .+    .      +.+|+..+.++ .|++|..+.+++..
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~  106 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLL  106 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeee
Confidence            78999999999999999999754  46689999996432  11    1      57899999999 99999999988654


Q ss_pred             cC------CCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecc
Q 014762          192 QH------SKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (419)
Q Consensus       192 ~~------~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfg  265 (419)
                      ..      ....+++|||++|.++.+.. .+++    ....+++.+|..+|+.|++|+|+||+||+++++ + ++|+|||
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i~liDfg  179 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-LRIIDLS  179 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-EEEEECC
Confidence            32      23578999999999997763 3333    245699999999999999999999999999987 5 9999999


Q ss_pred             cceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHH
Q 014762          266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM  313 (419)
Q Consensus       266 la~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~el  313 (419)
                      ..+.........           .+.+. ..|+.++|+||||+++..+
T Consensus       180 ~~~~~~e~~a~d-----------~~vle-r~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        180 GKRCTAQRKAKD-----------RIDLE-RHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             CcccccchhhHH-----------HHHHH-hHhcccccccceeEeehHH
Confidence            886543222111           02222 4577899999999987654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=4.5e-22  Score=173.54  Aligned_cols=181  Identities=17%  Similarity=0.157  Sum_probs=137.3

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-------HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      +...|++|+||+||.+.  ..+..++.+.++....       ..+.+|+++|++|.+++++++++++.      ..+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence            45679999999999874  3788888777754322       25789999999996678899998862      247999


Q ss_pred             EecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecC-CCCceEEcCCCCcEEEEecccceeccCCCcc----
Q 014762          202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----  276 (419)
Q Consensus       202 e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dl-k~~NILl~~~~~~~kl~Dfgla~~~~~~~~~----  276 (419)
                      ||+.|.+|......    ....++.|++.+|+++|++||+|||| ||+|||++.+ +.++|+|||+|....+....    
T Consensus        78 eyI~G~~L~~~~~~----~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~~r~L  152 (218)
T PRK12274         78 SYLAGAAMYQRPPR----GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARWMRLL  152 (218)
T ss_pred             eeecCccHHhhhhh----hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchHHHHH
Confidence            99999998754322    12357789999999999999999999 7999999977 78999999999865543310    


Q ss_pred             ----------eeecccccccccccccCCCCCC-ccccHHHHHHHHHHHHhCCCCCCC
Q 014762          277 ----------NVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFY  322 (419)
Q Consensus       277 ----------~~~~~~~~y~aPE~~~~~~~~~-~~~DiwSlG~~l~ell~g~~pf~~  322 (419)
                                .....++.+++|+...-....+ ...+.++.|+.+|.++|++.+.+.
T Consensus       153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                      1123456667776543222333 567899999999999999998754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=2.3e-22  Score=184.44  Aligned_cols=229  Identities=22%  Similarity=0.318  Sum_probs=140.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcC---------CCCeeEEEeEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCG---------GPNVVKLLDIVR  190 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~---------h~niv~l~~~~~  190 (419)
                      .+...+.||.|++|.||.++|..+|+.+|+|+..-      ...+++++|.-....+.+         |-.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            35667889999999999999999999999998741      223556666644444311         223333333332


Q ss_pred             ccC----------CC-----ccEEEEEecCCCChhhhcC------CC----CHHHHHHHHHHHHHHHHHHHHCCcEeecC
Q 014762          191 DQH----------SK-----TPSLIFEYVNSTDFKVLYP------TL----TDYDIRYYIYELLKALDYCHSQGIMHRDV  245 (419)
Q Consensus       191 ~~~----------~~-----~~~lv~e~~~~~~l~~~~~------~l----~~~~~~~~~~qi~~~L~~LH~~~ivH~Dl  245 (419)
                      .+.          ..     +.+++|+-+. ++|..+..      ..    .......+..|+++.+++||..|+||+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            111          01     2356777664 45554431      11    11122345589999999999999999999


Q ss_pred             CCCceEEcCCCCcEEEEecccceeccCCCcceeecccccccccccccCC-------CCCCccccHHHHHHHHHHHHhCCC
Q 014762          246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDMWSLGCMFAGMIFRKE  318 (419)
Q Consensus       246 k~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwSlG~~l~ell~g~~  318 (419)
                      +|+|++++.+ |.+.|+||+.....+  ........+..|.+||.....       ..++.+.|.|+||+++|.|++|+.
T Consensus       172 ~~~nfll~~~-G~v~Lg~F~~~~r~g--~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQD-GGVFLGDFSSLVRAG--TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TT-S-EEE--GGGEEETT--EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCC-CCEEEcChHHHeecC--ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999999998 999999999876543  222223455678889876331       247899999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCC
Q 014762          319 PFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ  398 (419)
Q Consensus       319 pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  398 (419)
                      ||.-.....                          ..            .|    ......++++.+++||+++|++||+
T Consensus       249 Pf~~~~~~~--------------------------~~------------~~----~f~~C~~~Pe~v~~LI~~lL~~~~~  286 (288)
T PF14531_consen  249 PFGLSSPEA--------------------------DP------------EW----DFSRCRDMPEPVQFLIRGLLQRNPE  286 (288)
T ss_dssp             STCCCGGGS--------------------------TS------------GG----GGTTSS---HHHHHHHHHHT-SSGG
T ss_pred             CCCCCCccc--------------------------cc------------cc----cchhcCCcCHHHHHHHHHHccCCcc
Confidence            993110000                          00            00    0111224899999999999999999


Q ss_pred             CC
Q 014762          399 DR  400 (419)
Q Consensus       399 ~R  400 (419)
                      +|
T Consensus       287 ~R  288 (288)
T PF14531_consen  287 DR  288 (288)
T ss_dssp             GS
T ss_pred             cC
Confidence            88

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=2.7e-22  Score=176.40  Aligned_cols=133  Identities=17%  Similarity=0.255  Sum_probs=104.2

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch------------HH-----------------HHHHHHHHHHhcCCC
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------------KK-----------------IKREIKILQNLCGGP  180 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------------~~-----------------~~~E~~~l~~l~~h~  180 (419)
                      .+.||+|+||+||+|.+. +|+.||+|++++...            ..                 ..+|+.++.++ .++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence            457999999999999886 899999999964311            11                 23499999999 666


Q ss_pred             CeeEEEeEEEccCCCccEEEEEecCCCChhhh-c--CCCCHHHHHHHHHHHHHHHHHH-HHCCcEeecCCCCceEEcCCC
Q 014762          181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDHEL  256 (419)
Q Consensus       181 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~l~~~~~~~~~~qi~~~L~~L-H~~~ivH~Dlk~~NILl~~~~  256 (419)
                      ++.....+...    ..++||||++++++... +  ..++...+..++.|++.+|.|+ |+.||+||||||+|||++.  
T Consensus        80 ~v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~--  153 (190)
T cd05147          80 GIPCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD--  153 (190)
T ss_pred             CCCCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--
Confidence            65433222211    12799999998876433 2  4688899999999999999999 7999999999999999984  


Q ss_pred             CcEEEEecccceec
Q 014762          257 RKLRLIDWGLAEFY  270 (419)
Q Consensus       257 ~~~kl~Dfgla~~~  270 (419)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            67999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.87  E-value=1.3e-22  Score=206.66  Aligned_cols=218  Identities=27%  Similarity=0.440  Sum_probs=160.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      .++|+.++.|..|++|.||.++++.+.+.+|+|+=++   ..+.|-  ++... +.|.+|                    
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---~lilRn--ilt~a-~npfvv--------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---NLILRN--ILTFA-GNPFVV--------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhccccc---chhhhc--ccccc-CCccee--------------------
Confidence            6789999999999999999999999999999954221   111111  22221 333333                    


Q ss_pred             cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-----
Q 014762          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----  275 (419)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-----  275 (419)
                         |+....+   +.++..        ++.+++|||+.||+|||+||+|.+|..- +.+|+.|||+++.......     
T Consensus       136 ---gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             ---chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhhh
Confidence               3333333   234432        2789999999999999999999999987 8999999999875422110     


Q ss_pred             -----------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          276 -----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       276 -----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                                 ....+||+.|+|||+++. +.|+..+|+|++|+++||.+-|..||| ++..++.+...+.....     
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpff-Gdtpeelfg~visd~i~-----  276 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISDDIE-----  276 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeecc-CCCHHHHHhhhhhhhcc-----
Confidence                       112389999999999987 789999999999999999999999995 55555555554432111     


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC---CHHHHhcCCCcccc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL---TAREAMVISSISPI  415 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---ta~elL~hp~f~~~  415 (419)
                              |++                    . ...+++++++++.++|+.+|..|.   .+.++.+|+||+.+
T Consensus       277 --------wpE--------------------~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  277 --------WPE--------------------E-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             --------ccc--------------------c-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence                    000                    0 123788999999999999999998   57788999999875

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2.7e-21  Score=170.46  Aligned_cols=134  Identities=17%  Similarity=0.205  Sum_probs=106.9

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-----------------------------HHHHHHHHHHHHhcCCC
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----------------------------KKIKREIKILQNLCGGP  180 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------------------------~~~~~E~~~l~~l~~h~  180 (419)
                      .+.||+|+||+||+|.+. +|+.||||++++...                             ..+.+|...+.++ .++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence            467999999999999876 899999999875321                             1235789999999 788


Q ss_pred             CeeEEEeEEEccCCCccEEEEEecCCCChhhh-c--CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCC
Q 014762          181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEL  256 (419)
Q Consensus       181 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~  256 (419)
                      ++.....+...    ..++||||++++++... +  ..++......++.|++.++.++|+ .||+||||||+|||++ + 
T Consensus        80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-  153 (190)
T cd05145          80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-  153 (190)
T ss_pred             CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-
Confidence            87544444322    13799999998854322 2  346778899999999999999999 9999999999999998 5 


Q ss_pred             CcEEEEecccceecc
Q 014762          257 RKLRLIDWGLAEFYH  271 (419)
Q Consensus       257 ~~~kl~Dfgla~~~~  271 (419)
                      +.++|+|||++....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            789999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.3e-21  Score=178.71  Aligned_cols=191  Identities=21%  Similarity=0.324  Sum_probs=130.8

Q ss_pred             cCCCCeeEEEeEEEcc-------------------------CCCccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHH
Q 014762          177 CGGPNVVKLLDIVRDQ-------------------------HSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELL  229 (419)
Q Consensus       177 ~~h~niv~l~~~~~~~-------------------------~~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~  229 (419)
                      ..|||||++.+.|.+.                         .+..+|+||...... |..++  +..+....+.++.|++
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~t-Lr~yl~~~~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQT-LREYLWTRHRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhh-HHHHHhcCCCchHHHHHHHHHHH
Confidence            3799999999877542                         224467777665543 34443  4577788888999999


Q ss_pred             HHHHHHHHCCcEeecCCCCceEEcCC---CCcEEEEecccceeccCC-------CcceeecccccccccccccCCCCC--
Q 014762          230 KALDYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYHPG-------KEYNVRVASRYFKGPELLVDLQDY--  297 (419)
Q Consensus       230 ~~L~~LH~~~ivH~Dlk~~NILl~~~---~~~~kl~Dfgla~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~--  297 (419)
                      +|+.|||++|+.|||+|++|||+.-+   ...+.|+|||.+-.....       .......|.-..||||+.......  
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999998433   346789999986332211       111223566678999997542211  


Q ss_pred             ---CccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCcccccc
Q 014762          298 ---DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN  374 (419)
Q Consensus       298 ---~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (419)
                         -.+.|.|+.|.+.||+++...||+..-.-   .      +..   ..|.+    .                  +  .
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~------L~~---r~Yqe----~------------------q--L  475 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---L------LDT---RTYQE----S------------------Q--L  475 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchh---e------ech---hhhhh----h------------------h--C
Confidence               14799999999999999999999641100   0      000   00000    0                  0  0


Q ss_pred             ccccCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 014762          375 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAR  404 (419)
Q Consensus       375 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~  404 (419)
                      ...++.+++.+++++..+|+.||++|+++.
T Consensus       476 Palp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  476 PALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             CCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            011234889999999999999999999853

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=4.1e-20  Score=191.90  Aligned_cols=192  Identities=20%  Similarity=0.412  Sum_probs=152.7

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcC---CCCeeEEEeEEEccCCCccE
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCG---GPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~---h~niv~l~~~~~~~~~~~~~  198 (419)
                      .....|.+.+.||+|+||+||+|.... |+.||+|+-++...-+|.--.+++.+| .   -+-|..+...+...  +.-+
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RL-k~~~~~~~~~~~~a~~~~--~~S~  770 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERL-KPQMLPSIMHISSAHVFQ--NASV  770 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhh-chhhhcchHHHHHHHccC--Ccce
Confidence            346789999999999999999998766 999999998876654444333444454 2   12333333333223  3345


Q ss_pred             EEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC------CCCcEEEEeccccee
Q 014762          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------ELRKLRLIDWGLAEF  269 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~------~~~~~kl~Dfgla~~  269 (419)
                      ||+||.+-|+|.+++.   ..++..+..++.|++.-++.||..+|||+||||+|.||..      +...++|+|||.+-.
T Consensus       771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            9999999999999884   4889999999999999999999999999999999999842      334689999999853


Q ss_pred             ---ccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCC
Q 014762          270 ---YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE  318 (419)
Q Consensus       270 ---~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~  318 (419)
                         ..++......++|..+-.+|+..| .+|++.+|.|.++.+++-|+.|+.
T Consensus       851 m~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  851 MKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             eeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHH
Confidence               344445567789999999999988 899999999999999999999984

>PRK10345 hypothetical protein; Provisional

Probab=99.82  E-value=8.9e-20  Score=161.96  Aligned_cols=133  Identities=19%  Similarity=0.239  Sum_probs=104.1

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhc----CCCCeeEEEeEEEccCC-Cc-cEEE
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLC----GGPNVVKLLDIVRDQHS-KT-PSLI  200 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~-~~-~~lv  200 (419)
                      ...||+|+||.||.  +..++.. +||++...   ..+.+.+|+.+++.+.    .||||++++|++..+.+ .. +.+|
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            46799999999996  6777666 68988643   4567899999999993    47999999999977542 23 2378


Q ss_pred             EEe--cCCCChhhhcCC--CCHHHHHHHHHHHHHHH-HHHHHCCcEeecCCCCceEEcCC---CCcEEEEecccc
Q 014762          201 FEY--VNSTDFKVLYPT--LTDYDIRYYIYELLKAL-DYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLA  267 (419)
Q Consensus       201 ~e~--~~~~~l~~~~~~--l~~~~~~~~~~qi~~~L-~~LH~~~ivH~Dlk~~NILl~~~---~~~~kl~Dfgla  267 (419)
                      +||  +.+++|.+++..  +++.  ..++.|++.++ +|||+++|+||||||+|||++.+   ...++|+||+.+
T Consensus        84 ~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  447899988853  4444  45678888888 99999999999999999999753   247999995444

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=1.2e-20  Score=192.84  Aligned_cols=240  Identities=22%  Similarity=0.380  Sum_probs=164.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHH---HHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIK---REIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~---~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      +|...+.||.+.|=+|.+|++.. | .|+||++-+..    ...+.   .|++ .. +.++||++.+..+...  .+..|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~-l~~~pn~lPfqk~~~t--~kAAy   97 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FA-LMKAPNCLPFQKVLVT--DKAAY   97 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HH-hhcCCcccchHHHHHh--hHHHH
Confidence            57778889999999999997543 3 48999985433    23333   3444 22 3489999998877533  36677


Q ss_pred             EEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec--cCC-
Q 014762          199 LIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY--HPG-  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~--~~~-  273 (419)
                      ||-+|......+.+-  +-+..-+.+.|+.|++.||.-+|..||+|+|||.+|||+..= +=+.|+||..-+..  ..+ 
T Consensus        98 lvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen   98 LVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccCCccCCCCC
Confidence            888888765544332  336777888999999999999999999999999999999876 34689999876532  111 


Q ss_pred             -Ccceee----cccccccccccccCCC---------C-CCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHc
Q 014762          274 -KEYNVR----VASRYFKGPELLVDLQ---------D-YDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVL  337 (419)
Q Consensus       274 -~~~~~~----~~~~~y~aPE~~~~~~---------~-~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~l  337 (419)
                       ...+..    ....+|.|||-+....         . .+++-||||+||+++||++ |+.||.     ..|+-.... .
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-----LSQL~aYr~-~  250 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-----LSQLLAYRS-G  250 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-----HHHHHhHhc-c
Confidence             122222    2335699999875411         1 4678999999999999988 455551     111111100 0


Q ss_pred             CCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      +....+..+++                               --+..++.++..|++.||++|.+|++.|+-
T Consensus       251 ~~~~~e~~Le~-------------------------------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  251 NADDPEQLLEK-------------------------------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CccCHHHHHHh-------------------------------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            01111111110                               014468999999999999999999999874

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=2.6e-19  Score=162.76  Aligned_cols=136  Identities=15%  Similarity=0.216  Sum_probs=107.5

Q ss_pred             CeEEEeeeeeeCceEEEEEE-EcCCCcEEEEEEecCcc---------------------------hHHHHHHHHHHHHhc
Q 014762          126 DYEVVRKVGRGKYSEVFEGI-NVNTNERCIIKILKPVK---------------------------KKKIKREIKILQNLC  177 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~-~~~~~~~vavK~~~~~~---------------------------~~~~~~E~~~l~~l~  177 (419)
                      -|++.+.||+|+||.||+|. +..+|+.||+|+++...                           ...+.+|+.++.++ 
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-  107 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-  107 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            47788999999999999998 67799999999986421                           02256899999999 


Q ss_pred             CCC--CeeEEEeEEEccCCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-cEeecCCCCceE
Q 014762          178 GGP--NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG-IMHRDVKPHNVM  251 (419)
Q Consensus       178 ~h~--niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~-ivH~Dlk~~NIL  251 (419)
                      .+.  .+.++++.   .   ..++||||+++.++....   ..+....+..++.|++.++.+||+.| ++|+||||+||+
T Consensus       108 ~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl  181 (237)
T smart00090      108 YEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL  181 (237)
T ss_pred             HhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence            442  33444442   1   237999999998876543   23455567789999999999999999 999999999999


Q ss_pred             EcCCCCcEEEEecccceec
Q 014762          252 IDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       252 l~~~~~~~kl~Dfgla~~~  270 (419)
                      ++ + +.++|+|||.+...
T Consensus       182 i~-~-~~i~LiDFg~a~~~  198 (237)
T smart00090      182 VH-D-GKVVIIDVSQSVEL  198 (237)
T ss_pred             EE-C-CCEEEEEChhhhcc
Confidence            99 4 78999999998643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.80  E-value=4e-20  Score=162.64  Aligned_cols=237  Identities=17%  Similarity=0.235  Sum_probs=170.3

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .+..++.+|.+...|..|+|++.  |..++.|+++..     ....|..|.-.|+-+ .||||..+++.|..+  .++.+
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsp--pnlv~  264 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSP--PNLVI  264 (448)
T ss_pred             hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCC--CCceE
Confidence            34556778999999999999764  555677777532     235688888888888 899999999999554  67889


Q ss_pred             EEEecCCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          200 IFEYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       200 v~e~~~~~~l~~~~~~-----l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      +..||+-|+|...+..     .+..++.+++.++++|++|||+..  |.-..|++..+++|++ -+.+|+ .+-+++.. 
T Consensus       265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltaris-mad~kfsf-  341 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARIS-MADTKFSF-  341 (448)
T ss_pred             eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhhee-cccceeee-
Confidence            9999999999888743     567788999999999999999863  4455799999999988 444443 12122211 


Q ss_pred             CCcceeecccccccccccccCCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                        ........+.|++||.+.....  --.++|+|||++++||+.|...||. ..++.+.-.++. .          +.  
T Consensus       342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfa-dlspmecgmkia-l----------eg--  405 (448)
T KOG0195|consen  342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFA-DLSPMECGMKIA-L----------EG--  405 (448)
T ss_pred             --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccc-cCCchhhhhhhh-h----------cc--
Confidence              1122456788999999876221  2257999999999999999999983 333322222111 0          00  


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL  407 (419)
                                            +....+.-++..+..||.-|++.||.+||....++
T Consensus       406 ----------------------lrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  406 ----------------------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ----------------------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                                  00111223688899999999999999999876653

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3.1e-18  Score=153.66  Aligned_cols=131  Identities=25%  Similarity=0.380  Sum_probs=108.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      +.||+|++|.||+|.+  +|..+++|+..+..           ...+.+|+.++..+ .|+++.....++.+.  ...++
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~l   76 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDP--ENFII   76 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeC--CCCEE
Confidence            5699999999999976  67789999865321           13577899999999 788887766666443  45679


Q ss_pred             EEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      +|||++|+++...+..... ....++.+++.+|.++|+.|++|+|++|.|||++ + +.++|+|||.+..
T Consensus        77 v~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~  143 (211)
T PRK14879         77 VMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence            9999999999988765554 7788999999999999999999999999999999 4 6799999999865

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=5.8e-18  Score=150.32  Aligned_cols=134  Identities=20%  Similarity=0.348  Sum_probs=105.7

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-------------------------hHHHHHHHHHHHHhcCCC
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------------------KKKIKREIKILQNLCGGP  180 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~E~~~l~~l~~h~  180 (419)
                      .|.+.+.||+|+||.||+|.. .+|+.||||++....                         .....+|+.++..+ .++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~   93 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEE   93 (198)
T ss_pred             hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHc
Confidence            377788999999999999976 479999999865321                         12356788889888 666


Q ss_pred             --CeeEEEeEEEccCCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCc
Q 014762          181 --NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK  258 (419)
Q Consensus       181 --niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~  258 (419)
                        .+...++.      ...++||||++++++......   .....++.+++.++.++|+.|++|+||||+||+++.+ +.
T Consensus        94 ~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~  163 (198)
T cd05144          94 GFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EK  163 (198)
T ss_pred             CCCCCceeec------CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-Cc
Confidence              34444432      234799999999998765431   3456788999999999999999999999999999987 78


Q ss_pred             EEEEecccceecc
Q 014762          259 LRLIDWGLAEFYH  271 (419)
Q Consensus       259 ~kl~Dfgla~~~~  271 (419)
                      ++|+|||.+....
T Consensus       164 ~~liDfg~~~~~~  176 (198)
T cd05144         164 IYIIDWPQMVSTD  176 (198)
T ss_pred             EEEEECCccccCC
Confidence            9999999986443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=4.7e-19  Score=169.69  Aligned_cols=173  Identities=19%  Similarity=0.377  Sum_probs=131.2

Q ss_pred             CccEEEEEecCCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          195 KTPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                      .++++.|++|...+|.+++.      ..+......++.|++.|++|   ++.+|+|+||.||+...+ ..+||.|||+..
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~t  404 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVT  404 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhhee
Confidence            35789999999999999983      35667788899999999999   999999999999999887 689999999987


Q ss_pred             eccCCC-------cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCc
Q 014762          269 FYHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTD  340 (419)
Q Consensus       269 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~  340 (419)
                      ......       ..+...||.+||+||.+.+ ..|+.++||||||++|+|++. -..++       +....+...    
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~-------er~~t~~d~----  472 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQF-------ERIATLTDI----  472 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHH-------HHHHhhhhh----
Confidence            665444       4456789999999999998 889999999999999999996 22222       111110000    


Q ss_pred             hHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                              ....+++               .+..      -.++-.+|+.+||...|++||++.+.--|.|.
T Consensus       473 --------r~g~ip~---------------~~~~------d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  473 --------RDGIIPP---------------EFLQ------DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             --------hcCCCCh---------------HHhh------cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                    0000000               0000      13456799999999999999988888777775

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.74  E-value=2.5e-17  Score=146.39  Aligned_cols=127  Identities=21%  Similarity=0.390  Sum_probs=99.3

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          132 KVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .||+|+||+||+|.  .+|..+++|......           ...+.+|+.++..+ .++++.....++...  ...++|
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~--~~~~lv   75 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDP--DNKTIV   75 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEEC--CCCEEE
Confidence            38999999999997  467889999864211           24567899999999 676544333333323  345799


Q ss_pred             EEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       201 ~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      |||++|+++...+.....    .++.+++.+|.+||+.|++|+|++|+||+++ + +.++++|||++..
T Consensus        76 ~e~~~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~  138 (199)
T TIGR03724        76 MEYIEGKPLKDVIEEGND----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKY  138 (199)
T ss_pred             EEEECCccHHHHHhhcHH----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence            999999999877543221    7889999999999999999999999999999 4 7899999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=2.5e-17  Score=167.91  Aligned_cols=135  Identities=19%  Similarity=0.346  Sum_probs=106.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEe--cCc---------chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~--~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      ...|...+.||+|+||+||+|.+...  .+++|+.  +..         ..+.+.+|+.++..+ +|++++....++.+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~  408 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeC
Confidence            34456688999999999999976433  3444432  110         124578899999999 899998877766543


Q ss_pred             CCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          193 HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                        ...++||||+++++|..++.     ....++.|++.+|.|||+.|++||||||+|||++ + +.++|+|||+++..
T Consensus       409 --~~~~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liDFGla~~~  477 (535)
T PRK09605        409 --EEKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLIDFGLGKYS  477 (535)
T ss_pred             --CCCEEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEeCcccccC
Confidence              44679999999999987764     4567899999999999999999999999999994 3 67999999999753

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.74  E-value=1.3e-17  Score=162.58  Aligned_cols=201  Identities=21%  Similarity=0.326  Sum_probs=147.9

Q ss_pred             HHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCc-EeecCCCC
Q 014762          174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGI-MHRDVKPH  248 (419)
Q Consensus       174 ~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~i-vH~Dlk~~  248 (419)
                      +.+ .|.|+.+++|.+.++  ...+.|.+||+.|++.+.+.    ++++.....++++++.||.|||.-.| .|+.+++.
T Consensus         2 ~~l-~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    2 RQL-DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS   78 (484)
T ss_pred             ccc-chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence            455 899999999999776  77889999999999999874    47778888899999999999998755 99999999


Q ss_pred             ceEEcCCCCcEEEEecccceeccCC---CcceeecccccccccccccCCC------CCCccccHHHHHHHHHHHHhCCCC
Q 014762          249 NVMIDHELRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQ------DYDYSLDMWSLGCMFAGMIFRKEP  319 (419)
Q Consensus       249 NILl~~~~~~~kl~Dfgla~~~~~~---~~~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwSlG~~l~ell~g~~p  319 (419)
                      |+++|.. ..+||+|||+.......   .......-...|.|||.+.+..      ..+.+.|+||||++++|+++...|
T Consensus        79 nClvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   79 NCLVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             cceeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999988 89999999998765421   1111122334599999986621      146789999999999999999999


Q ss_pred             CCCCCCCHHH--HHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCC
Q 014762          320 FFYGHDNHDQ--LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH  397 (419)
Q Consensus       320 f~~~~~~~~~--~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  397 (419)
                      |.......+.  +...++..+...+.           +..               ...   ..+.+++..++..||..+|
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~r-----------P~i---------------~~~---~e~~~~l~~l~~~cw~e~P  208 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFR-----------PSI---------------ELL---NELPPELLLLVARCWEEIP  208 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcC-----------cch---------------hhh---hhcchHHHHHHHHhcccCh
Confidence            9664443332  11111111111110           000               000   0256689999999999999


Q ss_pred             CCCCCHHHHh
Q 014762          398 QDRLTAREAM  407 (419)
Q Consensus       398 ~~Rpta~elL  407 (419)
                      ++||+++++-
T Consensus       209 ~~rPs~~~i~  218 (484)
T KOG1023|consen  209 EKRPSIEQIR  218 (484)
T ss_pred             hhCccHHHHH
Confidence            9999998863

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=2e-16  Score=139.05  Aligned_cols=132  Identities=20%  Similarity=0.326  Sum_probs=95.2

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch-----HHH----------------------HHHHHHHHHhcCC-CC
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-----KKI----------------------KREIKILQNLCGG-PN  181 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~----------------------~~E~~~l~~l~~h-~n  181 (419)
                      .+.||+|+||+||+|.+. +++.||||++.+...     ...                      ..|...+..+..+ -.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999875 899999999864321     111                      3455566665221 12


Q ss_pred             eeEEEeEEEccCCCccEEEEEecCCCChhh-hcCCCCH-HHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCc
Q 014762          182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LYPTLTD-YDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRK  258 (419)
Q Consensus       182 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~l~~-~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~  258 (419)
                      +.+.++.      ...++||||++++.+.. .+..... ..+..++.+++.++.++|. +||+|+||||+||+++ + +.
T Consensus        81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~~  152 (187)
T cd05119          81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-GK  152 (187)
T ss_pred             CCceEec------CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-Cc
Confidence            3444433      12479999999954321 1122222 6778899999999999999 9999999999999999 5 78


Q ss_pred             EEEEecccceec
Q 014762          259 LRLIDWGLAEFY  270 (419)
Q Consensus       259 ~kl~Dfgla~~~  270 (419)
                      ++|+|||.+...
T Consensus       153 ~~liDfg~a~~~  164 (187)
T cd05119         153 VYIIDVPQAVEI  164 (187)
T ss_pred             EEEEECcccccc
Confidence            999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=1.3e-18  Score=177.05  Aligned_cols=255  Identities=24%  Similarity=0.417  Sum_probs=191.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ...|.+.+.||+|+|+.|-...... ....+|+|.++...     ......|..+-..+.+|+|++.+++...+.  ...
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--~~~   96 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP--RSY   96 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC--ccc
Confidence            4456777789999999998876533 34456667665332     233445777777774599999999998554  667


Q ss_pred             EEEEEecCCCChhhhc-C----CCCHHHHHHHHHHHHHHHHHHH-HCCcEeecCCCCceEEcCCCC-cEEEEecccceec
Q 014762          198 SLIFEYVNSTDFKVLY-P----TLTDYDIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFY  270 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~-~----~l~~~~~~~~~~qi~~~L~~LH-~~~ivH~Dlk~~NILl~~~~~-~~kl~Dfgla~~~  270 (419)
                      ++.++|..++++.... .    ..+......++.|+..++.|+| ..++.|+|+||+|.+++.. + .++++|||+|...
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES-GSALKIADFGLATAY  175 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-CCcccCCCchhhccc
Confidence            7999999888877665 2    4667788899999999999999 9999999999999999988 5 8899999999876


Q ss_pred             cC-CCc---ceeecc-cccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          271 HP-GKE---YNVRVA-SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       271 ~~-~~~---~~~~~~-~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      .. ...   ....+| +..|+|||...+........|+||.|+++..+++|..|+..........               
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~---------------  240 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY---------------  240 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc---------------
Confidence            65 222   234577 8999999999875566789999999999999999999984322111000               


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                               ..+.+........+|         ..++....+++.+++..+|+.|.+.+++-.+||+..
T Consensus       241 ---------~~~~~~~~~~~~~~~---------~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  241 ---------SSWKSNKGRFTQLPW---------NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ---------eeecccccccccCcc---------ccCChhhhhcccccccCCchhccccccccccccccc
Confidence                     000000111112223         237888999999999999999999999999999986

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=6e-16  Score=140.99  Aligned_cols=131  Identities=18%  Similarity=0.323  Sum_probs=100.3

Q ss_pred             eeee-eeCceEEEEEEEcCCCcEEEEEEecC----------------cchHHHHHHHHHHHHhcCCCCe--eEEEeEEEc
Q 014762          131 RKVG-RGKYSEVFEGINVNTNERCIIKILKP----------------VKKKKIKREIKILQNLCGGPNV--VKLLDIVRD  191 (419)
Q Consensus       131 ~~lG-~G~fg~V~~~~~~~~~~~vavK~~~~----------------~~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~  191 (419)
                      ..|| .||.|+||.+..  .+..+++|.+..                .....+.+|+.++.++ .|+++  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence            3577 888999999854  477889988742                1224578899999999 77764  677776543


Q ss_pred             cCCC--ccEEEEEecCC-CChhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          192 QHSK--TPSLIFEYVNS-TDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       192 ~~~~--~~~lv~e~~~~-~~l~~~~~~--l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ....  ..++|||++++ .++..++..  +++.    .+.+++.+|.+||++||+|+||||.|||++.+ +.++|+|||.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~-~~v~LIDfg~  188 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPD-GKFWLIDFDR  188 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCC-CCEEEEECCC
Confidence            3222  23599999997 688777643  3333    35789999999999999999999999999987 6899999998


Q ss_pred             cee
Q 014762          267 AEF  269 (419)
Q Consensus       267 a~~  269 (419)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            865

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=1e-15  Score=128.94  Aligned_cols=132  Identities=22%  Similarity=0.328  Sum_probs=109.7

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCC-CCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      +.+.||.|.++.||++...  +..+++|...... ...+.+|+.++..+.++ .++.++++++...  ...+++|||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEecCC
Confidence            3577999999999999763  3789999987543 36788999999999433 6889998888543  567899999999


Q ss_pred             CChhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          207 TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       207 ~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      +.+..+    +......++.+++.+|+++|..   +++|+|++|+||+++.. +.++++|||.+..
T Consensus        78 ~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGY  138 (155)
T ss_pred             eecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccC
Confidence            877654    6667778899999999999984   79999999999999986 7899999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=5.3e-15  Score=144.54  Aligned_cols=247  Identities=21%  Similarity=0.253  Sum_probs=188.3

Q ss_pred             CCCeEEEeeeee--eCceEEEEEEE--cCCCcEEEEEEec-----CcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGR--GKYSEVFEGIN--VNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~--G~fg~V~~~~~--~~~~~~vavK~~~-----~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ...+.+...+|.  |++|.||.+..  ..++..+|+|.-+     +.....-.+|+...+++..|+|.++.+..+.+  .
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~  190 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--S  190 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--C
Confidence            445667788999  99999999987  7888899998743     12334456788888888889999998888854  4


Q ss_pred             CccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHH----HHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLK----ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~----~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ...++-+|++. .++..+.    ..+++..++....+...    ||.++|+.+++|-|+||.||++..+....+++|||+
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            66778888888 4444443    23788888899999998    999999999999999999999998856789999999


Q ss_pred             ceeccCCCcce-ee-----cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHHHcCC
Q 014762          267 AEFYHPGKEYN-VR-----VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHDQLVKIAKVLGT  339 (419)
Q Consensus       267 a~~~~~~~~~~-~~-----~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~-~~~~~~~i~~~lg~  339 (419)
                      ...+..+.... ..     .+...|++||...+  -++...|+||+|.+..+..++-.+.-.+.. ...++..+      
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~------  341 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG------  341 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc------
Confidence            98877655321 11     56667999999764  689999999999999999988877643321 11111110      


Q ss_pred             chHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                                                      .+..+.....+.++...+..|+..+|..|++++.+++|++..
T Consensus       342 --------------------------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  342 --------------------------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             --------------------------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence                                            011112223566777899999999999999999999999876

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=2.3e-13  Score=134.58  Aligned_cols=138  Identities=17%  Similarity=0.276  Sum_probs=94.5

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHH-------------------------------------------
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------------------------------------  167 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------------  167 (419)
                      +.||.|++|.||+|+. .+|+.||||+..+...+.+.                                           
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            5699999999999975 57899999998765433333                                           


Q ss_pred             HHHHHHHHhc---CCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhcCC--CCHHHHHHHHHHHHH-HHHHHHHCCcE
Q 014762          168 REIKILQNLC---GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLK-ALDYCHSQGIM  241 (419)
Q Consensus       168 ~E~~~l~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--l~~~~~~~~~~qi~~-~L~~LH~~~iv  241 (419)
                      +|...+.++.   .+.+-+.+-.++.+. ....+|||||++|.++.+....  ... ....++.+++. .+..+|..|++
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~  279 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFF  279 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCce
Confidence            3343333331   122223333333222 1335799999999988765421  111 23445566655 47788999999


Q ss_pred             eecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       242 H~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      |+|++|.||+++.+ +.++++|||++....+
T Consensus       280 H~D~hPgNilv~~~-g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       280 HADLHPGNIFVLKD-GKIIALDFGIVGRLSE  309 (437)
T ss_pred             eCCCCcccEEECCC-CcEEEEeCCCeeECCH
Confidence            99999999999887 8899999999976643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=5.4e-13  Score=115.14  Aligned_cols=127  Identities=20%  Similarity=0.264  Sum_probs=95.9

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCC
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (419)
                      ++.|+.|.++.||++..  .+..+++|...+..  ...+.+|+.++..+.+...+.+++....    ...++||||++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEecCCC
Confidence            46689999999999965  47789999986543  3456889999999843333445665542    1236999999998


Q ss_pred             ChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----EeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI-----MHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       208 ~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i-----vH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      ++...  .   ......+.+++.+|..||+.++     +|+|++|.||+++ + +.++++|||.+..
T Consensus        77 ~l~~~--~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~~  136 (170)
T cd05151          77 ELLTE--D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc--c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEecccccC
Confidence            87643  1   1123456899999999999875     9999999999999 4 5789999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=3.7e-12  Score=126.06  Aligned_cols=165  Identities=20%  Similarity=0.341  Sum_probs=126.8

Q ss_pred             EEEEcCCCcEEEEEEecCcch---HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhcCCCCHH
Q 014762          143 EGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY  219 (419)
Q Consensus       143 ~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~  219 (419)
                      .|..+.++.+|.|..++....   ....+-+..|+.+ +||||+++++.++..  ...|+|+|.+..  |..++..++..
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~--~~~ylvTErV~P--l~~~lk~l~~~  104 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEEE--GTLYLVTERVRP--LETVLKELGKE  104 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhccc--CceEEEeecccc--HHHHHHHhHHH
Confidence            466678888999988875444   5567788899999 999999999999654  678999998763  44556667788


Q ss_pred             HHHHHHHHHHHHHHHHH-HCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-ceeecccccccccccccCCCCC
Q 014762          220 DIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY  297 (419)
Q Consensus       220 ~~~~~~~qi~~~L~~LH-~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  297 (419)
                      .+...+.||+.||.||| +.+++|++|.-+.|+++.. |..||++|.++........ ......-..|..|+.+-.   -
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~---s  180 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP---S  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc---c
Confidence            88999999999999998 5789999999999999998 8999999998754332221 011112223566765422   2


Q ss_pred             CccccHHHHHHHHHHHHhC
Q 014762          298 DYSLDMWSLGCMFAGMIFR  316 (419)
Q Consensus       298 ~~~~DiwSlG~~l~ell~g  316 (419)
                      +...|.|.|||++++++.|
T Consensus       181 ~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccchhhhhHHHHHHHHhCc
Confidence            2567999999999999998

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.39  E-value=8.5e-12  Score=109.02  Aligned_cols=132  Identities=17%  Similarity=0.280  Sum_probs=96.6

Q ss_pred             eeeeeeCceEEEEEEEcC------CCcEEEEEEecCcc-------------------------hHHH----HHHHHHHHH
Q 014762          131 RKVGRGKYSEVFEGINVN------TNERCIIKILKPVK-------------------------KKKI----KREIKILQN  175 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~------~~~~vavK~~~~~~-------------------------~~~~----~~E~~~l~~  175 (419)
                      ..||.|--+.||.|....      .+..+|||+++...                         ++.+    ++|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            469999999999997543      35789999874110                         1122    379999998


Q ss_pred             hcCC-CCeeEEEeEEEccCCCccEEEEEecCCCChhh-hcC--CCCHHHHHHHHHHHHHHHHHH-HHCCcEeecCCCCce
Q 014762          176 LCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-LYP--TLTDYDIRYYIYELLKALDYC-HSQGIMHRDVKPHNV  250 (419)
Q Consensus       176 l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~--~l~~~~~~~~~~qi~~~L~~L-H~~~ivH~Dlk~~NI  250 (419)
                      +... -++.+.+++.      .-++||||++++.+.. .+.  .++..+...+..+++.+|..| |+.|+||+||++.||
T Consensus        83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            8432 4566666542      2359999998754321 122  345556777889999999999 899999999999999


Q ss_pred             EEcCCCCcEEEEecccceec
Q 014762          251 MIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       251 Ll~~~~~~~kl~Dfgla~~~  270 (419)
                      |++.  +.+.|+|||.+...
T Consensus       157 L~~~--~~v~iIDF~qav~~  174 (197)
T cd05146         157 LWHD--GKVWFIDVSQSVEP  174 (197)
T ss_pred             EEEC--CcEEEEECCCceeC
Confidence            9974  56899999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=2.2e-12  Score=129.30  Aligned_cols=137  Identities=13%  Similarity=0.315  Sum_probs=90.6

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHH----------------------------------------
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----------------------------------------  165 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------  165 (419)
                      .|+. +.||+|++|.||+|+...+|+.||||+..+...+.                                        
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3554 67999999999999988779999999997642211                                        


Q ss_pred             ---HHHHHHHHHHhc---CCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhc----CC-----CCHHHHHHHHHHHHH
Q 014762          166 ---IKREIKILQNLC---GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PT-----LTDYDIRYYIYELLK  230 (419)
Q Consensus       166 ---~~~E~~~l~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~-----l~~~~~~~~~~qi~~  230 (419)
                         +.+|+..+.++.   .+.+.+.+-.++.+- ....+|||||+.|+.+.+..    ..     +.+..+..++.|+  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence               223333333331   133334433333322 23456999999999886532    11     2222233333333  


Q ss_pred             HHHHHHHCCcEeecCCCCceEEcCCCC----cEEEEecccceeccC
Q 014762          231 ALDYCHSQGIMHRDVKPHNVMIDHELR----KLRLIDWGLAEFYHP  272 (419)
Q Consensus       231 ~L~~LH~~~ivH~Dlk~~NILl~~~~~----~~kl~Dfgla~~~~~  272 (419)
                           ...|++|+|+||.||+++.+ +    .++++|||++....+
T Consensus       277 -----f~~GffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FRDGFFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HhCCeeeCCCChHHeEEecC-CCCCCeEEEEecceEEECCH
Confidence                 46899999999999999987 5    899999999977653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=1.1e-12  Score=119.18  Aligned_cols=200  Identities=21%  Similarity=0.222  Sum_probs=137.4

Q ss_pred             HHHHhcCCCCeeEEEeEEEccC---CCccEEEEEecCCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC--C
Q 014762          172 ILQNLCGGPNVVKLLDIVRDQH---SKTPSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ--G  239 (419)
Q Consensus       172 ~l~~l~~h~niv~l~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~--~  239 (419)
                      -|..+ .|.|||+++.|+.+..   .....++.|||+.|++..+++       .+.....++++.||+.||.|||+.  -
T Consensus       120 nllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  120 NLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            34445 6899999999997542   234578899999999998873       377788899999999999999986  5


Q ss_pred             cEeecCCCCceEEcCCCCcEEEEecccceeccCC------CcceeecccccccccccccCCCCCCccccHHHHHHHHHHH
Q 014762          240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGM  313 (419)
Q Consensus       240 ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~el  313 (419)
                      |+|+++..+-|++..+ +-+|++--.-. ...+.      .......+-++|.+||.=.. ...+.++|||+||....+|
T Consensus       199 iihgnlTc~tifiq~n-gLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHN-GLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             cccCCcchhheeecCC-ceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHH
Confidence            9999999999999977 66665421111 00100      11122345677889997543 4567899999999999999


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhc
Q 014762          314 IFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL  393 (419)
Q Consensus       314 l~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  393 (419)
                      .-|..--..+.+..+.-..+....                                   +..     -.+.-++++++||
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i-----------------------------------~~l-----en~lqr~~i~kcl  315 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVI-----------------------------------IGL-----ENGLQRGSITKCL  315 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhhe-----------------------------------eec-----cCccccCcCcccc
Confidence            877654322222211111111100                                   000     0122357899999


Q ss_pred             CCCCCCCCCHHHHhcCCCcccc
Q 014762          394 RYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       394 ~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      +-.|..||+|.+++.||-+-+|
T Consensus       316 ~~eP~~rp~ar~llfHpllfeV  337 (458)
T KOG1266|consen  316 EGEPNGRPDARLLLFHPLLFEV  337 (458)
T ss_pred             cCCCCCCcchhhhhcCceeeec
Confidence            9999999999999999987655

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.35  E-value=2.3e-13  Score=139.95  Aligned_cols=253  Identities=22%  Similarity=0.297  Sum_probs=177.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..+.+.+.+-+-+|.+|.++.+.-..+|...++|+....      ..+...++-.++-.. .+|-+++..-.+  .....
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~rsP  878 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PCRSP  878 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CCCCC
Confidence            356788888999999999999877777766666654321      112222222222222 345555444433  22345


Q ss_pred             cEEEEEecCCCChhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-
Q 014762          197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~---l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-  272 (419)
                      .+|+++|.+++++...+.+   .+.+-.+.++..+..+++|||...++|+|++|.|+|...+ +..++.|||......- 
T Consensus       879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCccccccccccc
Confidence            6799999999998877643   5666777888889999999999999999999999999988 7889999984322100 


Q ss_pred             --------------------C-----------CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCC
Q 014762          273 --------------------G-----------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF  321 (419)
Q Consensus       273 --------------------~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~  321 (419)
                                          .           .......+|+.|.+||..++ ..-...+|+|++|++++|.++|..||.
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                                0           00112357888999999988 667788999999999999999999983


Q ss_pred             CCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC
Q 014762          322 YGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL  401 (419)
Q Consensus       322 ~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  401 (419)
                       .......+..|..                             ...+|...     ....+.+..+++.+.|..+|.+|.
T Consensus      1037 -a~tpq~~f~ni~~-----------------------------~~~~~p~g-----~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1037 -AETPQQIFENILN-----------------------------RDIPWPEG-----PEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred             -Ccchhhhhhcccc-----------------------------CCCCCCCC-----ccccChhhhhhhhhhhccCchhcc
Confidence             2222222222211                             11122221     123688899999999999999999


Q ss_pred             CHH---HHhcCCCcccc
Q 014762          402 TAR---EAMVISSISPI  415 (419)
Q Consensus       402 ta~---elL~hp~f~~~  415 (419)
                      ++.   ++-.||||+++
T Consensus      1082 ~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1082 GAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             CcccccccccCCccCCC
Confidence            887   88899999976

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=7.5e-13  Score=129.61  Aligned_cols=247  Identities=19%  Similarity=0.110  Sum_probs=176.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc-CCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV-NTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..+|..+..||.|.|+.|+.+... .++..+++|-+.+..     ...-..|+.+...+..|.+++.+...+...  ...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--r~~  341 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--RQG  341 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc--ccc
Confidence            567889999999999999987644 678888988775432     122346777777777889999888777443  445


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++-.||+++++.....   ..+.+...+.+..|++.++.++|+..++|+|+||+||++..+..-.+++|||....+.  -
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~--~  419 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA--F  419 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc--e
Confidence            5888999998876554   4578888899999999999999999999999999999998864566899999876421  1


Q ss_pred             cceeeccccccc-ccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          275 EYNVRVASRYFK-GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       275 ~~~~~~~~~~y~-aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      ..........++ ..|++.....+..+.|++|||..+.+.++|...-..+.    +...+..                  
T Consensus       420 ~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~------------------  477 (524)
T KOG0601|consen  420 SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRS------------------  477 (524)
T ss_pred             ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeec------------------
Confidence            112223333444 35655554677889999999999999998874321110    0000000                  


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                       .  ..........++..+...+...++..|+.+.++..|+-|...
T Consensus       478 -----------------~--~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  478 -----------------G--DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             -----------------c--cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence                             0  000001133678889999999999999999999998877643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.22  E-value=2.2e-10  Score=96.59  Aligned_cols=136  Identities=19%  Similarity=0.281  Sum_probs=96.9

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .+..|-+|+-+.|+++.  ..|+.++||.-.+.           .+++.++|+..|.++. --.|.--.-+|.+...+  
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~--   85 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGG--   85 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCC--
Confidence            46778999999999994  57888888854211           2456788999999873 22332222234344333  


Q ss_pred             EEEEEecCCC-Chhhhc----CC-CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcE--EEEeccccee
Q 014762          198 SLIFEYVNST-DFKVLY----PT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL--RLIDWGLAEF  269 (419)
Q Consensus       198 ~lv~e~~~~~-~l~~~~----~~-l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~--kl~Dfgla~~  269 (419)
                      .++|||++|. ++..++    .. ........++.++-+.+.-||.++|+|+||..+||++.++.+.+  .++|||++..
T Consensus        86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            4999999883 444444    22 23333367888999999999999999999999999998775554  8999999854

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.19  E-value=2.7e-10  Score=102.54  Aligned_cols=138  Identities=25%  Similarity=0.401  Sum_probs=104.0

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCC-CCeeEEEeEEEccC-CCccEEEEEec
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGG-PNVVKLLDIVRDQH-SKTPSLIFEYV  204 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~-~~~~~lv~e~~  204 (419)
                      +.||.|.++.||++.. .+|+.+++|+.....    ...+.+|+.+++.+..+ .++.+++.+..... ....++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            5689999999999975 346789999986532    46788999999999432 34567777764321 12568999999


Q ss_pred             CCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 014762          205 NSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHS---------------------------------------------  237 (419)
Q Consensus       205 ~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~---------------------------------------------  237 (419)
                      +|.++....  ..++......++.+++++|..||+                                             
T Consensus        83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (223)
T cd05154          83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR  162 (223)
T ss_pred             CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence            999887655  356777777777888888877773                                             


Q ss_pred             -----------CCcEeecCCCCceEEcCC-CCcEEEEeccccee
Q 014762          238 -----------QGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEF  269 (419)
Q Consensus       238 -----------~~ivH~Dlk~~NILl~~~-~~~~kl~Dfgla~~  269 (419)
                                 ..++|+|+++.||+++.+ .+.+.|+||+.+..
T Consensus       163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       246999999999999983 25678999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.19  E-value=1e-09  Score=105.86  Aligned_cols=164  Identities=17%  Similarity=0.257  Sum_probs=125.2

Q ss_pred             CceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEcc--CCCccEEEEEecCCC-Chh
Q 014762          137 KYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSLIFEYVNST-DFK  210 (419)
Q Consensus       137 ~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~lv~e~~~~~-~l~  210 (419)
                      ...+.|++....+|..|++|++..   ....+.-.-+++++++ .|+|+|++.++|...  +...+++||+|.++. +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            345789999999999999999932   2222333457788999 899999999988622  345688999998764 454


Q ss_pred             hhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          211 VLY------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       211 ~~~------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ++.                  ...++..++.++.|+..||.++|+.|+.-+-|.+.+||++.+ .+++|+..|.......
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~-~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK-MRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc-ceEEEecccceeeecC
Confidence            432                  136788999999999999999999999999999999999987 5888888887765543


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~p  319 (419)
                      +..             |.+.+    -.+-|.=.||.+++.|.+|..-
T Consensus       446 d~~-------------~~le~----~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT-------------EPLES----QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC-------------cchhH----HhhhhHHHHHHHHHHHhhcccc
Confidence            330             11222    2356888999999999999754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=4.1e-10  Score=95.35  Aligned_cols=126  Identities=21%  Similarity=0.357  Sum_probs=91.5

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecCc-----------chHHHHHHHHHHHHhcC-CCCeeEEEeEEEccCCCccEE
Q 014762          132 KVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .+++|+-+.+|.+..  -|..+++|.--+.           .+..-.+|+.++.++.. --+...++++.  +  ....+
T Consensus         3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~--~~~~I   76 (204)
T COG3642           3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P--DNGLI   76 (204)
T ss_pred             hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C--CCCEE
Confidence            478899999999854  3445777754221           12456689999988732 12444455554  3  33459


Q ss_pred             EEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      +|||.+|..+.+.+..-.    ..++..+-.-+.-||..||||+||.++||+++.+  .+.++|||++..
T Consensus        77 ~me~I~G~~lkd~l~~~~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          77 VMEYIEGELLKDALEEAR----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEeCChhHHHHHHhcc----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence            999999999987765442    4456667777888999999999999999999875  489999999864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.15  E-value=8.4e-10  Score=103.94  Aligned_cols=257  Identities=16%  Similarity=0.193  Sum_probs=156.9

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEE----eEEEcc-CCCccEEEEEe
Q 014762          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL----DIVRDQ-HSKTPSLIFEY  203 (419)
Q Consensus       129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~----~~~~~~-~~~~~~lv~e~  203 (419)
                      ..+.||+|+-+.+|-.-   .-...+-|++..-....-.+-+..|.....||-+-.-+    ....+. .+.-+.++|..
T Consensus        15 ~gr~LgqGgea~ly~l~---e~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          15 PGRPLGQGGEADLYTLG---EVRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             CCccccCCccceeeecc---hhhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            35679999999999642   22234558875333222223344455554565433211    111111 22235577776


Q ss_pred             cCCCC-hhh---------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          204 VNSTD-FKV---------LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       204 ~~~~~-l~~---------~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      +++.. ...         ..+...|..+.+.++.++.+.+-||+.|.+-+|++++|+|++++ ..|.|.|-..-.....+
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LVdsDsfqi~~ng  170 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLVDSDSFQINANG  170 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEEcccceeeccCC
Confidence            65541 222         22457889999999999999999999999999999999999988 78899986665555556


Q ss_pred             CcceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          274 KEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFR-KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g-~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ..+...+|...|.+||...-    .-.-+...|.|.||+++++++.| ++||. |...      +..  .+++.+.-+-.
T Consensus       171 ~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys-GI~~------~~~--ap~p~E~~Ia~  241 (637)
T COG4248         171 TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS-GIPL------ISD--APNPLETDIAH  241 (637)
T ss_pred             ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC-cccc------cCC--CCCcchhhhhc
Confidence            66677889999999997531    12346789999999999999887 88883 2110      000  01111111111


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCC--CCCCCCCHHHH
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY--DHQDRLTAREA  406 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--dP~~Rpta~el  406 (419)
                      ......++     .....++..   ..-....+++++..++.+|+..  ++.-|||++.-
T Consensus       242 g~f~ya~~-----~~~g~~p~P---~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW  293 (637)
T COG4248         242 GRFAYASD-----QRRGLKPPP---RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW  293 (637)
T ss_pred             ceeeechh-----ccCCCCCCC---CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence            11111111     011111111   1111233788999999999986  46789998753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.04  E-value=6.3e-11  Score=117.91  Aligned_cols=155  Identities=17%  Similarity=0.208  Sum_probs=111.3

Q ss_pred             HHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCccee----------ecccccccccccccCC
Q 014762          226 YELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----------RVASRYFKGPELLVDL  294 (419)
Q Consensus       226 ~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~----------~~~~~~y~aPE~~~~~  294 (419)
                      .+++.||.|+|. .++||+.|.|++|.++.+ +..||+.|+.+....+...+..          ......|.|||++.+ 
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-  183 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence            344599999996 599999999999999988 8899999998765443222211          123345999999987 


Q ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCcccccc
Q 014762          295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN  374 (419)
Q Consensus       295 ~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (419)
                      ...+.++|+||+||++|.+..|+.+.+.+.........-....+..                         ...      
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-------------------------~~~------  232 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-------------------------AFG------  232 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-------------------------ccc------
Confidence            7788999999999999999866666544332222111111000000                         000      


Q ss_pred             ccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          375 ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       375 ~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                        ....+++++++=+.++|..++..||++.+++..|||.+.
T Consensus       233 --~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  233 --YSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             --ccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence              013488999999999999999999999999999999865

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=3.5e-09  Score=92.25  Aligned_cols=122  Identities=25%  Similarity=0.403  Sum_probs=80.5

Q ss_pred             EEEEEEEcCCCcEEEEEEecCcc-----------------------------hHHHHHHHHHHHHhcCC-CCeeEEEeEE
Q 014762          140 EVFEGINVNTNERCIIKILKPVK-----------------------------KKKIKREIKILQNLCGG-PNVVKLLDIV  189 (419)
Q Consensus       140 ~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~~l~~h-~niv~l~~~~  189 (419)
                      .||.|.. .+|..+|+|+.+...                             .....+|...|.++... -++.+.+++-
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            3899964 577899999874210                             12356899999998433 2566776553


Q ss_pred             EccCCCccEEEEEecC--CCChhhhcCC-CCHHHHHHHHHHHHHHHHH-HHHCCcEeecCCCCceEEcCCCCcEEEEecc
Q 014762          190 RDQHSKTPSLIFEYVN--STDFKVLYPT-LTDYDIRYYIYELLKALDY-CHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (419)
Q Consensus       190 ~~~~~~~~~lv~e~~~--~~~l~~~~~~-l~~~~~~~~~~qi~~~L~~-LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfg  265 (419)
                        .    -++||||++  |..+..+... ++..+...++.+++..+.. +|+.||+|+|+.+.|||++.+  .+.|+|||
T Consensus        80 --~----~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~  151 (188)
T PF01163_consen   80 --R----NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG  151 (188)
T ss_dssp             --T----TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred             --C----CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence              2    249999999  6555444322 2345567778888886665 579999999999999999976  68999999


Q ss_pred             cceec
Q 014762          266 LAEFY  270 (419)
Q Consensus       266 la~~~  270 (419)
                      .+...
T Consensus       152 qav~~  156 (188)
T PF01163_consen  152 QAVDS  156 (188)
T ss_dssp             TEEET
T ss_pred             cceec
Confidence            88654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.93  E-value=4.2e-08  Score=90.61  Aligned_cols=126  Identities=18%  Similarity=0.149  Sum_probs=88.9

Q ss_pred             EEEEEEcCCCcEEEEEEecCcch--------------HHHHHHHHHHHHhcCCCCe--eEEEeEEEccC---CCccEEEE
Q 014762          141 VFEGINVNTNERCIIKILKPVKK--------------KKIKREIKILQNLCGGPNV--VKLLDIVRDQH---SKTPSLIF  201 (419)
Q Consensus       141 V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~E~~~l~~l~~h~ni--v~l~~~~~~~~---~~~~~lv~  201 (419)
                      |+++.  -.|+.+.||.......              ..+.+|...+.++ ...+|  ...+.+.....   ...-++|+
T Consensus        38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            55553  3566788887643221              1477899988887 22222  23344443211   23457999


Q ss_pred             EecCCC-ChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC------CCCcEEEEeccccee
Q 014762          202 EYVNST-DFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------ELRKLRLIDWGLAEF  269 (419)
Q Consensus       202 e~~~~~-~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~------~~~~~kl~Dfgla~~  269 (419)
                      |++++. ++.+++.     ..+......++.+++..+.-||+.||+|+|++++|||++.      +...+.++||+.++.
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            999986 7877753     3455677789999999999999999999999999999985      236789999998753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.85  E-value=2.4e-08  Score=89.77  Aligned_cols=133  Identities=22%  Similarity=0.352  Sum_probs=98.1

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-------------------------chHHHHHHHHHHHHhcCC-C
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------------------------KKKKIKREIKILQNLCGG-P  180 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-------------------------~~~~~~~E~~~l~~l~~h-~  180 (419)
                      +.+..+||-|--|.||.|.+. .|.++|||.-+-.                         .+...++|.++|.+|... -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            456788999999999999764 7889999975310                         123467899999999332 2


Q ss_pred             CeeEEEeEEEccCCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEE
Q 014762          181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (419)
Q Consensus       181 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~k  260 (419)
                      .+.+-+++-      .-++|||+++|..|....  ++.++...++..|++-+.-+-..|+||+|+++-||+++++ +.+.
T Consensus       172 ~VP~P~~~n------RHaVvMe~ieG~eL~~~r--~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~~~  242 (304)
T COG0478         172 KVPKPIAWN------RHAVVMEYIEGVELYRLR--LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GDIV  242 (304)
T ss_pred             CCCCccccc------cceeeeehcccceeeccc--CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CCEE
Confidence            455555542      235999999997765442  2455556666677776666668999999999999999998 7899


Q ss_pred             EEeccccee
Q 014762          261 LIDWGLAEF  269 (419)
Q Consensus       261 l~Dfgla~~  269 (419)
                      ++||--+..
T Consensus       243 vIDwPQ~v~  251 (304)
T COG0478         243 VIDWPQAVP  251 (304)
T ss_pred             EEeCccccc
Confidence            999976543

>PRK09902 hypothetical protein; Provisional

Probab=98.75  E-value=2.2e-07  Score=81.65  Aligned_cols=133  Identities=17%  Similarity=0.147  Sum_probs=94.9

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEec---------CcchHHHHHHHHHHHHhcCC-CCeeEEEeEEE---ccCCCccEE
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQNLCGG-PNVVKLLDIVR---DQHSKTPSL  199 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~---~~~~~~~~l  199 (419)
                      -|+||.|.|+....  .|+.+-+|.-.         +.....|.+|+..+..+... -.+.+.. ++.   ......-+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            46788889988643  34467778654         34567899999999988321 1133333 222   222233568


Q ss_pred             EEEecCC-CChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCc--EEEEeccccee
Q 014762          200 IFEYVNS-TDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEF  269 (419)
Q Consensus       200 v~e~~~~-~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~--~kl~Dfgla~~  269 (419)
                      |+|-+++ .+|.+++.     ..+......++.+++..+.-||+.|+.|+|+.+.|||++.+ +.  ++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence            9997765 47776652     34666778899999999999999999999999999999865 44  89999987653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.68  E-value=2.6e-07  Score=82.41  Aligned_cols=108  Identities=25%  Similarity=0.346  Sum_probs=80.9

Q ss_pred             hHHHHHHHHHHHHhcC-CCCeeEEEeEEEccC--CCccEEEEEecCCC-ChhhhcCC---CCHHHHHHHHHHHHHHHHHH
Q 014762          163 KKKIKREIKILQNLCG-GPNVVKLLDIVRDQH--SKTPSLIFEYVNST-DFKVLYPT---LTDYDIRYYIYELLKALDYC  235 (419)
Q Consensus       163 ~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~--~~~~~lv~e~~~~~-~l~~~~~~---l~~~~~~~~~~qi~~~L~~L  235 (419)
                      .....+|...+..+.. .=...+.+++.....  ....++|+|++++. +|..++..   .+......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            4567788888777721 112344555544321  23347999999885 78887754   66777888999999999999


Q ss_pred             HHCCcEeecCCCCceEEcCCC--CcEEEEecccceec
Q 014762          236 HSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFY  270 (419)
Q Consensus       236 H~~~ivH~Dlk~~NILl~~~~--~~~kl~Dfgla~~~  270 (419)
                      |+.||+|+|+++.|||++.+.  ..+.++||+.++..
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999999873  27899999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.52  E-value=9.6e-07  Score=88.42  Aligned_cols=135  Identities=16%  Similarity=0.374  Sum_probs=87.2

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHH-------------------------------------------H
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI-------------------------------------------K  167 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------------~  167 (419)
                      +.|+.++-|.||+|+. .+|+.||||+..|.-.+.+                                           .
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            5699999999999975 5699999999876443332                                           2


Q ss_pred             HHHHHHHHhc----CCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHH-HHHHHHHC
Q 014762          168 REIKILQNLC----GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLK-ALDYCHSQ  238 (419)
Q Consensus       168 ~E~~~l~~l~----~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~-~L~~LH~~  238 (419)
                      +|...+.++.    +.+++ .+=.++.+- ...-.|+|||++|-.+.+..    ..++...+   +..++. .+.-+-..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~i---a~~~~~~f~~q~~~d  284 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKEL---AELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-Eeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHH---HHHHHHHHHHHHHhc
Confidence            3443333331    22332 222233221 13346999999998776653    23443332   222222 22333358


Q ss_pred             CcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       239 ~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      |+.|.|..|.||+++.+ +++.+.|||+.....+
T Consensus       285 gffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence            99999999999999999 8999999999876553

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.50  E-value=2.8e-06  Score=76.89  Aligned_cols=138  Identities=22%  Similarity=0.424  Sum_probs=83.4

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCC-CCeeEEEeEEEcc-CCCccEEEEEecCC
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-PNVVKLLDIVRDQ-HSKTPSLIFEYVNS  206 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~-~~~~~~lv~e~~~~  206 (419)
                      ++.|+.|..+.||+.....  ..+++|..... ....+.+|..+++.+..+ ..+.+++...... .....+++|++++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            4679999999999996533  58999998765 456788999999988433 2356677654333 22346899999999


Q ss_pred             CChhhh----------------c--------C--CCCHHH------HHHH---------------HHHHHH-HHHHHHH-
Q 014762          207 TDFKVL----------------Y--------P--TLTDYD------IRYY---------------IYELLK-ALDYCHS-  237 (419)
Q Consensus       207 ~~l~~~----------------~--------~--~l~~~~------~~~~---------------~~qi~~-~L~~LH~-  237 (419)
                      ..+...                +        .  .+....      ....               ...+.. .+..+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            877660                0        0  000000      0000               111222 2333332 


Q ss_pred             ------CCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          238 ------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       238 ------~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                            ..++|+|+.+.|||++.+.+.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                  35999999999999994436667999997753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.50  E-value=2e-06  Score=76.72  Aligned_cols=133  Identities=16%  Similarity=0.265  Sum_probs=91.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----------------------hHH-----HHHHHHHHHHhc-CCCC
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------------------KKK-----IKREIKILQNLC-GGPN  181 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------------------~~~-----~~~E~~~l~~l~-~h~n  181 (419)
                      ...|..|.-+.||+|. ..++..+|+|+++...                      +.+     ...|+.-|.++. .+=.
T Consensus        53 ~g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            3467788888999996 4678999999986321                      011     235777777663 2234


Q ss_pred             eeEEEeEEEccCCCccEEEEEecCCCCh-hhhcCC--CCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCC
Q 014762          182 VVKLLDIVRDQHSKTPSLIFEYVNSTDF-KVLYPT--LTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELR  257 (419)
Q Consensus       182 iv~l~~~~~~~~~~~~~lv~e~~~~~~l-~~~~~~--l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~  257 (419)
                      +.+-+++.  .    -.|||||++.... ...+..  +...+...+..++++.+.-|-. .++||+||+.=|||+. + +
T Consensus       132 vP~Pi~~~--~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~-~  203 (268)
T COG1718         132 VPEPIAFR--N----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D-G  203 (268)
T ss_pred             CCCceeec--C----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C-C
Confidence            44555554  2    2499999976621 111221  2333677888899999998876 8999999999999999 4 6


Q ss_pred             cEEEEecccceecc
Q 014762          258 KLRLIDWGLAEFYH  271 (419)
Q Consensus       258 ~~kl~Dfgla~~~~  271 (419)
                      .+.|+|||-|....
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            78999999886543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.50  E-value=2.4e-06  Score=77.23  Aligned_cols=131  Identities=19%  Similarity=0.263  Sum_probs=81.6

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCC-CeeEEEeEEEccCCCccEEEEEecCCCC
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNSTD  208 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~~~~~  208 (419)
                      ..||+|..+.||+.    .+..+++|...+.. .....+|.+++..+.... .+.+.+++..+.  ....+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~--~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDG--GRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecC--CeeeeeeeecCCcc
Confidence            56899999999984    24467889887533 456789999999984332 246777777443  44568999999963


Q ss_pred             -hhhhc---------------------CCC-----CHHHH-HHHHH----------HHHH-HHHHHHH----CCcEeecC
Q 014762          209 -FKVLY---------------------PTL-----TDYDI-RYYIY----------ELLK-ALDYCHS----QGIMHRDV  245 (419)
Q Consensus       209 -l~~~~---------------------~~l-----~~~~~-~~~~~----------qi~~-~L~~LH~----~~ivH~Dl  245 (419)
                       +....                     ..+     ..... ..+-.          ++.. ...+|..    ..++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             11110                     110     10000 00100          0111 1222321    25789999


Q ss_pred             CCCceEEcCCCCcEEEEeccccee
Q 014762          246 KPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       246 k~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      .|.||+++.+ + +.++||+.+..
T Consensus       161 ~~~Nii~~~~-~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGK-G-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCC-C-cEEEechhcCc
Confidence            9999999987 5 89999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.44  E-value=1.8e-08  Score=99.66  Aligned_cols=242  Identities=17%  Similarity=0.147  Sum_probs=162.9

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCC-eeEEEeEEEccCCCccEEEEEe
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN-VVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      .-|...+-+++|+.++++|.+...+...+ .+.+...  ....-++++|.++ +||| .+..++-+  +.+....+.+++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~-n~P~~~v~~~~d~--~~E~~~~i~~~i  315 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKV-NNPNPVVRYLEDY--DGEDYLWIPMRI  315 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHc-cCCCCcccccccC--Ccccccchhhhh
Confidence            34556677999999999999776665555 6776543  4445578899999 9999 55555554  445677889999


Q ss_pred             cCCC-Chhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCccee
Q 014762          204 VNST-DFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  278 (419)
Q Consensus       204 ~~~~-~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~  278 (419)
                      ++.+ +.....    -.+...+...+.+.-+++++++|+-.=+|+|    ||+..++  ..+..||+....+......+.
T Consensus       316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~~t  389 (829)
T KOG0576|consen  316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKPRT  389 (829)
T ss_pred             hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCccccccc
Confidence            9877 221111    1244445556667778899999988778988    8888764  569999999877766555566


Q ss_pred             ecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhH
Q 014762          279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLD  358 (419)
Q Consensus       279 ~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~  358 (419)
                      ..+++.|+|||+... ..+....|.||+|+--.++--|-.|--.   +....    ...|..+           -.+.+.
T Consensus       390 ~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~---P~~~~----~~~g~~p-----------~s~~L~  450 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSS---PPAVL----PMIGNGP-----------NSPMLT  450 (829)
T ss_pred             CCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCC---Ccccc----CCCCCCC-----------Cccccc
Confidence            789999999999876 7889999999999876677666655421   00000    0011111           000000


Q ss_pred             HhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      +.      ..|.           ...-.++...|+.-.|..|+++.+++.|.+|+.
T Consensus       451 ~~------~aw~-----------~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  451 DK------SAWS-----------PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             hh------hhcC-----------cccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            00      0011           011125788999999999999999999988874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.44  E-value=3.1e-06  Score=77.54  Aligned_cols=75  Identities=21%  Similarity=0.204  Sum_probs=53.8

Q ss_pred             eeeeCc-eEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhh
Q 014762          133 VGRGKY-SEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV  211 (419)
Q Consensus       133 lG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~  211 (419)
                      |-.|.+ +.||+...  .+..+.+|+..........+|+.+++.+.++--+.+++++....  ...++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHhH
Confidence            444444 78999853  34678889886554556788999999986565566788877543  45679999999887653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.39  E-value=6.7e-06  Score=72.61  Aligned_cols=136  Identities=15%  Similarity=0.262  Sum_probs=87.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch------------HHHHHHHHHHHHhc--CCCCeeEEEeEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------------KKIKREIKILQNLC--GGPNVVKLLDIV  189 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~E~~~l~~l~--~h~niv~l~~~~  189 (419)
                      .++|...+.+-......|.+-  .-+|..+++|...+..+            ....+++..+.++.  +--....++-..
T Consensus        30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            567888888877776667665  44678889998764332            11233444444431  222233322222


Q ss_pred             Ecc---CCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          190 RDQ---HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       190 ~~~---~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ...   -....+++|||++|..+.+.. .+++    .+...+.+++.-||+.|+.|+|.+|.|++++.+  .++++||+.
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~  180 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIE-DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQG  180 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccch-hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECcc
Confidence            211   113346899999998876542 2332    244567788999999999999999999999965  489999986


Q ss_pred             ce
Q 014762          267 AE  268 (419)
Q Consensus       267 a~  268 (419)
                      .+
T Consensus       181 k~  182 (229)
T PF06176_consen  181 KR  182 (229)
T ss_pred             cc
Confidence            54

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.33  E-value=2.1e-06  Score=90.72  Aligned_cols=198  Identities=17%  Similarity=0.203  Sum_probs=134.2

Q ss_pred             HHHHHHHHHhcCCCCeeEEEeEEEccCCCc--cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcE
Q 014762          167 KREIKILQNLCGGPNVVKLLDIVRDQHSKT--PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIM  241 (419)
Q Consensus       167 ~~E~~~l~~l~~h~niv~l~~~~~~~~~~~--~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~iv  241 (419)
                      .-|...+.++ .|+|++.++.|-.......  ..+..+++...++...+   ...+....+.+..++.+||.|+|+....
T Consensus       230 E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~  308 (1351)
T KOG1035|consen  230 EIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE  308 (1351)
T ss_pred             HHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence            4466777787 8999999998875432222  22334667666665555   4578889999999999999999998666


Q ss_pred             eecCCCC---ceEEcCCCCcEEEE--ecccceeccCCCcceeecccccccccccccCCCCCC--ccccHHHHHHHHHHHH
Q 014762          242 HRDVKPH---NVMIDHELRKLRLI--DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD--YSLDMWSLGCMFAGMI  314 (419)
Q Consensus       242 H~Dlk~~---NILl~~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~DiwSlG~~l~ell  314 (419)
                      |.-+..+   +-..+.+ +.+.++  ||+.++.............+..+.++|.... ..++  ...|+|.+|.....+.
T Consensus       309 ~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  309 HVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             eeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhhh
Confidence            6655555   3333444 445555  8888776655444444455566778887654 3333  3479999999999998


Q ss_pred             hCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcC
Q 014762          315 FRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR  394 (419)
Q Consensus       315 ~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  394 (419)
                      .|..+-...       ..+...++.                                        ....+..++..+|+.
T Consensus       387 ~~~~i~~~~-------~~~~~~l~~----------------------------------------~~~~~~~d~~~~~~~  419 (1351)
T KOG1035|consen  387 QGEDISEKS-------AVPVSLLDV----------------------------------------LSTSELLDALPKCLD  419 (1351)
T ss_pred             hcCcccccc-------cchhhhhcc----------------------------------------ccchhhhhhhhhhcc
Confidence            877553111       000010000                                        012267899999999


Q ss_pred             CCCCCCCCHHHHhcCCCccc
Q 014762          395 YDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       395 ~dP~~Rpta~elL~hp~f~~  414 (419)
                      -++++|+++.+++.|+|.+.
T Consensus       420 ~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  420 EDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hhhhhccchhhhhhchhccc
Confidence            99999999999999999874

>PLN02876 acyl-CoA dehydrogenase

Probab=98.30  E-value=1.4e-05  Score=85.92  Aligned_cols=143  Identities=20%  Similarity=0.349  Sum_probs=91.4

Q ss_pred             EeeeeeeCceEEEEEEEcCCC--cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCe--eEEEeEEEccC-CCccEEE
Q 014762          130 VRKVGRGKYSEVFEGINVNTN--ERCIIKILKPV----KKKKIKREIKILQNLCGGPNV--VKLLDIVRDQH-SKTPSLI  200 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~--~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~ni--v~l~~~~~~~~-~~~~~lv  200 (419)
                      +..++.|.++.+|+.....++  ..+++|+....    ....+.+|+.+++.+..|.++  .+++.+|.+.. ....++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567899999999998654332  46777776432    235788999999999446654  78888886532 2457899


Q ss_pred             EEecCCCChhhh-----------------------cCCCC----------------HHHHHHHHH---------------
Q 014762          201 FEYVNSTDFKVL-----------------------YPTLT----------------DYDIRYYIY---------------  226 (419)
Q Consensus       201 ~e~~~~~~l~~~-----------------------~~~l~----------------~~~~~~~~~---------------  226 (419)
                      |||++|..+...                       +..++                ..++..+..               
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999988643210                       01111                012211111               


Q ss_pred             HHHHHHHHHHH-----------CCcEeecCCCCceEEcCCCC-cEEEEecccceeccC
Q 014762          227 ELLKALDYCHS-----------QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHP  272 (419)
Q Consensus       227 qi~~~L~~LH~-----------~~ivH~Dlk~~NILl~~~~~-~~kl~Dfgla~~~~~  272 (419)
                      .+...+++|..           ..+||+|+++.||+++.+.+ ..-|.||+++...++
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP  260 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ  260 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence            12234566642           24999999999999986423 357999999876543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.20  E-value=8.2e-05  Score=65.02  Aligned_cols=125  Identities=23%  Similarity=0.303  Sum_probs=90.5

Q ss_pred             CCeEEEeeeeeeCc-eEEEEEEEcCCCcEEEEEEecC------------c------------chHHHHHHHHHHHHhc--
Q 014762          125 DDYEVVRKVGRGKY-SEVFEGINVNTNERCIIKILKP------------V------------KKKKIKREIKILQNLC--  177 (419)
Q Consensus       125 ~~y~~~~~lG~G~f-g~V~~~~~~~~~~~vavK~~~~------------~------------~~~~~~~E~~~l~~l~--  177 (419)
                      .+++.++.||.|.- |.||++.  -+|+.+|+|+++.            .            ...-|..|.....+|.  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 9999995  4778999999421            0            0123677888877773  


Q ss_pred             CCCCe--eEEEeEEEcc----------------CCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014762          178 GGPNV--VKLLDIVRDQ----------------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG  239 (419)
Q Consensus       178 ~h~ni--v~l~~~~~~~----------------~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~  239 (419)
                      ++.++  |+++||+.-.                ......+|.||.....      .+...    -+.+|.+-|..+|..|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~~~~----~~~~~~~dl~~~~k~g  184 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PLQIR----DIPQMLRDLKILHKLG  184 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------ccchh----HHHHHHHHHHHHHHCC
Confidence            34455  9999988422                1112467888877554      22333    3456777888999999


Q ss_pred             cEeecCCCCceEEcCCCCcEEEEecccc
Q 014762          240 IMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (419)
Q Consensus       240 ivH~Dlk~~NILl~~~~~~~kl~Dfgla  267 (419)
                      |+-+|+++.|..   +   -+|+|||.+
T Consensus       185 I~~~Dv~~~ny~---~---G~lvDfs~~  206 (207)
T PF13095_consen  185 IVPRDVKPRNYR---G---GKLVDFSSS  206 (207)
T ss_pred             eeeccCcccccc---C---CEEEecccC
Confidence            999999999985   2   289999964

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.18  E-value=1.5e-05  Score=67.45  Aligned_cols=129  Identities=21%  Similarity=0.327  Sum_probs=90.8

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEec-CcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecC
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN  205 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~  205 (419)
                      .+..+.||+|.+|.||+|.+  .|..+|+|+-. +..+..+..|+++|..+.+----.+++.+-.+      .+.|||..
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~------~i~me~i~   95 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED------FIRMEYID   95 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh------hhhhhhhc
Confidence            34567799999999999965  56688999875 45567899999999998433333456655422      25699999


Q ss_pred             CCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCC--CceEEcCCCCcEEEEeccccee
Q 014762          206 STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP--HNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       206 ~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~--~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      |..|.......+...+    ..+++.---|-..||-|..|+-  .||++..  +.+.|+||..|+.
T Consensus        96 G~~L~~~~~~~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~--~~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIGGDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVND--RDVYIIDFDSATF  155 (201)
T ss_pred             CcchhhhhhcccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecC--CcEEEEEccchhh
Confidence            9888776544433333    3445554445677999999875  4666654  3689999998863

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.13  E-value=1.6e-05  Score=79.46  Aligned_cols=134  Identities=19%  Similarity=0.254  Sum_probs=85.4

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHH----------------------------------------HHHHH
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----------------------------------------IKREI  170 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~E~  170 (419)
                      +.||..+.|.||+|+. .+|+.||||+-++.-.+.                                        |.+|+
T Consensus       167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            5699999999999975 559999999976532211                                        23333


Q ss_pred             HHHHHhc---CCCC------eeEEEeEEEccCCCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHH
Q 014762          171 KILQNLC---GGPN------VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS  237 (419)
Q Consensus       171 ~~l~~l~---~h~n------iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~  237 (419)
                      +-..++.   .|-+      |.+++-.+.    ..-.|+||||+|.-+.+..    .+++...+..-+.+...  +-+=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHh
Confidence            3222221   2333      333333331    3356999999998655442    34666544433333222  22335


Q ss_pred             CCcEeecCCCCceEEcC---CCCcEEEEecccceecc
Q 014762          238 QGIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       238 ~~ivH~Dlk~~NILl~~---~~~~~kl~Dfgla~~~~  271 (419)
                      .|++|+|-.|.||++..   ....+.+-|||+.....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            78999999999999994   34788999999987554

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.13  E-value=6.2e-05  Score=66.21  Aligned_cols=128  Identities=20%  Similarity=0.371  Sum_probs=89.9

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-------------------hHHHHHHHHHHHHhc-----CCCCeeEE
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------------KKKIKREIKILQNLC-----GGPNVVKL  185 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------~~~~~~E~~~l~~l~-----~h~niv~l  185 (419)
                      ...||+|+.-.||.-   ..+....||+..+..                   .++..+|+.-...+.     .+.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346999999999973   344556789987766                   577788888877772     26789999


Q ss_pred             EeEEEccCCCccEEEEEecCCC------ChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC-
Q 014762          186 LDIVRDQHSKTPSLIFEYVNST------DFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL-  256 (419)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~------~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~-  256 (419)
                      +|+.+.+  ....+|+|.+.+.      +|.+++.  .++. .   +...+-+-.+||-+.+|+.+|++|.||++.... 
T Consensus        83 ~G~veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~  156 (199)
T PF10707_consen   83 YGFVETN--LGLGLVVELIRDADGNISPTLEDYLKEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS  156 (199)
T ss_pred             eEEEecC--CceEEEEEEEECCCCCcCccHHHHHHcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence            9999654  4566999987432      4555553  2443 2   333344555678899999999999999996542 


Q ss_pred             -C-cEEEEe-ccc
Q 014762          257 -R-KLRLID-WGL  266 (419)
Q Consensus       257 -~-~~kl~D-fgl  266 (419)
                       . .+.|+| ||.
T Consensus       157 ~~~~lvlIDG~G~  169 (199)
T PF10707_consen  157 GEFRLVLIDGLGE  169 (199)
T ss_pred             CceEEEEEeCCCC
Confidence             2 577777 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.09  E-value=2.9e-05  Score=70.71  Aligned_cols=75  Identities=12%  Similarity=0.174  Sum_probs=47.0

Q ss_pred             eeeeeeCce-EEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCC--CeeEEEeEEEccCC-CccEEEEEecC
Q 014762          131 RKVGRGKYS-EVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP--NVVKLLDIVRDQHS-KTPSLIFEYVN  205 (419)
Q Consensus       131 ~~lG~G~fg-~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~-~~~~lv~e~~~  205 (419)
                      +.|+.||.. .||+.     +..+++|+.+.. ....+.+|..++..+.++-  .+.+.++....... ...+++|++++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            457777776 48875     235778876643 3457889999999884331  23444444322211 24578999999


Q ss_pred             CCChh
Q 014762          206 STDFK  210 (419)
Q Consensus       206 ~~~l~  210 (419)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            87653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=98.02  E-value=0.00013  Score=68.76  Aligned_cols=79  Identities=9%  Similarity=0.144  Sum_probs=58.0

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCC--CCeeEEEeEEEcc-CCCccEEEEEec
Q 014762          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG--PNVVKLLDIVRDQ-HSKTPSLIFEYV  204 (419)
Q Consensus       129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~-~~~~~~lv~e~~  204 (419)
                      -.+.||.|..+.||.... .++ .+.+|..+.. ....+.+|...|+.+.++  -.+.++++++... ..+..++|||++
T Consensus        18 ~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         18 RVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            366799999999999743 233 5677876542 456899999999999554  3678899887543 234478999999


Q ss_pred             CCCCh
Q 014762          205 NSTDF  209 (419)
Q Consensus       205 ~~~~l  209 (419)
                      ++.++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            88653

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.93  E-value=0.00019  Score=65.23  Aligned_cols=74  Identities=16%  Similarity=0.297  Sum_probs=49.9

Q ss_pred             EeeeeeeCceEEEEEEEcC-CCcEEEEEEecCcch--HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCC
Q 014762          130 VRKVGRGKYSEVFEGINVN-TNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ++.|..|-...+|+..... +++.+++|+......  -...+|+.++..+..+.-..++++.+  +.    .++|||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEEeeCC
Confidence            4567888888999985432 356888998764332  23357899999885444455666554  21    289999988


Q ss_pred             CCh
Q 014762          207 TDF  209 (419)
Q Consensus       207 ~~l  209 (419)
                      ..+
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.83  E-value=0.00011  Score=64.23  Aligned_cols=96  Identities=23%  Similarity=0.206  Sum_probs=78.0

Q ss_pred             HHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhh------hcCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 014762          168 REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV------LYPTLTDYDIRYYIYELLKALDYCHS---Q  238 (419)
Q Consensus       168 ~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~------~~~~l~~~~~~~~~~qi~~~L~~LH~---~  238 (419)
                      .|.-+++.+.+.+++.+++|+|  .  .  +++.||.+.+++..      ..-..+|..+..++.++++.+++++.   .
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C--G--~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC--G--R--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC--C--C--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            5888899886667999999999  2  2  37899999765431      11346899999999999999999987   3


Q ss_pred             CcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       239 ~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      .+.-.|++++|+-++.+ +.+|++|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence            58889999999999977 78999999977543

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.75  E-value=0.00022  Score=65.78  Aligned_cols=128  Identities=22%  Similarity=0.255  Sum_probs=76.8

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCcch---HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCCh
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF  209 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l  209 (419)
                      +..|-.+.+|+..  .++..+++|...+...   -...+|..+++.+..+.-..+++...  .    .++||||++|..+
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~~   75 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEVI   75 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCccc
Confidence            5567778899885  4667888888654322   13578999999984442234455443  2    2489999998765


Q ss_pred             hhh-------c----------CC-------CCH-HHHHHHHHHH---------HHHHHHHHH--------CCcEeecCCC
Q 014762          210 KVL-------Y----------PT-------LTD-YDIRYYIYEL---------LKALDYCHS--------QGIMHRDVKP  247 (419)
Q Consensus       210 ~~~-------~----------~~-------l~~-~~~~~~~~qi---------~~~L~~LH~--------~~ivH~Dlk~  247 (419)
                      ...       .          ..       ++. ..+..+..++         ...+..+-.        ..++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            321       0          11       111 1111221111         111222221        2589999999


Q ss_pred             CceEEcCCCCcEEEEecccceec
Q 014762          248 HNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       248 ~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      .||+++.+ + +.|+||+.+...
T Consensus       156 ~Nil~~~~-~-~~lIDwE~a~~g  176 (256)
T TIGR02721       156 YNLVVTPQ-G-LKLIDWEYASDG  176 (256)
T ss_pred             CcEEEeCC-C-CEEEeccccCcC
Confidence            99999976 4 689999988643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.69  E-value=0.00031  Score=66.25  Aligned_cols=137  Identities=14%  Similarity=0.191  Sum_probs=84.5

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCC-CeeEEEeEEEc----cCCCccEEEEEec
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSLIFEYV  204 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~e~~  204 (419)
                      ++.|..|....+|+...  ++..+++|+...........|+.++..+.++- .+.+++....+    ...+..+.|++++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            55688888889999843  34578899987655667888999998884331 24454432110    1123467899999


Q ss_pred             CCCChhhh----c--------------CCC----------CHHHH--H--------HHHHHHHHHHHHHHH-------CC
Q 014762          205 NSTDFKVL----Y--------------PTL----------TDYDI--R--------YYIYELLKALDYCHS-------QG  239 (419)
Q Consensus       205 ~~~~l~~~----~--------------~~l----------~~~~~--~--------~~~~qi~~~L~~LH~-------~~  239 (419)
                      +|..+...    .              ..+          .+...  .        .....+..++.++.+       .+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            88765320    0              011          00000  0        011112334445443       37


Q ss_pred             cEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       240 ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      ++|+|+.|.||+++.+ +.+.|+||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGD-ELSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence            9999999999999976 5568999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.66  E-value=0.00056  Score=64.70  Aligned_cols=74  Identities=18%  Similarity=0.240  Sum_probs=49.6

Q ss_pred             EeeeeeeCceEEEEEEEcC------CCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          130 VRKVGRGKYSEVFEGINVN------TNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~------~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ++.|..|-...+|+.....      .++.+++|+.....  .....+|..++..+..+.-..++++.+.+  +    +|+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--~----~v~   76 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN--G----RIE   76 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC--C----chh
Confidence            3456667777889886432      25789999986542  24567899999988544444566766632  1    689


Q ss_pred             EecCCCCh
Q 014762          202 EYVNSTDF  209 (419)
Q Consensus       202 e~~~~~~l  209 (419)
                      ||++|..+
T Consensus        77 e~i~G~~l   84 (302)
T cd05156          77 EFIPSRTL   84 (302)
T ss_pred             heeCCCcC
Confidence            99888755

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.50  E-value=0.00093  Score=63.73  Aligned_cols=137  Identities=13%  Similarity=0.213  Sum_probs=77.1

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCC-CCeeEEEeEE----EccCCCccEEEEEec
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDIV----RDQHSKTPSLIFEYV  204 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~~----~~~~~~~~~lv~e~~  204 (419)
                      .+.|+.|...++|+... .+| .+++|++.....+....|+.++..|..+ -.+.+.+...    .....+..+++++|+
T Consensus        27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             cchhccccccceEEEEe-CCC-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            45577788889999853 334 6888988633445666777777777322 1133333211    001124467999999


Q ss_pred             CCCChhh-----h------c-------CCC----------CH-HHH-HH-----------HHHH-HHHHHHHHH------
Q 014762          205 NSTDFKV-----L------Y-------PTL----------TD-YDI-RY-----------YIYE-LLKALDYCH------  236 (419)
Q Consensus       205 ~~~~l~~-----~------~-------~~l----------~~-~~~-~~-----------~~~q-i~~~L~~LH------  236 (419)
                      +|.....     .      +       ..+          .+ ... ..           .+.+ +...++.+.      
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            8874311     1      0       111          01 010 00           1111 111223332      


Q ss_pred             -HCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          237 -SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       237 -~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                       ..++||+|+.+.||+++.+ ...-|+||+.+..
T Consensus       185 lp~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~  217 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGD-RLSGFIDFYFACN  217 (319)
T ss_pred             CCcccCCCCCCCCcEEEECC-ceEEEEecccccC
Confidence             2389999999999999865 4457999998854

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.47  E-value=0.0015  Score=63.71  Aligned_cols=74  Identities=18%  Similarity=0.239  Sum_probs=52.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecC----------cchHHHHHHHHHHHHhcCC--CCeeEEEeEEEccCCCcc
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~  197 (419)
                      .+.||.|.+..||++.+..+++.++||.-.+          -..++...|.+.|..+...  .++.+++.+-  +  ...
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~--~~~  106 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E--ELA  106 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CCC
Confidence            4679999999999998754446899997431          1345677888888876433  4567777774  2  335


Q ss_pred             EEEEEecCCC
Q 014762          198 SLIFEYVNST  207 (419)
Q Consensus       198 ~lv~e~~~~~  207 (419)
                      ++||||+++.
T Consensus       107 ~lVME~L~~~  116 (401)
T PRK09550        107 VTVMEDLSDH  116 (401)
T ss_pred             EEEEecCCCc
Confidence            6999998764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.32  E-value=0.00092  Score=65.75  Aligned_cols=175  Identities=18%  Similarity=0.193  Sum_probs=104.8

Q ss_pred             hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 014762          163 KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMH  242 (419)
Q Consensus       163 ~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH  242 (419)
                      ..++.-...+++.+ .|+|+..++++-...... ..+|+|+++.++-+.......  .       ..+++    .+++.|
T Consensus        26 s~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~r-~IVV~e~~~~Sled~~~~~~l--~-------~~s~~----~~~~~~   90 (725)
T KOG1093|consen   26 SIQILGRFQYLKSL-QHDNLCQYLDFSRGKHER-VIVVMEHYTMSLEDILKTGNL--K-------DESLL----AHGVLH   90 (725)
T ss_pred             HHHHhhhhHHHHhh-cCccceeeEeeecCccce-EEEEehhhccchHHHHHhccc--c-------hhhhc----ccccce
Confidence            34556677888888 999999999988765443 778999988654332221110  0       00111    222222


Q ss_pred             ecCCCCceEEcCCCCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 014762          243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY  322 (419)
Q Consensus       243 ~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~  322 (419)
                      -             +..+.+| -++.               .|  |-      ...+++||||+|.++.++.-|...+ .
T Consensus        91 ~-------------~~~~~td-~~~t---------------~~--~~------~~~pKsdVwsl~~i~~el~L~~~l~-~  132 (725)
T KOG1093|consen   91 L-------------NIIYITD-HFLT---------------KY--PS------PIGPKSDVWSLGFIILELYLGISLE-A  132 (725)
T ss_pred             e-------------hhhhccc-cccc---------------cC--CC------CCCcchhhhhHHHHHHHHHHhhHHH-H
Confidence            1             2334444 0000               01  11      1124999999999999999998765 3


Q ss_pred             CCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC
Q 014762          323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT  402 (419)
Q Consensus       323 ~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  402 (419)
                      .....+++..+.+..-.+.........         ..                ..-.++....++..+|+-..|..||.
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e---------~~----------------~~~~~d~~~~~~~~~c~~~~~~ir~l  187 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQELLSTAME---------HL----------------IQLLADKKRLPLLKKCLWLEPIIRPL  187 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhHHHHHHH---------HH----------------HHHhhhHhHHHHhccCCccccccccc
Confidence            444555555555433222211111000         00                00126778899999999999999999


Q ss_pred             HHHHhcCCCcccc
Q 014762          403 AREAMVISSISPI  415 (419)
Q Consensus       403 a~elL~hp~f~~~  415 (419)
                      ..++.+++-|..+
T Consensus       188 ~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  188 PMELSKRCSFTEV  200 (725)
T ss_pred             hhHHhcCccHHHH
Confidence            9999999998866

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.31  E-value=0.0019  Score=61.31  Aligned_cols=138  Identities=18%  Similarity=0.264  Sum_probs=82.0

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCC-CeeEEEeEEE----ccCCCccEEEEE
Q 014762          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP-NVVKLLDIVR----DQHSKTPSLIFE  202 (419)
Q Consensus       129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~-niv~l~~~~~----~~~~~~~~lv~e  202 (419)
                      .+..++.|....+|+... .+| .+++|+.... ..+....|..++..|.++- .+.+++....    ....+..+++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            356678887789998853 344 5778987643 2456677888888873221 2444443211    111245689999


Q ss_pred             ecCCCChhh-----h------c-------CCCC--------HHH---H--H----------HHHHHHHHHHHHHHH----
Q 014762          203 YVNSTDFKV-----L------Y-------PTLT--------DYD---I--R----------YYIYELLKALDYCHS----  237 (419)
Q Consensus       203 ~~~~~~l~~-----~------~-------~~l~--------~~~---~--~----------~~~~qi~~~L~~LH~----  237 (419)
                      |++|..+..     .      +       ..++        ...   .  .          .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998864321     0      0       1110        000   0  0          001123345555542    


Q ss_pred             ---CCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          238 ---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       238 ---~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                         .+++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECC-ceEEEeecccccC
Confidence               589999999999999987 5568999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.19  E-value=0.0067  Score=57.59  Aligned_cols=133  Identities=18%  Similarity=0.266  Sum_probs=90.2

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-------------------------hHH----HHHHHHHHHHhcCC
Q 014762          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------------------------KKK----IKREIKILQNLCGG  179 (419)
Q Consensus       129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------------~~~----~~~E~~~l~~l~~h  179 (419)
                      +-..|..|--+.||.|. ..+|..+|||+++.+-                         ++.    ...|+.-|.++ ..
T Consensus       148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~~  225 (520)
T KOG2270|consen  148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-NN  225 (520)
T ss_pred             cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-Hh
Confidence            44568889999999996 5678889999985210                         111    23577778877 32


Q ss_pred             CCeeEEEeEEEccCCCccEEEEEecCCCChhhh-c--CCCCHHHHHHHHHHHHHHHHHHH-HCCcEeecCCCCceEEcCC
Q 014762          180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-Y--PTLTDYDIRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHE  255 (419)
Q Consensus       180 ~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~l~~~~~~~~~~qi~~~L~~LH-~~~ivH~Dlk~~NILl~~~  255 (419)
                      -.|.----+..    +.-.|||++++....-.- +  -.++...+..+-.|++.-+.-|- .+++||.||.--|+|+.. 
T Consensus       226 aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-  300 (520)
T KOG2270|consen  226 AGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-  300 (520)
T ss_pred             cCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-
Confidence            22221111111    123599999985543221 2  24677778888788888888774 679999999999999985 


Q ss_pred             CCcEEEEeccccee
Q 014762          256 LRKLRLIDWGLAEF  269 (419)
Q Consensus       256 ~~~~kl~Dfgla~~  269 (419)
                       |.+.|+|-+-+..
T Consensus       301 -G~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 -GKLYIIDVSQSVE  313 (520)
T ss_pred             -CEEEEEEcccccc
Confidence             6799999987653

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.14  E-value=0.0038  Score=58.19  Aligned_cols=32  Identities=34%  Similarity=0.631  Sum_probs=25.8

Q ss_pred             CcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       239 ~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      .++|+|+++.|||++.+....-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            48999999999999975234579999988643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.10  E-value=0.0034  Score=60.16  Aligned_cols=137  Identities=17%  Similarity=0.251  Sum_probs=79.5

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcch--HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++ +.|..|-...+|+......   +..|++|+......  -.-.+|..+++.+..+.--.++++++  +++    +|
T Consensus        16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~G----~i   88 (330)
T PLN02421         16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GNG----MI   88 (330)
T ss_pred             ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CCc----Ee
Confidence            3443 4455577778898854332   33788998865332  12357888999885443345677766  322    68


Q ss_pred             EEecCCCChhhh-------c----------CC--------C-CHHHHHHHHHHH----------------------HHHH
Q 014762          201 FEYVNSTDFKVL-------Y----------PT--------L-TDYDIRYYIYEL----------------------LKAL  232 (419)
Q Consensus       201 ~e~~~~~~l~~~-------~----------~~--------l-~~~~~~~~~~qi----------------------~~~L  232 (419)
                      .+|+++..+...       +          ..        . .+..+..+..++                      ..-+
T Consensus        89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  168 (330)
T PLN02421         89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI  168 (330)
T ss_pred             ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence            899877654220       0          00        1 112222222211                      1112


Q ss_pred             HHHH----HC----CcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          233 DYCH----SQ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       233 ~~LH----~~----~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      ..+.    ..    -++|.|+.+.|||++++.+.++++||..|..
T Consensus       169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            2221    11    2799999999999986546899999998854

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.09  E-value=0.00077  Score=62.71  Aligned_cols=131  Identities=18%  Similarity=0.288  Sum_probs=91.3

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC----------cc---------------hHHHHHHHHHHHHhcCCC
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VK---------------KKKIKREIKILQNLCGGP  180 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~---------------~~~~~~E~~~l~~l~~h~  180 (419)
                      -+.+.+.||-|.-+.||.+.+ ..|++.++|+-.-          ..               +-...+|...|+.|..|.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            478899999999999999975 5677888885320          00               112456888888885443


Q ss_pred             C-eeEEEeEEEccCCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcE
Q 014762          181 N-VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKL  259 (419)
Q Consensus       181 n-iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~  259 (419)
                      . +.+.+++.      .-++|||++.+-.+.....-.+...+   ...+..-+.-|-.+|+||+|.+--||+++++ +.+
T Consensus       172 fpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~v~d~~~l---y~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~i  241 (465)
T KOG2268|consen  172 FPVPKPIDHN------RHCVVMELVDGYPLRQVRHVEDPPTL---YDDLMGLIVRLANHGLIHGDFNEFNIMVKDD-DKI  241 (465)
T ss_pred             CCCCCccccc------ceeeHHHhhcccceeeeeecCChHHH---HHHHHHHHHHHHHcCceecccchheeEEecC-CCE
Confidence            2 33344433      23689999988877665444444333   3344445566778999999999999999987 789


Q ss_pred             EEEecccc
Q 014762          260 RLIDWGLA  267 (419)
Q Consensus       260 kl~Dfgla  267 (419)
                      +++||--.
T Consensus       242 ~vIDFPQm  249 (465)
T KOG2268|consen  242 VVIDFPQM  249 (465)
T ss_pred             EEeechHh
Confidence            99999754

>PLN02236 choline kinase

Probab=96.95  E-value=0.012  Score=56.70  Aligned_cols=134  Identities=19%  Similarity=0.284  Sum_probs=80.8

Q ss_pred             EeeeeeeCceEEEEEEEcC----CCcEEEEEEecCcchH--HHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          130 VRKVGRGKYSEVFEGINVN----TNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~----~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      +..|-.|-...+|++....    +++.+++|+..+....  .-.+|..+++.+..+.--.++++.+  .++    .|.+|
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~g----~v~ef  114 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF--PNG----RVEEF  114 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE--CCc----eEEEe
Confidence            3456557778899886432    2467899988654321  2367899999885544445677776  322    68999


Q ss_pred             cCCCChhhh-------c----------CC--------C-CHHHHHHHHHH-----------------HHHHHHHHH----
Q 014762          204 VNSTDFKVL-------Y----------PT--------L-TDYDIRYYIYE-----------------LLKALDYCH----  236 (419)
Q Consensus       204 ~~~~~l~~~-------~----------~~--------l-~~~~~~~~~~q-----------------i~~~L~~LH----  236 (419)
                      +++.++...       .          ..        . ....+..+..+                 +...+..|.    
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            987665321       0          00        1 11222222211                 111222222    


Q ss_pred             ----HCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          237 ----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       237 ----~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                          ...++|+|+++.|||++.+.+.+.++||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence                125899999999999986546799999998754

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.93  E-value=0.00015  Score=79.19  Aligned_cols=152  Identities=11%  Similarity=-0.026  Sum_probs=108.0

Q ss_pred             HHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhc-C------CCCHHHHHHHHHHHHHHHHHHHHC
Q 014762          166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-P------TLTDYDIRYYIYELLKALDYCHSQ  238 (419)
Q Consensus       166 ~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~------~l~~~~~~~~~~qi~~~L~~LH~~  238 (419)
                      ...|..-++.. .|++++....-.....+...+..++|+.+|.+...+ +      .+.+.-+.....+...+..-+|+.
T Consensus      1276 ll~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            33455555555 788888777766555556667889999999887765 1      233333433334435666666643


Q ss_pred             -----CcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cceeecccccccccccccCCCCCCccccHHHHHHHHHH
Q 014762          239 -----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG  312 (419)
Q Consensus       239 -----~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~e  312 (419)
                           --+|+++|+-|.++..+ ..+|++++|+.+...+.. ......+++.|+.|+.... -.++.++|+|+.|+.+|.
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             ccCCccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHH
Confidence                 27899999999999988 678999999998443332 2344577888888887644 678888999999999999


Q ss_pred             HHhCCCCC
Q 014762          313 MIFRKEPF  320 (419)
Q Consensus       313 ll~g~~pf  320 (419)
                      ..-|..+|
T Consensus      1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred             HhcccHHH
Confidence            88777666

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.82  E-value=0.019  Score=54.16  Aligned_cols=124  Identities=19%  Similarity=0.353  Sum_probs=74.7

Q ss_pred             CcEEEEEEecC-----cchHHHHHHHHHHHHhcCC-CCeeEEEeEEEccCCCccEEEEEecCCCChhhhcCC--------
Q 014762          150 NERCIIKILKP-----VKKKKIKREIKILQNLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPT--------  215 (419)
Q Consensus       150 ~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------  215 (419)
                      ++.+++. ..+     .......+|..+++.+... --+...+++|.++.-...+.||+|++|.........        
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            7777777 221     2235667899999987331 234456777755433467899999988432211110        


Q ss_pred             ---------------------------CCHHHHHHHHHH--------------HHHHHHHHHHC--------CcEeecCC
Q 014762          216 ---------------------------LTDYDIRYYIYE--------------LLKALDYCHSQ--------GIMHRDVK  246 (419)
Q Consensus       216 ---------------------------l~~~~~~~~~~q--------------i~~~L~~LH~~--------~ivH~Dlk  246 (419)
                                                 ....++..+..+              ...-..||+.+        .++|+|+.
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                                       001111111111              12235566543        59999999


Q ss_pred             CCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          247 PHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       247 ~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +.|++++.+ +.+-|.||+++...++...
T Consensus       207 ~gNlii~~~-~~~gVlDwe~~~lGDP~~D  234 (321)
T COG3173         207 PGNLIIDPG-RPTGVLDWELATLGDPLED  234 (321)
T ss_pred             cCCEEEeCC-CeeEEEeccccccCCcHHH
Confidence            999999988 4489999999987655433

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.75  E-value=0.0051  Score=54.87  Aligned_cols=114  Identities=18%  Similarity=0.257  Sum_probs=59.8

Q ss_pred             CcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhh--c------------
Q 014762          150 NERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--Y------------  213 (419)
Q Consensus       150 ~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~--~------------  213 (419)
                      ++.|++++....  ..-.-.+|..+++.+..+..-.++++.+.+  +    .|++|+++..+..-  .            
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~--g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l   75 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN--G----RVEEFIEGRTLSPEDFRNPEILKRIAKLL   75 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT--E----EEEE--SSEE--CGGGGSHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC--C----cEEEEecccccChhhccChHHHHHHHHHH
Confidence            457888888655  234556788888888655566778887732  2    78899977654221  0            


Q ss_pred             ---CCC----------CHHHHHHH----------------------HHHHHHHHHHHHH--------CCcEeecCCCCce
Q 014762          214 ---PTL----------TDYDIRYY----------------------IYELLKALDYCHS--------QGIMHRDVKPHNV  250 (419)
Q Consensus       214 ---~~l----------~~~~~~~~----------------------~~qi~~~L~~LH~--------~~ivH~Dlk~~NI  250 (419)
                         ...          .+..+..+                      ..++..-+..+.+        ..++|+|+.+.||
T Consensus        76 ~~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Ni  155 (211)
T PF01633_consen   76 AKLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNI  155 (211)
T ss_dssp             HHHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGE
T ss_pred             HHHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccE
Confidence               000          00111111                      1112222232221        2589999999999


Q ss_pred             EEcCCCCcEEEEeccccee
Q 014762          251 MIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       251 Ll~~~~~~~kl~Dfgla~~  269 (419)
                      |++...+.++++||..|..
T Consensus       156 l~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  156 LINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EETSSSSCEEE--GTT-EE
T ss_pred             EeccCCCeEEEecHHHHhh
Confidence            9943348899999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.60  E-value=0.036  Score=52.88  Aligned_cols=133  Identities=25%  Similarity=0.320  Sum_probs=80.7

Q ss_pred             eeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCC--C---eeEEEeEEEccCC--CccEEEEEec
Q 014762          133 VGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGP--N---VVKLLDIVRDQHS--KTPSLIFEYV  204 (419)
Q Consensus       133 lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~--n---iv~l~~~~~~~~~--~~~~lv~e~~  204 (419)
                      |.+ .-..+|+... .+|+ +++|+..+. ...++.-|...+..|..+.  -   +..+=|-....-.  ...+-+++|+
T Consensus        34 l~s-~eN~~f~~~~-~~g~-~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l  110 (331)
T COG2334          34 LNS-EENSNFRVQT-EDGR-YILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL  110 (331)
T ss_pred             ccc-ccCceEEEEe-cCCC-eEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence            444 4457888853 3444 499999875 6678888999999884331  1   2222222111112  2667889999


Q ss_pred             CCCChhh-hc------------------CC-----------CCHH----HH---------HHHHHHHHHHHHHHHHC---
Q 014762          205 NSTDFKV-LY------------------PT-----------LTDY----DI---------RYYIYELLKALDYCHSQ---  238 (419)
Q Consensus       205 ~~~~l~~-~~------------------~~-----------l~~~----~~---------~~~~~qi~~~L~~LH~~---  238 (419)
                      +|..+.. ..                  +.           ..+.    ..         .....++...++.+.+.   
T Consensus       111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~  190 (331)
T COG2334         111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA  190 (331)
T ss_pred             CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence            9887762 11                  11           1111    00         11233444555555532   


Q ss_pred             -----C--cEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          239 -----G--IMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       239 -----~--ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                           +  +||+|+.|.||+++.+...+.++||+-+.
T Consensus       191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                 3  99999999999999883347899999774

>PTZ00384 choline kinase; Provisional

Probab=96.29  E-value=0.037  Score=54.04  Aligned_cols=75  Identities=17%  Similarity=0.207  Sum_probs=47.1

Q ss_pred             EeeeeeeCceEEEEEEEcCCC-c-----EEEEEEecCcch--HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          130 VRKVGRGKYSEVFEGINVNTN-E-----RCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~-~-----~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      +..|..|-...+|++...... .     .|.++.......  -.-.+|+.+++.+..+..-.++++.+.+      ++++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------g~l~  128 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------FTIQ  128 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC------EEEE
Confidence            345656888889998643321 1     245554332211  1235689999999666666778888732      3899


Q ss_pred             EecCCCChh
Q 014762          202 EYVNSTDFK  210 (419)
Q Consensus       202 e~~~~~~l~  210 (419)
                      ||++|..+.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999887653

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.27  E-value=0.043  Score=52.70  Aligned_cols=71  Identities=18%  Similarity=0.273  Sum_probs=45.5

Q ss_pred             eeeeeCceEEEEEEEcCCCcEEEEEEecC----------cchHHHHHHHHHHHHhcCC-C-CeeEEEeEEEccCCCccEE
Q 014762          132 KVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCGG-P-NVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       132 ~lG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~~~~~l  199 (419)
                      .||-|....||++.+..+++.++||.-.+          -..++...|...|+..... | .+.+++.+-  +  ....+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~--e~~~~   77 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--T--EMAVT   77 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--c--cccee
Confidence            47999999999998754446799986431          1234556677888765322 3 355555543  2  23358


Q ss_pred             EEEecCC
Q 014762          200 IFEYVNS  206 (419)
Q Consensus       200 v~e~~~~  206 (419)
                      |||+++.
T Consensus        78 vMEdL~~   84 (370)
T TIGR01767        78 VMEDLSH   84 (370)
T ss_pred             hHhhCcc
Confidence            9998854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.17  E-value=0.041  Score=52.11  Aligned_cols=30  Identities=23%  Similarity=0.582  Sum_probs=25.3

Q ss_pred             CCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       238 ~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      .+++|+|+.+.||+++.  +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC--CcEEEEECccccc
Confidence            47899999999999986  3578999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.02  E-value=0.059  Score=51.15  Aligned_cols=30  Identities=20%  Similarity=0.338  Sum_probs=26.6

Q ss_pred             CcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       239 ~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      +++|+|+.++|+|++.+ +.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence            79999999999999887 6789999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.93  E-value=0.027  Score=54.31  Aligned_cols=125  Identities=20%  Similarity=0.204  Sum_probs=75.7

Q ss_pred             eeeeeeCceEEEEEEE---------------cCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeE-------
Q 014762          131 RKVGRGKYSEVFEGIN---------------VNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDI-------  188 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~---------------~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~-------  188 (419)
                      ..||.|+-+.||+|..               ..+.+.||+|+..+...+.+.+...+|.....-+|++.=..+       
T Consensus       195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~v  274 (565)
T KOG1236|consen  195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEV  274 (565)
T ss_pred             cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchH
Confidence            3599999999999862               223457999999877766666666665543211222111111       


Q ss_pred             --------------------------EEc-----------cCCCccEEEEEecCCCChhhhcCC--CCHHHHHHHHHHHH
Q 014762          189 --------------------------VRD-----------QHSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELL  229 (419)
Q Consensus       189 --------------------------~~~-----------~~~~~~~lv~e~~~~~~l~~~~~~--l~~~~~~~~~~qi~  229 (419)
                                                |..           +......++-+|+.|-++..++..  .++...+.++.-..
T Consensus       275 kqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~  354 (565)
T KOG1236|consen  275 KQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGV  354 (565)
T ss_pred             HHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHHHHHHHH
Confidence                                      100           001123355567788777777644  44445555555555


Q ss_pred             HHHHHH-HHCCcEeecCCCCceEEcCC
Q 014762          230 KALDYC-HSQGIMHRDVKPHNVMIDHE  255 (419)
Q Consensus       230 ~~L~~L-H~~~ivH~Dlk~~NILl~~~  255 (419)
                      .|+--+ --.+++|.|+.|.||++..+
T Consensus       355 ~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  355 NALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             HHHHHHHHhhcceecccCCCcEEEEec
Confidence            554433 35689999999999999654

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.50  E-value=0.22  Score=48.72  Aligned_cols=71  Identities=18%  Similarity=0.296  Sum_probs=49.2

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecC----------cchHHHHHHHHHHHHhcC--CCCeeEEEeEEEccCCCcc
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP----------VKKKKIKREIKILQNLCG--GPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~~l~~l~~--h~niv~l~~~~~~~~~~~~  197 (419)
                      .+.||.|....||+..+  .+..++||.-.+          ....+-..|...|+.+..  ..++.+++.++.+    .-
T Consensus        37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~~  110 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----MA  110 (418)
T ss_pred             EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----CC
Confidence            66799999999999875  345688887541          123444556777776522  2478889998853    23


Q ss_pred             EEEEEecCC
Q 014762          198 SLIFEYVNS  206 (419)
Q Consensus       198 ~lv~e~~~~  206 (419)
                      +++||++++
T Consensus       111 vlvME~L~~  119 (418)
T PLN02756        111 LIGMRYLEP  119 (418)
T ss_pred             EEEEeecCC
Confidence            589999976

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.47  E-value=0.078  Score=49.63  Aligned_cols=77  Identities=14%  Similarity=0.190  Sum_probs=49.7

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhc--CCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLC--GGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      .+-.+.++.|....+|+..  .+++.+.+|+-.......+..|..-|+.|.  ..-.+.+.+++....  ...+||+||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEEEEee
Confidence            3446779999999999984  778889999988666778999999999883  233566788877544  3347999998


Q ss_pred             CCC
Q 014762          205 NST  207 (419)
Q Consensus       205 ~~~  207 (419)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=95.21  E-value=0.3  Score=54.09  Aligned_cols=137  Identities=18%  Similarity=0.289  Sum_probs=76.7

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCC-CC--eeEEEe--------EEEccCC-Ccc
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGG-PN--VVKLLD--------IVRDQHS-KTP  197 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h-~n--iv~l~~--------~~~~~~~-~~~  197 (419)
                      ..|+ |..-.+|+.. ..+|..+++|+.++.. ......|...|..|..+ +.  +.+.+-        .+....+ ...
T Consensus        31 ~~L~-s~~d~nf~v~-~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLT-TDDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEE-eCCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            3454 3456778774 4567789999998643 34555677777766432 22  222221        1112112 245


Q ss_pred             EEEEEecCCCChhhhc---------------------C---------CCCH-----------------HHHHHHHHHHHH
Q 014762          198 SLIFEYVNSTDFKVLY---------------------P---------TLTD-----------------YDIRYYIYELLK  230 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---------------------~---------~l~~-----------------~~~~~~~~qi~~  230 (419)
                      +-+++|++|..+....                     .         .+.|                 ...+.++.+++.
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            6789999987664410                     0         0111                 111222333333


Q ss_pred             HHH-----HHH--HCCcEeecCCCCceEEcCCCC-cE-EEEeccccee
Q 014762          231 ALD-----YCH--SQGIMHRDVKPHNVMIDHELR-KL-RLIDWGLAEF  269 (419)
Q Consensus       231 ~L~-----~LH--~~~ivH~Dlk~~NILl~~~~~-~~-kl~Dfgla~~  269 (419)
                      ..+     .+.  ..++||+|+++.|||++.+.. .+ -|+|||.+..
T Consensus       189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            222     121  247999999999999997631 44 4999998754

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.21  E-value=0.34  Score=46.37  Aligned_cols=68  Identities=16%  Similarity=0.173  Sum_probs=41.3

Q ss_pred             ceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCC-CeeE---EEe--EEEccCCCccEEEEEecCCCC
Q 014762          138 YSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVK---LLD--IVRDQHSKTPSLIFEYVNSTD  208 (419)
Q Consensus       138 fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~---l~~--~~~~~~~~~~~lv~e~~~~~~  208 (419)
                      -..||+.. ..++..+++|+..+.  ....+..|+..+..|..+. .++.   .-|  +..  .++..+.++++++|..
T Consensus        38 eN~vy~v~-~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~--~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         38 ENRVYQFG-DEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHE--HQGFRFALFPRRGGRA  113 (325)
T ss_pred             cceEEEEe-cCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEE--ECCEEEEEEeeeCCCC
Confidence            35688875 355678999998754  3566778998888774321 1122   111  111  1245677889888764

>PTZ00296 choline kinase; Provisional

Probab=95.13  E-value=0.21  Score=49.73  Aligned_cols=75  Identities=15%  Similarity=0.173  Sum_probs=48.3

Q ss_pred             EEeeeeeeCceEEEEEEEcC--------CCcEEEEEEecCcchH--HHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          129 VVRKVGRGKYSEVFEGINVN--------TNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       129 ~~~~lG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      -++.|..|-.-.+|++....        .++.|++++.......  .-.+|..+++.+..+.-=.++++.+  .+    .
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f--~g----g  182 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTF--SG----G  182 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEe--CC----C
Confidence            45667777778889886432        1567899988654322  2356888888874443334677776  22    2


Q ss_pred             EEEEecCCCCh
Q 014762          199 LIFEYVNSTDF  209 (419)
Q Consensus       199 lv~e~~~~~~l  209 (419)
                      .|.||++|..+
T Consensus       183 ~I~efi~g~~l  193 (442)
T PTZ00296        183 RIEEWLYGDPL  193 (442)
T ss_pred             EEEEeeCCccC
Confidence            68999987744

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.03  E-value=0.16  Score=49.43  Aligned_cols=73  Identities=21%  Similarity=0.248  Sum_probs=47.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecC---------cchHHHHHHHHHHHHhcC-CC-CeeEEEeEEEccCCCccE
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKP---------VKKKKIKREIKILQNLCG-GP-NVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---------~~~~~~~~E~~~l~~l~~-h~-niv~l~~~~~~~~~~~~~  198 (419)
                      .+.||-|.-..||++.+..+++.++||.-.+         -..++...|..+|+.... .| .+.+++.+=.    ....
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~----e~~~  109 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS----VMNC  109 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc----HHhh
Confidence            5679999999999998744456788886421         223566678888887632 24 4555665532    2234


Q ss_pred             EEEEecCC
Q 014762          199 LIFEYVNS  206 (419)
Q Consensus       199 lv~e~~~~  206 (419)
                      +|||+++.
T Consensus       110 ~vMEdL~~  117 (409)
T PRK12396        110 CVMEDLSD  117 (409)
T ss_pred             HHHHhCcc
Confidence            78888754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.51  E-value=0.22  Score=44.33  Aligned_cols=86  Identities=21%  Similarity=0.278  Sum_probs=59.2

Q ss_pred             hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCc
Q 014762          163 KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS--QGI  240 (419)
Q Consensus       163 ~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~--~~i  240 (419)
                      ..-+..+.+++.++.   .|+++.    .+++..+.++.|+|..-...         . ..++.-=+.+|.-.|+  .+.
T Consensus       102 ~~~y~nky~v~Armh---GilrL~----NDn~~~yGvIlE~Cy~~~i~---------~-~N~i~agi~~L~~fH~~~~~~  164 (308)
T PF07387_consen  102 DALYFNKYRVFARMH---GILRLK----NDNNYKYGVILERCYKIKIN---------F-SNFITAGIKDLMDFHSENQHC  164 (308)
T ss_pred             hhhhhhhhhHHHHhh---heeEee----cCCCceeEEEEeeccCcccc---------h-hHHHHHhHHHHHHhhccCCCe
Confidence            455778888988873   466665    23445567899988643211         1 1122222466777884  479


Q ss_pred             EeecCCCCceEEcCCCCcEEEEeccc
Q 014762          241 MHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       241 vH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      +|+|..|+||+-|.. |.+||.|-+.
T Consensus       165 lHGD~np~NiM~D~~-G~lKlVDP~~  189 (308)
T PF07387_consen  165 LHGDCNPDNIMCDKF-GYLKLVDPVC  189 (308)
T ss_pred             ecCCCChhheeecCC-CCEEecChhh
Confidence            999999999999998 8999999774

The function of this family is unknown.

>PRK06149 hypothetical protein; Provisional

Probab=94.05  E-value=0.73  Score=50.91  Aligned_cols=31  Identities=23%  Similarity=0.254  Sum_probs=25.2

Q ss_pred             CCcEeecCCCCceEEcCCC-C---cEEEEecccce
Q 014762          238 QGIMHRDVKPHNVMIDHEL-R---KLRLIDWGLAE  268 (419)
Q Consensus       238 ~~ivH~Dlk~~NILl~~~~-~---~~kl~Dfgla~  268 (419)
                      .++||.|+++.|||++.+. +   ..-|+|||.+.
T Consensus       208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             ccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            5899999999999998652 2   24799999875

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	419
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-167
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-166
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-166
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-166
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-166
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-166
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-165
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-165
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-165
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-165
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-137
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-137
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-137
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-137
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		1e-137
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-137
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-137
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-137
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-137
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-137
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-137
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-137
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-137
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-137
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-136
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-132
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-132
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-33
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-33
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-30
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-29
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-29
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-29
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-28
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-28
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-28
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-28
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-28
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-28
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-28
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-28
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-28
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-28
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-28
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-28
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-28
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-28
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-28
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-28
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-28
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-28
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-28
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-28
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-28
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-28
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-28
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-28
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-28
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-28
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-28
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-28
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-28
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-28
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-28
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-28
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-28
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-28
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-28
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-28
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-28
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-28
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-28
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-28
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-28
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-27
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-27
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-27
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-27
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-27
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-27
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-27
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-27
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-27
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-27
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-27
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-27
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-27
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-27
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-27
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-27
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-27
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-27
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-27
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-26
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-25
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-25
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-24
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-24
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-24
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-24
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-24
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-24
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-24
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-24
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-24
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-23
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-23
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-23
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-23
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-23
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-23
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-23
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-23
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-23
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-23
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-23
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-23
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-23
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-23
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-23
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-23
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-23
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-23
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-23
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-23
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-23
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-23
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-23
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-23
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-23
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-23
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-23
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-23
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-23
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-22
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-22
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-22
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-22
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-22
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-22
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-22
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-22
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-22
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-22
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-22
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-22
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-22
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-22
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-22
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-22
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-22
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-22
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-22
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-22
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-22
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-22
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-22
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-22
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-22
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-22
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-22
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-22
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-22
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-22
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-22
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-22
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-22
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-22
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-22
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-22
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-22
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-22
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-22
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-22
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-22
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-22
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-22
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-22
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-22
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-22
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-22
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-22
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-22
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-22
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-22
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-22
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-22
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-22
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-22
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-22
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-22
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-21
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-21
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-21
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-21
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-21
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-21
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-20
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-20
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-20
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-20
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-20
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-20
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-20
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-20
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-20
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-19
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-19
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-19
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-19
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-19
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-19
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-19
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-19
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-19
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-19
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-19
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-19
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-19
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-19
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-19
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-18
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-18
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-18
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-18
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-18
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-18
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-18
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-18
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-18
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-18
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-18
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-18
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-18
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-18
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-18
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-18
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-18
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-17
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-16
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-16
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-16
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-15
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-15
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-14
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-13
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-13
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-12
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-12
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-12
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-12
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-12
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-12
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-12
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		9e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-11
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-10
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-10
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-10
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-10
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-10
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		8e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		9e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		9e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
3soa_A	444	Full-Length Human Camkii Length = 444		3e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-09
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		7e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		8e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		9e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-06
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-06
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-06
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		7e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-05
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-05
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-05
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-05
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		5e-05
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-04
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-04
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-04
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-04
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-04
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-04
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-04
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-04
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-04

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  583 bits (1504), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 279/315 (88%), Positives = 288/315 (91%)
Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 1   MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60
Query: 154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                              LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 394 RYDHQDRLTAREAMV 408
           RYDHQ+RLTA EAM 
Sbjct: 301 RYDHQERLTALEAMT 315

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  581 bits (1497), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 279/315 (88%), Positives = 288/315 (91%)
Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 21  MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 80
Query: 154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                              LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 81  IIKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 140
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 141 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 200
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 201 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 260
Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTD LNAYLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 261 AKVLGTDGLNAYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 320
Query: 394 RYDHQDRLTAREAMV 408
           RYDHQ+RLTA EAM 
Sbjct: 321 RYDHQERLTALEAMT 335

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  581 bits (1497), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 278/314 (88%), Positives = 287/314 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 3   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 62
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 63  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 122
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 123 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 182
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 183 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 242
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 243 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 302
Query: 395 YDHQDRLTAREAMV 408
           YDHQ+RLTA EAM 
Sbjct: 303 YDHQERLTALEAMT 316

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  580 bits (1496), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 278/314 (88%), Positives = 287/314 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMV 408
           YDHQ+RLTA EAM 
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  580 bits (1495), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 278/314 (88%), Positives = 287/314 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNLCGGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMV 408
           YDHQ+RLTA EAM 
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  580 bits (1494), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 278/315 (88%), Positives = 287/315 (91%)
Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           MSKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C
Sbjct: 1   MSKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKC 60
Query: 154 XXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY 213
                              LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLY
Sbjct: 61  IIKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLY 120
Query: 214 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 273
           PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG
Sbjct: 121 PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI
Sbjct: 181 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 240
Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
           AKVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLL
Sbjct: 241 AKVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLL 300
Query: 394 RYDHQDRLTAREAMV 408
           RYDHQ+RLTA EAM 
Sbjct: 301 RYDHQERLTALEAMT 315

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  577 bits (1488), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 277/314 (88%), Positives = 286/314 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMV 408
           YDHQ+RLTA EAM 
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  577 bits (1487), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 277/314 (88%), Positives = 286/314 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLMGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMV 408
           YDHQ+RLTA EAM 
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  576 bits (1485), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 277/314 (88%), Positives = 286/314 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMV 408
           YDHQ+RLTA EAM 
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  576 bits (1485), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 277/314 (88%), Positives = 286/314 (91%)
Query: 95  SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCX 154
           SKARVY DVNVLRPKEYWDYE+LTVQWG+QDDYEVVRKVGRGKYSEVFEGINVN NE+C 
Sbjct: 1   SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 60
Query: 155 XXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP 214
                             LQNL GGPN+VKLLDIVRDQHSKTPSLIFEYVN+TDFKVLYP
Sbjct: 61  IKILKPVKKKKIKREIKILQNLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 120
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           KVLGTD LN YLNKY +ELDPQL+ALVGRHSRKPW KF+NADNQHLVSPEAIDFLDKLLR
Sbjct: 241 KVLGTDGLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLR 300
Query: 395 YDHQDRLTAREAMV 408
           YDHQ+RLTA EAM 
Sbjct: 301 YDHQERLTALEAMT 314

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  486 bits (1250), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 225/316 (71%), Positives = 266/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDY S  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYASHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKNKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  485 bits (1248), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 227/322 (70%), Positives = 269/322 (83%)
Query: 86  LAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGI 145
           L  +  P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE I
Sbjct: 3   LGSMSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAI 62
Query: 146 NVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205
           N+  NE+                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN
Sbjct: 63  NITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 122
Query: 206 STDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265
           +TDFK LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWG
Sbjct: 123 NTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG 182
Query: 266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
           LAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHD
Sbjct: 183 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 242
Query: 326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA 385
           N+DQLV+IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA
Sbjct: 243 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEA 302
Query: 386 IDFLDKLLRYDHQDRLTAREAM 407
           +DFLDKLLRYDHQ RLTAREAM
Sbjct: 303 LDFLDKLLRYDHQSRLTAREAM 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  485 bits (1248), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 227/324 (70%), Positives = 269/324 (83%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAMVISSISPI 415
           LLRYDHQ RLTAREAM      P+
Sbjct: 304 LLRYDHQSRLTAREAMEHPYFYPV 327

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  485 bits (1248), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/316 (71%), Positives = 267/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  485 bits (1248), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 225/316 (71%), Positives = 267/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVAVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNV+IDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  484 bits (1247), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/316 (71%), Positives = 267/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  484 bits (1247), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/316 (71%), Positives = 267/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  484 bits (1247), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/316 (71%), Positives = 267/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 3   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 63  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 303 LLRYDHQSRLTAREAM 318

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  484 bits (1247), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/316 (71%), Positives = 267/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  484 bits (1247), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/316 (71%), Positives = 267/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  484 bits (1247), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/316 (71%), Positives = 267/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  484 bits (1246), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/316 (71%), Positives = 267/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 3   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 63  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 303 LLRYDHQSRLTAREAM 318

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  484 bits (1245), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/316 (71%), Positives = 267/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  484 bits (1245), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 226/316 (71%), Positives = 267/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 2   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 61
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 62  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 122 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 302 LLRYDHQSRLTAREAM 317

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  481 bits (1239), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 225/316 (71%), Positives = 266/316 (84%)
Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 4   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           +                    L+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 64  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           L  TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 124 LRQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 183
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 244 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 303
Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 304 LLRYDHQSRLTAREAM 319

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  469 bits (1206), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 220/331 (66%), Positives = 264/331 (79%), Gaps = 1/331 (0%)
Query: 86  LAEIPLPAM-SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEG 144
           L  +P PA  S+ARVY +VN LR +EYWDYE+    WG+QDDY++VRK+GRGKYSEVFE 
Sbjct: 3   LGSMPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEA 62
Query: 145 INVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV 204
           IN+  NER                    L+NL GG N++KL+D V+D  SKTP+L+FEY+
Sbjct: 63  INITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYI 122
Query: 205 NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
           N+TDFK LY  LTD+DIR+Y+YELLKALDYCHS+GIMHRDVKPHNVMIDH+ +KLRLIDW
Sbjct: 123 NNTDFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDW 182
Query: 265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
           GLAEFYHP +EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFR+EPFF+G 
Sbjct: 183 GLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQ 242
Query: 325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE 384
           DN+DQLV+IAKVLGT+EL  YL KYH++LDP  + ++G+HSRK W  FI+++N+HLVSPE
Sbjct: 243 DNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPE 302
Query: 385 AIDFLDKLLRYDHQDRLTAREAMVISSISPI 415
           A+D LDKLLRYDHQ RLTA+EAM      P+
Sbjct: 303 ALDLLDKLLRYDHQQRLTAKEAMEHPYFYPV 333

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  468 bits (1204), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 219/328 (66%), Positives = 263/328 (80%), Gaps = 1/328 (0%)
Query: 89  IPLPAM-SKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINV 147
           +P PA  S+ARVY +VN LR +EYWDYE+    WG+QDDY++VRK+GRGKYSEVFE IN+
Sbjct: 1   MPGPAAGSRARVYAEVNSLRSREYWDYEAHVPSWGNQDDYQLVRKLGRGKYSEVFEAINI 60
Query: 148 NTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST 207
             NER                    L+NL GG N++KL+D V+D  SKTP+L+FEY+N+T
Sbjct: 61  TNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKLIDTVKDPVSKTPALVFEYINNT 120
Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           DFK LY  LTD+DIR+Y+YELLKALDYCHS+GIMHRDVKPHNVMIDH+ +KLRLIDWGLA
Sbjct: 121 DFKQLYQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLA 180
Query: 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 327
           EFYHP +EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFR+EPFF+G DN+
Sbjct: 181 EFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNY 240
Query: 328 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID 387
           DQLV+IAKVLGT+EL  YL KYH++LDP  + ++G+HSRK W  FI+++N+HLVSPEA+D
Sbjct: 241 DQLVRIAKVLGTEELYGYLKKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALD 300
Query: 388 FLDKLLRYDHQDRLTAREAMVISSISPI 415
            LDKLLRYDHQ RLTA+EAM      P+
Sbjct: 301 LLDKLLRYDHQQRLTAKEAMEHPYFYPV 328

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  138 bits (347), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 96/294 (32%), Positives = 148/294 (50%), Gaps = 20/294 (6%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  + Y+ + KVG G Y  V++  +        +R                    L+ L 
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL- 76
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
             PN+V L+D++  +   T  L+FE++     KVL      L D  I+ Y+Y+LL+ + +
Sbjct: 77  HHPNIVSLIDVIHSERCLT--LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 293
           CH   I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ P++L+ 
Sbjct: 135 CHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  S+D+WS+GC+FA MI  K P F G  + DQL KI  +LGT     +     L L
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             Q    V    +KPWS  I    Q     E ID L  +L +D   R++AR+AM
Sbjct: 253 WKQRTFQV--FEKKPWSSIIPGFCQ-----EGIDLLSNMLCFDPNKRISARDAM 299

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 96/294 (32%), Positives = 148/294 (50%), Gaps = 20/294 (6%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  + Y+ + KVG G Y  V++  +        +R                    L+ L 
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL- 76
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
             PN+V L+D++  +   T  L+FE++     KVL      L D  I+ Y+Y+LL+ + +
Sbjct: 77  HHPNIVSLIDVIHSERCLT--LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 293
           CH   I+HRD+KP N++I+ +   L+L D+GLA  F  P + Y   V + +++ P++L+ 
Sbjct: 135 CHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  S+D+WS+GC+FA MI  K P F G  + DQL KI  +LGT     +     L L
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             Q    V    +KPWS  I    Q     E ID L  +L +D   R++AR+AM
Sbjct: 253 WKQRTFQV--FEKKPWSSIIPGFCQ-----EGIDLLSNMLCFDPNKRISARDAM 299

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/303 (31%), Positives = 146/303 (48%), Gaps = 30/303 (9%)
Query: 120 QWGDQDD--YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC 177
           + G+Q +  Y   + +G G +  VF+   V ++E                     +  + 
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE---VAIKKVLQDKRFKNRELQIMRIV 89
Query: 178 GGPNVVKLLDIVRDQHSKTP----SLIFEYVNSTDFKV------LYPTLTDYDIRYYIYE 227
             PNVV L         K      +L+ EYV  T ++       L  T+    I+ Y+Y+
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           LL++L Y HS GI HRD+KP N+++D     L+LID+G A+    G+     + SRY++ 
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRA 209
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD--ELNAY 345
           PEL+    +Y  ++D+WS GC+ A ++ + +P F G    DQLV+I KVLGT   E    
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELM-QGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268
Query: 346 LNKYHLELD-PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
           +N  ++E   PQ+          P+SK           P+AID + +LL Y    RLTA 
Sbjct: 269 MNPNYMEHKFPQIRP-------HPFSKVFRPR----TPPDAIDLISRLLEYTPSARLTAI 317
Query: 405 EAM 407
           EA+
Sbjct: 318 EAL 320

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/230 (34%), Positives = 124/230 (53%), Gaps = 21/230 (9%)
Query: 188 IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD------IRYYIYELLKALDYCHSQGIM 241
           IV    +K  ++I EYV  T  KVL   +          I  YIY+L +A+ + HS GI 
Sbjct: 104 IVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC 163
Query: 242 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 301
           HRD+KP N++++ +   L+L D+G A+   P +     + SR+++ PEL++   +Y  S+
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSI 223
Query: 302 DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--TDELNAYLNKYHLELD-PQLD 358
           D+WS+GC+F  +I  K P F G  + DQLV+I +++G  T E    +N ++ E+  P L 
Sbjct: 224 DLWSIGCVFGELILGK-PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK 282
Query: 359 ALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
           A       K W K +      L    AID L+++LRY+   R+   EAM 
Sbjct: 283 A-------KDWRKILPEGTPSL----AIDLLEQILRYEPDLRINPYEAMA 321

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 115/221 (52%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV +T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFAF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 78/225 (34%), Positives = 115/225 (51%), Gaps = 27/225 (12%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 249 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 298
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVIS 410
             PW+K           PEAI    +LL Y    RLT  EA   S
Sbjct: 299 -HPWTKVFRPR----TPPEAIALCSRLLEYTPTARLTPLEACAHS 338

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 114 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 173
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 174 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 233
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 234 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 283
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 284 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 319

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 107 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 166
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 167 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 226
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 227 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 276
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 277 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 312

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/225 (34%), Positives = 116/225 (51%), Gaps = 27/225 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 133 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 192
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 193 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 252
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 253 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 302
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVIS 410
             PW+K      +    PEAI    +LL Y    RLT  EA   S
Sbjct: 303 -HPWTKVF----RPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 342

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 103 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 162
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 163 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 222
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 223 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 272
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 273 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 308

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/225 (34%), Positives = 116/225 (51%), Gaps = 27/225 (12%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 249 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 298
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVIS 410
             PW+K      +    PEAI    +LL Y    RLT  EA   S
Sbjct: 299 -HPWTKVF----RPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/225 (34%), Positives = 116/225 (51%), Gaps = 27/225 (12%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 131 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 190
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 191 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 250
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 251 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 300
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVIS 410
             PW+K      +    PEAI    +LL Y    RLT  EA   S
Sbjct: 301 -HPWTKVF----RPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 340

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/225 (34%), Positives = 115/225 (51%), Gaps = 27/225 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 174 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 233
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 234 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 293
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 294 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 343
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVIS 410
             PW+K           PEAI    +LL Y    RLT  EA   S
Sbjct: 344 -HPWTKVFRPR----TPPEAIALCSRLLEYTPTARLTPLEACAHS 383

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/225 (34%), Positives = 116/225 (51%), Gaps = 27/225 (12%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 123 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 182
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 183 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 242
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 243 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 292
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVIS 410
             PW+K      +    PEAI    +LL Y    RLT  EA   S
Sbjct: 293 -HPWTKVF----RPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 332

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 107 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 166
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 167 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 226
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 227 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 276
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 277 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 312

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 99  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 158
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 159 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 218
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 219 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 268
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 269 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 304

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 96  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 155
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 156 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 215
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 216 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 265
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 266 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 301

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 100 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 159
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 160 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 219
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 220 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 269
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 270 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 305

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/296 (28%), Positives = 149/296 (50%), Gaps = 23/296 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKAL 232
             PN+VKLLD++  ++     L+FE+++  D K       LT      I+ Y+++LL+ L
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 238 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 285

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 149/296 (50%), Gaps = 23/296 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKAL 232
             PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ L
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 238 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 285

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 149/295 (50%), Gaps = 21/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+V+    K +    LT      I+ Y+++LL+ L 
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 237
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 238 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 285

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 108 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 167
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 168 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 227
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 228 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 277
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 278 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 313

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 151/297 (50%), Gaps = 25/297 (8%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNL 176
           G  ++++ V K+G G Y  V++  N  T E     +                    L+ L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKA 231
              PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ 
Sbjct: 61  -NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPEL 290
           L +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+
Sbjct: 117 LAFCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L+  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           +   P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 235 M---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 283

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFAF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 149/295 (50%), Gaps = 21/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 177
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 235
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 283

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 149/296 (50%), Gaps = 23/296 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKAL 232
             PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ L
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 237
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 238 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 285

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 149/296 (50%), Gaps = 23/296 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKAL 232
             PN+VKLLD++  ++     L+FE++ S D K       LT      I+ Y+++LL+ L
Sbjct: 62  NHPNIVKLLDVIHTENKL--YLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELL 291
            +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 236
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 237 ---PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 284

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/221 (34%), Positives = 114/221 (51%), Gaps = 27/221 (12%)
Query: 198 SLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           +L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y HS GI HRD+KP N++
Sbjct: 95  NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFA 311
           +D +   L+L D+G A+    G+     + SRY++ PEL+    DY  S+D+WS GC+ A
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTD------ELNAYLNKYHLELDPQLDALVGRHS 365
            ++   +P F G    DQLV+I KVLGT       E+N    ++     PQ+ A      
Sbjct: 215 ELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---PQIKA------ 264
Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             PW+K           PEAI    +LL Y    RLT  EA
Sbjct: 265 -HPWTKVFRPRT----PPEAIALCSRLLEYTPTARLTPLEA 300

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 149/295 (50%), Gaps = 21/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 64  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 180
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 238
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 239 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 286

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 149/295 (50%), Gaps = 21/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 62  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 236
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 237 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 284

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 149/295 (50%), Gaps = 21/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 237
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 238 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 285

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 149/295 (50%), Gaps = 21/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 63  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 179
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 237
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 238 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 285

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 149/295 (50%), Gaps = 21/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 62  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 236
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 237 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 284

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 149/294 (50%), Gaps = 21/294 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCG 178
           D ++++ V K+G G Y  V++  N  T E    +                    L     
Sbjct: 5   DMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDY 234
            PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +
Sbjct: 65  HPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 293
           CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+ 
Sbjct: 123 CHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +  
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM-- 238
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 239 -PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 286

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 149/295 (50%), Gaps = 21/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 235
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 283

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 149/295 (50%), Gaps = 21/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 62  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 120 FCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 178
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 236
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 237 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 284

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 149/295 (50%), Gaps = 21/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 235
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 283

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 128/231 (55%), Gaps = 16/231 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+VKL D++  +  K   L+FE+++    K+L      L     + ++ +LL  + YCH 
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
           + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P++L+  + 
Sbjct: 119 RRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK 177
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   L   P+
Sbjct: 178 YSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---PK 233
Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            D     +   PW  F+       +    ID L K+L+ D   R+TA++A+
Sbjct: 234 YDPNFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 128/231 (55%), Gaps = 16/231 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+VKL D++  +  K   L+FE+++    K+L      L     + ++ +LL  + YCH 
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
           + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   V + +++ P++L+  + 
Sbjct: 119 RRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKK 177
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   L   P+
Sbjct: 178 YSTTIDIWSVGCIFAEMV-NGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---PK 233
Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            D     +   PW  F+       +    ID L K+L+ D   R+TA++A+
Sbjct: 234 YDPNFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 148/293 (50%), Gaps = 23/293 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKALDYC 235
           N+VKLLD++  ++     L+FE+V+  D K       LT      I+ Y+++LL+ L +C
Sbjct: 62  NIVKLLDVIHTENKL--YLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 281

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 149/295 (50%), Gaps = 21/295 (7%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLC 177
           G  ++++ V K+G G Y  V++  N  T E    +                    L    
Sbjct: 1   GHMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALD 233
             PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L 
Sbjct: 61  NHPNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +CHS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILL 177
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     + 
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM- 235
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 --PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 283

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 71/231 (30%), Positives = 128/231 (55%), Gaps = 16/231 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+VKL D++  +  K   L+FE+++    K+L      L     + ++ +LL  + YCH 
Sbjct: 61  NIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
           + ++HRD+KP N++I+ E  +L++ D+GLA  F  P ++Y   + + +++ P++L+  + 
Sbjct: 119 RRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   L   P+
Sbjct: 178 YSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---PK 233
Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            D     +   PW  F+       +    ID L K+L+ D   R+TA++A+
Sbjct: 234 YDPNFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQAL 279

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 235
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 282

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 70  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 128 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 186
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 242
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 243 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 289

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 70  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 127
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 128 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 186
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 242
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 243 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 289

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 62  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 120 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 234
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 281

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 150/293 (51%), Gaps = 23/293 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL-NH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 62  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 282

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 150/293 (51%), Gaps = 23/293 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++++ V K+G G Y  V++  N  T E     +                    L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL-NH 60
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 281

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 235
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 282

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 235
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 282

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 62  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 120 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 234
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 281

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 235
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 282

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 62  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 120 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 234
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 281

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 235
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 282

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 62  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 120 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 234
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 281

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 235
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 282

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 235
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 282

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 148/292 (50%), Gaps = 21/292 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYD---IRYYIYELLKALDYCH 236
           N+VKLLD++  ++     L+FE+++    K +    LT      I+ Y+++LL+ L +CH
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  +
Sbjct: 121 SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   P
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---P 235
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 236 DYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 282

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 148/293 (50%), Gaps = 23/293 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           ++++ V K+G G Y  V++  N  T E    +                    L      P
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYD---IRYYIYELLKALDYC 235
           N+VKLLD++  ++     L+FE+++  D K       LT      I+ Y+++LL+ L +C
Sbjct: 63  NIVKLLDVIHTENKL--YLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  F  P + Y   V + +++ PE+L+  
Sbjct: 120 HSHRVLHRDLKPENLLINTE-GAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 234
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           P       + +R+ +SK +   ++     +    L ++L YD   R++A+ A+
Sbjct: 235 PDYKPSFPKWARQDFSKVVPPLDE-----DGRSLLSQMLHYDPNKRISAKAAL 282

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 143/294 (48%), Gaps = 29/294 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-----GGPN 181
           YE + K+G G Y  VF+  N  T+E                     L+ +C        N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHE-IVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQ 238
           +V+L D++     K  +L+FE+ +    K       D D   ++ ++++LLK L +CHS+
Sbjct: 63  IVRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            ++HRD+KP N++I+    +L+L D+GLA  F  P + Y+  V + +++ P++L   + Y
Sbjct: 121 NVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             S+DMWS GC+FA +     P F G+D  DQL +I ++LGT              + Q 
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGT------------PTEEQW 227
Query: 358 DALVGRHSRKPWSKFINADNQHLVSPE----AIDFLDKLLRYDHQDRLTAREAM 407
            ++      KP+  +    +   V P+      D L  LL+ +   R++A EA+
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 153/333 (45%), Gaps = 42/333 (12%)
Query: 103 VNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXX 162
           ++++R K ++  +     W     Y     VG G Y  V   I+  + E+          
Sbjct: 20  MSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 79
Query: 163 XXXXXXXXXXLQNL----CGGPNVVKLLDIVRDQHSKTPS----------LIFEYVNSTD 208
                      + L        NV+ LLD+       TP+          L+  ++ +  
Sbjct: 80  QSEIFAKRAYRELLLLKHMQHENVIGLLDVF------TPASSLRNFYDFYLVMPFMQTDL 133
Query: 209 FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268
            K++    ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ +  +L+++D+GLA 
Sbjct: 134 QKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLAR 192
Query: 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
             H   E    V +R+++ PE+++    Y+ ++D+WS+GC+ A M+  K   F G D  D
Sbjct: 193 --HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLD 249
Query: 329 QLVKIAKVLG------TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 382
           QL +I KV G        +LN    K +++  PQ         RK +++          S
Sbjct: 250 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT-------PRKDFTQLFPR-----AS 297
Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMVISSISPI 415
           P+A D L+K+L  D   RLTA +A+      P 
Sbjct: 298 PQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 88/333 (26%), Positives = 153/333 (45%), Gaps = 42/333 (12%)
Query: 103 VNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXX 162
           ++++R K ++  +     W     Y     VG G Y  V   I+  + E+          
Sbjct: 2   LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61
Query: 163 XXXXXXXXXXLQNL----CGGPNVVKLLDIVRDQHSKTPS----------LIFEYVNSTD 208
                      + L        NV+ LLD+       TP+          L+  ++ +  
Sbjct: 62  QSEIFAKRAYRELLLLKHMQHENVIGLLDVF------TPASSLRNFYDFYLVMPFMQTDL 115
Query: 209 FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268
            K++    ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ +  +L+++D+GLA 
Sbjct: 116 QKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLAR 174
Query: 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD 328
             H   E    V +R+++ PE+++    Y+ ++D+WS+GC+ A M+  K   F G D  D
Sbjct: 175 --HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLD 231
Query: 329 QLVKIAKVLG------TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 382
           QL +I KV G        +LN    K +++  PQ         RK +++          S
Sbjct: 232 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT-------PRKDFTQLFPR-----AS 279
Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMVISSISPI 415
           P+A D L+K+L  D   RLTA +A+      P 
Sbjct: 280 PQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 143/294 (48%), Gaps = 29/294 (9%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-----GGPN 181
           YE + K+G G Y  VF+  N  T+E                     L+ +C        N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHE-IVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQ 238
           +V+L D++     K  +L+FE+ +    K       D D   ++ ++++LLK L +CHS+
Sbjct: 63  IVRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            ++HRD+KP N++I+    +L+L ++GLA  F  P + Y+  V + +++ P++L   + Y
Sbjct: 121 NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             S+DMWS GC+FA +     P F G+D  DQL +I ++LGT              + Q 
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT------------PTEEQW 227
Query: 358 DALVGRHSRKPWSKFINADNQHLVSPE----AIDFLDKLLRYDHQDRLTAREAM 407
            ++      KP+  +    +   V P+      D L  LL+ +   R++A EA+
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 155/324 (47%), Gaps = 50/324 (15%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           YE+V+K+G+G Y  V++ I+  T E     +                    L  L G  N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-YDIRYYIYELLKALDYCHSQGI 240
           +V LL+++R  + +   L+F+Y+ +    V+   + +    +Y +Y+L+K + Y HS G+
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGL 130
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--------------------- 279
           +HRD+KP N++++ E   +++ D+GL+  +      N+R                     
Sbjct: 131 LHRDMKPSNILLNAECH-VKVADFGLSRSF-----VNIRRVTNNIPLSINENTENFDDDQ 184
Query: 280 ------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                 VA+R+++ PE+L+    Y   +DMWSLGC+  G I   +P F G    +QL +I
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL-GEILCGKPIFPGSSTMNQLERI 243
Query: 334 AKVL------GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN----ADNQHLVSP 383
             V+        + + +   K  +E   +   +   + R  ++K+ N     + +   + 
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 384 EAIDFLDKLLRYDHQDRLTAREAM 407
           EA+D LDKLL+++   R++A +A+
Sbjct: 304 EALDLLDKLLQFNPNKRISANDAL 327

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 118/225 (52%), Gaps = 17/225 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNE-------RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           YE +  +G G+++ V++  + NTN+       +                    L      
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYC 235
           PN++ LLD     H    SL+F+++  TD +V+       LT   I+ Y+   L+ L+Y 
Sbjct: 72  PNIIGLLDAF--GHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDL 294
           H   I+HRD+KP+N+++D E   L+L D+GLA+ F  P + Y  +V +R+++ PELL   
Sbjct: 129 HQHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGA 187
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
           + Y   +DMW++GC+ A ++ R  PF  G  + DQL +I + LGT
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGT 231

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 90/331 (27%), Positives = 152/331 (45%), Gaps = 32/331 (9%)
Query: 93  AMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNER 152
           A S A  +T  +  RP  Y    + T+ W   + Y+ +  VG G Y  V    +V +  +
Sbjct: 20  AGSAAAPFTMSHKERPTFYRQELNKTI-WEVPERYQTLSPVGSGAYGSVCSSYDVKSGLK 78
Query: 153 CXXXXXX----XXXXXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN--- 205
                                   L       NV+ LLD+       TP+   E  N   
Sbjct: 79  IAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF------TPATSLEEFNDVY 132
Query: 206 ------STDFK--VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
                   D    V    LTD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  
Sbjct: 133 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC- 191
Query: 258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 317
           +L+++D+GLA   H   E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +
Sbjct: 192 ELKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249
Query: 318 EPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN 377
              F G D+ +QL +I ++ GT   +        E    +++L     R     FI A+ 
Sbjct: 250 T-LFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLPQMPKRNFADVFIGAN- 307
Query: 378 QHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
                P A+D L+K+L  D   R+TA EA+ 
Sbjct: 308 -----PLAVDLLEKMLVLDTDKRITASEALA 333

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 115/227 (50%), Gaps = 18/227 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC--------G 178
           YE V ++G G Y +VF+  ++    R                    ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 179 GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELLKA 231
            PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +    Y   +D+WS+GC+FA M FR++P F G  + DQL KI  V+G
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIG 236

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 115/227 (50%), Gaps = 18/227 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC--------G 178
           YE V ++G G Y +VF+  ++    R                    ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 179 GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELLKA 231
            PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +    Y   +D+WS+GC+FA M FR++P F G  + DQL KI  V+G
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIG 236

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 115/227 (50%), Gaps = 18/227 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC--------G 178
           YE V ++G G Y +VF+  ++    R                    ++ +          
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 179 GPNVVKLLDIV---RDQHSKTPSLIFEYVNS--TDF--KVLYPTLTDYDIRYYIYELLKA 231
            PNVV+L D+    R       +L+FE+V+   T +  KV  P +    I+  +++LL+ 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +    Y   +D+WS+GC+FA M FR++P F G  + DQL KI  V+G
Sbjct: 192 LQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIG 236

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 148/294 (50%), Gaps = 21/294 (7%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXX---XXXXXXXXXXXXXXLQNLCGGPNVV 183
           ++ + K+G G Y+ V++G+N  T                          L       N+V
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---------IRYYIYELLKALDY 234
           +L D++  ++  T  L+FE++++ D K    + T  +         ++Y+ ++LL+ L +
Sbjct: 67  RLYDVIHTENKLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVD 293
           CH   I+HRD+KP N++I+    +L+L D+GLA  F  P   ++  V + +++ P++L+ 
Sbjct: 124 CHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG 182
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  S+D+WS GC+ A MI  K P F G ++ +QL  I  ++GT   + + +   L  
Sbjct: 183 SRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL-- 239
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            P+ +  + +   +   + +    +  +    +DFL  LL+ +   RL+A++A+
Sbjct: 240 -PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 130/246 (52%), Gaps = 41/246 (16%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----------------PTLTDYDIRYY 224
           NV+ LLD+       TP+   E     DF  +Y                  L+D  +++ 
Sbjct: 88  NVIGLLDVF------TPATSIE-----DFSEVYLVTTLMGADLNNIVKSQALSDEHVQFL 136
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           +Y+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA      +E    VA+R+
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-SELRILDFGLAR--QADEEMTGYVATRW 193
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DEL 342
           ++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I +V+GT   E+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGTPSPEV 252
Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
            A ++  H      + +L     +   S F  A+      P AID L ++L  D   R++
Sbjct: 253 LAKISSEHAR--TYIQSLPPMPQKDLSSIFRGAN------PLAIDLLGRMLVLDSDQRVS 304
Query: 403 AREAMV 408
           A EA+ 
Sbjct: 305 AAEALA 310

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 115/196 (58%), Gaps = 14/196 (7%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
            L+D  +++ +Y+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA      +
Sbjct: 119 ALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLAR--QADE 175
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I 
Sbjct: 176 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIM 234
Query: 335 KVLGT--DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 392
           +V+GT   E+ A ++  H      + +L     +   S F  A+      P AID L ++
Sbjct: 235 EVVGTPSPEVLAKISSEHART--YIQSLPPMPQKDLSSIFRGAN------PLAIDLLGRM 286
Query: 393 LRYDHQDRLTAREAMV 408
           L  D   R++A EA+ 
Sbjct: 287 LVLDSDQRVSAAEALA 302

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 130/246 (52%), Gaps = 41/246 (16%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----------------PTLTDYDIRYY 224
           NV+ LLD+       TP+   E     DF  +Y                  L+D  +++ 
Sbjct: 88  NVIGLLDVF------TPATSIE-----DFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL 136
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
           +Y+LL+ L Y HS GI+HRD+KP NV ++ +  +LR++D+GLA      +E    VA+R+
Sbjct: 137 VYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-SELRILDFGLAR--QADEEMTGYVATRW 193
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DEL 342
           ++ PE++++   Y+ ++D+WS+GC+ A ++ + +  F G D  DQL +I +V+GT   E+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFPGSDYIDQLKRIMEVVGTPSPEV 252
Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
            A ++  H      + +L     +   S F  A+      P AID L ++L  D   R++
Sbjct: 253 LAKISSEHAR--TYIQSLPPMPQKDLSSIFRGAN------PLAIDLLGRMLVLDSDQRVS 304
Query: 403 AREAMV 408
           A EA+ 
Sbjct: 305 AAEALA 310

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 109/192 (56%), Gaps = 12/192 (6%)
Query: 221 IRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
           I+ ++++L++++   H  S  + HRD+KPHNV+++     L+L D+G A+   P +    
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
            + SRY++ PEL+   Q Y  ++D+WS+GC+FA M+   EP F G ++  QL +I +VLG
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHEIVRVLG 249
Query: 339 --TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 396
             + E+   LN  H ++D      +      PWS  + +D+    + EA D L  LL+Y 
Sbjct: 250 CPSREVLRKLNPSHTDVD------LYNSKGIPWSN-VFSDHSLKDAKEAYDLLSALLQYL 302
Query: 397 HQDRLTAREAMV 408
            ++R+   EA+ 
Sbjct: 303 PEERMKPYEALC 314

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/247 (30%), Positives = 131/247 (53%), Gaps = 43/247 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYE 227
           NV+ LLD+       TP    +  + TDF ++ P              L +  I++ +Y+
Sbjct: 85  NVIGLLDVF------TPDETLD--DFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 136
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           +LK L Y H+ GI+HRD+KP N+ ++ +  +L+++D+GLA       E    V +R+++ 
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR--QADSEMXGXVVTRWYRA 193
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DE 341
           PE++++   Y  ++D+WS+GC+ A MI  K   F G D+ DQL +I KV GT        
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKT-LFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
           L +   K +++  P+L+       +K ++  +        SP A++ L+K+L  D + R+
Sbjct: 253 LQSDEAKNYMKGLPELE-------KKDFASILTN-----ASPLAVNLLEKMLVLDAEQRV 300
Query: 402 TAREAMV 408
           TA EA+ 
Sbjct: 301 TAGEALA 307

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 137/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   L+   + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 162 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 277
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 278 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 329

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 134/240 (55%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRDQ--HSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCH 236
           NV+ + DI+R     +     I + +  TD   L  +  L++  I Y++Y++L+ L Y H
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH 161
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++I+     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 162 SANVLHRDLKPSNLLINTTC-DLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 277
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            ++    L +L  + ++  W+K F  +D++      A+D LD++L ++   R+T  EA+ 
Sbjct: 278 -MKARNYLQSLPSK-TKVAWAKLFPKSDSK------ALDLLDRMLTFNPNKRITVEEALA 329

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 147 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 262
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 263 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 314

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 137/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 140 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE---LNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+ E   LN  +N  
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPEQEDLNCIIN-- 255
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 256 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 307

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 144 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 259
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 260 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 311

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 257
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 258 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 309

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 144 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 259
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 260 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 311

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 162 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 277
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 278 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 329

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 257
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 258 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 309

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 147 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 262
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 263 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 314

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 147
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 148 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 263
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 264 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 315

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 138
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 139 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 254
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 255 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 306

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 140 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 255
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 256 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 307

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 128/248 (51%), Gaps = 49/248 (19%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-------YDIRYYIYELLKALD 233
           N+V L DI+  + S T  L+FEY++    K L   L D       ++++ ++++LL+ L 
Sbjct: 61  NIVTLHDIIHTEKSLT--LVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 292
           YCH Q ++HRD+KP N++I+ E  +L+L D+GLA     P K Y+  V + +++ P++L+
Sbjct: 115 YCHRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILL 173
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------------D 340
              DY   +DMW +GC+F  M   + P F G    +QL  I ++LGT            +
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232
Query: 341 ELNAY-LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
           E   Y   KY  E      AL+    R              +  +  D L KLL+++ ++
Sbjct: 233 EFKTYNYPKYRAE------ALLSHAPR--------------LDSDGADLLTKLLQFEGRN 272
Query: 400 RLTAREAM 407
           R++A +AM
Sbjct: 273 RISAEDAM 280

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 144 SANVLHRDLKPSNLLLN-TTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCGIN-- 259
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 260 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 311

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 149
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 150 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 265
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 266 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 317

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 257
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 258 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 309

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNXIIN-- 257
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 258 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 309

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 119/226 (52%), Gaps = 16/226 (7%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           D Y  + K+G G Y EV++ I+  TNE     R                    L+ L   
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
            N+++L  ++   H+    LIFEY  +   K +   P ++   I+ ++Y+L+  +++CHS
Sbjct: 94  -NIIELKSVI--HHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 238 QGIMHRDVKPHNVMID----HELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 292
           +  +HRD+KP N+++      E   L++ D+GLA  F  P +++   + + +++ PE+L+
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILL 210
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
             + Y  S+D+WS+ C++A M+  K P F G    DQL KI +VLG
Sbjct: 211 GSRHYSTSVDIWSIACIWAEMLM-KTPLFPGDSEIDQLFKIFEVLG 255

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIIN-- 261
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 262 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 313

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 138/240 (57%), Gaps = 24/240 (10%)
Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 142 SANVLHRDLKPSNLLLN-TTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNXIIN-- 257
Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
            L+    L +L  + ++ PW++ F NAD++      A+D LDK+L ++   R+   +A+ 
Sbjct: 258 -LKARNYLLSLPHK-NKVPWNRLFPNADSK------ALDLLDKMLTFNPHKRIEVEQALA 309

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 58/163 (35%), Positives = 97/163 (59%), Gaps = 8/163 (4%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDI-RYYIYELLKALDYCHS 237
           N+V LL++ + +  K   L+FE+V+ T  D   L+P   DY + + Y+++++  + +CHS
Sbjct: 85  NLVNLLEVCKKK--KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQD 296
             I+HRD+KP N+++      ++L D+G A     PG+ Y+  VA+R+++ PELLV    
Sbjct: 143 HNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
           Y  ++D+W++GC+   M F  EP F G  + DQL  I   LG 
Sbjct: 202 YGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGN 243

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELAKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 236 GTPG---------AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLV 286
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 287 LDSDKRITAAQALA 300

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 247 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 298 LDSDKRITAAQALA 311

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 247 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 298 LDSDKRITAAQALA 311

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTADEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 247 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 298 LDSDKRITAAQALA 311

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 141/311 (45%), Gaps = 20/311 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 25  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 83
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMX 200
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 201 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 259
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 260 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 313
Query: 398 QDRLTAREAMV 408
             R+TA +A+ 
Sbjct: 314 DKRITAAQALA 324

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 236 GTPG---------AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLV 286
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 287 LDSDKRITAAQALA 300

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/317 (26%), Positives = 142/317 (44%), Gaps = 32/317 (10%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 24  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 82
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN---------STDFK--V 211
                     L       NV+ LLD+       TP+   E  N           D    V
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIV 136
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
               LTD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H
Sbjct: 137 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--H 193
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL 
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLK 252
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            I +++GT                 + +L         + FI A+      P A+D L+K
Sbjct: 253 LILRLVGTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGAN------PLAVDLLEK 306
Query: 392 LLRYDHQDRLTAREAMV 408
           +L  D   R+TA +A+ 
Sbjct: 307 MLVLDSDKRITAAQALA 323

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 141/311 (45%), Gaps = 20/311 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 25  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 83
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 200
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 259
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 260 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 313
Query: 398 QDRLTAREAMV 408
             R+TA +A+ 
Sbjct: 314 DKRITAAQALA 324

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 141/311 (45%), Gaps = 20/311 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 240 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 293
Query: 398 QDRLTAREAMV 408
             R+TA +A+ 
Sbjct: 294 DKRITAAQALA 304

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 141/311 (45%), Gaps = 20/311 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 15  RPTFYRQELNKTI-WEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 73
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 74  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 133
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 134 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 190
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 191 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 249
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 250 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 303
Query: 398 QDRLTAREAMV 408
             R+TA +A+ 
Sbjct: 304 DKRITAAQALA 314

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 149/320 (46%), Gaps = 38/320 (11%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN---------STDFK--V 211
                     L       NV+ LLD+       TP+   E  N           D    V
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIV 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
               LTD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H
Sbjct: 124 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--H 180
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL 
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLK 239
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDF 388
            I +++GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D 
Sbjct: 240 LILRLVGTPG---------AELLKKISSESARNYIQSLAQMPKMNFANVFIGANPLAVDL 290
Query: 389 LDKLLRYDHQDRLTAREAMV 408
           L+K+L  D   R+TA +A+ 
Sbjct: 291 LEKMLVLDSDKRITAAQALA 310

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 2   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 177
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 236
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 237 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 287
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 288 LDSDKRITAAQALA 301

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDYGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 3   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 61
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 62  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 121
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 122 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 178
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 237
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 238 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 288
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 289 LDSDKRITAAQALA 302

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 141/311 (45%), Gaps = 20/311 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMA 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 177 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 236 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 289
Query: 398 QDRLTAREAMV 408
             R+TA +A+ 
Sbjct: 290 DKRITAAQALA 300

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 141/311 (45%), Gaps = 20/311 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMA 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 240 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 293
Query: 398 QDRLTAREAMV 408
             R+TA +A+ 
Sbjct: 294 DKRITAAQALA 304

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 1   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 119
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 176
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 235
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 236 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 286
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 287 LDSDKRITAAQALA 300

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 141/311 (45%), Gaps = 20/311 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMA 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 240 GTPGAELLKKISSESARNYIQSLAQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 293
Query: 398 QDRLTAREAMV 408
             R+TA +A+ 
Sbjct: 294 DKRITAAQALA 304

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/320 (27%), Positives = 149/320 (46%), Gaps = 38/320 (11%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN---------STDFK--V 211
                     L       NV+ LLD+       TP+   E  N           D    V
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIV 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
               LTD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ E  +L+++D+GLA   H
Sbjct: 124 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDSELKILDFGLAR--H 180
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL 
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLK 239
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDF 388
            I +++GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D 
Sbjct: 240 LILRLVGTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 290
Query: 389 LDKLLRYDHQDRLTAREAMV 408
           L+K+L  D   R+TA +A+ 
Sbjct: 291 LEKMLVLDSDKRITAAQALA 310

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 245 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 296 LDSDKRITAAQALA 309

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 2   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 120
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 121 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 177
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 178 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 236
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 237 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 287
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 288 LDSDKRITAAQALA 301

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 149/320 (46%), Gaps = 38/320 (11%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXX 166
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 17  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSII 75
Query: 167 XXXXX----XLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN---------STDFK--V 211
                     L       NV+ LLD+       TP+   E  N           D    V
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIV 129
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
               LTD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H
Sbjct: 130 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--H 186
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL 
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLK 245
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDF 388
            I +++GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D 
Sbjct: 246 LILRLVGTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 296
Query: 389 LDKLLRYDHQDRLTAREAMV 408
           L+K+L  D   R+TA +A+ 
Sbjct: 297 LEKMLVLDSDKRITAAQALA 316

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 141/311 (45%), Gaps = 20/311 (6%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 25  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 83
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 143
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 144 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 200
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 201 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 259
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
           GT                 + +L         + FI A+      P A+D L+K+L  D 
Sbjct: 260 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN------PLAVDLLEKMLVLDS 313
Query: 398 QDRLTAREAMV 408
             R+TA +A+ 
Sbjct: 314 DKRITAAQALA 324

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 28  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 86
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 203
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 204 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 262
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 263 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 313
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 314 LDSDKRITAAQALA 327

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 12  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 70
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 130
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 187
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 246
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 247 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 297
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 298 LDSDKRITAAQALA 311

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 129
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 130 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 186
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 245
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 246 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 296
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 297 LDSDKRITAAQALA 310

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 245 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 296 LDSDKRITAAQALA 309

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 4   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 62
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 63  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 122
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 123 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 179
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 180 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 238
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 239 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 289
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 290 LDSDKRITAAQALA 303

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 24  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 82
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 142
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 143 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 199
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 200 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 258
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 259 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 309
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 310 LDSDKRITAAQALA 323

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-SELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 242 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 293 LDSDKRITAAQALA 306

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 149/320 (46%), Gaps = 38/320 (11%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 16  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN---------STDFK--V 211
                     L       NV+ LLD+       TP+   E  N           D    V
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIV 128
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
               LTD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H
Sbjct: 129 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--H 185
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL 
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLK 244
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDF 388
            I +++GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D 
Sbjct: 245 LILRLVGTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 295
Query: 389 LDKLLRYDHQDRLTAREAMV 408
           L+K+L  D   R+TA +A+ 
Sbjct: 296 LEKMLVLDSDKRITAAQALA 315

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 17  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 192
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 251
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 252 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 302
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 303 LDSDKRITAAQALA 316

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 17  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 75
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 135
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 136 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 192
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 193 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 251
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 252 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 302
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 303 LDSDKRITAAQALA 316

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 242 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 293 LDSDKRITAAQALA 306

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 245 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 296 LDSDKRITAAQALA 309

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 16  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 74
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 134
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 135 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 191
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 192 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 250
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 251 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 301
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 302 LDSDKRITAAQALA 315

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/320 (26%), Positives = 149/320 (46%), Gaps = 38/320 (11%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 11  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 69
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN---------STDFK--V 211
                     L       NV+ LLD+       TP+   E  N           D    V
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIV 123
Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
               LTD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H
Sbjct: 124 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--H 180
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              E    VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL 
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLK 239
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDF 388
            I +++GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D 
Sbjct: 240 LILRLVGTPG---------AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 290
Query: 389 LDKLLRYDHQDRLTAREAMV 408
           L+K+L  D   R+TA +A+ 
Sbjct: 291 LEKMLVLDSDKRITAAQALA 310

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 242 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 293 LDSDKRITAAQALA 306

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 7   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 65
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 125
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 126 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMT 182
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 183 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 241
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 242 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 292
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 293 LDSDKRITAAQALA 306

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 147/311 (47%), Gaps = 31/311 (9%)
Query: 116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXX----XXXXXXXXXX 171
           S  V +   D+YE++  +G G Y  V       T ++                       
Sbjct: 46  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 105
Query: 172 XLQNLCGGPNVVKLLDIVRDQ----HSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYI 225
            +       N++ + DI+R        K+  ++ + + S   ++++ +  LT   +RY++
Sbjct: 106 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL 165
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--------EFYHPGKEYN 277
           Y+LL+ L Y HS  ++HRD+KP N++++    +L++ D+G+A        E  +   EY 
Sbjct: 166 YQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEY- 223
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PEL++ L +Y  ++D+WS+GC+F  M+ R++  F G +   QL  I  VL
Sbjct: 224 --VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-LFPGKNYVHQLQLIMMVL 280
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYD 396
           GT             +   + +L  R    PW   +  AD Q      A+  L ++LR++
Sbjct: 281 GTPSPAVIQAVGAERVRAYIQSLPPRQP-VPWETVYPGADRQ------ALSLLGRMLRFE 333
Query: 397 HQDRLTAREAM 407
              R++A  A+
Sbjct: 334 PSARISAAAAL 344

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 147/311 (47%), Gaps = 31/311 (9%)
Query: 116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXX----XXXXXXXXXX 171
           S  V +   D+YE++  +G G Y  V       T ++                       
Sbjct: 45  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 104
Query: 172 XLQNLCGGPNVVKLLDIVRDQ----HSKTPSLIFEYVNSTDFKVLYPT--LTDYDIRYYI 225
            +       N++ + DI+R        K+  ++ + + S   ++++ +  LT   +RY++
Sbjct: 105 KILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFL 164
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--------EFYHPGKEYN 277
           Y+LL+ L Y HS  ++HRD+KP N++++    +L++ D+G+A        E  +   EY 
Sbjct: 165 YQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEY- 222
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PEL++ L +Y  ++D+WS+GC+F  M+ R++  F G +   QL  I  VL
Sbjct: 223 --VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ-LFPGKNYVHQLQLIMMVL 279
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYD 396
           GT             +   + +L  R    PW   +  AD Q      A+  L ++LR++
Sbjct: 280 GTPSPAVIQAVGAERVRAYIQSLPPRQP-VPWETVYPGADRQ------ALSLLGRMLRFE 332
Query: 397 HQDRLTAREAM 407
              R++A  A+
Sbjct: 333 PSARISAAAAL 343

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  +G G Y  V    +  T  R              
Sbjct: 10  RPTFYRQELNKTI-WEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 68
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 128
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 129 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-XELKILDFGLAR--HTDDEMT 185
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 186 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 244
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 245 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 295
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 296 LDSDKRITAAQALA 309

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 28  RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 86
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 146
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA   H   E  
Sbjct: 147 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR--HTDDEMX 203
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 204 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 262
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 263 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 313
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 314 LDSDKRITAAQALA 327

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 147/314 (46%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDAGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 147/314 (46%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDGGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 148/314 (47%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFKVLYPT--LT 217
                     L       NV+ LLD+    R         +  ++   D   +  +  LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GL    H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-SELKILDFGLCR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 147/314 (46%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDRGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 147/314 (46%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++ +GLA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILGFGLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/314 (26%), Positives = 147/314 (46%), Gaps = 26/314 (8%)
Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXX----XXX 162
           RP  Y    + T+ W   + Y+ +  VG G Y  V    +  T  R              
Sbjct: 5   RPTFYRQELNKTI-WEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 63
Query: 163 XXXXXXXXXXLQNLCGGPNVVKLLDI---VRDQHSKTPSLIFEYVNSTDFK--VLYPTLT 217
                     L       NV+ LLD+    R         +  ++   D    V    LT
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 123
Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
           D  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+ LA   H   E  
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFYLAR--HTDDEMT 180
Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 181 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLV 239
Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--INADNQHL-VSPEAIDFLDKLLR 394
           GT            EL  ++ +   R+  +  ++   +N  N  +  +P A+D L+K+L 
Sbjct: 240 GTP---------GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 290
Query: 395 YDHQDRLTAREAMV 408
            D   R+TA +A+ 
Sbjct: 291 LDSDKRITAAQALA 304

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 145/313 (46%), Gaps = 26/313 (8%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 6   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 65
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----- 274
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 184
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 243
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           ++ G+     + N  + EL  +L+ LV    RK   +       ++  P A+D +DKLL 
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLE-LVKGQKRKVKDRL----KAYVRDPYALDLIDKLLV 298
Query: 395 YDHQDRLTAREAM 407
            D   R+ + +A+
Sbjct: 299 LDPAQRIDSDDAL 311

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 145/313 (46%), Gaps = 26/313 (8%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 5   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 64
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----- 274
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 183
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 184 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 242
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           ++ G+     + N  + EL  +L+ LV    RK   +       ++  P A+D +DKLL 
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLE-LVKGQKRKVKDRL----KAYVRDPYALDLIDKLLV 297
Query: 395 YDHQDRLTAREAM 407
            D   R+ + +A+
Sbjct: 298 LDPAQRIDSDDAL 310

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 145/313 (46%), Gaps = 26/313 (8%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 6   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 65
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----- 274
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 184
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 243
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           ++ G+     + N  + EL  +L+ LV    RK   +       ++  P A+D +DKLL 
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLE-LVKGQKRKVKDRL----KAYVRDPYALDLIDKLLV 298
Query: 395 YDHQDRLTAREAM 407
            D   R+ + +A+
Sbjct: 299 LDPAQRIDSDDAL 311

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 145/313 (46%), Gaps = 26/313 (8%)
Query: 114 YESLTVQWGDQ-DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXX 168
           Y+S+   + D+   YE + K+G+G + EVF+  +  T ++                    
Sbjct: 6   YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 65
Query: 169 XXXXLQNLCGGPNVVKLLDIVRDQHS------KTPSLIFEYVNSTDFKVLYPTLTDY--- 219
               +  L    NVV L++I R + S       +  L+F++       +L   L  +   
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 125
Query: 220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----- 274
           +I+  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K     
Sbjct: 126 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPN 184
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            Y  RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+
Sbjct: 185 RYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALIS 243
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           ++ G+     + N  + EL  +L+ LV    RK   +       ++  P A+D +DKLL 
Sbjct: 244 QLCGSITPEVWPNVDNYELYEKLE-LVKGQKRKVKDRL----KAYVRDPYALDLIDKLLV 298
Query: 395 YDHQDRLTAREAM 407
            D   R+ + +A+
Sbjct: 299 LDPAQRIDSDDAL 311

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 93/167 (55%), Gaps = 12/167 (7%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D      K   P L    I+  + + L+ 
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 132
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 133 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 192 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 236

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 94/167 (56%), Gaps = 12/167 (7%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D      K   P L    I+  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y      +  V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVL 183
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 20/221 (9%)
Query: 200 IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
           I + +  TD   +  T  L+D  I+Y+IY+ L+A+   H   ++HRD+KP N++I+    
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC- 149
Query: 258 KLRLIDWGLAEFYHPGKEYNVR-----------VASRYFKGPELLVDLQDYDYSLDMWSL 306
            L++ D+GLA         N             VA+R+++ PE+++    Y  ++D+WS 
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 366
           GC+ A +  R+ P F G D   QL+ I  ++GT   +  L         +    +  +  
Sbjct: 210 GCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268
Query: 367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            P  K         V+P+ ID L ++L +D   R+TA+EA+
Sbjct: 269 APLEKMFPR-----VNPKGIDLLQRMLVFDPAKRITAKEAL 304

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 20/221 (9%)
Query: 200 IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
           I + +  TD   +  T  L+D  I+Y+IY+ L+A+   H   ++HRD+KP N++I+    
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC- 149
Query: 258 KLRLIDWGLAEFYHPGKEYNVR-----------VASRYFKGPELLVDLQDYDYSLDMWSL 306
            L++ D+GLA         N             VA+R+++ PE+++    Y  ++D+WS 
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 366
           GC+ A +  R+ P F G D   QL+ I  ++GT   +  L         +    +  +  
Sbjct: 210 GCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268
Query: 367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            P  K         V+P+ ID L ++L +D   R+TA+EA+
Sbjct: 269 APLEKMFPR-----VNPKGIDLLQRMLVFDPAKRITAKEAL 304

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 20/221 (9%)
Query: 200 IFEYVNSTDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR 257
           I + +  TD   +  T  L+D  I+Y+IY+ L+A+   H   ++HRD+KP N++I+    
Sbjct: 91  IIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC- 149
Query: 258 KLRLIDWGLAEFYHPGKEYNVR-----------VASRYFKGPELLVDLQDYDYSLDMWSL 306
            L++ D+GLA         N             VA+R+++ PE+++    Y  ++D+WS 
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 307 GCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR 366
           GC+ A +  R+ P F G D   QL+ I  ++GT   +  L         +    +  +  
Sbjct: 210 GCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA 268
Query: 367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            P  K         V+P+ ID L ++L +D   R+TA+EA+
Sbjct: 269 APLEKMFPR-----VNPKGIDLLQRMLVFDPAKRITAKEAL 304

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 93/167 (55%), Gaps = 12/167 (7%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D      K   P L    I+  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVL 183
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 14/223 (6%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE-----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           + YE + K+G G Y  VF+  N +T +     +                    L+ L   
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KH 61
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 236
           PN+V LL++ R +  +   L+FEY + T    L      + ++ ++   ++ L+A+++CH
Sbjct: 62  PNLVNLLEVFRRK--RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQ 295
               +HRDVKP N++I      ++L D+G A     P   Y+  VA+R+++ PELLV   
Sbjct: 120 KHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
            Y   +D+W++GC+FA ++    P + G  + DQL  I K LG
Sbjct: 179 QYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLG 220

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 58/167 (34%), Positives = 93/167 (55%), Gaps = 12/167 (7%)
Query: 180 PNVVKLLDIV---RDQHSKTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKA 231
           PNVV+L+D+    R       +L+FE+V+  D      K   P L    I+  + + L+ 
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y         V + +++ PE+L
Sbjct: 125 LDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVL 183
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +    Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++G
Sbjct: 184 LQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 228

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 123/243 (50%), Gaps = 30/243 (12%)
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
           GP+  +L D V          I +    TD   +    P L ++  R ++Y+LL+ L Y 
Sbjct: 78  GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH-ARLFMYQLLRGLKYI 136
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA----SRYFKGPELL 291
           HS  ++HRD+KP N+ I+ E   L++ D+GLA    P   +   ++    +++++ P LL
Sbjct: 137 HSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL 196
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +   +Y  ++DMW+ GC+FA M+  K  F   H    +L ++  +L +      +   H 
Sbjct: 197 LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH----ELEQMQLILES------IPVVHE 246
Query: 352 ELDPQLDALVGRHSR-------KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
           E   +L +++  + R       KP ++ +       +S EA+DFL+++L +   DRLTA 
Sbjct: 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-----ISREAVDFLEQILTFSPMDRLTAE 301
Query: 405 EAM 407
           EA+
Sbjct: 302 EAL 304

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 121/236 (51%), Gaps = 12/236 (5%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V++  L    + Y +Y++L  + + H
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 141
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 142 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGM-G 199
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--DELNAYLN---KYHL 351
           Y  ++D+WS+GC+  G + +    F G D+ DQ  K+ + LGT   E  A L    + ++
Sbjct: 200 YKENVDIWSVGCIM-GELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 258
Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           E  P    +        W     ++   + + +A D L K+L  D   R++  EA+
Sbjct: 259 ENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 314

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT    A++ K    L P 
Sbjct: 202 YKENVDIWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGT-PCPAFMKK----LQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 121/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 121/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 148
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 149 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 206
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 207 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 260
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 261 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 320
Query: 407 M 407
           +
Sbjct: 321 L 321

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 203 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 256
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 407 M 407
           +
Sbjct: 317 L 317

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 124/249 (49%), Gaps = 22/249 (8%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E+++ +  Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 349 YHLELDPQLDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQ 398
           +  +L P +   V    +     F          AD++H  L + +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 399 DRLTAREAM 407
            R++  EA+
Sbjct: 308 KRISVDEAL 316

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 121/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 196 YKENVDLWSVGCIMGEMVCHK-ILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 249
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 250 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 309
Query: 407 M 407
           +
Sbjct: 310 L 310

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 121/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V++  L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+  G + +    F G D+ DQ  K+ + LGT        ++   L P 
Sbjct: 202 YAANVDIWSVGCIM-GELVKGCVIFQGTDHIDQWNKVIEQLGTPS-----AEFMAALQPT 255
Query: 357 LDALVGRHSRKPWSKF----------INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    + P  KF            ++   + + +A D L K+L  D   R++  EA
Sbjct: 256 VRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 124/249 (49%), Gaps = 22/249 (8%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E+++ +  Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 349 YHLELDPQLDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQ 398
           +  +L P +   V    +     F          AD++H  L + +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 399 DRLTAREAM 407
            R++  EA+
Sbjct: 308 KRISVDEAL 316

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 146 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGM-G 203
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   MI +    F G D+ DQ  K+ + LGT        ++  +L P 
Sbjct: 204 YKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTP-----CPEFMKKLQPT 257
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  EA
Sbjct: 258 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 317
Query: 407 M 407
           +
Sbjct: 318 L 318

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 136
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 137 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 194
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 195 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 248
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 407 M 407
           +
Sbjct: 309 L 309

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 182 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 239
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 240 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 293
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 407 M 407
           +
Sbjct: 354 L 354

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 142
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 143 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 200
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 201 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 254
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 255 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 314
Query: 407 M 407
           +
Sbjct: 315 L 315

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 137 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 194
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 195 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 248
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 407 M 407
           +
Sbjct: 309 L 309

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 196 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 249
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 250 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 407 M 407
           +
Sbjct: 310 L 310

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 203 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 256
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 257 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 407 M 407
           +
Sbjct: 317 L 317

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 182 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 239
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 240 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 293
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353
Query: 407 M 407
           +
Sbjct: 354 L 354

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 145 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 202
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 203 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 256
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 257 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 316
Query: 407 M 407
           +
Sbjct: 317 L 317

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 138 SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 195
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 196 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 249
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 250 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 309
Query: 407 M 407
           +
Sbjct: 310 L 310

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 122/241 (50%), Gaps = 22/241 (9%)
Query: 181 NVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++ LL++   Q +    +   L+ E +++   +V+   L    + Y +Y++L  + + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ PE+++ +  
Sbjct: 144 SAGIIHRDLKPSNIVVKSD-XTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-G 201
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           Y  ++D+WS+GC+   M+ R +  F G D  DQ  K+ + LGT        ++  +L P 
Sbjct: 202 YKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTP-----CPEFMKKLQPT 255
Query: 357 LDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQDRLTAREA 406
           +   V    +     F          AD++H  L + +A D L K+L  D   R++  +A
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 407 M 407
           +
Sbjct: 316 L 316

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 123/249 (49%), Gaps = 22/249 (8%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E+++ +  Y  ++D+WS+G +   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGVIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 349 YHLELDPQLDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQ 398
           +  +L P +   V    +     F          AD++H  L + +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 399 DRLTAREAM 407
            R++  EA+
Sbjct: 308 KRISVDEAL 316

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 123/249 (49%), Gaps = 22/249 (8%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
           L  +    N++ LL++   Q S    +   ++ E +++   +V+   L    + Y +Y++
Sbjct: 76  LMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQM 135
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L  + + HS GI+HRD+KP N+++  +   L+++D+GLA            V +RY++ P
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSD-ATLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E+++ +  Y  ++D+WS+G +   MI +    F G D+ DQ  K+ + LGT        +
Sbjct: 195 EVILGM-GYKENVDIWSVGVIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPS-----PE 247
Query: 349 YHLELDPQLDALVGRHSRKPWSKF--------INADNQH--LVSPEAIDFLDKLLRYDHQ 398
           +  +L P +   V    +     F          AD++H  L + +A D L K+L  D  
Sbjct: 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307
Query: 399 DRLTAREAM 407
            R++  EA+
Sbjct: 308 KRISVDEAL 316

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/340 (23%), Positives = 141/340 (41%), Gaps = 59/340 (17%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX----XXXXXXXXLQNLCGGP 180
           D+YE+   +GRG Y  V+   + N N+                         + N     
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 181 NVVKLLDIV--RDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYC 235
            +++L D++   D        I   +  +D K L+ T   LT+  ++  +Y LL    + 
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFI 147
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------------PG--- 273
           H  GI+HRD+KP N +++ +   +++ D+GLA   +                   PG   
Sbjct: 148 HESGIIHRDLKPANCLLNQDC-SVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 274 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FRKEP 319
               K+    V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFP 266
Query: 320 FFYGHD------NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFI 373
            F G        +H+   K+ +    D+LN   N      +  L  +  +   K    F 
Sbjct: 267 LFPGSSCFPLSPDHNS-KKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFP 325
Query: 374 NADNQHL------VSPEAIDFLDKLLRYDHQDRLTAREAM 407
             D   L      +S E ID L+ +LR++ Q R+T  +A+
Sbjct: 326 TRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKAL 365

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 117/237 (49%), Gaps = 19/237 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPS-----LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKA 231
           PN++ L DI    H + P+     L+ E + +   +V++     ++   I+Y++Y +L  
Sbjct: 89  PNILGLRDIF--VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L   H  G++HRD+ P N+++  +   + + D+ LA            V  R+++ PEL+
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + +   +DMWS GC+ A M F ++  F G   ++QL KI +V+GT ++   +     
Sbjct: 206 MQFKGFTKLVDMWSAGCVMAEM-FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSP 264
Query: 352 ELDPQLDALVGRHSRKPWSKFI-NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                L   +     + W+  +  AD      P A+D + K+L ++ Q R++  +A+
Sbjct: 265 SARDYLRNSLSNVPARAWTAVVPTAD------PVALDLIAKMLEFNPQRRISTEQAL 315

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 117/237 (49%), Gaps = 19/237 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPS-----LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKA 231
           PN++ L DI    H + P+     L+ E + +   +V++     ++   I+Y++Y +L  
Sbjct: 89  PNILGLRDIF--VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLG 146
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L   H  G++HRD+ P N+++  +   + + D+ LA            V  R+++ PEL+
Sbjct: 147 LHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
           +  + +   +DMWS GC+ A M F ++  F G   ++QL KI +V+GT ++   +     
Sbjct: 206 MQFKGFTKLVDMWSAGCVMAEM-FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSP 264
Query: 352 ELDPQLDALVGRHSRKPWSKFI-NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                L   +     + W+  +  AD      P A+D + K+L ++ Q R++  +A+
Sbjct: 265 SARDYLRNSLSNVPARAWTAVVPTAD------PVALDLIAKMLEFNPQRRISTEQAL 315

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/350 (23%), Positives = 143/350 (40%), Gaps = 64/350 (18%)
Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQ-----N 175
           W   D YE+   +G G Y  V E  +    +R                    L+     N
Sbjct: 49  WQIPDRYEIRHLIGTGSYGHVCEAYD-KLEKRVVAIKKILRVFEDLIDCKRILREIAILN 107
Query: 176 LCGGPNVVKLLDIV--RDQHSKTPSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLK 230
                +VVK+LDIV  +D        +   +  +DFK L+ T   LT+  I+  +Y LL 
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---------------------- 268
            + Y HS GI+HRD+KP N +++ +   +++ D+GLA                       
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 269 ---FYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI-------- 314
              F H     ++    V +R+++ PEL++  ++Y  ++D+WS+GC+FA ++        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 315 --FRKEPFFYGHD----NHDQLV----KIAKVLGTDELNAYLNKYHLELDPQLDALVGRH 364
               + P F G      + DQ      K       D+LN   N      +  ++AL    
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346
Query: 365 SRKPWSKFINADNQHLV------SPEAIDFLDKLLRYDHQDRLTAREAMV 408
           +++    F   +   L       S +AI  L ++L ++   R+T  E + 
Sbjct: 347 AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI 262
           Y+    F  +  +L+  ++R Y+  L KAL   H  GI+HRDVKP N + +  L+K  L+
Sbjct: 101 YLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALV 160
Query: 263 DWGLAEFYHPGK-----------------------------EYNVRVASRYFKGPELLVD 293
           D+GLA+  H  K                             +   R  +  F+ PE+L  
Sbjct: 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK 220
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
             +   ++DMWS G +F  ++  + PF+   D+   L +I  + G+ E
Sbjct: 221 CPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRE 268

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 123/259 (47%), Gaps = 35/259 (13%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----------PTLTDYDIRYYIYEL 228
           PNV+ L  +      +   L+F+Y     + ++              L    ++  +Y++
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 229 LKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYH----PGKEYNVRVA 281
           L  + Y H+  ++HRD+KP N+++     E  ++++ D G A  ++    P  + +  V 
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD---------NHDQLVK 332
           + +++ PELL+  + Y  ++D+W++GC+FA ++   EP F+            +HDQL +
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDR 256
Query: 333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWS--KFINADNQHLVSPEAIDF-- 388
           I  V+G     A  +   ++  P+   L+    R  ++    I    +H V P++  F  
Sbjct: 257 IFNVMG---FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313
Query: 389 LDKLLRYDHQDRLTAREAM 407
           L KLL  D   R+T+ +AM
Sbjct: 314 LQKLLTMDPIKRITSEQAM 332

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 79/343 (23%), Positives = 143/343 (41%), Gaps = 68/343 (19%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX----XXXXXXXXLQNLCGGP 180
           D+Y +   +GRG Y  V+   + NT +                         + N     
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 181 NVVKLLD-IVRDQHSKTPSL-IFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYC 235
            +++L D I+ D   K   L I   +  +D K L+ T   LT+  I+  +Y LL   ++ 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFI 145
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----------------- 278
           H  GI+HRD+KP N +++ +   +++ D+GLA   +  K+ N+                 
Sbjct: 146 HESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 279 ------RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FRKEPFFY 322
                  V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P F 
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 323 G-----------------HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHS 365
           G                   N DQL  I  ++GT   +   N    E+   +        
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF----- 319
Query: 366 RKPWSKFINADNQH-LVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P  K IN   ++  +S + I+ L+ +L+++   R+T  +A+
Sbjct: 320 --PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQAL 360

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 56/297 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 139
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K            KY 
Sbjct: 200 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKYT 245
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            EL PQ            W K         VS  A D + K+L Y    R++AR+A+
Sbjct: 246 FEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDAL 280

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 56/297 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 162
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 163 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 222
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K            KY 
Sbjct: 223 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKYT 268
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            EL PQ            W K         VS  A D + K+L Y    R++AR+A+
Sbjct: 269 FEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDAL 303

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 56/297 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 110 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 163
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 164 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 223
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K            KY 
Sbjct: 224 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKYT 269
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            EL PQ            W K         VS  A D + K+L Y    R++AR+A+
Sbjct: 270 FEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDAL 304

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 56/297 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 145
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 146 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 205
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K            KY 
Sbjct: 206 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKYT 251
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            EL PQ            W K         VS  A D + K+L Y    R++AR+A+
Sbjct: 252 FEL-PQ------------WKK---------VSESAKDLIRKMLTYVPSMRISARDAL 286

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 122/297 (41%), Gaps = 56/297 (18%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL-----CGG 179
           D Y+  R +G+G + EV    +  T + C                   L+ +        
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 180 PNVVKLLDIVRDQ-------HSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN+ KL +   D+          T   +F+ + S          ++ D    I ++L  +
Sbjct: 86  PNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISR------KRFSEVDAARIIRQVLSGI 139
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++ + +   +R+ID+GL+  +   K+   ++ + Y+  PE+
Sbjct: 140 TYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEV 199
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           L     YD   D+WS G +   ++    P F G + +D L K+ K            KY 
Sbjct: 200 LHGT--YDEKCDVWSTGVILY-ILLSGCPPFNGANEYDILKKVEK-----------GKYT 245
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            EL PQ            W K         VS  A D + K L Y    R++AR+A+
Sbjct: 246 FEL-PQ------------WKK---------VSESAKDLIRKXLTYVPSXRISARDAL 280

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 65  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 123 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WS G +   M+ R+ PF
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPF 203

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 75  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 133 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WS G +   M+ R+ PF
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPF 213

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/295 (22%), Positives = 125/295 (42%), Gaps = 57/295 (19%)
Query: 127 YEVVRKVGRGKYSEVF----EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNV 182
           Y+ V+K+G G Y EV     +  +V    +                    +  L   PN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 183 VKLLDIVRDQHS--------KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDY 234
           +KL D   D+ +        K   L  E ++   F        + D    I ++L  + Y
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF-------NEVDAAVIIKQVLSGVTY 151
Query: 235 CHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            H   I+HRD+KP N++++ + +   ++++D+GL+  +   K+   R+ + Y+  PE+L 
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL- 210
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
             + YD   D+WS+G +   ++    P F G  + + L K+ K            KY  +
Sbjct: 211 -RKKYDEKCDVWSIGVILF-ILLAGYPPFGGQTDQEILRKVEK-----------GKYTFD 257
Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             P+            W           VS  A D + ++L++D Q R++A++A+
Sbjct: 258 -SPE------------WKN---------VSEGAKDLIKQMLQFDSQRRISAQQAL 290

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 69  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 127 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WS G +   M+ R+ PF
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPF 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCGGP 180
           +Y++V+ +G G + +V    +  T ++                     +      L   P
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +++KL D+++ +      ++ EY  +   D+ V    +++ + R +  +++ A++YCH  
Sbjct: 74  HIIKLYDVIKSKDEII--MVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++       
Sbjct: 132 KIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WS G +   M+ R+ PF
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPF 212

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 81/148 (54%), Gaps = 8/148 (5%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNVVKL++++ D +     ++FE VN     +   L P L++   R+Y  +L+K ++Y H
Sbjct: 96  PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSEDQARFYFQDLIKGIEYLH 154
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            Q I+HRD+KP N+++  +   +++ D+G++ EF       +  V +  F  PE L + +
Sbjct: 155 YQKIIHRDIKPSNLLVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR 213
Query: 296 DY--DYSLDMWSLGCMFAGMIFRKEPFF 321
                 +LD+W++G      +F + PF 
Sbjct: 214 KIFSGKALDVWAMGVTLYCFVFGQCPFM 241

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 109/233 (46%), Gaps = 43/233 (18%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCH 236
           PN++KL D+  D+  K   L+ E+    + F+ +       + D    + ++L  + Y H
Sbjct: 106 PNIIKLFDVFEDK--KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLH 163
Query: 237 SQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
              I+HRD+KP N++++++  L  ++++D+GL+ F+    +   R+ + Y+  PE+L   
Sbjct: 164 KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-- 221
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y+   D+WS G +   ++    P F G ++ D + K+ K            KY+ + +
Sbjct: 222 KKYNEKCDVWSCGVIMY-ILLCGYPPFGGQNDQDIIKKVEK-----------GKYYFDFN 269
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                         W           +S EA + +  +L YD+  R TA EA+
Sbjct: 270 -------------DWKN---------ISDEAKELIKLMLTYDYNKRCTAEEAL 300

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 77/140 (55%), Gaps = 9/140 (6%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           ++E +    F+     L    +R + + +L+ LD  H   I+H D+KP N+++  + R  
Sbjct: 185 LYELIKKNKFQGFSLPL----VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318
           +++ID+G + + H  +     + SR+++ PE+++  + Y   +DMWSLGC+ A ++    
Sbjct: 241 IKVIDFGSSCYEH--QRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGY 296
Query: 319 PFFYGHDNHDQLVKIAKVLG 338
           P   G D  DQL  + ++LG
Sbjct: 297 PLLPGEDEGDQLACMIELLG 316

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    R                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 77/140 (55%), Gaps = 9/140 (6%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           ++E +    F+     L    +R + + +L+ LD  H   I+H D+KP N+++  + R  
Sbjct: 185 LYELIKKNKFQGFSLPL----VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318
           +++ID+G + + H  +     + SR+++ PE+++  + Y   +DMWSLGC+ A ++    
Sbjct: 241 IKVIDFGSSCYEH--QRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGY 296
Query: 319 PFFYGHDNHDQLVKIAKVLG 338
           P   G D  DQL  + ++LG
Sbjct: 297 PLLPGEDEGDQLACMIELLG 316

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 103/232 (44%), Gaps = 22/232 (9%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXX 170
           E+L  Q    + Y +V  +G+G + EV +  +  T +    +                  
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 171 XXLQNLCGGPNVVKLLDIVRDQHS-------KTPSLIFEYVNSTDFKVLYPTLTDYDIRY 223
             L      PN++KL +I+ D  S        T   +F+ +      +     +++D   
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAAR 125
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVA 281
            I ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+ 
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           + Y+  PE+L     YD   D+WS G +   ++    P FYG + +D L ++
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRV 234

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+VKL +++  +  KT  LI EY +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 71  PNIVKLFEVIETE--KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    + 
Sbjct: 129 QKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               +D+WSLG +   ++    PF
Sbjct: 188 DGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 77/140 (55%), Gaps = 9/140 (6%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           ++E +    F+     L    +R + + +L+ LD  H   I+H D+KP N+++  + R  
Sbjct: 185 LYELIKKNKFQGFSLPL----VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240
Query: 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKE 318
           +++ID+G + + H  +     + SR+++ PE+++  + Y   +DMWSLGC+ A ++    
Sbjct: 241 IKVIDFGSSCYEH--QRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL-TGY 296
Query: 319 PFFYGHDNHDQLVKIAKVLG 338
           P   G D  DQL  + ++LG
Sbjct: 297 PLLPGEDEGDQLACMIELLG 316

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 103/232 (44%), Gaps = 22/232 (9%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXX 170
           E+L  Q    + Y +V  +G+G + EV +  +  T +    +                  
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 171 XXLQNLCGGPNVVKLLDIVRDQHS-------KTPSLIFEYVNSTDFKVLYPTLTDYDIRY 223
             L      PN++KL +I+ D  S        T   +F+ +      +     +++D   
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAAR 125
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVA 281
            I ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+ 
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           + Y+  PE+L     YD   D+WS G +   ++    P FYG + +D L ++
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRV 234

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/232 (22%), Positives = 103/232 (44%), Gaps = 22/232 (9%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXX 170
           E+L  Q    + Y +V  +G+G + EV +  +  T +    +                  
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71
Query: 171 XXLQNLCGGPNVVKLLDIVRDQHS-------KTPSLIFEYVNSTDFKVLYPTLTDYDIRY 223
             L      PN++KL +I+ D  S        T   +F+ +      +     +++D   
Sbjct: 72  VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAAR 125
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVA 281
            I ++   + Y H   I+HRD+KP N++++ + +   +++ID+GL+  +    +   R+ 
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           + Y+  PE+L     YD   D+WS G +   ++    P FYG + +D L ++
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILY-ILLSGTPPFYGKNEYDILKRV 234

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 74  PNIVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH 131
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    + 
Sbjct: 132 QKYIVHRDLKAENLLLDGDM-NIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               +D+WSLG +   ++    PF
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 125/274 (45%), Gaps = 62/274 (22%)
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-------YPTLTDYDIRYYIY 226
           +NLC     V++ D   D H     + FE +  + F  L       YP    + +R+  +
Sbjct: 95  KNLC-----VQMFDWF-DYHGHM-CISFELLGLSTFDFLKDNNYLPYPI---HQVRHMAF 144
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMI---DHEL---------------RKLRLIDWGLAE 268
           +L +A+ + H   + H D+KP N++    D+EL                 +R++D+G A 
Sbjct: 145 QLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT 204
Query: 269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM----FAGMIFRKEPFFYGH 324
           F H  + ++  V++R+++ PE++++L  +    D+WS+GC+    + G        F  H
Sbjct: 205 FDH--EHHSTIVSTRHYRAPEVILEL-GWSQPCDVWSIGCIIFEYYVGFT-----LFQTH 256
Query: 325 DNHDQLVKIAKVLG--------TDELNAYLNKYHLELDPQLDALVGRHSR---KPWSKFI 373
           DN + L  + ++LG              Y  +  L+ D    A  GR+ R   KP  +++
Sbjct: 257 DNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSA--GRYVRENCKPLRRYL 314
Query: 374 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            ++ +     +  D ++ +L Y+   RLT  EA+
Sbjct: 315 TSEAEE--HHQLFDLIESMLEYEPAKRLTLGEAL 346

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 121/298 (40%), Gaps = 52/298 (17%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC---- 177
           G  D Y+ V+K+G G Y EV    +  T                       L  +     
Sbjct: 18  GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 77
Query: 178 -GGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
              PN++KL +   D+  +   L+ E        D  +L    ++ D    + ++L    
Sbjct: 78  LDHPNIMKLYEFFEDK--RNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 135
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           Y H   I+HRD+KP N++++ + R   ++++D+GL+  +  G +   R+ + Y+  PE+L
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 195
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
              + YD   D+WS G +   ++    P F G  + + L ++ K                
Sbjct: 196 --RKKYDEKCDVWSCGVILY-ILLCGYPPFGGQTDQEILKRVEK---------------- 236
Query: 352 ELDPQLDALVGRHSRKP--WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                     G+ S  P  W++         VS EA   +  +L Y+   R++A EA+
Sbjct: 237 ----------GKFSFDPPDWTQ---------VSDEAKQLVKLMLTYEPSKRISAEEAL 275

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    R                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+VKL +++  +  KT  LI EY +     D+ V +  + + + R    +++ A+ YCH
Sbjct: 74  PNIVKLFEVIETE--KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    +  +  PEL    + 
Sbjct: 132 QKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               +D+WSLG +   ++    PF
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++ 
Sbjct: 194 FVGTAQYVSPELLTE-KSAXKSSDLWALGCIIYQLVAGLPPFRAGNEG 240

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 194 FVGTAQYVSPELLTE-KSASKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/202 (21%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 68  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK 125
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    S  +  PEL    +   
Sbjct: 126 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 184
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 185 PEVDVWSLGVILYTLVSGSLPF 206

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 68/125 (54%), Gaps = 19/125 (15%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------PG 273
           ++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 274 KEYNVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              N+   + +  +   E+L     Y+  +DM+SLG +F  MI+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 332 KIAKV 336
           K+  V
Sbjct: 240 KLRSV 244

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 68/125 (54%), Gaps = 19/125 (15%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------PG 273
           ++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 274 KEYNVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              N+   + +  +   E+L     Y+  +DM+SLG +F  MI+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 332 KIAKV 336
           K+  V
Sbjct: 240 KLRSV 244

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 111/244 (45%), Gaps = 41/244 (16%)
Query: 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKL 259
           FE++   +F+  YP      +R+  Y+L  AL + H   + H D+KP N++ ++ E   L
Sbjct: 109 FEFLKENNFQP-YPLP---HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164
Query: 260 -----------------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
                            R+ D+G A F H  + +   VA+R+++ PE++++L  +    D
Sbjct: 165 YNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCD 221
Query: 303 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--------TDELNAYLNKYHLELD 354
           +WS+GC+     +R    F  H+N + LV + K+LG              Y  K  L  D
Sbjct: 222 VWSIGCILFEY-YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 280
Query: 355 PQ-LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS 413
               D    + + KP   ++  D+  L   +  D + ++L +D   R+T  EA+    + 
Sbjct: 281 ENSSDGRYVKENCKPLKSYMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEAL----LH 334
Query: 414 PIFS 417
           P F+
Sbjct: 335 PFFA 338

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 64/108 (59%), Gaps = 5/108 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++ 
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEG 240

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANA 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGPN 181
           +Y +++ +G+G +++V    ++ T +    +                    +  +   PN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           +VKL +++  +  KT  L+ EY +     D+ V +  + + + R    +++ A+ YCH +
Sbjct: 75  IVKLFEVIETE--KTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQK 132
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 298
            I+HRD+K  N+++D ++  +++ D+G +  +  G + +    +  +  PEL    +   
Sbjct: 133 FIVHRDLKAENLLLDADM-NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 299 YSLDMWSLGCMFAGMIFRKEPF 320
             +D+WSLG +   ++    PF
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPF 213

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 82/142 (57%), Gaps = 11/142 (7%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELR 257
           +++ + +T+F+ +   LT    R +  ++  AL +  +    I+H D+KP N+++ +  R
Sbjct: 123 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 178
Query: 258 K-LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++DMWSLGC+   M   
Sbjct: 179 SAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 234
Query: 317 KEPFFYGHDNHDQLVKIAKVLG 338
            EP F G +  DQ+ KI +VLG
Sbjct: 235 GEPLFSGANEVDQMNKIVEVLG 256

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 111/244 (45%), Gaps = 41/244 (16%)
Query: 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKL 259
           FE++   +F+  YP      +R+  Y+L  AL + H   + H D+KP N++ ++ E   L
Sbjct: 118 FEFLKENNFQP-YPLP---HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 173
Query: 260 -----------------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
                            R+ D+G A F H  + +   VA+R+++ PE++++L  +    D
Sbjct: 174 YNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCD 230
Query: 303 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--------TDELNAYLNKYHLELD 354
           +WS+GC+     +R    F  H+N + LV + K+LG              Y  K  L  D
Sbjct: 231 VWSIGCILFEY-YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 289
Query: 355 PQ-LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS 413
               D    + + KP   ++  D+  L   +  D + ++L +D   R+T  EA+    + 
Sbjct: 290 ENSSDGRYVKENCKPLKSYMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEAL----LH 343
Query: 414 PIFS 417
           P F+
Sbjct: 344 PFFA 347

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 82/142 (57%), Gaps = 11/142 (7%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELR 257
           +++ + +T+F+ +   LT    R +  ++  AL +  +    I+H D+KP N+++ +  R
Sbjct: 142 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 258 K-LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++DMWSLGC+   M   
Sbjct: 198 SAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 253
Query: 317 KEPFFYGHDNHDQLVKIAKVLG 338
            EP F G +  DQ+ KI +VLG
Sbjct: 254 GEPLFSGANEVDQMNKIVEVLG 275

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 111/244 (45%), Gaps = 41/244 (16%)
Query: 201 FEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKL 259
           FE++   +F+  YP      +R+  Y+L  AL + H   + H D+KP N++ ++ E   L
Sbjct: 141 FEFLKENNFQP-YPLP---HVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 196
Query: 260 -----------------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 302
                            R+ D+G A F H  + +   VA+R+++ PE++++L  +    D
Sbjct: 197 YNEHKSCEEKSVKNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILEL-GWAQPCD 253
Query: 303 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--------TDELNAYLNKYHLELD 354
           +WS+GC+     +R    F  H+N + LV + K+LG              Y  K  L  D
Sbjct: 254 VWSIGCILFE-YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWD 312
Query: 355 PQ-LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS 413
               D    + + KP   ++  D+  L   +  D + ++L +D   R+T  EA+    + 
Sbjct: 313 ENSSDGRYVKENCKPLKSYMLQDS--LEHVQLFDLMRRMLEFDPAQRITLAEAL----LH 366
Query: 414 PIFS 417
           P F+
Sbjct: 367 PFFA 370

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 131 RKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVKLLDIVR 190
           + +G G +S   + ++  +N+                     L+   G PN+VKL ++  
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH 76
Query: 191 DQ-HSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVK 246
           DQ H+    L+ E +N  + F+ +      ++ +  Y + +L+ A+ + H  G++HRD+K
Sbjct: 77  DQLHT---FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLK 133
Query: 247 PHNVMIDHELRKL--RLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDM 303
           P N++   E   L  ++ID+G A    P  +       + ++  PELL +   YD S D+
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL-NQNGYDESCDL 192
Query: 304 WSLGCMFAGMIFRKEPF 320
           WSLG +   M+  + PF
Sbjct: 193 WSLGVILYTMLSGQVPF 209

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 121/298 (40%), Gaps = 52/298 (17%)
Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC---- 177
           G  D Y+ V+K+G G Y EV    +  T                       L  +     
Sbjct: 1   GLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 178 -GGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
              PN++KL +   D+  +   L+ E        D  +L    ++ D    + ++L    
Sbjct: 61  LDHPNIMKLYEFFEDK--RNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 118
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           Y H   I+HRD+KP N++++ + R   ++++D+GL+  +  G +   R+ + Y+  PE+L
Sbjct: 119 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
              + YD   D+WS G +   ++    P F G  + + L ++ K                
Sbjct: 179 --RKKYDEKCDVWSCGVILY-ILLCGYPPFGGQTDQEILKRVEK---------------- 219
Query: 352 ELDPQLDALVGRHSRKP--WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                     G+ S  P  W++         VS EA   +  +L Y+   R++A EA+
Sbjct: 220 ----------GKFSFDPPDWTQ---------VSDEAKQLVKLMLTYEPSKRISAEEAL 258

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 138 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 196
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 197 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 242

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 105/243 (43%), Gaps = 48/243 (19%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSK-------TPSLIFEYVNSTDFKVLYPTLTDYDIRYYI 225
           + N    P ++ L D   D++         +   +F+ + + D+K     +++ ++  Y+
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-----MSEAEVINYM 155
Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
            +  + L + H   I+H D+KP N+M +  +   +++ID+GLA   +P +   V  A+  
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAE 215
Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           F  PE +VD +   +  DMW++G +   ++    PF                 G D+L  
Sbjct: 216 FAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLSPF----------------AGEDDLET 258
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
             N    + +   DA                     VSPEA DF+  LL+ + + RLT  
Sbjct: 259 LQNVKRCDWEFDEDAFSS------------------VSPEAKDFIKNLLQKEPRKRLTVH 300
Query: 405 EAM 407
           +A+
Sbjct: 301 DAL 303

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 82/142 (57%), Gaps = 11/142 (7%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHELR 257
           +++ + +T+F+ +   LT    R +  ++  AL +  +    I+H D+KP N+++ +  R
Sbjct: 142 LYDLLRNTNFRGVSLNLT----RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197
Query: 258 K-LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
             ++++D+G +     G+     + SR+++ PE+L+ +  YD ++DMWSLGC+   M   
Sbjct: 198 XAIKIVDFGSS--CQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEM-HT 253
Query: 317 KEPFFYGHDNHDQLVKIAKVLG 338
            EP F G +  DQ+ KI +VLG
Sbjct: 254 GEPLFSGANEVDQMNKIVEVLG 275

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 119/292 (40%), Gaps = 46/292 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D Y V   +G G YSE    ++  TN                      L+     PN++ 
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLR-YGQHPNIIT 85
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   L+ E +   +   K+L     ++ +  + ++ + K ++Y HSQG++
Sbjct: 86  LKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 242 HRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
           HRD+KP N++   E      LR+ D+G A+      E  + +   Y   F  PE+L   Q
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-KRQ 200
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            YD   D+WSLG +   M+    PF  G  +  +  +I   +G+ +              
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPE--EILTRIGSGKFT------------ 246
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                            ++  N + VS  A D + K+L  D   RLTA++ +
Sbjct: 247 -----------------LSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVL 281

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 194
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 195 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 82/346 (23%), Positives = 149/346 (43%), Gaps = 57/346 (16%)
Query: 117 LTVQWGD--QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQ 174
           L  Q GD     YE+V  +G G + +V E I+     R                    +Q
Sbjct: 4   LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ 63
Query: 175 NL----CGGPN----VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-----YPTLTDYDI 221
            L       PN     V++L+    +H     ++FE +  + +  +      P   D+ I
Sbjct: 64  VLEHLNTTDPNSTFRCVQMLEWF--EHHGHICIVFELLGLSTYDFIKENGFLPFRLDH-I 120
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVM-------------IDHELRKL-----RLID 263
           R   Y++ K++++ HS  + H D+KP N++             I  + R L     +++D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
           +G A +    + ++  V++R+++ PE+++ L  +    D+WS+GC+     +     F  
Sbjct: 181 FGSATY--DDEHHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEY-YLGFTVFPT 236
Query: 324 HDNHDQLVKIAKVLG------TDELNAYLNKYHLELDPQLDALVGRH-SR--KPWSKF-I 373
           HD+ + L  + ++LG        +       +H  LD    +  GR+ SR  KP  +F +
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 374 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV 419
           + D +H       D + K+L YD   R+T REA+      P F L+
Sbjct: 297 SQDVEH---ERLFDLIQKMLEYDPAKRITLREALK----HPFFDLL 335

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 191
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 192 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 237

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 189
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 190 -GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 247
Query: 315 FRKEPF--FYGHDNHDQ 329
             + PF      DN DQ
Sbjct: 248 AGRSPFDIVGSSDNPDQ 264

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 193
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 194 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 113 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 171
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 172 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 217

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS 194
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 195 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 240

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 110 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 168
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 169 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 214

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 112 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 170
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 171 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 216

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 111 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 169
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 170 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 140 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 198
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 199 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 244

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L DI  ++      LI E V+     DF     +LT+ +   ++ ++L  + Y H
Sbjct: 68  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 237 SQGIMHRDVKPHNVM-IDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S+ I H D+KP N+M +D  +   +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 184
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV---------LGTDELNA 344
            +      DMWS+G +   ++    PF  G    + L  I+ V           T EL  
Sbjct: 185 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAVNYDFDEEYFSNTSELAK 243
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADN 377
              +  L  DP+    + +     W K I   N
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 117 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 175
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 176 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 221

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 15/189 (7%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVLYP-TLTDYDIRYYIYELLKALDYCH 236
           PN+++L +   D       L+ E     +   +V++     + D    + ++L A+ YCH
Sbjct: 66  PNIIRLYETFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 237 SQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
              + HRD+KP N +   D     L+LID+GLA  + PGK    +V + Y+  P++L  L
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 183
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y    D WS G M   ++    PF    D  + ++KI +   T     +LN     + 
Sbjct: 184 --YGPECDEWSAGVMMYVLLCGYPPFSAPTD-XEVMLKIREGTFTFPEKDWLN-----VS 235
Query: 355 PQLDALVGR 363
           PQ ++L+ R
Sbjct: 236 PQAESLIRR 244

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L DI  ++      LI E V+     DF     +LT+ +   ++ ++L  + Y H
Sbjct: 89  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 146
Query: 237 SQGIMHRDVKPHNVM-IDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S+ I H D+KP N+M +D  +   +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 205
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV---------LGTDELNA 344
            +      DMWS+G +   ++    PF  G    + L  I+ V           T EL  
Sbjct: 206 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAVNYDFDEEYFSNTSELAK 264
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADN 377
              +  L  DP+    + +     W K I   N
Sbjct: 265 DFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRN 297

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 15/189 (7%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVLYP-TLTDYDIRYYIYELLKALDYCH 236
           PN+++L +   D       L+ E     +   +V++     + D    + ++L A+ YCH
Sbjct: 83  PNIIRLYETFEDNTDIY--LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 140
Query: 237 SQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
              + HRD+KP N +   D     L+LID+GLA  + PGK    +V + Y+  P++L  L
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL 200
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y    D WS G M   ++    PF    D  + ++KI +   T     +LN     + 
Sbjct: 201 --YGPECDEWSAGVMMYVLLCGYPPFSAPTD-XEVMLKIREGTFTFPEKDWLN-----VS 252
Query: 355 PQLDALVGR 363
           PQ ++L+ R
Sbjct: 253 PQAESLIRR 261

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 118/292 (40%), Gaps = 46/292 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D Y V   +G G YSE    ++  TN                      L+     PN++ 
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLR-YGQHPNIIT 85
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   L+ E +   +   K+L     ++ +  + ++ + K ++Y HSQG++
Sbjct: 86  LKDVYDD--GKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 242 HRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
           HRD+KP N++   E      LR+ D+G A+      E  + +   Y   F  PE+L   Q
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-KRQ 200
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            YD   D+WSLG +   M+    PF  G    D   +I   +G+ +              
Sbjct: 201 GYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSGKFT------------ 246
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                            ++  N + VS  A D + K+L  D   RLTA++ +
Sbjct: 247 -----------------LSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVL 281

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 98  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 157
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 158 -GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 215
Query: 315 FRKEPF--FYGHDNHDQ 329
             + PF      DN DQ
Sbjct: 216 AGRSPFDIVGSSDNPDQ 232

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 132 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANX 190
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 191 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 126 DYEVVRKVGRGKYSEVF------EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           ++ + +K+GRG++SEV+      +G+ V   +                     L+ L   
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 91
Query: 180 PNVVKL-LDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
           PNV+K     + D      +++ E  ++ D       FK     + +  +  Y  +L  A
Sbjct: 92  PNVIKYYASFIEDNEL---NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPEL 290
           L++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 149 LEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           + +   Y++  D+WSLGC+   M   + PF+
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 237

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 64/107 (59%), Gaps = 5/107 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NV 278
           R+Y  E++ AL+Y H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N 
Sbjct: 132 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS 190
Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
            V +  +  PELL + +    S D+W+LGC+   ++    PF  G++
Sbjct: 191 FVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNE 236

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY    +       L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL   LD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 127 FTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKEAIDHEK 185
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ Q + +S D WS G +   M+    P F G D  + +  I
Sbjct: 186 KAYSFCGTVEYM-APE-VVNRQGHSHSADWWSYGVLMFEMLTGSLP-FQGKDRKETMTLI 242
Query: 334 AKV 336
            K 
Sbjct: 243 LKA 245

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+     N+      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  S    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--STRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKKVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 83  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 142
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 143 -GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 200
Query: 315 FRKEPF--FYGHDNHDQ 329
             + PF      DN DQ
Sbjct: 201 AGRSPFDIVGSSDNPDQ 217

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK 181
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 182 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 238
Query: 334 AKV 336
            K 
Sbjct: 239 LKA 241

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/137 (32%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D          L +   R+Y  E+  AL+Y H +GI++RD+K  NV++D E
Sbjct: 87  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 146
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              ++L D+G+  E   PG   +    +  +  PE+L   +DY +S+D W+LG +   M+
Sbjct: 147 -GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 204
Query: 315 FRKEPF--FYGHDNHDQ 329
             + PF      DN DQ
Sbjct: 205 AGRSPFDIVGSSDNPDQ 221

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 124 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK 182
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 183 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 239
Query: 334 AKV 336
            K 
Sbjct: 240 LKA 242

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/123 (34%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPG 273
            T+ D+++Y+ EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL++    H  
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK 181
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
           K Y+      Y   PE +V+ + +  S D WS G +   M+    P F G D  + +  I
Sbjct: 182 KAYSFCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI 238
Query: 334 AKV 336
            K 
Sbjct: 239 LKA 241

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNST--DFKVLYPTLTDYDIRYYIYELLKALDY 234
           P+++KL D++      TP+   ++ EY      D+ V    +T+ + R +  +++ A++Y
Sbjct: 69  PHIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH   I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++   
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPF 320
                 +D+WS G +   M+  + PF
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 81/163 (49%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L DI  ++      LI E V+     DF     +LT+ +   ++ ++L  + Y H
Sbjct: 75  PNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 132
Query: 237 SQGIMHRDVKPHNVM-IDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S+ I H D+KP N+M +D  +   +++LID+G+A     G E+     +  F  PE +V+
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 191
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  I+ V
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAV 233

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 82/346 (23%), Positives = 147/346 (42%), Gaps = 57/346 (16%)
Query: 117 LTVQWGD--QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQ 174
           L  Q GD     YE+V  +G G + +V E I+     R                    +Q
Sbjct: 4   LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ 63
Query: 175 NL----CGGPN----VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-----YPTLTDYDI 221
            L       PN     V++L+    +H     ++FE +  + +  +      P   D+ I
Sbjct: 64  VLEHLNTTDPNSTFRCVQMLEWF--EHHGHICIVFELLGLSTYDFIKENGFLPFRLDH-I 120
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVM-------------IDHELRKL-----RLID 263
           R   Y++ K++++ HS  + H D+KP N++             I  + R L     +++D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
           +G A +    + ++  V  R+++ PE+++ L  +    D+WS+GC+     +     F  
Sbjct: 181 FGSATY--DDEHHSTLVXXRHYRAPEVILAL-GWSQPCDVWSIGCILIEY-YLGFTVFPT 236
Query: 324 HDNHDQLVKIAKVLG------TDELNAYLNKYHLELDPQLDALVGRH-SR--KPWSKF-I 373
           HD+ + L  + ++LG        +       +H  LD    +  GR+ SR  KP  +F +
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 374 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV 419
           + D +H       D + K+L YD   R+T REA+      P F L+
Sbjct: 297 SQDVEH---ERLFDLIQKMLEYDPAKRITLREALK----HPFFDLL 335

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY    +       L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLXGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+VKL +++  +  KT  L+ EY +     D+ V +    + + R    +++ A+ YCH
Sbjct: 73  PNIVKLFEVIETE--KTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH 130
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N+++D +   +++ D+G +  +  G + +    +  +  PEL    + 
Sbjct: 131 QKFIVHRDLKAENLLLDADX-NIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               +D+WSLG +   ++    PF
Sbjct: 190 DGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/303 (23%), Positives = 124/303 (40%), Gaps = 59/303 (19%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-------CXXXXXXXXXXXXXXXXXXXLQNL 176
           +D YE+   +G+G +S V   IN  T ++                           + ++
Sbjct: 23  EDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 177 CGGPNVVKLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
              P++V+LL+            +      L FE V   D   +Y   ++    +Y+ ++
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY---SEAVASHYMRQI 139
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKP NV++  +     ++L D+G+A +    G     RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHF 199
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE-LNA 344
             PE +V  + Y   +D+W  G +   ++    PF+                GT E L  
Sbjct: 200 MAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFY----------------GTKERLFE 242
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
            + K   +++P           + WS          +S  A D + ++L  D  +R+T  
Sbjct: 243 GIIKGKYKMNP-----------RQWSH---------ISESAKDLVRRMLMLDPAERITVY 282
Query: 405 EAM 407
           EA+
Sbjct: 283 EAL 285

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 25  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 141
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 142 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 199
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 200 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 81/158 (51%), Gaps = 11/158 (6%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G P+++ L+D    + S    L+F+ +      D+      L++ + R  +  LL
Sbjct: 153 LRQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ + H+  I+HRD+KP N+++D  + ++RL D+G +    PG++      +  +  PE
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 290 LLVDLQD-----YDYSLDMWSLGCMFAGMIFRKEPFFY 322
           +L    D     Y   +D+W+ G +   ++    PF++
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 179 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 106/242 (43%), Gaps = 43/242 (17%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN++ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H
Sbjct: 75  PNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 237 SQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           ++ I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVN 191
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            +      DMWS+G +   ++    PF  G    + L  I  V       +Y   +  E 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAV-------SY--DFDEEF 241
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS 413
             Q   L                        A DF+ KLL  + + RLT +EA+    I+
Sbjct: 242 FSQTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWIT 277
Query: 414 PI 415
           P+
Sbjct: 278 PV 279

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/330 (21%), Positives = 142/330 (43%), Gaps = 53/330 (16%)
Query: 91  LPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRK---VGRGKYSEVFEGINV 147
           +P  SK      V++  P   +D+  +T + G  + +  V K   +G G++ +V +    
Sbjct: 52  MPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEET 111
Query: 148 NTNERCXXXXXXXXXXXXXXXXXXXLQ--NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205
            T  +                    +   N     N+++L D    ++     L+ EYV+
Sbjct: 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV--LVMEYVD 169
Query: 206 STDF--KVLYPT--LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHELRKLR 260
             +   +++  +  LT+ D   ++ ++ + + + H   I+H D+KP N++ ++ + ++++
Sbjct: 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIK 229
Query: 261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD---YSLDMWSLGCMFAGMIFRK 317
           +ID+GLA  Y P ++  V   +  F  PE++    +YD   +  DMWS+G +   ++   
Sbjct: 230 IIDFGLARRYKPREKLKVNFGTPEFLAPEVV----NYDFVSFPTDMWSVGVIAYMLLSGL 285
Query: 318 EPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN 377
            PF   +D        A+ L     N    ++ LE +   D                   
Sbjct: 286 SPFLGDND--------AETLN----NILACRWDLEDEEFQD------------------- 314
Query: 378 QHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              +S EA +F+ KLL  +   R++A EA+
Sbjct: 315 ---ISEEAKEFISKLLIKEKSWRISASEAL 341

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 16  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 74
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 132
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 133 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 190
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 191 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 223

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 41/213 (19%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 239 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 297
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++ 
Sbjct: 298 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF-----NEP 351
Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
            +K  K++  +            L P+L                   N H VSP    FL
Sbjct: 352 PLKAMKMIRDN------------LPPRL------------------KNLHKVSPSLKGFL 381
Query: 390 DKLLRYDHQDRLTAREAM---VISSISPIFSLV 419
           D+LL  D   R TA E +    ++   P  S+V
Sbjct: 382 DRLLVRDPAQRATAAELLKHPFLAKAGPPASIV 414

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/298 (21%), Positives = 126/298 (42%), Gaps = 46/298 (15%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG--- 179
            D+Y+V  ++G+G +S V   ++  T  E                        +C     
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D ++++      L+F+ V   +     V     ++ D  + I ++L+++ YCH
Sbjct: 65  PNIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L   
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK- 181
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +D+W+ G +   ++    P F+  D H                         L 
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPP-FWDEDQH------------------------RLY 216
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI 412
            Q+ A    +    W           V+PEA   +D +L  + + R+TA +A+ +  I
Sbjct: 217 AQIKAGAYDYPSPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/298 (21%), Positives = 124/298 (41%), Gaps = 46/298 (15%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG--- 179
            D+Y+V  ++G+G +S V   ++  T  E                        +C     
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D +  Q      L+F+ V   +     V     ++ D  + I ++L+++ YCH
Sbjct: 64  PNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 121
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L   
Sbjct: 122 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK- 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +D+W+ G +   ++    P F+  D H                         L 
Sbjct: 181 DPYSKPVDIWACGVILYILLVGYPP-FWDEDQH------------------------RLY 215
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI 412
            Q+ A    +    W           V+PEA   +D +L  + + R+TA +A+ +  I
Sbjct: 216 AQIKAGAYDYPSPEWD---------TVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/298 (21%), Positives = 124/298 (41%), Gaps = 46/298 (15%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG--- 179
            D+Y+V  ++G+G +S V   ++  T  E                        +C     
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D +  Q      L+F+ V   +     V     ++ D  + I ++L+++ YCH
Sbjct: 65  PNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L   
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK- 181
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +D+W+ G +   ++    P F+  D H                         L 
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPP-FWDEDQH------------------------RLY 216
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI 412
            Q+ A    +    W           V+PEA   +D +L  + + R+TA +A+ +  I
Sbjct: 217 AQIKAGAYDYPSPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 4   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 120
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 121 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYL 178
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE  ++ + +D  +D+WSLG +    +  K PF
Sbjct: 179 PPE-XIEGRXHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
           P+++KL  ++      TP+   ++ EYV+     D+   +  + + + R    ++L A+D
Sbjct: 71  PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           YCH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++  
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +D+WS G +   ++    PF
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 46/288 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D YEV   +G G YS     I+  TN                      L+     PN++ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLR-YGQHPNIIT 80
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   ++ E +   +   K+L     ++ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDD--GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 242 HRDVKPHNVMIDHEL---RKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
           HRD+KP N++   E      +R+ D+G A+      E  + +   Y   F  PE+L + Q
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVL-ERQ 195
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            YD + D+WSLG +   M+    PF  G D+  +  +I   +G+ +              
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--EILARIGSGKF------------- 240
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
              +L G +    W+          VS  A D + K+L  D   RLTA
Sbjct: 241 ---SLSGGY----WNS---------VSDTAKDLVSKMLHVDPHQRLTA 272

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/294 (21%), Positives = 125/294 (42%), Gaps = 46/294 (15%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN-ERCXXXXXXXXXXXXXXXXXXXLQNLCGG---P 180
           D+Y+V  ++G+G +S V   ++  T  E                        +C     P
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D ++++      L+F+ V   +     V     ++ D  + I ++L+++ YCHS
Sbjct: 89  NIVRLHDSIQEESFHY--LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L    
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-D 205
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y   +D+W+ G +   ++    P F+  D H                         L  
Sbjct: 206 PYSKPVDIWACGVILY-ILLVGYPPFWDEDQH------------------------RLYA 240
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI 409
           Q+ A    +    W           V+PEA   +D +L  + + R+TA +A+ +
Sbjct: 241 QIKAGAYDYPSPEWD---------TVTPEAKSLIDSMLTVNPKKRITADQALKV 285

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 41/213 (19%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 162 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 220
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++ 
Sbjct: 221 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF-----NEP 274
Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
            +K  K++  +            L P+L                   N H VSP    FL
Sbjct: 275 PLKAMKMIRDN------------LPPRL------------------KNLHKVSPSLKGFL 304
Query: 390 DKLLRYDHQDRLTAREAM---VISSISPIFSLV 419
           D+LL  D   R TA E +    ++   P  S+V
Sbjct: 305 DRLLVRDPAQRATAAELLKHPFLAKAGPPASIV 337

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 25  ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 141
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  + 
Sbjct: 142 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYL 199
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 200 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 1   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 59
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 117
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYL 175
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 176 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXX 172
           D +SLT Q   ++ ++V+ K+G G Y  V++ I+  T +                     
Sbjct: 19  DEDSLTKQ--PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS 76
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSL--IFEYVNSTD----FKVLYPTLTDYDIRYYIY 226
           +   C  P+VVK        + K   L  + EY  +       ++   TLT+ +I   + 
Sbjct: 77  IMQQCDSPHVVKYYG----SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ 132
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
             LK L+Y H    +HRD+K  N++++ E    +L D+G+A +      + N  + + ++
Sbjct: 133 STLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDXMAKRNXVIGTPFW 191
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE++ ++  Y+   D+WSLG     M   K P+
Sbjct: 192 MAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPY 225

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 38/198 (19%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 117 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 175
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++ 
Sbjct: 176 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF-----NEP 229
Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
            +K  K++  +            L P+L                   N H VSP    FL
Sbjct: 230 PLKAMKMIRDN------------LPPRL------------------KNLHKVSPSLKGFL 259
Query: 390 DKLLRYDHQDRLTAREAM 407
           D+LL  D   R TA E +
Sbjct: 260 DRLLVRDPAQRATAAELL 277

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 38/198 (19%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 119 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 177
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++ 
Sbjct: 178 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF-----NEP 231
Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
            +K  K++  +            L P+L                   N H VSP    FL
Sbjct: 232 PLKAMKMIRDN------------LPPRL------------------KNLHKVSPSLKGFL 261
Query: 390 DKLLRYDHQDRLTAREAM 407
           D+LL  D   R TA E +
Sbjct: 262 DRLLVRDPAQRATAAELL 279

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 3   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 61
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 62  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 119
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 120 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 176
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 205

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-M 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 8   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 66
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 181
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 1   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 59
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 117
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ ++G +  + P         +  + 
Sbjct: 118 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSRRTTLCGTLDYL 175
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 176 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 38/198 (19%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 108 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 166
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++ 
Sbjct: 167 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF-----NEP 220
Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
            +K  K++  +            L P+L                   N H VSP    FL
Sbjct: 221 PLKAMKMIRDN------------LPPRL------------------KNLHKVSPSLKGFL 250
Query: 390 DKLLRYDHQDRLTAREAM 407
           D+LL  D   R TA E +
Sbjct: 251 DRLLVRDPAQRATAAELL 268

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 89/198 (44%), Gaps = 38/198 (19%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL   H+QG++HRD+K  ++++ H+ R ++L D+G  A+ 
Sbjct: 112 VTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQV 170
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
                     V + Y+  PEL+  L  Y   +D+WSLG M   M+  + P+F     ++ 
Sbjct: 171 SKEVPRRKXLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF-----NEP 224
Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
            +K  K++  +            L P+L                   N H VSP    FL
Sbjct: 225 PLKAMKMIRDN------------LPPRL------------------KNLHKVSPSLKGFL 254
Query: 390 DKLLRYDHQDRLTAREAM 407
           D+LL  D   R TA E +
Sbjct: 255 DRLLVRDPAQRATAAELL 272

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/303 (22%), Positives = 123/303 (40%), Gaps = 59/303 (19%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-------CXXXXXXXXXXXXXXXXXXXLQNL 176
           +D YE+   +G+G +S V   IN  T ++                           + ++
Sbjct: 25  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 84
Query: 177 CGGPNVVKLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
              P++V+LL+            +      L FE V   D   +Y   ++    +Y+ ++
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY---SEAVASHYMRQI 141
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKPH V++  +     ++L  +G+A +    G     RV + +F
Sbjct: 142 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 201
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE-LNA 344
             PE +V  + Y   +D+W  G +   ++    PF+                GT E L  
Sbjct: 202 MAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFY----------------GTKERLFE 244
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
            + K   +++P           + WS          +S  A D + ++L  D  +R+T  
Sbjct: 245 GIIKGKYKMNP-----------RQWSH---------ISESAKDLVRRMLMLDPAERITVY 284
Query: 405 EAM 407
           EA+
Sbjct: 285 EAL 287

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
           P+++KL  ++      TPS IF   EYV+     D+      L + + R    ++L  +D
Sbjct: 76  PHIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           YCH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++  
Sbjct: 131 YCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISG 189
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN------ 347
                  +D+WS G +   ++    PF    D+H   +      G      YLN      
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTLFKKICDGIFYTPQYLNPSVISL 246
Query: 348 -KYHLELDPQLDALVGRHSRKPWSK 371
            K+ L++DP   A +       W K
Sbjct: 247 LKHMLQVDPMKRATIKDIREHEWFK 271

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 14/214 (6%)
Query: 115 ESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXX 169
           ES   QW   +D+E+ R +G+GK+  V+      +      +                  
Sbjct: 2   ESKKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 170 XXXLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIY 226
              +Q+    PN+++L     D  +    LI EY            L+ +D      YI 
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 118
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           EL  AL YCHS+ ++HRD+KP N+++     +L++ ++G +  + P         +  + 
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLG-SAGELKIANFGWS-VHAPSSRRTTLCGTLDYL 176
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE +++ + +D  +D+WSLG +    +  K PF
Sbjct: 177 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 38/193 (19%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGK 274
           L +  I      +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+      
Sbjct: 138 LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVP 196
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           +    V + Y+  PE ++    Y   +D+WSLG M   M+  + P+F      D  V+  
Sbjct: 197 KRKXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEPPYF-----SDSPVQAM 250
Query: 335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLR 394
           K L                         R S  P  K     N H VSP   DFL+++L 
Sbjct: 251 KRL-------------------------RDSPPPKLK-----NSHKVSPVLRDFLERMLV 280
Query: 395 YDHQDRLTAREAM 407
            D Q+R TA+E +
Sbjct: 281 RDPQERATAQELL 293

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 123/293 (41%), Gaps = 47/293 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           D+Y++  ++G+G +S V   + + T +    +                    +  L   P
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I ++L+++++CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            GI+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +DMW+ G +   ++    P F+  D H                         L 
Sbjct: 181 DPYGKPVDMWACGVILY-ILLVGYPPFWDEDQH------------------------RLY 215
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            Q+ A         W           V+PEA D ++K+L  +   R+TA EA+
Sbjct: 216 QQIKAGAYDFPSPEWDT---------VTPEAKDLINKMLTINPAKRITASEAL 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 7   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 66  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-M 180
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/303 (22%), Positives = 123/303 (40%), Gaps = 59/303 (19%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER-------CXXXXXXXXXXXXXXXXXXXLQNL 176
           +D YE+   +G+G +S V   IN  T ++                           + ++
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 177 CGGPNVVKLLDIVRD--------QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYEL 228
              P++V+LL+            +      L FE V   D   +Y   ++    +Y+ ++
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY---SEAVASHYMRQI 139
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKPH V++  +     ++L  +G+A +    G     RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE-LNA 344
             PE +V  + Y   +D+W  G +   ++    PF+                GT E L  
Sbjct: 200 MAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFY----------------GTKERLFE 242
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
            + K   +++P           + WS          +S  A D + ++L  D  +R+T  
Sbjct: 243 GIIKGKYKMNP-----------RQWSH---------ISESAKDLVRRMLMLDPAERITVY 282
Query: 405 EAM 407
           EA+
Sbjct: 283 EAL 285

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 123/293 (41%), Gaps = 47/293 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           D+Y++  ++G+G +S V   + + T +    +                    +  L   P
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 63
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I ++L+++++CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            GI+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +DMW+ G +   ++    P F+  D H                         L 
Sbjct: 181 DPYGKPVDMWACGVILY-ILLVGYPPFWDEDQH------------------------RLY 215
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            Q+ A         W           V+PEA D ++K+L  +   R+TA EA+
Sbjct: 216 QQIKAGAYDFPSPEWDT---------VTPEAKDLINKMLTINPAKRITASEAL 259

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQ-NLCGG 179
           +D+ V R +GRG + EV+     +T +    +C                   +  +L   
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 180 PNVVKLLDIVRDQHSKTP-SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYC 235
            +   ++ +    H+    S I + +N  D       +   ++ D+R+Y  E++  L++ 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L    
Sbjct: 309 HNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGV 366
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            YD S D +SLGCM   ++    PF
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPE-M 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 54/217 (24%)
Query: 199 LIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254
           LIFE +  + ++++    Y      DI+ Y  E+LKAL+Y     + H D+KP N+++D 
Sbjct: 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172
Query: 255 --------ELRK----------------LRLIDWGLAEF---YHPGKEYNVRVASRYFKG 287
                    +R+                ++LID+G A F   YH        + +R ++ 
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGS-----IINTRQYRA 227
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
           PE++++L  +D S DMWS GC+ A + +     F  H++ + L  +  +           
Sbjct: 228 PEVILNL-GWDVSSDMWSFGCVLAEL-YTGSLLFRTHEHMEHLAMMESI----------- 274
Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE 384
                + P    ++   ++   SK++N D   L  PE
Sbjct: 275 -----IQPIPKNMLYEATKTNGSKYVNKDELKLAWPE 306

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 114/255 (44%), Gaps = 31/255 (12%)
Query: 93  AMSKARVYTDVNV-LRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           +M K+R Y  V   L P E W               E+V ++G G + +V++  N  T  
Sbjct: 1   SMRKSREYEHVRRDLDPNEVW---------------EIVGELGDGAFGKVYKAKNKETGA 45
Query: 152 RCXXXXXXXXXXXXXXXXXXXLQNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF 209
                                ++ L  C  P +VKLL      H     ++ E+      
Sbjct: 46  LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY--YHDGKLWIMIEFCPGGAV 103
Query: 210 KVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG 265
             +       LT+  I+    ++L+AL++ HS+ I+HRD+K  NV++  E   +RL D+G
Sbjct: 104 DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFG 162
Query: 266 L-AEFYHPGKEYNVRVASRYFKGPELLV--DLQD--YDYSLDMWSLGCMFAGMIFRKEPF 320
           + A+     ++ +  + + Y+  PE+++   ++D  YDY  D+WSLG     M  + EP 
Sbjct: 163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPP 221
Query: 321 FYGHDNHDQLVKIAK 335
            +  +    L+KIAK
Sbjct: 222 HHELNPMRVLLKIAK 236

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 66/125 (52%), Gaps = 19/125 (15%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-------------PG 273
           ++L+AL Y HSQGI+HR++KP N+ ID E R +++ D+GLA+  H             PG
Sbjct: 124 QILEALSYIHSQGIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 274 KEYNVR--VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
              N+   + +  +   E+L     Y+  +D +SLG +F   I+   PF  G +  + L 
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERVNILK 239
Query: 332 KIAKV 336
           K+  V
Sbjct: 240 KLRSV 244

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQ-NLCGG 179
           +D+ V R +GRG + EV+     +T +    +C                   +  +L   
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 180 PNVVKLLDIVRDQHSKTP-SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYC 235
            +   ++ +    H+    S I + +N  D       +   ++ D+R+Y  E++  L++ 
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 307
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L    
Sbjct: 308 HNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGV 365
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            YD S D +SLGCM   ++    PF
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALD 233
           P+++KL  ++      TP+   ++ EYV+     D+   +  + + + R    ++L A+D
Sbjct: 71  PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           YCH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++  
Sbjct: 126 YCHRHMVVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISG 184
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  +D+WS G +   ++    PF
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQ-NLCGG 179
           +D+ V R +GRG + EV+     +T +    +C                   +  +L   
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 180 PNVVKLLDIVRDQHSKTP-SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYC 235
            +   ++ +    H+    S I + +N  D       +   ++ D+R+Y  E++  L++ 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L    
Sbjct: 309 HNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGV 366
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            YD S D +SLGCM   ++    PF
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQ-NLCGG 179
           +D+ V R +GRG + EV+     +T +    +C                   +  +L   
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 180 PNVVKLLDIVRDQHSKTP-SLIFEYVNSTDFK---VLYPTLTDYDIRYYIYELLKALDYC 235
            +   ++ +    H+    S I + +N  D       +   ++ D+R+Y  E++  L++ 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           H++ +++RD+KP N+++D E   +R+ D GLA  +   K +   V +  +  PE+L    
Sbjct: 309 HNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGV 366
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            YD S D +SLGCM   ++    PF
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 69/151 (45%), Gaps = 15/151 (9%)
Query: 178 GGPNVVKLLDIVRDQHSKTPSL--------IFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
           G P V++LLD    Q      L        +F+Y+           L +   R +  +++
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVV 149
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            A+ +CHS+G++HRD+K  N++ID      +LID+G     H  + Y     +R +  PE
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFDGTRVYSPPE 208
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   Q +     +WSLG +   M+    PF
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPF 239

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +      DMWS+G +   ++    PF  G    + L  I  V       +Y         
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSV-------SY--------- 235
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP 414
              D     H+                S  A DF+ KLL  + + RLT +EA+    I+P
Sbjct: 236 -DFDEEFFSHT----------------SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 415 I 415
           +
Sbjct: 279 V 279

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+             +                     +Q
Sbjct: 1   QWA-LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQ 59
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 60  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 117
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 118 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 174
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 203

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 103/212 (48%), Gaps = 47/212 (22%)
Query: 200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK- 258
           IFE +N++ F+     L + +I  Y++++ +AL + HS  I H D++P N++  ++ R+ 
Sbjct: 88  IFERINTSAFE-----LNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENII--YQTRRS 140
Query: 259 --LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIF 315
             +++I++G A    PG  + +   +  +  PE  V   D    + DMWSLG +   ++ 
Sbjct: 141 STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE--VHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 316 RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINA 375
              PF    + + Q+++       + +NA   +Y  + +   +                 
Sbjct: 199 GINPFLA--ETNQQIIE-------NIMNA---EYTFDEEAFKE----------------- 229
Query: 376 DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                +S EA+DF+D+LL  + + R+TA EA+
Sbjct: 230 -----ISIEAMDFVDRLLVKERKSRMTASEAL 256

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +      DMWS+G +   ++    PF  G    + L  I  V       +Y         
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSV-------SY--------- 235
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP 414
              D     H+                S  A DF+ KLL  + + RLT +EA+    I+P
Sbjct: 236 -DFDEEFFSHT----------------SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 415 I 415
           +
Sbjct: 279 V 279

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +      DMWS+G +   ++    PF  G    + L  I  V       +Y   +  E  
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAV-------SY--DFDEEFF 242
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP 414
            Q   L                        A DF+ KLL  + + RLT +EA+    I+P
Sbjct: 243 SQTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 415 I 415
           +
Sbjct: 279 V 279

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +      DMWS+G +   ++    PF  G    + L  I  V       +Y   +  E  
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAV-------SY--DFDEEFF 242
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP 414
            Q   L                        A DF+ KLL  + + RLT +EA+    I+P
Sbjct: 243 SQTSEL------------------------AKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 415 I 415
           +
Sbjct: 279 V 279

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 105/241 (43%), Gaps = 43/241 (17%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  ++Y H+
Sbjct: 76  NVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 238 QGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           + I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  PE +V+ 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNY 192
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           +      DMWS+G +   ++    PF  G    + L  I  V       +Y         
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSV-------SY--------- 235
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP 414
              D     H+                S  A DF+ KLL  + + RLT +EA+    I+P
Sbjct: 236 -DFDEEFFSHT----------------SELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 415 I 415
           +
Sbjct: 279 V 279

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 93/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 7   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 66  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-M 180
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 209

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 14/213 (6%)
Query: 115 ESLTVQWGDQDD-YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXX 170
           E+L  Q  D ++ +  + K+G+G + EVF+GI+  T +                      
Sbjct: 16  ENLYFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE 75
Query: 171 XXLQNLCGGPNVVKLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYE 227
             + + C  P V K     ++D       +I EY+   +   +L P  L +  I   + E
Sbjct: 76  ITVLSQCDSPYVTKYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILRE 132
Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFK 286
           +LK LDY HS+  +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++ 
Sbjct: 133 ILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 191
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
            PE ++    YD   D+WSLG + A  + R EP
Sbjct: 192 APE-VIKQSAYDSKADIWSLG-ITAIELARGEP 222

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 9   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 68  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 182
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 211

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 4   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 63  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 177
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 206

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+E+ R +G+GK+  V+      +      +                     +Q
Sbjct: 5   QWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 64  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-M 178
Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++ + +D  +D+WSLG +    +  K PF
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 65  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 123 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 71/143 (49%), Gaps = 22/143 (15%)
Query: 198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIY-------------------ELLKALDYCHSQ 238
           SL + +   TD  ++   +   DIRY+IY                   +++  L++ H +
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR-YFKGPELLVDLQDY 297
            I++RD+KP NV++D +   +R+ D GLA     G+      A    F  PELL+  ++Y
Sbjct: 309 NIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEY 366
Query: 298 DYSLDMWSLGCMFAGMIFRKEPF 320
           D+S+D ++LG     MI  + PF
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPF 389

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 106/263 (40%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E +       DF      L +   R + +++L
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFV--LILERMEPVQDLFDFITERGALQEELARSFFWQVL 124
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 183
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 238
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 239 IRWCLALRPSDRPTFEEIQNHPW 261

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 104/220 (47%), Gaps = 15/220 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL--CGGPNVVK 184
           +E+V ++G G + +V++  N  T                       ++ L  C  P +VK
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGI 240
           LL      H     ++ E+        +       LT+  I+    ++L+AL++ HS+ I
Sbjct: 73  LLGAY--YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 130
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV--DLQD- 296
           +HRD+K  NV++  E   +RL D+G+ A+     ++ +  + + Y+  PE+++   ++D 
Sbjct: 131 IHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 297 -YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            YDY  D+WSLG     M  + EP  +  +    L+KIAK
Sbjct: 190 PYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 228

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + K+G+G + EVF+GI+  T +                        + + C  P V 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 184 KLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGI 240
           K     ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  
Sbjct: 69  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 126 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDS 183
Query: 300 SLDMWSLGCMFAGMIFRKEP 319
             D+WSLG + A  + R EP
Sbjct: 184 KADIWSLG-ITAIELARGEP 202

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 64/114 (56%), Gaps = 4/114 (3%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 281
           +Y+ E+  AL + H +GI++RD+KP N+M++H+   ++L D+GL  E  H G   +    
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +  +  PE+L+    ++ ++D WSLG +   M+    P F G +    + KI K
Sbjct: 184 TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKKTIDKILK 235

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 71/144 (49%), Gaps = 7/144 (4%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           N++K+LDI  +Q      L+ E   S      F   +P L +    Y   +L+ A+ Y  
Sbjct: 90  NIIKVLDIFENQGFF--QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + I+HRD+K  N++I  +   ++LID+G A +   GK +     +  +  PE+L+    
Sbjct: 148 LKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPY 206
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPF 320
               L+MWSLG     ++F + PF
Sbjct: 207 RGPELEMWSLGVTLYTLVFEENPF 230

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G Y EV   +N  T E                        +  +    N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 67  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 11/231 (4%)
Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXL 173
           YE +T     +D +E++ ++G G + +V++  N  T+                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 174 QNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELL 229
             L  C  PN+VKLLD    +++    + F    + D  +L     LT+  I+    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204
Query: 289 ELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + K+G+G + EVF+GI+  T +                        + + C  P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 184 KLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGI 240
           K     ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  
Sbjct: 84  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 141 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDS 198
Query: 300 SLDMWSLGCMFAGMIFRKEP 319
             D+WSLG + A  + R EP
Sbjct: 199 KADIWSLG-ITAIELARGEP 217

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 11/231 (4%)
Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXL 173
           YE +T     +D +E++ ++G G + +V++  N  T+                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 174 QNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELL 229
             L  C  PN+VKLLD    +++    + F    + D  +L     LT+  I+    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204
Query: 289 ELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 22  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 81
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 82  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 139
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 198
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 253
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 254 IRWCLALRPSDRPTFEEIQNHPW 276

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/294 (22%), Positives = 121/294 (41%), Gaps = 47/294 (15%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           Q  Y++  ++G+G +S V   + V   +    +                    +  L   
Sbjct: 21  QSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 80
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V+L D + ++      LIF+ V   +     V     ++ D  + I ++L+A+ +CH
Sbjct: 81  PNIVRLHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 138
Query: 237 SQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 293
             G++HRD+KP N+++  +L+   ++L D+GLA E     + +     +  +  PE+L  
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 198
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
              Y   +D+W+ G +   ++    P F+  D H                         L
Sbjct: 199 -DPYGKPVDLWACGVILY-ILLVGYPPFWDEDQH------------------------RL 232
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             Q+ A         W           V+PEA D ++K+L  +   R+TA EA+
Sbjct: 233 YQQIKAGAYDFPSPEWDT---------VTPEAKDLINKMLTINPSKRITAAEAL 277

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 11/231 (4%)
Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXL 173
           YE +T     +D +E++ ++G G + +V++  N  T+                      +
Sbjct: 26  YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 85
Query: 174 QNL--CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELL 229
             L  C  PN+VKLLD    +++    + F    + D  +L     LT+  I+    + L
Sbjct: 86  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 288
            AL+Y H   I+HRD+K  N++   +   ++L D+G+ A+     +  +  + + Y+  P
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204
Query: 289 ELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           E+++      + YDY  D+WSLG     M    EP  +  +    L+KIAK
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNPMRVLLKIAK 254

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 254
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 255 IRWCLALRPSDRPTFEEIQNHPW 277

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 267
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + K+G+G + EVF+GI+  T +                        + + C  P V 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 184 KLL-DIVRDQHSKTPSLIFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGI 240
           K     ++D       +I EY+   +   +L P  L +  I   + E+LK LDY HS+  
Sbjct: 69  KYYGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +HRD+K  NV++  E  +++L D+G+A +      + N  V + ++  PE ++    YD 
Sbjct: 126 IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDS 183
Query: 300 SLDMWSLGCMFAGMIFRKEP 319
             D+WSLG + A  + R EP
Sbjct: 184 KADIWSLG-ITAIELARGEP 202

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 266
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPW 289

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 266
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 239
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPW 262

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 266
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 64/114 (56%), Gaps = 4/114 (3%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVA 281
           +Y+ E+  AL + H +GI++RD+KP N+M++H+   ++L D+GL  E  H G   +    
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHXFCG 183
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +  +  PE+L+    ++ ++D WSLG +   M+    P F G +    + KI K
Sbjct: 184 TIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPP-FTGENRKKTIDKILK 235

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 267
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 15  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 72
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 73  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 132 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 221

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 118
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 119 RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 236
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 42  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 159
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 160 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 218
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 273
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 274 IRWCLALRPSDRPTFEEIQNHPW 296

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 67  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 124
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 125 RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 183
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 184 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 242
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 243 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 273

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 11/209 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D YEV   +G G YS     I+  TN                      L+     PN++ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLR-YGQHPNIIT 80
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDF--KVLYPTL-TDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D   K   ++ E     +   K+L     ++ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDD--GKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 242 HRDVKPHNVMIDHEL---RKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           HRD+KP N++   E      +R+ D+G A +             +  F  PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVL-ERQGY 197
Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
           D + D+WSLG +    +    PF  G D+
Sbjct: 198 DAACDIWSLGVLLYTXLTGYTPFANGPDD 226

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 7   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 66
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 67  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 124
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 125 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 183
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 238
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 239 IRWCLALRPSDRPTFEEIQNHPW 261

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 50  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 109
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 110 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 167
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 226
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 281
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 282 IRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 31  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 88
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 89  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 147
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 148 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 206
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 207 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 237

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 74
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 75  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 193 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 223

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 23  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 80
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 81  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 139
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 140 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 198
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 199 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 229

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 16  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 73
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 74  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 132
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 133 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 191
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 192 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 222

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 22  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 79
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 80  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 138
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 139 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 197
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 198 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 228

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 105/265 (39%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 234
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 21  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 78
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 79  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 137
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 138 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 196
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 197 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 227

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 74
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 75  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 193 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 223

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 106/265 (40%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSSECQHL 234
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 239
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 105/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 8   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 67
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 68  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 125
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 126 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 184
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 239
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPW 262

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 106/265 (40%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 179
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 234
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQ 259

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 106/265 (40%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 6   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 65
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 66  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 123
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 124 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 182
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     +++   +L
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSSECQHL 237
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 238 IRWCLALRPSDRPTFEEIQNHPWMQ 262

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 50  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 109
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 110 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 167
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 168 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 226
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 227 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 281
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 282 IRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 22  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 81
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 82  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 139
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 140 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 198
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 199 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 253
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 254 IRWCLALRPSDRPTFEEIQNHPW 276

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 254
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 255 IRWCLALRPSDRPTFEEIQNHPW 277

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSXECQHL 267
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 36  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 95
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 96  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 153
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 154 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 212
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 213 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSXECQHL 267
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 268 IRWCLALRPSDRPTFEEIQNHPW 290

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 35  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 94
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 95  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 152
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 153 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 211
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 212 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIGGQVFFRQRVSXECQHL 266
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 267 IRWCLALRPSDRPTFEEIQNHPW 289

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 55  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 114
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 115 KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 172
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 173 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 231
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 232 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 286
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 287 IRWCLALRPSDRPTFEEIQNHPW 309

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 100/229 (43%), Gaps = 23/229 (10%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+++ R +G+GK+  V+      +      +                     +Q
Sbjct: 8   QW-TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ 66
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P    +    +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSN-GELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-M 181
Query: 292 VDLQDYDYSLDMWSLGCM----FAGMIFRKEPFFYGHDNHDQLVKIAKV 336
           ++ + +D  +D+WSLG +      GM     P F  H   +   +I++V
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM-----PPFEAHTYQETYRRISRV 225

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY++ ++V G G   +V E  +  T ++C                        GGP++V
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW--QASGGPHIV 85
Query: 184 KLLDIVRDQHSKTPSL--IFEYVNSTD-FKVLYP----TLTDYDIRYYIYELLKALDYCH 236
            +LD+  + H     L  I E +   + F  +        T+ +    + ++  A+ + H
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 237 SQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S  I HRDVKP N++   + +   L+L D+G A+             + Y+  PE+L   
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVL-GP 203
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           + YD S DMWSLG +   ++    PF+
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFY 230

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 23/229 (10%)
Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQ 174
           QW   +D+++ R +G+GK+  V+      +      +                     +Q
Sbjct: 8   QW-TLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQ 66
Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKA 231
           +    PN+++L     D  +    LI EY            L+ +D      YI EL  A
Sbjct: 67  SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           L YCHS+ ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +
Sbjct: 125 LSYCHSKRVIHRDIKPENLLLGSN-GELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-M 181
Query: 292 VDLQDYDYSLDMWSLGCM----FAGMIFRKEPFFYGHDNHDQLVKIAKV 336
           ++ + +D  +D+WSLG +      GM     P F  H   +   +I++V
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM-----PPFEAHTYQETYRRISRV 225

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY++ ++V G G   +V E  +  T ++C                        GGP++V
Sbjct: 9   DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHW--QASGGPHIV 66
Query: 184 KLLDIVRDQHSKTPSL--IFEYVNSTD-FKVLYP----TLTDYDIRYYIYELLKALDYCH 236
            +LD+  + H     L  I E +   + F  +        T+ +    + ++  A+ + H
Sbjct: 67  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 237 SQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S  I HRDVKP N++   + +   L+L D+G A+             + Y+  PE+L   
Sbjct: 127 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVL-GP 184
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           + YD S DMWSLG +   ++    PF+
Sbjct: 185 EKYDKSCDMWSLGVIMYILLCGFPPFY 211

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 125 DDYEVVRKVGRGKYSEV-----FEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +DYEVV+ +GRG + EV          V   +                     +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALDY 234
           P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ ALD 
Sbjct: 134 PWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 290
            HS G +HRDVKP N+++D     L+L D+G        KE  VR    V +  +  PE+
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 25/263 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 23  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 82
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 83  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 140
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 141 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 199
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 200 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 254
Query: 347 NKYHLELDPQLDALVGRHSRKPW 369
            ++ L L P            PW
Sbjct: 255 IRWCLALRPXDRPTFEEIQNHPW 277

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 15  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 72
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 73  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 132 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVL-G 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 221

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 101/242 (41%), Gaps = 25/242 (10%)
Query: 90  PLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNT 149
           P+PA  +A    D +V       D E L         +  +R++G G +  V+   +V  
Sbjct: 28  PMPAGGRAGSLKDPDVAELFFKDDPEKL---------FSDLREIGHGSFGAVYFARDVRN 78
Query: 150 NERCXXXXXXXXXXXXXXXXXXXLQNL-----CGGPNVVKLLDIVRDQHSKTPSLIFEYV 204
           +E                     ++ +        PN ++       +H  T  L+ EY 
Sbjct: 79  SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH--TAWLVMEYC 136
Query: 205 --NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
             +++D  +V    L + +I    +  L+ L Y HS  ++HRDVK  N+++  E   ++L
Sbjct: 137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKL 195
Query: 262 IDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
            D+G A    P    N  V + Y+  PE  L +D   YD  +D+WSLG     +  RK P
Sbjct: 196 GDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
Query: 320 FF 321
            F
Sbjct: 253 LF 254

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 73  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 189
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 231

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 73  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 189
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 190 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 231

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 125 DDYEVVRKVGRGKYSEV-----FEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +DYEVV+ +GRG + EV          V   +                     +      
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALDY 234
           P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ ALD 
Sbjct: 129 PWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 290
            HS G +HRDVKP N+++D     L+L D+G        KE  VR    V +  +  PE+
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 25/214 (11%)
Query: 125 DDYEVVRKVGRGKYSEV-----FEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +DYEVV+ +GRG + EV          V   +                     +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALDY 234
           P VV+L    +D   +   ++ EY+   D   L   +++YD+     R+Y  E++ ALD 
Sbjct: 134 PWVVQLFYAFQDD--RYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLALDA 188
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 290
            HS G +HRDVKP N+++D     L+L D+G        KE  VR    V +  +  PE+
Sbjct: 189 IHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 291 LVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
           L        Y    D WS+G     M+    PF+
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 279

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 105/265 (39%), Gaps = 25/265 (9%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTN----------ERCXXXXXXXXXXXXXXXXXXXL 173
           +  Y+V   +G G +  V+ GI V+ N          +R                     
Sbjct: 30  ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 89
Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELL 229
           +   G   V++LLD      S    LI E         DF      L +   R + +++L
Sbjct: 90  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 147
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 148 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPPE 206
Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA---YL 346
            +   + +  S  +WSLG +   M+    PF      HD+ +   +V     ++    +L
Sbjct: 207 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EHDEEIIRGQVFFRQRVSXECQHL 261
Query: 347 NKYHLELDPQLDALVGRHSRKPWSK 371
            ++ L L P            PW +
Sbjct: 262 IRWCLALRPSDRPTFEEIQNHPWMQ 286

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 63/107 (58%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 135 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 193
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 194 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 11/147 (7%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYV--NSTDF-KVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN ++       +H  T  L+ EY   +++D  +V    L + +I    +  L+ L Y H
Sbjct: 75  PNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVDL 294
           S  ++HRDVK  N+++  E   ++L D+G A    P    N  V + Y+  PE  L +D 
Sbjct: 133 SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDE 188
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             YD  +D+WSLG     +  RK P F
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLF 215

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 63/107 (58%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 137 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 195
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 196 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  E+   L+  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             +  PE++ + + Y +S D W+LGC+   MI  + PF
Sbjct: 349 VGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 223 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
           +Y  E+   L+  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +
Sbjct: 290 FYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGT 348
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             +  PE++ + + Y +S D W+LGC+   MI  + PF
Sbjct: 349 VGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPF 385

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 14/184 (7%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVVKLLDI 188
           ++G+G + EV++GI+ +T E                        + + C  P + +    
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG- 84
Query: 189 VRDQHSKTPSL--IFEYVNS-TDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGIMHRD 244
               + K+  L  I EY+   +   +L P  L +  I   + E+LK LDY HS+  +HRD
Sbjct: 85  ---SYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRD 141
Query: 245 VKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 303
           +K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    YD+  D+
Sbjct: 142 IKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPE-VIKQSAYDFKADI 199
Query: 304 WSLG 307
           WSLG
Sbjct: 200 WSLG 203

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 63/107 (58%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 111 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 169
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   V   +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 170 ERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 37/196 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 110 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 169
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 225
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 226 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 256
Query: 392 LLRYDHQDRLTAREAM 407
           LL  D + R T  EA+
Sbjct: 257 LLVVDPKARFTTEEAL 272

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 37/196 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 226
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 227 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 257
Query: 392 LLRYDHQDRLTAREAM 407
           LL  D + R T  EA+
Sbjct: 258 LLVVDPKARFTTEEAL 273

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 37/196 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 226
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 227 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 257
Query: 392 LLRYDHQDRLTAREAM 407
           LL  D + R T  EA+
Sbjct: 258 LLVVDPKARFTTEEAL 273

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 74/141 (52%), Gaps = 7/141 (4%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDYCHSQGIMHRDVKPH 248
           Q  +    + EY+N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  
Sbjct: 88  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 147
Query: 249 NVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           N+++D +   +++ D+G+ +    G  + N    +  +  PE+L+  Q Y++S+D WS G
Sbjct: 148 NILLDKD-GHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG-QKYNHSVDWWSFG 205
Query: 308 CMFAGMIFRKEPFFYGHDNHD 328
            +   M+  + P F+G D  +
Sbjct: 206 VLLYEMLIGQSP-FHGQDEEE 225

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 37/196 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 226
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 227 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 257
Query: 392 LLRYDHQDRLTAREAM 407
           LL  D + R T  EA+
Sbjct: 258 LLVVDPKARFTTEEAL 273

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXX---XXXXXXXXLQNLCGGPN 181
           +D+++V+ +G G   EV   +N  T E                        +  +    N
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           VVK     R+ + +   L  EY +  + F  + P   + + D + + ++L+  + Y H  
Sbjct: 66  VVKFYGHRREGNIQY--LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 123
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKE--YNVRVASRYFKGPELLVDLQ 295
           GI HRD+KP N+++D E   L++ D+GLA  F +  +E   N    +  +  PELL   +
Sbjct: 124 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPF 320
            +   +D+WS G +   M+  + P+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 37/196 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 117 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 176
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 232
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 233 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 263
Query: 392 LLRYDHQDRLTAREAM 407
           LL  D + R T  EA+
Sbjct: 264 LLVVDPKARFTTEEAL 279

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 67/119 (56%), Gaps = 5/119 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL 216

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 67/119 (56%), Gaps = 5/119 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 105 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 163
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 164 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL 219

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 67/119 (56%), Gaps = 5/119 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL 216

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/293 (21%), Positives = 121/293 (41%), Gaps = 47/293 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXX----XXXXXXXLQNLCGGP 180
           ++Y++  ++G+G +S V   + V   +                         +  L   P
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      LIF+ V   +     V     ++ D  + I ++L+A+ +CH 
Sbjct: 71  NIVRLHDSISEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            G++HR++KP N+++  +L+   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK- 187
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +D+W+ G +   ++    P F+  D H                         L 
Sbjct: 188 DPYGKPVDLWACGVILY-ILLVGYPPFWDEDQH------------------------RLY 222
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            Q+ A         W           V+PEA D ++K+L  +   R+TA EA+
Sbjct: 223 QQIKAGAYDFPSPEWDT---------VTPEAKDLINKMLTINPSKRITAAEAL 266

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  + Y H
Sbjct: 74  PNVITLHEVYENKTDVI--LIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 237 SQGIMHRDVKPHNVM-IDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           S  I H D+KP N+M +D  + K  +++ID+GLA     G E+     +  F  PE +V+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVN 190
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
            +      DMWS+G +   ++    PF  G    + L  ++ V
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAV 232

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G PN+++L D    + +    L+F+ +      D+     TL++ + R  +  LL
Sbjct: 77  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPE 193
Query: 290 LL-VDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFY 322
           ++   + D    Y   +DMWS G +   ++    PF++
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 121/294 (41%), Gaps = 49/294 (16%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D E  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D WS+G +   ++    PF+                  DE +A L +  L+ 
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFY------------------DENDAKLFEQILKA 233
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           + + D+         W           +S  A DF+  L+  D + R T  +A+
Sbjct: 234 EYEFDSPY-------WDD---------ISDSAKDFIRHLMEKDPEKRFTCEQAL 271

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 76/165 (46%), Gaps = 9/165 (5%)
Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           DF      L +   R + +++L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G  
Sbjct: 146 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 205
Query: 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 327
                   Y     +R +  PE +   + +  S  +WSLG +   M+    PF      H
Sbjct: 206 ALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-----EH 259
Query: 328 DQLVKIAKVLGTDELNA---YLNKYHLELDPQLDALVGRHSRKPW 369
           D+ +   +V     +++   +L ++ L L P            PW
Sbjct: 260 DEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 121/294 (41%), Gaps = 49/294 (16%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D E  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D WS+G +   ++    PF+                  DE +A L +  L+ 
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFY------------------DENDAKLFEQILKA 233
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           + + D+         W           +S  A DF+  L+  D + R T  +A+
Sbjct: 234 EYEFDSPY-------WDD---------ISDSAKDFIRHLMEKDPEKRFTCEQAL 271

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 74/141 (52%), Gaps = 7/141 (4%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDYCHSQGIMHRDVKPH 248
           Q  +    + EY+N  D      +   +D+    +Y  E++  L + HS+GI++RD+K  
Sbjct: 89  QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 148
Query: 249 NVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           N+++D +   +++ D+G+ +    G  + N    +  +  PE+L+  Q Y++S+D WS G
Sbjct: 149 NILLDKD-GHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG-QKYNHSVDWWSFG 206
Query: 308 CMFAGMIFRKEPFFYGHDNHD 328
            +   M+  + P F+G D  +
Sbjct: 207 VLLYEMLIGQSP-FHGQDEEE 226

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 49/294 (16%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D +  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLDED-SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D WS+G +   ++    PF+                  DE +A L +  L+ 
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFY------------------DENDAKLFEQILKA 233
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           + + D+         W           +S  A DF+  L+  D + R T  +A+
Sbjct: 234 EYEFDSPY-------WDD---------ISDSAKDFIRHLMEKDPEKRFTCEQAL 271

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G PN+++L D    + +    L+F+ +      D+     TL++ + R  +  LL
Sbjct: 77  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 134
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 290 LL-VDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFY 322
           ++   + D    Y   +DMWS G +   ++    PF++
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 16/232 (6%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 73  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE 
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE- 186
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
           +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPEL 236

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 121/294 (41%), Gaps = 49/294 (16%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +D Y+    +G G +SEV    +  T +    +C                   L  +   
Sbjct: 17  RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI-KH 75
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI   +      LI + V+     D  V     T+ D    I+++L A+ Y H
Sbjct: 76  PNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 133
Query: 237 SQGIMHRDVKPHNVM---IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
             GI+HRD+KP N++   +D E  K+ + D+GL++   PG   +    +  +  PE+L  
Sbjct: 134 DLGIVHRDLKPENLLYYSLD-EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 192
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + Y  ++D WS+G +   ++    PF+                  DE +A L +  L+ 
Sbjct: 193 -KPYSKAVDCWSIGVIAYILLCGYPPFY------------------DENDAKLFEQILKA 233
Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           + + D+         W           +S  A DF+  L+  D + R T  +A+
Sbjct: 234 EYEFDSPY-------WDD---------ISDSAKDFIRHLMEKDPEKRFTCEQAL 271

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 67/119 (56%), Gaps = 5/119 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL 216

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 44/232 (18%)
Query: 186 LDIVRDQHSKTPSLIFEYVNST--DFK-VLYPTLTDYDIRYYIYELLKALDYCHSQGIMH 242
           +D+V+ Q    P    E +N +   F+  L     +  I   + ++  AL Y H+QGI H
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICH 191
Query: 243 RDVKPHNVMID-HELRKLRLIDWGLA-EFY--HPGKEYNV--RVASRYFKGPELL-VDLQ 295
           RD+KP N +   ++  +++L+D+GL+ EFY  + G+ Y +  +  + YF  PE+L    +
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y    D WS G +   ++    PF               V   D ++  LNK     +P
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPF-------------PGVNDADTISQVLNKKLCFENP 298
Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                N +++SP A D L  LL  +  +R  A  A+
Sbjct: 299 ---------------------NYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/316 (22%), Positives = 130/316 (41%), Gaps = 58/316 (18%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 73  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE 
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE- 186
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL        
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ------- 237
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE----- 405
              +P+  + + R                       DFL++ L  D + R +A+E     
Sbjct: 238 ---NPEKLSAIFR-----------------------DFLNRCLEMDVEKRGSAKELLQHQ 271
Query: 406 ----AMVISSISPIFS 417
               A  +SS++P+ +
Sbjct: 272 FLKIAKPLSSLTPLIA 287

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 67/119 (56%), Gaps = 5/119 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL 216

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 61/112 (54%), Gaps = 3/112 (2%)
Query: 211 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEF 269
           V +  + +  I      +L+AL Y H+QG++HRD+K  ++++  + R ++L D+G  A+ 
Sbjct: 133 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQV 191
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
                +    V + Y+  PE++  L  Y   +D+WSLG M   MI  + P+F
Sbjct: 192 SKEVPKRKXLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYF 242

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 17/155 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT--------DYDIRYYIYELLKA 231
           PN+V+  D + D+ + T  ++ EY    D   +    T        ++ +R  + +L  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-MTQLTLA 123
Query: 232 LDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYF 285
           L  CH +      ++HRD+KP NV +D + + ++L D+GLA   +  +++    V + Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAKEFVGTPYY 182
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 183 MSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 62/107 (57%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 117 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 175
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +       +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 176 ERKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 67/119 (56%), Gaps = 5/119 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 107 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 165
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 166 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL 221

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/316 (22%), Positives = 130/316 (41%), Gaps = 58/316 (18%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 14  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 73
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 74  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 129
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P + + +  V + Y+  PE 
Sbjct: 130 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPE- 187
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL        
Sbjct: 188 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ------- 238
Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE----- 405
              +P+  + + R                       DFL++ L  D + R +A+E     
Sbjct: 239 ---NPEKLSAIFR-----------------------DFLNRCLEMDVEKRGSAKELIQHQ 272
Query: 406 ----AMVISSISPIFS 417
               A  +SS++P+ +
Sbjct: 273 FLKIAKPLSSLTPLIA 288

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 62/107 (57%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 113 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 171
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +       +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 172 ERKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ + G PN+++L D    + +    L+F+ +      D+     TL++ + R  +  LL
Sbjct: 64  LRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALL 121
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  PE
Sbjct: 122 EVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 180
Query: 290 LL-VDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFY 322
           ++   + D    Y   +DMWS G +   ++    PF++
Sbjct: 181 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 62/107 (57%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            LT+ + RYY+ +++    Y H   ++HRD+K  N+ ++ +L ++++ D+GLA +  + G
Sbjct: 113 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG 171
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +       +  +  PE+L   + + + +D+WS+GC+   ++  K PF
Sbjct: 172 ERKKTLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 37/196 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 250 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 309
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 365
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 366 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 396
Query: 392 LLRYDHQDRLTAREAM 407
           LL  D + R T  EA+
Sbjct: 397 LLVVDPKARFTTEEAL 412

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 67/119 (56%), Gaps = 5/119 (4%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            T+   R+Y  E++ AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL  E    G 
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGA 160
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
                  +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHERLFEL 216

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 85/196 (43%), Gaps = 37/196 (18%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPG 273
           L +   + Y Y++L A+ Y H  GI+HRD+KP NV++  +     +++ D+G ++     
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 274 KEYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                   +  +  PE+LV +    Y+ ++D WSLG +    +    PF      H   V
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF----SEHRTQV 351
Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +   + + + N           P++           W++         VS +A+D + K
Sbjct: 352 SLKDQITSGKYN---------FIPEV-----------WAE---------VSEKALDLVKK 382
Query: 392 LLRYDHQDRLTAREAM 407
           LL  D + R T  EA+
Sbjct: 383 LLVVDPKARFTTEEAL 398

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT--------DYDIRYYIYELLKA 231
           PN+V+  D + D+ + T  ++ EY    D   +    T        ++ +R  + +L  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-MTQLTLA 123
Query: 232 LDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYF 285
           L  CH +      ++HRD+KP NV +D + + ++L D+GLA    H        V + Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYY 182
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 183 MSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 21/212 (9%)
Query: 125 DDYEVVRKVGRGKYSEV-----FEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           +DY+VV+ +GRG + EV          V   +                     +      
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELLKALDY 234
           P VV+L    +D   K   ++ EY+   D   L   +++YD+     ++Y  E++ ALD 
Sbjct: 135 PWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLALDA 189
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPELLV 292
            HS G++HRDVKP N+++D     L+L D+G   +    G  + +  V +  +  PE+L 
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLK 248
Query: 293 DLQD---YDYSLDMWSLGCMFAGMIFRKEPFF 321
                  Y    D WS+G     M+    PF+
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 280

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT--------DYDIRYYIYELLKA 231
           PN+V+  D + D+ + T  ++ EY    D   +    T        ++ +R  + +L  A
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV-MTQLTLA 123
Query: 232 LDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPGKEYNVRVASRYF 285
           L  CH +      ++HRD+KP NV +D + + ++L D+GLA    H        V + Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE + +   Y+   D+WSLGC+   +     PF
Sbjct: 183 MSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 60/106 (56%), Gaps = 3/106 (2%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK 274
            ++ + R+++++++  + Y HS GI+HRD+   N+++   +  +++ D+GLA +   P +
Sbjct: 109 FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHE 167
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           ++     +  +  PE+      +    D+WSLGCMF  ++  + PF
Sbjct: 168 KHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-------YPTLTDYDIRYYIYELLKALD 233
           NV++L+D++ ++  +   ++ EY      ++L       +P    +    Y  +L+  L+
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG---YFCQLIDGLE 123
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-GKEYNVRVA--SRYFKGPEL 290
           Y HSQGI+H+D+KP N+++      L++   G+AE  HP   +   R +  S  F+ PE+
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 291 LVDLQDYD-YSLDMWSLGCMFAGMIFRKEPF 320
              L  +  + +D+WS G     +     PF
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 69/318 (21%), Positives = 131/318 (41%), Gaps = 58/318 (18%)
Query: 117 LTVQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN 175
           + V  GD +  Y    K+G+G    V+  ++V T +                     +  
Sbjct: 12  IIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 71
Query: 176 L--CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELL 229
           +     PN+V  LD  +V D+      ++ EY+        V    + +  I     E L
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGP 288
           +AL++ HS  ++HR++K  N+++  +   ++L D+G      P + + +  V + Y+  P
Sbjct: 128 QALEFLHSNQVIHRNIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 186
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL      
Sbjct: 187 E-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ----- 238
Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE--- 405
                +P+  + + R                       DFL++ L  D + R +A+E   
Sbjct: 239 -----NPEKLSAIFR-----------------------DFLNRCLEMDVEKRGSAKELIQ 270
Query: 406 ------AMVISSISPIFS 417
                 A  +SS++P+ +
Sbjct: 271 HQFLKIAKPLSSLTPLIA 288

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 16/232 (6%)
Query: 119 VQWGD-QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNL- 176
           V  GD +  Y    K+G+G    V+  ++V T +                     +  + 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 177 -CGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKA 231
               PN+V  LD  +V D+      ++ EY+        V    + +  I     E L+A
Sbjct: 73  ENKNPNIVNYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-VASRYFKGPEL 290
           L++ HS  ++HRD+K  N+++  +   ++L D+G      P +      V + Y+  PE 
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPE- 186
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
           +V  + Y   +D+WSLG M   MI  + P+   ++N  + + +    GT EL
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPEL 236

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVL--YPTLTDYDIRYYIYELLKALDYC 235
           P +V L D   D +     +I+E+++  +   KV   +  +++ +   Y+ ++ K L + 
Sbjct: 214 PTLVNLHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H    +H D+KP N+M   +   +L+LID+GL     P +   V   +  F  PE + + 
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEG 330
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +   Y  DMWS+G +   ++    PF  G +N D+ ++  K
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVK 369

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 20/170 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYPTL------TDYDIRYYIYELLK 230
           PN+V+  +++      TP+   +I EY +  +   LY  +      ++ + R++  +LL 
Sbjct: 76  PNIVRFKEVIL-----TPTHLAIIMEYASGGE---LYERICNAGRFSEDEARFFFQQLLS 127
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            + YCHS  I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187
Query: 290 LLVDLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           +L+  Q+YD  + D+WS G     M+    PF    +  D    I ++L 
Sbjct: 188 VLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS 236

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 22/189 (11%)
Query: 221 IRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR 279
           I+  I  +L +  Y H++  I HRDVKP N+++D   R ++L D+G +E Y   K+    
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESE-YMVDKKIKGS 210
Query: 280 VASRYFKGPELLVDLQDYDYS-LDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
             +  F  PE   +   Y+ + +D+WSLG     M +   PF          +KI+ V  
Sbjct: 211 RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF---------SLKISLVEL 261
Query: 339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 398
            + +     +Y L+ +  L  L  + S           + + +S E IDFL   LR +  
Sbjct: 262 FNNIRTKNIEYPLDRNHFLYPLTNKKS---------TCSNNFLSNEDIDFLKLFLRKNPA 312
Query: 399 DRLTAREAM 407
           +R+T+ +A+
Sbjct: 313 ERITSEDAL 321

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--KVL--YPTLTDYDIRYYIYELLKALDYC 235
           P +V L D   D +     +I+E+++  +   KV   +  +++ +   Y+ ++ K L + 
Sbjct: 108 PTLVNLHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 165
Query: 236 HSQGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H    +H D+KP N+M   +   +L+LID+GL     P +   V   +  F  PE + + 
Sbjct: 166 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEG 224
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +   Y  DMWS+G +   ++    PF  G +N D+ ++  K
Sbjct: 225 KPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVK 263

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/107 (25%), Positives = 62/107 (57%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDG 196
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +       +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 197 ERKKTLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 84/167 (50%), Gaps = 17/167 (10%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPTL----TDYDIRYYIYELLKALDY 234
           P V+ L ++   +++    LI EY    + F +  P L    ++ D+   I ++L+ + Y
Sbjct: 89  PRVINLHEVY--ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 235 CHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            H   I+H D+KP N+++   + L  ++++D+G++       E    + +  +  PE+L 
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL- 205
Query: 293 DLQDYD---YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
              +YD    + DMW++G + A M+      F G DN +  + I++V
Sbjct: 206 ---NYDPITTATDMWNIG-IIAYMLLTHTSPFVGEDNQETYLNISQV 248

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           L +  I   + E+L+ L+Y H  G +HRDVK  N+++  +   +++ D+G++ F   G +
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGD 171
Query: 276 YNVRVASRYFKG------PELLVDLQDYDYSLDMWSLG 307
                  + F G      PE++  ++ YD+  D+WS G
Sbjct: 172 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 209

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           L +  I   + E+L+ L+Y H  G +HRDVK  N+++  +   +++ D+G++ F   G +
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATGGD 176
Query: 276 YNVRVASRYFKG------PELLVDLQDYDYSLDMWSLG 307
                  + F G      PE++  ++ YD+  D+WS G
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/214 (21%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVVK 184
           D +E++R +G+G + +V   +  N  ++                            NV K
Sbjct: 15  DHFEILRAIGKGSFGKVC-IVQKNDTKKMYAMKYMNKQKCVERNEVR---------NVFK 64
Query: 185 LLDIVRD-QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY---------------YIYEL 228
            L I++  +H    +L + + +  D  ++   L   D+RY               +I EL
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           + ALDY  +Q I+HRD+KP N+++D E   + + D+ +A       +      ++ +  P
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183
Query: 289 ELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPF 320
           E+    +   Y +++D WSLG     ++  + P+
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 9/104 (8%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  E+  AL Y HS  I++RD+KP N+++D +   + L D+GL +      E+N    
Sbjct: 142 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCK---ENIEHN-STT 196
Query: 282 SRYFKGPELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           S +   PE L    +  Q YD ++D W LG +   M++   PF+
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 240

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           ++Y  E+  AL+Y HS+ I++RD+KP N+++D     +++ D+G A+ Y P   Y +   
Sbjct: 109 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAK-YVPDVTYXLCGT 166
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE +V  + Y+ S+D WS G +   M+    PF+
Sbjct: 167 PDYI-APE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFY 204

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/107 (25%), Positives = 62/107 (57%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDG 196
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +       +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 197 ERKKXLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 15/211 (7%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQC--PHIV 118
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+       D   L+  + D   + +      E+ K    A+ Y 
Sbjct: 119 RIVDVYENLYAGRKCLLI-VXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L  
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-G 236
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S D WSLG +   ++    PF+  H
Sbjct: 237 PEKYDKSCDXWSLGVIXYILLCGYPPFYSNH 267

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/150 (22%), Positives = 71/150 (47%), Gaps = 13/150 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF-------KVLYPTLTDYDIRYYIYELLKAL 232
           PN++K+ ++  D H+    ++ E     +        +     L++  +   + +++ AL
Sbjct: 80  PNIIKIFEVFEDYHNMY--IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 233 DYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y HSQ ++H+D+KP N++         +++ID+GLAE +   +       +  +  PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
               +D  +  D+WS G +   ++    PF
Sbjct: 198 FK--RDVTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 85/190 (44%), Gaps = 16/190 (8%)
Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCXXXX---XXXXXXXXXXXXXXXLQNLCGGPNVV 183
           +  + ++G+G + EVF+GI+  T +                        + + C    V 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 184 KLLDIVRDQHSKTPSL--IFEYV---NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           K        + K   L  I EY+   ++ D     P   ++ I   + E+LK LDY HS+
Sbjct: 85  KYYG----SYLKGSKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSE 139
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
             +HRD+K  NV++  E   ++L D+G+A +      + N  V + ++  PE ++    Y
Sbjct: 140 KKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAY 197
Query: 298 DYSLDMWSLG 307
           D   D+WSLG
Sbjct: 198 DSKADIWSLG 207

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 195 KTPSLIF---EYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPH 248
           +TP  +F   E+VN  D          +D    R+Y  E++ AL + H +GI++RD+K  
Sbjct: 94  QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLD 153
Query: 249 NVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           NV++DHE    +L D+G+  E    G        +  +  PE+L ++  Y  ++D W++G
Sbjct: 154 NVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMG 211
Query: 308 CMFAGMIFRKEPF 320
            +   M+    PF
Sbjct: 212 VLLYEMLCGHAPF 224

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/308 (23%), Positives = 127/308 (41%), Gaps = 34/308 (11%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
            D +EV  ++GRG  S V+      T +                     +      PN++
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNII 111
Query: 184 KLLDIVRDQHSKTP---SLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           KL +I      +TP   SL+ E V      D  V     ++ D    + ++L+A+ Y H 
Sbjct: 112 KLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 238 QGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            GI+HRD+KP N++         L++ D+GL++             +  +  PE+L    
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA 226
Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD-----------ELNA 344
            Y   +DMWS+G +   ++   EPF+   +  DQ +   ++L  +            LNA
Sbjct: 227 -YGPEVDMWSVGIITYILLCGFEPFY--DERGDQFM-FRRILNCEYYFISPWWDEVSLNA 282
Query: 345 Y-LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
             L +  + LDP+      +  + PW     A+  H+ + +      KL  ++ + +L A
Sbjct: 283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQ-----KKLQEFNARRKLKA 337
Query: 404 REAMVISS 411
               V++S
Sbjct: 338 AVKAVVAS 345

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 65/114 (57%), Gaps = 6/114 (5%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 254 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 312
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 313 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL 363

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 65/114 (57%), Gaps = 6/114 (5%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTF 309
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 310 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL 360

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/293 (20%), Positives = 121/293 (41%), Gaps = 47/293 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           D+Y++   +G+G +S V   + + T      +                    +  L    
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHS 63
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I ++L+A+ +CH 
Sbjct: 64  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
            G++HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK- 180
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y   +D+W+ G +   ++    P F+  D H                        +L 
Sbjct: 181 EAYGKPVDIWACGVILY-ILLVGYPPFWDEDQH------------------------KLY 215
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            Q+ A         W           V+PEA + ++++L  +   R+TA EA+
Sbjct: 216 QQIKAGAYDFPSPEWDT---------VTPEAKNLINQMLTINPAKRITAHEAL 259

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 27/107 (25%), Positives = 62/107 (57%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G
Sbjct: 138 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDG 196
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +       +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 197 ERKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 242

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 65/114 (57%), Gaps = 6/114 (5%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 113 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXF 171
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 172 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL 222

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 65/114 (57%), Gaps = 6/114 (5%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 112 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXF 170
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 171 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL 221

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 65/114 (57%), Gaps = 6/114 (5%)
Query: 222 RYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
           R+Y  E++ ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G      
Sbjct: 111 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKXF 169
Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             +  +  PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L ++
Sbjct: 170 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFEL 220

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/107 (25%), Positives = 62/107 (57%), Gaps = 3/107 (2%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPG 273
            +T+ + RY++ + ++ + Y H+  ++HRD+K  N+ ++ ++  +++ D+GLA +    G
Sbjct: 122 AVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDG 180
Query: 274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +       +  +  PE+L   + + + +D+WSLGC+   ++  K PF
Sbjct: 181 ERKKDLCGTPNYIAPEVLCK-KGHSFEVDIWSLGCILYTLLVGKPPF 226

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/174 (24%), Positives = 84/174 (48%), Gaps = 11/174 (6%)
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFYHPGK 274
           T+ D    I ++L A+ Y H  GI+HRD+KP N++     E  K+ + D+GL++    G 
Sbjct: 118 TEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD 177
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVK 332
             +    +  +  PE+L   + Y  ++D WS+G +   ++    PF+  +D+   +Q++K
Sbjct: 178 VMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILK 236
Query: 333 IAKVLGT---DELNAYLNKY---HLELDPQLDALVGRHSRKPWSKFINADNQHL 380
                 +   D+++     +    +E DP       + +R PW     A N+++
Sbjct: 237 AEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAGDTALNKNI 290

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 33/197 (16%)
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYH--------PGK 274
           + ++  ALD+ H++GI HRD+KP N++ +H  ++  +++ D+GL                
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 275 EYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           E      S  +  PE++    +    YD   D+WSLG +   ++    P F G    D  
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-ILLSGYPPFVGRCGSD-- 233
Query: 331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
                  G D   A          P    ++    ++   +F + D  H +S  A D + 
Sbjct: 234 ------CGWDRGEAC---------PACQNMLFESIQEGKYEFPDKDWAH-ISCAAKDLIS 277
Query: 391 KLLRYDHQDRLTAREAM 407
           KLL  D + RL+A + +
Sbjct: 278 KLLVRDAKQRLSAAQVL 294

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE---FYHPGKEYN 277
           I +Y  ++L+ L Y H   I+HRD+K  NV+I+     L++ D+G ++     +P  E  
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE-- 181
Query: 278 VRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
               +  +  PE++    + Y  + D+WSLGC    M   K PF+
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 12/108 (11%)
Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
           I +Y  ++L+ L Y H   I+HRD+K  NV+I+     L++ D+G ++     +   +  
Sbjct: 110 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINP 164
Query: 281 ASRYFKG------PELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            +  F G      PE++    + Y  + D+WSLGC    M   K PF+
Sbjct: 165 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 212

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 13/154 (8%)
Query: 180 PNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPT------LTDYDIRYYIYELL 229
           PNVV   ++        P+    L  EY    D +           L +  IR  + ++ 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKL--RLIDWGLAEFYHPGKEYNVRVASRYFKG 287
            AL Y H   I+HRD+KP N+++    ++L  ++ID G A+    G+     V +  +  
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
           PELL + + Y  ++D WS G +    I    PF 
Sbjct: 192 PELL-EQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 61/133 (45%), Gaps = 9/133 (6%)
Query: 197 PSLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV 250
           P L  EY    D +           L +  IR  + ++  AL Y H   I+HRD+KP N+
Sbjct: 94  PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENI 153
Query: 251 MIDHELRKL--RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC 308
           ++    ++L  ++ID G A+    G+     V +  +  PELL + + Y  ++D WS G 
Sbjct: 154 VLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGT 212
Query: 309 MFAGMIFRKEPFF 321
           +    I    PF 
Sbjct: 213 LAFECITGFRPFL 225

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 107 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 164
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPF 320
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF
Sbjct: 165 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 223

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/279 (21%), Positives = 124/279 (44%), Gaps = 36/279 (12%)
Query: 125 DDYEVVRKVGRGKYSEVF-----EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           DD+++VR +G+GK+  V+     +   +   +                     +Q+    
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-------YIYELLKAL 232
           PN++++ +   D+  K   L+ E+    +   LY  L  +  R+       ++ EL  AL
Sbjct: 74  PNILRMYNYFHDR--KRIYLMLEFAPRGE---LYKELQKHG-RFDEQRSATFMEELADAL 127
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            YCH + ++HRD+KP N+++ ++  +L++ D+G +  + P         +  +  PE ++
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYK-GELKIADFGWS-VHAPSLRRRXMCGTLDYLPPE-MI 184
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLVKIAKVL------GTDELNA 344
           + + +D  +D+W  G +    +    PF      + H ++V +          G+ +L +
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS 244
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSP 383
            L +YH    PQ   L G     PW   + A+++ ++ P
Sbjct: 245 KLLRYH---PPQRLPLKGVMEH-PW---VKANSRRVLPP 276

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 6/98 (6%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPG 273
           TL +  I Y   E+L+ L + H   ++HRD+K  NV++  E  +++L+D+G+ A+     
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTV 183
Query: 274 KEYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLG 307
              N  + + Y+  PE++   ++    YD+  D+WSLG
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/207 (21%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 208
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPF 320
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF
Sbjct: 209 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCG 178
           ++D+E+++ +GRG + EV   + +   ER                     +      + G
Sbjct: 73  REDFEIIKVIGRGAFGEV-AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+YI E++ A+D 
Sbjct: 132 DCQWITALHYAF-QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 190
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK-EYNVRVASRYFKGPELLV 292
            H    +HRD+KP NV++D     +RL D+G   +    G  + +V V +  +  PE+L 
Sbjct: 191 IHQLHYVHRDIKPDNVLLDVN-GHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 249
Query: 293 DLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++D    Y    D WSLG     M++ + PF+
Sbjct: 250 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 208
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPF 320
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF
Sbjct: 209 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 104 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 161
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPF 320
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 151 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 208
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPF 320
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 267

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 103 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 160
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPF 320
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF
Sbjct: 161 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 219

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N+MI 
Sbjct: 108 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 167
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 168 -ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 224
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 225 VLYEVLTGEPPF 236

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQN-----LCG 178
           ++D+E+++ +GRG + EV   + +   ER                     +      + G
Sbjct: 89  REDFEIIKVIGRGAFGEV-AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNG 147
Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY---DI-RYYIYELLKALDY 234
               +  L     Q      L+ +Y    D   L     D    D+ R+YI E++ A+D 
Sbjct: 148 DCQWITALHYAF-QDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDS 206
Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK-EYNVRVASRYFKGPELLV 292
            H    +HRD+KP NV++D     +RL D+G   +    G  + +V V +  +  PE+L 
Sbjct: 207 IHQLHYVHRDIKPDNVLLDVN-GHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 293 DLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
            ++D    Y    D WSLG     M++ + PF+
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 298

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+GLA+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGLAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDT 180
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPF 320
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/207 (21%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 16  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPN 75
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 76  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 130
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  
Sbjct: 131 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK- 189
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 190 KEYDGKVADVWSCGVTLYVMLVGAYPF 216

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           ++  ++ + Y   +L+A+   H  GI+H D+KP N +I   +  L+LID+G+A    P  
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDX 180
Query: 275 EYNVR---VASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFRKEPF 320
              V+   V +  +  PE + D+                 D+WSLGC+   M + K PF
Sbjct: 181 XXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 239

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 56/107 (52%), Gaps = 4/107 (3%)
Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNV--MIDHELRKLRLIDWGLAEFYHPGK 274
           T+ D    I ++L A+ Y H  GI+HRD+KP N+  +   E  K+ + D+GL++    G 
Sbjct: 104 TEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             +    +  +  PE+L   + Y  ++D WS+G +   ++    PF+
Sbjct: 164 -MSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFY 208

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+GLA+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIQVTDFGLAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 63/132 (47%), Gaps = 11/132 (8%)
Query: 197 PSLIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 253
           P ++ EYV+    + +  T   +T       I +  +AL++ H  GI+HRDVKP N++I 
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILIS 150
Query: 254 HELRKLRLIDWGLAEFYHPGKEYNVRVA-----SRYFKGPELLVDLQDYDYSLDMWSLGC 308
                ++++D+G+A           + A     ++Y    +   D    D   D++SLGC
Sbjct: 151 -ATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGC 207
Query: 309 MFAGMIFRKEPF 320
           +   ++  + PF
Sbjct: 208 VLYEVLTGEPPF 219

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/293 (20%), Positives = 121/293 (41%), Gaps = 47/293 (16%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLC---GGP 180
           DDY++  ++G+G +S V   +    T E                        +C     P
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDF---KVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+V+L D + ++      L+F+ V   +     V     ++ D  + I+++L+++++ H 
Sbjct: 91  NIVRLHDSISEEGFHY--LVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQ 148
Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
             I+HRD+KP N+++  + +   ++L D+GLA E     + +     +  +  PE+L   
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK- 207
Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y   +D+W+ G +   ++    P F+  D H                        +L 
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPP-FWDEDQH------------------------KLY 242
Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            Q+ A         W           V+PEA + ++++L  +   R+TA +A+
Sbjct: 243 QQIKAGAYDFPSPEWDT---------VTPEAKNLINQMLTINPAKRITADQAL 286

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           +++K      DQ  K+  L+ EYV     +   P  ++    +  +  ++ + + Y HSQ
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR++   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 137 HYIHRNLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 196 KFY-YASDVWSFG 207

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIKVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 7/106 (6%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK-EYNVR 279
           R+Y+ E++ A+D  H    +HRD+KP N+++D     +RL D+G   +    G  + +V 
Sbjct: 178 RFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 280 VASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFF 321
           V +  +  PE+L  ++     Y    D WSLG     M++ + PF+
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 38/247 (15%)
Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIR---YYIYELLKALDY 234
           G  N+++L++   D       L+FE +              ++ R     + ++  ALD+
Sbjct: 69  GNKNILELIEFFED--DTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDF 126
Query: 235 CHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYH--------PGKEYNVRVASRY 284
            H++GI HRD+KP N++ +   ++  +++ D+ L                E      S  
Sbjct: 127 LHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 285 FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
           +  PE++    D    YD   D+WSLG +   M+    PF  GH   D      +V    
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFV-GHCGADCGWDRGEV---- 241
Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
                 NK    +        G++      +F + D  H +S EA D + KLL  D + R
Sbjct: 242 -CRVCQNKLFESIQE------GKY------EFPDKDWAH-ISSEAKDLISKLLVRDAKQR 287
Query: 401 LTAREAM 407
           L+A + +
Sbjct: 288 LSAAQVL 294

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N+MID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 44/195 (22%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL++ HS+  ++HRDVKP NV+I+  L ++++ D+G++ +        +    + + 
Sbjct: 162 IVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYM 220
Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            PE +   ++ + Y    D+WSLG     +   + P+        QL ++ +        
Sbjct: 221 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 272
Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                   E  PQL          P  KF         S E +DF  + L+ + ++R T 
Sbjct: 273 --------EPSPQL----------PADKF---------SAEFVDFTSQCLKKNSKERPTY 305
Query: 404 REAMVISSISPIFSL 418
            E M      P F+L
Sbjct: 306 PELMQ----HPFFTL 316

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLXGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 71/132 (53%), Gaps = 18/132 (13%)
Query: 227 ELLKALDYCHSQ-GIMHRDVKPHNVMID-----HELRKLRLIDWGLAEFYHPGKEYNVRV 280
           +LL  LDY H + GI+H D+KP NV+++       L ++++ D G A +Y   + Y   +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 196
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI---FRKEPFFYGHD---NHDQLVKIA 334
            +R ++ PE+L+    +    D+WS  C+   +I   F  EP   GH    + D + +I 
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEP-DEGHSYTKDDDHIAQII 254
Query: 335 KVLGTDELNAYL 346
           ++LG  EL +YL
Sbjct: 255 ELLG--ELPSYL 264

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 24/207 (11%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           ++GRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA------CAGLTSPRIVPLYGA 153
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y HS+ I+H DV
Sbjct: 154 VRE--GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 211
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDY 299
           K  NV++  +     L D+G A    P       +   Y  G      PE+++  +  D 
Sbjct: 212 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG-RSCDA 270
Query: 300 SLDMWSLGCMFAGMIFRKEP---FFYG 323
            +D+WS  CM   M+    P   FF G
Sbjct: 271 KVDVWSSCCMMLHMLNGCHPWTQFFRG 297

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLAGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 71/132 (53%), Gaps = 18/132 (13%)
Query: 227 ELLKALDYCHSQ-GIMHRDVKPHNVMID-----HELRKLRLIDWGLAEFYHPGKEYNVRV 280
           +LL  LDY H + GI+H D+KP NV+++       L ++++ D G A +Y   + Y   +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 196
Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI---FRKEPFFYGHD---NHDQLVKIA 334
            +R ++ PE+L+    +    D+WS  C+   +I   F  EP   GH    + D + +I 
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEP-DEGHSYTKDDDHIAQII 254
Query: 335 KVLGTDELNAYL 346
           ++LG  EL +YL
Sbjct: 255 ELLG--ELPSYL 264

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGI-------NVNTNERCXXXXXXXXXXXXXXXXXXXLQNL 176
           ++D  + R +G G + EV+EG+        +N   +                    ++NL
Sbjct: 7   REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 66
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYYIYEL 228
              P++VKL+ I+ ++ +     ++ Y         N    KVL  TL  Y +     ++
Sbjct: 67  -DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSL-----QI 118
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK-- 286
            KA+ Y  S   +HRD+   N+++      ++L D+GL+ +      Y   V     K  
Sbjct: 119 CKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 177
Query: 287 GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFY 322
            PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 178 SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 213

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGI-------NVNTNERCXXXXXXXXXXXXXXXXXXXLQNL 176
           ++D  + R +G G + EV+EG+        +N   +                    ++NL
Sbjct: 23  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 82
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYYIYEL 228
              P++VKL+ I+ ++ +     ++ Y         N    KVL  TL  Y +     ++
Sbjct: 83  -DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSL-----QI 134
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK-- 286
            KA+ Y  S   +HRD+   N+++      ++L D+GL+ +      Y   V     K  
Sbjct: 135 CKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 193
Query: 287 GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFY 322
            PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 194 SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 229

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 19/200 (9%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           +VGRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 81  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------CAGLSSPRIVPLYGA 134
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y H++ I+H DV
Sbjct: 135 VRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 192
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL-----LVDLQDYDYS 300
           K  NV++  +  +  L D+G A    P       +   Y  G E      +V  +  D  
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 252
Query: 301 LDMWSLGCMFAGMIFRKEPF 320
           +D+WS  CM   M+    P+
Sbjct: 253 VDIWSSCCMMLHMLNGCHPW 272

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 33/197 (16%)
Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYH--------PGK 274
           + ++  ALD+ H++GI HRD+KP N++ +H  ++  +++ D+ L                
Sbjct: 117 VQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 275 EYNVRVASRYFKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           E      S  +  PE++    +    YD   D+WSLG +   ++    P F G    D  
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-ILLSGYPPFVGRCGSD-- 233
Query: 331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
                  G D   A          P    ++    ++   +F + D  H +S  A D + 
Sbjct: 234 ------CGWDRGEAC---------PACQNMLFESIQEGKYEFPDKDWAH-ISCAAKDLIS 277
Query: 391 KLLRYDHQDRLTAREAM 407
           KLL  D + RL+A + +
Sbjct: 278 KLLVRDAKQRLSAAQVL 294

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 28/217 (12%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGI-------NVNTNERCXXXXXXXXXXXXXXXXXXXLQNL 176
           ++D  + R +G G + EV+EG+        +N   +                    ++NL
Sbjct: 11  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYYIYEL 228
              P++VKL+ I+ ++ +     ++ Y         N    KVL  TL  Y +     ++
Sbjct: 71  -DHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSL-----QI 122
Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK-- 286
            KA+ Y  S   +HRD+   N+++      ++L D+GL+ +      Y   V     K  
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 287 GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFY 322
            PE  ++ + +  + D+W    CM+  + F K+PFF+
Sbjct: 182 SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 77/200 (38%), Gaps = 19/200 (9%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           +VGRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------CAGLSSPRIVPLYGA 118
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y H++ I+H DV
Sbjct: 119 VRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL-----LVDLQDYDYS 300
           K  NV++  +  +  L D+G A    P       +   Y  G E      +V  +  D  
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 301 LDMWSLGCMFAGMIFRKEPF 320
           +D+WS  CM   M+    P+
Sbjct: 237 VDIWSSCCMMLHMLNGCHPW 256

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 70/133 (52%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           +++K      DQ  K+  L+ EYV     +   P  ++    +  +  ++ + + Y H+Q
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR++   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 137 HYIHRNLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 195
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 196 KFY-YASDVWSFG 207

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYF 285
           ++ K +DY HS+ ++HRD+KP N+ +  + +++++ D+GL     + GK    +   RY 
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 202
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMI------FRKEPFF 321
             PE  +  QDY   +D+++LG + A ++      F    FF
Sbjct: 203 -SPE-QISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 242

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIIIS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 28/166 (16%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY----------YIYELLK 230
           N+V ++D+  D+      L+ EY+         PTL++Y   +          +  ++L 
Sbjct: 72  NIVSMIDV--DEEDDCYYLVMEYIEG-------PTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGP 288
            + + H   I+HRD+KP N++ID   + L++ D+G+A+        + N  + +  +  P
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
           E     +  D   D++S+G +   M+  + PF     N +  V IA
Sbjct: 182 E-QAKGEATDECTDIYSIGIVLYEMLVGEPPF-----NGETAVSIA 221

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/279 (20%), Positives = 123/279 (44%), Gaps = 36/279 (12%)
Query: 125 DDYEVVRKVGRGKYSEVF-----EGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           DD+++ R +G+GK+  V+     +   +   +                     +Q+    
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-------YIYELLKAL 232
           PN++++ +   D+  K   L+ E+    +   LY  L  +  R+       ++ EL  AL
Sbjct: 75  PNILRMYNYFHDR--KRIYLMLEFAPRGE---LYKELQKHG-RFDEQRSATFMEELADAL 128
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            YCH + ++HRD+KP N+++ ++  +L++ D+G +  + P         +  +  PE ++
Sbjct: 129 HYCHERKVIHRDIKPENLLMGYK-GELKIADFGWS-VHAPSLRRRXMCGTLDYLPPE-MI 185
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLVKIAKVL------GTDELNA 344
           + + +D  +D+W  G +    +    PF      + H ++V +          G+ +L +
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS 245
Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSP 383
            L +YH    PQ   L G     PW   + A+++ ++ P
Sbjct: 246 KLLRYH---PPQRLPLKGVMEH-PW---VKANSRRVLPP 277

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWTLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 80/207 (38%), Gaps = 24/207 (11%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           ++GRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMA------CAGLTSPRIVPLYGA 134
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y HS+ I+H DV
Sbjct: 135 VRE--GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDV 192
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDY 299
           K  NV++  +     L D+G A    P       +   Y  G      PE+++  +  D 
Sbjct: 193 KADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG-RSCDA 251
Query: 300 SLDMWSLGCMFAGMIFRKEP---FFYG 323
            +D+WS  CM   M+    P   FF G
Sbjct: 252 KVDVWSSCCMMLHMLNGCHPWTQFFRG 278

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 130 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWTLCGT 187
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 188 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 225

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYQMAAGYPPFF 239

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 86/195 (44%), Gaps = 44/195 (22%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL++ HS+  ++HRDVKP NV+I + L ++++ D+G++ +       ++    + + 
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLI-NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYM 176
Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            PE +   ++ + Y    D+WSLG     +   + P+        QL ++ +        
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE-------- 228
Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                   E  PQL          P  KF         S E +DF  + L+ + ++R T 
Sbjct: 229 --------EPSPQL----------PADKF---------SAEFVDFTSQCLKKNSKERPTY 261
Query: 404 REAMVISSISPIFSL 418
            E M      P F+L
Sbjct: 262 PELMQ----HPFFTL 272

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           ++VK      DQ  K+  L+ EYV     +   P   +    +  +  ++ + + Y H+Q
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQ 131
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR +   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 132 HYIHRALAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 191 KFY-YASDVWSFG 202

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           ++VK      DQ  K+  L+ EYV     +   P   +    +  +  ++ + + Y H+Q
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HR +   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 131 HYIHRALAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 190 KFY-YASDVWSFG 201

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++  +G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 222
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 223 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIKVADFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID E   +++ D+G A+    G+ + +   
Sbjct: 131 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLID-EQGYIQVTDFGFAKRVK-GRTWXLCGT 188
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 189 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 226

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 137 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 194
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 195 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 137 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 194
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 195 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 232

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 145 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 202
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 203 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 240

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 222
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 223 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 139 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 196
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 197 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 234

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 56/100 (56%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G  + +   
Sbjct: 165 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GATWTLCGT 222
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 223 PEYL-APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 260

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/137 (23%), Positives = 67/137 (48%), Gaps = 7/137 (5%)
Query: 199 LIFEYVNSTDFKVLYPT---LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
           LI +Y+N  +           T+++++ Y+ E++ AL++ H  GI++RD+K  N+++D  
Sbjct: 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195
Query: 256 LRKLRLIDWGLAEFY---HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAG 312
              + L D+GL++ +      + Y+      Y     +      +D ++D WSLG +   
Sbjct: 196 -GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
Query: 313 MIFRKEPFFYGHDNHDQ 329
           ++    PF    + + Q
Sbjct: 255 LLTGASPFTVDGEKNSQ 271

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 77/200 (38%), Gaps = 19/200 (9%)
Query: 132 KVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVKLLDI 188
           ++GRG + EV    +  T  +C                       C G   P +V L   
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------CAGLSSPRIVPLYGA 132
Query: 189 VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDV 245
           VR+      ++  E +       L      L +    YY+ + L+ L+Y H++ I+H DV
Sbjct: 133 VRE--GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 190
Query: 246 KPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL-----LVDLQDYDYS 300
           K  NV++  +  +  L D+G A    P       +   Y  G E      +V  +  D  
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 250
Query: 301 LDMWSLGCMFAGMIFRKEPF 320
           +D+WS  CM   M+    P+
Sbjct: 251 VDIWSSCCMMLHMLNGCHPW 270

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +  +NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + YC
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++  +G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 36/211 (17%)
Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+                      + C  P++V
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC--PHIV 74
Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI----YELLK----ALDYC 235
           +++D+  + ++    L+   +   D   L+  + D   + +      E++K    A+ Y 
Sbjct: 75  RIVDVYENLYAGRKCLLI-VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 236 HSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++   +     L+L D+G A      KE                  
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA------KE----------------TT 171
Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
            + YD S DMWSLG +   ++    PF+  H
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 202

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 69/133 (51%), Gaps = 8/133 (6%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           +++K      D  + +  L+ EYV     +   P  ++    +  +  ++ + + Y H+Q
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRV---ASRYFKGPELLVDL 294
             +HRD+   NV++D++ R +++ D+GLA+    G E Y VR    +  ++  PE L + 
Sbjct: 154 HYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEY 212
Query: 295 QDYDYSLDMWSLG 307
           + Y Y+ D+WS G
Sbjct: 213 KFY-YASDVWSFG 224

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/207 (20%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLC-GGPN 181
           D D YE+V+ +G G +       +   NE                     + +     PN
Sbjct: 17  DSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPN 76
Query: 182 VVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALDYC 235
           +V+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + Y 
Sbjct: 77  IVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYA 131
Query: 236 HSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  
Sbjct: 132 HAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLK- 190
Query: 295 QDYDYSL-DMWSLGCMFAGMIFRKEPF 320
           ++YD  + D+WS G     M+    PF
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/279 (21%), Positives = 125/279 (44%), Gaps = 28/279 (10%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTN-----ERCXXXXXXXXXXXXXXXXXXXLQNLCGG 179
           DD+E+ R +G+GK+  V+      ++     +                     +Q     
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPTLTDYDIRY--YIYELLKALDYCH 236
           PN+++L +   D+  +   LI EY    + +K L  + T  + R    + EL  AL YCH
Sbjct: 83  PNILRLYNYFYDR--RRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCH 140
Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
            + ++HRD+KP N+++     +L++ D+G +  + P         +  +  PE +++ + 
Sbjct: 141 GKKVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPE-MIEGRM 197
Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKI-----AKV-LGTDELNAYLNK 348
           ++  +D+W +G +   ++    PF     N  + ++VK+     A V  G  +L + L  
Sbjct: 198 HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKL-- 255
Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAID 387
             L  +P     + + S  PW   + A+++ ++ P A+ 
Sbjct: 256 --LRHNPSERLPLAQVSAHPW---VRANSRRVLPPSALQ 289

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 64/132 (48%), Gaps = 18/132 (13%)
Query: 199 LIFEYVNSTDFKVLYPTLTDY---DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L + H +GI++RD+K  NVM+D E
Sbjct: 97  FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSE 156
Query: 256 LRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKG------PELLVDLQDYDYSLDMWSLGC 308
              +++ D+G+       KE+ +  V +R F G      PE++   Q Y  S+D W+ G 
Sbjct: 157 -GHIKIADFGMC------KEHMMDGVTTREFCGTPDYIAPEIIA-YQPYGKSVDWWAYGV 208
Query: 309 MFAGMIFRKEPF 320
           +   M+  + PF
Sbjct: 209 LLYEMLAGQPPF 220

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 67/140 (47%), Gaps = 11/140 (7%)
Query: 180 PNVVKLLDIVR--DQHSKTPS-LIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYC 235
           P++V++ + V   D+H      ++ EYV     K      L   +   Y+ E+L AL Y 
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYL 198
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS G+++ D+KP N+M+  E  +L+LID G     +    +     +  F+ PE++    
Sbjct: 199 HSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRIN---SFGYLYGTPGFQAPEIV--RT 251
Query: 296 DYDYSLDMWSLGCMFAGMIF 315
               + D++++G   A +  
Sbjct: 252 GPTVATDIYTVGRTLAALTL 271

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYF 285
           ++ K +DY HS+ +++RD+KP N+ +  + +++++ D+GL     + GK    +   RY 
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYM 188
Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMI------FRKEPFF 321
             PE  +  QDY   +D+++LG + A ++      F    FF
Sbjct: 189 -SPE-QISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFF 228

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/108 (26%), Positives = 56/108 (51%), Gaps = 20/108 (18%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+          RV 
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAK----------RVK 192
Query: 282 SRYFK--------GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            R +          PE+++  + Y+ ++D W+LG +   M     PFF
Sbjct: 193 GRTWXLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 56/100 (56%), Gaps = 4/100 (4%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           R+Y  +++   +Y HS  +++RD+KP N++ID +   +++ D+G A+    G+ + +   
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK-GRTWXLCGT 201
Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
             Y   P +++  + Y+ ++D W+LG +   M     PFF
Sbjct: 202 PEYL-APAIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 80/182 (43%), Gaps = 40/182 (21%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL++ HS+  ++HRDVKP NV+I+  L +++  D+G++ +       ++    + + 
Sbjct: 145 IVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKXCDFGISGYLVDDVAKDIDAGCKPYX 203
Query: 287 GPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            PE +   ++ + Y    D+WSLG     +   + P+        QL ++ +        
Sbjct: 204 APERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVE-------- 255
Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                   E  PQL          P  KF         S E +DF  + L+ + ++R T 
Sbjct: 256 --------EPSPQL----------PADKF---------SAEFVDFTSQCLKKNSKERPTY 288
Query: 404 RE 405
            E
Sbjct: 289 PE 290

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 15/118 (12%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG---LAEFYHP 272
           LT+  I + +  + + L+  H++G  HRD+KP N+++  E + + L+D G    A  +  
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVE 189
Query: 273 G-------KEYNVRVASRYFKGPELLVDLQDY---DYSLDMWSLGCMFAGMIFRKEPF 320
           G       +++  +  +  ++ PEL   +Q +   D   D+WSLGC+   M+F + P+
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPELF-SVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 59/126 (46%), Gaps = 6/126 (4%)
Query: 199 LIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L +  S+GI++RD+K  NVM+D E
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 478
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+G+  E    G        +  +  PE++   Q Y  S+D W+ G +   M+
Sbjct: 479 GH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEML 536
Query: 315 FRKEPF 320
             + PF
Sbjct: 537 AGQAPF 542

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/237 (19%), Positives = 99/237 (41%), Gaps = 26/237 (10%)
Query: 112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXX 171
           WD ++  +    ++  ++V+++G G++ EV+ G   N+ +                    
Sbjct: 3   WDKDAWEIP---RESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEA 59
Query: 172 XLQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DF-------KVLYPTLTDYDI 221
            L        +V+L  +V     +   +I EY+      DF       KVL P L D+  
Sbjct: 60  NLMKTLQHDKLVRLYAVV--TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 117
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
                ++ + + Y   +  +HRD++  NV++   L   ++ D+GLA       EY  R  
Sbjct: 118 -----QIAEGMAYIERKNYIHRDLRAANVLVSESLM-CKIADFGLARVIE-DNEYTAREG 170
Query: 282 SRY---FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +++   +  PE  ++   +    D+WS G +   ++   +  + G  N D +  +++
Sbjct: 171 AKFPIKWTAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQ 226

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 59/126 (46%), Gaps = 6/126 (4%)
Query: 199 LIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 255
            + EYVN  D       +  +      +Y  E+   L +  S+GI++RD+K  NVM+D E
Sbjct: 98  FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE 157
Query: 256 LRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI 314
              +++ D+G+  E    G        +  +  PE++   Q Y  S+D W+ G +   M+
Sbjct: 158 -GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEML 215
Query: 315 FRKEPF 320
             + PF
Sbjct: 216 AGQAPF 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 21/147 (14%)
Query: 180 PNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALD 233
           PNV++     +D+  +        + + EYV   DF  L       +    + +    L 
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHL-----GLEPITLLQQTTSGLA 132
Query: 234 YCHSQGIMHRDVKPHNVMID----HELRKLRLIDWGLAEFYHPGKEYNVRVA----SRYF 285
           + HS  I+HRD+KPHN++I     H   K  + D+GL +    G+    R +    +  +
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 286 KGPELLVD--LQDYDYSLDMWSLGCMF 310
             PE+L +   ++  Y++D++S GC+F
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVF 219

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 65/136 (47%), Gaps = 12/136 (8%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-----YDIRYYIYELLKALDYC 235
           N+VK   I  +       LI E++ S   K   P   +       ++Y + ++ K +DY 
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-QICKGMDYL 142
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELL 291
            S+  +HRD+   NV+++ E  ++++ D+GL +     KE       R +  ++  PE L
Sbjct: 143 GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 292 VDLQDYDYSLDMWSLG 307
           +  + Y  S D+WS G
Sbjct: 202 MQSKFYIAS-DVWSFG 216

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 76/145 (52%), Gaps = 13/145 (8%)
Query: 212 LYPTLTDYDIRYYI---YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 268
           L+ + T ++++  I    +  + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA 
Sbjct: 98  LHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDFGLAT 156
Query: 269 F---YHPGKEYNVRVASRYFKGPEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
               +    ++     S  +  PE+  + D   Y +  D+++ G +   ++  + P +  
Sbjct: 157 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-YSN 215
Query: 324 HDNHDQLVKIAKVLGTDELNAYLNK 348
            +N DQ++++   +G   L+  L+K
Sbjct: 216 INNRDQIIEM---VGRGSLSPDLSK 237

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 65/136 (47%), Gaps = 12/136 (8%)
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTD-----YDIRYYIYELLKALDYC 235
           N+VK   I  +       LI E++ S   K   P   +       ++Y + ++ K +DY 
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV-QICKGMDYL 130
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELL 291
            S+  +HRD+   NV+++ E  ++++ D+GL +     KE       R +  ++  PE L
Sbjct: 131 GSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 292 VDLQDYDYSLDMWSLG 307
           +  + Y  S D+WS G
Sbjct: 190 MQSKFYIAS-DVWSFG 204

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/152 (22%), Positives = 79/152 (51%), Gaps = 13/152 (8%)
Query: 205 NSTDFKVLYPTLTDYDIRYYI---YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
            S+ +  L+ + T ++++  I    +  + +DY H++ I+HRD+K +N+ + HE   +++
Sbjct: 103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKI 161
Query: 262 IDWGLA---EFYHPGKEYNVRVASRYFKGPEL--LVDLQDYDYSLDMWSLGCMFAGMIFR 316
            D+GLA     +    ++     S  +  PE+  + D   Y +  D+++ G +   ++  
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221
Query: 317 KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           + P +   +N DQ++++   +G   L+  L+K
Sbjct: 222 QLP-YSNINNRDQIIEM---VGRGSLSPDLSK 249

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++KAL Y   + G++HRDVKP N+++D E  +++L D+G++      K  +       + 
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191
Query: 287 GPELL----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
            PE +        DYD   D+WSLG     +   + P+     + + L K+
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 76/145 (52%), Gaps = 13/145 (8%)
Query: 212 LYPTLTDYDIRYYI---YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA- 267
           L+ + T ++++  I    +  + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA 
Sbjct: 110 LHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNTVKIGDFGLAT 168
Query: 268 --EFYHPGKEYNVRVASRYFKGPEL--LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
               +    ++     S  +  PE+  + D   Y +  D+++ G +   ++  + P +  
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP-YSN 227
Query: 324 HDNHDQLVKIAKVLGTDELNAYLNK 348
            +N DQ++++   +G   L+  L+K
Sbjct: 228 INNRDQIIEM---VGRGSLSPDLSK 249

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYN-VR 279
           R+Y+ E++ A+D  H  G +HRD+KP N+++D     +RL D+G   +    G   + V 
Sbjct: 165 RFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR-CGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 280 VASRYFKGPELLVDLQDYDY------SLDMWSLGCMFAGMIFRKEPFF 321
           V +  +  PE+L  +             D W+LG     M + + PF+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/223 (18%), Positives = 93/223 (41%), Gaps = 19/223 (8%)
Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCXXXXXXXXXXXXXXXXXXXLQNLCGGPNVV 183
           ++  ++V+K+G G++ EV+ G   N+ +                     L        +V
Sbjct: 11  RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 70
Query: 184 KLLDIVRDQHS-------KTPSLIFEYVNSTDF-KVLYPTLTDYDIRYYIYELLKALDYC 235
           +L  +V  +              + +++ S +  KVL P L D+       ++ + + Y 
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEGMAYI 125
Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLV 292
             +  +HRD++  NV++   L   ++ D+GLA       EY  R  +++   +  PE  +
Sbjct: 126 ERKNYIHRDLRAANVLVSESLM-CKIADFGLARVIE-DNEYTAREGAKFPIKWTAPE-AI 182
Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +   +    ++WS G +   ++   +  + G  N D +  +++
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQ 225

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
           +L +  +  Y+ + L AL + HSQG++H DVKP N+ +    R  +L D+GL        
Sbjct: 153 SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAG 211
Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
              V+     +  PELL     Y  + D++SLG
Sbjct: 212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLG 242

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 67/152 (44%), Gaps = 8/152 (5%)
Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNE----RCXXXXXXXXXXXXXXXXXXXLQNLCGGP 180
           + + + RK+G G + E++ G N+ TNE    +                    LQ   G P
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
           NV +   +  D +     L+   +    F      L+   +     +++  +++ HS+  
Sbjct: 67  NV-RWFGVEGDYNVLVMDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
Query: 241 MHRDVKPHNVMIDHELR--KLRLIDWGLAEFY 270
           +HRD+KP N ++    R  ++ +ID+GLA+ Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 71/134 (52%), Gaps = 18/134 (13%)
Query: 212 LYPTLTDYDIRYYIYELL-------KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
           LY  L   + ++ +++L+       + +DY H++ I+HRD+K +N+ + HE   +++ D+
Sbjct: 118 LYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL-HEGLTVKIGDF 176
Query: 265 GLAEF---YHPGKEYNVRVASRYFKGPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKE 318
           GLA     +   ++      S  +  PE ++ +QD   + +  D++S G +   ++  + 
Sbjct: 177 GLATVKSRWSGSQQVEQPTGSVLWMAPE-VIRMQDNNPFSFQSDVYSYGIVLYELMTGEL 235
Query: 319 PFFYGH-DNHDQLV 331
           P  Y H +N DQ++
Sbjct: 236 P--YSHINNRDQII 247

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 52/101 (51%), Gaps = 3/101 (2%)
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVAS 282
           +  ++  AL + H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + +
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGT 188
Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG 323
            Y+  PE+  + + Y+   D+W+LGC+   +   K  F  G
Sbjct: 189 PYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAG 228

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/111 (27%), Positives = 52/111 (46%), Gaps = 5/111 (4%)
Query: 229 LKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           +KAL++      I+HRD+KP N+++D     ++L D+G++               R +  
Sbjct: 135 VKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 193
Query: 288 PELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           PE +      Q YD   D+WSLG     +   + P+   +   DQL ++ K
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 110 PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 165
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 166 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 225 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 91  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 146
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 147 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 206 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +R+ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMRIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 83  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 138
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 139 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 198 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PNV+ LL I   +   +P ++  Y+   D +         PT+ D  +  +  ++ K + 
Sbjct: 109 PNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 165
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 287
           Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 166 YLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 224
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
             L    Q +    D+WS G +   ++ R  P
Sbjct: 225 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 97/233 (41%), Gaps = 28/233 (12%)
Query: 122 GDQDDYEVVRK-------VGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXL 173
           G   DYE+ R+       +G G++ +V +GI ++  N                      L
Sbjct: 3   GSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL 62
Query: 174 QNLCG-----GPNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRY 223
           Q          P++VKL+ ++    ++ P  +I E     + +        +L    +  
Sbjct: 63  QEALTMRQFDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 118
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 119 YAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKL 177
Query: 284 YFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             K   PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 178 PIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 228

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PNV+ LL I   +   +P ++  Y+   D +         PT+ D  +  +  ++ K + 
Sbjct: 88  PNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 144
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 287
           Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 145 YLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 203
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
             L    Q +    D+WS G +   ++ R  P
Sbjct: 204 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PNV+ LL I   +   +P ++  Y+   D +         PT+ D  +  +  ++ K + 
Sbjct: 90  PNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 146
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 287
           Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 147 YLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 205
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
             L    Q +    D+WS G +   ++ R  P
Sbjct: 206 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 31/160 (19%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRY-------YIYELLKAL 232
           PNV+K + ++     K  + I EY+     + +  ++   D +Y       +  ++   +
Sbjct: 67  PNVLKFIGVL--YKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGM 121
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-----EFYHP-----------GKEY 276
            Y HS  I+HRD+  HN ++  E + + + D+GLA     E   P            K Y
Sbjct: 122 AYLHSMNIIHRDLNSHNCLV-RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 316
            V V + Y+  PE +++ + YD  +D++S G +   +I R
Sbjct: 181 TV-VGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PNV+ LL I   +   +P ++  Y+   D +         PT+ D  +  +  ++ K + 
Sbjct: 86  PNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 142
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 287
           Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
             L    Q +    D+WS G +   ++ R  P
Sbjct: 202 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 18/152 (11%)
Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           PNV+ LL I   +   +P ++  Y+   D +         PT+ D  +  +  ++ K + 
Sbjct: 89  PNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMK 145
Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKG 287
           Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++   
Sbjct: 146 YLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMAL 204
Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
             L    Q +    D+WS G +   ++ R  P
Sbjct: 205 ESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 91  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 146
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++  
Sbjct: 147 KYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 206 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDY 258
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 259 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 295

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L F +  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 126 QARRPPGLEFSFNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 252 IDHELRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 183 VTED-NVMKIADFGLARDIHHIDXXKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 239
Query: 308 CMF 310
            + 
Sbjct: 240 VLL 242

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLV-TENNVMKIADFGLARDINNIDY 199
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 200 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 236

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 204
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 205 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 201
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 202 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 238

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y   K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--KTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 144 YAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKL 202
Query: 284 YFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             K   PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 203 PIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 253

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLCG--- 178
            ++  E+ R +G G++ +V +GI ++  N                      LQ       
Sbjct: 13  QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 72
Query: 179 --GPNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKA 231
              P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  A
Sbjct: 73  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 289
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 187
Query: 290 LLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 188 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 230

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 12/115 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--------KLRLIDWGLA 267
           + +  I Y +  +LKALDY H  G +HR VK  +++I  + +         L +I  G  
Sbjct: 109 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 168
Query: 268 E-FYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   H   +Y+V+V    +  PE+L  +LQ YD   D++S+G     +     PF
Sbjct: 169 QRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 221

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLCG--- 178
            ++  E+ R +G G++ +V +GI ++  N                      LQ       
Sbjct: 8   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 67
Query: 179 --GPNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKA 231
              P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  A
Sbjct: 68  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 289
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182
Query: 290 LLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 183 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 119 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 175
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 176 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 232
Query: 308 CMF 310
            + 
Sbjct: 233 VLL 235

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLCG--- 178
            ++  E+ R +G G++ +V +GI ++  N                      LQ       
Sbjct: 8   QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ 67
Query: 179 --GPNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKA 231
              P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  A
Sbjct: 68  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 289
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182
Query: 290 LLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 183 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 12/115 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--------KLRLIDWGLA 267
           + +  I Y +  +LKALDY H  G +HR VK  +++I  + +         L +I  G  
Sbjct: 125 MNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 268 E-FYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
           +   H   +Y+V+V    +  PE+L  +LQ YD   D++S+G     +     PF
Sbjct: 185 QRVVHDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 118 YAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKL 176
Query: 284 YFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             K   PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 177 PIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 227

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 284 YFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             K   PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 555 PIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 179 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 224

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 118 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 174
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 175 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 231
Query: 308 CMF 310
            + 
Sbjct: 232 VLL 234

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 117 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 175
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 176 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 221

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 126 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 183 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 239
Query: 308 CMF 310
            + 
Sbjct: 240 VLL 242

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 8/102 (7%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 132 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 189
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDN 326
            PE    LQ   YS+  D+WS+G     M   + P   G  +
Sbjct: 190 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGS 228

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 115 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 171
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 172 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 228
Query: 308 CMF 310
            + 
Sbjct: 229 VLL 231

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 120 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 179 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 224

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 284 YFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             K   PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 172 PIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 222

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH---- 271
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA   +    
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDX 212
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 XKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 142 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 200
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 201 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 246

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/225 (21%), Positives = 95/225 (42%), Gaps = 21/225 (9%)
Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNERCXXXXXXXXXXXXXXXXXXXLQNLCG--- 178
            ++  E+ R +G G++ +V +GI ++  N                      LQ       
Sbjct: 8   QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQ 67
Query: 179 --GPNVVKLLDIVRDQHSKTPS-LIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKA 231
              P++VKL+ ++    ++ P  +I E     + +        +L    +  Y Y+L  A
Sbjct: 68  FDHPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--GPE 289
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y         K   PE
Sbjct: 124 LAYLESKRFVHRDIAARNVLVS-ATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 182
Query: 290 LLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 183 -SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 225

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---YHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 143 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 201
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 202 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 247

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 167 QARRPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 224 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 280
Query: 308 CMF 310
            + 
Sbjct: 281 VLL 283

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVS-ATDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 284 YFK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             K   PE  ++ + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 555 PIKWMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH---- 271
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA   +    
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDX 212
Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 XKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 10/123 (8%)
Query: 192 QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM 251
           Q  + P L + Y  S + +     L+  D+    Y++ + ++Y  S+  +HRD+   NV+
Sbjct: 126 QAREPPGLEYSYNPSHNPE---EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 182
Query: 252 IDHELRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG 307
           +  +   +++ D+GLA   H      K  N R+  ++   PE L D + Y +  D+WS G
Sbjct: 183 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFG 239
Query: 308 CMF 310
            + 
Sbjct: 240 VLL 242

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 12/94 (12%)
Query: 234 YCHSQG----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFK 286
           +C  +G    I HRD K  NV++  +L  + L D+GLA  + PGK   + + +V +R + 
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAV-LADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 287 GPELL---VDLQ-DYDYSLDMWSLGCMFAGMIFR 316
            PE+L   ++ Q D    +DM+++G +   ++ R
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELVSR 226

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 173
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 219

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/209 (21%), Positives = 85/209 (40%), Gaps = 28/209 (13%)
Query: 131 RKVGRGKYSEVFEGINVNTNE---RCXXXXXXXXXXXXXXXXXXXLQNLCGG---PNVVK 184
           R +G+G +  V+ G  ++  +   +C                      L  G   PNV+ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQ 238
           L+ I+       P ++  Y+   D           PT+ D  +  +  ++ + ++Y   Q
Sbjct: 87  LIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKD--LISFGLQVARGMEYLAEQ 143
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELLV 292
             +HRD+   N M+D     +++ D+GLA      E+Y   +  + R+  ++      L 
Sbjct: 144 KFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTA----LE 198
Query: 293 DLQDYDYSL--DMWSLGCMFAGMIFRKEP 319
            LQ Y ++   D+WS G +   ++ R  P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 135 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 193
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 194 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 239

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 272
           L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +   +++ D+GLA   H    
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 190
Query: 273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 191 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 227

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/108 (25%), Positives = 59/108 (54%), Gaps = 9/108 (8%)
Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA---EFYHPGKEYNVRVASRYFK 286
           + +DY H++ I+HRD+K +N+ + HE   +++ D+GLA     +    ++     S  + 
Sbjct: 143 QGMDYLHAKSIIHRDLKSNNIFL-HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 201
Query: 287 GPELLVDLQD---YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            PE ++ +QD   Y +  D+++ G +   ++  + P +   +N DQ++
Sbjct: 202 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQII 247

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 80/212 (37%), Gaps = 29/212 (13%)
Query: 132 KVGRGKYSEVFEGINVNTNERCX--XXXXXXXXXXXXXXXXXXLQNLCG--GPNVVKLLD 187
           ++GRG +  V++G++  T                          + L G   PN+V+  D
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 188 IVRD--QHSKTPSLIFEYVNSTDFKVLYPTLTDYDI---RYYIYELLKALDYCHSQG--I 240
                 +  K   L+ E   S   K          I   R +  ++LK L + H++   I
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 300
           +HRD+K  N+ I      +++ D GLA          V + +  F  PE   +   YD S
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFXAPEXYEE--KYDES 209
Query: 301 LDMWSLG---------------CMFAGMIFRK 317
           +D+++ G               C  A  I+R+
Sbjct: 210 VDVYAFGXCXLEXATSEYPYSECQNAAQIYRR 241

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP--- 272
           L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +   +++ D+GLA   H    
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDY 205
Query: 273 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
             K  N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 206 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 242

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 4/94 (4%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 175 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLI-DSMANSFVGTRSYM 232
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
            PE L     Y    D+WS+G     M   + P 
Sbjct: 233 SPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 15/134 (11%)
Query: 185 LLDIVRDQHSKTPSLIFEYVNST------DFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           LL+ +R +  K      EY N        D  VL    T  D+  + Y++ K +++   +
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL----TFEDLLCFAYQVAKGMEFLEFK 191
Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVDLQ 295
             +HRD+   NV++ H  + +++ D+GLA        Y VR  +R    +  PE L +  
Sbjct: 192 SCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-G 249
Query: 296 DYDYSLDMWSLGCM 309
            Y    D+WS G +
Sbjct: 250 IYTIKSDVWSYGIL 263

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 11/101 (10%)
Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EF 269
           +T  D+    Y+L + ++Y  SQ  +HRD+   NV++  E   +++ D+GLA      ++
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDINNIDY 212
Query: 270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 310
           Y      N R+  ++   PE L D + Y +  D+WS G + 
Sbjct: 213 YK--NTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLM 249

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 150 PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 205
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 265 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM-ANSFVGTRSYM 197
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 198 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 91  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 146
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 147 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 206 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 92  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 147
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 148 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 207 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 180 PNVVKLLDI-VRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
           PNV+ LL I +R + S  P ++  Y+   D +         PT+ D  +  +  ++ K +
Sbjct: 91  PNVLSLLGICLRSEGS--PLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGM 146
Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRYFK 286
            +  S+  +HRD+   N M+D +   +++ D+GLA      EF     +   ++  ++  
Sbjct: 147 KFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP 319
              L    Q +    D+WS G +   ++ R  P
Sbjct: 206 LESL--QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 228 LLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++K L Y   +  IMHRDVKP N++++    +++L D+G++         N  V +R + 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYM 170
Query: 287 GPELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPF 320
            PE    LQ   YS+  D+WS+G     M   + P 
Sbjct: 171 SPE---RLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	419
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	0.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-70
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-68
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-67
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-64
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-61
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-60
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-59
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-58
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-58
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-58
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-58
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-57
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-57
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-57
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-57
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-57
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-56
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-56
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-56
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-56
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	9e-56
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-55
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-55
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-55
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-55
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-54
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-52
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-49
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-48
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-47
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-45
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-44
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-44
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-44
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-43
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-43
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-43
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-43
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-43
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-43
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-43
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-43
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-43
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-43
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-42
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-42
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-42
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-42
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-42
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-42
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-41
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-41
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-41
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-41
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-41
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-41
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-41
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-40
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-40
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-40
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-40
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-40
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-39
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-39
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-39
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-39
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-39
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-38
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-38
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-38
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-38
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-37
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-37
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-37
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-36
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-36
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-36
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-36
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-33
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-32
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-31
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-31
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-29
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-29
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-28
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-26
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-26
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-26
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-26
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-25
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	4e-17
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-16
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-16
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-15
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-15
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-15
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-15
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-14
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-13
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-13
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-12
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-12
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-12
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-11
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-11
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-11
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-10
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-10
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-06
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-09
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-09
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-09
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-09
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-08
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-08
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-08
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-08
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-07
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-07
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-07
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-07
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-07
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-07
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-07
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-07
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-07
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-06
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-06
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-06
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-06
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-06
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-06
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-06
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-06
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-05
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-05
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-05
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-05
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-05
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	2e-05
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-05
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-05
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-05
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-05
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-05
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-05
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-05
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-05
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-04
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-04
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-04
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	5e-04
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-04
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-04
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-04

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  548 bits (1415), Expect = 0.0
 Identities = 243/316 (76%), Positives = 286/316 (90%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 3   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 62

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 63  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 122

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302

Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 303 LLRYDHQSRLTAREAM 318

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  226 bits (578), Expect = 4e-70
 Identities = 92/294 (31%), Positives = 143/294 (48%), Gaps = 27/294 (9%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           Y   + +G G +  V++    ++ E   IK +   K+ K  RE++I++ L    N+V+L 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-RELQIMRKL-DHCNIVRLR 113

Query: 187 DIVRDQHSKTPS----LIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCH 236
                   K       L+ +YV  T ++V         TL    ++ Y+Y+L ++L Y H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           S GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL+    D
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 233

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYHLEL 353
           Y  S+D+WS GC+ A ++  + P F G    DQLV+I KVLGT   +++      Y    
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            PQ+          PW+K           PEAI    +LL Y    RLT  EA 
Sbjct: 293 FPQI-------KAHPWTKVFRPR----TPPEAIALCSRLLEYTPTARLTPLEAC 335

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  221 bits (566), Expect = 1e-68
 Identities = 97/297 (32%), Positives = 151/297 (50%), Gaps = 28/297 (9%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
           +  Y   + +G G +  VF+   V ++E  I K+L+   K+   RE++I++ +   PNVV
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIV-KHPNVV 95

Query: 184 KLLDIVRDQHSKTPS----LIFEYVNSTDFKVL--YP----TLTDYDIRYYIYELLKALD 233
            L         K       L+ EYV  T ++    Y     T+    I+ Y+Y+LL++L 
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           Y HS GI HRD+KP N+++D     L+LID+G A+    G+     + SRY++ PEL+  
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG 215

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYH 350
             +Y  ++D+WS GC+ A ++  + P F G    DQLV+I KVLGT   +++      Y 
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
               PQ+          P+SK           P+AID + +LL Y    RLTA EA+
Sbjct: 275 EHKFPQI-------RPHPFSKVFRPR----TPPDAIDLISRLLEYTPSARLTAIEAL 320

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  216 bits (553), Expect = 3e-67
 Identities = 80/301 (26%), Positives = 139/301 (46%), Gaps = 28/301 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK--ILKPVKKKKIKREIKILQNLCGGPNV 182
           D ++V R  G+G +  V  G   +T     IK  I  P  + +  + ++ L  L   PN+
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNI 81

Query: 183 VKLLDIVRDQHSKTPS-----LIFEYVNSTDFKVL--YP----TLTDYDIRYYIYELLKA 231
           V+L         +        ++ EYV  T  +    Y           I+ ++++L+++
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS 141

Query: 232 LDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +   H  S  + HRD+KPHNV+++     L+L D+G A+   P +     + SRY++ PE
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPE 201

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYL 346
           L+   Q Y  ++D+WS+GC+FA M+  + P F G ++  QL +I +VLG    + L    
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             +                  PWS   +  +    + EA D L  LL+Y  ++R+   EA
Sbjct: 261 PSHTDVDLYNS-------KGIPWSNVFSDHSLKD-AKEAYDLLSALLQYLPEERMKPYEA 312

Query: 407 M 407
           +
Sbjct: 313 L 313

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  209 bits (535), Expect = 3e-64
 Identities = 89/327 (27%), Positives = 149/327 (45%), Gaps = 61/327 (18%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLL 186
           Y + + +G G +  V E  ++ + +R  +K +    + K  RE+ I++ L    N++KL+
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDH-VNIIKLV 66

Query: 187 DIVRDQHSKTPS------------------------------------LIFEYVNSTDFK 210
           D       + P                                     +I EYV  T  K
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 211 VLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW 264
           VL        ++    I  YIY+L +A+ + HS GI HRD+KP N++++ +   L+L D+
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186

Query: 265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
           G A+   P +     + SR+++ PEL++   +Y  S+D+WS+GC+F  +I  K P F G 
Sbjct: 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PLFSGE 245

Query: 325 DNHDQLVKIAKVLGT---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHL 380
            + DQLV+I +++GT   +++      Y     P L         K W K          
Sbjct: 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL-------KAKDWRKILPEGTP--- 295

Query: 381 VSPEAIDFLDKLLRYDHQDRLTAREAM 407
               AID L+++LRY+   R+   EAM
Sbjct: 296 --SLAIDLLEQILRYEPDLRINPYEAM 320

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  200 bits (512), Expect = 1e-61
 Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 36/300 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
           + YE + K+G G Y  VF+  N +T +   IK        K               REI+
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIR 54

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYEL 228
           +L+ L   PN+V LL++ R    +   L+FEY + T    L  Y   + ++ ++   ++ 
Sbjct: 55  MLKQLKH-PNLVNLLEVFR--RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 287
           L+A+++CH    +HRDVKP N++I      ++L D+G A     P   Y+  VA+R+++ 
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRS 170

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
           PELLV    Y   +D+W++GC+FA ++    P + G  + DQL  I K LG       L 
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGD------LI 223

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             H ++        G     P            +S  A+  L   L  D  +RLT  + +
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  198 bits (506), Expect = 2e-60
 Identities = 86/301 (28%), Positives = 139/301 (46%), Gaps = 30/301 (9%)

Query: 121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-IK----REIKILQN 175
           +   + YE +  VG G Y  V +  N +T     IK        K +K    REIK+L+ 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPT-LTDYDIRYYIYELLKAL 232
           L    N+V LL++ +    K   L+FE+V+ T    L  +P  L    ++ Y+++++  +
Sbjct: 81  LRH-ENLVNLLEVCK--KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 291
            +CHS  I+HRD+KP N+++      ++L D+G A     PG+ Y+  VA+R+++ PELL
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELN----AYL 346
           V    Y  ++D+W++GC+   M F  EP F G  + DQL  I   LG     +       
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             +     P+         R+P  +         +S   ID   K L  D   R    E 
Sbjct: 256 PVFAGVRLPE------IKEREPLERRYPK-----LSEVVIDLAKKCLHIDPDKRPFCAEL 304

Query: 407 M 407
           +
Sbjct: 305 L 305

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  193 bits (493), Expect = 6e-59
 Identities = 87/303 (28%), Positives = 147/303 (48%), Gaps = 43/303 (14%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
             YE + K+G G Y  VF+  N  T+E         V  K+++             REI 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEI--------VALKRVRLDDDDEGVPSSALREIC 53

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
           +L+ L    N+V+L D++      T  L+FE+    D K         L    ++ ++++
Sbjct: 54  LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 286
           LLK L +CHS+ ++HRD+KP N++I+    +L+L ++GLA  +  P + Y+  V + +++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYR 168

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELNAY 345
            P++L   + Y  S+DMWS GC+FA +     P F G+D  DQL +I ++LGT  E    
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE---- 224

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQ-HLVSPEAIDFLDKLLRYDHQDRLTAR 404
                 E  P +  L        +    +  N    ++    D L  LL+ +   R++A 
Sbjct: 225 ------EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278

Query: 405 EAM 407
           EA+
Sbjct: 279 EAL 281

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  192 bits (491), Expect = 2e-58
 Identities = 86/311 (27%), Positives = 150/311 (48%), Gaps = 51/311 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------RE 169
             D Y  + K+G G Y EV++ I+  TNE         V  K+I+             RE
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNET--------VAIKRIRLEHEEEGVPGTAIRE 83

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIY 226
           + +L+ L    N+++L  ++   H     LIFEY    D K      P ++   I+ ++Y
Sbjct: 84  VSLLKELQH-RNIIELKSVIHHNHRLH--LIFEYA-ENDLKKYMDKNPDVSMRVIKSFLY 139

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRK----LRLIDWGLAEFYH-PGKEYNVRVA 281
           +L+  +++CHS+  +HRD+KP N+++          L++ D+GLA  +  P +++   + 
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199

Query: 282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-D 340
           + +++ PE+L+  + Y  S+D+WS+ C++A M+  K P F G    DQL KI +VLG  D
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKIFEVLGLPD 258

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV----SPEAIDFLDKLLRYD 396
           +             P + AL       P  KF     + ++      E +D L  +L  D
Sbjct: 259 D----------TTWPGVTALPDWKQSFP--KFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306

Query: 397 HQDRLTAREAM 407
              R++A+ A+
Sbjct: 307 PVKRISAKNAL 317

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  192 bits (490), Expect = 2e-58
 Identities = 80/309 (25%), Positives = 154/309 (49%), Gaps = 47/309 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------REIKI 172
             ++ + K+G G Y+ V++G+N  T           V  K++K            REI +
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVY--------VALKEVKLDSEEGTPSTAIREISL 56

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------NSTDFKVLYPTLTDYDIRYY 224
           ++ L    N+V+L D++  ++  T  L+FE++        +S         L    ++Y+
Sbjct: 57  MKELKH-ENIVRLYDVIHTENKLT--LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
            ++LL+ L +CH   I+HRD+KP N++I+   + L+L D+GLA  +  P   ++  V + 
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVTL 172

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DEL 342
           +++ P++L+  + Y  S+D+WS GC+ A MI   +P F G ++ +QL  I  ++GT +E 
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTNDEEQLKLIFDIMGTPNES 231

Query: 343 N----AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 398
                  L KY+  +  +          +   + +    +  +    +DFL  LL+ +  
Sbjct: 232 LWPSVTKLPKYNPNIQQR--------PPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283

Query: 399 DRLTAREAM 407
            RL+A++A+
Sbjct: 284 MRLSAKQAL 292

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  193 bits (492), Expect = 3e-58
 Identities = 89/318 (27%), Positives = 160/318 (50%), Gaps = 30/318 (9%)

Query: 104 NVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVK 162
           +++R K ++  +     W     Y     VG G Y  V   I+  + E+  IK + +P +
Sbjct: 3   SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ 62

Query: 163 K----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP 214
                K+  RE+ +L+++    NV+ LLD+     S        L+  ++ +   K++  
Sbjct: 63  SEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL 121

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 274
             ++  I+Y +Y++LK L Y HS G++HRD+KP N+ ++ +  +L+++D+GLA       
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAEM 180

Query: 275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI 333
             Y   V +R+++ PE+++    Y+ ++D+WS+GC+ A M+  K   F G D  DQL +I
Sbjct: 181 TGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDYLDQLTQI 236

Query: 334 AKVLGT---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFL 389
            KV G    + +    +K        L     +  RK +++ F  A       P+A D L
Sbjct: 237 LKVTGVPGTEFVQKLNDKAAKSYIQSL----PQTPRKDFTQLFPRAS------PQAADLL 286

Query: 390 DKLLRYDHQDRLTAREAM 407
           +K+L  D   RLTA +A+
Sbjct: 287 EKMLELDVDKRLTAAQAL 304

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  190 bits (485), Expect = 1e-57
 Identities = 77/304 (25%), Positives = 139/304 (45%), Gaps = 37/304 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGPNVV 183
           Y  ++ +G G    VF  ++ + ++R  IK +    P   K   REIKI++ L    N+V
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 71

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP-------------TLTDYDIRYYIYELLK 230
           K+ +I+    S+    +          ++                L +   R ++Y+LL+
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFK 286
            L Y HS  ++HRD+KP N+ I+ E   L++ D+GLA    P   +       + +++++
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELN 343
            P LL+   +Y  ++DMW+ GC+FA M+  K   F G    +Q+  I + +     ++  
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFAGAHELEQMQLILESIPVVHEEDRQ 250

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
             L+   + +             KP ++             EA+DFL+++L +   DRLT
Sbjct: 251 ELLSVIPVYIRND-----MTEPHKPLTQLLPGIS------REAVDFLEQILTFSPMDRLT 299

Query: 403 AREA 406
           A EA
Sbjct: 300 AEEA 303

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  188 bits (480), Expect = 4e-57
 Identities = 88/306 (28%), Positives = 150/306 (49%), Gaps = 51/306 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
           + Y  + K+G G Y  V++  N N  E            KKI+             REI 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGET--------FALKKIRLEKEDEGIPSTTIREIS 52

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYE 227
           IL+ L    N+VKL D++  +      L+FE++   D K L       L     + ++ +
Sbjct: 53  ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 286
           LL  + YCH + ++HRD+KP N++I+ E  +L++ D+GLA  +  P ++Y   + + +++
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELN-- 343
            P++L+  + Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT +  N  
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 344 --AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
               L KY              +   PW  F+       +    ID L K+L+ D   R+
Sbjct: 227 NVTELPKYDPNFT--------VYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRI 273

Query: 402 TAREAM 407
           TA++A+
Sbjct: 274 TAKQAL 279

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  188 bits (481), Expect = 4e-57
 Identities = 79/315 (25%), Positives = 137/315 (43%), Gaps = 60/315 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK----------------R 168
             YE V ++G G Y  V++  + ++           V  K ++                R
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHF--------VALKSVRVPNGGGGGGGLPISTVR 60

Query: 169 EIKILQNLCGG--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVL-----YPTLTD 218
           E+ +L+ L     PNVV+L+D+     +       L+FE+V   D +        P L  
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPA 119

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
             I+  + + L+ LD+ H+  I+HRD+KP N+++      ++L D+GLA  Y        
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADFGLARIYSYQMALTP 178

Query: 279 RVASRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
            V + +++ PE+L  LQ  Y   +DMWS+GC+FA M FR++P F G+   DQL KI  ++
Sbjct: 179 VVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLI 235

Query: 338 GT-DELN----AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 392
           G   E +      L +                  +P    +       +       L ++
Sbjct: 236 GLPPEDDWPRDVSLPRGAFP----------PRGPRPVQSVVPE-----MEESGAQLLLEM 280

Query: 393 LRYDHQDRLTAREAM 407
           L ++   R++A  A+
Sbjct: 281 LTFNPHKRISAFRAL 295

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  189 bits (482), Expect = 5e-57
 Identities = 83/305 (27%), Positives = 152/305 (49%), Gaps = 48/305 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------------REIKI 172
           + Y  + K+G G Y+ V++G +  T+          V  K+I+            RE+ +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNL--------VALKEIRLEHEEGAPCTAIREVSL 53

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYEL 228
           L++L    N+V L DI+  + S T  L+FEY++  D K         +  ++++ ++++L
Sbjct: 54  LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 287
           L+ L YCH Q ++HRD+KP N++I+    +L+L D+GLA     P K Y+  V + +++ 
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELN--- 343
           P++L+   DY   +DMW +GC+F  M   + P F G    +QL  I ++LGT  E     
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPG 227

Query: 344 -AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
                ++     P+       +  +             +  +  D L KLL+++ ++R++
Sbjct: 228 ILSNEEFKTYNYPK-------YRAEALLSHAPR-----LDSDGADLLTKLLQFEGRNRIS 275

Query: 403 AREAM 407
           A +AM
Sbjct: 276 AEDAM 280

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  189 bits (483), Expect = 6e-57
 Identities = 91/297 (30%), Positives = 152/297 (51%), Gaps = 30/297 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK--------REIKILQNL 176
             YE +  +G G+++ V++  + NTN+   IK +K   + + K        REIK+LQ L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKAL 232
              PN++ LLD     H    SL+F+++  TD +V+       LT   I+ Y+   L+ L
Sbjct: 70  SH-PNIIGLLDAF--GHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 291
           +Y H   I+HRD+KP+N+++D     L+L D+GLA  F  P + Y  +V +R+++ PELL
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184

Query: 292 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DELNAYLNKYH 350
              + Y   +DMW++GC+ A ++ R  PF  G  + DQL +I + LGT  E         
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTE--------- 234

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            E  P + +L    + K +              + +D +  L  ++   R+TA +A+
Sbjct: 235 -EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  187 bits (477), Expect = 2e-56
 Identities = 95/309 (30%), Positives = 153/309 (49%), Gaps = 50/309 (16%)

Query: 122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------R 168
           G  + Y+ + KVG G Y  V++  + +            V  K+I+             R
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKD-SQGRI--------VALKRIRLDAEDEGIPSTAIR 68

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYY 224
           EI +L+ L   PN+V L+D++  +   T  L+FE++   D K +       L D  I+ Y
Sbjct: 69  EISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFM-EKDLKKVLDENKTGLQDSQIKIY 124

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASR 283
           +Y+LL+ + +CH   I+HRD+KP N++I+ +   L+L D+GLA  +  P + Y   V + 
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTL 183

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT-DEL 342
           +++ P++L+  + Y  S+D+WS+GC+FA MI  K P F G  + DQL KI  +LGT +  
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTPNPR 242

Query: 343 N----AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 398
                  L  +                +KPWS  I          E ID L  +L +D  
Sbjct: 243 EWPQVQELPLWKQRTFQV-------FEKKPWSSIIPG-----FCQEGIDLLSNMLCFDPN 290

Query: 399 DRLTAREAM 407
            R++AR+AM
Sbjct: 291 KRISARDAM 299

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  188 bits (479), Expect = 4e-56
 Identities = 84/298 (28%), Positives = 154/298 (51%), Gaps = 31/298 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
             Y  ++ VG G Y  V   ++  T  +  IK + +P +     K+  RE+++L+++   
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH- 83

Query: 180 PNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLKALDY 234
            NV+ LLD+     +        L+  ++ +   K++    L +  I++ +Y++LK L Y
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVD 293
            H+ GI+HRD+KP N+ ++ +  +L+++D+GLA         Y   V +R+++ PE++++
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSEMTGY---VVTRWYRAPEVILN 199

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKYH 350
              Y  ++D+WS+GC+ A MI  K   F G D+ DQL +I KV GT   + +    +   
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK-TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258

Query: 351 LELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                 L        +K ++    NA      SP A++ L+K+L  D + R+TA EA+
Sbjct: 259 KNYMKGL----PELEKKDFASILTNA------SPLAVNLLEKMLVLDAEQRVTAGEAL 306

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  187 bits (478), Expect = 5e-56
 Identities = 83/314 (26%), Positives = 157/314 (50%), Gaps = 31/314 (9%)

Query: 109 KEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----KPVKK 163
             ++  E     W   + Y+ +  VG G Y  V    +  T  R  +K L       +  
Sbjct: 13  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72

Query: 164 KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYP-TLTD 218
           K+  RE+++L+++    NV+ LLD+     S        L+   + +    ++    LTD
Sbjct: 73  KRTYRELRLLKHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN 277
             +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +  +L+++D+GLA         Y 
Sbjct: 132 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTADEMTGY- 189

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I +++
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPGTDHIDQLKLILRLV 246

Query: 338 GT---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLL 393
           GT   + L    ++        L     +  +  ++  FI A+      P A+D L+K+L
Sbjct: 247 GTPGAELLKKISSESARNYIQSL----TQMPKMNFANVFIGAN------PLAVDLLEKML 296

Query: 394 RYDHQDRLTAREAM 407
             D   R+TA +A+
Sbjct: 297 VLDSDKRITAAQAL 310

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  186 bits (474), Expect = 8e-56
 Identities = 88/314 (28%), Positives = 146/314 (46%), Gaps = 60/314 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
             YE V ++G G Y +VF+  ++    R        V  K+++             RE+ 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRF-------VALKRVRVQTGEEGMPLSTIREVA 63

Query: 172 ILQNLCGG--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVL-----YPTLTDYDI 221
           +L++L     PNVV+L D+     +   +   L+FE+V   D          P +    I
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA 281
           +  +++LL+ LD+ HS  ++HRD+KP N+++     +++L D+GLA  Y         V 
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVV 181

Query: 282 SRYFKGPELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT- 339
           + +++ PE+L  LQ  Y   +D+WS+GC+FA M FR++P F G  + DQL KI  V+G  
Sbjct: 182 TLWYRAPEVL--LQSSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLP 238

Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL------VSPEAIDFLDKLL 393
            E          E  P+  AL       P   F +   Q +      +     D L K L
Sbjct: 239 GE----------EDWPRDVAL-------PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281

Query: 394 RYDHQDRLTAREAM 407
            ++   R++A  A+
Sbjct: 282 TFNPAKRISAYSAL 295

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  187 bits (476), Expect = 9e-56
 Identities = 76/325 (23%), Positives = 142/325 (43%), Gaps = 37/325 (11%)

Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK-- 163
              E    + +      Q  Y V R +  G Y  V  G++ +      IK +   V    
Sbjct: 4   AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGR 62

Query: 164 -----------KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF 209
                      K++ REI++L +    PN++ L DI             L+ E + +   
Sbjct: 63  TVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121

Query: 210 KVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
           +V++     ++   I+Y++Y +L  L   H  G++HRD+ P N+++      + + D+ L
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFNL 180

Query: 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
           A            V  R+++ PEL++  + +   +DMWS GC+ A M  RK   F G   
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGSTF 239

Query: 327 HDQLVKIAKVLGT---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVS 382
           ++QL KI +V+GT   +++  + +    +    L   +     + W+     AD      
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDY---LRNSLSNVPARAWTAVVPTAD------ 290

Query: 383 PEAIDFLDKLLRYDHQDRLTAREAM 407
           P A+D + K+L ++ Q R++  +A+
Sbjct: 291 PVALDLIAKMLEFNPQRRISTEQAL 315

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  186 bits (475), Expect = 1e-55
 Identities = 84/313 (26%), Positives = 150/313 (47%), Gaps = 37/313 (11%)

Query: 119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQ 174
           + +    D+++   +G G Y  V    +  T E   IK ++P  K     +  REIKIL+
Sbjct: 5   IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLYP-TLTDYDIRYYIYELLK 230
           +     N++ + +I R    +  +   +I E + +   +V+    L+D  I+Y+IY+ L+
Sbjct: 65  HF-KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLR 123

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----------- 279
           A+   H   ++HRD+KP N++I+     L++ D+GLA         N             
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
           VA+R+++ PE+++    Y  ++D+WS GC+ A +  R+ P F G D   QL+ I  ++GT
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGT 241

Query: 340 ----DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLR 394
               ++L    +    E    L      +   P  K F   +      P+ ID L ++L 
Sbjct: 242 PHSDNDLRCIESPRAREYIKSL----PMYPAAPLEKMFPRVN------PKGIDLLQRMLV 291

Query: 395 YDHQDRLTAREAM 407
           +D   R+TA+EA+
Sbjct: 292 FDPAKRITAKEAL 304

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  186 bits (475), Expect = 2e-55
 Identities = 84/321 (26%), Positives = 159/321 (49%), Gaps = 40/321 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
             YE+V+K+G+G Y  V++ I+  T E   +K I    +     ++  REI IL  L G 
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQ 238
            N+V LL+++R  + +   L+F+Y+ +    V+    L     +Y +Y+L+K + Y HS 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG 128

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR------------------- 279
           G++HRD+KP N++++ E   +++ D+GL+  +   +                        
Sbjct: 129 GLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187

Query: 280 ---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
              VA+R+++ PE+L+    Y   +DMWSLGC+   ++  K P F G    +QL +I  V
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFPGSSTMNQLERIIGV 246

Query: 337 LGT---DELNAYLNKY------HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAI 386
           +     +++ +  + +       L+   ++     R     W    +  + +   + EA+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306

Query: 387 DFLDKLLRYDHQDRLTAREAM 407
           D LDKLL+++   R++A +A+
Sbjct: 307 DLLDKLLQFNPNKRISANDAL 327

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  185 bits (472), Expect = 3e-55
 Identities = 83/299 (27%), Positives = 153/299 (51%), Gaps = 29/299 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
             Y  +  +G G Y  V    +     R  IK + P +     ++  REIKIL       
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHE 85

Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +      ++ + + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH 145

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 146 SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT---DELNAYLNKY 349
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+   ++LN  +N  
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263

Query: 350 HLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  L       ++ PW++ F NAD       +A+D LDK+L ++   R+   +A+
Sbjct: 264 ARNYLLSL----PHKNKVPWNRLFPNAD------SKALDLLDKMLTFNPHKRIEVEQAL 312

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  184 bits (469), Expect = 9e-55
 Identities = 87/316 (27%), Positives = 140/316 (44%), Gaps = 55/316 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK-------------REIK 171
             YE + K+G+G + EVF+  +  T ++        V  KK+              REIK
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQK--------VALKKVLMENEKEGFPITALREIK 68

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPS------LIFEYVNSTDFKVL----YPTLTDYDI 221
           ILQ L    NVV L++I R + S          L+F++    D   L        T  +I
Sbjct: 69  ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEI 126

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-----PGKEY 276
           +  +  LL  L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +          Y
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRY 185

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
             RV + +++ PELL+  +DY   +D+W  GC+ A M + + P   G+    QL  I+++
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQL 244

Query: 337 LGT-DELNAYLNKYHLELDPQLDALVGRHSRKPW----SKFINADNQHLVSPEAIDFLDK 391
            G+             E+ P +D        +       K  +    ++  P A+D +DK
Sbjct: 245 CGSITP----------EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 294

Query: 392 LLRYDHQDRLTAREAM 407
           LL  D   R+ + +A+
Sbjct: 295 LLVLDPAQRIDSDDAL 310

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  182 bits (465), Expect = 5e-54
 Identities = 74/318 (23%), Positives = 142/318 (44%), Gaps = 26/318 (8%)

Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK-- 163
           R   ++  E     +     Y+ ++ +G G    V    +        IK + +P +   
Sbjct: 7   RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66

Query: 164 --KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPTLT 217
             K+  RE+ +++ +    N++ LL++   Q S        ++ E +++   +V+   L 
Sbjct: 67  HAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 125

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
              + Y +Y++L  + + HS GI+HRD+KP N+++  +   L+++D+GLA          
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMT 184

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             V +RY++ PE+++    Y  ++D+WS+GC+   MI      F G D+ DQ  K+ + L
Sbjct: 185 PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQL 242

Query: 338 GT--DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADN------QHLVSPEAIDF 388
           GT   E    L                +++   + K F +           L + +A D 
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENR----PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 298

Query: 389 LDKLLRYDHQDRLTAREA 406
           L K+L  D   R++  EA
Sbjct: 299 LSKMLVIDASKRISVDEA 316

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  181 bits (462), Expect = 1e-52
 Identities = 73/320 (22%), Positives = 146/320 (45%), Gaps = 32/320 (10%)

Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK--- 163
             +++  E     +     Y+ ++ +G G    V    +   +    IK + +P +    
Sbjct: 45  DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104

Query: 164 -KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVLYPTLTD 218
            K+  RE+ +++ +    N++ LL++   Q +        L+ E +++   +V+   L  
Sbjct: 105 AKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163

Query: 219 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---E 275
             + Y +Y++L  + + HS GI+HRD+KP N+++  +   L+++D+GLA           
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTP 222

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           Y   V +RY++ PE+++    Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ +
Sbjct: 223 Y---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIE 277

Query: 336 VLGT--DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINAD------NQHLVSPEAI 386
            LGT   E    L                +++   + K F ++       +  L + +A 
Sbjct: 278 QLGTPCPEFMKKLQPTVRNYVENR----PKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 333

Query: 387 DFLDKLLRYDHQDRLTAREA 406
           D L K+L  D   R++  +A
Sbjct: 334 DLLSKMLVIDPAKRISVDDA 353

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  172 bits (438), Expect = 3e-49
 Identities = 88/373 (23%), Positives = 151/373 (40%), Gaps = 86/373 (23%)

Query: 108 PKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK--- 163
            K           W   D YE+   +G G Y  V E  +        IK IL+  +    
Sbjct: 36  SKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID 95

Query: 164 -KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLY--PTL 216
            K+I REI IL  L    +VVK+LDIV  +  +      ++ E  + +DF K+      L
Sbjct: 96  CKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYL 153

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           T+  I+  +Y LL  + Y HS GI+HRD+KP N +++ +   +++ D+GLA      +  
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENG 212

Query: 277 NVR----------------------------VASRYFKGPELLVDLQDYDYSLDMWSLGC 308
           N +                            V +R+++ PEL++  ++Y  ++D+WS+GC
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272

Query: 309 MFAGMI----------FRKEPFFYGHD--------------------NHDQLVKIAKVLG 338
           +FA ++            + P F G                      N DQL  I  +LG
Sbjct: 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG 332

Query: 339 T---DELNAYLNKYHLELDPQLDALVGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLR 394
           T   +++ A   +              +      ++ F  +        +AI  L ++L 
Sbjct: 333 TPSEEDIEALEKEDAKRYIRIF----PKREGTDLAERFPASS------ADAIHLLKRMLV 382

Query: 395 YDHQDRLTAREAM 407
           ++   R+T  E +
Sbjct: 383 FNPNKRITINECL 395

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  168 bits (427), Expect = 3e-48
 Identities = 77/326 (23%), Positives = 141/326 (43%), Gaps = 54/326 (16%)

Query: 124 QDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---------REIKIL 173
           +D +E    KVGRG Y  V++    +  +     +      K+I+         REI +L
Sbjct: 19  EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEGTGISMSACREIALL 72

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL------------YPTLTDYDI 221
           + L   PNV+ L  +      +   L+F+Y    D   +               L    +
Sbjct: 73  RELKH-PNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMV 130

Query: 222 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLA-EFYHPGKEY- 276
           +  +Y++L  + Y H+  ++HRD+KP N+++  E  +   +++ D G A  F  P K   
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLA 190

Query: 277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------- 325
             +  V + +++ PELL+  + Y  ++D+W++GC+FA ++   EP F+            
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPY 249

Query: 326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV---- 381
           +HDQL +I  V+G      + +   +   P+   L+    R  ++               
Sbjct: 250 HHDQLDRIFNVMGFPADKDWEDIKKM---PEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306

Query: 382 SPEAIDFLDKLLRYDHQDRLTAREAM 407
             +A   L KLL  D   R+T+ +AM
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAM 332

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  166 bits (423), Expect = 2e-47
 Identities = 78/348 (22%), Positives = 148/348 (42%), Gaps = 78/348 (22%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKK----KKIKREIKILQNLCGG 179
           D+Y +   +GRG Y  V+   + NT +   IK + +  +     K+I REI IL  L   
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KS 84

Query: 180 PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDF-KVLYP--TLTDYDIRYYIYELLKALD 233
             +++L D++            ++ E  + +D  K+      LT+  I+  +Y LL   +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR-------------- 279
           + H  GI+HRD+KP N +++ +   +++ D+GLA   +  K+ N+               
Sbjct: 144 FIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 280 ---------VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMI----------FRKEPF 320
                    V +R+++ PEL++  ++Y  S+D+WS GC+FA ++            + P 
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262

Query: 321 FYG-----------------HDNHDQLVKIAKVLGT---DELNAYLNKYHLELDPQLDAL 360
           F G                   N DQL  I  ++GT   D+L        ++        
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF--- 319

Query: 361 VGRHSRKPWSK-FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                     + + +       S + I+ L+ +L+++   R+T  +A+
Sbjct: 320 -PHRKPINLKQKYPSI------SDDGINLLESMLKFNPNKRITIDQAL 360

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  161 bits (410), Expect = 6e-45
 Identities = 71/293 (24%), Positives = 130/293 (44%), Gaps = 49/293 (16%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            + Y+ V+K+G G Y EV    +  T+    IKI     +      K+  E+ +L+ L  
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN++KL D   D+ +    L+ E        D  +      + D    I ++L  + Y 
Sbjct: 95  HPNIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152

Query: 236 HSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           H   I+HRD+KP N++++   +   ++++D+GL+  +   K+   R+ + Y+  PE+L  
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-- 210

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
            + YD   D+WS+G +   ++    P F G  + + L K+ K            KY  + 
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPP-FGGQTDQEILRKVEK-----------GKYTFD- 257

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                          W           VS  A D + ++L++D Q R++A++A
Sbjct: 258 ------------SPEWKN---------VSEGAKDLIKQMLQFDSQRRISAQQA 289

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  159 bits (405), Expect = 3e-44
 Identities = 71/295 (24%), Positives = 129/295 (43%), Gaps = 50/295 (16%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLC 177
            D Y+  R +G+G + EV    +  T + C +K++          K+ + RE+++L+ L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
             PN++KL +   D+      L+ E        D  +     ++ D    I ++L  + Y
Sbjct: 84  DHPNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141

Query: 235 CHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            H   I+HRD+KP N++++   +   +R+ID+GL+  +   K+   ++ + Y+  PE+L 
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
               YD   D+WS G +   ++    P F G + +D L K+              K    
Sbjct: 201 -HGTYDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKV-------------EKGKYT 245

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            +              W K         VS  A D + K+L Y    R++AR+A+
Sbjct: 246 FE-----------LPQWKK---------VSESAKDLIRKMLTYVPSMRISARDAL 280

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  154 bits (392), Expect = 3e-44
 Identities = 57/301 (18%), Positives = 119/301 (39%), Gaps = 61/301 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG 179
            D +   RK+G G + +V      ++    +IK +      V  ++I+ EI++L++L   
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNS-------TDFKVLYPTLTDYDIRYYIYELLKAL 232
           PN++K+ ++  D H+    ++ E              +     L++  +   + +++ AL
Sbjct: 80  PNIIKIFEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y HSQ ++H+D+KP N++         +++ID+GLAE +   +       +  +  PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197

Query: 291 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
               +D  +  D+WS G     +  G        F G    +   K              
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGC-----LPFTGTSLEEVQQKATYK---------- 240

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                    +                        ++P+A+D L ++L  D + R +A + 
Sbjct: 241 ---EPNYAVE-----------CRP----------LTPQAVDLLKQMLTKDPERRPSAAQV 276

Query: 407 M 407
           +
Sbjct: 277 L 277

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  154 bits (392), Expect = 7e-44
 Identities = 61/300 (20%), Positives = 123/300 (41%), Gaps = 63/300 (21%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKREIKILQNLCGGPN 181
            + Y +   +GRG++  V   +  ++ +  + K +  K   +  +K+EI IL       N
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKAL 232
           ++ L +           +IFE+++         ++ F+     L + +I  Y++++ +AL
Sbjct: 63  ILHLHESFESMEELV--MIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEAL 115

Query: 233 DYCHSQGIMHRDVKPHNVM-IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
            + HS  I H D++P N++        +++I++G A    PG  + +   +  +  PE+ 
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175

Query: 292 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
                   + DMWSLG     + +G+       F    N   +  I              
Sbjct: 176 -QHDVVSTATDMWSLGTLVYVLLSGI-----NPFLAETNQQIIENIMNA----------- 218

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                 D +            + +         +S EA+DF+D+LL  + + R+TA EA+
Sbjct: 219 --EYTFDEE-----------AFKE---------ISIEAMDFVDRLLVKERKSRMTASEAL 256

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  157 bits (400), Expect = 1e-43
 Identities = 67/301 (22%), Positives = 129/301 (42%), Gaps = 63/301 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            + Y +V  +G+G + EV +  +  T +   +K+      K      I RE+++L+ L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKAL 232
            PN++KL +I+ D  S    ++ E     +   L+         +++D    I ++   +
Sbjct: 80  HPNIMKLFEILEDSSSF--YIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGI 134

Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+HRD+KP N++++   +   +++ID+GL+  +    +   R+ + Y+  PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194

Query: 291 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
           L     YD   D+WS G     + +G      P FYG + +D L ++             
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSG-----TPPFYGKNEYDILKRVET----------- 236

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
            KY  +                W           +S +A D + K+L +    R+TA + 
Sbjct: 237 GKYAFD-------------LPQWRT---------ISDDAKDLIRKMLTFHPSLRITATQC 274

Query: 407 M 407
           +
Sbjct: 275 L 275

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  154 bits (391), Expect = 1e-43
 Identities = 69/298 (23%), Positives = 119/298 (39%), Gaps = 52/298 (17%)

Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
            DDY++ ++V G G   +V E  +  T ++C +K+L      K ++E+       GGP++
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84

Query: 183 VKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALDYC 235
           V +LD+  + H       +I E +   +      +      T+ +    + ++  A+ + 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144

Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS  I HRDVKP N++     +   L+L D+G A+             + Y+  PE+L  
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL-G 202

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            + YD S DMWSLG     +  G      P FY +        + + +            
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGF-----PPFYSNTGQAISPGMKRRIR---------LG 248

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                              WS+         VS +A   +  LL+ D  +RLT  + M
Sbjct: 249 QYGFP-----------NPEWSE---------VSEDAKQLIRLLLKTDPTERLTITQFM 286

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  153 bits (389), Expect = 1e-43
 Identities = 61/303 (20%), Positives = 109/303 (35%), Gaps = 61/303 (20%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG- 179
            Y +++++G G  S+VF+ +N    +   IK               + EI  L  L    
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
             +++L D       +   ++ E  N      L    ++  ++ + Y   +L+A+   H 
Sbjct: 88  DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDL 294
            GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D+
Sbjct: 146 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 295 ----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
                            D+WSLGC+   M + K PF    +   +L  I           
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 254

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
               + +E                               +  D L   L+ D + R++  
Sbjct: 255 --PNHEIEFPDI------------------------PEKDLQDVLKCCLKRDPKQRISIP 288

Query: 405 EAM 407
           E +
Sbjct: 289 ELL 291

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  155 bits (393), Expect = 2e-43
 Identities = 70/301 (23%), Positives = 129/301 (42%), Gaps = 64/301 (21%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERC---IIKILKPVKKKKIKREIKILQNLCGGP 180
            D Y+++ ++G G +  V   +   T        I    P+ K  +K EI I+  L   P
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-P 108

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKA 231
            ++ L D   D++     LI E+++         + D+K     +++ ++  Y+ +  + 
Sbjct: 109 KLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEG 161

Query: 232 LDYCHSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
           L + H   I+H D+KP N+M    +   +++ID+GLA   +P +   V  A+  F  PE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221

Query: 291 LVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
           + D +   +  DMW++G     + +G+       F G D+ + L  + +           
Sbjct: 222 V-DREPVGFYTDMWAIGVLGYVLLSGL-----SPFAGEDDLETLQNVKRC---------- 265

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                E D              +S          VSPEA DF+  LL+ + + RLT  +A
Sbjct: 266 ---DWEFDED-----------AFSS---------VSPEAKDFIKNLLQKEPRKRLTVHDA 302

Query: 407 M 407
           +
Sbjct: 303 L 303

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  155 bits (394), Expect = 2e-43
 Identities = 67/300 (22%), Positives = 118/300 (39%), Gaps = 53/300 (17%)

Query: 123 DQDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN 181
             DDY+V  +V G G   +V +  N  T E+  +K+L+     K +RE+++       P+
Sbjct: 59  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPH 116

Query: 182 VVKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALDY 234
           +V+++D+  + ++      ++ E ++  +             T+ +    +  + +A+ Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 235 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            HS  I HRDVKP N++         L+L D+G A+             + Y+  PE+L 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL- 235

Query: 293 DLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKI-AKVLGTDELNAYLN 347
             + YD S DMWSLG     +  G      P FY +        +  ++           
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIR---------- 280

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
               E                WS+         VS E    +  LL+ +   R+T  E M
Sbjct: 281 MGQYEFP-----------NPEWSE---------VSEEVKMLIRNLLKTEPTQRMTITEFM 320

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  154 bits (390), Expect = 2e-43
 Identities = 61/303 (20%), Positives = 108/303 (35%), Gaps = 61/303 (20%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG- 179
            Y +++++G G  S+VF+ +N    +   IK               + EI  L  L    
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
             +++L D       +   ++ E  N      L    ++  ++ + Y   +L+A+   H 
Sbjct: 69  DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 293
            GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D 
Sbjct: 127 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 294 ---------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
                            D+WSLGC+   M + K PF    +   +L  I           
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 235

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
               + +E                               +  D L   L+ D + R++  
Sbjct: 236 --PNHEIEFPDI------------------------PEKDLQDVLKCCLKRDPKQRISIP 269

Query: 405 EAM 407
           E +
Sbjct: 270 ELL 272

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  158 bits (402), Expect = 2e-43
 Identities = 63/356 (17%), Positives = 128/356 (35%), Gaps = 65/356 (18%)

Query: 69  TTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGD-QDDY 127
             +  +     +  + +     +          D  V    + +  + + ++     D Y
Sbjct: 100 VLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHY 159

Query: 128 EVVRKVGRGKYSEVFEGINVNTNERC---IIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
           ++  ++G G +  V       T        +       K+ +++EI+ +  L   P +V 
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVN 218

Query: 185 LLDIVRDQHSKTPSLIFEYVN---------STDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           L D   D +     +I+E+++             K     +++ +   Y+ ++ K L + 
Sbjct: 219 LHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHM 271

Query: 236 HSQGIMHRDVKPHNVMI-DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           H    +H D+KP N+M       +L+LID+GL     P +   V   +  F  PE+  + 
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EG 330

Query: 295 QDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
           +   Y  DMWS+G     + +G+       F G ++ + L  +                 
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGL-----SPFGGENDDETLRNVKSC-------------D 372

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
             +D              +S          +S +  DF+ KLL  D   R+T  +A
Sbjct: 373 WNMD-----------DSAFSG---------ISEDGKDFIRKLLLADPNTRMTIHQA 408

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  152 bits (387), Expect = 4e-43
 Identities = 62/301 (20%), Positives = 122/301 (40%), Gaps = 58/301 (19%)

Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLC 177
            + Y +  K  GRGK++ V + I+ +T +    K           + +I  EI +L+   
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-F----KVLYPTLTDYDIRYYIYELLKAL 232
             P V+ L ++  +       LI EY    + F      L   +++ D+   I ++L+ +
Sbjct: 87  SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144

Query: 233 DYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
            Y H   I+H D+KP N+++   + L  ++++D+G++       E    + +  +  PE+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204

Query: 291 LVDLQDYDYSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
           L +      + DMW++G     +           F G DN +  + I++V          
Sbjct: 205 L-NYDPITTATDMWNIGIIAYMLLTHT-----SPFVGEDNQETYLNISQV---------- 248

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
              +++              + +S          VS  A DF+  LL  + + R TA   
Sbjct: 249 ---NVDYS-----------EETFSS---------VSQLATDFIQSLLVKNPEKRPTAEIC 285

Query: 407 M 407
           +
Sbjct: 286 L 286

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  152 bits (386), Expect = 4e-43
 Identities = 72/302 (23%), Positives = 131/302 (43%), Gaps = 61/302 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
           +D Y++  ++G G+++ V +    +T      K +K          V +++I+RE+ IL+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
            +    NV+ L D+  ++      LI E V+     DF     +L++ +   +I ++L  
Sbjct: 71  QV-LHHNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           ++Y H++ I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           E++ + +      DMWS+G     + +G        F G    + L  I  V        
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITSV-------- 233

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                  + D +            +S           S  A DF+ KLL  + + RLT +
Sbjct: 234 -----SYDFDEE-----------FFSH---------TSELAKDFIRKLLVKETRKRLTIQ 268

Query: 405 EA 406
           EA
Sbjct: 269 EA 270

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  154 bits (392), Expect = 6e-43
 Identities = 55/296 (18%), Positives = 108/296 (36%), Gaps = 52/296 (17%)

Query: 126 DYEVVRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
            +     +G G     V+ G+    N    +K + P       RE+++L+     PNV++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 185 LLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHSQGIM 241
                +D+  +   +  E   +T  + +          +    + +    L + HS  I+
Sbjct: 83  YFCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 242 HRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVD 293
           HRD+KPHN++I         K  + D+GL +    G+    R      +  +  PE+L +
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 294 L--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
              ++  Y++D++S GC+F  +I      F         + +                  
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA---------------- 244

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                LD L       P                A + ++K++  D Q R +A+  +
Sbjct: 245 ---CSLDCL------HPEKH---------EDVIARELIEKMIAMDPQKRPSAKHVL 282

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  155 bits (394), Expect = 1e-42
 Identities = 73/304 (24%), Positives = 134/304 (44%), Gaps = 60/304 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----------------PVKKKKIKR 168
           + Y  VRK+G G Y EV      N +    IK++K                    ++I  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FK--VLYPTLTDYDIRYYI 225
           EI +L++L   PN++KL D+  D+      L+ E+    + F+  +      + D    +
Sbjct: 96  EISLLKSL-DHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINRHKFDECDAANIM 152

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
            ++L  + Y H   I+HRD+KP N++++  + L  ++++D+GL+ F+    +   R+ + 
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
           Y+  PE+L   + Y+   D+WS G +   ++    P F G ++ D + K+ K        
Sbjct: 213 YYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPP-FGGQNDQDIIKKVEK-------- 261

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
               KY+ +                W           +S EA + +  +L YD+  R TA
Sbjct: 262 ---GKYYFD-------------FNDWKN---------ISDEAKELIKLMLTYDYNKRCTA 296

Query: 404 REAM 407
            EA+
Sbjct: 297 EEAL 300

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  149 bits (379), Expect = 2e-42
 Identities = 68/296 (22%), Positives = 116/296 (39%), Gaps = 55/296 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
              Y +   +GRG + EV   +   T  R   K +         + K+EI+I+++L   P
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHP 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           N+++L +   D       L+ E        +  V      + D    + ++L A+ YCH 
Sbjct: 67  NIIRLYETFEDNTDI--YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124

Query: 238 QGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
             + HRD+KP N +         L+LID+GLA  + PGK    +V + Y+  P++L    
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 182

Query: 296 DYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
            Y    D WS G     +  G      P F    + + ++KI +             +  
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGY-----PPFSAPTDSEVMLKIRE-----------GTFTF 226

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                          K W           VSP+A   + +LL    + R+T+ +A+
Sbjct: 227 P-------------EKDWLN---------VSPQAESLIRRLLTKSPKQRITSLQAL 260

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  149 bits (379), Expect = 3e-42
 Identities = 67/298 (22%), Positives = 128/298 (42%), Gaps = 57/298 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            + Y +V  +G+G + EV +  +  T +   +K+      K      I RE+++L+ L  
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN++KL +I+ D  S    ++ E        D  +     +++D    I ++   + Y 
Sbjct: 80  HPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137

Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           H   I+HRD+KP N++++   +   +++ID+GL+  +    +   R+ + Y+  PE+L  
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-- 195

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
              YD   D+WS G     + +G      P FYG + +D L ++              KY
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGT-----PPFYGKNEYDILKRVET-----------GKY 239

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             +                W           +S +A D + K+L +    R+TA + +
Sbjct: 240 AFD-------------LPQWRT---------ISDDAKDLIRKMLTFHPSLRITATQCL 275

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  150 bits (380), Expect = 3e-42
 Identities = 53/303 (17%), Positives = 109/303 (35%), Gaps = 30/303 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK----IKREIKILQNLCGGP 180
             + +   +G+G  + VF G +  T +   IK+   +   +      RE ++L+ L    
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLKALDY 234
           N+VKL  I  +  ++   LI E+      + VL        L + +    + +++  +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 235 CHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
               GI+HR++KP N+M           +L D+G A      +++     +  +  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 292 -------VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
                     + Y  ++D+WS+G  F        PF            + K++      A
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                  E  P     +      P S  ++      +       L  +L  D +      
Sbjct: 248 ISGVQKAENGP-----IDWSGDMPVSCSLSRG----LQVLLTPVLANILEADQEKCWGFD 298

Query: 405 EAM 407
           +  
Sbjct: 299 QFF 301

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  151 bits (384), Expect = 4e-42
 Identities = 61/303 (20%), Positives = 108/303 (35%), Gaps = 61/303 (20%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG-G 179
            Y +++++G G  S+VF+ +N    +   IK               + EI  L  L    
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL--YPTLTDYDIRYYIYELLKALDYCHS 237
             +++L D       +   ++ E  N      L    ++  ++ + Y   +L+A+   H 
Sbjct: 116 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 293
            GI+H D+KP N +I      L+LID+G+A    P     V+   V +  +  PE + D 
Sbjct: 174 HGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 294 ---------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
                            D+WSLGC+   M + K PF    +   +L  I           
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 282

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
               + +E                               +  D L   L+ D + R++  
Sbjct: 283 --PNHEIEFPDI------------------------PEKDLQDVLKCCLKRDPKQRISIP 316

Query: 405 EAM 407
           E +
Sbjct: 317 ELL 319

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  148 bits (375), Expect = 9e-42
 Identities = 71/305 (23%), Positives = 133/305 (43%), Gaps = 65/305 (21%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
           +D YE+  ++G G+++ V +     T +    K +K          V +++I+RE+ IL+
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELL 229
            +   PN++ L DI  ++      LI E V  +     DF     +LT+ +   ++ ++L
Sbjct: 64  EI-RHPNIITLHDIFENKTDVV--LILELV--SGGELFDFLAEKESLTEDEATQFLKQIL 118

Query: 230 KALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
             + Y HS+ I H D+KP N+M+   +    +++LID+G+A     G E+     +  F 
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178

Query: 287 GPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
            PE++ + +      DMWS+G     + +G        F G    + L  I+ V      
Sbjct: 179 APEIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGETKQETLTNISAV------ 226

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT 402
                  + + D +            +S           S  A DF+ +LL  D + R+T
Sbjct: 227 -------NYDFDEE-----------YFSN---------TSELAKDFIRRLLVKDPKRRMT 259

Query: 403 AREAM 407
             +++
Sbjct: 260 IAQSL 264

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  148 bits (377), Expect = 1e-41
 Identities = 68/303 (22%), Positives = 130/303 (42%), Gaps = 61/303 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
            D Y+   ++G G+++ V +    +T  +   K +K          V ++ I+RE+ IL+
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
            +   PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  
Sbjct: 70  EI-QHPNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126

Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           + Y HS  I H D+KP N+M+   +    ++++ID+GLA     G E+     +  F  P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186

Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           E++ + +      DMWS+G     + +G        F G    + L  ++ V        
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANVSAV-------- 232

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                + E + +            +S           S  A DF+ +LL  D + R+T +
Sbjct: 233 -----NYEFEDE-----------YFSN---------TSALAKDFIRRLLVKDPKKRMTIQ 267

Query: 405 EAM 407
           +++
Sbjct: 268 DSL 270

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  149 bits (378), Expect = 2e-41
 Identities = 72/303 (23%), Positives = 134/303 (44%), Gaps = 61/303 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---------PVKKKKIKREIKILQ 174
           +D Y++  ++G G+++ V +    +T      K +K          V +++I+RE+ IL+
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKA 231
            +   PN++ L D+  ++      LI E V+     DF     +L++ +   +I ++L  
Sbjct: 71  QV-LHPNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127

Query: 232 LDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           ++Y H++ I H D+KP N+M+   +  +  ++LID+GLA     G E+     +  F  P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187

Query: 289 ELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
           E++ + +      DMWS+G     + +G        F G    + L  I  V        
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITAV-------- 233

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
                  + D +            +S+          S  A DF+ KLL  + + RLT +
Sbjct: 234 -----SYDFDEE-----------FFSQ---------TSELAKDFIRKLLVKETRKRLTIQ 268

Query: 405 EAM 407
           EA+
Sbjct: 269 EAL 271

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  147 bits (373), Expect = 2e-41
 Identities = 65/316 (20%), Positives = 110/316 (34%), Gaps = 70/316 (22%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPN 181
             D+E +  +G+G + +V +  N   +    IK ++    K   I  E+ +L +L     
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63

Query: 182 VVKLLDIVRDQHSKTPS-----------LIFEYVNS---TDFKVLYPTLTDYD-IRYYIY 226
           VV+      ++ +               +  EY  +    D           D       
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 286
           ++L+AL Y HSQGI+HRD+KP N+ ID   R +++ D+GLA+  H   +     +     
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 287 G---------------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                            E+L     Y+  +DM+SLG +F  MI+   PF  G      ++
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-ERVNIL 238

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           K             L    +E  P                                 +  
Sbjct: 239 KK------------LRSVSIEFPPDF-----------DDNK---------MKVEKKIIRL 266

Query: 392 LLRYDHQDRLTAREAM 407
           L+ +D   R  AR  +
Sbjct: 267 LIDHDPNKRPGARTLL 282

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  147 bits (373), Expect = 2e-41
 Identities = 66/308 (21%), Positives = 116/308 (37%), Gaps = 65/308 (21%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------------PVKKKKIKREIK 171
            ++YE    +GRG  S V   I+  T +   +KI+                ++   +E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYEL 228
           IL+ + G PN+++L D           L+F+ +      D+     TL++ + R  +  L
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L+ +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  P
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192

Query: 289 ELL-----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
           E++      +   Y   +DMWS G     + AG      P F+       L  I      
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-----PPFWHRKQMLMLRMIMS---- 243

Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
                    Y                   W            S    D + + L    Q 
Sbjct: 244 -------GNYQFG-------------SPEWDD---------YSDTVKDLVSRFLVVQPQK 274

Query: 400 RLTAREAM 407
           R TA EA+
Sbjct: 275 RYTAEEAL 282

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  149 bits (377), Expect = 3e-41
 Identities = 72/336 (21%), Positives = 144/336 (42%), Gaps = 63/336 (18%)

Query: 90  PLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGD-QDDYEVVRK--VGRGKYSEVFEGIN 146
            +P  SK      V++  P   +D+  +T + G     Y V +   +G G++ +V +   
Sbjct: 51  RMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEE 110

Query: 147 VNTNERC---IIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY 203
             T  +    IIK      K+++K EI ++  L    N+++L D    ++     L+ EY
Sbjct: 111 TATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIV--LVMEY 167

Query: 204 VNS-------TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM-IDHE 255
           V+         D        T+ D   ++ ++ + + + H   I+H D+KP N++ ++ +
Sbjct: 168 VDGGELFDRIIDESYNL---TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD 224

Query: 256 LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLG----CMFA 311
            +++++ID+GLA  Y P ++  V   +  F  PE++ +     +  DMWS+G     + +
Sbjct: 225 AKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLS 283

Query: 312 GMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSK 371
           G+       F G ++ + L  I                  +L+ +            +  
Sbjct: 284 GL-----SPFLGDNDAETLNNILAC-------------RWDLEDE-----------EFQD 314

Query: 372 FINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                    +S EA +F+ KLL  +   R++A EA+
Sbjct: 315 ---------ISEEAKEFISKLLIKEKSWRISASEAL 341

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  147 bits (374), Expect = 6e-41
 Identities = 69/298 (23%), Positives = 131/298 (43%), Gaps = 56/298 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            D+Y+V  ++G+G +S V   ++  T      KI     L     +K++RE +I + L  
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN+V+L D ++++      L+F+ V      +  V     ++ D  + I ++L+++ YC
Sbjct: 88  -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144

Query: 236 HSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L  
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 203

Query: 294 LQDYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
              Y   +D+W+ G +      G      P F+  D H    +I               Y
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGY-----PPFWDEDQHRLYAQIKA-----------GAY 247

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                              W           V+PEA   +D +L  + + R+TA +A+
Sbjct: 248 DYP-------------SPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQAL 283

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  146 bits (370), Expect = 8e-41
 Identities = 59/290 (20%), Positives = 97/290 (33%), Gaps = 52/290 (17%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG 178
           Q  ++ + ++G G Y EVF+  +        +K        P  + +   E+   + +  
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYC 235
            P  V+L      +      L  E    +  +       +L +  +  Y+ + L AL + 
Sbjct: 116 HPCCVRLEQ--AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HSQG++H DVKP N+ +    R  +L D+GL           V+     +  PELL    
Sbjct: 174 HSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-- 230

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  + D++SLG     +    E    G     QL +                   E   
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQ-QLRQ--------------GYLPPEFTA 275

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
            L                        S E    L  +L  D + R TA  
Sbjct: 276 GL------------------------SSELRSVLVMMLEPDPKLRATAEA 301

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  148 bits (375), Expect = 2e-40
 Identities = 72/320 (22%), Positives = 148/320 (46%), Gaps = 50/320 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----GG 179
           YEV++ +G+G + +V +  +   ++   +K+++  K+  ++   EI+IL++L        
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 180 PNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 230
            NV+ +L+         +  +  S   +L +E +    F+     L    +R + + +L+
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLS--MNL-YELIKKNKFQGFSLPL----VRKFAHSILQ 211

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            LD  H   I+H D+KP N+++  + R  +++ID+G + + H  + Y   + SR+++ PE
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTY-IQSRFYRAPE 269

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG----------- 338
           +++    Y   +DMWSLGC+ A +     P   G D  DQL  + ++LG           
Sbjct: 270 VILGA-RYGMPIDMWSLGCILAEL-LTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327

Query: 339 --TDELNAYLNKYHLELDPQLDALVGRHSRK---------PWSKFINADNQHLVSPEAID 387
              + +++     +  +    D  V  +  +         P S+      +    P  +D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387

Query: 388 FLDKLLRYDHQDRLTAREAM 407
           FL + L +D   R+T  +A+
Sbjct: 388 FLKQCLEWDPAVRMTPGQAL 407

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  144 bits (366), Expect = 2e-40
 Identities = 69/298 (23%), Positives = 131/298 (43%), Gaps = 56/298 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCG 178
            D+Y+V  ++G+G +S V   ++  T      KI     L     +K++RE +I + L  
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN+V+L D ++++      L+F+ V      +  V     ++ D  + I ++L+++ YC
Sbjct: 65  -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121

Query: 236 HSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           HS GI+HR++KP N+++  + +   ++L D+GLA   +  + ++    +  +  PE+L  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 180

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
              Y   +D+W+ G     +  G      P F+  D H    +I               Y
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGY-----PPFWDEDQHRLYAQIKA-----------GAY 224

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                              W           V+PEA   +D +L  + + R+TA +A+
Sbjct: 225 DYP-------------SPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQAL 260

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  147 bits (372), Expect = 2e-40
 Identities = 53/305 (17%), Positives = 106/305 (34%), Gaps = 34/305 (11%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGP 180
             + +   +G+G  + VF G +  T +   IK+   +          RE ++L+ L    
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLKALDY 234
           N+VKL  I  +  ++   LI E+      + VL        L + +    + +++  +++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 235 CHSQGIMHRDVKPHNVMIDHELRK---LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
               GI+HR++KP N+M           +L D+G A      +++     +  +  P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 292 -------VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
                     + Y  ++D+WS+G  F        PF            + K++      A
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQ--HLVSPEAIDFLDKLLRYDHQDRLT 402
                  E  P             WS  +         +       L  +L  D +    
Sbjct: 248 ISGVQKAENGP-----------IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 403 AREAM 407
             +  
Sbjct: 297 FDQFF 301

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  146 bits (371), Expect = 6e-40
 Identities = 52/317 (16%), Positives = 108/317 (34%), Gaps = 69/317 (21%)

Query: 124 QDDYEVVRKVGRGKYSEV-FEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
           ++     + +G G    V F+G          +K +          EIK+L      PNV
Sbjct: 14  KNLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNV 71

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNST---------DFKVLYPTLTDYDIRYYIYELLKALD 233
           ++              +  E  N                     +Y+    + ++   + 
Sbjct: 72  IRYYCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 234 YCHSQGIMHRDVKPHNVMID------------HELRKLRLIDWGLAEFYHPGKEY----- 276
           + HS  I+HRD+KP N+++              E  ++ + D+GL +    G+       
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 277 NVRVASRYFKGPELLVDLQD------YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
           N    +  ++ PELL +  +         S+D++S+GC+F  ++ + +  F   D + + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRE 247

Query: 331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
             I +             + L+                            +  EA D + 
Sbjct: 248 SNIIR-----------GIFSLDEMK----------CLHDRS---------LIAEATDLIS 277

Query: 391 KLLRYDHQDRLTAREAM 407
           +++ +D   R TA + +
Sbjct: 278 QMIDHDPLKRPTAMKVL 294

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  144 bits (366), Expect = 9e-40
 Identities = 65/306 (21%), Positives = 121/306 (39%), Gaps = 64/306 (20%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK-----------KIKREIKIL 173
             Y+    +GRG  S V   ++  T     +KI++   ++             +RE  IL
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLK 230
           + + G P+++ L+D           L+F+ +      D+      L++ + R  +  LL+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFM--FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
           A+ + H+  I+HRD+KP N+++D  + ++RL D+G +    PG++      +  +  PE+
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270

Query: 291 L-----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           L          Y   +D+W+ G     + AG      P F+       L  I +      
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGS-----PPFWHRRQILMLRMIME------ 319

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                 +Y                   W            S    D + +LL+ D + RL
Sbjct: 320 -----GQYQFS-------------SPEWDD---------RSSTVKDLISRLLQVDPEARL 352

Query: 402 TAREAM 407
           TA +A+
Sbjct: 353 TAEQAL 358

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  143 bits (363), Expect = 1e-39
 Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 53/300 (17%)

Query: 124 QDDYEV---VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 180
              Y++    + +G G +S   + ++  +N+   +KI+    +   ++EI  L+   G P
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD-F-----KVLYPTLTDYDIRYYIYELLKALDY 234
           N+VKL ++  DQ      L+ E +N  + F     K  +   ++ +  Y + +L+ A+ +
Sbjct: 67  NIVKLHEVFHDQLHT--FLVMELLNGGELFERIKKKKHF---SETEASYIMRKLVSAVSH 121

Query: 235 CHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 291
            H  G++HRD+KP N++     +  ++++ID+G A    P  +       + ++  PELL
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181

Query: 292 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
            +   YD S D+WSLG     M +G        F  HD         +++        + 
Sbjct: 182 -NQNGYDESCDLWSLGVILYTMLSGQ-----VPFQSHDRSLTCTSAVEIM------KKIK 229

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           K     +            + W           VS EA D +  LL  D   RL      
Sbjct: 230 KGDFSFEG-----------EAWKN---------VSQEAKDLIQGLLTVDPNKRLKMSGLR 269

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  143 bits (363), Expect = 1e-39
 Identities = 68/342 (19%), Positives = 119/342 (34%), Gaps = 95/342 (27%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------PVKKKKIKREIKILQN 175
           Q  Y +   +G+G Y  V   I   T     IKI+         P   ++IK E+++++ 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV------------------------------- 204
           L   PN+ +L ++  D+      L+ E                                 
Sbjct: 85  LHH-PNIARLYEVYEDEQYI--CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 205 ------------NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 252
                            + L     +  I   + ++  AL Y H+QGI HRD+KP N + 
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201

Query: 253 DH-ELRKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELL-VDLQDYDYSLDMWS 305
              +  +++L+D+GL++ ++            +  + YF  PE+L    + Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 306 LGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHS 365
            G +   ++    PF     N      I++VL             L  +           
Sbjct: 262 AGVLLHLLLMGAVPFP--GVNDADT--ISQVL----------NKKLCFE----------- 296

Query: 366 RKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              ++          +SP A D L  LL  +  +R  A  A+
Sbjct: 297 NPNYNV---------LSPLARDLLSNLLNRNVDERFDAMRAL 329

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  143 bits (363), Expect = 2e-39
 Identities = 69/306 (22%), Positives = 131/306 (42%), Gaps = 65/306 (21%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------PVKKKKIKREIKILQN 175
           +D YE+   +G+G +S V   IN  T ++  +KI+          +  + +KRE  I   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS-------TDFKVLYPTLTDYDIRYYIYEL 228
           L   P++V+LL+           ++FE+++                  ++    +Y+ ++
Sbjct: 83  L-KHPHIVELLETYSSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 229 LKALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           L+AL YCH   I+HRDVKPH V++        ++L  +G+A +    G     RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 286 KGPELLVDLQDYDYSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
             PE++   + Y   +D+W  G     + +G      PF   +   ++L +   ++    
Sbjct: 200 MAPEVV-KREPYGKPVDVWGCGVILFILLSGC----LPF---YGTKERLFE--GII---- 245

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                 K   +++P           + WS          +S  A D + ++L  D  +R+
Sbjct: 246 ------KGKYKMNP-----------RQWSH---------ISESAKDLVRRMLMLDPAERI 279

Query: 402 TAREAM 407
           T  EA+
Sbjct: 280 TVYEAL 285

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  143 bits (362), Expect = 3e-39
 Identities = 72/296 (24%), Positives = 117/296 (39%), Gaps = 55/296 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIK-ILKPVKKKKIKREIKILQNLCGGPNV 182
            D +EV  ++GRG  S V+      T +   +K + K V KK ++ EI +L  L   PN+
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNI 110

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
           +KL +I         SL+ E V  T     D  V     ++ D    + ++L+A+ Y H 
Sbjct: 111 IKLKEIFETPTEI--SLVLELV--TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166

Query: 238 QGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
            GI+HRD+KP N++         L++ D+GL++             +  +  PE+L    
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-C 225

Query: 296 DYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL 351
            Y   +DMWS+G +      G        FY       +    ++L              
Sbjct: 226 AYGPEVDMWSVGIITYILLCGF-----EPFYDERGDQFM--FRRIL----------NCEY 268

Query: 352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                            W +         VS  A D + KL+  D + RLT  +A+
Sbjct: 269 YFIS-----------PWWDE---------VSLNAKDLVRKLIVLDPKKRLTTFQAL 304

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  144 bits (364), Expect = 6e-39
 Identities = 67/306 (21%), Positives = 122/306 (39%), Gaps = 63/306 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----------KPVKKKKIKREIKI 172
           +D+Y + + +G G   EV       T ++  I+I+           +      ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELL 229
           L+ L   P ++K+ +    +      ++ E +      D  V    L +   + Y Y++L
Sbjct: 194 LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249

Query: 230 KALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
            A+ Y H  GI+HRD+KP NV++    E   +++ D+G ++             +  +  
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309

Query: 288 PELLVDLQD--YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           PE+LV +    Y+ ++D WSLG       +G      PF           +I        
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITS------ 359

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                 KY+   +              W++         VS +A+D + KLL  D + R 
Sbjct: 360 -----GKYNFIPE-------------VWAE---------VSEKALDLVKKLLVVDPKARF 392

Query: 402 TAREAM 407
           T  EA+
Sbjct: 393 TTEEAL 398

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  139 bits (352), Expect = 3e-38
 Identities = 67/298 (22%), Positives = 114/298 (38%), Gaps = 59/298 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
           +  +  +  +G G +SEVF      T +   +K +      +   ++ EI +L+ +    
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-E 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDYC 235
           N+V L DI          L+ + V  +     D  +     T+ D    I ++L A+ Y 
Sbjct: 67  NIVTLEDIYESTTHY--YLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 236 HSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           H  GI+HRD+KP N++     E  K+ + D+GL++    G   +    +  +  PE+L  
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            + Y  ++D WS+G     +  G      P FY         KI +             Y
Sbjct: 182 -KPYSKAVDCWSIGVITYILLCGY-----PPFYEETESKLFEKIKE-----------GYY 224

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             E                W           +S  A DF+  LL  D  +R T  +A+
Sbjct: 225 EFE-------------SPFWDD---------ISESAKDFICHLLEKDPNERYTCEKAL 260

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  140 bits (354), Expect = 3e-38
 Identities = 69/294 (23%), Positives = 113/294 (38%), Gaps = 50/294 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK 184
           D YEV   +G G YS     I+  TN    +KI+    K+    EI+IL      PN++ 
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80

Query: 185 LLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIM 241
           L D+  D       ++ E +      D  +     ++ +    ++ + K ++Y H+QG++
Sbjct: 81  LKDVYDDGKYV--YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138

Query: 242 HRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 297
           HRD+KP N++          +R+ D+G A+              +  F  PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGY 197

Query: 298 DYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
           D + D+WSLG     M  G        F    +      +A++                L
Sbjct: 198 DAACDIWSLGVLLYTMLTGY-----TPFANGPDDTPEEILARIG----------SGKFSL 242

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                          W+          VS  A D + K+L  D   RLTA   +
Sbjct: 243 S-----------GGYWNS---------VSDTAKDLVSKMLHVDPHQRLTAALVL 276

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  139 bits (352), Expect = 3e-38
 Identities = 64/314 (20%), Positives = 129/314 (41%), Gaps = 60/314 (19%)

Query: 124 QDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGG 179
           +D Y++   V G G ++ V   IN+ T++   +KI+       + ++ RE+++L    G 
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-F-----KVLYPTLTDYDIRYYIYELLKALD 233
            NV++L++   ++      L+FE +           +  +    + +    + ++  ALD
Sbjct: 71  RNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALD 125

Query: 234 YCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNV--------RVASR 283
           + H++GI HRD+KP N++ +H  ++  +++ D+ L        + +            S 
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 284 YFKGPELL----VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            +  PE++     +   YD   D+WSLG     + +G      P F G    D      +
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY-----PPFVGRCGSDCGWDRGE 240

Query: 336 VLGTDELNAYLN--KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
                +   + +  +   E              K W+          +S  A D + KLL
Sbjct: 241 ACPACQNMLFESIQEGKYEFP-----------DKDWAH---------ISCAAKDLISKLL 280

Query: 394 RYDHQDRLTAREAM 407
             D + RL+A + +
Sbjct: 281 VRDAKQRLSAAQVL 294

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  141 bits (357), Expect = 9e-38
 Identities = 69/300 (23%), Positives = 129/300 (43%), Gaps = 61/300 (20%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
           ++Y++  ++G+G +S V   + V   +     I     L     +K++RE +I + L   
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST-----DFKVLYPTLTDYDIRYYIYELLKALDY 234
           PN+V+L D + ++      LIF+ V  T     +  V     ++ D  + I ++L+A+ +
Sbjct: 70  PNIVRLHDSISEEGHH--YLIFDLV--TGGELFEDIVAREYYSEADASHCIQQILEAVLH 125

Query: 235 CHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 291
           CH  G++HR++KP N+++  +L+   ++L D+GLA       + +     +  +  PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185

Query: 292 VDLQDYDYSLDMWSLGCMF----AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN 347
                Y   +D+W+ G +      G      P F+  D H    +I              
Sbjct: 186 -RKDPYGKPVDLWACGVILYILLVGY-----PPFWDEDQHRLYQQIKA-----------G 228

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            Y                   W           V+PEA D ++K+L  +   R+TA EA+
Sbjct: 229 AYDFP-------------SPEWDT---------VTPEAKDLINKMLTINPSKRITAAEAL 266

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  138 bits (349), Expect = 1e-37
 Identities = 69/306 (22%), Positives = 122/306 (39%), Gaps = 63/306 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKI 172
           +D+Y + + +G G   EV       T ++  IKI+   K              ++ EI+I
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELL 229
           L+ L   P ++K+ +    +      ++ E +      D  V    L +   + Y Y++L
Sbjct: 69  LKKL-NHPCIIKIKNFFDAEDY---YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 230 KALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
            A+ Y H  GI+HRD+KP NV++    E   +++ D+G ++             +  +  
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 288 PELLVDLQD--YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
           PE+LV +    Y+ ++D WSLG       +G      PF           +I        
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITS------ 234

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                 KY+   +              W++         VS +A+D + KLL  D + R 
Sbjct: 235 -----GKYNFIPE-------------VWAE---------VSEKALDLVKKLLVVDPKARF 267

Query: 402 TAREAM 407
           T  EA+
Sbjct: 268 TTEEAL 273

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  136 bits (345), Expect = 3e-37
 Identities = 64/301 (21%), Positives = 111/301 (36%), Gaps = 74/301 (24%)

Query: 122 GDQDDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 180
              DDY+V  +V G G   +V +  N  T E+  +K+L+     K +RE+++       P
Sbjct: 14  AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCP 71

Query: 181 NVVKLLDIVRDQHSKTPS--LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKALD 233
           ++V+++D+  + ++      ++ E ++  +             T+ +    +  + +A+ 
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131

Query: 234 YCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           Y HS  I HRDVKP N++         L+L D+G A                     E  
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KETT 171

Query: 292 VDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKI-AKVLGTDELNAYL 346
              + YD S DMWSLG     +  G      P FY +        +  ++          
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIR--------- 215

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                E                WS+         VS E    +  LL+ +   R+T  E 
Sbjct: 216 -MGQYEFP-----------NPEWSE---------VSEEVKMLIRNLLKTEPTQRMTITEF 254

Query: 407 M 407
           M
Sbjct: 255 M 255

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  137 bits (346), Expect = 6e-37
 Identities = 44/321 (13%), Positives = 80/321 (24%), Gaps = 71/321 (22%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNL--- 176
             ++V  +  G  S VF   +V   E   +K+          + +++         L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 177 --------------------CGGPNVVKLLDIVRDQHSKTPSLIFEYVNST--------- 207
                                  P   +L     D       L+    +           
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
              V         +     +L++      S+G++H    P N+ I  + R L L D    
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLGDVSAL 241

Query: 268 EFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN 326
             +  G           +   E L      + ++L+ W LG     +     PF      
Sbjct: 242 --WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 327 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 386
                K   +                          R        F +      +     
Sbjct: 300 IKGSWKRPSL--------------------------RVPGTDSLAFGSCTP---LPDFVK 330

Query: 387 DFLDKLLRYDHQDRLTAREAM 407
             + + L +D + RL   EAM
Sbjct: 331 TLIGRFLNFDRRRRLLPLEAM 351

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  136 bits (345), Expect = 1e-36
 Identities = 67/316 (21%), Positives = 133/316 (42%), Gaps = 39/316 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC------- 177
           Y +VRK+G G +S V+   ++  N    +KI++  K   +  + EIK+LQ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 178 ---GGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYEL 228
              G  +++KLLD    +  +     ++FE +      ++    +  +    ++    +L
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 229 LKALDYCHSQ-GIMHRDVKPHNVMIDHELR-----KLRLIDWGLAEFYHPGKEYNVRVAS 282
           L  LDY H + GI+H D+KP NV+++         ++++ D G A +Y   + Y   + +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQT 198

Query: 283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD------NHDQLVKIAKV 336
           R ++ PE+L+    +    D+WS  C+   +I      F   +      + D + +I ++
Sbjct: 199 REYRSPEVLLGAP-WGCGADIWSTACLIFELITGD-FLFEPDEGHSYTKDDDHIAQIIEL 256

Query: 337 LG--TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA---IDFLDK 391
           LG     L           + +         +    + +  +       EA    DFL  
Sbjct: 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316

Query: 392 LLRYDHQDRLTAREAM 407
           +L+ D + R  A   +
Sbjct: 317 MLQLDPRKRADAGGLV 332

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  136 bits (345), Expect = 1e-36
 Identities = 69/327 (21%), Positives = 140/327 (42%), Gaps = 57/327 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----GG 179
           YE+   +G+G + +V +  +    E   IKI+K  K    + + E+++L+ +        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 180 PNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK 230
             +V L           +V +  S   +L ++ + +T+F+ +   L     R +  ++  
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS--YNL-YDLLRNTNFRGVSLNL----TRKFAQQMCT 168

Query: 231 ALDYCHSQ--GIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           AL +  +    I+H D+KP N+++ +  R  ++++D+G +      +     + SR+++ 
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRS 226

Query: 288 PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG--------- 338
           PE+L+ +  YD ++DMWSLGC+   M    EP F G +  DQ+ KI +VLG         
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284

Query: 339 -----------------TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLV 381
                              +      +Y      +L  ++G  +  P  +        + 
Sbjct: 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVA 344

Query: 382 SPEA-IDFLDKLLRYDHQDRLTAREAM 407
                 D + ++L YD + R+    A+
Sbjct: 345 DYLKFKDLILRMLDYDPKTRIQPYYAL 371

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  133 bits (338), Expect = 1e-36
 Identities = 51/302 (16%), Positives = 99/302 (32%), Gaps = 67/302 (22%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
             D++ +  +G G + +VF+  +    +  +IK +K    +K +RE+K L  L    N+V
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDH-VNIV 67

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--------------------PTLTDYDIRY 223
                         +       S   K L+                      L       
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKT-KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
              ++ K +DY HS+ +++RD+KP N+ +    +++++ D+GL        +      + 
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            +  PE +   QDY   +D+++LG + A ++   +  F        L             
Sbjct: 186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG---------- 234

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                    +                              +    L KLL    +DR   
Sbjct: 235 --------IISDI------------------------FDKKEKTLLQKLLSKKPEDRPNT 262

Query: 404 RE 405
            E
Sbjct: 263 SE 264

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  135 bits (341), Expect = 2e-36
 Identities = 72/329 (21%), Positives = 139/329 (42%), Gaps = 65/329 (19%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPVKK--KKIKREIKILQNLC-----G 178
           YE+V  +G G + +V E I+         +KI+K V +  +  + EI++L++L       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 179 GPNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
               V++L+         IV +      S  ++++    F           IR   Y++ 
Sbjct: 76  TFRCVQMLEWFEHHGHICIVFELLG--LST-YDFIKENGFLPFRLDH----IRKMAYQIC 128

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELR------------------KLRLIDWGLAEFYH 271
           K++++ HS  + H D+KP N++                         ++++D+G A +  
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNH 327
                 + V++R+++ PE+++ L  +    D+WS+GC     + G        F  HD+ 
Sbjct: 189 E-HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLG-----FTVFPTHDSK 240

Query: 328 DQLVKIAKVLGT--DEL--NAYLNKYH--LELDPQLDALVGRHSR---KPWSKFINADNQ 378
           + L  + ++LG     +       KY     LD    +  GR+     KP  +F+ + + 
Sbjct: 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300

Query: 379 HLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                   D + K+L YD   R+T REA+
Sbjct: 301 EH--ERLFDLIQKMLEYDPAKRITLREAL 327

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  135 bits (342), Expect = 2e-36
 Identities = 70/325 (21%), Positives = 138/325 (42%), Gaps = 57/325 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGI-NVNTNERCIIKILKPVKK--KKIKREIKILQNLC-----G 178
           YE+V  +G G + +V E + +     +  +KI++ V K  +  + EI +L+ +       
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 179 GPNVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELL 229
               V + D         I  +      +  FE++   +F+          +R+  Y+L 
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLG--KNT-FEFLKENNFQPYPLPH----VRHMAYQLC 133

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRK------------------LRLIDWGLAEFYH 271
            AL + H   + H D+KP N++  +   +                  +R+ D+G A F H
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                 + VA+R+++ PE++++L  +    D+WS+GC+     +R    F  H+N + LV
Sbjct: 194 E-HHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLV 249

Query: 332 KIAKVLGT--DEL--NAYLNKYHLE-----LDPQLDALVGRHSRKPWSKFINADNQHLVS 382
            + K+LG     +       KY  +      +   D    + + KP   ++  D+     
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH-- 307

Query: 383 PEAIDFLDKLLRYDHQDRLTAREAM 407
            +  D + ++L +D   R+T  EA+
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEAL 332

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  135 bits (341), Expect = 3e-36
 Identities = 67/329 (20%), Positives = 135/329 (41%), Gaps = 59/329 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNL----CGGP 180
           + V+RK+G G +  V    +++  +   +K+++ +KK  +  K E  IL+ +        
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 181 NVVKLLD---------IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
           N+VK            ++ +     PSL +E +   ++   +       I+ Y  E+LKA
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLG--PSL-YEIITRNNYNGFHIED----IKLYCIEILKA 149

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRK------------------------LRLIDWGLA 267
           L+Y     + H D+KP N+++D    +                        ++LID+G A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH 327
            F       ++ + +R ++ PE++++L  +D S DMWS GC+ A + +     F  H++ 
Sbjct: 210 TFKSD-YHGSI-INTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL-YTGSLLFRTHEHM 265

Query: 328 DQLVKIAKVLGT--DEL-----NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL 380
           + L  +  ++      +         +KY  + + +L       S             + 
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325

Query: 381 VS--PEAIDFLDKLLRYDHQDRLTAREAM 407
           +       DFL  +L+ D   R +  E +
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELL 354

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  138 bits (349), Expect = 7e-36
 Identities = 67/299 (22%), Positives = 118/299 (39%), Gaps = 32/299 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
             +E+  ++G G +  V   I+ +T E+  IK  +    P  +++   EI+I++ L   P
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP 72

Query: 181 NVVKLLDIVRDQHSKTPS----LIFEYVNSTD-FKVL-----YPTLTDYDIRYYIYELLK 230
           NVV   ++        P+    L  EY    D  K L        L +  IR  + ++  
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 231 ALDYCHSQGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           AL Y H   I+HRD+KP N+++    +    ++ID G A+    G+     V +  +  P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           ELL + + Y  ++D WS G +    I    P F  +    Q     +    + +  Y   
Sbjct: 193 ELL-EQKKYTVTVDYWSFGTLAFECITGFRP-FLPNWQPVQWHGKVREKSNEHIVVY--- 247

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                   L   V   S  P    ++      +      +L  +L +  + R T  +  
Sbjct: 248 ------DDLTGAVKFSSVLPTPNHLSGILAGKLER----WLQCMLMWHQRQRGTDPQNP 296

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  130 bits (328), Expect = 1e-34
 Identities = 58/296 (19%), Positives = 100/296 (33%), Gaps = 58/296 (19%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
           +        +VGRG + EV    +  T  +C +K ++   +     E+     L   P +
Sbjct: 56  EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-PRI 112

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG 239
           V L   VR+      ++  E +              L +    YY+ + L+ L+Y H++ 
Sbjct: 113 VPLYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVD 293
           I+H DVK  NV++  +  +  L D+G A    P       +   Y  G      PE +V 
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVM 229

Query: 294 LQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            +  D  +D+WS  C    M  G        +  +      +KIA               
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNG-----CHPWTQYFRGPLCLKIAS-------------- 270

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                             P       +     +P     + + LR +   R +A E
Sbjct: 271 ---------------EPPP-----IREIPPSCAPLTAQAIQEGLRKEPVHRASAME 306

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  128 bits (324), Expect = 2e-34
 Identities = 52/310 (16%), Positives = 98/310 (31%), Gaps = 71/310 (22%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCG 178
             ++  + K+G G++  VF+ +         IK  K      V ++   RE+     L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 179 GPNVVKLLDIVRDQHSKTPSLIF-EYVNS-------TDFKVLYPTLTDYDIRYYIYELLK 230
             +VV+      +       LI  EY N        ++   +     + +++  + ++ +
Sbjct: 70  HSHVVRYFSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-------------- 276
            L Y HS  ++H D+KP N+ I          + G  + +   K                
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
             V      F   E+L +   +    D+++L          +     G   H    +I +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH----EIRQ 242

Query: 336 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 395
                                     GR  R P         Q L S E  + L  ++  
Sbjct: 243 --------------------------GRLPRIP---------QVL-SQEFTELLKVMIHP 266

Query: 396 DHQDRLTARE 405
           D + R +A  
Sbjct: 267 DPERRPSAMA 276

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  128 bits (324), Expect = 4e-34
 Identities = 56/339 (16%), Positives = 120/339 (35%), Gaps = 66/339 (19%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERC 153
           M  +  +   +  R   Y  ++   V   ++  Y  ++K+G G +S V     ++     
Sbjct: 1   MGSSHHHHHHSSGRENLY--FQGHMVIIDNKH-YLFIQKLGEGGFSYVDLVEGLHDGHFY 57

Query: 154 IIKIL---KPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS--LIFEYVNSTD 208
            +K +   +   +++ +RE  + +     PN+++L+     +        L+  +     
Sbjct: 58  ALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT 116

Query: 209 -------FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
                   K     LT+  I + +  + + L+  H++G  HRD+KP N+++  E  +  L
Sbjct: 117 LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVL 175

Query: 262 IDWGLAEFYHPGKEYNVRVASR----------YFKGPELLVDLQDY---DYSLDMWSLGC 308
           +D G         E + +  +            ++ PE L  +Q +   D   D+WSLGC
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGC 234

Query: 309 MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKP 368
           +   M+F + P+       D +    +           N+  +   P+            
Sbjct: 235 VLYAMMFGEGPYDMVFQKGDSVALAVQ-----------NQLSIPQSPR------------ 271

Query: 369 WSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                        S      L+ ++  D   R      +
Sbjct: 272 ------------HSSALWQLLNSMMTVDPHQRPHIPLLL 298

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  127 bits (321), Expect = 5e-34
 Identities = 60/308 (19%), Positives = 114/308 (37%), Gaps = 58/308 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
           +DYEV+  +G G Y    +    +  +  + K      +   +K+ +  E+ +L+ L   
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKAL 232
           PN+V+  D + D+ + T  ++ EY    D              L +  +   + +L  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 233 DYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 286
             CH +      ++HRD+KP NV +D + + ++L D+GLA   +    +    V + Y+ 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +     Y+   D+WSLGC+   +     PF     +  +L                
Sbjct: 184 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAG-------------- 226

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                         +     +              S E  + + ++L      R +  E 
Sbjct: 227 -------------KIREGKFRRIPYRY--------SDELNEIITRMLNLKDYHRPSVEEI 265

Query: 407 MVISSISP 414
           +    I  
Sbjct: 266 LENPLILE 273

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  126 bits (319), Expect = 1e-33
 Identities = 51/314 (16%), Positives = 105/314 (33%), Gaps = 75/314 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
            D+E ++ +GRG +  VFE  N   +    IK ++     + ++K+ RE+K L  L   P
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 63

Query: 181 NVVKLLDIVRDQHSKTPS----------LIFEYVNSTDFKVL------YPTLTDYDIRYY 224
            +V+  +   ++++              +  +     + K                  + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-------EFYHPGKEYN 277
             ++ +A+++ HS+G+MHRD+KP N+    +   +++ D+GL        E         
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 278 VRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
                    G      PE +     Y + +D++SLG +   +++   PF    +    L 
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
            +                             +       K           P     +  
Sbjct: 239 DVRN--------------------------LKFPPLFTQK----------YPCEYVMVQD 262

Query: 392 LLRYDHQDRLTARE 405
           +L     +R  A  
Sbjct: 263 MLSPSPMERPEAIN 276

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  125 bits (316), Expect = 2e-33
 Identities = 65/303 (21%), Positives = 127/303 (41%), Gaps = 75/303 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--------KIKREIKILQNL 176
           +D+E+ R +G+GK+  V+      +     +K+L   K +        +++RE++I  +L
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT--LTDYDIRYYIYELLKALD 233
              PN+++L     D  +    LI EY      ++ L       +     YI EL  AL 
Sbjct: 67  RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--------EYNVRVASRYF 285
           YCHS+ ++HRD+KP N+++      L++ D+G +      +        +Y   +     
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLDY---LP---- 175

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNA 344
             PE++   + +D  +D+WSLG +    +  K PF    + + +   +I++V        
Sbjct: 176 --PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE--ANTYQETYKRISRV-------- 222

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
              ++     P             +           V+  A D + +LL+++   R   R
Sbjct: 223 ---EFTF---P------------DF-----------VTEGARDLISRLLKHNPSQRPMLR 253

Query: 405 EAM 407
           E +
Sbjct: 254 EVL 256

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  124 bits (314), Expect = 7e-33
 Identities = 63/296 (21%), Positives = 117/296 (39%), Gaps = 55/296 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIK------ILKPVKKKKIKREIKILQNLCG 178
            ++ + +K+GRG++SEV+    +       +K      ++    +    +EI +L+ L  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------FKVLYPTLTDYDIRYYIYELLKA 231
            PNV+K      + +    +++ E  ++ D       FK     + +  +  Y  +L  A
Sbjct: 92  -PNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 290
           L++ HS+ +MHRD+KP NV I      ++L D GL  F+       +  V + Y+  PE 
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNAYLNKY 349
           + +   Y++  D+WSLGC+   M   + PF+    N   L  KI +              
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-------------- 252

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                         +   P   +         S E    ++  +  D + R     
Sbjct: 253 ------------CDYPPLPSDHY---------SEELRQLVNMCINPDPEKRPDVTY 287

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  123 bits (311), Expect = 3e-32
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 25/201 (12%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---------KPVKKKKIKREIKILQN 175
             Y+V   +G G +  V+ GI V+ N    IK +         +     ++  E+ +L+ 
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 176 LC-GGPNVVKLLDIVRDQHSKTPS---LIFEYVNST----DFKVLYPTLTDYDIRYYIYE 227
           +  G   V++LLD       + P    LI E         DF      L +   R + ++
Sbjct: 103 VSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 287
           +L+A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSP 216

Query: 288 PELLVDLQDYD-YSLDMWSLG 307
           PE +     Y   S  +WSLG
Sbjct: 217 PEWIRY-HRYHGRSAAVWSLG 236

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  121 bits (306), Expect = 5e-32
 Identities = 62/304 (20%), Positives = 129/304 (42%), Gaps = 74/304 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
           +D++V   +G+G ++ V+   +++T     IK++      K    ++++ E+KI   L  
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYP---TLTDYDIRYYIYELLKALDY 234
            P++++L +   D  S    L+ E  ++ +  + L       ++ + R+++++++  + Y
Sbjct: 71  -PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRY 284
            HS GI+HRD+   N+++   +  +++ D+GLA       E          Y   ++   
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMN-IKIADFGLATQLKMPHEKHYTLCGTPNY---IS--- 180

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELN 343
              PE+      +    D+WSLGCMF  ++  + PF    D     + K+          
Sbjct: 181 ---PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFD--TDTVKNTLNKVVL-------- 226

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                Y +   P             +           +S EA D + +LLR +  DRL+ 
Sbjct: 227 ---ADYEM---P------------SF-----------LSIEAKDLIHQLLRRNPADRLSL 257

Query: 404 REAM 407
              +
Sbjct: 258 SSVL 261

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  121 bits (306), Expect = 6e-32
 Identities = 54/286 (18%), Positives = 108/286 (37%), Gaps = 51/286 (17%)

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGGPNVVKLL 186
           ++GRG +  V++G++  T        L+  K  K      K E ++L+ L   PN+V+  
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFY 91

Query: 187 DIVRDQHSKTPSLIF--EYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG-- 239
           D           ++   E + S     +   +  +    +R +  ++LK L + H++   
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           I+HRD+K  N+ I      +++ D GLA          V + +  F  PE+    + YD 
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EEKYDE 208

Query: 300 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 359
           S+D+++ G     M   + P +    N  Q+ +                           
Sbjct: 209 SVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRVT------------------------ 243

Query: 360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                     S    A    +  PE  + ++  +R +  +R + ++
Sbjct: 244 ----------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  122 bits (309), Expect = 9e-32
 Identities = 54/293 (18%), Positives = 117/293 (39%), Gaps = 55/293 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGG 179
           + Y  ++K+G G + +     +     + +IK      +   ++++ +RE+ +L N+   
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL----YPTLTDYDIRYYIYELLKALDY 234
           PN+V+  +   +  + +  ++ +Y    D FK +         +  I  +  ++  AL +
Sbjct: 83  PNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 293
            H + I+HRD+K  N+ +  +   ++L D+G+A   +   E     + + Y+  PE+  +
Sbjct: 141 VHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNAYLNKYHLE 352
            + Y+   D+W+LGC+   +   K  F     +   LV KI                   
Sbjct: 200 -KPYNNKSDIWALGCVLYELCTLKHAFE--AGSMKNLVLKIIS----------------- 239

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                    G     P S           S +    + +L + + +DR +   
Sbjct: 240 ---------GSF--PPVSLHY--------SYDLRSLVSQLFKRNPRDRPSVNS 273

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  122 bits (307), Expect = 1e-31
 Identities = 65/303 (21%), Positives = 123/303 (40%), Gaps = 73/303 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
             Y   R +G+G +++ FE  + +T E    KI+      KP +++K+  EI I ++L  
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
             +VV       D  +    ++ E        +       LT+ + RYY+ +++    Y 
Sbjct: 101 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 285
           H   ++HRD+K  N+ ++ +L  +++ D+GLA       E          Y   +A    
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 209

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL-VKIAKVLGTDELNA 344
             PE+L   + + + +D+WS+GC+   ++  K PF        +  ++I K         
Sbjct: 210 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKK--------- 255

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
             N+Y +   P                         ++P A   + K+L+ D   R T  
Sbjct: 256 --NEYSI---P------------KH-----------INPVAASLIQKMLQTDPTARPTIN 287

Query: 405 EAM 407
           E +
Sbjct: 288 ELL 290

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (305), Expect = 1e-31
 Identities = 65/303 (21%), Positives = 123/303 (40%), Gaps = 73/303 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCG 178
             Y   R +G+G +++ FE  + +T E    KI+      KP +++K+  EI I ++L  
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
             +VV       D  +    ++ E        +       LT+ + RYY+ +++    Y 
Sbjct: 75  -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 285
           H   ++HRD+K  N+ ++ +L  +++ D+GLA       E          Y   +A    
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDLE-VKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 183

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL-VKIAKVLGTDELNA 344
             PE+L   + + + +D+WS+GC+   ++  K PF        +  ++I K         
Sbjct: 184 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKK--------- 229

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR 404
             N+Y +   P                         ++P A   + K+L+ D   R T  
Sbjct: 230 --NEYSI---P------------KH-----------INPVAASLIQKMLQTDPTARPTIN 261

Query: 405 EAM 407
           E +
Sbjct: 262 ELL 264

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  120 bits (303), Expect = 2e-31
 Identities = 63/302 (20%), Positives = 124/302 (41%), Gaps = 73/302 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           DD+++ R +G+GK+  V+            +K+L   +      + +++REI+I  +L  
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL--YPTLTDYDIRYYIYELLKALDYC 235
            PN++++ +   D   K   L+ E+    + +K L  +    +     ++ EL  AL YC
Sbjct: 74  -PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---------EYNVRVASRYFK 286
           H + ++HRD+KP N+++ ++   L++ D+G +  + P           +Y   +      
Sbjct: 131 HERKVIHRDIKPENLLMGYKGE-LKIADFGWS-VHAPSLRRRTMCGTLDY---LP----- 180

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNAY 345
            PE++   + +D  +D+W  G +    +    PF     +H +   +I  V         
Sbjct: 181 -PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFD--SPSHTETHRRIVNV--------- 227

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                    P            P+           +S  + D + KLLRY    RL  + 
Sbjct: 228 --DLKF---P------------PF-----------LSDGSKDLISKLLRYHPPQRLPLKG 259

Query: 406 AM 407
            M
Sbjct: 260 VM 261

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (305), Expect = 2e-31
 Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 34/226 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGPNVV 183
             V R +  G ++ V+E  +V +     +K L   +  K + I +E+  ++ L G PN+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 184 KLLD--IVRDQHSKTPSLIF----EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKAL 232
           +      +  + S T    F    E       + L        L+   +    Y+  +A+
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 233 DYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR------- 283
            + H Q   I+HRD+K  N+++ ++   ++L D+G A       +Y+     R       
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 284 ------YFKGPELLVDL---QDYDYSLDMWSLGCMFAGMIFRKEPF 320
                  ++ PE ++DL          D+W+LGC+   + FR+ PF
Sbjct: 209 TRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  120 bits (302), Expect = 8e-31
 Identities = 43/280 (15%), Positives = 96/280 (34%), Gaps = 38/280 (13%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-----ERCIIKILKPVKKKKIKREIKILQNLC 177
                 V   +G G +++V+E    + N     ++ ++K+ KP    +     ++++ L 
Sbjct: 63  GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122

Query: 178 GG--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF--------KVLYPTLTDYDIRYYIYE 227
                  +K       Q+     L+ E  +                  +    +  +   
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELR----------KLRLIDWGLA---EFYHPGK 274
           +L  ++  H   I+H D+KP N ++ +              L LID G +   + +  G 
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 334
            +  +  +  F+  E+L + + ++Y +D + +      M+F             +   + 
Sbjct: 241 IFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299

Query: 335 KV-----LGTDELNAYLNKYHLELDPQLDALVGRHSRKPW 369
           +      +  +  +  LN       P LD L  R   K  
Sbjct: 300 RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL--RQKLKKV 337

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  119 bits (300), Expect = 9e-31
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 27/203 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---------KPVKKKKIKREIKILQN 175
            +Y +   +G+G +  VF G  +    +  IK++                   E+ +L  
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 176 LCGG---PNVVKLLDIVRDQHSKTPS---LIFEYVNST----DFKVLYPTLTDYDIRYYI 225
           +  G   P V++LLD       +T     L+ E         D+      L +   R + 
Sbjct: 91  VGAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 285
            +++ A+ +CHS+G++HRD+K  N++ID      +LID+G     H    Y     +R +
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVY 204

Query: 286 KGPELLVDLQDYD-YSLDMWSLG 307
             PE +     Y      +WSLG
Sbjct: 205 SPPEWISR-HQYHALPATVWSLG 226

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  118 bits (297), Expect = 3e-30
 Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 21/211 (9%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----------PVKKKKIKREIKILQ 174
            Y  +  +G G +  V+  ++   N+  ++K +K             K  K+  EI IL 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST----DFKVLYPTLTDYDIRYYIYELLK 230
            +    N++K+LDI  +Q      L+ E   S      F   +P L +    Y   +L+ 
Sbjct: 85  RVEH-ANIIKVLDIFENQ--GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 290
           A+ Y   + I+HRD+K  N++I  +   ++LID+G A +   GK +     +  +  PE+
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFT-IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 291 LVDLQDYD-YSLDMWSLGCMFAGMIFRKEPF 320
           L+    Y    L+MWSLG     ++F + PF
Sbjct: 201 LMG-NPYRGPELEMWSLGVTLYTLVFEENPF 230

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  115 bits (291), Expect = 1e-29
 Identities = 64/293 (21%), Positives = 110/293 (37%), Gaps = 67/293 (22%)

Query: 133 VGRGKYSEVFEGINVNTNERCIIKILKPVKK---KKIKREIKILQNLCGGPNVVKLLDIV 189
           +G+G Y  V+ G +++   R  IK +        + +  EI + ++L    N+V+ L   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSF 88

Query: 190 RDQHSKTPSLIFEYVN----STDFKVLYPTLTDYD--IRYYIYELLKALDYCHSQGIMHR 243
            +       +  E V     S   +  +  L D +  I +Y  ++L+ L Y H   I+HR
Sbjct: 89  SENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146

Query: 244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE-LLVDLQD 296
           D+K  NV+I+     L++ D+G +      +   +   +  F G      PE +    + 
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201

Query: 297 YDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
           Y  + D+WSLGC    M  G    K PF+   +    + K+              K H E
Sbjct: 202 YGKAADIWSLGCTIIEMATG----KPPFYELGEPQAAMFKVGM-----------FKVHPE 246

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
           +   +                        S EA  F+ K    D   R  A +
Sbjct: 247 IPESM------------------------SAEAKAFILKCFEPDPDKRACAND 275

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  116 bits (293), Expect = 1e-29
 Identities = 66/317 (20%), Positives = 122/317 (38%), Gaps = 60/317 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--------------------PVKKK 164
           +DY ++R + +GK++++        N+   +K  +                      K  
Sbjct: 31  NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 165 KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-----------NSTDFKVLY 213
             K E++I+ ++      +    I+ +       +I+EY+                K   
Sbjct: 89  DFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 214 PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
             +    I+  I  +L +  Y H++  I HRDVKP N+++D   R ++L D+G +E Y  
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESE-YMV 203

Query: 273 GKEYNVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
            K+      +  F  PE   +   Y+   +D+WSLG     M +   PF     +  +L 
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF-SLKISLVELF 262

Query: 332 -KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
             I                   LD         H   P +   +  + + +S E IDFL 
Sbjct: 263 NNIRTK-----------NIEYPLDRN-------HFLYPLTNKKSTCSNNFLSNEDIDFLK 304

Query: 391 KLLRYDHQDRLTAREAM 407
             LR +  +R+T+ +A+
Sbjct: 305 LFLRKNPAERITSEDAL 321

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  117 bits (293), Expect = 2e-29
 Identities = 43/331 (12%), Positives = 92/331 (27%), Gaps = 95/331 (28%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNL--- 176
                  +G+       E  +  T E   + +    ++      K++K E+  L+ L   
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 177 ---------------------CGGPNVVKLLDIVRDQHSKTPSLIFEYVNST-------- 207
                                     ++++    RD    +   ++  + S         
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 208 -DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL 266
                 + +L  +       ++++ L   H  G++H  ++P ++++D     + L  +  
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEH 252

Query: 267 AEFYHPGKEYNVRVASRYFKGPELLVDLQD----------YDYSLDMWSLGCMFAGMIFR 316
                      V   SR F+ PEL                  +S D W+LG +   +   
Sbjct: 253 L---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 317 KEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINAD 376
             P                   T +     +++                           
Sbjct: 310 DLPI------------------TKDAALGGSEWIFRSCKN-------------------- 331

Query: 377 NQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
               +       L+  LRY  +DRL   +AM
Sbjct: 332 ----IPQPVRALLEGFLRYPKEDRLLPLQAM 358

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  114 bits (288), Expect = 5e-29
 Identities = 52/194 (26%), Positives = 105/194 (54%), Gaps = 20/194 (10%)

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKI-----LKPVKKKKIKREIKILQNLCGGP 180
           +Y +++ +G+G +++V    ++ T     IKI     L P   +K+ RE++I++ L   P
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74

Query: 181 NVVKLLDIVRDQHSKTPS---LIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           N+VKL +++     +T     LI EY +     D+ V +  + + + R    +++ A+ Y
Sbjct: 75  NIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH + I+HRD+K  N+++D ++  +++ D+G +  +  G + +    +  +  PEL    
Sbjct: 130 CHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG- 187

Query: 295 QDYD-YSLDMWSLG 307
           + YD   +D+WSLG
Sbjct: 188 KKYDGPEVDVWSLG 201

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  112 bits (283), Expect = 2e-28
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 17/196 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-------PVKKKKIKREIKILQNLCGG 179
           Y +   +G G Y +V E ++  T  R  +KILK       P  +  +K+EI++L+ L   
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH- 65

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
            NV++L+D++ ++  +   ++ EY           V            Y  +L+  L+Y 
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLV 292
           HSQGI+H+D+KP N+++      L++   G+AE  HP    +       S  F+ PE+  
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGT-LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184

Query: 293 DLQDYD-YSLDMWSLG 307
            L  +  + +D+WS G
Sbjct: 185 GLDTFSGFKVDIWSAG 200

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  110 bits (277), Expect = 8e-28
 Identities = 64/299 (21%), Positives = 117/299 (39%), Gaps = 65/299 (21%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
           +D+++V+ +G G Y EV   +N  T E   +KI+   +     + IK+EI I + L    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           NVVK          +  ++ +   EY +     D       + + D + + ++L+  + Y
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 291
            H  GI HRD+KP N+++D     L++ D+GLA  +       +      +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 292 VDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
              +++    +D+WS G     M AG +    P+    D+  +     +           
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE----------- 223

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                           +    PW K              +  L K+L  +   R+T  +
Sbjct: 224 ---------------KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPD 258

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 2e-27
 Identities = 67/304 (22%), Positives = 122/304 (40%), Gaps = 65/304 (21%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI--LKPVKKKKIKREIKILQNLCGGPN 181
              +E+V  VG G Y +V++G +V T +   IK+  +   ++++IK+EI +L+      N
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 182 VVKLLDIVRDQHSKTPS----LIFEY---------VNSTDFKVLYPTLTDYDIRYYIYEL 228
           +         ++         L+ E+         + +T       TL +  I Y   E+
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREI 138

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 287
           L+ L + H   ++HRD+K  NV++     +++L+D+G+ A+        N  + + Y+  
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 288 PELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDE 341
           PE++   ++    YD+  D+WSLG     M     P     D H    L  I +      
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC---DMHPMRALFLIPR------ 248

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                N       P+L +       K WSK                F++  L  +H  R 
Sbjct: 249 -----NP-----APRLKS-------KKWSKKFQ------------SFIESCLVKNHSQRP 279

Query: 402 TARE 405
              +
Sbjct: 280 ATEQ 283

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  108 bits (272), Expect = 9e-27
 Identities = 64/299 (21%), Positives = 117/299 (39%), Gaps = 65/299 (21%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
           +D+++V+ +G G Y EV   +N  T E   +KI+   +     + IK+EI I + L    
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           NVVK          +  ++ +   EY +     D       + + D + + ++L+  + Y
Sbjct: 66  NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 291
            H  GI HRD+KP N+++D     L++ D+GLA  +       +      +  +  PELL
Sbjct: 121 LHGIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 292 VDLQDYD-YSLDMWSLG----CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
              +++    +D+WS G     M AG +    P+    D+  +     +           
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE----------- 223

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                           +    PW K              +  L K+L  +   R+T  +
Sbjct: 224 ---------------KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPD 258

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  105 bits (264), Expect = 6e-26
 Identities = 63/326 (19%), Positives = 115/326 (35%), Gaps = 80/326 (24%)

Query: 115 ESLTVQW-GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKRE 169
           +S  + W  ++DDYE+   +G G  + V         E+  IK +          ++ +E
Sbjct: 4   DSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKE 63

Query: 170 IKILQNLCGGPNVVK----------------------LLDIVRDQHSKTPSLIFEYVNST 207
           I+ +   C  PN+V                       +LDI++   +K            
Sbjct: 64  IQAMS-QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------- 114

Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                   L +  I   + E+L+ L+Y H  G +HRDVK  N+++  +   +++ D+G++
Sbjct: 115 -----SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVS 168

Query: 268 EFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFF 321
            F   G +       + F G      PE++  ++ YD+  D+WS G     +     P+ 
Sbjct: 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY- 227

Query: 322 YGHDNH--DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQH 379
             H       L+   +                   P L+  V         K+       
Sbjct: 228 --HKYPPMKVLMLTLQ----------------NDPPSLETGVQDKEML--KKY------- 260

Query: 380 LVSPEAIDFLDKLLRYDHQDRLTARE 405
                    +   L+ D + R TA E
Sbjct: 261 --GKSFRKMISLCLQKDPEKRPTAAE 284

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  105 bits (264), Expect = 7e-26
 Identities = 56/229 (24%), Positives = 110/229 (48%), Gaps = 38/229 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKK------------------- 164
           Y +  ++G+G Y  V    N N N    +K+L   K +++                    
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 165 -------KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLYPT- 215
                  ++ +EI IL+     PNVVKL++++ D +     ++FE VN     +V     
Sbjct: 75  QPRGPIEQVYQEIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           L++   R+Y  +L+K ++Y H Q I+HRD+KP N+++  +   +++ D+G++  +     
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDA 192

Query: 276 Y-NVRVASRYFKGPELLVDL-QDYD-YSLDMWSLGC-MFAGMIFRKEPF 320
             +  V +  F  PE L +  + +   +LD+W++G  ++   +F + PF
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC-FVFGQCPF 240

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  106 bits (267), Expect = 7e-26
 Identities = 47/193 (24%), Positives = 91/193 (47%), Gaps = 17/193 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL--KPVKKKKIKREIKILQNLCGGPNV 182
           D Y+ V+ +G G +       +  T E   +K +       + ++REI   ++L   PN+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNI 78

Query: 183 VKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
           V+  +++      TP+ +    EY +     +        ++ + R++  +LL  + YCH
Sbjct: 79  VRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 237 SQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S  I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+  Q
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-Q 192

Query: 296 DYD-YSLDMWSLG 307
           +YD    D+WS G
Sbjct: 193 EYDGKIADVWSCG 205

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  104 bits (262), Expect = 8e-26
 Identities = 54/194 (27%), Positives = 95/194 (48%), Gaps = 21/194 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGP 180
           Y +   +G G + +V  G +  T  +  +KIL   K        KIKREI+ L+     P
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-P 71

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           +++KL  ++      TP+  F   EYV+     D+   +  + + + R    ++L A+DY
Sbjct: 72  HIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++   
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 184

Query: 295 QDYD-YSLDMWSLG 307
           + Y    +D+WS G
Sbjct: 185 RLYAGPEVDIWSCG 198

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  105 bits (264), Expect = 1e-25
 Identities = 50/193 (25%), Positives = 95/193 (49%), Gaps = 20/193 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL------KPVKKKKIKREIKILQNLCGGP 180
           Y +   +G G + +V    +  T ++  +K +      K     +++REI  L+ L   P
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST--DFKVLYPTLTDYDIRYYIYELLKALDYC 235
           +++KL D++      TP+ I    EY      D+ V    +T+ + R +  +++ A++YC
Sbjct: 70  HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           H   I+HRD+KP N+++D  L  +++ D+GL+     G        S  +  PE++   +
Sbjct: 125 HRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-K 182

Query: 296 DYD-YSLDMWSLG 307
            Y    +D+WS G
Sbjct: 183 LYAGPEVDVWSCG 195

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  105 bits (264), Expect = 2e-25
 Identities = 59/319 (18%), Positives = 109/319 (34%), Gaps = 47/319 (14%)

Query: 123 DQDDYEVVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQN 175
           +   YE++  +G+G      V       T E   ++ +            ++ E+ + + 
Sbjct: 23  EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK- 81

Query: 176 LCGGPNVVKLLD--IVRDQHSKTPSL--IFEYVNS---TDF-KVLYP-TLTDYDIRYYIY 226
           L   PN+V      I  ++      L  +  ++      D     +   + +  I Y + 
Sbjct: 82  LFNHPNIVPYRATFIADNE------LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE--FYHPGKEYNVRVASRY 284
            +LKALDY H  G +HR VK  +++I  +  K+ L           H  ++  V    +Y
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 285 FKG------PELLV-DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ--LVKIAK 335
                    PE+L  +LQ YD   D++S+G     +     PF    D      L++   
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF---KDMPATQMLLEKLN 251

Query: 336 ---------VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAI 386
                         E         +      D+L     R       +       SP   
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

Query: 387 DFLDKLLRYDHQDRLTARE 405
            F+++ L+ +   R +A  
Sbjct: 312 HFVEQCLQRNPDARPSAST 330

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (259), Expect = 3e-25
 Identities = 67/292 (22%), Positives = 119/292 (40%), Gaps = 54/292 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-KKIKREIKILQNLCGGPNV 182
           ++ ++V+ K+G G Y  V++ I+  T +   IK +      ++I +EI I+Q  C  P+V
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ-CDSPHV 86

Query: 183 VKLLDIVRDQHSKTPSL--IFEYVNS---TD-FKVLYPTLTDYDIRYYIYELLKALDYCH 236
           VK        + K   L  + EY  +   +D  ++   TLT+ +I   +   LK L+Y H
Sbjct: 87  VKYYG----SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
               +HRD+K  N++++ E    +L D+G+  +      + N  + + ++  PE++ +  
Sbjct: 143 FMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 200

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLEL 353
            Y+   D+WSLG     M   K P+    D H    +  I                    
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYA---DIHPMRAIFMIPT----------------NP 241

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
            P                        L S    DF+ + L    + R TA +
Sbjct: 242 PPTF------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQ 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  102 bits (257), Expect = 8e-25
 Identities = 65/295 (22%), Positives = 127/295 (43%), Gaps = 60/295 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
           +   +   K+G G    V      ++  +  +K++   K  +++ +  E+ I+++     
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD-YQHF 102

Query: 181 NVVKLLD--IVRDQHSKTPSL--IFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALD 233
           NVV++    +V ++      L  + E++     TD  V    L +  I      +L+AL 
Sbjct: 103 NVVEMYKSYLVGEE------LWVLMEFLQGGALTDI-VSQVRLNEEQIATVCEAVLQALA 155

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 292
           Y H+QG++HRD+K  ++++  +  +++L D+G  A+      +    V + Y+  PE++ 
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYH 350
               Y   +D+WSLG M   M+  + P+F    +     + ++                 
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYF---SDSPVQAMKRLRD--------------- 255

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
               P+L                   N H VSP   DFL+++L  D Q+R TA+E
Sbjct: 256 -SPPPKL------------------KNSHKVSPVLRDFLERMLVRDPQERATAQE 291

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  102 bits (256), Expect = 8e-25
 Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 57/293 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGG 179
           ++ +  + K+G+G + EVF+GI+  T +   IKI+       + + I++EI +L   C  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 79

Query: 180 PNVVKLLDIVRDQHSKTPSL--IFEYVN--STDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           P V K        + K   L  I EY+   S    +    L +  I   + E+LK LDY 
Sbjct: 80  PYVTKYYG----SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYL 135

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS+  +HRD+K  NV++     +++L D+G+  +      + N  V + ++  PE++   
Sbjct: 136 HSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ- 193

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLE 352
             YD   D+WSLG     +   + P     + H    L  I K           N     
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHS---ELHPMKVLFLIPK-----------NN---- 235

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
             P L+          +SK +             +F++  L  +   R TA+E
Sbjct: 236 -PPTLE--------GNYSKPLK------------EFVEACLNKEPSFRPTAKE 267

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  102 bits (255), Expect = 1e-24
 Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 56/293 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL---KPVKKKKIKREIKILQNLCGGP 180
           +  Y    K+G+G    V+  ++V T +   I+ +   +  KK+ I  EI +++     P
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNP 77

Query: 181 NVVKLLDIVRDQHSKTPSL--IFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYC 235
           N+V  LD     +     L  + EY+     TD  V    + +  I     E L+AL++ 
Sbjct: 78  NIVNYLD----SYLVGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFL 132

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+K  N+++  +   ++L D+G  A+      + +  V + Y+  PE +V  
Sbjct: 133 HSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTR 190

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLE 352
           + Y   +D+WSLG M   MI  + P+    + +    L  IA                  
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALYLIAT----------------N 231

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
             P+L                   N   +S    DFL++ L  D + R +A+E
Sbjct: 232 GTPEL------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  104 bits (261), Expect = 1e-24
 Identities = 55/194 (28%), Positives = 94/194 (48%), Gaps = 21/194 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGP 180
           Y +   +G G + +V  G +  T  +  +KIL   K        KI+REI+ L+     P
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-P 76

Query: 181 NVVKLLDIVRDQHSKTPSLIF---EYVNST---DFKVLYPTLTDYDIRYYIYELLKALDY 234
           +++KL  ++      TPS IF   EYV+     D+      L + + R    ++L  +DY
Sbjct: 77  HIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           CH   ++HRD+KP NV++D  +   ++ D+GL+     G+       S  +  PE++   
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 189

Query: 295 QDYD-YSLDMWSLG 307
           + Y    +D+WS G
Sbjct: 190 RLYAGPEVDIWSSG 203

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  100 bits (250), Expect = 6e-24
 Identities = 70/298 (23%), Positives = 124/298 (41%), Gaps = 59/298 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGP 180
            + +E+V ++G G + +V++  N  T      K+++     + +    EI+IL   C  P
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHP 76

Query: 181 NVVKLLDIVRDQHSKTPSL--IFEYVNS---TD-FKVLYPTLTDYDIRYYIYELLKALDY 234
            +VKLL      +     L  + E+            L   LT+  I+    ++L+AL++
Sbjct: 77  YIVKLLG----AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVD 293
            HS+ I+HRD+K  NV++  E   +RL D+G+ A+     ++ +  + + Y+  PE+++ 
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMC 191

Query: 294 LQ----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLN 347
                  YDY  D+WSLG     M   + P     + +    L+KIAK           +
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHH---ELNPMRVLLKIAK-----------S 237

Query: 348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                  P L                        S E  DFL   L  + + R +A +
Sbjct: 238 D-----PPTL------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  100 bits (250), Expect = 7e-24
 Identities = 55/360 (15%), Positives = 113/360 (31%), Gaps = 120/360 (33%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGG 179
             D+E ++ +GRG +  VFE  N   +    IK +    + + ++K+ RE+K L  L   
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EH 63

Query: 180 PNVVKLLD----------------------------------------IVRDQHSKTPSL 199
           P +V+  +                                        I R     T + 
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123

Query: 200 IFEYVNSTDFKVLY--------PTLTDY-------------DIRYYIYELLKALDYCHSQ 238
           + +   S+    LY          L D+                +   ++ +A+++ HS+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----------- 287
           G+MHRD+KP N+    +   +++ D+GL       +E    +                  
Sbjct: 184 GLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 288 --PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 345
             PE +    +Y + +D++SLG +   +++    F    +    +  +            
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN---------- 288

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                            +       K           P+    +  +L     +R  A +
Sbjct: 289 ----------------LKFPLLFTQK----------YPQEHMMVQDMLSPSPTERPEATD 322

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  100 bits (251), Expect = 8e-24
 Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 62/297 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK------IKREIKILQNLC 177
           +  +  +R++G G +  V+   +V  +E   IK +    K+       I +E++ LQ   
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-L 111

Query: 178 GGPNVVKLLDIVRDQHSKTPSL--IFEYVN---STDFKVLYPTLTDYDIRYYIYELLKAL 232
             PN ++        + +  +   + EY     S   +V    L + +I    +  L+ L
Sbjct: 112 RHPNTIQYRG----CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            Y HS  ++HRDVK  N+++      ++L D+G A    P   +   V + Y+  PE+++
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPANSF---VGTPYWMAPEVIL 223

Query: 293 DLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNK 348
            + +  YD  +D+WSLG     +  RK P F   + +    L  IA+           N+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQ-----------NE 269

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                 P L +            +         S    +F+D  L+   QDR T+  
Sbjct: 270 -----SPALQS----------GHW---------SEYFRNFVDSCLQKIPQDRPTSEV 302

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (255), Expect = 1e-23
 Identities = 70/353 (19%), Positives = 128/353 (36%), Gaps = 73/353 (20%)

Query: 79  DKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWG-------DQDDYEVVR 131
            ++E+    ++          Y  V          Y +  +QW         ++ +   R
Sbjct: 131 QRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR 190

Query: 132 KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNLCGGPNV 182
            +G+G + EV       T +    K L+   KK+IK+         E +IL+       V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILE-KVNSRFV 246

Query: 183 VKLLDIVRDQHS--KTPS---LIFEYVNSTD-----FKVLYPTLTDYDIRYYIYELLKAL 232
           V L           +T     L+   +N  D     + +      +    +Y  E+   L
Sbjct: 247 VSL-------AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
           +  H + I++RD+KP N+++D     +R+ D GLA     G+    RV +  +  PE++ 
Sbjct: 300 EDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVK 358

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
           + + Y +S D W+LGC+   MI  + P F       +  ++ +++          +Y   
Sbjct: 359 N-ERYTFSPDWWALGCLLYEMIAGQSP-FQQRKKKIKREEVERLVKEVPE-----EYSER 411

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                                        SP+A     +LL  D  +RL  R 
Sbjct: 412 F----------------------------SPQARSLCSQLLCKDPAERLGCRG 436

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 99.0 bits (246), Expect = 7e-23
 Identities = 43/328 (13%), Positives = 92/328 (28%), Gaps = 92/328 (28%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCGGP 180
                 +G+       E  +  T E   + +    ++      K++K E+  L+ L G  
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 181 NVVKLLDIVRD-------QHSKTPSLIFEYVNSTDFKVLY-------------------- 213
           N  +    +R        +  +   +I   ++  D  VL                     
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 214 ------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                  +L  +       ++++ L   H  G++H  ++P ++++D     + L  +   
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHL 258

Query: 268 EFYHPGKEYNVRVASRY----FKGPELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEP 319
                G      +   +         +L   Q       ++ D W+LG     +     P
Sbjct: 259 V--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 320 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQH 379
                              TD+     +++                              
Sbjct: 317 N------------------TDDAALGGSEWIFRSCKN----------------------- 335

Query: 380 LVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            +       L+  LRY  +DRL   +AM
Sbjct: 336 -IPQPVRALLEGFLRYPKEDRLLPLQAM 362

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 99.2 bits (247), Expect = 2e-22
 Identities = 70/296 (23%), Positives = 115/296 (38%), Gaps = 66/296 (22%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQ- 174
           +D+ V R +GRG + EV+     +T +   +K L    KK+IK          E  +L  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSL 245

Query: 175 -NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYI 225
            +    P +V +            TP     I + +N  D    L      ++ D+R+Y 
Sbjct: 246 VSTGDCPFIVCM-------SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 285
            E++  L++ H++ +++RD+KP N+++D     +R+ D GLA      K+ +  V +  +
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLAC-DFSKKKPHASVGTHGY 356

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 345
             PE+L     YD S D +SLGCM   ++    P F  H   D+       L        
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKHEIDRMTL-------- 407

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                                               SPE    L+ LL+ D   RL
Sbjct: 408 ------------------TMAVELPDSF--------SPELRSLLEGLLQRDVNRRL 437

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 52/295 (17%), Positives = 105/295 (35%), Gaps = 49/295 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCG 178
           + +D E + ++G G   +V++     T     +K +       + K+I  ++ ++     
Sbjct: 23  EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVN--STDFKVLYP-TLTDYDIRYYIYELLKALDYC 235
            P +V+              +  E +   +   K      + +  +      ++KAL Y 
Sbjct: 83  CPYIVQCFGTFITNTDV--FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140

Query: 236 HSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE----L 290
             + G++HRDVKP N+++D    +++L D+G++      K  +       +  PE     
Sbjct: 141 KEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
                DYD   D+WSLG     +   + P+     + + L K+ +               
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--------------- 244

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
            E  P L           +            S +   F+   L  DH+ R    +
Sbjct: 245 -EEPPLLP------GHMGF------------SGDFQSFVKDCLTKDHRKRPKYNK 280

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 98.3 bits (245), Expect = 2e-22
 Identities = 73/362 (20%), Positives = 132/362 (36%), Gaps = 76/362 (20%)

Query: 73  YEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQ-------D 125
            +   + +        +  P +     +      +      Y    +QW          D
Sbjct: 126 LDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGED 185

Query: 126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR---------EIKILQNL 176
            +   R +GRG + EVF      T +    K L    KK++K+         E KIL   
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKRLKKRKGYQGAMVEKKILA-K 241

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTDFKV-LYPTLTDYDI------RYY 224
                +V L           +T +   L+   +N  D +  +Y    D          +Y
Sbjct: 242 VHSRFIVSL-------AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASR 283
             +++  L++ H + I++RD+KP NV++D +   +R+ D GLA E      +      + 
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTP 353

Query: 284 YFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
            F  PELL+  ++YD+S+D ++LG     MI  + P F       +  ++ + +    + 
Sbjct: 354 GFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP-FRARGEKVENKELKQRVLEQAV- 410

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                Y  +                             SP + DF + LL+ D + RL  
Sbjct: 411 ----TYPDKF----------------------------SPASKDFCEALLQKDPEKRLGF 438

Query: 404 RE 405
           R+
Sbjct: 439 RD 440

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 95.3 bits (237), Expect = 6e-22
 Identities = 59/300 (19%), Positives = 113/300 (37%), Gaps = 30/300 (10%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    VF+  +  +      K+    +KP  + +I RE+++L   C  P
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 91

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYD---IRYYIYELLKALDYCHS 237
            +V              S+  E+++      +           +      ++K L Y   
Sbjct: 92  YIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 238 QG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK----EYNVRVASRYFKGPELLV 292
           +  IMHRDVKP N++++    +++L D+G++     G+      N  V +R +  PE L 
Sbjct: 150 KHKIMHRDVKPSNILVNSR-GEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERL- 202

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
               Y    D+WS+G     M   + P     D  +  +     +  D            
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGDAAETPPRPRTPG 261

Query: 353 LDPQLDALVGRHSRKPWS--KFINADN-----QHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                  +  R     +    +I  +        + S E  DF++K L  +  +R   ++
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 77/384 (20%), Positives = 141/384 (36%), Gaps = 83/384 (21%)

Query: 102 DVNVLRPKEYWDYESLTVQWGD--QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK 159
           D     P +Y       V+ GD     Y V+RK+G G +S V+   ++   +   +K++K
Sbjct: 12  DDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK 71

Query: 160 PVKK--KKIKREIKILQNLC-------GGPNVVKLLDI--VRDQHSKTPSLIFEY--VNS 206
             +   +    EI++L+++            VV+LLD   +   +     ++FE    + 
Sbjct: 72  SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHL 131

Query: 207 TDFKVLYPT--LTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMI----------- 252
             + +      L    ++  I ++L+ LDY H++  I+H D+KP N+++           
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191

Query: 253 -------------------------------------DHELRKLRLIDWGLAEFYHPGKE 275
                                                + E  K+++ D G A      K 
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKH 249

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH------DQ 329
           +   + +R ++  E+L+    Y+   D+WS  CM    +   +  F  H         D 
Sbjct: 250 FTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFE-LATGDYLFEPHSGEEYTRDEDH 307

Query: 330 LVKIAKVLGT--DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE--- 384
           +  I ++LG    +L             + D L      KPW  F     ++  S E   
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGD-LKHITKLKPWGLFEVLVEKYEWSQEEAA 366

Query: 385 -AIDFLDKLLRYDHQDRLTAREAM 407
              DFL  +L    + R TA E +
Sbjct: 367 GFTDFLLPMLELIPEKRATAAECL 390

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 56/316 (17%), Positives = 111/316 (35%), Gaps = 90/316 (28%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL----KPVKKKKIKREIKILQNLCGGP 180
           +D + + ++GRG Y  V + ++  + +   +K +       ++K++  ++ ++      P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 181 NVVK---------------------LLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY 219
            +V+                          +  +S    +I E +               
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126

Query: 220 DIRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 278
            +       +KAL++      I+HRD+KP N+++D     ++L D+G++       +   
Sbjct: 127 -LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGIS------GQLVD 178

Query: 279 RVASRYFKG------PELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
            +A     G      PE +      Q YD   D+WSLG     +   + P+   +   DQ
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

Query: 330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFL 389
           L ++ K                   PQL             +F         SP  I+F+
Sbjct: 239 LTQVVK----------------GDPPQLSN-------SEEREF---------SPSFINFV 266

Query: 390 DKLLRYDHQDRLTARE 405
           +  L  D   R   +E
Sbjct: 267 NLCLTKDESKRPKYKE 282

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 91.9 bits (229), Expect = 5e-21
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 71/299 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKI---KREIKILQNLCG 178
           +D++  + +G G +S V     + T+    IKIL+    +K+ K+    RE  ++  L  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 88

Query: 179 GPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLKA 231
            P  VKL        + +          Y  + +  K +    +  +   R+Y  E++ A
Sbjct: 89  HPFFVKLY------FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           L+Y H +GI+HRD+KP N++++ ++  +++ D+G A+     +    R  S  F G    
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAK-VLSPESKQARANS--FVGTAQY 198

Query: 288 --PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVLGTDELNA 344
             PELL + +    S D+W+LGC+   ++    PF     N   +  KI K         
Sbjct: 199 VSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR--AGNEYLIFQKIIK--------- 246

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
              +Y     P+                          P+A D ++KLL  D   RL  
Sbjct: 247 --LEYDF---PE-----------------------KFFPKARDLVEKLLVLDATKRLGC 277

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 68/308 (22%), Positives = 113/308 (36%), Gaps = 82/308 (26%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           DD+E+++ +GRG +SEV       T +   +KI+   K   +KR        E  +L N 
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVN- 117

Query: 177 CGGPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTD-FKVLY---PTLTDYDIRYYIYEL 228
                + +L        + +  +   L+ EY    D   +L      +     R+Y+ E+
Sbjct: 118 GDRRWITQL------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFK 286
           + A+D  H  G +HRD+KP N+++D     +RL D+G         +      V S    
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSC------LKLRADGTVRSLVAV 224

Query: 287 G------PELL------VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           G      PE+L           Y    D W+LG   +  M + + PF+   D+  +    
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE-MFYGQTPFY--ADSTAET--Y 279

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
            K++   E                                       V  EA DF+ +LL
Sbjct: 280 GKIVHYKE-----------------------------HLSLPLVDEGVPEEARDFIQRLL 310

Query: 394 RYDHQDRL 401
               + RL
Sbjct: 311 C-PPETRL 317

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 88.8 bits (220), Expect = 3e-19
 Identities = 45/212 (21%), Positives = 86/212 (40%), Gaps = 17/212 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVK----KKKIKREIKILQNLCGGPN 181
           YEV   +  G    ++  ++ N N R + +K L        +     E + L  +   P+
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPS 140

Query: 182 VVKLLDIVRDQHSKTPSLIF---EYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHS 237
           +V++ + V         + +   EYV     K      L   +   Y+ E+L AL Y HS
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            G+++ D+KP N+M+  E  +L+LID G          +     +  F+ PE++      
Sbjct: 201 IGLVYNDLKPENIMLTEE--QLKLIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPT- 254

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 329
             + D++++G   A +          + +   
Sbjct: 255 VAT-DIYTVGRTLAALTLDLPTRNGRYVDGLP 285

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 86.7 bits (215), Expect = 9e-19
 Identities = 66/306 (21%), Positives = 119/306 (38%), Gaps = 80/306 (26%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           +D+E+++ +GRG + EV      N ++   +KIL   K + +KR        E  +L N 
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY---PTLTDYDIRYYIYE 227
                +  L       H   +  +   L+ +Y    D   +L      L +   R+Y+ E
Sbjct: 131 GDSKWITTL-------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE--YNVRVASRYF 285
           ++ A+D  H    +HRD+KP N+++D     +RL D+G         +   +  V S   
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSC------LKLMEDGTVQSSVA 236

Query: 286 KG------PELLVDLQD----YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            G      PE+L  ++     Y    D WSLG     M++ + PF+   ++  +     K
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY--AESLVET--YGK 292

Query: 336 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 395
           ++         +K   +   Q+                       VS  A D + +L+  
Sbjct: 293 IMN--------HKERFQFPTQVTD---------------------VSENAKDLIRRLIC- 322

Query: 396 DHQDRL 401
             + RL
Sbjct: 323 SREHRL 328

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 80/304 (26%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKR---EIKILQNLCG 178
           +DYEVV+ +GRG + EV    + +T +   +K+L     +K+        E  I+     
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-AN 127

Query: 179 GPNVVKLLDIVRDQHS-KTPS---LIFEYVNSTDFKVLYPTLTDYDI-----RYYIYELL 229
            P VV+L       ++ +      ++ EY+   D   L   +++YD+     R+Y  E++
Sbjct: 128 SPWVVQL------FYAFQDDRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVV 178

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKG 287
            ALD  HS G +HRDVKP N+++D     L+L D+G         + N    V      G
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTC------MKMNKEGMVRCDTAVG 231

Query: 288 ------PELLVD---LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL- 337
                 PE+L        Y    D WS+G     M+    PF+   D+       +K++ 
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGT--YSKIMN 287

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
             + L      +  + D                          +S EA + +   L  D 
Sbjct: 288 HKNSL-----TFPDDND--------------------------ISKEAKNLICAFLT-DR 315

Query: 398 QDRL 401
           + RL
Sbjct: 316 EVRL 319

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 71/301 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
            D++++R +GRG Y++V       T+    +K++K   V   +    ++ E  + +    
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P +V L       HS  +T S    + EYVN  D    +     L +   R+Y  E+  
Sbjct: 69  HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
           AL+Y H +GI++RD+K  NV++D E   ++L D+G+  E   PG           Y   +
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNY---I 177

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
           A      PE+L   +DY +S+D W+LG +   M+  + PF                   D
Sbjct: 178 A------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF-------------------D 211

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
            + +  N      D     ++ +  R P            +S +A   L   L  D ++R
Sbjct: 212 IVGSSDNPDQNTEDYLFQVILEKQIRIP----------RSLSVKAASVLKSFLNKDPKER 261

Query: 401 L 401
           L
Sbjct: 262 L 262

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 71/308 (23%), Positives = 119/308 (38%), Gaps = 86/308 (27%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
            D+  ++ +G+G + +V    +        +K+L+  KK  +K+        E  +L   
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHIMSERNVLLKN 95

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
              P +V L       H   +T      + +Y+N  + F  L       +   R+Y  E+
Sbjct: 96  VKHPFLVGL-------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI 148

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNV 278
             AL Y HS  I++RD+KP N+++D +   + L D+GL  E               EY  
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCGTPEY-- 205

Query: 279 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV-KIAKVL 337
            +A      PE+L   Q YD ++D W LG +   M++   PF+    N  ++   I    
Sbjct: 206 -LA------PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY--SRNTAEMYDNI---- 251

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
                        L    QL         KP            ++  A   L+ LL+ D 
Sbjct: 252 -------------LNKPLQL---------KPN-----------ITNSARHLLEGLLQKDR 278

Query: 398 QDRLTARE 405
             RL A++
Sbjct: 279 TKRLGAKD 286

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 52/299 (17%), Positives = 106/299 (35%), Gaps = 72/299 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
           D +E++R +G+G + +V      +T +   +K +      ++     + +E++I+Q L  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P +V L           +      ++ + +   D    L       +  ++ +I EL+ 
Sbjct: 74  HPFLVNL-------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 287
           ALDY  +Q I+HRD+KP N+++D     + + D+ +A                   G   
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIA------AMLPRETQITTMAGTKP 179

Query: 288 ---PELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL 342
              PE+        Y +++D WSLG     ++  + P ++   +      +         
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP-YHIRSSTSSKEIVHTFE----- 233

Query: 343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                                 +   +            S E +  L KLL  +   R 
Sbjct: 234 ---------------------TTVVTYPSAW--------SQEMVSLLKKLLEPNPDQRF 263

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.5 bits (207), Expect = 7e-18
 Identities = 64/295 (21%), Positives = 114/295 (38%), Gaps = 72/295 (24%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
           D ++ ++ +G G +  V    +  +     +KIL    V K K       E +ILQ    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99

Query: 179 GPNVVKLLDIVRDQHSKTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKAL 232
            P +VKL     +   K  S   ++ EYV   + F  L      ++   R+Y  +++   
Sbjct: 100 FPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 287
           +Y HS  +++RD+KP N++ID +   +++ D+G A      K    R  +    G     
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFA------KRVKGRTWT--LCGTPEAL 205

Query: 288 -PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE+++  + Y+ ++D W+LG +   M     PFF   D   Q+                
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF--ADQPIQI---------------- 246

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
             Y   +  ++           +            S +  D L  LL+ D   R 
Sbjct: 247 --YEKIVSGKVR----------FPSHF--------SSDLKDLLRNLLQVDLTKRF 281

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 71/301 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
            D++++R +GRG Y++V       T+    ++++K   V   +    ++ E  + +    
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P +V L       HS  +T S    + EYVN  D    +     L +   R+Y  E+  
Sbjct: 112 HPFLVGL-------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 164

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
           AL+Y H +GI++RD+K  NV++D E   ++L D+G+  E   PG           Y   +
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNY---I 220

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
           A      PE+L   +DY +S+D W+LG +   M+  + PF                   D
Sbjct: 221 A------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF-------------------D 254

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
            + +  N      D     ++ +  R P            +S +A   L   L  D ++R
Sbjct: 255 IVGSSDNPDQNTEDYLFQVILEKQIRIP----------RSLSVKAASVLKSFLNKDPKER 304

Query: 401 L 401
           L
Sbjct: 305 L 305

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 66/304 (21%), Positives = 113/304 (37%), Gaps = 86/304 (28%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQN 175
           D++E +R +G+G + +V       T +   +K+LK   K  I           E +IL  
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79

Query: 176 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYE 227
               P + +L           +TP     + E+VN  D    +  +    +   R+Y  E
Sbjct: 80  ARNHPFLTQL-------FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 132

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYN 277
           ++ AL + H +GI++RD+K  NV++DHE    +L D+G+  E    G          +Y 
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDY- 190

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             +A      PE+L +   Y  ++D W++G +   M+    P F   +  D    I    
Sbjct: 191 --IA------PEILQE-MLYGPAVDWWAMGVLLYEMLCGHAP-FEAENEDDLFEAILN-- 238

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
             DE+      Y   L                              +A   L   +  + 
Sbjct: 239 --DEV-----VYPTWL----------------------------HEDATGILKSFMTKNP 263

Query: 398 QDRL 401
             RL
Sbjct: 264 TMRL 267

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 61/297 (20%), Positives = 120/297 (40%), Gaps = 56/297 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKI----LKPVKKKKIKREIKILQNLCGGP 180
           DD E + ++GRG Y  V +  +V + +   +K     +   ++K++  ++ I       P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVN-STD-----FKVLYPTLTDYDIRYYIYELLKALDY 234
             V     +  +      +  E ++ S D           T+ +  +      ++KAL++
Sbjct: 67  FTVTFYGALFREG--DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 235 CHSQG-IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE---L 290
            HS+  ++HRDVKP NV+I+    ++++ D+G++ +       ++    + +  PE    
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINP 183

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNK 348
            ++ + Y    D+WSLG     +   + P  Y        QL ++ +             
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTPFQQLKQVVE------------- 228

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
              E  PQL          P  KF         S E +DF  + L+ + ++R T  E
Sbjct: 229 ---EPSPQL----------PADKF---------SAEFVDFTSQCLKKNSKERPTYPE 263

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 74/302 (24%), Positives = 128/302 (42%), Gaps = 83/302 (27%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           +D++ ++ +G+G + +V       T     +KIL+  K+  I +        E ++LQN 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQN- 61

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
              P +  L           +T      + EY N  + F  L      T+   R+Y  E+
Sbjct: 62  TRHPFLTAL-------KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYF 285
           + AL+Y HS+ +++RD+K  N+M+D +   +++ D+GL       KE       + +  F
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC------KEGISDGATMKT--F 165

Query: 286 KG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
            G      PE+L D  DY  ++D W LG +   M+  + P FY   +H++L +   +L  
Sbjct: 166 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYN-QDHERLFE--LIL-M 219

Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
           +E+                       R P            +SPEA   L  LL+ D + 
Sbjct: 220 EEI-----------------------RFP----------RTLSPEAKSLLAGLLKKDPKQ 246

Query: 400 RL 401
           RL
Sbjct: 247 RL 248

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 65/308 (21%), Positives = 112/308 (36%), Gaps = 94/308 (30%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKI---------KREIKILQN 175
            D+  +  +G+G + +V       T+E   +KILK   K  +           E ++L  
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76

Query: 176 LCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYE 227
               P + +L       HS  +T      + EYVN  D    +       +    +Y  E
Sbjct: 77  PGKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129

Query: 228 LLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYN 277
           +   L +  S+GI++RD+K  NVM+D E   +++ D+G+  E    G          +Y 
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDY- 187

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVKI 333
             +A      PE++   Q Y  S+D W+ G     M AG     +  F G ++ D+L   
Sbjct: 188 --IA------PEIIAY-QPYGKSVDWWAFGVLLYEMLAG-----QAPFEG-EDEDEL--- 229

Query: 334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL 393
                                    +++  +   P            +S EA+     L+
Sbjct: 230 -----------------------FQSIMEHNVAYP----------KSMSKEAVAICKGLM 256

Query: 394 RYDHQDRL 401
                 RL
Sbjct: 257 TKHPGKRL 264

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 37/156 (23%), Positives = 71/156 (45%), Gaps = 18/156 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPNVVKL 185
           + V +K+G G + E+  G N+ TNE   IK+     +  ++  E +  + L  G  + ++
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
                             PSL  E +    F +   T +   +     +L+  ++Y HS+
Sbjct: 71  YYFGPCGKYNAMVLELLGPSL--EDL----FDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124

Query: 239 GIMHRDVKPHNVMI----DHELRKLRLIDWGLAEFY 270
            +++RDVKP N +I    +   + + +ID+ LA+ Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 62/305 (20%), Positives = 116/305 (38%), Gaps = 80/305 (26%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
           +D+ + + +G+G + +VF      TN+   IK LK   V           E ++L     
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYP--TLTDYDIRYYIYELLK 230
            P +  +           +T      + EY+N  D    +            +Y  E++ 
Sbjct: 77  HPFLTHM-------FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EYNVRV 280
            L + HS+GI++RD+K  N+++D +   +++ D+G+  E               +Y   +
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDY---I 185

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
           A      PE+L+  Q Y++S+D WS G +   M+  + P F+G  + ++L          
Sbjct: 186 A------PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHG-QDEEEL---------- 226

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
                             ++   +   P            +  EA D L KL   + + R
Sbjct: 227 ----------------FHSIRMDNPFYP----------RWLEKEAKDLLVKLFVREPEKR 260

Query: 401 LTARE 405
           L  R 
Sbjct: 261 LGVRG 265

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 82.4 bits (203), Expect = 4e-17
 Identities = 66/302 (21%), Positives = 110/302 (36%), Gaps = 82/302 (27%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
            D+  +  +G+G + +V       T+E   +KILK  K   I+         E ++L   
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALP 398

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLYPT--LTDYDIRYYIYEL 228
              P + +L       HS  +T      + EYVN  D    +       +    +Y  E+
Sbjct: 399 GKPPFLTQL-------HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI 451

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYF 285
              L +  S+GI++RD+K  NVM+D E   +++ D+G+       KE     V   +  F
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMC------KENIWDGVTTKT--F 502

Query: 286 KG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 339
            G      PE++   Q Y  S+D W+ G +   M+  + P F G D  +    I +    
Sbjct: 503 CGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDELFQSIME---- 556

Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD 399
             +                         P            +S EA+     L+      
Sbjct: 557 HNV-----------------------AYP----------KSMSKEAVAICKGLMTKHPGK 583

Query: 400 RL 401
           RL
Sbjct: 584 RL 585

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 80.4 bits (199), Expect = 8e-17
 Identities = 68/310 (21%), Positives = 131/310 (42%), Gaps = 87/310 (28%)

Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKK----IKREIKILQ 174
           +++E+++ +G G Y +VF   +    +T +   +K+LK    V+K K     + E ++L+
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 175 NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIY 226
           ++   P +V L       H   +T +   LI +Y+N  + F  L      T+++++ Y+ 
Sbjct: 114 HIRQSPFLVTL-------HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG 166

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE----YNVRVAS 282
           E++ AL++ H  GI++RD+K  N+++D     + L D+GL+      KE       R   
Sbjct: 167 EIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLS------KEFVADETERAYD 219

Query: 283 RYFKG------PELLVDL-QDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLV 331
             F G      P+++      +D ++D WSLG     +  G        F      +   
Sbjct: 220 --FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-----SPFTVDGEKNSQA 272

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +I++ +   E                          P+ + +        S  A D + +
Sbjct: 273 EISRRILKSEP-------------------------PYPQEM--------SALAKDLIQR 299

Query: 392 LLRYDHQDRL 401
           LL  D + RL
Sbjct: 300 LLMKDPKKRL 309

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 74/306 (24%), Positives = 125/306 (40%), Gaps = 89/306 (29%)

Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKPVKKKKIKR--------EIKIL 173
             +E+++ +G+G + +VF   +    +  +   +K+LK   K  +K         E  IL
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDIL 80

Query: 174 QNLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYI 225
                 P +VKL       H   +T     LI +++   D F  L      T+ D+++Y+
Sbjct: 81  VE-VNHPFIVKL-------HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------E 275
            EL  ALD+ HS GI++RD+KP N+++D E   ++L D+GL+ E     K         E
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVE 191

Query: 276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           Y   +A      PE++   + +  S D WS G +   M+    P F G D  + +  I  
Sbjct: 192 Y---MA------PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMI-- 238

Query: 336 VLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 395
                          L+    +           +           +SPEA   L  L + 
Sbjct: 239 ---------------LKAKLGM---------PQF-----------LSPEAQSLLRMLFKR 263

Query: 396 DHQDRL 401
           +  +RL
Sbjct: 264 NPANRL 269

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 36/154 (23%), Positives = 69/154 (44%), Gaps = 16/154 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
           Y + RK+G G + +++ G ++   E   IK+     K  ++  E KI + + GG  +  +
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
                +            PSL  E +    F       +   +     +++  ++Y HS+
Sbjct: 71  RWCGAEGDYNVMVMELLGPSL--EDL----FNFCSRKFSLKTVLLLADQMISRIEYIHSK 124

Query: 239 GIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFY 270
             +HRDVKP N ++    +   + +ID+GLA+ Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 79/309 (25%), Positives = 128/309 (41%), Gaps = 93/309 (30%)

Query: 125 DDYEVVRKVGRGKYSEVF---EGINVNTNERCIIKILKP---VKKKK----IKREIKILQ 174
           + +E++R +G+G Y +VF   +    NT +   +K+LK    V+  K     K E  IL+
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 175 NLCGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIY 226
                P +V L           +T     LI EY++  + F  L       +    +Y+ 
Sbjct: 77  E-VKHPFIVDL-------IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGK---------EY 276
           E+  AL + H +GI++RD+KP N+M++H+   ++L D+GL  E  H G          EY
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGC----MFAGMIFRKEPFFYGHDNHDQLVK 332
              +A      PE+L+    ++ ++D WSLG     M  G      P F G +    + K
Sbjct: 188 ---MA------PEILMR-SGHNRAVDWWSLGALMYDMLTG-----APPFTGENRKKTIDK 232

Query: 333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL 392
           I K     +L                         P+           ++ EA D L KL
Sbjct: 233 ILK----CKL-----NL-----------------PPY-----------LTQEARDLLKKL 255

Query: 393 LRYDHQDRL 401
           L+ +   RL
Sbjct: 256 LKRNAASRL 264

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 31/156 (19%), Positives = 67/156 (42%), Gaps = 18/156 (11%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
           Y+V R++G G +  +FEG N+  N++  IK         +++ E +  + L G   +  +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
               ++            PSL  E +      +     +   +     ++L  +   H +
Sbjct: 72  YYFGQEGLHNVLVIDLLGPSL--EDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125

Query: 239 GIMHRDVKPHNVMI----DHELRKLRLIDWGLAEFY 270
            +++RD+KP N +I          + ++D+G+ +FY
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 70/295 (23%), Positives = 126/295 (42%), Gaps = 68/295 (23%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKR--------EIKILQNL 176
           +++E ++ +G+G + +V       T     +KILK  K+  + +        E ++LQN 
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQN- 204

Query: 177 CGGPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
              P +  L           +T      + EY N  + F  L      ++   R+Y  E+
Sbjct: 205 SRHPFLTAL-------KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257

Query: 229 LKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFK 286
           + ALDY HS+  +++RD+K  N+M+D +   +++ D+GL  E    G        +  + 
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE+L D  DY  ++D W LG +   M+  + PF+  + +H++L +   +L  +E+    
Sbjct: 317 APEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY--NQDHEKLFE--LIL-MEEI---- 366

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                              R P            + PEA   L  LL+ D + RL
Sbjct: 367 -------------------RFP----------RTLGPEAKSLLSGLLKKDPKQRL 392

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 36/150 (24%), Positives = 68/150 (45%), Gaps = 13/150 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           Y++V K+G G  S V+   +   N +  IK +           K+ +RE+     L    
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
           N+V ++D+  +       L+ EY+           +  L+      +  ++L  + + H 
Sbjct: 72  NIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             I+HRD+KP N++ID     L++ D+G+A
Sbjct: 130 MRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 57/297 (19%), Positives = 115/297 (38%), Gaps = 76/297 (25%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKK----IKREIKILQNLCG 178
            D++++R +G G +  V    + +      +K+LK   V + K       E  +L  +  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 64

Query: 179 GPNVVKLLDIVRDQHS--KTPS---LIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLK 230
            P ++++           +      +I +Y+   + F +L       +   ++Y  E+  
Sbjct: 65  HPFIIRM-------WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 117

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 287
           AL+Y HS+ I++RD+KP N+++D     +++ D+G A      K       +    G   
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFA------KYVPDVTYT--LCGTPD 168

Query: 288 ---PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA 344
              PE++   + Y+ S+D WS G +   M+    PF+    N  +  +  K+L       
Sbjct: 169 YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKTYE--KIL------- 216

Query: 345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                              ++   +  F         + +  D L +L+  D   RL
Sbjct: 217 -------------------NAELRFPPFF--------NEDVKDLLSRLITRDLSQRL 246

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 27/169 (15%), Positives = 63/169 (37%), Gaps = 21/169 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGPNVVK 184
           + + +K+G G +  ++     N  E+    ++K    +   +  E+K  Q +     + K
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 185 LLDIVRDQHSKTPSLIF---EYVNSTDFKV-----LYPTLTDYDIRYYIY---------- 226
            ++  +  +   P              ++      L   L     +   +          
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGK 274
            +L  L+Y H    +H D+K  N+++ ++   ++ L D+GL+  Y P  
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 76.6 bits (189), Expect = 8e-16
 Identities = 48/217 (22%), Positives = 86/217 (39%), Gaps = 38/217 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPN 181
           D  + EV   VGRG +  V +       +   IK ++    +K    E++ L  +   PN
Sbjct: 6   DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH-PN 62

Query: 182 VVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
           +VKL             L+ EY    + + VL+     P  T      +  +  + + Y 
Sbjct: 63  IVKLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 236 HS---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 287
           HS   + ++HRD+KP N+++      L++ D+G A                +        
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQTHMTNNKGSA 167

Query: 288 ----PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
               PE+     +Y    D++S G +   +I R++PF
Sbjct: 168 AWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 16/154 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKL 185
           + + RK+G G + E++ G N+ TNE   IK+     K  ++  E KI + L GG  +  +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 186 LDIVRDQHSKT-------PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
                +            PSL  E +    F      L+   +     +++  +++ HS+
Sbjct: 69  RWFGVEGDYNVLVMDLLGPSL--EDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122

Query: 239 GIMHRDVKPHNVMI--DHELRKLRLIDWGLAEFY 270
             +HRD+KP N ++       ++ +ID+GLA+ Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 19/153 (12%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKI---LQNLC 177
           Y + R VGRG   +V+E  +        +K++       PV + +++RE +    LQ   
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-- 93

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDY 234
             P+VV + D    +      +    +N  D   +      L        + ++  ALD 
Sbjct: 94  --PHVVPIHD--FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            H+ G  HRDVKP N+++  +     L+D+G+A
Sbjct: 150 AHAAGATHRDVKPENILVSAD-DFAYLVDFGIA 181

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 47/225 (20%), Positives = 88/225 (39%), Gaps = 33/225 (14%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGG 179
              D      +G+G + +  +  +  T E  ++K L       ++   +E+K+++ L   
Sbjct: 8   RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH- 66

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-ALD----- 233
           PNV+K + ++     K  + I EY+       L   +   D +Y   + +  A D     
Sbjct: 67  PNVLKFIGVLY--KDKRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAKDIASGM 121

Query: 234 -YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF---------YHPGKEYNVRVASR 283
            Y HS  I+HRD+  HN ++      + + D+GLA                +   R    
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKN-VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 284 YFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
              G      PE++   + YD  +D++S G +   +I R      
Sbjct: 181 TVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 52/231 (22%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------KKKKIKREIKI 172
             ++ E  +++G+G +  V +G  V       IK L             K ++ +RE+ I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLK-A 231
           + NL   PN+VKL  ++ +     P ++ E+V   D   LY  L D          L+  
Sbjct: 77  MSNLN-HPNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLM 128

Query: 232 LD------YCHSQG--IMHRDVKPHNVMIDHELRK----LRLIDWGLAEFYHPGKEYNVR 279
           LD      Y  +Q   I+HRD++  N+ +           ++ D+GL+           +
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----------Q 177

Query: 280 VASRYFKG---------PELLVDLQD-YDYSLDMWSLGCMFAGMIFRKEPF 320
            +     G         PE +   ++ Y    D +S   +   ++  + PF
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 41/208 (19%), Positives = 78/208 (37%), Gaps = 27/208 (12%)

Query: 117 LTVQWG-DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREI 170
           +    G D      + K+      E+++G     +   ++K+LK       K +    E 
Sbjct: 1   MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEEC 58

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYI- 225
             L+     PNV+ +L   +   +  P+LI  ++   + + VL+     + D        
Sbjct: 59  PRLRIFSH-PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117

Query: 226 YELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR-VA 281
            ++ + + + H+    I    +   +VMID ++   R+    +   F  PG+ Y    VA
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT-ARISMADVKFSFQSPGRMYAPAWVA 176

Query: 282 SRYFKGPELLVDLQDYDYSL--DMWSLG 307
                 PE L    +       DMWS  
Sbjct: 177 ------PEALQKKPEDTNRRSADMWSFA 198

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 13/152 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCGGP 180
           YE+   +G G  SEV    ++  +    +K+L+      P    + +RE +    L   P
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72

Query: 181 NVVKLLDI--VRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            +V + D           P ++ EYV+    + +      +T       I +  +AL++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           H  GI+HRDVKP N+MI      ++++D+G+A
Sbjct: 133 HQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 28/244 (11%), Positives = 72/244 (29%), Gaps = 41/244 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGP 180
           Y ++   G     + ++ ++   + +  +  + P         ++       L  +   P
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHSQG 239
            V ++LD+V  +      ++ E++     + V   + +       +  L  A D  H  G
Sbjct: 92  GVARVLDVVHTRA--GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 299
           +      P  V +  +         G           +V +A                + 
Sbjct: 150 VALSIDHPSRVRVSID---------G-----------DVVLAYPATMPDA--------NP 181

Query: 300 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA 359
             D+  +G     ++  + P           +  A+     +          ++  Q+ A
Sbjct: 182 QDDIRGIGASLYALLVNRWPL--PEAGVRSGLAPAERDTAGQPIE-PADIDRDIPFQISA 238

Query: 360 LVGR 363
           +  R
Sbjct: 239 VAAR 242

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 29/173 (16%), Positives = 69/173 (39%), Gaps = 26/173 (15%)

Query: 127 YEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN 181
           ++V   +G+G +  ++        +V ++  C++K+ +P     +  E+K  Q       
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95

Query: 182 VVKLLDIVRDQHSKTPSLIF---EYVNSTDFKVLYPTLTDYDIRYYI------------- 225
           + K +   + ++   P          N   ++ +       D++                
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155

Query: 226 ---YELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGK 274
                +L  L+Y H    +H D+K  N++++++   ++ L+D+GLA  Y P  
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.5 bits (169), Expect = 3e-13
 Identities = 44/328 (13%), Positives = 91/328 (27%), Gaps = 70/328 (21%)

Query: 120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-----------KPVKKKKIKR 168
                +  +   K+G G + EVF+ I    +    IKI+                ++I  
Sbjct: 15  HCLPTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72

Query: 169 EIKILQNLCG--------GPNVVKLLD--IVRDQHSK----------------------- 195
           EI I + L              + L     V+  +                         
Sbjct: 73  EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132

Query: 196 ---TPSLIFEYVNSTD--FKVLYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHN 249
                 ++ E+        ++     +    +  +++L  +L    +     HRD+   N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192

Query: 250 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCM 309
           V++               +       Y +   S       L V + DY  S        +
Sbjct: 193 VLLK--------------KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238

Query: 310 FAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGR-HSRKP 368
           F  +    E  F G    D    I +++  +  N +   +       L  L  +   +  
Sbjct: 239 FCDV-SMDEDLFTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT 295

Query: 369 WSKFINADNQHLVSPEAIDFLDKLLRYD 396
           +    N      +  +  +F   +L + 
Sbjct: 296 FKTKCNTPAMKQIKRKIQEFHRTMLNFS 323

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 67.8 bits (166), Expect = 9e-13
 Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 35/223 (15%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
             +  E+   +G+G++ +V+ G     +    I+++        + K  KRE+   +   
Sbjct: 31  PFEQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87

Query: 178 GGPNVVKLLDIVRDQHSKTPSL--IFEYV-NSTDFKVLYPTLTDYDIRYYI---YELLKA 231
              NVV  +          P L  I       T + V+       D+        E++K 
Sbjct: 88  H-ENVVLFMGAC----MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           + Y H++GI+H+D+K  NV  D+   K+ + D+GL       +        R   G    
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200

Query: 288 --PELL--------VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
             PE++         D   +    D+++LG ++  +  R+ PF
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 37/214 (17%), Positives = 83/214 (38%), Gaps = 30/214 (14%)

Query: 119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVKKKKIKREIKILQ-NL 176
           VQ        +   +G+G++ EV+ G         + +KI    +++   RE +I Q  +
Sbjct: 36  VQRTIARTIVLQESIGKGRFGEVWRGK---WRGEEVAVKIFSSREERSWFREAEIYQTVM 92

Query: 177 CGGPNVVKLLDIVRDQHSKTP--SLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKAL 232
               N++  +      +       L+ +Y  + + F  L       +    +       L
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 152

Query: 233 DYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY 284
            + H +         I HRD+K  N+++        + D GLA  +    +  + +A  +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDT-IDIAPNH 210

Query: 285 FKG------PELL---VDLQDYDYSL--DMWSLG 307
             G      PE+L   ++++ ++     D++++G
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 41/230 (17%), Positives = 96/230 (41%), Gaps = 37/230 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
                 V +++G G +  V++G     +    +K+L      P + +  K E+ +L+   
Sbjct: 22  PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYIYELLK-ALD-- 233
              N++  +           +++ ++   S+    LY  L   + ++ + +L+  A    
Sbjct: 79  H-VNILLFMGYSTAPQ---LAIVTQWCEGSS----LYHHLHASETKFEMKKLIDIARQTA 130

Query: 234 ----YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 287
               Y H++ I+HRD+K +N+ +  +   +++ D+GLA         +         G  
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQL---SGSI 186

Query: 288 ----PELLVDLQDYDYSL--DMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
               PE++       YS   D+++ G +   ++  + P+    +N DQ++
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII 235

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 28/216 (12%)

Query: 116 SLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ- 174
            L VQ       ++V+++G+G+Y EV+ G      E+  +K+    ++    RE +I Q 
Sbjct: 28  PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQT 85

Query: 175 NLCGGPNVVKLLDIVRDQHSKTP--SLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLK 230
            L    N++  +              LI +Y  N + +  L  T  D      + Y  + 
Sbjct: 86  VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVS 145

Query: 231 ALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 282
            L + H++         I HRD+K  N+++        + D GLA  +       V +  
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVKFISDTN-EVDIPP 203

Query: 283 RYFKG------PELL---VDLQDYDYSL--DMWSLG 307
               G      PE+L   ++   +   +  DM+S G
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 43/204 (21%), Positives = 92/204 (45%), Gaps = 31/204 (15%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLC 177
              D  +  K+G G +  V       ++    +KIL           +  RE+ I++ L 
Sbjct: 35  PWCDLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLR 92

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY-----PTLTDYDIRYYIYELLKA 231
             PN+V  +  V        S++ EY+   + +++L+       L +       Y++ K 
Sbjct: 93  H-PNIVLFMGAVTQP--PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149

Query: 232 LDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-- 287
           ++Y H++   I+HR++K  N+++D +   +++ D+GL+       + +  ++S+   G  
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYT-VKVCDFGLSRL-----KASTFLSSKSAAGTP 203

Query: 288 ----PELLVDLQDYDYSLDMWSLG 307
               PE+L D +  +   D++S G
Sbjct: 204 EWMAPEVLRD-EPSNEKSDVYSFG 226

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 46/204 (22%), Positives = 78/204 (38%), Gaps = 28/204 (13%)

Query: 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ-NLCGGPNVVKLL 186
            ++  VG+G+Y EV+ G     N    +KI     +K   RE ++    +    N++  +
Sbjct: 11  TLLECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 187 --DIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALDYCHSQ---- 238
             D+     S    LI  Y    + +  L  T  D      I   +   L + H +    
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 239 ----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------P 288
                I HRD+K  N+++    +   + D GLA  +       + V +    G      P
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAP 186

Query: 289 ELL-----VDLQDYDYSLDMWSLG 307
           E+L     VD  D    +D+W+ G
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFG 210

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.8 bits (153), Expect = 4e-11
 Identities = 28/176 (15%), Positives = 58/176 (32%), Gaps = 30/176 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNT--------NERCIIKILKPVKKKKIKREIKILQNLCG 178
           +++     R     ++E    +T         ++  +K+    K  ++  E    Q    
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAK 101

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV-----LYPTLTDYDIRYY--------- 224
              V K   +        P+ +   V+   ++      L  +L    +            
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSA-LDVSPKHVLSERS 160

Query: 225 ----IYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE 275
                  LL AL++ H    +H +V   N+ +D E   ++ L  +G A  Y P  +
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 41/223 (18%), Positives = 88/223 (39%), Gaps = 38/223 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-------KKKIKREIKILQN 175
           D  +  +   +G G + +V+    +       +K  +           + +++E K+   
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAM 62

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI-YELLKALD 233
           L   PN++ L  +   +      L+ E+       +VL       DI      ++ + ++
Sbjct: 63  LKH-PNIIALRGVCLKE--PNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMN 119

Query: 234 YCHSQG---IMHRDVKPHNVMIDHELRK-------LRLIDWGLAEFYHPGKEYNVRVASR 283
           Y H +    I+HRD+K  N++I  ++         L++ D+GLA  +H   + +      
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS------ 173

Query: 284 YFKG------PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 320
              G      PE++     +    D+WS G +   ++  + PF
Sbjct: 174 -AAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF 214

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 59.1 bits (143), Expect = 7e-10
 Identities = 41/230 (17%), Positives = 88/230 (38%), Gaps = 46/230 (20%)

Query: 113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVKKKKIKREIK 171
                ++     D+ +++  +GRG+Y  V++G     +ER + +K+     ++    E  
Sbjct: 4   AASEPSLDL---DNLKLLELIGRGRYGAVYKGS---LDERPVAVKVFSFANRQNFINEKN 57

Query: 172 I-----LQNLCGGPNVVKLL--DIVRDQHSKTP-SLIFEYV-NSTDFKVLYPTLTDYDIR 222
           I     +++     N+ + +  D       +    L+ EY  N +  K L    +D+   
Sbjct: 58  IYRVPLMEH----DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSS 113

Query: 223 YYI-YELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
             + + + + L Y H++          I HRD+   NV++ ++     + D+GL+     
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTG 172

Query: 273 GKEYNVRVASRYFKG---------PELL------VDLQDYDYSLDMWSLG 307
            +                      PE+L       D +     +DM++LG
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 60.3 bits (145), Expect = 7e-10
 Identities = 66/407 (16%), Positives = 126/407 (30%), Gaps = 126/407 (30%)

Query: 72  VYEGAIIDKIEERNLAEIPLPAMSKA-------------RVYTDVNVLRPKEYWDYESLT 118
           V+E A +D  + +++ ++P   +SK                      L  K+    +   
Sbjct: 24  VFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF- 82

Query: 119 VQWGDQDDY----EVVRKVGRGK------YSEVFEGINVNTNERCIIKILKPVKKKKIKR 168
           V+   + +Y      ++   R        Y E  + +  N N+    K    V + +   
Sbjct: 83  VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY-NDNQV-FAK--YNVSRLQPYL 138

Query: 169 EIKI-LQNLCGGPNVV--------K--L-LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTL 216
           +++  L  L    NV+        K  + LD+            ++     DFK+ +  L
Sbjct: 139 KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS---------YKVQCKMDFKIFWLNL 189

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
            + +    + E+L+ L        +++         DH       I    AE        
Sbjct: 190 KNCNSPETVLEMLQKL--------LYQIDPNWTSRSDHSSNIKLRIHSIQAEL------- 234

Query: 277 NVRVASRYFKGPE----LLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
                 R  K       LLV  ++Q+   + + ++L C                      
Sbjct: 235 -----RRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSC---------------------- 266

Query: 331 VKIAKVLGT-------DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL--- 380
               K+L T       D L+A     H+ LD     L     +    K+++   Q L   
Sbjct: 267 ----KILLTTRFKQVTDFLSA-ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE 321

Query: 381 ---VSPEAI--------DFLDKLLRYDH--QDRLTAREAMVISSISP 414
               +P  +        D L     + H   D+LT      ++ + P
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP 368

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 5e-06
 Identities = 41/332 (12%), Positives = 102/332 (30%), Gaps = 87/332 (26%)

Query: 126 DYEVVRKVGRGKYSEVF-----EGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP 180
             +V   +     + +        +  +  +  ++K L   + + + RE+         P
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD-CRPQDLPREVLT-----TNP 327

Query: 181 NVVKLL---------------DIVRDQHSKTPSLIFEYVNSTDFKVLYPTLT----DYDI 221
             + ++                +  D+ +         +   +++ ++  L+       I
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387

Query: 222 RYYIYELL----------KALDYCHSQGIMHRDVKP-----HNVMID--------HELRK 258
              +  L+            ++  H   ++ +  K       ++ ++        + L +
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHR 447

Query: 259 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD-YDYS--------LDMWSLGCM 309
             ++D            YN+    + F   +L+    D Y YS        ++      +
Sbjct: 448 -SIVD-----------HYNIP---KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTL 492

Query: 310 FAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD---ELNAYLNKYHLELDPQLDALVGRHSR 366
           F  M+F    F      HD     A     +   +L  Y   Y  + DP+ + LV     
Sbjct: 493 FR-MVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY-KPYICDNDPKYERLV----- 545

Query: 367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQ 398
                F+    ++L+  +  D L   L  + +
Sbjct: 546 NAILDFLPKIEENLICSKYTDLLRIALMAEDE 577

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 6e-06
 Identities = 56/374 (14%), Positives = 111/374 (29%), Gaps = 83/374 (22%)

Query: 57  YNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARVYTDVNVLRPKEYWDYES 116
            N   +   I              IE+R+         +  +V+   NV R + Y     
Sbjct: 89  INYKFLMSPIKTEQRQPSMMTRMYIEQRD------RLYNDNQVFAKYNVSRLQPYLKLRQ 142

Query: 117 LTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKI--LKPVKKKKIKREIKIL 173
             ++     +  +   +G GK     +       +  +  KI  L        +  +++L
Sbjct: 143 ALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML 202

Query: 174 QNLCG--GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKA 231
           Q L     PN     D     HS    L                     I+  +  LLK+
Sbjct: 203 QKLLYQIDPNWTSRSD-----HSSNIKLRIH-----------------SIQAELRRLLKS 240

Query: 232 LDYCHSQGIMHRDVKPHNV--MIDHELRKL---RLIDWGLAEFYHPGKEYNVRV--ASRY 284
             Y +   ++  +V+        +   + L   R     + +F       ++ +   S  
Sbjct: 241 KPYENCLLVL-LNVQNAKAWNAFNLSCKILLTTR--FKQVTDFLSAATTTHISLDHHSMT 297

Query: 285 FKGPELL------VDLQDYDYSLDMWSLGCMFAGMI---FRKEPF---FYGHDNHDQLVK 332
               E+       +D +  D   ++ +       +I    R        + H N D+L  
Sbjct: 298 LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT 357

Query: 333 IAK----VLGTDELNAYLNKYHLELDPQLDALVGRHSRKP-------WSKFINADNQHLV 381
           I +    VL   E     ++  L + P   A +      P       W          ++
Sbjct: 358 IIESSLNVLEPAEYRKMFDR--LSVFPP-SAHI------PTILLSLIWFD--------VI 400

Query: 382 SPEAIDFLDKLLRY 395
             + +  ++KL +Y
Sbjct: 401 KSDVMVVVNKLHKY 414

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 44/220 (20%), Positives = 84/220 (38%), Gaps = 32/220 (14%)

Query: 112 WDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--KIKRE 169
              E+L  Q       +++    RG++  V++      NE   +KI     K+  + + E
Sbjct: 14  LGTENLYFQS---MPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQNEYE 68

Query: 170 IKILQNLCGGPNVVKLL--DIVRDQHSKTPSLIFEYV-NSTDFKVLYPTLTDYDIRYYI- 225
           +  L  +    N+++ +  +           LI  +    +    L   +  ++   +I 
Sbjct: 69  VYSLPGMKH-ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127

Query: 226 YELLKALDYCHSQ----------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
             + + L Y H             I HRD+K  NV++ + L    + D+GLA  +  GK 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT-ACIADFGLALKFEAGKS 186

Query: 276 YNVRVAS----RYFKGPELLVD----LQDYDYSLDMWSLG 307
                      RY   PE+L       +D    +DM+++G
Sbjct: 187 AGDTHGQVGTRRYM-APEVLEGAINFQRDAFLRIDMYAMG 225

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKP----VKKKKIKREIKILQ 174
           ++   + +R +G G + +V          NT E+  +K LKP         +K+EI+IL+
Sbjct: 19  EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELL 229
           NL    N+VK   I  +       LI E++ S   K  Y       +       Y  ++ 
Sbjct: 79  NLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQIC 136

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           K +DY  S+  +HRD+   NV+++ E + +++ D+GL +     KEY
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEY 182

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 47/192 (24%), Positives = 88/192 (45%), Gaps = 17/192 (8%)

Query: 130 VRKVGRGKYSEVFEGI----NVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGPN 181
           +R +G G + +V        N  T E   +K LK    P  +   K+EI IL+ L    +
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EH 94

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFK--VLYPTLTDYDIRYYIYELLKALDYCHSQG 239
           ++K      D  + +  L+ EYV     +  +   ++    +  +  ++ + + Y H+Q 
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154

Query: 240 IMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQ 295
            +HRD+   NV++D++   +++ D+GLA       + Y VR           PE L + +
Sbjct: 155 YIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213

Query: 296 DYDYSLDMWSLG 307
            + Y+ D+WS G
Sbjct: 214 -FYYASDVWSFG 224

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 55.7 bits (135), Expect = 9e-09
 Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 28/230 (12%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCG 178
           + +D  +  ++GRG + EVF G     N    +K  +       K K  +E +IL+    
Sbjct: 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS- 170

Query: 179 GPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKAL 232
            PN+V+L+ +   +    P  I  E V   DF   +       L    +   + +    +
Sbjct: 171 HPNIVRLIGVCTQKQ---PIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGM 226

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF--K--GP 288
           +Y  S+  +HRD+   N ++  +   L++ D+G++     G  Y      R    K   P
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNV-LKISDFGMSREEADG-VYAASGGLRQVPVKWTAP 284

Query: 289 ELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           E L   +   YS   D+WS G  ++        P +    N      + K
Sbjct: 285 EALNYGR---YSSESDVWSFGILLWETFSLGASP-YPNLSNQQTREFVEK 330

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 54/310 (17%), Positives = 113/310 (36%), Gaps = 31/310 (10%)

Query: 40  APIAHHPILRTPCRSSTYNLNIITDTIAATTVVYEGAIIDKIEERNLAEIPLPAMSKARV 99
            P+ HH       R+S     ++         +     +     +      L       V
Sbjct: 5   DPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTV 64

Query: 100 YTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IK 156
           + D++ L P+     + + +             +GRG +  V+ G  ++ + + I   +K
Sbjct: 65  HIDLSALNPELVQAVQHVVIG-PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 123

Query: 157 ILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL 212
            L  +    +  +   E  I+++    PNV+ LL I        P ++  Y+   D +  
Sbjct: 124 SLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRN- 180

Query: 213 Y-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
           +        T  D+  +  ++ K + +  S+  +HRD+   N M+D +   +++ D+GLA
Sbjct: 181 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLA 239

Query: 268 EFYHPGKEYNVRVASRYFKG--------PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKE 318
              +  +  +V   +              E L   Q +    D+WS G  ++  M     
Sbjct: 240 RDMYDKEFDSVHNKT---GAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAP 295

Query: 319 PFFYGHDNHD 328
           P +   +  D
Sbjct: 296 P-YPDVNTFD 304

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 43/225 (19%), Positives = 99/225 (44%), Gaps = 20/225 (8%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 276

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNS---TDF--KVLYPTLTDYDIRYYIYELLKALDY 234
           N+V+LL +   +    P  I  E++      D+  +     ++   + Y   ++  A++Y
Sbjct: 277 NLVQLLGVCTREP---PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELL 291
              +  +HR++   N ++      +++ D+GL+     G  Y     +++   +  PE L
Sbjct: 334 LEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESL 391

Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
                +    D+W+ G  ++    +   P + G D       + K
Sbjct: 392 AY-NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 434

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 18/200 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILK---PVKKKKIKREIKILQN 175
           ++   + + ++G+G +  V          NT     +K L+   P +++  +REI+IL+ 
Sbjct: 21  EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDF-KVLYPTLTDYDIRYYIYELLKA 231
           L     +VK   +      ++  L+ EY+ S    DF +     L    +  Y  ++ K 
Sbjct: 81  L-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRY-FK--G 287
           ++Y  S+  +HRD+   N++++ E   +++ D+GLA+     K+ Y VR   +       
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198

Query: 288 PELLVDLQDYDYSLDMWSLG 307
           PE L D   +    D+WS G
Sbjct: 199 PESLSDNI-FSRQSDVWSFG 217

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 50/262 (19%), Positives = 115/262 (43%), Gaps = 33/262 (12%)

Query: 100 YTDVNVLRPKEYWDYESLTVQWGDQDDYEV-------VRKVGRGKYSEVFEG----INVN 148
           + D ++   +  +   ++   + D+D  +        ++++G+G +  V       +  N
Sbjct: 9   HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68

Query: 149 TNERCIIKILKPVKKKKIK---REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVN 205
           T E   +K L+   ++ ++   REI+IL++L    N+VK   +      +   LI EY+ 
Sbjct: 69  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLP 127

Query: 206 S---TDF-KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRL 261
                D+ +     +    +  Y  ++ K ++Y  ++  +HRD+   N+++++E R +++
Sbjct: 128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR-VKI 186

Query: 262 IDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFR 316
            D+GL        + Y V+           PE L + + +  + D+WS G  ++      
Sbjct: 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLY------ 239

Query: 317 KEPFFYGHDNHDQLVKIAKVLG 338
            E F Y   +     +  +++G
Sbjct: 240 -ELFTYIEKSKSPPAEFMRMIG 260

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 46/232 (19%), Positives = 105/232 (45%), Gaps = 26/232 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEG----INVNTNERCIIKILKPVKKKKIK---REIKILQN 175
           ++   + ++++G+G +  V       +  NT E   +K L+   ++ ++   REI+IL++
Sbjct: 8   EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNS---TDF-KVLYPTLTDYDIRYYIYELLKA 231
           L    N+VK   +      +   LI EY+      D+ +     +    +  Y  ++ K 
Sbjct: 68  LQH-DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--G 287
           ++Y  ++  +HRD+   N+++++E R +++ D+GL        + + V+           
Sbjct: 127 MEYLGTKRYIHRDLATRNILVENENR-VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 288 PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG 338
           PE L + + +  + D+WS G  ++       E F Y   +     +  +++G
Sbjct: 186 PESLTESK-FSVASDVWSFGVVLY-------ELFTYIEKSKSPPAEFMRMIG 229

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 46/225 (20%), Positives = 93/225 (41%), Gaps = 26/225 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPV----KKKKIKREIKILQN 175
                     +GRG +  V+ G  ++ + + I   +K L  +    +  +   E  I+++
Sbjct: 23  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 82

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLK 230
               PNV+ LL I       +P ++  Y+   D +  +        T  D+  +  ++ K
Sbjct: 83  FS-HPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAK 139

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA------EFYHPGKEYNVRVASRY 284
            + Y  S+  +HRD+   N M+D +   +++ D+GLA      E+Y    +   ++  ++
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198

Query: 285 FKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
               E L   Q +    D+WS G  ++  M     P +   +  D
Sbjct: 199 M-ALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFD 240

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 48/225 (21%), Positives = 94/225 (41%), Gaps = 22/225 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++   +  K+G+G + EV+ G   N   R  IK LKP  +  +   +E ++++ L    
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 322

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDY 234
            +V+L  +V    S+ P  I  EY++               L    +     ++   + Y
Sbjct: 323 KLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELL 291
                 +HRD++  N+++   L   ++ D+GLA       EY  R  +++  K   PE  
Sbjct: 379 VERMNYVHRDLRAANILVGENL-VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 436

Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +    +    D+WS G  +       + P + G  N + L ++ +
Sbjct: 437 LY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 479

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 53/233 (22%), Positives = 102/233 (43%), Gaps = 32/233 (13%)

Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
             DYE+        R +G G++ +V +GI ++     +   IK  K       ++K  +E
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRY 223
              ++     P++VKL+ ++    ++ P  I  E     + +  +      +L    +  
Sbjct: 442 ALTMRQFDH-PHIVKLIGVI----TENPVWIIMELCTLGELRS-FLQVRKFSLDLASLIL 495

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR 283
           Y Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+ +      Y       
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKL 554

Query: 284 YFKG--PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
             K   PE +   + +  + D+W  G CM+  ++   +P F G  N+D + +I
Sbjct: 555 PIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 25/163 (15%)

Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
             DYE+        R +G G++ +V +GI ++     +   IK  K       ++K  +E
Sbjct: 7   TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 66

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYY 224
              ++     P++VKL+ ++    ++ P  I  E     +     +V   +L    +  Y
Sbjct: 67  ALTMRQFD-HPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            Y+L  AL Y  S+  +HRD+   NV++      ++L D+GL+
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLS 163

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 40/163 (24%), Positives = 71/163 (43%), Gaps = 25/163 (15%)

Query: 124 QDDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKRE 169
              Y +        R +G G + EV+EG+  N     I   +K  K       K+K   E
Sbjct: 4   GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYY 224
             I++NL   P++VKL+ I+     + P+ I  E     +     +    +L    +  Y
Sbjct: 64  AVIMKNLD-HPHIVKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118

Query: 225 IYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             ++ KA+ Y  S   +HRD+   N+++      ++L D+GL+
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLS 160

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 47/225 (20%), Positives = 94/225 (41%), Gaps = 22/225 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++   +  K+G+G + EV+ G   N   R  IK LKP  +  +   +E ++++ L    
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HE 239

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDY 234
            +V+L  +V    S+ P  I  EY++               L    +     ++   + Y
Sbjct: 240 KLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELL 291
                 +HRD++  N+++   L   ++ D+GLA       EY  R  +++   +  PE  
Sbjct: 296 VERMNYVHRDLRAANILVGENL-VCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAA 353

Query: 292 VDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +    +    D+WS G  +       + P + G  N + L ++ +
Sbjct: 354 LY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 396

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 45/226 (19%), Positives = 87/226 (38%), Gaps = 28/226 (12%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI---NVNTNERCIIKILKPV----KKKKIKREIKILQN 175
           ++      R +G+G +  V+ G          +C IK L  +    + +   RE  +++ 
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK----VLYPTLTDYDIRYYIYELLKA 231
           L   PNV+ L+ I+       P ++  Y+   D            T  D+  +  ++ + 
Sbjct: 79  LNH-PNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 287
           ++Y   Q  +HRD+   N M+D     +++ D+GLA      + Y+V+            
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHR---HARLPV 192

Query: 288 ----PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
                E L     +    D+WS G  ++  +     P +   D  D
Sbjct: 193 KWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFD 236

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 49.2 bits (118), Expect = 8e-07
 Identities = 31/238 (13%), Positives = 78/238 (32%), Gaps = 39/238 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-------IKILKPV---KKKKIKREIKI 172
             +D      +G+G ++++F+G+     +          +K+L        +       +
Sbjct: 6   RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65

Query: 173 LQNLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIY 226
           +  L    ++V    +         +++  E+V        Y       +          
Sbjct: 66  MSKLS-HKHLVLNYGVCVCGD---ENILVQEFVKFGSLD-TYLKKNKNCINILWKLEVAK 120

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI-------DWGLAEFYHPGKEYNVR 279
           +L  A+ +     ++H +V   N+++  E  +           D G++    P      R
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180

Query: 280 V---ASRYFKGPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
           +          PE + + ++ + + D WS G  ++       +P     D+  +L   
Sbjct: 181 IPWVP------PECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 46/236 (19%), Positives = 92/236 (38%), Gaps = 36/236 (15%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP-----VKKKKIKRE 169
           +D  +        R +G+G++  V E      +   +   +K+LK         ++  RE
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75

Query: 170 IKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFK---------VLYPTL 216
              ++     P+V KL+ +     +K       +I  ++   D                L
Sbjct: 76  AACMKEFDH-PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
               +  ++ ++   ++Y  S+  +HRD+   N M+  +   + + D+GL+   + G  Y
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGDYY 193

Query: 277 NVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHD 328
               AS+   K    E L D   Y    D+W+ G  M+  M   + P + G +N +
Sbjct: 194 RQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAE 247

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 46/228 (20%), Positives = 100/228 (43%), Gaps = 26/228 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 11  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HP 69

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
           N+V+LL +   +    P  I  E++   +    Y        ++   + Y   ++  A++
Sbjct: 70  NLVQLLGVCTREP---PFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQISSAME 125

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPEL 290
           Y   +  +HRD+   N ++      +++ D+GL+     G  Y     +++  K   PE 
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 183

Query: 291 LVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
              L    +S+  D+W+ G  ++    +   P + G D       + K
Sbjct: 184 ---LAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 227

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 37/213 (17%), Positives = 86/213 (40%), Gaps = 33/213 (15%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNERCI---IKILKP-----VKKKKIKRE 169
           +D  +        + +G G++  V EG     +   +   +K +K       + ++   E
Sbjct: 27  EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86

Query: 170 IKILQNLCGGPNVVKLLDIVRD---QHSKTPSLIFEYVNSTDFK---------VLYPTLT 217
              +++    PNV++LL +  +   Q    P +I  ++   D                + 
Sbjct: 87  AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
              +  ++ ++   ++Y  ++  +HRD+   N M+  ++  + + D+GL++  + G  Y 
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYR 204

Query: 278 VRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
               ++   K    E L D + Y    D+W+ G
Sbjct: 205 QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFG 236

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 46/223 (20%), Positives = 88/223 (39%), Gaps = 41/223 (18%)

Query: 123 DQDDYEV-------VRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKI 166
           D   +E         + +GRG + +V E          T     +K+LK      + + +
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77

Query: 167 KREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NST 207
             E+KIL ++    NVV LL     +      +I E+                       
Sbjct: 78  MSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136

Query: 208 DFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
              +    LT   +  Y +++ K +++  S+  +HRD+   N+++  +   +++ D+GLA
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLA 195

Query: 268 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
              +   +Y  +  +R   K   PE + D + Y    D+WS G
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 23/147 (15%), Positives = 59/147 (40%), Gaps = 17/147 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI-NVNTNERCI---IKILKP----VKKKKIKREIKILQ 174
                   + +G G++ EV++G+   ++ ++ +   IK LK      ++     E  I+ 
Sbjct: 42  HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELL 229
                 N+++L  ++       P +I  EY+ +       +      +   +   +  + 
Sbjct: 102 QFS-HHNIIRLEGVISKYK---PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 157

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHEL 256
             + Y  +   +HRD+   N++++  L
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNL 184

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 31/146 (21%), Positives = 60/146 (41%), Gaps = 16/146 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKREIKILQN 175
           D  +  + + VG G++ EV  G     +++ I   IK LK      +++    E  I+  
Sbjct: 43  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLK 230
               PN+++L  +V       P +I  EY+ +       +      T   +   +  +  
Sbjct: 103 FD-HPNIIRLEGVVTKSK---PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHEL 256
            + Y    G +HRD+   N++I+  L
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNL 184

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 29/172 (16%), Positives = 67/172 (38%), Gaps = 33/172 (19%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEGINVNTNE-----RCIIKILKP----VKKKKIKR 168
           D++EV        R++G+G +  V+EG+     +     R  IK +       ++ +   
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------NSTDFKVLYPT 215
           E  +++      +VV+LL +V         +I E +              +     +   
Sbjct: 78  EASVMKEF-NCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            +   +     E+   + Y ++   +HRD+   N M+  +   +++ D+G+ 
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMT 185

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 44/229 (19%), Positives = 100/229 (43%), Gaps = 23/229 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI----IKILK----PVKKKKIKREIKILQ 174
            + +++ ++ +G G +  V++G+ +   E+      IK L+    P   K+I  E  ++ 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
           ++   P+V +LL I       T  LI + +      D+ +     +    +  +  ++ K
Sbjct: 73  SVD-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
            ++Y   + ++HRD+   NV++      +++ D+GLA+     ++       +   K   
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 288 PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            E ++    Y +  D+WS G  ++  M F  +P+  G    +    + K
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 29/146 (19%), Positives = 56/146 (38%), Gaps = 16/146 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP----VKKKKIKREIKILQN 175
           +     + + +G G   EV  G      +R +   IK LK      +++    E  I+  
Sbjct: 47  EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLK 230
               PN+++L  +V        ++I  EY+ +       +      T   +   +  +  
Sbjct: 107 FDH-PNIIRLEGVVTRGR---LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHEL 256
            + Y    G +HRD+   NV++D  L
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNL 188

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 40/199 (20%), Positives = 88/199 (44%), Gaps = 26/199 (13%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++  ++V ++G G++ EV+ G   N + +  +K LK   +       E  +++ L    
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQ 68

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALD 233
            +V+L  +V    ++ P  I  EY+ +      +        LT   +     ++ + + 
Sbjct: 69  RLVRLYAVV----TQEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPEL 290
           +   +  +HRD++  N+++   L   ++ D+GLA       EY  R  +++  K   PE 
Sbjct: 124 FIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEA 181

Query: 291 LVDLQDYDYSL--DMWSLG 307
           +       +++  D+WS G
Sbjct: 182 INYGT---FTIKSDVWSFG 197

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 38/231 (16%), Positives = 95/231 (41%), Gaps = 27/231 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILK----PVKKKKIKREIKILQ 174
            + +   ++ +G G +  V +G+      +      IK+++        + +   +  + 
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
           +L    ++V+LL +       +  L+ +Y+   +  D  +     L    +  +  ++ K
Sbjct: 71  SLDH-AHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
            + Y    G++HR++   NV++     ++++ D+G+A+   P  +  +   ++   K   
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185

Query: 288 PELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            E    +    Y+   D+WS G  ++  M F  EP+  G    +    + K
Sbjct: 186 LE---SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEK 232

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 45.6 bits (109), Expect = 1e-05
 Identities = 27/153 (17%), Positives = 69/153 (45%), Gaps = 15/153 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            +++  +++++G G++  V  G          +K++K   + + +  +E + +  L   P
Sbjct: 6   KREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HP 63

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDY 234
            +VK   +   ++   P  I  EY+++      Y       L    +    Y++ + + +
Sbjct: 64  KLVKFYGVCSKEY---PIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAF 119

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             S   +HRD+   N ++D +L  +++ D+G+ 
Sbjct: 120 LESHQFIHRDLAARNCLVDRDL-CVKVSDFGMT 151

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 30/152 (19%), Positives = 68/152 (44%), Gaps = 13/152 (8%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  D   ++++G G++  V  G          IK++K   + + +   E K++ NL    
Sbjct: 22  DPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HE 79

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
            +V+L  +   Q    P  I  EY+ +       + +        +     ++ +A++Y 
Sbjct: 80  KLVQLYGVCTKQR---PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            S+  +HRD+   N +++ +   +++ D+GL+
Sbjct: 137 ESKQFLHRDLAARNCLVNDQG-VVKVSDFGLS 167

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 31/193 (16%), Positives = 71/193 (36%), Gaps = 32/193 (16%)

Query: 94  MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVR----KVGRGKYSEVFEGINVNT 149
           M K   +  ++  +    +  + + V W  +   +  +     +G+G  +++     ++ 
Sbjct: 301 MHKNGRWMSLDETKIIPNYRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSYLDF 360

Query: 150 NERCIIKILKP-----------VKKKKIKREIKILQNL--CGGPNVVKLLDIVRDQHSKT 196
           +   IIK               ++K +  RE + L  +   G P        + D     
Sbjct: 361 D--VIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA-----PYIFDVDLDN 413

Query: 197 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL 256
             ++  Y+N    K +     D       Y++ + +   H   ++H D+   N + D   
Sbjct: 414 KRIMMSYINGKLAKDVIEDNLDI-----AYKIGEIVGKLHKNDVIHNDLTTSNFIFD--- 465

Query: 257 RKLRLIDWGLAEF 269
           + L +ID+GL + 
Sbjct: 466 KDLYIIDFGLGKI 478

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 43/227 (18%), Positives = 101/227 (44%), Gaps = 26/227 (11%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++  ++ +K+G G++ EV+     N + +  +K +KP  +  +    E  +++ L    
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HD 243

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
            +VKL  +V    +K P  I  E++   +  DF             +  +  ++ + + +
Sbjct: 244 KLVKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELL 291
              +  +HRD++  N+++   L   ++ D+GLA       EY  R  +++  K   PE +
Sbjct: 300 IEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAI 357

Query: 292 VDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
                  +++  D+WS G  +   + + + P + G  N + +  + +
Sbjct: 358 NFGS---FTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALER 400

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 44.5 bits (106), Expect = 4e-05
 Identities = 46/221 (20%), Positives = 84/221 (38%), Gaps = 40/221 (18%)

Query: 125 DDYEV-------VRKVGRGKYSEVFEG-----INVNTNERCIIKILKP----VKKKKIKR 168
             +E         + +G G + +V E      I  +      +K+LKP     +++ +  
Sbjct: 16  HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75

Query: 169 EIKILQNLCGGPNVVKLLDIVRDQH-------------------SKTPSLIFEYVNSTDF 209
           E+K+L  L    N+V LL                           K  S I    +    
Sbjct: 76  ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 210 KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
           +     L   D+  + Y++ K + +  S+  +HRD+   N+++    R  ++ D+GLA  
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARD 194

Query: 270 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
                 Y V+  +R   K   PE + +   Y +  D+WS G
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 33/173 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
           D   + + +G G + +V                    +K+LK          +  E++++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
           + +    N++ LL            +I EY                    +    +V   
Sbjct: 95  KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            +T  D+    Y+L + ++Y  SQ  +HRD+   NV++      +++ D+GLA
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLA 204

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 44/229 (19%), Positives = 100/229 (43%), Gaps = 23/229 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI----IKILK----PVKKKKIKREIKILQ 174
            + +++ ++ +G G +  V++G+ +   E+      IK L+    P   K+I  E  ++ 
Sbjct: 13  KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 72

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYV---NSTDF-KVLYPTLTDYDIRYYIYELLK 230
           ++   P+V +LL I       T  LI + +      D+ +     +    +  +  ++ K
Sbjct: 73  SVD-NPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--G 287
            ++Y   + ++HRD+   NV++      +++ D+GLA+     ++       +   K   
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187

Query: 288 PELLVDLQDYDYSLDMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
            E ++    Y +  D+WS G  ++  M F  +P+  G    +    + K
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 43.7 bits (104), Expect = 5e-05
 Identities = 39/226 (17%), Positives = 89/226 (39%), Gaps = 24/226 (10%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  +   V+++G G++  V  G      ++  IK ++   + ++    E +++  L   P
Sbjct: 6   DPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HP 63

Query: 181 NVVKLLDIVRDQHSKTPSLI-FEYVNSTDF----KVLYPTLTDYDIRYYIYELLKALDYC 235
            +V+L  +  +Q    P  +  E++         +          +     ++ + + Y 
Sbjct: 64  KLVQLYGVCLEQA---PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLV 292
               ++HRD+   N ++      +++ D+G+  F     +Y     +++  K   PE+  
Sbjct: 121 EEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEV-- 176

Query: 293 DLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
                 YS   D+WS G  M+      K P +    N + +  I+ 
Sbjct: 177 -FSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDIST 220

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 47/213 (22%), Positives = 87/213 (40%), Gaps = 35/213 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKIKREIKILQN 175
           ++ +  + +G G + +V E         +   +  +K+LK      +K+ +  E+KI+ +
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSL-IFEYV-----------------NSTDFKVLYPTLT 217
           L    N+V LL          P L I EY                      F +   T +
Sbjct: 106 LGQHENIVNLLGACTHGG---PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
             D+ ++  ++ + + +  S+  +HRDV   NV++ +     ++ D+GLA        Y 
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYI 221

Query: 278 VRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
           V+  +R   K   PE + D   Y    D+WS G
Sbjct: 222 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYG 253

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 43.4 bits (103), Expect = 7e-05
 Identities = 27/153 (17%), Positives = 69/153 (45%), Gaps = 15/153 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPN 181
           +  + ++++ +G+G++ +V  G       +  +K +K     +    E  ++  L    N
Sbjct: 19  NMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR-HSN 75

Query: 182 VVKLLDIVRDQHSKTPSL--IFEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
           +V+LL ++ ++      L  + EY+   +  D+        L    +  +  ++ +A++Y
Sbjct: 76  LVQLLGVIVEEK---GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                 +HRD+   NV++  +    ++ D+GL 
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLT 164

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 43.0 bits (102), Expect = 9e-05
 Identities = 31/187 (16%), Positives = 63/187 (33%), Gaps = 40/187 (21%)

Query: 108 PKEYW--DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGI--NVNTNERCIIKILKP--- 160
           P  Y   D+  +  Q            +G G + +V +             IK +K    
Sbjct: 16  PTIYPVLDWNDIKFQ----------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65

Query: 161 -VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------------- 204
               +    E+++L  L   PN++ LL     +      L  EY                
Sbjct: 66  KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVL 123

Query: 205 ----NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR 260
                         TL+   + ++  ++ + +DY   +  +HRD+   N+++       +
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAK 182

Query: 261 LIDWGLA 267
           + D+GL+
Sbjct: 183 IADFGLS 189

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 43.0 bits (102), Expect = 9e-05
 Identities = 46/239 (19%), Positives = 90/239 (37%), Gaps = 41/239 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKP------VKKKKIKREIKIL 173
            + D  ++ K+G G +  V  G     + + +   +K LKP             RE+  +
Sbjct: 16  GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 75

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLI----------FEYVNSTDFKVLYPTLTDYDIRY 223
            +L    N+++L  +V       P  +           + +       L  TL+      
Sbjct: 76  HSLD-HRNLIRLYGVV----LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR----- 125

Query: 224 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVAS 282
           Y  ++ + + Y  S+  +HRD+   N+++      +++ D+GL          Y ++   
Sbjct: 126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHR 184

Query: 283 RY-FK--GPELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
           +  F    PE L       +S   D W  G  ++    + +EP + G +    L KI K
Sbjct: 185 KVPFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDK 239

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 31/173 (17%), Positives = 64/173 (36%), Gaps = 33/173 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
           D   + + +G G + +V                    +K+LK          +  E++++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
           + +    N++ LL            +I EY                    +    +V   
Sbjct: 141 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            +T  D+    Y+L + ++Y  SQ  +HRD+   NV++      +++ D+GLA
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLA 250

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 29/173 (16%), Positives = 65/173 (37%), Gaps = 33/173 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-------NVNTNERCIIKILKP----VKKKKIKREIKIL 173
           D   + + +G G + +V             N   +  +K+LK          +  E++++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------------------NSTDFKVLYP 214
           + +    N++ LL            +I EY                    +         
Sbjct: 129 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186

Query: 215 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
            L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +   +++ D+GLA
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLA 238

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 28/182 (15%), Positives = 63/182 (34%), Gaps = 32/182 (17%)

Query: 104 NVLRPKEYWD--YESLTVQWG-DQDDYEVVRKVGRGKYSEVFEGI--NVNTNERCI---I 155
           + L+     +  Y S        + D  +  ++G G + +VF     N+   +  +   +
Sbjct: 17  SGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAV 76

Query: 156 KILKPVKKKKIK---REIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-------- 204
           K LK   +   +   RE ++L  L    ++V+   +  +   +   ++FEY+        
Sbjct: 77  KALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRF 133

Query: 205 ----------NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 254
                      +    V    L    +     ++   + Y      +HRD+   N ++  
Sbjct: 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193

Query: 255 EL 256
            L
Sbjct: 194 GL 195

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 27/162 (16%), Positives = 72/162 (44%), Gaps = 15/162 (9%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPN 181
           +  + ++++ +G+G++ +V  G       +  +K +K     +    E  ++  L    N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQAFLAEASVMTQLR-HSN 247

Query: 182 VVKLLDIVRDQHSKTPSL--IFEYV---NSTDF--KVLYPTLTDYDIRYYIYELLKALDY 234
           +V+LL ++ ++      L  + EY+   +  D+        L    +  +  ++ +A++Y
Sbjct: 248 LVQLLGVIVEEK---GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304

Query: 235 CHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
                 +HRD+   NV++  +    ++ D+GL +     ++ 
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDT 345

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 28/168 (16%), Positives = 64/168 (38%), Gaps = 36/168 (21%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---------------------VKKKK 165
             + + +G GK S VF   +      C++K  K                      +  + 
Sbjct: 92  DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150

Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYI 225
            + E + LQ L G   V K+     +      +++ E +++ +       +   +    +
Sbjct: 151 ARNEFRALQKLQGLA-VPKVYAWEGN------AVLMELIDAKEL----YRVRVENPDEVL 199

Query: 226 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHP 272
             +L+ +   + +GI+H D+  +NV++  E   + +ID+  + E    
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEE 245

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 42/221 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKP----VKKKKIKREIKILQN 175
           ++ E  + +G G + +V             + +  +K+LK      +++ +  E+K++  
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYV--------------------------NSTDF 209
           L    N+V LL            LIFEY                              + 
Sbjct: 105 LGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 210 KVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 269
           +     LT  D+  + Y++ K +++   +  +HRD+   NV++    + +++ D+GLA  
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKICDFGLARD 221

Query: 270 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSLG 307
                 Y VR  +R   K   PE L +   Y    D+WS G
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYG 261

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 40.3 bits (95), Expect = 6e-04
 Identities = 39/240 (16%), Positives = 95/240 (39%), Gaps = 46/240 (19%)

Query: 125 DDYEVVR--------KVGRGKYSEVFEGI-NVNTNERCI-IKILKP----VKKKKIKREI 170
               + R        ++G G +  V +G+  +   +  + IK+LK        +++ RE 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLI----------FEYVNSTDFKVLYPTLTDYD 220
           +I+  L   P +V+L+ +          ++           +++     ++    + +  
Sbjct: 62  QIMHQLD-NPYIVRLIGVC----QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-- 114

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVR 279
               ++++   + Y   +  +HRD+   NV++ +     ++ D+GL+         Y  R
Sbjct: 115 ---LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTAR 170

Query: 280 VASRY-FK--GPELLVDLQDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKI 333
            A ++  K   PE    +    +S   D+WS G  M+  + + ++P +      + +  I
Sbjct: 171 SAGKWPLKWYAPE---CINFRKFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 226

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 43/224 (19%), Positives = 89/224 (39%), Gaps = 30/224 (13%)

Query: 131 RKVGRGKYSEVFEGINVNTNERCI---IKILK-----PVKKKKIKREIKILQNLCGGPNV 182
           +++G G +  V +G      +      +KILK     P  K ++  E  ++Q L   P +
Sbjct: 23  KELGSGNFGTVKKGY-YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYI 80

Query: 183 VKLLDIVRDQHSKTPS-LIFEYVNS---TDFKVLYPTLTDYDIRYYIYELLKALDYCHSQ 238
           V+++ I           L+ E         +      + D +I   ++++   + Y    
Sbjct: 81  VRMIGIC----EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 136

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDL 294
             +HRD+   NV++  +    ++ D+GL+         Y  +   ++  K   PE    +
Sbjct: 137 NFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC---I 192

Query: 295 QDYDYSL--DMWSLG-CMFAGMIFRKEPFFYGHDNHDQLVKIAK 335
             Y +S   D+WS G  M+    + ++P + G    +    + K
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAMLEK 235

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.3 bits (94), Expect = 8e-04
 Identities = 26/121 (21%), Positives = 53/121 (43%), Gaps = 5/121 (4%)

Query: 190 RDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHN 249
                +  SL           +    LT   +  Y +++ K +++  S+  +HRD+   N
Sbjct: 164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 223

Query: 250 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDMWSL 306
           +++  +   +++ D+GLA   +   +Y  +  +R   K   PE + D + Y    D+WS 
Sbjct: 224 ILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSF 281

Query: 307 G 307
           G
Sbjct: 282 G 282

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	419
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.45
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.11
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.93
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.75
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.73
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.44
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.41
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.2
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.95
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.87
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.76
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.62
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.58
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.57
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.55
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.44
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.35
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.29
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.27
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.07
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.72
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.54
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.35
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.96
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.7
2k21_A	138	Potassium voltage-gated channel subfamily E member	86.63

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-60  Score=453.85  Aligned_cols=252  Identities=23%  Similarity=0.386  Sum_probs=215.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .+.|+++++||+|+||+||+|++..+|+.||||+++.   ...+.+.+|+.+|+.+ +|||||+++++|.++  ..+|+|
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEE
Confidence            3569999999999999999999999999999999953   3456788999999999 999999999999764  678999


Q ss_pred             EEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cce
Q 014762          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (419)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~  277 (419)
                      ||||++|+|..++  ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...... ...
T Consensus       150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBC
T ss_pred             EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC-CCEEEecCcCceecCCCCCccc
Confidence            9999999998876  579999999999999999999999999999999999999988 899999999998775443 345


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+.+....                  
T Consensus       229 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~~~------------------  288 (346)
T 4fih_A          229 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLPP------------------  288 (346)
T ss_dssp             CCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSSCC------------------
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCCC------------------
Confidence            6789999999999877 789999999999999999999999984 33444444433321100                  


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                      .......+|+++++||.+||+.||++|||++|+|+||||+..
T Consensus       289 ----------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          289 ----------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             ----------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ----------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence                            001112379999999999999999999999999999999864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-60  Score=448.22  Aligned_cols=249  Identities=27%  Similarity=0.469  Sum_probs=214.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++++.||+|+||+||+|++..+|+.||||++++      ...+.+.+|+.+|+++ +|||||+++++|.++  ..+
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~  107 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDD--EKL  107 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEE
Confidence            3579999999999999999999999999999999963      2346789999999999 999999999999654  778


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      |+||||++||+|.+++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECCTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCC
Confidence            9999999999998887   569999999999999999999999999999999999999988 899999999999875432


Q ss_pred             ---cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          275 ---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       275 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                         .....+||+.|+|||++.+ ..|+.++||||+||++|+|++|+.||. +.+..+.+..+.+.  .           .
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~--~-----------~  251 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEGLIFAKIIKL--E-----------Y  251 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT--C-----------C
T ss_pred             CcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcC--C-----------C
Confidence               2345689999999999987 789999999999999999999999984 34444444444321  0           0


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHH------HhcCCCcccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE------AMVISSISPI  415 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e------lL~hp~f~~~  415 (419)
                      .                        .+..+++++++||++||+.||++|||++|      +++||||+++
T Consensus       252 ~------------------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          252 D------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             C------------------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             C------------------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            0                        11237899999999999999999999988      5899999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.7e-60  Score=457.45  Aligned_cols=290  Identities=28%  Similarity=0.456  Sum_probs=232.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .++|++.++||+|+||+||+|++.   .+++.||+|.+.+. ...++.+|+.+|+.+.+||||++++++|.+.  .++|+
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~--~~~~l   97 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN--DHVVI   97 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--TEEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--CEEEE
Confidence            568999999999999999999875   46789999988643 4567889999999987899999999999664  78899


Q ss_pred             EEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-----
Q 014762          200 IFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-----  274 (419)
                      ||||+++++|.++++.+++.+++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+|+......     
T Consensus        98 vmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~  177 (361)
T 4f9c_A           98 AMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK  177 (361)
T ss_dssp             EEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred             EEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence            999999999999999999999999999999999999999999999999999999876799999999998654321     


Q ss_pred             ------------------------cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 014762          275 ------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (419)
Q Consensus       275 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~  330 (419)
                                              .....+||+.|+|||++.+...|+.++||||+||++|||++|+.||+.+.++.+++
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l  257 (361)
T 4f9c_A          178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL  257 (361)
T ss_dssp             GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence                                    12335799999999999886679999999999999999999999999999999999


Q ss_pred             HHHHHHcCCchHHHHHhhcCCC------C-ChhhHHhhccCC----------CCCccccccccccCCCCHHHHHHHHHhc
Q 014762          331 VKIAKVLGTDELNAYLNKYHLE------L-DPQLDALVGRHS----------RKPWSKFINADNQHLVSPEAIDFLDKLL  393 (419)
Q Consensus       331 ~~i~~~lg~~~~~~~~~~~~~~------~-~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~li~~~L  393 (419)
                      ..|.+.+|.++...........      . ............          ..........+....+|++++|||++||
T Consensus       258 ~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL  337 (361)
T 4f9c_A          258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLL  337 (361)
T ss_dssp             HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHT
T ss_pred             HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence            9999999987665544322110      0 001111110000          0000011112233458999999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCcccc
Q 014762          394 RYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       394 ~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      ++||++|+||+|+|+||||+++
T Consensus       338 ~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          338 DLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             CSCTTTSCCHHHHHTSGGGTTC
T ss_pred             cCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.3e-60  Score=440.34  Aligned_cols=254  Identities=21%  Similarity=0.396  Sum_probs=208.5

Q ss_pred             CCCCCe-EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc--C
Q 014762          122 GDQDDY-EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--H  193 (419)
Q Consensus       122 ~~~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~  193 (419)
                      ....+| ++.++||+|+||+||+|.+..++..||+|++...     ..+.+.+|+.+++++ +|||||+++++|.+.  .
T Consensus        22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~  100 (290)
T 3fpq_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKG  100 (290)
T ss_dssp             CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETT
T ss_pred             CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCC
Confidence            334555 7788899999999999999999999999998632     245689999999999 999999999998653  3


Q ss_pred             CCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                      ...+++|||||++|+|..++   ..+++..++.++.||+.||+|||++|  ||||||||+|||++.+.+.+||+|||+|+
T Consensus       101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            35689999999999999887   56999999999999999999999998  99999999999998644889999999998


Q ss_pred             eccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ... .......+||+.|+|||++.+  .|+.++|||||||++|||++|+.||.. .++...+...+.. +..+       
T Consensus       181 ~~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~-~~~~~~~~~~i~~-~~~~-------  248 (290)
T 3fpq_A          181 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTS-GVKP-------  248 (290)
T ss_dssp             GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTT-CSSHHHHHHHHTT-TCCC-------
T ss_pred             eCC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC-CCcHHHHHHHHHc-CCCC-------
Confidence            643 334456789999999998864  699999999999999999999999843 3333333222110 0000       


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                                ......+++++++||.+||+.||++|||++|+|+||||+.
T Consensus       249 --------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 --------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             --------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             --------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                                      0011236889999999999999999999999999999985

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-60  Score=454.19  Aligned_cols=250  Identities=19%  Similarity=0.382  Sum_probs=207.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|+++++||+|+||+||+|++..+|+.||||+++..     ..+.+.+|+.+|+++ +|||||+++++|.++  ..+
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~--~~~   98 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEEN--GSL   98 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEEC--CEE
Confidence            357899999999999999999999999999999999643     246788999999999 999999999999764  778


Q ss_pred             EEEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      |+|||||+||+|.+++.     .+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+....
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNS  177 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTT-CCEEECSTTEESCCCH
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CCEEEcccccceeecC
Confidence            99999999999988872     36899999999999999999999999999999999999988 8999999999987653


Q ss_pred             CCc-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          273 GKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       273 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      ... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+.+..-+            
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~~~~~------------  243 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFE-AGSMKNLVLKIISGSFP------------  243 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTCCC------------
T ss_pred             CcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCCC------------
Confidence            322 244689999999999987 789999999999999999999999983 44444444444331000            


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                              .....+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       244 ------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          244 ------------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             ------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             ------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                                    011237899999999999999999999999999999974

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5e-60  Score=437.76  Aligned_cols=247  Identities=23%  Similarity=0.479  Sum_probs=194.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||+||+|++..+|+.||||++++.      ..+.+.+|+.+++++ +|||||++++++.++  ..+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~   89 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSK--DEII   89 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--CEEE
Confidence            6899999999999999999999999999999998642      245689999999999 999999999999654  7789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||||++ |+|.+++   ..+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus        90 ivmEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~~  167 (275)
T 3hyh_A           90 MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGNF  167 (275)
T ss_dssp             EEEECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-CCEEECCSSCC--------
T ss_pred             EEEeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-CCEEEeecCCCeecCCCCc
Confidence            9999995 5666654   569999999999999999999999999999999999999988 8899999999988766555


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ....+||+.|+|||++.+...++.++||||+||++|+|++|+.||. +.+..+.+..+.+.  .           ..   
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~-~~~~~~~~~~i~~~--~-----------~~---  230 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD-DESIPVLFKNISNG--V-----------YT---  230 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT--C-----------CC---
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcC--C-----------CC---
Confidence            5667999999999999874445789999999999999999999984 33333333322210  0           00   


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                           .+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus       231 ---------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          231 ---------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ---------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ---------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence                                 01237899999999999999999999999999999973

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.5e-59  Score=456.08  Aligned_cols=252  Identities=23%  Similarity=0.388  Sum_probs=216.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .+.|+++++||+|+||+||+|.+..+|+.||||+++.   ...+.+.+|+.+|+.+ +|||||+++++|.+.  ..+|+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEEC--CEEEEE
Confidence            4679999999999999999999999999999999963   3456789999999999 999999999999764  678999


Q ss_pred             EEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Ccce
Q 014762          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYN  277 (419)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~~~  277 (419)
                      ||||+||+|..++  ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+..... ....
T Consensus       227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT-CCEEECCCTTCEECCSSCCCBC
T ss_pred             EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEecCccceECCCCCcccc
Confidence            9999999998887  569999999999999999999999999999999999999988 89999999999877544 3345


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+......                  
T Consensus       306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~~~------------------  365 (423)
T 4fie_A          306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLPP------------------  365 (423)
T ss_dssp             CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCC------------------
T ss_pred             ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCCC------------------
Confidence            6789999999999877 789999999999999999999999984 33444444433321100                  


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                      .......+++++++||.+||+.||++||||+|+|+||||+..
T Consensus       366 ----------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          366 ----------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             ----------------CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ----------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence                            001123479999999999999999999999999999999864

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-59  Score=454.45  Aligned_cols=285  Identities=27%  Similarity=0.519  Sum_probs=227.4

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc----
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----  192 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----  192 (419)
                      ...++|++++.||+|+||+||+|++..+|+.||||+++..     ..+.+.+|+.+|+.+ +|||||++++++...    
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccc
Confidence            3467899999999999999999999999999999999643     235678999999999 999999999998643    


Q ss_pred             CCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      ....+|+|||||+| +|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.
T Consensus       130 ~~~~~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla~~  207 (398)
T 4b99_A          130 EFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMARG  207 (398)
T ss_dssp             TCCCEEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBC
T ss_pred             cCCEEEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC-CCEEEeecceeee
Confidence            33678999999975 566655   459999999999999999999999999999999999999988 8999999999986


Q ss_pred             ccCC-----CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          270 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       270 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      ....     ......+||+.|+|||++.+...++.++||||+||++|||++|+.|| .+.+..+++..|.+..|.++...
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF-~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF-PGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCChHH
Confidence            5432     22345689999999999988667899999999999999999999887 67888899999999999876543


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      +.......... ...........+|....     ..++++++|||.+||++||++||||+|+|+||||+...
T Consensus       287 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-----~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          287 IQAVGAERVRA-YIQSLPPRQPVPWETVY-----PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             TC-----CHHH-HHHSSCCCCCCCHHHHS-----TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhhh-hhhcCCCcCCCCHHHhC-----CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            21111000000 00000111112222222     23789999999999999999999999999999998763

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.2e-59  Score=438.17  Aligned_cols=249  Identities=28%  Similarity=0.467  Sum_probs=205.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      .++|++++.||+|+||+||+|++.   .+++.||||+++..     ....+.+|+.+|+++ +|||||+++++|.++  .
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~   99 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTE--G   99 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEET--T
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--C
Confidence            467999999999999999999874   46789999998643     235688999999999 999999999999764  7


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .+|+|||||+||+|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-SCEEEESSEEEEC---
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC-CCEEecccccceeccC
Confidence            789999999999998887   569999999999999999999999999999999999999988 8999999999986543


Q ss_pred             C-CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          273 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       273 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      . ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+.+.  .           .
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~~--~-----------~  243 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQ-GKDRKETMTMILKA--K-----------L  243 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--C-----------C
T ss_pred             CCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCC-CcCHHHHHHHHHcC--C-----------C
Confidence            3 33455789999999999987 789999999999999999999999983 44444444444321  0           0


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                              ..+..+|+++++||++||+.||++|||     ++|+++||||+.+
T Consensus       244 ------------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          244 ------------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             ------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             ------------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence                                    011237999999999999999999998     4799999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-57  Score=434.46  Aligned_cols=325  Identities=75%  Similarity=1.274  Sum_probs=299.3

Q ss_pred             CcCcccccccccccCCCcccCCCCCceeccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHH
Q 014762           92 PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIK  171 (419)
Q Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~  171 (419)
                      |..+.++...+.....+..++++....+.++..++|++.++||+|+||+||+|.+..+++.||+|+++....+.+.+|+.
T Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~   82 (330)
T 3nsz_A            3 PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK   82 (330)
T ss_dssp             SCCCCCSSSTTTTTTSCHHHHCGGGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHH
T ss_pred             CCCCceeEeccccccCchhHHHhhhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHH
Confidence            34456777788888888899999888888888999999999999999999999999999999999999888899999999


Q ss_pred             HHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceE
Q 014762          172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVM  251 (419)
Q Consensus       172 ~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NIL  251 (419)
                      +++.+.+||||+++++++.+......++||||++++++..++..+++..++.++.|++.||+|||++||+||||||+|||
T Consensus        83 ~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil  162 (330)
T 3nsz_A           83 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM  162 (330)
T ss_dssp             HHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             HHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence            99999559999999999987667788999999999999999999999999999999999999999999999999999999


Q ss_pred             EcCCCCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014762          252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (419)
Q Consensus       252 l~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~  331 (419)
                      ++.+...+||+|||+++............++..|+|||++.+...++.++|||||||++|+|++|+.||+.+.+..+++.
T Consensus       163 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~  242 (330)
T 3nsz_A          163 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  242 (330)
T ss_dssp             EETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             EcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence            99875589999999998877666666678999999999998767799999999999999999999999999999999999


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISS  411 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~  411 (419)
                      .+.+.++.+....+........++.+...........|..+........+++++.+||.+||++||++|||++|+|+|||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~  322 (330)
T 3nsz_A          243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  322 (330)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCcc
Confidence            99999999999888888889999999998888888999888887777789999999999999999999999999999999


Q ss_pred             ccccc
Q 014762          412 ISPIF  416 (419)
Q Consensus       412 f~~~~  416 (419)
                      |+++.
T Consensus       323 f~~~~  327 (330)
T 3nsz_A          323 FYTVV  327 (330)
T ss_dssp             GTTCC
T ss_pred             Hhhhc
Confidence            99875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.3e-58  Score=436.47  Aligned_cols=253  Identities=22%  Similarity=0.306  Sum_probs=209.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      .+.|++.++||+|+||+||+|++..+|+.||||+++...  ...+|+.+++.+ +|||||+++++|.++  ..+|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l-~HpnIV~l~~~~~~~--~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGL-SSPRIVPLYGAVREG--PWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTC-CCTTBCCEEEEEEET--TEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEEEec
Confidence            467999999999999999999999999999999997432  235799999999 999999999999664  678999999


Q ss_pred             cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-----
Q 014762          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----  275 (419)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-----  275 (419)
                      |+||+|..++   ..+++..++.++.|++.||+|||++|||||||||+|||++.+...+||+|||+|+.......     
T Consensus       132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~  211 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL  211 (336)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence            9999999887   56999999999999999999999999999999999999998844799999999987654322     


Q ss_pred             -ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                       ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+...  .++..           
T Consensus       212 ~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~--~~~~~-----------  276 (336)
T 4g3f_A          212 TGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWT-QYFRGPLCLKIASE--PPPIR-----------  276 (336)
T ss_dssp             --CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSST-TTCCSCCHHHHHHS--CCGGG-----------
T ss_pred             cCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHcC--CCCch-----------
Confidence             123479999999999988 789999999999999999999999984 33333333333321  11100           


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHH-------------hcCCCcccccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA-------------MVISSISPIFS  417 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el-------------L~hp~f~~~~~  417 (419)
                                           ..+..+++++.+||.+||+.||++|||+.|+             |+|||+..+++
T Consensus       277 ---------------------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          277 ---------------------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             ---------------------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             ---------------------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence                                 1123479999999999999999999999997             68999988754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.4e-57  Score=425.66  Aligned_cols=249  Identities=20%  Similarity=0.386  Sum_probs=193.6

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC------
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS------  194 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------  194 (419)
                      ++|++++.||+|+||+||+|++..+|+.||||+++..    ..+.+.+|+.+|+++ +|||||+++++|.+.+.      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence            4699999999999999999999999999999998632    235688999999999 99999999999875432      


Q ss_pred             ----CccEEEEEecCCCChhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEec
Q 014762          195 ----KTPSLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (419)
Q Consensus       195 ----~~~~lv~e~~~~~~l~~~~~~------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Df  264 (419)
                          .++|+|||||++|+|.+++..      .++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~-~~vKl~DF  162 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDF  162 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC-CcEEEccC
Confidence                246899999999999988732      4556688999999999999999999999999999999988 89999999


Q ss_pred             ccceeccCCCc-------------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014762          265 GLAEFYHPGKE-------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (419)
Q Consensus       265 gla~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~  331 (419)
                      |+|+.......             .+..+||+.|+|||++.+ ..|+.++|||||||++|||++   ||..   ..+...
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~---~~~~~~  235 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFST---QMERVR  235 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSS---HHHHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCC---ccHHHH
Confidence            99987654321             123579999999999987 789999999999999999995   7732   222222


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISS  411 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~  411 (419)
                      .+......            ..++.+.                     ..++.+.+||++||+.||++|||+.|+|+|||
T Consensus       236 ~~~~~~~~------------~~p~~~~---------------------~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~  282 (299)
T 4g31_A          236 TLTDVRNL------------KFPPLFT---------------------QKYPCEYVMVQDMLSPSPMERPEAINIIENAV  282 (299)
T ss_dssp             HHHHHHTT------------CCCHHHH---------------------HHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHhcC------------CCCCCCc---------------------ccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            22221111            1111111                     13677899999999999999999999999999


Q ss_pred             cccc
Q 014762          412 ISPI  415 (419)
Q Consensus       412 f~~~  415 (419)
                      |+++
T Consensus       283 ~~~~  286 (299)
T 4g31_A          283 FEDL  286 (299)
T ss_dssp             GCCC
T ss_pred             hCCC
Confidence            9976

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.7e-56  Score=418.94  Aligned_cols=249  Identities=18%  Similarity=0.334  Sum_probs=203.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|.+.++||+|+||+||+|++.     .++..||||+++...   .++|.+|+.+|+++ +|||||+++|+|.+  .
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~   87 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--G   87 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--C
Confidence            4678999999999999999999864     367899999997543   46789999999999 99999999999965  4


Q ss_pred             CccEEEEEecCCCChhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCc
Q 014762          195 KTPSLIFEYVNSTDFKVLYP----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK  258 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~----------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~  258 (419)
                      ...++|||||++|+|..++.                .+++.++..++.|++.||+|||+++||||||||+|||++.+ +.
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~-~~  166 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LL  166 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC-Cc
Confidence            67899999999999998872                48999999999999999999999999999999999999988 88


Q ss_pred             EEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 014762          259 LRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIA  334 (419)
Q Consensus       259 ~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~  334 (419)
                      +||+|||+|+........   ....||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||. +.+..+.+..+.
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~i~  244 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVIECIT  244 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHH
Confidence            999999999866443322   22468899999999987 789999999999999999998 899983 344443333332


Q ss_pred             HHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          335 KVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      +.  .          .                        ...+..+++++.+||.+||+.||++|||+.|++  +||++
T Consensus       245 ~~--~----------~------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          245 QG--R----------V------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             HT--C----------C------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             cC--C----------C------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence            21  0          0                        001224789999999999999999999999994  47765


Q ss_pred             c
Q 014762          415 I  415 (419)
Q Consensus       415 ~  415 (419)
                      +
T Consensus       287 ~  287 (299)
T 4asz_A          287 L  287 (299)
T ss_dssp             H
T ss_pred             H
Confidence            5

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.4e-55  Score=413.21  Aligned_cols=245  Identities=18%  Similarity=0.303  Sum_probs=201.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..+++++.++||+|+||+||+|...     .+++.||||+++..    ..+.|.+|+.+++++ +|||||+++|+|.+  
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~--  100 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTK--  100 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEE--
Confidence            4567889999999999999999853     46789999999643    347899999999999 99999999999965  


Q ss_pred             CCccEEEEEecCCCChhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC
Q 014762          194 SKTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~  254 (419)
                      ...+++|||||++|+|..++                   ..+++.++..++.||+.||+|||+++||||||||+|||++.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            46788999999999999886                   23889999999999999999999999999999999999998


Q ss_pred             CCCcEEEEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014762          255 ELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (419)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~  330 (419)
                      + +.+||+|||+|+.......   .....||+.|+|||++.+ ..|+.++|||||||++|||+| |..|| .+.+..+..
T Consensus       181 ~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf-~~~~~~~~~  257 (308)
T 4gt4_A          181 K-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVV  257 (308)
T ss_dssp             G-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTCCHHHHH
T ss_pred             C-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCC-CCCCHHHHH
Confidence            8 8899999999986643322   234578999999999987 789999999999999999998 78887 344443333


Q ss_pred             HHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       331 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      ..+.+  |.                          .        ...+..+++++.+||.+||+.||++|||+.|++++
T Consensus       258 ~~i~~--~~--------------------------~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          258 EMIRN--RQ--------------------------V--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHT--TC--------------------------C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHc--CC--------------------------C--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            32221  00                          0        00123478999999999999999999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.5e-55  Score=414.60  Aligned_cols=244  Identities=16%  Similarity=0.313  Sum_probs=196.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|.+.++||+|+||+||+|++.     .++..||||+++...   .+.|.+|+.+|+++ +|||||+++|+|.+  .
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~  115 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTE--G  115 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--C
Confidence            4578999999999999999999864     468899999997543   46799999999999 99999999999965  4


Q ss_pred             CccEEEEEecCCCChhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC
Q 014762          195 KTPSLIFEYVNSTDFKVLYP------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL  256 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~  256 (419)
                      ..+++|||||++|+|..++.                  .+++.++..++.|++.||+|||+++||||||||+|||++.+ 
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~-  194 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-  194 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC-
Confidence            67899999999999988762                  38899999999999999999999999999999999999988 


Q ss_pred             CcEEEEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 014762          257 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVK  332 (419)
Q Consensus       257 ~~~kl~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~  332 (419)
                      +.+||+|||+|+.......   .....||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||. +.++.+.+..
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~  272 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY-QLSNTEAIDC  272 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTC-SSCHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCC-CCCHHHHHHH
Confidence            8999999999987644332   234578999999999987 789999999999999999999 899984 3343333333


Q ss_pred             HHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       333 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      +.+.  .          .                        ...+..+++++.+||.+||+.||++|||+.|+++
T Consensus       273 i~~g--~----------~------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~  312 (329)
T 4aoj_A          273 ITQG--R----------E------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA  312 (329)
T ss_dssp             HHHT--C----------C------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred             HHcC--C----------C------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            3221  0          0                        0112247999999999999999999999999987

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.4e-55  Score=410.43  Aligned_cols=249  Identities=15%  Similarity=0.296  Sum_probs=198.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..+++++.++||+|+||+||+|++.   ..||||+++..     ..+.|.+|+.+++++ +|||||+++|++.+   ..+
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~---~~~  106 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK---DNL  106 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC---CeE
Confidence            4678899999999999999999753   35999998632     246789999999999 99999999999854   457


Q ss_pred             EEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++|||||++|+|.+++    ..+++..+..++.|++.||+|||+++||||||||+|||++.+ +.+||+|||+|+.....
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCBC----
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCceecccC
Confidence            8999999999999876    358999999999999999999999999999999999999988 89999999999875432


Q ss_pred             C---cceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcC-CchHHHHHh
Q 014762          274 K---EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG-TDELNAYLN  347 (419)
Q Consensus       274 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg-~~~~~~~~~  347 (419)
                      .   .....+||+.|+|||++.+  ...|+.++|||||||++|||+||+.||. +.++.+.+..++..-. .+..     
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~-~~~~~~~~~~~~~~~~~~p~~-----  259 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS-HINNRDQIIFMVGRGYASPDL-----  259 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHHHTTCCCCCS-----
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC-CCChHHHHHHHHhcCCCCCCc-----
Confidence            2   2344689999999999864  2468999999999999999999999984 4444444443332100 0000     


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHH------hcCCCc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA------MVISSI  412 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el------L~hp~f  412 (419)
                                                 ......+++++.+|+.+||+.||++|||+.|+      |+|++-
T Consensus       260 ---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          260 ---------------------------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             ---------------------------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             ---------------------------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence                                       01123478999999999999999999999976      566653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.2e-54  Score=441.19  Aligned_cols=254  Identities=24%  Similarity=0.415  Sum_probs=218.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .++|++++.||+|+||+||+|.+..+|+.||+|++...   ..+.+.+|+.+|+.+ +|||||+++++|.+.  ..+++|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~--~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDD--NEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECS--SEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEE
Confidence            36899999999999999999999999999999998643   246688999999999 999999999999654  788999


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC-CCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~-~~~~kl~Dfgla~~~~~~~~  275 (419)
                      ||||+||+|..++    ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+...+...
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            9999999998876    358999999999999999999999999999999999999864 36899999999999887777


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..|| .+.+..+.+..+.+.....               
T Consensus       313 ~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf-~~~~~~~~~~~i~~~~~~~---------------  375 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNM---------------  375 (573)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHTTCCCC---------------
T ss_pred             eeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHhCCCCC---------------
Confidence            777899999999999987 78999999999999999999999998 3444444554443311110               


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                        .......+|+++++||++||+.||++|||+.|+|+||||+..
T Consensus       376 ------------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          376 ------------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             ------------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             ------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence                              011122379999999999999999999999999999999864

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.6e-54  Score=435.02  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=207.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHH---HHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKRE---IKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++++.||+|+||+||+|++..+|+.||||++++..      .....+|   +.+++.+ +|||||+++++|.+.  
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~--  264 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP--  264 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS--
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEEC--
Confidence            578999999999999999999999999999999996422      2334444   4455555 899999999999654  


Q ss_pred             CccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..+|+||||++||+|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~-G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS  343 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC-CCEEecccceeeecC
Confidence            7899999999999998887   569999999999999999999999999999999999999988 899999999998775


Q ss_pred             CCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~-~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ... ....+||+.|+|||++.+...|+.++|+|||||++|||++|+.||..... +...+...+..            ..
T Consensus       344 ~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~------------~~  410 (689)
T 3v5w_A          344 KKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT------------MA  410 (689)
T ss_dssp             SCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH------------CC
T ss_pred             CCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC------------CC
Confidence            443 34569999999999997546799999999999999999999999953221 11111111100            00


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                              ...+..+|+++++||.+||+.||++|++     |+|+++||||+++
T Consensus       411 ------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          411 ------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence                                    0112247999999999999999999998     8999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.7e-54  Score=410.57  Aligned_cols=248  Identities=21%  Similarity=0.353  Sum_probs=203.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.++||+|+||+||+|.+..+     ++.||||.++...    .+.+.+|+.+|.++..|||||+++|+|..+ 
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-  140 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-  140 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence            468899999999999999999987654     3689999997532    356889999999995559999999999654 


Q ss_pred             CCccEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~  254 (419)
                      +..+++|||||++|+|..++.                   .+++..+..++.||+.||+|||+++||||||||+|||++.
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence            356789999999999988862                   2789999999999999999999999999999999999998


Q ss_pred             CCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014762          255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (419)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~  330 (419)
                      + +.+||+|||+|+........   ....||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||. +.+..+.+
T Consensus       221 ~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~-~~~~~~~~  297 (353)
T 4ase_A          221 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKIDEEF  297 (353)
T ss_dssp             G-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST-TCCCSHHH
T ss_pred             C-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCC-CCCHHHHH
Confidence            8 89999999999876544332   23578899999999987 789999999999999999998 898984 33333333


Q ss_pred             HHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       331 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      ...+.. |.                                  ....+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       298 ~~~i~~-g~----------------------------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          298 CRRLKE-GT----------------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHH-TC----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHc-CC----------------------------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            322221 00                                  001122478999999999999999999999999987

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.8e-51  Score=384.55  Aligned_cols=280  Identities=29%  Similarity=0.529  Sum_probs=226.9

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|++.++||+|+||+||+|.+..+++.||+|+++...     .+.+.+|+.+++++ +||||+++++++.+.  ...++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   78 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSD--KKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeC--CEEEE
Confidence            58999999999999999999999999999999986322     36788999999999 899999999999654  67899


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-Cc
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KE  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~~  275 (419)
                      ||||++++.+..+.   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus        79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCSCCSC
T ss_pred             EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecCCcccc
Confidence            99999987665543   469999999999999999999999999999999999999988 88999999999876533 23


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....+|..|+|||++.+...++.++|||||||++|+|++|+.||+.+.+..+.+..+.+.++.+....+.......   
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---  234 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP---  234 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST---
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc---
Confidence            34567899999999998755689999999999999999999999998888888999998888876554332111100   


Q ss_pred             hhHHhhccCCCCCcc-ccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          356 QLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                            ......... ..........+++++++||++||++||++|||++|+|+||||+++..
T Consensus       235 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          235 ------DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             ------TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             ------cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence                  000000000 00011112347899999999999999999999999999999998753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.2e-51  Score=408.32  Aligned_cols=283  Identities=25%  Similarity=0.456  Sum_probs=224.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----C
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----S  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~  194 (419)
                      .++|+++++||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+++.+ +||||+++++++....    .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccC
Confidence            68899999999999999999999999999999999642     246688999999999 9999999999996542    2


Q ss_pred             CccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          195 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ...++||||++++.+......+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus       140 ~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~  218 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSF  218 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCCC-----CC
T ss_pred             CeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC-CCEEEEEEEeeeecCCCc
Confidence            4579999999998777777789999999999999999999999999999999999999988 789999999998876655


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.|| .+.+..+++..+.+.+|.+....+..     ..
T Consensus       219 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF-~g~~~~~~~~~i~~~lg~p~~~~~~~-----~~  291 (464)
T 3ttj_A          219 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKK-----LQ  291 (464)
T ss_dssp             CC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHTT-----SC
T ss_pred             ccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHH-----cc
Confidence            5666789999999999988 68999999999999999999999887 67788889999999999876654321     11


Q ss_pred             hhhHHhhccCC---CCCccccccccc-------cCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHS---RKPWSKFINADN-------QHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      +..........   ...+...+....       ....++++++||++||++||++|||++|+|+||||+..
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence            22222221111   111111111000       00125679999999999999999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.5e-51  Score=398.06  Aligned_cols=290  Identities=28%  Similarity=0.530  Sum_probs=220.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...     ..+.+.+|+.++..+.+||||+++++++..++....+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            46899999999999999999999999999999998532     2356779999999995699999999999876667889


Q ss_pred             EEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC---
Q 014762          199 LIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG---  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~---  273 (419)
                      +||||+++ +|..++  ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....   
T Consensus        88 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~  165 (388)
T 3oz6_A           88 LVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRV  165 (388)
T ss_dssp             EEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEESSSCCCC
T ss_pred             EEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC-CCEEecCCcccccccccccc
Confidence            99999995 666655  468999999999999999999999999999999999999988 88999999999865321   


Q ss_pred             -------------------CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014762          274 -------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA  334 (419)
Q Consensus       274 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~  334 (419)
                                         ......+||+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~  244 (388)
T 3oz6_A          166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-PGSSTMNQLERII  244 (388)
T ss_dssp             CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHH
Confidence                               11233579999999999987678999999999999999999999887 6778888999999


Q ss_pred             HHcCCchHHHHHhhcCCCCChhhHHhhccC--CCCCccccc--------cccccCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 014762          335 KVLGTDELNAYLNKYHLELDPQLDALVGRH--SRKPWSKFI--------NADNQHLVSPEAIDFLDKLLRYDHQDRLTAR  404 (419)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~  404 (419)
                      +.+|.+....+..............+....  ....+...+        .......+++++.+||.+||++||++|||++
T Consensus       245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~  324 (388)
T 3oz6_A          245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN  324 (388)
T ss_dssp             HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence            999988766543211111111111111100  001111110        1112235789999999999999999999999


Q ss_pred             HHhcCCCccccc
Q 014762          405 EAMVISSISPIF  416 (419)
Q Consensus       405 elL~hp~f~~~~  416 (419)
                      |+|+||||+.+.
T Consensus       325 e~l~Hp~~~~~~  336 (388)
T 3oz6_A          325 DALKHPFVSIFH  336 (388)
T ss_dssp             HHTTSTTTTTTC
T ss_pred             HHhCCHHHHHhc
Confidence            999999998653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.4e-50  Score=384.31  Aligned_cols=285  Identities=32%  Similarity=0.599  Sum_probs=223.5

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      .+..++|+++++||+|+||+||+|.+. +|+.||+|++....     .+.+.+|+.+++++ +||||+++++++.+  ..
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~   92 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS--ER   92 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC--SS
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc--CC
Confidence            345789999999999999999999884 58999999986422     35688999999999 89999999999954  47


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ..++||||++++.+..+.   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        93 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           93 CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARAFGI  171 (311)
T ss_dssp             CEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEETTS
T ss_pred             EEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC-CCEEEccCcCceecCC
Confidence            789999999975444333   348999999999999999999999999999999999999988 7899999999987653


Q ss_pred             C-CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          273 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       273 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      . .......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....+......
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF-PGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            3 23345678999999999877567899999999999999999999987 566777788888888887654433211100


Q ss_pred             CCChhhHH-hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccccC
Q 014762          352 ELDPQLDA-LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFSLV  419 (419)
Q Consensus       352 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~  419 (419)
                         +.+.. ........+|...     ...+++++.+||.+||++||++|||++|+|+||||+++.+.+
T Consensus       251 ---~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~i  311 (311)
T 3niz_A          251 ---PLWKQRTFQVFEKKPWSSI-----IPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQI  311 (311)
T ss_dssp             ---HHHHSCCCCCCCCCCHHHH-----STTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTTC
T ss_pred             ---chhhhcccccccCCcHHHh-----CcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCccC
Confidence               00000 0000111122211     123788999999999999999999999999999999987643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.6e-52  Score=390.04  Aligned_cols=264  Identities=18%  Similarity=0.197  Sum_probs=190.5

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHH--HHHHHHhcCCCCeeEEEeEEEccCC--CccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKRE--IKILQNLCGGPNVVKLLDIVRDQHS--KTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E--~~~l~~l~~h~niv~l~~~~~~~~~--~~~~lv  200 (419)
                      .+|.+.++||+|+||+||+|++  +|+.||||+++....+.+.+|  +..+.++ +|||||+++++|.+++.  ..++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence            4688999999999999999976  689999999987666555554  4445677 89999999999976543  257899


Q ss_pred             EEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~--------~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ||||++|+|..++  ..+++..+..++.|++.||+|||++        +||||||||+|||++.+ +.+||+|||+|+..
T Consensus        80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCCCCccc
Confidence            9999999999987  5689999999999999999999987        99999999999999988 89999999999877


Q ss_pred             cCCCcc-----eeecccccccccccccCCC-----CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCc
Q 014762          271 HPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (419)
Q Consensus       271 ~~~~~~-----~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~  340 (419)
                      ......     ...+||+.|+|||++.+..     .++.++|||||||++|||+||..||....+.......+  ....+
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~--~~~~~  236 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL--VPSDP  236 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT--SCSSC
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc--ccccc
Confidence            544322     2357999999999987521     36789999999999999999987763221110000000  00000


Q ss_pred             hHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ......           ........+...+.   ......+++.+.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~-----------~~~~~~~~rp~~p~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          237 SVEEMR-----------KVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             CHHHHH-----------HHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hHHHHH-----------HHHhcccCCCCCCc---cccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            000000           00000000000000   0001113457889999999999999999999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3e-50  Score=389.38  Aligned_cols=254  Identities=28%  Similarity=0.466  Sum_probs=215.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|+++..         ..+.+.+|+.+++.+ +||||+++++++.+.  
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--   87 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENR--   87 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeC--
Confidence            67899999999999999999999999999999998642         236789999999999 899999999999654  


Q ss_pred             CccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC---cEEEEecccce
Q 014762          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAE  268 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~---~~kl~Dfgla~  268 (419)
                      ...++||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+..   .+||+|||+++
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            6789999999999998887   35899999999999999999999999999999999999987632   79999999998


Q ss_pred             eccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ............||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.+....         
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~-~~~~~~~~~~i~~~~~~---------  236 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAVSYD---------  236 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTCCC---------
T ss_pred             EcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCCC---------
Confidence            8776655566789999999999876 789999999999999999999999984 33434444433321111         


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                          .++.                    ....+++++++||.+||+.||++|||+.|+|+||||+++
T Consensus       237 ----~~~~--------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          237 ----FDEE--------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             ----CCHH--------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             ----CCch--------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence                0000                    012378999999999999999999999999999999865

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-50  Score=385.99  Aligned_cols=250  Identities=23%  Similarity=0.444  Sum_probs=212.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...     ..+.+.+|+.+++.+ +||||+++++++..  ....+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~~   90 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIET--EKTLY   90 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEE
Confidence            56899999999999999999999999999999998643     235678999999999 89999999999965  46789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||||++++++..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~  169 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGK  169 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTCCGGGSSSCG
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC-CCEEEeeccCceecCCCCc
Confidence            999999999998876   579999999999999999999999999999999999999988 8899999999987766666


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ....+||+.|+|||++.+....+.++|||||||++|+|++|+.||. +.+..+....+...             ..    
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~-------------~~----  231 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRG-------------KY----  231 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-------------CC----
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------CC----
Confidence            6667899999999999884434589999999999999999999983 33322222222210             00    


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                          ..+..+++++.+|+++||+.||++|||++|+++||||+..
T Consensus       232 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          232 --------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred             --------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence                                0012368999999999999999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.6e-50  Score=397.21  Aligned_cols=287  Identities=28%  Similarity=0.524  Sum_probs=225.3

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC-
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-  194 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-  194 (419)
                      +...++|++.+.||+|+||+||+|.+..+++.||||+++..     ..+.+.+|+.+++.+ +||||+++++++..... 
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~  100 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLL  100 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCC
Confidence            44578999999999999999999999999999999999642     236788999999999 89999999999965422 


Q ss_pred             --CccEEEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          195 --KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       195 --~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                        ...|+||||+++ +|..++.   .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus       101 ~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~kL~DFGla~~  178 (432)
T 3n9x_A          101 KFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSVKVCDFGLART  178 (432)
T ss_dssp             TCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred             cCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCEEEccCCCccc
Confidence              568999999985 7766653   48999999999999999999999999999999999999988 8899999999987


Q ss_pred             ccCCCc-----------------------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhC----------
Q 014762          270 YHPGKE-----------------------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR----------  316 (419)
Q Consensus       270 ~~~~~~-----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g----------  316 (419)
                      ......                       ....+||++|+|||++.....++.++|||||||++|||++|          
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            654321                       24568899999999976657899999999999999999974          


Q ss_pred             CCCCCCCCC-----------------CHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccC
Q 014762          317 KEPFFYGHD-----------------NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQH  379 (419)
Q Consensus       317 ~~pf~~~~~-----------------~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (419)
                      +.|++.+.+                 ..+++..+.+.+|.+....+....    .+................+.  ....
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~--~~~~  332 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN----KPEVIKYIKLFPHRKPINLK--QKYP  332 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCC----CHHHHHHHHTSCCCCCCCHH--HHST
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhcc----CHHHHHHHHhCCCCCCCCHH--HHCC
Confidence            556665554                 367888899999998776543211    11122222111111110000  0112


Q ss_pred             CCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          380 LVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       380 ~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      .+++++.+||++||++||++|||++|+|+||||++++
T Consensus       333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            3799999999999999999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-49  Score=374.61  Aligned_cols=254  Identities=26%  Similarity=0.440  Sum_probs=213.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .++|++.++||+|+||+||+|.+..+++.||+|++..   ...+.+.+|+.+++.+ +||||+++++++...  ...++|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEEC--CEEEEE
Confidence            5689999999999999999999999999999999853   3456788999999999 999999999999654  678999


Q ss_pred             EEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-ce
Q 014762          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YN  277 (419)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~~  277 (419)
                      |||+++++|..++  ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++........ ..
T Consensus        96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBC
T ss_pred             EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC-CCEEEeeCCCceecCCcccccC
Confidence            9999999999887  458999999999999999999999999999999999999988 7899999999987654433 34


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+... +.+.                
T Consensus       175 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~~~~~-~~~~----------------  235 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATN-GTPE----------------  235 (297)
T ss_dssp             CCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHH-CSCC----------------
T ss_pred             CccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-CCCC----------------
Confidence            4679999999999987 789999999999999999999999984 22323333222211 1000                


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                       ......+++.+.+||.+||+.||++|||++|+|+||||+...+
T Consensus       236 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          236 -----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             -----------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             -----------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence                             0011237899999999999999999999999999999997653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.4e-50  Score=380.80  Aligned_cols=284  Identities=26%  Similarity=0.547  Sum_probs=210.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .++|+++++||+|+||+||+|.+..+|+.||+|+++..    ..+.+.+|+.+++.+ +||||+++++++.+  ....++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHT--ENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECC--TTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEE--CCeEEE
Confidence            46899999999999999999999999999999998632    236788999999999 99999999999955  467899


Q ss_pred             EEEecCCCChhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          200 IFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       200 v~e~~~~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ||||+++ +|..++         ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAF  158 (317)
T ss_dssp             EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCSSCEET
T ss_pred             EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC-CCEEECcCccceec
Confidence            9999995 666554         248999999999999999999999999999999999999988 88999999999876


Q ss_pred             cCC-CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       271 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ... .......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.+|.+....+....
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF-PGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            533 22344678999999999977567899999999999999999999998 5666677888888887765443222111


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ....   +.......................+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       238 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          238 KLPK---YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             GCTT---CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             hhhh---cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence            1000   000000001111112222223345889999999999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-50  Score=380.16  Aligned_cols=254  Identities=24%  Similarity=0.430  Sum_probs=215.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.+.||+|+||+||+|.+..+++.+|+|.++..  ....+.+|+.+++.+ +||||+++++++.+.  ...++||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~lv~   80 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESM--EELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecC--CEEEEEE
Confidence            67899999999999999999999999999999998743  345688999999999 999999999999664  6789999


Q ss_pred             EecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC-CCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~-~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      ||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ .+.+||+|||+++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~  160 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence            9999999988773    48999999999999999999999999999999999999873 378999999999988766666


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.+.....+..             
T Consensus       161 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~~-------------  225 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYTFDEE-------------  225 (321)
T ss_dssp             EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCCCHH-------------
T ss_pred             ccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCc-CCCHHHHHHHHHcCCCCCChh-------------
Confidence            67789999999999877 678999999999999999999999984 333344444433321111111             


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                          ....+++++.+|+.+||+.||++|||+.|+|+||||++.
T Consensus       226 --------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          226 --------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             --------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             --------------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                                012378999999999999999999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.1e-50  Score=400.03  Aligned_cols=285  Identities=30%  Similarity=0.524  Sum_probs=210.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc---CC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---HS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~  194 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+|+.+ +||||+++++++...   ..
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccC
Confidence            468899999999999999999999999999999998642     236688999999999 999999999998543   23


Q ss_pred             CccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ...|+||||+++ +|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       130 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          130 DELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLARTVD  207 (458)
T ss_dssp             CCEEEEECCCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBCTT
T ss_pred             ceEEEEEecccc-chhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC-CCEeecccccchhcc
Confidence            568999999864 565554   348999999999999999999999999999999999999988 799999999998754


Q ss_pred             CCC----------------------------cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhC-------
Q 014762          272 PGK----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR-------  316 (419)
Q Consensus       272 ~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g-------  316 (419)
                      ...                            .....+||++|+|||++.....++.++|||||||++|||++|       
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            221                            123457899999999876657899999999999999999984       


Q ss_pred             ---CCCCCCCCC--------------------CHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccc
Q 014762          317 ---KEPFFYGHD--------------------NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFI  373 (419)
Q Consensus       317 ---~~pf~~~~~--------------------~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (419)
                         +.|+|.+.+                    ..+++..+.+.+|.+....+....    ..................+.
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE----KEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSS----CHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcC----CHHHHHHHHhcCCCCCCCHH
Confidence               334445443                    257788899999988766543211    11111111111111111111


Q ss_pred             cccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          374 NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       374 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                        .....+++++.+||++||++||++|||++|+|+||||+++.
T Consensus       364 --~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          364 --ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             --GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             --HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence              11234689999999999999999999999999999999874

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9.1e-50  Score=377.99  Aligned_cols=279  Identities=27%  Similarity=0.491  Sum_probs=219.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--------hHHHHHHHHHHHHhc--CCCCeeEEEeEEEcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLC--GGPNVVKLLDIVRDQ  192 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~  192 (419)
                      ..++|++.++||+|+||+||+|++..+++.||+|++....        ...+.+|+.+++.+.  +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4789999999999999999999999999999999986322        356778888888773  499999999999764


Q ss_pred             CCC---ccEEEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEec
Q 014762          193 HSK---TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (419)
Q Consensus       193 ~~~---~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Df  264 (419)
                      ...   ..++||||+++ +|..++.     .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Df  164 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADF  164 (308)
T ss_dssp             CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT-SCEEECSC
T ss_pred             CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEEeeC
Confidence            322   57899999985 7766652     28999999999999999999999999999999999999988 88999999


Q ss_pred             ccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       265 gla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      |+++............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.++...
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhh
Confidence            99987765555566788999999999987 77999999999999999999999987 56667778888888887765443


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      +.......  .   ............     .....+++++.+||.+||++||++|||+.|+|+||||+..
T Consensus       243 ~~~~~~~~--~---~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          243 WPRDVSLP--R---GAFPPRGPRPVQ-----SVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SCSSCSSC--G---GGSCCCCCCCHH-----HHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             ccchhhcc--c---cccCCCCCCcHH-----HhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            32111110  0   000000001111     1123478999999999999999999999999999999865

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-49  Score=384.77  Aligned_cols=281  Identities=30%  Similarity=0.553  Sum_probs=223.1

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC-
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-  194 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-  194 (419)
                      +...++|++.+.||+|+||+||+|.+..+|+.||||++...     ..+.+.+|+.+++.+ +||||+++++++..... 
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL   99 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCcc
Confidence            34578999999999999999999999999999999998532     235678999999999 89999999999965422 


Q ss_pred             ---CccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          195 ---KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       195 ---~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                         ...++||||+ +++|..++  ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQ  177 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred             ccCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC-CCEEEEeeecccc
Confidence               3569999999 77887776  569999999999999999999999999999999999999988 8899999999987


Q ss_pred             ccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ...  ......+|..|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+++..+.+..|.++...+..-.
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            543  2344678999999999987668999999999999999999999987 5677788899999999987765432110


Q ss_pred             CCCCChhhHHhhc---cCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          350 HLELDPQLDALVG---RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       350 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                          .........   ......+....     ..+++++.+||.+||+.||++|||++|+|+||||+.+.
T Consensus       255 ----~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          255 ----SDEAKNYMKGLPELEKKDFASIL-----TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             ----CHHHHHHHHHSCCCCCCCGGGTC-----TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             ----hHHHHHHHHhCCCCCCCCHHHHC-----CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence                011111111   11112222221     24789999999999999999999999999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.6e-50  Score=385.52  Aligned_cols=251  Identities=22%  Similarity=0.379  Sum_probs=208.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++++.||+|+||+||+|++..+|+.||+|+++..      ..+.+.+|..++..+.+||||+++++++.+.  ..
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~   98 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP--DR   98 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC--CE
Confidence            357899999999999999999999999999999999642      2356778999999887899999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-  272 (419)
                      .++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... 
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC-CCEEEccccceeecccC
Confidence            89999999999998876   569999999999999999999999999999999999999988 8999999999986432 


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+...             ...
T Consensus       178 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~-------------~~~  242 (353)
T 3txo_A          178 GVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILND-------------EVV  242 (353)
T ss_dssp             --------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-------------CCC
T ss_pred             CccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCC-CCCHHHHHHHHHcC-------------CCC
Confidence            233445689999999999977 779999999999999999999999983 34444444443321             000


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta------~elL~hp~f~~~  415 (419)
                                              .+..+++++.+||++||+.||++|||+      +|+++||||+.+
T Consensus       243 ------------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          243 ------------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             ------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             ------------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence                                    012368899999999999999999999      899999999976

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-49  Score=392.41  Aligned_cols=283  Identities=31%  Similarity=0.519  Sum_probs=227.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEcc----CCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~~~l  199 (419)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++... .....+|+.+++.+ +||||++++++|...    ...++++
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-chhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEe
Confidence            44699999999999999999999999999999998643 23345899999999 999999999998542    2234679


Q ss_pred             EEEecCCCChhhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          200 IFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       200 v~e~~~~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ||||++++.....      ...+++..++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+++.....
T Consensus       131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence            9999997544322      1468999999999999999999999999999999999999977577899999999887655


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++.++.+.+|.+....+........
T Consensus       211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            55556788999999999987567999999999999999999999887 56777889999999999887765543211100


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      ...    .......+|...+    ...+++++.+||++||++||++|||+.|+|+||||+.++.
T Consensus       290 ~~~----~p~~~~~~~~~~~----~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          290 EFK----FPQIKAHPWTKVF----RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             CCC----CCCCCCCCHHHHS----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhc----cCccCCCCHHHhc----CCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            000    0011122333222    1246899999999999999999999999999999987753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.1e-49  Score=371.92  Aligned_cols=276  Identities=31%  Similarity=0.609  Sum_probs=214.8

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|++.+.||+|+||+||+|.+ .+|+.||+|++....     .+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l   77 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTK--KRLVL   77 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECS--SCEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccC--CeEEE
Confidence            5899999999999999999988 778999999986432     36788999999999 899999999999654  67899


Q ss_pred             EEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-C
Q 014762          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~  274 (419)
                      ||||+++ ++..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .
T Consensus        78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC---
T ss_pred             EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEeECccccccCcccc
Confidence            9999997 555554    458999999999999999999999999999999999999988 88999999999765432 2


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....+.......  
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  232 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELP--  232 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHHCCCChhhchhhhccc--
Confidence            2344578999999999977567899999999999999999999998 4556677777888777765443322111000  


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                       .+..........+|..+     ...+++++.+||++||+.||++|||++|+|+||||++.
T Consensus       233 -~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          233 -KYDPNFTVYEPLPWESF-----LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             -TCCTTCCCCCCCCGGGT-----CCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             -ccccccccccCccHHHH-----hhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence             00000000111122211     23478999999999999999999999999999999863

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-49  Score=388.12  Aligned_cols=283  Identities=28%  Similarity=0.532  Sum_probs=228.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEcc----------
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----------  192 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----------  192 (419)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|++... .....+|+.+++.+ +||||++++++|...          
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTC-CCTTBCCEEEEEEEC----------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHc-CCCCccchhheeeecCccccccccc
Confidence            367899999999999999999999999999999998643 33345899999999 999999999998542          


Q ss_pred             --------------------------CCCccEEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014762          193 --------------------------HSKTPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQG  239 (419)
Q Consensus       193 --------------------------~~~~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~  239 (419)
                                                .....++||||+++ ++...+       ..+++..++.++.|++.||+|||++|
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                      23447899999996 443332       46899999999999999999999999


Q ss_pred             cEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 014762          240 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (419)
Q Consensus       240 ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~p  319 (419)
                      |+||||||+|||++.+.+.+||+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|+.|
T Consensus       162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  241 (383)
T 3eb0_A          162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL  241 (383)
T ss_dssp             EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence            99999999999998654899999999999876666666678899999999998756799999999999999999999988


Q ss_pred             CCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCC
Q 014762          320 FFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD  399 (419)
Q Consensus       320 f~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  399 (419)
                      | .+.+..+++..+++.+|.+....+...........    ........|...+    ...+++++.+||.+||++||++
T Consensus       242 f-~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          242 F-SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR----FPTLKAKDWRKIL----PEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             S-CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CC----CCCCCCCCHHHHS----CTTCCHHHHHHHHHHCCSSGGG
T ss_pred             C-CCCChHHHHHHHHHHhCCCCHHHHHHhCccccccc----CCccCcccHHhhC----CCCCCHHHHHHHHHHccCChhh
Confidence            7 56778889999999999988776543221100000    0011112222222    2347899999999999999999


Q ss_pred             CCCHHHHhcCCCcccccc
Q 014762          400 RLTAREAMVISSISPIFS  417 (419)
Q Consensus       400 Rpta~elL~hp~f~~~~~  417 (419)
                      |||+.|+|+||||+.++.
T Consensus       313 R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          313 RINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             SCCHHHHHTSGGGHHHHH
T ss_pred             CCCHHHHhcCHHHHHHHh
Confidence            999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.8e-49  Score=377.52  Aligned_cols=249  Identities=26%  Similarity=0.451  Sum_probs=210.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++++.||+|+||+||+|++..+|+.||+|+++..      ....+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~--~~~   80 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECS--SEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeC--CEE
Confidence            46899999999999999999999999999999999642      345688999999999 899999999999654  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-C
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-G  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~  273 (419)
                      ++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... .
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC-CCEEEeeccchhhcccCC
Confidence            9999999999998776   468999999999999999999999999999999999999988 8999999999986432 3


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      ......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.. .+..+....+...             ... 
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~-------------~~~-  223 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILME-------------EIR-  223 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC-------------CCC-
T ss_pred             CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcC-------------CCC-
Confidence            33455689999999999877 7899999999999999999999999842 2222222222210             000 


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                             .+..+++++.+||.+||+.||++||     |++|+++||||+.+
T Consensus       224 -----------------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          224 -----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             -----------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             -----------------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence                                   0123789999999999999999999     99999999999876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-49  Score=376.32  Aligned_cols=254  Identities=26%  Similarity=0.435  Sum_probs=213.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|+++..         ..+.+.+|+.+++.+ +||||+++++++.+.  
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--   86 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENK--   86 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--
Confidence            46799999999999999999999999999999998642         246789999999999 899999999999654  


Q ss_pred             CccEEEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC---CcEEEEecccce
Q 014762          195 KTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAE  268 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~---~~~kl~Dfgla~  268 (419)
                      ...++||||+++++|..++.   .+++..+..++.|++.||.|||++||+||||||+|||++.+.   ..+||+|||+++
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            67899999999999998873   489999999999999999999999999999999999998762   179999999998


Q ss_pred             eccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ............||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.......+..     
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~-----  239 (326)
T 2y0a_A          167 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFEDE-----  239 (326)
T ss_dssp             ECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHTCCCCCHH-----
T ss_pred             ECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHhcCCCcCcc-----
Confidence            8765555556789999999999876 789999999999999999999999984 333333343333211110000     


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                                  ....+++.+.+||.+||+.||++|||+.|+|+||||++.
T Consensus       240 ----------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          240 ----------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             ----------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             ----------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence                                        012368899999999999999999999999999999865

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-49  Score=370.73  Aligned_cols=253  Identities=25%  Similarity=0.474  Sum_probs=206.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------------------------hHHHHHHHHHHH
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------------------KKKIKREIKILQ  174 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~~l~  174 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....                             .+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            578999999999999999999999999999999986432                             245889999999


Q ss_pred             HhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE
Q 014762          175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (419)
Q Consensus       175 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl  252 (419)
                      .+ +||||+++++++.+......++||||++++++..+.  ..+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus        92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            99 999999999999876667889999999999988765  458999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecccceeccCCCc-ceeecccccccccccccCCCC--CCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 014762          253 DHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (419)
Q Consensus       253 ~~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~  329 (419)
                      +.+ +.+||+|||+++....... .....||+.|+|||++.+...  ++.++|||||||++|+|++|+.||... +....
T Consensus       171 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~  248 (298)
T 2zv2_A          171 GED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE-RIMCL  248 (298)
T ss_dssp             CTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHH
T ss_pred             CCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc-cHHHH
Confidence            988 7899999999987654332 344678999999999876322  478899999999999999999998421 11111


Q ss_pred             HHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       330 ~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      ...+..             ...                      .......+++++.+||.+||+.||++|||+.|+++|
T Consensus       249 ~~~~~~-------------~~~----------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          249 HSKIKS-------------QAL----------------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HHHHHH-------------CCC----------------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HHHHhc-------------ccC----------------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            111111             000                      001112478999999999999999999999999999


Q ss_pred             CCccc
Q 014762          410 SSISP  414 (419)
Q Consensus       410 p~f~~  414 (419)
                      |||+.
T Consensus       294 p~~~~  298 (298)
T 2zv2_A          294 PWVTR  298 (298)
T ss_dssp             HHHHC
T ss_pred             ccccC
Confidence            99963

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.2e-49  Score=371.72  Aligned_cols=283  Identities=29%  Similarity=0.470  Sum_probs=217.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.++||+|+||+||+|.+..+|+.||+|++....     .+.+.+|+.+++++ +||||+++++++.+.  ...+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~   78 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRK--RRLH   78 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecC--CeEE
Confidence            368999999999999999999999999999999985432     35677899999999 899999999999654  6788


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      +||||++++++..+.   ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||++....... 
T Consensus        79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred             EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCccc
Confidence            999999999988775   458999999999999999999999999999999999999988 899999999998765332 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+....+.+.++..............  
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  234 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ--  234 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG--
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhccccccccccccccc--
Confidence            3345678999999999987577899999999999999999999987 5566677777777777654332211100000  


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                       .+.   ......+............+++++.+||.+||++||++|||++|+|+||||+++++
T Consensus       235 -~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          235 -YFS---GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             -GGT---TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             -ccc---cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence             000   00000000000000011347899999999999999999999999999999999865

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=379.80  Aligned_cols=280  Identities=27%  Similarity=0.545  Sum_probs=216.2

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch----HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++|++.++||+|+||+||+|.+..+++.||+|+++....    ..+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTE--KSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECS--SCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeC--CEEEEE
Confidence            579999999999999999999999999999999974332    2355799999999 899999999999654  678999


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-c
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-E  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~  275 (419)
                      |||+++ ++..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... .
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~  156 (324)
T 3mtl_A           79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKT  156 (324)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT-CCEEECSSSEEECC------
T ss_pred             eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC-CCEEEccCcccccccCCccc
Confidence            999996 555544    348999999999999999999999999999999999999988 789999999997654322 2


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+.+|.+....+.....   ..
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~  232 (324)
T 3mtl_A          157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILS---NE  232 (324)
T ss_dssp             ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGG---CH
T ss_pred             cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHhchhhhc---ch
Confidence            344578999999999987667899999999999999999999887 56677788888888888765443321100   00


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      .+...    ....+...........+++++.+||.+||++||++|||++|+|+||||+++.+
T Consensus       233 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          233 EFKTY----NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHHHT----CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             hhccc----ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            00000    00000000001112347899999999999999999999999999999998865

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.7e-49  Score=384.18  Aligned_cols=252  Identities=25%  Similarity=0.439  Sum_probs=210.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++++.||+|+||+||+|++..+++.||+|++++..      .+.+.+|..++.++.+||||++++++|.+.  ...
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--~~~  128 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRL  128 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--CEE
Confidence            568999999999999999999999999999999996432      245788999999887899999999999654  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec-cCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY-HPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~-~~~  273 (419)
                      ++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.. ...
T Consensus       129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTT
T ss_pred             EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC-CCEEEeecceeeecccCC
Confidence            9999999999998776   569999999999999999999999999999999999999988 89999999999863 333


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-------HHHHHHHHHHcCCchHHHHH
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-------HDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-------~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......       .+.+.+.+.           
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~-----------  275 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-----------  275 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH-----------
T ss_pred             CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh-----------
Confidence            44556789999999999987 78999999999999999999999999532111       111111110           


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCCCcccc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMVISSISPI  415 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta------~elL~hp~f~~~  415 (419)
                       ....                        ..+..+++++.+||++||+.||++|||+      +|+++||||+++
T Consensus       276 -~~~~------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          276 -EKQI------------------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             -HCCC------------------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             -cccc------------------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence             0000                        0112378999999999999999999995      799999999976

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-48  Score=373.25  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=208.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....    .+.+.+|+.+++.+ +||||+++++++.+  ....+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~   81 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQY   81 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CCeEE
Confidence            3678999999999999999999999999999999986432    35688999999999 99999999999965  46789


Q ss_pred             EEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          199 LIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      +||||+++++|..++.   .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...... 
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTE
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC-CCEEEEEeeccceeccCCc
Confidence            9999999999988874   48999999999999999999999999999999999999988 789999999998654322 


Q ss_pred             --cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       275 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                        ......||+.|+|||++.+...++.++|||||||++|+|++|+.||..................              
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------  226 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------------  226 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT--------------
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc--------------
Confidence              2234578999999999987444578999999999999999999999543333222222111000              


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                  ....         ...+++++.+||.+||+.||++|||+.|+++||||+..
T Consensus       227 ------------~~~~---------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          227 ------------YLNP---------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             ------------TSTT---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             ------------cCCc---------cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence                        0000         12378999999999999999999999999999999854

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.8e-49  Score=383.68  Aligned_cols=282  Identities=32%  Similarity=0.530  Sum_probs=224.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----CCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~~~l  199 (419)
                      ..+|++.+.||+|+||+||+|.+..+++ +|+|.+... .....+|+.+++.+ +||||++++++|....    ....++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~-~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD-KRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecC-cchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEE
Confidence            4579999999999999999999877776 777776432 22334799999999 9999999999996532    223789


Q ss_pred             EEEecCCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          200 IFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       200 v~e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ||||++++.+....      ..+++..++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+++.....
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~  195 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG  195 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence            99999987655432      569999999999999999999999999999999999999954489999999999887666


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+.+|.+....+........
T Consensus       196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF-PGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            65566788999999999987567999999999999999999999987 67777889999999999987765532211000


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      ..    ........+|...    ....+++++.+||.+||++||++|||+.|+|+||||+.++.
T Consensus       275 ~~----~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          275 EH----KFPQIRPHPFSKV----FRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             SS----CCCCCCCCCHHHH----SCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hh----ccccccCCcHHHh----ccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            00    0000111122211    12347899999999999999999999999999999998753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.3e-49  Score=376.60  Aligned_cols=251  Identities=24%  Similarity=0.397  Sum_probs=211.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|+++..      ..+.+.+|..++..+.+||||+++++++.+.  ..
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--~~   92 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--EN   92 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--CE
Confidence            467899999999999999999999999999999999642      3456788999998876899999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-  272 (419)
                      .++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... 
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC-CCEEEeEChhhhhcccC
Confidence            89999999999998876   569999999999999999999999999999999999999988 8999999999986432 


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||. +.+..+....+...  .           . 
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~--~-----------~-  235 (345)
T 1xjd_A          172 DAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRMD--N-----------P-  235 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--C-----------C-
T ss_pred             CCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHhC--C-----------C-
Confidence            233455689999999999987 789999999999999999999999984 33333333333210  0           0 


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~-elL~hp~f~~~  415 (419)
                                             ..+..+++++.+||.+||+.||++|||+. ++++||||+.+
T Consensus       236 -----------------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          236 -----------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             -----------------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence                                   00123789999999999999999999998 99999999876

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.4e-48  Score=376.81  Aligned_cols=253  Identities=26%  Similarity=0.436  Sum_probs=209.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++...        ..+.+.+|+.+++.+ +||||+++++++.+.  .
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~   99 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSD--G   99 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--T
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--C
Confidence            56799999999999999999999999999999998532        356789999999999 999999999999664  6


Q ss_pred             ccEEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC--CcEEEEeccc
Q 014762          196 TPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGL  266 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~--~~~kl~Dfgl  266 (419)
                      ..++||||+++++|...+       ..+++..+..++.|++.||+|||++||+||||||+|||++.+.  ..+||+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            789999999999997654       1389999999999999999999999999999999999998652  3499999999


Q ss_pred             ceeccCCCc-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          267 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       267 a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      ++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..  ...+....+.+...       
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~-------  249 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKY-------  249 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCC-------
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCC-------
Confidence            987655433 345679999999999977 6799999999999999999999999943  12222222222100       


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                            ...+                    .....+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       250 ------~~~~--------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          250 ------KMNP--------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             ------CCCH--------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             ------CCCc--------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence                  0000                    0012378999999999999999999999999999999864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9e-49  Score=379.59  Aligned_cols=253  Identities=26%  Similarity=0.483  Sum_probs=210.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++...     ..+.+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~  104 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE--SFHY  104 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEEE
Confidence            46799999999999999999999999999999999643     235688999999999 999999999999654  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCC
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~  273 (419)
                      +||||+.+++|...+   ..+++..+..++.|++.||+|||++||+||||||+|||++.+  .+.+||+|||++......
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            999999999997776   348999999999999999999999999999999999999865  246999999999877655


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+....             ...
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~-~~~~~~~~~~i~~~~-------------~~~  249 (362)
T 2bdw_A          185 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKAGA-------------YDY  249 (362)
T ss_dssp             CSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTC-------------CCC
T ss_pred             cccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCC-------------CCC
Confidence            55556789999999999877 689999999999999999999999984 233333333322210             000


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      +           ..         ....+++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       250 ~-----------~~---------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          250 P-----------SP---------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             C-----------TT---------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             C-----------cc---------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            0           00         11237899999999999999999999999999999975

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-48  Score=380.20  Aligned_cols=254  Identities=26%  Similarity=0.468  Sum_probs=214.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++...   ....+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDK--YEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECS--SEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeC--CEEEEE
Confidence            46799999999999999999999999999999998753   345688999999999 999999999999654  678999


Q ss_pred             EEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC-CCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~-~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+.+++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ .+.+||+|||+++.......
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            99999999988773    58999999999999999999999999999999999999853 36799999999998776666


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+....             ..   
T Consensus       207 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~-~~~~~~~~~~i~~~~-------------~~---  268 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRCD-------------WE---  268 (387)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHCC-------------CC---
T ss_pred             eeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhCC-------------CC---
Confidence            666789999999999877 789999999999999999999999984 333333333332210             00   


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                       ........+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       269 -----------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          269 -----------------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             -----------------CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             -----------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence                             0011112378999999999999999999999999999999864

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-48  Score=369.81  Aligned_cols=247  Identities=21%  Similarity=0.425  Sum_probs=210.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.+.||+|+||+||+|++..+|+.||+|+++..      ..+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~--~~~   81 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDA--QQI   81 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECS--SEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeC--CEE
Confidence            46899999999999999999999999999999999642      345678899999999 999999999999654  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....  
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS--
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC-CCEEEeecCcceecCC--
Confidence            9999999999998887   468999999999999999999999999999999999999988 8999999999987543  


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.. .+..+....+.+.             ...  
T Consensus       159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~-------------~~~--  221 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA-------------ELR--  221 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHC-------------CCC--
T ss_pred             ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC-------------CCC--
Confidence            2344689999999999887 7899999999999999999999999843 3333333333221             000  


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                            .+..+++++.+||++||+.||++||     |++|+++||||+.+
T Consensus       222 ----------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          222 ----------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             ----------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence                                  0123789999999999999999999     99999999999876

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-48  Score=379.64  Aligned_cols=279  Identities=27%  Similarity=0.525  Sum_probs=211.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc----C
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----H  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~  193 (419)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++...     ..+.+.+|+.+++.+ +||||+++++++...    .
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCcccc
Confidence            358899999999999999999999999999999998642     235678999999999 899999999999643    2


Q ss_pred             CCccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          194 SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ....++|+|++ +++|..++  ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTA  183 (367)
T ss_dssp             CCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECC--------
T ss_pred             CCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC-CCEEEeecccccccc
Confidence            25678999999 56776665  469999999999999999999999999999999999999988 789999999998654


Q ss_pred             CCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      .  ......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+.+|.+....+..-   
T Consensus       184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~~---  257 (367)
T 2fst_X          184 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKI---  257 (367)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHTTC---
T ss_pred             c--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHHh---
Confidence            3  2344688999999999887567999999999999999999999997 667778889999999998765543211   


Q ss_pred             CCChhhHHhhccC---CCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          352 ELDPQLDALVGRH---SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       352 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                       ............   ....+....     ..+++++.+||++||++||++|||+.|+|+||||+.+.
T Consensus       258 -~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          258 -SSESARNYIQSLTQMPKMNFANVF-----IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             -CCHHHHHHHHTSCCCCCCCHHHHT-----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             -hhHHHHHHHhccCCCCCCCHHHHC-----CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence             111111111111   111221111     23689999999999999999999999999999999764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.5e-49  Score=384.52  Aligned_cols=255  Identities=25%  Similarity=0.375  Sum_probs=213.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|+||+||+|++..+++.||+|+++..      ..+.+.+|+.+++.+ +||||++++++|.+  ...
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~  143 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DRY  143 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEEC--SSE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCE
Confidence            467899999999999999999999999999999998642      234588999999999 99999999999965  477


Q ss_pred             cEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      .++||||+++|+|..++  ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus       144 ~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTTS
T ss_pred             EEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC-CCEEEeccceeEeeccCC
Confidence            89999999999998877  468999999999999999999999999999999999999988 899999999998765543


Q ss_pred             c--ceeecccccccccccccCCC---CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          275 E--YNVRVASRYFKGPELLVDLQ---DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       275 ~--~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      .  ....+||+.|+|||++.+..   .++.++|||||||++|||++|+.||. +.+..+....+.+....          
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~----------  291 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKNS----------  291 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHH----------
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC-CCChhhHHHHHHhcccc----------
Confidence            2  23568999999999997632   17899999999999999999999984 33444444444321000          


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~  415 (419)
                                             ........+++++++||++||+.+|++  |+|++|+++||||+++
T Consensus       292 -----------------------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          292 -----------------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             -----------------------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             -----------------------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence                                   000011237899999999999999988  9999999999999986

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=386.60  Aligned_cols=254  Identities=26%  Similarity=0.442  Sum_probs=209.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.+|+|++....     .+.+.+|+.+++.+ +||||+++++++.+.  ...+
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~--~~~~   86 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEE--GHHY   86 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECS--SEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEEC--CEEE
Confidence            568999999999999999999999999999999986432     35688999999999 999999999999654  7789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCC
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~  273 (419)
                      +||||+.+++|...+   ..+++..+..++.|++.||+|||++||+||||||+|||++.+  .+.+||+|||++......
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            999999999997766   569999999999999999999999999999999999999853  368999999999776543


Q ss_pred             Cc-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          274 KE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       274 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+......             
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~-------------  231 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFW-DEDQHRLYQQIKAGAYD-------------  231 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTCCC-------------
T ss_pred             CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC-CccHHHHHHHHHhCCCC-------------
Confidence            32 345689999999999876 689999999999999999999999984 33333333333221000             


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      .                    .......+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       232 ~--------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          232 F--------------------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             C--------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             C--------------------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            0                    001112378999999999999999999999999999999753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.2e-48  Score=372.35  Aligned_cols=253  Identities=25%  Similarity=0.429  Sum_probs=209.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++...      .+.+.+|..++.++.+||||+++++++.+.  ...
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~~   85 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--SRL   85 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC--CEE
Confidence            568999999999999999999999999999999996432      345778999999876899999999999654  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc-CC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~-~~  273 (419)
                      ++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++... ..
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCGGGCBCSCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEEeccccccccCCC
Confidence            9999999999998876   569999999999999999999999999999999999999988 899999999998643 23


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC-------HHHHHHHHHHcCCchHHHHH
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN-------HDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~-------~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......       .+.+...+.           
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~-----------  232 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL-----------  232 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH-----------
T ss_pred             CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH-----------
Confidence            34455689999999999987 78999999999999999999999999532111       111111000           


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH------HHHhcCCCccccc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA------REAMVISSISPIF  416 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta------~elL~hp~f~~~~  416 (419)
                       ....                        ..+..+++++.+||.+||+.||++|||+      +|+++||||+++.
T Consensus       233 -~~~~------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          233 -EKQI------------------------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             -HCCC------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             -cCCC------------------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence             0000                        0112378999999999999999999995      8999999998763

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-48  Score=377.11  Aligned_cols=256  Identities=23%  Similarity=0.418  Sum_probs=199.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...  ..+.+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~lv   94 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLAII   94 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeC--CEEEEE
Confidence            478999999999999999999999999999999999743  346788999999999 899999999999654  678999


Q ss_pred             EEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC-CcEEEEecccceeccCCCcc
Q 014762          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~-~~~kl~Dfgla~~~~~~~~~  276 (419)
                      |||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+. +.+||+|||+++........
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~  174 (361)
T 3uc3_A           95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  174 (361)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence            9999999998876   5699999999999999999999999999999999999998662 35999999999865444444


Q ss_pred             eeecccccccccccccCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          277 NVRVASRYFKGPELLVDLQDYD-YSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~-~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ....||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||............+.......          .    
T Consensus       175 ~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~----------~----  239 (361)
T 3uc3_A          175 KSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK----------Y----  239 (361)
T ss_dssp             ------CTTSCHHHHHC-SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC----------C----
T ss_pred             CCCcCCCCcCChhhhcC-CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC----------C----
Confidence            56689999999999987 4554 459999999999999999999954333222222221111100          0    


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                        .......+++++.+||.+||+.||++|||+.|+++||||+.
T Consensus       240 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~  280 (361)
T 3uc3_A          240 ------------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK  280 (361)
T ss_dssp             ------------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred             ------------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence                              00011237899999999999999999999999999999954

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5e-48  Score=366.76  Aligned_cols=246  Identities=22%  Similarity=0.301  Sum_probs=198.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.++||+|+||+||+|.+..+|+.||||++...     ......+|+..+..+.+||||++++++|.+  ....+
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~  133 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILY  133 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEE
Confidence            47899999999999999999999999999999998542     223455677777666689999999999965  47789


Q ss_pred             EEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +||||+++ ++..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus       134 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          134 LQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EEEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEECCCTTCEECC---
T ss_pred             EEEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEccceeeeecccCC
Confidence            99999955 555544    359999999999999999999999999999999999999988 789999999998876555


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......||..|+|||++.+  .++.++|||||||++|||++|..||+..    +....+....               ..
T Consensus       212 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~---------------~~  270 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGY---------------LP  270 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTC---------------CC
T ss_pred             CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccC---------------CC
Confidence            5556679999999999865  6899999999999999999998777421    1111111100               00


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      +                    .....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus       271 ~--------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          271 P--------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             H--------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             c--------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            0                    011237899999999999999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=377.19  Aligned_cols=256  Identities=27%  Similarity=0.383  Sum_probs=196.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+.  ...++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFETP--TEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEECS--SEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEecC--CeEEEEEE
Confidence            56799999999999999999999999999999999754 346688999999999 899999999999654  67899999


Q ss_pred             ecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC--CCCcEEEEecccceeccCCCcce
Q 014762          203 YVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYN  277 (419)
Q Consensus       203 ~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~--~~~~~kl~Dfgla~~~~~~~~~~  277 (419)
                      |+++++|..++.   .+++..+..++.|++.||+|||++||+||||||+|||++.  +.+.+||+|||+++.........
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  208 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK  208 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence            999999988763   4899999999999999999999999999999999999975  23789999999998765544445


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+..+.+....             .    
T Consensus       209 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-------------~----  270 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-------------F----  270 (349)
T ss_dssp             ----CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-------------C----
T ss_pred             cccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-------------c----
Confidence            5688999999999987 679999999999999999999999996443333233332221000             0    


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                      .......++.++.+||++||+.||++|||+.|+|+||||+...
T Consensus       271 ----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          271 ----------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             ----------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             ----------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence                            0001123789999999999999999999999999999998653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.4e-48  Score=378.30  Aligned_cols=281  Identities=26%  Similarity=0.487  Sum_probs=216.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--------------hHHHHHHHHHHHHhcCCCCeeEEEeE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------------KKKIKREIKILQNLCGGPNVVKLLDI  188 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv~l~~~  188 (419)
                      ..++|++.+.||+|+||+||+|.+.. |+.||||++....              .+.+.+|+.+++.+ +||||++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~   97 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDI   97 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeee
Confidence            46889999999999999999998754 8999999985321              26788999999999 89999999999


Q ss_pred             EEcc---CCCccEEEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEE
Q 014762          189 VRDQ---HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (419)
Q Consensus       189 ~~~~---~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~  262 (419)
                      +...   .....++||||++++.+..+..   .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN-NDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEEC
T ss_pred             EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC-CCEEEE
Confidence            8642   3346799999999654444432   48999999999999999999999999999999999999988 789999


Q ss_pred             ecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchH
Q 014762          263 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL  342 (419)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~  342 (419)
                      |||+++............+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+.+..
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-RGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCh
Confidence            9999986655555556788999999999877567999999999999999999999998 566677888888888888776


Q ss_pred             HHHHhhcCCCCChhhHHhhcc----CCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          343 NAYLNKYHLELDPQLDALVGR----HSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      .......    .+........    .....|..     ....+++.+.+||.+||++||++|||+.|+|+||||+.+.
T Consensus       256 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          256 EDVVMFS----SPSARDYLRNSLSNVPARAWTA-----VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             HHHHHTS----CHHHHHHTTTCCCCCCCCCHHH-----HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHhhhcc----chhhhHHHHhhcccCChhhHHh-----hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence            6543211    1111111111    11111211     1224688999999999999999999999999999999874

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8e-49  Score=375.17  Aligned_cols=282  Identities=28%  Similarity=0.541  Sum_probs=214.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|++.++||+|+||+||+|.+..+++.||+|+++...     .+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~  108 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHN--HRL  108 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEET--TEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecC--CEE
Confidence            3578999999999999999999999999999999996432     34567899999999 999999999999664  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC----CCcEEEEecccceec
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFY  270 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~----~~~~kl~Dfgla~~~  270 (419)
                      ++||||+++ +|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+    .+.+||+|||+++..
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            999999996 666655   468999999999999999999999999999999999999533    256999999999766


Q ss_pred             cCC-CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       271 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+.++.+....+....
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF-PGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc-CCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            433 23344578999999999987566899999999999999999999987 5566677788888877766543322111


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ..   +.+.............    ......+++++.+||.+||++||++|||++|+|+||||+++.
T Consensus       267 ~~---~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          267 AL---PDWKQSFPKFRGKTLK----RVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             GS---TTCCTTCCCCCCCCHH----HHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hh---hhhhhhhhhhccccHh----hhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence            00   0000000000001111    111223789999999999999999999999999999999763

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.3e-48  Score=377.46  Aligned_cols=253  Identities=21%  Similarity=0.435  Sum_probs=213.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++...      ..+.+.+|+.+++.+ +||||++++++|.+.  ..
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~   89 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDE--ED   89 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--CE
Confidence            357899999999999999999999999999999998632      346788999999999 999999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++||||+.+++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC-CCEEEeccceeeeccCC
Confidence            89999999999998877   358999999999999999999999999999999999999988 89999999999987766


Q ss_pred             CcceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~-~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ......+||+.|+|||++.+  ...++.++|||||||++|+|++|+.||..... ...........            ..
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------------~~  236 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET------------TV  236 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH------------CC
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh------------cc
Confidence            66667789999999999864  24589999999999999999999999953322 11111111110            00


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-HHHHhcCCCcccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-AREAMVISSISPI  415 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-a~elL~hp~f~~~  415 (419)
                      .                        ..+..+++++.+||.+||+.||++||+ ++++++||||+++
T Consensus       237 ~------------------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          237 V------------------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             C------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             c------------------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            0                        011237899999999999999999998 9999999999976

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.1e-48  Score=378.77  Aligned_cols=289  Identities=19%  Similarity=0.213  Sum_probs=208.6

Q ss_pred             CCCCeEEEeeeeee--CceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRG--KYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.++||+|  +||+||+|++..+|+.||||+++...     .+.+.+|+.+++.+ +||||+++++++.+.  .
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~   99 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD--N   99 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--T
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEEC--C
Confidence            57789999999999  99999999999999999999996432     35678899999999 899999999999764  6


Q ss_pred             ccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ..++||||+++++|..++     ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||.+...
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~kl~dfg~~~~~  178 (389)
T 3gni_B          100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCGGGCEEC
T ss_pred             EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccccceee
Confidence            789999999999998876     568999999999999999999999999999999999999988 89999999998654


Q ss_pred             cCCC--------cceeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCC--
Q 014762          271 HPGK--------EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT--  339 (419)
Q Consensus       271 ~~~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~--  339 (419)
                      ....        ......||..|+|||++.+. ..++.++|||||||++|+|++|+.||.. .+..+.+..+....-+  
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD-MPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT-CCSTTHHHHC--------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCCcc
Confidence            3211        11224788889999998763 4689999999999999999999999854 3333333322211000  


Q ss_pred             ---chH--HHHH-hhcCCCCChhhHH-hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          340 ---DEL--NAYL-NKYHLELDPQLDA-LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       340 ---~~~--~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                         ...  .... ............. .....................+++++.+||++||++||++|||++|+|+||||
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence               000  0000 0000000000000 00000000111111112234578999999999999999999999999999999


Q ss_pred             cccc
Q 014762          413 SPIF  416 (419)
Q Consensus       413 ~~~~  416 (419)
                      +.+.
T Consensus       338 ~~~~  341 (389)
T 3gni_B          338 KQIK  341 (389)
T ss_dssp             GGC-
T ss_pred             HHHh
Confidence            9875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.2e-48  Score=374.04  Aligned_cols=251  Identities=23%  Similarity=0.359  Sum_probs=211.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++++.||+|+||+||+|++..+|+.||+|+++..      ..+.+.+|..++..+.+||||+++++++.+.  ..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--~~   95 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DR   95 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS--SE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--CE
Confidence            367899999999999999999999999999999999642      3456788999998876899999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-  272 (419)
                      .++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... 
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC-CcEEEEeCCcccccccC
Confidence            89999999999998876   569999999999999999999999999999999999999988 8999999999986432 


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||. +.+..+....+...             ...
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~-------------~~~  239 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH-------------NVA  239 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-------------CCC
T ss_pred             CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCC-CCCHHHHHHHHHhC-------------CCC
Confidence            233455689999999999977 789999999999999999999999984 33333333333321             000


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                              .+..+++++.+||.+||+.||++||     +++++++||||+.+
T Consensus       240 ------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          240 ------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             ------------------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             ------------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence                                    0123789999999999999999999     47999999999875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=380.29  Aligned_cols=251  Identities=25%  Similarity=0.423  Sum_probs=205.2

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec
Q 014762          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       128 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      ...+.||+|+||+||+|.+..+|+.||+|+++..   ..+.+.+|+.+++++ +||||+++++++.+.  ...++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESK--NDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEEEeCC
Confidence            3367899999999999999999999999999753   346788999999999 999999999999654  6789999999


Q ss_pred             CCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC-CCCcEEEEecccceeccCCCcceee
Q 014762          205 NSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKEYNVR  279 (419)
Q Consensus       205 ~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~-~~~~~kl~Dfgla~~~~~~~~~~~~  279 (419)
                      ++++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||+.. +.+.+||+|||+++...........
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~  248 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN  248 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence            999987765    35899999999999999999999999999999999999942 3378999999999987766666667


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      .||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.......                   
T Consensus       249 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~-------------------  307 (373)
T 2x4f_A          249 FGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILACRWDL-------------------  307 (373)
T ss_dssp             CSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCS-------------------
T ss_pred             cCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhccCCC-------------------
Confidence            89999999999876 779999999999999999999999984 444444444444321100                   


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                    .......+++++.+||.+||+.||++|||+.|+|+||||++.+
T Consensus       308 --------------~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          308 --------------EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             --------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             --------------ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                          0011123789999999999999999999999999999998763

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.6e-48  Score=367.95  Aligned_cols=255  Identities=27%  Similarity=0.451  Sum_probs=213.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|+++..         ..+.+.+|+.+++.+ +||||+++++++.+.  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--   87 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENR--   87 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecC--
Confidence            56799999999999999999999999999999998642         246789999999999 899999999999654  


Q ss_pred             CccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC---cEEEEecccce
Q 014762          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAE  268 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~---~~kl~Dfgla~  268 (419)
                      ...++||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+..   .+||+|||+++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            6789999999999998887   34899999999999999999999999999999999999987732   79999999998


Q ss_pred             eccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+......         
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~~~---------  236 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSVSYD---------  236 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTCCC---------
T ss_pred             ecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcccc---------
Confidence            8766555556679999999999876 789999999999999999999999984 33333333333221111         


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                          .++.                    ....+++.+.+||.+||+.||++|||+.|+++||||+++.
T Consensus       237 ----~~~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          237 ----FDEE--------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             ----CCHH--------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             ----cChh--------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence                0000                    0123688999999999999999999999999999999764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2e-48  Score=373.01  Aligned_cols=248  Identities=21%  Similarity=0.401  Sum_probs=206.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...      ....+.+|+.+++.+ +||||+++++++...  ...
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~   84 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTP--TDI   84 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEE
Confidence            57899999999999999999999999999999998632      235788999999999 899999999999654  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||++ +++..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++.....+.
T Consensus        85 ~lv~E~~~-g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           85 VMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEECCCC-EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTSB
T ss_pred             EEEEECCC-CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-CCEEEEEeccceeccCCc
Confidence            99999995 5555554   569999999999999999999999999999999999999988 789999999998776666


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.......                           
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---------------------------  215 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---------------------------  215 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---------------------------
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---------------------------
Confidence            66667899999999999873334789999999999999999999994211100                           


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                           ........      ....+..+++++.+||++||+.||++|||++|+++||||+.
T Consensus       216 -----~~~~i~~~------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          216 -----LFKKVNSC------VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             -----CBCCCCSS------CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             -----HHHHHHcC------CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                 00000000      01112347899999999999999999999999999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.2e-48  Score=371.52  Aligned_cols=258  Identities=26%  Similarity=0.433  Sum_probs=190.2

Q ss_pred             CeEEE---eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          126 DYEVV---RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       126 ~y~~~---~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      +|++.   +.||+|+||+||+|.+..+++.||+|+++......+.+|+.+++.+.+||||+++++++.+.  ...++|||
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--~~~~lv~e   86 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ--LHTFLVME   86 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEEEEEEC
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--CEEEEEEE
Confidence            35543   67999999999999999999999999998777788999999999995699999999999654  67899999


Q ss_pred             ecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC--CcEEEEecccceeccCCC-cc
Q 014762          203 YVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPGK-EY  276 (419)
Q Consensus       203 ~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~--~~~kl~Dfgla~~~~~~~-~~  276 (419)
                      |+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+.  ..+||+|||+++...... ..
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  166 (325)
T 3kn6_A           87 LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL  166 (325)
T ss_dssp             CCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence            99999998876   4589999999999999999999999999999999999998652  279999999998765433 23


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH--HHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~--~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.......  ....++.+.+.         ...... 
T Consensus       167 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~---------~~~~~~-  235 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK---------KGDFSF-  235 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT---------TTCCCC-
T ss_pred             cccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH---------cCCCCC-
Confidence            45678999999999877 789999999999999999999999994322110  00011111100         000000 


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                         .......+++++.+||++||+.||++|||+.|+++||||++.
T Consensus       236 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          236 -------------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             -------------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             -------------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence                               000112378999999999999999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.2e-48  Score=374.71  Aligned_cols=280  Identities=27%  Similarity=0.548  Sum_probs=226.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC---CC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~  195 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....    .+.+.+|+.++.++ +||||+++++++....   ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccc
Confidence            3679999999999999999999999999999999997432    35688999999999 8999999999996532   24


Q ss_pred             ccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ..++||||+++ +|..++  ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       104 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          104 DVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPD  181 (364)
T ss_dssp             CEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCGG
T ss_pred             eEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC-CCEEEEeCcceEecCCC
Confidence            67999999996 666654  569999999999999999999999999999999999999988 78999999999876533


Q ss_pred             Cc----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          274 KE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       274 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ..    .....||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+...+|.+....+....
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS-CCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            22    234578999999999877567999999999999999999999887 6677788899999998887765543211


Q ss_pred             CCCCChhhHHhh---ccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALV---GRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      .    .......   ......+|....     ..+++++.+||.+||++||++|||+.|+|+||||++.
T Consensus       261 ~----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          261 N----LKARNYLLSLPHKNKVPWNRLF-----PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             C----HHHHHHHHTSCCCCCCCHHHHC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             h----hhHHHHHHhcCCccCCCHHHhC-----CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            0    0111111   111112222211     2378999999999999999999999999999999976

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=9e-48  Score=372.24  Aligned_cols=281  Identities=22%  Similarity=0.390  Sum_probs=219.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhc----CCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLC----GGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.++||+|+||+||+|++..+++.||||+++..  ..+.+.+|+.+++.+.    +||||+++++++...  ..
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~--~~  110 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY--DH  110 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--TE
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--Ce
Confidence            378999999999999999999999999999999999743  3456788999999983    399999999999664  67


Q ss_pred             cEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC-----------------
Q 014762          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-----------------  254 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~-----------------  254 (419)
                      .++||||+ +++|..++     ..+++..++.++.|++.||+|||++||+||||||+|||++.                 
T Consensus       111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~  189 (360)
T 3llt_A          111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK  189 (360)
T ss_dssp             EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred             eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence            89999999 78887775     24899999999999999999999999999999999999975                 


Q ss_pred             -------CCCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH
Q 014762          255 -------ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH  327 (419)
Q Consensus       255 -------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~  327 (419)
                             ..+.+||+|||+++....  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..
T Consensus       190 ~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~  265 (360)
T 3llt_A          190 KIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLF-RTHEHM  265 (360)
T ss_dssp             EEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHH
T ss_pred             cccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCC-CCCcHH
Confidence                   237899999999986543  2344678999999999987 78999999999999999999999998 456667


Q ss_pred             HHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCcccccc------------ccccCCCCHHHHHHHHHhcCC
Q 014762          328 DQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFIN------------ADNQHLVSPEAIDFLDKLLRY  395 (419)
Q Consensus       328 ~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~li~~~L~~  395 (419)
                      +.+..+....+..+.................   .......|.....            .......++.+.+||.+||++
T Consensus       266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  342 (360)
T 3llt_A          266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVN---KDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI  342 (360)
T ss_dssp             HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEE---TTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHhcCCCCHHHHhhhhhccCccccC---cccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence            7788888887776654433221111000000   0000000100000            000112457889999999999


Q ss_pred             CCCCCCCHHHHhcCCCcc
Q 014762          396 DHQDRLTAREAMVISSIS  413 (419)
Q Consensus       396 dP~~Rpta~elL~hp~f~  413 (419)
                      ||++|||++|+|+||||+
T Consensus       343 dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          343 DPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             SGGGSCCHHHHTTSGGGC
T ss_pred             ChhhCCCHHHHhcCcccC
Confidence            999999999999999996

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.1e-48  Score=378.45  Aligned_cols=283  Identities=25%  Similarity=0.456  Sum_probs=211.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----C
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----S  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~  194 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...     ..+.+.+|+.+++.+ +||||+++++++....    .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccc
Confidence            57899999999999999999999999999999998642     235678999999999 9999999999996543    2


Q ss_pred             CccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          195 KTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ...++||||++++........+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus       103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~  181 (371)
T 2xrw_A          103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSF  181 (371)
T ss_dssp             CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC--------
T ss_pred             cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEEEeeccccccccc
Confidence            3679999999976555555779999999999999999999999999999999999999988 789999999998765544


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+++..+.+.+|.+....+..     ..
T Consensus       182 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~  254 (371)
T 2xrw_A          182 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMKK-----LQ  254 (371)
T ss_dssp             --------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHC-CCCCCHHHHTT-----SC
T ss_pred             ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHH-----hh
Confidence            4455688999999999987 78999999999999999999999997 56666777888888777765433211     11


Q ss_pred             hhhHHhhccCCC---CCcccccccc-------ccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSR---KPWSKFINAD-------NQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~---~~~~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      +...........   ..+.......       .....++++++||++||+.||++|||++|+|+||||+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence            111111111110   0010000000       001125679999999999999999999999999999854

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.5e-48  Score=359.54  Aligned_cols=257  Identities=26%  Similarity=0.454  Sum_probs=213.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....     .+.+.+|+.+++++ +||||+++++++.+.  ...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   80 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEE--SFH   80 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcC--CEE
Confidence            3688999999999999999999999999999999986432     35678999999999 899999999999654  677


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC--CcEEEEecccceeccC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHP  272 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~--~~~kl~Dfgla~~~~~  272 (419)
                      ++||||+.++++...+   ..+++..+..++.|++.||+|||++||+||||||+||+++.+.  +.+||+|||++.....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            8999999999987665   5689999999999999999999999999999999999998652  3499999999987766


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      ........++..|+|||++.+ ..++.++||||||+++|+|++|+.||.. .+..+....+.......            
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~------------  226 (284)
T 3kk8_A          161 SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDY------------  226 (284)
T ss_dssp             SCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCC------------
T ss_pred             CccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccC------------
Confidence            555556789999999999877 7789999999999999999999999842 23333333222210000            


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                           .......+++++.+|+.+||+.||++|||++|+|+||||++..+
T Consensus       227 ---------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          227 ---------------------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             ---------------------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             ---------------------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence                                 00011237899999999999999999999999999999987643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.4e-48  Score=375.57  Aligned_cols=282  Identities=30%  Similarity=0.541  Sum_probs=221.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC--
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK--  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~--  195 (419)
                      ..++|.+.+.||+|+||+||+|.+..+|+.||+|++....     .+.+.+|+.+++.+ +||||+++++++......  
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTT
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCccc
Confidence            4679999999999999999999999999999999996421     35678999999999 899999999999654322  


Q ss_pred             --ccEEEEEecCCCChhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 --TPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 --~~~lv~e~~~~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                        ..++||||+.+ ++...+ ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus       119 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          119 FYDFYLVMPFMQT-DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHADA  196 (371)
T ss_dssp             CCCCEEEEECCCE-EHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECSTTCC-----
T ss_pred             ceeEEEEEccccc-cHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC-CCEEEEecCccccccc
Confidence              24899999995 555554 569999999999999999999999999999999999999988 8899999999976543


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                        ......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..|.+....... .   
T Consensus       197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~-~---  269 (371)
T 4exu_A          197 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQK-L---  269 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHTT-C---
T ss_pred             --CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCcHHHHHH-h---
Confidence              2344578999999999987568999999999999999999999998 56677788888888888776543321 0   


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ...................+..  ....+++++.+||.+||++||++|||+.|+|+||||++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQ--LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHH--HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhhhhccCCCcchhHHH--hccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence            0111111111111111111111  1123789999999999999999999999999999999764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.8e-48  Score=371.13  Aligned_cols=248  Identities=22%  Similarity=0.379  Sum_probs=211.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++++.||+|+||+||+|++..+|+.||+|+++..      ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~  115 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDN--SN  115 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcC--CE
Confidence            357899999999999999999999999999999998642      345688999999999 999999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSSC
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC-CCEEEcccccceeccCC
Confidence            89999999999998876   469999999999999999999999999999999999999988 88999999999876432


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                        ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+...  .           .. 
T Consensus       195 --~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~--~-----------~~-  256 (350)
T 1rdq_E          195 --TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSG--K-----------VR-  256 (350)
T ss_dssp             --BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--C-----------CC-
T ss_pred             --cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCC-CCCHHHHHHHHHcC--C-----------CC-
Confidence              334689999999999987 789999999999999999999999984 33333333333220  0           00 


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                             .+..+++++.+||++||+.||++||+     ++|+++||||+.+
T Consensus       257 -----------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          257 -----------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             -----------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             -----------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence                                   01237899999999999999999998     9999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1e-47  Score=358.13  Aligned_cols=253  Identities=26%  Similarity=0.446  Sum_probs=213.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .++|++.+.||+|+||+||+|.+..++..+|+|.+..   ...+.+.+|+.+++.+ +||||+++++++.+  ....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFED--NTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCeEEEE
Confidence            5679999999999999999999999999999999864   3457889999999999 99999999999965  4678999


Q ss_pred             EEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE---cCCCCcEEEEecccceeccCCC
Q 014762          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl---~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      |||+++++|..++   ..+++..+..++.|++.||+|||++||+|+||||+|||+   +.+ +.+||+|||++.......
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT-CCEEECCCTTCEECCTTS
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCC-CcEEEEecccceeccCcc
Confidence            9999999997765   568999999999999999999999999999999999999   555 789999999998877666


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......+|+.|+|||++.+  .++.++|||||||++|+|++|+.||. +.+..+....+.+.....+...          
T Consensus       164 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~----------  230 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFS-APTDSEVMLKIREGTFTFPEKD----------  230 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCHHH----------
T ss_pred             chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCCCCchh----------
Confidence            6666789999999999865  48999999999999999999999984 3333333333333211111110          


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                             ...+++++.+|+.+||+.||++|||+.++|+||||++..
T Consensus       231 -----------------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          231 -----------------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             -----------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             -----------------------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                                   113689999999999999999999999999999998653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.1e-48  Score=386.92  Aligned_cols=256  Identities=24%  Similarity=0.382  Sum_probs=212.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.++||+|+||+||+|++..+++.||+|++++..      ...+.+|+.++..+ +||||++++++|.+.  ..
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~--~~  148 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDD--NN  148 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECS--SE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC--CE
Confidence            4678999999999999999999999999999999996422      23488999999998 999999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++|+|..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred             EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC-CCEEEcchhhhhhccc
Confidence            89999999999998887    358999999999999999999999999999999999999988 8999999999987654


Q ss_pred             CCcc--eeeccccccccccccc----CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          273 GKEY--NVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       273 ~~~~--~~~~~~~~y~aPE~~~----~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ....  ...+||+.|+|||++.    +...++.++|||||||++|||++|+.||. +.+..+....+.....        
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~--------  298 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKE--------  298 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHH--------
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC-CCChhHHHHhhhhccc--------
Confidence            4332  3358999999999986    23568999999999999999999999984 3444444444432100        


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCC--CCCHHHHhcCCCcccc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQD--RLTAREAMVISSISPI  415 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~--Rpta~elL~hp~f~~~  415 (419)
                       .  ...+                     .....+++++++||++||+.+|++  |++++|+++||||+.+
T Consensus       299 -~--~~~p---------------------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          299 -R--FQFP---------------------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             -H--CCCC---------------------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             -c--ccCC---------------------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence             0  0000                     001237899999999999999988  9999999999999876

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.7e-48  Score=373.74  Aligned_cols=285  Identities=29%  Similarity=0.459  Sum_probs=218.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----  193 (419)
                      ..++|++.++||+|+||+||+|.+..+|+.||+|++...     ....+.+|+.+++.+ +||||+++++++....    
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC-----
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccc
Confidence            357899999999999999999999999999999998532     235688999999999 8999999999997643    


Q ss_pred             --CCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          194 --SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       194 --~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                        ....++||||++++.+..+.   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus        94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~  172 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLAR  172 (351)
T ss_dssp             ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred             cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CCEEEccchhcc
Confidence              35689999999975544443   468999999999999999999999999999999999999988 789999999998


Q ss_pred             eccCC-----CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHH
Q 014762          269 FYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (419)
Q Consensus       269 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~  343 (419)
                      .....     .......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+..+..+..
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChh
Confidence            76422     22234578999999999987567899999999999999999999887 5666677777787777765433


Q ss_pred             HHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      .+...........   . .. .................++++.+||.+||++||++|||++|+|+||||+..
T Consensus       252 ~~~~~~~~~~~~~---~-~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          252 VWPNVDNYELYEK---L-EL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             TSTTGGGCGGGTS---S-CC-CSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             hccccccchhhcc---c-cc-ccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence            2211100000000   0 00 000000000000001147789999999999999999999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.4e-48  Score=368.90  Aligned_cols=249  Identities=19%  Similarity=0.352  Sum_probs=200.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC------
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS------  194 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------  194 (419)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.    ...+.+.+|+.+++++ +||||++++++|.+...      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhh
Confidence            579999999999999999999999999999999863    2346789999999999 89999999999865422      


Q ss_pred             -------------------------------------------------CccEEEEEecCCCChhhhcC------CCCHH
Q 014762          195 -------------------------------------------------KTPSLIFEYVNSTDFKVLYP------TLTDY  219 (419)
Q Consensus       195 -------------------------------------------------~~~~lv~e~~~~~~l~~~~~------~l~~~  219 (419)
                                                                       ...++||||+++++|..++.      ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                             23789999999999998873      25666


Q ss_pred             HHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-------------cceeeccccccc
Q 014762          220 DIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-------------EYNVRVASRYFK  286 (419)
Q Consensus       220 ~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-------------~~~~~~~~~~y~  286 (419)
                      .+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......             ......||+.|+
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            789999999999999999999999999999999988 799999999998765442             123346899999


Q ss_pred             ccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCC
Q 014762          287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSR  366 (419)
Q Consensus       287 aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (419)
                      |||++.+ ..++.++|||||||++|+|++|..|+      .+....+......            ......         
T Consensus       244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~------~~~~~~~~~~~~~------------~~~~~~---------  295 (332)
T 3qd2_B          244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQ------MERVRIITDVRNL------------KFPLLF---------  295 (332)
T ss_dssp             CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCH------HHHHHHHHHHHTT------------CCCHHH---------
T ss_pred             ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCCh------hHHHHHHHHhhcc------------CCCccc---------
Confidence            9999987 78999999999999999999987664      1111111111000            000000         


Q ss_pred             CCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          367 KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                  ...++++.+||.+||+.||++|||+.|+|+||||+++
T Consensus       296 ------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          296 ------------TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ------------HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ------------ccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence                        0146788999999999999999999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.1e-47  Score=376.99  Aligned_cols=281  Identities=23%  Similarity=0.463  Sum_probs=219.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhc-----CCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC-----GGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-----~h~niv~l~~~~~~~~~~~  196 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||||+++...  ...+.+|+.+++.+.     +|+||+++++++...  ..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--NH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--TE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--Ce
Confidence            678999999999999999999999999999999997543  356788999998873     567999999999654  77


Q ss_pred             cEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCc--EEEEeccccee
Q 014762          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEF  269 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~--~kl~Dfgla~~  269 (419)
                      .++||||+++ ++..++     ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.  +||+|||+++.
T Consensus       174 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~-~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST-TSCCEEECCCTTCEE
T ss_pred             EEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC-CCcceEEeeccccee
Confidence            8999999985 555544     348999999999999999999999999999999999999987 44  99999999976


Q ss_pred             ccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ...  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+++..+.+.+|.++...+....
T Consensus       252 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf-~~~~~~~~l~~i~~~~~~p~~~~~~~~~  327 (429)
T 3kvw_A          252 EHQ--RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLL-PGEDEGDQLACMIELLGMPSQKLLDASK  327 (429)
T ss_dssp             TTC--CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred             cCC--cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence            543  2334688999999999987 77999999999999999999999886 6777888899999999987765432110


Q ss_pred             CC------CCChhhHHh--------------------hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH
Q 014762          350 HL------ELDPQLDAL--------------------VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA  403 (419)
Q Consensus       350 ~~------~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta  403 (419)
                      ..      ...+.+...                    ........|..    ......++++.+||++||++||++|||+
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGN----ALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHH----HTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHh----hccccchHHHHHHHHHHCCCChhhCCCH
Confidence            00      000000000                    00000001111    1112357889999999999999999999


Q ss_pred             HHHhcCCCccccc
Q 014762          404 REAMVISSISPIF  416 (419)
Q Consensus       404 ~elL~hp~f~~~~  416 (419)
                      +|+|+||||+...
T Consensus       404 ~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          404 GQALRHPWLRRRL  416 (429)
T ss_dssp             HHHHTSTTTC---
T ss_pred             HHHhCChhhccCC
Confidence            9999999999753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.6e-48  Score=380.76  Aligned_cols=255  Identities=24%  Similarity=0.417  Sum_probs=200.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....           ...+.+|+.+++++ +||||+++++++.. 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec-
Confidence            578999999999999999999999999999999986432           12478999999999 99999999999854 


Q ss_pred             CCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccc
Q 014762          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLA  267 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla  267 (419)
                        ...++||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+  ...+||+|||++
T Consensus       212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a  289 (419)
T 3i6u_A          212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  289 (419)
T ss_dssp             --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred             --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence              3478999999999998876   458999999999999999999999999999999999999754  235999999999


Q ss_pred             eeccCCCcceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          268 EFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      +............||+.|+|||++.+  ...++.++|||||||++|+|++|..||............+...         
T Consensus       290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~---------  360 (419)
T 3i6u_A          290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG---------  360 (419)
T ss_dssp             TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTT---------
T ss_pred             eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcC---------
Confidence            87765555556789999999999853  3568899999999999999999999985433222222222110         


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                          .....+                    .....+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       361 ----~~~~~~--------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          361 ----KYNFIP--------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             ----CCCCCH--------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             ----CCCCCc--------------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence                000000                    0012378999999999999999999999999999999864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-47  Score=359.86  Aligned_cols=251  Identities=22%  Similarity=0.422  Sum_probs=202.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .++|++.++||+|+||+||+|.+..++..+|+|++...    ..+.+.+|+.+++.+ +||||+++++++.+  ....++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l   97 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFED--YHNMYI   97 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheec--CCeEEE
Confidence            57899999999999999999999999999999998643    347789999999999 99999999999965  467899


Q ss_pred             EEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceec
Q 014762          200 IFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFY  270 (419)
Q Consensus       200 v~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~  270 (419)
                      ||||+++++|...+       ..+++..+..++.|++.||+|||++||+||||||+|||++.+  .+.+||+|||+++..
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988766       569999999999999999999999999999999999999543  267999999999876


Q ss_pred             cCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ..........++..|+|||++.  ..++.++|||||||++|+|++|+.||. +.+..+....... ...           
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~-~~~~~~~~~~~~~-~~~-----------  242 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFT-GTSLEEVQQKATY-KEP-----------  242 (285)
T ss_dssp             ---------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH-CCC-----------
T ss_pred             CCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCC-CCCHHHHHhhhcc-CCc-----------
Confidence            6555556678999999999875  468999999999999999999999984 2222221111111 000           


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                       .                     .......+++++.+|+.+||+.||++|||+.|+|+||||++
T Consensus       243 -~---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          243 -N---------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             -C---------------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             -c---------------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence             0                     00001226889999999999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.6e-48  Score=373.49  Aligned_cols=287  Identities=27%  Similarity=0.453  Sum_probs=217.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC-----Cc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS-----KT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~-----~~  196 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...  ......+|+..+..+ +||||++++++|.....     ..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccccccee
Confidence            56899999999999999999999999999999988543  345677888888988 99999999999965322     23


Q ss_pred             cEEEEEecCCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          197 PSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                      .++||||++++.+..+.      ..+++..+..++.|++.||.|||  ++||+||||||+|||++...+.+||+|||+++
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~  180 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK  180 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence            78999999987544322      35889999999999999999999  99999999999999999744899999999998


Q ss_pred             eccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ............+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....+...
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF-RGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc-CCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            8766655566788999999999977566899999999999999999999987 566677788888888888766544322


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      .........    ......+|...+.. .....++++.+||.+||++||++|||+.|+|+||||+.+.+
T Consensus       260 ~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          260 NPSHTDVDL----YNSKGIPWSNVFSD-HSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             CTTCCCGGG----GCCCCCCHHHHTTT-CCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             ccchhhccc----cccccCCcccccch-hhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence            111111110    11112223222211 11235788999999999999999999999999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.6e-48  Score=379.50  Aligned_cols=256  Identities=26%  Similarity=0.402  Sum_probs=201.6

Q ss_pred             CCCeEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEc--cCCCccEEE
Q 014762          124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  200 (419)
                      .++|.+. +.||+|+||+||+|.+..+|+.||||+++.  ...+.+|+.++.++.+||||++++++|..  .....+++|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv  137 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV  137 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence            4568776 689999999999999999999999999963  45678999998776699999999999864  234578999


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCC
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~  273 (419)
                      |||+++++|..++.     .+++..++.++.|++.||+|||++||+||||||+|||++.+  .+.+||+|||+++.....
T Consensus       138 ~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             EECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             EEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            99999999988873     38999999999999999999999999999999999999873  378999999999877655


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH---HHHHHHHHHcCCchHHHHHhhcC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH---DQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~---~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......   .....+..             ..
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~-------------~~  283 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-------------GQ  283 (400)
T ss_dssp             ---------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH-------------TC
T ss_pred             CccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc-------------Cc
Confidence            55566788999999999876 789999999999999999999999995432211   01111110             00


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      ...                    .......+++++.+||++||+.||++|||+.|+++||||.+.
T Consensus       284 ~~~--------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          284 YEF--------------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             CCC--------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ccC--------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            000                    001112478999999999999999999999999999999753

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-48  Score=370.92  Aligned_cols=277  Identities=30%  Similarity=0.545  Sum_probs=215.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++....        .+.+.+|+.+++.+ +||||+++++++.+  ..
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~   85 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KS   85 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TT
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEee--CC
Confidence            578999999999999999999999999999999986422        24678999999999 89999999999954  46


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+++ ++...+.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFG  163 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTT
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-CCEEEEecccceecc
Confidence            78899999997 5555542    48899999999999999999999999999999999999988 889999999998664


Q ss_pred             CC-CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          272 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       272 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      .. .......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+..+.+....+.....
T Consensus       164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence            32 23345678999999999977566899999999999999999998665 66777778888888777665443321111


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      ......    .......++..     ....+++++.+||++||+.||++|||+.|+|+||||++.
T Consensus       243 ~~~~~~----~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          243 LPDYVT----FKSFPGIPLHH-----IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             STTCCC----CCCCCCCCHHH-----HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             Cccccc----ccccCCCChHH-----hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence            000000    00000001111     113478999999999999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-47  Score=366.94  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=208.3

Q ss_pred             CCCeEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|.+. +.||+|+||+||+|.+..+++.||+|+++..     ....+.+|+.++..+..||||+++++++.+  ....
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~  104 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEI  104 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeE
Confidence            5678887 8899999999999999999999999998642     246788999999999778999999999965  4678


Q ss_pred             EEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceec
Q 014762          198 SLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFY  270 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~  270 (419)
                      ++||||+.+++|..++     ..+++..+..++.|++.||+|||++||+||||||+|||++..  .+.+||+|||+++..
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence            9999999999998886     458999999999999999999999999999999999999871  278999999999887


Q ss_pred             cCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ..........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+........         
T Consensus       185 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~---------  253 (327)
T 3lm5_A          185 GHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFV-GEDNQETYLNISQVNVDYS---------  253 (327)
T ss_dssp             ---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCC---------
T ss_pred             CCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHhcccccC---------
Confidence            65555556789999999999876 789999999999999999999999983 3333333333332211100         


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                              ......+++.+.+||.+||+.||++|||++++|+||||+++
T Consensus       254 ------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          254 ------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             ------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             ------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence                                    01112378899999999999999999999999999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.9e-48  Score=370.72  Aligned_cols=258  Identities=26%  Similarity=0.436  Sum_probs=208.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC--------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..        ...+.+.+|+.+++.+ +||||+++++++.+  ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~  101 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED--EQ  101 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc--CC
Confidence            5789999999999999999999999999999999853        2346788999999999 89999999999965  46


Q ss_pred             ccEEEEEecCCCChhhhcCC-------------------------------------------CCHHHHHHHHHHHHHHH
Q 014762          196 TPSLIFEYVNSTDFKVLYPT-------------------------------------------LTDYDIRYYIYELLKAL  232 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~~-------------------------------------------l~~~~~~~~~~qi~~~L  232 (419)
                      ..++||||+++++|..++..                                           +++..++.++.|++.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            78999999999999887731                                           25677888999999999


Q ss_pred             HHHHHCCcEeecCCCCceEEcCCC-CcEEEEecccceeccCCC-----cceeecccccccccccccCC-CCCCccccHHH
Q 014762          233 DYCHSQGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDL-QDYDYSLDMWS  305 (419)
Q Consensus       233 ~~LH~~~ivH~Dlk~~NILl~~~~-~~~kl~Dfgla~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwS  305 (419)
                      +|||++||+||||||+|||++.+. ..+||+|||+++......     ......+|+.|+|||++.+. ..++.++||||
T Consensus       182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            999999999999999999998662 279999999998653321     12446789999999998642 57899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHH
Q 014762          306 LGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA  385 (419)
Q Consensus       306 lG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  385 (419)
                      |||++|+|++|+.||. +.+..+....+.......                                 .......+++++
T Consensus       262 lG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~  307 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFP-GVNDADTISQVLNKKLCF---------------------------------ENPNYNVLSPLA  307 (345)
T ss_dssp             HHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCT---------------------------------TSGGGGGSCHHH
T ss_pred             HHHHHHHHHHCCCCCC-CCChHHHHHHHHhccccc---------------------------------CCcccccCCHHH
Confidence            9999999999999983 334444443333211000                                 000112268999


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHhcCCCccccccc
Q 014762          386 IDFLDKLLRYDHQDRLTAREAMVISSISPIFSL  418 (419)
Q Consensus       386 ~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~~  418 (419)
                      .+||.+||+.||++|||+.++|+||||+++.+.
T Consensus       308 ~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          308 RDLLSNLLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999999999999999999999988654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-47  Score=366.06  Aligned_cols=249  Identities=28%  Similarity=0.467  Sum_probs=201.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      .++|++.+.||+|+||+||+|++.   .+++.||+|+++..       ....+.+|+.+++.+ +||||+++++++..  
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT--   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC--
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc--
Confidence            578999999999999999999875   68999999998743       234577899999999 89999999999965  


Q ss_pred             CCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ....++||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKES  171 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-SCEEECCCSCC---
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-CcEEEEeCCccccc
Confidence            46789999999999998876   458999999999999999999999999999999999999988 88999999999754


Q ss_pred             cCC-CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       271 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.+..            
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~~------------  237 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKILKCK------------  237 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTC------------
T ss_pred             ccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCC------------
Confidence            332 22334578999999999977 778999999999999999999999984 333333333333210            


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                       ..                        .+..+++++.+||.+||+.||++||     |++|+++||||+.+
T Consensus       238 -~~------------------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          238 -LN------------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             -CC------------------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             -CC------------------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence             00                        0123689999999999999999999     89999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.6e-48  Score=373.43  Aligned_cols=255  Identities=29%  Similarity=0.447  Sum_probs=208.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|+++... ....+|+.++.++.+||||+++++++.+  ....++||||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~   97 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTEL   97 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeC
Confidence            567999999999999999999999999999999997543 3456799999988789999999999965  4778999999


Q ss_pred             cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC---cEEEEecccceeccCCC-cc
Q 014762          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAEFYHPGK-EY  276 (419)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~---~~kl~Dfgla~~~~~~~-~~  276 (419)
                      +++++|...+   ..+++..+..++.|++.||+|||++||+||||||+|||+..+.+   .+||+|||+++...... ..
T Consensus        98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  177 (342)
T 2qr7_A           98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL  177 (342)
T ss_dssp             CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence            9999988776   45899999999999999999999999999999999999855422   59999999998765433 33


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-CHH-HHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-NHD-QLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~-~~~-~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ...++|+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ..+ .+..+..             ..... 
T Consensus       178 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~-------------~~~~~-  242 (342)
T 2qr7_A          178 MTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS-------------GKFSL-  242 (342)
T ss_dssp             CCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH-------------CCCCC-
T ss_pred             eccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc-------------CCccc-
Confidence            45688999999999876 6689999999999999999999999954321 222 2222211             00000 


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                         ....+..+++++.+||++||+.||++|||+.++++||||.+.
T Consensus       243 -------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          243 -------------------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             -------------------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             -------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence                               001122479999999999999999999999999999999754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2e-47  Score=386.21  Aligned_cols=255  Identities=28%  Similarity=0.484  Sum_probs=212.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----------------chHHHHHHHHHHHHhcCCCCeeEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------------KKKKIKREIKILQNLCGGPNVVKLL  186 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~~E~~~l~~l~~h~niv~l~  186 (419)
                      ..++|+++++||+|+||+||+|.+..+++.||+|++...                ..+.+.+|+.+++.+ +||||++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~  112 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLF  112 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEE
Confidence            367899999999999999999999999999999998642                235688999999999 899999999


Q ss_pred             eEEEccCCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC--cEEE
Q 014762          187 DIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRL  261 (419)
Q Consensus       187 ~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~--~~kl  261 (419)
                      +++.+  ....++||||+++++|...+   ..+++..+..++.|++.||+|||++||+||||||+|||++.+..  .+||
T Consensus       113 ~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          113 DVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            99965  47789999999999997766   57999999999999999999999999999999999999987632  6999


Q ss_pred             EecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCch
Q 014762          262 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (419)
Q Consensus       262 ~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~  341 (419)
                      +|||+++............||+.|+|||++.+  .++.++||||+||++|+|++|..||. +.+..+.+..+.+.....+
T Consensus       191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~  267 (504)
T 3q5i_A          191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFG-GQNDQDIIKKVEKGKYYFD  267 (504)
T ss_dssp             CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCC
T ss_pred             EECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCCCC
Confidence            99999998776666666789999999999764  69999999999999999999999983 4444444444433111111


Q ss_pred             HHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ...                                 ...+++++++||++||++||++|||++|+|+||||+...
T Consensus       268 ~~~---------------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          268 FND---------------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHH---------------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             ccc---------------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            111                                 123789999999999999999999999999999998653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.9e-48  Score=380.20  Aligned_cols=287  Identities=24%  Similarity=0.484  Sum_probs=207.1

Q ss_pred             CCCeEE-EeeeeeeCceEEEEEEEc--CCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEV-VRKVGRGKYSEVFEGINV--NTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~-~~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .+.|++ .++||+|+||+||+|.+.  .+++.||+|++.... ...+.+|+.+++.+ +||||+++++++........++
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEE
Confidence            345666 447999999999999965  578899999997543 46788999999999 8999999999998766688999


Q ss_pred             EEEecCCCChhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE----cCCCCcEEEEec
Q 014762          200 IFEYVNSTDFKVLY-----------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDW  264 (419)
Q Consensus       200 v~e~~~~~~l~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl----~~~~~~~kl~Df  264 (419)
                      ||||++++.+..+.           ..+++..++.++.|++.||+|||++||+||||||+|||+    +.+ +.+||+||
T Consensus        98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kl~Df  176 (405)
T 3rgf_A           98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GRVKIADM  176 (405)
T ss_dssp             EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT-TCEEECCT
T ss_pred             EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC-CcEEEEEC
Confidence            99999875433322           138999999999999999999999999999999999999    444 78999999


Q ss_pred             ccceeccCC----CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHH
Q 014762          265 GLAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--------NHDQLVK  332 (419)
Q Consensus       265 gla~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--------~~~~~~~  332 (419)
                      |+++.....    .......||..|+|||++.+...++.++|||||||++|+|++|+.||.....        ..+++..
T Consensus       177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~  256 (405)
T 3rgf_A          177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  256 (405)
T ss_dssp             TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred             CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence            999876432    2223467899999999998756699999999999999999999999854332        3578888


Q ss_pred             HHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCcccc--c--cccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF--I--NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       333 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      +.+.+|.+....|...........   .........+...  .  ........++++.+||++||++||++|||++|+|+
T Consensus       257 i~~~~g~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          257 IFNVMGFPADKDWEDIKKMPEHST---LMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHCCCCTTTCGGGGGSTTHHH---HHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhCCCChhhcchhhcCcchhh---hhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            999998876554432211111111   1111111100000  0  00111224788999999999999999999999999


Q ss_pred             CCCcccc
Q 014762          409 ISSISPI  415 (419)
Q Consensus       409 hp~f~~~  415 (419)
                      ||||+..
T Consensus       334 hp~f~~~  340 (405)
T 3rgf_A          334 DPYFLED  340 (405)
T ss_dssp             SGGGTSS
T ss_pred             ChhhccC
Confidence            9999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.2e-47  Score=368.42  Aligned_cols=254  Identities=24%  Similarity=0.413  Sum_probs=211.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++....           .+.+.+|+.+++++.+||||+++++++.. 
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  171 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-  171 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence            357999999999999999999999999999999986432           35678899999998779999999999965 


Q ss_pred             CCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                       ....++||||+++++|..++   ..+++..+..++.|++.||.|||+.||+|+||||+|||++.+ +.+||+|||++..
T Consensus       172 -~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~  249 (365)
T 2y7j_A          172 -SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCH  249 (365)
T ss_dssp             -SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred             -CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEecCcccc
Confidence             46789999999999998876   469999999999999999999999999999999999999988 8899999999988


Q ss_pred             ccCCCcceeecccccccccccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          270 YHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      ...........||+.|+|||++.+     ...++.++|||||||++|+|++|..||.. .+..+.+..+.......... 
T Consensus       250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~-  327 (365)
T 2y7j_A          250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSSP-  327 (365)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCHH-
T ss_pred             cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCCc-
Confidence            776665666789999999999863     13588999999999999999999999843 22222333222211100000 


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                                      ....+++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus       328 --------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          328 --------------------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             --------------------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             --------------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence                                            01236889999999999999999999999999999973

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-47  Score=382.75  Aligned_cols=249  Identities=23%  Similarity=0.416  Sum_probs=212.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|.+.+.||+|+||+||+|.+..+|+.||||+++..      ..+.+.+|+.+++.+ +||||+++++++...  ...
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~--~~~   91 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTP--SDI   91 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEE
Confidence            57899999999999999999999999999999999643      235688999999999 899999999999654  678


Q ss_pred             EEEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||+++++|..++.   .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT-CCEEECCCSSCEECCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC-CCeEEEeccchhhccccc
Confidence            99999999999998873   58999999999999999999999999999999999999988 789999999999876655


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||. +.+..+....+....                 
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~-----------------  232 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDHVPTLFKKICDGI-----------------  232 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC-CSSSHHHHHHHHTTC-----------------
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhcCC-----------------
Confidence            55667899999999999874344789999999999999999999984 333333333322100                 


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                          ...+..+++++.+||++||+.||++|||+.|+++||||+.
T Consensus       233 --------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          233 --------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             --------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence                                0011237889999999999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.5e-48  Score=376.43  Aligned_cols=299  Identities=23%  Similarity=0.358  Sum_probs=224.4

Q ss_pred             CCCCceeccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhc-------CCCCee
Q 014762          113 DYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC-------GGPNVV  183 (419)
Q Consensus       113 ~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~-------~h~niv  183 (419)
                      .|..+..+....++|++.++||+|+||+||+|.+..+++.||+|+++...  .+.+.+|+.+++.+.       +|+||+
T Consensus        25 ~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv  104 (397)
T 1wak_A           25 GYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV  104 (397)
T ss_dssp             -CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred             CceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence            34445554445789999999999999999999999999999999997543  467889999999983       278899


Q ss_pred             EEEeEEEcc--CCCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCceEEcCCC
Q 014762          184 KLLDIVRDQ--HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEL  256 (419)
Q Consensus       184 ~l~~~~~~~--~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlk~~NILl~~~~  256 (419)
                      ++++++...  .....++||||++++++..+.    ..+++..++.++.|++.||+|||++ ||+||||||+|||++.+.
T Consensus       105 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          105 QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred             eeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence            999998632  346789999999776666554    3489999999999999999999998 999999999999998662


Q ss_pred             ------------------------------------------------CcEEEEecccceeccCCCcceeeccccccccc
Q 014762          257 ------------------------------------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP  288 (419)
Q Consensus       257 ------------------------------------------------~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aP  288 (419)
                                                                      ..+||+|||+++.....  .....+|..|+||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aP  262 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCH
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCC
Confidence                                                            27999999999876432  3445789999999


Q ss_pred             ccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-----CHHHHHHHHHHcCCchHHHHHhhcCC-CCChhhHHhhc
Q 014762          289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD-----NHDQLVKIAKVLGTDELNAYLNKYHL-ELDPQLDALVG  362 (419)
Q Consensus       289 E~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~-----~~~~~~~i~~~lg~~~~~~~~~~~~~-~~~~~~~~~~~  362 (419)
                      |++.+ ..++.++|||||||++|+|++|+.||.....     ..+++..+.+.+|..+...+...... ...........
T Consensus       263 E~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          263 EVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             hhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            99987 6799999999999999999999999954332     35567788888888665543321110 00000000000


Q ss_pred             cCCCCCccccc----cccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          363 RHSRKPWSKFI----NADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       363 ~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      .....+|....    ........++++.+||.+||+.||++|||++|+|+||||++
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            00011111000    00011124567899999999999999999999999999974

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=376.62  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=210.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|++++.      ..+.+.+|..++..+ +||||++++++|.+.  ..
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~--~~  135 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDE--NY  135 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECS--SE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeC--CE
Confidence            467899999999999999999999999999999999642      224578999999998 999999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++++|..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC-CCEEEeechhheeccC
Confidence            89999999999998886    369999999999999999999999999999999999999988 8999999999987655


Q ss_pred             CCcc--eeecccccccccccccC------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          273 GKEY--NVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       273 ~~~~--~~~~~~~~y~aPE~~~~------~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      ....  ...+||+.|+|||++.+      ...++.++|||||||++|||++|+.||. +.+..+....+.....      
T Consensus       215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~~~------  287 (412)
T 2vd5_A          215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-ADSTAETYGKIVHYKE------  287 (412)
T ss_dssp             TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHH------
T ss_pred             CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhccc------
Confidence            4432  23589999999999872      2568999999999999999999999984 3344444444432100      


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCC---CCHHHHhcCCCcccc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR---LTAREAMVISSISPI  415 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pta~elL~hp~f~~~  415 (419)
                         .  ...+                     .....+++++++||++||+ +|++|   +|++|+++||||+.+
T Consensus       288 ---~--~~~p---------------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          288 ---H--LSLP---------------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             ---H--CCCC-------------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             ---C--cCCC---------------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence               0  0000                     0012379999999999999 99998   599999999999876

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-47  Score=387.56  Aligned_cols=253  Identities=25%  Similarity=0.396  Sum_probs=214.3

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ...++|++.+.||+|+||+||+|++..+|+.||+|++...      ....+.+|+.+++.+ +||||+++++++.+.  .
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--~  257 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETK--D  257 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeC--C
Confidence            3567899999999999999999999999999999998642      235678999999999 999999999999654  6


Q ss_pred             ccEEEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          196 TPSLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ..++||||+++++|..++.     .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-g~vKL~DFGla~~~  336 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHV  336 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC-CCeEEEecccceec
Confidence            7899999999999988762     38999999999999999999999999999999999999988 89999999999887


Q ss_pred             cCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHcCCchHHHHHhh
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      .........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....  ..+.+...+....          
T Consensus       337 ~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~----------  405 (576)
T 2acx_A          337 PEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP----------  405 (576)
T ss_dssp             CTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC----------
T ss_pred             ccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc----------
Confidence            66655566789999999999987 6799999999999999999999999954322  2222222211100          


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                        .                        .....+++++.+||++||+.||++||     |++|+++||||+.+
T Consensus       406 --~------------------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          406 --E------------------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             --C------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             --c------------------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence              0                        00123789999999999999999999     89999999999975

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.5e-47  Score=360.72  Aligned_cols=250  Identities=22%  Similarity=0.393  Sum_probs=208.5

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .|+..++||+|+||+||+|.+..+|+.||||++...   ..+.+.+|+.+++.+ +||||+++++++...  ...++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVG--EELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC--CEEEEEEe
Confidence            477788999999999999999999999999998643   346788999999999 999999999999764  67889999


Q ss_pred             ecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cceee
Q 014762          203 YVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYNVR  279 (419)
Q Consensus       203 ~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~~~  279 (419)
                      |+++++|..++.  .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++....... .....
T Consensus       123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CcEEEeeeeeeeecccCccccccc
Confidence            999999998874  58999999999999999999999999999999999999988 789999999998765432 23446


Q ss_pred             cccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHH
Q 014762          280 VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDA  359 (419)
Q Consensus       280 ~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~  359 (419)
                      .||..|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+... ..+.                  
T Consensus       202 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~-~~~~------------------  260 (321)
T 2c30_A          202 VGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDS-PPPK------------------  260 (321)
T ss_dssp             CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHS-SCCC------------------
T ss_pred             cCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcC-CCCC------------------
Confidence            78999999999877 7899999999999999999999999843 2222222222111 0000                  


Q ss_pred             hhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          360 LVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                     ......+++++.+|+.+||+.||++|||+.|+++||||++.
T Consensus       261 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          261 ---------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             ---------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             ---------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence                           00112368899999999999999999999999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.6e-48  Score=383.52  Aligned_cols=250  Identities=26%  Similarity=0.435  Sum_probs=202.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|+++..      ....+.+|+.+++.+ +||||++++++|...  ..
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~--~~  222 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTH--DR  222 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEET--TE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeC--CE
Confidence            357899999999999999999999999999999998642      234577899999998 899999999999664  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++++|..++   ..+++..++.++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|||+++....
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC-CCEEEccCCCceeccC
Confidence            89999999999998776   568999999999999999999998 999999999999999988 8999999999976432


Q ss_pred             C-CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          273 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       273 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      . ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+...             ..
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~-------------~~  366 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILME-------------EI  366 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC-------------CC
T ss_pred             CCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhC-------------CC
Confidence            2 33345689999999999987 7899999999999999999999999842 2322222222210             00


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                      .                        .+..+++++.+||.+||+.||++||     |++|+++||||+++
T Consensus       367 ~------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          367 R------------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             C------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             C------------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            0                        0123789999999999999999999     99999999999976

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.3e-47  Score=356.82  Aligned_cols=255  Identities=27%  Similarity=0.458  Sum_probs=208.3

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ++|++.+.||+|+||+||+|.+..+++.||+|+++..         ..+.+.+|+.+++++ +||||+++++++.+.  .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~   81 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENK--T   81 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--S
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCC--C
Confidence            5799999999999999999999999999999998642         256789999999999 899999999999654  6


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC---CcEEEEeccccee
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAEF  269 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~---~~~kl~Dfgla~~  269 (419)
                      ..++||||+++++|..++   ..+++..+..++.|++.||.|||++|++|+||||+||+++.+.   ..+||+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            789999999999998876   4699999999999999999999999999999999999998762   2799999999987


Q ss_pred             ccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ...........++..|+|||++.+ ..++.++||||||+++|+|++|..||. +.+..+.+..+.........       
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~-------  232 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAVNYDFDE-------  232 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTTCCCCCH-------
T ss_pred             ccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCC-CcchHHHHHHhHhcccCCcc-------
Confidence            765555555678999999999876 779999999999999999999999984 33333333322211100000       


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                                .....+++.+.+|+.+||+.||++|||+.++++||||+.++.
T Consensus       233 --------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          233 --------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             --------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             --------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence                                      001236889999999999999999999999999999998753

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-47  Score=385.20  Aligned_cols=254  Identities=24%  Similarity=0.474  Sum_probs=211.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.++||+|+||+||+|.+..+++.||+|++..     .....+.+|+.+++++ +||||+++++++.+  ....+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~   97 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY   97 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEc--CCEEE
Confidence            5789999999999999999999999999999999852     3456789999999999 99999999999965  46789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCC
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~  273 (419)
                      +||||+.+++|...+   ..+++..+..++.|++.||.|||++||+||||||+|||++.+  .+.+||+|||+++.....
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            999999999997765   579999999999999999999999999999999999999643  257999999999877665


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|..||. +.+..+.+..+........            
T Consensus       178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~------------  242 (486)
T 3mwu_A          178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYAFD------------  242 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCSC------------
T ss_pred             CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCC------------
Confidence            55566789999999999875  59999999999999999999999984 3444444443332110000            


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                           ......+++++++||.+||+.||++|||+.++|+||||+...
T Consensus       243 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          243 ---------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             ---------------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             ---------------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence                                 001123789999999999999999999999999999998653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-48  Score=367.11  Aligned_cols=276  Identities=18%  Similarity=0.313  Sum_probs=212.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++..    ..+.+.+|+.+++++ +||||+++++++........+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEE
Confidence            467899999999999999999999999999999999742    346778999999999 899999999999877667889


Q ss_pred             EEEEecCCCChhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE----cCCCCcEEEEecccce
Q 014762          199 LIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWGLAE  268 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~~------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl----~~~~~~~kl~Dfgla~  268 (419)
                      +||||+++++|..++..      +++..+..++.|++.||+|||++||+||||||+|||+    +.+ +.+||+|||+++
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~Dfg~a~  164 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAAR  164 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSC-EEEEECCCTTCE
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCC-ceEEEccCCCce
Confidence            99999999999888732      8999999999999999999999999999999999998    544 679999999999


Q ss_pred             eccCCCcceeecccccccccccccC-------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCch
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVD-------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~  341 (419)
                      ............+|..|+|||++..       ...++.++|||||||++|+|++|+.||............+.+.++..+
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            8776666566789999999999852       267899999999999999999999999644333322222222221111


Q ss_pred             HHHHHhhcCCCCChhhHHhhccCCCCCccccccc--cccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014762          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINA--DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISS  411 (419)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~  411 (419)
                      ...+         ......  ......|......  .....+++.+.+||++||++||++|||++|+|+||-
T Consensus       245 ~~~~---------~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          245 SGAI---------SGVQKA--ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             TTCC---------EEEECS--TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cccc---------hhhhcc--cCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            0000         000000  0000011111111  111224567889999999999999999999999873

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.5e-47  Score=366.95  Aligned_cols=286  Identities=28%  Similarity=0.513  Sum_probs=220.6

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEcc---CC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQ---HS  194 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~  194 (419)
                      ...++|++.+.||+|+||+||+|.+..+|+.||||+++...    ...+.+|+.+++.+ +||||+++++++...   ..
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCcc
Confidence            34789999999999999999999999999999999996433    34677999999999 899999999988643   23


Q ss_pred             CccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          195 KTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ...++||||+++ +|..++  ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        87 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           87 NEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECC-
T ss_pred             ceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC-CcEEEEeccccccccc
Confidence            568999999985 666655  569999999999999999999999999999999999999988 7899999999987643


Q ss_pred             CCc-----------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCch
Q 014762          273 GKE-----------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (419)
Q Consensus       273 ~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~  341 (419)
                      ...           .....||..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+....|.+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF-PGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCc
Confidence            221           122467899999999876577999999999999999999999987 45566677777777777654


Q ss_pred             HHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ......   .................+....  ......+++++.+||.+||+.||++|||+.|+|+||||+.+.
T Consensus       244 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          244 SDNDLR---CIESPRAREYIKSLPMYPAAPL--EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             STTTTT---TCCCHHHHHHHHTSCCCCCCCH--HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhcccc---ccccchhhHHhhcccCCCCcch--hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            221100   0011111111111111000000  011124789999999999999999999999999999998764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.5e-47  Score=386.29  Aligned_cols=253  Identities=27%  Similarity=0.492  Sum_probs=209.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|+++++||+|+||+||+|.+..++..||+|++...     ....+.+|+.+++.+ +||||++++++|.+.  ...+
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~~  112 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDK--RNYY  112 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--CEEE
Confidence            45799999999999999999999999999999998642     346788999999999 999999999999654  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCC
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~  273 (419)
                      +||||+.+++|...+   ..+++..+..++.|++.||.|||++||+||||||+|||++.+  .+.+||+|||+++.....
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999987765   569999999999999999999999999999999999999764  245999999999887766


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......||+.|+|||++.  ..++.++||||+||++|+|++|..||. +.+..+.+..+.......             
T Consensus       193 ~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~-------------  256 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYTF-------------  256 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCC-------------
T ss_pred             ccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCC-------------
Confidence            6666678999999999875  469999999999999999999999983 334444443333211100             


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                          .......+++++.+||++||+.||++|||+.|+|+||||+..
T Consensus       257 --------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          257 --------------------DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             --------------------CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             --------------------CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence                                001112378999999999999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.8e-47  Score=364.83  Aligned_cols=281  Identities=30%  Similarity=0.548  Sum_probs=218.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC----
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS----  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~----  194 (419)
                      .++|.+.+.||+|+||+||+|.+..+|+.||||++....     .+.+.+|+.+++.+ +||||+++++++.....    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccc
Confidence            578999999999999999999999999999999986422     35678999999999 89999999999965432    


Q ss_pred             CccEEEEEecCCCChhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          195 KTPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ...++||||+++ ++..++ ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.... 
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~-  178 (353)
T 3coi_A          102 YDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHADA-  178 (353)
T ss_dssp             CCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-CCEEECSTTCTTC----
T ss_pred             eeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC-CcEEEeecccccCCCC-
Confidence            235899999995 665554 469999999999999999999999999999999999999988 7899999999976542 


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       ......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..|.+....... .   .
T Consensus       179 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~-~---~  252 (353)
T 3coi_A          179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQK-L---N  252 (353)
T ss_dssp             ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS-BSSCHHHHHHHHHHHHCBCCHHHHTT-C---S
T ss_pred             -CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHH-H---h
Confidence             2334578999999999877567899999999999999999999998 45566777888888888765443211 0   0


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ..................+.  .....+++++.+||.+||+.||++|||++++|+||||+.++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFT--QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTT--TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hHHHHHHHHhCcCCCCccHH--HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence            11111111111111111111  11124789999999999999999999999999999999765

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-46  Score=354.40  Aligned_cols=257  Identities=24%  Similarity=0.389  Sum_probs=213.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------------hHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVR  190 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~  190 (419)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|+++...            .+.+.+|+.+++++.+||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4688999999999999999999999999999999986432            3567899999999956999999999996


Q ss_pred             ccCCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccc
Q 014762          191 DQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (419)
Q Consensus       191 ~~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla  267 (419)
                      .  ....++||||+++++|..++   ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++
T Consensus        95 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~  171 (298)
T 1phk_A           95 T--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFS  171 (298)
T ss_dssp             C--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTC
T ss_pred             c--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC-CcEEEecccch
Confidence            5  47789999999999998886   468999999999999999999999999999999999999988 78999999999


Q ss_pred             eeccCCCcceeeccccccccccccc-----CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchH
Q 014762          268 EFYHPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL  342 (419)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~  342 (419)
                      .............++..|+|||++.     ....++.++|||||||++|+|++|..||.. .+..+....+.....    
T Consensus       172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~----  246 (298)
T 1phk_A          172 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNY----  246 (298)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC----
T ss_pred             hhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCc----
Confidence            8876665556678899999999985     235688999999999999999999999843 222222222222100    


Q ss_pred             HHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                               ..                    .......+++++.+|+.+||+.||++|||+.|+|+||||++..
T Consensus       247 ---------~~--------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          247 ---------QF--------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             ---------CC--------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             ---------cc--------------------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence                     00                    0001123788999999999999999999999999999999763

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=367.61  Aligned_cols=244  Identities=26%  Similarity=0.433  Sum_probs=207.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----------chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++..           ..+.+.+|+.+++.+ +||||+++++++.+ 
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~-  100 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFEN-  100 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEEC-
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEee-
Confidence            56899999999999999999999999999999998643           234577899999999 99999999999965 


Q ss_pred             CCCccEEEEEecCCC-Chhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          193 HSKTPSLIFEYVNST-DFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~-~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                       ....++||||+.++ ++..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus       101 -~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~  178 (335)
T 3dls_A          101 -QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAA  178 (335)
T ss_dssp             -SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred             -CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-CcEEEeecccce
Confidence             46788999999776 887776   358999999999999999999999999999999999999988 889999999999


Q ss_pred             eccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ............||+.|+|||++.+...++.++|||||||++|+|++|..||.....                       
T Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------------  235 (335)
T 3dls_A          179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------------------  235 (335)
T ss_dssp             ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------------
T ss_pred             ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------------
Confidence            877666666678999999999998743348899999999999999999999932000                       


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                 ....          ....+..+++++.+||.+||+.||++|||++++++||||++.
T Consensus       236 -----------~~~~----------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          236 -----------TVEA----------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             -----------GTTT----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             -----------HHhh----------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                       0000          001122378999999999999999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.8e-47  Score=370.05  Aligned_cols=250  Identities=24%  Similarity=0.418  Sum_probs=202.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHH-HHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKIL-QNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l-~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++++.||+|+||+||+|++..+++.||+|++++..      ...+.+|..++ +.+ +||||++++++|.+.  .
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~--~  112 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTA--D  112 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECS--S
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeC--C
Confidence            4578999999999999999999999999999999996432      23455676663 455 899999999999654  6


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc-
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~-  271 (419)
                      ..++||||+++++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++... 
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCBCGGGBC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEeeCcccccccc
Confidence            789999999999998876   468999999999999999999999999999999999999988 899999999998643 


Q ss_pred             CCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      ........+||+.|+|||++.+ ..++.++|+|||||++|||++|..||. +.+..+....+...             ..
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~-------------~~  256 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNK-------------PL  256 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSBHHHHHHHHHHS-------------CC
T ss_pred             CCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHhc-------------cc
Confidence            2334455689999999999987 789999999999999999999999984 33333333333220             00


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH----HHHhcCCCcccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA----REAMVISSISPI  415 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta----~elL~hp~f~~~  415 (419)
                                              .....+++++.+||++||+.||++||++    .++++||||+.+
T Consensus       257 ------------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          257 ------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             ------------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence                                    0012378999999999999999999987    699999999876

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.5e-47  Score=366.48  Aligned_cols=281  Identities=28%  Similarity=0.458  Sum_probs=217.8

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      +...++|++.+.||+|+||+||+|.+..+|+.||+|++....     .+.+.+|+.+++.+ +||||+++++++.+.  .
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~   97 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKK--K   97 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--T
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecC--C
Confidence            345788999999999999999999999999999999985332     34577899999999 899999999999654  6


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ..++||||++++++..+.   ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++....
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCTTC-----
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC-CcEEEEeCCCceeecC
Confidence            789999999999988774   569999999999999999999999999999999999999988 7999999999976543


Q ss_pred             C-CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH--Hhhc
Q 014762          273 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY--LNKY  349 (419)
Q Consensus       273 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~--~~~~  349 (419)
                      . .......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.......  ....
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-PGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            3 23345678999999999987557899999999999999999999887 556666777777777776433221  1110


Q ss_pred             CCCCChhhHHhhccCCCCCcc-ccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      ..     +.    ........ ..........+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       256 ~~-----~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          256 PV-----FA----GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GG-----GT----TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cc-----cc----cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            00     00    00000000 000001112478999999999999999999999999999999854

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.2e-46  Score=364.48  Aligned_cols=281  Identities=23%  Similarity=0.387  Sum_probs=216.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCC-----eeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPN-----VVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~n-----iv~l~~~~~~~~~~  195 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++...  ...+.+|+.++..+..|++     ++++++++...  .
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~--~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR--N  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--T
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--C
Confidence            3689999999999999999999999999999999997543  3567789999998854664     99999999664  6


Q ss_pred             ccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeecCCCCceEEcC-CCCcEEEEecccc
Q 014762          196 TPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLA  267 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlk~~NILl~~-~~~~~kl~Dfgla  267 (419)
                      ..++||||+++ +|..++     ..+++..++.++.|++.||.|||  +.||+||||||+|||++. +.+.+||+|||++
T Consensus       130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            78999999986 666554     34899999999999999999999  579999999999999964 2368999999999


Q ss_pred             eeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      +.....  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.+|.++...+..
T Consensus       209 ~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~  284 (382)
T 2vx3_A          209 CQLGQR--IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLF-SGANEVDQMNKIVEVLGIPPAHILDQ  284 (382)
T ss_dssp             EETTCC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eecccc--cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            876432  344678999999999987 67999999999999999999999997 56677788888888888766543321


Q ss_pred             hcCCCCChhhHHhhccCCCCCcccc--------------------cccc---------cc----CCCCHHHHHHHHHhcC
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKF--------------------INAD---------NQ----HLVSPEAIDFLDKLLR  394 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~---------~~----~~~~~~~~~li~~~L~  394 (419)
                            .+.............|...                    +...         ..    ...++++.+||++||+
T Consensus       285 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  358 (382)
T 2vx3_A          285 ------APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD  358 (382)
T ss_dssp             ------CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC
T ss_pred             ------hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC
Confidence                  1111111111111111100                    0000         00    0011478999999999


Q ss_pred             CCCCCCCCHHHHhcCCCccccc
Q 014762          395 YDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       395 ~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      +||++|||++|+|+||||+...
T Consensus       359 ~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          359 YDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             SCTTTSCCHHHHTTSGGGCC--
T ss_pred             CChhhCCCHHHHhcCcccccCC
Confidence            9999999999999999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-47  Score=385.99  Aligned_cols=253  Identities=28%  Similarity=0.478  Sum_probs=213.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++..      ...+.+.+|+.+++++ +||||+++++++.+  ....
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~  101 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED--KGYF  101 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCEE
Confidence            5689999999999999999999999999999999853      2356789999999999 99999999999965  4678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC--CCCcEEEEecccceeccC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~--~~~~~kl~Dfgla~~~~~  272 (419)
                      ++||||+.+++|...+   ..+++..+..++.|++.||.|||++||+||||||+|||++.  +.+.+||+|||+++....
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999997766   56899999999999999999999999999999999999953  237899999999987766


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      ........||+.|+|||++.+  .++.++|||||||++|+|++|..||. +.+..+.+..+.+......           
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~-----------  247 (484)
T 3nyv_A          182 SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFN-GANEYDILKKVEKGKYTFE-----------  247 (484)
T ss_dssp             CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCC-----------
T ss_pred             ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcCCCCCC-----------
Confidence            665566789999999999865  69999999999999999999999983 4444444444332110000           


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                            ...+..+++++++||++||+.||++|||+.|+|+||||+..
T Consensus       248 ----------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          248 ----------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             ----------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             ----------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence                                  01112378999999999999999999999999999999865

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.7e-47  Score=359.81  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=206.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....           ...+.+|+.+++.+ +||||+++++++...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCC
Confidence            467999999999999999999999999999999986432           23578999999999 999999999999653


Q ss_pred             CCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC--CcEEEEecccc
Q 014762          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLA  267 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~--~~~kl~Dfgla  267 (419)
                         ..++||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+.  ..+||+|||++
T Consensus        88 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           88 ---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             ---SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             ---ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence               378999999999988776   4589999999999999999999999999999999999998762  24999999999


Q ss_pred             eeccCCCcceeeccccccccccccc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          268 EFYHPGKEYNVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      +............+|..|+|||++.  +...++.++|||||||++|+|++|..||............+....        
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------  236 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK--------  236 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC--------
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc--------
Confidence            8776544444567899999999974  236789999999999999999999999854333322222222110        


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                           ....+.                    ....+++++.+||.+||+.||++|||+.++|+||||+..
T Consensus       237 -----~~~~~~--------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          237 -----YNFIPE--------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             -----CCCCHH--------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             -----cccCch--------------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence                 000000                    012378899999999999999999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.6e-47  Score=359.00  Aligned_cols=263  Identities=22%  Similarity=0.361  Sum_probs=201.4

Q ss_pred             CCCCeEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++|++. +.||+|+||+||+|.+..+++.||||++...   ..+.+.+|+.++.++.+||||+++++++.+.  ...+
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--~~~~   87 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE--DRFY   87 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--CEEE
Confidence            36789885 7799999999999999999999999998643   3567899999999965899999999999664  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC--cEEEEecccceeccCC
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHPG  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~--~~kl~Dfgla~~~~~~  273 (419)
                      +||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+..  .+||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            999999999998876   56899999999999999999999999999999999999987622  3999999998765322


Q ss_pred             C--------cceeecccccccccccccCC----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHH----------HHH
Q 014762          274 K--------EYNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHD----------QLV  331 (419)
Q Consensus       274 ~--------~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~----------~~~  331 (419)
                      .        ......||..|+|||++.+.    ..++.++|||||||++|+|++|+.||........          ...
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence            1        11234689999999998641    3578999999999999999999999954322110          000


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISS  411 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~  411 (419)
                      .+.+         ...........                    .....+++++.+||++||+.||++|||+.|+|+|||
T Consensus       248 ~~~~---------~i~~~~~~~~~--------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~  298 (316)
T 2ac3_A          248 MLFE---------SIQEGKYEFPD--------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW  298 (316)
T ss_dssp             HHHH---------HHHHCCCCCCH--------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred             HHHH---------HHhccCcccCc--------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence            0000         00000000000                    001237889999999999999999999999999999


Q ss_pred             ccccc
Q 014762          412 ISPIF  416 (419)
Q Consensus       412 f~~~~  416 (419)
                      |+...
T Consensus       299 ~~~~~  303 (316)
T 2ac3_A          299 VQGCA  303 (316)
T ss_dssp             CC---
T ss_pred             hcCCC
Confidence            98753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.8e-47  Score=354.09  Aligned_cols=250  Identities=25%  Similarity=0.447  Sum_probs=206.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|+||+||+|.+..++..||+|++...      ....+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   83 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDA--TR   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecC--CE
Confidence            357899999999999999999999999999999998532      245688999999999 899999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++||||++++++...+   ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||++......
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT-SCEEECSCCEESCC---
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC-CCEEEEeccccccCCcc
Confidence            88999999999998776   568999999999999999999999999999999999999988 88999999998654332


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||. +.+..+....+....             .  
T Consensus       163 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~-------------~--  224 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRVE-------------F--  224 (279)
T ss_dssp             ------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTC-------------C--
T ss_pred             -cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCC-CCcHHHHHHHHHhCC-------------C--
Confidence             2344578999999999877 788999999999999999999999983 222222222222110             0  


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                            ..+..+++++.+||.+||+.||++|||+.|+++||||++..
T Consensus       225 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          225 ----------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             ----------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence                                  01123688999999999999999999999999999998754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-46  Score=349.13  Aligned_cols=254  Identities=24%  Similarity=0.368  Sum_probs=209.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++..    ..+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   82 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREG--NIQYL   82 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcC--CEEEE
Confidence            35799999999999999999999999999999998633    246788999999999 999999999999654  67889


Q ss_pred             EEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC--
Q 014762          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~--  274 (419)
                      ||||+++++|..++.   .+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++.......  
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTEE
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC-CCEEEeeCCCccccCCCcch
Confidence            999999999988874   48999999999999999999999999999999999999988 789999999997654322  


Q ss_pred             -cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       275 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       ......++..|+|||++.+...++.++|||||||++|+|++|..||............+.....               
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------  226 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------  226 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT---------------
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc---------------
Confidence             1234578899999999877444578999999999999999999999544433332222211000               


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                 ...         ....+++++.+||.+||+.||++|||++|+++||||++..
T Consensus       227 -----------~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          227 -----------YLN---------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             -----------TST---------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -----------ccC---------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence                       000         0123788999999999999999999999999999998653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.7e-46  Score=356.62  Aligned_cols=281  Identities=28%  Similarity=0.515  Sum_probs=221.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-CCCcEEEEEEecCcc-----hHHHHHHHHHHHHhc--CCCCeeEEEeEEEc---
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-NTNERCIIKILKPVK-----KKKIKREIKILQNLC--GGPNVVKLLDIVRD---  191 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~--~h~niv~l~~~~~~---  191 (419)
                      ..++|++.+.||+|+||+||+|.+. .+|+.||+|+++...     ...+.+|+.+++.+.  +||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3578999999999999999999985 678999999986322     346778888887764  79999999999862   


Q ss_pred             cCCCccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          192 QHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ......++||||+++ +|..++     ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+
T Consensus        89 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~-~~~kl~Dfg~  166 (326)
T 1blx_A           89 DRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGL  166 (326)
T ss_dssp             SSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCS
T ss_pred             CCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-CCEEEecCcc
Confidence            234678899999995 776665     238999999999999999999999999999999999999988 7899999999


Q ss_pred             ceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       267 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ++............++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.+....+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~  244 (326)
T 1blx_A          167 ARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWP  244 (326)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             cccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCcccCc
Confidence            987654444455678999999999987 67999999999999999999999997 4556667777888877766544332


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      ......  .   ...........     ......+++++.+||.+||+.||++|||+.|+|+||||+++..
T Consensus       245 ~~~~~~--~---~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          245 RDVALP--R---QAFHSKSAQPI-----EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             TTCSSC--G---GGSCCCCCCCG-----GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccc--h---hhhcccCcchh-----hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence            111100  0   00000001111     1122347899999999999999999999999999999998753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.9e-46  Score=351.99  Aligned_cols=252  Identities=20%  Similarity=0.365  Sum_probs=206.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc--CCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  196 (419)
                      ...|++.+.||+|+||+||+|.+..++..||+|.+...     ..+.+.+|+.+++.+ +||||+++++++...  ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCce
Confidence            55689999999999999999999999999999998632     245688999999999 899999999998653  3456


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      .++||||+++++|..++   ..+++..+..++.|++.||.|||++|  |+|+||||+|||++.+.+.+||+|||++....
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            89999999999998887   56899999999999999999999999  99999999999998544899999999997544


Q ss_pred             CCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      . .......+++.|+|||++.+  .++.++|||||||++|+|++|+.||....+.......+.....+            
T Consensus       184 ~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  248 (290)
T 1t4h_A          184 A-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------------  248 (290)
T ss_dssp             T-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------------
T ss_pred             c-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc------------
Confidence            3 33345678999999998764  59999999999999999999999984333222222221110000            


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                             .......++++.+||.+||+.||++|||+.|+|+||||++
T Consensus       249 -----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          249 -----------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             -----------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             -----------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                                   0011236789999999999999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.2e-47  Score=354.51  Aligned_cols=253  Identities=21%  Similarity=0.343  Sum_probs=190.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch----HHHH-HHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIK-REIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~-~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|+++....    .... ++...++.+ +||||+++++++.+.  ...
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~--~~~   81 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFRE--GDV   81 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SSE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeecc--CCE
Confidence            36789999999999999999999999999999999964321    2233 344445556 999999999999654  678


Q ss_pred             EEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          198 SLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      ++||||+++ ++..++       ..+++..+..++.|++.||+|||++ ||+||||||+|||++.+ +.+||+|||+++.
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~  159 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT-CCEEBCCC-----
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecCCccc
Confidence            999999986 554433       4699999999999999999999998 99999999999999988 7899999999987


Q ss_pred             ccCCCcceeecccccccccccc---cCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          270 YHPGKEYNVRVASRYFKGPELL---VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ...........+|+.|+|||++   .....++.++|||||||++|+|++|+.||.........+.........       
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------  232 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-------  232 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC-------
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC-------
Confidence            7655555556899999999997   233678999999999999999999999995434433333333221000       


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                                  ......+++++.+|+.+||+.||++|||+.|+++||||+..
T Consensus       233 ----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          233 ----------------------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             ----------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ----------------------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence                                        00112378899999999999999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-46  Score=392.24  Aligned_cols=250  Identities=23%  Similarity=0.365  Sum_probs=213.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++++.||+|+||+||+|.+..+++.||||+++..      ..+.+.+|..++..+.+||||+++++++.+  ...+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~~  417 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRL  417 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCEE
Confidence            57899999999999999999999999999999998642      335678899999988789999999999954  4778


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc-CC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~-~~  273 (419)
                      ++||||+++++|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++... ..
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS-SCEEECCCTTCEECCCTT
T ss_pred             EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC-CcEEEeecceeeccccCC
Confidence            9999999999998877   569999999999999999999999999999999999999988 899999999998643 23


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+.+..+.+.             ..  
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~-------------~~--  559 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH-------------NV--  559 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHSS-------------CC--
T ss_pred             cccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCC-CCCHHHHHHHHHhC-------------CC--
Confidence            34455789999999999977 789999999999999999999999984 34444444433320             00  


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH-----HHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA-----REAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta-----~elL~hp~f~~~  415 (419)
                                            ..+..+++++.+||++||+.||++|+++     +|+++||||+.+
T Consensus       560 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          560 ----------------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             ----------------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence                                  0112378999999999999999999997     999999999976

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-46  Score=379.81  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=210.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|+++..      ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~--~~  259 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETK--TD  259 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--SE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeC--CE
Confidence            467899999999999999999999999999999999642      235688999999999 999999999999654  67


Q ss_pred             cEEEEEecCCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          197 PSLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      .++||||+++++|..++.       .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~-g~vkL~DFGla~~  338 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAVE  338 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC-CCEEEeecceeee
Confidence            899999999999987752       48999999999999999999999999999999999999988 8999999999987


Q ss_pred             ccCCCcc-eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHH-HHHHHHcCCchHHHH
Q 014762          270 YHPGKEY-NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQL-VKIAKVLGTDELNAY  345 (419)
Q Consensus       270 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--~~~~~-~~i~~~lg~~~~~~~  345 (419)
                      ....... ...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....  ....+ ..+...         
T Consensus       339 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~---------  408 (543)
T 3c4z_A          339 LKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ---------  408 (543)
T ss_dssp             CCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC---------
T ss_pred             ccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc---------
Confidence            6554433 34589999999999987 7899999999999999999999999954322  11111 111110         


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                          ..                        ..+..+++++.+||++||+.||++||+     ++++++||||+++
T Consensus       409 ----~~------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          409 ----AV------------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             ----CC------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             ----cc------------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence                00                        001237899999999999999999995     5899999999976

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.6e-46  Score=355.75  Aligned_cols=285  Identities=23%  Similarity=0.448  Sum_probs=217.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEE-cCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCC------CeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGIN-VNTNERCIIKILKPVK--KKKIKREIKILQNLCGGP------NVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~-~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~------niv~l~~~~~~~~~  194 (419)
                      .++|++.+.||+|+||+||+|.+ ..+++.||+|+++...  .+.+.+|+.+++.+ +|+      +++++++++...  
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~~--   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEHH--   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEET--
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccccC--
Confidence            67999999999999999999998 5688999999997543  36788999999988 444      599999999654  


Q ss_pred             CccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--------------
Q 014762          195 KTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--------------  255 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--------------  255 (419)
                      ...++||||+ ++++..++     ..+++..+..++.|++.||+|||++||+||||||+|||++.+              
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            6789999999 66666655     247899999999999999999999999999999999999863              


Q ss_pred             ----CCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014762          256 ----LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (419)
Q Consensus       256 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~  331 (419)
                          .+.+||+|||+++....  ......+|..|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+...
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~  244 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVF-PTHDSKEHLA  244 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSC-CCSCHHHHHH
T ss_pred             ccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCC-CCCChHHHHH
Confidence                25799999999987543  2334578999999999987 78999999999999999999999998 4556666777


Q ss_pred             HHHHHcCCchHHHHHhhcCC--------CCChh--hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC
Q 014762          332 KIAKVLGTDELNAYLNKYHL--------ELDPQ--LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL  401 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  401 (419)
                      .+.+..+..+..........        .+...  ........ ........  ......++++.+||.+||+.||++||
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA-CKPLKEFM--LSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH-CCCGGGGC--SCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhc-Ccchhhhc--ccchhhHHHHHHHHHHHhCcCccccc
Confidence            77777776554433221100        00000  00000000 00011100  01122467899999999999999999


Q ss_pred             CHHHHhcCCCcccccccC
Q 014762          402 TAREAMVISSISPIFSLV  419 (419)
Q Consensus       402 ta~elL~hp~f~~~~~~~  419 (419)
                      |+.|+++||||+.+++.+
T Consensus       322 t~~ell~hp~f~~~~~~~  339 (339)
T 1z57_A          322 TLREALKHPFFDLLKKSI  339 (339)
T ss_dssp             CHHHHTTSGGGGGGGC--
T ss_pred             CHHHHhcCHHHHHHhccC
Confidence            999999999999997643

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=354.98  Aligned_cols=283  Identities=28%  Similarity=0.487  Sum_probs=213.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEcc--------
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQ--------  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--------  192 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....   .+.+.+|+.+++.+ +||||+++++++...        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccc
Confidence            678999999999999999999999999999999986443   35688999999999 999999999998432        


Q ss_pred             ----CCCccEEEEEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          193 ----HSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       193 ----~~~~~~lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                          .....++||||+++ +|..++.  .+++..++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+
T Consensus        89 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~  167 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL  167 (320)
T ss_dssp             --CCSCSEEEEEEECCSE-EHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ccccccCceeEEeeccCC-CHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence                23567899999984 7777764  5899999999999999999999999999999999999986557899999999


Q ss_pred             ceeccCCC----cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchH
Q 014762          267 AEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDEL  342 (419)
Q Consensus       267 a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~  342 (419)
                      ++......    ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~  246 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF-AGAHELEQMQLILESIPVVHE  246 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHSCCCCH
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCch
Confidence            98654321    2233467888999999876577999999999999999999999998 445556666666666555433


Q ss_pred             HHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          343 NAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ........ ......... ......++..     ....+++++.+||.+||+.||++|||++|+|+||||+.+.
T Consensus       247 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          247 EDRQELLS-VIPVYIRND-MTEPHKPLTQ-----LLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHHHHHHT-TSCHHHHHH-TTSCCCCHHH-----HSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             hhhhhhhh-cCccccccc-ccCCCCChhH-----hcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            32211110 011111100 0011111111     1124789999999999999999999999999999999764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=349.66  Aligned_cols=250  Identities=22%  Similarity=0.440  Sum_probs=186.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++...      ..+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   86 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDS--NYV   86 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECS--SEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccC--CeE
Confidence            46799999999999999999999999999999998643      236788999999999 899999999999654  678


Q ss_pred             EEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++||||+++++|..++    ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT-CCEEECCCTTCEECC--
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEEeecceeeccCC
Confidence            9999999999998876    348999999999999999999999999999999999999988 78999999999876432


Q ss_pred             C-cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          274 K-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       274 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      . ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .+.+..+.                  
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~------------------  225 (278)
T 3cok_A          166 HEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTV-KNTLNKVV------------------  225 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC-C-----CC------------------
T ss_pred             CCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhH-HHHHHHHh------------------
Confidence            2 2234578899999999876 6789999999999999999999999843221 11111000                  


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                   ..      ....+..++.++.+||.+||+.||++|||++++++||||+...
T Consensus       226 -------------~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          226 -------------LA------DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             -------------SS------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             -------------hc------ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence                         00      0011223788999999999999999999999999999998654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.8e-46  Score=348.09  Aligned_cols=250  Identities=23%  Similarity=0.376  Sum_probs=200.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++...      ..+.+.+|+.+++.+ +||||+++++++...  ...
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~   86 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTP--TDF   86 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC--CeE
Confidence            57899999999999999999999999999999998643      235788999999999 899999999999654  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||+++++|.+++   ..+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC--
T ss_pred             EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC-CCEEEeecccccccCCCc
Confidence            9999999999998876   468999999999999999999999999999999999999988 789999999998766554


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|+|||.+.+....+.++||||||+++|+|++|..||.. .+..+....+...             ..   
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~-------------~~---  228 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGG-------------VF---  228 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC-------------CC---
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcC-------------cc---
Confidence            445567899999999988733346899999999999999999999842 2222222221110             00   


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                           ..+..+++++.+++.+||+.||++|||+.|+++||||++.
T Consensus       229 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          229 ---------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ---------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence                                 0012368899999999999999999999999999999854

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2e-46  Score=353.63  Aligned_cols=265  Identities=26%  Similarity=0.397  Sum_probs=209.7

Q ss_pred             CCCceeccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEE
Q 014762          114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVR  190 (419)
Q Consensus       114 ~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~  190 (419)
                      |+.........++|++.+.||+|+||+||+|.+..+++.||+|++...   ..+.+.+|+.+++.+ +||||+++++++.
T Consensus         8 ~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~   86 (302)
T 2j7t_A            8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYY   86 (302)
T ss_dssp             --CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred             hcccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeee
Confidence            344444555678999999999999999999999999999999998643   346788999999999 9999999999996


Q ss_pred             ccCCCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          191 DQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       191 ~~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ..  ...++||||++++++..++    ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||+
T Consensus        87 ~~--~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~  163 (302)
T 2j7t_A           87 HD--GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLADFGV  163 (302)
T ss_dssp             CC---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-SCEEECCCHH
T ss_pred             eC--CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC-CCEEEEECCC
Confidence            54  6789999999999998765    469999999999999999999999999999999999999988 7899999998


Q ss_pred             ceeccCC-Ccceeeccccccccccccc----CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCch
Q 014762          267 AEFYHPG-KEYNVRVASRYFKGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (419)
Q Consensus       267 a~~~~~~-~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~  341 (419)
                      +...... .......++..|+|||++.    ....++.++|||||||++|+|++|..||. ..+..+....+......  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~--  240 (302)
T 2j7t_A          164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSDPP--  240 (302)
T ss_dssp             HHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCC--
T ss_pred             CccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc-cCCHHHHHHHHhccCCc--
Confidence            7543211 1123357889999999984    23678999999999999999999999984 22222222222211000  


Q ss_pred             HHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                                      .......++.++.+||.+||+.||++|||+.++++||||+.+.+
T Consensus       241 --------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          241 --------------------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             --------------------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             --------------------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence                                            00011236889999999999999999999999999999998753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.7e-46  Score=350.00  Aligned_cols=254  Identities=23%  Similarity=0.400  Sum_probs=211.4

Q ss_pred             eccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          119 VQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       119 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      +.....++|++.+.||+|+||+||+|.+..+++.+|+|++...      ..+.+.+|+.+++.+ +||||+++++++.+.
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~   87 (294)
T 2rku_A            9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDN   87 (294)
T ss_dssp             EETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred             eCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccC
Confidence            3445578899999999999999999999999999999998643      245688999999999 999999999999654


Q ss_pred             CCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          193 HSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                        ...++||||++++++..++   ..+++..+..++.|++.||+|||++|++|+||||+|||++.+ +.+||+|||++..
T Consensus        88 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~  164 (294)
T 2rku_A           88 --DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATK  164 (294)
T ss_dssp             --SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred             --CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-CCEEEEeccCcee
Confidence              6789999999999998876   468999999999999999999999999999999999999988 7899999999987


Q ss_pred             ccCC-CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          270 YHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       270 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      .... .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.. ....+....+..             
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~-------------  229 (294)
T 2rku_A          165 VEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKK-------------  229 (294)
T ss_dssp             CCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHT-------------
T ss_pred             cccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhh-------------
Confidence            6532 23344678999999999876 6789999999999999999999999842 222222211110             


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      ...                        ..+..+++++.+++.+||+.||++|||++|+++||||+..
T Consensus       230 ~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          230 NEY------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             TCC------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             ccC------------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence            000                        0112368899999999999999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.8e-46  Score=353.32  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=207.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|+++..   ..+.+.+|+.+++.+ +||||+++++++.+.  ...++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv   84 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYEST--THYYLV   84 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECS--SEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccC--CEEEEE
Confidence            46799999999999999999999999999999998743   345688999999999 999999999999654  678999


Q ss_pred             EEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE---cCCCCcEEEEecccceeccCCC
Q 014762          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl---~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      |||+++++|..++   ..+++..+..++.|++.||+|||++||+|+||||+||++   +.+ +.+||+|||+++.... .
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~-~  162 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEEN-SKIMITDFGLSKMEQN-G  162 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCCCCC-B
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCC-CCEEEccCCcceecCC-C
Confidence            9999999998775   568999999999999999999999999999999999999   444 7899999999976443 2


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......++..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+.+...             .. 
T Consensus       163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~-------------~~-  226 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYY-------------EF-  226 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCC-------------CC-
T ss_pred             ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC-------------CC-
Confidence            2344578999999999877 7899999999999999999999999842 232323333222100             00 


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                         .......+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus       227 -------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          227 -------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             -------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             -------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                               001112378999999999999999999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.8e-46  Score=356.81  Aligned_cols=253  Identities=23%  Similarity=0.396  Sum_probs=211.7

Q ss_pred             ccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          120 QWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       120 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      .....++|.+.+.||+|+||+||+|.+..+++.+|+|++...      ..+.+.+|+.+++.+ +||||+++++++.+. 
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-  113 (335)
T 2owb_A           36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDN-  113 (335)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECS-
T ss_pred             CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-
Confidence            344578899999999999999999999999999999998643      346788999999999 999999999999654 


Q ss_pred             CCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                       ...++||||+++++|..++   ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++..
T Consensus       114 -~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          114 -DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKV  191 (335)
T ss_dssp             -SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred             -CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-CCEEEeeccCceec
Confidence             6789999999999998876   468999999999999999999999999999999999999988 78999999999876


Q ss_pred             cCC-CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          271 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       271 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.. ....+....+...             
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~-------------  256 (335)
T 2owb_A          192 EYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKN-------------  256 (335)
T ss_dssp             CSTTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHT-------------
T ss_pred             ccCcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcC-------------
Confidence            533 23344678999999999987 6789999999999999999999999842 2222222221110             


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      ..                        .....+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       257 ~~------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          257 EY------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             CC------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             CC------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            00                        0012368899999999999999999999999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.4e-46  Score=348.49  Aligned_cols=250  Identities=23%  Similarity=0.432  Sum_probs=209.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...      ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~   88 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDR--KR   88 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcC--CE
Confidence            357899999999999999999999999999999998532      246788999999999 899999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++||||+++++|..++   ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++......
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-GELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-CCEEECCCTTCEECSSS
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC-CCEEEecccccccCccc
Confidence            89999999999998776   468999999999999999999999999999999999999988 78999999998765432


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       ......++..|+|||++.+ ..++.++||||||+++|+|++|..||.. .+..+....+...             ..  
T Consensus       168 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~-------------~~--  229 (284)
T 2vgo_A          168 -RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVNV-------------DL--  229 (284)
T ss_dssp             -CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTT-------------CC--
T ss_pred             -ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhcc-------------cc--
Confidence             2344578999999999887 6789999999999999999999999842 2222222221110             00  


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                            ..+..+++++.+||.+||+.||++|||++++++||||+...
T Consensus       230 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          230 ----------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             ----------------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                                  01123688999999999999999999999999999998653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.5e-46  Score=357.60  Aligned_cols=249  Identities=27%  Similarity=0.383  Sum_probs=203.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++....      .+.+.+|+.+++++ +||||+++++++.+.  ...
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~  129 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTA  129 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--CeE
Confidence            356999999999999999999999999999999986321      25688999999999 899999999999664  678


Q ss_pred             EEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++||||+.++ +...+    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus       130 ~lv~e~~~g~-l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          130 WLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EEEEECCSEE-HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSSB
T ss_pred             EEEEecCCCC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEeeccCceecCCC
Confidence            8999999864 44333    569999999999999999999999999999999999999988 89999999999765432


Q ss_pred             CcceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          274 KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                         ....||+.|+|||++.+  ...++.++|||||||++|||++|+.||.. .+..+.+..+.....+            
T Consensus       208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~-~~~~~~~~~~~~~~~~------------  271 (348)
T 1u5q_A          208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESP------------  271 (348)
T ss_dssp             ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCC------------
T ss_pred             ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCC------------
Confidence               34578999999999852  36789999999999999999999999843 2222222222211000            


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                             ......+++.+.+||.+||+.||++|||++++++||||...+
T Consensus       272 -----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          272 -----------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence                                   000123688999999999999999999999999999997653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1e-45  Score=345.76  Aligned_cols=248  Identities=19%  Similarity=0.231  Sum_probs=201.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++..     ....+.+|+..+..+.+||||+++++++.+.  ...+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~~~   87 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DHML   87 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--CeEE
Confidence            56899999999999999999999999999999998642     3456788999999987899999999999654  6789


Q ss_pred             EEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC----------------
Q 014762          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----------------  255 (419)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~----------------  255 (419)
                      +||||+++++|..++       ..+++..+..++.|++.||+|||++||+||||||+|||++.+                
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999998876       448999999999999999999999999999999999999843                


Q ss_pred             --CCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 014762          256 --LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI  333 (419)
Q Consensus       256 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i  333 (419)
                        ...+||+|||.+.......   ...+|..|+|||++.+...++.++|||||||++|+|++|..++...    +....+
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~  240 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEI  240 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHH
T ss_pred             CCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHH
Confidence              2478999999998765432   3468999999999987446778999999999999999998766321    111111


Q ss_pred             HHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       334 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                      .+             ...                       ...+..+++++.+|+.+||+.||++|||+.|+++||||+
T Consensus       241 ~~-------------~~~-----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  284 (289)
T 1x8b_A          241 RQ-------------GRL-----------------------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL  284 (289)
T ss_dssp             HT-------------TCC-----------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred             Hc-------------CCC-----------------------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence            11             000                       001123789999999999999999999999999999998


Q ss_pred             ccc
Q 014762          414 PIF  416 (419)
Q Consensus       414 ~~~  416 (419)
                      +..
T Consensus       285 ~~~  287 (289)
T 1x8b_A          285 SAS  287 (289)
T ss_dssp             ---
T ss_pred             hhc
Confidence            754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-45  Score=354.85  Aligned_cols=283  Identities=24%  Similarity=0.439  Sum_probs=215.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCC-cEEEEEEecCc--chHHHHHHHHHHHHhcCCCC------eeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-ERCIIKILKPV--KKKKIKREIKILQNLCGGPN------VVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~n------iv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.+..++ +.||+|+++..  ..+.+.+|+.+++.+ .|++      ++.+++++... 
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~-   94 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNFH-   94 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEET-
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeeeC-
Confidence            3689999999999999999999998777 78999999753  346788899999998 5554      89999998654 


Q ss_pred             CCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE-----------------
Q 014762          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI-----------------  252 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl-----------------  252 (419)
                       ...++||||++++++..+.    ..+++..+..++.|++.||+|||++||+||||||+|||+                 
T Consensus        95 -~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           95 -GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             -TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             -CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence             6789999999766655443    358999999999999999999999999999999999999                 


Q ss_pred             --cCCCCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 014762          253 --DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (419)
Q Consensus       253 --~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~  330 (419)
                        +.+ +.+||+|||+++....  ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+
T Consensus       174 ~~~~~-~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~  248 (355)
T 2eu9_A          174 KSVKN-TSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLF-QTHENREHL  248 (355)
T ss_dssp             EEESC-CCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHH
T ss_pred             cccCC-CcEEEeecCccccccc--cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHH
Confidence              334 7899999999987543  2344578999999999987 78999999999999999999999998 455666777


Q ss_pred             HHHHHHcCCchHHHHHhhcCC--------CCChhh--HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCC
Q 014762          331 VKIAKVLGTDELNAYLNKYHL--------ELDPQL--DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR  400 (419)
Q Consensus       331 ~~i~~~lg~~~~~~~~~~~~~--------~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  400 (419)
                      ..+.+..+..+..........        .+....  ....... ..++....  ......+.++.+||.+||+.||++|
T Consensus       249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKEN-CKPLKSYM--LQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH-CCCGGGGC--SCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcccccc-CCcccccc--cccchhHHHHHHHHHHHhcCChhhC
Confidence            778888877655433221100        000000  0000000 00000000  0011235678999999999999999


Q ss_pred             CCHHHHhcCCCccccc
Q 014762          401 LTAREAMVISSISPIF  416 (419)
Q Consensus       401 pta~elL~hp~f~~~~  416 (419)
                      ||+.|+|+||||+.+.
T Consensus       326 pt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          326 ITLAEALLHPFFAGLT  341 (355)
T ss_dssp             CCHHHHTTSGGGGGCC
T ss_pred             cCHHHHhcChhhcCCC
Confidence            9999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.7e-46  Score=364.96  Aligned_cols=261  Identities=16%  Similarity=0.175  Sum_probs=190.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhc-CCCCeeEEE-------eEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLC-GGPNVVKLL-------DIV  189 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~-~h~niv~l~-------~~~  189 (419)
                      ..+|++.+.||+|+||+||+|.+..+|+.||+|++....      .+.+.+|+.+++.+. +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345999999999999999999999999999999997532      356778877777774 499988755       555


Q ss_pred             EccCC---------------CccEEEEEecCCCChhhhcC----CCCHHHH------HHHHHHHHHHHHHHHHCCcEeec
Q 014762          190 RDQHS---------------KTPSLIFEYVNSTDFKVLYP----TLTDYDI------RYYIYELLKALDYCHSQGIMHRD  244 (419)
Q Consensus       190 ~~~~~---------------~~~~lv~e~~~~~~l~~~~~----~l~~~~~------~~~~~qi~~~L~~LH~~~ivH~D  244 (419)
                      ..+..               ...++||||++ ++|..++.    .+.+...      ..++.|++.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            43322               33799999999 78888763    3444444      56779999999999999999999


Q ss_pred             CCCCceEEcCCCCcEEEEecccceeccCCCcceeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 014762          245 VKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYG  323 (419)
Q Consensus       245 lk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~  323 (419)
                      |||+|||++.+ +.+||+|||+++....  ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||...
T Consensus       220 ikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          220 FTPDNLFIMPD-GRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             CSGGGEEECTT-SCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CCHHHEEECCC-CCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            99999999988 8899999999987642  22245677999999998642 46899999999999999999999999432


Q ss_pred             CCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH
Q 014762          324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA  403 (419)
Q Consensus       324 ~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta  403 (419)
                      .....                          ..+.   ...................+++++.+||.+||+.||++|||+
T Consensus       297 ~~~~~--------------------------~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  347 (371)
T 3q60_A          297 TPGIK--------------------------GSWK---RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP  347 (371)
T ss_dssp             CTTCT--------------------------TCCC---BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH
T ss_pred             Ccccc--------------------------cchh---hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence            11100                          0000   000000000001111123579999999999999999999999


Q ss_pred             HHHhcCCCcccccc
Q 014762          404 REAMVISSISPIFS  417 (419)
Q Consensus       404 ~elL~hp~f~~~~~  417 (419)
                      .++|+||||+++..
T Consensus       348 ~e~l~hp~f~~~~~  361 (371)
T 3q60_A          348 LEAMETPEFLQLQN  361 (371)
T ss_dssp             HHHTTSHHHHHHHH
T ss_pred             HHHhcCHHHHHHHH
Confidence            99999999998753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-46  Score=357.15  Aligned_cols=254  Identities=22%  Similarity=0.349  Sum_probs=202.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC--
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK--  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~--  195 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++...      ...+.+|+.+++.+ +||||+++++++......  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCc
Confidence            678999999999999999999999999999999996432      24678999999999 999999999998754322  


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ..++||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-SCEEECCCSCC-----
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC-CCEEEeeccCcccccc
Confidence            458999999999998886   469999999999999999999999999999999999999988 7899999999976543


Q ss_pred             CCc----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          273 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       273 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ...    .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+...........+...     
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~-----  241 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPPSA-----  241 (311)
T ss_dssp             -------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHCCCCCHHH-----
T ss_pred             cccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhcCCCCCccc-----
Confidence            322    223468999999999987 789999999999999999999999983 333333333322211111100     


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                                  ....+++++.+||.+||+.||++||++.++|.|+|++.
T Consensus       242 ----------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          242 ----------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             ----------------------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ----------------------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                                        01237899999999999999999999999999999874

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-46  Score=364.30  Aligned_cols=280  Identities=21%  Similarity=0.291  Sum_probs=210.6

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ....++|++.+.||+|+||+||+|.+..+++.||+|++...    ..+.+.+|+.+++.+ +||||+++++++.+.  ..
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~  105 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GE  105 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEET--TE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEEC--CE
Confidence            34477899999999999999999999999999999998643    235688999999999 999999999999764  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++++|..++   ..+++..+..++.|++.||+|||+. ||+||||||+|||++.+ +.+||+|||++.....
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID  184 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHH
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC-CCEEEEECCCCccccc
Confidence            89999999999998886   4689999999999999999999996 99999999999999988 7899999999865432


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH--cCCchHHHHH-hhc
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV--LGTDELNAYL-NKY  349 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~--lg~~~~~~~~-~~~  349 (419)
                      . ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||...  +.+....+...  .+........ ...
T Consensus       185 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          185 S-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPP--DAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             H-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCC--CHHHHHHHHC-----------------
T ss_pred             c-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHhcccccccCCCCCCCcccC
Confidence            2 2234578999999999987 78999999999999999999999999532  23333222211  1110000000 000


Q ss_pred             C-------CCC------ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          350 H-------LEL------DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       350 ~-------~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      .       ...      ...........        ........+++++.+||.+||++||++|||++|+|+||||+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEP--------PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSC--------CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccC--------CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence            0       000      00000000000        00111234788999999999999999999999999999998753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=350.51  Aligned_cols=256  Identities=23%  Similarity=0.385  Sum_probs=204.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC--cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccC----CCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH----SKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~----~~~  196 (419)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|++..  ...+.+.+|+.+++++.+||||+++++++....    ...
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            47899999999999999999999999999999999864  345788999999999978999999999997643    467


Q ss_pred             cEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          197 PSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      .++||||+++++|..++     ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+|||++....
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCTTTC---
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC-CCEEEeeCcCceecC
Confidence            89999999999998876     358999999999999999999999999999999999999987 789999999987654


Q ss_pred             CCC-cceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          272 PGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       272 ~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ... ......++..|+|||++..    ...++.++|||||||++|+|++|..||.. .+..+....+... ..       
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~-~~-------  251 (326)
T 2x7f_A          181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRN-PA-------  251 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHS-CC-------
T ss_pred             cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcC-cc-------
Confidence            322 2234578999999999862    25689999999999999999999999832 2222222211110 00       


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                                 .......+++.+.+||.+||..||++|||+.++++||||++.
T Consensus       252 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          252 ---------------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             ---------------------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ---------------------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                                       000112368899999999999999999999999999999865

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.1e-46  Score=348.64  Aligned_cols=255  Identities=24%  Similarity=0.476  Sum_probs=210.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++..     ...+.+.+|+.+++++ +||||+++++++.+.  ...+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   97 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDS--SSFY   97 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCC--CeEE
Confidence            4689999999999999999999999999999999853     2356788999999999 999999999999654  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC--CcEEEEecccceeccCC
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~--~~~kl~Dfgla~~~~~~  273 (419)
                      +||||+.++++...+   ..+++..+..++.|++.||.|||++|++|+||||+||+++.+.  ..+||+|||++......
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            999999999987765   5799999999999999999999999999999999999997652  36999999999876655


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......++..|+|||.+.+  .++.++||||||+++|+|++|..||.. .+..+....+.+.             ....
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~-------------~~~~  241 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETG-------------KYAF  241 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC-------------CCCC
T ss_pred             CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcC-------------CCCC
Confidence            54455678899999999865  589999999999999999999999843 3322222222210             0000


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                                          .......+++++.+||.+||+.||++|||+.|+|+||||+...+
T Consensus       242 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          242 --------------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             --------------------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             --------------------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                                00011237899999999999999999999999999999987653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-46  Score=360.05  Aligned_cols=255  Identities=23%  Similarity=0.407  Sum_probs=205.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      .++|++.+.||+|+||+||+|++.   .+++.||||+++..       ..+.+.+|+.++.++.+||||+++++++... 
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-  131 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  131 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence            578999999999999999999884   58999999998642       2356778999999997799999999999654 


Q ss_pred             CCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                       ...++||||+++++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus       132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          132 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEF  209 (355)
T ss_dssp             -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred             -ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CcEEEeeCCCCeec
Confidence             6788999999999998876   469999999999999999999999999999999999999988 78999999999865


Q ss_pred             cCCCc--ceeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          271 HPGKE--YNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       271 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      .....  .....||..|+|||++.+. ..++.++|||||||++|+|++|+.||......... ..+....         .
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~---------~  279 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRI---------L  279 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHH---------H
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHHH---------h
Confidence            43222  2335789999999998752 45789999999999999999999999543222111 1111100         0


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                      ...                        ......+++.+.+||.+||+.||++||     |+.|+++||||+.+
T Consensus       280 ~~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          280 KSE------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             HCC------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             ccC------------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            000                        001123788999999999999999999     99999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.1e-47  Score=374.17  Aligned_cols=246  Identities=17%  Similarity=0.240  Sum_probs=195.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhc--CCCCeeEEE-------eE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLC--GGPNVVKLL-------DI  188 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~--~h~niv~l~-------~~  188 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...      ..+.+.+|+.+++.+.  +||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            57899999999999999999999899999999998532      2467889995544442  799999998       66


Q ss_pred             EEccCC----------C-----ccEEEEEecCCCChhhhcC---CCCH-------HHHHHHHHHHHHHHHHHHHCCcEee
Q 014762          189 VRDQHS----------K-----TPSLIFEYVNSTDFKVLYP---TLTD-------YDIRYYIYELLKALDYCHSQGIMHR  243 (419)
Q Consensus       189 ~~~~~~----------~-----~~~lv~e~~~~~~l~~~~~---~l~~-------~~~~~~~~qi~~~L~~LH~~~ivH~  243 (419)
                      +.+.+.          .     ..++||||+ +|+|..++.   .+++       ..+..++.|++.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            654321          1     378999999 578887763   3444       7778899999999999999999999


Q ss_pred             cCCCCceEEcCCCCcEEEEecccceeccCCCcceeecccccccccccccCCC-----------CCCccccHHHHHHHHHH
Q 014762          244 DVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ-----------DYDYSLDMWSLGCMFAG  312 (419)
Q Consensus       244 Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~~DiwSlG~~l~e  312 (419)
                      ||||+|||++.+ +.+||+|||+++...  .......| ..|+|||++.+ .           .++.++|||||||++|+
T Consensus       231 Dikp~NIll~~~-~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~-~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          231 YLRPVDIVLDQR-GGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEAR-RATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCCGGGEEECTT-CCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHH-HTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCC-CCEEEEechhheecC--CcccCCCC-cCccChhhhcc-cccccccccccccCChhhhHHHHHHHHHH
Confidence            999999999988 899999999998643  23344566 99999999987 4           79999999999999999


Q ss_pred             HHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHh
Q 014762          313 MIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKL  392 (419)
Q Consensus       313 ll~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  392 (419)
                      |++|+.||.... ..+..                           .            ...  .....+++++.+||.+|
T Consensus       306 lltg~~Pf~~~~-~~~~~---------------------------~------------~~~--~~~~~~~~~~~~li~~~  343 (377)
T 3byv_A          306 IWCADLPITKDA-ALGGS---------------------------E------------WIF--RSCKNIPQPVRALLEGF  343 (377)
T ss_dssp             HHHSSCCC-------CCS---------------------------G------------GGG--SSCCCCCHHHHHHHHHH
T ss_pred             HHHCCCCCcccc-cccch---------------------------h------------hhh--hhccCCCHHHHHHHHHH
Confidence            999999983211 00000                           0            000  00124789999999999


Q ss_pred             cCCCCCCCCCHHHHhcCCCcccccc
Q 014762          393 LRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       393 L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      |+.||++|||+.|+++||||+++++
T Consensus       344 L~~dp~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          344 LRYPKEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             TCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred             cCCCchhCCCHHHHhhChHHHHHHH
Confidence            9999999999999999999998764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.9e-46  Score=355.78  Aligned_cols=250  Identities=23%  Similarity=0.413  Sum_probs=195.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCC--CCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|++...     ..+.+.+|+.++..+ +|  |||+++++++...  .
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~~~iv~~~~~~~~~--~   82 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIRLYDYEITD--Q   82 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHH-TTTCTTBCCEEEEEECS--S
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhh-hhcCCceEEEeeeEeeC--C
Confidence            467899999999999999999987 56889999998632     235688999999999 55  9999999999654  6


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ..++||| +.+++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.  +.+||+|||+++....
T Consensus        83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~--~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCCC--
T ss_pred             EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC--CcEEEeecccccccCc
Confidence            7899999 5667777776   46899999999999999999999999999999999999974  6799999999987654


Q ss_pred             CCc---ceeecccccccccccccC----------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCC
Q 014762          273 GKE---YNVRVASRYFKGPELLVD----------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (419)
Q Consensus       273 ~~~---~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~  339 (419)
                      ...   .....||+.|+|||++.+          ...++.++|||||||++|+|++|+.||....+....+..+.   ..
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~  236 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DP  236 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CT
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh---cC
Confidence            332   234579999999999853          25688999999999999999999999943222222221111   10


Q ss_pred             chHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      .                        .        ....+...++++.+|+.+||+.||++|||+.|+|+||||+.
T Consensus       237 ~------------------------~--------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  279 (343)
T 3dbq_A          237 N------------------------H--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  279 (343)
T ss_dssp             T------------------------S--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred             C------------------------c--------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence            0                        0        00011225778999999999999999999999999999974

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-45  Score=361.28  Aligned_cols=251  Identities=23%  Similarity=0.410  Sum_probs=197.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcC-CCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~~  197 (419)
                      ..+|++.+.||+|+||+||+|.+.. ++.||||++...     ..+.+.+|+.++.++.. ||||+++++++...  ...
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--~~~  131 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QYI  131 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS--SEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC--CEE
Confidence            4569999999999999999998754 899999998642     23668899999999943 69999999999654  668


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||| +.+++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.  +.+||+|||+++......
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~--~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS--SCEEECCCSSSCCC----
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC--CeEEEEecCccccccCCC
Confidence            99999 5677887775   46899999999999999999999999999999999999964  679999999998765433


Q ss_pred             c---ceeecccccccccccccCC----------CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCch
Q 014762          275 E---YNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (419)
Q Consensus       275 ~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~  341 (419)
                      .   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|+.||....+....+..+.   ... 
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~---~~~-  284 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPN-  284 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH---CTT-
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh---Ccc-
Confidence            2   2345799999999998641          3689999999999999999999999953322222222211   100 


Q ss_pred             HHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                             ..        ...+...++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       285 -----------------------~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          285 -----------------------HE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             -----------------------SC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             -----------------------cc--------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence                                   00        00112247889999999999999999999999999999753

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.6e-46  Score=346.60  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=206.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|.+...     ..+.+.+|+.+++++ +||||+++++++.+......+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence            56899999999999999999999999999999998642     245688999999999 899999999998766667889


Q ss_pred             EEEEecCCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-----cEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          199 LIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~-----ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      +||||+++++|..++.       .+++..+..++.|++.||+|||+.|     |+|+||||+|||++.+ +.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg~  162 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGL  162 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCCCH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecCch
Confidence            9999999999988763       3899999999999999999999999     9999999999999988 7899999999


Q ss_pred             ceeccCCCc-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          267 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       267 a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      ++....... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+....+.+.  .      
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~--~------  232 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREG--K------  232 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHT--C------
T ss_pred             heeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcc-cCHHHHHHHHhhc--c------
Confidence            976543322 233578899999999987 6799999999999999999999999842 2222222222110  0      


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                           .                       ......+++++.+++.+||+.||++|||+.|+++|+|+.+
T Consensus       233 -----~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          233 -----F-----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             -----C-----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             -----c-----------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                 0                       0001237899999999999999999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.7e-46  Score=352.71  Aligned_cols=263  Identities=20%  Similarity=0.322  Sum_probs=188.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++...    ..+.+.+|+.+++.+ +||||+++++++...  ...+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~   89 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVK--DELW   89 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESS--SCEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeec--CCcE
Confidence            468899999999999999999999889999999998643    245678899999999 899999999999664  5688


Q ss_pred             EEEEecCCCChhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccc
Q 014762          199 LIFEYVNSTDFKVLYP-----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~-----------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla  267 (419)
                      +||||+++++|..++.           .+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~  168 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVS  168 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCCHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-CCEEEEeccch
Confidence            9999999999988763           38999999999999999999999999999999999999988 78999999998


Q ss_pred             eeccCCC------cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCch
Q 014762          268 EFYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (419)
Q Consensus       268 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~  341 (419)
                      .......      ......+|..|+|||++.+...++.++|||||||++|+|++|+.||... +..+......... .+.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~-~~~  246 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY-PPMKVLMLTLQND-PPS  246 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHTSS-CCC
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC-chhhHHHHHhccC-CCc
Confidence            7654322      1233578899999999865456899999999999999999999998432 2222221111100 000


Q ss_pred             HHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      .                          ............+++++.+|+.+||+.||++|||+.++++||||++.+.
T Consensus       247 ~--------------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          247 L--------------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             T--------------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             c--------------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            0                          0000011112347889999999999999999999999999999998753

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.8e-45  Score=346.23  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=209.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .+.|++.+.||+|+||+||+|.+..+++.||+|++...    ..+.+.+|+.+++.+ +||||+++++++.+.  ...++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~l   97 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKD--TKLWI   97 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEE
Confidence            56799999999999999999999999999999998643    347789999999999 999999999999764  67899


Q ss_pred             EEEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cc
Q 014762          200 IFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (419)
Q Consensus       200 v~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~  276 (419)
                      ||||+++++|..++.  .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++....... ..
T Consensus        98 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             EEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECBTTBCCB
T ss_pred             EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC-CCEEEeecccceecCcccccc
Confidence            999999999998874  58999999999999999999999999999999999999988 789999999998765433 22


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++|..||.. ....+....+.+. .                  
T Consensus       177 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~-~------------------  235 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKN-N------------------  235 (303)
T ss_dssp             CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHS-C------------------
T ss_pred             CccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCC-cCHHHHHHHhhcC-C------------------
Confidence            44578899999999877 7789999999999999999999999842 2222211111110 0                  


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                       .......++..+.+|+.+||+.||++|||+.++++||||...
T Consensus       236 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          236 -----------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             -----------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             -----------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                             000112378899999999999999999999999999999643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.1e-45  Score=355.66  Aligned_cols=268  Identities=22%  Similarity=0.386  Sum_probs=210.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch--------------------HHHHHHHHHHHHhcCCCCee
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--------------------KKIKREIKILQNLCGGPNVV  183 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--------------------~~~~~E~~~l~~l~~h~niv  183 (419)
                      .++|++.+.||+|+||+||+|.+  +|+.||+|++.....                    +.+.+|+.+++.+ +||||+
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~  106 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCL  106 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcc
Confidence            57899999999999999999987  899999999863211                    7899999999999 899999


Q ss_pred             EEEeEEEccCCCccEEEEEecCCCChhhh------c-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceE
Q 014762          184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVL------Y-----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVM  251 (419)
Q Consensus       184 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~------~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NIL  251 (419)
                      ++++++.+.  ...++||||+++++|..+      +     ..+++..+..++.|++.||.|||+ +||+|+||||+||+
T Consensus       107 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          107 TCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             CCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             eEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            999999664  678999999999999887      3     358999999999999999999999 99999999999999


Q ss_pred             EcCCCCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 014762          252 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY-SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL  330 (419)
Q Consensus       252 l~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~  330 (419)
                      ++.+ +.+||+|||++...... ......++..|+|||++.+...++. ++|||||||++|+|++|..||.......+..
T Consensus       185 ~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          185 MDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             ECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             EcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9988 78999999999876543 3345678999999999987436666 9999999999999999999985444434444


Q ss_pred             HHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014762          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVIS  410 (419)
Q Consensus       331 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp  410 (419)
                      ..+....             ..........     ...+...........+++++.+||.+||+.||++|||++|+++||
T Consensus       263 ~~i~~~~-------------~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp  324 (348)
T 2pml_X          263 NNIRTKN-------------IEYPLDRNHF-----LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE  324 (348)
T ss_dssp             HHHTSCC-------------CCCCCSSSSS-----TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             HHHhccC-------------cCCccchhhh-----hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            3332210             0000000000     000000000111234789999999999999999999999999999


Q ss_pred             Cccccc
Q 014762          411 SISPIF  416 (419)
Q Consensus       411 ~f~~~~  416 (419)
                      ||++..
T Consensus       325 ~f~~~~  330 (348)
T 2pml_X          325 WLADTN  330 (348)
T ss_dssp             GGTTCC
T ss_pred             cccCCC
Confidence            999764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.4e-45  Score=346.54  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=205.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|.+... ..+.+.+|+.+++.+ +||||+++++++...  ...++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFKN--TDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC--CEEEEEe
Confidence            467899999999999999999999999999999998743 457789999999999 999999999999654  6789999


Q ss_pred             EecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cc
Q 014762          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (419)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~  276 (419)
                      ||+++++|..++    ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++....... ..
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECBTTBSCB
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC-CCEEEeecccchhhhhhcccc
Confidence            999999998876    468999999999999999999999999999999999999988 789999999998765432 23


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....++..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+... ..+                
T Consensus       183 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~-~~~----------------  243 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTN-PPP----------------  243 (314)
T ss_dssp             CCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHS-CCC----------------
T ss_pred             CccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhcC-CCc----------------
Confidence            44578899999999877 6789999999999999999999999842 2222111111110 000                


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                 .      ......+++++.+||.+||+.||++|||+.++++||||+...
T Consensus       244 -----------~------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          244 -----------T------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             -----------C------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             -----------c------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                       0      001123688999999999999999999999999999998764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=345.60  Aligned_cols=253  Identities=26%  Similarity=0.413  Sum_probs=203.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++..       ..+.+.+|+.+++.+ +||||+++++++.......
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---C
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCe
Confidence            46899999999999999999999999999999999642       246788999999999 8999999999997666678


Q ss_pred             cEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||++++....+.    ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||++.....
T Consensus        83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECCT
T ss_pred             EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC-CcEEeeccccccccCc
Confidence            89999999988333222    358999999999999999999999999999999999999988 8899999999987643


Q ss_pred             C---CcceeecccccccccccccCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          273 G---KEYNVRVASRYFKGPELLVDLQ-DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       273 ~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      .   .......++..|+|||++.+.. .++.++|||||||++|+|++|+.||. +.+..+....+.+             
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~i~~-------------  227 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE-GDNIYKLFENIGK-------------  227 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHH-------------
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC-CchHHHHHHHHhc-------------
Confidence            2   2223456889999999987522 24789999999999999999999984 2222222222111             


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ...                        .....+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       228 ~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          228 GSY------------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             CCC------------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             CCC------------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence            000                        01123788999999999999999999999999999998653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-45  Score=357.34  Aligned_cols=290  Identities=24%  Similarity=0.408  Sum_probs=216.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhc----------CCCCeeEEEeEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC----------GGPNVVKLLDIVR  190 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~----------~h~niv~l~~~~~  190 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++....  .+.+.+|+.+++++.          +||||+++++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            3678999999999999999999999999999999997543  466889999999883          2899999999987


Q ss_pred             cc--CCCccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCceEEcCC-----CC
Q 014762          191 DQ--HSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHE-----LR  257 (419)
Q Consensus       191 ~~--~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlk~~NILl~~~-----~~  257 (419)
                      ..  .....++||||+ +++|..++     ..+++..+..++.|++.||+|||++ ||+||||||+|||++.+     ..
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence            54  233788999999 77777765     3489999999999999999999998 99999999999999532     24


Q ss_pred             cEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHH
Q 014762          258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-----DNHDQLVK  332 (419)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~-----~~~~~~~~  332 (419)
                      .+||+|||+++....  ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||....     ...+.+..
T Consensus       176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  252 (373)
T 1q8y_A          176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  252 (373)
T ss_dssp             EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eEEEcccccccccCC--CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence            799999999987643  2344578999999999987 679999999999999999999999995432     24556777


Q ss_pred             HHHHcCCchHHHHHhhcCCCCChhhHHhhccC-CCCCcc--cccc--ccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHh
Q 014762          333 IAKVLGTDELNAYLNKYHLELDPQLDALVGRH-SRKPWS--KFIN--ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM  407 (419)
Q Consensus       333 i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL  407 (419)
                      +.+.+|..+...+................... ....|.  ....  ......+++++.+||.+||+.||++|||++|+|
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  332 (373)
T 1q8y_A          253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  332 (373)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence            88888876654332111000000000000000 000000  0000  001122467889999999999999999999999


Q ss_pred             cCCCccccc
Q 014762          408 VISSISPIF  416 (419)
Q Consensus       408 ~hp~f~~~~  416 (419)
                      +||||++..
T Consensus       333 ~hp~f~~~~  341 (373)
T 1q8y_A          333 NHPWLKDTL  341 (373)
T ss_dssp             TCGGGTTCT
T ss_pred             hChhhhccc
Confidence            999999764

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.5e-45  Score=345.76  Aligned_cols=254  Identities=26%  Similarity=0.403  Sum_probs=198.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc---------
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ---------  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---------  192 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++...  ..+.+.+|+.+++.+ +||||+++++++.+.         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcc
Confidence            45799999999999999999999999999999998643  346788999999999 899999999988653         


Q ss_pred             --CCCccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          193 --HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       193 --~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                        .....++||||+++++|..++.    .+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~  162 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIGDFGL  162 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC-CCEEEeeCcc
Confidence              2356789999999999998873    46788999999999999999999999999999999999988 7899999999


Q ss_pred             ceeccCC---------------CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014762          267 AEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (419)
Q Consensus       267 a~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~  331 (419)
                      +......               .......++..|+|||++.+...++.++|||||||++|+|++   ||..+.+..+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~  239 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK  239 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence            9765422               122345688899999999875579999999999999999997   6532221111111


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCC
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISS  411 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~  411 (419)
                      .+..             .....+                    .......++.+.+|+++||+.||++|||+.++++|||
T Consensus       240 ~~~~-------------~~~~~~--------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  286 (303)
T 1zy4_A          240 KLRS-------------VSIEFP--------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW  286 (303)
T ss_dssp             HHHS-------------TTCCCC--------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred             hccc-------------cccccC--------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence            1110             000000                    0111236788999999999999999999999999999


Q ss_pred             cccc
Q 014762          412 ISPI  415 (419)
Q Consensus       412 f~~~  415 (419)
                      |+..
T Consensus       287 ~~~~  290 (303)
T 1zy4_A          287 LPVK  290 (303)
T ss_dssp             SCCC
T ss_pred             cCCC
Confidence            9754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.7e-45  Score=344.50  Aligned_cols=243  Identities=19%  Similarity=0.326  Sum_probs=191.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|++.+.||+|+||+||+|.+  +|+.||+|++....     .+.+.+|+.+++++ +||||+++++++.+  ....
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~  109 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQ--PPNL  109 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--TTCC
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCce
Confidence            467899999999999999999975  68899999986432     35688999999999 89999999999954  4668


Q ss_pred             EEEEEecCCCChhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          198 SLIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~~------l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      ++||||+++++|..++..      +++..+..++.|++.||+|||++|  |+||||||+|||++.+ +.+||+|||+++.
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~  188 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRL  188 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCCcc
Confidence            899999999999888732      899999999999999999999999  9999999999999988 8999999999976


Q ss_pred             ccCCC-cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          270 YHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       270 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ..... ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+......         
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~-~~~~~~~~~~~~~~~~~---------  257 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWG-NLNPAQVVAAVGFKCKR---------  257 (309)
T ss_dssp             -------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTT-TSCHHHHHHHHHHSCCC---------
T ss_pred             ccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCCC---------
Confidence            54332 2244678999999999987 778999999999999999999999983 22222222221110000         


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                ......+++++.+||.+||+.||++|||+.++++
T Consensus       258 --------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          258 --------------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             --------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                      0111237899999999999999999999999987

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=346.99  Aligned_cols=252  Identities=19%  Similarity=0.309  Sum_probs=204.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|.+...   ..+.+.+|+.+++++ +||||+++++++.+.  ...++
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~l   84 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKD--KRLNF   84 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecC--CeeEE
Confidence            367899999999999999999999999999999988643   346788999999999 899999999999764  67889


Q ss_pred             EEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      ||||+++++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-SCEEECCCTTCEECC----
T ss_pred             EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-CCEEEeecccceecccccc
Confidence            99999999998886    458999999999999999999999999999999999999988 8899999999987643322


Q ss_pred             c---------------eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCc
Q 014762          276 Y---------------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (419)
Q Consensus       276 ~---------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~  340 (419)
                      .               ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---------  233 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---------  233 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS---------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh---------
Confidence            1               13478999999999987 7899999999999999999999998843221110000         


Q ss_pred             hHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                    ....            ..........+++++.+++.+||+.||++|||+.++++  ||+.++
T Consensus       234 --------------~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          234 --------------LNVR------------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             --------------BCHH------------HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred             --------------hhhh------------ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence                          0000            00001112347889999999999999999999999988  666554

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-45  Score=346.77  Aligned_cols=253  Identities=21%  Similarity=0.336  Sum_probs=198.3

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++...      ..+.+.+|+.++..+ +||||+++++++.+  ..
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~   84 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEE--DD   84 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEEC--SS
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeee--CC
Confidence            3467899999999999999999999999999999998431      235788999999999 89999999999965  46


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ..++||||+++++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCSSSTTC--
T ss_pred             eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEEeCCCcccccc
Confidence            789999999999998886   468999999999999999999999999999999999999988 8899999999976543


Q ss_pred             CCc--ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          273 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       273 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ...  .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||. +.+..+........ ..+...       
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~-~~~~~~~~~~~~~~-~~~~~~-------  233 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFN-GETAVSIAIKHIQD-SVPNVT-------  233 (294)
T ss_dssp             -----------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSC-SSCHHHHHHHHHSS-CCCCHH-------
T ss_pred             ccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhhc-cCCCcc-------
Confidence            322  233578999999999987 778999999999999999999999983 22222222111110 000000       


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                                              ......+++.+.++|.+||+.||++||+..+.+.+.|.
T Consensus       234 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          234 ------------------------TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             ------------------------HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             ------------------------hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence                                    01122378999999999999999999955555555443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=341.58  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=199.7

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      |.....||+|+||+||+|.+..++..||+|.+...   ..+.+.+|+.+++.+ +||||+++++++...  ...++||||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~  100 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSEN--GFIKIFMEQ  100 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEEEEEC
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeC--CcEEEEEEe
Confidence            34455799999999999999999999999998643   246788999999999 999999999999654  678899999


Q ss_pred             cCCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-c
Q 014762          204 VNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-Y  276 (419)
Q Consensus       204 ~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-~  276 (419)
                      +++++|..++.      .+++..+..++.|++.||+|||++|++|+||||+||+++.+.+.+||+|||++........ .
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~  180 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT  180 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcc
Confidence            99999988762      3568889999999999999999999999999999999998448999999999987653322 2


Q ss_pred             eeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          277 NVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ....++..|+|||++.+. ..++.++|||||||++|+|++|+.||............... ..                 
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~-----------------  242 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-FK-----------------  242 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-HC-----------------
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-cc-----------------
Confidence            345788999999998652 23889999999999999999999998432221111111100 00                 


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                             .          .......+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus       243 -------~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          243 -------V----------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             -------C----------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             -------c----------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence                   0          0011123789999999999999999999999999999998654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=359.04  Aligned_cols=273  Identities=18%  Similarity=0.319  Sum_probs=208.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++|++.+.||+|+||+||+|.+..+|+.||||+++..    ..+.+.+|+.+++++ +||||+++++++........+
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeE
Confidence            467899999999999999999999999999999999743    346778999999999 899999999999877666889


Q ss_pred             EEEEecCCCChhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE----cCCCCcEEEEecccce
Q 014762          199 LIFEYVNSTDFKVLYPT------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHELRKLRLIDWGLAE  268 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~~------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl----~~~~~~~kl~Dfgla~  268 (419)
                      +||||+++++|..++..      +++..+..++.|++.||+|||++||+||||||+|||+    +.+ +.+||+|||+++
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~-~~~kL~DFG~a~  164 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ-SVYKLTDFGAAR  164 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSC-EEEEECCGGGCE
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCc-eeEEEecCCCce
Confidence            99999999999998743      8999999999999999999999999999999999998    544 679999999998


Q ss_pred             eccCCCcceeecccccccccccccCC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCch
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE  341 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~  341 (419)
                      ............||..|+|||++.+.       ..++.++|||||||++|+|++|+.||............+.+.++..+
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            87665555567899999999998541       35788999999999999999999999643332222222222222111


Q ss_pred             HHHHHhhcCCCCChhhHHhhccCCCCCccccccccc--cCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADN--QHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ...+         .....  .......|........  ...+++.+.+++++||++||++|||+.++++
T Consensus       245 ~~~~---------~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          245 SGAI---------SGVQK--AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             TTCC---------EEEEC--STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             cccc---------hhhee--ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            1100         00000  0000011111111111  1224567889999999999999999999865

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.6e-45  Score=352.32  Aligned_cols=248  Identities=19%  Similarity=0.311  Sum_probs=201.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEE-----EcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~-----~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.     +..+++.||||+++...    .+.+.+|+.++.++.+||||+++++++.+. 
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-   98 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   98 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence            46889999999999999999998     55677899999997532    356889999999997899999999999654 


Q ss_pred             CCccEEEEEecCCCChhhhcCC----------------------------------------------------------
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPT----------------------------------------------------------  215 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~----------------------------------------------------------  215 (419)
                      ....++||||+++++|..++..                                                          
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            3457899999999999887621                                                          


Q ss_pred             -----------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc---ceeecc
Q 014762          216 -----------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVA  281 (419)
Q Consensus       216 -----------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~---~~~~~~  281 (419)
                                 +++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......   .....+
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  257 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARL  257 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecccccchhccccCC
Confidence                       8889999999999999999999999999999999999988 7899999999986543322   233567


Q ss_pred             cccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHh
Q 014762          282 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDAL  360 (419)
Q Consensus       282 ~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~  360 (419)
                      |..|+|||++.+ ..++.++|||||||++|+|++ |..||............+... ..                     
T Consensus       258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~---------------------  314 (359)
T 3vhe_A          258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-TR---------------------  314 (359)
T ss_dssp             CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT-CC---------------------
T ss_pred             CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC-CC---------------------
Confidence            888999999887 789999999999999999998 998984333333222222210 00                     


Q ss_pred             hccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          361 VGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                    ...+..+++++.+++.+||+.||++|||+.|+++|
T Consensus       315 --------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          315 --------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                          00112378899999999999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.8e-45  Score=352.68  Aligned_cols=246  Identities=19%  Similarity=0.293  Sum_probs=199.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-------CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (419)
                      ..++|++.+.||+|+||+||+|.+.       .++..||+|+++...    .+.+.+|+.+++.+.+||||++++++|.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3578999999999999999999875       345679999997532    35688999999999779999999999954


Q ss_pred             cCCCccEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE
Q 014762          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (419)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl  252 (419)
                        ....++||||+++++|..++.                   .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus       159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  236 (370)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred             --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence              467899999999999988762                   37889999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014762          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (419)
Q Consensus       253 ~~~~~~~kl~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~  328 (419)
                      +.+ +.+||+|||+++.......   .....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+
T Consensus       237 ~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~-~~~~~~  313 (370)
T 2psq_A          237 TEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVEE  313 (370)
T ss_dssp             CTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGG
T ss_pred             CCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCC-CCCHHH
Confidence            988 8899999999987654322   223456778999999987 789999999999999999999 888873 333332


Q ss_pred             HHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       329 ~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ....+....                                    ....+..+++++.++|.+||+.||++|||+.|+++
T Consensus       314 ~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          314 LFKLLKEGH------------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             HHHHHHTTC------------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCC------------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            222211100                                    00111237889999999999999999999999987


Q ss_pred             C
Q 014762          409 I  409 (419)
Q Consensus       409 h  409 (419)
                      +
T Consensus       358 ~  358 (370)
T 2psq_A          358 D  358 (370)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6e-45  Score=349.33  Aligned_cols=259  Identities=25%  Similarity=0.397  Sum_probs=182.7

Q ss_pred             CCCCeEEEe-eeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEcc--CCCccEE
Q 014762          123 DQDDYEVVR-KVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKTPSL  199 (419)
Q Consensus       123 ~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~~~l  199 (419)
                      ..++|++.+ .||+|+||+||+|.+..+|+.||+|++...  ....+|+..+.+..+||||+++++++...  .....++
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  103 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI  103 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence            467899966 599999999999999999999999999643  33445555544444999999999999652  2345789


Q ss_pred             EEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccC
Q 014762          200 IFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       200 v~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~  272 (419)
                      ||||+++++|..++.     .+++..++.++.|++.||+|||++||+||||||+|||++.+  .+.+||+|||+++....
T Consensus       104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            999999999988762     48999999999999999999999999999999999999864  24699999999986543


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      . ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......         ..  
T Consensus       184 ~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~---------~~--  249 (336)
T 3fhr_A          184 N-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ-AISPGMKRRIRL---------GQ--  249 (336)
T ss_dssp             ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------------
T ss_pred             c-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccch-hhhhhHHHhhhc---------cc--
Confidence            2 3344678999999999866 67899999999999999999999998432211 110000000000         00  


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                        ..........+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus       250 ------------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          250 ------------------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             -------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             ------------------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence                              000011122478999999999999999999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.1e-45  Score=345.70  Aligned_cols=249  Identities=25%  Similarity=0.388  Sum_probs=205.9

Q ss_pred             cCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------hHHHHHHHHHHHHhc-CCCCeeEEEeEEE
Q 014762          121 WGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC-GGPNVVKLLDIVR  190 (419)
Q Consensus       121 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~-~h~niv~l~~~~~  190 (419)
                      ....++|++.+.||+|+||+||+|.+..+++.||+|+++...         .+.+.+|+.+++++. +|+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            345788999999999999999999999999999999986432         245778999999994 3699999999996


Q ss_pred             ccCCCccEEEEEecCC-CChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          191 DQHSKTPSLIFEYVNS-TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       191 ~~~~~~~~lv~e~~~~-~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ..  ...++|||++.+ ++|..++   ..+++..+..++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+
T Consensus       119 ~~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          119 RP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             CS--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             cC--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            54  678899999976 7888776   46899999999999999999999999999999999999995448999999999


Q ss_pred             ceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       267 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ++..... ......+|..|+|||++.+...++.++|||||||++|+|++|+.||...    +   .+..           
T Consensus       197 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~---~~~~-----------  257 (320)
T 3a99_A          197 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E---EIIR-----------  257 (320)
T ss_dssp             CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---HHHH-----------
T ss_pred             ccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----h---hhhc-----------
Confidence            9876533 3344578999999999876444578999999999999999999998321    0   0000           


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                        ...                        .....+++++.+||.+||+.||++|||++|+++||||+++.
T Consensus       258 --~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          258 --GQV------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             --CCC------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             --ccc------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence              000                        01123789999999999999999999999999999999764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=346.01  Aligned_cols=244  Identities=16%  Similarity=0.300  Sum_probs=197.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.+.||+|+||+||+|.+..+++   .||||+++..    ..+.+.+|+.+++.+ +||||+++++++.+  ..
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~  123 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR--GR  123 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG--GG
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence            46789999999999999999999886555   4999999753    245688999999999 89999999999955  46


Q ss_pred             ccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+++++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLE  202 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCSSCEECC
T ss_pred             ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-CCEEECCCCcccccc
Confidence            788999999999998887    368999999999999999999999999999999999999988 899999999998765


Q ss_pred             CCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .....    ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+.....        
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~~~~--------  272 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYW-NMTNRDVISSVEEGYR--------  272 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TSCHHHHHHHHHTTCC--------
T ss_pred             cCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHcCCC--------
Confidence            43221    22345667999999976 678999999999999999999 898883 3333332222221100        


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                  ......+++++.+||.+||..||++|||+.++++
T Consensus       273 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          273 ----------------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                        0011237899999999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-44  Score=338.93  Aligned_cols=262  Identities=19%  Similarity=0.357  Sum_probs=200.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.++||+|+||+||+|.    +..+++.||+|++....   .+.+.+|+.+++++ +||||+++++++......
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHT
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence            46889999999999999999998    56789999999997544   35688999999999 899999999999765556


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLP  165 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCSCC---
T ss_pred             ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEccCccccccc
Confidence            7899999999999988873    38999999999999999999999999999999999999988 899999999998765


Q ss_pred             CCCc----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          272 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       272 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ....    .....++..|+|||++.+ ..++.++|||||||++|+|++|..|+..   .....   ....+.........
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~---~~~~~---~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKS---PPAEF---MRMIGNDKQGQMIV  238 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCS---HHHHH---HHHHCTTCCTHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCC---ChHHH---HhhhcCccccchhH
Confidence            4322    122346677999999987 6799999999999999999999998832   11111   11112111000000


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                             ............        ......+++++.+|+.+||+.||++|||+.|+++
T Consensus       239 -------~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          239 -------FHLIELLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             -------HHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------HHHHHHHhccCc--------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                   000000000000        1112347899999999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-45  Score=355.27  Aligned_cols=249  Identities=17%  Similarity=0.284  Sum_probs=199.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEE-----EcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.     +..+++.||||+++..    ....+.+|+.+++++ +||||+++++++.+  
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--  145 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ--  145 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEec--
Confidence            36789999999999999999998     4567889999998642    234688999999999 99999999999955  


Q ss_pred             CCccEEEEEecCCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEE
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRL  261 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl  261 (419)
                      ....++||||+.+++|..++.          .+++..+..++.|++.||+|||++||+||||||+|||++.+  ...+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            466789999999999988762          38999999999999999999999999999999999999854  135999


Q ss_pred             EecccceeccCC---CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHc
Q 014762          262 IDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVL  337 (419)
Q Consensus       262 ~Dfgla~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~l  337 (419)
                      +|||+++.....   .......+|..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....+... 
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~-~~~~~~~~~~i~~~-  302 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVLEFVTSG-  302 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHTT-
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcC-
Confidence            999999754221   22233567889999999987 789999999999999999998 888873 33333322222110 


Q ss_pred             CCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ..                                   ......+++++.+|+.+||+.||++|||+.+++++.++
T Consensus       303 ~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          303 GR-----------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             CC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC-----------------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            00                                   00112378899999999999999999999999997654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.4e-44  Score=340.69  Aligned_cols=256  Identities=23%  Similarity=0.312  Sum_probs=199.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHH--hcCCCCeeEEEeEEEcc--CCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQN--LCGGPNVVKLLDIVRDQ--HSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~--l~~h~niv~l~~~~~~~--~~~~~~  198 (419)
                      ..++|++.+.||+|+||+||+|.+  +++.||||++.......+.+|.+++..  + +||||+++++++...  .....+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhc-cCcCeeeEEEeeccccCCCceeE
Confidence            467899999999999999999976  789999999988777888888888887  5 899999999987543  235678


Q ss_pred             EEEEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHH--------HCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          199 LIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH--------~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                      +||||+++++|..++.  .+++..+..++.|++.||+|||        ++||+||||||+|||++.+ +.+||+|||+++
T Consensus        83 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~  161 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAV  161 (301)
T ss_dssp             EEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred             EehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC-CCEEEeeCCCee
Confidence            9999999999999874  5899999999999999999999        9999999999999999988 789999999998


Q ss_pred             eccCCCcc-----eeecccccccccccccCCC-----CCCccccHHHHHHHHHHHHhC----------CCCCCCCCCCHH
Q 014762          269 FYHPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFR----------KEPFFYGHDNHD  328 (419)
Q Consensus       269 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwSlG~~l~ell~g----------~~pf~~~~~~~~  328 (419)
                      ........     ....||..|+|||++.+..     .++.++|||||||++|||++|          ..||........
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~  241 (301)
T 3q4u_A          162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP  241 (301)
T ss_dssp             EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence            76543322     2247899999999987632     345799999999999999999          778754333222


Q ss_pred             HHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       329 ~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ....+.+.....                       ......   ........+++++.+|+.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~-----------------------~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          242 SFEDMRKVVCVD-----------------------QQRPNI---PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CHHHHHHHHTTS-----------------------CCCCCC---CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             chhhhhHHHhcc-----------------------CCCCCC---ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            222222211100                       000000   000001124678999999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=340.81  Aligned_cols=255  Identities=20%  Similarity=0.299  Sum_probs=187.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch----HH-HHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KK-IKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~-~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|++.....    .+ +.++..+++.+ +||||+++++++...  ...
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~--~~~   99 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITN--TDV   99 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECS--SEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC--CcE
Confidence            35789999999999999999999999999999999964322    22 33344456666 999999999999654  678


Q ss_pred             EEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ++||||+ ++.+..+.    ..+++..+..++.|++.||.|||++ |++|+||||+|||++.+ +.+||+|||++.....
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-SCEEECCCTTC-----
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-CCEEEEECCCchhccC
Confidence            9999999 44444443    4689999999999999999999995 99999999999999988 7899999999977655


Q ss_pred             CCcceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          273 GKEYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ........++..|+|||++.+    ...++.++|||||||++|+|++|+.||.......+.+..+......         
T Consensus       178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------  248 (318)
T 2dyl_A          178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP---------  248 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC---------
T ss_pred             CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC---------
Confidence            544455678999999999852    2568899999999999999999999995444444434333221000         


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                               .......+++++.+||.+||+.||++|||+.++++||||+...
T Consensus       249 -------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          249 -------------------------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             -------------------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             -------------------------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence                                     0001123789999999999999999999999999999998653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-44  Score=334.42  Aligned_cols=244  Identities=16%  Similarity=0.333  Sum_probs=199.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++...  ..+.+.+|+.+++++ +||||+++++++.+  ....++|
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   83 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV   83 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCceEEE
Confidence            4578999999999999999999876 5778999999753  457799999999999 89999999999955  4678999


Q ss_pred             EEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-
Q 014762          201 FEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      |||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++....... 
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEeccccccccccccccc
Confidence            99999999988872    38999999999999999999999999999999999999888 7899999999976543221 


Q ss_pred             -ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+....                
T Consensus       163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~-~~~~~~~~~~~~~~~----------------  224 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGF----------------  224 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTC----------------
T ss_pred             cccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHhcCc----------------
Confidence             123355677999999876 679999999999999999999 888873 333333322221100                


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                          ....+..+++++.+++.+||+.||++|||+.++++|
T Consensus       225 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          225 --------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                                001112368899999999999999999999999984

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.8e-44  Score=343.79  Aligned_cols=254  Identities=18%  Similarity=0.320  Sum_probs=186.7

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ...++|++.+.||+|+||+||+|.+..++.   .||+|+++..     ..+.+.+|+.+++++ +||||+++++++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccc
Confidence            347789999999999999999999877765   8999998642     346788999999999 9999999999997643


Q ss_pred             CC----ccEEEEEecCCCChhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEE
Q 014762          194 SK----TPSLIFEYVNSTDFKVLYP---------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (419)
Q Consensus       194 ~~----~~~lv~e~~~~~~l~~~~~---------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~k  260 (419)
                      ..    ..++||||+.+++|..++.         .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+|
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~-~~~k  177 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVC  177 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC-CCEE
Confidence            22    2389999999999988762         48999999999999999999999999999999999999988 8999


Q ss_pred             EEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014762          261 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (419)
Q Consensus       261 l~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~  336 (419)
                      |+|||+++........   ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+...
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~-~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPY-AGIENAEIYNYLIGG  255 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTT
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCc-cccChHHHHHHHhcC
Confidence            9999999876443322   23456678999999877 679999999999999999999 78777 343433333322211


Q ss_pred             cCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-------HHHHhcC
Q 014762          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-------AREAMVI  409 (419)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------a~elL~h  409 (419)
                      ..                                    ......+++++.+|+.+||+.||++|||       .+++++|
T Consensus       256 ~~------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          256 NR------------------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             CC------------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CC------------------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            00                                    0011237889999999999999999999       7888899


Q ss_pred             CCcccc
Q 014762          410 SSISPI  415 (419)
Q Consensus       410 p~f~~~  415 (419)
                      ||+.+.
T Consensus       300 ~~~~~~  305 (323)
T 3qup_A          300 LSVLST  305 (323)
T ss_dssp             ------
T ss_pred             hhhcCC
Confidence            998764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1e-43  Score=334.29  Aligned_cols=249  Identities=15%  Similarity=0.248  Sum_probs=203.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.++..+.+|+|++++++++..  ....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEEE
Confidence            67899999999999999999999999999999998643 446788999999999889999999999965  467889999


Q ss_pred             ecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC----CcEEEEecccceeccCCC
Q 014762          203 YVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL----RKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       203 ~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~----~~~kl~Dfgla~~~~~~~  274 (419)
                      |+ +++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+.    ..+||+|||+++......
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99 889888763    589999999999999999999999999999999999998662    239999999998765432


Q ss_pred             c--------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHcCCchHHH
Q 014762          275 E--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       275 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--~~~~~~~i~~~lg~~~~~~  344 (419)
                      .        .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.....  ..+.+..+.......+...
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  244 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence            2        234578999999999877 7799999999999999999999999954322  2222222222111111110


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      .                                ...+++++.+++.+||+.||++|||+.++++
T Consensus       245 ~--------------------------------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          245 L--------------------------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             H--------------------------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             H--------------------------------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            0                                1137899999999999999999999999876

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.6e-45  Score=348.06  Aligned_cols=267  Identities=18%  Similarity=0.247  Sum_probs=199.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch--HHHHHHHHHHHHhcCCCCeeEEEeEEEccC--CCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQH--SKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~~~~~  198 (419)
                      ..++|++.++||+|+||+||+|++.  ++.||||+++....  ....+|+.++.++ +||||+++++++....  ...++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEE
Confidence            4678999999999999999999764  79999999975443  3456688889998 8999999999997653  23468


Q ss_pred             EEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC----------CcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          199 LIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ----------GIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       199 lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~----------~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      +||||+++++|..++  ..+++..+..++.|++.||+|||+.          ||+||||||+|||++.+ +.+||+|||+
T Consensus        99 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~-~~~kL~DFg~  177 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGL  177 (322)
T ss_dssp             EEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT-CCEEECCCTT
T ss_pred             EEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC-CeEEEccCCc
Confidence            999999999999887  4589999999999999999999999          99999999999999988 8899999999


Q ss_pred             ceeccCCCc---ceeecccccccccccccCC----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCC
Q 014762          267 AEFYHPGKE---YNVRVASRYFKGPELLVDL----QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (419)
Q Consensus       267 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~  339 (419)
                      ++.......   .....||..|+|||++.+.    ..++.++|||||||++|+|++|+.||....+.. .........+.
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~  256 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY-MLPFEEEIGQH  256 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC-CCTTHHHHCSS
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh-ccchhhhhccC
Confidence            987654332   2235789999999998762    245678899999999999999999985432211 11111111111


Q ss_pred             chHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      +.......           ...............   .....++++.+||.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~-----------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          257 PSLEDMQE-----------VVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CCHHHHHH-----------HHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             Cchhhhhh-----------hhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11111110           000011111111111   11123466999999999999999999999987

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-44  Score=352.70  Aligned_cols=244  Identities=20%  Similarity=0.358  Sum_probs=198.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++...    .+.+.+|+.+++++ +||||+++++++..  ....+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~  188 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIY  188 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECS--SSSCE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEec--CCCcE
Confidence            4678999999999999999999999999999999987532    24678999999999 99999999999954  46788


Q ss_pred             EEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          199 LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +||||+++++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECTTSE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-CcEEECcCCCceecCCCc
Confidence            999999999998876    348999999999999999999999999999999999999988 889999999998654322


Q ss_pred             cc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          275 EY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       275 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ..   ....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+... .......           
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~-~~~~~~~~~-~~~~~~~-----------  333 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYP-NLSNQQTRE-FVEKGGR-----------  333 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSST-TSCHHHHHH-HHHTTCC-----------
T ss_pred             eeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHH-HHHcCCC-----------
Confidence            11   11234667999999876 678999999999999999998 888873 333222221 1110000           


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                              ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       334 ------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 ------------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                    0012237889999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.7e-44  Score=330.71  Aligned_cols=244  Identities=16%  Similarity=0.281  Sum_probs=199.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|+++..  ..+.+.+|+.++.++ +||||+++++++.+  ....++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   81 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSK--EYPIYIV   81 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCceEEE
Confidence            4678999999999999999999764 6778999999753  457789999999999 89999999999954  4678999


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      |||+++++|..++    ..+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++.........
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT-CCEEECCTTCEEECCTTCEE
T ss_pred             EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC-CCEEEccCccceecchhhhh
Confidence            9999999998876    348999999999999999999999999999999999999988 88999999999876544322


Q ss_pred             --eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       277 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                        ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. ..+..+....+....                
T Consensus       161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~~----------------  222 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYD-LYTNSEVVLKVSQGH----------------  222 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHTTC----------------
T ss_pred             cccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCcc-ccChHHHHHHHHcCC----------------
Confidence              22345567999999876 678999999999999999999 888873 323222222221100                


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                          ....+..+++++.+++.+||+.||++|||+.+++++
T Consensus       223 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          223 --------------------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                000112368899999999999999999999999984

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=8.6e-44  Score=340.33  Aligned_cols=247  Identities=19%  Similarity=0.292  Sum_probs=199.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++... ..+.+.+|+.+++.+.+||||+++++++...  ...++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG--KYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET--TEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecC--CccEEEEE
Confidence            57899999999999999999999999999999998643 3457899999999998899999999999664  67899999


Q ss_pred             ecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCc-----EEEEecccceeccCC
Q 014762          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK-----LRLIDWGLAEFYHPG  273 (419)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~-----~kl~Dfgla~~~~~~  273 (419)
                      |+ +++|.+++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.     +||+|||+++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP-GNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTCTTSEEECCCTTCEESBCT
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC-CCCCCceEEEEEcccceeeecC
Confidence            99 88888775    469999999999999999999999999999999999999977 55     999999999876443


Q ss_pred             Cc--------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHcCCchHH
Q 014762          274 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDELN  343 (419)
Q Consensus       274 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~--~~~~~~i~~~lg~~~~~  343 (419)
                      ..        .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......  .+.+..+.......+..
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  242 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE  242 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence            22        234678999999999987 78999999999999999999999998543211  11222221110000000


Q ss_pred             HHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ..                                ...++ ++.+++.+||+.||++|||+.++++
T Consensus       243 ~~--------------------------------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          243 VL--------------------------------CENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HH--------------------------------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HH--------------------------------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            00                                01134 8999999999999999999999876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-44  Score=342.20  Aligned_cols=247  Identities=21%  Similarity=0.341  Sum_probs=200.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.+.     .++..||+|++...    ..+.+.+|+.++.++.+||||+++++++..  
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence            4688999999999999999999873     46678999998643    346788999999999789999999999965  


Q ss_pred             CCccEEEEEecCCCChhhhcCC--------------------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPT--------------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKP  247 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~--------------------------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~  247 (419)
                      ....++||||+++++|..++..                          +++..+..++.|++.||+|||++||+||||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            4678899999999999887622                          68889999999999999999999999999999


Q ss_pred             CceEEcCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCC
Q 014762          248 HNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG  323 (419)
Q Consensus       248 ~NILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~  323 (419)
                      +|||++.+ +.+||+|||++.........   ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||...
T Consensus       201 ~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~  278 (344)
T 1rjb_A          201 RNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI  278 (344)
T ss_dssp             GGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999988 89999999999866443322   23456778999999877 679999999999999999998 88888433


Q ss_pred             CCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH
Q 014762          324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA  403 (419)
Q Consensus       324 ~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta  403 (419)
                       ...+....+....-                                   .......+++++.+|+.+||+.||++|||+
T Consensus       279 -~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  322 (344)
T 1rjb_A          279 -PVDANFYKLIQNGF-----------------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSF  322 (344)
T ss_dssp             -CCSHHHHHHHHTTC-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             -CcHHHHHHHHhcCC-----------------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence             32222222221000                                   000112368999999999999999999999


Q ss_pred             HHHhcC
Q 014762          404 REAMVI  409 (419)
Q Consensus       404 ~elL~h  409 (419)
                      .+++++
T Consensus       323 ~~l~~~  328 (344)
T 1rjb_A          323 PNLTSF  328 (344)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999884

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.7e-44  Score=344.59  Aligned_cols=257  Identities=20%  Similarity=0.342  Sum_probs=181.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHH-HHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIK-ILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|++.+.||+|+||+||+|.+..+|+.||+|+++...    ...+.+|+. +++.+ +||||+++++++...  ...
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~--~~~   96 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFRE--GDC   96 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECS--SEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeC--Cce
Confidence            4688999999999999999999999999999999996532    234556666 44455 999999999999654  678


Q ss_pred             EEEEEecCCCChhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          198 SLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                      ++||||+++ ++..++        ..+++..+..++.|++.||.|||+. ||+||||||+|||++.+ +.+||+|||+++
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~  174 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGISG  174 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-TEEEECCCSSSC
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-CCEEEccCCCce
Confidence            899999997 443332        4589999999999999999999998 99999999999999988 899999999998


Q ss_pred             eccCCCcceeeccccccccccccc---CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      ............++..|+|||++.   ....++.++|||||||++|+|++|+.||.......+.+..+            
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------------  242 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV------------  242 (327)
T ss_dssp             C------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCC------------
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHH------------
Confidence            765554445557899999999983   22568999999999999999999999984321111111000            


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                         ..... ..........+++++.+|+.+||+.||++|||+.++++||||....
T Consensus       243 -------------------~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          243 -------------------VKGDP-PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             -------------------CCSCC-CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             -------------------hcCCC-CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence                               00000 0001111234789999999999999999999999999999998653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.8e-43  Score=331.17  Aligned_cols=245  Identities=18%  Similarity=0.290  Sum_probs=199.1

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----------hHHHHHHHHHHHHhcCCCCeeEEEeEEEc
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----------KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (419)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++....          .+.+.+|+.+++++ +||||+++++++.+
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHN   94 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecC
Confidence            35789999999999999999999999999999999985322          16788999999999 89999999999944


Q ss_pred             cCCCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCceEEcCCCCc-----EE
Q 014762          192 QHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRK-----LR  260 (419)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlk~~NILl~~~~~~-----~k  260 (419)
                      .    .++||||++++++...+    ..+++..+..++.|++.||+|||++|  |+||||||+|||++.+ +.     +|
T Consensus        95 ~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~k  169 (287)
T 4f0f_A           95 P----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAK  169 (287)
T ss_dssp             T----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEE
T ss_pred             C----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEE
Confidence            3    26999999999997765    35899999999999999999999999  9999999999999876 43     99


Q ss_pred             EEecccceeccCCCcceeecccccccccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCC
Q 014762          261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (419)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~  339 (419)
                      |+|||+++...  .......+|..|+|||++.+ ...++.++|||||||++|+|++|+.||.................+.
T Consensus       170 l~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          170 VADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             ECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             eCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            99999997543  23344678999999999843 2457899999999999999999999995443333222222211111


Q ss_pred             chHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      .                                  ......+++++.+|+.+||+.||++|||+.|+++
T Consensus       248 ~----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          248 R----------------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             C----------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C----------------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            0                                  0111237899999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=339.81  Aligned_cols=248  Identities=24%  Similarity=0.394  Sum_probs=197.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------hHHHHHHHHHHHHhc---CCCCeeEEEeEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC---GGPNVVKLLDIVR  190 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~---~h~niv~l~~~~~  190 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|+++...         ...+.+|+.++.++.   +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            3678999999999999999999999999999999996432         234567999999885   6999999999996


Q ss_pred             ccCCCccEEEEEe-cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          191 DQHSKTPSLIFEY-VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       191 ~~~~~~~~lv~e~-~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ..  ...++|||+ +.+++|..++   ..+++..+..++.|++.||+|||++||+|+||||+||+++.+.+.+||+|||+
T Consensus       109 ~~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          109 TQ--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             ------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             cC--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            54  667899999 7889998876   45899999999999999999999999999999999999994448999999999


Q ss_pred             ceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          267 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       267 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ++..... ......++..|+|||++.+....+.++|||||||++|+|++|+.||...    .   .+..           
T Consensus       187 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~---~~~~-----------  247 (312)
T 2iwi_A          187 GALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----Q---EILE-----------  247 (312)
T ss_dssp             CEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---HHHH-----------
T ss_pred             hhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----H---HHhh-----------
Confidence            9876543 3344678999999999876344456899999999999999999998321    0   0100           


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                        ...                        .....+++++.+||.+||+.||++|||++|+++||||+...+
T Consensus       248 --~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          248 --AEL------------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             --TCC------------------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             --hcc------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence              000                        011237889999999999999999999999999999997654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2e-44  Score=337.88  Aligned_cols=242  Identities=14%  Similarity=0.246  Sum_probs=198.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCC-------cEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-------ERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-------~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      ..++|++.+.||+|+||+||+|.+..++       ..||+|++...   ..+.+.+|+.+++++ +||||+++++++.+ 
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-   83 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVC-   83 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECC-
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEe-
Confidence            4678999999999999999999988877       46999998643   346788999999999 89999999999965 


Q ss_pred             CCCccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCc--------EE
Q 014762          193 HSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--------LR  260 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~--------~k  260 (419)
                       ....++||||+++++|..++.    .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.        +|
T Consensus        84 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~~~~~~k  161 (289)
T 4fvq_A           84 -GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE-EDRKTGNPPFIK  161 (289)
T ss_dssp             -TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC-CBGGGTBCCEEE
T ss_pred             -CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC-Ccccccccceee
Confidence             466789999999999988873    38999999999999999999999999999999999999877 44        99


Q ss_pred             EEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCc
Q 014762          261 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (419)
Q Consensus       261 l~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~  340 (419)
                      |+|||++.....   .....++..|+|||++.+...++.++|||||||++|+|++|..|++...+...........    
T Consensus       162 l~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~----  234 (289)
T 4fvq_A          162 LSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR----  234 (289)
T ss_dssp             ECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT----
T ss_pred             eccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc----
Confidence            999999865432   2334678889999999875679999999999999999999877776554433222211100    


Q ss_pred             hHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                        ...+...++++.+|+.+||+.||++|||+.++++|
T Consensus       235 ----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          235 ----------------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             ----------------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ----------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                                              00011257789999999999999999999999884

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-44  Score=347.63  Aligned_cols=246  Identities=18%  Similarity=0.306  Sum_probs=200.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCC-------CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNT-------NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-------~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (419)
                      ..++|++.++||+|+||+||+|.+..+       +..||+|+++...    .+.+.+|+.+++.+.+||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            467899999999999999999987543       3579999997532    35688999999999889999999999955


Q ss_pred             cCCCccEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE
Q 014762          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (419)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl  252 (419)
                        ....++||||+++++|..++.                   .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus       147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence              467889999999999988762                   38999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014762          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (419)
Q Consensus       253 ~~~~~~~kl~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~  328 (419)
                      +.+ +.+||+|||+++.......   .....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+
T Consensus       225 ~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~-~~~~~~  301 (382)
T 3tt0_A          225 TED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP-GVPVEE  301 (382)
T ss_dssp             CTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHH
T ss_pred             cCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHH
Confidence            988 8899999999986654322   233456778999999987 789999999999999999999 888873 333222


Q ss_pred             HHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       329 ~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ....+.+..                                    .......+++++.+|+.+||+.||++|||+.|+++
T Consensus       302 ~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  345 (382)
T 3tt0_A          302 LFKLLKEGH------------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  345 (382)
T ss_dssp             HHHHHHTTC------------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCC------------------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            222211100                                    00111237899999999999999999999999987


Q ss_pred             C
Q 014762          409 I  409 (419)
Q Consensus       409 h  409 (419)
                      +
T Consensus       346 ~  346 (382)
T 3tt0_A          346 D  346 (382)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.1e-44  Score=341.56  Aligned_cols=245  Identities=18%  Similarity=0.317  Sum_probs=193.6

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEE----EEEEecC----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERC----IIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~v----avK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ...++|++.+.||+|+||+||+|.+..+++.+    |+|.+..    ...+.+.+|+.+++++ +||||++++++|... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS-
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC-
Confidence            34678999999999999999999988887754    7777743    2346789999999999 999999999999753 


Q ss_pred             CCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                        ..++|+||+.++++..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        90 --~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~  166 (327)
T 3poz_A           90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKL  166 (327)
T ss_dssp             --SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTHHHH
T ss_pred             --CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCcceeE
Confidence              467999999999998876    358999999999999999999999999999999999999988 8999999999987


Q ss_pred             ccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          270 YHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       270 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      .......   ....+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +.+..+.. .+......      
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~-~~~~~~~~------  237 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEIS-SILEKGER------  237 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHH-HHHHTTCC------
T ss_pred             ccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCcc-CCCHHHHH-HHHHcCCC------
Confidence            6543322   23355778999999987 789999999999999999999 898883 32222222 21110000      


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                   ......++.++.+++.+||+.||++|||+.+++++
T Consensus       238 -----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          238 -----------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -----------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             -----------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                                         00112368899999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.6e-44  Score=337.23  Aligned_cols=247  Identities=21%  Similarity=0.329  Sum_probs=201.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.+     ..+++.||+|+++...    .+.+.+|+.+++++.+||||+++++++.+  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence            367899999999999999999985     4577899999997532    46788999999999789999999999955  


Q ss_pred             CCccEEEEEecCCCChhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP---------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl  252 (419)
                      ....++||||+++++|..++.                     .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            467889999999999988762                     38999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014762          253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (419)
Q Consensus       253 ~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~  328 (419)
                      +.+ +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||... ...+
T Consensus       179 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~  255 (313)
T 1t46_A          179 THG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGM-PVDS  255 (313)
T ss_dssp             ETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CSSH
T ss_pred             cCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcc-cchh
Confidence            988 89999999999876544332   23356678999999877 789999999999999999999 88887433 3222


Q ss_pred             HHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       329 ~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ...........                                   ......+++++.+++.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          256 KFYKMIKEGFR-----------------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             HHHHHHHHTCC-----------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCCC-----------------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            22222211000                                   0011236889999999999999999999999987


Q ss_pred             C
Q 014762          409 I  409 (419)
Q Consensus       409 h  409 (419)
                      +
T Consensus       301 ~  301 (313)
T 1t46_A          301 L  301 (313)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=356.48  Aligned_cols=254  Identities=20%  Similarity=0.294  Sum_probs=192.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      ...+|++.+.||+|+||+||.. ...+++.||||++.+.....+.+|+.+++.+.+||||+++++++.+.  ...++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR--QFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEET--TEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC--CEEEEEEE
Confidence            3567999999999999997643 45789999999998766667889999999987799999999999654  67899999


Q ss_pred             ecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC----CCcEEEEecccceeccCCC
Q 014762          203 YVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       203 ~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~----~~~~kl~Dfgla~~~~~~~  274 (419)
                      |+++ +|..++.    .+.+..+..++.|++.||+|||++||+||||||+|||++.+    ...+||+|||+++......
T Consensus        99 ~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A           99 LCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             CCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             CCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            9985 6666652    24555678899999999999999999999999999999532    1368899999998765432


Q ss_pred             ----cceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          275 ----EYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       275 ----~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                          ......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||..  ........+.   +.....    
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~--~~~~~~~~~~---~~~~~~----  248 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK--SLQRQANILL---GACSLD----  248 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS--TTTHHHHHHT---TCCCCT----
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch--hhHHHHHHHh---ccCCcc----
Confidence                2234579999999999874  2567889999999999999999 8878732  2222221111   110000    


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                          ..      ......+..+.+||.+||+.||++|||+.|+++||||..+
T Consensus       249 --------------------~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          249 --------------------CL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             --------------------TS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             --------------------cc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence                                00      0001135568899999999999999999999999999865

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.5e-44  Score=333.95  Aligned_cols=244  Identities=18%  Similarity=0.302  Sum_probs=197.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|+++..  ..+.+.+|+.++..+ +||||+++++++.+  ....++|
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   97 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFII   97 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEec--CCCeEEE
Confidence            4678999999999999999999764 6778999999754  457789999999999 89999999999954  4678999


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      |||+++++|..++    ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++....... 
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-SCEEECSTTGGGGBCCHHHH
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-CCEEEccccccccccccccc
Confidence            9999999998876    459999999999999999999999999999999999999988 7899999999976543221 


Q ss_pred             -ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       .....+|..|+|||++.+ ..++.++||||||+++|+|++ |+.||. ..+..+....+.+...               
T Consensus       177 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~~~---------------  239 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYE-RFTNSETAEHIAQGLR---------------  239 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHTTCC---------------
T ss_pred             cccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccChhHHHHHHhcccC---------------
Confidence             122345677999999986 679999999999999999998 888883 3333332322221100               


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                           ...+..+++.+.+++.+||+.||++|||+.++++|
T Consensus       240 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          240 ---------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                 00112368899999999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.6e-44  Score=332.76  Aligned_cols=243  Identities=21%  Similarity=0.342  Sum_probs=204.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEc------------
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD------------  191 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~------------  191 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++.. .+.+.+|+.+++.+ +||||+++++++..            
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-NEKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-SGGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC--------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccc
Confidence            56799999999999999999999999999999999754 35678999999999 99999999998854            


Q ss_pred             --cCCCccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEec
Q 014762          192 --QHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDW  264 (419)
Q Consensus       192 --~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Df  264 (419)
                        ......++||||+++++|..++     ..+++..+..++.|++.||.|||++||+|+||||+|||++.+ +.+||+||
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Df  166 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQVKIGDF  166 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-CCEEECcc
Confidence              1234578999999999998876     468999999999999999999999999999999999999988 89999999


Q ss_pred             ccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          265 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       265 gla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      |++.............++..|+|||++.+ ..++.++|||||||++|+|++|..|+..      . ......        
T Consensus       167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~------~-~~~~~~--------  230 (284)
T 2a19_B          167 GLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFE------T-SKFFTD--------  230 (284)
T ss_dssp             TTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHH------H-HHHHHH--------
T ss_pred             hhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchh------H-HHHHHH--------
Confidence            99988766555556678999999999987 7789999999999999999999988731      0 000000        


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                       ....                          .....+++++.++|.+||+.||++|||+.|+++|.+.
T Consensus       231 -~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          231 -LRDG--------------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             -HHTT--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -hhcc--------------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             0000                          0012368899999999999999999999999998654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.6e-43  Score=341.62  Aligned_cols=256  Identities=14%  Similarity=0.208  Sum_probs=195.9

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCC-----CcEEEEEEecCcchHHHHHHHHHHHHhc--------------CCCCe
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNT-----NERCIIKILKPVKKKKIKREIKILQNLC--------------GGPNV  182 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~E~~~l~~l~--------------~h~ni  182 (419)
                      ...++|++.++||+|+||+||+|.+..+     ++.||+|++.... ..+.+|+.++..+.              +||||
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i  110 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV  110 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence            4577999999999999999999988765     5889999986543 23444444444432              69999


Q ss_pred             eEEEeEEEccC--CCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEc--C
Q 014762          183 VKLLDIVRDQH--SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--H  254 (419)
Q Consensus       183 v~l~~~~~~~~--~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~--~  254 (419)
                      +++++++....  ....++||||+ +++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++  .
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence            99999987542  25578999999 89998876    4689999999999999999999999999999999999998  5


Q ss_pred             CCCcEEEEecccceeccCCCcc--------eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC
Q 014762          255 ELRKLRLIDWGLAEFYHPGKEY--------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN  326 (419)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~  326 (419)
                      + +.+||+|||+++........        ....||..|+|||++.+ ..++.++|||||||++|+|++|+.||.....+
T Consensus       190 ~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          190 P-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             T-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             C-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            5 78999999999876432211        23358999999999987 67999999999999999999999999644444


Q ss_pred             HHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHH
Q 014762          327 HDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA  406 (419)
Q Consensus       327 ~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el  406 (419)
                      ............ ..........                       +   ....+++++.+|+..||+.||++|||+.++
T Consensus       268 ~~~~~~~~~~~~-~~~~~~~~~~-----------------------~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l  320 (364)
T 3op5_A          268 PKYVRDSKIRYR-ENIASLMDKC-----------------------F---PAANAPGEIAKYMETVKLLDYTEKPLYENL  320 (364)
T ss_dssp             HHHHHHHHHHHH-HCHHHHHHHH-----------------------S---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             HHHHHHHHHHhh-hhHHHHHHHh-----------------------c---ccccCHHHHHHHHHHHhcCCCCCCCCHHHH
Confidence            333322221111 1111111100                       0   012378999999999999999999999998


Q ss_pred             hc
Q 014762          407 MV  408 (419)
Q Consensus       407 L~  408 (419)
                      ++
T Consensus       321 ~~  322 (364)
T 3op5_A          321 RD  322 (364)
T ss_dssp             HH
T ss_pred             HH
Confidence            76

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-44  Score=342.64  Aligned_cols=244  Identities=18%  Similarity=0.341  Sum_probs=198.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.+.     .+++.||+|+++...    .+.+.+|+.+++.+ +||||+++++++.+  
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--  121 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV--  121 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcc--
Confidence            4678999999999999999999987     355899999997532    35688999999999 99999999999955  


Q ss_pred             CCccEEEEEecCCCChhhhc---------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCC
Q 014762          194 SKTPSLIFEYVNSTDFKVLY---------------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVK  246 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---------------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk  246 (419)
                      ....++||||+++++|..++                           ..+++..+..++.|++.||+|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            46789999999999998876                           358889999999999999999999999999999


Q ss_pred             CCceEEcCCCCcEEEEecccceeccCCC---cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 014762          247 PHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY  322 (419)
Q Consensus       247 ~~NILl~~~~~~~kl~Dfgla~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~  322 (419)
                      |+|||++.+ +.+||+|||+++......   ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||. 
T Consensus       202 p~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-  278 (343)
T 1luf_A          202 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY-  278 (343)
T ss_dssp             GGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-
T ss_pred             cceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCC-
Confidence            999999988 789999999997654322   1233467888999999877 679999999999999999999 888884 


Q ss_pred             CCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC
Q 014762          323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT  402 (419)
Q Consensus       323 ~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  402 (419)
                      +.+..+....+.+.  .           .                       ......+++++.+++.+||+.||++|||
T Consensus       279 ~~~~~~~~~~~~~~--~-----------~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps  322 (343)
T 1luf_A          279 GMAHEEVIYYVRDG--N-----------I-----------------------LACPENCPLELYNLMRLCWSKLPADRPS  322 (343)
T ss_dssp             TSCHHHHHHHHHTT--C-----------C-----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCChHHHHHHHhCC--C-----------c-----------------------CCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence            22222222221110  0           0                       0011237889999999999999999999


Q ss_pred             HHHHhc
Q 014762          403 AREAMV  408 (419)
Q Consensus       403 a~elL~  408 (419)
                      +.++++
T Consensus       323 ~~~~~~  328 (343)
T 1luf_A          323 FCSIHR  328 (343)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999987

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.9e-44  Score=338.05  Aligned_cols=245  Identities=18%  Similarity=0.316  Sum_probs=199.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.+.     .++..||+|++....    .+.+.+|+.+++.+ +||||+++++++.+  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--   97 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQ--   97 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEec--
Confidence            3678999999999999999999873     456899999997432    35688999999999 99999999999955  


Q ss_pred             CCccEEEEEecCCCChhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVK  246 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk  246 (419)
                      ....++||||+++++|..++.                           .+++..+..++.|++.||+|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            467889999999999988762                           17889999999999999999999999999999


Q ss_pred             CCceEEcCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 014762          247 PHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFY  322 (419)
Q Consensus       247 ~~NILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~  322 (419)
                      |+|||++.+ +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. 
T Consensus       178 p~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-  254 (314)
T 2ivs_A          178 ARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP-  254 (314)
T ss_dssp             GGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-
T ss_pred             hheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCC-
Confidence            999999988 88999999999876543322   23356678999999987 678999999999999999999 888873 


Q ss_pred             CCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC
Q 014762          323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT  402 (419)
Q Consensus       323 ~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  402 (419)
                      +.+..+....+....                                    .......+++++.+++.+||+.||++|||
T Consensus       255 ~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps  298 (314)
T 2ivs_A          255 GIPPERLFNLLKTGH------------------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPV  298 (314)
T ss_dssp             TCCGGGHHHHHHTTC------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCHHHHHHHhhcCC------------------------------------cCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            333222222211100                                    00011237899999999999999999999


Q ss_pred             HHHHhcC
Q 014762          403 AREAMVI  409 (419)
Q Consensus       403 a~elL~h  409 (419)
                      +.+++++
T Consensus       299 ~~~l~~~  305 (314)
T 2ivs_A          299 FADISKD  305 (314)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.6e-44  Score=333.24  Aligned_cols=243  Identities=22%  Similarity=0.397  Sum_probs=188.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.+.||+|+||+||+|.+..+   +..||+|.+...    ..+.+.+|+.+++++ +||||+++++++.+   .
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---S
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEcc---C
Confidence            467899999999999999999998654   456999998643    245688999999999 99999999999843   4


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME  167 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC--------
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECccccccccC
Confidence            6789999999999988763    58999999999999999999999999999999999999988 899999999998765


Q ss_pred             CCCcc--eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          272 PGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       272 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      .....  ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+....           
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~-~~~~~~~~~~i~~~~-----------  234 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENGE-----------  234 (281)
T ss_dssp             -----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTTC-----------
T ss_pred             cccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCC-cCCHHHHHHHHHcCC-----------
Confidence            43322  23355678999999876 679999999999999999997 888873 333333332221100           


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                       .                        ......+++++.+++.+||+.||++|||+.++++
T Consensus       235 -~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          235 -R------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             -C------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -C------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             0                        0011237899999999999999999999999987

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.2e-44  Score=341.19  Aligned_cols=244  Identities=17%  Similarity=0.292  Sum_probs=195.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcE----EEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~----vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.    ||+|.+...    ....+.+|+.+++.+ +||||+++++++.+   
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---   86 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG---   86 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB---
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC---
Confidence            478899999999999999999999888876    777777432    235677899999999 99999999999853   


Q ss_pred             CccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ...++||||+.+++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGVADLL  165 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-SCEEECSCSGGGGS
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-CeEEECCCCccccc
Confidence            5578999999999998876    358899999999999999999999999999999999999988 78999999999876


Q ss_pred             cCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          271 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       271 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .....   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+....+... .        
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~-~--------  234 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEKG-E--------  234 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TSCTTHHHHHHHTT-C--------
T ss_pred             CcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCcc-ccCHHHHHHHHHcC-C--------
Confidence            54332   234567778999999987 679999999999999999999 999984 22222222221110 0        


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                 .......++.++.+++.+||+.||++|||+.+++++
T Consensus       235 ---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          235 ---------------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             ---------------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       000112257789999999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.5e-43  Score=328.78  Aligned_cols=244  Identities=16%  Similarity=0.315  Sum_probs=189.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.+.||+|+||+||+|.+  +++.||+|++...       ..+.+.+|+.+++.+ +||||+++++++.+  ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~   79 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLK--EP   79 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECC--C-
T ss_pred             chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEec--CC
Confidence            467899999999999999999986  4889999998632       235688999999999 89999999999955  46


Q ss_pred             ccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeecCCCCceEEcCC-------CCcEEEEe
Q 014762          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHE-------LRKLRLID  263 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlk~~NILl~~~-------~~~~kl~D  263 (419)
                      ..++||||+++++|..++  ..+++..+..++.|++.||+|||++|   |+||||||+|||++.+       .+.+||+|
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           80 NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             -CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             ceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            788999999999999887  46899999999999999999999999   9999999999999862       36799999


Q ss_pred             cccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHH
Q 014762          264 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (419)
Q Consensus       264 fgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~  343 (419)
                      ||+++....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.. .+.......+... .     
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~-~-----  230 (271)
T 3dtc_A          160 FGLAREWHRTTK-MSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRG-IDGLAVAYGVAMN-K-----  230 (271)
T ss_dssp             CCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHTS-C-----
T ss_pred             CCcccccccccc-cCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHhhhcC-C-----
Confidence            999976543322 34578999999999877 6799999999999999999999999842 2222111111100 0     


Q ss_pred             HHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                   ........+++++.+++.+||+.||++|||+.|++++
T Consensus       231 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          231 -----------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             -----------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence                                         0001112378999999999999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.6e-43  Score=332.34  Aligned_cols=261  Identities=22%  Similarity=0.366  Sum_probs=202.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ...+|++.++||+|+||+||+|.    +..+++.||+|++...    ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGG   97 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCC
Confidence            35679999999999999999998    5678999999998743    346789999999999 89999999999987766


Q ss_pred             CccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ...++||||+++++|..++    ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||++...
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAI  176 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEEC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECcccccccc
Confidence            7789999999999998886    458999999999999999999999999999999999999988 89999999999877


Q ss_pred             cCCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          271 HPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       271 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      ......    ....+|..|+|||++.+ ..++.++|||||||++|+|++|..|+.      ..........++.......
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~------~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDS------SPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGG------SHHHHHHHHHCSCCGGGHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCc------chhhHHhhccCCcccccCH
Confidence            554322    23457777999999877 678899999999999999999998862      1122222222221110000


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                              ...........        .......+++++.+|+.+||+.||++|||+.++++
T Consensus       250 --------~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          250 --------TRLVNTLKEGK--------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             --------HHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             --------HHHHHHHhccC--------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                    00000000000        01112347899999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.4e-43  Score=338.46  Aligned_cols=262  Identities=19%  Similarity=0.302  Sum_probs=204.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.+.||+|+||+||+|.    +..+++.||+|++....   .+.+.+|+.+++++ +||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSC
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCc
Confidence            46789999999999999999998    56789999999997543   35588999999999 999999999999876677


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+++++|..++.    .+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++...
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCGGGCEECC
T ss_pred             eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEEEcccccceecc
Confidence            8899999999999988763    48999999999999999999999999999999999999988 899999999998765


Q ss_pred             CCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      .....    ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||....  .+...........+.....  
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~--  253 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPS--AEFLRMMGCERDVPALSRL--  253 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--HHHHHHCC----CCHHHHH--
T ss_pred             cCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCcccc--chhhhhcccccccccHHHH--
Confidence            44322    22457777999999877 678999999999999999999999984211  1101000000000000000  


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                ........        .......+++++.+|+.+||+.||++|||+.|++++
T Consensus       254 ----------~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          254 ----------LELLEEGQ--------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             ----------HHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----------HHHhhccc--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      00000000        011123478999999999999999999999999763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-43  Score=334.35  Aligned_cols=252  Identities=23%  Similarity=0.409  Sum_probs=195.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcC-CCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCG-GPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++...     ..+.+.+|+.++.++.. ||||+++++++...  ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--~~  102 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD--QY  102 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS--SE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC--CE
Confidence            4678999999999999999999874 5889999998532     23678899999999943 69999999999654  67


Q ss_pred             cEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          197 PSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      .++||| +.+++|..++   ..+++..+..++.|++.||.|||++||+||||||+|||++.  +.+||+|||+++.....
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~--~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET--TEEEECCCSSSCC----
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC--CeEEEeeccccccccCc
Confidence            899999 5667777765   46899999999999999999999999999999999999974  68999999999866433


Q ss_pred             Cc---ceeecccccccccccccCC----------CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCc
Q 014762          274 KE---YNVRVASRYFKGPELLVDL----------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (419)
Q Consensus       274 ~~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~  340 (419)
                      ..   .....++..|+|||++.+.          ..++.++|||||||++|+|++|+.||.........+..+.   ...
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~  256 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII---DPN  256 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---CTT
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH---hcc
Confidence            22   2345789999999998641          3688999999999999999999999853332222222111   000


Q ss_pred             hHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                              .        ........++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       257 ------------------------~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          257 ------------------------H--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             ------------------------S--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             ------------------------c--------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence                                    0        000112257889999999999999999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=338.68  Aligned_cols=256  Identities=14%  Similarity=0.157  Sum_probs=196.6

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEecCcc--------------hHHHHHHHHHHHHhcCCCCeeE
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPVK--------------KKKIKREIKILQNLCGGPNVVK  184 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~~--------------~~~~~~E~~~l~~l~~h~niv~  184 (419)
                      ...++|++.+.||+|+||+||+|.+..   ++..+|+|++....              ...+.+|+.++..+ +||||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~  112 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPL  112 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCC
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcce
Confidence            456899999999999999999999987   78899999986432              12355778888888 9999999


Q ss_pred             EEeEEEcc--CCCccEEEEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC--
Q 014762          185 LLDIVRDQ--HSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--  257 (419)
Q Consensus       185 l~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~--  257 (419)
                      +++++...  .....++||||+ +++|..++.   .+++..+..++.|++.||+|||++||+||||||+|||++.+ +  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPD  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-STT
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CCC
Confidence            99998762  246789999999 899998874   58999999999999999999999999999999999999877 4  


Q ss_pred             cEEEEecccceeccCCC--------cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 014762          258 KLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (419)
Q Consensus       258 ~~kl~Dfgla~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~  329 (419)
                      .+||+|||+++......        ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.....+...
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            89999999998764321        1134578999999999987 67999999999999999999999999544444443


Q ss_pred             HHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       330 ~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ............            ......               ......+++++.++|.+||+.||++|||++++++
T Consensus       270 ~~~~~~~~~~~~------------~~~~~~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          270 VQTAKTNLLDEL------------PQSVLK---------------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHTT------------THHHHH---------------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhcccc------------cHHHHh---------------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            333222111000            000000               0001137899999999999999999999999876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.3e-44  Score=353.87  Aligned_cols=255  Identities=20%  Similarity=0.296  Sum_probs=191.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      .+.|...+.||+|+||+||.+ ...+|+.||||++.....+.+.+|+.++..+.+||||+++++++.+  ....++||||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E~   90 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALEL   90 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred             hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEec
Confidence            566777899999999999875 4568999999999876677888999999987689999999999965  4778999999


Q ss_pred             cCCCChhhhcCCC----------CHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC------------CCcEEE
Q 014762          204 VNSTDFKVLYPTL----------TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------LRKLRL  261 (419)
Q Consensus       204 ~~~~~l~~~~~~l----------~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~------------~~~~kl  261 (419)
                      ++ ++|.+++...          ++..+..++.|++.||+|||++||+||||||+|||++.+            ...+||
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            97 4887776321          223456799999999999999999999999999999753            247999


Q ss_pred             EecccceeccCCCc-----ceeecccccccccccccC------CCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014762          262 IDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVD------LQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQ  329 (419)
Q Consensus       262 ~Dfgla~~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~  329 (419)
                      +|||+++.......     .....||+.|+|||++.+      ...++.++|||||||++|||++ |..||.... ..+ 
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~-~~~-  247 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY-SRE-  247 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT-THH-
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch-hhH-
Confidence            99999987654332     223579999999999865      2568999999999999999999 888883221 111 


Q ss_pred             HHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       330 ~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                       ..+....             ...             ....    ......+++++.+||.+||+.||++|||+.++++|
T Consensus       248 -~~i~~~~-------------~~~-------------~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 -SNIIRGI-------------FSL-------------DEMK----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             -HHHHHTC-------------CCC-------------CCCT----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHhcCC-------------CCc-------------cccc----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence             1111100             000             0000    00011246789999999999999999999999999


Q ss_pred             CCcccc
Q 014762          410 SSISPI  415 (419)
Q Consensus       410 p~f~~~  415 (419)
                      |||.+.
T Consensus       297 p~f~~~  302 (434)
T 2rio_A          297 PLFWPK  302 (434)
T ss_dssp             GGGSCH
T ss_pred             CccCCc
Confidence            999753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-43  Score=336.08  Aligned_cols=248  Identities=20%  Similarity=0.323  Sum_probs=201.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEE-----cCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGIN-----VNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.+     ..+++.||+|+++...    .+.+.+|+.++.++.+||||+++++++... 
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-  103 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-  103 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence            467899999999999999999985     3577899999997532    356889999999997799999999998654 


Q ss_pred             CCccEEEEEecCCCChhhhcCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYPT-------------------LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~~-------------------l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~  254 (419)
                      ....++||||+++++|..++..                   +++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  183 (316)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence            3458899999999999888732                   788999999999999999999999999999999999998


Q ss_pred             CCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014762          255 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQL  330 (419)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~  330 (419)
                      + +.+||+|||+++........   ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||..........
T Consensus       184 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~  261 (316)
T 2xir_A          184 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  261 (316)
T ss_dssp             G-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             C-CCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence            7 78999999999866443322   23456788999999977 779999999999999999998 888884433333322


Q ss_pred             HHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       331 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      ..+... ..                                   ......+++++.+++.+||+.||++|||+.++++|
T Consensus       262 ~~~~~~-~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          262 RRLKEG-TR-----------------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHT-CC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccC-cc-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222211 00                                   00112368899999999999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.4e-43  Score=336.44  Aligned_cols=247  Identities=19%  Similarity=0.293  Sum_probs=200.5

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCc-----EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ  192 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~  192 (419)
                      ...++|++.+.||+|+||+||+|.+..++.     .||+|.+...    ..+.+.+|+.+++.+.+||||+++++++.. 
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  121 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-  121 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence            347899999999999999999999877664     7999999753    245688999999999779999999999954 


Q ss_pred             CCCccEEEEEecCCCChhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC
Q 014762          193 HSKTPSLIFEYVNSTDFKVLYP-----------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE  255 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~~-----------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~  255 (419)
                       ....++||||+++++|..++.                 .+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus       122 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          122 -GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             -CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence             467899999999999988752                 37899999999999999999999999999999999999988


Q ss_pred             CCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 014762          256 LRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLV  331 (419)
Q Consensus       256 ~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~  331 (419)
                       +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.. ........
T Consensus       201 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~  277 (333)
T 2i1m_A          201 -HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPG-ILVNSKFY  277 (333)
T ss_dssp             -GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT-CCSSHHHH
T ss_pred             -CeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcc-cchhHHHH
Confidence             88999999999865433322   23456778999999887 679999999999999999998 8888743 33322222


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      .+......                                   ......+++++.+++.+||+.||++|||+.++++
T Consensus       278 ~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          278 KLVKDGYQ-----------------------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHTCC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCC-----------------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            22211000                                   0011236889999999999999999999999987

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-42  Score=326.93  Aligned_cols=249  Identities=16%  Similarity=0.268  Sum_probs=198.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.+++.+ .|++++..+..+... ....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHh-hcCCCCCccccccCC-CCceEEEE
Confidence            367899999999999999999999999999999998643 346789999999999 777766656655433 36778999


Q ss_pred             EecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEc---CCCCcEEEEecccceeccCCC
Q 014762          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~---~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ||+ +++|.+++    ..+++..+..++.|++.||+|||++||+||||||+|||++   .+ +.+||+|||+++......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~-~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGT-TCEEECCCTTCEECBCTT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCC-CeEEEeeCCCcccccccc
Confidence            999 88888776    3689999999999999999999999999999999999995   44 789999999998765433


Q ss_pred             c--------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--CCHHHHHHHHHHcCCchHHH
Q 014762          275 E--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH--DNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       275 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~--~~~~~~~~i~~~lg~~~~~~  344 (419)
                      .        .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||....  +..+.+..+....-..+...
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence            2        234578999999999987 679999999999999999999999995422  22223333222100000000


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                      ....+++++.+|+.+||+.||++|||+.++++
T Consensus       242 --------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          242 --------------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             --------------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             --------------------------------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                                            01237899999999999999999999999886

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.5e-43  Score=356.71  Aligned_cols=244  Identities=18%  Similarity=0.350  Sum_probs=201.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.++||+|+||+||+|.+..++..||||+++..  ..+.+.+|+.+++++ +||||++++++|..  ....++|
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--~~~~~lv  294 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII  294 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEec--CCcEEEE
Confidence            467899999999999999999999999999999999753  457899999999999 99999999999955  4678899


Q ss_pred             EEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+.+++|..++     ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCEECCTTCCE
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-CcEEEeecccceeccCCce
Confidence            9999999998887     348899999999999999999999999999999999999988 7899999999987653322


Q ss_pred             c--eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .  ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+...            .   
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~------------~---  436 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKD------------Y---  436 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTT------------C---
T ss_pred             eecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC------------C---
Confidence            1  12345567999999876 679999999999999999999 87777 333333322222110            0   


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                           ....+..+++++.+||.+||+.||++|||+.++++
T Consensus       437 ---------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 ---------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                                 00112247899999999999999999999999976

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.2e-43  Score=336.13  Aligned_cols=246  Identities=19%  Similarity=0.308  Sum_probs=198.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-------CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-------NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (419)
                      ..++|++.+.||+|+||+||+|.+.       .++..||+|+++...    .+.+.+|+.+++.+.+||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            4688999999999999999999875       467789999997532    35688999999999789999999999955


Q ss_pred             cCCCccEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE
Q 014762          192 QHSKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (419)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl  252 (419)
                        ....++||||+++++|..++.                   .+++..+..++.|++.||+|||++||+|+||||+|||+
T Consensus       113 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          113 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             --SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             --CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence              467899999999999988762                   27889999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014762          253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHD  328 (419)
Q Consensus       253 ~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~  328 (419)
                      +.+ +.+||+|||+++........   ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+
T Consensus       191 ~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~  267 (334)
T 2pvf_A          191 TEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVEE  267 (334)
T ss_dssp             CTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-TCCHHH
T ss_pred             cCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcC-cCCHHH
Confidence            988 88999999999876543322   22356678999999877 678999999999999999999 888873 333222


Q ss_pred             HHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       329 ~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ....+.....                                    ......+++++.+++.+||+.||++|||+.|+++
T Consensus       268 ~~~~~~~~~~------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  311 (334)
T 2pvf_A          268 LFKLLKEGHR------------------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  311 (334)
T ss_dssp             HHHHHHHTCC------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCC------------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2222211000                                    0011237889999999999999999999999987


Q ss_pred             C
Q 014762          409 I  409 (419)
Q Consensus       409 h  409 (419)
                      +
T Consensus       312 ~  312 (334)
T 2pvf_A          312 D  312 (334)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.2e-43  Score=331.77  Aligned_cols=248  Identities=24%  Similarity=0.431  Sum_probs=191.4

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ...++|++.+.||+|+||+||+|.+..+|+.||+|++...      ..+.+.+|+.+++.+ +||||+++++++...  .
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~  105 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIED--N  105 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--T
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--C
Confidence            3467899999999999999999999999999999998642      235688999999999 999999999999764  6


Q ss_pred             ccEEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          196 TPSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                      ..++||||+++++|..++       ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++.
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~  184 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGR  184 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCC----
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC-CCEEEEecccee
Confidence            788999999999998876       348999999999999999999999999999999999999987 789999999987


Q ss_pred             eccCCCc-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          269 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       269 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ....... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........+.........+       
T Consensus       185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  256 (310)
T 2wqm_A          185 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-------  256 (310)
T ss_dssp             --------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC-------
T ss_pred             eecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC-------
Confidence            6543322 234578899999999877 7899999999999999999999999964433332222211110000       


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                 ......+++++.+|+.+||..||++|||+.++++
T Consensus       257 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          257 ---------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             ---------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                                       0001237889999999999999999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.2e-43  Score=347.86  Aligned_cols=241  Identities=17%  Similarity=0.344  Sum_probs=197.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ..++|++.+.||+|+||+||+|.+  .|+.||||+++.. ..+.+.+|+.+++++ +||||+++++++.... ...++||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~~iv~  266 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GGLYIVT  266 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECTT-SCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCC-CceEEEE
Confidence            467899999999999999999976  4789999999754 457899999999999 9999999999986542 4688999


Q ss_pred             EecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      ||+++++|..++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.....  .
T Consensus       267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~--~  343 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--Q  343 (450)
T ss_dssp             ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-SCEEECCCTTCEECC-----
T ss_pred             EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-CCEEEeeCCCccccccc--c
Confidence            9999999988873     27899999999999999999999999999999999999988 88999999999864322  2


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+.+.            .      
T Consensus       344 ~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~-~~~~~~~~~~i~~~------------~------  403 (450)
T 1k9a_A          344 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKG------------Y------  403 (450)
T ss_dssp             ---CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSST-TSCTTTHHHHHHTT------------C------
T ss_pred             cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcC------------C------
Confidence            23366788999999987 789999999999999999998 998873 33333333222110            0      


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                        ....+..+++++.+||.+||+.||++|||+.++++
T Consensus       404 ------------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          404 ------------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                              00112347899999999999999999999999976

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.9e-43  Score=329.79  Aligned_cols=244  Identities=18%  Similarity=0.342  Sum_probs=202.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.+.||+|+||+||+|.+..++..||+|++...  ..+.+.+|+.+++.+ +||||+++++++.+  ....++|
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v   87 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII   87 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCEEEE
Confidence            578899999999999999999999999999999999754  346788999999999 89999999999954  4678999


Q ss_pred             EEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+++++|..++     ..+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++........
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-GCEEECCCCGGGTSCSSSS
T ss_pred             EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-CCEEEccCccceeccCCcc
Confidence            9999999998876     238999999999999999999999999999999999999988 7899999999987654332


Q ss_pred             c--eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .  ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +.+..+....+....               
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~-~~~~~~~~~~~~~~~---------------  229 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKDY---------------  229 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGGHHHHHHTTC---------------
T ss_pred             ccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhccC---------------
Confidence            2  23456778999999977 679999999999999999999 877773 333222222221100               


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                           .......+++++.+|+.+||+.||++|||+.++++
T Consensus       230 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          230 ---------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                                 00111237899999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.7e-43  Score=327.21  Aligned_cols=249  Identities=16%  Similarity=0.271  Sum_probs=194.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.. ...+.+.+|+.+++.+ .|++++..++.+... ....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecCC-CCceEEEE
Confidence            46889999999999999999999999999999998753 3345788999999999 677766666655432 36778999


Q ss_pred             EecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE---cCCCCcEEEEecccceeccCCC
Q 014762          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl---~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ||+ +++|..++    ..+++..+..++.|++.||.|||++||+||||||+|||+   +.+ +.+||+|||+++......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG-NLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGT-TCEEECCCTTCEECBCTT
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCC-CeEEEecCccceeccCcc
Confidence            999 88888775    468999999999999999999999999999999999999   555 789999999998765432


Q ss_pred             c--------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHcCCchHHH
Q 014762          275 E--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD--NHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       275 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~--~~~~~~~i~~~lg~~~~~~  344 (419)
                      .        .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.....  ..+....+....-..+...
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence            2        234578999999999987 6799999999999999999999999954221  1122222221100000000


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                      ....+++++.+|+.+||+.||++|||+.++++
T Consensus       242 --------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          242 --------------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             --------------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             --------------------------------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                                            01236889999999999999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.5e-43  Score=326.90  Aligned_cols=244  Identities=23%  Similarity=0.394  Sum_probs=195.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.+.||+|+||+||+|.+..   ++..||+|.+...    ..+.+.+|+.+++.+ +||||+++++++.+   .
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE---E   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS---S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---C
Confidence            46789999999999999999998654   3446999998753    346788999999999 99999999999854   3


Q ss_pred             ccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+.+++|..++    ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||++....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCCCGGGCC-
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCccCCCcccc
Confidence            468999999999998877    348999999999999999999999999999999999999988 899999999998654


Q ss_pred             CCCc--ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          272 PGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       272 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ....  .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||... +..+....+.....          
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~-~~~~~~~~~~~~~~----------  232 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEKGDR----------  232 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CGGGHHHHHHHTCC----------
T ss_pred             cccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccC-ChHHHHHHHhcCCC----------
Confidence            4322  223456778999999876 679999999999999999998 99998432 22222222211000          


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                ......+++.+.+++.+||+.||++|||+.|++++
T Consensus       233 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          233 --------------------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                      00112378899999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.9e-44  Score=341.14  Aligned_cols=274  Identities=19%  Similarity=0.299  Sum_probs=201.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHH--HhcCCCCeeEEEeEEEc---cCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ--NLCGGPNVVKLLDIVRD---QHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~--~l~~h~niv~l~~~~~~---~~~~~~  197 (419)
                      ..++|++.+.||+|+||+||+|.+  +++.||||+++......+..|..++.  .+ +||||+++++.+..   ......
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceE
Confidence            467899999999999999999965  78999999998777777766666654  36 89999999986643   233457


Q ss_pred             EEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---------CcEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          198 SLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---------~ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ++||||+++++|..++  ...++..+..++.|++.||+|||+.         ||+||||||+|||++.+ +.+||+|||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kL~DFG~  166 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGL  166 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-SCEEECCCTT
T ss_pred             EEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-CcEEEeeccc
Confidence            8999999999999887  4578899999999999999999999         99999999999999988 8899999999


Q ss_pred             ceeccCCC---------cceeecccccccccccccCC------CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014762          267 AEFYHPGK---------EYNVRVASRYFKGPELLVDL------QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (419)
Q Consensus       267 a~~~~~~~---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~  331 (419)
                      ++......         ......||..|+|||++.+.      ..++.++|||||||++|||++|+.||+.+....+...
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            98764322         11234689999999998752      2456789999999999999999999887655433222


Q ss_pred             HHHHHcCC-chHHHHHhhcCCCCChhhHHhhccC-CCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc-
Q 014762          332 KIAKVLGT-DELNAYLNKYHLELDPQLDALVGRH-SRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV-  408 (419)
Q Consensus       332 ~i~~~lg~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~-  408 (419)
                      .+....+. +.....            ....... ........  ......+++++.+||.+||+.||++|||+.|+++ 
T Consensus       247 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDM------------QVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             TTHHHHCSSCCHHHH------------HHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhhcccCCCchHHHH------------HhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence            22222221 111111            0001000 00111100  0011124568999999999999999999999954 


Q ss_pred             -----CCCccc
Q 014762          409 -----ISSISP  414 (419)
Q Consensus       409 -----hp~f~~  414 (419)
                           ++|-++
T Consensus       313 L~~ll~~~~~~  323 (336)
T 3g2f_A          313 MAELMMIWERN  323 (336)
T ss_dssp             HHHHHHCCCC-
T ss_pred             HHHHHHHHHhc
Confidence                 566654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-42  Score=329.84  Aligned_cols=245  Identities=20%  Similarity=0.308  Sum_probs=190.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++...      .+.+.+|+.+++.+ +||||+++++++...  ...
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~~  109 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEID--GQL  109 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeC--CeE
Confidence            578999999999999999999999999999999986432      36688999999999 999999999999664  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||+++++|..++   ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||++.......
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSCCC--------
T ss_pred             EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC-CCEEEecCccCccccccc
Confidence            9999999999998887   459999999999999999999999999999999999999988 789999999987654432


Q ss_pred             c--ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          275 E--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       275 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .  .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...  ....+..........            
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~------------  253 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGD--QLSVMGAHINQAIPR------------  253 (309)
T ss_dssp             --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSC--HHHHHHHHHHSCCCC------------
T ss_pred             cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCc--hHHHHHHHhccCCCC------------
Confidence            2  234578899999999877 78899999999999999999999998421  111221111110000            


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-CHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-TAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-ta~elL~  408 (419)
                                           .......+++++.++|.+||+.||++|| |++++++
T Consensus       254 ---------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          254 ---------------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ---------------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ---------------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence                                 0011224788999999999999999999 8888765

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.5e-43  Score=344.25  Aligned_cols=244  Identities=18%  Similarity=0.328  Sum_probs=187.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.+.||+|+||+||+|++.   .++..||||+++..    ..+.+.+|+.+++++ +||||+++++++.+  ..
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~  119 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTK--SK  119 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CC
Confidence            4568999999999999999999876   46778999998743    245688999999999 99999999999954  46


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-CCEEECcCccccccc
Confidence            7889999999999998872    58999999999999999999999999999999999999988 889999999998765


Q ss_pred             CCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .....    ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||.. .+..+....+....         
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~-~~~~~~~~~i~~~~---------  267 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWE-MSNQDVIKAVDEGY---------  267 (373)
T ss_dssp             ---------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTT-CCHHHHHHHHHTTE---------
T ss_pred             cCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCC---------
Confidence            43221    12234667999999977 789999999999999999998 9999842 22222222211100         


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                 .......++.++.+++.+||+.||++|||+.++++
T Consensus       268 ---------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          268 ---------------------------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             ---------------------------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence                                       00011236889999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.5e-43  Score=324.71  Aligned_cols=244  Identities=16%  Similarity=0.319  Sum_probs=199.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +.++|++.+.||+|+||+||+|.+. +++.||+|++...  ..+.+.+|+.+++.+ +||||+++++++.+  ....++|
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv   81 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLV   81 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCeEEE
Confidence            4578999999999999999999875 6788999999754  457889999999999 89999999999955  4678899


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      |||+++++|..++    ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++........ 
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHHHH
T ss_pred             EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-CCEEEccccccccccccccc
Confidence            9999999998876    348999999999999999999999999999999999999987 7899999999976543211 


Q ss_pred             -ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +.+..+....+....                
T Consensus       161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~i~~~~----------------  222 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGF----------------  222 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTC----------------
T ss_pred             ccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCC-CCCHHHHHHHHhcCC----------------
Confidence             123456678999999876 678999999999999999999 788873 333222222221100                


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                          ....+..+++++.+++.+||+.||++|||+.+++++
T Consensus       223 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          223 --------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                000112368899999999999999999999999873

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.2e-42  Score=324.07  Aligned_cols=242  Identities=17%  Similarity=0.312  Sum_probs=198.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.+.||+|+||+||+|.+. ++..||+|.++..  ..+.+.+|+.+++.+ +||||+++++++.+   ...++|
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v   85 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYII   85 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC---CCcEEE
Confidence            3678999999999999999999864 6778999999753  457889999999999 99999999999853   457899


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+.+++|.+++.     .+++..+..++.|++.||+|||++||+|+||||+||+++.+ +.+||+|||++........
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred             EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CCEEECCCcccccccCccc
Confidence            99999999999885     58999999999999999999999999999999999999987 8899999999987654332


Q ss_pred             c--eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .  ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +.+..+....+.+..               
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~~~~~---------------  227 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYP-GMTNPEVIQNLERGY---------------  227 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTTC---------------
T ss_pred             ccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCc-ccCHHHHHHHHhccc---------------
Confidence            2  22345678999999876 678999999999999999999 888873 333333222221100               


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                           .......+++++.+++.+||+.||++|||+.++++
T Consensus       228 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          228 ---------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                 00011237899999999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.5e-44  Score=370.03  Aligned_cols=276  Identities=23%  Similarity=0.368  Sum_probs=206.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEc----cCCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRD----QHSK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~----~~~~  195 (419)
                      .++|++.++||+|+||+||+|.+..+|+.||||+++..    ..+.+.+|+.+++++ +||||+++++++..    ....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCC
Confidence            47899999999999999999999999999999998643    245688999999999 99999999999754    1246


Q ss_pred             ccEEEEEecCCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC--cEEEEecccc
Q 014762          196 TPSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR--KLRLIDWGLA  267 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~--~~kl~Dfgla  267 (419)
                      ..++||||+++++|..++.      .+++..+..++.|++.||+|||++||+||||||+|||++.+..  .+||+|||++
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            6789999999999988873      4889999999999999999999999999999999999987622  4899999999


Q ss_pred             eeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          268 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       268 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      .............+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... ...   ..........    
T Consensus       172 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-~~~---~~~i~~~~~~----  242 (676)
T 3qa8_A          172 KELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-VQW---HGKVREKSNE----  242 (676)
T ss_dssp             CBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-HHS---STTCC---------
T ss_pred             cccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccch-hhh---hhhhhcccch----
Confidence            88766655566789999999999877 78999999999999999999999999532111 000   0000000000    


Q ss_pred             hcCCCCChhhHHhhccCCCCCcccccc--ccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFIN--ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                        ........      .....+.....  ......+++.+.+||.+||++||++|||+.++++||||+.+.+
T Consensus       243 --~~~~~~~l------~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          243 --HIVVYDDL------TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             ---CCSCCCC------SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             --hhhhhhhh------ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence              00000000      00001111100  0111236788999999999999999999999999999998754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.3e-43  Score=350.75  Aligned_cols=242  Identities=15%  Similarity=0.291  Sum_probs=199.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.++||+|+||+||+|.+. ++..||||+++..  ..+.+.+|+.+++.+ +||||+++++++..   ...++|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~---~~~~lv  260 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYII  260 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEeC---CccEEE
Confidence            4678999999999999999999864 5778999999753  457899999999999 99999999999852   567899


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+.+++|..++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus       261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCHHH
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCCce
Confidence            99999999998874     58899999999999999999999999999999999999988 8899999999986543221


Q ss_pred             --ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                        .....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.....              
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~~~--------------  403 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGYR--------------  403 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHHTCC--------------
T ss_pred             eccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCC--------------
Confidence              122345678999999876 679999999999999999999 88887 34443333333222100              


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                            ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       404 ----------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          404 ----------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence                                  0011237899999999999999999999999876

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.5e-43  Score=334.65  Aligned_cols=251  Identities=18%  Similarity=0.330  Sum_probs=202.2

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.+.     .+++.||+|.+....    ...+.+|+.+++.+ +||||+++++++.+  
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--   99 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--   99 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEcc--
Confidence            4678999999999999999999876     467889999997432    34688999999999 99999999999954  


Q ss_pred             CCccEEEEEecCCCChhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEE
Q 014762          194 SKTPSLIFEYVNSTDFKVLY-------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~k  260 (419)
                      ....++||||+++++|..++             ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+|
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~-~~~k  178 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK  178 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEE
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC-CeEE
Confidence            46788999999999998876             246889999999999999999999999999999999999988 7899


Q ss_pred             EEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014762          261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (419)
Q Consensus       261 l~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~  336 (419)
                      |+|||+++.......   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+.+.
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~  256 (322)
T 1p4o_A          179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEG  256 (322)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTT-TTSCHHHHHHHHHTT
T ss_pred             ECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCcc-ccCCHHHHHHHHHcC
Confidence            999999976543322   122356778999999877 679999999999999999999 77776 333332222222110


Q ss_pred             cCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC------C
Q 014762          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI------S  410 (419)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h------p  410 (419)
                       ..                                   ......+++++.+|+.+||+.||++|||+.|++++      +
T Consensus       257 -~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          257 -GL-----------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             -CC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             -Cc-----------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence             00                                   00112378999999999999999999999999986      6


Q ss_pred             Ccccc
Q 014762          411 SISPI  415 (419)
Q Consensus       411 ~f~~~  415 (419)
                      +|+.+
T Consensus       301 ~~~~~  305 (322)
T 1p4o_A          301 GFREV  305 (322)
T ss_dssp             THHHH
T ss_pred             CCccc
Confidence            66654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.3e-43  Score=329.13  Aligned_cols=247  Identities=15%  Similarity=0.305  Sum_probs=189.0

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ...++|++.++||+|+||+||+|.+.   ..+|+|+++..     ..+.+.+|+.+++.+ +||||+++++++..   ..
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~---~~   93 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQ   93 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SS
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeeccC---Cc
Confidence            45788999999999999999999753   35999998632     235688999999999 89999999997633   45


Q ss_pred             cEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+.+++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSR  172 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC-------
T ss_pred             cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CCEEEccceecccccc
Confidence            78999999999998877    348999999999999999999999999999999999999988 8999999999976543


Q ss_pred             C---CcceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          273 G---KEYNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       273 ~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      .   .......+|..|+|||++..  ...++.++|||||||++|+|++|+.||.. ....+.+..+.......+      
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~------  245 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN-INNRDQIIEMVGRGSLSP------  245 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS-CCCHHHHHHHHHHTSCCC------
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc-cchHHHHHHHhcccccCc------
Confidence            1   22234578999999999862  25688999999999999999999999843 344444433332111100      


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                          .+.     .....+++++.+|+.+||+.||++|||+.++++
T Consensus       246 --------------------~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          246 --------------------DLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             --------------------CTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------chh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                000     011237899999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.4e-43  Score=328.01  Aligned_cols=245  Identities=20%  Similarity=0.297  Sum_probs=196.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..+|++.+.||+|+||+||+|.+..++   ..+|+|.++...    .+.+.+|+.+++++ +||||+++++++... ...
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~  101 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGS  101 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS-SSC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcC-CCc
Confidence            456999999999999999999865433   358999987432    35688999999999 899999999997543 356


Q ss_pred             cEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYD  180 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSCGGGCCCSC
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-CCEEECcccccccccc
Confidence            789999999999988873    48899999999999999999999999999999999999988 7999999999986543


Q ss_pred             CCc-----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          273 GKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       273 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ...     .....+|..|+|||.+.+ ..++.++|||||||++|+|++|..|++.+.+..+....+.....         
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~---------  250 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---------  250 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---------
T ss_pred             cchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---------
Confidence            321     223456778999999977 67999999999999999999977777666555444433322100         


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                 ......+++.+.+++.+||+.||++|||+.|+++
T Consensus       251 ---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 ---------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                       0011236889999999999999999999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.5e-43  Score=338.26  Aligned_cols=246  Identities=18%  Similarity=0.306  Sum_probs=197.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEE--EEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERC--IIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~v--avK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ..++|++.+.||+|+||+||+|.+..++..+  |+|.++..    ..+.+.+|+.++.++.+||||+++++++.+.  ..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~~  100 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY  100 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--Cc
Confidence            3578999999999999999999999888865  99988642    3456889999999997899999999999654  67


Q ss_pred             cEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC
Q 014762          197 PSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~  257 (419)
                      .++||||+++++|..++.                   .+++..+..++.|++.||+|||++||+||||||+|||++.+ +
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~  179 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y  179 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-G
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC-C
Confidence            899999999999988762                   48999999999999999999999999999999999999988 7


Q ss_pred             cEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014762          258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKV  336 (419)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~  336 (419)
                      .+||+|||+++............++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +.+..+....+...
T Consensus       180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQG  257 (327)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHGGGT
T ss_pred             eEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCC-CCcHHHHHHHhhcC
Confidence            899999999975433333344566788999999876 678999999999999999998 999983 22222211111000


Q ss_pred             cCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       337 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                          ........+++++.+|+.+||+.||++|||+++++++
T Consensus       258 ------------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          258 ------------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ------------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                                0001112368899999999999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=325.87  Aligned_cols=244  Identities=17%  Similarity=0.327  Sum_probs=198.7

Q ss_pred             CCCCeEEEe-eeeeeCceEEEEEEEc--CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVR-KVGRGKYSEVFEGINV--NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~-~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|.+.+ .||+|+||+||+|.+.  .++..||+|+++..    ..+.+.+|+.+++.+ +||||+++++++..   .
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~   82 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E   82 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC---C
Confidence            467788887 9999999999999854  46788999999753    245688999999999 99999999999943   4


Q ss_pred             ccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+++++|..++    ..+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||++....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALG  161 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcccceeeec
Confidence            578999999999999887    348999999999999999999999999999999999999987 899999999998765


Q ss_pred             CCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .....    ....+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +.+..+....+...  .       
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~i~~~--~-------  230 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQG--K-------  230 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCTHHHHHHHHTT--C-------
T ss_pred             cCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHhcC--C-------
Confidence            43322    22345778999999876 678999999999999999998 999983 33333333222110  0       


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                 .......+++++.++|.+||+.||++|||+.+++++
T Consensus       231 ---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          231 ---------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             ---------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                       000112378999999999999999999999999985

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.2e-43  Score=332.18  Aligned_cols=247  Identities=19%  Similarity=0.314  Sum_probs=190.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcC---CCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVN---TNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|.+.+.||+|+||+||+|.+..   ++..||+|+++..     ..+.+.+|+.+++++ +||||+++++++.....
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC---
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccc
Confidence            46789999999999999999998765   5568999998643     235688999999999 89999999999976533


Q ss_pred             C---ccEEEEEecCCCChhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEE
Q 014762          195 K---TPSLIFEYVNSTDFKVLY---------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (419)
Q Consensus       195 ~---~~~lv~e~~~~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~  262 (419)
                      .   ..++||||+++++|..++         ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kl~  189 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-MTVCVA  189 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT-SCEEEC
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEEe
Confidence            2   458999999999998876         358999999999999999999999999999999999999988 789999


Q ss_pred             ecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcC
Q 014762          263 DWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLG  338 (419)
Q Consensus       263 Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg  338 (419)
                      |||+++.......   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+.....
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPY-PGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTTCC
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCC-ccCCHHHHHHHHHcCCC
Confidence            9999976643322   223456778999999987 789999999999999999999 77776 33333333322221000


Q ss_pred             CchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          339 TDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                          ......+++++.+++.+||+.||++|||+.+++++
T Consensus       268 ------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 ------------------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ------------------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ------------------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                                00112378899999999999999999999999873

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=329.20  Aligned_cols=241  Identities=21%  Similarity=0.303  Sum_probs=190.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      +.++|++.+.||+|+||+||+|.+  .++.||+|.+... ..+.+.+|+.+++++ +||||+++++++.    ...++||
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~----~~~~lv~   78 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACL----NPVCLVM   78 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCT----TTTEEEE
T ss_pred             CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEc----CCcEEEE
Confidence            467899999999999999999976  4788999999654 456789999999999 9999999999884    2378999


Q ss_pred             EecCCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          202 EYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHS---QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       202 e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ||+++++|..++.      .+++..+..++.|++.||+|||+   +||+||||||+|||++.+...+||+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            9999999988873      36888999999999999999999   89999999999999998744589999999976542


Q ss_pred             CCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          273 GKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       273 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                      .  .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||................ +.             
T Consensus       159 ~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~-------------  221 (307)
T 2eva_A          159 H--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GT-------------  221 (307)
T ss_dssp             --------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TC-------------
T ss_pred             c--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CC-------------
Confidence            2  234568999999999877 789999999999999999999999985333222211111100 00             


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                           .......+++.+.+++.+||+.||++|||+.++++
T Consensus       222 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          222 ---------------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             ---------------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                 00011237889999999999999999999999987

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-43  Score=334.07  Aligned_cols=244  Identities=18%  Similarity=0.329  Sum_probs=192.2

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEE----EEEEecC----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERC----IIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~v----avK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ...++|++.+.||+|+||+||+|.+..+++.+    |+|.+..    ...+.+.+|+.+++.+ +||||+++++++... 
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS-
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC-
Confidence            34788999999999999999999998888765    6666642    3457889999999999 899999999999753 


Q ss_pred             CCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                        ..++|++|+.++++..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        90 --~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~  166 (327)
T 3lzb_A           90 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKL  166 (327)
T ss_dssp             --SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC---
T ss_pred             --CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCcceeE
Confidence              377999999999998876    358999999999999999999999999999999999999988 8899999999987


Q ss_pred             ccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          270 YHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       270 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      .......   ....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+... .       
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~~-~-------  236 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKG-E-------  236 (327)
T ss_dssp             -------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTT-C-------
T ss_pred             ccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHcC-C-------
Confidence            6433322   22345678999999987 789999999999999999999 888883 33322222211110 0       


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                  .......++.++.+++++||+.||++|||+.|+++
T Consensus       237 ----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          237 ----------------------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             ----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                        00011236889999999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.8e-43  Score=331.99  Aligned_cols=258  Identities=16%  Similarity=0.239  Sum_probs=199.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|++...   ..+.+.+|+.+++.+ +||||+++++++..  ....++
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDE--RNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCC--TTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeEEE
Confidence            478899999999999999999985 57899999998643   346788999999999 89999999999954  467889


Q ss_pred             EEEecCCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          200 IFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       200 v~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      ||||+++++|..++.       .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT-CCEEECCCTTCEECSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC-CCEEEeeccccccccc
Confidence            999999999988873       38899999999999999999999999999999999999988 8999999999986543


Q ss_pred             CC---cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCH--HHHHHHHHHcCCchHHHHHh
Q 014762          273 GK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNH--DQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       273 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~--~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ..   ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||.......  ............        
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~--------  262 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN--------  262 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT--------
T ss_pred             ccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc--------
Confidence            22   2233468899999999877 679999999999999999999999995432211  000000000000        


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                       .  ....            .............++..+.+++.+||+.||++|||+.|++++
T Consensus       263 -~--~~~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          263 -G--QLEQ------------IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             -T--CCCS------------SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -c--cHHH------------hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             0  0000            000000000111245678999999999999999999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=325.78  Aligned_cols=245  Identities=20%  Similarity=0.310  Sum_probs=199.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .-.|.+.++||+|+||+||+|.+..++.   .+|+|.++...    .+.+.+|+.+++.+ +||||+++++++.+.. ..
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~   97 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPE-GL   97 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSS-SC
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCC-CC
Confidence            3457778999999999999998765554   79999987432    35688999999999 9999999999996543 34


Q ss_pred             cEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+.+++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-FTVKVADFGLARDILD  176 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECCTTSSCTTTT
T ss_pred             cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEeCcCCCcccccC
Confidence            58999999999998886    348899999999999999999999999999999999999988 7899999999975543


Q ss_pred             CC-----cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          273 GK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       273 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ..     ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|++...+..+....+......        
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--------  247 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL--------  247 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC--------
T ss_pred             CcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC--------
Confidence            22     2233466788999999977 789999999999999999999888887665554443333221100        


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                  .....+++++.+++.+||+.||++|||+.++++
T Consensus       248 ----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          248 ----------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                        011236889999999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.8e-43  Score=334.34  Aligned_cols=260  Identities=17%  Similarity=0.228  Sum_probs=198.8

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ...++|++.+.||+|+||+||+|.+ .+|+.||+|++....    ...+.+|+.+++.+ +||||+++++++..  ....
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~  102 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT--PTER  102 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECC--SSCC
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEec--CCce
Confidence            4578899999999999999999974 578999999987533    23688999999999 89999999999955  4667


Q ss_pred             EEEEEecCCCChhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeecCCCCceEEcCCCCcEEEEecccc
Q 014762          198 SLIFEYVNSTDFKVLYP-------TLTDYDIRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHELRKLRLIDWGLA  267 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlk~~NILl~~~~~~~kl~Dfgla  267 (419)
                      ++||||+.+++|..++.       .+++..+..++.|++.||+|||++   ||+||||||+|||++.+ +.+||+|||++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~~  181 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA  181 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEEECCCSSC
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEEeccCccc
Confidence            89999999999988762       289999999999999999999999   99999999999999988 78999999999


Q ss_pred             eeccCCCc--ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          268 EFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       268 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      +.......  .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......        . -.......+
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~-~~~~~~~~~  251 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLA--------N-DDDVMLLDW  251 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT--------T-TSCSBHHHH
T ss_pred             cccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccc--------c-ccchhHHHH
Confidence            87653332  233458999999999876 67899999999999999999999998310000        0 000000111


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccc----cccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCC
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINA----DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVIS  410 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp  410 (419)
                      ...              .............    ......++.+.+++.+||+.||++|||+.|+++|-
T Consensus       252 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          252 VKG--------------LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             HTT--------------TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             HHH--------------HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence            000              0000000011100    11112346789999999999999999999999863

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.9e-43  Score=322.81  Aligned_cols=242  Identities=17%  Similarity=0.261  Sum_probs=196.1

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|++.+.||+|+||+||+|.+  +++.||+|+++...     .+.+.+|+.+++.+ +||||+++++++.+......
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSC
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCe
Confidence            357899999999999999999987  48899999997432     35688999999999 89999999999977655788


Q ss_pred             EEEEEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          198 SLIFEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ++||||+++++|..++.     .+++..+..++.|++.||+|||++|  ++|+||||+|||++.+ +.++|+|||++...
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSF  163 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTT
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceeee
Confidence            99999999999998873     3899999999999999999999999  9999999999999988 78899999887543


Q ss_pred             cCCCcceeecccccccccccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ..    ....+|+.|+|||++.+..  .++.++|||||||++|+|++|+.||. +.+..+....+.....          
T Consensus       164 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~~----------  228 (271)
T 3kmu_A          164 QS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DLSNMEIGMKVALEGL----------  228 (271)
T ss_dssp             SC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT-TSCHHHHHHHHHHSCC----------
T ss_pred             cc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc-ccChHHHHHHHHhcCC----------
Confidence            22    2357889999999987621  23348999999999999999999984 2222222222211000          


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                               ....+..+++++.+++.+||+.||++|||++++++
T Consensus       229 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          229 -------------------------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             -------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     00111237899999999999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=6.5e-43  Score=338.94  Aligned_cols=240  Identities=15%  Similarity=0.222  Sum_probs=195.4

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEE-----EEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcC---CCCeeEEEeEEEccC
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVKKKKIKREIKILQNLCG---GPNVVKLLDIVRDQH  193 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~---h~niv~l~~~~~~~~  193 (419)
                      ...++|++.++||+|+||+||+|     .+..+++.||+|+++......+.+|+.++..+ .   |+||+++++++... 
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l-~~~~~~~iv~~~~~~~~~-  139 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERL-KPSMQHMFMKFYSAHLFQ-  139 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHS-CGGGGGGBCCEEEEEECS-
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHh-hhhhhhhhhhhheeeecC-
Confidence            34788999999999999999999     46788999999999988888999999999988 5   89999999999654 


Q ss_pred             CCccEEEEEecCCCChhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC-----------
Q 014762          194 SKTPSLIFEYVNSTDFKVLY--------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-----------  254 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~-----------  254 (419)
                       ...++||||+++++|..++        ..+++..+..++.|++.||+|||++||+||||||+|||++.           
T Consensus       140 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~  218 (365)
T 3e7e_A          140 -NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL  218 (365)
T ss_dssp             -SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred             -CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence             6678999999999998886        24899999999999999999999999999999999999987           


Q ss_pred             CCCcEEEEecccceecc---CCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014762          255 ELRKLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (419)
Q Consensus       255 ~~~~~kl~Dfgla~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~  331 (419)
                      + +.+||+|||+++...   .........||..|+|||++.+ ..++.++|||||||++|||++|+.||.........  
T Consensus       219 ~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--  294 (365)
T 3e7e_A          219 S-AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK--  294 (365)
T ss_dssp             C-TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred             c-CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence            5 789999999997653   2233345679999999999987 67999999999999999999999998432111000  


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                              ..........++.+.+++.+||+.+|.+|++..+.+.
T Consensus       295 ----------------------------------------~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          295 ----------------------------------------PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             ----------------------------------------ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             ----------------------------------------echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence                                                    0000000114667899999999999999976544444

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-42  Score=325.89  Aligned_cols=243  Identities=18%  Similarity=0.321  Sum_probs=195.7

Q ss_pred             CCCCeEEEe-eeeeeCceEEEEEEE--cCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVR-KVGRGKYSEVFEGIN--VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~-~lG~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|++.+ .||+|+||+||+|.+  ..+++.||+|+++...     .+.+.+|+.+++.+ +||||+++++++..   
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---   89 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---   89 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEECC---
Confidence            467899998 999999999999954  5678899999997432     46788999999999 89999999999943   


Q ss_pred             CccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ...++||||+++++|..++   ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||++....
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALR  168 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCCcceeec
Confidence            5678999999999998886   458999999999999999999999999999999999999988 899999999998765


Q ss_pred             CCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .....    ....++..|+|||++.+ ..++.++||||||+++|+|++ |+.||. +.+..+ ..........       
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~-~~~~~~~~~~-------  238 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSE-VTAMLEKGER-------  238 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST-TCCHHH-HHHHHHTTCC-------
T ss_pred             cCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCC-CCCHHH-HHHHHHcCCC-------
Confidence            44332    12345678999999876 678999999999999999999 998883 222222 2211110000       


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                  ......+++++.+++.+||+.||++|||+.++++
T Consensus       239 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 ----------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             ----------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                        0011237899999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-43  Score=334.29  Aligned_cols=257  Identities=19%  Similarity=0.284  Sum_probs=193.9

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHh-cCCCCeeEEEeEEEccCC--CccEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQHS--KTPSL  199 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~--~~~~l  199 (419)
                      ..++|++.+.||+|+||+||+|.+  +++.||||++.........+|.+++..+ .+||||+++++++.....  ...++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            357899999999999999999976  4899999999876666777777766654 289999999999976533  57899


Q ss_pred             EEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          200 IFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       200 v~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~--------~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      ||||+++++|..++  ..+++..+..++.|++.||+|||++        ||+||||||+|||++.+ +.+||+|||+++.
T Consensus       113 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl~Dfg~a~~  191 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVK  191 (337)
T ss_dssp             EECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred             EEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCEEEEeCCCcee
Confidence            99999999999887  4689999999999999999999998        99999999999999988 7899999999976


Q ss_pred             ccCCCcc-----eeecccccccccccccCCCCCCcc------ccHHHHHHHHHHHHhC----------CCCCCCCCCCHH
Q 014762          270 YHPGKEY-----NVRVASRYFKGPELLVDLQDYDYS------LDMWSLGCMFAGMIFR----------KEPFFYGHDNHD  328 (419)
Q Consensus       270 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~------~DiwSlG~~l~ell~g----------~~pf~~~~~~~~  328 (419)
                      .......     ....||..|+|||++.+ ..++..      +|||||||++|||++|          ..||........
T Consensus       192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          192 FISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP  270 (337)
T ss_dssp             CC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence            6433222     23478999999999876 444443      9999999999999999          555532211111


Q ss_pred             HHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          329 QLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       329 ~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ....+......                       .........   ......+++++.+|+.+||+.||++|||+.++++
T Consensus       271 ~~~~~~~~~~~-----------------------~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          271 SYEDMREIVCI-----------------------KKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             CHHHHHHHHTT-----------------------SCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhhhHHHHhh-----------------------hccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            11111111000                       000000000   0011125678999999999999999999999987


Q ss_pred             C
Q 014762          409 I  409 (419)
Q Consensus       409 h  409 (419)
                      |
T Consensus       325 ~  325 (337)
T 3mdy_A          325 T  325 (337)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.9e-43  Score=336.15  Aligned_cols=249  Identities=17%  Similarity=0.275  Sum_probs=195.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEE-----EcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGI-----NVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.     +..++..||+|.+...    ....+.+|+.+++++ +||||+++++++..  
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ--  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcC--
Confidence            46789999999999999999998     5567889999998642    235688999999999 99999999999965  


Q ss_pred             CCccEEEEEecCCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEE
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRL  261 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl  261 (419)
                      ....++||||+++++|..++.          .+++..+..++.|++.||.|||++||+||||||+|||++.+  ...+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            466789999999999988762          38899999999999999999999999999999999999843  246999


Q ss_pred             EecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHc
Q 014762          262 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVL  337 (419)
Q Consensus       262 ~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~l  337 (419)
                      +|||++........   .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+... 
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~~-  261 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVLEFVTSG-  261 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHTT-
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CcCHHHHHHHHhcC-
Confidence            99999875533222   223467888999999877 679999999999999999998 888873 32222222221110 


Q ss_pred             CCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                      ..                                   ......+++.+.++|.+||+.||++|||+.+++++.|+
T Consensus       262 ~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          262 GR-----------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             CC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC-----------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            00                                   00112378899999999999999999999999998765

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-42  Score=330.77  Aligned_cols=244  Identities=15%  Similarity=0.299  Sum_probs=191.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCC----cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|++.+.||+|+||+||+|.+..++    ..||+|+++..    ....+.+|+.+++.+ +||||+++++++..  .
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~  118 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y  118 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEec--C
Confidence            4678999999999999999999876554    35999999743    234688999999999 99999999999954  4


Q ss_pred             CccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ...++||||+++++|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-CcEEECCCCcchhh
Confidence            6789999999999998876    358999999999999999999999999999999999999988 88999999999876


Q ss_pred             cCCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          271 HPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       271 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      ......    ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. +.+..+....+.+...       
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~~~~~~-------  268 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAINDGFR-------  268 (333)
T ss_dssp             -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTCC-------
T ss_pred             ccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHCCCc-------
Confidence            433221    22345678999999876 789999999999999999999 999984 2222222222211000       


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                   ......+++++.+++.+||+.||++|||+.++++
T Consensus       269 -----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  302 (333)
T 1mqb_A          269 -----------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  302 (333)
T ss_dssp             -----------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                         0011237889999999999999999999999987

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.9e-42  Score=325.15  Aligned_cols=239  Identities=26%  Similarity=0.383  Sum_probs=188.0

Q ss_pred             CCCeEEE-eeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEc--cCCCccEEE
Q 014762          124 QDDYEVV-RKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  200 (419)
                      .++|.+. +.||+|+||+||+|.+..+++.||+|+++.  ...+.+|+.++.++.+||||+++++++..  ......++|
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv   93 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   93 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence            5678887 779999999999999999999999999963  45678999998666699999999999865  234678999


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCC
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~  273 (419)
                      |||+++++|..++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+  .+.+||+|||++....  
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--  171 (299)
T 3m2w_A           94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--  171 (299)
T ss_dssp             ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred             EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence            99999999988762     48999999999999999999999999999999999999973  3789999999986432  


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                                         + ..++.++|||||||++|+|++|+.||...... +....+.                   
T Consensus       172 -------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~-------------------  211 (299)
T 3m2w_A          172 -------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMK-------------------  211 (299)
T ss_dssp             -------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSC-------------------
T ss_pred             -------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcch-hhhHHHH-------------------
Confidence                               1 45778999999999999999999998422111 0000000                   


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                              ........  .........+++++.+||.+||+.||++|||+.|+|+||||++..
T Consensus       212 --------~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          212 --------TRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             --------CSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             --------HHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence                    00000000  000011134789999999999999999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.9e-43  Score=331.60  Aligned_cols=262  Identities=21%  Similarity=0.355  Sum_probs=200.6

Q ss_pred             eEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          127 YEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      |+++++||+|+||+||++.    +..+++.||+|+++...    .+.+.+|+.+++.+ +||||+++++++.+......+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceEE
Confidence            4999999999999998775    34588999999997533    45688999999999 899999999999877667889


Q ss_pred             EEEEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-
Q 014762          199 LIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      +||||+++++|..++.  .+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||++........ 
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~  190 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY  190 (318)
T ss_dssp             EEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECCTTCSE
T ss_pred             EEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC-CCEEECCccccccccccccc
Confidence            9999999999999874  58999999999999999999999999999999999999988 8899999999987765432 


Q ss_pred             ---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 ---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                         .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...   ....   ....+........      
T Consensus       191 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~---~~~~---~~~~~~~~~~~~~------  257 (318)
T 3lxp_A          191 YRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSP---PTKF---LELIGIAQGQMTV------  257 (318)
T ss_dssp             EEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH---HHHH---HHHHCSCCHHHHH------
T ss_pred             cccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCccccc---chhh---hhhhcccccchhH------
Confidence               223457778999999977 67889999999999999999999998421   1111   1111111000000      


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                        ............        ......+++++.+||.+||+.||++|||+.|+++  +|+.+
T Consensus       258 --~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~l  308 (318)
T 3lxp_A          258 --LRLTELLERGER--------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKTV  308 (318)
T ss_dssp             --HHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             --HHHHHHHhcccC--------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHHH
Confidence              000000010000        1112347899999999999999999999999986  44443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=334.08  Aligned_cols=251  Identities=20%  Similarity=0.340  Sum_probs=196.3

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc--CCCc
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSKT  196 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~~  196 (419)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++...   ..+.+.+|+.+++.+ +||||+++++++...  ....
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCce
Confidence            3578899999999999999999999999999999988533   346788999999999 999999999998632  3356


Q ss_pred             cEEEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          197 PSLIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      .++||||+.+++|..++       ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~dfg~~~~  183 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCSSCEE
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-CCEEEEecCcchh
Confidence            78999999999998766       348999999999999999999999999999999999999988 7899999999876


Q ss_pred             ccCCCc----------ceeecccccccccccccCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHc
Q 014762          270 YHPGKE----------YNVRVASRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL  337 (419)
Q Consensus       270 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~l  337 (419)
                      ......          .....+|..|+|||++.+..  .++.++|||||||++|+|++|+.||......           
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------  252 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-----------  252 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-----------
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-----------
Confidence            432111          12235688999999986522  3689999999999999999999998210000           


Q ss_pred             CCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      + ........              ..         ........+++++.++|.+||+.||++|||+.+++++
T Consensus       253 ~-~~~~~~~~--------------~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          253 G-DSVALAVQ--------------NQ---------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             T-SCHHHHHH--------------CC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c-chhhHHhh--------------cc---------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            0 00000000              00         0001112378899999999999999999999999884

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8.7e-43  Score=347.46  Aligned_cols=242  Identities=18%  Similarity=0.307  Sum_probs=194.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ..++|++.++||+|+||+||+|.+.. +..||||+++..  ..+.+.+|+.+++++ +||||+++++++.+   ...++|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~---~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC---CceEEE
Confidence            46789999999999999999998754 567999999753  357899999999999 99999999999854   567899


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+++++|.+++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus       257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC-------
T ss_pred             ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CCEEECCCccceecCCCce
Confidence            99999999998874     48999999999999999999999999999999999999987 7899999999987643322


Q ss_pred             --ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          276 --YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       276 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                        .....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+..            .  
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~~------------~--  399 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGY------------R--  399 (452)
T ss_dssp             -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTC------------C--
T ss_pred             ecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC------------C--
Confidence              123345678999999876 689999999999999999999 88887 3433333333221100            0  


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                            ...+..+++.+.+||.+||+.||++|||++++++
T Consensus       400 ----------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          400 ----------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                  0011237899999999999999999999999987

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.6e-43  Score=336.78  Aligned_cols=252  Identities=15%  Similarity=0.183  Sum_probs=198.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcC--------CCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeE----------
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVN--------TNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVK----------  184 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~----------  184 (419)
                      ..++|++.+.||+|+||+||+|.+..        .++.||+|++...  +.+.+|+.+++++ +||||++          
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHH-CCHHHHHHHHHHTTCTT
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHh-cccchhhhhhhhccCCc
Confidence            36789999999999999999999887        4889999999743  5788999999999 8999887          


Q ss_pred             -----EEeEEEccCCCccEEEEEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC
Q 014762          185 -----LLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (419)
Q Consensus       185 -----l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~  254 (419)
                           +++++..+ ....++||||+ +++|..++     ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus       117 ~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~  194 (352)
T 2jii_A          117 LAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP  194 (352)
T ss_dssp             CSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred             cCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence                 56666542 46789999999 89998886     45899999999999999999999999999999999999998


Q ss_pred             CCC--cEEEEecccceeccCCCc--------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 014762          255 ELR--KLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH  324 (419)
Q Consensus       255 ~~~--~~kl~Dfgla~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~  324 (419)
                      + +  .+||+|||+++.......        .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       195 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          195 E-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             T-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             C-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            7 5  899999999976543221        123478899999999887 689999999999999999999999996544


Q ss_pred             CCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHH
Q 014762          325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR  404 (419)
Q Consensus       325 ~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~  404 (419)
                      ...+.+..........         ...                .  .........+++++.+|+.+||+.||++|||++
T Consensus       273 ~~~~~~~~~~~~~~~~---------~~~----------------~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  325 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDK---------PGP----------------F--VGPCGHWIRPSETLQKYLKVVMALTYEEKPPYA  325 (352)
T ss_dssp             TCHHHHHHHHHHHHHS---------CCC----------------E--ECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             cCHHHHHHHHHhccCC---------hhh----------------h--hhhccccCCCcHHHHHHHHHHHhCChhhCCCHH
Confidence            3444433322211000         000                0  000001123689999999999999999999999


Q ss_pred             HHhc
Q 014762          405 EAMV  408 (419)
Q Consensus       405 elL~  408 (419)
                      ++++
T Consensus       326 ~l~~  329 (352)
T 2jii_A          326 MLRN  329 (352)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9976

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=332.07  Aligned_cols=244  Identities=21%  Similarity=0.357  Sum_probs=181.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEc------cCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRD------QHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~------~~~  194 (419)
                      ..+|++.+.||+|+||+||+|.+..+++.||+|++....   .+.+.+|+.++.++.+||||+++++++..      ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            568999999999999999999999999999999885432   45688999999999569999999999953      223


Q ss_pred             CccEEEEEecCCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          195 KTPSLIFEYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      ...+++|||+++ +|..++      ..+++..+..++.|++.||+|||++|  |+||||||+|||++.+ +.+||+|||+
T Consensus       107 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SCEEBCCCTT
T ss_pred             ceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CCEEEecCcc
Confidence            457899999985 555544      34999999999999999999999999  9999999999999988 7899999999


Q ss_pred             ceeccCCCcc-------------eeeccccccccccccc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014762          267 AEFYHPGKEY-------------NVRVASRYFKGPELLV--DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (419)
Q Consensus       267 a~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~  331 (419)
                      ++........             ....+|..|+|||++.  ....++.++|||||||++|+|++|+.||..... .    
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~----  259 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-L----  259 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH-H----
Confidence            9876543221             1345888999999983  226788999999999999999999999832111 0    


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      .+..                                   ...........++.+.+|+++||+.||++|||+.|++++
T Consensus       260 ~~~~-----------------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          260 RIVN-----------------------------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             -----------------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             Hhhc-----------------------------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            0000                                   000001112357789999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-43  Score=339.59  Aligned_cols=245  Identities=19%  Similarity=0.297  Sum_probs=187.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ...|++.+.||+|+||+||+|.+..++   ..||+|.++..    ..+.+.+|+.+++++ +||||+++++++... ...
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~-~~~  165 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGS  165 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCC-SSC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC-CCC
Confidence            446889999999999999999875443   46899998642    346788999999999 899999999987543 356


Q ss_pred             cEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYD  244 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC--------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-CCEEEeeccccccccc
Confidence            789999999999998873    47889999999999999999999999999999999999988 7899999999986543


Q ss_pred             CCc-----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          273 GKE-----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       273 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ...     .....++..|+|||++.+ ..++.++|||||||++|||++|+.|++.+.+..+....+.+.  .        
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--~--------  313 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R--------  313 (373)
T ss_dssp             -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--C--------
T ss_pred             cccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--C--------
Confidence            221     123456678999999877 789999999999999999999655554544443333222110  0        


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                ....+..+++.+.++|.+||+.||++|||+.|+++
T Consensus       314 --------------------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          314 --------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             --------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                      00011237889999999999999999999999987

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5e-42  Score=327.55  Aligned_cols=262  Identities=19%  Similarity=0.364  Sum_probs=200.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEE----EcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGI----NVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.+.||+|+||+||+|.    +..+++.||+|++....   .+.+.+|+.+++.+ +||||+++++++......
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCC
Confidence            35679999999999999999998    46789999999997543   35788999999999 899999999999766556


Q ss_pred             ccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+++++|..++    ..+++..+..++.|++.||+|||++||+|+||||+|||++.+ +.+||+|||+++...
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLP  196 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred             ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC-CcEEEecCcchhhcc
Confidence            789999999999998876    348999999999999999999999999999999999999988 899999999998765


Q ss_pred             CCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      .....    ....++..|+|||++.+ ..++.++|||||||++|+|++|..||...      .....+..+.........
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~------~~~~~~~~~~~~~~~~~~  269 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSP------PAEFMRMIGNDKQGQMIV  269 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSH------HHHHHHHHCTTCCTHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCC------HHHHHHhhccccchhhhH
Confidence            44322    22356667999999877 67899999999999999999999987321      111112222211100000


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                             ..+..........        .....+++++.++|.+||+.||++|||+.|+++
T Consensus       270 -------~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          270 -------FHLIELLKNNGRL--------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             -------HHHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------HHHHHHhhcCCCC--------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                   0000111110000        112347899999999999999999999999987

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.1e-42  Score=322.44  Aligned_cols=241  Identities=16%  Similarity=0.324  Sum_probs=190.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ..++|++.+.||+|+||+||+|.+  +|+.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++... ....++||
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~   94 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVT   94 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEE
T ss_pred             ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC-CCceEEEE
Confidence            367899999999999999999976  5889999999754 456789999999999 899999999997543 34678999


Q ss_pred             EecCCCChhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLYPT-----LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~~~-----l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      ||+++++|.+++..     +++..+..++.|++.||+|||++|++|+||||+||+++.+ +.+||+|||++......  .
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~--~  171 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--Q  171 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC-CcEEEeecccccccccc--c
Confidence            99999999888742     8899999999999999999999999999999999999988 78999999998765432  2


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ....++..|+|||++.+ ..++.++||||||+++|+|++ |+.||.. .+..+....+.+.                   
T Consensus       172 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~-~~~~~~~~~~~~~-------------------  230 (278)
T 1byg_A          172 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKG-------------------  230 (278)
T ss_dssp             ----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTT-------------------
T ss_pred             cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcC-------------------
Confidence            23467788999999876 679999999999999999998 8888832 2222222111100                   


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                       ........+++++.+++.+||+.||++|||+.++++
T Consensus       231 -----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          231 -----------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                             000112247899999999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6e-42  Score=328.72  Aligned_cols=257  Identities=19%  Similarity=0.248  Sum_probs=199.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHh-cCCCCeeEEEeEEEccCC--CccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNL-CGGPNVVKLLDIVRDQHS--KTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l-~~h~niv~l~~~~~~~~~--~~~~lv  200 (419)
                      .++|++.+.||+|+||+||+|.+  +|+.||+|+++......+.+|++++..+ .+||||+++++++.....  ...++|
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv  118 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV  118 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence            56899999999999999999976  5899999999887778889999999883 289999999999976532  278999


Q ss_pred             EEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHH--------HCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH--------~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      |||+++++|..++  ..+++..+..++.|++.||+|||        ++||+||||||+|||++.+ +.+||+|||++...
T Consensus       119 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~  197 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH  197 (342)
T ss_dssp             ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT-SCEEECCCTTCEEE
T ss_pred             EeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC-CCEEEEECCCceec
Confidence            9999999999887  45899999999999999999999        8999999999999999988 78999999999876


Q ss_pred             cCCCc-----ceeecccccccccccccCCCC-----CCccccHHHHHHHHHHHHhC----------CCCCCCCCCCHHHH
Q 014762          271 HPGKE-----YNVRVASRYFKGPELLVDLQD-----YDYSLDMWSLGCMFAGMIFR----------KEPFFYGHDNHDQL  330 (419)
Q Consensus       271 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwSlG~~l~ell~g----------~~pf~~~~~~~~~~  330 (419)
                      .....     .....+|..|+|||++.+...     ++.++|||||||++|+|++|          ..||..........
T Consensus       198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~  277 (342)
T 1b6c_B          198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  277 (342)
T ss_dssp             ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH
Confidence            54432     233478999999999876322     23689999999999999999          67875432221111


Q ss_pred             HHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       331 ~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      ..+.+....                       ...........   ....+++.+.+|+.+||+.||++|||+.++++|
T Consensus       278 ~~~~~~~~~-----------------------~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          278 EEMRKVVCE-----------------------QKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHHTT-----------------------SCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHH-----------------------HHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            111111000                       00000000000   011245678999999999999999999999884

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-41  Score=340.22  Aligned_cols=248  Identities=19%  Similarity=0.299  Sum_probs=197.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .++|++.++||+|+||+||+|.+..+++.||||+++. .....+.+|+.+++.+..++++..+..++..  ....++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEEE
Confidence            6789999999999999999999999999999999864 3345788999999999544666666666543  367789999


Q ss_pred             ecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEc---CCCCcEEEEecccceeccCCCc
Q 014762          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~---~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |+ +++|..++    ..+++..+..++.||+.||+|||++||+||||||+|||++   .+ +.+||+|||+++.......
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~-~~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGT-TCEEECCCTTCEECBCTTT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCC-CeEEEEeCCcceeccCCcc
Confidence            99 88888776    4699999999999999999999999999999999999994   44 7899999999987654332


Q ss_pred             c--------eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHcCCchHHHH
Q 014762          276 Y--------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       276 ~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~--~~~~~~i~~~lg~~~~~~~  345 (419)
                      .        ....||..|+|||++.+ ..++.++|||||||++|+|++|+.||......  .+.+..+....-.......
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL  240 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred             ccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence            1        24578999999999987 78999999999999999999999999543221  2222222221100111100


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                      ...+++++.+||.+||+.||++|||+.++++
T Consensus       241 --------------------------------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          241 --------------------------------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             --------------------------------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             --------------------------------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                            1136889999999999999999999998765

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.9e-42  Score=353.69  Aligned_cols=240  Identities=18%  Similarity=0.306  Sum_probs=191.4

Q ss_pred             CeEEE-eeeeeeCceEEEEEEE--cCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          126 DYEVV-RKVGRGKYSEVFEGIN--VNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       126 ~y~~~-~~lG~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .+.+. ++||+|+||+||+|.+  ..+++.||||+++...     .+.+.+|+.+++++ +||||+++++++.+   ...
T Consensus       369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---~~~  444 (635)
T 4fl3_A          369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESW  444 (635)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SSE
T ss_pred             hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---CCE
Confidence            34443 4799999999999954  4567899999997432     46799999999999 89999999999964   347


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||+.+++|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus       445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC--
T ss_pred             EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcCCccccccCc
Confidence            8999999999998887   458999999999999999999999999999999999999988 899999999998765433


Q ss_pred             c----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          275 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       275 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      .    .....+|..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+.. .          
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~~~-~----------  590 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEKGE-R----------  590 (635)
T ss_dssp             -----------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTC-C----------
T ss_pred             cccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC-C----------
Confidence            2    122345678999999976 789999999999999999998 99898 3333333322222100 0          


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                               ......+++++.+||.+||+.||++|||+.++++
T Consensus       591 -------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          591 -------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                     0011237899999999999999999999999976

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=351.02  Aligned_cols=243  Identities=16%  Similarity=0.325  Sum_probs=194.8

Q ss_pred             CCCCeEEEe-eeeeeCceEEEEEEEc--CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVR-KVGRGKYSEVFEGINV--NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~-~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..+++.+.+ +||+|+||+||+|.+.  .++..||||+++..    ..+.+.+|+.+|+++ +||||+++++++..   .
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---~  408 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E  408 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES---S
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc---C
Confidence            356677776 8999999999999875  35667999999753    357899999999999 99999999999965   4


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+.+++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISDFGLSKALG  487 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCSTTTTCC
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-CcEEEeeccCccccc
Confidence            5889999999999998773    48999999999999999999999999999999999999988 899999999998664


Q ss_pred             CCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .....    ....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+..         
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~~~---------  556 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQGK---------  556 (613)
T ss_dssp             --------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCSHHHHHHHHTTC---------
T ss_pred             CCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcCC---------
Confidence            33221    12334578999999976 789999999999999999998 99898 3444444333322100         


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                         .                        ...+..+++++.++|.+||+.||++|||+.++++
T Consensus       557 ---~------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          557 ---R------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             ---C------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             ---C------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence               0                        0011237899999999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.6e-42  Score=350.78  Aligned_cols=241  Identities=18%  Similarity=0.309  Sum_probs=197.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.++||+|+||+||+|.+.. +..||||+++..  ..+.+.+|+.+|+++ +||||+++++++.+   ...++||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---~~~~lv~  340 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT  340 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred             hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee---ccceEee
Confidence            5679999999999999999998754 567999999753  357899999999999 99999999999854   5678999


Q ss_pred             EecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-
Q 014762          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      ||+.+++|.+++.     .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++....... 
T Consensus       341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~  419 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT  419 (535)
T ss_dssp             CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCTTSTTTCCCHHHH
T ss_pred             ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-CcEEEcccccceecCCCcee
Confidence            9999999998874     38999999999999999999999999999999999999987 7899999999976543211 


Q ss_pred             -ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       .....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+....+.+..+.+..            .   
T Consensus       420 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~-~~~~~~~~~~~i~~~~------------~---  482 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGY------------R---  482 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSS-TTCCHHHHHHHHHTTC------------C---
T ss_pred             cccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC------------C---
Confidence             122345678999999887 689999999999999999999 88887 3433333333221100            0   


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                           ......+++++.+||.+||+.||++|||++++++
T Consensus       483 ---------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          483 ---------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                 0011237899999999999999999999999987

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.8e-43  Score=345.31  Aligned_cols=246  Identities=16%  Similarity=0.222  Sum_probs=184.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCC-CCe---------e----
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGG-PNV---------V----  183 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h-~ni---------v----  183 (419)
                      ..+|...+.||+|+||+||+|.+..+|+.||||+++..      ..+.+.+|+.+++.+ .| +|.         +    
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchh
Confidence            44588899999999999999999999999999998722      246788999999988 55 321         1    


Q ss_pred             --------EEEeEEEccC---CCccEEEEEecCCCChhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q 014762          184 --------KLLDIVRDQH---SKTPSLIFEYVNSTDFKVLYP----------TLTDYDIRYYIYELLKALDYCHSQGIMH  242 (419)
Q Consensus       184 --------~l~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~----------~l~~~~~~~~~~qi~~~L~~LH~~~ivH  242 (419)
                              .+..++....   ....+++|+++. ++|..++.          .+++..+..++.|++.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                    1111121111   234566676654 66666652          2567788889999999999999999999


Q ss_pred             ecCCCCceEEcCCCCcEEEEecccceeccCCCcceeeccccccccccccc---------CCCCCCccccHHHHHHHHHHH
Q 014762          243 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---------DLQDYDYSLDMWSLGCMFAGM  313 (419)
Q Consensus       243 ~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DiwSlG~~l~el  313 (419)
                      |||||+|||++.+ +.+||+|||+++.....  .....| ..|+|||++.         ....++.++|||||||++|+|
T Consensus       235 rDiKp~NILl~~~-~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          235 TYLRPVDIVLDQR-GGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             SCCCGGGEEECTT-CCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecC-CeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            9999999999988 78999999999865432  344567 9999999983         225688999999999999999


Q ss_pred             HhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhc
Q 014762          314 IFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLL  393 (419)
Q Consensus       314 l~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  393 (419)
                      ++|+.||.... ..+..                           .            ..+  .....+++++.+||.+||
T Consensus       311 ltg~~Pf~~~~-~~~~~---------------------------~------------~~~--~~~~~~~~~~~~li~~~l  348 (413)
T 3dzo_A          311 WCADLPNTDDA-ALGGS---------------------------E------------WIF--RSCKNIPQPVRALLEGFL  348 (413)
T ss_dssp             HHSSCCCCTTG-GGSCS---------------------------G------------GGG--SSCCCCCHHHHHHHHHHT
T ss_pred             HHCCCCCCCcc-hhhhH---------------------------H------------HHH--hhcccCCHHHHHHHHHHc
Confidence            99999994211 00000                           0            000  011237899999999999


Q ss_pred             CCCCCCCCCHHHHhcCCCcccccc
Q 014762          394 RYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       394 ~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      +.||++|||+.++++||||+.+++
T Consensus       349 ~~dP~~Rpt~~~~l~~~~~~~~~~  372 (413)
T 3dzo_A          349 RYPKEDRLLPLQAMETPEYEQLRT  372 (413)
T ss_dssp             CSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             cCChhhCcCHHHHHhCHHHHHHHH
Confidence            999999999999999999998764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.3e-41  Score=318.84  Aligned_cols=252  Identities=18%  Similarity=0.269  Sum_probs=193.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ...|...++||+|+||+||+|.+  +++.||+|++...       ..+.+.+|+.+++.+ +||||+++++++.+  ...
T Consensus        30 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~  104 (307)
T 2nru_A           30 RPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSD--GDD  104 (307)
T ss_dssp             SBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSS
T ss_pred             ccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEec--CCc
Confidence            33455568899999999999965  6889999998632       246788999999999 99999999999955  467


Q ss_pred             cEEEEEecCCCChhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          197 PSLIFEYVNSTDFKVLYP------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      .++||||+++++|..++.      .+++..+..++.|++.||.|||++||+|+||||+||+++.+ +.+||+|||+++..
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~  183 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARAS  183 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-CcEEEeeccccccc
Confidence            889999999999988762      48999999999999999999999999999999999999988 78999999999876


Q ss_pred             cCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHc--CCchHHHH
Q 014762          271 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL--GTDELNAY  345 (419)
Q Consensus       271 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~l--g~~~~~~~  345 (419)
                      .....   .....|+..|+|||.+.+  .++.++|||||||++|+|++|..||...... +.+..+.+..  ....+..+
T Consensus       184 ~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  260 (307)
T 2nru_A          184 EKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDY  260 (307)
T ss_dssp             CSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTHHHHHHHTTSCCHHHH
T ss_pred             ccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHHHHHHhhhhhhhhhhh
Confidence            54322   223468899999998865  5899999999999999999999998533222 1111111111  01111111


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      .               ....         .......++.+.+++.+||+.||++|||+.++++
T Consensus       261 ~---------------~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~  299 (307)
T 2nru_A          261 I---------------DKKM---------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ  299 (307)
T ss_dssp             S---------------CSSC---------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             c---------------cccc---------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            0               0000         0001124567899999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=9.4e-42  Score=319.83  Aligned_cols=244  Identities=19%  Similarity=0.300  Sum_probs=188.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcC-CCc--EEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNE--RCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~--~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.+.||+|+||+||+|.+.. +++  .||+|+++..      ..+.+.+|+.+++.+ +||||+++++++... 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-   93 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-   93 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccC-
Confidence            46789999999999999999998643 333  6899988642      246788999999999 899999999999653 


Q ss_pred             CCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          194 SKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                        ..++||||+.+++|..++    ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||++..
T Consensus        94 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~  170 (291)
T 1u46_A           94 --PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRA  170 (291)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEE
T ss_pred             --CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEcccccccc
Confidence              378999999999998876    358999999999999999999999999999999999999988 8999999999987


Q ss_pred             ccCCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          270 YHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       270 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      .......    ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +.+..+....+... +.     
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~-~~-----  242 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWI-GLNGSQILHKIDKE-GE-----  242 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTS-CC-----
T ss_pred             ccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcc-cCCHHHHHHHHHcc-CC-----
Confidence            6544321    23456678999999876 678999999999999999999 898883 33322222222110 00     


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                   .......+++++.+++.+||+.||++|||+.++++
T Consensus       243 -----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          243 -----------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             -----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                                         00011237899999999999999999999999987

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.4e-42  Score=330.07  Aligned_cols=246  Identities=18%  Similarity=0.210  Sum_probs=186.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhc--------CCCCeeE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLC--------GGPNVVK  184 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~--------~h~niv~  184 (419)
                      .++|++.++||+|+||+||+|++  +|+.||||++....           .+.+.+|+.+++.+.        +||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            56799999999999999999987  78999999996432           277899999999984        4888888


Q ss_pred             EEeEEEcc----------------------------CCCccEEEEEecCCCCh-hhhc-CCCCHHHHHHHHHHHHHHHHH
Q 014762          185 LLDIVRDQ----------------------------HSKTPSLIFEYVNSTDF-KVLY-PTLTDYDIRYYIYELLKALDY  234 (419)
Q Consensus       185 l~~~~~~~----------------------------~~~~~~lv~e~~~~~~l-~~~~-~~l~~~~~~~~~~qi~~~L~~  234 (419)
                      +.+.+...                            .....++||||+.+|++ ..+. ..+++..++.++.|++.||+|
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence            88765311                            14678999999998854 4443 458999999999999999999


Q ss_pred             HH-HCCcEeecCCCCceEEcCCCC--------------------cEEEEecccceeccCCCcceeecccccccccccccC
Q 014762          235 CH-SQGIMHRDVKPHNVMIDHELR--------------------KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD  293 (419)
Q Consensus       235 LH-~~~ivH~Dlk~~NILl~~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~  293 (419)
                      || ++||+||||||+|||++.+ +                    .+||+|||+|+.....    ...||+.|+|||++.+
T Consensus       177 lH~~~~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          177 AEASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHCCBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHhCCEeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            99 9999999999999999987 4                    8999999999876532    3589999999999986


Q ss_pred             CCCCCccccHHHHHHH-HHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCcccc
Q 014762          294 LQDYDYSLDMWSLGCM-FAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKF  372 (419)
Q Consensus       294 ~~~~~~~~DiwSlG~~-l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (419)
                       .. +.++||||+|++ .+++++|..||............+.+....            .             ....   
T Consensus       252 -~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~------------~-------------~~~~---  301 (336)
T 2vuw_A          252 -DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF------------K-------------TKCN---  301 (336)
T ss_dssp             -CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC------------S-------------SCCC---
T ss_pred             -CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc------------C-------------cccc---
Confidence             33 899999998777 777888998872100000011111110000            0             0000   


Q ss_pred             ccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHh-cCCCcc
Q 014762          373 INADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM-VISSIS  413 (419)
Q Consensus       373 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL-~hp~f~  413 (419)
                        ......+++++++||++||++|     ||+|+| +||||+
T Consensus       302 --~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          302 --TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             --SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             --hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence              0001126789999999999977     999999 999996

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.1e-41  Score=346.95  Aligned_cols=243  Identities=22%  Similarity=0.407  Sum_probs=195.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCC---CcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNT---NERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|++.+.||+|+||+||+|.+..+   +..||+|.++...    .+.+.+|+.+++++ +||||+++++++.+   .
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---S
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec---C
Confidence            357899999999999999999988654   4579999986432    36788999999999 99999999999843   4


Q ss_pred             ccEEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+++++|..++.    .+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYME  542 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCCCCSCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CCEEEEecCCCeecC
Confidence            5789999999999988873    58999999999999999999999999999999999999988 899999999998765


Q ss_pred             CCCcc--eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          272 PGKEY--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       272 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      .....  ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+.....          
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf-~~~~~~~~~~~i~~~~~----------  610 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGER----------  610 (656)
T ss_dssp             C----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHHTCC----------
T ss_pred             CCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHcCCC----------
Confidence            43322  23356678999999876 689999999999999999997 88887 33333333333222100          


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                        .                        ..+..+++.+.+||.+||..||++|||+.++++
T Consensus       611 --~------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          611 --L------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             --C------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --C------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence              0                        011237899999999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.9e-41  Score=317.47  Aligned_cols=242  Identities=19%  Similarity=0.300  Sum_probs=190.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|++.+.||+|+||+||+|.+..   .+|+|+++..     ..+.+.+|+.+++.+ +||||+++++++.+.  ...
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~  104 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSP--PHL  104 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECS--SCE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC--Cce
Confidence            46789999999999999999998743   4999998642     235678899999999 999999999999754  568


Q ss_pred             EEEEEecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++||||+++++|..++.    .+++..+..++.|++.||+|||++|++|+||||+|||++ + +.+||+|||+++.....
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N-GKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC-----
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-C-CCEEEeecCCccccccc
Confidence            89999999999999874    489999999999999999999999999999999999998 4 68999999998654321


Q ss_pred             ------CcceeecccccccccccccC--------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCC
Q 014762          274 ------KEYNVRVASRYFKGPELLVD--------LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT  339 (419)
Q Consensus       274 ------~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~  339 (419)
                            .......++..|+|||++.+        ...++.++|||||||++|+|++|+.||.. ....+....+....  
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~--  259 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGM--  259 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTC--
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCC--
Confidence                  22233468889999999864        24578999999999999999999999842 22222222111100  


Q ss_pred             chHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                       ........+++++.+++.+||..||++|||+.++++
T Consensus       260 ---------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          260 ---------------------------------KPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             ---------------------------------CCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             ---------------------------------CCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                                             000011236888999999999999999999999987

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-40  Score=347.66  Aligned_cols=241  Identities=22%  Similarity=0.320  Sum_probs=196.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcC-CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC--
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVN-TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK--  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~--  195 (419)
                      ..++|++.+.||+|+||+||+|.+.. +|+.||||++....    ...+.+|+.++.++ +||||+++++++......  
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSC
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCC
Confidence            36899999999999999999999976 78999999986432    34678999999999 899999999999764321  


Q ss_pred             -ccEEEEEecCCCChhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          196 -TPSLIFEYVNSTDFKVLY-PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       196 -~~~lv~e~~~~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                       ..|+||||+++++|..++ ..+++..+..++.|++.||+|||++||+||||||+|||++.+  .+||+|||+++.....
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC
T ss_pred             ceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhcccC
Confidence             168999999999998776 469999999999999999999999999999999999999875  7899999999876543


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                         ....||+.|+|||++.+  .++.++|||||||++|+|++|..||......           +.+.           .
T Consensus       235 ---~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------~~~~-----------~  287 (681)
T 2pzi_A          235 ---GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------GLPE-----------D  287 (681)
T ss_dssp             ---SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------SCCT-----------T
T ss_pred             ---CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-----------cccc-----------c
Confidence               44578999999999865  3589999999999999999998877311000           0000           0


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      .+                      ....++.+.+||.+||+.||++|||+.+.+.|+|+.-+
T Consensus       288 ~~----------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          288 DP----------------------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             CH----------------------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cc----------------------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            00                      00136789999999999999999999999999887644

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=6.6e-40  Score=307.09  Aligned_cols=222  Identities=13%  Similarity=0.137  Sum_probs=177.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....      .+.+.+|+.++..+ +||||+++++++.+.  ...
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~~  106 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTR--AGG  106 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEEC--CcE
Confidence            578999999999999999999999999999999997532      26788999999999 999999999999664  678


Q ss_pred             EEEEEecCCCChhhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          198 SLIFEYVNSTDFKVLYPT-LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~~-l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      ++||||+++++|..++.. ....++..++.|++.||+|||++||+||||||+|||++.+ +.+||+++|.          
T Consensus       107 ~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~-g~~kl~~~~~----------  175 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPAT----------  175 (286)
T ss_dssp             EEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT-SCEEECSCCC----------
T ss_pred             EEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC-CCEEEEeccc----------
Confidence            999999999999988743 5667888999999999999999999999999999999988 7889885432          


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                               +        ..++.++|||||||++|+|++|+.||....... .+....                      
T Consensus       176 ---------~--------~~~~~~~Di~slG~il~elltg~~Pf~~~~~~~-~~~~~~----------------------  215 (286)
T 3uqc_A          176 ---------M--------PDANPQDDIRGIGASLYALLVNRWPLPEAGVRS-GLAPAE----------------------  215 (286)
T ss_dssp             ---------C--------TTCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC-CSEECC----------------------
T ss_pred             ---------c--------CCCCchhHHHHHHHHHHHHHHCCCCCCcCCcch-hhHHHH----------------------
Confidence                     2        247899999999999999999999984321110 000000                      


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                           ... .....  ........+++++.+||.+||+.||++| |+.|+++
T Consensus       216 -----~~~-~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          216 -----RDT-AGQPI--EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             -----BCT-TSCBC--CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             -----HHh-ccCCC--ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence                 000 00000  0001113478999999999999999999 9999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=8.9e-34  Score=289.08  Aligned_cols=185  Identities=19%  Similarity=0.141  Sum_probs=129.1

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc-------------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV-------------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ...+.|++|.+..++..-.|+.+++|++...             ..+++.+|+++|+++..|+||++++++++++  ...
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--~~~  317 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA--QSG  317 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS--SEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC--CEE
Confidence            3467777888777777778999999998532             1356899999999998899999999999654  778


Q ss_pred             EEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cc
Q 014762          198 SLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~  276 (419)
                      ||||||++|++|.+++..........|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...... ..
T Consensus       318 yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-SCEEECCCTTEESCC---CCS
T ss_pred             EEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCC-CCEEEeecccCeeCCCCCccc
Confidence            9999999999999988432222234588999999999999999999999999999988 899999999998765432 33


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCC
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF  320 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf  320 (419)
                      ...+||+.|+|||++.+  .+..++|+||+|++++++.++..++
T Consensus       397 ~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             HHHHHHHHHHHHHHC-------------------CCCCTTHHHH
T ss_pred             cCceechhhccHHHhCC--CCCCcccccccccchhhhccccchh
Confidence            45689999999999875  5678899999999988876655443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1e-27  Score=243.03  Aligned_cols=180  Identities=17%  Similarity=0.235  Sum_probs=140.0

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       128 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      ...+.||+|+||+||+|  ...+..+++|......           .+.+.+|+.+++++ +||||+++..++...  ..
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~--~~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDL--DN  413 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEET--TT
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeC--Cc
Confidence            44668999999999999  4567888999864211           24578999999999 999999554444333  45


Q ss_pred             cEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          197 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      .++||||+++++|.+++..     +..++.|++.||+|||++||+||||||+|||++.   .+||+|||+++........
T Consensus       414 ~~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          414 KRIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             TEEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred             cEEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence            6899999999999999876     6789999999999999999999999999999997   7999999999987543221


Q ss_pred             --------eeecccccccccccccC-CCCCCccccHHHHHHHHHHHHhCCCCC
Q 014762          277 --------NVRVASRYFKGPELLVD-LQDYDYSLDMWSLGCMFAGMIFRKEPF  320 (419)
Q Consensus       277 --------~~~~~~~~y~aPE~~~~-~~~~~~~~DiwSlG~~l~ell~g~~pf  320 (419)
                              ....||+.|+|||++.+ ...|+..+|+||..+-..+-+.++.+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                    24579999999999864 135788899999999888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=2.2e-24  Score=200.91  Aligned_cols=143  Identities=18%  Similarity=0.243  Sum_probs=117.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---------------------chHHHHHHHHHHHHhcCCCCe
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------------------KKKKIKREIKILQNLCGGPNV  182 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------------------~~~~~~~E~~~l~~l~~h~ni  182 (419)
                      ...|++.+.||+|+||.||+|.+ .+|+.||+|+++..                     ....+.+|+.+++++ +  | 
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-  163 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-  163 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-
Confidence            45577889999999999999998 88999999999632                     234688999999999 4  4 


Q ss_pred             eEEEeEEEccCCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEE
Q 014762          183 VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLI  262 (419)
Q Consensus       183 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~  262 (419)
                      +++.+++..   ...++||||+++++|.. +.   ......++.|++.||.|||++||+||||||+|||++ + +.+||+
T Consensus       164 ~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~---~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~  234 (282)
T 1zar_A          164 LAVPKVYAW---EGNAVLMELIDAKELYR-VR---VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWII  234 (282)
T ss_dssp             SSSCCEEEE---ETTEEEEECCCCEEGGG-CC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEEC
T ss_pred             CCcCeEEec---cceEEEEEecCCCcHHH-cc---hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEE
Confidence            666666543   44689999999999987 32   234557999999999999999999999999999999 6 899999


Q ss_pred             ecccceeccCCCcceeeccccccccccccc
Q 014762          263 DWGLAEFYHPGKEYNVRVASRYFKGPELLV  292 (419)
Q Consensus       263 Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~  292 (419)
                      |||+|+..            ..+.|||++.
T Consensus       235 DFG~a~~~------------~~~~a~e~l~  252 (282)
T 1zar_A          235 DFPQSVEV------------GEEGWREILE  252 (282)
T ss_dssp             CCTTCEET------------TSTTHHHHHH
T ss_pred             ECCCCeEC------------CCCCHHHHHH
Confidence            99998642            3457888764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=5.6e-22  Score=182.32  Aligned_cols=135  Identities=18%  Similarity=0.206  Sum_probs=108.2

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcE--EEEEEecCcc---------------------------hHHHHHHHHHHHHh
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPVK---------------------------KKKIKREIKILQNL  176 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~--vavK~~~~~~---------------------------~~~~~~E~~~l~~l  176 (419)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||+++...                           ...+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478899999999999999998788999  9999975321                           12578899999999


Q ss_pred             cCCCCe--eEEEeEEEccCCCccEEEEEecCC-C----ChhhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeecCCCC
Q 014762          177 CGGPNV--VKLLDIVRDQHSKTPSLIFEYVNS-T----DFKVLYPTLTDYDIRYYIYELLKALDYCH-SQGIMHRDVKPH  248 (419)
Q Consensus       177 ~~h~ni--v~l~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~ivH~Dlk~~  248 (419)
                       .|+++  ..+++.      ...++||||+++ |    .+.......++..+..++.|++.||.||| ++||+||||||+
T Consensus       128 -~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          128 -KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             -HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             -HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence             66653  344432      245799999953 3    66665544456678899999999999999 999999999999


Q ss_pred             ceEEcCCCCcEEEEecccceec
Q 014762          249 NVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       249 NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      |||++.   .++|+|||+|...
T Consensus       201 NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS---SEEECCCTTCEET
T ss_pred             HEEEcC---cEEEEECcccccC
Confidence            999987   7999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=8.6e-18  Score=161.05  Aligned_cols=135  Identities=16%  Similarity=0.239  Sum_probs=99.5

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----------------hHH--------HHHHHHHHHHhcCC
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----------------KKK--------IKREIKILQNLCGG  179 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------~~~--------~~~E~~~l~~l~~h  179 (419)
                      .-|++.++||+|+||.||+|.+ .+|+.||||+++...                 ...        ..+|...|.++ .+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~  172 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YE  172 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HH
T ss_pred             CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hh
Confidence            3499999999999999999986 579999999975311                 001        23567777776 33


Q ss_pred             CCe--eEEEeEEEccCCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC
Q 014762          180 PNV--VKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (419)
Q Consensus       180 ~ni--v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~  257 (419)
                      ..+  ...++..      ..+|||||++|..+..+...   .....++.|++.+|.|||++|||||||||.|||++.+..
T Consensus       173 ~gv~vp~p~~~~------~~~LVME~i~G~~L~~l~~~---~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          173 EGFPVPEPIAQS------RHTIVMSLVDALPMRQVSSV---PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             TTCSCCCEEEEE------TTEEEEECCSCEEGGGCCCC---SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred             cCCCCCeeeecc------CceEEEEecCCccHhhhccc---HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence            332  2222221      23699999999888765432   344668899999999999999999999999999987621


Q ss_pred             ---------cEEEEecccceec
Q 014762          258 ---------KLRLIDWGLAEFY  270 (419)
Q Consensus       258 ---------~~kl~Dfgla~~~  270 (419)
                               .+.|+||+-+...
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     3789999987653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.45  E-value=5.5e-13  Score=122.26  Aligned_cols=138  Identities=18%  Similarity=0.229  Sum_probs=110.9

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      +.|++...+|.|+.+.||++..  .+..+++|+...   .....+.+|+.+++.+.++..+.++++++.+.  ...++||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~   89 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLM   89 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEEEE
Confidence            3578888899999999999853  467899999874   34467999999999996677888999988653  6678999


Q ss_pred             EecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 014762          202 EYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS--------------------------------------------  237 (419)
Q Consensus       202 e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~--------------------------------------------  237 (419)
                      ||++|.++......  ......++.+++.+|..||+                                            
T Consensus        90 e~i~G~~l~~~~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           90 SEADGVLCSEEYED--EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             ECCSSEEHHHHCCT--TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             EecCCeehhhccCC--cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            99999999876432  22344678899999999998                                            


Q ss_pred             ---------------CCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          238 ---------------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       238 ---------------~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                                     ..++|+|+++.|||++.+ ..+.|+||+.+..
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~  213 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhccc
Confidence                           458999999999999864 5567999997753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.33  E-value=8.9e-12  Score=113.67  Aligned_cols=135  Identities=18%  Similarity=0.171  Sum_probs=99.6

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCC-eeEEEeEEEccCCCccEEEEEec
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPN-VVKLLDIVRDQHSKTPSLIFEYV  204 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~~~~lv~e~~  204 (419)
                      +|.+....+.|..+.||++. ..+|..+++|+........+.+|+.+++.+..+.- +.+++++....  ...++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEEEEEec
Confidence            45544433456669999985 45677899999876555678899999999955422 56688877543  5578999999


Q ss_pred             CCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------------
Q 014762          205 NSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQG---------------------------------------------  239 (419)
Q Consensus       205 ~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---------------------------------------------  239 (419)
                      +|.++.  ....+.   ..++.+++..|..||+..                                             
T Consensus        98 ~G~~l~--~~~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A           98 PGQDLL--SSHLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             SSEETT--TSCCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             CCcccC--cCcCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence            999884  333332   356677888888888643                                             


Q ss_pred             -------------cEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          240 -------------IMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       240 -------------ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                                   ++|+|++|.|||++.+ +.+.|+|||.+..
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~  214 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhccc
Confidence                         9999999999999865 5567999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=4.2e-11  Score=114.95  Aligned_cols=140  Identities=20%  Similarity=0.358  Sum_probs=107.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEec--Ccc----hHHHHHHHHHHHHhcC-CCCeeEEEeEEEccCC-CccEEEE
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILK--PVK----KKKIKREIKILQNLCG-GPNVVKLLDIVRDQHS-KTPSLIF  201 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~--~~~----~~~~~~E~~~l~~l~~-h~niv~l~~~~~~~~~-~~~~lv~  201 (419)
                      ++.|+.|.++.||+...  .+..+++|+..  +..    ...+.+|+.+++.+.. +..+.+++.++.+... +..++||
T Consensus        43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            67799999999999854  34678888876  332    3578899999999943 3457888888865421 4578999


Q ss_pred             EecCCCChh-hhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 014762          202 EYVNSTDFK-VLYPTLTDYDIRYYIYELLKALDYCHS-------------------------------------------  237 (419)
Q Consensus       202 e~~~~~~l~-~~~~~l~~~~~~~~~~qi~~~L~~LH~-------------------------------------------  237 (419)
                      ||++|..+. .....++..+...++.+++..|..||+                                           
T Consensus       121 e~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (359)
T 3dxp_A          121 EFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL  200 (359)
T ss_dssp             ECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred             EecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence            999998874 345678888889999999999999997                                           


Q ss_pred             ---------------CCcEeecCCCCceEEcCCCC-cEEEEecccceecc
Q 014762          238 ---------------QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYH  271 (419)
Q Consensus       238 ---------------~~ivH~Dlk~~NILl~~~~~-~~kl~Dfgla~~~~  271 (419)
                                     ..++|+|+++.|||++.+.. .+.|+||+.+....
T Consensus       201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                           35899999999999997633 35899999987643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.11  E-value=9.8e-11  Score=109.67  Aligned_cols=183  Identities=17%  Similarity=0.256  Sum_probs=124.1

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCC--eeEEEeEEEccC-CCccEEEEEecC
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPN--VVKLLDIVRDQH-SKTPSLIFEYVN  205 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~n--iv~l~~~~~~~~-~~~~~lv~e~~~  205 (419)
                      ++.++.|.+..||+..     ..+++|+.... ....+.+|+.+++.+..+..  +.+.+....... ....++||++++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            3458999999999862     46889987644 34678899999998844332  334444432221 124578999999


Q ss_pred             CCChhh-hcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 014762          206 STDFKV-LYPTLTDYDIRYYIYELLKALDYCHS-----------------------------------------------  237 (419)
Q Consensus       206 ~~~l~~-~~~~l~~~~~~~~~~qi~~~L~~LH~-----------------------------------------------  237 (419)
                      |..+.. ....++..+...++.+++..|..||+                                               
T Consensus       100 G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  179 (304)
T 3sg8_A          100 GVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD  179 (304)
T ss_dssp             CEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred             CeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence            988764 44667888888888999998888886                                               


Q ss_pred             -----------CCcEeecCCCCceEEcCC-CCcEEEEecccceeccCCCcceeeccc-----c--------cc--cc-cc
Q 014762          238 -----------QGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEYNVRVAS-----R--------YF--KG-PE  289 (419)
Q Consensus       238 -----------~~ivH~Dlk~~NILl~~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~-----~--------~y--~a-PE  289 (419)
                                 ..++|+|+++.||+++.+ ...+.|+||+.+....+..........     .        .|  .. |+
T Consensus       180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~  259 (304)
T 3sg8_A          180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPT  259 (304)
T ss_dssp             HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHH
T ss_pred             HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHH
Confidence                       137999999999999974 356789999998765432211100000     0        01  11 22


Q ss_pred             cccCCCCCCccccHHHHHHHHHHHHhCCCCC
Q 014762          290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF  320 (419)
Q Consensus       290 ~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf  320 (419)
                      ...   ......+.|++|.++|.+.+|..+|
T Consensus       260 ~~~---r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          260 VLE---KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHH---HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHH---HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111   1123368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.75  E-value=1.8e-07  Score=87.53  Aligned_cols=137  Identities=18%  Similarity=0.261  Sum_probs=97.5

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCC-C-CeeEEEeEEEccCCCccEEEEEecCC
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGG-P-NVVKLLDIVRDQHSKTPSLIFEYVNS  206 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h-~-niv~l~~~~~~~~~~~~~lv~e~~~~  206 (419)
                      ++.++.|....||+.     |..+++|+.... ....+.+|..+|+.+..+ + .+.+.+.+.... .+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEEEEeccCC
Confidence            456888998999987     567888886432 346788999999999443 2 245666666422 3556899999999


Q ss_pred             CChhh-hcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q 014762          207 TDFKV-LYPTLTDYDIRYYIYELLKALDYCHSQ-----------------------------------------------  238 (419)
Q Consensus       207 ~~l~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~-----------------------------------------------  238 (419)
                      ..+.. ....++..+...++.++...|..||+.                                               
T Consensus        98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  177 (306)
T 3tdw_A           98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ  177 (306)
T ss_dssp             EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred             eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence            88765 334556666666666666666666632                                               


Q ss_pred             -------------CcEeecCCCCceEEcC---CCCcEEEEecccceeccC
Q 014762          239 -------------GIMHRDVKPHNVMIDH---ELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       239 -------------~ivH~Dlk~~NILl~~---~~~~~kl~Dfgla~~~~~  272 (419)
                                   .++|+|+++.||+++.   +...+.|+||+.+....+
T Consensus       178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~  227 (306)
T 3tdw_A          178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP  227 (306)
T ss_dssp             HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred             HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence                         3599999999999987   324458999999876543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.73  E-value=9.4e-08  Score=87.50  Aligned_cols=134  Identities=14%  Similarity=0.106  Sum_probs=94.7

Q ss_pred             eeeeeCce-EEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChh
Q 014762          132 KVGRGKYS-EVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK  210 (419)
Q Consensus       132 ~lG~G~fg-~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~  210 (419)
                      .+..|..| +||+.....++..+++|+-.......+.+|...|+.+..+--+.++++++.+.  ...++|||+++|.++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCcccc
Confidence            35556555 69998777778889999987777778899999999996554577888888654  5678999999998776


Q ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------------C-
Q 014762          211 VLYPTLTDYDIRYYIYELLKALDYCHS---------------------------------------------------Q-  238 (419)
Q Consensus       211 ~~~~~l~~~~~~~~~~qi~~~L~~LH~---------------------------------------------------~-  238 (419)
                      ...... ......+..++...|.-||+                                                   . 
T Consensus       109 ~~~~~~-~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  187 (272)
T 4gkh_A          109 QVLEEY-PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLL  187 (272)
T ss_dssp             HHHHHC-GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTC
T ss_pred             ccccCC-HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcc
Confidence            543211 11222333444444444441                                                   1 


Q ss_pred             ------CcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          239 ------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       239 ------~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                            .++|+|+.+.|||++.+ +.+-|+||+.+..
T Consensus       188 ~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~  223 (272)
T 4gkh_A          188 PFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI  223 (272)
T ss_dssp             CCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred             cccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence                  27999999999999876 5567999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.41  E-value=7.1e-07  Score=85.11  Aligned_cols=83  Identities=13%  Similarity=0.157  Sum_probs=57.9

Q ss_pred             EEEeee-eeeCceEEEEEEEc--C----CCcEEEEEEecCcc------hHHHHHHHHHHHHhcCC--CCeeEEEeEEEcc
Q 014762          128 EVVRKV-GRGKYSEVFEGINV--N----TNERCIIKILKPVK------KKKIKREIKILQNLCGG--PNVVKLLDIVRDQ  192 (419)
Q Consensus       128 ~~~~~l-G~G~fg~V~~~~~~--~----~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~  192 (419)
                      ...+.| +.|..+.+|+....  .    ++..+++|+.....      ...+.+|+.+++.+..+  -.+.+++.++.+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 88888999987542  1    26678899876433      25688999999988554  3567788877543


Q ss_pred             C-CCccEEEEEecCCCChh
Q 014762          193 H-SKTPSLIFEYVNSTDFK  210 (419)
Q Consensus       193 ~-~~~~~lv~e~~~~~~l~  210 (419)
                      . ....++||||++|..+.
T Consensus       103 ~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCC
T ss_pred             CccCCceEEEEecCCCChh
Confidence            2 13467999999887654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.20  E-value=5.8e-06  Score=80.02  Aligned_cols=74  Identities=18%  Similarity=0.232  Sum_probs=49.5

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----------chHHHHHHHHHHHHhcCC-CC-eeEEEeEEEccCCCcc
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------KKKKIKREIKILQNLCGG-PN-VVKLLDIVRDQHSKTP  197 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~E~~~l~~l~~h-~n-iv~l~~~~~~~~~~~~  197 (419)
                      .+.||.|.++.||++.+..+++.+++|...+.          ..+.+.+|..+++.+... +. +.+++.+.  .  ...
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~--~~~  110 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA  110 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C--Ccc
Confidence            56799999999999976556788999986432          124567899999987432 33 34555442  2  335


Q ss_pred             EEEEEecCCC
Q 014762          198 SLIFEYVNST  207 (419)
Q Consensus       198 ~lv~e~~~~~  207 (419)
                      ++|||++++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            7999999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.95  E-value=1.9e-05  Score=74.41  Aligned_cols=135  Identities=16%  Similarity=0.208  Sum_probs=78.0

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCC-CCeeEEEeE-----EEccCCCccEEEEEe
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG-PNVVKLLDI-----VRDQHSKTPSLIFEY  203 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h-~niv~l~~~-----~~~~~~~~~~lv~e~  203 (419)
                      ++.|+.|..+.||+... .+ ..+++|+... ....+..|..+++.+..+ -.+.+++..     +. ......+++|+|
T Consensus        37 ~~~l~gG~~n~~~~v~~-~~-~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~-~~~~~~~~l~~~  112 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHT-DS-GAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYS-KHGSFLFVVYDW  112 (346)
T ss_dssp             EEECC----CEEEEEEE-TT-EEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCE-EETTEEEEEEEC
T ss_pred             eeeccccccCcEEEEEe-CC-CCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEE-EECCEEEEEEEe
Confidence            45577777899999854 33 4589999875 334556677777766321 123344331     11 112456899999


Q ss_pred             cCCCChh-----h----------h---cCCC-------------CHHH-------------------------------H
Q 014762          204 VNSTDFK-----V----------L---YPTL-------------TDYD-------------------------------I  221 (419)
Q Consensus       204 ~~~~~l~-----~----------~---~~~l-------------~~~~-------------------------------~  221 (419)
                      ++|..+.     .          +   ...+             .+..                               +
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986432     0          0   0111             1110                               0


Q ss_pred             HHHHHHHHHHHHHHHH-------------CCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          222 RYYIYELLKALDYCHS-------------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       222 ~~~~~qi~~~L~~LH~-------------~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                      ..+..++..++++|++             ..++|+|+++.|||++.+ +.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGG-GCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCC-CcEEEEehhhccc
Confidence            1111223345666652             579999999999999766 6789999998754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.87  E-value=8.9e-05  Score=69.12  Aligned_cols=76  Identities=20%  Similarity=0.186  Sum_probs=59.7

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCC--CCeeEEEeEEEccCCCccEEEEEecCCC
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (419)
                      .+.|+.|....+|+...  ++..+++|+........+.+|...|+.|...  ..+.+.+.+....  ...++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEeccCC
Confidence            56799999999999853  5678889998766667789999999988433  5677888877543  5678999999887


Q ss_pred             Ch
Q 014762          208 DF  209 (419)
Q Consensus       208 ~l  209 (419)
                      ..
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.76  E-value=0.00013  Score=67.56  Aligned_cols=70  Identities=11%  Similarity=0.078  Sum_probs=45.5

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcch--HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEec-CC
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYV-NS  206 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~-~~  206 (419)
                      ++.|+.|....+|+.      ..+++|+..+...  -...+|+.+++.+..+.-..++++.+  ..  .-++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~--~~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PA--TGVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT--TCCEEEECCTTC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CC--CCEEEEeecCCC
Confidence            567999999999998      5688898865322  12357888888774433225666554  22  234899999 66


Q ss_pred             CCh
Q 014762          207 TDF  209 (419)
Q Consensus       207 ~~l  209 (419)
                      ..+
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.62  E-value=9.1e-05  Score=72.17  Aligned_cols=78  Identities=13%  Similarity=0.128  Sum_probs=47.2

Q ss_pred             HCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeecc--cccccccccccCCC--CCCccccHHHHHHHHHH
Q 014762          237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVA--SRYFKGPELLVDLQ--DYDYSLDMWSLGCMFAG  312 (419)
Q Consensus       237 ~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~--~~~y~aPE~~~~~~--~~~~~~DiwSlG~~l~e  312 (419)
                      ...++|+|+++.|||++.+ + +.++||+.+....+.........  ...|.+|+......  .-....++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSS-C-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCC-C-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            4579999999999999876 4 89999999876543222111111  12355655443111  11223455577777777


Q ss_pred             HHhC
Q 014762          313 MIFR  316 (419)
Q Consensus       313 ll~g  316 (419)
                      .+.+
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.58  E-value=0.00017  Score=67.28  Aligned_cols=139  Identities=16%  Similarity=0.197  Sum_probs=80.0

Q ss_pred             EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-cchHHHHHHHHHHHHhcCCC-CeeEEEeEEEc----cCCCccEEEE
Q 014762          128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGP-NVVKLLDIVRD----QHSKTPSLIF  201 (419)
Q Consensus       128 ~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~----~~~~~~~lv~  201 (419)
                      .-++.|+.|....+|+... .+| .+++|+... .....+..|+.++..+..+. .+.+++....+    ...+..++++
T Consensus        25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            3456788888899999864 334 688999876 34567788999988884331 12333321100    0113467899


Q ss_pred             EecCCCChhh-----h-------------cCCC--------CHHHHHH---------------HHHHHHHHHHHHHH---
Q 014762          202 EYVNSTDFKV-----L-------------YPTL--------TDYDIRY---------------YIYELLKALDYCHS---  237 (419)
Q Consensus       202 e~~~~~~l~~-----~-------------~~~l--------~~~~~~~---------------~~~qi~~~L~~LH~---  237 (419)
                      +|++|..+..     .             ...+        .......               +...+...++++.+   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998865321     0             0111        1010000               00113445556653   


Q ss_pred             ----CCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          238 ----QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       238 ----~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                          .+++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence                369999999999999876 4457999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.57  E-value=0.00015  Score=68.24  Aligned_cols=137  Identities=15%  Similarity=0.131  Sum_probs=73.4

Q ss_pred             EeeeeeeCceE-EEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCC-CeeEEEeEEEccCCCccEEEEEecCCC
Q 014762          130 VRKVGRGKYSE-VFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNST  207 (419)
Q Consensus       130 ~~~lG~G~fg~-V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (419)
                      .+.|+.|.... +|+.. ..+|..+++|...+.....+..|+.+++.+..+. .+.+++.+.  ....  +++||++++.
T Consensus        23 ~~~l~gg~s~~~~~r~~-~~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLR-SPTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEE-CTTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEE-cCCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCCCc
Confidence            34565554444 66763 2236677777765443356677888888874432 345666653  2222  6899998775


Q ss_pred             Chhhhc-----------------------------CCCCHHHHHH--------HH------------HHHHHHHHHHH--
Q 014762          208 DFKVLY-----------------------------PTLTDYDIRY--------YI------------YELLKALDYCH--  236 (419)
Q Consensus       208 ~l~~~~-----------------------------~~l~~~~~~~--------~~------------~qi~~~L~~LH--  236 (419)
                      .+...+                             +.++......        +.            ..+...++.+-  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            543211                             0111111100        00            01112233331  


Q ss_pred             ----HCCcEeecCCCCceEEcCC---CCcEEEEecccceecc
Q 014762          237 ----SQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYH  271 (419)
Q Consensus       237 ----~~~ivH~Dlk~~NILl~~~---~~~~kl~Dfgla~~~~  271 (419)
                          ...++|+|+.+.|||++.+   .+.+.|+||+.+....
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence                2369999999999999863   1468999999987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.55  E-value=0.00027  Score=68.97  Aligned_cols=73  Identities=15%  Similarity=0.167  Sum_probs=52.2

Q ss_pred             EeeeeeeCceEEEEEEEcC-------CCcEEEEEEecCcch-HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          130 VRKVGRGKYSEVFEGINVN-------TNERCIIKILKPVKK-KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ++.|+.|....||++....       ++..+++|+...... ..+.+|..+++.+..+.-..++++.+  .+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC----CEEE
Confidence            4568888889999997542       257899999854233 66778999999885544446777776  32    2899


Q ss_pred             EecCCCC
Q 014762          202 EYVNSTD  208 (419)
Q Consensus       202 e~~~~~~  208 (419)
                      ||++|..
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998644

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.44  E-value=0.00061  Score=65.18  Aligned_cols=134  Identities=13%  Similarity=0.191  Sum_probs=82.5

Q ss_pred             eeeeeeCceEEEEEEEcC-------CCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          131 RKVGRGKYSEVFEGINVN-------TNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      +.|..|-...+|++....       +++.+++|+..+.  ......+|..+++.+..+.-..++++.+  +++    +||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~g----~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF--PEG----RLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TTE----EEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CCc----cEE
Confidence            457777778889886532       3578999987432  3456678999999885554456777776  322    899


Q ss_pred             EecCCCChhhh--------------c-----------CCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 014762          202 EYVNSTDFKVL--------------Y-----------PTLT--DYDIRYYIYELL-------------------KALDYC  235 (419)
Q Consensus       202 e~~~~~~l~~~--------------~-----------~~l~--~~~~~~~~~qi~-------------------~~L~~L  235 (419)
                      ||++|..+...              +           +...  +.++..+..++.                   ..++.|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99988654211              0           0111  244455544432                   223444


Q ss_pred             HH--------CCcEeecCCCCceEEcCC---CCcEEEEecccceec
Q 014762          236 HS--------QGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFY  270 (419)
Q Consensus       236 H~--------~~ivH~Dlk~~NILl~~~---~~~~kl~Dfgla~~~  270 (419)
                      .+        ..++|+|+.+.||+++.+   .+.+.++||..+...
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~  255 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN  255 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence            32        259999999999999865   357899999988643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.35  E-value=0.0015  Score=59.88  Aligned_cols=76  Identities=14%  Similarity=0.118  Sum_probs=54.8

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCC--CeeEEEeEEEccCCCccEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGP--NVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~--niv~l~~~~~~~~~~~~~lv  200 (419)
                      ...-++.+|.|..+.||+.. ..+|+.+++|+.....   ...+.+|+..|+.|....  -+.+.++..  .    .++|
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv   88 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLA   88 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEE
T ss_pred             CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEE
Confidence            45567889999999999996 5788999999875332   346889999999984331  344555542  2    3589


Q ss_pred             EEecCCCC
Q 014762          201 FEYVNSTD  208 (419)
Q Consensus       201 ~e~~~~~~  208 (419)
                      |||+.++.
T Consensus        89 ~e~l~~~~   96 (288)
T 3f7w_A           89 MEWVDERP   96 (288)
T ss_dssp             EECCCCCC
T ss_pred             EEeecccC
Confidence            99987654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.29  E-value=0.0013  Score=64.52  Aligned_cols=74  Identities=15%  Similarity=0.216  Sum_probs=49.6

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchH--HHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEecCCC
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST  207 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~  207 (419)
                      ++.|+.|-...+|++....++..+++|+..+....  ...+|..++..+..+.-..++++.+  .+    .+||||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN----GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEEeeCCc
Confidence            56788899999999976444578999988543221  1268999999995444346778777  32    2699999875


Q ss_pred             Ch
Q 014762          208 DF  209 (419)
Q Consensus       208 ~l  209 (419)
                      .+
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.27  E-value=0.0008  Score=62.88  Aligned_cols=134  Identities=15%  Similarity=0.164  Sum_probs=79.0

Q ss_pred             eeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCC-CeeEEEeEEEcc----CCCccEEEEEe
Q 014762          131 RKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLLDIVRDQ----HSKTPSLIFEY  203 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~----~~~~~~lv~e~  203 (419)
                      ..++ |....||+.. ..+|+.+++|+..+.  ....+..|..++..+..+. .+.+++.. .+.    ..+..+++|++
T Consensus        32 ~~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEE-cCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence            3466 7788999874 345667999999743  4567888999988884331 23444443 110    12345789999


Q ss_pred             cCCCChhh-----h------c-------C--------CCCHHHH----HHHH---------------HHHHHHHHHHH--
Q 014762          204 VNSTDFKV-----L------Y-------P--------TLTDYDI----RYYI---------------YELLKALDYCH--  236 (419)
Q Consensus       204 ~~~~~l~~-----~------~-------~--------~l~~~~~----~~~~---------------~qi~~~L~~LH--  236 (419)
                      ++|..+..     .      +       .        ..+....    ..++               ..+-..++.+.  
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            98754321     0      0       0        0111111    1111               01111233332  


Q ss_pred             -----HCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          237 -----SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       237 -----~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                           ...++|+|+++.|||++ +  .+.|+||+.+...
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~g  224 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D--GPMFVDLDDARNG  224 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S--SEEECCCTTCCEE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C--CCEEEECCCCCcC
Confidence                 23589999999999998 4  6899999987654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.07  E-value=0.0018  Score=61.71  Aligned_cols=73  Identities=15%  Similarity=0.190  Sum_probs=45.2

Q ss_pred             EeeeeeeCceEEEEEEEcC--------CCcEEEEEEecCcchH--HHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          130 VRKVGRGKYSEVFEGINVN--------TNERCIIKILKPVKKK--KIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~--~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ...|+.|....+|+.....        .+..+++|+.......  ...+|..+++.+..+.-..++++.+  .    -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~----~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N----GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C----CcE
Confidence            4568888888999986533        1367889987643221  2468898998885443344666654  2    248


Q ss_pred             EEEecCCCC
Q 014762          200 IFEYVNSTD  208 (419)
Q Consensus       200 v~e~~~~~~  208 (419)
                      ||||++|..
T Consensus       112 v~e~i~G~~  120 (369)
T 3c5i_A          112 IEEWLYGDP  120 (369)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEecCCc
Confidence            999998754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.72  E-value=0.02  Score=49.72  Aligned_cols=97  Identities=9%  Similarity=0.005  Sum_probs=59.4

Q ss_pred             Chhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcceeeccc
Q 014762          208 DFKVLY----PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS  282 (419)
Q Consensus       208 ~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  282 (419)
                      +|...+    .++++++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+ |.|.+.+ +.+.           ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-G~V~f~~-~~s~-----------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-GAVTLAP-AADD-----------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-SCEEECC-C-----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-Cceeccc-cccc-----------ccc
Confidence            455544    679999999999999999876622 121233345678888877 6655543 1110           112


Q ss_pred             ccccccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 014762          283 RYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEP  319 (419)
Q Consensus       283 ~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~p  319 (419)
                      ..+.+||...  ...+.+.=|||||+++|..+--..|
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence            3456888753  3567888999999999998865544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.35  E-value=0.013  Score=54.98  Aligned_cols=71  Identities=8%  Similarity=0.178  Sum_probs=43.5

Q ss_pred             eeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCC--CCeeEEEeEEEc----cCCCccEEEEEecCCC
Q 014762          134 GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGG--PNVVKLLDIVRD----QHSKTPSLIFEYVNST  207 (419)
Q Consensus       134 G~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~----~~~~~~~lv~e~~~~~  207 (419)
                      |.|....||+... .+| .+++|+.....   ..+|+.++..|..+  |++.+.+....+    ......+++|+|++|.
T Consensus        32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~---~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           32 GADTNAFAYQADS-ESK-SYFIKLKYGYH---DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             TSCSSCEEEEEEC-SSC-EEEEEEEECSS---CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             cCccccceEEEEe-CCC-CEEEEEecCcc---chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            4444678999853 445 89999886544   25677777777322  324444432110    1135568999999887


Q ss_pred             Ch
Q 014762          208 DF  209 (419)
Q Consensus       208 ~l  209 (419)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            55

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.96  E-value=0.019  Score=55.64  Aligned_cols=74  Identities=16%  Similarity=0.212  Sum_probs=49.4

Q ss_pred             EeeeeeeCceEEEEEEEcCC-------CcEEEEEEecCcch--HHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          130 VRKVGRGKYSEVFEGINVNT-------NERCIIKILKPVKK--KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~-------~~~vavK~~~~~~~--~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      ++.+..|-...+|+......       +..+++++..+...  -...+|..+++.+..+.-..++++.+  .  +  ++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~--~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--E--GRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--T--EEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--C--CEE
Confidence            45677788888999865421       57899998754321  23468999998885444455666654  2  1  589


Q ss_pred             EEecCCCCh
Q 014762          201 FEYVNSTDF  209 (419)
Q Consensus       201 ~e~~~~~~l  209 (419)
                      |||++|..+
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.70  E-value=0.038  Score=53.12  Aligned_cols=31  Identities=29%  Similarity=0.523  Sum_probs=25.3

Q ss_pred             cEeecCCCCceEEcC-----CCCcEEEEecccceec
Q 014762          240 IMHRDVKPHNVMIDH-----ELRKLRLIDWGLAEFY  270 (419)
Q Consensus       240 ivH~Dlk~~NILl~~-----~~~~~kl~Dfgla~~~  270 (419)
                      ++|+|+.+.|||+..     +...+.++||..|...
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            689999999999942     3367999999998653

>2k21_A Potassium voltage-gated channel subfamily E member; KCNE1, membrane protein, potassium channel, MINK, auxilliary subunit, micelles, ION transport; NMR {Homo sapiens}

Probab=86.63  E-value=0.57  Score=35.99  Aligned_cols=21  Identities=29%  Similarity=0.517  Sum_probs=11.3

Q ss_pred             cccccchhhHhhhhccchhhh
Q 014762            9 KHKHKHPAVLAAQVQVLPLRF   29 (419)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~   29 (419)
                      .|.|.|+++|.-...+.||=.
T Consensus         3 ~~~~~~~~~~~n~t~~~~~L~   23 (138)
T 2k21_A            3 HHHHHHGMILSNTTAVTPFLT   23 (138)
T ss_dssp             -------CTTHHHHHHCTTHH
T ss_pred             ccccccceeecCchHHHHHHH
Confidence            366789999998888888643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	419
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-107
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-54
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-52
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-52
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-51
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-50
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-50
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-49
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-49
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-49
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-48
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-47
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-46
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-44
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-37
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-35
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-35
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-34
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-32
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-32
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-32
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-32
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-32
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-32
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-32
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-30
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-30
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-30
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-30
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-28
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-27
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-26
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-26
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-18

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  317 bits (814), Expect = e-107
 Identities = 243/316 (76%), Positives = 286/316 (90%)

Query: 92  PAMSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNE 151
           P  S+ARVYTDVN  RP+EYWDYES  V+WG+QDDY++VRK+GRGKYSEVFE IN+  NE
Sbjct: 2   PVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNE 61

Query: 152 RCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           + ++KILKPVKKKKIKREIKIL+NL GGPN++ L DIV+D  S+TP+L+FE+VN+TDFK 
Sbjct: 62  KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121

Query: 212 LYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 271
           LY TLTDYDIR+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYH
Sbjct: 122 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181

Query: 272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           PG+EYNVRVASRYFKGPELLVD Q YDYSLDMWSLGCM A MIFRKEPFF+GHDN+DQLV
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +IAKVLGT++L  Y++KY++ELDP+ + ++GRHSRK W +F++++NQHLVSPEA+DFLDK
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

Query: 392 LLRYDHQDRLTAREAM 407
           LLRYDHQ RLTAREAM
Sbjct: 302 LLRYDHQSRLTAREAM 317

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-57
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 21/295 (7%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNV 182
            +  Y   + +G G +  V++    ++ E   IK +    K+   RE++I++ L    N+
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKL-DHCNI 75

Query: 183 VKLLDIVRDQHSKTPS----LIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKAL 232
           V+L         K       L+ +YV  T ++V         TL    ++ Y+Y+L ++L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 292
            Y HS GI HRD+KP N+++D +   L+L D+G A+    G+     + SRY++ PEL+ 
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
              DY  S+D+WS GC+ A ++  + P F G    DQLV+I KVLGT             
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            + +      +    PW+K           PEAI    +LL Y    RLT  EA 
Sbjct: 255 TEFKFP----QIKAHPWTKVFRPR----TPPEAIALCSRLLEYTPTARLTPLEAC 301

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 5e-54
 Identities = 57/297 (19%), Positives = 112/297 (37%), Gaps = 20/297 (6%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK----PVKKKKIKREIKILQNLCGGP 180
           DD+E + ++G G    VF+  +  +      K++     P  + +I RE+++L      P
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCHS 237
            +V              S+  E+++      +      + +  +      ++K L Y   
Sbjct: 65  YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 238 Q-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
           +  IMHRDVKP N++++     ++L D+G++         N  V +R +  PE L     
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-TH 179

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DELNAYLNKYH 350
           Y    D+WS+G     M   + P         +L+   +V G                  
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             +D +    +        ++        + S E  DF++K L  +  +R   ++ M
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 79/295 (26%), Positives = 148/295 (50%), Gaps = 21/295 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK----KKIKREIKILQNLCGGP 180
             Y  +  +G G Y  V    +     R  IK + P +     ++  REIKIL       
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-E 66

Query: 181 NVVKLLDIVRD---QHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALDYCH 236
           N++ + DI+R    +  K   L+   + +  +K+L    L++  I Y++Y++L+ L Y H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 292
           S  ++HRD+KP N++++     L++ D+GLA    P  ++       VA+R+++ PE+++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
           + + Y  S+D+WS+GC+ A M+  + P F G    DQL  I  +LG+          +L+
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
               L + +   ++ PW++            +A+D LDK+L ++   R+   +A+
Sbjct: 245 ARNYLLS-LPHKNKVPWNRLFPN-----ADSKALDLLDKMLTFNPHKRIEVEQAL 293

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 8e-52
 Identities = 82/307 (26%), Positives = 156/307 (50%), Gaps = 21/307 (6%)

Query: 111 YWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKK 165
           ++  E     W  +  Y  ++ VG G Y  V   ++  T  +  IK L       +  K+
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 166 IKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS----LIFEYVNSTDFKVL-YPTLTDYD 220
             RE+++L+++    NV+ LLD+     +        L+  ++ +   K++ +  L +  
Sbjct: 64  AYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
           I++ +Y++LK L Y H+ GI+HRD+KP N+ ++ +    +++D+GLA       E    V
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYV 179

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            +R+++ PE++++   Y  ++D+WS+GC+ A MI  K   F G D+ DQL +I KV GT 
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL-FKGSDHLDQLKEIMKVTGTP 238

Query: 341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDR 400
               ++ +   +        +    +K ++  +        SP A++ L+K+L  D + R
Sbjct: 239 PAE-FVQRLQSDEAKNYMKGLPELEKKDFASILTN-----ASPLAVNLLEKMLVLDAEQR 292

Query: 401 LTAREAM 407
           +TA EA+
Sbjct: 293 VTAGEAL 299

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 9e-51
 Identities = 88/302 (29%), Positives = 147/302 (48%), Gaps = 27/302 (8%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
             YE + K+G+G + EVF+  +  T ++  +K +    +K+       REIKILQ L   
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KH 68

Query: 180 PNVVKLLDIVRDQHSK------TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLK 230
            NVV L++I R + S       +  L+F++       +L       T  +I+  +  LL 
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-----YNVRVASRYF 285
            L Y H   I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + ++
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 286 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY 345
           + PELL+  +DY   +D+W  GC+ A M  R  P   G+    QL  I+++ G+     +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
            N  + EL  +L+ +     +    K  +    ++  P A+D +DKLL  D   R+ + +
Sbjct: 247 PNVDNYELYEKLELV-----KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301

Query: 406 AM 407
           A+
Sbjct: 302 AL 303

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  169 bits (429), Expect = 2e-50
 Identities = 86/292 (29%), Positives = 152/292 (52%), Gaps = 23/292 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGG 179
           + Y  + K+G G Y  V++  N N  E   +K ++  K          REI IL+ L   
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 236
            N+VKL D++  +      L+FE+++    K+L      L     + ++ +LL  + YCH
Sbjct: 60  SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 295
            + ++HRD+KP N++I+ E   L++ D+GLA  +  P ++Y   + + +++ P++L+  +
Sbjct: 118 DRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  ++D+WS+GC+FA M+    P F G    DQL++I ++LGT     + N   L   P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---P 232

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           + D     +   PW  F+       +    ID L K+L+ D   R+TA++A+
Sbjct: 233 KYDPNFTVYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRITAKQAL 279

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 4e-50
 Identities = 83/311 (26%), Positives = 151/311 (48%), Gaps = 22/311 (7%)

Query: 107 RPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PV 161
           RP  ++  E     W   + Y+ +  VG G Y  V    +  T  R  +K L       +
Sbjct: 1   RP-TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59

Query: 162 KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS---KTPSLIFEYVNSTDFKVLY--PTL 216
             K+  RE+++L+++    NV+ LLD+     S        +  ++   D   +     L
Sbjct: 60  HAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118

Query: 217 TDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY 276
           TD  +++ IY++L+ L Y HS  I+HRD+KP N+ ++ +    +++D+GLA   H   E 
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEM 175

Query: 277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 336
              VA+R+++ PE++++   Y+ ++D+WS+GC+ A ++  +   F G D+ DQL  I ++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL-FPGTDHIDQLKLILRL 234

Query: 337 LGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYD 396
           +GT                 + +L         + FI        +P A+D L+K+L  D
Sbjct: 235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIG------ANPLAVDLLEKMLVLD 288

Query: 397 HQDRLTAREAM 407
              R+TA +A+
Sbjct: 289 SDKRITAAQAL 299

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 1e-49
 Identities = 84/292 (28%), Positives = 146/292 (50%), Gaps = 26/292 (8%)

Query: 128 EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK--------KKIKREIKILQNLCGG 179
           E +  +G G+++ V++  + NTN+   IK +K   +        +   REIK+LQ L   
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH- 59

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCH 236
           PN++ LLD     H    SL+F+++ +    ++      LT   I+ Y+   L+ L+Y H
Sbjct: 60  PNIIGLLDA--FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
              I+HRD+KP+N+++D     L+L D+GLA  F  P + Y  +V +R+++ PELL   +
Sbjct: 118 QHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y   +DMW++GC+ A ++ R  PF  G  + DQL +I + LGT     + +   L    
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
              +  G      +S             + +D +  L  ++   R+TA +A+
Sbjct: 236 TFKSFPGIPLHHIFSA---------AGDDLLDLIQGLFLFNPCARITATQAL 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-49
 Identities = 84/293 (28%), Positives = 157/293 (53%), Gaps = 23/293 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
           ++++ V K+G G Y  V++  N  T E   +K ++   + +       REI +L+ L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYC 235
           PN+VKLLD++  ++     L+FE+++    K +       +    I+ Y+++LL+ L +C
Sbjct: 61  PNIVKLLDVIHTENKLY--LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDL 294
           HS  ++HRD+KP N++I+ E   ++L D+GLA  +  P + Y   V + +++ PE+L+  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D+WSLGC+FA M+ R+   F G    DQL +I + LGT +   +     +   
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM--- 233

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
           P       + +R+ +SK +       +  +    L ++L YD   R++A+ A+
Sbjct: 234 PDYKPSFPKWARQDFSKVVPP-----LDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  169 bits (428), Expect = 2e-49
 Identities = 66/291 (22%), Positives = 130/291 (44%), Gaps = 46/291 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK---PVKKKKIKREIKILQNLCGGPN 181
           D Y+++ ++G G +  V   +   T    + K +    P+ K  +K EI I+  L   P 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHS 237
           ++ L D   D++     LI E+++  +           +++ ++  Y+ +  + L + H 
Sbjct: 88  LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 238 QGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
             I+H D+KP N+M +  +   +++ID+GLA   +P +   V  A+  F  PE++ D + 
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREP 204

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
             +  DMW++G +   ++    P F G D+ + L  + +     + +A+ +         
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRCDWEFDEDAFSS--------- 254

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                   VSPEA DF+  LL+ + + RLT  +A+
Sbjct: 255 ------------------------VSPEAKDFIKNLLQKEPRKRLTVHDAL 281

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (422), Expect = 3e-49
 Identities = 82/292 (28%), Positives = 143/292 (48%), Gaps = 21/292 (7%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKK-----IKREIKILQNLCGG 179
             YE + K+G G Y  VF+  N  T+E   +K ++     +       REI +L+ L   
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYCH 236
            N+V+L D++      T  L+FE+ +      F      L    ++ ++++LLK L +CH
Sbjct: 61  KNIVRLHDVLHSDKKLT--LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           S+ ++HRD+KP N++I+      +L ++GLA  F  P + Y+  V + +++ P++L   +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y  S+DMWS GC+FA +     P F G+D  DQL +I ++LGT     + +   L   P
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL---P 234

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                    +       +       ++    D L  LL+ +   R++A EA+
Sbjct: 235 DYKPYPMYPATTSLVNVVPK-----LNATGRDLLQNLLKCNPVQRISAEEAL 281

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  164 bits (417), Expect = 1e-48
 Identities = 65/304 (21%), Positives = 117/304 (38%), Gaps = 57/304 (18%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIK 171
            ++YE    +GRG  S V   I+  T +   +KI+                ++   +E+ 
Sbjct: 2   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY--PTLTDYDIRYYIYEL 228
           IL+ + G PN+++L D           L+F+ +   + F  L    TL++ + R  +  L
Sbjct: 62  ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119

Query: 229 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 288
           L+ +   H   I+HRD+KP N+++D ++  ++L D+G +    PG++      +  +  P
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178

Query: 289 ELL-----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN 343
           E++      +   Y   +DMWS G +   ++    P F+       L  I          
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMIMS-------- 229

Query: 344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA 403
                Y        D                       S    D + + L    Q R TA
Sbjct: 230 ---GNYQFGSPEWDD----------------------YSDTVKDLVSRFLVVQPQKRYTA 264

Query: 404 REAM 407
            EA+
Sbjct: 265 EEAL 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 4e-48
 Identities = 67/306 (21%), Positives = 128/306 (41%), Gaps = 51/306 (16%)

Query: 114 YESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK---REI 170
           YE +T     +D +E++ ++G G + +V++  N  T+     K++    +++++    EI
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 171 KILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIY 226
            IL +    PN+VKLLD    +++    ++ E+        +       LT+  I+    
Sbjct: 61  DILASCDH-PNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117

Query: 227 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 285
           + L AL+Y H   I+HRD+K  N++   +   ++L D+G++ +     +  +  + + Y+
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 286 KGPELLV----DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
             PE+++      + YDY  D+WSLG     M   + P  +  +    L+KIAK      
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAKS----- 230

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                    L    +                         S    DFL K L  +   R 
Sbjct: 231 -----EPPTLAQPSR------------------------WSSNFKDFLKKCLEKNVDARW 261

Query: 402 TAREAM 407
           T  + +
Sbjct: 262 TTSQLL 267

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 5e-48
 Identities = 82/298 (27%), Positives = 140/298 (46%), Gaps = 28/298 (9%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCI-IKILKPVK-----KKKIKREIKILQNLCG 178
             YE V ++G G Y +VF+  ++    R + +K ++             RE+ +L++L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 179 G--PNVVKLLDIVRDQHSKTPS---LIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 229
              PNVV+L D+     +   +   L+FE+V+      L     P +    I+  +++LL
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           + LD+ HS  ++HRD+KP N+++    +  +L D+GLA  Y         V + +++ PE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
           +L+    Y   +D+WS+GC+FA M  RK P F G  + DQL KI  V+G      +    
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            L             S +P  KF+       +     D L K L ++   R++A  A+
Sbjct: 244 ALP-----RQAFHSKSAQPIEKFVTD-----IDELGKDLLLKCLTFNPAKRISAYSAL 291

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 6e-48
 Identities = 63/290 (21%), Positives = 123/290 (42%), Gaps = 45/290 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNV 182
           + Y +   +GRG++  V   +  ++ +  + K +K     +  +K+EI IL       N+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNI 63

Query: 183 VKLLDIVRDQHSKTPSLIFEYVNSTD-FKVL---YPTLTDYDIRYYIYELLKALDYCHSQ 238
           + L +           +IFE+++  D F+ +      L + +I  Y++++ +AL + HS 
Sbjct: 64  LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 239 GIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            I H D++P N++        +++I++G A    PG  + +   +  +  PE+       
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVV 180

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             + DMWSLG +   ++    P F    N   +  I     T +  A+            
Sbjct: 181 STATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMNAEYTFDEEAFKE---------- 229

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                  +S EA+DF+D+LL  + + R+TA EA+
Sbjct: 230 -----------------------ISIEAMDFVDRLLVKERKSRMTASEAL 256

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  163 bits (413), Expect = 3e-47
 Identities = 60/291 (20%), Positives = 117/291 (40%), Gaps = 46/291 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPN 181
           D Y++  ++G G +  V       T      K +       K+ +++EI+ +  L   P 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84

Query: 182 VVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL----YPTLTDYDIRYYIYELLKALDYCHS 237
           +V L D   D +     +I+E+++  +        +  +++ +   Y+ ++ K L + H 
Sbjct: 85  LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 238 QGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
              +H D+KP N+M   +   +L+LID+GL     P +   V   +  F  PE+    + 
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KP 201

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
             Y  DMWS+G +   ++    P F G ++ + L  +       + +A+           
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKSCDWNMDDSAFSG--------- 251

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                   +S +  DF+ KLL  D   R+T  +A+
Sbjct: 252 ------------------------ISEDGKDFIRKLLLADPNTRMTIHQAL 278

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 7e-47
 Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 43/293 (14%)

Query: 125 DDYEVVRKV-GRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVV 183
           DDY+V  +V G G   +V +  N  T E+  +K+L+     K +RE+++       P++V
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68

Query: 184 KLLDIVRDQHS--KTPSLIFEYVNSTDF-----KVLYPTLTDYDIRYYIYELLKALDYCH 236
           +++D+  + ++  K   ++ E ++  +             T+ +    +  + +A+ Y H
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128

Query: 237 SQGIMHRDVKPHNVMIDHELRK--LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           S  I HRDVKP N++   +     L+L D+G A+             + Y+  PE+L   
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP- 187

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + YD S DMWSLG +   ++    PF Y +        +   +                 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRI----------------- 229

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                      R    +F N +    VS E    +  LL+ +   R+T  E M
Sbjct: 230 -----------RMGQYEFPNPEWSE-VSEEVKMLIRNLLKTEPTQRMTITEFM 270

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-46
 Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 49/293 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGP 180
           +D+++V+ +G G Y EV   +N  T E   +KI+   +     + IK+EI I + L    
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS 237
           NVVK     R        L  EY      F  + P   + + D + + ++L+  + Y H 
Sbjct: 64  NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 294
            GI HRD+KP N+++D     L++ D+GLA  +         N    +  +  PELL   
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + +   +D+WS G +   M+  +   +    +  Q     K                   
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWK------------------- 220

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                   +    PW K         +    +  L K+L  +   R+T  +  
Sbjct: 221 ------EKKTYLNPWKK---------IDSAPLALLHKILVENPSARITIPDIK 258

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 3e-46
 Identities = 63/292 (21%), Positives = 119/292 (40%), Gaps = 53/292 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D+E+ R +G+GK+  V+      +     +K+L   +      + +++RE++I  +L  
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            PN+++L     D       LI EY                 +     YI EL  AL YC
Sbjct: 66  -PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+ ++HRD+KP N+++      L++ D+G +  + P         +  +  PE++   +
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEG-R 179

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            +D  +D+WSLG +    +  K P F  +   +   +I++V  T                
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRVEFTFP-------------- 224

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                    V+  A D + +LL+++   R   RE +
Sbjct: 225 -----------------------DFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 4e-46
 Identities = 70/312 (22%), Positives = 144/312 (46%), Gaps = 18/312 (5%)

Query: 110 EYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKK 164
           +++  E     +     Y+ ++ +G G    V    +   +    IK L          K
Sbjct: 2   QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61

Query: 165 KIKREIKILQNLCGGPNVVKLLDIVRDQHS----KTPSLIFEYVNSTDFKVLYPTLTDYD 220
           +  RE+ +++ +    N++ LL++   Q +    +   L+ E +++   +V+   L    
Sbjct: 62  RAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 120

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRV 280
           + Y +Y++L  + + HS GI+HRD+KP N+++  +    +++D+GLA            V
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYV 179

Query: 281 ASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD 340
            +RY++ PE+++    Y  ++D+WS+GC+   M+  K   F G D  DQ  K+ + LGT 
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTP 237

Query: 341 -----ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRY 395
                +      + ++E  P+   L             ++++  L + +A D L K+L  
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297

Query: 396 DHQDRLTAREAM 407
           D   R++  +A+
Sbjct: 298 DPAKRISVDDAL 309

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 1e-44
 Identities = 63/290 (21%), Positives = 117/290 (40%), Gaps = 46/290 (15%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGP 180
           +  Y    K+G+G    V+  ++V T +   I+ +      KK+ I  EI +++     P
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP 77

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHSQ 238
           N+V  LD           ++ EY+       +     + +  I     E L+AL++ HS 
Sbjct: 78  NIVNYLDSYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 239 GIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
            ++HRD+K  N+++  +   ++L D+G   +      + +  V + Y+  PE++   + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 193

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
              +D+WSLG M   MI  + P +   +    L  IA                L+   +L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIAT----------NGTPELQNPEKL 242

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                   S    DFL++ L  D + R +A+E +
Sbjct: 243 ------------------------SAIFRDFLNRCLDMDVEKRGSAKELL 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (388), Expect = 5e-44
 Identities = 67/294 (22%), Positives = 117/294 (39%), Gaps = 54/294 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK------KKIKREIKILQNLCG 178
             +  +R++G G +  V+   +V  +E   IK +    K      + I +E++ LQ L  
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            PN ++       +H  T  L+ EY   +     +V    L + +I    +  L+ L Y 
Sbjct: 75  -PNTIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS  ++HRDVK  N+++      ++L D+G A    P   +   V + Y+  PE+++ + 
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMD 187

Query: 296 D--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
           +  YD  +D+WSLG     +  RK P F   +    L  IA+           N+     
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQ-----------NESPALQ 235

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                       S    +F+D  L+   QDR T+   +
Sbjct: 236 SGH------------------------WSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 7e-44
 Identities = 65/301 (21%), Positives = 118/301 (39%), Gaps = 58/301 (19%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGG 179
           +DYEV+  +G G Y    +    +  +  + K L        +K+ +  E+ +L+ L   
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY------PTLTDYDIRYYIYELLKAL 232
           PN+V+  D + D+ + T  ++ EY    D   V+         L +  +   + +L  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 233 DYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 286
             CH +      ++HRD+KP NV +D +   ++L D+GLA   +    +    V + Y+ 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +     Y+   D+WSLGC+   +     P F      +   KI +           
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKIRE----------- 228

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                          G+  R P+            S E  + + ++L      R +  E 
Sbjct: 229 ---------------GKFRRIPYR----------YSDELNEIITRMLNLKDYHRPSVEEI 263

Query: 407 M 407
           +
Sbjct: 264 L 264

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  151 bits (383), Expect = 2e-43
 Identities = 69/293 (23%), Positives = 120/293 (40%), Gaps = 47/293 (16%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGG 179
           +D Y+    +G G +SEV    +  T +   IK +       K+  ++ EI +L  +   
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 66

Query: 180 PNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY--PTLTDYDIRYYIYELLKALDYCH 236
           PN+V L DI          LI + V+  + F  +      T+ D    I+++L A+ Y H
Sbjct: 67  PNIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 237 SQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
             GI+HRD+KP N++     E  K+ + D+GL++   PG   +    +  +  PE+L   
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ- 183

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + Y  ++D WS+G +   ++    P FY  ++     +I K                   
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP-FYDENDAKLFEQILKA------------------ 224

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                         W           +S  A DF+  L+  D + R T  +A+
Sbjct: 225 ------EYEFDSPYWDD---------ISDSAKDFIRHLMEKDPEKRFTCEQAL 262

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-42
 Identities = 66/300 (22%), Positives = 121/300 (40%), Gaps = 55/300 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCG 178
           +D++  + +G G +S V     + T+    IKIL+        K   + RE  ++  L  
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYC 235
            P  VKL    +D           Y  + +   +     +  +   R+Y  E++ AL+Y 
Sbjct: 68  -PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLV 292
           H +GI+HRD+KP N++++ ++  +++ D+G A+   P  +    N  V +  +  PELL 
Sbjct: 125 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 293 DLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE 352
           + +    S D+W+LGC+   ++    P F   + +    KI K+               +
Sbjct: 184 E-KSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIKL-------------EYD 228

Query: 353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI 412
              +                          P+A D ++KLL  D   RL   E      +
Sbjct: 229 FPEK------------------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-41
 Identities = 66/298 (22%), Positives = 127/298 (42%), Gaps = 53/298 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQN 175
           D Y+   ++G G+++ V +    +T  +   K +K  +         ++ I+RE+ IL+ 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKAL 232
           +   PNV+ L ++  ++      LI E V      DF     +LT+ +   ++ ++L  +
Sbjct: 70  IQ-HPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126

Query: 233 DYCHSQGIMHRDVKPHNVMIDHE---LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
            Y HS  I H D+KP N+M+        ++++ID+GLA     G E+     +  F  PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
           ++ + +      DMWS+G +   ++    P F G    + L  ++ V             
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANVSAV------------- 231

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                            + +S           S  A DF+ +LL  D + R+T ++++
Sbjct: 232 -----------NYEFEDEYFSN---------TSALAKDFIRRLLVKDPKKRMTIQDSL 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 61/298 (20%), Positives = 111/298 (37%), Gaps = 61/298 (20%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQ 174
           +  Y+V   +G G +  V+ GI V+ N    IK ++  +           ++  E+ +L+
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62

Query: 175 NLCGG-PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 229
            +  G   V++LLD      S    LI E          +      L +   R + +++L
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFDFITERGALQEELARSFFWQVL 120

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           +A+ +CH+ G++HRD+K  N++ID    +L+LID+G          Y     +R +  PE
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPE 179

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
            +   + +  S  +WSLG +   M+    PF +  +                    + + 
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------------IIRG 219

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
            +    +                        VS E    +   L     DR T  E  
Sbjct: 220 QVFFRQR------------------------VSSECQHLIRWCLALRPSDRPTFEEIQ 253

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 4e-40
 Identities = 53/293 (18%), Positives = 111/293 (37%), Gaps = 51/293 (17%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPN 181
            +   ++GRG +  V++G++  T        L+  K     +++ K E ++L+ L   PN
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69

Query: 182 VVKLLDIVRD--QHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYCH 236
           +V+  D      +  K   L+ E + S   K     +  +    +R +  ++LK L + H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 237 SQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 294
           ++   I+HRD+K  N+ I      +++ D GLA          V + +  F  PE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--E 186

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           + YD S+D+++ G     M   + P+    +      ++                    D
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-----------GVKPASFD 235

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                       PE  + ++  +R +  +R + ++ +
Sbjct: 236 KV------------------------AIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 1e-39
 Identities = 60/293 (20%), Positives = 115/293 (39%), Gaps = 52/293 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D+ + + +G+G + +VF      TN+   IK LK          +    E ++L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALDYC 235
            P +  +    + + +     + EY+N  D                 +Y  E++  L + 
Sbjct: 62  HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 294
           HS+GI++RD+K  N+++D +    ++ D+G+  E      + N    +  +  PE+L+  
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG- 177

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
           Q Y++S+D WS G +   M+  + P F+G D  +    I                     
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSI--------------------- 215

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                   R     + +++          EA D L KL   + + RL  R  +
Sbjct: 216 --------RMDNPFYPRWL--------EKEAKDLLVKLFVREPEKRLGVRGDI 252

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  141 bits (355), Expect = 9e-39
 Identities = 66/292 (22%), Positives = 116/292 (39%), Gaps = 50/292 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D+ V R +GRG + EV+     +T +   +K L   +      +     E  +L  +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 179 G--PNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKALD 233
           G  P +V +            S I + +N  D       +   ++ D+R+Y  E++  L+
Sbjct: 64  GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 293
           + H++ +++RD+KP N+++D     +R+ D GLA  +   K +     +  +  PE+L  
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 179

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
              YD S D +SLGCM   ++    P F  H   D+           E++       +EL
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH----------EIDRMTLTMAVEL 228

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
                                       SPE    L+ LL+ D   RL    
Sbjct: 229 PDS------------------------FSPELRSLLEGLLQRDVNRRLGCLG 256

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  134 bits (337), Expect = 4e-37
 Identities = 58/298 (19%), Positives = 104/298 (34%), Gaps = 50/298 (16%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLC 177
            D YE+   +G G  SEV    ++  +    +K+L+      P    + +RE +    L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64

Query: 178 GGPNVVKLLDIVRDQHSKTPS--LIFEYVNSTDFKVL---YPTLTDYDIRYYIYELLKAL 232
             P +V + D    +    P   ++ EYV+    + +      +T       I +  +AL
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 289
           ++ H  GI+HRDVKP N+MI            I   +A+  +   +    + +  +  PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 290 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY 349
                   D   D++SLGC+   ++  + P F G        +                 
Sbjct: 185 QARG-DSVDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQHV--------------- 227

Query: 350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                        R    P S          +S +    + K L  + ++R      M
Sbjct: 228 -------------REDPIPPSARHEG-----LSADLDAVVLKALAKNPENRYQTAAEM 267

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 6e-37
 Identities = 43/299 (14%), Positives = 110/299 (36%), Gaps = 54/299 (18%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-----PVKKKKIKREIKILQNLC 177
                 V +++G G +  V++G     +    +K+L      P + +  K E+ +L+   
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62

Query: 178 GGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY---PTLTDYDIRYYIYELLKALD 233
              N++  +           +++ ++   +  +  L+          +     +  + +D
Sbjct: 63  H-VNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPEL 290
           Y H++ I+HRD+K +N+ +  +L  +++ D+GLA         +       S  +  PE+
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 291 LVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           +       Y +  D+++ G +   ++  + P +   +N DQ++ +               
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQIIFM--------------- 221

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                       VGR    P    + ++            + + L+    +R    + +
Sbjct: 222 ------------VGRGYLSPDLSKVRSN----CPKAMKRLMAECLKKKRDERPLFPQIL 264

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-35
 Identities = 53/321 (16%), Positives = 105/321 (32%), Gaps = 77/321 (23%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER-----CIIKILK----PVKKKKIKREIKIL 173
            +++ E  + +G G + +V        ++        +K+LK      +++ +  E+K++
Sbjct: 35  PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD------------------------- 208
             L    N+V LL       S    LIFEY    D                         
Sbjct: 95  TQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 209 -FKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
             +     LT  D+  + Y++ K +++   +  +HRD+   NV++ H    +++ D+GLA
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLA 211

Query: 268 EFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH 324
                   Y VR        +  PE L +   Y    D+WS G +   +       + G 
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 325 DNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPE 384
                  K+ +           N + ++                             + E
Sbjct: 271 PVDANFYKLIQ-----------NGFKMDQPFY------------------------ATEE 295

Query: 385 AIDFLDKLLRYDHQDRLTARE 405
               +     +D + R +   
Sbjct: 296 IYIIMQSCWAFDSRKRPSFPN 316

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 1e-35
 Identities = 39/291 (13%), Positives = 101/291 (34%), Gaps = 50/291 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK-PVKKKKIKREIKILQNLCGGPN 181
           +  + ++++ +G+G++ +V  G       +  +K +K     +    E  ++  L    N
Sbjct: 5   NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SN 61

Query: 182 VVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY----PTLTDYDIRYYIYELLKALDYCH 236
           +V+LL ++ ++      ++ EY+   +    L       L    +  +  ++ +A++Y  
Sbjct: 62  LVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 296
               +HRD+   NV++  +    ++ D+GL +     +  +       +  PE L + + 
Sbjct: 121 GNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KK 176

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           +    D+WS G +   +       +      D + ++ K             Y ++    
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------GYKMDAPDG 224

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                     P   + +      D   R +  +  
Sbjct: 225 ------------------------CPPAVYEVMKNCWHLDAAMRPSFLQLR 251

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  130 bits (328), Expect = 5e-35
 Identities = 65/313 (20%), Positives = 123/313 (39%), Gaps = 33/313 (10%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNL-------- 176
           Y +VRK+G G +S V+   ++  N    +KI++   V  +  + EIK+LQ +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 177 --CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDF------KVLYPTLTDYDIRYYIYEL 228
              G  +++KLLD    +      ++  +    +       K  +  +    ++    +L
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 229 LKALDYC-HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS---RY 284
           L  LDY     GI+H D+KP NV+++       LI   +A+  +          S   R 
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 285 FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF-----FYGHDNHDQLVKIAKVLGT 339
           ++ PE+L+    +    D+WS  C+   +I     F          + D + +I ++LG 
Sbjct: 195 YRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 340 DELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHL-----VSPEAIDFLDKLLR 394
                  N  +         L+   S+  +    +   +        + E  DFL  +L+
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313

Query: 395 YDHQDRLTAREAM 407
            D + R  A   +
Sbjct: 314 LDPRKRADAGGLV 326

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 7e-35
 Identities = 44/303 (14%), Positives = 103/303 (33%), Gaps = 52/303 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++  ++V ++G G++ EV+ G   N + +  +K LK   +       E  +++ L    
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-Q 68

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
            +V+L  +V  +      +I EY+ +              LT   +     ++ + + + 
Sbjct: 69  RLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-PELLVDL 294
             +  +HRD++  N+++   L   ++ D+GLA      +      A    K      ++ 
Sbjct: 126 EERNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             +    D+WS G +   ++      + G  N + +  + +             Y +   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------GYRMVRP 232

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP 414
                                        E    +    +   +DR T     + S +  
Sbjct: 233 DN------------------------CPEELYQLMRLCWKERPEDRPTFDY--LRSVLED 266

Query: 415 IFS 417
            F+
Sbjct: 267 FFT 269

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-34
 Identities = 42/301 (13%), Positives = 92/301 (30%), Gaps = 56/301 (18%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---IKILKPVK------KKKIKREIKIL 173
            + D  ++ K+G G +  V  G     + + +   +K LKP             RE+  +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELL 229
            +L    N+++L  +V     K   ++ E                      +  Y  ++ 
Sbjct: 66  HSLDH-RNLIRLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 230 KALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR---VASRYFK 286
           + + Y  S+  +HRD+   N+++      +++ D+GL        ++ V        +  
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
                +  + + ++ D W  G     M    +  + G +    L KI K           
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----------- 229

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
               L                                +  + + +   +  +DR T    
Sbjct: 230 EGERLPRPED------------------------CPQDIYNVMVQCWAHKPEDRPTFVAL 265

Query: 407 M 407
            
Sbjct: 266 R 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (317), Expect = 6e-34
 Identities = 46/297 (15%), Positives = 97/297 (32%), Gaps = 47/297 (15%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVV 183
           + Y + RK+G G + +++ G ++   E   IK+     K  ++  E KI + + GG  + 
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTD---FKVLYPTLTDYDIRYYIYELLKALDYCHSQGI 240
            +     +       ++ E +  +    F       +   +     +++  ++Y HS+  
Sbjct: 67  TIRWCGAEGDY--NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124

Query: 241 MHRDVKPHNVMIDHELRKLRL--IDWGLAEFYHPGKEYNVR--------VASRYFKGPEL 290
           +HRDVKP N ++    +   +  ID+GLA+ Y   + +             +  +     
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
            +   +     D+ SLG +           + G     +  K  +               
Sbjct: 185 HLG-IEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYER--------------- 227

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                         S K  S  I    +     E   +L+        D+       
Sbjct: 228 -------------ISEKKMSTPIEVLCKG-YPSEFATYLNFCRSLRFDDKPDYSYLR 270

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 6e-34
 Identities = 47/304 (15%), Positives = 106/304 (34%), Gaps = 54/304 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
            ++   +  K+G+G + EV+ G    T  R  IK LKP  +  +   +E ++++ L    
Sbjct: 15  PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRH-E 72

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYC 235
            +V+L  +V ++      ++ EY++               L    +     ++   + Y 
Sbjct: 73  KLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVD 293
                +HRD++  N+++   L   ++ D+GLA      +            +  PE  + 
Sbjct: 130 ERMNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 294 LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL 353
              +    D+WS G +   +  +    + G  N + L ++               Y +  
Sbjct: 189 -GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------------ERGYRMPC 235

Query: 354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS 413
            P+                              D + +  R + ++R T     + + + 
Sbjct: 236 PPE------------------------CPESLHDLMCQCWRKEPEERPTFEY--LQAFLE 269

Query: 414 PIFS 417
             F+
Sbjct: 270 DYFT 273

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  126 bits (318), Expect = 7e-34
 Identities = 52/293 (17%), Positives = 107/293 (36%), Gaps = 54/293 (18%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNLCG 178
            D++++R +G G +  V    + +      +K+LK        + +    E  +L  +  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNST---DFKVLYPTLTDYDIRYYIYELLKALDYC 235
            P ++++    +D        I +Y+                +   ++Y  E+  AL+Y 
Sbjct: 63  HPFIIRMWGTFQDAQQIFM--IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 295
           HS+ I++RD+KP N+++D     +++ D+G A++            +  +  PE++   +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST-K 176

Query: 296 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP 355
            Y+ S+D WS G +   M+    P FY  +      KI                      
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKILN-------------------- 215

Query: 356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
                       P+            + +  D L +L+  D   RL   +   
Sbjct: 216 ------AELRFPPF-----------FNEDVKDLLSRLITRDLSQRLGNLQNGT 251

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-33
 Identities = 54/298 (18%), Positives = 120/298 (40%), Gaps = 49/298 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPVK-------KKKIKREIKILQ 174
           +++E+++ +G G Y +VF    +   +T +   +K+LK           +  + E ++L+
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALD 233
           ++   P +V L    + +      L +         +      T+++++ Y+ E++ AL+
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 234 YCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPEL 290
           + H  GI++RD+K  N+++D     + L D+GL++ +   +    Y+      Y     +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
                 +D ++D WSLG +   ++    P F      +   +I++ +   E         
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISRRILKSEP-------- 253

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
                            P+ + +        S  A D + +LL  D + RL       
Sbjct: 254 -----------------PYPQEM--------SALAKDLIQRLLMKDPKKRLGCGPRDA 286

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 3e-33
 Identities = 45/310 (14%), Positives = 95/310 (30%), Gaps = 65/310 (20%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK------PVKKKKIKREIKILQNL 176
           D +D +    +G G + +V +        R    I +          +    E+++L  L
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 177 CGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-------------------FKVLYPTLT 217
              PN++ LL     +H     L  EY    +                         TL+
Sbjct: 68  GHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 218 DYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 277
              + ++  ++ + +DY   +  +HRD+   N+++       ++ D+GL+       +  
Sbjct: 126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKT 184

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
           +      +   E L     Y  + D+WS G +   ++      + G    +   K+    
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 239

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
                      Y LE                               E  D + +  R   
Sbjct: 240 --------PQGYRLEKPLN------------------------CDDEVYDLMRQCWREKP 267

Query: 398 QDRLTAREAM 407
            +R +  + +
Sbjct: 268 YERPSFAQIL 277

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-33
 Identities = 54/289 (18%), Positives = 102/289 (35%), Gaps = 47/289 (16%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCG 178
           +D++ ++ +G+G + +V       T     +KIL+               E ++LQN   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 179 GPNVVKLLDIVRD-QHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 237
            P +  L    +                           T+   R+Y  E++ AL+Y HS
Sbjct: 65  -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
           + +++RD+K  N+M+D +   +++ D+GL +                      +++  DY
Sbjct: 124 RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
             ++D W LG +   M+  + P FY  D+      I                        
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELI------------------------ 217

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                      + + +        SPEA   L  LL+ D + RL    +
Sbjct: 218 -----LMEEIRFPRTL--------SPEAKSLLAGLLKKDPKQRLGGGPS 253

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 1e-32
 Identities = 42/293 (14%), Positives = 99/293 (33%), Gaps = 50/293 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  +   V+++G G++  V  G  +N  ++  IK ++   + ++    E +++  L   P
Sbjct: 3   DPSELTFVQEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIEEAEVMMKLSH-P 60

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYVNSTD----FKVLYPTLTDYDIRYYIYELLKALDYCH 236
            +V+L  +  +Q      L+FE++         +          +     ++ + + Y  
Sbjct: 61  KLVQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPELLVDL 294
              ++HRD+   N ++      +++ D+G+  F    +  +         +  PE+    
Sbjct: 119 EACVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF- 176

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             Y    D+WS G +   +    +  +    N + +  I+                    
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST------------------- 217

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  G    KP           L S      ++   +   +DR      +
Sbjct: 218 -------GFRLYKP----------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  122 bits (308), Expect = 1e-32
 Identities = 38/231 (16%), Positives = 90/231 (38%), Gaps = 20/231 (8%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKIL-KPVKKKKIKREIKILQNLCGGPNVVKL 185
           Y+V R++G G +  +FEG N+  N++  IK   +     +++ E +  + L G   +  +
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 186 LDIVRDQHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMH 242
                 Q      L+ + +  +   +L       +   +     ++L  +   H + +++
Sbjct: 67  YYF--GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 243 RDVKPHNVMIDHELRK----LRLIDWGLAEFYHPG--------KEYNVRVASRYFKGPEL 290
           RD+KP N +I     K    + ++D+G+ +FY           +E      +  +     
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
            +  ++     D+ +LG +F   +      + G        K  ++    +
Sbjct: 185 HLG-REQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNKQKYERIGEKKQ 233

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (306), Expect = 2e-32
 Identities = 42/293 (14%), Positives = 104/293 (35%), Gaps = 48/293 (16%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILK--PVKKKKIKREIKILQNLCGGP 180
           ++ D  +  K+G G+Y EV+EG+    +    +K LK   ++ ++  +E  +++ +   P
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-P 73

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY----PTLTDYDIRYYIYELLKALDYC 235
           N+V+LL +   +      +I E++        L       ++   + Y   ++  A++Y 
Sbjct: 74  NLVQLLGVCTREPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 236 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDL 294
             +  +HRD+   N ++      +++ D+GL+          +              +  
Sbjct: 132 EKKNFIHRDLAARNCLVGENHL-VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             +    D+W+ G +   +       + G D   Q+ ++ +             Y +E  
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLE-----------KDYRMERP 238

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                                        +  + +    +++  DR +  E  
Sbjct: 239 EG------------------------CPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-32
 Identities = 52/295 (17%), Positives = 104/295 (35%), Gaps = 53/295 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQN 175
            ++  E+ R +G G++ +V +GI ++     +   +K  K        +K  +E   ++ 
Sbjct: 5   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP----TLTDYDIRYYIYELLKA 231
               P++VKL+ ++ +       +I E     + +        +L    +  Y Y+L  A
Sbjct: 65  F-DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKGPEL 290
           L Y  S+  +HRD+   NV++      ++L D+GL+ +      Y   +           
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179

Query: 291 LVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH 350
            ++ + +  + D+W  G     ++      F G  N+D + +I             N   
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI------------ENGER 227

Query: 351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE 405
           L + P                           P     + K   YD   R    E
Sbjct: 228 LPMPPN------------------------CPPTLYSLMTKCWAYDPSRRPRFTE 258

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-32
 Identities = 47/293 (16%), Positives = 105/293 (35%), Gaps = 50/293 (17%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGP 180
           D  D   ++++G G++  V  G          IK++K   + + +   E K++ NL    
Sbjct: 2   DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-E 59

Query: 181 NVVKLLDIVRDQHSKTPSLIFEYV-NSTDFKVLY---PTLTDYDIRYYIYELLKALDYCH 236
            +V+L  +   Q  +   +I EY+ N      L           +     ++ +A++Y  
Sbjct: 60  KLVQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 237 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDL 294
           S+  +HRD+   N +++ +   +++ D+GL+ +    +  +         +  PE+L+  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY- 175

Query: 295 QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD 354
             +    D+W+ G +   +    +  +    N +    IA+                   
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ------------------- 216

Query: 355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
                  G    +P          HL S +    +         +R T +  +
Sbjct: 217 -------GLRLYRP----------HLASEKVYTIMYSCWHEKADERPTFKILL 252

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 3e-32
 Identities = 51/317 (16%), Positives = 98/317 (30%), Gaps = 70/317 (22%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVK----KKKIKREIKIL 173
            ++     + +G G + +V E      I  +      +K+LKP      ++ +  E+K+L
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD---------------------FKVL 212
             L    N+V LL            +I EY    D                      +  
Sbjct: 81  SYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
              L   D+  + Y++ K + +  S+  +HRD+   N+++ H     ++ D+GLA     
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKN 197

Query: 273 GKEYNVRVASRYFKG--PELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
              Y V+  +R          +    Y +  D+WS G     +       + G     + 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
            K+ K             + +                                E  D + 
Sbjct: 258 YKMIK-----------EGFRMLSPEH------------------------APAEMYDIMK 282

Query: 391 KLLRYDHQDRLTAREAM 407
                D   R T ++ +
Sbjct: 283 TCWDADPLKRPTFKQIV 299

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (305), Expect = 3e-32
 Identities = 45/301 (14%), Positives = 94/301 (31%), Gaps = 56/301 (18%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKK-------KKIKREIKILQN 175
           D    ++ + +G G++ EV  G      +R I   +K +K        +    E  I+  
Sbjct: 24  DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKA 231
               PNV+ L  +V         +I E++ +              T   +   +  +   
Sbjct: 84  FDH-PNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 291
           + Y      +HRD+   N++++  L   ++ D+GL+ F           ++   K P   
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199

Query: 292 VD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
                   + +  + D+WS G +   ++   E  ++   N D +  I +           
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ----------- 248

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
                 L P +D                              +    + D   R    + 
Sbjct: 249 ---DYRLPPPMD----------------------CPSALHQLMLDCWQKDRNHRPKFGQI 283

Query: 407 M 407
           +
Sbjct: 284 V 284

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (305), Expect = 8e-32
 Identities = 57/291 (19%), Positives = 111/291 (38%), Gaps = 50/291 (17%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIK------REIKILQNLCG 178
           D ++ ++ +G G +  V    +  +     +KIL   K  K+K       E +ILQ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99

Query: 179 GPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-YPTLTDYDIRYYIYELLKALDYCHS 237
            P +VKL    +D  +    + +         +      ++   R+Y  +++   +Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 238 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 297
             +++RD+KP N++ID +   +++ D+G A+             +     PE+++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGY 215

Query: 298 DYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL 357
           + ++D W+LG +   M     PFF   D   Q+ +                         
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFF--ADQPIQIYEK------------------------ 249

Query: 358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV 408
              +     +  S F         S +  D L  LL+ D   R    +  V
Sbjct: 250 ---IVSGKVRFPSHF---------SSDLKDLLRNLLQVDLTKRFGNLKNGV 288

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 3e-30
 Identities = 45/299 (15%), Positives = 102/299 (34%), Gaps = 57/299 (19%)

Query: 124 QDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPVKKKK----IKREIKILQN 175
           + +++ ++ +G G +  V++G+ +   E+      IK L+     K    I  E  ++ +
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDY----DIRYYIYELLKA 231
           +   P+V +LL I      +   LI + +             D      +  +  ++ K 
Sbjct: 68  VDN-PHVCRLLGICLTSTVQ---LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGP 288
           ++Y   + ++HRD+   NV++      +++ D+GLA+     ++            +   
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
           E ++  + Y +  D+WS G     ++      + G    +    + K             
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------G 229

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             L   P                          + +    + K    D   R   RE +
Sbjct: 230 ERLPQPPI------------------------CTIDVYMIMVKCWMIDADSRPKFRELI 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 5e-30
 Identities = 43/299 (14%), Positives = 100/299 (33%), Gaps = 55/299 (18%)

Query: 123 DQDDYEVV-RKVGRGKYSEVFEGINVNTNERCI--IKILKPVKKKK----IKREIKILQN 175
            +D+  +   ++G G +  V +G+     ++    IK+LK   +K     + RE +I+  
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 176 LCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTD-FKVLY---PTLTDYDIRYYIYELLKA 231
           L   P +V+L+ + + +      L+ E        K L      +   ++   ++++   
Sbjct: 66  L-DNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121

Query: 232 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASR---YFKGP 288
           + Y   +  +HRD+   NV++ +     ++ D+GL++       Y    ++         
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 289 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK 348
              ++ + +    D+WS G      +   +  +      + +  I               
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------EQG 228

Query: 349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAM 407
             +E  P+                          PE    +     Y  +DR       
Sbjct: 229 KRMECPPE------------------------CPPELYALMSDCWIYKWEDRPDFLTVE 263

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  115 bits (289), Expect = 5e-30
 Identities = 47/320 (14%), Positives = 95/320 (29%), Gaps = 78/320 (24%)

Query: 124 QDDYEVVRKVGRGKYSEVFEG-----INVNTNERCIIKILKPVK----KKKIKREIKILQ 174
           +++ E VR +G G +  VF+      +         +K+LK       +   +RE  ++ 
Sbjct: 12  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFK------------------------ 210
                PN+VKLL +      K   L+FEY+   D                          
Sbjct: 72  EFDN-PNIVKLLGV--CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128

Query: 211 ---VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                 P L+  +      ++   + Y   +  +HRD+   N ++   +  +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLS 187

Query: 268 EFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHD 325
              +    Y      A      P   +    Y    D+W+ G +   +       +YG  
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247

Query: 326 NHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEA 385
           + + +  +             +   L                                E 
Sbjct: 248 HEEVIYYV------------RDGNILACPEN------------------------CPLEL 271

Query: 386 IDFLDKLLRYDHQDRLTARE 405
            + +         DR +   
Sbjct: 272 YNLMRLCWSKLPADRPSFCS 291

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 8e-30
 Identities = 44/300 (14%), Positives = 95/300 (31%), Gaps = 58/300 (19%)

Query: 131 RKVGRGKYSEVFEGI--NVNTNERCIIKILK-----PVKKKKIKREIKILQNLCGGPNVV 183
           +++G G +  V +G        +   +KILK     P  K ++  E  ++Q L   P +V
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71

Query: 184 KLLDIVRDQHSKTPSLIFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGI 240
           +++ I   +      L+ E                + D +I   ++++   + Y      
Sbjct: 72  RMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128

Query: 241 MHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD 296
           +HRD+   NV++  +    ++ D+GL++     + Y            +  PE +     
Sbjct: 129 VHRDLAARNVLLVTQHY-AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YK 186

Query: 297 YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ 356
           +    D+WS G +        +  + G    +    + K               +     
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------------GERMGCPAG 234

Query: 357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF 416
                                      E  D ++    YD ++R       V   +   +
Sbjct: 235 ------------------------CPREMYDLMNLCWTYDVENRPGFAA--VELRLRNYY 268

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 1e-28
 Identities = 61/335 (18%), Positives = 122/335 (36%), Gaps = 59/335 (17%)

Query: 99  VYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCI---I 155
           V+ D++ L P+     + + +             +GRG +  V+ G  ++ + + I   +
Sbjct: 2   VHIDLSALNPELVQAVQHVVIGP-SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60

Query: 156 KILKPVKK----KKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKV 211
           K L  +       +   E  I+++    PNV+ LL I        P ++  Y+   D + 
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSH-PNVLSLLGICLRSEGS-PLVVLPYMKHGDLRN 118

Query: 212 LY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA 267
                    T  D+  +  ++ K + +  S+  +HRD+   N M+D +   +++ D+GLA
Sbjct: 119 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLA 177

Query: 268 EFYHPGKEYNVRVASRY-----FKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFY 322
              +  +  +V   +       +   E L   Q +    D+WS G +   ++ R  P + 
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYP 236

Query: 323 GHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVS 382
             +  D  V + +                          GR   +P              
Sbjct: 237 DVNTFDITVYLLQ--------------------------GRRLLQP----------EYCP 260

Query: 383 PEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS 417
               + + K      + R +  E  ++S IS IFS
Sbjct: 261 DPLYEVMLKCWHPKAEMRPSFSE--LVSRISAIFS 293

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 9e-28
 Identities = 39/301 (12%), Positives = 96/301 (31%), Gaps = 57/301 (18%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER----CIIKILKPV----KKKKIKREIKILQ 174
                   + +G G++ EV++G+   ++ +      IK LK      ++     E  I+ 
Sbjct: 5   HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 175 NLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLK 230
                 N+++L  ++         +I EY+ +              +   +   +  +  
Sbjct: 65  QFSH-HNIIRLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121

Query: 231 ALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----NVRVASRYFK 286
            + Y  +   +HRD+   N++++  L   ++ D+GL+       E     +       + 
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 287 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL 346
            PE +   +    S D+WS G +   ++   E  ++   NH+ +  I             
Sbjct: 181 APEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------N 227

Query: 347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA 406
           + + L                                     + +  + +   R    + 
Sbjct: 228 DGFRLPTPMD------------------------CPSAIYQLMMQCWQQERARRPKFADI 263

Query: 407 M 407
           +
Sbjct: 264 V 264

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 7e-27
 Identities = 43/317 (13%), Positives = 100/317 (31%), Gaps = 71/317 (22%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-------RCIIKILKPVKKKK----IKREIK 171
            +D   + + +G G + +V     +  ++       +  +K+LK    +K    +  E++
Sbjct: 11  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70

Query: 172 ILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL------------------- 212
           +++ +    N++ LL            +I EY +  + +                     
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 213 YPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 272
              L+  D+    Y++ + ++Y  S+  +HRD+   NV++  +    ++ D+GLA   H 
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 273 GKEYNVRVASRYFKGPELLVDLQD--YDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQL 330
              Y      R          L D  Y +  D+WS G +   +       + G    +  
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247

Query: 331 VKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLD 390
             +               + ++                             + E    + 
Sbjct: 248 KLL------------KEGHRMDKPSN------------------------CTNELYMMMR 271

Query: 391 KLLRYDHQDRLTAREAM 407
                    R T ++ +
Sbjct: 272 DCWHAVPSQRPTFKQLV 288

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-26
 Identities = 45/310 (14%), Positives = 99/310 (31%), Gaps = 66/310 (21%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKIL 173
            ++   + R++G+G +  V+EG+           R  IK +        + +   E  ++
Sbjct: 18  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVL-------------YPTLTDYD 220
           +      +VV+LL +V     +   +I E +   D K                   +   
Sbjct: 78  KEF-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 221 IRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---N 277
           +     E+   + Y ++   +HRD+   N M+  +   +++ D+G+    +    Y    
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGG 193

Query: 278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL 337
             +    +  PE L D   +    D+WS G +   +    E  + G  N   L  +    
Sbjct: 194 KGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV---- 248

Query: 338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDH 397
                   +    L+                                  + +    +Y+ 
Sbjct: 249 --------MEGGLLDKPDN------------------------CPDMLFELMRMCWQYNP 276

Query: 398 QDRLTAREAM 407
           + R +  E +
Sbjct: 277 KMRPSFLEII 286

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 3e-26
 Identities = 46/316 (14%), Positives = 103/316 (32%), Gaps = 69/316 (21%)

Query: 123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCI-----IKILKP----VKKKKIKREIKIL 173
            +D  ++ + +GRG + +V E      ++        +K+LK      + + +  E+KIL
Sbjct: 11  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLY------------------PT 215
            ++    NVV LL            ++           L                     
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 216 LTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 275
           LT   +  Y +++ K +++  S+  +HRD+   N+++  +   +++ D+GLA   +   +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDPD 189

Query: 276 Y----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV 331
           Y    + R+  ++     +    + Y    D+WS G +   +       + G    ++  
Sbjct: 190 YVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDK 391
           +  K               +                              +PE    +  
Sbjct: 248 RRLK-----------EGTRMRAPDY------------------------TTPEMYQTMLD 272

Query: 392 LLRYDHQDRLTAREAM 407
               +   R T  E +
Sbjct: 273 CWHGEPSQRPTFSELV 288

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 7e-26
 Identities = 50/306 (16%), Positives = 100/306 (32%), Gaps = 42/306 (13%)

Query: 125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQ-NLCGGPNVV 183
               +   +G+G++ EV+ G      E   +KI    +++   RE +I Q  +    N++
Sbjct: 3   RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 184 KLLDIVRDQHSKTPS--LIFEYVNSTD-FKVLY-PTLTDYDIRYYIYELLKALDYCHSQ- 238
             +      +       L+ +Y      F  L   T+T   +          L + H + 
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 239 -------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-----NVRVASRYFK 286
                   I HRD+K  N+++        + D GLA  +    +      N RV ++ + 
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179

Query: 287 GPELL-----VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDE 341
            PE+L     +   +     D++++G +F  +  R        D       +     + E
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239

Query: 342 LNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL 401
                         ++  +V     +P     N              + +    +   RL
Sbjct: 240 --------------EMRKVVCEQKLRP--NIPNRWQSCEALRVMAKIMRECWYANGAARL 283

Query: 402 TAREAM 407
           TA    
Sbjct: 284 TALRIK 289

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.0 bits (199), Expect = 1e-18
 Identities = 31/203 (15%), Positives = 69/203 (33%), Gaps = 34/203 (16%)

Query: 127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------------VKKKKIKREIKILQ 174
             + + +G GK S VF   +      C++K  K                      + I  
Sbjct: 2   DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 175 NLCGGPNVVKLLD--IVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKAL 232
                  + KL    + +    +  +++ E +++ +   +       +    +  +L+ +
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV----ENPDEVLDMILEEV 116

Query: 233 DYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA-EFYHPGKEY----NVRVASRYFKG 287
              + +GI+H D+  +NV++      + +ID+  + E    G       +VR    YF  
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS- 173

Query: 288 PELLVDLQDYDYSLDMWSLGCMF 310
                  + Y    D+ S     
Sbjct: 174 -------RTYRTEKDINSAIDRI 189

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	419
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.47
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.1
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.88
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.13
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.11
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.44

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.9e-64  Score=477.13  Aligned_cols=323  Identities=75%  Similarity=1.274  Sum_probs=296.7

Q ss_pred             CcccccccccccCCCcccCCCCCceeccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHH
Q 014762           94 MSKARVYTDVNVLRPKEYWDYESLTVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKIL  173 (419)
Q Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l  173 (419)
                      .++++++.+.+...+.++++|+...+.++..++|+++++||+|+||+||+|++..+|+.||||+++....+.+.+|+.+|
T Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il   83 (328)
T d3bqca1           4 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKIL   83 (328)
T ss_dssp             CCCCSSSTTTTTTSCHHHHCGGGCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHH
T ss_pred             CCcceeeccccccCCCccchhhhcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHH
Confidence            46778899999999999999999999999999999999999999999999999999999999999988889999999999


Q ss_pred             HHhcCCCCeeEEEeEEEccCCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEc
Q 014762          174 QNLCGGPNVVKLLDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID  253 (419)
Q Consensus       174 ~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~  253 (419)
                      +.+.+||||++++++|........++||||+++++|....+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus        84 ~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~  163 (328)
T d3bqca1          84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID  163 (328)
T ss_dssp             HHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred             HhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc
Confidence            99966999999999998776778999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCcEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 014762          254 HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKI  333 (419)
Q Consensus       254 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i  333 (419)
                      .+.+.+||+|||+|+............+|+.|+|||.+.+...++.++||||+||++|+|++|+.||..+.+..++...+
T Consensus       164 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i  243 (328)
T d3bqca1         164 HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  243 (328)
T ss_dssp             TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred             CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHH
Confidence            87567999999999988776666777899999999999886678999999999999999999999998888888889999


Q ss_pred             HHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          334 AKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       334 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                      .+.+|.+....+...........+...........+...........+++++.|||++||++||++||||+|+|+||||+
T Consensus       244 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~  323 (328)
T d3bqca1         244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  323 (328)
T ss_dssp             HHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            99999888888888888888888777777777778887777777777999999999999999999999999999999999


Q ss_pred             ccc
Q 014762          414 PIF  416 (419)
Q Consensus       414 ~~~  416 (419)
                      +|.
T Consensus       324 ~v~  326 (328)
T d3bqca1         324 TVV  326 (328)
T ss_dssp             TSC
T ss_pred             CCC
Confidence            874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-59  Score=431.35  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=209.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .++|+++++||+|+||+||+|++..+|+.||||+++..    ..+.+.+|+.+++++ +||||+++++++.++  +..++
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~--~~~~i   80 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREG--NIQYL   80 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccC--ceeEE
Confidence            46899999999999999999999999999999998643    235688999999999 999999999999764  67899


Q ss_pred             EEEecCCCChhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC--
Q 014762          200 IFEYVNSTDFKVLYP---TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK--  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~--  274 (419)
                      ||||+++|+|.+++.   .+++.+++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+......  
T Consensus        81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECEETTEE
T ss_pred             EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC-CCEEEccchhheeeccCCcc
Confidence            999999999988873   48999999999999999999999999999999999999988 789999999998764332  


Q ss_pred             -cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          275 -EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       275 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                       .....+||+.|+|||++.+...++.++|||||||++|+|++|+.||....+.......+... ..              
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-~~--------------  224 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KT--------------  224 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-CT--------------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CC--------------
Confidence             23446899999999999873445688999999999999999999996444333322222110 00              


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                 ...+         ...+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus       225 -----------~~~~---------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         225 -----------YLNP---------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             -----------TSTT---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             -----------CCCc---------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                       0001         1237899999999999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-58  Score=431.51  Aligned_cols=252  Identities=26%  Similarity=0.448  Sum_probs=214.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .++|+++++||+|+||+||+|.+..+|+.||||+++.   ...+.+.+|+.+++++ +||||++++++|.++  ..+++|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~iv   95 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV   95 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEEC--CEEEEE
Confidence            5679999999999999999999999999999999863   3356789999999999 999999999999764  678999


Q ss_pred             EEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cce
Q 014762          201 FEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EYN  277 (419)
Q Consensus       201 ~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~~  277 (419)
                      |||+++|+|..+.  ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ...
T Consensus        96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCBC
T ss_pred             EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-CcEeeccchhheeecccccccc
Confidence            9999999998876  569999999999999999999999999999999999999988 899999999998775443 345


Q ss_pred             eecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhh
Q 014762          278 VRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQL  357 (419)
Q Consensus       278 ~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~  357 (419)
                      ..+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+... +.+.                
T Consensus       175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~~~~~-~~~~----------------  235 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATN-GTPE----------------  235 (293)
T ss_dssp             CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHH-CSCC----------------
T ss_pred             ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCC-CCCHHHHHHHHHhC-CCCC----------------
Confidence            5689999999999987 789999999999999999999999983 33333444333321 1000                


Q ss_pred             HHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          358 DALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                       ...+..+++++++||.+||+.||++|||+.|+|+||||+..
T Consensus       236 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         236 -----------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             -----------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -----------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                             01112378999999999999999999999999999999753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-58  Score=426.26  Aligned_cols=247  Identities=25%  Similarity=0.464  Sum_probs=211.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      -++|++.+.||+|+||+||+|++..+++.||+|++.+      ...+.+.+|+.+++++ +||||+++++++.++  ...
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~   81 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDA--TRV   81 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEEC--CEE
Confidence            3679999999999999999999999999999999853      2346788999999999 999999999999654  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||+++|+|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+..... 
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCSCSCCCCC-
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC-CCEeecccceeeecCCC-
Confidence            9999999999998876   569999999999999999999999999999999999999988 78999999999866533 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+.             ..   
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~-------------~~---  221 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV-------------EF---  221 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTT-------------CC---
T ss_pred             cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCC-CCCHHHHHHHHHcC-------------CC---
Confidence            3455689999999999987 789999999999999999999999983 33333333332210             00   


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                           ..+..+++++++||.+||+.||++|||++|+|+||||+.
T Consensus       222 ---------------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         222 ---------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ---------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                                 011237899999999999999999999999999999974

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-58  Score=428.08  Aligned_cols=258  Identities=25%  Similarity=0.393  Sum_probs=213.6

Q ss_pred             eeccCCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC---cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          118 TVQWGDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP---VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       118 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .......+.|+++++||+|+||+||+|++..+|+.||+|+++.   ...+.+.+|+.+|+++ +|||||++++++.++  
T Consensus         5 ~r~~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--   81 (288)
T d2jfla1           5 TRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYE--   81 (288)
T ss_dssp             EESSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEET--
T ss_pred             cCCCCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC--
Confidence            3333345679999999999999999999999999999999864   3346788999999999 999999999999764  


Q ss_pred             CccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ...++||||+++|+|..++    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        82 ~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKN  160 (288)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred             CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC-CCEEEEechhhhcc
Confidence            6789999999999998775    359999999999999999999999999999999999999988 78999999999765


Q ss_pred             cCCC-cceeecccccccccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          271 HPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       271 ~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      .... ......||+.|+|||++..    ...|+.++|||||||++|+|++|+.||. +.+..+.+..+.+...+      
T Consensus       161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~-~~~~~~~~~~i~~~~~~------  233 (288)
T d2jfla1         161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKIAKSEPP------  233 (288)
T ss_dssp             HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT-TSCGGGHHHHHHHSCCC------
T ss_pred             CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC-CCCHHHHHHHHHcCCCC------
Confidence            4321 2234689999999999852    2568999999999999999999999984 44444444444321000      


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                                  .......+++++++||.+||+.||++|||++|+|+||||+.
T Consensus       234 ----------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         234 ----------------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             ----------------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             ----------------------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                                        00111237899999999999999999999999999999974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-58  Score=421.93  Aligned_cols=251  Identities=20%  Similarity=0.379  Sum_probs=206.2

Q ss_pred             CCCe-EEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc--CCC
Q 014762          124 QDDY-EVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ--HSK  195 (419)
Q Consensus       124 ~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~--~~~  195 (419)
                      .++| ++.++||+|+||+||+|.+..++..||+|.+...     ..+.+.+|+++|+++ +||||++++++|.+.  ...
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCC
Confidence            4455 6778899999999999999999999999998642     235688999999999 899999999998653  345


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      .+++||||+++++|..++   ..+++..++.++.|++.||+|||+++  |+||||||+|||++.+.+.+||+|||+|+..
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            689999999999998876   46999999999999999999999998  9999999999999764478999999999864


Q ss_pred             cCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      .. ......+||+.|+|||++.+  .++.++|||||||++|||++|+.||....+..+....+.....+.          
T Consensus       166 ~~-~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~----------  232 (270)
T d1t4ha_         166 RA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA----------  232 (270)
T ss_dssp             CT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----------
T ss_pred             cC-CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc----------
Confidence            43 33455689999999999864  699999999999999999999999843332222222221110000          


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                                               .....+++++.+||.+||+.||++|||++|+|+||||+
T Consensus       233 -------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         233 -------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             -------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             -------------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                                     01123688999999999999999999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-58  Score=439.28  Aligned_cols=283  Identities=21%  Similarity=0.315  Sum_probs=214.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..++|+++++||+|+||+||+|++..+|+.||+|+++.    ...+.+.+|+.+|+++ +|||||+++++|.++  ..++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~~   80 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEIS   80 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECS--SEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEE
Confidence            46789999999999999999999999999999999863    2346788999999999 999999999999764  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      +||||+++|+|..++   ..+++..++.++.|++.||.|||+ +||+||||||+|||++.+ +.+||+|||+|+..... 
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHHH-
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-CCEEEeeCCCccccCCC-
Confidence            999999999998887   469999999999999999999997 599999999999999988 89999999999866432 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh------
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK------  348 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~------  348 (419)
                      .....+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||........+........|..........      
T Consensus       159 ~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence            2344689999999999988 789999999999999999999999997666555555444444333221100000      


Q ss_pred             --cCCCC--ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          349 --YHLEL--DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       349 --~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                        .....  ................    .......+|.++.|||.+||++||++||||+|+|+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPP----PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCC----CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccccchhHHHHHhhhhccCC----ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence              00000  0000000000000000    001112368899999999999999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-58  Score=422.09  Aligned_cols=249  Identities=25%  Similarity=0.424  Sum_probs=198.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      .++|++++.||+|+||+||+|+++.+|+.||+|+++...     .+.+.+|+.+++++ +||||+++++++.+.....++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence            367999999999999999999999999999999986432     35688999999999 999999999999876667789


Q ss_pred             EEEEecCCCChhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeecCCCCceEEcCCCCcEEEEeccc
Q 014762          199 LIFEYVNSTDFKVLY-------PTLTDYDIRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHELRKLRLIDWGL  266 (419)
Q Consensus       199 lv~e~~~~~~l~~~~-------~~l~~~~~~~~~~qi~~~L~~LH~~~-----ivH~Dlk~~NILl~~~~~~~kl~Dfgl  266 (419)
                      +||||+++|+|.+++       ..+++..++.++.|++.||+|||++|     |+||||||+|||++.+ +.+||+|||+
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~  160 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGL  160 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccc
Confidence            999999999998876       35999999999999999999999876     9999999999999988 8899999999


Q ss_pred             ceeccCCCc-ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          267 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       267 a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      |+....... .....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+....+.+.  .      
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~-~~~~~~~~~~i~~~--~------  230 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREG--K------  230 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHT--C------
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCC-CCCHHHHHHHHHcC--C------
Confidence            987654433 345689999999999977 789999999999999999999999984 33333333332220  0      


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSI  412 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f  412 (419)
                           .                  .     ..+..+|+++.+||++||+.||++|||++|+|+|||+
T Consensus       231 -----~------------------~-----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         231 -----F------------------R-----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -----C------------------C-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----C------------------C-----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                 0                  0     0112378999999999999999999999999999995

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3e-57  Score=433.02  Aligned_cols=254  Identities=24%  Similarity=0.414  Sum_probs=218.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .++|++++.||+|+||+||+|++..+|+.||||++....   .+.+.+|+.+|+++ +|||||++++++.++  +.+++|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDD--NEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEET--TEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEE
Confidence            458999999999999999999999999999999996533   45688999999999 899999999999764  778999


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC-CCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~-~~~~kl~Dfgla~~~~~~~~  275 (419)
                      ||||++|+|..++    ..+++..++.++.||+.||+|||++|||||||||+|||++.+ .+.+||+|||+|+.......
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            9999999998776    248999999999999999999999999999999999999653 36899999999998877777


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.......+              
T Consensus       182 ~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~--------------  245 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMD--------------  245 (350)
T ss_dssp             EEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCSC--------------
T ss_pred             cceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCC--------------
Confidence            777899999999999987 789999999999999999999999984 4455555555543211110              


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                         ......+++++++||++||+.||++|||++|+|+||||+..
T Consensus       246 -------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         246 -------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             -------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             -------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                               00112378999999999999999999999999999999865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-57  Score=421.51  Aligned_cols=254  Identities=26%  Similarity=0.433  Sum_probs=215.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc---------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV---------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++..         ..+.+.+|+.+|+++ +|||||+++++|.+.  
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--   85 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENK--   85 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS--
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--
Confidence            56899999999999999999999999999999998532         246789999999999 999999999999654  


Q ss_pred             CccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCC---CcEEEEecccce
Q 014762          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEL---RKLRLIDWGLAE  268 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~---~~~kl~Dfgla~  268 (419)
                      ...++|||||++|+|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+.   ..+||+|||+|+
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~  165 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  165 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence            7789999999999998876   5699999999999999999999999999999999999998762   259999999999


Q ss_pred             eccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+.....+..     
T Consensus       166 ~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~-----  238 (293)
T d1jksa_         166 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFEDE-----  238 (293)
T ss_dssp             ECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHTTCCCCCHH-----
T ss_pred             hcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCC-CCCHHHHHHHHHhcCCCCCch-----
Confidence            8876666666789999999999987 789999999999999999999999984 444444444443211110000     


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                                  ....+|+++++||++||+.||++|||++|+|+||||++.
T Consensus       239 ----------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         239 ----------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             ----------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             ----------------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                                        012378999999999999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-57  Score=422.13  Aligned_cols=248  Identities=27%  Similarity=0.472  Sum_probs=208.8

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.      ...+.+.+|+.+++++ +||||++++++|.++  +..+
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~~   84 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDD--EKLY   84 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECS--SEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEEC--CEEE
Confidence            579999999999999999999999999999999863      2346789999999999 999999999999654  7789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-  274 (419)
                      +||||+++|+|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... 
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC-ceEEecccccceecccCCc
Confidence            999999999998775   579999999999999999999999999999999999999988 789999999998765332 


Q ss_pred             --cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          275 --EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       275 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+.             .. 
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~-------------~~-  227 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKL-------------EY-  227 (288)
T ss_dssp             ------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHTT-------------CC-
T ss_pred             ccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCC-CcCHHHHHHHHHcC-------------CC-
Confidence              2234579999999999987 789999999999999999999999984 33333333333210             00 


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHH------HhcCCCcccc
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE------AMVISSISPI  415 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e------lL~hp~f~~~  415 (419)
                                             ..+..+++++++||++||+.||++|||++|      +++||||+++
T Consensus       228 -----------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         228 -----------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             -----------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence                                   011237899999999999999999999998      5889999887

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.3e-57  Score=431.64  Aligned_cols=254  Identities=25%  Similarity=0.444  Sum_probs=217.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .++|++++.||+|+||+||+|.+..+|+.||||+++...   .+.+.+|+.+|+++ +||||++++++|.++  ..+++|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDK--YEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECS--SEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEE
Confidence            467999999999999999999999999999999986533   45678999999999 999999999999654  778999


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC-CCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~-~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+++|+|...+    ..+++.+++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|||+|+.......
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            9999999997765    24899999999999999999999999999999999999984 347899999999998887777


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....+|+.|+|||++.+ ..|+.++|||||||++|+|++|+.|| .+.+..+.+..+.+.....               
T Consensus       185 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~~---------------  247 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEF---------------  247 (352)
T ss_dssp             EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHHCCCCC---------------
T ss_pred             eeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCC---------------
Confidence            777899999999999987 78999999999999999999999998 4444455555444321110               


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                        .......+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       248 ------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         248 ------------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             ------------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                              011122479999999999999999999999999999999754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-57  Score=428.82  Aligned_cols=253  Identities=27%  Similarity=0.442  Sum_probs=196.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...    ..+.+.+|+.+|+++ +||||+++++++.++  ..+++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~~l   84 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESG--GHLYL   84 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEE
Confidence            56799999999999999999999999999999998643    235677999999999 999999999999654  77899


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC--CCCcEEEEecccceeccCCC
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--ELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~--~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ||||++|++|.+++   ..+++..+..++.|++.||+|||++||+||||||+|||+..  +.+.+||+|||+|+......
T Consensus        85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~  164 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS  164 (307)
T ss_dssp             EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence            99999999998876   45999999999999999999999999999999999999953  23789999999998776665


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||. +.+..+....+.+...             .  
T Consensus       165 ~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~~~-------------~--  227 (307)
T d1a06a_         165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEY-------------E--  227 (307)
T ss_dssp             --------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHTTCC-------------C--
T ss_pred             eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHhccCC-------------C--
Confidence            5566789999999999987 789999999999999999999999984 3333333333322100             0  


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                        ........+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus       228 ------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         228 ------------------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             ------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             ------------------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                              001112347999999999999999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=426.61  Aligned_cols=273  Identities=29%  Similarity=0.513  Sum_probs=220.2

Q ss_pred             EEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          129 VVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       129 ~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      .+++||+|+||+||+|++..+|+.||||+++...        .+.+.+|+.+++++ +||||+++++++.+  ..++++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~--~~~~~iv   78 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KSNISLV   78 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TTCCEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeecc--CCceeeh
Confidence            4688999999999999999999999999986322        24588999999999 99999999999955  4678999


Q ss_pred             EEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC-cc
Q 014762          201 FEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-EY  276 (419)
Q Consensus       201 ~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~-~~  276 (419)
                      |||+.++++..+.   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...... ..
T Consensus        79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~  157 (299)
T d1ua2a_          79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAY  157 (299)
T ss_dssp             EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCC
T ss_pred             hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-CccccccCccccccCCCcccc
Confidence            9999999887766   358999999999999999999999999999999999999988 899999999998765433 33


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ...+||+.|+|||++.+...|+.++|||||||++|||++|..|| .+.++.+++..+.+.+|.+....+...........
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf-~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ua2a_         158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT  236 (299)
T ss_dssp             CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred             cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC-CCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence            44679999999999987567899999999999999999998765 67788889999999888776544322111111000


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      +    ......++.     .....+++++.+||.+||++||++||||+|+|+||||++.
T Consensus       237 ~----~~~~~~~~~-----~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         237 F----KSFPGIPLH-----HIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             C----CCCCCCCHH-----HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             h----ccCCCCChH-----HhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence            0    000011111     1112478999999999999999999999999999999865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-56  Score=421.55  Aligned_cols=249  Identities=26%  Similarity=0.451  Sum_probs=213.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      -++|++++.||+|+||+||+|++..+|+.||||++++.      ..+.+.+|+.+|+++ +||||++++++|.+.  ..+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~~   80 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRL   80 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECS--SEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccc--ccc
Confidence            46799999999999999999999999999999998632      346788999999999 899999999999654  788


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC-C
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-G  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~-~  273 (419)
                      ++||||+++|+|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.... .
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTT
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC-CCEEEeecccccccccCC
Confidence            9999999999998876   569999999999999999999999999999999999999988 8999999999987644 3


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+....+...  .           .  
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~-~~~~~~~~~~i~~~--~-----------~--  222 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILME--E-----------I--  222 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--C-----------C--
T ss_pred             cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCC-CcCHHHHHHHHhcC--C-----------C--
Confidence            34455789999999999987 789999999999999999999999984 33333333332220  0           0  


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                            ..+..+|+++++||++||+.||++|+     |++|+++||||+++
T Consensus       223 ----------------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         223 ----------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             ----------------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence                                  01123799999999999999999999     59999999999876

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-56  Score=421.02  Aligned_cols=248  Identities=27%  Similarity=0.387  Sum_probs=207.9

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ..|+.+++||+|+||+||+|++..+|+.||||+++...      .+.+.+|+.+|+++ +|||||++++++.++  ...+
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~   91 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTAW   91 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEEC--CEEE
Confidence            45999999999999999999999999999999986432      24688999999999 899999999999664  6789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +|||||.+|++..+.   ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+....   
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-CCEEEeecccccccCC---
Confidence            999999999887654   569999999999999999999999999999999999999988 8999999999986543   


Q ss_pred             ceeecccccccccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 YNVRVASRYFKGPELLVD--LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .....||+.|+|||++.+  ...|+.++|||||||++|||++|..||. +.+..+.+..+...-.+              
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~-~~~~~~~~~~i~~~~~~--------------  232 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESP--------------  232 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCC--------------
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCC--------------
Confidence            234689999999999864  2468999999999999999999999984 33333333333221000              


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                           ......+|+++++||++||+.||++|||++|+|+||||+.-
T Consensus       233 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         233 ---------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             ---------------------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence                                 00112378999999999999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.6e-56  Score=410.59  Aligned_cols=255  Identities=24%  Similarity=0.389  Sum_probs=214.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------------hHHHHHHHHHHHHhcCCCCeeEEEeEEEc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------------KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (419)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++...            .+.+.+|+.+++++..||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            578999999999999999999999999999999986421            23578999999999559999999999965


Q ss_pred             cCCCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          192 QHSKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                        .+++|+||||+++++|.+++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus        82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~  158 (277)
T d1phka_          82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSC  158 (277)
T ss_dssp             --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred             --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-CCeEEccchhee
Confidence              47889999999999998887   569999999999999999999999999999999999999988 889999999999


Q ss_pred             eccCCCcceeecccccccccccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHH
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELN  343 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~  343 (419)
                      ............||..|+|||.+.+     ...++.++||||+||++|+|++|+.||. +.+..+....+.+.--.    
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~-~~~~~~~~~~i~~~~~~----  233 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNYQ----  233 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCC----
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC-CCCHHHHHHHHHhCCCC----
Confidence            8876666666789999999999853     2457889999999999999999999984 33434444333321000    


Q ss_pred             HHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          344 AYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                                   ........+|+++++|+.+||+.||++|||++|+|+||||+..
T Consensus       234 -----------------------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         234 -----------------------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             -----------------------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             -----------------------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence                                         0000112389999999999999999999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-56  Score=415.19  Aligned_cols=279  Identities=29%  Similarity=0.568  Sum_probs=223.7

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|+++++||+|+||+||+|.+..+|+.||||+++..     ..+.+.+|+.+++++ +||||++++++|.+.  ...++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~--~~~~i   78 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTE--NKLYL   78 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccc--cceeE
Confidence            6899999999999999999999999999999998632     246788999999999 999999999999764  67899


Q ss_pred             EEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-C
Q 014762          200 IFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (419)
Q Consensus       200 v~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~  274 (419)
                      ||||+.++.+....    ..+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||.|+..... .
T Consensus        79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCSB
T ss_pred             EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc-CcceeccCCcceeccCCcc
Confidence            99999987665442    459999999999999999999999999999999999999988 78999999999876543 3


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......||+.|+|||++.....++.++||||+||++|+|++|+.|| .+.+..+++..+.+..+.+....+...      
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~------  230 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGV------  230 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTG------
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC-CCCCHHHHHHHHHHhcCCCchhhcccc------
Confidence            3445689999999999887566789999999999999999999998 466667788888877776543322110      


Q ss_pred             hhhHHhhccCCC-CCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          355 PQLDALVGRHSR-KPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       355 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                         ......... ..+...........+++++.+||++||+.||++|||+.|+|+||||+++..
T Consensus       231 ---~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         231 ---TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             ---GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ---ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence               000000000 000000001112347899999999999999999999999999999998764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.8e-56  Score=417.14  Aligned_cols=246  Identities=21%  Similarity=0.430  Sum_probs=211.1

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++++.||+|+||+||+|++..+|+.||||+++.      ...+.+.+|+.+++.+ +||||+++++++.++  ...+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~   80 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDA--QQIF   80 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECS--SEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeC--Ceee
Confidence            579999999999999999999999999999999863      2346788999999999 999999999999654  7889


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      +||||+.|+++..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....  
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSSC--
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC-CCEEEecCccceEeccc--
Confidence            999999999988776   568999999999999999999999999999999999999988 89999999999886533  


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||. +.+..+....+.+.  .           .    
T Consensus       158 ~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~--~-----------~----  218 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILNA--E-----------L----  218 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHC--C-----------C----
T ss_pred             cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCC-CcCHHHHHHHHHcC--C-----------C----
Confidence            345689999999999877 789999999999999999999999984 33333333333221  0           0    


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                          ..+..+++++.+++++||+.||++|+     |++++++||||+++
T Consensus       219 --------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         219 --------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             --------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence                                01123789999999999999999996     99999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-56  Score=418.14  Aligned_cols=280  Identities=28%  Similarity=0.499  Sum_probs=225.8

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCC-CcEEEEEEecCc-----chHHHHHHHHHHHHhc--CCCCeeEEEeEEEcc---
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNT-NERCIIKILKPV-----KKKKIKREIKILQNLC--GGPNVVKLLDIVRDQ---  192 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~vavK~~~~~-----~~~~~~~E~~~l~~l~--~h~niv~l~~~~~~~---  192 (419)
                      .++|+++++||+|+||+||+|++..+ ++.||||+++..     ....+.+|+.+++.+.  +||||++++++|...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            57899999999999999999999765 677999998532     2345778888887763  799999999998642   


Q ss_pred             CCCccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccce
Q 014762          193 HSKTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE  268 (419)
Q Consensus       193 ~~~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~  268 (419)
                      .....+++|||++++++....    ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~-~~~kl~dfg~~~  164 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR  164 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC-CCeeecchhhhh
Confidence            335688999999998775443    458999999999999999999999999999999999999988 789999999998


Q ss_pred             eccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          269 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       269 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ............||+.|+|||++.+ ..|+.++||||+||++|||++|+.|| .+.+..+++..+.+.+|.+....+...
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCchhccccc
Confidence            7665566677899999999999987 78999999999999999999999998 566778888899998887665443221


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ....     ..........+..     .....+++++++||++||++||++||||.|+|+||||+++.
T Consensus       243 ~~~~-----~~~~~~~~~~~~~-----~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         243 VALP-----RQAFHSKSAQPIE-----KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             CSSC-----GGGSCCCCCCCGG-----GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccch-----hhhhccccccchh-----hccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence            1110     0000111111111     12234789999999999999999999999999999999884

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=423.20  Aligned_cols=281  Identities=31%  Similarity=0.518  Sum_probs=229.1

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEcc----CCCccEEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSKTPSLIF  201 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~~~~lv~  201 (419)
                      +|+.+++||+|+||+||+|++..+|+.||||+++... ....+|+.+|+++ +||||++++++|...    +..++++||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            6999999999999999999999999999999996432 3445899999999 999999999998642    335678999


Q ss_pred             EecCCCChhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          202 EYVNSTDFKVLY------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       202 e~~~~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      ||++++++..+.      ..+++..++.++.|++.||+|||++||+||||||+|||++.+...+||+|||+++.......
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence            999988654432      35999999999999999999999999999999999999998856899999999998776666


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....||..|+|||++.+...++.++||||+||++|||++|+.|| .+.+..+++..+.+.+|.+..+.+..........
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC-CCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence            666789999999999887678999999999999999999999887 5666788899999999988776554322111111


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                      .+    ......+|..    .....+++++.+||.+||++||++||||.|+|+||||+++++
T Consensus       258 ~~----~~~~~~~~~~----~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         258 KF----PQIKAHPWTK----VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             CC----CCCCCCCGGG----TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             cc----cccccCchhh----hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            00    0011111111    122347899999999999999999999999999999998754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=417.32  Aligned_cols=253  Identities=25%  Similarity=0.436  Sum_probs=216.3

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++++.||+|+||+||+|.+..+|+.||||+++...  ...+.+|+.+|+.+ +||||++++++|.++  ..+|+||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~lvm   80 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESM--EELVMIF   80 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEEE
Confidence            578999999999999999999999999999999997544  34578999999999 999999999999764  6789999


Q ss_pred             EecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC-CCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-LRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~-~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      |||+|++|..++.    .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++........
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~  160 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence            9999999988773    48999999999999999999999999999999999999864 357999999999987766666


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....+|+.|+|||.+.+ ..++.++||||+||++|+|++|..||. +.+..+.+..+.+..-..+...            
T Consensus       161 ~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~-~~~~~~~~~~i~~~~~~~~~~~------------  226 (321)
T d1tkia_         161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYTFDEEA------------  226 (321)
T ss_dssp             EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCCCHHH------------
T ss_pred             cccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCChhh------------
Confidence            77889999999999877 779999999999999999999999983 4444444444443211111110            


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                           ...+|+++++||.+||+.||++|||+.|+|+||||++
T Consensus       227 ---------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         227 ---------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ---------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ---------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                                 1237899999999999999999999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-55  Score=418.74  Aligned_cols=247  Identities=22%  Similarity=0.369  Sum_probs=212.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      .++|++++.||+|+||+||+|++..+|+.||||+++.      ...+.+.+|+.+|+.+ +||||+++++++.+.  ...
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~  116 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDN--SNL  116 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccc--ccc
Confidence            4689999999999999999999999999999999863      2345688999999999 999999999999654  678


Q ss_pred             EEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          198 SLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      ++||||+.+|++..++   ..+++..++.++.||+.||.|||++|||||||||+|||++.+ +.+||+|||+|+..... 
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSSC-
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC-CCEEeeeceeeeecccc-
Confidence            8999999999998876   579999999999999999999999999999999999999988 89999999999876533 


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                       .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.....                
T Consensus       195 -~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~~~----------------  255 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSGKV----------------  255 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCC----------------
T ss_pred             -cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCC-CcCHHHHHHHHhcCCC----------------
Confidence             345689999999999987 789999999999999999999999984 3333333433332100                


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~  415 (419)
                                           ..+..+++++.+||++||+.||++|+     |++++++||||+.+
T Consensus       256 ---------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         256 ---------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             ---------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence                                 01123799999999999999999995     99999999999876

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-56  Score=420.59  Aligned_cols=258  Identities=25%  Similarity=0.394  Sum_probs=209.2

Q ss_pred             CCCeEEEee-eeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCCCeeEEEeEEEc--cCCCccEEE
Q 014762          124 QDDYEVVRK-VGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGPNVVKLLDIVRD--QHSKTPSLI  200 (419)
Q Consensus       124 ~~~y~~~~~-lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~--~~~~~~~lv  200 (419)
                      .++|+++++ ||+|+||+||+|.+..+++.||||+++.  .+.+.+|+.++.++.+||||++++++|.+  ....++|+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            467998865 9999999999999999999999999963  46788999998776689999999999965  234678999


Q ss_pred             EEecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCC
Q 014762          201 FEYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       201 ~e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~  273 (419)
                      ||||+||+|.+++.     .+++.+++.++.|++.||+|||++||+||||||+|||++.+  .+.+||+|||+|+.....
T Consensus        88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence            99999999988762     48999999999999999999999999999999999999863  357999999999987776


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.. .+..+....+........         .. 
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~-~~~~~~~~~~~~~i~~~~---------~~-  235 (335)
T d2ozaa1         168 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPGMKTRIRMGQ---------YE-  235 (335)
T ss_dssp             CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEE-TTCC--------CCCSCS---------SS-
T ss_pred             CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCC-CCHHHHHHHHHHHHhcCC---------CC-
Confidence            66677889999999999877 7899999999999999999999999942 222222222211110000         00 


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                                         +.......+|+++.+||++||+.||++|||+.|+|+||||++
T Consensus       236 -------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         236 -------------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             -------------------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             -------------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence                               000011237899999999999999999999999999999964

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.6e-54  Score=404.22  Aligned_cols=276  Identities=30%  Similarity=0.571  Sum_probs=220.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|+++++||+|+||+||+|++. +|+.||||+++...     .+.+.+|+.+|+++ +||||++++++|.++  ...++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~i   77 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTK--KRLVL   77 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECS--SCEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccC--CceeE
Confidence            68999999999999999999885 78999999986432     46789999999999 899999999999654  67889


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      ++||+.++++..+.   ..+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||.+........ 
T Consensus        78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC----
T ss_pred             EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC-CCEEecccccceecccCccc
Confidence            99999998877765   458999999999999999999999999999999999999988 8899999999987654332 


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....+++.|+|||.+.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.+....+.......   
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---  232 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELP---  232 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGST---
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCChhhccchhhhh---
Confidence            344578899999999987677899999999999999999999998 5666777888888888876554332211110   


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      ............++.     .....+++++.|||++||++||++||||+|+|+||||++
T Consensus       233 ~~~~~~~~~~~~~~~-----~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWE-----SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCTTCCCCCCCCGG-----GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hcccccccccCcchh-----hhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            000000111111122     122347899999999999999999999999999999984

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=410.56  Aligned_cols=249  Identities=24%  Similarity=0.418  Sum_probs=210.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC------cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP------VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPS  198 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~  198 (419)
                      ++|++++.||+|+||+||+|.+..+|+.||||++++      ...+.+.+|..++.+..+||||+++++++.+.  +..|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y   79 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF   79 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence            679999999999999999999999999999999963      23356777888776433999999999999664  7789


Q ss_pred             EEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC-C
Q 014762          199 LIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-K  274 (419)
Q Consensus       199 lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~-~  274 (419)
                      +||||+++|+|..++   ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .
T Consensus        80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTC
T ss_pred             EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-Cceeccccchhhhcccccc
Confidence            999999999999887   569999999999999999999999999999999999999988 89999999999865543 3


Q ss_pred             cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          275 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       275 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                      ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+..  +.+.             
T Consensus       159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~--~~~~-------------  221 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRM--DNPF-------------  221 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--CCCC-------------
T ss_pred             cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHHc--CCCC-------------
Confidence            3345689999999999988 789999999999999999999999983 4444433333321  1100             


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHH-HHhcCCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAR-EAMVISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~-elL~hp~f~~~  415 (419)
                                            .+..+|+++.+||++||+.||++|||+. |+++||||+++
T Consensus       222 ----------------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         222 ----------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             ----------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             ----------------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence                                  0123789999999999999999999995 89999999876

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8e-55  Score=418.59  Aligned_cols=252  Identities=25%  Similarity=0.409  Sum_probs=206.2

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHH---HHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKRE---IKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E---~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      -++|++.+.||+|+||+||+|++..+|+.||||++....      ...+.+|   +.+++.+ +||||++++++|.++  
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~--   79 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP--   79 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS--
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEEC--
Confidence            468999999999999999999999999999999986322      2334455   4555555 799999999999664  


Q ss_pred             CccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          195 KTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..+|+||||+++++|..++   ..+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+...
T Consensus        80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~  158 (364)
T d1omwa3          80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFS  158 (364)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-SCEEECCCTTCEECS
T ss_pred             CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC-CcEEEeeeceeeecC
Confidence            6789999999999998876   468999999999999999999999999999999999999988 889999999998765


Q ss_pred             CCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCC
Q 014762          272 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHL  351 (419)
Q Consensus       272 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~  351 (419)
                      .. ......||+.|+|||++.+...|+.++|||||||++|||++|+.||...... +.. .+.+.....           
T Consensus       159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~-~~~~~~~~~-----------  224 (364)
T d1omwa3         159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKH-EIDRMTLTM-----------  224 (364)
T ss_dssp             SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-CHH-HHHHHSSSC-----------
T ss_pred             CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-HHH-HHHHhcccC-----------
Confidence            43 3345689999999999976467999999999999999999999999533221 111 111110000           


Q ss_pred             CCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCC-----HHHHhcCCCcccc
Q 014762          352 ELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLT-----AREAMVISSISPI  415 (419)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-----a~elL~hp~f~~~  415 (419)
                                            ....+..+++++++||.+||+.||++|||     |+|+++||||+++
T Consensus       225 ----------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         225 ----------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             ----------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             ----------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence                                  00112347999999999999999999999     8999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=414.00  Aligned_cols=283  Identities=29%  Similarity=0.520  Sum_probs=222.6

Q ss_pred             CCCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC---
Q 014762          122 GDQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH---  193 (419)
Q Consensus       122 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---  193 (419)
                      ...++|+++++||+|+||+||+|.+..+|+.||||+++...     .+.+.+|+.+|+.+ +|||||+++++|....   
T Consensus        15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTT
T ss_pred             ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCcccc
Confidence            35789999999999999999999999999999999997422     35678999999999 9999999999997543   


Q ss_pred             -CCccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          194 -SKTPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       194 -~~~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                       ...+++||||+ +.++....  ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+|++|||+|+..
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQA  171 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred             ccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc-cccccccccceecc
Confidence             23579999999 45565554  579999999999999999999999999999999999999988 88999999999876


Q ss_pred             cCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          271 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       271 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      ..  ..+...+|+.|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+.+..+....+.++...+.. ..
T Consensus       172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  247 (346)
T d1cm8a_         172 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQR-LQ  247 (346)
T ss_dssp             CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHT-CS
T ss_pred             CC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC-CCCChHHHHHHHHhccCCCcHHHHhh-hc
Confidence            43  3355689999999999987667899999999999999999999987 56677778888888888776554321 11


Q ss_pred             CCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          351 LELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ..................+....     ..+++++.+||++||++||++||||.|+|+||||+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFASIL-----TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTC-----TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             chhhhhhhccCCcccccchHHhc-----cCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            11111111111222222332222     34789999999999999999999999999999999764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=402.11  Aligned_cols=245  Identities=25%  Similarity=0.407  Sum_probs=204.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------hHHHHHHHHHHHHhc-CCCCeeEEEeEEEccC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------KKKIKREIKILQNLC-GGPNVVKLLDIVRDQH  193 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~~l~~l~-~h~niv~l~~~~~~~~  193 (419)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++...         ..++.+|+.+++++. .||||+++++++.++ 
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence            578999999999999999999999999999999986321         234678999999983 389999999999664 


Q ss_pred             CCccEEEEEecCC-CChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          194 SKTPSLIFEYVNS-TDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       194 ~~~~~lv~e~~~~-~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                       +..++||||+.+ +++..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+.+.+||+|||+|+.
T Consensus        82 -~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          82 -DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             -SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             -CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence             678999999976 5665554   56999999999999999999999999999999999999997767999999999987


Q ss_pred             ccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          270 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       270 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ... ...+...||+.|+|||++.+...++.++|||||||++|+|++|+.||..    .+   .+.+             .
T Consensus       161 ~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~~---~i~~-------------~  219 (273)
T d1xwsa_         161 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DE---EIIR-------------G  219 (273)
T ss_dssp             CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS----HH---HHHH-------------C
T ss_pred             ccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC----ch---HHhh-------------c
Confidence            543 3344568999999999998744557889999999999999999999932    11   1111             0


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      ..                        ..+..+|+++++||++||+.||++|||++|+|+||||+++
T Consensus       220 ~~------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         220 QV------------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CC------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             cc------------------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            00                        0112479999999999999999999999999999999976

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=402.59  Aligned_cols=280  Identities=29%  Similarity=0.525  Sum_probs=227.4

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSL  199 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l  199 (419)
                      ++|+++++||+|+||+||+|++..+|+.||||+++..     ..+.+.+|+.+++.+ +||||++++++|.+.  ...++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~--~~~~i   78 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSD--KKLTL   78 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccc--cceeE
Confidence            6899999999999999999999999999999998532     246788999999999 999999999999664  67889


Q ss_pred             EEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-
Q 014762          200 IFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       200 v~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      +++++.++++..+.   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||.++....... 
T Consensus        79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~~~  157 (292)
T d1unla_          79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSCCSC
T ss_pred             EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC-CceeeeecchhhcccCCCcc
Confidence            99999999887765   568999999999999999999999999999999999999988 7899999999987754433 


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....++..|+|||++.+...++.++||||+||++|||++|+.||+.+.+..+++..+....+.+....+.......   
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  234 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP---  234 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST---
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc---
Confidence            34456778899999988756689999999999999999999999998888888888888877775543221111100   


Q ss_pred             hhHHhhccCCCCCcc-ccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccccc
Q 014762          356 QLDALVGRHSRKPWS-KFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIFS  417 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~~  417 (419)
                            ......... ..........+++++.+||++||++||++||||+|+|+||||+++..
T Consensus       235 ------~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         235 ------DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             ------TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             ------cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                  000000000 00011112347899999999999999999999999999999998653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-54  Score=398.85  Aligned_cols=248  Identities=16%  Similarity=0.292  Sum_probs=208.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.++||+|+||+||+|.+ .++..||||+++..  ..+.+.+|+.+++++ +|||||+++|++.+   ...++||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~---~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc---CCeEEEE
Confidence            57899999999999999999986 46788999999743  457899999999999 99999999998854   4568999


Q ss_pred             EecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      ||+++|+|..++.     .+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||+|+........
T Consensus        87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCEE
T ss_pred             EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccceEEccCCccc
Confidence            9999999988663     48999999999999999999999999999999999999988 89999999999887644322


Q ss_pred             --eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       277 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                        ....+|..|+|||++.+ ..++.++|||||||++|||+||+.|++...+..+.+..+.+...                
T Consensus       166 ~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~----------------  228 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------------  228 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------------
T ss_pred             cccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----------------
Confidence              33567889999999876 67999999999999999999988888766555544443322100                


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--CCCccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV--ISSISP  414 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~--hp~f~~  414 (419)
                                          ...+..+++++.+|+.+||+.||++|||++|+++  |+||+.
T Consensus       229 --------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         229 --------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                                0111247899999999999999999999999998  788864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=393.57  Aligned_cols=250  Identities=16%  Similarity=0.321  Sum_probs=198.7

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC--cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +.++|++.++||+|+||+||+|.+. +++.||||+++.  ...+++.+|+.+++++ +||||++++|+|..+  ...++|
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~--~~~~lv   78 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQ--APICLV   78 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSCEEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccC--CceEEE
Confidence            3568999999999999999999865 567899999974  3457899999999999 999999999999654  678899


Q ss_pred             EEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          201 FEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       201 ~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      |||+++|+|..++    ..+++..+..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++........
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-GCEEECSCC-----------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-CCeEecccchheeccCCCce
Confidence            9999999998875    347899999999999999999999999999999999999988 78999999999876544332


Q ss_pred             --eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          277 --NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       277 --~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                        ....||..|+|||++.+ ..++.++|||||||++|||++++.|++...+..+.+..+......               
T Consensus       158 ~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---------------  221 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL---------------  221 (263)
T ss_dssp             -------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC---------------
T ss_pred             eecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC---------------
Confidence              33578899999999987 789999999999999999999777776665554444443321000               


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                                           ..+..+++++.+|+.+||+.||++|||++|+++|  |+.+.
T Consensus       222 ---------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~--L~~i~  260 (263)
T d1sm2a_         222 ---------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ--LAEIA  260 (263)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHHH
T ss_pred             ---------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH--HHHHH
Confidence                                 0112368899999999999999999999999986  55543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.4e-54  Score=400.07  Aligned_cols=245  Identities=17%  Similarity=0.329  Sum_probs=206.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC--cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLI  200 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv  200 (419)
                      +.++|++.++||+|+||+||+|.+..+|+.||||+++.  ...+++.+|+.+|+++ +|||||+++++|.+  ....++|
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv   91 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII   91 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEee--CCeeEEE
Confidence            46789999999999999999999999999999999864  3457899999999999 99999999999954  4678899


Q ss_pred             EEecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          201 FEYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       201 ~e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      |||+++|++..++     ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.......
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSSS
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-CcEEEccccceeecCCCCc
Confidence            9999999998875     358999999999999999999999999999999999999988 8999999999987654433


Q ss_pred             c--eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          276 Y--NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       276 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .  ....++..|+|||++.+ ..++.++|||||||++|||++|+.||+.+.+..+....+....                
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~----------------  233 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------------  233 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------------
T ss_pred             eeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC----------------
Confidence            2  23457888999999887 7899999999999999999999988876555443332221100                


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                          ....+..+++++.+||.+||+.||++|||++|+++
T Consensus       234 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         234 --------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                00112347899999999999999999999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=404.50  Aligned_cols=283  Identities=30%  Similarity=0.473  Sum_probs=217.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC-----
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH-----  193 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~-----  193 (419)
                      -++|+++++||+|+||+||+|++..+|+.||||++...     ..+.+.+|+.+|+++ +|||++++++++....     
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence            57899999999999999999999999999999998532     346688999999999 8999999999986532     


Q ss_pred             -CCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          194 -SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       194 -~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                       ..+.++||||+.++++....   ..+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg~~~~  166 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARA  166 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC-CcEEeeecceeee
Confidence             35689999999998877655   468999999999999999999999999999999999999988 8899999999976


Q ss_pred             ccCCC-----cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          270 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       270 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      .....     .....+||+.|+|||++.+...++.++||||+||++|||++|+.|| .+.++.+.+..+.+..+......
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC-CCCCHHHHHHHHHHhcCCCChhh
Confidence            65322     2233578999999999987668999999999999999999999887 56677777888888777655332


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISP  414 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~  414 (419)
                      ...............  ..........   .......++++.|||.+||++||++||||+|+|+||||+.
T Consensus       246 ~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         246 WPNVDNYELYEKLEL--VKGQKRKVKD---RLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             STTCCCC-------C--CSSCCBCHHH---HHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             ccccchhhhhhhhcc--cccccccchh---hhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            211110000000000  0000000000   0001124778999999999999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=407.23  Aligned_cols=282  Identities=26%  Similarity=0.468  Sum_probs=217.3

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEcc----CCC
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQ----HSK  195 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~----~~~  195 (419)
                      ++|+++++||+|+||+||+|++..+|+.||||+++..     ..+.+.+|+.+++++ +||||++++++|...    ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence            7899999999999999999999999999999999632     234688999999999 999999999999654    346


Q ss_pred             ccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc
Q 014762          196 TPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE  275 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~  275 (419)
                      ++|+||||+.++++......+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+|++|||+++.......
T Consensus        96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~-~~~kl~df~~~~~~~~~~~  174 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFM  174 (355)
T ss_dssp             EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC---------
T ss_pred             eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc-cceeeechhhhhccccccc
Confidence            789999999999998888999999999999999999999999999999999999999988 7889999999987776666


Q ss_pred             ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          276 YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       276 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      .....+|+.|+|||++.+ ..++.++||||+||++++|++|+.|| .+.+...+...+...++.+....+..     ...
T Consensus       175 ~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~-----~~~  247 (355)
T d2b1pa1         175 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKK-----LQP  247 (355)
T ss_dssp             ------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHTT-----SCH
T ss_pred             cccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCC-CCCCHHHHHHHHHHhccCCCHHHHHH-----hhh
Confidence            677789999999999988 78999999999999999999999887 56677778888888887765543321     112


Q ss_pred             hhHHhhccC---CCCCccccccc-------cccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          356 QLDALVGRH---SRKPWSKFINA-------DNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       356 ~~~~~~~~~---~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                      .........   ....+......       ......++++.+||++||++||++||||+|+|+||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            222211111   11111111100       0111246789999999999999999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=402.03  Aligned_cols=283  Identities=27%  Similarity=0.530  Sum_probs=219.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC--Cc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--KT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--~~  196 (419)
                      ..++|+++++||+|+||+||+|++..+|+.||||++++..    .+.+.+|+.+|+++ +||||+++++++.....  ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccc
Confidence            3678999999999999999999999999999999997433    35678999999999 99999999999965421  12


Q ss_pred             cEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCC
Q 014762          197 PSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~  274 (419)
                      .+++++|+.+++|..++  ..+++..++.++.|++.||+|||++|||||||||+|||++.+ +.+||+|||+++......
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDH  163 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCGGG
T ss_pred             eEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC-CCEEEcccCceeeccCCC
Confidence            34555677788998876  579999999999999999999999999999999999999988 899999999998764332


Q ss_pred             c----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcC
Q 014762          275 E----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYH  350 (419)
Q Consensus       275 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~  350 (419)
                      .    ....+||+.|+|||++.....++.++||||+||++|+|++|+.|| .+.+..++...+...++.+........  
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~--  240 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCI--  240 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHTC--
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC-CCCCHHHHHHHHhhhccCCChhhhhhh--
Confidence            2    344578999999999876577899999999999999999999998 455556677777776666554432111  


Q ss_pred             CCCChhhHHhhc--cCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          351 LELDPQLDALVG--RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       351 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                       ...........  .....+|....     ..+++++++|+.+||+.||++||||+|+|+||||+...
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~~~~~-----~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         241 -INLKARNYLLSLPHKNKVPWNRLF-----PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             -CCHHHHHHHHTSCCCCCCCHHHHC-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             -hhhhhhcccccCCccCCCCHHHhC-----CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence             11111111111  11112222222     23788999999999999999999999999999999654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-53  Score=392.12  Aligned_cols=246  Identities=15%  Similarity=0.314  Sum_probs=196.8

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-----cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCcc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-----VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~  197 (419)
                      ..++|++.++||+|+||+||+|+.   +..||||+++.     ...+.+.+|+.+++++ +||||+++++++.+   ..+
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~---~~~   78 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQL   78 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec---cEE
Confidence            467899999999999999999964   23599999863     2346788999999999 99999999998843   457


Q ss_pred             EEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          198 SLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       198 ~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ++||||+++|+|..++    ..+++..+..++.|+++||+|||++|||||||||+|||++.+ +.+||+|||+|+.....
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SSEEECCCCCSCC----
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CCEEEccccceeecccc
Confidence            8999999999998876    348999999999999999999999999999999999999988 88999999999876433


Q ss_pred             C---cceeecccccccccccccCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcC-CchHHHHHh
Q 014762          274 K---EYNVRVASRYFKGPELLVDL--QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG-TDELNAYLN  347 (419)
Q Consensus       274 ~---~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg-~~~~~~~~~  347 (419)
                      .   ......||+.|+|||++.+.  ..|+.++|||||||++|||+||+.||. +.++.+.+.......- .+..     
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~-~~~~~~~~~~~~~~~~~~p~~-----  231 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDL-----  231 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHHHHTSCCCCG-----
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC-CCChHHHHHHHHhcCCCCCcc-----
Confidence            2   22345789999999998642  358999999999999999999999984 4444444443332111 1100     


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                 ......+++++.+||.+||+.||++|||+.|++++
T Consensus       232 ---------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         232 ---------------------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             ---------------------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                       01123478999999999999999999999999985

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-52  Score=394.92  Aligned_cols=247  Identities=21%  Similarity=0.359  Sum_probs=203.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCc-----EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE-----RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.++||+|+||+||+|++..+++     .||+|.+...    ....+.+|+.++.++.+|||||+++++|.+. 
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-  113 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-  113 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-
Confidence            45789999999999999999999876554     6999998532    3457889999999987899999999999654 


Q ss_pred             CCccEEEEEecCCCChhhhcC--------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP--------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKP  247 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~--------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~  247 (419)
                       ...++||||+++|+|..++.                          .+++..+..++.|++.||+|||++|||||||||
T Consensus       114 -~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp  192 (325)
T d1rjba_         114 -GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  192 (325)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             -CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence             67899999999999988762                          378899999999999999999999999999999


Q ss_pred             CceEEcCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCC
Q 014762          248 HNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYG  323 (419)
Q Consensus       248 ~NILl~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~  323 (419)
                      +|||++.+ +.+||+|||+|+........   ....+|+.|+|||++.+ ..++.++|||||||++|||++ |+.|| .+
T Consensus       193 ~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf-~~  269 (325)
T d1rjba_         193 RNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY-PG  269 (325)
T ss_dssp             GGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSS-TT
T ss_pred             hccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCC-CC
Confidence            99999988 89999999999876544332   23467899999999887 789999999999999999998 78887 44


Q ss_pred             CCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH
Q 014762          324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA  403 (419)
Q Consensus       324 ~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta  403 (419)
                      .+..+.+.++++.-.                                   ..+.+..+++++.+||.+||+.||++|||+
T Consensus       270 ~~~~~~~~~~~~~~~-----------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~  314 (325)
T d1rjba_         270 IPVDANFYKLIQNGF-----------------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSF  314 (325)
T ss_dssp             CCCSHHHHHHHHTTC-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHHHhcCC-----------------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence            444444444433100                                   001123478999999999999999999999


Q ss_pred             HHHhcC
Q 014762          404 REAMVI  409 (419)
Q Consensus       404 ~elL~h  409 (419)
                      +|+++|
T Consensus       315 ~ei~~~  320 (325)
T d1rjba_         315 PNLTSF  320 (325)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-53  Score=390.77  Aligned_cols=248  Identities=18%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             CCCCeEEEe-eeeeeCceEEEEEEEcC--CCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVR-KVGRGKYSEVFEGINVN--TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~-~lG~G~fg~V~~~~~~~--~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      ..++|.+.+ +||+|+||+||+|.+..  ++..||||+++..    ..+.+.+|+.+|+++ +|||||+++|++.+   .
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~---~   81 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E   81 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc---C
Confidence            467788888 49999999999998654  4557999999643    246788999999999 99999999999964   3


Q ss_pred             ccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      .+++||||+++|+|..++    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALG  160 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred             eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cceeeccchhhhccc
Confidence            578999999999998875    348999999999999999999999999999999999999988 899999999998776


Q ss_pred             CCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          272 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       272 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .....    ....||..|+|||++.+ ..++.++|||||||++|||+| |+.||. +.+..+....+.+  |.       
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~-~~~~~~~~~~i~~--~~-------  229 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQ--GK-------  229 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCTHHHHHHHHT--TC-------
T ss_pred             ccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCC-CCCHHHHHHHHHc--CC-------
Confidence            54332    23457888999999877 689999999999999999998 888883 4444443333221  00       


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHH---hcCCCcc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA---MVISSIS  413 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el---L~hp~f~  413 (419)
                                                 ..+.+..+++++.+||.+||+.||++|||+.++   |+|+|++
T Consensus       230 ---------------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         230 ---------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             ---------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                                       001123478999999999999999999999888   6677764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=383.24  Aligned_cols=243  Identities=19%  Similarity=0.312  Sum_probs=203.1

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC--cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP--VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.++||+|+||+||+|++ .+++.||||+++.  ...+++.+|+.+++++ +||||++++|+|.++  +.+++||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~--~~~~iv~   78 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQ--RPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCS--SSEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeC--CceEEEE
Confidence            46788999999999999999997 5788999999974  3457899999999999 999999999999654  6789999


Q ss_pred             EecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc-
Q 014762          202 EYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-  276 (419)
Q Consensus       202 e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~-  276 (419)
                      ||+++|++..++    ..+++..+..++.|+++||+|||++||+||||||+|||++.+ +.+||+|||+++........ 
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSCCC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-CcEEECcchhheeccCCCcee
Confidence            999999988774    468999999999999999999999999999999999999988 88999999999876543332 


Q ss_pred             -eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          277 -NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       277 -~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                       ....+|..|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+....+.+...                
T Consensus       158 ~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf-~~~~~~~~~~~i~~~~~----------------  219 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQGLR----------------  219 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTTCC----------------
T ss_pred             ecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCC-CCCCHHHHHHHHHhCCC----------------
Confidence             23568889999999987 789999999999999999998 78787 44444443333322100                


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                          ...+..+++++.+||++||+.||++|||++++++|
T Consensus       220 --------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         220 --------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                                01112378899999999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=388.69  Aligned_cols=249  Identities=17%  Similarity=0.283  Sum_probs=204.6

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.++||+|+||+||+|.+..+ +.||||+++..  ..+.+.+|+.+++++ +|||||+++|+|.+   ...++||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~---~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec---CCeEEEE
Confidence            57899999999999999999987654 57999999743  357899999999999 99999999999843   3468999


Q ss_pred             EecCCCChhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCc-
Q 014762          202 EYVNSTDFKVLY-----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       202 e~~~~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      ||+++|++..++     ..+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....... 
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC--------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhhccCCCce
Confidence            999999988776     358999999999999999999999999999999999999988 8899999999987654332 


Q ss_pred             -ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCC
Q 014762          276 -YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELD  354 (419)
Q Consensus       276 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~  354 (419)
                       .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.|++.+....+.+..+.+....               
T Consensus       170 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---------------  233 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------------  233 (285)
T ss_dssp             ------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------------
T ss_pred             eeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---------------
Confidence             234578899999999987 789999999999999999999988887776665555544321100               


Q ss_pred             hhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc--CCCcccc
Q 014762          355 PQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV--ISSISPI  415 (419)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~--hp~f~~~  415 (419)
                                           +.+..+++++++||.+||+.||++|||++++++  ++||+..
T Consensus       234 ---------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         234 ---------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ---------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                                 112237899999999999999999999999988  8898765

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-52  Score=390.10  Aligned_cols=245  Identities=17%  Similarity=0.290  Sum_probs=189.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCc---EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE---RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSK  195 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~  195 (419)
                      +.++|++.+.||+|+||+||+|.+..+++   .||||.+...    ..+.+.+|+.+|+++ +|||||+++|+|..  ..
T Consensus        24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~--~~  100 (299)
T d1jpaa_          24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTK--ST  100 (299)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred             ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--CC
Confidence            35789999999999999999999877665   5889988643    235789999999999 99999999999954  46


Q ss_pred             ccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceecc
Q 014762          196 TPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  271 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~  271 (419)
                      ..++||||+++|+|..++    ..+++.++..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-CcEEECCcccceEcc
Confidence            789999999999998865    358999999999999999999999999999999999999988 899999999998765


Q ss_pred             CCCcc------eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHH
Q 014762          272 PGKEY------NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       272 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~  344 (419)
                      .....      ....+|+.|+|||++.+ ..++.++|||||||++|||+| |+.||. +.+..+....+.+...      
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~-~~~~~~~~~~i~~~~~------  251 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMTNQDVINAIEQDYR------  251 (299)
T ss_dssp             ----------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTCC------
T ss_pred             CCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCC------
Confidence            43221      12356788999999887 789999999999999999998 788873 3333333332221000      


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                    ...+..+++++.+|+.+||+.||++|||+.|++++
T Consensus       252 ------------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         252 ------------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             ------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ------------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                          00112378999999999999999999999998763

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=388.42  Aligned_cols=241  Identities=18%  Similarity=0.328  Sum_probs=193.8

Q ss_pred             eeeeeeCceEEEEEEEc--CCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEEe
Q 014762          131 RKVGRGKYSEVFEGINV--NTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFEY  203 (419)
Q Consensus       131 ~~lG~G~fg~V~~~~~~--~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~  203 (419)
                      ++||+|+||+||+|.+.  .+++.||||+++..     ..+.+.+|+.+|+++ +|||||+++++|.+   ...++||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~---~~~~lvmE~   88 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESWMLVMEM   88 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---SSEEEEEEC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc---CCEEEEEEc
Confidence            46999999999999754  45678999998642     245789999999999 99999999999954   346899999


Q ss_pred             cCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc----
Q 014762          204 VNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----  276 (419)
Q Consensus       204 ~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~----  276 (419)
                      +++|+|..++   ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++........    
T Consensus        89 ~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          89 AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             CTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Ccccccchhhhhhccccccccccc
Confidence            9999998876   459999999999999999999999999999999999999988 89999999999876544332    


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCCh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDP  355 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~  355 (419)
                      ....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||. +.+..+....+.+  |.          .     
T Consensus       168 ~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~-~~~~~~~~~~i~~--~~----------~-----  228 (277)
T d1xbba_         168 THGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK--GE----------R-----  228 (277)
T ss_dssp             ---CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHT--TC----------C-----
T ss_pred             cccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCC-CCCHHHHHHHHHc--CC----------C-----
Confidence            22467889999999987 679999999999999999998 788873 3333332222211  00          0     


Q ss_pred             hhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHH---hcCCCccc
Q 014762          356 QLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREA---MVISSISP  414 (419)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~el---L~hp~f~~  414 (419)
                                         ...+..+++++.+||.+||+.||++|||++++   |+|+|++-
T Consensus       229 -------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         229 -------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                               01112478999999999999999999999998   56766653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=397.92  Aligned_cols=282  Identities=27%  Similarity=0.521  Sum_probs=220.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC---CC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH---SK  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~  195 (419)
                      .++|+++++||+|+||+||+|++..+|+.||||+++..     ..+.+.+|+.+|+++ +|||++++++++....   ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccC
Confidence            57899999999999999999999999999999999643     235678999999999 9999999999996431   23


Q ss_pred             ccEEEEEecCCCChhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCC
Q 014762          196 TPSLIFEYVNSTDFKVLY--PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  273 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~  273 (419)
                      ..+++++|+.+++|..++  +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|++|||++....  
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~-~~~kl~dfg~a~~~~--  172 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHTD--  172 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC----CCT--
T ss_pred             ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc-ccccccccchhcccC--
Confidence            345677888899998886  469999999999999999999999999999999999999988 889999999997543  


Q ss_pred             CcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCC
Q 014762          274 KEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLEL  353 (419)
Q Consensus       274 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~  353 (419)
                      .......|++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+.......+.+..+.+.......    ..
T Consensus       173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~----~~  247 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKK----IS  247 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHTT----CC
T ss_pred             cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChHHhhh----cc
Confidence            33445678899999999887667899999999999999999999887 56677777788888777655443211    11


Q ss_pred             ChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCccccc
Q 014762          354 DPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPIF  416 (419)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~~  416 (419)
                      ..............+...+.  .....++++++|||++||+.||++||||.|+|+||||+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFA--NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHH--HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             chhhhhhhhhcccCCCcchh--hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            11111111111111111111  11134789999999999999999999999999999999764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.1e-52  Score=386.88  Aligned_cols=253  Identities=22%  Similarity=0.355  Sum_probs=199.0

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc------hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC--C
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK------KKKIKREIKILQNLCGGPNVVKLLDIVRDQHS--K  195 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~--~  195 (419)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++...      .+.+.+|+.+++.+ +||||+++++++.....  .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCc
Confidence            578999999999999999999999999999999996422      34688999999999 99999999999976533  3


Q ss_pred             ccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          196 TPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       196 ~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .+|+||||++|++|..++   ..+++.+++.++.|++.||+|||++||+||||||+|||++.+ +..+++|||.+.....
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-SCEEECCCTTCEECC-
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc-ccceeehhhhhhhhcc
Confidence            478999999999998766   469999999999999999999999999999999999999988 7899999999876543


Q ss_pred             CC----cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhh
Q 014762          273 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNK  348 (419)
Q Consensus       273 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~  348 (419)
                      ..    .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+...-..+        
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~~~~~~~~~--------  233 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIP--------  233 (277)
T ss_dssp             ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHCCCCC--------
T ss_pred             ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCC-CcCHHHHHHHHHhcCCCC--------
Confidence            22    2344579999999999987 789999999999999999999999983 334333333333211100        


Q ss_pred             cCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcc
Q 014762          349 YHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSIS  413 (419)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~  413 (419)
                                               .......+|+++.+||.+||+.||++||+..+.|.|+|.+
T Consensus       234 -------------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 -------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             -------------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -------------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                     0111234899999999999999999999544444566653

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-51  Score=380.93  Aligned_cols=245  Identities=15%  Similarity=0.283  Sum_probs=194.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCC----cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN----ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..+.|++.+.||+|+||+||+|.+..++    ..||||.++..    ....+.+|+.+++++ +|||||+++|++.+  .
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~--~   81 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y   81 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEec--C
Confidence            3567999999999999999999877654    46999998643    234688999999999 89999999999954  4


Q ss_pred             CccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ...++||||+.++++....    ..+++.++..++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+++..
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~  160 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVL  160 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-CeEEEcccchhhcc
Confidence            6788999999999987754    468999999999999999999999999999999999999988 89999999999876


Q ss_pred             cCCCc----ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHH
Q 014762          271 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYL  346 (419)
Q Consensus       271 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~  346 (419)
                      .....    .....||..|+|||++.+ ..++.++|||||||++|||++|+.|++.+.+..+.+..+.+...        
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--------  231 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR--------  231 (283)
T ss_dssp             -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--------
T ss_pred             cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC--------
Confidence            54322    123467889999999987 78999999999999999999988888666555444433321100        


Q ss_pred             hhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          347 NKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                  ...+..+++++.+|+.+||+.||++|||+.|+++
T Consensus       232 ----------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         232 ----------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ----------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                        0111237889999999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=383.42  Aligned_cols=245  Identities=18%  Similarity=0.299  Sum_probs=195.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCc----EEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNE----RCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      ..++|+++++||+|+||+||+|.+..+|+    .||+|.++..    ..+.+.+|+.+++++ +|||||+++|+|.+   
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~---   82 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLT---   82 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEES---
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---
Confidence            35679999999999999999999888876    5888887532    346799999999999 99999999999975   


Q ss_pred             CccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ...++++||+.++++...+    ..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~~kl~DFGla~~~  161 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLL  161 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCCSHHHHT
T ss_pred             CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CCeEeeccccceec
Confidence            3467899999999887654    468999999999999999999999999999999999999988 89999999999876


Q ss_pred             cCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          271 HPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       271 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ......   ....||..|+|||++.+ ..++.++|||||||++|||+|++.|++.+.+..+....+.+...         
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~---------  231 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---------  231 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC---------
T ss_pred             ccccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            543332   23467899999999987 78999999999999999999944444455444443332222000         


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                                 ...+..+++++.+|+.+||+.||++|||+.|+++|
T Consensus       232 ---------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         232 ---------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             ---------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence                                       00112378999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-51  Score=381.32  Aligned_cols=249  Identities=20%  Similarity=0.308  Sum_probs=196.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.++||+|+||+||+|.+..     +++.||||+++..    ..+.+.+|..++.++.+|+||+.+++++..+ 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-   89 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-   89 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence            35789999999999999999998754     4568999998643    2356778889998887899999999988654 


Q ss_pred             CCccEEEEEecCCCChhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP-------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH  254 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~-------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~  254 (419)
                      ....++||||+++|+|..++.                   .+++..+..++.|++.||+|||++|||||||||+|||++.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence            356789999999999988762                   3789999999999999999999999999999999999998


Q ss_pred             CCCcEEEEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014762          255 ELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLV  331 (419)
Q Consensus       255 ~~~~~kl~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~  331 (419)
                      + +.+||+|||+|+.......   .....||+.|+|||++.+ ..++.++|||||||++|||++|..|++.+.+..+.+.
T Consensus       170 ~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~  247 (299)
T d1ywna1         170 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  247 (299)
T ss_dssp             G-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred             C-CcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            8 8899999999986644332   234578999999999987 7899999999999999999998765555555544444


Q ss_pred             HHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          332 KIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       332 ~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      .....-..                                   ...+..+++++.+||.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         248 RRLKEGTR-----------------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHTCC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCC-----------------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33321100                                   01112378999999999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-51  Score=376.85  Aligned_cols=243  Identities=21%  Similarity=0.377  Sum_probs=189.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCC---cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      .++|++.+.||+|+||+||+|.+..++   ..||||.++..    ..+.+.+|+.+++++ +||||+++++++.+   ..
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---SS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---Ce
Confidence            578999999999999999999886543   46889988643    235688999999999 99999999999953   56


Q ss_pred             cEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccC
Q 014762          197 PSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  272 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~  272 (419)
                      .++||||+++|++..++    ..+++..+..++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+|+....
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMED  160 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC---------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchhheeccC
Confidence            78999999999998764    358999999999999999999999999999999999999988 8999999999987654


Q ss_pred             CCc--ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhc
Q 014762          273 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKY  349 (419)
Q Consensus       273 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~  349 (419)
                      ...  .....+|+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+.+...           
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~-~~~~~~~~~~~i~~~~~-----------  227 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGER-----------  227 (273)
T ss_dssp             ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTTCC-----------
T ss_pred             CcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCC-----------
Confidence            332  234567889999999987 789999999999999999998 66665 44444444443322100           


Q ss_pred             CCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          350 HLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                               ...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       228 -------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         228 -------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                     01122478999999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=381.74  Aligned_cols=256  Identities=23%  Similarity=0.396  Sum_probs=206.4

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEc---CCCcEEEEEEecCc-------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINV---NTNERCIIKILKPV-------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      .++|+++++||+|+||+||+|.+.   .+|+.||||+++..       ..+.+.+|+.+++++.+||||+++++++.+. 
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-  101 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-  101 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-
Confidence            477999999999999999999874   47899999998632       2456889999999995558999999999665 


Q ss_pred             CCccEEEEEecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          194 SKTPSLIFEYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                       ...+++|||+.+++|..++   ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus       102 -~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         102 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEF  179 (322)
T ss_dssp             -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred             -CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccchhhh
Confidence             6788999999999998876   568899999999999999999999999999999999999988 89999999999876


Q ss_pred             cCCC--cceeecccccccccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHh
Q 014762          271 HPGK--EYNVRVASRYFKGPELLVDL-QDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLN  347 (419)
Q Consensus       271 ~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~  347 (419)
                      ....  ......|++.|++||.+.+. ..++.++|||||||+||+|++|+.||... +..+....+.+...         
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~-~~~~~~~~i~~~~~---------  249 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD-GEKNSQAEISRRIL---------  249 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT-TSCCCHHHHHHHHH---------
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhcc---------
Confidence            4332  23456789999999999753 35788999999999999999999998543 22222222221100         


Q ss_pred             hcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCC-----CHHHHhcCCCccccc
Q 014762          348 KYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRL-----TAREAMVISSISPIF  416 (419)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~  416 (419)
                      ..                        ....+..+++++.+||.+||++||++||     ||+|+++||||+++.
T Consensus       250 ~~------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         250 KS------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             HC------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             cC------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            00                        0001123799999999999999999999     599999999998864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.1e-51  Score=381.30  Aligned_cols=251  Identities=18%  Similarity=0.291  Sum_probs=205.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      .+++|+++++||+|+||+||+|++.     .+++.||||+++...    .+.+.+|+.+++++ +||||++++++|..  
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~--   87 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV--   87 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeecc--
Confidence            3678999999999999999999865     356789999996432    45789999999999 99999999999955  


Q ss_pred             CCccEEEEEecCCCChhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCC
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP---------------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVK  246 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---------------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk  246 (419)
                      ....+++|||+++|+|..++.                           .+++..+..++.|++.||+|||+++|||||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            467889999999999988762                           37888999999999999999999999999999


Q ss_pred             CCceEEcCCCCcEEEEecccceeccCCC---cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 014762          247 PHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYG  323 (419)
Q Consensus       247 ~~NILl~~~~~~~kl~Dfgla~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~  323 (419)
                      |+|||++.+ +.+||+|||+|+......   ......+++.|+|||.+.+ ..++.++|||||||++|||++|..|++.+
T Consensus       168 p~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         168 TRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             GGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence            999999988 789999999997654332   2234578889999999987 78999999999999999999998766566


Q ss_pred             CCCHHHHHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCH
Q 014762          324 HDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTA  403 (419)
Q Consensus       324 ~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta  403 (419)
                      .+..+....+.+...                                    ...+..+++++.+||.+||+.||++|||+
T Consensus       246 ~~~~e~~~~v~~~~~------------------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~  289 (301)
T d1lufa_         246 MAHEEVIYYVRDGNI------------------------------------LACPENCPLELYNLMRLCWSKLPADRPSF  289 (301)
T ss_dssp             SCHHHHHHHHHTTCC------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCHHHHHHHHHcCCC------------------------------------CCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence            555554444322100                                    00122478999999999999999999999


Q ss_pred             HHHhcCCCccccc
Q 014762          404 REAMVISSISPIF  416 (419)
Q Consensus       404 ~elL~hp~f~~~~  416 (419)
                      .|+++  +|+.+.
T Consensus       290 ~ev~~--~L~~i~  300 (301)
T d1lufa_         290 CSIHR--ILQRMC  300 (301)
T ss_dssp             HHHHH--HHHHTT
T ss_pred             HHHHH--HHHHhc
Confidence            99976  555543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-51  Score=382.78  Aligned_cols=247  Identities=18%  Similarity=0.302  Sum_probs=202.5

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcE--EEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNER--CIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKT  196 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~  196 (419)
                      +-++|++.++||+|+||+||+|.+..+|..  ||||.++..    ..+.+.+|+.+|.++.+||||++++++|.+.  ..
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~   85 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY   85 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--Ce
Confidence            457899999999999999999999888875  677877532    3457899999999986799999999999764  67


Q ss_pred             cEEEEEecCCCChhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCC
Q 014762          197 PSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELR  257 (419)
Q Consensus       197 ~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~  257 (419)
                      .++||||+++|+|..++                   ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~-~  164 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-Y  164 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-G
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC-C
Confidence            89999999999998876                   348999999999999999999999999999999999999988 7


Q ss_pred             cEEEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHc
Q 014762          258 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL  337 (419)
Q Consensus       258 ~~kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~l  337 (419)
                      .+||+|||+++............+|..|+|||.+.+ ..++.++|||||||++|||++|..|++.+.+..+....+.+. 
T Consensus       165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-  242 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-  242 (309)
T ss_dssp             CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-
T ss_pred             ceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-
Confidence            899999999986654444455678999999999987 789999999999999999999887766655544433322110 


Q ss_pred             CCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                 .                        ..+.+..+++++.+||.+||+.||++|||+.|++++
T Consensus       243 -----------~------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 -----------Y------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -----------C------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------C------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                       0                        001122378999999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=369.50  Aligned_cols=247  Identities=16%  Similarity=0.313  Sum_probs=194.6

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc-hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK-KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ..++|++.++||+|+||+||+|.+  .|..||||+++... .+.+.+|+.+++++ +||||++++|+|.+.. ..+++||
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~-~~~~lv~   80 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GGLYIVT   80 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecC-CcEEEEE
Confidence            356799999999999999999986  57899999997543 57799999999999 9999999999985432 4578999


Q ss_pred             EecCCCChhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc
Q 014762          202 EYVNSTDFKVLYP-----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY  276 (419)
Q Consensus       202 e~~~~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~  276 (419)
                      ||+++|+|..++.     .+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||+++.....  .
T Consensus        81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~~--~  157 (262)
T d1byga_          81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST--Q  157 (262)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----------
T ss_pred             eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-CCEeecccccceecCCC--C
Confidence            9999999998863     38999999999999999999999999999999999999988 88999999999865432  3


Q ss_pred             eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCCCChh
Q 014762          277 NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLELDPQ  356 (419)
Q Consensus       277 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~~~~~  356 (419)
                      ....++..|+|||++.+ ..++.++|||||||++|||++++.|++.+.+..+....+.+.            .       
T Consensus       158 ~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~------------~-------  217 (262)
T d1byga_         158 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------Y-------  217 (262)
T ss_dssp             ----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT------------C-------
T ss_pred             ccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------------C-------
Confidence            34567889999999987 789999999999999999999544444444444333332110            0       


Q ss_pred             hHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcCCCcccc
Q 014762          357 LDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVISSISPI  415 (419)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~hp~f~~~  415 (419)
                                       ..+....+++++.+||++||..||++|||+.++++  +|+.+
T Consensus       218 -----------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~--~L~~i  257 (262)
T d1byga_         218 -----------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE--QLEHI  257 (262)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             -----------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH--HHHHH
Confidence                             00112237899999999999999999999999988  45544

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=368.02  Aligned_cols=243  Identities=19%  Similarity=0.289  Sum_probs=190.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCC-C--cEEEEEEecCc------chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCC
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNT-N--ERCIIKILKPV------KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHS  194 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~--~~vavK~~~~~------~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~  194 (419)
                      .++|++.+.||+|+||+||+|+...+ +  ..||||++++.      ..+.+.+|+.+|+++ +||||++++|+|.+   
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~---   82 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT---   82 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee---
Confidence            56799999999999999999986433 3  36899988632      235789999999999 99999999999954   


Q ss_pred             CccEEEEEecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          195 KTPSLIFEYVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       195 ~~~~lv~e~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      ...++||||++++++...+    ..+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus        83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~~~~  161 (273)
T d1u46a_          83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRAL  161 (273)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEEC
T ss_pred             cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhhhhc
Confidence            3568999999999987765    459999999999999999999999999999999999999988 79999999999987


Q ss_pred             cCCCcc----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHcCCchHHHH
Q 014762          271 HPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIF-RKEPFFYGHDNHDQLVKIAKVLGTDELNAY  345 (419)
Q Consensus       271 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~-g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~  345 (419)
                      ......    ....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+. +       
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf-~~~~~~~~~~~i~~~-~-------  231 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKE-G-------  231 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTS-C-------
T ss_pred             ccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCC-CCcCHHHHHHHHHhC-C-------
Confidence            544332    22356778999999987 789999999999999999998 78887 444444444433221 0       


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                 ...+....+++++.+||.+||+.||++|||+.|+++
T Consensus       232 ---------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         232 ---------------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             ---------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                       000112347899999999999999999999999974

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-49  Score=369.51  Aligned_cols=247  Identities=21%  Similarity=0.326  Sum_probs=207.4

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEc-----CCCcEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINV-----NTNERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      ..++|++.++||+|+||.||+|++.     .+++.||||+++..    ....+.+|+.+++++.+|||||+++++|.+. 
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-   99 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-   99 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-
Confidence            4579999999999999999999853     46778999999753    2356889999999997799999999999554 


Q ss_pred             CCccEEEEEecCCCChhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE
Q 014762          194 SKTPSLIFEYVNSTDFKVLYP---------------------TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~~---------------------~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl  252 (419)
                       ...++||||+++|++..++.                     .+++..+..++.||+.||+|||++++|||||||+|||+
T Consensus       100 -~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         100 -GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (311)
T ss_dssp             -SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             -CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence             66889999999999988752                     48899999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecccceeccCCCcc---eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 014762          253 DHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (419)
Q Consensus       253 ~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~  329 (419)
                      +.+ +.+|++|||+++........   ....+|+.|+|||++.+ ..++.++|||||||++|||++++.|++.+.+..+.
T Consensus       179 ~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         179 THG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             ETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             ccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            988 89999999999876543322   33578899999999987 78999999999999999999987787777776666


Q ss_pred             HHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       330 ~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      +.++.+.--.                                   ...+..+++++.+||.+||+.||++|||++++++
T Consensus       257 ~~~~i~~~~~-----------------------------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFR-----------------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCC-----------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCC-----------------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6655432100                                   0111237899999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=372.08  Aligned_cols=252  Identities=17%  Similarity=0.291  Sum_probs=208.3

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcC-----CCcEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEccC
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVN-----TNERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRDQH  193 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~  193 (419)
                      +.++|++.++||+|+||+||+|.+..     ++..||||+++...    ...+.+|+.+++++ +||||++++++|..  
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~--   94 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--   94 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEec--
Confidence            35789999999999999999998753     45789999997432    24588999999999 89999999999954  


Q ss_pred             CCccEEEEEecCCCChhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEE
Q 014762          194 SKTPSLIFEYVNSTDFKVLY-------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLR  260 (419)
Q Consensus       194 ~~~~~lv~e~~~~~~l~~~~-------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~k  260 (419)
                      ....++||||+.+|++..++             ..+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+|
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~-~~~K  173 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVK  173 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC-ceEE
Confidence            46788999999999998875             236888999999999999999999999999999999999988 8999


Q ss_pred             EEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHc
Q 014762          261 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVL  337 (419)
Q Consensus       261 l~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~l  337 (419)
                      |+|||+++.......   .....+|+.|+|||.+.+ ..++.++|||||||++|||++|..|++.+.+..+.+..+.+..
T Consensus       174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~  252 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG  252 (308)
T ss_dssp             ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             EeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence            999999986643322   233467899999999987 7899999999999999999999766666666655555443210


Q ss_pred             CCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc------CCC
Q 014762          338 GTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV------ISS  411 (419)
Q Consensus       338 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~------hp~  411 (419)
                      .                                    .+.+..+++.+.++|.+||+.||++|||++++++      +|+
T Consensus       253 ~------------------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         253 L------------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             C------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             C------------------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            0                                    0011237899999999999999999999999998      888


Q ss_pred             cccc
Q 014762          412 ISPI  415 (419)
Q Consensus       412 f~~~  415 (419)
                      |+++
T Consensus       297 ~~~~  300 (308)
T d1p4oa_         297 FREV  300 (308)
T ss_dssp             HHHH
T ss_pred             CcCC
Confidence            8764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=369.61  Aligned_cols=246  Identities=18%  Similarity=0.316  Sum_probs=195.0

Q ss_pred             CCCCeEEEeeeeeeCceEEEEEEEcCCC-------cEEEEEEecCcc----hHHHHHHHHHHHHhcCCCCeeEEEeEEEc
Q 014762          123 DQDDYEVVRKVGRGKYSEVFEGINVNTN-------ERCIIKILKPVK----KKKIKREIKILQNLCGGPNVVKLLDIVRD  191 (419)
Q Consensus       123 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-------~~vavK~~~~~~----~~~~~~E~~~l~~l~~h~niv~l~~~~~~  191 (419)
                      ..++|++.+.||+|+||.||+|++..++       ..||||+++...    ..++.+|+..+.++.+|||||+++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            4678999999999999999999876554       479999996432    35678899999998789999999999965


Q ss_pred             cCCCccEEEEEecCCCChhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEE
Q 014762          192 QHSKTPSLIFEYVNSTDFKVLY-------------------PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMI  252 (419)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~~-------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl  252 (419)
                      +  ...++||||+++|++..++                   ..+++..+..++.|++.||+|||+++||||||||+|||+
T Consensus        91 ~--~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          91 D--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             S--SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             C--CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            4  6788999999999998886                   247999999999999999999999999999999999999


Q ss_pred             cCCCCcEEEEecccceeccCCCc---ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 014762          253 DHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ  329 (419)
Q Consensus       253 ~~~~~~~kl~Dfgla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~  329 (419)
                      +.+ +.+||+|||+++.......   .....+++.|+|||++.+ +.|+.++|||||||++|||++++.|++.+.+..+.
T Consensus       169 ~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         169 TED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             CTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             cCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            988 8899999999987654332   233578889999999987 78999999999999999999854444444443332


Q ss_pred             HHHHHHHcCCchHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          330 LVKIAKVLGTDELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       330 ~~~i~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ...+.+  |.                                  ..+.+..+++++.+||.+||+.||++|||+.|+++
T Consensus       247 ~~~i~~--~~----------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKE--GH----------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHT--TC----------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHc--CC----------------------------------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            222211  00                                  00112247899999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=367.04  Aligned_cols=241  Identities=20%  Similarity=0.329  Sum_probs=192.6

Q ss_pred             EEeeeeeeCceEEEEEEEcCCC---cEEEEEEecCc----chHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          129 VVRKVGRGKYSEVFEGINVNTN---ERCIIKILKPV----KKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       129 ~~~~lG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      +.++||+|+||+||+|.+..++   ..||||.++..    ..+++.+|+++|+++ +||||++++|++... ....++||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~lv~  108 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSPLVVL  108 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEET-TTEEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEec-CCceEEEE
Confidence            3578999999999999976643   36899998642    236789999999999 899999999998653 35678999


Q ss_pred             EecCCCChhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecccceeccCCCcc-
Q 014762          202 EYVNSTDFKVLYP----TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY-  276 (419)
Q Consensus       202 e~~~~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~~~~~~~-  276 (419)
                      ||++++++..++.    .+++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||+++........ 
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCCC
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-CCEEEecccchhhcccccccc
Confidence            9999999988763    46788899999999999999999999999999999999988 88999999999876543221 


Q ss_pred             ----eeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCchHHHHHhhcCCC
Q 014762          277 ----NVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDELNAYLNKYHLE  352 (419)
Q Consensus       277 ----~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~~~~~~~~~~~~~  352 (419)
                          ....||..|+|||++.+ ..++.++||||||+++|||++|+.||+...+..+....+.+  |.             
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~-------------  251 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GR-------------  251 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TC-------------
T ss_pred             ceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CC-------------
Confidence                22467889999999887 78999999999999999999999998655444333332221  00             


Q ss_pred             CChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          353 LDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                                   +        ...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       252 -------------~--------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         252 -------------R--------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             -------------C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------C--------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                         0        01112478899999999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.7e-48  Score=370.51  Aligned_cols=289  Identities=23%  Similarity=0.356  Sum_probs=212.5

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc--hHHHHHHHHHHHHhc----------CCCCeeEEEeEEEc
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK--KKKIKREIKILQNLC----------GGPNVVKLLDIVRD  191 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~----------~h~niv~l~~~~~~  191 (419)
                      .++|+++++||+|+||+||+|++..+|+.||||+++...  .+.+.+|+.+++.+.          +|+||+++++++..
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            357999999999999999999999999999999997543  366788999998872          36889999999876


Q ss_pred             cCCCccEEEEEecCCCChhhh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeecCCCCceEEcCCCC-----cE
Q 014762          192 QHSKTPSLIFEYVNSTDFKVL------YPTLTDYDIRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHELR-----KL  259 (419)
Q Consensus       192 ~~~~~~~lv~e~~~~~~l~~~------~~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlk~~NILl~~~~~-----~~  259 (419)
                      ......+++++++........      ...+++..++.++.|++.||+|||+ .||+||||||+|||++.+..     .+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence            655667778877755542221      1468999999999999999999998 89999999999999986522     48


Q ss_pred             EEEecccceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHHHH
Q 014762          260 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGH-----DNHDQLVKIA  334 (419)
Q Consensus       260 kl~Dfgla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~-----~~~~~~~~i~  334 (419)
                      +++|||.+....  .......||+.|+|||++.+ ..++.++||||+||++++|++|+.||....     ...+.+....
T Consensus       172 kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~  248 (362)
T d1q8ya_         172 KIADLGNACWYD--EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  248 (362)
T ss_dssp             EECCCTTCEETT--BCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             eEeecccccccc--cccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence            999999997654  23345689999999999987 789999999999999999999999985322     2345667778


Q ss_pred             HHcCCchHHHHHhhcCCCCChhhHHhhccC---CCCCcccccc--ccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhcC
Q 014762          335 KVLGTDELNAYLNKYHLELDPQLDALVGRH---SRKPWSKFIN--ADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMVI  409 (419)
Q Consensus       335 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~h  409 (419)
                      ..+|..+.......................   ....+.....  .......++++.|||.+||++||++||||+|+|+|
T Consensus       249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            888876554432211000000000000000   0001111010  01112246789999999999999999999999999


Q ss_pred             CCcccc
Q 014762          410 SSISPI  415 (419)
Q Consensus       410 p~f~~~  415 (419)
                      |||+++
T Consensus       329 p~f~~~  334 (362)
T d1q8ya_         329 PWLKDT  334 (362)
T ss_dssp             GGGTTC
T ss_pred             cccCCC
Confidence            999965

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-47  Score=357.25  Aligned_cols=253  Identities=16%  Similarity=0.220  Sum_probs=193.9

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhcCCCC-eeEEEeEEEccCCCccEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLCGGPN-VVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~h~n-iv~l~~~~~~~~~~~~~lv~  201 (419)
                      .++|++.+.||+|+||+||+|++..+|+.||||++... ..+++.+|+.+++.+ +|+| |+.+.+++.+  ....++||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l-~~~~~i~~~~~~~~~--~~~~~ivm   82 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE--GDYNVMVM   82 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHS-TTSTTCCCEEEEEEE--TTEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHc-cCCCcccEEEEEEec--CCEEEEEE
Confidence            46899999999999999999999999999999998643 346788999999999 5555 5555555543  36778999


Q ss_pred             EecCCCChhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC--CCcEEEEecccceeccCCCc-
Q 014762          202 EYVNSTDFKVLY---PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--LRKLRLIDWGLAEFYHPGKE-  275 (419)
Q Consensus       202 e~~~~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~--~~~~kl~Dfgla~~~~~~~~-  275 (419)
                      ||++++......   ..+++..+..++.|++.||+|||++||+||||||+|||++..  ...+||+|||+|+....... 
T Consensus        83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            999776555443   569999999999999999999999999999999999998643  35799999999987654322 


Q ss_pred             -------ceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcC---CchHHHH
Q 014762          276 -------YNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLG---TDELNAY  345 (419)
Q Consensus       276 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg---~~~~~~~  345 (419)
                             .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+....+.....   ..+..  
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~--  238 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLK-AATKRQKYERISEKKMSTPIE--  238 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHSCHH--
T ss_pred             cceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccc-hHHHHHHHHHhhcccCCCChh--
Confidence                   233479999999999987 789999999999999999999999985332 2222211111100   00000  


Q ss_pred             HhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHH---HhcCCCcc
Q 014762          346 LNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTARE---AMVISSIS  413 (419)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e---lL~hp~f~  413 (419)
                                                    .....+++++.+||.+||+.||++|||+.+   +|+|+|.+
T Consensus       239 ------------------------------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         239 ------------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             ------------------------------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ------------------------------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence                                          001237899999999999999999999874   46776654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=359.68  Aligned_cols=264  Identities=18%  Similarity=0.203  Sum_probs=191.3

Q ss_pred             CCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHH--HHhcCCCCeeEEEeEEEccCC--CccEEE
Q 014762          125 DDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVKKKKIKREIKIL--QNLCGGPNVVKLLDIVRDQHS--KTPSLI  200 (419)
Q Consensus       125 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l--~~l~~h~niv~l~~~~~~~~~--~~~~lv  200 (419)
                      .+|.+.++||+|+||+||+|++  +|+.||||+++....+.+.+|.+++  ..+ +||||+++++++.++..  ..+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEE
Confidence            4688999999999999999975  6899999999876666665665554  456 89999999999976543  357899


Q ss_pred             EEecCCCChhhhcC--CCCHHHHHHHHHHHHHHHHHHHH--------CCcEeecCCCCceEEcCCCCcEEEEecccceec
Q 014762          201 FEYVNSTDFKVLYP--TLTDYDIRYYIYELLKALDYCHS--------QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  270 (419)
Q Consensus       201 ~e~~~~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~LH~--------~~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~~  270 (419)
                      |||+++|+|..++.  .+++..+..++.|++.||+|||+        +||+||||||+|||++.+ +.+||+|||+++..
T Consensus        80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCCTTCEEE
T ss_pred             EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEecCccccc
Confidence            99999999999884  68999999999999999999996        599999999999999988 89999999999877


Q ss_pred             cCCCc-----ceeecccccccccccccCCC-----CCCccccHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHcCCc
Q 014762          271 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD  340 (419)
Q Consensus       271 ~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~~~~~~~i~~~lg~~  340 (419)
                      .....     .....||+.|+|||++.+..     .++.++|||||||++|||++|..||............+  .....
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~--~~~~~  236 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL--VPSDP  236 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT--SCSSC
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc--ccccc
Confidence            54432     23457899999999986521     25678999999999999999988774322111000000  00000


Q ss_pred             hHHHHHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          341 ELNAYLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                      ......           ........+.....   .........++.+|+.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~-----------~~~~~~~~~p~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         237 SVEEMR-----------KVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             CHHHHH-----------HHHTTSCCCCCCCG---GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             hHHHHH-----------HHHhccccCCCCCc---ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            000000           00000000000000   0001113356889999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2e-45  Score=343.38  Aligned_cols=249  Identities=15%  Similarity=0.245  Sum_probs=197.7

Q ss_pred             CCCeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          124 QDDYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       124 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .++|++.++||+|+||+||+|++..+|+.||||+++. ...+.+.+|+.+++.+.+|+|++.+++++...  ...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--LHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--TEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecC--CccEEEEE
Confidence            4689999999999999999999999999999999854 34466889999999996669999999999654  67889999


Q ss_pred             ecCCCChhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCC----CCcEEEEecccceeccCCC
Q 014762          203 YVNSTDFKVLY----PTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----LRKLRLIDWGLAEFYHPGK  274 (419)
Q Consensus       203 ~~~~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~----~~~~kl~Dfgla~~~~~~~  274 (419)
                      |++ +++..++    ..++...+..++.|++.||+|||++||+||||||+|||++.+    .+.+||+|||+|+......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          82 LLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            995 5655554    468999999999999999999999999999999999999742    3679999999998764321


Q ss_pred             --------cceeecccccccccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHcCCchHHH
Q 014762          275 --------EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDN--HDQLVKIAKVLGTDELNA  344 (419)
Q Consensus       275 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l~ell~g~~pf~~~~~~--~~~~~~i~~~lg~~~~~~  344 (419)
                              ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  .+....+.......+...
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  239 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence                    1233579999999999987 78999999999999999999999999533222  222222222110011110


Q ss_pred             HHhhcCCCCChhhHHhhccCCCCCccccccccccCCCCHHHHHHHHHhcCCCCCCCCCHHHHhc
Q 014762          345 YLNKYHLELDPQLDALVGRHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAREAMV  408 (419)
Q Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~elL~  408 (419)
                                                      ....+++++.+++..|+..+|++||+.+.+.+
T Consensus       240 --------------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         240 --------------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             --------------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             --------------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                                            01237889999999999999999999776644

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.8e-25  Score=194.11  Aligned_cols=167  Identities=18%  Similarity=0.217  Sum_probs=121.8

Q ss_pred             eEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---------------------hHHHHHHHHHHHHhcCCCCeeEE
Q 014762          127 YEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---------------------KKKIKREIKILQNLCGGPNVVKL  185 (419)
Q Consensus       127 y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~E~~~l~~l~~h~niv~l  185 (419)
                      +.+.++||+|+||+||+|.+ .+|+.||||+++...                     .....+|...+.++ .|.+++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence            46789999999999999987 478999999875311                     12345688899998 89999988


Q ss_pred             EeEEEccCCCccEEEEEecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeecCCCCceEEcCCCCcEEEEecc
Q 014762          186 LDIVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWG  265 (419)
Q Consensus       186 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk~~NILl~~~~~~~kl~Dfg  265 (419)
                      +++.  .    .+++|||+++..+..    ++......++.|++.+|+|||++||+||||||+|||++++  .++|+|||
T Consensus        80 ~~~~--~----~~lvme~~~~~~~~~----l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG  147 (191)
T d1zara2          80 YAWE--G----NAVLMELIDAKELYR----VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP  147 (191)
T ss_dssp             EEEE--T----TEEEEECCCCEEGGG----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred             EEec--C----CEEEEEeeccccccc----hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence            8764  2    269999999877653    4555667899999999999999999999999999999965  58999999


Q ss_pred             cceeccCCCcceeecccccccccccccCCCCCCccccHHHHHHHH
Q 014762          266 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF  310 (419)
Q Consensus       266 la~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG~~l  310 (419)
                      .|................. .-.+.+ . ..|+.++|+||..--+
T Consensus       148 ~a~~~~~~~~~~~l~rd~~-~~~~~f-~-r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         148 QSVEVGEEGWREILERDVR-NIITYF-S-RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TCEETTSTTHHHHHHHHHH-HHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred             CcccCCCCCcHHHHHHHHH-HHHHHH-c-CCCCCcccHHHHHHHH
Confidence            9976543322110000000 001112 2 5688999999976433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.47  E-value=7.4e-07  Score=78.82  Aligned_cols=137  Identities=18%  Similarity=0.219  Sum_probs=88.6

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCcc---hHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEEE
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPVK---KKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIFE  202 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e  202 (419)
                      .|+..+..+.++.+.||+..  .+++.+++|+.....   ...+.+|...+..+..+--+.+++.+..++  +..++||+
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv~~   90 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLLMS   90 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEEEE
Confidence            45555554445557899873  566677888876432   345788999999885554567788777544  56789999


Q ss_pred             ecCCCChhhhcCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 014762          203 YVNSTDFKVLYPTLTDYDIRYYIYELLKALDYCH----------------------------------------------  236 (419)
Q Consensus       203 ~~~~~~l~~~~~~l~~~~~~~~~~qi~~~L~~LH----------------------------------------------  236 (419)
                      +++|..+........  ....++.++...+..||                                              
T Consensus        91 ~l~G~~~~~~~~~~~--~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T d1j7la_          91 EADGVLCSEEYEDEQ--SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             CCSSEEHHHHTTTCS--CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHH
T ss_pred             ecccccccccccccc--cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHH
Confidence            999988755432211  11112222222222222                                              


Q ss_pred             -------HC------CcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          237 -------SQ------GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       237 -------~~------~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                             +.      .++|+|+.|.|||++.+ +.+-|+||+.+..
T Consensus       169 ~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~  213 (263)
T d1j7la_         169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhccc
Confidence                   11      37999999999999865 4556999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.10  E-value=1.2e-05  Score=70.32  Aligned_cols=134  Identities=17%  Similarity=0.114  Sum_probs=84.3

Q ss_pred             eeeeeCc-eEEEEEEEcCCCcEEEEEEecCcchHHHHHHHHHHHHhcCCC-CeeEEEeEEEccCCCccEEEEEecCCCCh
Q 014762          132 KVGRGKY-SEVFEGINVNTNERCIIKILKPVKKKKIKREIKILQNLCGGP-NVVKLLDIVRDQHSKTPSLIFEYVNSTDF  209 (419)
Q Consensus       132 ~lG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~~~~~l  209 (419)
                      .+..|.. +.||+.. ..++..+++|.........+.+|...++.+..+. .+.+++.+..++  ...++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeeecccc
Confidence            3444443 6789885 4567778899988777777889999998884332 256677776543  567899999988765


Q ss_pred             hhhc-----------------CCCC---------HHHHHHHH--------------------HHHHHHHHHHHHC-----
Q 014762          210 KVLY-----------------PTLT---------DYDIRYYI--------------------YELLKALDYCHSQ-----  238 (419)
Q Consensus       210 ~~~~-----------------~~l~---------~~~~~~~~--------------------~qi~~~L~~LH~~-----  238 (419)
                      ....                 ..++         ......-.                    ......+..+.+.     
T Consensus        94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             ccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            3321                 0000         00000000                    0011223334332     


Q ss_pred             --CcEeecCCCCceEEcCCCCcEEEEeccccee
Q 014762          239 --GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  269 (419)
Q Consensus       239 --~ivH~Dlk~~NILl~~~~~~~kl~Dfgla~~  269 (419)
                        .++|+|+.|.|||++.+ ..+-|+||+.+..
T Consensus       174 ~~~liHgD~~~~Nvl~~~~-~~~~iID~~~~~~  205 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENG-RFSGFIDCGRLGV  205 (255)
T ss_dssp             CEEEECSSCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred             CceEEeCCCCCcceEEeCC-ceEEEEEchhccc
Confidence              38999999999999876 5567999998754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.88  E-value=3.4e-05  Score=72.18  Aligned_cols=75  Identities=16%  Similarity=0.174  Sum_probs=49.3

Q ss_pred             EeeeeeeCceEEEEEEEcCCCcEEEEEEecCc----------chHHHHHHHHHHHHhcCC--CCeeEEEeEEEccCCCcc
Q 014762          130 VRKVGRGKYSEVFEGINVNTNERCIIKILKPV----------KKKKIKREIKILQNLCGG--PNVVKLLDIVRDQHSKTP  197 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~E~~~l~~l~~h--~niv~l~~~~~~~~~~~~  197 (419)
                      .+.||.|....||+..+..+++.+++|.-.+.          ..++..+|...|..+..+  ..+.+++.+.  +  ...
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~--~~~  106 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T--EMA  106 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T--TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--C--CCC
Confidence            45689999999999987777888999975431          224566788888877443  2455666554  3  234


Q ss_pred             EEEEEecCCCC
Q 014762          198 SLIFEYVNSTD  208 (419)
Q Consensus       198 ~lv~e~~~~~~  208 (419)
                      ++|||++++..
T Consensus       107 ~lvmE~L~~~~  117 (392)
T d2pula1         107 VTVMEDLSHLK  117 (392)
T ss_dssp             EEEECCCTTSE
T ss_pred             EEEEeccCCcc
Confidence            68999997653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.13  E-value=0.00026  Score=64.13  Aligned_cols=67  Identities=16%  Similarity=0.254  Sum_probs=43.3

Q ss_pred             eEEEEEEEcCCCcEEEEEEecCc--chHHHHHHHHHHHHhcCCC-CeeEEEe-----EEEccCCCccEEEEEecCCCC
Q 014762          139 SEVFEGINVNTNERCIIKILKPV--KKKKIKREIKILQNLCGGP-NVVKLLD-----IVRDQHSKTPSLIFEYVNSTD  208 (419)
Q Consensus       139 g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~h~-niv~l~~-----~~~~~~~~~~~lv~e~~~~~~  208 (419)
                      -.||++. ..+|+.+++|+..+.  ..+++..|...+..|..+. -++..+.     .+  ......+.+++++.|..
T Consensus        36 N~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~--~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL--NHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE--EETTEEEEEEECCCCEE
T ss_pred             ceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeee--eeeeEEEEEEeecCCcC
Confidence            5799985 467888999999875  4577889999998884221 1111111     11  12245677888887654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.11  E-value=0.00089  Score=62.20  Aligned_cols=74  Identities=15%  Similarity=0.178  Sum_probs=51.9

Q ss_pred             EeeeeeeCceEEEEEEEcC-------CCcEEEEEEecC-cchHHHHHHHHHHHHhcCCCCeeEEEeEEEccCCCccEEEE
Q 014762          130 VRKVGRGKYSEVFEGINVN-------TNERCIIKILKP-VKKKKIKREIKILQNLCGGPNVVKLLDIVRDQHSKTPSLIF  201 (419)
Q Consensus       130 ~~~lG~G~fg~V~~~~~~~-------~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~  201 (419)
                      ++.|+.|-.-.+|++....       ..+.|++++... ...-...+|..+++.+..+.-..++++++.+      .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------ceEE
Confidence            4568888889999987543       245677887653 2234466899999988665545688888832      3899


Q ss_pred             EecCCCCh
Q 014762          202 EYVNSTDF  209 (419)
Q Consensus       202 e~~~~~~l  209 (419)
                      ||++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.44  E-value=0.0015  Score=58.45  Aligned_cols=50  Identities=12%  Similarity=0.191  Sum_probs=32.2

Q ss_pred             CeEEEeeeeeeCceEEEEEEEcCCCcEEEEEEecCc-chHHHHHHHHHHHHhc
Q 014762          126 DYEVVRKVGRGKYSEVFEGINVNTNERCIIKILKPV-KKKKIKREIKILQNLC  177 (419)
Q Consensus       126 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~  177 (419)
                      +..-.+.|..|---+.|+... .+| .+++|++... ..+.+..|+.++..|.
T Consensus        19 ~~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1          19 SLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             CEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred             CceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence            344456677787788999853 344 5899998653 4567788888888883